PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhao, W; Zhang, LN; Wang, XL; Zhang, J; Yu, HX				Zhao, Wei; Zhang, Le-Ning; Wang, Xiao-Long; Zhang, Ji; Yu, Hai-Xiang			Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1	FASEB JOURNAL			English	Article						TAZ; YAP1; proliferation; apoptosis	E-CADHERIN; POOR-PROGNOSIS; DOWN-REGULATION; PROGRESSION; EXPRESSION; CONTRIBUTES; PROMOTES; METASTASIS; OVEREXPRESSION; PROLIFERATION	Metastatic growth is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC). Metastasis is believed to be initiated by an increase in cell motility mediated by the loss of cell-cell adhesion because of the suppression of E-cadherin [encoded by cadherin 1 (CDH1)]. However, very little is known about the molecular mechanism of CDH1 regulation. Therefore, we hypothesized that non-small cell lung cancerassociated transcript-1 (NSCLCAT1) suppresses functional CDH1 and mediates the Hippo signaling pathway, resulting in increased cell migration and invasion, and reduced apoptosis. Initially, microarray profiling and target prediction programs were employed to identify whether NSCLCAT1 targets CDH1. Next, quantitative PCR was used to determine the expression pattern of NSCLCAT1 in 114 specimens. The biologic functions of NSCLCAT1 in NSCLC were assessed through the up-regulation and down-regulation of the levels of endogenous NSCLCAT1 with the use of NSCLCAT1 vector or small interfering RNA against NSCLCAT1 in NSCLC cells. Furthermore, the Hippo signaling pathway in NSCLC cells was blocked by applying the verteporfin treatment to have a better understanding on the pivotal role of the Hippo signaling pathway in NSCLC. Microarray expression profiles of long noncoding RNAs, GSE19804 and GSE27262), revealed that NSCLCAT1 was up-regulated in NSCLC. Among patients with NSCLC, we determined that the NSCLCAT1 was robustly induced, whereas CDH1 was suppressed. The luciferase activity determination identified CDH1 as a NSCLCAT1 target. NSCLCAT1 was found to increase cell viability, migration, and invasion and to reduce apoptosis in NSCLC cells. The results from the quantitative PCR and Western blot analysis revealed that NSCLCAT1 modulated the Hippo signaling pathway. Furthermore, the inhibition of the Hippo signaling pathway by verteporfin treatment led to the loss of the effect of NSCLCAT1 on NSCLC cells. In summary, our findings suggested that NSCLCAT1 potentially has a role in NSCLC and NSCLCAT1-mediated regulation of the Hippo signaling pathway through the transcriptional repression of CDH1; therefore, the functional suppression or inhibition of NSCLCAT1 could be used as a novel therapeutic pathway in the control of aggressive and metastatic NSCLC.Zhao, W., Zhang, L.-N., Wang, X.-L., Zhang, J., Yu, H.-X. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.	[Zhao, Wei; Zhang, Le-Ning; Wang, Xiao-Long; Zhang, Ji; Yu, Hai-Xiang] Jilin Univ, Dept Thorac Surg, China Japan Union Hosp, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China	Jilin University	Yu, HX (corresponding author), Jilin Univ, Dept Thorac Surg, China Japan Union Hosp, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China.	yu_haixiang1980@yeah.net						Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Cai Q, 2017, ONCOTARGET, V8, P47957, DOI 10.18632/oncotarget.18204; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Cui JD, 2015, INT J CLIN EXP PATHO, V8, P12400; Cui Y, 2017, ONCOTARGET, V8, P17785, DOI 10.18632/oncotarget.14854; Ding X, 2017, CLIN TRANSL ONCOL, V19, P546, DOI 10.1007/s12094-016-1562-5; Fujita A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-469; He R, 2017, BIOMED PHARMACOTHER, V95, P331, DOI 10.1016/j.biopha.2017.08.057; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Li XL, 2013, MED RES REV, V33, P517, DOI 10.1002/med.21254; Lin XY, 2014, TUMOR BIOL, V35, P6435, DOI 10.1007/s13277-014-1826-z; Ling ZQ, 2011, INT J MOL MED, V27, P625, DOI 10.3892/ijmm.2011.640; Liu XF, 2013, FEBS LETT, V587, P3995, DOI 10.1016/j.febslet.2013.10.036; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Nie W, 2016, CANCER LETT, V371, P99, DOI 10.1016/j.canlet.2015.11.024; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pilli T, 2017, THYROID, V27, P1053, DOI 10.1089/thy.2017.0035; Reardon SN, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.098871; Redis RS, 2013, ONCOTARGET, V4, P1748, DOI 10.18632/oncotarget.1292; Shi Q, 2017, CANCER BIOMARK, V20, P539, DOI 10.3233/CBM-170350; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song YM, 2015, EXP THER MED, V9, P1292, DOI 10.3892/etm.2015.2232; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xia ZX, 2016, EXP MOL PATHOL, V100, P353, DOI 10.1016/j.yexmp.2015.10.004; Xiao L, 2016, ONCOTARGET, V7, P40038, DOI 10.18632/oncotarget.9480; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Xu CM, 2013, CANCER GENE THER, V20, P453, DOI 10.1038/cgt.2013.40; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Xu WR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/278917; Yeung B, 2016, INT J CANCER, V138, P533, DOI 10.1002/ijc.29457; Yu QW, 2015, DRUG DES DEV THER, V9, P2171, DOI 10.2147/DDDT.S78537; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zang CS, 2016, ONCOTARGET, V7, P11696, DOI 10.18632/oncotarget.7077; Zhang HM, 2015, TUMOR BIOL, V36, P2947, DOI 10.1007/s13277-014-2925-6; Zhang M, 2016, BIOMED PHARMACOTHER, V80, P73, DOI 10.1016/j.biopha.2016.02.036; Zheng SY, 2012, ASIAN PAC J CANCER P, V13, P1557, DOI 10.7314/APJCP.2012.13.4.1557; Zheng XY, 2017, ONCOTARGET, V8, P78734, DOI 10.18632/oncotarget.20223; Zhou FZ, 2017, ONCOL REP, V38, P1857, DOI 10.3892/or.2017.5835; Zhou S, 2017, TUMOR BIOL, V39	43	17	17	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1151	1166		10.1096/fj.201800408R	http://dx.doi.org/10.1096/fj.201800408R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148675				2022-12-26	WOS:000457401500091
J	Qiu, RD; Zhang, J; Xiang, X				Qiu, Rongde; Zhang, Jun; Xiang, Xin			p25 of the dynactin complex plays a dual role in cargo binding and dynactin regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynein; kinesin; microtubule; molecular motor; cytoskeleton; Aspergillus; dynactin; endosome; intracellular transport; p25	ACTIN-RELATED PROTEIN; MICROTUBULE PLUS-END; DYNEIN HEAVY-CHAIN; EARLY-ENDOSOME INTERACTION; LONG-DISTANCE MOVEMENT; ASPERGILLUS-NIDULANS; CYTOPLASMIC DYNEIN; IN-VIVO; POINTED-END; ORGANELLE TRANSPORT	Cytoplasmic dynein binds its cargoes via the dynactin complex and cargo adapters, and the dynactin pointed-end protein p25 is required for dynein-dynactin binding to the early endosomal dynein adapter HookA (Hook in the fungus Aspergillus nidulans). However, it is unclear whether the HookA-dynein-dynactin interaction requires p27, another pointed-end protein forming heterodimers with p25 within vertebrate dynactin. Here, live-cell imaging and biochemical pulldown experiments revealed that although p27 is a component of the dynactin complex in A. nidulans, it is dispensable for dynein-dynactin to interact with C-HookA (cytosolic HookA lacking its early endosome-binding C terminus) and is not critical for dynein-mediated early endosome transport. Using mutagenesis, imaging, and biochemical approaches, we found that several p25 regions are required for the C-HookA-dynein-dynactin interaction, with the N terminus and loop1 being the most critical regions. Interestingly, p25 was also important for the microtubule (MT) plus-end accumulation of dynactin. This p25 function in dynactin localization also involved p25's N terminus and the loop1 critical for the C-HookA-dynein-dynactin interaction. Given that dynactin's MT plus-end localization does not require HookA and that the kinesin-1-dependent plus-end accumulation of dynactin is unnecessary for the C-HookA-dynein-dynactin interaction, our results indicate that p25 plays a dual role in cargo binding and dynactin regulation. As cargo adapters are implicated in dynein activation via binding to dynactin's pointed end to switch the conformation of p150, a major dynactin component, our results suggest p25 as a critical pointed-end protein involved in this process.	[Qiu, Rongde; Zhang, Jun; Xiang, Xin] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Xiang, X (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	xin.xiang@usuhs.edu		Qiu, Rongde/0000-0003-2078-9718	National Institutes of Health [RO1 GM097580, RO1 GM121850]; Uniformed Services University bridge grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097580, P01GM068087, R01GM121850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University bridge grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM097580 and RO1 GM121850 (to X. X.) and a Uniformed Services University bridge grant (to X. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Cheong FKY, 2014, MOL BIOL CELL, V25, P2171, DOI 10.1091/mbc.E14-03-0842; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Efimov VP, 2006, MOL BIOL CELL, V17, P2021, DOI 10.1091/mbc.E05-11-1084; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Grotjahn DA, 2018, NAT STRUCT MOL BIOL, V25, P203, DOI 10.1038/s41594-018-0027-7; Guo XL, 2016, P NATL ACAD SCI USA, V113, pE5318, DOI 10.1073/pnas.1601844113; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lee IH, 2001, MOL BIOL CELL, V12, P2195, DOI 10.1091/mbc.12.7.2195; Lee IG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03412-8; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li SH, 2005, MOL BIOL CELL, V16, P3591, DOI 10.1091/mbc.E04-12-1071; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Parisi G, 2004, FEBS LETT, V562, P1, DOI 10.1016/S0014-5793(04)00165-6; Penalva MA, 2017, MOL BIOL CELL, V28, P947, DOI 10.1091/mbc.E16-08-0566; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Qiu RD, 2013, J BIOL CHEM, V288, P2271, DOI 10.1074/jbc.M112.412403; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Reck-Peterson SL, 2018, NAT REV MOL CELL BIO, V19, P382, DOI 10.1038/s41580-018-0004-3; Riquelme M, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00068-17; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schroeder CM, 2016, J CELL BIOL, V214, P309, DOI 10.1083/jcb.201604002; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Steinberg G, 2018, FUNGAL KINGDOM, P231, DOI 10.1128/microbiolspec.FUNK-0034-2016; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Urnavicius L, 2018, NATURE, V554, P202, DOI 10.1038/nature25462; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wedlich-Soldner R, 2002, EMBO J, V21, P2946, DOI 10.1093/emboj/cdf296; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890; Xiang X, 2015, CELL MOL LIFE SCI, V72, P3267, DOI 10.1007/s00018-015-1926-y; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Yao XL, 2014, MOL BIOL CELL, V25, P2181, DOI 10.1091/mbc.E14-04-0873; Yao XL, 2012, TRAFFIC, V13, P375, DOI 10.1111/j.1600-0854.2011.01312.x; Yeh TY, 2013, EMBO J, V32, P1023, DOI 10.1038/emboj.2013.30; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; Zeng CJT, 2014, MOL MICROBIOL, V94, P506, DOI 10.1111/mmi.12792; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2008, TRAFFIC, V9, P1073, DOI 10.1111/j.1600-0854.2008.00748.x; Zhang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29818-4; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang J, 2013, CYTOSKELETON, V70, P215, DOI 10.1002/cm.21102; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zheng WJ, 2017, BIOCHEMISTRY-US, V56, P313, DOI 10.1021/acs.biochem.6b01002; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013	71	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15606	15619		10.1074/jbc.RA118.004000	http://dx.doi.org/10.1074/jbc.RA118.004000			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143531	hybrid, Green Published			2022-12-26	WOS:000446549200024
J	Langeslag, SJE				Langeslag, Sandra J. E.			Effects of organization and disorganization on pleasantness, calmness, and the frontal negativity in the event-related potential	PLOS ONE			English	Article							SYMMETRY; ERP	A preference for organization is associated with several disorders, but is widespread in the general population as well. It remains unclear whether organization and various degrees of disorganization elicit pleasant or unpleasant feelings (i.e., valence), calming or arousing feelings (i.e., arousal), and a frontal negativity in the event-related potential (ERP) related to cognitive control. This study tested how organization, slight disorganization, and total disorganization affect valence, arousal, and the frontal negativity. Participants passively viewed organized, slightly disorganized, totally disorganized, and control pictures while their electroencephalogram was recorded. They also rated the valence and arousal elicited by each picture and completed questionnaires assessing desire for order and organization behavior. Organized pictures made participants feel most pleasant, control pictures made participants feel less pleasant, slightly disorganized pictures made participants feel even less pleasant, and totally disorganized pictures made participants feel least pleasant. There were no significant effects on arousal. Totally disorganized pictures elicited a frontal negativity in the ERP between 200-2000 ms after stimulus onset, which might reflect inhibition of rearranging behavior. Individual differences in desire for order and organization behavior did not correlate with valence, arousal, or the frontal negativity. The current study design and findings could be a starting point for examining the differences between adaptive and maladaptive preferences for organization and aversions to disorganization.	[Langeslag, Sandra J. E.] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Langeslag, SJE (corresponding author), Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA.	langeslags@umsl.edu	Langeslag, Sandra/GRE-6148-2022					American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Borod J. C., 1993, NEUROPSYCHOLOGY, V7, P427; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bryden M. P., 1982, LATERALITY FUNCTIONA; de Vries FE, 2013, CNS SPECTRUMS, V18, P34, DOI 10.1017/S1092852912000703; Evans DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038966; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G., 2012, OXFORD HDB EVENT REL, P441, DOI 10.1093/oxfordhb/9780195374148.013.0222; Hofmann SG, 2008, CLIN PSYCHOL REV, V28, P1, DOI 10.1016/j.cpr.2007.09.003; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Kalat J., 2012, EMOTION; LeDoux J. E., 1996, EMOTIONAL BRAIN; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Radomsky AS, 2004, BEHAV RES THER, V42, P893, DOI 10.1016/j.brat.2003.07.001; Rodriguez NM, 2013, J INTELLECT DEV DIS, V38, P242, DOI 10.3109/13668250.2013.812192; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sari BA, 2017, COGNITION EMOTION, V31, P995, DOI 10.1080/02699931.2016.1170668; Shepherd K, 2011, PERCEPTION, V40, P1254, DOI 10.1068/p7057; Tullett AM, 2015, SOC COGN AFFECT NEUR, V10, P628, DOI 10.1093/scan/nsu097	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202726	10.1371/journal.pone.0202726	http://dx.doi.org/10.1371/journal.pone.0202726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161183	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900040
J	Meng, J; Chen, YPP				Meng, Jing; Chen, Yi-Ping Phoebe			A database of simulated tumor genomes towards accurate detection of somatic small variants in cancer	PLOS ONE			English	Article							MUTATION IDENTIFICATION; PERFORMANCE; SIGNATURES; REVEALS	Somatic mutations promote the transformation of normal cells to cancer. Accurate identification of such mutations facilitates cancer diagnosis and treatment, but biological and technological noises, including intra-tumor heterogeneity, sample contamination, uncertainties in base sequencing and read alignment, pose a big challenge to somatic mutation discovery. A number of callers have been developed to predict them from paired tumor/normal or unpaired tumor sequencing data. However, the small size of currently available experimentally validated somatic sites limits evaluation and then improvement of callers. Fortunately, NIST reference material NA12878 genome has been well-characterized with publicly available high-confidence genotype calls, and biological and technological noises can be computationally generalized to the number of sub-clones, the VAFs, the sequencing and mapping qualities. We used BAMSurgeon to create simulated tumors by introducing somatic small variants (SNVs and small indels) into homozygous reference or wildtype sites of NA12878. We generated 135 simulated tumors from 5 pre-tumors/normals. These simulated tumors vary in sequencing and subsequent mapping error profiles, read length, the number of subclones, the VAF, the mutation frequency across the genome and the genomic context. Furthermore, these pure tumor/normal pairs can be mixed at desired ratios within each pair to simulate sample contamination. This database (a total size of 15 terabytes) will be of great use to benchmark somatic small variant callers and guide their improvement.	[Meng, Jing; Chen, Yi-Ping Phoebe] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia	La Trobe University	Meng, J (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia.	jing.mengrabbit@gmail.com	Chen, Yi-Ping Phoebe/B-8844-2008	Chen, Yi-Ping Phoebe/0000-0002-4122-3767	La Trobe University	La Trobe University	This work was supported by La Trobe University full fee scholarship.	Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bradley G, 2017, ORAL DIS; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Eberle MA, 2017, GENOME RES, V27, P157, DOI 10.1101/gr.210500.116; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Fang LT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0758-2; Fu Y, 2016, CANCER RES, V76, P5954, DOI 10.1158/0008-5472.CAN-15-3457; Griffith M, 2015, CELL SYST, V1, P210, DOI 10.1016/j.cels.2015.08.015; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kalatskaya I, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0446-9; Kim S., BIORXIV; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Korthauer KD, 2015, BIOINFORMATICS, V31, P1526, DOI 10.1093/bioinformatics/btu858; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mwenifumbo JC, 2013, NAT REV GENET, V14, P321, DOI 10.1038/nrg3445; Narzisi G, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0023-9; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Poplin R., BIORXIV; Prasetyanti PR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0600-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tokheim CJ, 2016, P NATL ACAD SCI USA, V113, P14330, DOI 10.1073/pnas.1616440113; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202982	10.1371/journal.pone.0202982	http://dx.doi.org/10.1371/journal.pone.0202982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161165	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900060
J	Fittler, A; Vida, RG; Radics, V; Botz, L				Fittler, Andras; Vida, Robert Gyorgy; Radics, Valter; Botz, Lajos			A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs	PLOS ONE			English	Article							PRESCRIPTION DRUGS; PATIENT SAFETY; UNITED-STATES; AVAILABILITY; PHARMACIES; IMPACT; MONEY; CALL	Introduction Drug shortages mean a challenge to healthcare systems. Exposed patients or health care providers may seek alternative resources for these products online. The purpose of our study was to analyze the online availability of oncology shortage drugs at national and at international levels in 2014 and 2016. Methods We tested the online accessibility of oncology shortage drugs by simulating the Internet search method of patients. Search results were evaluated according to operational, distributional, and patient safety characteristics. Results In 2014 and 2016 all (100%) antineoplastic agents affected by shortages were available on the Internet without medical prescription. The number of relevant websites among search engine results has decreased from 112 to 98, while online vendors actually offering oncology shortage drugs for sale has risen from 66.1% to 80.6% within relevant websites in the two evaluated years. None of the online sellers were classified as legitimate or accredited by LegitScript and VIPPS online pharmacy verification databases. Conclusion According to our findings shortage oncology drugs are widely available online. To manage shortages and illegal Internet trade national and international standardized shortage reporting and information systems, regularly updated Internet pharmacy verification databases are needed. As well, institutional procurement and medication use review policies are required.	[Fittler, Andras] Univ Pecs, Fac Pharm, Dept Pharmaceut, Pecs, Hungary; Univ Pecs, Fac Pharm, Cent Clin Pharm, Pecs, Hungary	University of Pecs; University of Pecs	Fittler, A (corresponding author), Univ Pecs, Fac Pharm, Dept Pharmaceut, Pecs, Hungary.	fittler.andras@pte.hu	Vida, Róbert György/AAC-5740-2019; Fittler, András/O-1768-2019	Vida, Róbert György/0000-0003-1176-0251; Fittler, András/0000-0002-8243-6179	European Union; European Social Fund	European Union(European Commission); European Social Fund(European Social Fund (ESF))	The project has been supported by the European Union, co-financed by the European Social Fund within the framework of Comprehensive Development for Implementing Smart Specialization Strategies at the University of PeAcs.	Alsheikh Mona, 2016, Hosp Pharm, V51, P370, DOI 10.1310/hpj5105-370; Alwon BM, 2015, INT J CLIN PHARM-NET, V37, P148, DOI 10.1007/s11096-014-0056-1; Anna Gu, 2011, INNOVATIONS PHARM, V2; ASHP Expert Panel on Drug Product Shortages, 2009, Am J Health Syst Pharm, V66, P1399, DOI 10.2146/ajhp090026; Bauters T, 2016, J ONCOL PHARM PRACT, V22, P766, DOI 10.1177/1078155215610915; Blackstone EA, 2014, AM HEALTH DRUG BENEF, V7, P216; Butterfield Lindsay, 2015, J Pediatr Pharmacol Ther, V20, P149, DOI 10.5863/1551-6776-20.2.149; Cancer medicines shortages in Europe, 2017, REP EC INT UNIT SUPP; Caulder Celeste R, 2015, Hosp Pharm, V50, P279, DOI 10.1310/hpj5004-279; Center for Drug Evaluation and Research FDA, 2006, MAN POL PROC DRUG SH, P2; de Lemos ML, 2016, J ONCOL PHARM PRACT, V22, P566, DOI 10.1177/1078155215589980; De Weerdt E, 2017, APPL HEALTH ECON HEA, V15, P441, DOI 10.1007/s40258-016-0264-z; De Weerdt E, 2015, FRONT PHARMACOL, V6, DOI [10.3329/fphar.2015.00253, 10.3389/fphar.2015.00253]; European Association of Hospital Pharmacists, 2012, EAHP STAT MED SHORT; European Association of Hospital Pharmacists, 2014, EAHPS 2014 SURV MED; European Association of Hospital Pharmacists, 2013, MED SHORT EUR HOSP; European Federation of Pharmaceutical Industries and Associations, 2014, EFPIA GOOD PRACT REV; European Medicines Agency, 2012, EMA5907452012; Fittler A, 2014, EUROPEAN J HOSP PHAR, V21, pA67; Fittler A, 2013, J MED INTERNET RES, V15, P227, DOI 10.2196/jmir.2606; Food and Drug Administration, FDA ACTS PREV MOR DR; Food and Drug Administration, FDA DRUG SHORT CURR; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Gabay Michael, 2015, Hosp Pharm, V50, P681, DOI 10.1310/hpj5008-681; GAO, 2016, GAO16595; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Goldsack JC, 2014, AM J HEALTH-SYST PH, V71, P571, DOI 10.2146/ajhp130569; Gray A, 2012, B WORLD HEALTH ORGAN, V90, P158, DOI 10.2471/BLT.11.101303; Hawley KL, 2016, ACAD EMERG MED, V23, P63, DOI 10.1111/acem.12838; Holloway Kathleen, DRUG THERAPEUTICS PR, P1; Hughes Kaitlin M, 2015, J Pediatr Pharmacol Ther, V20, P453, DOI 10.5863/1551-6776-20.6.453; Huys Isabelle, 2013, Int J Pharm Pract, V21, P1, DOI 10.1111/ijpp.12012; IMS Institute for Healthcare Informatics, 2011, DRUG SHORT CLOS LOOK; Institute for Safe Medication Practices, 2014, DRUG SHORT SUMM; Institute for Safe Medication Practices (ISMP), 2010, ISMP MED SAFETY ALER, V15, P1; International Pharmaceutical Federation, 2013, REP INT SUMM MED SHO; International Pharmaceutical Federation, 2011, FIP CALLS ATT MED SH; INTERPOL, OP PANG COMB SAL ILL; ISPE, 2013, REP ISPE DRUG SHORT; Iyengar S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0674-7; Kaposy C, 2014, J BIOETHIC INQ, V11, P85, DOI 10.1007/s11673-013-9494-z; Kehl KL, 2015, J ONCOL PRACT, V11, pE154, DOI 10.1200/JOP.2014.000380; Lagan BM, 2014, PHARMACOEPIDEM DR S, V23, P411, DOI 10.1002/pds.3565; Levaggi R, 2012, HEALTH POLICY, V106, P241, DOI 10.1016/j.healthpol.2012.05.003; Levaggi R, 2009, HEALTH POLICY, V92, P187, DOI 10.1016/j.healthpol.2009.03.010; Liang BA, 2012, NAT REV UROL, V9, P480, DOI 10.1038/nrurol.2012.148; Liang BA, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1999; Liang BA, 2012, VACCINE, V30, P105, DOI 10.1016/j.vaccine.2011.11.016; Liang BA, 2009, AM J LAW MED, V35, P125, DOI 10.1177/009885880903500104; Link MP, 2012, J CLIN ONCOL, V30, P692, DOI 10.1200/JCO.2011.41.0936; Mackey Tim K, 2016, Br Med Bull, V118, P110, DOI 10.1093/bmb/ldw016; Mackey T, 2015, INT J CLIN PHARM-NET, V37, P1076, DOI 10.1007/s11096-015-0154-8; Mackey TK, 2012, J ONCOL PRACT, V8, P341, DOI 10.1200/JOP.2012.000579; Mackey TK, 2011, J PHARM SCI-US, V100, P4571, DOI 10.1002/jps.22679; Malone C, 2016, Ulster Med J, V85, P174; Mazer-Amirshahi M, 2017, J CRIT CARE, V41, P283, DOI 10.1016/j.jcrc.2017.06.005; McKeever AE, 2013, CLIN J ONCOL NURS, V17, P490, DOI 10.1188/13.CJON.490-495; McLaughlin M, 2013, J MANAGE CARE PHARM, V19, P783, DOI 10.18553/jmcp.2013.19.9.783; McLaughlin MM, 2014, AM J HEALTH-SYST PH, V71, P2074, DOI 10.2146/ajhp140116; Monteith S, 2016, J AFFECT DISORDERS, V193, P59, DOI 10.1016/j.jad.2015.12.043; National Association of Boards of Pharmacy, 2016, PHARM GEN TOP LEV DO; National Institute of Pharmacy and Nutrition, TEMP DUG SHORT; Nyaka Bernadett, 2016, J HUNGARIAN INTERDIS, V15, P42; Orizio G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1795; Orizio G, 2009, EUR J PUBLIC HEALTH, V19, P375, DOI 10.1093/eurpub/ckn146; Parsons HM, 2016, J ONCOL PRACT, V12, pE289, DOI 10.1200/JOP.2015.007237; Pauwels K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119322; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Quadri F, 2015, CLIN INFECT DIS, V60, P1737, DOI 10.1093/cid/civ201; Reed BN, 2016, AM HEART J, V175, P130, DOI 10.1016/j.ahj.2016.02.004; Ridley DB, 2016, HEALTH AFFAIR, V35, P235, DOI 10.1377/hlthaff.2015.0420; Romito Bryan, 2015, Hosp Pharm, V50, P798, DOI 10.1310/hpj5009-798; Schweitzer SO, 2013, AM J PUBLIC HEALTH, V103, pE10, DOI 10.2105/AJPH.2013.301239; Stephens Martin, 2011, HOSP PHARM 11 STRAT, P181; Taylor Phil, 2012, DRUG SHORTAGES RAISI; US Government Accountability Office, 2014, GAO14194; Valgus J, 2013, J ONCOL PRACT, V9, pE21, DOI 10.1200/JOP.2012.000779; Verified Internet Pharmacy Practice Sites (VIPPS) National Association of Boards of Pharmacy, VIPPS ACCR PHARM LIS; Vida RG, 2017, INT J CLIN PHARM-NET, V39, P78, DOI 10.1007/s11096-016-0398-y; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220; Yang CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165183	81	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203185	10.1371/journal.pone.0203185	http://dx.doi.org/10.1371/journal.pone.0203185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153304	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700049
J	Watanabe, M; Masieri, S; Costantini, D; Tozzi, R; De Giorgi, F; Gangitano, E; Tuccinardi, D; Poggiogalle, E; Mariani, S; Basciani, S; Petrangeli, E; Gnessi, L; Lubrano, C				Watanabe, Mikiko; Masieri, Simonetta; Costantini, Daniela; Tozzi, Rossella; De Giorgi, Francesca; Gangitano, Elena; Tuccinardi, Dario; Poggiogalle, Eleonora; Mariani, Stefania; Basciani, Sabrina; Petrangeli, Elisa; Gnessi, Lucio; Lubrano, Carla			Overweight and obese patients with nickel allergy have a worse metabolic profile compared to weight matched non-allergic individuals	PLOS ONE			English	Article							GROWTH-HORMONE; INSULIN-RESISTANCE; PATCH-TEST; INFLAMMATION; HEALTH; HYPERSENSITIVITY; PROLACTIN; SECRETION; IMPACT; AXIS	Background A lack of balance between energy intake and expenditure due to overeating or reduced physical activity does not seem to explain entirely the obesity epidemic we are facing, and further factors are therefore being evaluated. Nickel (Ni) is a ubiquitous heavy metal implied in several health conditions. Regarding this, the European Food Safety Authority has recently released an alert on the possible deleterious effects of dietary Ni on human health given the current levels of Ni dietary intake in some countries. Pre-clinical studies have also suggested its role as an endocrine disruptor and have linked its exposure to energy metabolism and glucose homeostasis dysregulation. Ni allergy is common in the general population, but preliminary data suggest it being even more widespread among overweight patients. Objectives The aim of this study has been to evaluate the presence of Ni allergy and its association with the metabolic and endocrine profile in overweight and obese individuals. Methods We have evaluated 1128 consecutive overweight and obese outpatients. 784 were suspected of being allergic to Ni and 666 were assessed for it. Presence of Ni allergy and correlation with body mass index (BMI), body composition, metabolic parameters and hormonal levels were evaluated. Results We report that Ni allergy is more frequent in presence of weight excess and is associated with worse metabolic parameters and impaired Growth Hormone secretion. Conclusions We confirm that Ni allergy is more common in obese patients, and we report for the first time its association with worse metabolic parameters and impaired function of the GH-IGF1 axis in human subjects.	[Watanabe, Mikiko; Costantini, Daniela; Tozzi, Rossella; De Giorgi, Francesca; Gangitano, Elena; Poggiogalle, Eleonora; Mariani, Stefania; Basciani, Sabrina; Petrangeli, Elisa; Gnessi, Lucio; Lubrano, Carla] Sapienza Univ Rome, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, Rome, Italy; [Masieri, Simonetta] Sapienza Univ Rome, Dept Sensory Organs, Rome, Italy; [Tuccinardi, Dario] Univ Campus Biomed Rome, Dept Endocrinol & Diabet, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Watanabe, M (corresponding author), Sapienza Univ Rome, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, Rome, Italy.	mikiko.watanabe@uniroma1.it	Gnessi, Lucio/K-8025-2016; Poggiogalle, Eleonora/AAB-9338-2019; watanabe, Mikiko/AAL-6316-2020; Tozzi, Rossella/AAB-9253-2019; Tuccinardi, Dario/AAN-9540-2020; Tuccinardi, Dario/AAB-8423-2019	Gnessi, Lucio/0000-0001-8217-2372; watanabe, Mikiko/0000-0003-2225-8814; Tuccinardi, Dario/0000-0002-9139-7159; MASIERI, Simonetta/0000-0003-0423-9505; Gangitano, Elena/0000-0003-1044-2278				Ahlstrom MG, 2017, CONTACT DERMATITIS, V77, P193, DOI 10.1111/cod.12846; Antico A, 1999, ALLERGY ASTHMA PROC, V20, P235, DOI 10.2500/108854199778338991; Benford D, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4002; Braga M, 2013, INT J IMMUNOPATH PH, V26, P707, DOI 10.1177/039463201302600314; Bunt SNW, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2759-1; Buyukozturk S, 2015, INT IMMUNOPHARMACOL, V26, P92, DOI 10.1016/j.intimp.2015.03.012; CARLSON HE, 1984, LIFE SCI, V35, P1747, DOI 10.1016/0024-3205(84)90271-6; Chen YW, 2009, ISLETS, V1, P169, DOI 10.4161/isl.1.3.9262; Christensen O B, 1975, Contact Dermatitis, V1, P136, DOI 10.1111/j.1600-0536.1975.tb05354.x; Cook DM, 2009, ENDOCR PRACT S2, P1, DOI DOI 10.4158/EP.15.S2.1; Das KK, 2008, INDIAN J MED RES, V128, P412; Di Tola M, 2014, BIOL TRACE ELEM RES, V159, P81, DOI 10.1007/s12011-014-9991-x; DORMER RL, 1974, BIOCHEM J, V140, P135, DOI 10.1042/bj1400135; Dzugkoeva FS, 2016, B EXP BIOL MED+, V162, P199, DOI 10.1007/s10517-016-3575-z; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Grottoli S, 2003, CLIN ENDOCRINOL, V58, P220, DOI 10.1046/j.1365-2265.2003.01699.x; Gupta S, 2000, NITRIC OXIDE-BIOL CH, V4, P129, DOI 10.1006/niox.2000.0278; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ihlebaek C, 2002, SCAND J PUBLIC HEALT, V30, P20, DOI 10.1080/140349401753481547; Jacob SE, 2015, PEDIATR DERMATOL, V32, P779, DOI 10.1111/pde.12639; LABELLA FS, 1973, NATURE, V245, P330, DOI 10.1038/245330a0; Lachapelle J.-M., 2012, PATCH TESTING PRICK; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Lin YC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014215; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Lusi EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123265; Maccario M, 2000, INT J OBESITY, V24, pS96, DOI 10.1038/sj.ijo.0801289; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nijhawan RI, 2009, DERMATOL CLIN, V27, P355, DOI 10.1016/j.det.2009.05.005; Patriarca M, 1997, AM J CLIN NUTR, V66, P616, DOI 10.1093/ajcn/66.3.616; Pizzutelli S, 2011, EUR ANN ALLERGY CLIN, V43, P5; Rietschel RL, 2008, DERMATITIS, V19, P16, DOI 10.2310/6620.2008.06062; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Saito M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020202; Saraswathi V, 2013, METABOLISM, V62, P1673, DOI 10.1016/j.metabol.2013.07.007; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schmidt M, 2011, J MOL MED, V89, P961, DOI 10.1007/s00109-011-0780-0; Seetho IW, 2013, CLIN ENDOCRINOL, V79, P163, DOI 10.1111/cen.12256; Tol J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-582; Wolfe Brenda L, 2002, Eat Disord, V10, P115, DOI 10.1080/10640260290081687; Xu XH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-40	41	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202683	10.1371/journal.pone.0202683	http://dx.doi.org/10.1371/journal.pone.0202683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153310	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700021
J	Meneguz, M; Gasco, L; Tomberlin, JK				Meneguz, Marco; Gasco, Laura; Tomberlin, Jeffery K.			Impact of pH and feeding system on black soldier fly (Hermetia illucens, L; Diptera: Stratiomyidae) larval development	PLOS ONE			English	Article							GROWTH-PERFORMANCE; FLIES DIPTERA; HOUSE-FLIES; DIET PH; SUPPLEMENT; CONVERSION; BACTERIA; AMMONIA; MANURE; WATER	Black soldier fly (BSF) is a generalist species able to reduce large quantities of organic substrates and is thus considered as an interesting solution for waste management. Moreover, as BSF larvae accumulate high quantities of nutrients during their growth, they are valued because of their potential to produce products such as protein meal or fat for livestock feeds. Abiotic factors can influence larva growth, and a more detailed knowledge and control of these parameters can lead to the development of mass BSF breeding for the production of innovative products for animal feeds. As little information is available on the effects of the pH of substrates and feeding systems, the aim of this study was to evaluate the impact of these two factors on the activities of BSF larvae, prepupae, and adults. An experiment was performed with two fixed factors: i) pH (4.0; 6.1; 7.5; 9.5) and ii) feeding system (batch feeding system (TFS) or daily feeding system (DFS)). The pH treatments impacted larval weight on the first, third, and fifth day, but not at the end of the trial. Larval activity increased pH values from the fourth day onward, with final values of around 8.9-9.4 in all the treatments. The weight of the prepupae ranged from between 0.094 and 0.100 g. The final weight of the larvae and pupae, sex ratio, ingested food, larval mortality, percentage of emergence, and time to reach the pupa stadium were all affected by the feeding system. DFS showed the heaviest final larval weight (0.149 g), but required a longer time (11.3 d) than TFS to reach the prepupa stadium. The findings of this research could be useful for the mass production of BSF. Evaluation of an appropriate feeding system and initial pH value of the substrate are important parameters to reduce the time and to increase the weight in the production of larvae.	[Meneguz, Marco; Gasco, Laura] Univ Turin, Dept Agr Forestry & Food Sci, Turin, Italy; [Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Turin; Texas A&M University System; Texas A&M University College Station	Gasco, L (corresponding author), Univ Turin, Dept Agr Forestry & Food Sci, Turin, Italy.	laura.gasco@unito.it	menegeuz, marco/L-1083-2019; Meneguz, Marco/AAX-8043-2021	menegeuz, marco/0000-0001-8007-2044; GASCO, Laura/0000-0002-1829-7936				Alattar AM, 2012, THESIS; Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; Alpas H, 2000, INT J FOOD MICROBIOL, V60, P33, DOI 10.1016/S0168-1605(00)00324-X; [Anonymous], 1972, LIMITS GROWTH; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Booth IR, 2007, NOVART FDN SYMP, P19, DOI [10.1002/9780470515631.ch3, DOI 10.1002/9780470515631.CH3]; Cammack JA, 2017, INSECTS, V8, DOI 10.3390/insects8020056; CHAN HT, 1995, J ECON ENTOMOL, V88, P569, DOI 10.1093/jee/88.3.569; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chaudhury MF, 2009, J ECON ENTOMOL, V102, P799, DOI 10.1603/029.102.0242; Choi Youngcheol, 2009, International Journal of Industrial Entomology, V19, P171; Clark TM, 2004, J EXP BIOL, V207, P2297, DOI 10.1242/jeb.01021; Diener S, 2011, WASTE BIOMASS VALORI, V2, P357, DOI 10.1007/s12649-011-9079-1; DREW RAI, 1983, OECOLOGIA, V60, P279, DOI 10.1007/BF00376839; Erickson MC, 2004, J FOOD PROTECT, V67, P685, DOI 10.4315/0362-028X-67.4.685; Gasco L, 2018, SPRBRIEF MOLEC SCI, P1, DOI 10.1007/978-3-319-77941-6_1; Gasco L, 2016, ANIM FEED SCI TECH, V220, P34, DOI 10.1016/j.anifeedsci.2016.07.003; Henry M, 2015, ANIM FEED SCI TECH, V203, P1, DOI 10.1016/j.anifeedsci.2015.03.001; HOGSETTE JA, 1992, J ECON ENTOMOL, V85, P2291, DOI 10.1093/jee/85.6.2291; Holman BWB, 2013, J ANIM PHYSIOL AN N, V97, P615, DOI 10.1111/j.1439-0396.2012.01328.x; Holmes LA, 2012, ENVIRON ENTOMOL, V41, P971, DOI 10.1603/EN12054; Jeon H, 2011, CURR MICROBIOL, V62, P1390, DOI 10.1007/s00284-011-9874-8; Kim W, 2011, J ASIA-PAC ENTOMOL, V14, P11, DOI 10.1016/j.aspen.2010.11.003; Lam K, 2009, ENTOMOL EXP APPL, V133, P292, DOI 10.1111/j.1570-7458.2009.00928.x; Lam K, 2009, NATURWISSENSCHAFTEN, V96, P1127, DOI 10.1007/s00114-009-0574-1; LECLERCQ M, 1969, Bulletin des Recherches Agronomiques de Gembloux, V4, P139; Leong SY, 2016, WASTE MANAGE, V47, P84, DOI 10.1016/j.wasman.2015.03.030; Ma JH, 2018, ENVIRON ENTOMOL, V47, P159, DOI 10.1093/ee/nvx186; Marono S, 2017, POULTRY SCI, V96, P1783, DOI 10.3382/ps/pew461; MENDONCA AF, 1994, APPL ENVIRON MICROB, V60, P4009, DOI 10.1128/AEM.60.11.4009-4014.1994; Meneguz M, 2018, J SCI FOOD AGR, V98, P5776, DOI 10.1002/jsfa.9127; Nguyen TTX, 2015, ENVIRON ENTOMOL, V44, P406, DOI 10.1093/ee/nvv002; Nguyen TTX, 2013, J MED ENTOMOL, V50, P898, DOI 10.1603/ME12260; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nitayavardhana S, 2010, BIORESOURCE TECHNOL, V101, P9078, DOI 10.1016/j.biortech.2010.07.048; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; Paz ASP, 2015, WASTE BIOMASS VALORI, V6, P1059, DOI 10.1007/s12649-015-9418-8; Popa R, 2012, J ECON ENTOMOL, V105, P374, DOI 10.1603/EC11192; Renna M, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0191-3; Roncarati A, 2015, J INSECTS FOOD FEED, V1, P233, DOI 10.3920/JIFF2014.0006; Schiavone A, 2018, ANIMAL, V12, P2032, DOI 10.1017/S1751731117003743; Schiavone A, 2017, ITAL J ANIM SCI, V16, P93, DOI 10.1080/1828051X.2016.1249968; Schiavone A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0181-5; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; Tinder AC, 2017, J INSECTS FOOD FEED, V3, P121, DOI 10.3920/JIFF2016.0048; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; TURNBULL PC, 1973, AVIAN DIS, V17, P72, DOI 10.2307/1588921; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; Van Huis A, 2013, EDIBLE INSECTS FUTUR; Villas-Boas SG, 2002, ANIM FEED SCI TECH, V98, P1, DOI 10.1016/S0377-8401(02)00017-2; Wissinger SA, 2004, WETLANDS, V24, P777, DOI 10.1672/0277-5212(2004)024[0777:TROLCI]2.0.CO;2; Yu GH, 2011, ENVIRON ENTOMOL, V40, P30, DOI 10.1603/EN10126; Zheng LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02563; Zhu FX, 2012, BIORESOURCE TECHNOL, V116, P485, DOI 10.1016/j.biortech.2012.04.008	56	52	57	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202591	10.1371/journal.pone.0202591	http://dx.doi.org/10.1371/journal.pone.0202591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148867	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200016
J	Osiecki, MJ; McElwain, SDL; Lott, WB				Osiecki, Michael J.; McElwain, Sean D. L.; Lott, William B.			Modelling mesenchymal stromal cell growth in a packed bed bioreactor with a gas permeable wall	PLOS ONE			English	Article							STEM-CELLS; PERFUSION BIOREACTOR; IN-VITRO; MATHEMATICAL-MODEL; OXYGEN-TRANSPORT; CULTURE-SYSTEM; SHEAR-STRESS; SOLID TUMOR; EXPANSION; TISSUE	A mathematical model was developed for mesenchymal stromal cell (MSC) growth in a packed bed bioreactor that improves oxygen availability by allowing oxygen diffusion through a gas-permeable wall. The governing equations for oxygen, glucose and lactate, the inhibitory waste product, were developed assuming Michaelis-Menten kinetics, together with an equation for the medium flow based on Darcy's Law. The conservation law for the cells includes the effects of inhibition as the cells reach confluence, nutrient and waste product concentrations, and the assumption that the cells can migrate on the scaffold. The equations were solved using the finite element package, COMSOL. Previous experimental results collected using a packed bed bioreactor with gas permeable walls to expand MSCs produced a lower cell yield than was obtained using a traditional cell culture flask. This mathematical model suggests that the main contributors to the observed low cell yield were a non-uniform initial cell seeding profile and a potential lag phase as cells recovered from the initial seeding procedure. Lactate build-up was predicted to have only a small effect at lower flow rates. Thus, the most important parameters to optimise cell expansion in the proliferation of MSCs in a bioreactor with gas permeable wall are the initial cell seeding protocol and the handling of the cells during the seeding process. The mathematical model was then used to identify and characterise potential enhancements to the bioreactor design, including incorporating a central gas permeable capillary to further enhance oxygen availability to the cells. Finally, to evaluate the issues and limitations that might be encountered scale-up of the bioreactor, the mathematical model was used to investigate modifications to the bioreactor design geometry and packing density.	[Osiecki, Michael J.; McElwain, Sean D. L.; Lott, William B.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Osiecki, Michael J.; Lott, William B.] Queensland Univ Technol, Sci & Engn Fac, Sch Chem Phys & Mech Engn, Brisbane, Qld, Australia; [McElwain, Sean D. L.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Osiecki, MJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Osiecki, MJ (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Sch Chem Phys & Mech Engn, Brisbane, Qld, Australia.	m.osiecki@hdr.qut.edu.au						Andrade PZ, 2015, J TISSUE ENG REGEN M, V9, P1172, DOI 10.1002/term.1731; BALTZ JM, 1991, MOL REPROD DEV, V28, P351, DOI 10.1002/mrd.1080280407; Bear J, 1988, DYNAMICS FLUIDS PORO; Campolo M, 2013, AICHE J, V59, P3131, DOI 10.1002/aic.14084; Chen JP, 2006, J BIOSCI BIOENG, V102, P41, DOI 10.1263/jbb.102.41; Chung CA, 2007, BIOTECHNOL BIOENG, V97, P1603, DOI 10.1002/bit.21378; Coletti F, 2006, IND ENG CHEM RES, V45, P8158, DOI 10.1021/ie051144v; Craven S, 2013, BIOTECHNOL PROGR, V29, P186, DOI 10.1002/btpr.1664; David B, 2011, TISSUE ENG PART C-ME, V17, P505, DOI [10.1089/ten.tec.2010.0468, 10.1089/ten.TEC.2010.0468]; De Napoli IE, 2011, J MEMBRANE SCI, V379, P341, DOI 10.1016/j.memsci.2011.06.001; Donato D, 2014, PROCESSES, V2, P34, DOI 10.3390/pr2010034; dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Green DW., 2007, PERRYS CHEM ENG HDB; GREENSPAN HP, 1972, STUD APPL MATH, V51, P317; Higuera G, 2009, TISSUE ENG PT A, V15, P2653, DOI [10.1089/ten.tea.2008.0328, 10.1089/ten.TEA.2008.0328]; Housler GJ, 2012, TISSUE ENG PART C-ME, V18, P133, DOI [10.1089/ten.tec.2011.0305, 10.1089/ten.TEC.2011.0305]; Kim MC, 2013, MICROFLUID NANOFLUID, V15, P285, DOI 10.1007/s10404-013-1142-8; Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874; Kitagawa T, 2006, BIOTECHNOL BIOENG, V93, P947, DOI 10.1002/bit.20797; KLEINSTREUER C, 1986, BIOTECHNOL BIOENG, V28, P1233, DOI 10.1002/bit.260280815; Lanfrey PY, 2010, CHEM ENG SCI, V65, P1891, DOI 10.1016/j.ces.2009.11.011; Lewis MC, 2005, BIOTECHNOL BIOENG, V91, P607, DOI 10.1002/bit.20508; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI [10.1089/ten.tea.2008.0540, 10.1089/ten.TEA.2008.0540]; Li M, 2012, J TISSUE ENG REGEN M, V6, P369, DOI 10.1002/term.439; Li Y, 2003, CYTOTECHNOLOGY, V41, P23, DOI 10.1023/A:1024283521966; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; MCELWAIN DLS, 1977, MATH BIOSCI, V35, P267, DOI 10.1016/0025-5564(77)90028-1; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Mizukami A, 2013, BIOTECHNOL PROGR, V29, P568, DOI 10.1002/btpr.1707; Mohebbi-Kalhori D, 2012, J ARTIF ORGANS, V15, P250, DOI 10.1007/s10047-012-0649-1; Nold P, 2013, BIOCHEM BIOPH RES CO, V430, P325, DOI 10.1016/j.bbrc.2012.11.001; Osiecki MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144941; OYAAS J, 1995, BIOTECHNOL BIOENG, V47, P492, DOI 10.1002/bit.260470411; Pattappa G, 2011, J CELL PHYSIOL, V226, P2562, DOI 10.1002/jcp.22605; Polinkovsky M, 2009, LAB CHIP, V9, P1073, DOI 10.1039/b816191g; Sarkar S, 2011, ANN BIOMED ENG, V39, P2346, DOI 10.1007/s10439-011-0337-y; Schop D, 2009, TISSUE ENG PT A, V15, P1877, DOI 10.1089/ten.tea.2008.0345; Shakeel M, 2013, MATH MED BIOL, V30, P21, DOI 10.1093/imammb/dqr022; Shakeel M, 2013, MATH BIOSCI, V242, P86, DOI 10.1016/j.mbs.2012.12.004; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Weber C, 2010, INT J ARTIF ORGANS, V33, P512, DOI 10.1177/039139881003300802; Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759; Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007; Zeng AP, 1998, BIOTECHNOL PROGR, V14, P434, DOI 10.1021/bp9800337; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184; Zhu XH, 2010, CHEM ENG SCI, V65, P2108, DOI 10.1016/j.ces.2009.12.006	51	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202079	10.1371/journal.pone.0202079	http://dx.doi.org/10.1371/journal.pone.0202079			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148832	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200007
J	Berg, AO; Jorgensen, KN; Nerhus, M; Athanasiu, L; Popejoy, AB; Bettella, F; Norbom, LCB; Gurholt, TP; Dahl, SR; Andreassen, OA; Djurovic, S; Agartz, I; Melle, I				Berg, Akiah Ottesen; Jorgensen, Kjetil N.; Nerhus, Mari; Athanasiu, Lavinia; Popejoy, Alice B.; Bettella, Francesco; Norbom, Linn Christin Bonaventure; Gurholt, Tiril P.; Dahl, Sandra R.; Andreassen, Ole A.; Djurovic, Srdjan; Agartz, Ingrid; Melle, Ingrid			Vitamin D levels, brain volume, and genetic architecture in patients with psychosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; D DEFICIENCY; D-RECEPTOR; MULTIPLE-SCLEROSIS; CALCIUM-METABOLISM; BIPOLAR DISORDER; D INSUFFICIENCY; SOCIAL STRESS; ANIMAL-MODEL; OLDER-ADULTS	Background Lower vitamin D levels are found in people with schizophrenia and depressive disorders, and also associated with neuroimaging abnormalities such as reduced brain volume in both animals and humans. Reduced whole brain and increased ventricular volume are also systematically reported in schizophrenia. Even though vitamin D deficiency has been proposed as a risk mechanism for schizophrenia there exist no studies to date of the association between vitamin D levels and brain volume in this population. Therefore, we investigated the relationship between vitamin D levels and brain phenotypes in psychotic disorders, and assessed possible interactions with genetic variants in vitamin D receptor (VDR) and other genetic variants that play a role in vitamin D levels in the body. Methods Our sample consisted of 83 psychosis patients and 101 healthy controls. We measured vitamin D levels as serum 25-hydroxyvitamin D. All participants were genotyped and neuroimaging conducted by structural magnetic resonance imaging. Results Vitamin D levels were significantly positively associated with peripheral grey matter volume in patients (beta 860.6; 95% confidence interval (CI) 333.4 +/- 1466, p<.003). A significant interaction effect of BSML marker (rs1544410) was observed to mediate the association between patient status and both white matter volume (beta 23603.3; 95% CI 2732.8 +/- 48708.6, p<.05) and whole brain volume (beta 46670.6, 95% CI 8817.8 +/- 93888.3, p<.04). Vitamin D did not predict ventricular volume, which rather was associated with patient status (beta 4423.3, 95% CI 1583.2 +/- 7267.8p < .002) and CYP24A1 marker (rs6013897) (beta 2491.5, 95% CI 269.7 +/- 4978.5, p < .04). Conclusions This is the first study of the association between vitamin D levels and brain volume in patients with psychotic disorders that takes into account possible interaction with genetic polymorphisms. The present findings warrant replication in independent samples.	[Berg, Akiah Ottesen; Jorgensen, Kjetil N.; Nerhus, Mari; Athanasiu, Lavinia; Popejoy, Alice B.; Bettella, Francesco; Norbom, Linn Christin Bonaventure; Andreassen, Ole A.; Agartz, Ingrid; Melle, Ingrid] Univ Oslo, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway; [Berg, Akiah Ottesen; Nerhus, Mari; Athanasiu, Lavinia; Popejoy, Alice B.; Bettella, Francesco; Norbom, Linn Christin Bonaventure; Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Jorgensen, Kjetil N.; Norbom, Linn Christin Bonaventure; Gurholt, Tiril P.; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Nerhus, Mari] Akershus Univ Hosp, Div Mental Hlth, Lorenskog, Norway; [Popejoy, Alice B.] Univ Washington, Inst Publ Hlth Genet, Seattle, WA 98195 USA; [Dahl, Sandra R.] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, KG Jebsen Ctr Psychosis Res, Dept Clin Sci, NORMENT, Bergen, Norway; [Agartz, Ingrid] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden	University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Oslo; University of Washington; University of Washington Seattle; University of Oslo; University of Oslo; University of Bergen; Karolinska Institutet	Berg, AO (corresponding author), Univ Oslo, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway.; Berg, AO (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway.	a.o.berg@medisin.uio.no	Andreassen, Ole A./AAY-7531-2020; Gurholt, Tiril/S-1457-2019	Gurholt, Tiril/0000-0002-1272-7616; Djurovic, Srdjan/0000-0002-8140-8061; Nerhus, Mari/0000-0002-0468-4230	KG Jebsen Stiftelsen [SKGJ-MED-008]; Research Council of Norway [223273, 181831]; South-Eastern Norway Regional Health Authority [2017-112, 2006-258]	KG Jebsen Stiftelsen; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	Funding for this study was provided to the Norwegian Centre for Mental Health Research by the KG Jebsen Stiftelsen (Grant #SKGJ-MED-008; http://stiftkgj.no/what-we-do/k-g-jebsen-centres-of-medical-research/?lang=en), the Research Council of Norway (Grants #223273 and #181831; https://www.forskningsradet.no/en/Home_page/1177315753906) and the South-Eastern Norway Regional Health Authority (Grants #2017-112 and #2006-258; https://www.helse-sorost.no/helsefaglig/forskning). Neither had any role in study design, data collection, analysis and interpretation, writing of the report, or the decision to submit the paper for publication.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Al-Diwani AAJ, 2017, IMMUNOLOGY, V152, P388, DOI 10.1111/imm.12795; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Annweiler C, 2015, EXP GERONTOL, V63, P41, DOI 10.1016/j.exger.2015.01.049; Annweiler C, 2014, MATURITAS, V78, P30, DOI 10.1016/j.maturitas.2014.02.013; Annweiler C, 2013, MOL NUTR FOOD RES, V57, P267, DOI 10.1002/mnfr.201200418; Annweiler C, 2011, GERIATR PSYCHOL NEUR, V9, P259, DOI 10.1684/pnv.2011.0288; Berg AO, 2010, J CLIN PSYCHIAT, V71, P1598, DOI 10.4088/JCP.09m05299yel; Berger Gregor E, 2003, Psychopharmacol Bull, V37, P79; Berk M, 2007, MED HYPOTHESES, V69, P1316, DOI 10.1016/j.mehy.2007.04.001; Beydoun MA, 2012, AM J CLIN NUTR, V95, P163, DOI 10.3945/ajcn.111.017137; Bowman GL, 2012, NEUROLOGY, V78, P241, DOI 10.1212/WNL.0b013e3182436598; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Burton GJ, 2016, PHYSIOL REV, V96, P1509, DOI 10.1152/physrev.00029.2015; Calvello R, 2017, J NEUROIMMUNE PHARM, V12, P327, DOI 10.1007/s11481-016-9720-7; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chung Y, 2015, J NERV MENT DIS, V203, P336, DOI 10.1097/NMD.0000000000000286; Corporation I, IBM SPSS STAT WINDOW; Crews M, 2013, SCHIZOPHR RES, V150, P533, DOI 10.1016/j.schres.2013.08.036; Dealberto MJ, 2007, MED HYPOTHESES, V68, P259, DOI 10.1016/j.mehy.2006.07.040; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D W, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS247, DOI 10.1016/j.psyneuen.2009.04.015; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; Farid K, 2012, NUCL MED COMMUN, V33, P1048, DOI 10.1097/MNM.0b013e32835674c4; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; FIRST MB, 1996, STRUCTURAL CLIN INTE; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Groves NJ, 2017, PSYCHONEUROENDOCRINO, V86, P53, DOI 10.1016/j.psyneuen.2017.09.003; Gurholt TP, 2017, SCHIZOPHRENIA BULL, V43, pS241; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Handoko H, 2006, AM J HUM BIOL, V18, P415, DOI 10.1002/ajhb.20504; Harms LR, 2008, BEHAV BRAIN RES, V187, P343, DOI 10.1016/j.bbr.2007.09.032; Holvik K, 2005, EUR J CLIN NUTR, V59, P57, DOI 10.1038/sj.ejcn.1602033; Jorde R, 2012, ANN HUM GENET, V76, P200, DOI 10.1111/j.1469-1809.2012.00703.x; Karakis I, 2016, J ALZHEIMERS DIS, V51, P451, DOI 10.3233/JAD-150991; Kinney DK, 2010, MED HYPOTHESES, V74, P555, DOI 10.1016/j.mehy.2009.09.040; Lambrinoudaki I, 2013, NEUROL SCI, V34, P1433, DOI 10.1007/s10072-012-1259-7; LEMAY M, 1984, AM J ROENTGENOL, V143, P383, DOI 10.2214/ajr.143.2.383; Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mizrahi R, 2016, NEUROPSYCHOPHARMACOL, V41, P666, DOI 10.1038/npp.2015.274; Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111/j.1365-2265.2005.02226.x; Mowry EM, 2016, EUR J NEUROL, V23, P327, DOI 10.1111/ene.12844; Mowry EM, 2011, J NEUROL SCI, V311, P19, DOI 10.1016/j.jns.2011.06.035; National Centre for Biotechnology Information, 2017, CYP24A1 CYT P450 FAM, DOI [10.1016/j.bbr.2007.09.032, DOI 10.1016/J.BBR.2007.09.032]; Nerhus M, 2017, J CLIN PSYCHIAT; Nerhus M, 2016, SCHIZOPHR RES, V178, P44, DOI 10.1016/j.schres.2016.08.024; Nerhus M, 2015, PSYCHIAT RES, V230, P616, DOI 10.1016/j.psychres.2015.10.015; Plozer E, 2015, NUTR NEUROSCI, V18, P37, DOI 10.1179/1476830514Y.0000000109; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehn AE, 2004, NEUROSCIENCE, V129, P381, DOI 10.1016/j.neuroscience.2004.07.047; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sferruzzi-Perri AN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00033; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Shivakumar V, 2015, PSYCHIAT RES-NEUROIM, V233, P175, DOI 10.1016/j.pscychresns.2015.06.006; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041575; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Valipour G, 2014, J CLIN ENDOCR METAB, V99, P3863, DOI 10.1210/jc.2014-1887; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; Virani A., 2012, CLIN HDB PSYCHOTROPI; Walhovd KB, 2014, NEUROBIOL AGING, V35, P1055, DOI 10.1016/j.neurobiolaging.2013.11.011; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Weinstock-Guttman B, 2011, J NEUROL NEUROSUR PS, V82, P189, DOI 10.1136/jnnp.2010.227942; WMA, 2008, 59 WMA; Xiong DH, 2005, J MED GENET, V42, P228, DOI 10.1136/jmg.2004.024083; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou Y, 2014, J STEROID BIOCHEM, V144, P207, DOI 10.1016/j.jsbmb.2013.10.004; Zivadinov R, 2013, J NEUROL NEUROSUR PS, V84, P1075, DOI 10.1136/jnnp-2012-304661	80	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0200250	10.1371/journal.pone.0200250	http://dx.doi.org/10.1371/journal.pone.0200250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142216	gold, Green Published, Green Submitted			2022-12-26	WOS:000442722500001
J	Genty, J; Nomigni, MT; Anton, F; Hanesch, U				Genty, Julien; Nomigni, Milene Tetsi; Anton, Fernand; Hanesch, Ulrike			The combination of postnatal maternal separation and social stress in young adulthood does not lead to enhanced inflammatory pain sensitivity and depression-related behavior in rats	PLOS ONE			English	Article							CENTRAL GLUCOCORTICOID-RECEPTORS; INDUCED VISCERAL HYPERSENSITIVITY; ADJUVANT-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; EARLY-LIFE ADVERSITY; SPINAL-CORD; NEUROPATHIC PAIN; PERIPHERAL INFLAMMATION; CENTRAL SENSITIZATION; GLIAL ACTIVATION	The cumulative and match/mismatch hypotheses of stress are still under discussion regarding the effects of early life stress (ELS) on the vulnerability or resilience to psychopathology. In this context, an additional stress in later life (second hit) often leads to stress-related disorders that frequently include comorbid pain states. We previously observed that maternal separation (MS), a model of ELS, reduces vulnerability to neuropathic and inflammatory pain in rats. In the present study, we investigated the effects of an additional later stressor on the vulnerability to inflammatory pain. Sprague Dawley pups were divided into 4 groups: controls (CON, no stress), MS, social stress (SS) and MS+SS. At young adult age (from 7 to 15 weeks), stress- as well as pain-related parameters were evaluated prior and during 21 days following the induction of paw inflammation with complete Freund's adjuvant (CFA). Finally spinal glutamatergic transmission, immunocompetent cells, pro-inflammatory cytokines and growth factors were examined using qPCR. None of the stress conditions had a significant impact on corticosterone levels and anhedonia. In the forced swim test, MS and SS displayed increased passive coping whereas the combination of both stressors revoked this effect. The different stress conditions had no influence on basal mechanical thresholds and heat sensitivity. At 4 days post-inflammation all stress groups displayed lower mechanical thresholds than CON but the respective values were comparable at 7, 10, and 14 days. Only on day 21, MS rats were more sensitive to mechanical stimulation compared to the other groups. Regarding noxious heat sensitivity, MS+SS animals were significantly less sensitive than CON at 10 and 21 days after CFA-injection. qPCR results were mitigated. Despite the finding that stress conditions differentially affected different players of glutamatergic transmission, astrocyte activity and NGF expression, our biochemical results could not readily be related to the behavioral observations, precluding a congruent conclusion. The present results do neither confirm the cumulative nor corroborate or disprove the match/mismatch hypothesis.	[Genty, Julien; Nomigni, Milene Tetsi; Anton, Fernand; Hanesch, Ulrike] Univ Luxembourg, Inst Hlth & Behav, Res Grp Stress Pain & Pain Modulat, Luxembourg, Luxembourg	University of Luxembourg	Genty, J (corresponding author), Univ Luxembourg, Inst Hlth & Behav, Res Grp Stress Pain & Pain Modulat, Luxembourg, Luxembourg.	julien.genty@uni.lu						Albers KM, 2006, J NEUROSCI, V26, P2981, DOI 10.1523/JNEUROSCI.4863-05.2006; Avitsur R, 2005, BRAIN BEHAV IMMUN, V19, P311, DOI 10.1016/j.bbi.2004.09.005; Avitsur R, 2009, IMMUNOL ALLERGY CLIN, V29, P285, DOI 10.1016/j.iac.2009.02.006; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Banik RK, 2002, EXP ANIM TOKYO, V51, P197, DOI 10.1538/expanim.51.197; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bao L, 2001, NEUROREPORT, V12, P3905, DOI 10.1097/00001756-200112210-00010; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Blackburn-Munro G, 2001, J NEUROENDOCRINOL, V13, P1009, DOI 10.1046/j.0007-1331.2001.00727.x; Bodnar TS, 2015, ENDOCRINOLOGY, V156, P4604, DOI 10.1210/en.2015-1497; Bodnar TS, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Bogen O, 2008, EUR J NEUROSCI, V28, P12, DOI 10.1111/j.1460-9568.2008.06308.x; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; BROWN GW, 1981, PSYCHOL MED, V11, P581, DOI 10.1017/S0033291700052880; Burke NN, 2013, J PAIN, V14, P1173, DOI 10.1016/j.jpain.2013.05.003; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Calcia MA, 2016, PSYCHOPHARMACOLOGY, V233, P1637, DOI 10.1007/s00213-016-4218-9; Castagne V, 2009, EUR J PHARMACOL, V616, P128, DOI 10.1016/j.ejphar.2009.06.018; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008; de Kloet ER, 2016, HINDAWI PUBLISHING C, V2016, P1, DOI DOI 10.1155/2016/6503162; Dimatelis JJ, 2012, METAB BRAIN DIS, V27, P393, DOI 10.1007/s11011-012-9304-z; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; DUNCAN GE, 1986, J PHARMACOL EXP THER, V238, P758; Engler H, 2008, PSYCHONEUROENDOCRINO, V33, P108, DOI 10.1016/j.psyneuen.2007.10.007; Fang M, 2003, NEUROSCIENCE, V117, P503, DOI 10.1016/S0306-4522(02)00958-2; Fisher K, 1996, PAIN, V68, P255, DOI 10.1016/S0304-3959(96)03212-5; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Genty J, 2018, NEUROSCI LETT, V674, P117, DOI 10.1016/j.neulet.2018.03.044; Genty J, 2018, NEUROBIOL STRESS, V8, P21, DOI 10.1016/j.ynstr.2017.11.002; Golovatscka V, 2012, NEUROIMMUNOMODULAT, V19, P367, DOI 10.1159/000342092; Guo W, 2002, J NEUROSCI, V22, P6208; Hurley LL, 2014, BEHAV BRAIN RES, V268, P1, DOI 10.1016/j.bbr.2014.03.052; Iwata M, 2016, BIOL PSYCHIAT, V80, P12, DOI 10.1016/j.biopsych.2015.11.026; Jankord R, 2011, ENDOCRINOLOGY, V152, P629, DOI 10.1210/en.2010-0658; JONES MW, 1995, NEUROPHARMACOLOGY, V34, P1025, DOI 10.1016/0028-3908(95)00055-B; Juif PE, 2016, EUR J NEUROSCI, V44, P1952, DOI 10.1111/ejn.13294; Konig C, 2016, J NEUROSCI, V36, P9782, DOI 10.1523/JNEUROSCI.4159-15.2016; Konig C, 2014, ARTHRITIS RHEUMATOL, V66, P599, DOI 10.1002/art.38271; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Larsson M, 2009, MOL NEUROBIOL, V40, P260, DOI 10.1007/s12035-009-8086-8; Le Coz GM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00070; Lee PR, 2003, MOL BRAIN RES, V115, P55, DOI 10.1016/S0169-328X(03)00180-3; Lin T, 2007, J NEUROIMMUNOL, V192, P40, DOI 10.1016/j.jneuroim.2007.09.003; Lino-de-Oliveira C, 2002, NEUROSCI LETT, V335, P87, DOI 10.1016/S0304-3940(02)01119-9; Liu XJ, 2010, EUR J NEUROSCI, V32, P278, DOI 10.1111/j.1460-9568.2010.07351.x; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mayhew J, 2015, J NEUROENDOCRINOL, V27, P498, DOI 10.1111/jne.12273; McCormick CM, 2010, BRAIN COGNITION, V72, P73, DOI 10.1016/j.bandc.2009.06.003; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2010, METABOLISM, V59, pS9, DOI 10.1016/j.metabol.2010.07.012; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORMEDE P, 1990, PHYSIOL BEHAV, V47, P1099, DOI 10.1016/0031-9384(90)90358-B; Musholt K, 2009, DEV NEUROBIOL, V69, P203, DOI 10.1002/dneu.20694; Neugebauer V, 1999, J NEUROPHYSIOL, V82, P272, DOI 10.1152/jn.1999.82.1.272; Nishinaka T, 2016, EUR J PAIN, V20, P1346, DOI 10.1002/ejp.860; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Pfau ML, 2015, NEUROBIOL STRESS, V1, P66, DOI 10.1016/j.ynstr.2014.09.004; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Prusator DK, 2016, NEUROGASTROENT MOTIL, V28, P1876, DOI 10.1111/nmo.12891; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Roque S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00192; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; SAPOLSKY RM, 1986, BRAIN RES REV, V11, P65, DOI 10.1016/0165-0173(86)90010-X; SARLIS NJ, 1992, ENDOCRINOLOGY, V130, P1775, DOI 10.1210/en.130.4.1775; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Stark JL, 2001, AM J PHYSIOL-REG I, V280, pR1799, DOI 10.1152/ajpregu.2001.280.6.R1799; Sterlemann V, 2010, HIPPOCAMPUS, V20, P540, DOI 10.1002/hipo.20655; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Strekalova T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-9; Szekanecz Z, 2000, ARTHRITIS RHEUM, V43, P1266, DOI 10.1002/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P; Tirelli E, 2003, NEUROSCI BIOBEHAV R, V27, P163, DOI 10.1016/S0149-7634(03)00018-6; Tsang SW, 2012, EUR J PAIN, V16, P463, DOI 10.1016/j.ejpain.2011.07.005; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; VANBODEGOM M, 2017, FRONT CELL NEUROSCI, V11, DOI DOI 10.3389/FNCEL.2017.00001; Vazquez E, 2012, ARTHRITIS RHEUM-US, V64, P2233, DOI 10.1002/art.34384; Vilela FC, 2017, INT J DEV NEUROSCI, V62, P8, DOI 10.1016/j.ijdevneu.2017.07.003; Vincent MY, 2014, EUR J NEUROSCI, V39, P1671, DOI 10.1111/ejn.12538; Walker K, 2001, NEUROPHARMACOLOGY, V40, P1, DOI 10.1016/S0028-3908(00)00113-1; Wang SX, 2006, PAIN, V120, P78, DOI 10.1016/j.pain.2005.10.015; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Wood SK, 2015, NEUROBIOL STRESS, V1, P164, DOI 10.1016/j.ynstr.2014.11.002; Zalosnik MI, 2014, STRESS, V17, P445, DOI 10.3109/10253890.2014.936005; Zhang HY, 2015, NEUROSCI LETT, V592, P76, DOI 10.1016/j.neulet.2015.03.006; Zhu J, 1998, J NEUROSCI RES, V54, P373, DOI 10.1002/(SICI)1097-4547(19981101)54:3<373::AID-JNR8>3.3.CO;2-Q	103	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202599	10.1371/journal.pone.0202599	http://dx.doi.org/10.1371/journal.pone.0202599			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142161	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500021
J	Tan, ZF; Meng, H; Dong, DW; Zhao, Y; Xu, AD				Tan, Zefeng; Meng, Heng; Dong, Dawei; Zhao, Ying; Xu, Anding			Blood pressure variability estimated by ARV is a predictor of poor short-term outcomes in a prospective cohort of minor ischemic stroke	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; TIME RATE; PLASMINOGEN-ACTIVATOR; IMPACT; CLASSIFICATION; COMPLICATIONS; THROMBOLYSIS; PROFILES; CHINA; INDEX	Prior studies have shown that patients with minor ischemic stroke have substantial disability rates at hospital discharge. We sought to determine whether blood pressure variability (BPV) estimated by average real variability (ARV) is one of the predictors of poor outcome at 90 days. Four hundred fifty-one consecutive patients with ischemic stroke treated within 7 days after onset were enrolled prospectively. Baseline magnetic resonance imaging (MRI) was performed on all subjects. Blood pressure was measured for all recruited patients every 2 hours in the first 24 hours after admission, followed by measurements collected every 4 hours from day 2 to day 7 after admission. ARV was used to estimate BPV. A total of 192 patients with minor ischemic stroke were enrolled, and 11 of them (5.7%) had poor outcomes. Univariate regression analysis showed that early neurological deterioration (X-2 = 21.44, P = 0.000), severe symptomatic large artery stenosis or occlusion (X-2 = 9.260, P = 0.000), large artery atherosclerotic stroke (X-2 = 7.14, P = 0.002), total cholesterol (TC), and D2-7 SBP-ARV (t = 5.449, P = 0.001) of the poor outcome group were significantly higher than those of the good outcome group. Multivariate logistic regression analysis showed that early neurological deterioration (OR 4.369, 95% CI 3.54, 15.65; P = 0.001), severe symptomatic large artery stenosis or occlusion (OR 5.56, 95% CI 3.56, 13.65; P = 0.000), large artery atherosclerotic stroke (OR 3.56, 95% CI 1.45, 7.48; P = 0.004), and D2-7 SBP-ARV (OR 3.96, 95% CI 1.90, 20.18, P = 0.008) were significantly related to poor outcomes. In conclusion, approximately 5.7% of minor ischemic stroke patients had poor outcomes. D2-7 SBP-ARV, early neurologic deterioration, severe symptomatic artery stenosis or occlusion, and large atherosclerotic stroke were the independent risk factors of poor short-term outcomes.	[Tan, Zefeng; Meng, Heng; Dong, Dawei; Zhao, Ying; Xu, Anding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Jinan University	Xu, AD (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	tlil@jnu.edu.cn		Tan, Zefeng/0000-0001-8284-612X	Natural Science Foundation of Guangdong Province [2014A030313384]; Cultivation and Innovation Fund of Jinan University [2161533]; Medical Scientific Research Foundation of Guangdong Province [201512316463467]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Cultivation and Innovation Fund of Jinan University; Medical Scientific Research Foundation of Guangdong Province	This work was supported by Natural Science Foundation of Guangdong Province (No.2014A030313384), the Cultivation and Innovation Fund of Jinan University (grant No. 2161533), Medical Scientific Research Foundation of Guangdong Province, (No. 201512316463467), http://kyjj.gdwskj.cn/.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Aslanyan S, 2003, STROKE, V34, P2420, DOI 10.1161/01.STR.0000091233.04524.0C; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bilo G, 2007, J HYPERTENS, V25, P2058, DOI 10.1097/HJH.0b013e32829c6a60; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; Chalmers J, 1999, J HYPERTENS, V17, P151; Delgado-Mederos R, 2008, NEUROLOGY, V71, P552, DOI 10.1212/01.wnl.0000318294.36223.69; Dolan E, 2010, HYPERTENSION, V56, P179, DOI 10.1161/HYPERTENSIONAHA.110.154708; Endo K, 2013, STROKE, V44, P816, DOI 10.1161/STROKEAHA.112.681007; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Fink JN, 2001, NEUROLOGY, V57, P1739, DOI 10.1212/WNL.57.9.1739; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; Ishitsuka K, 2014, HYPERTENSION, V63, P54, DOI 10.1161/HYPERTENSIONAHA.113.02189; Kang J, 2012, NEUROLOGY, V79, P2018, DOI 10.1212/WNL.0b013e3182749eb8; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Li Y, 2006, HYPERTENSION, V47, P359, DOI 10.1161/01.HYP.0000200695.34024.4c; MacWilliam JA, 1914, BRIT MED J, V1914, P693, DOI 10.1136/bmj.1.2778.693; Mancia G, 1997, HDB HYPERTENSION PAT, V17, P117; Manios E, 2011, J HYPERTENS, V29, P1109, DOI 10.1097/HJH.0b013e3283454ff4; Manning LS, 2015, STROKE, V46, P2482, DOI 10.1161/STROKEAHA.115.010075; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Ohkubo T, 2007, J EPIDEMIOL, V17, P109, DOI 10.2188/jea.17.109; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Pierdomenico SD, 2006, AM J HYPERTENS, V19, P991, DOI 10.1016/j.amjhyper.2006.03.009; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Saeed NP, 2013, CEREBROVASC DIS, V35, P257, DOI 10.1159/000347075; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Sare GM, 2009, STROKE, V40, P2098, DOI 10.1161/STROKEAHA.108.539155; Sato S, 2014, NEUROLOGY, V83, P174, DOI 10.1212/WNL.0000000000000572; Schillaci G, 2014, HYPERTENSION, V63, P217, DOI 10.1161/HYPERTENSIONAHA.113.02436; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Smith EE, 2011, STROKE, V42, P3110, DOI 10.1161/STROKEAHA.111.613208; Stamatelopoulos KS, 2010, J HYPERTENS, V28, P51, DOI 10.1097/HJH.0b013e328331b6c8; Stead LG, 2006, NEUROLOGY, V66, P1878, DOI 10.1212/01.wnl.0000219628.78513.b5; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tomii Y, 2011, STROKE, V42, P3511, DOI 10.1161/STROKEAHA.111.628586; Verdecchia P, 2007, AM J HYPERTENS, V20, P154, DOI 10.1016/j.amjhyper.2006.07.017; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wu LY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0505-z; Yamamoto H, 1998, ARCH NEUROL-CHICAGO, V55, P481, DOI 10.1001/archneur.55.4.481; Yong M, 2005, STROKE, V36, P2619, DOI 10.1161/01.STR.0000189998.74892.24; Yong M, 2008, STROKE, V39, P366, DOI 10.1161/STROKEAHA.107.492330; Zakopoulos NA, 2005, HYPERTENSION, V45, P505, DOI 10.1161/01.HYP.0000158306.87582.43; Zakopoulos NA, 2006, J HYPERTENS, V24, P2071, DOI 10.1097/01.hjh.0000244957.47114.88; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202317	10.1371/journal.pone.0202317	http://dx.doi.org/10.1371/journal.pone.0202317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142202	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500009
J	Tran, VT; Djima, MM; Messou, E; Moisan, J; Gregoire, JP; Ekouevi, DK				Viet-Thi Tran; Djima, Mariam Mama; Messou, Eugene; Moisan, Jocelyne; Gregoire, Jean-Pierre; Ekouevi, Didier K.			Avoidable workload of care for patients living with HIV infection in Abidjan, Cote d'Ivoire: A cross-sectional study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; ADHERENCE; TIME; REGIMENS; IMPROVE; QUALITY; BURDEN; HEALTH; MODEL	Objective People living with HIV infection (PLWHIV) in Sub-Saharan Africa cope with an increasing workload of care (doctor visits, lab tests, medication management, refills, etc.) in a context of poor health service organization. We aimed to describe the workload of care for PLWHIV in Sub-Saharan Africa and assess to what extent simple adjustments in care organization could reduce this workload of care. Methods Adult PLWHIV under antiretroviral treatment for at least 1 year were recruited in three centers (two public, one private) in Abidjan, Cote d'Ivoire. Using methods inspired from sociology, we precisely described all health-related activities (HRAs) performed by patients, in 1 month, in terms of time, money and opportunity costs. Then, we assessed the theoretical avoidable workload of care if patients' visits and tests had been grouped on the same days. Results We enrolled 476 PLWHIV in the study. Patients devoted 6.7 hours (SD = 6.3), on average, in HRAs per month and spent 5% (SD = 11) of their monthly revenue, on average, on health activities. However, we found great inter-patient heterogeneity in the mixture of activities performed (managing medications; dietary recommendations; visits, tests, support groups; administrative tasks; etc.) and their time allocation, temporal dispersion and opportunity costs (personal, familial, social or professional costs). For 22% of patients, grouping activities on the same days could reduce both time and cost requirements by 20%. Conclusion PLWHIV in Cote d'Ivoire have a heavy workload of care. Grouping visits and tests on the same days may be a simple and feasible way to reduce patients' investment of time and money in their care.	[Viet-Thi Tran; Djima, Mariam Mama; Messou, Eugene; Ekouevi, Didier K.] Programme PAC CI, Abidjan, Cote Ivoire; [Viet-Thi Tran] Ctr Rech Epidemiol & Stat Sorbonne Paris Cite, METHODS Team, CRESS, UMR1153, Paris, France; [Djima, Mariam Mama] Inst Pasteur, Abidjan, Cote Ivoire; [Djima, Mariam Mama; Moisan, Jocelyne; Gregoire, Jean-Pierre] Laval Univ, Fac Pharm, Quebec City, PQ, Canada; [Ekouevi, Didier K.] Bordeaux Populat Hlth UMR1219, Bordeaux, France	UDICE-French Research Universities; Universite Paris Cite; Laval University	Tran, VT (corresponding author), Programme PAC CI, Abidjan, Cote Ivoire.; Tran, VT (corresponding author), Ctr Rech Epidemiol & Stat Sorbonne Paris Cite, METHODS Team, CRESS, UMR1153, Paris, France.	thi-tran-viet@aphp.fr	EKOUEVI, Didier K/E-7960-2014; Tran, Viet-Thi/Q-2789-2019; Tran, Viet-Thi/F-1023-2018	Tran, Viet-Thi/0000-0003-1863-6739; Tran, Viet-Thi/0000-0003-1863-6739	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales - ANRS) [12365]; Fondation pour la Recherche Medicale [40284]	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales - ANRS); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales - ANRS) [grant number 12365]; and the "Fondation pour la Recherche Medicale" [grant number 40284 to Viet-Thi Tran]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Belli RF, 1998, MEMORY, V6, P383, DOI 10.1080/741942610; Bezabhe WM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003361; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Croome N, 2017, AIDS, V31, P995, DOI 10.1097/QAD.0000000000001416; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; du Vaure CB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010119; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ellman T, 2015, NEW ENGL J MED, V372, P303, DOI 10.1056/NEJMp1414730; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Gandhi RT, 2012, CLIN INFECT DIS, V54, P733, DOI 10.1093/cid/cir933; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Haas AD, 2015, LANCET HIV, V2, pE271, DOI 10.1016/S2352-3018(15)00087-9; Hirschhorn Lisa R, 2012, AIDS, V26 Suppl 1, pS65; Hoffmann CJ, 2016, AIDS EDUC PREV, V28, P351, DOI 10.1521/aeap.2016.28.4.351; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Jowsey T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1044; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kwena ZA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19876; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; Mabuto T, 2018, AIDS BEHAV, V22, P3751, DOI 10.1007/s10461-018-2089-2; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Ministere de la Lutte contre le Sida. Suivi de la declaration d'engagement sur le VIH/SIDA (UNGASS), 2008, SUIV DECL ENG VIH SI; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Naidoo L, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.1084; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Russell LB, 2005, J FAM PRACTICE, V54, P52; Sebaaly JC, 2017, ANN PHARMACOTHER, V51, P332, DOI 10.1177/1060028016682531; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Sidorkiewicz S, 2016, ANN FAM MED, V14, P415, DOI 10.1370/afm.1965; Sidorkiewicz S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010510; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x; Tran VT, 2016, MOTUHS BOT STUDY PRO; UNAIDS, 2014, 90 90 90 AMB TREATM; Vrijens B, 2005, STAT MED, V24, P2719, DOI 10.1002/sim.2130; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011	43	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202911	10.1371/journal.pone.0202911	http://dx.doi.org/10.1371/journal.pone.0202911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142165	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500048
J	Kohatsu, L; Bolu, O; Schmitz, ME; Chang, KR; Lemwayi, R; Arnett, N; Mwasekaga, M; Nkengasong, J; Mosha, F; Westerman, LE				Kohatsu, Luciana; Bolu, Omotayo; Schmitz, Mary E.; Chang, Karen; Lemwayi, Ruth; Arnett, Nichole; Mwasekaga, Michael; Nkengasong, John; Mosha, Fausta; Westerman, Larry E.			Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube	PLOS ONE			English	Article							T-CELL ENUMERATION; CAPILLARY BLOOD; COUNTS; SETTINGS; CLINICS	Introduction Effective point-of-care testing (POCT) is reliant on optimal specimen collection, quality assured testing, and expedited return of results. Many of the POCT are designed to be used with fingerstick capillary blood to simplify the blood collection burden. However, fingerstick blood collection has inherent errors in sampling. An evaluation of the use of capillary and venous blood with CD4 POCT was conducted. Methods Three different specimen collection methods were evaluated for compatibility using the Alere Pima CD4 assay at 5 HIV/AIDS healthcare sites in Dar es Salaam, Tanzania. At each site, whole blood specimens were collected from enrolled patients by venipuncture and fingerstick. Pima CD4 testing was performed at site of collection on venipuncture specimens (Venous) and fingerstick blood directly applied to a Pima CD4 cartridge (Capillary-Direct) and collected into an EDTA microtube (Capillary-Microtube). Venous blood was also tested at the laboratory by the reference CD4 method and Pima for comparison analysis. Results All three specimen collection methods were successfully collected by healthcare workers for use with the Pima CD4 assay. When compared to the reference CD4 method, Pima CD4 testing with the Capillary-Microtube method performed similarly to Venous, while Pima CD4 counts with the Capillary-Direct method were slightly more biased (-20 cells/mu L) and variable (-229 to +189 cells/mu L limit of agreement). Even though all three collection methods had similar invalid Pima testing rates (10.5%, 9.8%, and 8.3% for Capillary-Direct, Capillary-Microtube, and Venous respectively), the ability to perform repeat testing with Capillary-Microtube and Venous specimens increased the likelihood of acquiring a valid CD4 result with the Pima assay. Conclusions Capillary blood, either directly applied to Pima CD4 cartridges or collected in an EDTA microtube, and venous blood are suitable specimens for Pima CD4 testing. The advantages of capillary blood collection in an EDTA microtube are that it uses fingerstick collection which mimics venous blood and allows extra testing without additional blood collection.	[Kohatsu, Luciana; Bolu, Omotayo; Arnett, Nichole; Nkengasong, John; Westerman, Larry E.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Schmitz, Mary E.; Chang, Karen; Mwasekaga, Michael] US Ctr Dis Control & Prevent, Dar Es Salaam, Tanzania; [Schmitz, Mary E.; Chang, Karen] Assoc Sch & Programs Publ Hlth, Allan Rosenfield Global Hlth Fellowship, Washington, DC USA; [Lemwayi, Ruth; Mosha, Fausta] African Field Epidemiol Network, Dar Es Salaam, Tanzania; [Mosha, Fausta] Govt Tanzania, Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania	Centers for Disease Control & Prevention - USA	Kohatsu, L; Westerman, LE (corresponding author), US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA.	iee2@cdc.gov; lwesterman@cdc.gov		Westeman, Larry/0000-0001-9564-0673	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [U2GPS002728]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (U2GPS002728) to OB.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bond MM, 2015, AM J CLIN PATHOL, V144, P885, DOI 10.1309/AJCP1L7DKMPCHPEH; (CLSI) CLSI, 2008, APPR STAND, V28, pH04; DAAE LNW, 1988, SCAND J CLIN LAB INV, V48, P723, DOI 10.3109/00365518809085796; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kayiran SM, 2003, CLIN LAB HAEMATOL, V25, P9, DOI 10.1046/j.1365-2257.2003.00484.x; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; MacLennan CA, 2007, AIDS, V21, P1643, DOI 10.1097/QAD.0b013e32823bcb03; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Neufeld L, 2002, SALUD PUBLICA MEXICO, V44, P219, DOI 10.1590/S0036-36342002000300005; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sitoe N, 2011, J IMMUNOL METHODS, V372, P1, DOI 10.1016/j.jim.2011.07.008; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Tatsumi N, 2002, INT J HEMATOL, V75, P261, DOI 10.1007/BF02982039; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; Wade D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075484; WESTGARD JO, 1973, CLIN CHEM, V19, P49; Westgard JO., 2020, BASIC METHOD VALIDAT, V4th ed.; World Health Organization, 2015, GUID START ANT THER; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yang ZW, 2001, CLIN LAB HAEMATOL, V23, P155, DOI 10.1046/j.1365-2257.2001.00388.x; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202018	10.1371/journal.pone.0202018	http://dx.doi.org/10.1371/journal.pone.0202018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138398	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100034
J	Pothmann, CEM; Baumann, S; Jensen, KO; Mica, L; Osterhoff, G; Simmen, HP; Sprengel, K				Pothmann, Carina Eva Maria; Baumann, Stephen; Jensen, Kai Oliver; Mica, Ladislav; Osterhoff, Georg; Simmen, Hans-Peter; Sprengel, Kai			Assessment of polytraumatized patients according to the Berlin Definition: Does the addition of physiological data really improve interobserver reliability?	PLOS ONE			English	Article							INJURY SEVERITY SCORE; TRAUMA; SCALE; INTERRATER; AGREEMENT; TRISS; CARE; ISS	Background Several new definitions for categorizing the severely injured as the Berlin Definition have been developed. Here, severely injured patients are selected by additive physiological parameters and by the general Abbreviated Injury Scale (AIS)-based assessment. However, all definitions should conform to an AIS severity coding applied by an expert. We examined the dependence of individual coding on defining injury severity in general and in identifying polytrauma according to several definitions. A precise definition of polytrauma is important for quality management. Methods We investigated the interobserver reliability (IR) between several polytrauma definitions for identifying polytrauma using several cut-off levels (ISS >= 16, >= 18, >= 20, >= 25 points, and the Berlin Definition). One hundred and eighty-seven patients were included for analyzing IR of the polytrauma definitions. IR for polytrauma definitions was assessed by Cohen's kappa. Results IR for identifying polytrauma according to the relevant definitions showed moderate agreement (<0.60) in the ISS cutoff categories (ISS >= 16, >= 18, and >= 20 points), while ISS >= 25 points just reached substantial agreement (0.62) and the Berlin Definition demonstrated a correlation of 0.77 which is nearly perfect agreement (>0.80). Conclusion Compared with the ISS-based definitions of polytrauma, the Berlin Definition proved less dependent on the individual rater. This underlines the need to redefine the selection of severely injured patients. Using the Berlin Definition for identifying polytrauma could improve the comparability of patient data across studies, in trauma center benchmarking, and in quality assurance.	[Pothmann, Carina Eva Maria; Baumann, Stephen; Jensen, Kai Oliver; Mica, Ladislav; Osterhoff, Georg; Simmen, Hans-Peter; Sprengel, Kai] Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Sprengel, K (corresponding author), Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland.	kai.sprengel@usz.ch	Jensen, Kai/AAF-2316-2020; Sprengel, Kai/G-4780-2014	Simmen, Hans-Peter/0000-0002-5201-4549; Sprengel, Kai/0000-0001-5921-8272; Pothmann, Carina/0000-0003-1973-3151; Jensen, Kai Oliver/0000-0002-6207-8087; Osterhoff, Georg/0000-0001-5051-0998				[Anonymous], 1971, JAMA, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Butcher NE, 2013, J TRAUMA ACUTE CARE, V74, P884, DOI 10.1097/TA.0b013e31827e1bad; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249; Gennarelli TA, 2008, ABBREVIATED INJURY S; Gordic S, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140616; Joosse P, 2014, HEALTH INF MANAG J, V43, P17, DOI 10.1177/183335831404300203; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; MacKenzie EJ, 1978, P AM ASS AUTOMOTIVE, V22, P55; Moos RM, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14334; Neale Rachel, 2003, Emerg Med (Fremantle), V15, P38, DOI 10.1046/j.1442-2026.2003.00406.x; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032; Rogers FB, 1997, J TRAUMA, V43, P65, DOI 10.1097/00005373-199707000-00016; TEASDALE G, 1974, LANCET, V2, P81; TSCHERNE H, 1984, LANGENBECK ARCH CHIR, V364, P71, DOI 10.1007/BF01823174; WAYDHAS C, 1992, UNFALLCHIRURG, V95, P67; World Health Organization, 2004, GLOBAL BURDEN DIS; ZOLTIE N, 1993, BMJ-BRIT MED J, V307, P906, DOI 10.1136/bmj.307.6909.906	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201818	10.1371/journal.pone.0201818	http://dx.doi.org/10.1371/journal.pone.0201818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138313	Green Published, Green Accepted, gold			2022-12-26	WOS:000442800100025
J	Sandstedt, M; Sopasakis, VR; Lundqvist, A; Vukusic, K; Oldfors, A; Dellgren, G; Sandstedt, J; Hulten, LM				Sandstedt, Mikael; Sopasakis, Victoria Rotter; Lundqvist, Annika; Vukusic, Kristina; Oldfors, Anders; Dellgren, Goran; Sandstedt, Joakim; Hulten, Lillemor Mattsson			Hypoxic cardiac fibroblasts from failing human hearts decrease cardiomyocyte beating frequency in an ALOX15 dependent manner	PLOS ONE			English	Article							12/15 LIPOXYGENASE; 12/15-LIPOXYGENASE; BAICALEIN; EXPRESSION; 15-LIPOXYGENASE-2; INFLAMMATION; MACROPHAGES; INHIBITORS; INJURY; POTENT	A common denominator for patients with heart failure is the correlation between elevated serum levels of proinflammatory cytokines and adverse clinical outcomes. Furthermore, lipoxygenase-induced inflammation is reportedly involved in the pathology of heart failure. Cardiac fibroblasts, which are abundant in cardiac tissue, are known to be activated by inflammation. We previously showed high expression of the lipoxygenase arachidonate 15 lipoxygenase (ALOX15), which catalyzes the conversion of arachidonic acid to 15-hydroxy eicosatetraenoic acid (15-HETE), in ischemic cardiac tissue. The exact roles of ALOX15 and 15-HETE in the pathogenesis of heart failure are however unknown. Biopsies were collected from all chambers of explanted failing human hearts from heart transplantation patients, as well as from the left ventricles from organ donors not suffering from chronic heart failure. Biopsies from the left ventricles underwent quantitative immunohistochemical analysis for ALOX15/B. Gene expression of ALOX enzymes, as well as 15-HETE levels, were examined in cardiac fibroblasts which had been cultured in either hypoxic or normoxic conditions after isolation from failing hearts. After the addition of fibroblast supernatants to human induced pluripotent stem cell-derived cardiomyocytes, intracellular calcium concentrations were measured to examine the effect of paracrine signaling on cardiomyocyte beating frequency. While ALOX15 and ALOX15B were expressed throughout failing hearts as well as in hearts from organ donors, ALOX15 was expressed at significantly higher levels in donor hearts. Hypoxia resulted in a significant increase in gene and protein expression of ALOX15 and ALOX15B in fibroblasts isolated from the different chambers of failing hearts. Finally, preconditioned medium from hypoxic fibroblasts decreased the beating frequency of human cardiomyocytes derived from induced pluripotent stem cells in an ALOX15-dependent manner. In summary, our results demonstrate that ALOX15/B signaling by hypoxic cardiac fibroblasts may play an important role in ischemic cardiomyopathy, by decreasing cardiomyocyte beating frequency.	[Sandstedt, Mikael; Sopasakis, Victoria Rotter; Vukusic, Kristina; Sandstedt, Joakim; Hulten, Lillemor Mattsson] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Sandstedt, Mikael; Sopasakis, Victoria Rotter; Vukusic, Kristina; Sandstedt, Joakim; Hulten, Lillemor Mattsson] Univ Gothenburg, Dept Clin Chem & Transfus Med, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Lundqvist, Annika; Hulten, Lillemor Mattsson] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden; [Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol & Genet, Gothenburg, Sweden; [Dellgren, Goran] Univ Gothenburg, Dept Cardiothorac Surg, Sahlgrenska Univ Hosp, Gothenburg, Sweden; [Dellgren, Goran] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Hulten, LM (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem, Gothenburg, Sweden.; Hulten, LM (corresponding author), Univ Gothenburg, Dept Clin Chem & Transfus Med, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.; Hulten, LM (corresponding author), Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	Lillemor.Mattsson@wlab.gu.se	Sandstedt, Mikael/GRO-7230-2022	Sandstedt, Mikael/0000-0002-3124-6359; Oldfors, Anders/0000-0002-5758-7397; Mattsson Hulten, Lillemor/0000-0003-1273-3466	Swedish Research Council [2013-03558]; Swedish Heart-Lung Foundation [20150355]; Swedish Federal Government under the LUA/ALF [ALFGBG-426991]; Emelle Foundation, Laboratory Medicine at Sahlgrenska University Hospital; Swedish Society of Medicine; Medical Society of Gothenburg; foundations of Sahlgrenska University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Federal Government under the LUA/ALF; Emelle Foundation, Laboratory Medicine at Sahlgrenska University Hospital; Swedish Society of Medicine; Medical Society of Gothenburg; foundations of Sahlgrenska University Hospital	This work was supported by the Swedish Research Council 2013-03558, the Swedish Heart-Lung Foundation 20150355, the Swedish Federal Government under the LUA/ALF agreement ALFGBG-426991, the Emelle Foundation, Laboratory Medicine at Sahlgrenska University Hospital, the Swedish Society of Medicine, the Medical Society of Gothenburg and grants from the foundations of Sahlgrenska University Hospital.	Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haworth RA, 2010, AM J PHYSIOL-HEART C, V299, pH165, DOI 10.1152/ajpheart.00906.2009; Honda M, 2011, J PHARMACOL SCI, V117, P149, DOI 10.1254/jphs.11038FP; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Lapchak PA, 2007, NEUROSCIENCE, V150, P585, DOI 10.1016/j.neuroscience.2007.09.033; Lindner D, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0428-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundqvist A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161629; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; Magnusson LU, 2012, BIOCHEM BIOPH RES CO, V424, P327, DOI 10.1016/j.bbrc.2012.06.117; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Rai G, 2014, J MED CHEM, V57, P4035, DOI 10.1021/jm401915r; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Ripplinger CM, 2009, HEART RHYTHM, V6, P87, DOI 10.1016/j.hrthm.2008.09.019; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Song LN, 2014, APOPTOSIS, V19, P567, DOI 10.1007/s10495-013-0946-z; Spach MS, 2007, CIRC RES, V101, P743, DOI 10.1161/CIRCRESAHA.107.163956; Suzuki H, 2015, DIABETES, V64, P618, DOI 10.2337/db13-1896; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; van Leyen K, 2014, FUTURE MED CHEM, V6, P1853, DOI 10.4155/fmc.14.129; Wu MY, 2012, J CELL BIOCHEM, V113, P2279, DOI 10.1002/jcb.24098	33	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202693	10.1371/journal.pone.0202693	http://dx.doi.org/10.1371/journal.pone.0202693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138423	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100108
J	Schneller, LM; Bansal-Travers, M; Goniewicz, ML; McIntosh, S; Ossip, D; O'Connor, RJ				Schneller, Liane M.; Bansal-Travers, Maansi; Goniewicz, Maciej L.; McIntosh, Scott; Ossip, Deborah; O'Connor, Richard J.			Use of flavored electronic cigarette refill liquids among adults and youth in the US-Results from Wave 2 of the Population Assessment of Tobacco and Health Study (2014-2015)	PLOS ONE			English	Article							PRODUCT USE; NICOTINE; PREFERENCES; REASONS; SMOKERS	Introduction Flavored e-cigarettes are enticing to new users and established cigarette smokers using e-cigarettes to quit smoking due to the wide variety of flavor options. However, specific flavor combinations that are popular among e-cigarette users are understudied. Recently, the Deeming rule extended the US Food and Drug Administration's authority over all tobacco products, including e-cigarettes. Methods The Population Assessment of Tobacco and Health Study Wave 2 data were analyzed to assess the prevalence of self-reported flavor categories that are used individually and in combination with other flavor categories among past 30-day youth and adult e-cigarette users in the US. Results Most youth and adult participants reported using a flavored e-cigarette. Reporting an individual flavor category was more common than reporting a combination of flavor categories. Fruit flavor was the most common flavor category reported among youth, and 'menthol/mint' was most common among adults. Fruit and candy/other sweets were the most common flavor categories reported together among both youth and adult past 30-day e-cigarette users. Conclusions The use of flavored e-cigarettes is very popular among youth and adults. Most consumers reported using a single flavor category, although some consumers did use a combination of flavor categories. Preference for menthol/mint among adults may represent from associations with tobacco cigarettes. Typically, sweeter flavors, such as fruit, were among the most popular flavor categories reported, both individually and in combination with other flavors, while more bitter flavors (i.e.: clove/spice) were less common.	[Schneller, Liane M.; Bansal-Travers, Maansi; Goniewicz, Maciej L.; O'Connor, Richard J.] Roswell Pk Comprehens Canc Ctr, Dept Hlth Behav, Buffalo, NY 14203 USA; [McIntosh, Scott; Ossip, Deborah] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Rochester, NY 14642 USA	University of Rochester	O'Connor, RJ (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Hlth Behav, Buffalo, NY 14203 USA.	Richard.OConnor@Roswellpark.org	Bansal-Travers, Maansi/AFM-0150-2022; Bansal-Travers, Maansi/AAH-2486-2022; Goniewicz, Maciej L/D-8986-2012; Goniewicz, Maciej Lukasz/Z-1604-2019	Bansal-Travers, Maansi/0000-0002-7944-3570; Bansal-Travers, Maansi/0000-0002-7944-3570; Goniewicz, Maciej Lukasz/0000-0001-6748-3068	Roswell Park Cancer Institute; National Cancer Institute (NCI) [P30CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Roswell Park Cancer Institute and National Cancer Institute (NCI) grant P30CA016056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], [No title captured]; Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Audrain-McGovern J, 2016, DRUG ALCOHOL DEPEN, V166, P263, DOI 10.1016/j.drugalcdep.2016.06.030; Berg CJ, 2016, INT J PUBLIC HEALTH, V61, P225, DOI 10.1007/s00038-015-0764-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Coleman BN, 2017, TOB CONTROL, V26, pe117, DOI 10.1136/tobaccocontrol-2016-053462; Dai HY, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2513; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Fairchild AL, 2014, NEW ENGL J MED, V370, P293, DOI 10.1056/NEJMp1313940; Gindi R.M., 2015, ELECT CIGARETTE USE; Hoffman AC, 2016, TOB CONTROL, V25, pii32, DOI 10.1136/tobaccocontrol-2016-053192; Kasza KA, 2017, NEW ENGL J MED, V376, P342, DOI 10.1056/NEJMsa1607538; Kim H, 2016, TOB CONTROL, V25, pii55, DOI 10.1136/tobaccocontrol-2016-053221; Kowitt SD, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040338; Leigh NJ, 2016, TOB CONTROL, V25, pii81, DOI 10.1136/tobaccocontrol-2016-053205; Morean ME, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189015; Pesko MF, 2016, ADDICTION, V111, P734, DOI 10.1111/add.13257; Soule EK, 2016, DRUG ALCOHOL DEPEN, V166, P168, DOI 10.1016/j.drugalcdep.2016.07.007; United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse and United States Department of Health and Human Services. Food and Drug Administration. Center for Tobacco Products, 2017, POP ASS TOB HLTH PAT; Villanti AC, 2017, AM J PREV MED, V53, P139, DOI 10.1016/j.amepre.2017.01.026; Yingst JM, 2017, NICOTINE TOB RES, V19, P1381, DOI 10.1093/ntr/ntw383; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	22	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202744	10.1371/journal.pone.0202744	http://dx.doi.org/10.1371/journal.pone.0202744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138412	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100116
J	Shin, E; Kim, JJ; Lee, S; Ko, KS; Rhee, BD; Han, J; Kim, N				Shin, Eunji; Kim, Jung Joo; Lee, Seonjoong; Ko, Kyung Soo; Rhee, Byoung Doo; Han, Jin; Kim, Nari			Hemodynamics in diabetic human aorta using computational fluid dynamics	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; BLOOD-FLOW; MORTALITY; DISSECTION; SIMULATION; STIFFNESS; PARAMETERS; MORBIDITY; INDEXES; DISEASE	Three-dimensional (3D) computational aortic models have been established to reproduce aortic diseases such as aortic aneurysm and dissection; however, no such models have been developed to study diabetes mellitus (DM). To characterize biomechanical properties of the human aorta with DM, reconstructed aortic CT images were converted into DICOM format, and imported into the 3D segmentation using Mimics software. This resulted in a 3D reconstruction of the complete aorta, including three branches. We applied a pulsatile blood pressure waveform for the ascending aorta to provide a biomimetic environment using COMSOL Multiphysics software. Hemodynamics were compared between the control and DM models. We observed that mean blood flow velocity, aortic pressure, and von Mises stress values were lower in the DM model than in the control model. Furthermore, the range of aortic movement was lower in the DM model than in the control model, suggesting that the DM aortic wall is more susceptible to rupture. When comparing biomechanical properties in discrete regions of the aorta, all values were higher in the ascending aorta for both control and DM models, corresponding to the location of most aortic lesions. We have developed a compute based that integrates advanced image processing strategies and computational techniques based on finite element method to perform hemodynamics analysis based on CT images. Our study of image-based CFD analysis hopes to provide a better understanding of the relationship between aortic hemodynamic and developing pathophysiology of aortic diseases.	[Shin, Eunji; Kim, Jung Joo; Lee, Seonjoong; Han, Jin; Kim, Nari] Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Natl Leading Res Lab Cardiovasc Engn,Dept Physiol, Busan, South Korea; [Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Inje University; Inje University	Kim, N (corresponding author), Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Natl Leading Res Lab Cardiovasc Engn,Dept Physiol, Busan, South Korea.	narikim43@gmail.com		Kim, Jung Joo/0000-0002-4003-1966	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029133, 2011-0028925]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP	This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029133 and 2011-0028925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BD, 2015, J MAGN RESON IMAGING, V42, P954, DOI 10.1002/jmri.24847; Artoli AM, 2006, J BIOMECH, V39, P873, DOI 10.1016/j.jbiomech.2005.01.033; Baieth H E Abdel, 2008, Int J Biomed Sci, V4, P323; Bathe M, 1999, J BIOMECH ENG-T ASME, V121, P361, DOI 10.1115/1.2798332; BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Carson JL, 2002, J AM COLL CARDIOL, V40, P418, DOI 10.1016/S0735-1097(02)01969-1; Coughlin Steven S., 1994, Annals of Epidemiology, V4, P67; CRAWFORD ES, 1990, ANN SURG, V211, P521, DOI 10.1097/00000658-199005000-00002; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Emoto M, 1998, DIABETES CARE, V21, P1178, DOI 10.2337/diacare.21.7.1178; Endo S, 2014, BIORHEOLOGY, V51, P239, DOI 10.3233/BIR-14005; Fata B, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024619; Giannakoulas G, 2005, MED HYPOTHESES, V65, P1191, DOI 10.1016/j.mehy.2005.06.017; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Janka HU, 1996, DIABETES RES CLIN PR, V30, pS85; Khanafer K, 2009, J BIOMECH, V42, P2642, DOI 10.1016/j.jbiomech.2009.08.010; Kleinstreuer C, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-19; Komolafe OA, 2013, INT J MORPHOL, V31, P716, DOI 10.4067/S0717-95022013000200060; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Le Devehat C, 2004, CLIN HEMORHEOL MICRO, V30, P297; Leung JH, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-33; Lin S, 2017, BIOMED RES INT, V2017, DOI [10.1155/2017/70230781016/j.jvs.2010.05.086, DOI 10.1155/2017/70230781016/J.JVS.2010.05.086]; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Mala GM, 1999, INT J HEAT FLUID FL, V20, P142; Marwick TH, 2006, HEART, V92, P296, DOI 10.1136/hrt.2005.067231; Miyama N, 2010, J VASC SURG, V52, P975, DOI 10.1016/j.jvs.2010.05.086; Moore DJ, 2009, VASC HEALTH RISK MAN, V5, P1015; Morris L, 2005, J BIOMECH ENG-T ASME, V127, P767, DOI 10.1115/1.1992521; Nathan DP, 2011, ANN THORAC SURG, V91, P458, DOI 10.1016/j.athoracsur.2010.10.042; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; OXLUND H, 1989, DIABETOLOGIA, V32, P748, DOI 10.1007/BF00274536; Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15; Reymond P, 2013, MED ENG PHYS, V35, P784, DOI 10.1016/j.medengphy.2012.08.009; ROBERTS CS, 1991, J AM COLL CARDIOL, V17, P712, DOI 10.1016/S0735-1097(10)80188-3; Salau B A, 2012, Pak J Biol Sci, V15, P694, DOI 10.3923/pjbs.2012.694.697; Scotti CM, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-64; Shahcheraghi N, 2002, J BIOMECH ENG-T ASME, V124, P378, DOI 10.1115/1.1487357; Smith A, 2005, J AM SOC NEPHROL, V16, P1069, DOI 10.1681/ASN.2004090769; Tang DL, 2005, J BIOMECH ENG-T ASME, V127, P1185, DOI 10.1115/1.2073668; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Vasava P, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/861837; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhou YQ, 2010, ARTERIOSCL THROM VAS, V30, P1181, DOI 10.1161/ATVBAHA.110.204198; Zimmet P., 2002, BR J DIABETES VASC D, V2, P435; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202671	10.1371/journal.pone.0202671	http://dx.doi.org/10.1371/journal.pone.0202671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138473	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100103
J	Takayama, K; Harimoto, K; Sato, T; Sakurai, Y; Taguchi, M; Kanda, T; Takeuchi, M				Takayama, Kei; Harimoto, Kozo; Sato, Tomohito; Sakurai, Yutaka; Taguchi, Manzo; Kanda, Takayuki; Takeuchi, Masaru			Age-related differences in the clinical features of ocular sarcoidosis	PLOS ONE			English	Article							RISK-FACTORS; DIAGNOSIS; HORMONES; UVEITIS; CELLS; LUNG	The distribution of age at diagnosis in ocular sarcoidosis has shifted towards the older age groups in developed countries. In systemic sarcoidosis, age-related differences in the clinical presentation, which reflect the therapeutic strategies, was reported. We retrospectively compared 100 consecutive patients from April 2010 to March 2016 who were initially diagnosed with ocular sarcoidosis by International Workshop on Ocular Sarcoidosis criteria. They were classified into elder (>65 years: 50 patients) and younger (<= 65 years: 50 patients) groups by the age at diagnosis of uveitis associated with sarcoidosis. All patients received ophthalmic examination to assess the presence of seven intraocular signs and 4 laboratory parameters. Significantly fewer ocular signs (2.8 +/- 1.5 and 3.6 +/- 1.5; P = 0.0034) and abnormal laboratory results (1.5 +/- 1.2 and 2.0 +/- 1.2; P = 0.023) were detected in the elder group than in the younger group; statistical differences were found between the groups regarding the frequencies of mutton-fat keratic precipitates (40% and 64%; P = 0.012), vitreous opacities (60% and 78%; P = 0.0059), bilateral inflammation (64% and 80%; P = 0.012), and bilateral hilar lymphadenopathy between the groups (52% and 78%; P < 0.001). Multiple linear regression analysis showed negative correlations between age and number of detected ocular signs (r = -0.36, P < 0.001) and laboratory results (r = -0.20, P = 0.023). The characteristic ocular signs and abnormal laboratory results had a lower frequency in the elder patients compared with the younger patients. Probable or possible ocular sarcoidosis by the international criteria should increase with increased life expectancy in developed countries.	[Takayama, Kei; Harimoto, Kozo; Sato, Tomohito; Sakurai, Yutaka; Taguchi, Manzo; Kanda, Takayuki; Takeuchi, Masaru] Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan	Takeuchi, M (corresponding author), Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama, Japan.	masatake@ndmc.ac.jp		Takeuchi, Masaru/0000-0002-4913-7089	Japan Society for the Promotion of Science [16K11337, 17K16964]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by grants from the Grant-in-Aid for Scientific Research C (M. Takeuchi: 16K11337) and the Grant-in-Aid for Young Scientists B (K.T.: 17K16964) from the Japan Society for the Promotion of Science. The grants and funds had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acharya NR, 2018, OPHTHALMOLOGY, V125, P119, DOI 10.1016/j.ophtha.2017.07.006; Agarwal R, 2013, RESP CARE, V58, P683, DOI 10.4187/respcare.02101; Barnard J, 2005, J OCCUP ENVIRON MED, V47, P226, DOI 10.1097/01.jom.0000155711.88781.91; Bui KM, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/1869-5760-4-8; Cozier YC, 2012, AM J EPIDEMIOL, V176, P635, DOI 10.1093/aje/kws145; Crick RP, 1961, BRIT J OPHTHALMOL, V45, P461; DelaRosa O, 2002, EXP GERONTOL, V37, P213, DOI 10.1016/S0531-5565(01)00186-3; Govender P, 2015, CLIN CHEST MED, V36, P585, DOI 10.1016/j.ccm.2015.08.003; Hazeldine J, 2013, AGEING RES REV, V12, P1069, DOI 10.1016/j.arr.2013.04.003; Herbort CP, 2009, OCUL IMMUNOL INFLAMM, V17, P160, DOI 10.1080/09273940902818861; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; Koba T, 2017, REV PORT PNEUMOL, V23, P331; Merkt W, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0851-7; Mocchegiani E, 2009, J CLIN IMMUNOL, V29, P416, DOI 10.1007/s10875-009-9298-4; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Ocampo VVD, 2001, OPHTHALMOLOGY, V108, P1296, DOI 10.1016/S0161-6420(01)00601-7; OHARA K, 1992, JPN J OPHTHALMOL, V36, P452; Rochepeau C, 2017, BRIT J OPHTHALMOL, V101, P856, DOI 10.1136/bjophthalmol-2016-309767; ROTHOVA A, 1989, DOC OPHTHALMOL, V72, P287, DOI 10.1007/BF00153496; Sawahata M, 2016, SARCOIDOSIS VASC DIF, V33, P112; Sawahata M, 2015, RESP MED, V109, P272, DOI 10.1016/j.rmed.2014.12.012; SHIRAI M, 1995, EUR RESPIR J, V8, P272, DOI 10.1183/09031936.95.08020272; Smith JA, 1998, ADV EXP MED BIOL, V438, P599; Snyder-Cappione JE, 2013, EUR J IMMUNOL, V43, P2194, DOI 10.1002/eji.201243185; Tajima K, 2011, RESPIRATION, V81, P491, DOI 10.1159/000324295; Tondell A, 2014, SARCOIDOSIS VASC DIF, V31, P316	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202585	10.1371/journal.pone.0202585	http://dx.doi.org/10.1371/journal.pone.0202585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138345	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100088
J	Zhang, MX; La Rosa, PS; Eswaran, H; Nehorai, A				Zhang, Mengxue; La Rosa, Patricio S.; Eswaran, Hari; Nehorai, Arye			Estimating uterine source current during contractions using magnetomyography measurements	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; SMOOTH-MUSCLE; PROPAGATION; PREGNANCY; UTERUS; LABOR	Understanding the uterine source of the electrophysiological activity of contractions during pregnancy is of scientific interest and potential clinical applications. In this work, we propose a method to estimate uterine source currents from magnetomyography (MMG) temporal course measurements on the abdominal surface. In particular, we develop a linear forward model, based on the quasistatic Maxwell's equations and a realistic four-compartment volume conductor, relating the magnetic fields to the source currents on the uterine surface through a lead-field matrix. To compute the lead-field matrix, we use a finite element method that considers the anisotropic property of the myometrium. We estimate the source currents by minimizing a constrained least-squares problem to solve the non-uniqueness issue of the inverse problem. Because we lack the ground truth of the source current, we propose to predict the intrauterine pressure from our estimated source currents by using an absolute-value-based method and compare the result with real abdominal deflection recorded during contractile activity. We test the feasibility of the lead-field matrix by displaying the lead fields that are generated by putative source currents at different locations in the myometrium: cervix and fundus, left and right, front and back. We then illustrate our method by using three synthetic MMG data sets, which are generated using our previously developed multiscale model of uterine contractions, and three real MMG data sets, one of which has simultaneous real abdominal deflection measurements. The numerical results demonstrate the ability of our method to capture the local contractile activity of human uterus during pregnancy. Moreover, the predicted intrauterine pressure is in fair agreement with the real abdominal deflection with respect to the timing of uterine contractions.	[Zhang, Mengxue; Nehorai, Arye] Washington Univ, Preston M Green Dept Elect & Syst Engn, St Louis, MO 63130 USA; [La Rosa, Patricio S.] Monsanto Co, Geospatial Analyt, Global IT Analyt, St Louis, MO USA; [Eswaran, Hari] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	Washington University (WUSTL); Monsanto; University of Arkansas System; University of Arkansas Medical Sciences	Nehorai, A (corresponding author), Washington Univ, Preston M Green Dept Elect & Syst Engn, St Louis, MO 63130 USA.	nehorai@wustl.edu		Nehorai, Arye/0000-0002-9055-9865	National Institute of Biomedical Imaging and Bioengineering [R01EB016567]; Monsanto Company	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Monsanto Company	This study was funded by National Institute of Biomedical Imaging and Bioengineering (https://www.nibib.nih.gov/) grant R01EB016567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Monsanto Company provided support in the form of salaries for author PSL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AHLFORS SP, 1992, ELECTROEN CLIN NEURO, V82, P225, DOI 10.1016/0013-4694(92)90172-E; ALVAREZ C H, 1950, Surg Gynecol Obstet, V91, P641; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Barclay M, 2010, REPROD SCI, V17, P948, DOI 10.1177/1933719110376544; Bibin L, 2010, IEEE T BIO-MED ENG, V57, P2346, DOI 10.1109/TBME.2010.2053367; Buhimschi CS, 2009, AM J OBSTET GYNECOL, V200, P1, DOI 10.1016/j.ajog.2008.09.007; El Marroun H, 2012, INT J EPIDEMIOL, V41, P773, DOI 10.1093/ije/dys043; Eswaran H, 2002, AM J OBSTET GYNECOL, V187, P145, DOI 10.1067/mob.2002.123031; Fuchs A. R., 1969, Biology of Reproduction, V1, P344, DOI 10.1095/biolreprod1.4.344; Grant M., 2014, CVX MATLAB SOFTWARE; Gulmezoglu AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945.pub3; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hansen Per Christian, 1998, MATH MODEL COMPUT, V4; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Hunter William, 1774, ANATOMIA UTERI HUMAN; Jeremic A, 2003, P ANN INT IEEE EMBS, V25, P2335, DOI 10.1109/IEMBS.2003.1280384; Khan RN, 1997, AM J PHYSIOL-CELL PH, V273, pC1721, DOI 10.1152/ajpcell.1997.273.5.C1721; La Rosa Patricio S, 2012, BMC Med Phys, V12, P4, DOI 10.1186/1756-6649-12-4; Lai DK, 2009, IEEE ENG MED BIO, P1778, DOI 10.1109/IEMBS.2009.5334014; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; Lammers WJEP, 2015, AM J PHYSIOL-REG I, V309, pR1439, DOI 10.1152/ajpregu.00187.2015; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; LAMMERS WJEP, 1994, AM J PHYSIOL-CELL PH, V267, pC1210, DOI 10.1152/ajpcell.1994.267.5.C1210; Lew S, 2017, CLIN NEUROPHYSIOL, V128, P2470, DOI 10.1016/j.clinph.2017.08.026; McCormick MC, 2011, ANNU REV PUBL HEALTH, V32, P367, DOI 10.1146/annurev-publhealth-090810-182459; Parkington HC, 1999, AM J OBSTET GYNECOL, V181, P1445, DOI 10.1016/S0002-9378(99)70390-X; Peters MJ, 2001, ELECTROMAGNETICS, V21, P545, DOI 10.1080/027263401752246199; Peters MJ, 2005, FETAL MAGNETOCARDIOG, P1, DOI [10.1007/0-387-24024-1_1, DOI 10.1007/0-387-24024-1_1]; PLONSEY R, 1981, MED BIOL ENG COMPUT, V19, P311, DOI 10.1007/BF02442550; Rabotti C, 2015, ACTA PHYSIOL, V213, P406, DOI 10.1111/apha.12424; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P519, DOI 10.1109/TBME.2009.2035440; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Skowronski MD, 2006, IEEE T BIO-MED ENG, V53, P1983, DOI 10.1109/TBME.2006.877104; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; WANG JZ, 1992, IEEE T BIO-MED ENG, V39, P665, DOI 10.1109/10.142641; WILLIAMSON SJ, 1981, J MAGN MAGN MATER, V22, P129, DOI 10.1016/0304-8853(81)90078-0; Yetik IS, 2005, IEEE T BIO-MED ENG, V52, P471, DOI 10.1109/TBME.2004.843289; Young RC, 1999, OBSTET GYNECOL, V93, P94, DOI 10.1016/S0029-7844(98)00345-7; Young RC, 2018, BEST PRACTICE RES CL; Young RC, 2016, REPRODUCTION, V152, pR51, DOI 10.1530/REP-16-0156; Zahran S, 2017, IEEE ENG MED BIO, P2948, DOI 10.1109/EMBC.2017.8037475; Zhang MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152421; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202184	10.1371/journal.pone.0202184	http://dx.doi.org/10.1371/journal.pone.0202184			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138376	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100044
J	DeSantis, LRG; Alexander, J; Biedron, EM; Johnson, PS; Frank, AS; Martin, JM; Williams, L				DeSantis, Larisa R. G.; Alexander, Jagger; Biedron, Eva M.; Johnson, Phyllis S.; Frank, Austin S.; Martin, John M.; Williams, Lindsay			Effects of climate on dental mesowear of extant koalas and two broadly distributed kangaroos throughout their geographic range	PLOS ONE			English	Article							TOOTH WEAR; PHASCOLARCTOS-CINEREUS; NORTH-AMERICA; DIET SELECTION; MARSUPIALIA; PLEISTOCENE; VEGETATION; MICROWEAR; HABITS; HORSES	Dental mesowear analysis can classify the diets of extant herbivores into general categories such as grazers, mixed-feeders, and browsers by using the gross wear patterns found on individual teeth. This wear presumably results from both abrasion (food-on-tooth wear) and attrition (tooth-on-tooth wear) of individual teeth. Mesowear analyses on extinct ungulates have helped generate hypotheses regarding the dietary ecology of mammals across space and time, and recent developments have expanded the use of dental mesowear analysis to herbivorous marsupial taxa including kangaroos, wombats, possums, koalas, and relatives. However, the diet of some of the most ubiquitous kangaroos (e.g., Macropus giganteus) along with numerous other species cannot be successfully classified by dental mesowear analysis. Further, it is not well understood whether climate variables (including precipitation, relative humidity, and temperature) are correlated with dental mesowear variables including various measures of shape and relief. Here, we examine the relationship between dental mesowear variables (including traditional methods scoring the sharpest cusp and a new potential assessment of multiple cusps) and climate variables in the grazers/mixed feeders Macropus giganteus and Macropus fuliginosus, and the obligate browser Phascolarctos cinereus. We find that dental mesowear of mandibular teeth is capable of differentiating the dietary habits of koalas and the kangaroo species. Furthermore, both Macropus giganteus and Phascolarctos cinereus exhibit mesowear correlated with mean minimum temperature, while Macropus fuliginosus dental mesowear is unaffected by temperature, despite significant differences in mean minimum and mean maximum temperature across their distribution (and in the specimens examined here). Contrary to expectations that individuals from drier regions would have blunter and lower relief teeth, dental mesowear is unrelated to proxies of relative aridity-including mean annual precipitation and relative humidity. Collectively, dental mesowear in these marsupials is related to feeding behavior with increased wear in cooler regions (in Macropus giganteus and Phascolarctos cinereus) potentially related to more or different food resources consumed.	[DeSantis, Larisa R. G.; Alexander, Jagger; Biedron, Eva M.; Frank, Austin S.; Martin, John M.; Williams, Lindsay] Vanderbilt Univ, Dept Earth & Environm Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Johnson, Phyllis S.] Vanderbilt Univ, Dept Anthropol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		Johnson, Phyllis/0000-0001-9826-6189; DeSantis, Larisa/0000-0003-1159-9154	National Science Foundation [1455198]; Vanderbilt University	National Science Foundation(National Science Foundation (NSF)); Vanderbilt University	National Science Foundation (#1455198) and Vanderbilt University.	Addinsoft, XLSTAT 2017 DAT AN S; Arman SD, 2015, AUSTRAL ECOL, V40, P909, DOI 10.1111/aec.12273; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Australian Government Bureau of Meteorology, CLIM DAT ONL; Briscoe NJ, 2015, J BIOGEOGR, V42, P791, DOI 10.1111/jbi.12445; Butler K, 2014, PALAEOGEOGR PALAEOCL, V408, P11, DOI 10.1016/j.palaeo.2014.04.024; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Clauss M, 2007, J ZOO WILDLIFE MED, V38, P433, DOI 10.1638/06-032.1; Clifton Irene Delma, 2007, Australian Mammalogy, V29, P85; Davis NE, 2008, WILDLIFE RES, V35, P684, DOI 10.1071/WR08042; DAWSON T. J., 1995, KANGAROOS; DeSantis LRG, 2016, SURF TOPOGR-METROL, V4, DOI 10.1088/2051-672X/4/2/023002; ELLIS WAH, 1995, AUST J ZOOL, V43, P59, DOI 10.1071/ZO9950059; ESRI, 2015, ARCGIS DESKT 10 4 RE; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Gentry AW, 2009, PALAEONTOL Z, V83, P373, DOI 10.1007/s12542-009-0018-4; GEORGE GG, 1977, B ZOO MANAGE, V8, P30; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Hedberg C, 2017, J ZOOL, V301, P206, DOI 10.1111/jzo.12413; Kaiser Thomas M., 2006, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V103, P187; Kaiser TM, 2013, MAMMAL REV, V43, P34, DOI 10.1111/j.1365-2907.2011.00203.x; Kaiser TM, 2009, MAMM BIOL, V74, P425, DOI 10.1016/j.mambio.2008.09.003; Kaiser TM, 2003, J MORPHOL, V258, P67, DOI 10.1002/jmor.10125; Kubo MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090745; Loffredo LF, 2014, PALAEOGEOGR PALAEOCL, V395, P42, DOI 10.1016/j.palaeo.2013.12.020; Louys J, 2012, P ROY SOC B-BIOL SCI, V279, P4441, DOI 10.1098/rspb.2012.1473; Martin RW, 1985, WILDLIFE RES, V12, P355, DOI DOI 10.1071/WR9850355; MCARTHUR C, 1988, J ZOOL, V215, P491, DOI 10.1111/j.1469-7998.1988.tb02855.x; Menkhorst P, FIELD GUIDE MAMMALS; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; Moore BD, 2000, AUST J ZOOL, V48, P317, DOI 10.1071/ZO99034; Murphy BP, 2007, GEOCHIM COSMOCHIM AC, V71, P3847, DOI 10.1016/j.gca.2007.05.012; NOWAK RM, 2005, WALKERS MARSUPIALS W; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; Rivals F, 2007, QUATERNARY RES, V68, P338, DOI 10.1016/j.yqres.2007.07.012; Saarinen J, 2016, J QUATERNARY SCI, V31, P799, DOI 10.1002/jqs.2906; SANSON GD, 1980, AUST J ZOOL, V28, P341, DOI 10.1071/ZO9800341; SANSON GD, 1979, ANAT REC, V193, P674; Schmidt B, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P219; Semprebon GM, 2010, PALAEOGEOGR PALAEOCL, V295, P131, DOI 10.1016/j.palaeo.2010.05.033; U.S. National Aeronautics and Space Administration, 2007, SURT MET SOL EN GLOB; ULLREY DE, 1981, AUST J ZOOL, V29, P839, DOI 10.1071/ZO9810839; Yamada E, 2012, MAMM STUDY, V37, P93, DOI 10.3106/041.037.0210	43	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201962	10.1371/journal.pone.0201962	http://dx.doi.org/10.1371/journal.pone.0201962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133503	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400054
J	Kojima, H; Hirooka, K; Nitta, E; Ukegawa, K; Sonoda, S; Sakamoto, T				Kojima, Hirokazu; Hirooka, Kazuyuki; Nitta, Eri; Ukegawa, Kaori; Sonoda, Shozo; Sakamoto, Taiji			Changes in choroidal area after intraocular pressure reduction following trabeculectomy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OCULAR PERFUSION-PRESSURE; NORMAL-TENSION GLAUCOMA; AXIAL LENGTH; THICKNESS; EYES; BINARIZATION; SURGERY; IMAGES	Purpose To investigate changes of the macular and peripapillary choroidal areas after trabeculectomy. Methods This prospective and interventional study examined 74 eyes of 74 patients with glaucoma uncontrolled by medical therapy. Enhanced depth imaging optical coherence tomography (EDI-OCT) recorded macular and peripapillary choroidal images at 1 day before trabeculectomy and at 2 weeks after surgery. The Niblack method was used to covert luminal and interstitial areas to binary images. Results At baseline, the mean intraocular pressure (IOP) was 17.6 +/- 6.3 mmHg, while it was 6.5 +/- 2.9 mmHg after trabeculectomy (P < 0.001). Increases were observed for the macular choroidal area after the surgery, with the total area increasing from 317,853 +/- 95,728 mu m(2) to 368,597 +/- 104,393 mu m(2), while the luminal area increased from 210,355 +/- 73,650 mu m(2) to 249,464 +/- 77,195 mu m(2), and the interstitial area increased from 107,498 +/- 27,613 mu m(2) to 119,133 +/- 31,811 mu m(2) (all P < 0.001). Increases were also observed after the surgery for the peripapillary choroidal area, with the total area increasing from 1,629,440 +/- 460,429 mu m(2) to 1,974,289 +/- 500,496 mu m(2), while the luminal area increased from 920,141 +/- 328,690 mu m(2) to 1,179,843 +/- 357,601 mu m(2), and the interstitial area increased from 709,299 +/- 153,179 mu m(2) to 794,446 +/- 169,029 mu m(2) (all P < 0.001). There was a significant increase in the ratio of the luminal to choroidal area in the macular area (67.2%) and in the peripapillary area (59.1%). Factors associated with the changes in the peripapillary choroidal area included decreases in the diastolic blood pressure and IOP. Conclusions A reduction in the IOP after trabeculectomy led to increases in the macular and peripapillary choroidal areas. Observed changes in the choroidal area after trabeculectomy are primarily due to increases in the luminal areas.	[Kojima, Hirokazu; Hirooka, Kazuyuki; Nitta, Eri; Ukegawa, Kaori] Kagawa Univ, Dept Ophthalmol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa, Japan; [Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Kagawa University; Kagoshima University	Hirooka, K (corresponding author), Kagawa Univ, Dept Ophthalmol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa, Japan.	kazuyk@med.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26462689]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funded by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26462689).	Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chen SD, 2014, INVEST OPHTH VIS SCI, V55, P2608, DOI 10.1167/iovs.13-13595; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Francis BA, 2005, BRIT J OPHTHALMOL, V89, P17, DOI 10.1136/bjo.2004.043950; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Hirooka K, 2012, CLIN EXP OPHTHALMOL, V40, P576, DOI 10.1111/j.1442-9071.2012.02762.x; Huang CK, 2012, CURR EYE RES, V37, P381, DOI 10.3109/02713683.2011.620729; Januleviciene I, 2015, J GLAUCOMA, V24, pe52, DOI 10.1097/IJG.0000000000000055; Kadziauskiene A, 2016, ACTA OPHTHALMOL, V94, P586, DOI 10.1111/aos.13057; Kara N, 2013, EYE, V27, P940, DOI 10.1038/eye.2013.116; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2015, AM J OPHTHALMOL, V160, P1211, DOI 10.1016/j.ajo.2015.08.018; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Zhang XM, 2017, INVEST OPHTH VIS SCI, V58, P3278, DOI 10.1167/iovs.17-21598	22	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201973	10.1371/journal.pone.0201973	http://dx.doi.org/10.1371/journal.pone.0201973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133501	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400055
J	Korshoej, AR; Hansen, FL; Mikic, N; von Oettingen, G; Sorensen, JCH; Thielscher, A				Korshoej, Anders Rosendal; Hansen, Frederik Lundgaard; Mikic, Nikola; von Oettingen, Gorm; Hedemann Sorensen, Jens Christian; Thielscher, Axel			Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations	PLOS ONE			English	Article							RANDOMIZED PHASE-III; ADJUVANT TEMOZOLOMIDE; DIELECTRIC-PROPERTIES; GLIOBLASTOMA; CONDUCTIVITY; STANDARD; THERAPY; TISSUE; CARE; RADIOTHERAPY	Tumor treating fields (TTFields) is a new modality used for the treatment of glioblastoma. It is based on antineoplastic low-intensity electric fields induced by two pairs of electrode arrays placed on the patient's scalp. The layout of the arrays greatly impacts the intensity (dose) of TTFields in the pathology. The present study systematically characterizes the impact of array position on the TTFields distribution calculated in a realistic human head model using finite element methods. We investigate systematic rotations of arrays around a central craniocaudal axis of the head and identify optimal layouts for a large range of (nineteen) different frontoparietal tumor positions. In addition, we present comprehensive graphical representations and animations to support the users' understanding of TTFields. For most tumors, we identified two optimal array positions. These positions varied with the translation of the tumor in the anterior-posterior direction but not in the left-right direction. The two optimal directions were oriented approximately orthogonally and when combining two pairs of orthogonal arrays, equivalent to clinical TTFields therapy, we correspondingly found a single optimum position. In most cases, an oblique layout with the fields oriented at forty-five degrees to the sagittal plane was superior to the commonly used anterior-posterior and left-right combinations of arrays. The oblique configuration may be used as an effective and viable configuration for most frontoparietal tumors. Our results may be applied to assist clinical decision-making in various challenging situations associated with TTFields. This includes situations in which circumstances, such as therapy-induced skin rash, scar tissue or shunt therapy, etc., require layouts alternative to the prescribed. More accurate distributions should, however, be based on patient-specific models. Future work is needed to assess the robustness of the presented results towards variations in conductivity.	[Korshoej, Anders Rosendal; Hansen, Frederik Lundgaard; Mikic, Nikola; von Oettingen, Gorm; Hedemann Sorensen, Jens Christian] Aarhus Univ Hosp, Dept Neurosurg, Aarhus C, Denmark; [Korshoej, Anders Rosendal; Hansen, Frederik Lundgaard; von Oettingen, Gorm; Hedemann Sorensen, Jens Christian] Aarhus Univ, Dept Clin Med, Palle Juul Jensens Blvd, Aarhus N, Denmark; [Thielscher, Axel] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Kettegaards Alle, Hvidovre, Denmark; [Thielscher, Axel] Tech Univ Denmark, Dept Elect Engn, Lyngby, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Technical University of Denmark	Korshoej, AR (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, Aarhus C, Denmark.; Korshoej, AR (corresponding author), Aarhus Univ, Dept Clin Med, Palle Juul Jensens Blvd, Aarhus N, Denmark.	andekors@rm.dk		Thielscher, Axel/0000-0002-4752-5854; Korshoej, Anders/0000-0003-4285-8171	Lundbeckfonden [R118-A11308, R59 A5399]; NovoNordisk fonden [11413]	Lundbeckfonden(Lundbeckfonden); NovoNordisk fonden(Novo Nordisk Foundation)	Lundbeckfonden (PI:Axel Thielscher; Grant Nr. R118-A11308 and PI:Hartwig Siebner; Grant Nr. R59 A5399, Grant of Excellence "ContAct"), an Interdisciplinary Synergy Grant "Basics" sponsored by NovoNordisk fonden (recipients: Hartwig Siebner, Axel Thielscher & Lars K. Hansen, Grant Nr. 11413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SEMINARS ONCOLOGY; [Anonymous], 2016, ENG MED BIOL SOC EMB; [Anonymous], [No title captured]; [Anonymous], 2015, ASCO ANN M P; [Anonymous], 2013, SEMINARS ONCOLOGY; Becker KP, 2012, CANCER J, V18, P12, DOI 10.1097/PPO.0b013e318244d7eb; Correlation of a magnetic resonance brain image and tissue impedance, 1990, P 12 ANN INT C IEEE; Davies AM, 2013, ANN NY ACAD SCI, V1291, P86, DOI 10.1111/nyas.12112; Dobes Martin, 2011, Surg Neurol Int, V2, P176, DOI 10.4103/2152-7806.90696; Dular P, 1998, IEEE T MAGN, V34, P3395, DOI 10.1109/20.717799; Fonkem E, 2012, NOVOTTF 100A NEW TRE; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Gabriel C, 2006, BIOENGINEERING BIOPH, V1, P87; GEDDES LA, 1987, NEUROSURGERY, V20, P94; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; Gera N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125269; Haus H.A., 1989, ELECTROMAGNETIC FIEL; Hottinger AF, 2014, CHIN J CANCER, V33, P32, DOI 10.5732/cjc.013.10207; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Korshoej AR, 2017, NEURO-ONCOLOGY, V19, P73; Korshoej AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179214; Korshoej AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164051; Latikka J, 2001, PHYS MED BIOL, V46, P1611, DOI 10.1088/0031-9155/46/6/302; Lok E, 2017, CANC MED; Lok E, 2015, CANC MED; Lok E, 2015, EXPERT REV MED DEVIC, V12, P717, DOI 10.1586/17434440.2015.1086641; LU Y, 1992, INT J HYPERTHER, V8, P755, DOI 10.3109/02656739209005023; Mehta M, 2017, CRIT REV ONCOL HEMAT, V111, P60, DOI 10.1016/j.critrevonc.2017.01.005; Miranda PC, 2014, PHYS MED BIOL, V59, P4137, DOI 10.1088/0031-9155/59/15/4137; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Mrugala MM, 2013, DISCOV MED, V15, P221; Mun EJ, 2017, CLIN CANCER RES; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Rulseh AM, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-220; Salvador R., 2015, IEEE EMBC; Saturnino GB, 2015, NEUROIMAGE, V120, P25, DOI 10.1016/j.neuroimage.2015.06.067; Stanley Humphries, 1997, FINITE ELEMENT METHO; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou265.40; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taillibert S, 2015, CURR OPIN NEUROL, V28, P659, DOI 10.1097/WCO.0000000000000250; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wenger C, 2018, IEEE REV BIOMEDICAL; Wenger C, 2015, INT J RAD ONCOLOGY B; Wenger C, 2015, PHYS MED BIOL, V60, P7339, DOI 10.1088/0031-9155/60/18/7339; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479	53	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201957	10.1371/journal.pone.0201957	http://dx.doi.org/10.1371/journal.pone.0201957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133493	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400052
J	Mugisho, OO; Rupenthal, ID; Squirrell, DM; Bould, SJ; Danesh-Meyer, HV; Zhang, J; Green, CR; Acosta, ML				Mugisho, Odunayo O.; Rupenthal, Ilva D.; Squirrell, David M.; Bould, Sarah J.; Danesh-Meyer, Helen, V; Zhang, Jie; Green, Colin R.; Acosta, Monica L.			Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy	PLOS ONE			English	Article							BLOOD-RETINAL BARRIER; MACULAR-EDEMA; HYPERREFLECTIVE FOCI; MOUSE MODEL; NOD MICE; CELLS; DEATH; PATHOPHYSIOLOGY; HYPERGLYCEMIA; PERSPECTIVES	Diabetic retinopathy is a vascular disease of the retina characterised by hyperglycaemic and inflammatory processes. Most animal models of diabetic retinopathy are hyperglycaemia-only models that do not account for the significant role that inflammation plays in the development of the disease. In the present study, we present data on the establishment of a new animal model of diabetic retinopathy that incorporates both hyperglycaemia and inflammation. We hypothesized that inflammation may trigger and worsen the development of diabetic retinopathy in a hyperglycaemic environment. Pro-inflammatory cytokines, IL-1 beta and TNF-alpha, were therefore injected into the vitreous of non-obese diabetic (NOD) mice. CD1 mice were used as same genetic background controls. Fundus and optical coherence tomography images were obtained before (day 0) as well as on days 2 and 7 after intravitreal cytokine injection to assess vessel dilation and beading, retinal and vitreous hyper-reflective foci and retinal thickness. Astrogliosis and microgliosis were assessed using immunohistochemistry. Results showed that intravitreal cytokines induced vessel dilation, beading, severe vitreous hyper-reflective foci, retinal oedema, increased astrogliosis and microglia upregulation in diabetic NOD mice. Intravitreal injection of inflammatory cytokines into the eyes of diabetic mice therefore appears to provide a new model of diabetic retinopathy that could be used for the study of disease progression and treatment strategies.	[Mugisho, Odunayo O.; Rupenthal, Ilva D.] Univ Auckland, Dept Ophthalmol, Buchanan Ocular Therapeut Unit, Auckland, New Zealand; [Mugisho, Odunayo O.; Rupenthal, Ilva D.; Squirrell, David M.; Bould, Sarah J.; Danesh-Meyer, Helen, V; Zhang, Jie; Green, Colin R.; Acosta, Monica L.] Univ Auckland, New Zealand Natl Eye Ctr, Auckland, New Zealand; [Squirrell, David M.; Bould, Sarah J.; Danesh-Meyer, Helen, V; Zhang, Jie; Green, Colin R.] Univ Auckland, Dept Ophthalmol, Auckland, New Zealand; [Acosta, Monica L.] Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Acosta, ML (corresponding author), Univ Auckland, New Zealand Natl Eye Ctr, Auckland, New Zealand.; Acosta, ML (corresponding author), Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand.	m.acosta@auckland.ac.nz	Zhang, Jie/I-6135-2019; Green, Colin R/B-5663-2012; Rupenthal, Ilva D/M-5340-2016; Acosta, Monica/H-2700-2019; Mugisho, Lola/AAH-6173-2020	Zhang, Jie/0000-0003-1572-8339; Green, Colin R/0000-0003-3459-6298; Rupenthal, Ilva D/0000-0001-5997-5994; Acosta, Monica/0000-0002-5018-339X; Mugisho, Lola/0000-0002-4519-6727	Lottery Health Research [3707605]; Buchanan Ocular Therapeutics Unit, Faculty of Medical and Health Sciences, University of Auckland, New Zealand	Lottery Health Research; Buchanan Ocular Therapeutics Unit, Faculty of Medical and Health Sciences, University of Auckland, New Zealand	The work was supported by 3707605 Lottery Health Research, https://www.communitymatters.govt.nz/lottery-health-research/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; O.O.M. received a doctoral scholarship from the Buchanan Ocular Therapeutics Unit, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. C.R.G. holds the W&B Hadden Chair in Ophthalmology.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; BETTERLE C, 1984, DIABETOLOGIA, V26, P431; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Coscas G, 2017, ACTA OPHTHALMOL, P95; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; ELASRAR AM, 1992, AM J OPHTHALMOL, V114, P731, DOI 10.1016/S0002-9394(14)74052-8; ELNER SG, 1995, CURR EYE RES, V14, P1045, DOI 10.3109/02713689508998529; Fan HL, 2004, J IMMUNOL, V172, P4834, DOI 10.4049/jimmunol.172.8.4834; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; FERRICK MR, 1991, INVEST OPHTH VIS SCI, V32, P1534; FERRIS FL, 1984, SURV OPHTHALMOL, V28, P452, DOI 10.1016/0039-6257(84)90227-3; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Frydkjaer-Olsen U, 2017, INT OPHTHALMOL; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kheir WJ, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0910-3; Kida T, 2017, GRAEF ARCH CLIN EXP, V255, P1149, DOI 10.1007/s00417-017-3631-z; Kim BY, 2006, AM J OPHTHALMOL, V142, P405, DOI 10.1016/j.ajo.2006.04.023; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kokona D, 2017, EXP EYE RES, V154, P159, DOI 10.1016/j.exer.2016.11.020; Korot E, 2016, JAMA OPHTHALMOL, V134, P15, DOI 10.1001/jamaophthalmol.2015.3949; Lee S, 2008, MICROCIRCULATION, V15, P379, DOI 10.1080/10739680701829802; Li WY, 1997, CHINESE MED J-PEKING, V110, P659; Liao YR, 2017, BIOCHEM BIOPH RES CO, V493, P1136, DOI 10.1016/j.bbrc.2017.08.085; Liu YL, 2012, MOL MED, V18, P1387, DOI 10.2119/molmed.2012.00008; Losso JN, 2010, J AGR FOOD CHEM, V58, P8246, DOI 10.1021/jf1012067; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Masser DR, 2017, J NEUROCHEM, V143, P595, DOI 10.1111/jnc.14216; McLenachan S, 2015, EXP EYE RES, V138, P6, DOI 10.1016/j.exer.2015.06.023; Mizukami T, 2017, OPHTHALMOLOGICA, V238, P74, DOI 10.1159/000473886; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Oswal Kadambari S, 2013, BMC Res Notes, V6, P167, DOI 10.1186/1756-0500-6-167; Rakoczy EP, 2010, AM J PATHOL, V177, P2659, DOI 10.2353/ajpath.2010.090883; Renner M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00254; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Rottgers E, 2009, CLIN EXP OPTOM, V92, P142, DOI 10.1111/j.1444-0938.2008.00335.x; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; SERREZE DV, 1988, J IMMUNOL, V140, P3801; SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625; Shaw SG, 2006, EXP BIOL MED, V231, P1101; Silva PS, 2015, OPHTHALMOLOGY, V122, P949, DOI 10.1016/j.ophtha.2015.01.008; Song SJ, 2014, DIABETES METAB J, V38, P416, DOI 10.4093/dmj.2014.38.6.416; Stefanini FR, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/632307; Sullivan KA, 2008, CURR DRUG TARGETS, V9, P3; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Takahashi Y, 2011, CLIN OPHTHALMOL, V5, P619, DOI 10.2147/OPTH.S20863; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Urbancic M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/251528; Ventura-Oliveira D, 2002, BRAZ J MED BIOL RES, V35, P1347, DOI 10.1590/S0100-879X2002001100013; Wisniewska-Kruk J, 2014, EXP EYE RES, V122, P123, DOI 10.1016/j.exer.2014.03.005; Yeadon J, 2014, SKINNY NONDIABETIC C; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	55	28	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202156	10.1371/journal.pone.0202156	http://dx.doi.org/10.1371/journal.pone.0202156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133488	Green Submitted, gold, Green Published			2022-12-26	WOS:000442500400059
J	Rodriguez-Valero, N; Oroz, ML; Sanchez, DC; Vladimirov, A; Espriu, M; Vera, I; Sanz, S; Moreno, JLG; Munoz, J; Carbayo, MJL				Rodriguez-Valero, Natalia; Luengo Oroz, Miguel; Cuadrado Sanchez, Daniel; Vladimirov, Alexander; Espriu, Marina; Vera, Isabel; Sanz, Sergi; Gonzalez Moreno, Jose Luis; Munoz, Jose; Ledesma Carbayo, Maria Jesus			Mobile based surveillance platform for detecting Zika virus among Spanish Delegates attending the Rio de Janeiro Olympic Games	PLOS ONE			English	Article							BRAZIL; OUTBREAK	Background Zika virus has created a major epidemic in Central and South America, especially in Brazil, during 2015-16. The infection is strongly associated with fetal malformations, mainly microcephaly, and neurological symptoms in adults. During the preparation of the Rio de Janeiro Olympic Games in 2016, members of Olympic Delegations worldwide expressed their concern about the health consequences of being infected with Zika virus. A major risk highlighted by the scientific community was the impact on the spreading of the virus into new territories immediately after the Games. Objectives To detect real-time incidence of symptoms compatible with arboviral diseases and other tropical imported diseases among the Spanish Olympic Delegation (SOD) attending the Rio Olympic Games in 2016. Methods We developed a surveillance platform based on a mobile application installed in participant's smartphones that monitored the health status of the SOD through a daily interactive check of the user health status including geo-localization data. The results were evaluated by a study physician on-call through a web-based platform monitoring system. Participants presenting severe symptoms or those compatible with Zika infection prompted an alarm in the system triggering specialized medical assistance and allowing early detection and control of the introduction of arboviral diseases in Spain. Summary of the results The system was downloaded by 189 participants and used by 143 of them (76%). Median age was 38 years (IQR 16), and 134 (71%) were male. Mean duration of travel was 19 days (+/-9SD). During the Games the highest accumulated incidence observed was for headache: 6.06% cough: 5.30% and conjunctivitis: 3.03%. The incidence rate of cough during the Olympic Games was 1.1% per day per person, followed by headache 0.8% and 0.4% conjunctivitis or diarrhea. In our cohort we observed that non-athletes experienced more incidence of symptoms, except for incidence of cough which was the same in the two groups (1.1%). No participants reported symptoms fulfilling Zika definition case. Conclusion Our system did not find cases fulfilling Zika definition amongst participants of the SOD during the Games, consistent with limited cases of Zika in Rio during the Games. The app showed good usability and the web based monitoring platform allowed to manage infectious cases in real-time. The overall system has proven to serve as a real-time surveillance platform for detecting symptoms that could be present in tropical imported diseases, especially arboviral diseases, contributing to the preparedness for the introduction of vector borne-diseases in non-endemic countries.	[Rodriguez-Valero, Natalia; Espriu, Marina; Vera, Isabel; Sanz, Sergi; Munoz, Jose] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin,Dept Int Hlth, Barcelona, Spain; [Luengo Oroz, Miguel; Cuadrado Sanchez, Daniel; Vladimirov, Alexander; Gonzalez Moreno, Jose Luis; Ledesma Carbayo, Maria Jesus] Univ Politecn Madrid, Biomed Image Technol, Elect Engn, Madrid, Spain; [Luengo Oroz, Miguel; Cuadrado Sanchez, Daniel; Vladimirov, Alexander; Gonzalez Moreno, Jose Luis; Ledesma Carbayo, Maria Jesus] CIBER BBN, Madrid, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universidad Politecnica de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Rodriguez-Valero, N (corresponding author), Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin,Dept Int Hlth, Barcelona, Spain.	natalia.rodriguez@isgloal.org	Gutierrez, Jose Muñoz/AAH-6954-2020; Luengo-Oroz, Miguel A/C-2245-2011; Rodriguez-Valero, Natalia/AAD-7083-2020; Gutiérrez, Jose Muñoz/X-5917-2018; Sanz, Sergi/AAY-7211-2020; Ledesma-Carbayo, Maria J/D-5529-2009; Gutiérrez, José/GSJ-1846-2022	Gutierrez, Jose Muñoz/0000-0002-0945-1735; Luengo-Oroz, Miguel A/0000-0002-8694-2001; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Ledesma-Carbayo, Maria J/0000-0001-6846-3923; Fernandez, Ivette/0000-0001-5179-0477	Fundacio La Caixa; Spanish Olympic Committe	Fundacio La Caixa(La Caixa FoundationEuropean Commission); Spanish Olympic Committe	The Project was financed by fundings from Fundacio La Caixa and Spanish Olympic Committe to develop it. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2016, WASHINGTON POST; de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016; Blazquez Ana-Belen, 2016, World J Virol, V5, P135; Cao-Lormeau V, 2016, LANCET, V6736; Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; European Centre for Disease Control, 2016, RAP RISK ASS ZIK VIR; European Centre for Disease Control, 2016, CAS DEF ZIK VIR; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1; Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59; Guerrisi C, 2016, J INFECT DIS, V214, pS386, DOI 10.1093/infdis/jiw280; Leal Neto Onicio, 2017, JMIR Public Health Surveill, V3, pe26, DOI 10.2196/publichealth.7313; Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Pagliari C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004795; Pan American Health Organization/World Health, ZIK EP REP BRAZ; Rodriguez-Valero N, 2017, EMERG INFECT DIS, V23, P1426, DOI 10.3201/eid2308.170415; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO, V47; Wojcik OP, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-7	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201943	10.1371/journal.pone.0201943	http://dx.doi.org/10.1371/journal.pone.0201943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133492	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000442500400050
J	Zechariah, A; Sajesh, PK; Santhosh, S; Bathrachalam, C; Megha, M; Pandiyan, J; Jishnu, M; Kobragade, RS; Long, SY; Zong, JC; Latimer, EM; Heaggans, SY; Hayward, GS				Zechariah, A.; Sajesh, P. K.; Santhosh, S.; Bathrachalam, C.; Megha, M.; Pandiyan, J.; Jishnu, M.; Kobragade, R. S.; Long, S. Y.; Zong, J-C; Latimer, E. M.; Heaggans, S. Y.; Hayward, G. S.			Extended genotypic evaluation and comparison of twenty-two cases of lethal EEHV1 hemorrhagic disease in wild and captive Asian elephants in India	PLOS ONE			English	Article							ENDOTHELIOTROPIC HERPESVIRUSES 1A; AFRICAN ELEPHANTS; MAXIMUS; INFECTION; POPULATION; VIRUS; CONSERVATION; VALIDATION; ASSAYS; 1B	Thirteen new lethal cases of acute hemorrhagic disease (HD) with typical histopathogical features were identified in young Asian elephants (Elephas maximus indicus) in India between 2013 and 2017. Eight occurred amongst free-ranging wild herds, with three more in camp-raised orphans and two in captive-born calves. All were confirmed to have high levels of Elephant Endotheliotropic Herpesvirus type 1A (EEHV1A) DNA detected within gross pathological lesions from necropsy tissue by multi-locus PCR DNA sequencing. The strains involved were all significantly different from one another and from nine previously described cases from Southern India (which included one example of EEHV1B). Overall, eight selected dispersed PCR loci totaling up to 6.1-kb in size were analyzed for most of the 22 cases, with extensive subtype clustering data being obtained at four hypervariable gene loci. In addition to the previously identified U48(gH-TK) and U51(vGPCR1) gene loci, these included two newly identified E5(vGPCR5) and E54(vOX2-1) loci mapping far outside of the classic EEHV1A versus EEHV1B subtype chimeric domains and towards the novel end segments of the genome that had not been evaluated previously. The high levels of genetic divergence and mosaic scrambling observed between adjacent loci match closely to the overall range of divergence found within 45 analyzed North American and European cases, but include some common relatively unique polymorphic features and preferred subtypes that appear to distinguish most but not all Indian strains from both those in Thailand and those outside range countries. Furthermore, more than half of the Indian cases studied here involved calves living within wild herds, whereas nearly all other cases identified in Asia so far represent rescued camp orphans or captive-born calves.	[Zechariah, A.; Jishnu, M.] Govt Kerala, Dept Forests & Wildlife, Sultan Battery, Wayanad, India; [Sajesh, P. K.; Santhosh, S.; Bathrachalam, C.; Megha, M.] SciGenom Res Fdn, Cheruthuruthy, Kerala, India; [Pandiyan, J.] AVC Coll, Mayiladuthurai, Tamil Nadu, India; [Kobragade, R. S.] Tadoba Andhari Tiger Reserve, Chandrapur, Maharashtra, India; [Long, S. Y.; Zong, J-C; Heaggans, S. Y.; Hayward, G. S.] Johns Hopkins Sch Med, Dept Oncol, Viral Oncol Program, Baltimore, MD 21205 USA; [Latimer, E. M.] Smithsonians Natl Zool Pk, Wildlife Hlth Sci, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Hayward, GS (corresponding author), Johns Hopkins Sch Med, Dept Oncol, Viral Oncol Program, Baltimore, MD 21205 USA.	ghayward@jhmi.edu	Pandiyan, Jeganathan/F-5231-2013	Latimer, Erin/0000-0001-7250-8768; Pandiyan, Jeganathan/0000-0002-9573-7587	US Fish and Wildlife Service Asian Elephant Conservation Fund; SciGenom Research Foundation; International Elephant Foundation; Morris Animal Foundation [D15ZO-610]; Institute of Museum and Library Services [MG-30-13-0086]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011089] Funding Source: NIH RePORTER	US Fish and Wildlife Service Asian Elephant Conservation Fund; SciGenom Research Foundation; International Elephant Foundation; Morris Animal Foundation; Institute of Museum and Library Services; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some field research by A.Z. in India was supported by the US Fish and Wildlife Service Asian Elephant Conservation Fund. Sequencing services in India were supported by the SciGenom Research Foundation. PCR primer sequence design and DNA sequence analysis work carried out at Johns Hopkins University were supported by funds awarded to GSH by the International Elephant Foundation. SYL was the recipient of a Postdoctoral Fellowship from the Morris Animal Foundation (D15ZO-610) and was also supported by a grant from the Institute of Museum and Library Services (MG-30-13-0086 subcontract to GSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins L, 2013, J ZOO WILDLIFE MED, V44, P136, DOI 10.1638/1042-7260-44.1.136; Bouchard B, 2014, J ZOO WILDLIFE MED, V45, P704, DOI 10.1638/2013-0264R1.1; Fuery A, 2016, J ZOO WILDLIFE MED, V47, P311, DOI 10.1638/2015-0072.1; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; Kendall R, 2016, J ZOO WILDLIFE MED, V47, P405, DOI 10.1638/2015-0217.1; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Lertwatcharasarakul P, 2015, THAI J VET MED, V45, P73; Ling PD, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00091-16; Ling PD, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00081-15; Ling PD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-13; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; OSSENT P, 1990, VET PATHOL, V27, P131, DOI 10.1177/030098589002700212; Pellett PE, 2014, J VIROL, V88, P13520, DOI 10.1128/JVI.02359-14; Pursell T, 2016, J VIROL METHODS, V237, P138, DOI 10.1016/j.jviromet.2016.08.010; Reid CE, 2006, VET QUART, V28, P61, DOI 10.1080/01652176.2006.9695209; Richman LK, 2014, J VIROL, V88, P13523, DOI 10.1128/JVI.01673-14; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Richman LK, 2000, J WILDLIFE DIS, V36, P1, DOI 10.7589/0090-3558-36.1.1; Schmitt DL, 2000, J ZOO WILDLIFE MED, V31, P518, DOI 10.1638/1042-7260(2000)031[0518:UOFFTT]2.0.CO;2; Sripiboon S, 2016, INFECT GENET EVOL, V44, P487, DOI 10.1016/j.meegid.2016.08.004; Sripiboon S, 2013, J ZOO WILDLIFE MED, V44, P100, DOI 10.1638/1042-7260-44.1.100; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P42, DOI 10.1638/1042-7260-44.1.42; Stanton JJ, 2012, J VIROL METHODS, V186, P73, DOI 10.1016/j.jviromet.2012.07.024; Stanton JJ, 2010, AM J VET RES, V71, P925, DOI 10.2460/ajvr.71.8.925; Vidya TNC, 2005, ANIM CONSERV, V8, P377, DOI 10.1017/S1367943005002428; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Wiedner E, 2012, ZOO WILD ANIMAL MED, V7, P537, DOI [10.1016/C2009-0-63976-3, DOI 10.1016/C2009-0-63976-3]; Wilkie GS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06299; Wilkie GS, 2013, J VIROL, V87, P6700, DOI 10.1128/JVI.00655-13; WILKIE NM, 1979, COLD SPRING HARB SYM, V43, P827, DOI 10.1101/SQB.1979.043.01.089; ZACHARIAH A, 2013, J WILDLIFE DIS, V49, P383; Zong J-C, 2008, P INT EL CONS RES S, P23; Zong JC, 2016, J VIROL, V90, P3028, DOI 10.1128/JVI.02936-15; Zong JC, 2014, J VIROL, V88, P13547, DOI 10.1128/JVI.01675-14	36	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202438	10.1371/journal.pone.0202438	http://dx.doi.org/10.1371/journal.pone.0202438			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133540	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400071
J	Ries, D; Carriquiry, A; Shook, R				Ries, Daniel; Carriquiry, Alicia; Shook, Robin			Modeling energy balance while correcting for measurement error via free knot splines	PLOS ONE			English	Article							DOUBLY LABELED WATER; CONDITIONALLY HETEROSCEDASTIC MEASUREMENT; RANDOMIZED CONTROLLED-TRIAL; NUTRITIONAL EPIDEMIOLOGY; CALORIE RESTRICTION; ACTIVITY MONITORS; WEARABLE DEVICES; BODY-COMPOSITION; IDENTICAL-TWINS; WEIGHT-GAIN	Measurements of energy balance components (energy intake, energy expenditure, changes in energy stores) are often plagued with measurement error. Doubly-labeled water can measure energy intake (EI) with negligible error, but is expensive and cumbersome. An alternative approach that is gaining popularity is to use the energy balance principle, by measuring energy expenditure (EE) and change in energy stores (ES) and then back-calculate EI. Gold standard methods for EE and ES exist and are known to give accurate measurements, albeit at a high cost. We propose a joint statistical model to assess the measurement error in cheaper, non-intrusive measures of EE and ES. We let the unknown true EE and ES for individuals be latent variables, and model them using a bivariate distribution. We try both a bivariate Normal as well as a Dirichlet Process Mixture Model, and compare the results via simulation. Our approach, is the first to account for the dependencies that exist in individuals' daily EE and ES. We employ semiparametric regression with free knot splines for measurements with error, and linear components for error free covariates. We adopt a Bayesian approach to estimation and inference and use Reversible Jump Markov Chain Monte Carlo to generate draws from the posterior distribution. Based on the semiparameteric regression, we develop a calibration equation that adjusts a cheaper, less reliable estimate, closer to the true value. Along with this calibrated value, our method also gives credible intervals to assess uncertainty. A simulation study shows our calibration helps produce a more accurate estimate. Our approach compares favorably in terms of prediction to other commonly used models.	[Ries, Daniel] Sandia Natl Labs, Stat Sci Dept, POB 5800, Albuquerque, NM 87185 USA; [Ries, Daniel; Carriquiry, Alicia] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Shook, Robin] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA	United States Department of Energy (DOE); Sandia National Laboratories; Iowa State University	Ries, D (corresponding author), Sandia Natl Labs, Stat Sci Dept, POB 5800, Albuquerque, NM 87185 USA.; Ries, D (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.	dries@sandia.gov		Ries, Daniel/0000-0002-5029-4647	NIH [HL091024]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by NIH grant HL091024. There was no additional external funding received for this study. This paper describes objective technical results and analysis. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the U.S. Department of Energy or the United States Government.	alger K., 2014, WEARABLE TECHNOLOGY; [Anonymous], 2007, PROJECT REPROT; Berry SM, 2002, J AM STAT ASSOC, V97, P160, DOI 10.1198/016214502753479301; Bouchard C, 1996, METABOLISM, V45, P1042, DOI 10.1016/S0026-0495(96)90277-2; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bouchard C, 1994, Obes Res, V2, P400; Bouten CVC, 1996, J APPL PHYSIOL, V81, P1019, DOI 10.1152/jappl.1996.81.2.1019; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Caroll R, MEASUREMENT ERROR NO; de Boor C., 2001, APPL MATH SCI, V27; de Jonge L, 2007, AM J CLIN NUTR, V85, P73, DOI 10.1093/ajcn/85.1.73; Denison DGT, 1998, J ROY STAT SOC B, V60, P333, DOI 10.1111/1467-9868.00128; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Fuller W.A., 2009, MEASUREMENT ERROR MO; Gelman A., 2021, BAYESIAN DATA ANAL; Gilmore LA, 2014, AM J CLIN NUTR, V100, P806, DOI 10.3945/ajcn.114.087122; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hall KD, 2011, AM J CLIN NUTR, V94, P66, DOI 10.3945/ajcn.111.014399; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Kipnis V, 2016, BIOMETRICS, V72, P106, DOI 10.1111/biom.12377; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Leitenstorfer F, 2007, BIOSTATISTICS, V8, P654, DOI 10.1093/biostatistics/kxl036; Murakami H, 2016, JAMA INTERN MED, V176, P702, DOI 10.1001/jamainternmed.2016.0152; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Pharm FEAB, 2015, HEALTHC INFORM RES, V21, P315, DOI 10.4258/hir.2015.21.4.315; Racette SB, 2012, AM J PHYSIOL-ENDOC M, V302, pE441, DOI 10.1152/ajpendo.00290.2011; Sanghvi A, 2015, AM J CLIN NUTR, V102, P353, DOI 10.3945/ajcn.115.111070; Sarkar A, 2014, BIOMETRICS, V70, P823, DOI 10.1111/biom.12197; Sarkar A, 2014, J COMPUT GRAPH STAT, V23, P1101, DOI 10.1080/10618600.2014.899237; Shook RP, 2018, J NUTR, V148, P490, DOI 10.1093/jn/nxx029; Sinha S, 2010, BIOMETRICS, V66, P444, DOI 10.1111/j.1541-0420.2009.01309.x; Takezawa K, 2006, INTRODUCTION TO NONPARAMETRIC REGRESSION, P1; Thomas DM, 2014, AM J CLIN NUTR, V100, P787, DOI 10.3945/ajcn.113.079822; Thomas Diana M., 2011, Journal of Biological Dynamics, V5, P579, DOI 10.1080/17513758.2010.508541; Tooze JA, 2002, STAT METHODS MED RES, V11, P341, DOI 10.1191/0962280202sm291ra; vonHelmholtz H., 1847, ERHALTUNG KRAFT ERHA; Wang W, 2015, AM STAT, V69, P28, DOI 10.1080/00031305.2014.969445	39	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201892	10.1371/journal.pone.0201892	http://dx.doi.org/10.1371/journal.pone.0201892			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161152	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900016
J	Schmidt, FA; Connolly, F; Maas, MB; Grittner, U; Harms, L; Brandt, A; Paull, F; Schreiber, S; Ruprecht, K				Schmidt, Felix A.; Connolly, Florian; Maas, Matthew B.; Grittner, Ulrike; Harms, Lutz; Brandt, Alexander; Paull, Friedemann; Schreiber, Stephan; Ruprecht, Klemens			Objective assessment of a relative afferent pupillary defect by B-mode ultrasound	PLOS ONE			English	Article							OPTICA SPECTRUM DISORDERS; VISUAL-SYSTEM DAMAGE; MULTIPLE-SCLEROSIS; NEURITIS; CRITERIA	Purpose To evaluate B-mode ultrasound as a novel method for objective and quantitative assessment of a relative afferent pupillary defect (RAPD) in a prospective case-control study. Methods Seventeen patients with unilateral optic neuropathy and a clinically detectable RAPD and 17 age and sex matched healthy controls were examined with B-mode ultrasound using an Esaote-Mylab25 system according to current guidelines for orbital insonation. The swinging flashlight test was performed during ultrasound assessment with a standardized light stimulus using a penlight. Results B-mode ultrasound RAPD examination was doable in approximately 5 minutes only and was well tolerated by all participants. Compared to the unaffected contralateral eyes, eyes with RAPD showed lower absolute constriction amplitude of the pupillary diameter (mean [SD] 0.8 [0.4] vs. 2.1 [0.4] mm; p = 0.009) and a longer pupillary constriction time after ipsilateral light stimulus (mean [SD] 1240 [180] vs. 710 [200] ms; p= 0.008). In eyes affected by RAPD, visual acuity correlated with the absolute constriction amplitude (r= 0.75, p = 0.001). Conclusions B-mode ultrasound enables fast, easy and objective quantification of a RAPD and can thus be applied in clinical practice to document a RAPD.	[Schmidt, Felix A.; Connolly, Florian; Harms, Lutz; Brandt, Alexander; Paull, Friedemann; Ruprecht, Klemens] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Schmidt, Felix A.; Connolly, Florian; Grittner, Ulrike; Harms, Lutz; Brandt, Alexander; Paull, Friedemann; Ruprecht, Klemens] Berlin Inst Hlth, Neurocure Cluster Excellence, Berlin, Germany; [Schmidt, Felix A.; Brandt, Alexander; Paull, Friedemann] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Schmidt, Felix A.] BIH, Berlin, Germany; [Maas, Matthew B.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grittner, Ulrike] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Biostat & Clin Epidemiol, Berlin, Germany; [Paull, Friedemann] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paull, Friedemann] Charite Univ Med Berlin, Berlin, Germany; [Schreiber, Stephan] Asklepios Fachklinikum Brandenburg, Dept Neurol, Brandenburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Northwestern University; Feinberg School of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, FA (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Neurol, Berlin, Germany.; Schmidt, FA (corresponding author), Berlin Inst Hlth, Neurocure Cluster Excellence, Berlin, Germany.; Schmidt, FA (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany.; Schmidt, FA (corresponding author), BIH, Berlin, Germany.	felix.schmidt@charite.de	Grittner, Ulrike/I-2026-2019	Grittner, Ulrike/0000-0003-2595-0224; paul, friedemann/0000-0002-6378-0070; Schreiber, Stephan J./0000-0003-0902-3447				Bennett JL, 2015, MULT SCLER J, V21, P678, DOI 10.1177/1352458514567216; Bennett JL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000104; Bremner FD, 2004, EYE, V18, P1175, DOI 10.1038/sj.eye.6701560; Cayless A, 2016, Z MED PHYS, V26, P143, DOI 10.1016/j.zemedi.2015.10.001; Cree BAC, 2016, MULT SCLER J, V22, P862, DOI 10.1177/1352458515620934; Di Maggio G, 2014, MULT SCLER J, V20, P1342, DOI 10.1177/1352458514524293; Galetta SL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000135; Kalaboukhova L, 2007, ACTA OPHTHALMOL SCAN, V85, P519, DOI 10.1111/j.1600-0420.2007.00863.x; Kidd DP, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000270; Kuchling J, 2017, EPMA J, V8, P279, DOI 10.1007/s13167-017-0102-x; Lankaranian Dara, 2005, Trans Am Ophthalmol Soc, V103, P200; LOEWENFELD IE, 1974, AM J OPHTHALMOL, V78, P304, DOI 10.1016/0002-9394(74)90093-2; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; MCGRAW P, 1995, BRIT MED J, V310, P1481, DOI 10.1136/bmj.310.6993.1481; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Oertel FC, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000334; Pache F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0720-6; Petzold A, 2014, NAT REV NEUROL, V10, P447, DOI 10.1038/nrneurol.2014.108; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; Schippling S, 2015, MULT SCLER J, V21, P163, DOI 10.1177/1352458514538110; Schmidt F, 2017, MULT SCLER RELAT DIS, V11, P45, DOI 10.1016/j.msard.2016.11.008; Schmidt FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189016; Sepulveda M, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000225; THOMPSON HS, 1981, SURV OPHTHALMOL, V26, P39, DOI 10.1016/0039-6257(81)90124-7; Trier H G, 1982, Ultraschall Med, V3, P164, DOI 10.1055/s-2007-1010120; Volpe NJ, 2000, OPHTHALMOLOGY, V107, P1913, DOI 10.1016/S0161-6420(00)00354-7; Waldman AT, NEUROL NEUROIMMUNOL, V4; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202774	10.1371/journal.pone.0202774	http://dx.doi.org/10.1371/journal.pone.0202774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148895	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000442804200022
J	Lu, ZY; Li, JS; Shen, Q; Zhang, B; Zhang, H; Zhang, FF; Wang, SL				Lu, Zhaoyi; Li, Junsheng; Shen, Qian; Zhang, Bing; Zhang, Hao; Zhang, Fangfang; Wang, Shenglei			Modification of 6SV to remove skylight reflected at the air-water interface: Application to atmospheric correction of Landsat 8 OLI imagery in inland waters	PLOS ONE			English	Article							TOTAL SUSPENDED MATTER; LAKE TAIHU; CORRECTION ALGORITHM; LEAVING RADIANCE; TM IMAGE; SATELLITE; VALIDATION; RETRIEVAL; QUALITY; SEAWIFS	During the atmospheric correction of remote sensing data in inland waters, the original Second Simulation of the Satellite Signal in the Solar Spectrum-Vector version (6SV) model does not eliminate the specular reflection of downward skylight radiance at the air-water interface. Thus, we propose a modified version of the 6SV model (M6SV) that does remove reflected skylight at the air-water interface. We apply the new model to the atmospheric correction of a Landsat 8 Operational Land Imager (OLI) image over Taihu Lake, China, where the aerosol optical depth is known. In situ reflectance measurements acquired concurrently with the L8/OLI image are used to validate the performance of the new M6SV algorithm. To further analyze the merits and demerits of M6SV, the model is compared with two short-wave infrared (SWIR)-based atmospheric correction models: the Sea-Viewing Wide Field-of-View Sensor Data Analysis System short-wave infrared (SD-SWIR) model and the Vanhellemont & Ruddick short-wave infrared with a per scene fixed aerosol type (VR-SWIR-F) model. Comparisons of results from all three L8/OLI image atmospheric corrections with the in situ remote sensing reflectance data show that M6SV produces reliable atmospheric corrections in the green and red spectral bands and is an effective alternative for Landsat 8 OLI atmospheric correction in inland waters.	[Lu, Zhaoyi; Li, Junsheng; Shen, Qian; Zhang, Bing; Zhang, Hao; Zhang, Fangfang; Wang, Shenglei] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China; [Lu, Zhaoyi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shen, Q (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China.	shenqian@radi.ac.cn		Lu, Zhao Y/0000-0003-0417-4190	National Key Research and Development Program of China [2016YFB0501502]; High Resolution Earth Observation Systems of the National Science and Technology Major Projects [41-Y20A31-9003-15/17]; National Natural Science Foundation of China [91638201, 41571361, 41471308]	National Key Research and Development Program of China; High Resolution Earth Observation Systems of the National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was jointly supported by the National Key Research and Development Program of China (2016YFB0501502), the High Resolution Earth Observation Systems of the National Science and Technology Major Projects (41-Y20A31-9003-15/17 to J.L.), the National Natural Science Foundation of China (No. 91638201 to B.Z., 41571361 to Q.S., 41471308 to J.L.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara E, 2016, REMOTE SENS LETT, V7, P661, DOI 10.1080/2150704X.2016.1177242; ANGSTROM A, 1964, TELLUS, V16, P64, DOI 10.1111/j.2153-3490.1964.tb00144.x; Chen J, 2017, IEEE T GEOSCI REMOTE, V55, P2201, DOI 10.1109/TGRS.2016.2638828; Chen J, 2014, IEEE T GEOSCI REMOTE, V52, P3959, DOI 10.1109/TGRS.2013.2278340; Chen J, 2013, ADV SPACE RES, V51, P1750, DOI 10.1016/j.asr.2012.11.032; Chen J, 2013, INT J REMOTE SENS, V34, P3787, DOI 10.1080/01431161.2012.761740; Chen J, 2011, IEEE J-STARS, V4, P882, DOI 10.1109/JSTARS.2011.2154300; Concha Javier A., 2014, 2014 IEEE Geoscience and Remote Sensing Symposium. (IGARSS). Proceedings, P4458, DOI 10.1109/IGARSS.2014.6947481; Franz BA, 2015, J APPL REMOTE SENS, V9, DOI 10.1117/1.JRS.9.096070; Gitelson AA, 2007, REMOTE SENS ENVIRON, V109, P464, DOI 10.1016/j.rse.2007.01.016; Gong SQ, 2008, INT J REMOTE SENS, V29, P2199, DOI 10.1080/01431160701422262; GORDON HR, 1994, APPL OPTICS, V33, P443, DOI 10.1364/AO.33.000443; Gordon HR, 1999, NAS503163 NASA; HARRINGTON JA, 1992, REMOTE SENS ENVIRON, V39, P15, DOI 10.1016/0034-4257(92)90137-9; Irons JR, 2012, REMOTE SENS ENVIRON, V122, P11, DOI 10.1016/j.rse.2011.08.026; Kloiber SN, 2002, REMOTE SENS ENVIRON, V82, P38, DOI 10.1016/S0034-4257(02)00022-6; Kotchenova SY, 2006, APPL OPTICS, V45, P6762, DOI 10.1364/AO.45.006762; Li JS, 2014, AQUAT ECOSYST HEALTH, V17, P280, DOI 10.1080/14634988.2014.941776; Lv CG, 2015, REMOTE SENS INFO, V30, P43; MAYO M, 1995, INT J REMOTE SENS, V16, P175, DOI 10.1080/01431169508954386; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; Mobley CD, 2015, APPL OPTICS, V54, P4828, DOI 10.1364/AO.54.004828; Nazeer M, 2014, INT J REMOTE SENS, V35, P6271, DOI 10.1080/01431161.2014.951742; Oyama Y, 2009, ISPRS J PHOTOGRAMM, V64, P73, DOI 10.1016/j.isprsjprs.2008.04.005; Pahlevan N, 2014, REMOTE SENS ENVIRON, V154, P272, DOI 10.1016/j.rse.2014.08.001; Ruddick K., OCEAN COLOUR REMOTE; Salama S, 2002, INT S OPT SCI TECHN; Solar Light Company Inc, 2001, MTP05 SOL LIGHT CO I; [唐军武 Tang Junwu], 2004, [遥感学报, Journal of Remote Sensing], V8, P37; Tian LQ, 2010, SCI CHINA TECHNOL SC, V53, P191, DOI 10.1007/s11431-010-3221-3; Vanhellemont Q, 2014, ESA SPECIAL PUBLICAT, P726; Vanhellemont Q, 2015, REMOTE SENS ENVIRON, V161, P89, DOI 10.1016/j.rse.2015.02.007; Vermote E., 2006, 2 SIMULATION SATELLI; Wang D, 2007, CHINESE GEOGR SCI, V17, P364, DOI 10.1007/s11769-007-0364-7; Wang MH, 2011, REMOTE SENS ENVIRON, V115, P841, DOI 10.1016/j.rse.2010.11.012; Wang MH, 2002, INT J REMOTE SENS, V23, P2693, DOI 10.1080/01431160110115591; Wu CQ, 2010, SCI CHINA EARTH SCI, V53, P45, DOI 10.1007/s11430-010-4129-2; Zhang B, 2008, ENVIRON MONIT ASSESS, V145, P339, DOI 10.1007/s10661-007-0043-2; Zhang B, 2012, HYPERSPECTRAL REMOTE, P131; Zhang FF, 2015, IEEE J-STARS, V8, P350, DOI 10.1109/JSTARS.2014.2333540; Zhang MW, 2014, IEEE T GEOSCI REMOTE, V52, P4686, DOI 10.1109/TGRS.2013.2283523	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202883	10.1371/journal.pone.0202883	http://dx.doi.org/10.1371/journal.pone.0202883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142203	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500045
J	Maier, IL; Scalzo, F; Leyhe, JR; Schregel, K; Behme, D; Tsogkas, I; Psychogios, MN; Liebeskind, DS				Maier, Ilko L.; Scalzo, Fabien; Leyhe, Johanna R.; Schregel, Katharina; Behme, Daniel; Tsogkas, Ioannis; Psychogios, Marios-Nikos; Liebeskind, David S.			Validation of collateral scoring on flat-detector multiphase CT angiography in patients with acute ischemic stroke	PLOS ONE			English	Article							ONE-STOP MANAGEMENT; INTERVENTIONAL MANAGEMENT; ENDOVASCULAR TREATMENT; III TRIAL; TIME; REPERFUSION; OUTCOMES; FEASIBILITY; PERFUSION; SUITE	Background The pivotal impact of collateral circulation on outcomes in endovascular therapy has fueled the development of numerous CTA collateral scales, yet synchronized validation with conventional angiography has never occurred. We validated multiphase flat-detector CTA (mpFDCTA) for collateral imaging in patients undergoing endovascular stroke treatment. Materials and methods Consecutive acute ischemic stroke patient data, including mpFDCTA shortly followed by digital subtraction angiography (DSA), in the setting of acute ICA- or MCA-occlusions were analyzed. An independent core lab scored mpFDCTA with an established collateral scale and separately graded American Society of Interventional and Therapeutic Neuroradiology (ASITN) collateral score on DSA, blind to all other data. Results 24 consecutive cases (age 76.7 +/- 7.3 years; 58.3% women; baseline NIHSS median 17 (4-23)) of acute ICA- or MCA-occlusion were analyzed. Time from mpFDCTA to intracranial DSA was 23.04 +/- 7.6 minutes. Median mpFDCTA collateral score was 3 (0-5) and median DSA ASITN collateral score was 2 (0-3), including the full range of potential collateral grades. mpFDCTA and ASITN collateral score were strongly correlated (r = 0.86, p<0.001). mpFDCTA provided more complete collateral data compared to selective DSA injections in cases of ICA-occlusion. ROC analyses for prediction of clinical outcomes revealed an AUC of 0.76 for mpFDCTA- and 0.70 for DSA ASITN collaterals. Conclusions mpFDCTA in the angiography suite provides a validated measure of collaterals, offering distinct advantages over conventional angiography. Direct patient transfer to the angiography suite and mpFDCTA collateral grading provides a novel and reliable triage paradigm for acute ischemic stroke.	[Maier, Ilko L.] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Scalzo, Fabien; Liebeskind, David S.] Neurovasc Imaging Res Core, Los Angeles, CA USA; [Leyhe, Johanna R.; Schregel, Katharina; Behme, Daniel; Tsogkas, Ioannis; Psychogios, Marios-Nikos] Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany	University of Gottingen; University of Gottingen	Psychogios, MN (corresponding author), Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany.	m.psychogios@med.uni-goettingen.de	Scalzo, Fabien/AAM-6328-2020; Behme, Daniel/H-4551-2019	Scalzo, Fabien/0000-0001-9755-8104; 	Niedersachsische Ministerium fur Wissenschaft und Kultur [11-76251-99-52/14]	Niedersachsische Ministerium fur Wissenschaft und Kultur	This work was supported by the "Niedersachsische Ministerium fur Wissenschaft und Kultur" (grant number 11-76251-99-52/14 to I.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amans MR, 2015, AUSTIN J CEREBROVASC, V2, P1036; Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Higashida Randall, 2003, J Vasc Interv Radiol, V14, pS493; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Leyhe JR, 2017, J NEUROINTERV SURG, V9, P1253, DOI 10.1136/neurintsurg-2016-012866; Liebeskind DS, 2014, STROKE, V45, P759, DOI 10.1161/STROKEAHA.113.004072; Liebeskind DS, 2011, J CEREBR BLOOD F MET, V31, P1293, DOI 10.1038/jcbfm.2010.224; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; Maier IL, AJNR AM J NEURORADIO; Menon BK, 2011, AM J NEURORADIOL, V32, P1640, DOI 10.3174/ajnr.A2564; Menon BK, 2016, CIRCULATION, V133, P2279, DOI 10.1161/CIRCULATIONAHA.115.019983; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Psychogios MN, 2010, AM J NEURORADIOL, V31, P1226, DOI 10.3174/ajnr.A2086; Psychogios MN, 2018, STROKE, V49; Psychogios MN, 2017, STROKE, V48, P3152, DOI 10.1161/STROKEAHA.117.018077; Psychogios MN, 2017, CLIN NEURORADIOL, V27, P389, DOI 10.1007/s00062-017-0574-z; Sallustio F, 2017, J NEUROINTERV SURG, V9, P940, DOI 10.1136/neurintsurg-2016-012628; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Schregel K, 2018, JOVE-J VIS EXP, DOI 10.3791/56397; Vagal A, 2016, STROKE, V47, P535, DOI 10.1161/STROKEAHA.115.011461; Yang P, 2017, AM J NEURORADIOL, V38, P747, DOI 10.3174/ajnr.A5072	25	10	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202592	10.1371/journal.pone.0202592	http://dx.doi.org/10.1371/journal.pone.0202592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142167	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500020
J	Santos, SS; Augusto, DG; Alves, PAC; Pereira, JS; Duarte, LMB; Melo, PC; Gross, E; Kaneto, CM; Silva, A; Santos, JL				Santos, Simone S.; Augusto, Danillo G.; Casaes Alves, Patricia A.; Pereira, Julia S.; Duarte, Larissa M. B.; Melo, Poliana C.; Gross, Eduardo; Kaneto, Carla M.; Silva, Aline; Santos, Jane L.			Trichoderma asperelloides ethanolic extracts efficiently inhibit Staphylococcus growth and biofilm formation	PLOS ONE			English	Article							FOOD-CONTACT SURFACES; ENDOPHYTIC FUNGUS; AUREUS; EPIDERMIDIS; RESISTANCE; FERMENTATION; TEMPERATURE; SENSITIVITY; METABOLITES; EXPRESSION	Fungi from the widely distributed genus Trichoderma are of great biotechnological interest, being currently used in a vast range of applications. Here, we report that high-molecular weight fraction (HWF) derived from Trichoderma asperelloides ethanolic extract exhibits antibiotic activity against staphylococcal biofilms. The antibacterial and anti-biofilm properties of T. asperelloides extracts were evaluated by well-established assays in Staphylococcus aureus ATCC strains (29213 and 6538) and in one clinical isolate from bovine mastitis. The HWF from T. asperelloides eradicated S. aureus by causing substantial matrix de-structuring and biomass reduction (p < 10(-5)) at concentrations as low as 2.3 mu g mL(-1). Additionally, we present ultra-structure analysis by the use of scanning electron microscopy as well as transmission microscopy, which showed that T. asperelloides killed cells through cell wall and membrane disturbance. Remarkably, the HWF from T. asperelloides killed S. aureus and eradicated its biofilms in a greater performance than gentamicin (p < 10(-5)), a known potent antibiotic against S. aureus. Our results indicate that extract from T. asperelloides may represent a promising candidate for the development of new antibiotics against gram-positive bacteria.	[Santos, Simone S.; Augusto, Danillo G.; Kaneto, Carla M.; Santos, Jane L.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Imunobiol, Ilheus, Brazil; [Augusto, Danillo G.] Univ Fed Parana, Lab Genet Mol Humana, Curitiba, Parana, Brazil; [Casaes Alves, Patricia A.; Gross, Eduardo] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Microscopia Eletron, Ilheus, Brazil; [Pereira, Julia S.; Duarte, Larissa M. B.] Ctr Fed Educ Tecnol Minas Gerais, Dept Engn Mat, Belo Horizonte, MG, Brazil; [Melo, Poliana C.] Univ Estadual Santa Cruz, Dept Ciencias Agr, Hosp Vet, Ilheus, Brazil; [Silva, Aline] Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Microbiol, Ilheus, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal do Parana; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	Santos, JL (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Imunobiol, Ilheus, Brazil.	jlsantos@uesc.br	Gross, Eduardo/B-9738-2017; Augusto, Danillo G/H-8179-2019; Avaliação, PPGCS/ABF-2467-2020	Gross, Eduardo/0000-0002-1057-0432; Augusto, Danillo G/0000-0001-5665-8547; Santos Pereira, Julia/0000-0001-7987-1594; Batista Duarte, Larissa Mara/0000-0002-3870-3786; Setubal dos Santos, Simone/0000-0002-5848-8198	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: Fundacao de Amparo a Pesquisa do Estado da Bahia - J.L.S.; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - S.S.S.	Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Ansari MA, 2015, INDIAN J MED MICROBI, V33, P101, DOI 10.4103/0255-0857.148402; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V9th; Meira QGD, 2012, FOOD CONTROL, V25, P469, DOI 10.1016/j.foodcont.2011.11.030; de Souza EL, 2014, BRAZ J MICROBIOL, V45, P67, DOI 10.1590/S1517-83822014000100010; Del Pozo JL, 2008, INT J ARTIF ORGANS, V31, P786, DOI 10.1177/039139880803100906; Di Ciccio P, 2015, FOOD CONTROL, V50, P930, DOI 10.1016/j.foodcont.2014.10.048; Ding G, 2012, CHEM BIODIVERS, V9, P1205, DOI 10.1002/cbdv.201100185; Dos Santos Andrea G, 2017, Front Microbiol, V8, P1681, DOI 10.3389/fmicb.2017.01681; Feresin GE, 2001, J ETHNOPHARMACOL, V78, P103, DOI 10.1016/S0378-8741(01)00322-1; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GOULARD C, 1995, J ANTIBIOT, V48, P1248, DOI 10.7164/antibiotics.48.1248; Guzman-Guzman P, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0481-y; Harman GE, 2000, PLANT DIS, V84, P377, DOI 10.1094/PDIS.2000.84.4.377; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Kundu A., 2008, Asian Journal of Experimental Sciences, V22, P373; Leite B, 2013, ENFERM INFEC MICR CL, V31, P655, DOI 10.1016/j.eimc.2012.11.011; Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551; Melo PD, 2014, PESQUI VET BRASIL, V34, P109, DOI 10.1590/S0100-736X2014000200002; Oh SU, 2002, J ANTIBIOT, V55, P557, DOI 10.7164/antibiotics.55.557; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pleszczynska M, 2015, INT J BIOL MACROMOL, V79, P761, DOI 10.1016/j.ijbiomac.2015.05.052; Rode TM, 2007, INT J FOOD MICROBIOL, V116, P372, DOI 10.1016/j.ijfoodmicro.2007.02.017; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sadykova V S, 2015, Prikl Biokhim Mikrobiol, V51, P340; Samuels GJ, 2010, MYCOLOGIA, V102, P944, DOI 10.3852/09-243; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Shale K, 2005, FOOD MICROBIOL, V22, P433, DOI 10.1016/j.fm.2004.09.007; Susi P, 2011, J ENVIRON MANAGE, V92, P1681, DOI 10.1016/j.jenvman.2011.03.004; Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452; Vazquez-Sanchez D, 2014, FOOD CONTROL, V39, P8, DOI 10.1016/j.foodcont.2013.09.029; Wang YH, 2012, PHYTOMEDICINE, V19, P364, DOI 10.1016/j.phymed.2011.10.011; Wiater A, 2013, INT J BIOL MACROMOL, V58, P199, DOI 10.1016/j.ijbiomac.2013.03.063; Yano A, 2010, APPL MICROBIOL BIOT, V86, P615, DOI 10.1007/s00253-009-2323-y; Zhang JC, 2017, NAT PROD RES, V31, P2745, DOI 10.1080/14786419.2017.1295235	38	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202828	10.1371/journal.pone.0202828	http://dx.doi.org/10.1371/journal.pone.0202828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142222	gold, Green Published, Green Submitted			2022-12-26	WOS:000442722500039
J	Ribes, TFA; Nagamachi, CY; Aleixo, A; Pinheiro, MLS; O'Brien, PCM; Ferguson-Smith, MA; Yang, FT; Suarez, P; Pieczarka, JC				Augusto Ribes, Talita Fernanda; Nagamachi, Cleusa Yoshiko; Aleixo, Alexandre; Silva Pinheiro, Melquizedec Luiz; O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew; Yang, Fengtang; Suarez, Pablo; Pieczarka, Julio Cesar			Chromosome painting in Glyphorynchus spirurus (Vieillot, 1819) detects a new fission in Passeriformes	PLOS ONE			English	Article							SYNTENY CONSERVATION; CHICKEN; EVOLUTION; PSITTACIFORMES; REARRANGEMENTS; AMAZONIA; BIRDS; AVES	Glyphorynchus spirurus (GSP), also called the Wedge-billed Woodcreeper (Furnariidae) has an extensive distribution in the Americas, including the Atlantic coast of Brazil. Nevertheless, there is no information about its karyotype or genome organization. To contribute to the knowledge of chromosomal evolution in Passeriformes we analysed the karyotype of Glyphorynchus spirurus by classic and molecular cytogenetics methods. We show that Glyphorynchus spirurus has a 2n = 80 karyotype with a fundamental number (FN) of 84, similar to the avian putative ancestral karyotype (PAK). Glyphorynchus spirurus pair 1 was heteromorphic in the Tapajos population whereby the short arms varied in sizes, possibly due to a pericentric inversion, as described in other Furnariidae birds. FISH with the Histone H5 probe revealed a signal in the pericentromeric region of G. spirurus chromosome 5 and rDNA 18S showed interstitial signal in GSP-1. Chromosome painting with Gallus gallus (GGA) macrochromosomes 1-9 probes showed disruption of chromosome syntenies of GGA-1, 2 and 4 by fission in Glyphorynchus spirurus. Our results confirm that the GGA1 centric fission is a synapomorphic character for the phylogenetic branch composed of Strigiformes, Passeriformes, Columbiformes and Falconiformes. On the other hand, the GGA-2 fission is reported here for the first time in Passeriformes. Chromosome painting with BOE whole chromosome probes confirmed these rearrangements in Glyphorynchus spirurus revealed by Gallus gallus 1-9 probes, in addition to enabling the establishment of genome-wide homology map.	[Augusto Ribes, Talita Fernanda; Nagamachi, Cleusa Yoshiko; Silva Pinheiro, Melquizedec Luiz; Pieczarka, Julio Cesar] Univ Fed Para, Ctr Estudos Avancados Biodiversidade, Inst Ciencias Biol, Lab Citogenet, Belem, Para, Brazil; [Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] Conselho Nacl Desenvolvimento Cient & Tecnol, CNPq Researcher, Brasilia, DF, Brazil; [Aleixo, Alexandre] Museu Paraense Emilio Goeldi, Dept Zool, Belem, Para, Brazil; [O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Dept Vet Med, Cambridge, England; [Yang, Fengtang] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Suarez, Pablo] UNaM, CONICET, IBS, Puerto Iguazu, Misiones, Argentina	Universidade Federal do Para; Museu Paraense Emilio Goeldi; University of Cambridge; Wellcome Trust Sanger Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pieczarka, JC (corresponding author), Univ Fed Para, Ctr Estudos Avancados Biodiversidade, Inst Ciencias Biol, Lab Citogenet, Belem, Para, Brazil.; Pieczarka, JC (corresponding author), Conselho Nacl Desenvolvimento Cient & Tecnol, CNPq Researcher, Brasilia, DF, Brazil.	juliopieczarka@gmail.com	Yang, Fan/GYU-4249-2022; Pieczarka, Julio C/E-7585-2016; Aleixo, Alexandre/L-3135-2013; ribas, talita/AAN-1096-2021; Nagamachi, Cleusa/AAV-8985-2021	Pieczarka, Julio C/0000-0003-2951-8877; Aleixo, Alexandre/0000-0002-7816-9725; Yang, Fengtang/0000-0002-3573-2354	Fundacao Amazonia de Amparo a Estudos e Pesquisas [2010/110447, 007/2011]; Banco Nacional de Desenvolvimento Economico e Social [2.318.697.0001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [552032/2010-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [047/2012]	Fundacao Amazonia de Amparo a Estudos e Pesquisas(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Banco Nacional de Desenvolvimento Economico e Social; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JCP: Source: Fundacao Amazonia de Amparo a Estudos e Pesquisas, URL: http://www.fapespa.pa.gov.br, Grant number: 2010/110447; JCP: Source: Banco Nacional de Desenvolvimento Economico e Social, URL: https://www.bndes.gov.br/wps/portal/site/home, Grant number: 2.318.697.0001; CYN: Source: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, URL: http://cnpq.br, Grant number: 552032/2010-7; CYN: Source: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, URL: http://www.capes.gov.br, Grant number: 047/2012; CYN: Source: Fundacao Amazonia de Amparo a Estudos e Pesquisas, URL: http://www.fapespa.pa.gov.br, Grant number: 007/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MR, 2007, GENET MOL RES, V6, P500; Barbosa MD, 2013, GENET MOL BIOL, V36, P70, DOI 10.1590/S1415-47572013000100010; Cracraft J, 1975, ORNITHOL MONOGR, P49; de Oliveira EHC, 2005, CHROMOSOMA, V114, P338, DOI 10.1007/s00412-005-0009-5; Derjusheva S, 2004, CHROMOSOME RES, V12, P715, DOI 10.1023/B:CHRO.0000045779.50641.00; dos Santos MD, 2015, GENETICA, V143, P535, DOI 10.1007/s10709-015-9851-4; Fernandes AM, 2013, MOL PHYLOGENET EVOL, V66, P270, DOI 10.1016/j.ympev.2012.09.033; Furo ID, 2017, CYTOGENET GENOME RES, V151, P151, DOI 10.1159/000464458; Garnero Analia del V., 2000, Nucleus (Calcutta), V43, P64; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Guttenbach M, 2003, CYTOGENET GENOME RES, V103, P173, DOI 10.1159/000076309; Haffer J, 2001, AMAZONIANA, V16, P579; Hansmann T, 2009, CYTOGENET GENOME RES, V126, P281, DOI 10.1159/000251965; Itoh Y, 2005, CHROMOSOME RES, V13, P47, DOI 10.1007/s10577-005-6602-x; Kretschmer R, 2015, BIOL J LINN SOC, V115, P391, DOI 10.1111/bij.12504; Kretschmer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103338; Marantz C, 2003, HDB BIRDS WORLD BROA, P354; Moyle RG, 2009, CLADISTICS, V25, P386, DOI 10.1111/j.1096-0031.2009.00259.x; Nanda I, 2007, CYTOGENET GENOME RES, V117, P43, DOI 10.1159/000103164; Nanda I, 2006, CYTOGENET GENOME RES, V112, P286, DOI 10.1159/000089883; Nanda I, 2011, CYTOGENET GENOME RES, V132, P165, DOI 10.1159/000322358; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nanda I, 2008, CYTOGENET GENOME RES, V122, P150, DOI 10.1159/000163092; Nie WH, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0484-0; Nie WH, 2009, CHROMOSOME RES, V17, P99, DOI 10.1007/s10577-009-9021-6; Nishida C, 2014, CYTOGENET GENOME RES, V142, P179, DOI 10.1159/000358407; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Ribas TFA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-119; Sarg B, 2015, J PROTEOMICS, V113, P162, DOI 10.1016/j.jprot.2014.10.004; Skinner BM, 2012, HEREDITY, V108, P37, DOI 10.1038/hdy.2011.99; Volker M, 2010, GENOME RES, V20, P503, DOI 10.1101/gr.103663.109	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202040	10.1371/journal.pone.0202040	http://dx.doi.org/10.1371/journal.pone.0202040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138388	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100036
J	Kelty-Stephen, DG				Kelty-Stephen, Damian G.			Multifractal evidence of nonlinear interactions stabilizing posture for phasmids in windy conditions: A reanalysis of insect postural-sway data	PLOS ONE			English	Article							EXTATOSOMA-TIARATUM; HUMAN COGNITION; DYNAMICS; FLUCTUATIONS; VARIABILITY; COMPLEXITY; CASCADES; SYSTEM; MOTION; NOISE	The present work is a reanalysis of prior work documenting postural sway in phasmids (i.e., "stick insects") [1]. The prior work pursued the possibility that postural sway was an evolutionary adaptation supporting motion camouflage to avoid the attention of predators. For instance, swaying along with leaves blown by the wind might reduce the likelihood of standing out to a predator. The present work addresses the alternative-but by no means conflicting and perhaps more explanatory-proposal that phasmid postural sway carries evidence of the tensegrity-like structures allowing postural stabilization under wind-like stimulation. Tensegrity structures are prestressed architectures embodying nonlinear interactions across scales of space and time that provide context-sensitive responses faster than neural tissue can support. Multifractal modeling of the postural-displacement series initially recorded in [1] offers a metric equally effective for quantifying complexity of phasmid postural sway under wind stimulation as for quantifying complexity of human postural sway [2-7]. Furthermore, multifractal modeling offers a means to demonstrate empirically the nonlinear interactions across space and time scales in body-wide coordination that tensegrity-based hypotheses predict. Specifically, multifractal modeling allows diagnosing the strength and direction of nonlinear interactions across time scale as the difference between multifractal estimates for the original postural-displacement series and for a sample of best-fitting linear models of the series. The reduction of postural sway directly following the application of wind stimulus appears as a significant decrease in the multifractal structure for original postural-displacement series as compared to best-fitting linear models of those series. This decrease indicates the capacity for nonlinear interactions across time scale to constrict variability, which is an aspect of nonlinear dynamics often overshadowed by the possibility that nonlinearity can produce more variability. This work offers the longer-range opportunity that multifractal modeling could provide a common language within which to coordinate behavioral sciences across a wide range of species.	[Kelty-Stephen, Damian G.] Grinnell Coll, Dept Psychol, Grinnell, IA 50112 USA		Kelty-Stephen, DG (corresponding author), Grinnell Coll, Dept Psychol, Grinnell, IA 50112 USA.			Kelty-Stephen, Damian/0000-0001-7332-8486				Amaral LAN, 2001, PHYS REV LETT, V86, P6026, DOI 10.1103/PhysRevLett.86.6026; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; Bashan A, 2008, PHYSICA A, V387, P5080, DOI 10.1016/j.physa.2008.04.023; BASSLER U, 1979, J COMP PHYSIOL, V132, P209; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bian X, 2016, BEHAV ECOL, V27, P83, DOI 10.1093/beheco/arv125; Box GEP, 1976, TIME SERIES ANAL FOR, P1; Brown IE, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P148; Bryce RM, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00315; Caballero C, 2017, EUR J HUM MOV, V38, P12; Cavanaugh JT, 2017, J NEUROL PHYS THER, V41, P245, DOI 10.1097/NPT.0000000000000199; Cham JG, 2002, INT J ROBOT RES, V21, P869, DOI 10.1177/0278364902021010837; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Endlein T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2868; Frantsevich L, 2002, ZOOLOGY, V105, P225, DOI 10.1078/0944-2006-00067; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; Holden JG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00209; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Hossner EJ, 2016, HUM MOVEMENT SCI, V47, P246, DOI 10.1016/j.humov.2015.11.019; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Ihlen EAF, 2013, J BIOMECH, V46, P484, DOI 10.1016/j.jbiomech.2012.10.016; Ihlen EAF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00141; Ihlen EAF, 2010, J EXP PSYCHOL GEN, V139, P436, DOI 10.1037/a0019098; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Ivanov PC, 2001, CHAOS, V11, P641, DOI 10.1063/1.1395631; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Jahed Z, 2015, BIOPHYS J, V109, P501, DOI 10.1016/j.bpj.2015.06.057; KELSO JAS, 1984, J EXP PSYCHOL HUMAN, V10, P812, DOI 10.1037/0096-1523.10.6.812; Kelty-Stephen DG, 2017, ECOL PSYCHOL, V29, P259, DOI 10.1080/10407413.2017.1368355; Kiely J, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.00262, 10.3389/fpsya.2016.00262]; Koslucher F, 2016, EXP BRAIN RES, V234, P2709, DOI 10.1007/s00221-016-4675-8; Kuznetsov NA, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00062; Kuznetsova A, IMERTEST TESTS LINEA; Lee JT, 2017, COMPLEXITY, DOI 10.1155/2017/7015243; MANDELBROT BB, 1974, J FLUID MECH, V62, P331, DOI 10.1017/S0022112074000711; MANDELBROT BB, 1989, E MAJ INT S, V45, P3; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P495, DOI 10.5194/npg-11-495-2004; Marsden C D, 1983, Adv Neurol, V39, P645; Morales CJ, 2002, ANN BIOMED ENG, V30, P588, DOI 10.1114/1.1478082; Moreno MA, 2011, NEUROSCI LETT, V490, P126, DOI 10.1016/j.neulet.2010.12.041; Moritz CT, 2005, J EXP BIOL, V208, P939, DOI 10.1242/jeb.01472; Munafo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166900; Munafo J, 2016, EXP BRAIN RES, V234, P2721, DOI 10.1007/s00221-016-4676-7; Palatinus Z, 2014, J EXP PSYCHOL HUMAN, V40, P1808, DOI 10.1037/a0037247; Palatinus Z, 2013, ANN BIOMED ENG, V41, P1625, DOI 10.1007/s10439-012-0706-1; Reynolds AM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.030106; RICCIO GE, 1993, VARIABILITY AND MOTOR CONTROL, P317; Schertzer D, 2004, GEOPHYS MONOGR SER, V150, P317, DOI 10.1029/150GM25; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shimizu Y, 2002, FRACTALS, V10, P103, DOI 10.1142/S0218348X02001130; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Singh N. B., 2003, Advances in arid legumes research, P1; Sternad D, 2018, CURR OPIN BEHAV SCI, V20, P183, DOI 10.1016/j.cobeha.2018.01.004; Stoffregen T.A., 1990, ECOL PSYCHOL, V2, P251, DOI [10.1207/s15326969-co0203_3, DOI 10.1207/S15326969-CO0203_3]; Stoffregen TA, 2005, ECOL PSYCHOL, V17, P75, DOI 10.1207/s15326969eco1702_2; STOFFREGEN TA, 1985, J EXP PSYCHOL HUMAN, V11, P554, DOI 10.1037/0096-1523.11.5.554; STOFFREGEN TA, 1986, PERCEPT PSYCHOPHYS, V39, P355, DOI 10.3758/BF03203004; Turvey MT, 2006, MENT LEX, V1, P7, DOI 10.1075/ml.1.1.04tur; Turvey MT, 2014, J MOTOR BEHAV, V46, P143, DOI 10.1080/00222895.2013.798252; VENEZIANO D, 1995, PHYS REV E, V52, P1387, DOI 10.1103/PhysRevE.52.1387; Wagenmakers EJ, 2005, J EXP PSYCHOL GEN, V134, P108, DOI 10.1037/0096-3445.134.1.108; Zamir M, 2003, J THEOR BIOL, V225, P407, DOI 10.1016/S0022-5193(03)00261-3	66	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202367	10.1371/journal.pone.0202367	http://dx.doi.org/10.1371/journal.pone.0202367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138323	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100057
J	Lai, S; Gao, JM; Zhou, ZL; Yang, XW; Xu, YJ; Zhou, ZY; Chen, G				Lai, Sha; Gao, Jianmin; Zhou, Zhongliang; Yang, Xiaowei; Xu, Yongjian; Zhou, Zhiying; Chen, Gang			Prevalences and trends of chronic diseases in Shaanxi Province, China: Evidence from representative cross-sectional surveys in 2003, 2008 and 2013	PLOS ONE			English	Article							PREVENTING CHRONIC DISEASES; NONCOMMUNICABLE DISEASES; RISK-FACTORS; HEALTH; HYPERTENSION; AWARENESS; ADULTS; WORLD; WOMEN; UNEMPLOYMENT	Objectives Non-communicable diseases, which can refer to chronic diseases that are not caused by infectious agents and can endure for a long time, are currently regarded as a critical public health problem in China. This study aimed to estimate the prevalences of self-reported physician-diagnosed chronic diseases among urban and rural populations aged 15 years and older in Shaanxi Province, China, during 2003-2013 and explore how these changes differ by subpopulation. Methods Three independent cross-sectional surveys were implemented in 2003, 2008 and 2013 in Shaanxi Province. A multistage stratified cluster random sampling method was used in each wave to collect representative samples. In total, 10,568 residents in 2003, 15,453 in 2008 and 48,808 in 2013 were included in this analysis. Information on self-reported physician-diagnosed chronic diseases was collected using face-to-face interviews in each survey. Multilevel Poisson regression with robust error variance was employed to calculate the adjusted prevalence ratios to estimate the relative change in chronic conditions in 2008 and 2013, compared to that in 2003. Results In 2013, 23.9%/22.1% of urban/rural residents, respectively, reported having at least one chronic condition, which represents an increase from 17.0%/15.1%, respectively, in 2008 and 12.8%/10.9%, respectively, in 2003. Adjusted for socio-demographic characteristics, the prevalence of chronic diseases was significantly higher in 2013 than that in 2003. Among the chronic diseases studied, the prevalence of hypertension and diabetes has increased dramatically over a decade. The increase in chronic diseases occurred mainly among the middle-aged and elderly. Conclusions Chronic diseases are highly prevalent and continuously increasing in the adult population in Shaanxi Province from 2003 to 2013. Given its large aging population, China may face a greater chronic disease burden. A national chronic disease surveillance system and screening program should be established to acquire comprehensive information regarding the distribution and trends of chronic diseases.	[Lai, Sha; Gao, Jianmin; Zhou, Zhongliang; Yang, Xiaowei; Xu, Yongjian] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China; [Zhou, Zhiying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian, Shaanxi, Peoples R China; [Chen, Gang] Monash Univ, Ctr Hlth Econ, Clayton, Vic, Australia	Xi'an Jiaotong University; Xi'an Jiaotong University; Monash University	Gao, JM; Zhou, ZL (corresponding author), Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China.	gaojm@mail.xjtu.edu.cn; zzliang1981@mail.xjtu.edu.cn		Chen, Gang/0000-0002-8385-5965	China Medical Board	China Medical Board	This study is supported by China Medical Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Chen LX, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1687-4; Chen WS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-82; Chinese Center for Disease Control and Prevention, GLOB AD TOB SURV GAT; Chinese center for disease control and prevention, REP CHRON DIS CHIN; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; De Vogli R, 2005, TOB CONTROL, V14, P389, DOI 10.1136/tc.2004.010611; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Fu CW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-862; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hao W, 1998, PSYCHIAT CLIN NEUROS, V52, pS324, DOI 10.1111/j.1440-1819.1998.tb03258.x; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Huang XB, 2012, HEART, V98, pE109, DOI 10.1136/heartjnl-2012-302920a.288; International Institute for Applied Systems Analysis, CHIN POP AG SEX 1950; Levesque JF, 2013, INT J PUBLIC HEALTH, V58, P435, DOI 10.1007/s00038-013-0446-5; Li Yuan, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P869; Lin JD, 2010, PUBLIC HEALTH, V124, P345, DOI 10.1016/j.puhe.2010.03.004; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Mossakowski KN, 2008, SOC SCI MED, V67, P947, DOI 10.1016/j.socscimed.2008.05.019; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; National Bureau of Statistics of the People's Republic of China, B 6 CENS DAT 2010; Pardeshi Geeta S, 2010, Indian J Community Med, V35, P391, DOI 10.4103/0970-0218.69256; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Shaanxi Provincial Bureau of Statistic, SHAANX 2017 STAT YB; Simoes EJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1787-1; Sozmen K, 2014, IRAN J PUBLIC HEALTH, V43, P736; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Sun HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105469; Tan ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065958; Tian MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-948; Wang H, 2006, HEALTH POLICY, V78, P167, DOI 10.1016/j.healthpol.2005.09.008; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang LD, 2002, 2002 NUTR HLTH SURVE; World Health Organization, CHRON DIS HLTH PROM; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu YH, 2014, MED SCI MONITOR, V20, P379, DOI 10.12659/MSM.890204; Yang, 2005, DEATHS THEIR RISK FA; Yang F, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0597-8; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2015, LANCET, V385, P1019, DOI 10.1016/S0140-6736(15)60174-X; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003; Zhou Y, 2015, MATURITAS, V80, P282, DOI 10.1016/j.maturitas.2014.12.001; Zhu SZ, 2015, DIABETES EDUCATOR, V41, P599, DOI 10.1177/0145721715598382	52	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202886	10.1371/journal.pone.0202886	http://dx.doi.org/10.1371/journal.pone.0202886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138444	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100138
J	Pesaro, AE; Katz, M; Liberman, M; Pereira, C; Mangueira, CLP; de Carvalho, AEZ; Carvalho, KS; Nomura, CH; Franken, M; Serrano, CV				Pesaro, Antonio E.; Katz, Marcelo; Liberman, Marcel; Pereira, Carolina; Mangueira, Cristovao L. P.; de Carvalho, Ana E. Z.; Carvalho, Karina S.; Nomura, Cesar H.; Franken, Marcelo; Serrano Jr, Carlos, V			Circulating osteogenic proteins are associated with coronary artery calcification and increase after myocardial infarction	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; KAPPA-B LIGAND; FACTOR-BETA 1; C-REACTIVE PROTEIN; VASCULAR CALCIFICATION; RECEPTOR ACTIVATOR; HEART-DISEASE; CARDIOVASCULAR EVENTS; POSTMENOPAUSAL WOMEN; RANK LIGAND	Background Coronary artery calcification (CAC) and atherosclerotic inflammation associate with increased risk of myocardial infarction (MI). Vascular calcification is regulated by osteogenic proteins (OPs). It is unknown whether an association exists between CAC and plasma OPs and if they are affected by atherothrombotic inflammation. We tested the association of osteogenic and inflammatory proteins with CAC and assessed these biomarkers after MI. Methods Circulating OPs (osteoprotegerin, RANKL, fetuin-A, Matrix Gla protein [MGP]) and inflammatory proteins (C-reactive protein, oxidized-LDL, tumoral necrosis factor-alpha, transforming growth factor [TGF]-beta 1) were compared between stable patients with CAC (CAC >= 100 AU, n = 100) and controls (CAC = 0 AU, n = 30). The association between biomarkers and CAC was tested by multivariate analysis. In patients with MI (n = 40), biomarkers were compared between acute phase and 1-2 months post-MI, using controls as a baseline. Results MGP and fetuin-A levels were higher within individuals with CAC. Higher levels of MGP and RANKL were associated with CAC (OR 3.12 [95% CI 1.20-8.11], p = 0.02; and OR 1.75 [95% CI 1.04-2.94] respectively, p = 0.035). After MI, C-reactive protein, OPG and oxidized-LDL levels increased in the acute phase, whereas MGP and TGF-beta 1 increased 1-2 months post-MI. Conclusions Higher MGP and RANKL levels associate with CAC. These findings highlight the potential role of these proteins as modulators and markers of CAC. In addition, the post-MI increase in OPG and MGP, as well as of inflammatory proteins suggest that the regulation of these OPs is affected by atherothrombotic inflammation.	[Pesaro, Antonio E.; Katz, Marcelo; Liberman, Marcel; Pereira, Carolina; Mangueira, Cristovao L. P.; de Carvalho, Ana E. Z.; Carvalho, Karina S.; Nomura, Cesar H.; Franken, Marcelo; Serrano Jr, Carlos, V] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein	Pesaro, AE (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.	antonioepp@einstein.br	Carvalho, Karina IL/J-6789-2012; Liberman, Marcel/V-7471-2019; Liberman, Marcel/D-7243-2013; Zulim de Carvalho, Ana Eduarda/M-6309-2017	Carvalho, Karina IL/0000-0002-7763-8139; Liberman, Marcel/0000-0002-0040-1547; Zulim de Carvalho, Ana Eduarda/0000-0001-9246-8839; Pesaro, Antonio/0000-0003-3133-4989	Sao Paulo Research Foundation [FAPESP/2013/06799-0]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the Sao Paulo Research Foundation (http://www.fapesp.br/; FAPESP/2013/06799-0). No industry support was provided for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; Anand DV, 2006, J AM COLL CARDIOL, V47, P1850, DOI 10.1016/j.jacc.2005.12.054; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Chen C, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-18; Crisafulli A, 2005, CLIN SCI, V109, P389, DOI 10.1042/CS20050058; Dalmeijer GW, 2014, J THROMB HAEMOST, V12, P1028, DOI 10.1111/jth.12609; Dalmeijer GW, 2013, DIABETES CARE, V36, P3766, DOI 10.2337/dc13-0065; Demer LL, 2002, INT J EPIDEMIOL, V31, P737, DOI 10.1093/ije/31.4.737; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Di Stefano R, 2009, BIOMED PHARMACOTHER, V63, P773, DOI 10.1016/j.biopha.2009.06.004; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Hamirani YS, 2008, ATHEROSCLEROSIS, V201, P1, DOI 10.1016/j.atherosclerosis.2008.04.045; He LP, 2010, HEART, V96, P339, DOI 10.1136/hrt.2009.174912; Ix JH, 2012, CLIN CHEM, V58, P887, DOI 10.1373/clinchem.2011.177725; Jono S, 2004, THROMB HAEMOSTASIS, V91, P790, DOI 10.1160/TH03-08-0572; Ketlogetswe KS, 2015, JAIDS-J ACQ IMM DEF, V70, P362, DOI 10.1097/QAI.0000000000000725; Liberman M, 2013, EINSTEIN-SAO PAULO, V11, P376, DOI 10.1590/S1679-45082013000300021; Lim P, 2013, AM J CARDIOL, V111, P31, DOI 10.1016/j.amjcard.2012.08.042; Lopes-Virella MF, 2011, ATHEROSCLEROSIS, V214, P462, DOI 10.1016/j.atherosclerosis.2010.11.012; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Margonato A, 2015, J CARDIOVASC MED, V16, P156, DOI 10.2459/JCM.0b013e328365b57d; Mayer O, 2014, ATHEROSCLEROSIS, V235, P162, DOI 10.1016/j.atherosclerosis.2014.04.027; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Nakahara T, 2017, JACC-CARDIOVASC IMAG, V10, P582, DOI 10.1016/j.jcmg.2017.03.005; Ndip A, 2011, DIABETES, V60, P2187, DOI 10.2337/db10-1220; O'Donnell CJ, 2006, ARTERIOSCL THROM VAS, V26, P2769, DOI 10.1161/01.ATV.0000245793.83158.06; Okwuosa TM, 2012, JACC-CARDIOVASC IMAG, V5, P144, DOI 10.1016/j.jcmg.2011.11.008; Otsuka G, 2006, ARTERIOSCL THROM VAS, V26, P737, DOI 10.1161/01.ATV.0000201087.23877.e1; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Poornima IG, 2014, MENOPAUSE, V21, P702, DOI [10.1097/GME.0000000000000127, 10.1097/gme.0000000000000127]; Raaz-Schrauder D, 2012, CYTOKINE, V57, P251, DOI 10.1016/j.cyto.2011.11.015; Rath D, 2014, ATHEROSCLEROSIS, V237, P754, DOI 10.1016/j.atherosclerosis.2014.10.021; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Samelson EJ, 2014, J BONE MINER RES, V29, P450, DOI 10.1002/jbmr.2043; Sandberg WJ, 2006, ARTERIOSCL THROM VAS, V26, P857, DOI 10.1161/01.ATV.0000204334.48195.6a; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; Semb AG, 2009, ARTERIOSCL THROM VAS, V29, P975, DOI 10.1161/ATVBAHA.109.184101; Shea MK, 2011, J NUTR, V141, P1529, DOI 10.3945/jn.111.139634; Shetelig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173034; Smith WB, 1996, J IMMUNOL, V157, P360; Thomsen SB, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-86; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Wayhs R, 2002, J AM COLL CARDIOL, V39, P225, DOI 10.1016/S0735-1097(01)01737-5	50	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202738	10.1371/journal.pone.0202738	http://dx.doi.org/10.1371/journal.pone.0202738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138356	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100113
J	Rauca, VF; Licarete, E; Luput, L; Sesarman, A; Patras, L; Bulzu, P; Rakosy-Tican, E; Banciu, M				Rauca, Valentin-Florian; Licarete, Emilia; Luput, Lavinia; Sesarman, Aline; Patras, Laura; Bulzu, Paul; Rakosy-Tican, Elena; Banciu, Manuela			Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; LIPOSOMAL PREDNISOLONE PHOSPHATE; OXIDATIVE STRESS; L-TYROSINE; HIF-1-ALPHA EXPRESSION; DISRUPTING AGENT; L-DOPA; CANCER; PROGRESSION; MELANOGENESIS	The major drawback of current anti-angiogenic therapies is drug resistance, mainly caused by overexpression of the transcription factor, hypoxia-inducible factor 1 alpha (HIF-1 alpha) as a result of treatment-induced hypoxia, which stimulates cancer cells to develop aggressive and immunosuppressive phenotypes. Moreover, the cancer cell resistance to anti-angiogenic therapies is deeply mediated by the communication between tumor cells and tumor-associated macrophages (TAMs)-the most important microenvironmental cells for the coordination of all supportive processes in tumor development. Thus, simultaneous targeting of TAMs and cancer cells could improve the outcome of the anti-angiogenic therapies. Since our previous studies proved that simvastatin (SIM) exerts strong antiproliferative actions on B16.F10 murine melanoma cells via reduction of TAMs-mediated oxidative stress and inhibition of intratumor production of HIF-l alpha, we investigated whether the antitumor efficacy of the anti-angiogenic agent-5,6-dimethylxanthenone-4-acetic acid (DMXAA) could be improved by its co-administration with the lipophilic statin. Our results provide confirmatory evidence for the ability of the combined treatment to suppress the aggressive phenotype of the B16.F10 melanoma cells co-cultured with TAMs under hypoxia-mimicking conditions in vitro. Thus, proliferation and migration capacity of the melanoma cells were strongly decelerated after the co-administration of SIM and DMXAA. Moreover, our data suggested that the anti-oxidant action of the combined treatment, as a result of melanogenesis stimulation, might be the principal cause for the simultaneous suppression of key molecules involved in melanoma cell aggressiveness, present in melanoma cells (HIF-1 alpha) as well as in TAMs (arginase-1). Finally, the concomitant suppression of these proteins might have contributed to a very strong inhibition of the angiogenic capacity of the cell co-culture microenvironment.	[Rauca, Valentin-Florian; Licarete, Emilia; Luput, Lavinia; Sesarman, Aline; Patras, Laura; Bulzu, Paul; Rakosy-Tican, Elena; Banciu, Manuela] Babes Bolyai Univ, Fac Biol & Geol, Dept Mol Biol & Biotechnol, Cluj Napoca, Romania; [Rauca, Valentin-Florian; Licarete, Emilia; Luput, Lavinia; Sesarman, Aline; Patras, Laura; Bulzu, Paul; Banciu, Manuela] Babes Bolyai Univ, Mol Biol Ctr, Inst Interdisciplinary Res Bionanosci, Cluj Napoca, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Banciu, M (corresponding author), Babes Bolyai Univ, Fac Biol & Geol, Dept Mol Biol & Biotechnol, Cluj Napoca, Romania.; Banciu, M (corresponding author), Babes Bolyai Univ, Mol Biol Ctr, Inst Interdisciplinary Res Bionanosci, Cluj Napoca, Romania.	manuela.banciu@ubbcluj.ro	Sesarman, Alina/F-6841-2011; Licarete, Emilia/O-7030-2014; Rauca, Valentin-Florian/AAK-4598-2020; Bulzu, Paul-Adrian/G-8748-2019; Bulzu, Paul-Adrian/AAC-8936-2021; Patras, Laura/C-4477-2017; Licarete, Emilia/ABC-4370-2020; Banciu, Manuela/D-6425-2011; Rakosy-Tican, Elena/G-2289-2011	Sesarman, Alina/0000-0002-7491-9955; Licarete, Emilia/0000-0003-1190-6003; Rauca, Valentin-Florian/0000-0002-5879-9308; Bulzu, Paul-Adrian/0000-0002-5637-9940; Patras, Laura/0000-0002-6981-3881; Licarete, Emilia/0000-0003-1190-6003; Rakosy-Tican, Elena/0000-0002-0982-8547; Banciu, Manuela/0000-0003-2556-4008	CNCS-UEFISCDI under Ministery of Education, Research and Innovation within PNCDI II [PN-II-RU-TE-2014-4-1191, 235/01.10.2015]; Ministry of Research and Innovation within PNCDI III [PN-III-P4-ID-PCE-2016-0342, 91/2017]	CNCS-UEFISCDI under Ministery of Education, Research and Innovation within PNCDI II; Ministry of Research and Innovation within PNCDI III	This work is supported by Romanian grants awarded by CNCS-UEFISCDI under Ministery of Education, Research and Innovation, project number PN-II-RU-TE-2014-4-1191, contract no. 235/01.10.2015 within PNCDI II and under Ministry of Research and Innovation, project number PN-III-P4-ID-PCE-2016-0342, contract no. 91/2017, within PNCDI III.	Al Okail MS, 2010, J SAUDI CHEM SOC, V14, P197, DOI 10.1016/j.jscs.2010.02.005; Alupei MC, 2014, ANTI-CANCER DRUG, V25, P393, DOI 10.1097/CAD.0000000000000065; Alupei MC, 2015, CANCER LETT, V356, P946, DOI 10.1016/j.canlet.2014.11.010; Banciu M, 2008, NEOPLASIA, V10, P108, DOI 10.1593/neo.07913; Banciu M, 2006, J CONTROL RELEASE, V113, P1, DOI 10.1016/j.jconrel.2006.03.019; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Casanovas O, 2012, NATURE, V484, P44, DOI 10.1038/484044a; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Downey CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099988; Falleni M, 2017, MELANOMA RES, V27, P200, DOI 10.1097/CMR.0000000000000352; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; Haase-Kohn C, 2014, BIOCHEM BIOPH RES CO, V446, P143, DOI 10.1016/j.bbrc.2014.02.126; Hiss DC, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-5; Itakura E, 2011, MODERN PATHOL, V24, P801, DOI 10.1038/modpathol.2011.5; Jassar AS, 2005, CANCER RES, V65, P11752, DOI 10.1158/0008-5472.CAN-05-1658; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Li G, 2017, BIOMED PHARMACOTHER, V85, P418, DOI 10.1016/j.biopha.2016.11.045; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Licarete E, 2017, ONCOL LETT, V13, P3942, DOI 10.3892/ol.2017.5928; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luput L, 2017, ONCOL REP, V37, P2472, DOI 10.3892/or.2017.5466; Magina S, 2011, ARCH DERMATOL RES, V303, P201, DOI 10.1007/s00403-011-1126-z; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; McDonald PC, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00027; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Orsolic N, 2016, CHEM-BIOL INTERACT, V256, P111, DOI 10.1016/j.cbi.2016.06.027; Patras L, 2016, ONCOL LETT, V12, P1183, DOI 10.3892/ol.2016.4708; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Seth A, 2017, ONCOTARGET, V8, P5371, DOI 10.18632/oncotarget.14260; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; SLOMINSKI A, 1990, J THEOR BIOL, V143, P123, DOI 10.1016/S0022-5193(05)80292-9; SLOMINSKI A, 1989, PIGM CELL RES, V2, P109, DOI 10.1111/j.1600-0749.1989.tb00170.x; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1988, J CELL SCI, V89, P287; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Tsai Ming-Ju, 2014, ISRN Biochem, V2014, P351959, DOI 10.1155/2014/351959; Wang MN, 2017, J CANCER, V8, P761, DOI 10.7150/jca.17648; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Wu DL, 2011, JOVE-J VIS EXP, DOI 10.3791/2899; Yang L, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0430-2; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhu F, 2014, ONCOL REP, V31, P2049, DOI 10.3892/or.2014.3060	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202827	10.1371/journal.pone.0202827	http://dx.doi.org/10.1371/journal.pone.0202827			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138430	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100134
J	Zhan, LX; Lu, ZW; Zhu, XY; Xu, WS; Li, LX; Li, XY; Chen, SY; Sun, WW; Xu, E				Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En			Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKII inactivation in adult rats	FASEB JOURNAL			English	Article						apoptosis; dynamin-related protein 1; necroptosis; ischemic tolerance	DEPENDENT PROTEIN-KINASE; PROGRAMMED CELL-DEATH; MIXED LINEAGE KINASE; MITOCHONDRIAL FISSION; CHEMICAL INHIBITOR; NEUROPROTECTION; DRP1; PHOSPHORYLATION; FRAGMENTATION; CONTRIBUTES	Hypoxic preconditioning (HPC) alleviates the selective and delayed neuronal death in the hippocampal CA1 region induced by transient global cerebral ischemia (tGCI). This type of cell death may include different programmed cell death mechanisms, namely, apoptosis and necroptosis. Although apoptotic signaling is well defined, the mechanisms that underlie neuronal necroptosis are yet to be fully elucidated. In this study, we investigated whether HPC protects neurons from cerebral ischemia-induced necroptosis. We observed that tGCI up-regulated the expression of receptor-interacting protein (RIP) 3 and increased the interaction of RIP1-RIP3 in CA1 at the early stage of reperfusion. The pretreatment with HPC or necrostatin-1 decreased the expression of RIP3 and the formation of RIP1-RIP3 after tGCI. We also found that HPC decreased the expression and the activity of caspase-8 in CA1 after tGCI, and notably, the pretreatment with Z-VAD-FMK, a pan-caspase inhibitor, did not trigger necroptosis but attenuated the tGCI-induced neuronal damage. Furthermore, we demonstrated that HPC decreased the activation of calcium-calmodulin kinase (CaMK) II and the interaction of RIP1 and CaMKII induced by tGCI. Intriguingly, the pretreatment with a CaMKs inhibitor KN-93 before tGCI resulted in significantly reduced RIP1-3 interaction and tGCI-induced neuronal damage. Finally, we ascertained that HPC prevented the dephosphorylation of dynamin-related protein 1 (Drp1)-Ser637 (serine 637) and inhibited the translocation of Drp1 to mitochondria induced by tGCI. Importantly, the treatment with a Drp1 inhibitor Mdivi-1 or necrostatin-1 before tGCI also abolished Drp1 dephosphorylation at Ser637 and mitochondrial translocation. Taken together, our results highlight that HPC attenuates necroptotic neuronal death induced by tGCI via Drp1-dependent mitochondrial signaling pathways mediated by CaMKII inactivation.Zhan, L., Lu, Z., Zhu, X., Xu, W., Li, L., Li, X., Chen, S., Sun, W., Xu, E. Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKII inactivation in adult rats.	[Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En] Minist Educ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En] Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China; [Zhan, Lixuan; Lu, Zhiwei; Zhu, Xinyong; Xu, Wensheng; Li, Luxi; Li, Xinyu; Chen, Siyuan; Sun, Weiwen; Xu, En] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Lu, Zhiwei] Guangzhou Med Univ, Guangzhou Huai Hosp, Affiliated Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Xu, E (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China.				National Natural Science Foundation of China [81571140]; Natural Science Foundation of Guangdong, China [2015A030313461]; Project of Science and Technology Program of Guangzhou Bureau of Education, China [1201630280]; Science and Technology Program of Guangzhou, China [201510010118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Project of Science and Technology Program of Guangzhou Bureau of Education, China; Science and Technology Program of Guangzhou, China	The authors thank Peifeng Du (Guangzhou International Bio-Island Investment and Development Co., Guangzhou, China) for editing this paper. This work was supported by the National Natural Science Foundation of China (Grant 81571140), the Natural Science Foundation of Guangdong, China (Grant 2015A030313461), the Project of Science and Technology Program of Guangzhou Bureau of Education, China (Grant 1201630280), and the Science and Technology Program of Guangzhou, China (Grant 201510010118). The authors declare no conflicts of interest.	Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen WW, 2012, J NEUROCHEM, V120, P70, DOI 10.1111/j.1471-4159.2011.07526.x; Cho Bongki, 2013, Exp Neurobiol, V22, P149, DOI 10.5607/en.2013.22.3.149; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang HC, 2015, P NATL ACAD SCI USA, V112, P8768, DOI 10.1073/pnas.1501831112; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Li YL, 2008, NEUROSCI LETT, V447, P120, DOI 10.1016/j.neulet.2008.08.037; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Martinon F, 2000, FEBS LETT, V468, P134, DOI 10.1016/S0014-5793(00)01212-6; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Nomura M, 2014, CANCER RES, V74, P1056, DOI 10.1158/0008-5472.CAN-13-1283; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Szobi A, 2014, MOL CELL BIOCHEM, V388, P269, DOI 10.1007/s11010-013-1918-x; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Thornton C, 2015, CLIN CHIM ACTA, V451, P35, DOI 10.1016/j.cca.2015.01.026; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Vieira M, 2014, NEUROBIOL DIS, V68, P26, DOI 10.1016/j.nbd.2014.04.002; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Wang Y, 2011, NEUROCHEM RES, V36, P2381, DOI 10.1007/s11064-011-0564-5; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Zhan LX, 2017, BRAIN PATHOL, V27, P822, DOI 10.1111/bpa.12472; Zhan LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.330; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035; Zhan LX, 2011, NEUROCHEM INT, V59, P65, DOI 10.1016/j.neuint.2011.04.016; Zhan LX, 2010, J NEUROCHEM, V114, P897, DOI 10.1111/j.1471-4159.2010.06816.x; Zhang YF, 2014, TOXICOL LETT, V225, P445, DOI 10.1016/j.toxlet.2014.01.005; Zhu PP, 2014, MOL NEUROBIOL, V49, P1338, DOI 10.1007/s12035-013-8611-7; Zhu TN, 2014, J NEUROPATH EXP NEUR, V73, P975, DOI 10.1097/NEN.0000000000000118	55	23	25	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1313	1329		10.1096/fj.201800111RR	http://dx.doi.org/10.1096/fj.201800111RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148677	Bronze			2022-12-26	WOS:000457401500104
J	Madigan, JP; Hou, F; Ye, LL; Hu, JC; Dong, AP; Tempel, W; Yohe, ME; Randazzo, PA; Jenkins, LMM; Gottesman, MM; Tong, YF				Madigan, James P.; Hou, Feng; Ye, Linlei; Hu, Jicheng; Dong, Aiping; Tempel, Wolfram; Yohe, Marielle E.; Randazzo, Paul A.; Jenkins, Lisa M. Miller; Gottesman, Michael M.; Tong, Yufeng			The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; Akt PKB; 14-3-3 protein; E3 ubiquitin ligase; protein stability; ubiquitylation (ubiquitination); tuberous sclerosis complex (TSC); mTORC1; phospho-switch	PROTEIN-KINASE-B; UBIQUITIN LIGASES; STRUCTURAL BASIS; DOMAIN FAMILY; BETA-TRCP; INSULIN; PHOSPHATASE; ACTIVATION; MODEL; IDENTIFICATION	The tuberous sclerosis complex (TSC) is a negative regulator of mTOR complex 1, a signaling node promoting cellular growth in response to various nutrients and growth factors. However, several regulators in TSC signaling still await discovery and characterization. Using pulldown and MS approaches, here we identified the TSC complex member, TBC1 domain family member 7 (TBC1D7), as a binding partner for PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1), a negative regulator of Akt kinase signaling. Most TBC domain-containing proteins function as Rab GTPase-activating proteins (RabGAPs), but the crystal structure of TBC1D7 revealed that it lacks residues critical for RabGAP activity. Sequence analysis identified a putative site for both Akt-mediated phosphorylation and 14-3-3 binding at Ser-124, and we found that Akt phosphorylates TBC1D7 at Ser-124. However, this phosphorylation had no effect on the binding of TBC1D7 to TSC1, but stabilized TBC1D7. Moreover, 14-3-3 protein both bound and stabilized TBC1D7 in a growth factor-dependent manner, and a phospho-deficient substitution, S124A, prevented this interaction. The crystal structure of 14-3-3 in complex with a phospho-Ser-124 TBC1D7 peptide confirmed the direct interaction between 14-3-3 and TBC1D7. The sequence immediately upstream of Ser-124 aligned with a canonical -TrCP degron, and we found that the E3 ubiquitin ligase -TrCP2 ubiquitinates TBC1D7 and decreases its stability. Our findings reveal that Akt activity determines the phosphorylation status of TBC1D7 at the phospho-switch Ser-124, which governs binding to either 14-3-3 or -TrCP2, resulting in increased or decreased stability of TBC1D7, respectively.	[Madigan, James P.; Jenkins, Lisa M. Miller; Gottesman, Michael M.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yohe, Marielle E.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Randazzo, Paul A.] NCI, Lab Cell & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hou, Feng; Hu, Jicheng; Dong, Aiping; Tempel, Wolfram; Tong, Yufeng] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Ye, Linlei] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada; [Tong, Yufeng] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; Structural Genomics Consortium; University of Toronto; University of Windsor	Gottesman, MM (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Tong, YF (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Tong, YF (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	mgottesman@nih.gov; yufeng.tong@uwindsor.ca	Jenkins, Lisa/AAI-2490-2021	Tong, Yufeng/0000-0001-7740-1812; Gottesman, Michael/0000-0001-8908-2097	United States Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZICBC011430] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Amy K. Wernimont and John R. Walker for critical review of the TBC1D7 and 14-3-3 zeta crystal structures, respectively. Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, is operated by UChicago Argonne, LLC, for the United States Department of Energy Office of Biological and Environmental Research under contract DE-AC02-06CH11357. We also thank George Leiman (Laboratory of Cell Biology) for editorial assistance.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agarwal NK, 2014, ONCOTARGET, V5, P815, DOI 10.18632/oncotarget.1774; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bhogaraju S, 2014, PROTEINS, V82, P2282, DOI 10.1002/prot.24597; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Cowtan K., 2006, INT TABLES CRYSTALLO, P705; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fiordalisi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064309; Fischer B, 2016, NAT STRUCT MOL BIOL, V23, P965, DOI 10.1038/nsmb.3297; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gabernet-Castello C, 2013, MOL BIOL CELL, V24, P1574, DOI 10.1091/mbc.E12-07-0557; Gai ZC, 2016, J MOL CELL BIOL, V8, P411, DOI 10.1093/jmcb/mjw001; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Lee EK, 2014, ONCOGENE, V33, P2011, DOI 10.1038/onc.2013.144; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lima AJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093940; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Qin JY, 2016, J BIOL CHEM, V291, P8591, DOI 10.1074/jbc.M115.701870; Reiterer V, 2017, BIOCHEM SOC T, V45, P449, DOI 10.1042/BST20160279; Reiterer V, 2014, TRENDS CELL BIOL, V24, P489, DOI 10.1016/j.tcb.2014.03.008; Ren SX, 2018, J CELL BIOL, V217, P517, DOI 10.1083/jcb.201706027; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Sierecki E, 2014, BIOCHEMISTRY-US, V53, P3971, DOI 10.1021/bi500428j; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takeda K, 2013, GENES CELLS, V18, P369, DOI 10.1111/gtc.12043; Tempel W, 2008, PROTEINS, V71, P497, DOI 10.1002/prot.21885; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Toker Alex, 2014, Advances in Biological Regulation, V55, P28, DOI 10.1016/j.jbior.2014.04.001; Tong YF, 2014, METHODS MOL BIOL, V1140, P179, DOI 10.1007/978-1-4939-0354-2_14; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhu G, 2015, ONCOGENE, V34, P5971, DOI 10.1038/onc.2015.45	89	8	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16142	16159		10.1074/jbc.RA118.003525	http://dx.doi.org/10.1074/jbc.RA118.003525			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30143532	Green Published, hybrid			2022-12-26	WOS:000447833600002
J	Eisinger, KRT; Woolfrey, KM; Swanson, SP; Schnell, SA; Meitzen, J; Dell'Acqua, M; Mermelstein, PG				Eisinger, Katherine R. Tonn; Woolfrey, Kevin M.; Swanson, Samuel P.; Schnell, Stephen A.; Meitzen, John; Dell'Acqua, Mark; Mermelstein, Paul G.			Palmitoylation of caveolin-1 is regulated by the same DHHC acyltransferases that modify steroid hormone receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; post-translational modification (PTM); protein palmitoylation; caveolin; membrane protein; DHHC	PROTEIN PALMITOYLATION; ESTROGEN-RECEPTORS; ALPHA; LOCALIZATION; NUMBER; TARGET	Palmitoylation is a reversible post-translational addition of a 16-carbon lipid chain involved in trafficking and compartmentalizing target proteins. It is important for many cellular functions, including signaling via membrane-localized estrogen receptors (ERs). Within the nervous system, palmitoylation of ER is necessary for membrane surface localization and mediation of downstream signaling through the activation of metabotropic glutamate receptors (mGluRs). Substitution of the single palmitoylation site on ER alpha prevents its physical association with the integral membrane protein caveolin-1 (CAV1), required for the formation of the ER/mGluR signaling complex. Interestingly, siRNA knockdown of either of two palmitoyl acyltransferases, zinc finger DHHC type-containing 7 (DHHC7) or DHHC21, also eliminates this signaling mechanism. Because ER has only one palmitoylation site, we hypothesized that one of these DHHCs palmitoylates CAV1. We investigated this possibility by using an acyl-biotin exchange assay in HEK293 cells in conjunction with DHHC overexpression and found that DHHC7 increases CAV1 palmitoylation. Substitution of the palmitoylation sites on CAV1 eliminated this effect but did not disrupt the ability of the DHHC enzyme to associate with CAV1. In contrast, siRNA-mediated knockdown of DHHC7 alone was not sufficient to decrease CAV1 palmitoylation but rather required simultaneous knockdown of DHHC21. These findings provide additional information about the overall influence of palmitoylation on the membrane-initiated estrogen signaling pathway and highlight the importance of considering the influence of palmitoylation on other CAV1-dependent processes.	[Eisinger, Katherine R. Tonn; Swanson, Samuel P.; Schnell, Stephen A.; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Eisinger, Katherine R. Tonn; Mermelstein, Paul G.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Woolfrey, Kevin M.; Dell'Acqua, Mark] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Meitzen, John] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; North Carolina State University	Mermelstein, PG (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	pmerm@umn.edu		Eisinger, Katherine/0000-0002-3548-5381	National Institutes of Health [R01DA035008, R01DA041808, R01NS040701, R01MH109471, T32DA007234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234, R01DA041808, R01DA035008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01DA035008 and R01DA041808 (to P. G. M.), R01NS040701 (to M. L. D.), and R01MH109471 (to J. M.). K. R. T. E. was supported by National Institutes of Health Grant T32DA007234 (to P. G. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acconcia F, 2004, BIOCHEM BIOPH RES CO, V316, P878, DOI 10.1016/j.bbrc.2004.02.129; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Chatterjee M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10867; Christensen A, 2012, ENDOCRINOLOGY, V153, P3872, DOI 10.1210/en.2012-1312; Cornil CA, 2012, FRONT NEUROENDOCRIN, V33, P425, DOI 10.1016/j.yfrne.2012.08.003; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; Eisinger KRT, 2018, STEROIDS, V133, P53, DOI 10.1016/j.steroids.2017.11.013; Fernandez-Rojo MA, 2016, TRENDS MOL MED, V22, P889, DOI 10.1016/j.molmed.2016.08.007; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; Globa AK, 2017, CURR OPIN NEUROBIOL, V45, P210, DOI 10.1016/j.conb.2017.02.016; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Hedges VL, 2018, ENDOCRINOLOGY, V159, P1328, DOI 10.1210/en.2018-00039; Jayachandran M, 2001, AM J PHYSIOL-HEART C, V281, pH1327, DOI 10.1152/ajpheart.2001.281.3.H1327; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kassan A, 2017, J NEUROPHYSIOL, V117, P436, DOI 10.1152/jn.00481.2016; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; Meitzen J, 2019, STEROIDS, V142, P21, DOI 10.1016/j.steroids.2017.09.012; Meitzen J, 2013, ENDOCRINOLOGY, V154, P4293, DOI 10.1210/en.2013-1172; Mukherjee R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090918; Parat MO, 2001, J BIOL CHEM, V276, P15776, DOI 10.1074/jbc.M006722200; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2001, J BIOL CHEM, V276, P38121; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seredynski AL, 2015, J NEUROSCI, V35, P13110, DOI 10.1523/JNEUROSCI.2056-15.2015; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Tabatadze N, 2013, ENDOCRINOLOGY, V154, P819, DOI 10.1210/en.2012-1870; Turi A, 2001, CELL BIOL INT, V25, P785, DOI 10.1006/cbir.2001.0769; Woolfrey KM, 2015, J NEUROSCI, V35, P442, DOI 10.1523/JNEUROSCI.2243-14.2015; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Zhu Q, 2004, J UROLOGY, V171, P467, DOI 10.1097/01.ju.0000099480.18735.49; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200	48	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15901	15911		10.1074/jbc.RA118.004167	http://dx.doi.org/10.1074/jbc.RA118.004167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30158247	Green Published, hybrid			2022-12-26	WOS:000447256000014
J	Chen, JY; Parekh, M; Seliman, H; Bakshinskaya, D; Dai, W; Kwan, K; Chen, KY; Liu, AYC				Chen, Justin Y.; Parekh, Miloni; Seliman, Hadear; Bakshinskaya, Dariya; Dai, Wei; Kwan, Kelvin; Chen, Kuang Yu; Liu, Alice Y. C.			Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington's disease; aggregation; heat shock protein (HSP); chaperone; heat shock factor protein 1 (HSF1); neurodegeneration; HSP chaperones; heat shock; inclusion bodies; polyQ-mHtt protein; transcription factor sequestration; CREB	INTRINSICALLY DISORDERED PROTEINS; GENE-EXPRESSION; NUCLEOCYTOPLASMIC TRANSPORT; NEURODEGENERATIVE DISORDERS; INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE DISEASES; NEURAL DIFFERENTIATION; AGGREGATES SEQUESTER; DIPLOID FIBROBLASTS; QUALITY-CONTROL	PolyQ-expanded huntingtin (mHtt) variants form aggregates, termed inclusion bodies (IBs), in individuals with and models of Huntington's disease (HD). The role of IB versus diffusible mHtt in neurotoxicity remains unclear. Using a ponasterone (PA)-inducible cell model of HD, here we evaluated the effects of heat shock on the appearance and functional outcome of Htt103Q(Exon1)-EGFP expression. Quantitative image analysis indicated that 80-90% of this mHtt protein initially appears as diffuse signals in the cytosol, with IBs forming at high mHtt expression. A 2-h heat shock during the PA induction reduced the diffuse signal, but greatly increased mHtt IB formation in both cytosol and nucleus. Dose- and time-dependent mHtt expression suggested that nucleated polymerization drives IB formation. RNA-mediated knockdown of heat shock protein 70 (HSP70) and heat shock cognate 70 protein (HSC70) provided evidence for their involvement in promoting diffuse mHtt to form IBs. Reporter gene assays assessing the impacts of diffuse versus IB mHtt showed concordance of diffuse mHtt expression with the repression of heat shock factor 1, cAMP-responsive element-binding protein (CREB), and NF-B activity. CREB repression was reversed by heat shock coinciding with mHtt IB formation. In an embryonic striatal neuron-derived HD model, the chemical chaperone sorbitol similarly promoted the structuring of diffuse mHtt into IBs and supported cell survival under stress. Our results provide evidence that mHtt IB formation is a chaperone-supported cellular coping mechanism that depletes diffusible mHtt conformers, alleviates transcription factor dysfunction, and promotes neuron survival.	[Chen, Justin Y.; Parekh, Miloni; Seliman, Hadear; Bakshinskaya, Dariya; Dai, Wei; Kwan, Kelvin; Liu, Alice Y. C.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Chen, Kuang Yu] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Chen, Justin Y.] Univ N Carolina, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Chen, Justin Y.] North Carolina State Univ, Raleigh, NC 27695 USA; [Parekh, Miloni] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Bakshinskaya, Dariya] Univ Calif Berkeley, Helen Wills Neurosci Inst, 132 Barker Hall, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of North Carolina; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California Berkeley	Liu, AYC (corresponding author), 604 Allison Rd, Piscataway, NJ 08854 USA.	liu@dls.rutgers.edu		Chen, Kuang Yu/0000-0002-5629-7785; Liu, Alice Y./0000-0002-6984-1671	Chemistry and Chemical Biology Fund of Rutgers [800177]; National Institutes of Health [R01 5DC15000]; Aresty Research Fellowships from Rutgers University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015000] Funding Source: NIH RePORTER	Chemistry and Chemical Biology Fund of Rutgers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aresty Research Fellowships from Rutgers University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by internal University funding (to A. Y. C. L.), the Chemistry and Chemical Biology Fund 800177 of Rutgers (to K. Y. C.), and National Institutes of Health Grant R01 5DC15000 (to K. K.). M. P., H. S., and D. B. were supported by Aresty Research Fellowships from Rutgers University while working on this research project. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ami D, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-17; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bersuker K, 2013, J BIOL CHEM, V288, P23633, DOI 10.1074/jbc.C113.481945; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chafekar SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037929; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Duncan Emma J, 2015, Subcell Biochem, V78, P243, DOI 10.1007/978-3-319-11731-7_12; Dyson HJ, 2016, BIOPHYS J, V110, P1013, DOI 10.1016/j.bpj.2016.01.030; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halliday M, 2014, J BIOL CHEM, V289, P19862, DOI 10.1074/jbc.R114.568477; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Jancic D, 2009, CEREB CORTEX, V19, P2535, DOI 10.1093/cercor/bhp004; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Levine ZA, 2015, P NATL ACAD SCI USA, V112, P2758, DOI 10.1073/pnas.1418155112; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Liu A Y, 1996, EXS, V77, P393; LIU AYC, 1989, J BIOL CHEM, V264, P12037; LIU AYC, 1991, J CELL PHYSIOL, V149, P560, DOI 10.1002/jcp.1041490327; Liu DJ, 2014, J CELL PHYSIOL, V229, P1224, DOI 10.1002/jcp.24556; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Margulis J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00218; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Naik V, 2016, MOL BIOTECHNOL, V58, P251, DOI 10.1007/s12033-016-9923-4; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Pugazhenthi S, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-60; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Reijonen S, 2010, CELL MOL LIFE SCI, V67, P1929, DOI 10.1007/s00018-010-0305-y; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sabareesan AT, 2016, J MOL BIOL, V428, P3935, DOI 10.1016/j.jmb.2016.08.015; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sarah Kishinevsky AC, 2013, J ALZHEMERS DIS S10, ps10, DOI DOI 10.4172/2161-0460.S10-007; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; SORGER PK, 1987, EMBO J, V6, P993, DOI 10.1002/j.1460-2075.1987.tb04850.x; Street TO, 2006, P NATL ACAD SCI USA, V103, P17064, DOI 10.1073/pnas.0606236103; Tan Z, 2015, MOL PSYCHIATR, V20, P1286, DOI 10.1038/mp.2015.81; Todd TW, 2013, MOL CELLS, V36, P185, DOI 10.1007/s10059-013-0167-x; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; van Hagen M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3745-z; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P793, DOI 10.1001/archneur.57.6.793; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	86	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15581	15593		10.1074/jbc.RA118.002933	http://dx.doi.org/10.1074/jbc.RA118.002933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143534	Green Published, hybrid			2022-12-26	WOS:000446549200022
J	Horiuchi, M; Kuga, T; Saito, Y; Nagano, M; Adachi, J; Tomonaga, T; Yamaguchi, N; Nakayama, Y				Horiuchi, Maria; Kuga, Takahisa; Saito, Youhei; Nagano, Maiko; Adachi, Jun; Tomonaga, Takeshi; Yamaguchi, Naoto; Nakayama, Yuji			The tyrosine kinase v-Src causes mitotic slippage by phosphorylating an inhibitory tyrosine residue of Cdk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src; cyclin-dependent kinase (CDK); phosphorylation; mitosis; cell cycle; Cdk1; mitotic slippage; pTyr-15; v-Src; cancer; microtubule-targeting agent; spindle checkpoint; tyrosine kinase	M-PHASE PROGRESSION; CYTOKINESIS FAILURE; FAMILY KINASES; CELL-CYCLE; SPINDLE FORMATION; CANCER-CELLS; IN-VIVO; C-SRC; ACTIVATION; MITOSIS	The nonreceptor tyrosine kinase v-Src is an oncogene first identified in Rous sarcoma virus. The oncogenic effects of v-Src have been intensively studied; however, its effects on chromosomal integrity are not fully understood. Here, using HeLa S3/v-Src cells having inducible v-Src expression, we found that v-Src causes mitotic slippage in addition to cytokinesis failure, even when the spindle assembly checkpoint is not satisfied because of the presence of microtubule-targeting agents. v-Src's effect on mitotic slippage was also observed in cells after a knockdown of C-terminal Src kinase (Csk), a protein-tyrosine kinase that inhibits Src-family kinases and was partially inhibited by PP2, an Src-family kinase inhibitor. Proteomic analysis and in vitro kinase assay revealed that v-Src phosphorylates cyclin-dependent kinase 1 (Cdk1) at Tyr-15. This phosphorylation attenuated Cdk1 kinase activity, resulting in a decrease in the phosphorylation of Cdk1 substrates. Furthermore, v-Src-induced mitotic slippage reduced the sensitivity of the cells to microtubule-targeting agents, and cells that survived the microtubule-targeting agents exhibited polyploidy. These results suggest that v-Src causes mitotic slippage by attenuating Cdk1 kinase activity via direct phosphorylation of Cdk1 at Tyr-15. On the basis of these findings, we propose a model for v-Src-induced oncogenesis, in which v-Src-promoted mitotic slippage due to Cdk1 phosphorylation generates genetic diversity via abnormal cell division of polyploid cells and also increases the tolerance of cancer cells to microtubule-targeting agents.	[Horiuchi, Maria; Kuga, Takahisa; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto 6078414, Japan; [Nagano, Maiko; Adachi, Jun; Tomonaga, Takeshi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Proteome Res, Osaka 5670085, Japan; [Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba 2608675, Japan	Kyoto Pharmaceutical University; Chiba University	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp	Adachi, Jun/H-2813-2014; Kuga, Takahisa/AAX-9334-2020	Adachi, Jun/0000-0003-1220-3246; Nakayama, Yuji/0000-0001-7882-0066; Saito, Youhei/0000-0002-8545-6925	Japan Society for the Promotion of Science [16K08253, 25460076]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT [S1511024L, S1311035]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science 16K08253 and 25460076, a grant from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University), the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to T. K. and Y. S.), and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities Grants S1511024L (to T. K.) and S1311035 (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi J, 2014, J PROTEOME RES, V13, P5461, DOI 10.1021/pr500845u; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Chow JPH, 2011, MOL CELL BIOL, V31, P1478, DOI 10.1128/MCB.00891-10; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Honda T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19599-1; Honda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38751; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Ikeuchi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060871; Iwamoto E, 2016, J CELL BIOCHEM, V117, P1340, DOI 10.1002/jcb.25424; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1991, CANCER RES, V51, P2212; Kakae K, 2017, CELL SIGNAL, V30, P19, DOI 10.1016/j.cellsig.2016.11.014; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kesavan KP, 2002, J BIOL CHEM, V277, P14666, DOI 10.1074/jbc.M111911200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; Nakayama Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040811; Nakayama Y, 2014, J CELL BIOCHEM, V115, P763, DOI 10.1002/jcb.24720; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Okamoto M, 2016, J CELL BIOCHEM, V117, P894, DOI 10.1002/jcb.25373; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	55	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15524	15537		10.1074/jbc.RA118.002784	http://dx.doi.org/10.1074/jbc.RA118.002784			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135207	Green Published, hybrid			2022-12-26	WOS:000446549200018
J	Fontes, PK; Ereno, RL; Peixoto, AR; Carvalho, RF; Scarano, WR; Trinca, LA; Barros, CM; Castilho, ACD				Fontes, Patricia Kubo; Ereno, Ronaldo Luis; Peixoto, Andre Rebello; Carvalho, Robson Francisco; Scarano, Wellerson Rodrigo; Trinca, Luzia Aparecida; Barros, Ciro Moraes; de Souza Castilho, Anthony Cesar			Can the antral follicular count modulate the gene expression of bovine oviducts in Aberdeen Angus and Nelore heifers?	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; CILIARY BEAT FREQUENCY; FOLLICLES GREATER-THAN-OR-EQUAL-TO-3 MM; HUMAN FALLOPIAN-TUBE; ALPHA-L-FUCOSIDASES; IN-VITRO; EPITHELIAL-CELLS; ESTROUS-CYCLE; BOS-INDICUS; CONDITIONED MEDIUM	The number of visible ovarian antral follicles (antral follicle count D AFC) is repeatable in bovine individuals, but highly variable between animals, and with differences between Bos taurus and Bos indicus breeds. Several studies have tried to determine the correlation between AFC and increased fertility in cattle. While the impacts of AFC on embryo production, hormonal levels, and pregnancy rates have been described, the molecular effects of AFC on bovine oviducts have not yet been investigated. Here, the aim was to investigate the impact of breeds, such as Aberdeen Angus and Nelore heifer with high or low AFC, on abundance of transcripts and protein related to oviductal transport, sperm reservoir formation, monospermy control, and gamete interaction in the oviducts. In summary, the ovulation side was the major factor that affected transcript abundance on bovine oviducts. However, a discreet effect among AFC and cattle breeds was also observed. Based on this, we concluded and reinforced here that differential microenvironments between ipsilateral and contralateral oviducts have a major effect on modulating the transcripts related to oviductal transport, sperm reservoir formation, monospermy control, and gamete interaction. However, we cannot exclude that there is minimal effect of AFC or breed on regulation of some genes (such as AGTR1, ACE1, FUCA1, and VEGFA) in bovine oviducts.	[Fontes, Patricia Kubo; Ereno, Ronaldo Luis; Barros, Ciro Moraes] Univ Estadual Paulista UNESP, Inst Biosci, Dept Pharmacol, Botucatu, SP, Brazil; [Peixoto, Andre Rebello; Carvalho, Robson Francisco; Scarano, Wellerson Rodrigo] Univ Estadual Paulista UNESP, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil; [Trinca, Luzia Aparecida] Univ Estadual Paulista UNESP, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil; [de Souza Castilho, Anthony Cesar] Univ Western Sao Paulo UNOESTE, Dept Anim Sci, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade do Oeste Paulista	Castilho, ACD (corresponding author), Univ Western Sao Paulo UNOESTE, Dept Anim Sci, Presidente Prudente, SP, Brazil.	castilho.anthony@gmail.com	Carvalho, Robson Francisco/AAE-4134-2020; Carvalho, Robson Francisco/E-1161-2012; Scarano, Wellerson Rodrigo/T-7792-2019; Fontes, Patricia Kubo/R-8362-2017; Castilho, Anthony/AAS-2147-2021; Trinca, Luzia/C-7849-2012	Carvalho, Robson Francisco/0000-0002-4901-7714; Carvalho, Robson Francisco/0000-0002-4901-7714; Scarano, Wellerson Rodrigo/0000-0002-6682-2934; Fontes, Patricia Kubo/0000-0002-4280-9575; Castilho, Anthony/0000-0003-1666-7021; Trinca, Luzia/0000-0003-1106-8505	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50514-8, 2011/50964-0, 2012/09498-9, 2013/08629-5, 2013/114803]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We confirm the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, the present work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/) grants #2012/50514-8 and 2011/50964-0 (CMB), scholarships #2012/09498-9 and 2013/08629-5 (PKF), and 2013/114803 (ASC).	Aldarmahi A, 2014, REPROD FERT DEVELOP, V26, P358, DOI 10.1071/RD12222; ANDERSON SH, 1994, BIOL REPROD, V51, P795, DOI 10.1095/biolreprod51.4.795; Batista EOS, 2014, REPROD DOMEST ANIM, V49, P448, DOI 10.1111/rda.12304; Bauersachs S, 2004, J MOL ENDOCRINOL, V32, P449, DOI 10.1677/jme.0.0320449; Besenfelder U, 2012, REPROD DOMEST ANIM, V47, P156, DOI 10.1111/j.1439-0531.2012.02070.x; Boilard M, 2004, BIOL REPROD, V71, P1879, DOI 10.1095/biolreprod.103.026849; Boni R, 1997, THERIOGENOLOGY, V48, P277, DOI 10.1016/S0093-691X(97)84075-7; BOTTARI SP, 1993, FRONT NEUROENDOCRIN, V14, P123, DOI 10.1006/frne.1993.1005; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; Burns DS, 2005, BIOL REPROD, V73, P54, DOI 10.1095/biolreprod.104.036277; Bylander A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-48; Carrasco LC, 2008, REPROD FERT DEVELOP, V20, P808, DOI 10.1071/RD08113; Carvalho JBP, 2008, THERIOGENOLOGY, V69, P167, DOI 10.1016/j.theriogenology.2007.08.035; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P331, DOI 10.1111/j.1439-0531.2012.02157.x; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Croxatto Horacio B, 2002, Reprod Biomed Online, V4, P160; ELLINGTON JE, 1993, BIOL REPROD, V48, P851, DOI 10.1095/biolreprod48.4.851; EYESTONE WH, 1989, J REPROD FERTIL, V85, P715, DOI 10.1530/jrf.0.0850715; Fazeli A, 2004, BIOL REPROD, V71, P60, DOI 10.1095/biolreprod.103.026815; Figueiredo RA, 1997, THERIOGENOLOGY, V47, P1489, DOI 10.1016/S0093-691X(97)00156-8; Georgiou AS, 2007, J PROTEOME RES, V6, P4656, DOI 10.1021/pr070349m; Goncalves PB, 2012, REPRODUCTION, V143, P11, DOI 10.1530/REP-11-0192; Gonella-Diaza AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145321; GRIPPO AA, 1995, J REPROD FERTIL, V105, P57; HALBERT SA, 1976, SCIENCE, V191, P1052, DOI 10.1126/science.1251215; HARPER MJK, 1980, AM J PHYSIOL, V238, pE157, DOI 10.1152/ajpendo.1980.238.2.E157; Haxel BR, 2001, EUR ARCH OTO-RHINO-L, V258, P230, DOI 10.1007/s004050100339; Hermoso M, 2001, PFLUG ARCH EUR J PHY, V442, P336, DOI 10.1007/s004240100550; HUNTER RHF, 1984, REPROD NUTR DEV, V24, P597, DOI 10.1051/rnd:19840508; Ignotz GG, 2007, BIOL REPROD, V77, P906, DOI 10.1095/biolreprod.107.062505; Ireland J, 2007, HUM REPROD, V22, P1687, DOI 10.1093/humrep/dem071; Jimenez-Krassel F, 2009, BIOL REPROD, V80, P1272, DOI 10.1095/biolreprod.108.075093; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Kodithuwakku SP, 2007, REPRODUCTION, V133, P1087, DOI 10.1530/REP-06-0201; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; LEFEBVRE R, 1995, BIOL REPROD, V53, P1066, DOI 10.1095/biolreprod53.5.1066; Lefebvre R, 1997, BIOL REPROD, V56, P1198, DOI 10.1095/biolreprod56.5.1198; Lin P, 2012, THERIOGENOLOGY, V78, P1824, DOI 10.1016/j.theriogenology.2012.07.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMBARD L, 1950, J MORPHOL, V86, P1, DOI 10.1002/jmor.1050860102; Loureiro B, 2016, THERIOGENOLOGY, V86, P523, DOI 10.1016/j.theriogenology.2016.02.001; Lyons RA, 2006, HUM REPROD UPDATE, V12, P363, DOI 10.1093/humupd/dml012; Lyons RA, 2006, HUM REPROD, V21, P52, DOI 10.1093/humrep/dei306; Marin-Briggiler CI, 2010, FERTIL STERIL, V93, P1574, DOI 10.1016/j.fertnstert.2008.12.132; McNeel AK, 2017, ANIM REPROD SCI, V179, P1, DOI 10.1016/j.anireprosci.2017.01.004; Menezo Y, 1997, EUR J OBSTET GYN R B, V73, P99, DOI 10.1016/S0301-2115(97)02729-2; Mollo M.R., 2007, ACTA SCI VET, V35, P958; Mondejar I, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111385; Mossa F, 2012, J DAIRY SCI, V95, P2355, DOI 10.3168/jds.2011-4325; Mossa F, 2010, REPRODUCTION, V140, P713, DOI 10.1530/REP-10-0214; Mossa F, 2010, REPROD FERT DEVELOP, V22, P550, DOI 10.1071/RD09100; Nagai K, 2016, BIOMED RES-TOKYO, V37, P63, DOI 10.2220/biomedres.37.63; Nishimura A, 2010, EXP PHYSIOL, V95, P819, DOI 10.1113/expphysiol.2010.052555; Phopin K, 2013, MOL REPROD DEV, V80, P273, DOI 10.1002/mrd.22164; Ponnampalam AP, 2006, MOL HUM REPROD, V12, P661, DOI 10.1093/molehr/gal075; Romero-Aguirregomezcorta J, 2015, VET J, V203, P109, DOI 10.1016/j.tvjl.2014.11.006; RUCKEBUSCH Y, 1975, J REPROD FERTIL, V43, P23, DOI 10.1530/jrf.0.0430023; Saridogan E, 1996, J CLIN ENDOCR METAB, V81, P2719, DOI 10.1210/jc.81.7.2719; Sartori R, 2011, ANIM REPROD SCI, V124, P244, DOI 10.1016/j.anireprosci.2011.02.006; SAVIO JD, 1988, J REPROD FERTIL, V83, P663, DOI 10.1530/jrf.0.0830663; Schatz G, 2013, CELLS TISSUES ORGANS, V198, P457, DOI 10.1159/000360155; SEGERSON EC, 1984, J ANIM SCI, V59, P1026, DOI 10.2527/jas1984.5941026x; Silva-Santos KC, 2014, REPROD DOMEST ANIM, V49, P228, DOI 10.1111/rda.12255; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2002, REPROD DOMEST ANIM, V37, P140, DOI 10.1046/j.1439-0531.2002.00346.x; Suarez SS, 2016, CELL TISSUE RES, V363, P185, DOI 10.1007/s00441-015-2244-2; Talbot P, 1999, MOL BIOL CELL, V10, P5, DOI 10.1091/mbc.10.1.5; Tanghe S, 2004, MOL REPROD DEV, V68, P492, DOI 10.1002/mrd.20095; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venditti JJ, 2010, BIOL REPROD, V82, P572, DOI 10.1095/biolreprod.109.076695; Wijayagunawardane MPB, 1998, THERIOGENOLOGY, V49, P607, DOI 10.1016/S0093-691X(98)00011-9; Wijayagunawardane MPB, 2005, MOL REPROD DEV, V72, P511, DOI 10.1002/mrd.20379; Wijayagunawardane MPB, 2004, J CARDIOVASC PHARM, V44, pS248, DOI 10.1097/01.fjc.0000166253.66486.4f; Wijayagunawardane MPB, 2004, J REPROD DEVELOP, V50, P57, DOI 10.1262/jrd.50.57; Wijayagunawardane MPB, 1999, THERIOGENOLOGY, V52, P791, DOI 10.1016/S0093-691X(99)00172-7; Wijayagunawardane MPB, 2003, BIOL REPROD, V69, P1341, DOI 10.1095/biolreprod.103.017327; Wijayagunawardane MPB, 2001, BIOL REPROD, V65, P799, DOI 10.1095/biolreprod65.3.799; Wijayagunawardane MPB, 2001, J ENDOCRINOL, V168, P117, DOI 10.1677/joe.0.1680117; Wolfenson D, 2004, THERIOGENOLOGY, V62, P1042, DOI 10.1016/j.theriogenology.2003.12.020; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yaniz JL, 2000, ANAT REC, V260, P268, DOI 10.1002/1097-0185(20001101)260:3<268::AID-AR60>3.0.CO;2-L; Yeste M, 2014, MOL REPROD DEV, V81, P805, DOI 10.1002/mrd.22350	83	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202017	10.1371/journal.pone.0202017	http://dx.doi.org/10.1371/journal.pone.0202017			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157205	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400027
J	Partridge, DR; Clark, JA				Partridge, Dustin R.; Clark, J. Alan			Urban green roofs provide habitat for migrating and breeding birds and their arthropod prey	PLOS ONE			English	Article							SPECIES RICHNESS; CONSERVATION IMPLICATIONS; SPRING MIGRATION; STOPOVER SITES; LAND-USE; URBANIZATION; BIODIVERSITY; DIVERSITY; CONNECTIVITY; COMMUNITIES	The world is rapidly urbanizing, and many previously biodiverse areas are now mostly composed of impervious surface. This loss of natural habitat causes local bird communities to become dominated by urban dweller and urban utilizer species and reduces the amount of habitat available for migrating and breeding birds. Green roofs can increase green space in urban landscapes, potentially providing new habitat for wildlife. We surveyed birds and arthropods, an important food source for birds, on green roofs and nearby comparable conventional (non-green) roofs in New York City during spring migration and summer breeding seasons. We predicted that green roofs would have a greater abundance and richness of both birds and arthropods than conventional roofs during both migration and the breeding season for birds. Furthermore, we predicted we would find more urban avoider and urban utilizer bird species on green roofs than conventional roofs. We found that both birds and arthropods were more abundant and rich on green roofs than conventional roofs. In addition, green roofs hosted more urban avoider and utilizer bird species than conventional roofs. Our study shows that birds use green roofs as stopover habitat during migration and as foraging habitat during the breeding season. Establishing green roofs in urban landscapes increases the amount of habitat available for migrating and breeding birds and can partially mitigate the loss of habitat due to increasing urbanization.	[Partridge, Dustin R.; Clark, J. Alan] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	Fordham University	Partridge, DR (corresponding author), Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA.	DPartridge@fordham.edu						ABLE K. P., 1999, GATHERINGS ANGELS MI; Alquezar RD, 2015, WILSON J ORNITHOL, V127, P712, DOI 10.1676/14-104.1; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Baumann Nathalie, 2006, Urban Habitats, V4, P37; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; BLAKE JG, 1986, AUK, V103, P328, DOI 10.1093/auk/103.2.328; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Braaker S, 2014, ECOLOGY, V95, P1010, DOI 10.1890/13-0705.1; Braaker S, 2017, J ANIM ECOL, V86, P521, DOI 10.1111/1365-2656.12648; Brenneisen Stephan, 2006, Urban Habitats, V4, P27; Bricklin RB, 2016, URBAN NATURALIST, V11, P1; Buchholz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137723; Buler JJ, 2011, J ORNITHOL, V152, P101, DOI 10.1007/s10336-010-0640-7; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Carbo-Ramirez P, 2011, LANDSCAPE URBAN PLAN, V100, P213, DOI 10.1016/j.landurbplan.2010.12.008; Catry P, 2004, J AVIAN BIOL, V35, P170, DOI 10.1111/j.0908-8857.2004.03112.x; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chernetsov N., 2012, PASSERINE MIGRATION; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; Cochran William W., 2005, P274; Cohen EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041818; Colla S.H.R., 2009, CITIES ENV CATE, V2, P4; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; DeSante DF, 2008, MAPS MANUAL; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Drent RJ, 2006, J ORNITHOL, V147, P122, DOI 10.1007/s10336-006-0066-4; Eakin CJ, 2015, WILDLIFE SOC B, V39, P574, DOI 10.1002/wsb.566; Evans BS, 2015, ECOLOGY, V96, P1631, DOI 10.1890/14-0171.1; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P625, DOI 10.1111/j.1466-8238.2006.00253.x; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Evans KL, 2005, GLOBAL ECOL BIOGEOGR, V14, P187, DOI 10.1111/j.1466-822X.2004.00139.x; Evans Ogden LJ, 1996, FATAL LIGHT AWARE PR, V1, P3; Farnsworth G, 2011, BIRDS N AM ONLINE; Ferenc M, 2016, URBAN ECOSYST, V19, P1265, DOI 10.1007/s11252-016-0558-9; Ferenc M, 2014, URBAN ECOSYST, V17, P625, DOI 10.1007/s11252-013-0328-x; Fernandez-Canero R, 2010, J ANIM VET ADV, V9, P2041; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P2023, DOI 10.1023/A:1013133308987; Fischer JD, 2015, CONSERV BIOL, V29, P1246, DOI 10.1111/cobi.12451; Fornal-Pieniak B., 2012, EKOLOGIA BRATISLAVA, V31, P379; Forys EA, 2013, SOUTHEAST NAT, V12, P238, DOI 10.1656/058.012.0119; Fowle M. T., 2001, NEW YORK CITY AUDUBO; Galbrun L, 2017, BUILD ENVIRON, V116, P130, DOI 10.1016/j.buildenv.2017.02.008; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gonsalves S, 2016, THESIS; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; Gregoire BG, 2011, ECOL ENG, V37, P963, DOI 10.1016/j.ecoleng.2011.02.004; Grootaert P., 2010, MANUAL FIELD RECORDI, P377, DOI 10.1128/AEM.00759-10; HAGAN JM, 1991, ORNIS SCAND, V22, P129, DOI 10.2307/3676543; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hall-Karlsson K. Susanna S., 2008, Ringing & Migration, V24, P95; Huang Y, 2015, URBAN FOR URBAN GREE, V14, P1027, DOI 10.1016/j.ufug.2015.09.010; Huff MH, 2000, PNWGTR501 US FOR SER; Hutto RL, 2009, J FIELD ORNITHOL, V80, P387, DOI 10.1111/j.1557-9263.2009.00245.x; Hutto RL, 1998, AUK, V115, P823, DOI 10.2307/4089500; Jim CY, 2011, URBAN FOR URBAN GREE, V10, P19, DOI 10.1016/j.ufug.2010.11.001; Johnston Richard F., 2001, P49; Jokimaki J., 2014, URBAN ECOSYST, P1; Jokimaki Jukka, 2000, Urban Ecosystems, V3, P21, DOI 10.1023/A:1009505418327; Kang W, 2015, URBAN ECOSYST, V18, P857, DOI 10.1007/s11252-014-0433-5; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Keller JK, 2003, FOREST ECOL MANAG, V174, P541, DOI 10.1016/S0378-1127(02)00074-9; Kelly JF, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1434; Kimsey LS, 2009, ZOOTAXA, P30, DOI 10.11646/zootaxa.2224.1.2; KING AP, 1983, NATURE, V305, P704, DOI 10.1038/305704a0; Klingbeil BT, 2015, PEERJ, V3, DOI 10.7717/peerj.973; Ksiazek K, 2012, LANDSCAPE URBAN PLAN, V107, P401, DOI 10.1016/j.landurbplan.2012.07.008; Ksiazek-Mikenas K., 2018, URBAN NATURALIST, V1, P52; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Larsen R.J., 2012, INTRO MATH STAT ITS; LODGE DM, 1985, FRESHWATER BIOL, V15, P695, DOI 10.1111/j.1365-2427.1985.tb00243.x; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Lowther P.E., 2006, BIRDS N AM ONLINE, DOI 10.2173/bna.12; Lowther PE, 2014, BIRDS N AM ONLINE; Luckett K., 2009, GREEN ROOF CONSTRUCT; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; Maciejowski JM, 2013, CONF CONTR FAULT-TOL, P1, DOI 10.1109/SysTol.2013.6693820; MacIvor JS, 2015, ECOL STUD-ANAL SYNTH, V223, P333, DOI 10.1007/978-3-319-14983-7_14; MacIvor JS, 2011, URBAN ECOSYST, V14, P225, DOI 10.1007/s11252-010-0149-0; Madre F, 2013, ECOL ENG, V57, P109, DOI 10.1016/j.ecoleng.2013.04.029; Magura T, 2009, CONTRIBUTIONS SOIL Z, P97; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marzluff JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167829; Marzluff JM, 2016, URBAN ECOSYST, V19, P1597, DOI 10.1007/s11252-015-0483-3; Mason J, 2007, LANDSCAPE URBAN PLAN, V80, P153, DOI 10.1016/j.landurbplan.2006.07.002; Matteson KC, 2007, THESIS; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney M.L., 2018, URBAN NATURALIST, VSI, P73; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McWilliams G. M., 2000, BIRDS PENNSYLVANIA; Mehlman DW, 2005, AUK, V122, P1281, DOI 10.1642/0004-8038(2005)122[1281:CSSFFM]2.0.CO;2; Moore F.R., 2005, BIRD CONSERVATION IM, P684; Moore Frank R., 1995, P121; Moorman CE, 2012, WILSON J ORNITHOL, V124, P31, DOI 10.1676/11-020.1; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Nichols J.D., 1993, ECOLOGY MANAGEMENT M, P576; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; NOWICKI S, 1988, MUSIC PERCEPT, V5, P391; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Oliver AJ, 2011, LANDSCAPE URBAN PLAN, V102, P215, DOI 10.1016/j.landurbplan.2011.04.007; Parkins KL, 2015, GLOB ECOL CONSERV, V4, P349, DOI 10.1016/j.gecco.2015.07.011; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; Poole A., 2005, BIRDS N AM ONLINE; Rega CC, 2015, J URBAN PLANNING DEV, V141, DOI [10.1061/(ASCE)UP.943-5444.0000279, DOI 10.1061/(ASCE)UP.943-5444.0000279]; Rempel RS, 2013, J FIELD ORNITHOL, V84, P86, DOI 10.1111/jofo.12008; Richmond M. E., 2008, 2 ATLAS BREEDING BIR, P258; Robbins M.B., 1992, BIRDS MISSOURI THEIR; Robbins S., 1991, WISCONSIN BIRDLIFE P; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Santamouris M, 2014, SOL ENERGY, V103, P682, DOI 10.1016/j.solener.2012.07.003; Schrader S, 2006, PEDOBIOLOGIA, V50, P347, DOI 10.1016/j.pedobi.2006.06.003; Seewagen CL, 2008, NORTHEAST NAT, V15, P87, DOI 10.1656/1092-6194(2008)15[87:LCONMP]2.0.CO;2; Seewagen CL, 2011, CONDOR, V113, P284, DOI 10.1525/cond.2011.100136; Seewagen CL, 2010, ACTA OECOL, V36, P484, DOI 10.1016/j.actao.2010.06.005; Smith RJ, 2007, AUK, V124, P107, DOI 10.1642/0004-8038(2007)124[107:SHATSO]2.0.CO;2; Soldatini C, 2008, ITAL J ZOOL, V75, P295, DOI 10.1080/11250000701884805; Southwood T.R.E., 2009, ECOLOGICAL METHODS; Speak AF, 2012, ATMOS ENVIRON, V61, P283, DOI 10.1016/j.atmosenv.2012.07.043; Spiers J. D., 2004, Small Fruits Review, V3, P361, DOI 10.1300/J301v03n03_13; Staicer Cynthia A., 1996, P426; Starry O, 2018, URBAN NATURALIST, V1, P1, DOI DOI 10.1016/J.ECOLENG.2018.04.002; Stephen WP, 2005, J KANSAS ENTOMOL SOC, V78, P373, DOI 10.2317/0410.03.1; Stracey CM, 2012, J AVIAN BIOL, V43, P50, DOI 10.1111/j.1600-048X.2011.05520.x; STRICKLAND A. H., 1954, PLANT PATHOL, V3, P73, DOI 10.1111/j.1365-3059.1954.tb00698.x; Strohbach MW, 2013, LANDSCAPE URBAN PLAN, V114, P69, DOI 10.1016/j.landurbplan.2013.02.007; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; United Nations, 2014, DEMOGR RES; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wang JW, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1905; Washburn BE, 2016, ENVIRON MANAGE, V57, P1230, DOI 10.1007/s00267-016-0687-1; White C.M., 2020, BIRDS OF THE WORLD; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Williams NSG, 2014, J APPL ECOL, V51, P1643, DOI 10.1111/1365-2664.12333	144	16	16	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202298	10.1371/journal.pone.0202298	http://dx.doi.org/10.1371/journal.pone.0202298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157217	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400051
J	Porzycki, J; Schmidt-Polonczyk, N; Was, J				Porzycki, Jakub; Schmidt-Polonczyk, Natalia; Was, Jaroslaw			Pedestrian behavior during evacuation from road tunnel in smoke condition - Empirical results	PLOS ONE			English	Article							RAIL TUNNELS; SPEED; DYNAMICS; MODELS	Five evacuation experiments were performed in a road tunnel in order to test how pedestrians react when exposed to reduced visibility, how the decision making process is carried out, and finally what is the impact of various circumstances like: different level of smokiness, competitive behavior or learning effect on an evacuation process. In four experiments pedestrians were exposed to artificial, non-toxic smoke. During evacuation of a group of people gathered in low and moderate level of smokiness (when Cs < 0.5m(-1)) we observed multi-line patterns created by pedestrians. Decision making was engaged in only by the first group of passengers, while under heavy smokiness Cs > 0.7m(-1) we have observed decision making by small groups and characteristic double-lines patterns. In four experiments the same group of participants was involved, and a learning effect was observed: increasingly shorter pre-movement time and decreasing time required to leave the main tunnel. We show, that movement speed in smoke is influenced by the evacuees' attitude and familiarity with environment and evacuation procedures and not only by the visibility level.	[Porzycki, Jakub; Was, Jaroslaw] AGH Univ Sci & Technol, Fac Elect Engn Automat Comp Sci & Biomed Engn, Al Mickiewicza 30, PL-30059 Krakow, Poland; [Schmidt-Polonczyk, Natalia] AGH Univ Sci & Technol, Fac Min & Geoengn, Al Mickiewicza 30, PL-30059 Krakow, Poland	AGH University of Science & Technology; AGH University of Science & Technology	Porzycki, J (corresponding author), AGH Univ Sci & Technol, Fac Elect Engn Automat Comp Sci & Biomed Engn, Al Mickiewicza 30, PL-30059 Krakow, Poland.	porzycki@agh.edu.pl	; Porzycki, Jakub/A-2424-2017; Was, Jaroslaw/B-5835-2012	Schmidt-Polonczyk, Natalia/0000-0003-0674-9680; Porzycki, Jakub/0000-0001-9077-9836; Was, Jaroslaw/0000-0003-2964-745X	AGH University of Science and Technology [11.11.120.859, 15.11.100.078]	AGH University of Science and Technology	The work was supported by AGH University of Science and Technology grant no 11.11.120.859 and 15.11.100.078. There was no additional external funding received for this study.	Abulhassan Y, 2018, SAFETY SCI, V108, P203, DOI 10.1016/j.ssci.2017.07.017; Abulhassan Y, 2016, SAFETY SCI, V89, P249, DOI 10.1016/j.ssci.2016.06.021; Beard A., 2012, HDB TUNNEL FIRE SAFE, DOI [10.1680/htfs.41530, DOI 10.1680/HTFS.41530]; DONALD I, 1992, EUR J SOC PSYCHOL, V22, P203, DOI 10.1002/ejsp.2420220302; Frantzich H, 2000, EXPT UTVARDERING MOG; Frantzich H, 2004, EVACUATION EXPT SMOK; Frantzich H, 2003, UTRYMNING GENOM TAT; Fridolf K, 2013, FIRE TECHNOL, V49, P451, DOI 10.1007/s10694-011-0217-x; Fridolf K, 2014, SAFETY SCI, V62, P515, DOI 10.1016/j.ssci.2013.10.008; Fridolf K, 2013, FIRE SAFETY J, V59, P8, DOI 10.1016/j.firesaf.2013.03.007; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Jin T., 1985, FIRE SCI TECHNOLOGY, V5, P79, DOI [10.3210/fst.5.79, DOI 10.3210/FST.5.79]; Jin T, 1976, VISIBILITY FIRE SMOK; Kinateder M, 2013, TRANSPORT RES F-TRAF, V17, P20, DOI 10.1016/j.trf.2012.09.001; Kirchner A, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10011; Lovreglio R, 2015, PHYSICA A, V438, P308, DOI 10.1016/j.physa.2015.06.040; Lubas R, 2016, J SUPERCOMPUT, V72, P2170, DOI 10.1007/s11227-016-1718-7; Mikame Y, 2014, STUDY SAFETY RELATIV; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Mu N, 2014, PROCEDIA ENGINEER, V71, P333, DOI 10.1016/j.proeng.2014.04.048; Nilsson, 2016, WAY FINDING LIGHTING, V8; Nilsson D., 2009, EXIT CHOICE FIRE EME; Nilsson D, 2018, FIRE SAFETY J, V97, P119, DOI 10.1016/j.firesaf.2017.07.001; Nilsson D, 2009, FIRE SAFETY J, V44, P458, DOI 10.1016/j.firesaf.2008.09.009; Oswald M, 2007, FULL SCALE EVACUATIO, P41, DOI [10.1007/978-3-540-47064-9_4, DOI 10.1007/978-3-540-47064-9_4]; Oswald M, 2011, ADV RES WORKSH EV HU; Oswald M, 2010, PEDESTRIAN AND EVACUATION DYNAMICS 2008, P67, DOI 10.1007/978-3-642-04504-2_5; Porzycki J, 2016, GRANULARITY PREMOVEM, P305, DOI [10.1007/978-3-319-33482-0_39, DOI 10.1007/978-3-319-33482-0_39]; Purser D., 2009, P FIR PROT LIF SAF B, P23; Ronchi E, 2013, FIRE TECHNOL, V49, P411, DOI 10.1007/s10694-012-0280-y; Ronchi E., 2010, P 12 INT INT 2010 C, P837; Ronchi E, 2018, FIRE SAFETY J, V97, P126, DOI 10.1016/j.firesaf.2017.06.002; Ronchi E, 2016, FIRE TECHNOL, V52, P623, DOI 10.1007/s10694-015-0462-5; Ronchi E, 2012, FIRE TECHNOL, V48, P961, DOI 10.1007/s10694-012-0256-y; Seike M, 2012, EXPT INVESTIGATIONS; Seike M, 2017, FIRE SAFETY J, V91, P901, DOI 10.1016/j.firesaf.2017.04.034; Seike M, 2016, TUNN UNDERGR SP TECH, V53, P61, DOI 10.1016/j.tust.2016.01.003; Voeltzel ADix A, 2004, COMP ANAL MONT BLANC	38	14	14	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201732	10.1371/journal.pone.0201732	http://dx.doi.org/10.1371/journal.pone.0201732			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157277	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400013
J	Rath, EM; Cheng, YY; Pinese, M; Sarun, KH; Hudson, AL; Weir, C; Wang, YD; Hakansson, AP; Howell, VM; Liu, GJ; Reid, G; Knott, RB; Duff, AP; Church, WB				Rath, Emma M.; Cheng, Yuen Yee; Pinese, Mark; Sarun, Kadir H.; Hudson, Amanda L.; Weir, Christopher; Wang, Yiwei D.; Hakansson, Anders P.; Howell, Viive M.; Liu, Guo Jun; Reid, Glen; Knott, Robert B.; Duff, Anthony P.; Church, W. Bret			BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; HUMAN ALPHA-LACTALBUMIN; MITOCHONDRIAL PERMEABILITY TRANSITION; SMALL-ANGLE SCATTERING; PROTEIN-LIPID COMPLEX; HUMAN-MILK PROTEIN; X-RAY-SCATTERING; TUMOR-CELLS; ATP SYNTHASE; FATTY-ACID	Malignant pleural mesothelioma is an aggressive cancer with poor prognosis. Here we have investigated in vitro efficacy of BAMLET and BLAGLET complexes (anti-cancer complexes consisting of oleic acid and bovine alpha-lactalbumin or beta-lactoglobulin respectively) in killing mesothelioma cells, determined BAMLET and BLAGLET structures, and investigated possible biological mechanisms. We performed cell viability assays on 16 mesothelioma cell lines. BAMLET and BLAGLET having increasing oleic acid content inhibited human and rat mesothelioma cell line proliferation at decreasing doses. Most of the non-cancer primary human fibroblasts were more resistant to BAMLET than were human mesothelioma cells. BAMLET showed similar cytotoxicity to cisplatin-resistant, pemetrexed-resistant, vinorelbine-resistant, and parental rat mesothelioma cells, indicating the BAMLET anti-cancer mechanism may be different to drugs currently used to treat mesothelioma. Cisplatin, pemetrexed, gemcitabine, vinorelbine, and BAMLET, did not demonstrate a therapeutic window for mesothelioma compared with immortalised non-cancer mesothelial cells. We demonstrated by quantitative PCR that ATP synthase is downregulated in mesothelioma cells in response to regular dosing with BAMLET. We sought structural insight for BAMLET and BLAGLET activity by performing small angle X-ray scattering, circular dichroism, and scanning electron microscopy. Our results indicate the structural mechanism by which BAMLET and BLAGLET achieve increased cytotoxicity by holding increasing amounts of oleic acid in an active cytotoxic state encapsulated in increasingly unfolded protein. Our structural studies revealed similarity in the molecular structure of the protein components of these two complexes and in their encapsulation of the fatty acid, and differences in the microscopic structure and structural stability. BAMLET forms rounded aggregates and BLAGLET forms long fibre-like aggregates whose aggregation is more stable than that of BAMLET due to intermolecular disulphide bonds. The results reported here indicate that BAMLET and BLAGLET may be effective second-line treatment options for mesothelioma.	[Rath, Emma M.; Church, W. Bret] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Cheng, Yuen Yee; Sarun, Kadir H.; Reid, Glen] ADRI, Concord, NSW, Australia; [Cheng, Yuen Yee; Reid, Glen] Univ Sydney, Sydney, NSW, Australia; [Pinese, Mark] Kinghorn Canc Ctr, Sydney, NSW, Australia; [Pinese, Mark] Garvan Inst Med Res, Sydney, NSW, Australia; [Hudson, Amanda L.; Howell, Viive M.] Univ Sydney, Kolling Inst, Bill Walsh Translat Canc Res Lab, Sydney, NSW, Australia; [Weir, Christopher] Univ Sydney, Kolling Inst, Northern Blood Res Ctr, Sydney, NSW, Australia; [Wang, Yiwei D.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res, Concord, NSW, Australia; [Hakansson, Anders P.] Lund Univ, Div Expt Infect Med, Lund, Sweden; [Liu, Guo Jun; Knott, Robert B.; Duff, Anthony P.] ANSTO, New Illawarra Rd, Lucas Heights, NSW, Australia; [Liu, Guo Jun] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Liu, Guo Jun] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Kolling Institute of Medical Research; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Lund University; Australian Nuclear Science & Technology Organisation; University of Sydney; University of Sydney	Church, WB (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.; Cheng, YY (corresponding author), ADRI, Concord, NSW, Australia.; Cheng, YY (corresponding author), Univ Sydney, Sydney, NSW, Australia.	yuen.cheng@sydney.edu.au; bret.church@sydney.edu.au	Cheng, Yuen/AAU-2402-2020; Research Institute, ANZAC/CAE-9030-2022; Hakansson, Anders P/AAX-1225-2020	Hakansson, Anders P/0000-0002-2834-6009; Duff, Anthony/0000-0003-3586-360X; Rath, Emma/0000-0002-8430-5236; Liu, Guo-Jun/0000-0002-4278-8372; Sarun, Kadir/0000-0003-4592-0671	Australian Postgraduate Research Award; Bill Walsh Translational Cancer Research Laboratory; Swedish Medical Research Council (VR)	Australian Postgraduate Research Award; Bill Walsh Translational Cancer Research Laboratory; Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council)	Author EMR received support from an Australian Postgraduate Research Award. ALH and VMH received support from the Bill Walsh Translational Cancer Research Laboratory. APH was funded through Swedish Medical Research Council (VR) grants. Neither these funders nor any past or current employers of all authors had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALBERTS AS, 1988, J CLIN ONCOL, V6, P527, DOI 10.1200/JCO.1988.6.3.527; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3389, DOI DOI 10.1093/NAR/25.17; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Alvarellos ML, 2014, PHARMACOGENET GENOM, V24, P564, DOI 10.1097/FPC.0000000000000086; ARONSON JF, 1981, IN VITRO CELL DEV B, V17, P61, DOI 10.1007/BF02618032; BOWMAN R V, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P611; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; Britten CD, 1999, CANCER CHEMOTH PHARM, V44, P105, DOI 10.1007/s002800050953; BRODERSEN R, 1990, EUR J BIOCHEM, V189, P343, DOI 10.1111/j.1432-1033.1990.tb15495.x; Bueno R, 2001, J THORAC CARDIOV SUR, V121, P225, DOI 10.1067/mtc.2001.111176; CHAHINIAN AP, 1984, CANCER RES, V44, P1688; Cheng YY, 2013, J THORAC ONCOL, V8, P1317, DOI 10.1097/JTO.0b013e3182a0840a; Clementi EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080649; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; CRAIGHEAD JE, 1987, AM J PATHOL, V129, P448; Delgado Y, 2015, FEBS OPEN BIO, V5, P397, DOI 10.1016/j.fob.2015.04.010; Driscoll T, 2005, AM J IND MED, V48, P419, DOI 10.1002/ajim.20209; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Fang B, 2015, J DAIRY SCI, V98, P2898, DOI 10.3168/jds.2014-8993; Fang B, 2014, BBA-MOL CELL BIOL L, V1841, P535, DOI 10.1016/j.bbalip.2013.12.008; Fang B, 2012, PROTEIN J, V31, P564, DOI 10.1007/s10930-012-9434-5; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Fontana A, 2013, BBA-PROTEINS PROTEOM, V1834, P1125, DOI 10.1016/j.bbapap.2013.02.041; Frislev HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15003-6; Frislev HS, 2016, BBA-PROTEINS PROTEOM, V1864, P847, DOI 10.1016/j.bbapap.2016.04.003; Furlow B, 2016, LANCET RESP MED, V4, P545, DOI 10.1016/S2213-2600(16)30144-8; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; GLATTER O, 1977, ACTA PHYS AUSTRIACA, V47, P83; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1374; Gultekin KE, 2013, GENET MOL RES, V12, P5405, DOI 10.4238/2013.November.11.2; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024; Ho CSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053051; Hoda MA, 2012, BRIT J CANCER, V107, P1978, DOI 10.1038/bjc.2012.519; HOLIAT SM, 1981, CANCER TREAT REP, V65, P1113; Hudson AL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06152; Hughes A, 2002, J CLIN ONCOL, V20, P3533, DOI 10.1200/JCO.2002.10.073; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Kaspersen JD, 2014, CHEMBIOCHEM, V15, P2693, DOI 10.1002/cbic.201402407; Kataev AA, 2013, BIOCHEM MOSC SUPPL S, V7, P141, DOI 10.1134/S1990747812030105; KE Y, 1989, AM J PATHOL, V134, P979; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Knyazeva EL, 2008, BIOCHEMISTRY-US, V47, P13127, DOI 10.1021/bi801423s; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kondola S, 2016, THER ADV RESPIR DIS, V10, P275, DOI 10.1177/1753465816628800; KRARUPHANSEN A, 1991, CANCER CHEMOTH PHARM, V28, P319, DOI 10.1007/BF00685684; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Le GV, 2011, RESPIROLOGY, V16, P767, DOI 10.1111/j.1440-1843.2011.01975.x; Leigh J, 2003, INT J OCCUP ENV HEAL, V9, P206, DOI 10.1179/oeh.2003.9.3.206; Li W, 2017, INT J ONCOL, V50, P1312, DOI 10.3892/ijo.2017.3878; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Liskova K, 2010, J AGR FOOD CHEM, V58, P4421, DOI 10.1021/jf903901j; Liskova Kamila, 2011, THESIS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marks LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063158; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mercer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026093; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moriya M, 2014, ONCOL REP, V31, P1109, DOI 10.3892/or.2013.2948; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Nadeem A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16432; Nielsen SB, 2010, J MOL BIOL, V398, P351, DOI 10.1016/j.jmb.2010.03.012; Nowak AK, 2012, ANN CARDIOTHORAC SUR, V1, P508, DOI 10.3978/j.issn.2225-319X.2012.10.05; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Permyakov SE, 2004, BIOCHEMISTRY-US, V43, P5575, DOI 10.1021/bi049584y; Permyakov SE, 2011, BIOCHIMIE, V93, P1495, DOI 10.1016/j.biochi.2011.05.002; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; R Core Team, 2013, R LANG ENV STAT COMP; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Rath EM, 2017, PROTEINS, V85, P1371, DOI 10.1002/prot.25298; Rath EM, 2015, J PHARM PHARM SCI, V18, P773, DOI 10.18433/J3G60C; Rath EM, 2014, PROTEINS, V82, P1400, DOI 10.1002/prot.24508; Relan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058132; Remon J, 2013, CANCER TREAT REV, V39, P584, DOI 10.1016/j.ctrv.2012.12.005; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1973, NATURWISSENSCHAFTEN, V60, P399, DOI 10.1007/BF00623551; SAMSON MK, 1979, CANCER TREAT REP, V63, P2027; Scagliotti G., 2001, European Journal of Cancer, V37, pS20, DOI 10.1016/S0959-8049(01)80558-X; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schultz RM, 1999, SEMIN ONCOL, V26, P68; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058578; Sullivan L. M., 2013, Food Digestion, V4, P7; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Trulsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017179; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; von Seggern D.H., 2007, CRC STANDARD CURVES, V2nd ed.; Vukojevic V, 2010, LANGMUIR, V26, P14782, DOI 10.1021/la1026416; Wang WJ, 2012, CLIN EXP MED, V12, P3, DOI 10.1007/s10238-011-0133-x; Wang YW, 2015, ADV HEALTHC MATER, V4, P577, DOI 10.1002/adhm.201400571; Wen H., 2011, J BIOANAL BIOMED S, V5; Wen HZ, 2015, J MOL BIOL, V427, P3177, DOI 10.1016/j.jmb.2015.08.009; Wen HZ, 2013, BBA-BIOMEMBRANES, V1828, P2691, DOI 10.1016/j.bbamem.2013.07.026; Xiao ZW, 2013, BJU INT, V112, pE201, DOI 10.1111/j.1464-410X.2012.11737.x; Zhang X, 2008, ACTA PHARMACOL SIN, V29, P942, DOI 10.1111/j.1745-7254.2008.00830.x; Zhao WL, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-92; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	126	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203003	10.1371/journal.pone.0203003	http://dx.doi.org/10.1371/journal.pone.0203003			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157247	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400082
J	Dominguez, JM; Dominguez, JH; Xie, DH; Kelly, KJ				Dominguez, James M., II; Dominguez, Jesus H.; Xie, Danhui; Kelly, K. J.			Human extracellular microvesicles from renal tubules reverse kidney ischemia-reperfusion injury in rats	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; CELL TRANSPLANTATION; IN-VIVO; FAILURE; PROGRESSION; HYPOXIA; AKI; TRANSITION; MORTALITY; EXOSOMES	Hypoxic acute kidney injury, a major unresolved problem, initiates, or aggravates, renal functional and structural decline. There is no treatment for hypoxic acute renal injury and its sequelae. We tested the hypothesis that human kidney tubular cells, or their extracellular vesicles (exosomes), prevent renal injury when infused intravenously 24 hours after 50 minutes of bilateral renal ischemia in Nude rats. Cells and their exosomes were from harvested human kidneys declined for transplantation. Injections of either cells or exosomes, given after 24 and 48 hours of reperfusion, preserved renal function and structure in both treatment groups. However, exosomes were superior to cells; and maintained renal vascular and epithelial networks, prevented renal oxidant stress, and apoptosis; and restrained activation of pro-inflammatory and pro-fibrogenic pathways. Exosomes worked in 24 hours, consistent with functional rather than regenerative activity. Comprehensive proteomic analysis identified 6152 renal proteins from all cellular compartments; and 628 were altered by ischemia at all cell levels, while 377 were significantly improved by exosome infusions. We conclude that renal damage from severe ischemia was broad, and human renal exosomes prevented most protein alterations. Thus, exosomes seem to acutely correct a critical and consequential abnormality during reperfusion. In their absence, renal structure and cells transition to a chronic state of fibrosis and extensive renal cell loss.	[Dominguez, James M., II; Dominguez, Jesus H.; Xie, Danhui; Kelly, K. J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Dominguez, Jesus H.; Kelly, K. J.] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Dominguez, JH (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.; Dominguez, JH (corresponding author), Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.	jhdoming@iu.edu			NIH [R01 DK 082739]; Paul Teschan Research Fund of Dialysis Clinics, Inc.; U.S. Department of Veterans Affairs (Merit Review Grant); University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center; Indiana Clinical and Translational Sciences Institute; DCI Paul Teschan Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Teschan Research Fund of Dialysis Clinics, Inc.; U.S. Department of Veterans Affairs (Merit Review Grant); University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center; Indiana Clinical and Translational Sciences Institute; DCI Paul Teschan Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by NIH grant R01 DK 082739, Paul Teschan Research Fund of Dialysis Clinics, Inc., U.S. Department of Veterans Affairs (Merit Review Grant), University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center, Indiana Clinical and Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Merit Review Grant to JHD, NIH grant R01 DK 082739, Indiana Clinical and Translational Sciences Institute, and research grant from DCI Paul Teschan Research and from University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center to KJK. We thank Dr. Tim E. Taber for supporting the human kidney donations and Indiana Donor Network staff for their contribution with rejected kidneys. We are also grateful to Jennifer Nelson and Dr. Sarah Tersey, from the Islet and Physiology Core of the Center for Diabetes and Metabolic Diseases at Indiana University, for conducting exosome analysis.	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; BERTRAM JF, 1992, CELL TISSUE RES, V270, P37, DOI 10.1007/BF00381877; Bonventre JV, 2002, CURR OPIN NEPHROL HY, V11, P43, DOI 10.1097/00041552-200201000-00007; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Collino F, 2015, J AM SOC NEPHROL, V26, P2349, DOI 10.1681/ASN.2014070710; Dominguez JH, 2017, J AM SOC NEPHROL, V28, P3533, DOI 10.1681/ASN.2016121278; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; Islam CF, 1997, BRIT J UROL, V79, P842, DOI 10.1046/j.1464-410X.1997.00209.x; Jonker SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150863; Kelly KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131677; Kelly KJ, 2013, PHYSIOL GENOMICS, V45, P710, DOI 10.1152/physiolgenomics.00028.2013; Kelly KJ, 2009, AM J PHYSIOL-RENAL, V297, pF923, DOI 10.1152/ajprenal.00205.2009; Kelly KJ, 2015, AM J NEPHROL, V41, P48, DOI 10.1159/000371426; Kelly KJ, 2013, AM J PHYSIOL-RENAL, V305, pF1804, DOI 10.1152/ajprenal.00097.2013; Kelly KJ, 2012, AM J PHYSIOL-RENAL, V303, pF357, DOI 10.1152/ajprenal.00680.2011; Kelly KJ, 2010, AM J PHYSIOL-RENAL, V299, pF453, DOI 10.1152/ajprenal.00050.2010; Kelly KJ, 2009, AM J PHYSIOL-RENAL, V296, pF1355, DOI 10.1152/ajprenal.90622.2008; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Koritzinsky EH, 2017, J CELL PHYSIOL, V232, P1587, DOI 10.1002/jcp.25387; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; Oosthuyzen W, 2016, J AM SOC NEPHROL, V27, P3345, DOI 10.1681/ASN.2015050568; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Reese PP, 2016, J AM SOC NEPHROL, V27, P973, DOI 10.1681/ASN.2015010023; Rolstad B, 2001, IMMUNOL REV, V184, P136, DOI 10.1034/j.1600-065x.2001.1840113.x; Tanaka S, 2014, AM J PHYSIOL-RENAL, V307, pF1187, DOI 10.1152/ajprenal.00425.2014; Wang CJ, 2017, HUM IMMUNOL, V78, P9, DOI 10.1016/j.humimm.2016.08.007; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	33	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202550	10.1371/journal.pone.0202550	http://dx.doi.org/10.1371/journal.pone.0202550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148844	Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200014
J	Golestaneh, L; Bellin, E; Neugarten, J; Lo, YT				Golestaneh, Ladan; Bellin, Eran; Neugarten, Joel; Lo, Yungtai			Avoidable visits to the emergency department (ED) and their association with sex, age and race in a cohort of low socio-economic status patients on hemodialysis in the Bronx	PLOS ONE			English	Article							INCIDENT DIALYSIS PATIENTS; PATIENTS APPROACHING ESRD; PSYCHOSOCIAL FACTORS; MAINTENANCE HEMODIALYSIS; BEHAVIORAL COMPLIANCE; SOCIAL SUPPORT; RENAL-DISEASE; MORTALITY; OUTCOMES; CARE	Background In national samples drawn from the USRDS, female patients utilize the hospital ED and inpatient services at a higher rate than their male counterparts and have a higher rate of re-hospitalization. We wanted to explore the association of sex with avoidable ED visits made by a cohort of patients on hemodialysis in a mostly minority, lower socioeconomic status (SES), population in the Bronx to test the applicability of the USRDS findings. Methods We used Montefiore's clinical database to build a cohort of patients on hemodialysis with a first ED visit between 2013 and 2017. All ED visits after the index ED visit and those within one year prior to the index visit were recorded. None of the ED visits resulted in a hospitalization and were thus labeled "avoidable". Bivariate analysis tested the association of demographic and clinical variables with sex. We used negative binomial regression to test the association of each variable with avoidable ED visit count. The multivariate model used negative binomial regression with avoidable ED visit count as outcome and sex as the exposure variable and included ancestral variables age and race. Potential mediators were added to the model to measure their effects on the association of sex with avoidable ED visits. Results Four thousand six hundred and seventy three subjects on hemodialysis were identified as having at least one avoidable ED visit, in the period of 2013-2017 at one of four ED sites affiliated with Montefiore Medical Center in the Bronx. Over 5 years (2012-2017), the median number of ED visits made by the study sample was 4 (25-75% IQR: 2-8). Female patients on hemodialysis in our cohort were older, more commonly black, had lower SES scores, less commonly had commercial insurance and were less commonly married than their male counterparts. Female sex was not significantly associated with a higher rate of avoidable ED visits in the total cohort.(1.053(0.99-1.12) Female sex was significantly associated with outcome in non-Hispanic whites only and in those subjects younger than 44 years old.(IRR 1.30(1.06-1.69), 1.17(1.00-1.38) in non-Hispanic White and younger age group, respectively.) Marital status, SES and hemoglobin levels possibly mediated the association of sex and outcome in our population. (>25% change in the coefficient for sex with respect to outcome when variable added to the model). Conclusion In this single center study of a lower-socioeconomic status, mostly minority dialysis population, the association of female sex with avoidable ED visits was not significant. These results suggest the association of sex with hospitalization outcomes, described by national datasets that determine quality indicators, are not consistent across different types of populations with some mediation possible by SES and marital status in poorer neighborhoods.	[Golestaneh, Ladan; Neugarten, Joel] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Renal Div, Bronx, NY 10467 USA; [Bellin, Eran; Lo, Yungtai] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Golestaneh, L (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Renal Div, Bronx, NY 10467 USA.	lgolesta@montefiore.org		Golestaneh, Ladan/0000-0003-1848-582X				Adams SV, 2017, J AM SOC NEPHROL, V28, P2721, DOI 10.1681/ASN.2016090986; Beberashvili I, 2009, J RENAL NUTR, V19, P238, DOI 10.1053/j.jrn.2008.11.007; Bellin E, 2015, RIDDLES ACCOUNTABLE; Bellin E, 2010, ACAD MED, V85, P1362, DOI 10.1097/ACM.0b013e3181df0f3b; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Borges MCC, 2017, CLIN NUTR ESPEN, V17, P63, DOI 10.1016/j.clnesp.2016.10.006; Hakim RM, 2014, J AM SOC NEPHROL, V25, P1891, DOI 10.1681/ASN.2014030270; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Huang J., 2015, CHIN RURAL EC, V2015, P10, DOI DOI 10.1016/j.agrformet.2015.10.013; Johns TS, 2014, J AM SOC NEPHROL, V25, P2649, DOI 10.1681/ASN.2013111207; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kalbfleisch J, 2015, J AM SOC NEPHROL, V26, P2641, DOI 10.1681/ASN.2014050512; Kimmel PL, 2000, AM J KIDNEY DIS, V35, pS132, DOI 10.1016/S0272-6386(00)70240-X; Kimmel PL, 2003, ADV RENAL REPLACE TH, V10, P61, DOI 10.1053/jarr.2003.50000; Kimmel PL, 1998, KIDNEY INT, V54, P245, DOI 10.1046/j.1523-1755.1998.00989.x; KIMMEL PL, 1995, J AM SOC NEPHROL, V5, P1826; Komenda P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195323; Lovasik BP, 2016, JAMA INTERN MED, V176, P1563, DOI 10.1001/jamainternmed.2016.4975; Martin M, 2015, ATHEROSCLEROSIS, V241, P264, DOI 10.1016/j.atherosclerosis.2015.02.048; Newman KL, 2017, TRANSPLANTATION, V101, P2913, DOI 10.1097/TP.0000000000001839; Norris KC, 2017, SEMIN DIALYSIS, V30, P213, DOI 10.1111/sdi.12589; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P1480, DOI 10.2215/CJN.01240210; Ronksley PE, 2016, CLIN J AM SOC NEPHRO, V11, P2022, DOI 10.2215/CJN.04690416; Ronksley PE, 2017, CLIN J AM SOC NEPHRO, V12, P304, DOI 10.2215/CJN.06280616; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Services CfMaM, 2017, ESRD QUAL INC PROGR; Services CfMaM, 2017, FIN PY 2018 CLIN MEA; Services CfMaM, END STAG REN DIS ESR, P1017; Sturm G, 2010, NEPHROL DIAL TRANSPL, V25, P2715, DOI 10.1093/ndt/gfq101; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; United States Renal Data S, 2016, ESRD US, P2; United States Renal Data S, 2017, US REN DAT S ANN REP; United States Renal Data S, 2013, EC COSTS ESRD; United States Renal Data S, 2017, ANN DAT REP HIGHL; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; USRDS, 2017, USRDS ANN DAT REP, V23, DOI [10.1681/ASN.2016090986, DOI 10.1681/ASN.2016090986]; Wiebe N, 2014, AM J KIDNEY DIS, V64, P230, DOI 10.1053/j.ajkd.2014.03.012; Yan GF, 2015, CLIN J AM SOC NEPHRO, V10, P1979, DOI 10.2215/CJN.02800315; Yan GF, 2014, CLIN J AM SOC NEPHRO, V9, P1402, DOI 10.2215/CJN.12621213; Yan GF, 2013, CLIN J AM SOC NEPHRO, V8, P610, DOI 10.2215/CJN.07780812	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202697	10.1371/journal.pone.0202697	http://dx.doi.org/10.1371/journal.pone.0202697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142175	gold, Green Submitted, Green Published			2022-12-26	WOS:000442722500025
J	Pan, XY; Wenzel, A; Jensen, LJ; Gorodkin, J				Pan, Xiaoyong; Wenzel, Anne; Jensen, Lars Juhl; Gorodkin, Jan			Genome-wide identification of clusters of predicted microRNA binding sites as microRNA sponge candidates	PLOS ONE			English	Article							CERNA HYPOTHESIS; NONCODING RNAS; CIRCULAR RNAS; MIRNA; DATABASE; BIOGENESIS; TARGETS	The number of discovered natural miRNA sponges in plants, viruses, and mammals is increasing steadily. Some sponges like ciRS-7 for miR-7 contain multiple nearby miRNA binding sites. We hypothesize that such clusters of miRNA binding sites on the genome can function together as a sponge. No systematic effort has been made in search for clusters of miRNA targets. Here, we, to our knowledge, make the first genome-wide target site predictions for clusters of mature human miRNAs. For each miRNA, we predict the target sites on a genome-wide scale, build a graph with edge weights based on the pairwise distances between sites, and apply Markov clustering to identify genomic regions with high binding site density. Significant clusters are then extracted based on cluster size difference between real and shuffled genomes preserving local properties such as the GC content. We then use conservation and binding energy to filter a final set of miRNA target site clusters or sponge candidates. Our pipeline predicts 3673 sponge candidates for 1250 miRNAs, including the experimentally verified miR-7 sponge ciRS-7. In addition, we point explicitly to 19 high-confidence candidates overlapping annotated genomic sequence. The full list of candidates is freely available at http://rth.dk/resources/mirnasponge, where detailed properties for individual candidates can be explored, such as alignment details, conservation, accessibility and target profiles, which facilitates selection of sponge candidates for further context specific analysis.	[Pan, Xiaoyong; Wenzel, Anne; Jensen, Lars Juhl; Gorodkin, Jan] Univ Copenhagen, Dept Vet & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Pan, Xiaoyong; Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dis Syst Biol Program, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Jensen, LJ; Gorodkin, J (corresponding author), Univ Copenhagen, Dept Vet & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark.; Jensen, LJ (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dis Syst Biol Program, Copenhagen, Denmark.	lars.juhl.jensen@cpr.ku.dk; gorodkin@rth.dk	ravegnini, gloria/K-1330-2016; Jensen, Lars Juhl/C-6492-2008	ravegnini, gloria/0000-0002-7774-402X; Jensen, Lars Juhl/0000-0001-7885-715X; Wenzel, Anne/0000-0001-6187-4156; Gorodkin, Jan/0000-0001-5823-4000	University of Copenhagen; Novo Nordisk Foundation [NNF14CC0001]; Danish Center for Scientific Computing (DCSC/DEiC); Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies) [0603-00320B]	University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Center for Scientific Computing (DCSC/DEiC); Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies)	This project was mainly financed by University of Copenhagen with additional support from the Novo Nordisk Foundation [NNF14CC0001], the Danish Center for Scientific Computing (DCSC/DEiC), and Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies) [0603-00320B].	Alkan F, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1325; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-459; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-3; Cheng EC, 2013, DEV CELL, V25, P1, DOI 10.1016/j.devcel.2013.03.020; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gerlach W, 2006, BIOINFORMATICS, V22, P762, DOI 10.1093/bioinformatics/btk041; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guo JN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0482-3; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Holohan Kelly N., 2013, Frontiers in Genetics, V3, P323, DOI 10.3389/fgene.2012.00323; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Junge A, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw167; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kluiver J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029275; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarver AL, 2012, BIOINFORMATION, V8, P731, DOI 10.6026/97320630008731; Smit A, 1996, REPEATMASKER OPEN 30; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomas LF, 2014, BIOINFORMATICS, V30, P2243, DOI 10.1093/bioinformatics/btu257; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Le TY, 2017, BRIEF BIOINFORM, V18, P577, DOI 10.1093/bib/bbw042; Van Dongen S., 2000, THESIS; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115	52	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202369	10.1371/journal.pone.0202369	http://dx.doi.org/10.1371/journal.pone.0202369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142196	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500012
J	Song, L; Ouedraogo, JP; Kolbusz, M; Nguyen, TTM; Tsang, A				Song, Letian; Ouedraogo, Jean-Paul; Kolbusz, Magdalena; Thi Truc Minh Nguyen; Tsang, Adrian			Efficient genome editing using tRNA promoter-driven CRISPR/Cas9 gRNA in Aspergillus niger	PLOS ONE			English	Article							POLYMERASE-III; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGI; TRANSCRIPTION; GENES; CRISPR-CAS9; REPAIR; TRANSFORMATION; EXPRESSION; SEQUENCES	As a powerful tool for fast and precise genome editing, the CRISPR/Cas9 system has been applied in filamentous fungi to improve the efficiency of genome alteration. However, the method of delivering guide RNA (gRNA) remains a bottleneck in performing CRISPR mutagenesis in Aspergillus species. Here we report a gRNA transcription driven by endogenous tRNA promoters which include a tRNA gene plus 100 base pairs of upstream sequence. Co-transformation of a cas9-expressing plasmid with a linear DNA coding for gRNA demonstrated that 36 of the 37 tRNA promoters tested were able to generate the intended mutation in A. niger. When gRNA and cas9 were expressed in a single extra-chromosomal plasmid, the efficiency of gene mutation was as high as 97%. Co-transformation with DNA template for homologous recombination, the CRISPR/Cas9 system resulted similar to 42% efficiency of gene replacement in a strain with a functioning non-homologous end joining machinery (kusA(+)), and an efficiency of >90% gene replacement in a kusA-background. Our results demonstrate that tRNA promoter-mediated gRNA expressions are reliable and efficient in genome editing in A. niger.	[Song, Letian; Ouedraogo, Jean-Paul; Kolbusz, Magdalena; Thi Truc Minh Nguyen; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada	Ouedraogo, JP (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.	jean-paul.ouedraogo@concordia.ca		Ouedraogo, Jean-Paul/0000-0002-9735-6235; Nguyen, Thi Truc Minh/0000-0003-4696-166X	NSERC Strategic Industrial Biocatalysis Network	NSERC Strategic Industrial Biocatalysis Network	This work was supported by NSERC Strategic Industrial Biocatalysis Network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksenko A, 1996, MOL MICROBIOL, V19, P565, DOI 10.1046/j.1365-2958.1996.400937.x; Andersen MR, 2014, BRIEF FUNCT GENOMICS, V13, P451, DOI 10.1093/bfgp/elu029; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BALLANCE DJ, 1985, GENE, V36, P321, DOI 10.1016/0378-1119(85)90187-8; Bellaiche Y, 1999, GENETICS, V152, P1037; Bennett J. W., 1991, MORE GENE MANIPULATI, P441; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GOOSEN T, 1987, CURR GENET, V11, P499, DOI 10.1007/BF00384612; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; HANG YD, 1984, BIOTECHNOL LETT, V6, P763, DOI 10.1007/BF00133071; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kruszka K, 2003, EMBO J, V22, P621, DOI 10.1093/emboj/cdg040; Kudo, 2000, GENOME INFORM, V11, P301, DOI [10.11234/gi1990.11.301, DOI 10.11234/GI1990.11.301]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li YR, 2011, J AM CHEM SOC, V133, P15773, DOI 10.1021/ja206906d; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MALE G, 2015, NAT COMMUN, V6, DOI DOI 10.1038/NC0MMS8387; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2015, ADV BIOCHEM ENG BIOT, V149, P91, DOI 10.1007/10_2014_297; Meyer V, 2011, APPL ENVIRON MICROB, V77, P2975, DOI 10.1128/AEM.02740-10; Nodvig CS, 2018, FUNGAL GENET BIOL, V115, P78, DOI 10.1016/j.fgb.2018.01.004; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Ouedraogo JP, 2016, J BIOTECHNOL, V222, P25, DOI 10.1016/j.jbiotec.2016.02.012; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; SHARP S, 1981, NUCLEIC ACIDS RES, V9, P5867, DOI 10.1093/nar/9.22.5867; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Storms R, 2005, PLASMID, V53, P191, DOI 10.1016/j.plasmid.2004.10.001; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Sugano SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00883-5; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Weyda I, 2017, J MICROBIOL METH, V135, P26, DOI 10.1016/j.mimet.2017.01.015; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; YOUNG LS, 1991, MOL CELL BIOL, V11, P1382, DOI 10.1128/MCB.11.3.1382; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang JX, 2011, CURR MICROBIOL, V62, P1342, DOI 10.1007/s00284-010-9853-5; Zhang T, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2148	66	54	57	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202868	10.1371/journal.pone.0202868	http://dx.doi.org/10.1371/journal.pone.0202868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142205	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000442722500044
J	Li, LF; Lan, MX; Lu, WF; Li, ZB; Xia, T; Zhu, JY; Ye, M; Gao, X; Wu, GX				Li, Lifang; Lan, Mingxian; Lu, Wufeng; Li, Zhaobo; Xia, Tao; Zhu, Jiaying; Ye, Min; Gao, Xi; Wu, Guoxing			De novo transcriptomic analysis of the alimentary tract of the tephritid gall fly, Procecidochares utilis	PLOS ONE			English	Article							S-TRANSFERASE GENES; MOTH SPODOPTERA-LITURA; EUPATORIUM-ADENOPHORUM; DROSOPHILA-MELANOGASTER; INSECTICIDE RESISTANCE; EXPRESSION PROFILES; CROFTON WEED; FURANOCOUMARIN METABOLISM; DETOXIFICATION ENZYMES; AGERATINA-ADENOPHORA	The tephritid gall fly, Procecidochares utilis, is an important obligate parasitic insect of the malignant weed Eupatorium adenophorum which biosynthesizes toxic secondary metabolites. Insect alimentary tracts secrete several enzymes that are used for detoxification, including cytochrome P450s, glutathione S-transferases, and carboxylesterases. To explore the adaptation of P. utilis to its toxic host plant, E. adenophorum at molecular level, we sequenced the transcriptome of the alimentary tract of P. utilis using Illumina sequencing. Sequencing and de novo assembly yielded 62,443 high-quality contigs with an average length of 604 bp that were further assembled into 45,985 unigenes with an average length of 674 bp and an N50 of 983 bp. Among the unigenes, 30,430 (66.17%) were annotated by alignment against the NCBI non-redundant protein (Nr) database, while 16,700 (36.32%), 16,267 (35.37%), and 11,530 (25.07%) were assigned functions using the Clusters of Orthologous Groups (COG), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Ontology (GO) databases, respectively. Using the comprehensive transcriptome data set, we manually identified several important gene families likely to be involved in the detoxification of toxic compounds including 21 unigenes within the glutathione S-transferase (GST) family, 22 unigenes within the cytochrome P450 (P450) family, and 16 unigenes within the carboxylesterase (CarE) family. Quantitative PCR was used to verify eight, six, and two genes of GSTs, P450s, and CarEs, respectively, in different P. utilis tissues and at different developmental stages. The detoxification enzyme genes were mainly expressed in the foregut and midgut. Moreover, the unigenes were higher expressed in the larvae, pupae, and 3-day adults, while they were expressed at lower levels in eggs. These transcriptomic data provide a valuable molecular resource for better understanding the function of the P. utilis alimentary canal. These identified genes could be pinpoints to address the molecular mechanisms of P. utilis interacting with toxic plant host.	[Li, Lifang; Lan, Mingxian; Lu, Wufeng; Li, Zhaobo; Xia, Tao; Ye, Min; Gao, Xi; Wu, Guoxing] Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China; [Zhu, Jiaying] Southwest Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University; Southwest Forestry University - China	Gao, X; Wu, GX (corresponding author), Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources Y, Kunming, Yunnan, Peoples R China.	chonchon@163.com; wugx1@163.com	Gao, Xi/AAY-4077-2021	Gao, Xi/0000-0003-0990-3452	Natural Science Foundation of China [31460491, 31501706]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China (Grant No. 31460491 and 31501706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlJabr AM, 2017, MOLECULES, V22, DOI 10.3390/molecules22010169; BENNETT PH, 1986, AUST J BOT, V34, P473, DOI 10.1071/BT9860473; Bhaskara S, 2006, GENE, V377, P56, DOI 10.1016/j.gene.2006.02.032; Cai QN, 2009, J CHEM ECOL, V35, P320, DOI 10.1007/s10886-009-9603-y; Chen Cheng-Yu, 2015, Acta Entomologica Sinica, V58, P1126; Chen CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183111; Chen JS, 2002, INSECT MOL BIOL, V11, P175, DOI 10.1046/j.1365-2583.2002.00323.x; Chen J, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/ieu174; Chen X. D., 1990, Chinese Journal of Applied Ecology, V1, P315; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Dey S, 2005, MICROSC RES TECHNIQ, V66, P31, DOI 10.1002/jemt.20140; Dong LM, 2017, MOLECULES, V22, DOI 10.3390/molecules22040592; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gao X, 2014, GENET MOL RES, V13, P2857, DOI 10.4238/2014.March.19.1; Vejares SG, 2010, COMP BIOCHEM PHYS C, V151, P351, DOI 10.1016/j.cbpc.2009.12.008; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YQ, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex014; Hu FLY, 2015, J MICROB BIOCH TECH, V7; Huang XB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09277-z; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; Jensen HR, 2006, J AGR FOOD CHEM, V54, P1289, DOI 10.1021/jf052046n; Jin Y, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/194976; Jing TX, 2017, COMP BIOCHEM PHYS B, V206, P35, DOI 10.1016/j.cbpb.2017.01.008; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Li Ai-Fang, 2006, Zhiwu Shengtai Xuebao, V30, P496; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li YongMing, 2008, Journal of Yunnan Agricultural University, V23, P42; Li YunShou, 2001, Entomological Knowledge, V38, P214; Lindroth RL, 2001, USDA ROCKY, P273; Linser PJ, 2014, ADV INSECT PHYSIOL, V47, P1, DOI 10.1016/B978-0-12-800197-4.00001-4; Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2006, WEED SCI, V54, P452, DOI 10.1614/WS-05-174R1.1; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Meng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093100; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Oelrichs Peter B., 1995, Natural Toxins, V3, P350, DOI 10.1002/nt.2620030505; OSULLIVAN BM, 1985, AUST VET J, V62, P30, DOI 10.1111/j.1751-0813.1985.tb06044.x; Ouyang CB, 2015, NAT PRODUCT BIOPROSP, V5, P29, DOI 10.1007/s13659-014-0050-2; Pan L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155682; Pavlidi N, 2015, PESTIC BIOCHEM PHYS, V121, P53, DOI 10.1016/j.pestbp.2015.01.009; Peng Lu, 2010, Acta Entomologica Sinica, V53, P572; Petersen RA, 2001, INSECT BIOCHEM MOLEC, V31, P679, DOI 10.1016/S0965-1748(00)00174-0; Qin GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058410; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Qiu ZY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071110; Rahman O., 1990, Indian Journal of Weed Science, V22, P98; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 1998, P NATL ACAD SCI USA, V95, P14284, DOI 10.1073/pnas.95.24.14284; Ren Na-Na, 2015, Acta Entomologica Sinica, V58, P288, DOI 10.16380/j.kcxb.2015.03.008; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Rupasinghe SG, 2007, PROTEIN ENG DES SEL, V20, P615, DOI 10.1093/protein/gzm063; Rymer C, 2008, ANIM FEED SCI TECH, V141, P49, DOI 10.1016/j.anifeedsci.2007.04.013; Sang WG, 2010, BIOL INVASIONS, V12, P1721, DOI 10.1007/s10530-009-9584-3; Sasabe M, 2004, GENE, V338, P163, DOI 10.1016/j.gene.2004.04.028; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Scian M, 2015, ACTA CRYSTALLOGR D, V71, P2089, DOI 10.1107/S1399004715013929; Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359; Shabab M, 2014, FEBS J, V281, P2769, DOI 10.1111/febs.12819; Shen Guang-mao, 2015, Scientia Agricultura Sinica, V48, P3857; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; [申光茂 Shen Guangmao], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1947; Shen XM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081361; Spit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32460; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Van Leeuwen T, 2005, PEST MANAG SCI, V61, P499, DOI 10.1002/ps.1001; Visitpanich T, 1979, RAISING RABBITS HIGH; Wan FH, 2010, SCI CHINA LIFE SCI, V53, P1291, DOI 10.1007/s11427-010-4080-7; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157656; Wang RL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112278; Wang RL, 2017, INSECT SCI, V24, P235, DOI 10.1111/1744-7917.12315; Wang RL, 2015, INT J MOL SCI, V16, P22606, DOI 10.3390/ijms160922606; Wang RL, 2015, J INSECT PHYSIOL, V75, P54, DOI 10.1016/j.jinsphys.2015.02.013; Wang RL, 2015, J CHEM ECOL, V41, P111, DOI 10.1007/s10886-014-0540-z; [王瑞龙 Wang Ruilong], 2012, [生态学报, Acta Ecologica Sinica], V32, P5191; Wheeler MM, 2010, ARCH INSECT BIOCHEM, V73, P30, DOI 10.1002/arch.20333; Wu K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160009; Wu ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03306-7; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; You YC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1343-5; Yu LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08952; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zhang Jianhua, 2016, PLoS One, V11, pe0155254, DOI 10.1371/journal.pone.0155254; Zhao GD, 2014, MOL BIOL REP, V41, P1607, DOI 10.1007/s11033-013-3007-3; Zhao YJ, 2012, WEED SCI, V60, P431, DOI 10.1614/WS-D-11-00198.1; Zhou D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143387; Zhu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-174; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu L, 2000, CHINESE J ECOL, V19, P36; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4; Zou FM, 2011, MOL BIOL REP, V38, P639, DOI 10.1007/s11033-010-0150-y	96	5	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201679	10.1371/journal.pone.0201679	http://dx.doi.org/10.1371/journal.pone.0201679			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138350	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100022
J	Reinhold, T; Giannitsis, E; Mockel, M; Frankenstein, L; Vafaie, M; Vollert, JO; Slagman, A				Reinhold, Thomas; Giannitsis, Evangelos; Moeckel, Martin; Frankenstein, Lutz; Vafaie, Mehrshad; Vollert, Joern O.; Slagman, Anna			Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome	PLOS ONE			English	Article							HEALTH ECONOMIC-EVALUATION	Background Symptoms indicating acute coronary syndrome are commonly seen in emergency rooms, but only 10% of patients are actually diagnosed with acute myocardial infarction (AMI). The Guidelines for the diagnosis of patients with suspected AMI include either multiple testing of cardiac troponin (cTN) or a single combined test of cTN and copeptin, which facilitates earlier diagnosis or exclusion of AMI. The aim of the present analysis was to investigate the impact of combined copeptin/cTN testing on health care resource consumption and related costs both during and after initial hospital treatment. Methods and results The analysis was based on the BIC-8 trial and financial data of participating study sites. A cost analysis was carried out primarily from the hospital perspective and secondarily from the perspective of German statutory health insurers. The underlying assumptions of the investigation were tested for robustness in additional sensitivity analyses. In total, the data of 713 patients (n = 359 combined copeptin/cTN testing, n = 354 serial cTN testing) were evaluated. From a hospital perspective, the combined copeptin/cTN testing showed a reduced number of medical procedures and a lower frequency of inpatient admissions. The average staff time was significantly reduced by a mean of 49 minutes (95% confidence interval (CI) 46 to 53) per patient, accompanied by a significant mean reduction of 131 minutes (95%Cl 104 to 158) in the time patients stayed in the emergency room. The initial hospital treatment was less cost-intensive. Over the entire study period, no significant cost differences were observed between the groups for health insurance. Conclusion The combined copeptin/cTN testing has the potential to save costs and staff time in acute care and for the entire hospital stay. The primary explanations for these findings are early identification and ruling out patients without AMI along with the associated reduced need for acute medical treatment.	[Reinhold, Thomas] Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Giannitsis, Evangelos; Frankenstein, Lutz; Vafaie, Mehrshad] Univ Hosp Heidelberg, Dept Angiol Cardiol & Pneumol, Heidelberg, Germany; [Moeckel, Martin; Slagman, Anna] Charite Univ Med Berlin, Dept Cardiol, Div Emergency Med, Berlin, Germany; [Moeckel, Martin; Slagman, Anna] Charite Univ Med Berlin, Dept Cardiol, CPU, Berlin, Germany; [Moeckel, Martin] JCU, Cairns, Australia; [Vollert, Joern O.] ThermoSci BRAHMS GmbH, Hennigsdorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reinhold, T (corresponding author), Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	thomas.reinhold@charite.de	Mockel, Martin/AAC-2600-2019	Mockel, Martin/0000-0002-7691-3709; Reinhold, Thomas/0000-0001-5169-7029; Slagman, Anna/0000-0003-2608-0347	Thermo Fisher Scientific BRAHMS GmbH	Thermo Fisher Scientific BRAHMS GmbH	This work is an investigator initiated analysis and was financially supported by Thermo Fisher Scientific BRAHMS GmbH (https://www.brahms.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambavane A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187662; Bock JO, 2015, GESUNDHEITSWESEN, V77, P53, DOI 10.1055/s-0034-1374621; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Cheng QL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009746; Deutsche Krankenhausgesellschaft, 2016, DKG NT BAND TAR DTSC; Domenico C, 2013, LIGANDASSAY, V18, P68; Julicher P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013653; Kaambwa B, 2017, INT J CARDIOL, V238, P144, DOI 10.1016/j.ijcard.2017.02.141; Krauth C, 2005, GESUNDHEITSWESEN, V67, P736, DOI 10.1055/s-2005-858698; Mockel M, 2013, EUR J EMERG MED, V20, P103, DOI 10.1097/MEJ.0b013e328351e609; Mockel M, 2015, EUR HEART J, V36, P369, DOI 10.1093/eurheartj/ehu178; Reinhold T, 2010, J PUBLIC HEALTH-HEID, V18, P327, DOI 10.1007/s10389-010-0315-0; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Schwabe U, 2014, ARZNEIMITTELVERORDNU; Shortt C, 2017, CLIN CHEM, V63, P593, DOI 10.1373/clinchem.2016.261776; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Vaidya A, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-77	17	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202133	10.1371/journal.pone.0202133	http://dx.doi.org/10.1371/journal.pone.0202133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138394	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000442800100041
J	Sampaio, NG; Kocan, M; Schofield, L; Pfleger, KDG; Eriksson, EM				Sampaio, Natalia G.; Kocan, Martina; Schofield, Louis; Pfleger, Kevin D. G.; Eriksson, Emily M.			Investigation of interactions between TLR2, MyD88 and TIRAP by bioluminescence resonance energy transfer is hampered by artefacts of protein overexpression	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TRANSFER BRET; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; BINDING; FAMILY; IDENTIFICATION; ACTIVATION; INDUCTION; PATHWAY	Toll like receptors (TLRs) are important pattern recognition receptors that can detect pathogen and danger associated molecular patterns to initiate an innate immune response. TLR1 and 2 heterodimerize at the plasma membrane upon binding to triacylated lipopeptides from bacterial cell walls, or to the synthetic ligand Pam3CSK4. TLR1/2 dimers interact with adaptor molecules TIRAP and MyD88 to initiate a signalling cascade that leads to activation of key transcription factors, including NF-kB. Despite TLRs being extensively studied over the last two decades, the real-time kinetics of ligand binding and receptor activation remains largely unexplored. We aimed to study the kinetics of TLR activation and recruitment of adaptors, using TLR1/2 dimer interactions with adaptors MyD88 and TIRAP. Bioluminescence resonance energy transfer (BRET) allows detection of real-time protein-protein interactions in living cells, and was applied to study adaptor recruitment to TLRs. Energy transfer showed interactions between TLR2 and TI RAP, and between TLR2 and MyD88 only in the presence of TI RAP. Quantitative BRET and confocal microscopy confirmed that TIRAP is necessary for MyD88 interaction with TLR2. Furthermore, constitutive proximity between the proteins in the absence of Pam3CSK4 stimulation was observed with BRET, and was not abrogated with lowered protein expression, changes in protein tagging strategies, or use of the brighter NanoLuc luciferase. However, co-immunoprecipitation studies did not demonstrate constitutive interaction between these proteins, suggesting that the interaction observed with BRET likely represents artefacts of protein overexpression. Thus, caution should be taken when utilizing protein overexpression in BRET studies and in investigations of the TLR pathway.	[Sampaio, Natalia G.; Schofield, Louis; Eriksson, Emily M.] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Sampaio, Natalia G.; Eriksson, Emily M.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Kocan, Martina] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Schofield, Louis] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia; [Pfleger, Kevin D. G.] Univ Western Australia, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Pfleger, Kevin D. G.] Univ Western Australia, Ctr Med Res, Nedlands, WA, Australia; [Pfleger, Kevin D. G.] Dimerix Ltd, Nedlands, WA, Australia; [Sampaio, Natalia G.] Univ Oxford, MRC, Radcliffe Dept Med, Weatherall Inst Mol Med,Human Immunol Unit, Oxford, England; [Kocan, Martina] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Monash University; James Cook University; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; University of Oxford; Florey Institute of Neuroscience & Mental Health	Sampaio, NG (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia.; Sampaio, NG (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Sampaio, NG (corresponding author), Univ Oxford, MRC, Radcliffe Dept Med, Weatherall Inst Mol Med,Human Immunol Unit, Oxford, England.	Natalia.sampaio@rdm.ox.ac.uk	Sampaio, Natalia G./N-8024-2019	Sampaio, Natalia G./0000-0002-8396-1354; Kocan, Martina/0000-0003-3468-6197; Eriksson, Emily/0000-0002-7851-973X; Pfleger, Kevin/0000-0001-8261-9189	NHMRC [APP1038030, APP106722, APP1126395]; NHMRC RD Wright Biomedical Research Fellowship [1085842]; Australian Research Council [LP160100857]; Promega; BMG Labtech; Dimerix	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC RD Wright Biomedical Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Promega; BMG Labtech; Dimerix	This work was supported by Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council (NHMRC) Independent Research Institute Infrastructure Support Scheme; NHMRC Dora Lush Scholarship, Grant/Award Number: APP1038030 (NGS); NHMRC Grant/Award Numbers: APP106722 and APP1126395 (EME); NHMRC RD Wright Biomedical Research Fellowship Grant/Award Number 1085842 (KDGP). BRET work in the laboratory of KDGP is funded in part by Australian Research Council Linkage Grant LP160100857, with Promega, BMG Labtech and Dimerix as industry partners. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Bovijn C, 2013, J BIOL CHEM, V288, P12054, DOI 10.1074/jbc.M112.415810; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Dacres H, 2012, BIOCHEM BIOPH RES CO, V425, P625, DOI 10.1016/j.bbrc.2012.07.133; Feng CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032359; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Joosten LAB, 2016, NAT REV RHEUMATOL, V12, P344, DOI 10.1038/nrrheum.2016.61; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kocan Martina, 2010, Front Endocrinol (Lausanne), V1, P12, DOI 10.3389/fendo.2010.00012; Kocan M, 2011, METHODS MOL BIOL, V746, P357, DOI 10.1007/978-1-61779-126-0_20; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Petrezselyova S, 2015, CELL MOL BIOL LETT, V20, P773, DOI 10.1515/cmble-2015-0047; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Snyder GA, 2014, J BIOL CHEM, V289, P669, DOI 10.1074/jbc.M113.523407; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Szalai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109503; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Vyncke L, 2016, STRUCTURE, V24, P437, DOI 10.1016/j.str.2015.12.018; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; White CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03486-2	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202408	10.1371/journal.pone.0202408	http://dx.doi.org/10.1371/journal.pone.0202408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138457	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100062
J	Sasaki, A; Mizuno, M; Ozeki, N; Katano, H; Otabe, K; Tsuji, K; Koga, H; Mochizuki, M; Sekiya, I				Sasaki, Akari; Mizuno, Mitsuru; Ozeki, Nobutake; Katano, Hisako; Otabe, Koji; Tsuji, Kunikazu; Koga, Hideyuki; Mochizuki, Manabu; Sekiya, Ichiro			Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow	PLOS ONE			English	Article							STROMAL CELLS; CARTILAGE DEFECTS; CRUCIATE LIGAMENT; DIFFERENTIATION; OSTEOARTHRITIS; TRANSPLANTATION; SUBPOPULATION; PERIOSTEUM; EXPANSION; COLONIES	Osteoarthritis (OA), a common chronic joint disorder in both humans and canines, is characterized by a progressive loss of articular cartilage. Canines can serve as an animal model of OA for human medicine, and this research can simultaneously establish effective veterinary treatments for canine OA. One attractive treatment that can lead to cartilage regeneration is the use of mesenchymal stem cells (MSCs). However, for canine OA, little information is available regarding the best source of MSCs. The purpose of this study was to identify a promising MSC source for canine cartilage regeneration. We collected synovial, infrapatellar fat pad, inguinal adipose, and bone marrow tissues from six canines and then conducted a donor-matched comparison of the properties of MSCs derived from these four tissues. We examined the surface epitope expression, proliferation capacity, and trilineage differentiation potential of all four populations. Adherent cells derived from all four tissue sources exhibited positivity for CD90 and CD44 and negativity for CD45 and CD11 b. The positive rate for CD90 was higher for synovium-derived than for adipose-derived and bone marrow-derived MSCs. Synovium-derived and infrapatellar fat pad-derived MSCs displayed substantial proliferation ability, and all four populations underwent trilineage differentiation. During chondrogenesis, the wet weight was heavier for cartilage pellets derived from synovium MSCs than from the other three sources. The synovium is therefore a promising source for MSCs for canine cartilage regeneration. Our findings provide useful information about canine MSCs that may be applicable to regenerative medicine for treatment of OA.	[Sasaki, Akari; Mizuno, Mitsuru; Ozeki, Nobutake; Katano, Hisako; Otabe, Koji; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan; [Sasaki, Akari; Mochizuki, Manabu] Univ Tokyo, Dept Vet Med Sci, Tokyo, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Dept Cartilage Regenerat, Tokyo, Japan; [Koga, Hideyuki] Tokyo Med & Dent Univ, Dept Joint Surg & Sports Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan.	sekiya.arm@tmd.ac.jp	Mitsuru, Mizuno/K-3962-2017; Tsuji, Kunikazu/HDM-9242-2022; Koga, Hideyuki/B-2448-2019	Mitsuru, Mizuno/0000-0002-4410-3621; Tsuji, Kunikazu/0000-0002-1013-8359; Koga, Hideyuki/0000-0003-4574-1796; Sasaki, Akari/0000-0003-1671-5054	Japan Society for the Promotion of Science (JSPS KAKENHI) [16H06262]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS KAKENHI) Grant-in-Aid for Young Scientists (A) to Mitsuru Mizuno (No. 16H06262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23940-z; Cachon T, 2018, VET J, V235, P1, DOI 10.1016/j.tvjl.2018.02.017; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Guercio A, 2013, CELL BIOL INT, V37, P789, DOI 10.1002/cbin.10090; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hodgkiss-Geere HM, 2012, VET J, V194, P361, DOI 10.1016/j.tvjl.2012.05.011; Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; Kang R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0137-7; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Krawetz RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043616; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Nakamura T, 2012, CYTOTHERAPY, V14, P327, DOI 10.3109/14653249.2011.638912; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Ock SA, 2013, CELL TRANSPLANT, V22, P2311, DOI 10.3727/096368912X657981; Russell KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167442; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Sekiya I, 2015, CLIN ORTHOP RELAT R, V473, P2316, DOI 10.1007/s11999-015-4324-8; Strickland SM, 2018, CURR REV MUSCULOSKE, V11, P221, DOI 10.1007/s12178-018-9477-0; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Volk SW, 2012, CELL TRANSPLANT, V21, P2189, DOI 10.3727/096368912X636821; Wijekoon HMS, 2017, RES VET SCI, V114, P370, DOI 10.1016/j.rvsc.2017.07.004; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z	40	36	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202922	10.1371/journal.pone.0202922	http://dx.doi.org/10.1371/journal.pone.0202922			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138399	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100141
J	Yu, XH; Liu, YH; Yin, LL; Peng, YB; Peng, YC; Gao, YX; Yuan, BW; Zhu, QL; Cao, TY; Xie, BW; Sun, LQ; Chen, Y; Gong, ZC; Qiu, YZ; Fan, XG; Li, X				Yu, Xiaohui; Liu, Youhong; Yin, Linglong; Peng, Yongbo; Peng, Yuchong; Gao, Yingxue; Yuan, Bowen; Zhu, Qianling; Cao, Tuoyu; Xie, Bowen; Sun, Lunquan; Chen, Yan; Gong, Zhicheng; Qiu, Yuanzheng; Fan, Xuegong; Li, Xiong			Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; CELL-CYCLE; NASOPHARYNGEAL CARCINOMA; DNA-REPLICATION; MAMMALIAN CDC6; EXPRESSION; TRANSCRIPTION; ACTIVATION; APOPTOSIS; TARGETS	Ionizing radiation (IR) is a conventional cancer therapeutic, to which cancer cells develop radioresistance with exposure. The residual cancer cells after radiation treatment also have increased metastatic potential. The mechanisms by which cancer cells develop radioresistance and gain metastatic potential are still unknown. In this study acute IR exposure induced cancer cell senescence and apoptosis, but after long-term IR exposure, cancer cells exhibited radioresistance. The proliferation of radioresistant cells was retarded, and most cells were arrested in G0/G1 phase. The radioresistant cells simultaneously showed resistance to further IR-induced apoptosis, premature senescence, and epithelial to mesenchymal transformation (EMT). Acute IR exposure steadily elevated CDC6 protein levels due to the attenuation of ubiquitination, while CDC6 overexpression was observed in the radioresistant cells because the insufficiency of CDC6 phosphorylation blocked protein translocation from nucleus to cytoplasm, resulting in subcellular protein accumulation when the cells were arrested in G0/G1 phase. CDC6 ectopic overexpression in CNE2 cells resulted in apoptosis resistance, G0/G1 cell cycle arrest, premature senescence, and EMT, similar to the characteristics of radioresistant CNE2-R cells. Targeting CDC6 with siRNA promoted IR-induced senescence, sensitized cancer cells to IR-induced apoptosis, and reversed EMT. Furthermore, CDC6 depletion synergistically repressed the growth of CNE2-R xenografts when combined with IR. The study describes for the first time cell models for IR-induced senescence, apoptosis resistance, and EMT, three major mechanisms by which radioresistance develops. CDC6 is a novel radioresistance switch regulating senescence, apoptosis, and EMT. These studies suggest that CDC6(high)KI67(low) represents a new diagnostic marker of radiosensitivity, and CDC6 represents a new therapeutic target for cancer radiosensitization.	[Yu, Xiaohui; Liu, Youhong; Yin, Linglong; Peng, Yuchong; Gao, Yingxue; Yuan, Bowen; Zhu, Qianling; Cao, Tuoyu; Xie, Bowen; Sun, Lunquan; Li, Xiong] Cent South Univ, Xiangya Hosp, Ctr Mol Med, Changsha, Hunan, Peoples R China; [Yu, Xiaohui; Liu, Youhong; Yin, Linglong; Peng, Yuchong; Gao, Yingxue; Yuan, Bowen; Zhu, Qianling; Cao, Tuoyu; Xie, Bowen; Sun, Lunquan; Li, Xiong] Cent South Univ, Xiangya Hosp, Hunan Key Lab Mol Radiat Oncol, Changsha, Hunan, Peoples R China; [Peng, Yongbo] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Changsha, Hunan, Peoples R China; [Chen, Yan] Cent South Univ, Xiangya Hosp 3, Dept Pathol, Changsha, Hunan, Peoples R China; [Gong, Zhicheng] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China; [Qiu, Yuanzheng] Cent South Univ, Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China; [Fan, Xuegong] Cent South Univ, Xiangya Hosp, Hunan Key Lab Viral Hepatitis, Changsha, Hunan, Peoples R China	Central South University; Central South University; Hunan University; Central South University; Central South University; Central South University; Central South University	Li, X (corresponding author), Cent South Univ, Xiangya Hosp, Ctr Mol Med, Changsha, Hunan, Peoples R China.; Li, X (corresponding author), Cent South Univ, Xiangya Hosp, Hunan Key Lab Mol Radiat Oncol, Changsha, Hunan, Peoples R China.	lixiongxiangya@csu.edu.cn	Peng, Yong-bo/ADE-0574-2022	Peng, Yong-bo/0000-0003-4861-7184	National Natural Science Foundation of China (NSFC) [81572542]; Doctoral Fund of Ministry of Education of China (RFDP) [20130162110029]; Scientific Research Funds for Returned Overseas Chinese Scholars, Ministry of Education of China (SRF for ROCS, SEM) [2014-1685]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China (RFDP); Scientific Research Funds for Returned Overseas Chinese Scholars, Ministry of Education of China (SRF for ROCS, SEM)	We thank Pro. Zhiqiang Xiao and the members of the Hunan Key Laboratory of Viral Hepatitis and Center of Molecular Medicine, Xiangya Hospital, Central South University for constructive discussion of this study. This work was supported by grants from the National Natural Science Foundation of China (NSFC, 81572542), the Doctoral Fund of Ministry of Education of China (RFDP, 20130162110029), and Scientific Research Funds for Returned Overseas Chinese Scholars, Ministry of Education of China (SRF for ROCS, SEM, 2014-1685).	Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chang JC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004766; Chen W, 2015, CANCER BIOL MED, V12, P23, DOI 10.7497/j.issn.2095-3941.2014.0015; Clijsters L, 2013, J CELL BIOL, V201, P1013, DOI 10.1083/jcb.201211019; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng DR, 2003, CANCER RES, V63, P7356; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lee M, 2014, BMB REP, V47, P51, DOI 10.5483/BMBRep.2014.47.2.005; Li G, 2013, EUR J CANCER, V49, P2596, DOI 10.1016/j.ejca.2013.03.001; Liu YH, 2014, BBA-GENE REGUL MECH, V1839, P297, DOI 10.1016/j.bbagrm.2014.02.016; Liu YH, 2014, MOL CARCINOGEN, V53, P380, DOI 10.1002/mc.21989; Liu YH, 2010, J CELL BIOCHEM, V111, P1546, DOI 10.1002/jcb.22886; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Raleigh DR, 2013, FUTURE ONCOL, V9, P219, DOI [10.2217/FON.12.185, 10.2217/fon.12.185]; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Sideridou M, 2011, J CELL BIOL, V195, P1123, DOI 10.1083/jcb.201108121; Smit MA, 2010, AGING-US, V2, P735, DOI 10.18632/aging.100209; Su ZW, 2016, ONCOL REP, V36, P72, DOI 10.3892/or.2016.4768; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Walter D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10530; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Young A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-808	34	32	32	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					549	563		10.1038/s41388-018-0460-4	http://dx.doi.org/10.1038/s41388-018-0460-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30158672	Green Published, hybrid			2022-12-26	WOS:000456589800007
J	Zuo, YA; Wang, PF; Sun, JF; Guo, SC; Wang, GQ; Zuo, T; Fan, SL; Zhou, P; Liang, MF; Shi, XL; Wang, XQ; Zhang, LQ				Zuo, Yanan; Wang, Pengfei; Sun, Jianfeng; Guo, Shichun; Wang, Guiqin; Zuo, Teng; Fan, Shilong; Zhou, Paul; Liang, Mifang; Shi, Xuanling; Wang, Xinquan; Zhang, Linqi			Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; influenza virus; monoclonal antibody; structural biology; X-ray crystallography; vaccine development; virology; mutagenesis; infectious disease; antigenic variation; escape mutants; H5N1; HPAI; neutralizing antibodies; receptor-binding site; antiviral vaccine	HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; A VIRUSES; PROCESSING ENDOPROTEASES; AIRBORNE TRANSMISSION; MONOCLONAL-ANTIBODY; ANTIGENIC STRUCTURE; UNIVERSAL VACCINE; ESCAPE MUTANTS; HONG-KONG; INFECTION	The highly pathogenic avian influenza virus H5N1 is a major threat to global public health and therefore a high-priority target of current vaccine development. The receptor-binding site (RBS) on the globular head of hemagglutinin (HA) in the viral envelope is one of the major target sites for antibody recognition against H5N1 and other influenza viruses. Here, we report the identification and characterization of a pair of human RBS-specific antibodies, designated FLD21.140 and AVFluIgG03, that are mutually complementary in their neutralizing activities against a diverse panel of H5N1 viruses. Crystallographic analysis and site-directed mutagenesis revealed that the two antibodies share a similar RBS-binding mode, and their individual specificities are governed by residues at positions 133a, 144, and 145. Specifically, FLD21.140 preferred Leu-133a/Lys-144/Ser-145, whereas AVFluIgG03 favored Ser-133a/Thr-144/Pro-145 residue triplets, both of which perfectly matched the most prevalent residues in viruses from epidemic-originating regions. Of note, according to an analysis of 3758 H5 HA sequences available in the Influenza Virus Database at the National Center for Biotechnology Information, the residues Leu-133a/Ser-133a and Ser-145/Pro-145 constituted more than 87.6 and 99.3% of all residues at these two positions, respectively. Taken together, our results provide a structural understanding for the neutralizing complementarity of these two antibodies and improve our understanding of the RBS-specific antibody response against H5N1 infection in humans.	[Zuo, Yanan; Zuo, Teng; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med, Beijing 100084, Peoples R China; [Wang, Pengfei; Sun, Jianfeng; Fan, Shilong; Wang, Xinquan] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci,Key Lab Prot Sci,Minist Educ, Beijing 100084, Peoples R China; [Guo, Shichun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Liang, Mifang] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 100084, Peoples R China; [Wang, Guiqin; Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med, Beijing 100084, Peoples R China.; Wang, XQ (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci,Key Lab Prot Sci,Minist Educ, Beijing 100084, Peoples R China.	xinquanwang@mail.tsinghua.edu.cn; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022	Fan, Shilong/0000-0001-9272-2438	National Natural Science Foundation of China [81530065, 81661128042, 31470751, U1405228]; Ministry of Science and Technology of the People's Republic of China [2016YFD0500307, 2012ZX10001-004, 2012ZX10001-006, 2012ZX10001-009, 2017ZX10201-101, 2014CB542500-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 81530065, 81661128042, 31470751, and U1405228 and by Ministry of Science and Technology of the People's Republic of China Grants 2016YFD0500307, 2012ZX10001-004, 2012ZX10001-006, 2012ZX10001-009, 2017ZX10201-101, and 2014CB542500-03. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira HL, 2010, AVIAN DIS, V54, P565, DOI 10.1637/8750-033009-ResNote.1; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Gronsang D, 2017, ARCH VIROL, V162, P2257, DOI 10.1007/s00705-017-3350-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; He F., 2013, INFLUENZA RES TREAT, V2013, P1; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004192; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohkura T, 2012, BIOCHEM BIOPH RES CO, V418, P38, DOI 10.1016/j.bbrc.2011.12.108; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perdue ML, 1997, VIRUS RES, V49, P173, DOI 10.1016/S0168-1702(97)01468-8; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Prabakaran M, 2010, J VIROL, V84, P11822, DOI 10.1128/JVI.00891-10; Prabhu N, 2009, ANTIVIR THER, V14, P911, DOI 10.3851/IMP1413; Qian MR, 2013, J VIROL, V87, P3571, DOI 10.1128/JVI.01292-12; Rudneva IA, 2010, VIRAL IMMUNOL, V23, P181, DOI 10.1089/vim.2009.0086; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Simmons CP, 2007, FUTURE VIROL, V2, P325, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Tan YR, 2015, J VIROL, V89, P3712, DOI 10.1128/JVI.03014-14; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tian HY, 2015, P NATL ACAD SCI USA, V112, P172, DOI 10.1073/pnas.1405216112; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Velkov T, 2013, MOL IMMUNOL, V56, P705, DOI 10.1016/j.molimm.2013.07.010; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; Webster RG, 2005, ARCH VIROL, P117; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Winarski KL, 2015, P NATL ACAD SCI USA, V112, P9346, DOI 10.1073/pnas.1502762112; Wu RP, 2014, ANTIVIR RES, V106, P13, DOI 10.1016/j.antiviral.2014.03.005; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855	70	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16503	16517		10.1074/jbc.RA118.004604	http://dx.doi.org/10.1074/jbc.RA118.004604			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30154240	Green Published, hybrid			2022-12-26	WOS:000447833600031
J	Kumaraswamy, A; Mamidi, A; Desai, P; Sivagnanam, A; Perumalsamy, LR; Ramakrishnan, C; Gromiha, M; Rajalingam, K; Mahalingam, S				Kumaraswamy, Anbarasu; Mamidi, Anitha; Desai, Pavitra; Sivagnanam, Ananthi; Perumalsamy, Lakshmi Revathi; Ramakrishnan, Chandrasekaran; Gromiha, Michael; Rajalingam, Krishnaraj; Mahalingam, Sundarasamy			The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras protein; Myc (c-Myc); tumor cell biology; tumor suppressor gene; ubiquitination (ubiquitination); cell-penetrating peptide (CPP); cell cycle; cell proliferation; cancer; transcription factor; colony forming assay; MAX; Peptide inhibitor; Ras effectors; RASSF7	FREE-ENERGY CALCULATIONS; MOLECULAR-MECHANICS; PHOSPHOLIPASE A(2); UBIQUITIN LIGASE; CONTINUUM MODELS; LEUCINE-ZIPPER; FORCE-FIELDS; CELL-DEATH; PROTEIN; CANCER	c-Myc is a proto-oncogene controlling expression of multiple genes involved in cell growth and differentiation. Although the functional role of c-Myc as a transcriptional regulator has been intensively studied, targeting this protein in cancer remains a challenge. Here, we report a trimodal regulation of c-Myc function by the Ras effector, Ras-association domain family member 7 (RASSF7), a nonenzymatic protein modulating protein-protein interactions to regulate cell proliferation. Using HEK293T and HeLa cell lines, we provide evidence that RASSF7 destabilizes the c-Myc protein by promoting Cullin4B-mediated polyubiquitination and degradation. Furthermore, RASSF7 competed with MYC-associated factor X (MAX) in the formation of a heterodimeric complex with c-Myc and attenuated its occupancy on target gene promoters to regulate transcription. Consequently, RASSF7 inhibited c-Myc-mediated oncogenic transformation, and an inverse correlation between the expression levels of the RASSF7 and c-Myc genes was evident in human cancers. Furthermore, we found that RASSF7 interacts with c-Myc via its RA and leucine zipper (LZ) domains and LZ domain peptide is sufficient to inhibit c-Myc function, suggesting that this peptide might be used to target oncogenic c-Myc. These results unveil that RASSF7 and c-Myc are functionally linked in the control of tumorigenesis and open up potential therapeutic avenues for targeting the undruggable c-Myc protein in a subset of human cancers.	[Kumaraswamy, Anbarasu; Mamidi, Anitha; Desai, Pavitra; Sivagnanam, Ananthi; Perumalsamy, Lakshmi Revathi; Mahalingam, Sundarasamy] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Natl Canc Tissue Biobank,Lab Mol Cell Biol, Madras 600036, Tamil Nadu, India; [Ramakrishnan, Chandrasekaran; Gromiha, Michael] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Prot Bioinformat Lab, Madras 600036, Tamil Nadu, India; [Rajalingam, Krishnaraj] Univ Med Ctr Mainz, Inst Immunol, MSU FZI, JGU, D-55131 Mainz, Germany	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mahalingam, S (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Lab Mol Cell Biol, Rm 403, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in	Chandrasekaran, Ramakrishnan/AAP-6328-2021; Kumaraswamy, Anbarasu/Q-2208-2019; Gromiha, Michael/H-8493-2019	Kumaraswamy, Anbarasu/0000-0002-9997-7430; Chandrasekaran, Ramakrishnan/0000-0003-4622-2496; Sivagnanam, Ananthi/0000-0002-4777-587X	Department of Science and Technology from the Government of India [VI-D&P/411/2012-2013/TDT (G)]	Department of Science and Technology from the Government of India	This work was supported by Department of Science and Technology Grant VI-D&P/411/2012-2013/TDT (G) from the Government of India (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Bidwell GL, 2009, EXPERT OPIN DRUG DEL, V6, P1033, DOI 10.1517/17425240903143745; Bidwell GL, 2005, MOL CANCER THER, V4, P1076, DOI 10.1158/1535-7163.MCT-04-0253; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Camarda R, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00035; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; Datta D, 2015, J BIOL CHEM, V290, P21536, DOI 10.1074/jbc.M115.637280; Djos A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-40; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ehrkamp Anja, 2013, Cancers (Basel), V5, P639, DOI 10.3390/cancers5020639; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gade P, 2012, METHODS MOL BIOL, V809, P85, DOI 10.1007/978-1-61779-376-9_6; Gulsen T, 2016, DEV BIOL, V409, P502, DOI 10.1016/j.ydbio.2015.11.001; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hutter S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040107; Jiang H, 2009, MOL PHARMACOL, V76, P491, DOI 10.1124/mol.109.054858; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Karthik IP, 2018, J BIOL CHEM, V293, P5624, DOI 10.1074/jbc.RA117.000623; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MOSHIER JA, 1993, CANCER RES, V53, P2618; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Patra SK, 2008, EXP CELL RES, V314, P1193, DOI 10.1016/j.yexcr.2008.01.012; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Ramakrishnan C, 2010, J PHYS CHEM B, V114, P13463, DOI 10.1021/jp102073f; Ramakrishnan C, 2014, CHEM BIOL DRUG DES, V84, P379, DOI 10.1111/cbdd.12332; Recino A, 2010, BIOCHEM J, V430, P207, DOI 10.1042/BJ20100883; Sabnis HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040114; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Shin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14269; Shinawi T, 2012, EPIGENETICS-US, V7, P211, DOI 10.4161/epi.7.3.19222; Suryaraja R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.91; Takahashi S, 2011, CELL DEATH DIFFER, V18, P645, DOI 10.1038/cdd.2010.137; Thoompumkal IJ, 2016, CELL CYCLE, V15, P3251, DOI 10.1080/15384101.2016.1242534; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Vos MD, 2006, METHOD ENZYMOL, V407, P311, DOI 10.1016/S0076-6879(05)07026-6; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang JM, 2006, CURR COMPUT-AID DRUG, V2, P287, DOI 10.2174/157340906778226454; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Young S. Y., 2003, MOL CELL, V11, P1177, DOI [10.1016/S1097-2765(03)00173-4, DOI 10.1016/S1097-2765(03)00173-4]; Zenonos K, 2013, WORLD J GASTRO ONCOL, V5, P97, DOI 10.4251/wjgo.v5.i5.97	58	6	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15691	15705		10.1074/jbc.RA118.004452	http://dx.doi.org/10.1074/jbc.RA118.004452			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139745	Green Published, hybrid			2022-12-26	WOS:000446549200031
J	Eriksen, A; Wabakken, P; Maartmann, E; Zimmermann, B				Eriksen, Ane; Wabakken, Petter; Maartmann, Erling; Zimmermann, Barbara			Den site selection by male brown bears at the population's expansion front	PLOS ONE			English	Article							URSUS-ARCTOS; HABITAT; RANGE; SEX; SCANDINAVIA; PERIPHERY; MOVEMENTS; PREDATION; NORTHERN; BEHAVIOR	Brown bears (Ursus arctos) spend about half of the year in winter dens. In order to preserve energy, bears may select denning locations that minimize temperature loss and human disturbance. In expanding animal populations, demographic structure and individual behavior at the expansion front can differ from core areas. We conducted a non-invasive study of male brown bear den sites at the male-biased, low-density western expansion front of the Scandinavian brown bear population, comparing den locations to the available habitat. Compared to the higher-density population core in which intraspecific avoidance may affect den site selection of subordinate bears, we expected resource competition in the periphery to be low, and all bears to be able to select optimal den sites. In addition, bears in the periphery had access to free-ranging domestic sheep during summer. We found that males in the periphery denned on high-elevation slopes, probably providing good drainage, longer periods of consistent, insulating snow cover and fewer melting-freezing events. Forests were the principal denning habitat and no dens were found in alpine areas. The Scandinavian brown bears have a history of intense harvest, including culling at the den. This may have exerted a selection pressure to avoid denning in open alpine habitat which compared to forests provide little cover. The bears denned away from main roads and in steep, rugged terrain, probably limiting human access. The odds for finding a bear den decreased with increasing distance to the population core where females could be found. Previous studies have documented directed movement of male brown bears from the male-biased population periphery toward the core areas during the mating season. In this way, denning males may be trading off between low resource competition and access to sheep in the low-density periphery, and mating opportunities in the higher-density population core.	[Eriksen, Ane; Wabakken, Petter; Maartmann, Erling; Zimmermann, Barbara] Inland Norway Univ Appl Sci, Dept Forestry & Wildlife Management, Evenstad, Norway	Inland Norway University of Applied Sciences	Eriksen, A (corresponding author), Inland Norway Univ Appl Sci, Dept Forestry & Wildlife Management, Evenstad, Norway.	ane.eriksen@inn.no	Eriksen, Ane/H-2773-2013; Zimmermann, Barbara/AAA-2631-2019	Eriksen, Ane/0000-0002-9073-8812; Zimmermann, Barbara/0000-0001-5133-9379	Hedmark; Norwegian Environment Agency; Inland Norway (INN) University of Applied Sciences; INN University	Hedmark; Norwegian Environment Agency; Inland Norway (INN) University of Applied Sciences; INN University	The study was funded by the County Governor of Hedmark (www.fylkesmannen.no/en/Hedmark/) to PW. DNA analyses were financed and made publicly available by the Norwegian Environment Agency (http://www.miljodirektoratet.no) to PW. Further financial support was provided by Inland Norway (INN) University of Applied Sciences (www.inn.no) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Norwegian Nature Inspectorate (SNO) for assistance with field work, to everybody who reported bear tracks and dens throughout the study period, and to Juuli Vanni for useful discussions. The study was funded by the County Governor of Hedmark. DNA analyses were performed by the Norwegian Institute of Bioeconomy (NIBIO), and financed and made publicly available by the Norwegian Environment Agency. Further financial support was provided by INN University.	Aames SG, 2016, 56 NORSK I BIOOK NIB; [Anonymous], 2021, LANG ENV STAT COMP; Bischof R, 2016, CONSERV LETT, V9, P122, DOI 10.1111/conl.12183; Blanchard B.M., 1987, BEARS THEIR BIOL MAN, V7, P99, DOI [10.2307/3872615, DOI 10.2307/3872615]; Blix AS, 2016, J EXP BIOL, V219, P1093, DOI 10.1242/jeb.120477; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; BREITENMOSER U, 1993, J WILDLIFE MANAGE, V57, P135, DOI 10.2307/3809010; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; CRAIGHEAD F C JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P84; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Dahle B, 2013, WILDLIFE BIOL, V19, P165, DOI 10.2981/10-113; Delgado MM, 2014, PLOS ONE, V9, P8; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eiken HG, 2009, FORENS SCI INT-GEN S, V2, P273, DOI 10.1016/j.fsigss.2009.07.007; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Elfstrom M, 2009, URSUS, V20, P85, DOI 10.2192/09GR005.1; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Evans AL, 2016, ECOPHYSIOLOGY BROWN; EVANS AL, 2012, PLOS ONE, V7, P8; Fox J., 2019, R COMPANION APPL REG, V.; Friebe A, 2001, URSUS-SERIES, V12, P37; Goldstein MI, 2010, J WILDLIFE MANAGE, V74, P35, DOI 10.2193/2008-490; Groff C, 1998, URSUS-SERIES, V10, P275; Henriksen S., 2015, NORSK RODLISTE ARTER; HUBER D, 1993, ACTA THERIOL, V38, P151, DOI 10.4098/AT.arch.93-13; Hudina S, 2015, BIOL INVASIONS, V17, P3101, DOI 10.1007/s10530-015-0936-x; Jerina K, 2008, J MAMMAL, V89, P1491, DOI 10.1644/07-MAMM-A-357.1; Jerina K, 2013, EUR J WILDLIFE RES, V59, P459, DOI 10.1007/s10344-013-0690-2; Johnsen K, 2018, ANN ZOOL FENN, V55, P173, DOI 10.5735/086.055.0604; Johnsen K, 2017, ECOL EVOL, V7, P115, DOI 10.1002/ece3.2635; Kojola L, 2003, URSUS-SERIES, V14, P17; Krofel M, 2010, URSUS, V21, P23, DOI 10.2192/09SC015.1; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Manel S, 2004, MOL ECOL, V13, P1327, DOI 10.1111/j.1365-294X.2004.02074.x; Manly BFL., 2007, RESOURCE SELECTION A; Matson G., 1993, LAB MANUAL CEMENTUM; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Mikle N, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1467; Nicholson KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150333; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Petram W, 2004, BIOL CONSERV, V119, P129, DOI 10.1016/j.biocon.2003.07.021; Pigeon KE, 2016, J WILDLIFE MANAGE, V80, P884, DOI 10.1002/jwmg.1069; PULLIAINEN ERKKI, 1965, ANN ZOOL FENNICI, V2, P215; Raby CR, 2009, BEHAV PROCESS, V80, P314, DOI 10.1016/j.beproc.2008.12.005; ROGERS L, 1981, NAT HIST, V90, P64; Rovbase, ROVB; RStudio Team, 2012, INTEGRATED DEV R; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Sahlen E, 2011, URSUS, V22, P152, DOI 10.2192/URSUS-D-10-00007.1; Sahlen V, 2006, SKANDINAVISKA BJORNP, V2006-4, P43; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; Schregel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180701; Sheriff MJ, 2009, J MAMMAL, V90, P761, DOI 10.1644/08-MAMM-A-247R.1; SOBYE E, 2014, HEIMEN, V51, P3; Stenset NE, 2016, WILDLIFE BIOL, V22, P107, DOI 10.2981/wlb.00194; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Storaas T, 2005, PROJECT MOOSE TRAFFI; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; SWENSON JE, 1994, BIOL CONSERV, V70, P9, DOI 10.1016/0006-3207(94)90293-3; Swenson JE, 2001, BROWN BEAR PREDATION; Swenson JE, 1996, UTREDNING FORETATT I; Swenson JE, 2007, OECOLOGIA, V153, P37, DOI 10.1007/s00442-007-0715-1; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Swenson Jon E., 1994, NINA Forskningsrapport, V53, P1; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Taranger A, 1915, NON TRADITIONAL REF, pVIII; Wabakken P, 1994, SLUTTRAPPORT SAUPROS; Wabakken P, 1992, SVENSK NORSKE BJORNE	74	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202653	10.1371/journal.pone.0202653	http://dx.doi.org/10.1371/journal.pone.0202653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161161	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900035
J	Maskew, M; Jamieson, L; Mohomi, G; Long, L; Mongwenyana, C; Nyoni, C; Mokaba, D; Fox, MP; Sanne, I; Rosen, S				Maskew, Mhairi; Jamieson, Lise; Mohomi, Given; Long, Lawrence; Mongwenyana, Constance; Nyoni, Cynthia; Mokaba, Dorah; Fox, Matthew P.; Sanne, Ian; Rosen, Sydney			Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care	PLOS ONE			English	Article							JOHANNESBURG; THERAPY	Introduction Initiating and retaining pregnant women on antiretroviral therapy (ART) to prevent motherto-child HIV transmission (PMTCT) remains a major challenge facing African HIV programs, particularly during the critical final months prior to delivery. In 2013, South Africa implemented its "Option B" PMTCT regimen (three-drug ART throughout pregnancy and breastfeeding, regardless of maternal CD4 count) and introduced once-daily fixed-dose combinations and lifelong ART. Currently, the uptake of Option B and its possible impact on adherence to PMTCT during the critical final months of pregnancy is unclear. Materials and methods We prospectively collected visit data from a cohort of adult, HIV-infected, pregnant women between July 2013-August 2014 to estimate three models of adherence to PMTCT during the final 16 weeks immediately preceding delivery. Adherence was defined according to possession of antiretroviral drugs, which was inferred from clinic visit records under varying assumptions in each model. We describe uptake of the PMTCT regimen, gestational age at initiation, and model possible scenarios of adherence through delivery after the implementation of Option B. Results Among 138 women enrolled (median (IQR) age 28 years (24-32), median CD4 count 378 cells/mm(3)), median (IQR) gestational age at initiation was 22 weeks (16-26). Estimates of adherence during the final 16 weeks of pregnancy prior to delivery ranged from 75% (52-89%) under the best case scenario assumptions to 52% (30-75%) under the worst case scenario assumptions. Estimates of the proportion of women who would achieve 80% adherence to PMTCT were <50% across all models. Conclusions Despite the switch to Option B and once-daily dosing, South African women continue to initiate PMTCT late in pregnancy, and estimations of regimen adherence, as modelled using PMTCT visit attendance data, is poor, with <50% of women reaching 80% adherence during final months of pregnancy across all models. Further guideline changes and interventions are needed to achieve vertical transmission goals.	[Maskew, Mhairi; Jamieson, Lise; Mohomi, Given; Long, Lawrence; Mongwenyana, Constance; Nyoni, Cynthia; Fox, Matthew P.; Sanne, Ian; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Long, Lawrence; Sanne, Ian; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Mokaba, Dorah] City Johannesburg, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA	University of Witwatersrand; Boston University; Boston University	Maskew, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	mmaskew@heroza.org	Sanne, Ian/ABH-2231-2020; Fox, Matthew/K-2004-2019	Long, Lawrence/0000-0003-4986-4988; MASKEW, MHAIRI/0000-0003-4238-0200	President's Emergency Program For AIDS Relief; NIH Office of AIDS Research, through NIH from the National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI100015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100015] Funding Source: NIH RePORTER	President's Emergency Program For AIDS Relief; NIH Office of AIDS Research, through NIH from the National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the President's Emergency Program For AIDS Relief and the NIH Office of AIDS Research, through NIH grant number U01 AI100015 to Boston University, from the National Institute of Allergy and Infectious Diseases (NIAID). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clouse K, 2017, J ACQUIR IMMUNE DEFI, V74; Clouse K, 2013, TROP MED INT HEAL, V18; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Genberg B, 2011, 6 INT C HIV TREATM P; Goga AE, 2016, AIDS 2016; Goga AE, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020405; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Henegar CE, 2015, AIDS BEHAV, V19, P612, DOI 10.1007/s10461-014-0953-2; Hoenigl M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32947; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Leach-lemens C, 2016, AIDS MAP, P2; McMahon SA, 2016, AIDS BEHAV, P1; Myer L, 2016, HIV MED, P1; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health (South Africa), 2014, NAT CONS GUID PREV M; Nkomo P, 2015, S AFR J HIV MED, V16, P100, DOI 10.4102/sajhivmed.v16i1.386; PEPFAR, 2003, PEPFAR DASHB; Rustagi AS, 2016, INT J STD AIDS; Schnippel K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0778-2; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Woelk GB, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20837	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201955	10.1371/journal.pone.0201955	http://dx.doi.org/10.1371/journal.pone.0201955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161147	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900018
J	Dalrymple, KA; Wall, N; Spezio, M; Hazlett, HC; Piven, J; Elison, JT				Dalrymple, Kirsten A.; Wall, Natalie; Spezio, Michael; Hazlett, Heather C.; Piven, Joseph; Elison, Jed T.			Rapid face orienting in infants and school-age children with and without autism: Exploring measurement invariance in eye-tracking	PLOS ONE			English	Article							SPECTRUM DISORDER; INDIVIDUALS; RECOGNITION; INFORMATION; ATTENTION; STIMULI; BUBBLES	Questions concerning the ontogenetic stability of autism have recently received increased attention as long-term longitudinal studies have appeared in the literature. Most experimental measures are designed for specific ages and functioning levels, yet developing experimental tasks appropriate for a wide range of ages and functioning levels is critical for future long-term longitudinal studies, and treatment studies implemented at different ages. Accordingly, we designed an eye-tracking task to measure preferential orienting to facial features and implemented it with groups of participants with varying levels of functioning: infants, and school-age children with and without autism. All groups fixated eyes first, revealing an early and stable orienting bias. This indicates common bias towards the eyes across participants regardless of age or diagnosis. We also demonstrate that this eye-tracking task can be used with diverse populations who range in age and cognitive functioning. Our developmental approach has conceptual implications for future work focused on task development and particularly new experimental measures that offer measurement equivalence across broad age ranges, intellectual functioning and verbal abilities.	[Dalrymple, Kirsten A.; Wall, Natalie; Elison, Jed T.] Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA; [Spezio, Michael] Scripps Coll, Psychol & Neurosci, Claremont, CA 91711 USA; [Spezio, Michael] Eppendorf, Univ Med Ctr, Inst Syst Neurosci, Hamburg, Germany; [Hazlett, Heather C.; Piven, Joseph] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27515 USA	University of Minnesota System; University of Minnesota Twin Cities; Claremont Colleges; Scripps College; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of North Carolina; University of North Carolina Chapel Hill	Dalrymple, KA (corresponding author), Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA.	kad@umn.edu		Dalrymple, Kirsten/0000-0001-8772-7787	National Institute of Mental Health [NIMH RO1 MH104324]; National Institute of Child Health and Human Development [NICHD P30 HD03110]; Autism Speaks [2099]; Canadian Institutes of Health Research [201211BPF-295776-233239]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Autism Speaks; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by a National Institute of Mental Health (www.nimh.nih.gov) award to JTE (NIMH RO1 MH104324), a National Institute of Child Health and Human Development (www.nichd.nih.gov) award to JP (NICHD P30 HD03110), an Autism Speaks (act.autismspeaks.org) award to HCH (award number 2099), and a Banting Postdoctoral Fellowship through the Canadian Institutes of Health Research (banting.fellowships-bourses.gc.ca) to KAD (201211BPF-295776-233239).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR BIOL, V18, P1090, DOI 10.1016/j.cub.2008.06.073; Anderson DK, 2014, J CHILD PSYCHOL PSYC, V55, P485, DOI 10.1111/jcpp.12178; Canfield RL, 1997, MONOGRAPHS SOC RES C, pi; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; Duku E, 2013, J CHILD PSYCHOL PSYC, V54, P1346, DOI 10.1111/jcpp.12103; Falck-Ytter T, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-28; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Flanagan HE, 2015, J AUTISM DEV DISORD, V45, P2691, DOI 10.1007/s10803-015-2433-6; Georgiades S, 2014, J AUTISM DEV DISORD, V44, P3045, DOI 10.1007/s10803-014-2167-x; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Guillon Q, 2014, NEUROSCI BIOBEHAV R, V42, P279, DOI 10.1016/j.neubiorev.2014.03.013; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Humphreys K, 2006, INFANT BEHAV DEV, V29, P471, DOI 10.1016/j.infbeh.2006.02.002; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; LANGDELL T, 1978, J CHILD PSYCHOL PSYC, V19, P255, DOI 10.1111/j.1469-7610.1978.tb00468.x; Levy J, 2012, BIOL LETT; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2015, AMERICAN J MEDICAL G; Lundqvist D., 1998, KAROLINSKA DIRECTED; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Rice K, 2012, J AM ACAD CHILD PSY, V51, P238, DOI 10.1016/j.jaac.2011.12.017; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Shah P, 2013, CURR BIOL, V23, pR1087, DOI 10.1016/j.cub.2013.10.034; Shic F, 2008, P 2009 S EYE TRACK R; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Szatmari P, 2015, JAMA PSYCHIAT, V72, P276, DOI 10.1001/jamapsychiatry.2014.2463; Wass SV, 2014, INFANCY, V19, P427, DOI 10.1111/infa.12055	34	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202875	10.1371/journal.pone.0202875	http://dx.doi.org/10.1371/journal.pone.0202875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153278	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700029
J	Park, S; Kang, J; Choi, S; Park, H; Hwang, E; Kang, Y; Kim, A; Holzapfel, W; Ji, Y				Park, Soyoung; Kang, Jihee; Choi, Sanghaeng; Park, Haryung; Hwang, Eunchong; Kang, Yoongu; Kim, Aram; Holzapfel, Wilhelm; Ji, Yosep			Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PROBIOTICS; DIET; MILK; MODULATION	Thanks to recent scientific progress a relationship between the intestinal microbiota and metabolic diseases could be established. A deeper understanding of underlying mechanisms has opened ways towards new approaches for alleviating conditions associated with metabolic diseases. Dysbiosis appears to be a major underlying factor associated with metabolic syndrome and related adverse health conditions. A major focus has therefore shifted to controlling of the gut microbiota through administration of functional lactic acid bacteria (LAB). The scope for health promotion and/or support by probiotics such as LAB has thereby been widened beyond the improving of intestinal health, also to include anti-obesity, anti-diabetic and cholesterol-lowering effects. In this study we investigated the cholesterol-lowering and microbiota modulatory potential of a LAB strain, Lactobacillus rhamnosus BFE5264, isolated from Maasai fermented milk. A mouse model receiving a high-cholesterol diet served as model for evaluating its functionality. The administration of L. rhamnosus BFE5264 resulted in a significant reduction of the serum cholesterol level that was accompanied by changes in intestinal microbiota and the production of short chain fatty acid (SCFA) in comparison to the control group. This strain also beneficially influenced the regulation of cholesterol metabolism in the liver in a pattern similar to that resulting from statin treatment, a drug inhibiting cholesterol biosynthesis in the liver.	[Park, Soyoung; Park, Haryung; Hwang, Eunchong; Holzapfel, Wilhelm; Ji, Yosep] Handong Global Univ, Adv Green Energy & Environm, Pohang, Gyungbuk, South Korea; [Kang, Jihee; Choi, Sanghaeng] AtoGen Co Ltd, Daejeon, South Korea; [Kang, Yoongu; Kim, Aram] Handong Global Univ, Life Sci, Pohang, Gyungbuk, South Korea	Handong Global University; Handong Global University	Ji, Y (corresponding author), Handong Global Univ, Adv Green Energy & Environm, Pohang, Gyungbuk, South Korea.	jiyosep@gmail.com	Park, Grace/U-1673-2018		Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [916001-2]; AtoGen Co. Ltd.	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; AtoGen Co. Ltd.	Funding for this work was provided by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (as part of the (multi-ministerial) Genome Technology to Business Translation Program). The grant number is 916001-2. The funder (AtoGen Co. Ltd.) provided support in the form of salaries for authors [JK, SC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Funding for this work was provided by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (as part of the (multi-ministerial) Genome Technology to Business Translation Program). The grant number is 916001-2.	Anandaraja S, 2005, INT J CARDIOL, V102, P117, DOI 10.1016/j.ijcard.2004.05.009; Arora T, 2016, J INTERN MED, V280, P339, DOI 10.1111/joim.12508; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Bueld JE, 1996, PHARMACOL TOXICOL, V78, P229, DOI 10.1111/j.1600-0773.1996.tb00210.x; Butel MJ, 2014, MED MALADIES INFECT, V44, P1, DOI 10.1016/j.medmal.2013.10.002; Cammarota G, 2014, INTERN EMERG MED, V9, P365, DOI 10.1007/s11739-014-1069-4; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; DEMIGNE C, 1995, BRIT J NUTR, V74, P209, DOI 10.1079/BJN19950124; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; EICHHOLZER M, 1993, INT J VITAM NUTR RES, V63, P159; Hippe B, 2015, SCFA PRODUCING GUT M, P181; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MANN GV, 1974, AM J CLIN NUTR, V27, P464, DOI 10.1093/ajcn/27.5.464; Mathara JM, 2008, INT J FOOD MICROBIOL, V126, P57, DOI 10.1016/j.ijfoodmicro.2008.04.027; MORA S, 2015, FASEB J S1, V29; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; Patrignani F, 2006, INT J FOOD MICROBIOL, V107, P1, DOI 10.1016/j.ijfoodmicro.2005.08.004; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Weitkunat K, 2016, MOL NUTR FOOD RES, V60, P2611, DOI 10.1002/mnfr.201600305; Yoon HS, 2013, J SCI FOOD AGR, V93, P781, DOI 10.1002/jsfa.5797; Yoon HS, 2011, PROBIOTICS ANTIMICRO, V3, P194, DOI 10.1007/s12602-011-9086-3	28	36	38	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203150	10.1371/journal.pone.0203150	http://dx.doi.org/10.1371/journal.pone.0203150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153290	gold, Green Submitted, Green Published			2022-12-26	WOS:000443001700048
J	Ross, A; Wu, J; Carlock, C; Glass, W; Lou, YH				Ross, April; Wu, Jean; Carlock, Colin; Glass, William, II; Lou, Ya-Huan			Inter-molecular epitope spreading does not lead to extension of autoimmunity beyond target tissue in autoimmune glomerulonephritis	PLOS ONE			English	Article							T-CELL EPITOPE; PEPTIDE; ANTIGEN; ANTIBODY; DISEASE; AUTOANTIBODIES; IDENTIFICATION; MECHANISM; CHAIN; RATS	Inter-molecular epitope spreading during autoimmune pathogenesis leads to generation of new pathogenic epitopes on other autoantigens beyond the original one. It raises an important question as whether autoimmunity extends beyond the target tissues if new epitopes are on the molecules shared with other tissues. This study is aimed addressing this question in a rat anti-glomerular basement membrane (GBM) glomerulonephritis model induced by a T cell epitope of glomerulus-specific collagen4 alpha 3. We have demonstrated inter-molecular B cell epitope spreading. Four novel epitopes were first identified by screening a phage display random peptide library against autoantibodies isolated from the GBM of immunized rats. All four epitopes were derived from GBM proteins with three from laminins and one from collagen4 alpha 4. Three out of four synthetic peptides were nephritogenic. Importantly, two peptides from lamininal and laminin beta 1, respectively, induced severe inflammation in glomeruli but not in the interstitial tissues, despite the presence of more abundant laminins in the tubular basement membranes. Our study suggests that surrounding tissues may display a lower or altered susceptibility to autoimmune inflammation. Thus, preventing extension of autoimmune inflammation beyond the original target tissue.	[Ross, April; Wu, Jean; Carlock, Colin; Lou, Ya-Huan] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost Sci, Houston, TX 77030 USA; [Glass, William, II] Univ Texas Hlth Sci Ctr Houston, McGoven Med Sch, Dept Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Lou, YH (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost Sci, Houston, TX 77030 USA.	Yahuan.Lou@uth.tmc.EDU			National Institute of Diabetes and Digestive and Kidney Diseases - NIH [R01-DK60029, R01-DK077857, R01-DK077857S4]	National Institute of Diabetes and Digestive and Kidney Diseases - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases - NIH (https://www.niddk.nih.gov/) R01-DK60029 YLOU, R01-DK077857 YLOU, NIH supplement R01-DK077857S4 AROSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; Bolton WK, 2005, J AM SOC NEPHROL, V16, P2657, DOI 10.1681/ASN.2004100823; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265, DOI 10.4049/jimmunol.166.8.5265; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; Chen LL, 2006, J AM SOC NEPHROL, V17, P3076, DOI 10.1681/ASN.2006070688; Deshmukh US, 2005, CLIN IMMUNOL, V117, P112, DOI 10.1016/j.clim.2005.07.002; Dromey JA, 2004, J IMMUNOL, V172, P4084, DOI 10.4049/jimmunol.172.7.4084; Gianani R, 1996, P NATL ACAD SCI USA, V93, P2257, DOI 10.1073/pnas.93.6.2257; Gordon FL, 2001, J NEUROIMMUNOL, V112, P15, DOI 10.1016/S0165-5728(00)00341-6; HUDSON BG, 1989, LAB INVEST, V61, P256; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lou YH, 1996, J IMMUNOL, V156, P3535; LOU YH, 1995, J IMMUNOL, V155, P3667; LOU YH, 1993, J IMMUNOL, V151, P5790; Mamula MJ, 1998, IMMUNOL REV, V164, P231, DOI 10.1111/j.1600-065X.1998.tb01223.x; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Ooi JD, 2013, J AM SOC NEPHROL, V24, P419, DOI 10.1681/ASN.2012070705; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Putcha BDK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129216; RHIM SH, 1992, J CLIN INVEST, V89, P28, DOI 10.1172/JCI115572; Robertson J, 2005, J AM SOC NEPHROL, V16, P3256, DOI 10.1681/ASN.2005040421; Robertson J, 2005, KIDNEY INT, V68, P1061, DOI 10.1111/j.1523-1755.2005.00498.x; SERCARZ EE, 1994, CURR OPIN IMMUNOL, V6, P875, DOI 10.1016/0952-7915(94)90007-8; SUGISAKI T, 1980, CLIN IMMUNOL IMMUNOP, V15, P33, DOI 10.1016/0090-1229(80)90018-5; Talken BL, 2001, J IMMUNOL, V167, P562, DOI 10.4049/jimmunol.167.1.562; WILSON CB, 1974, ANNU REV MED, V25, P83, DOI 10.1146/annurev.me.25.020174.000503; Wu J, 2004, J IMMUNOL, V172, P4567, DOI 10.4049/jimmunol.172.7.4567; Wu J, 2003, KIDNEY INT, V64, P1292, DOI 10.1046/j.1523-1755.2003.00227.x; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; Wu J, 2001, J IMMUNOL, V167, P2388, DOI 10.4049/jimmunol.167.4.2388; Zhou C, 2010, AM J NEPHROL, V32, P324, DOI 10.1159/000319490	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202988	10.1371/journal.pone.0202988	http://dx.doi.org/10.1371/journal.pone.0202988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153280	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700035
J	Cao, JMD; Prieto, A; Lopez, G; Fernandez-Antonio, R; Diaz, P; Lopez, C; Remesar, S; Diez-Banos, P; Fernandez, G				Diaz Cao, Jose Manuel; Prieto, Alberto; Lopez, Gonzalo; Fernandez-Antonio, Ricardo; Diaz, Pablo; Lopez, Ceferino; Remesar, Susana; Diez-Banos, Pablo; Fernandez, Gonzalo			Molecular assessment of visitor personal protective equipment contamination with the Aleutian mink disease virus and porcine circovirus-2 in mink and porcine farms	PLOS ONE			English	Article							BIOSECURITY MEASURES; PIG HERDS; FOMITES; TYPE-2; DISINFECTANTS; TRANSMISSION; RECOVERY; EFFICACY; SPAIN	Personal protective equipment (PPE) is an element of biosecurity intended to prevent the access or spread of diseases in farms. Nevertheless, to date no extensive reports exist about the effectiveness of different available PPE on farms. Thus, our aim was to estimate the degree of protection of PPE from viral contamination during farm visits. Two farms, infected with Aleutian mink disease virus and porcine circovirus-2 respectively, were visited by six visitors wearing different combinations of PPE: coveralls with hood and bootcovers, both with a certified barrier to infective agents (certified PPE group) and non-certified bootcover and coverall without hood (non-certified PPE group). Seventy-two swab samples from PPE and both hair and street clothes under PPE were taken after the visit and analysed by qPCR. Our results reveal viral exposure during visits, and the external protections of body and shoes were contaminated in all cases (24/24). In addition, protection from viral contamination varied noticeably according to the biosecurity elements used. A higher number of positives were detected in the non-certified PPE group than in the certified PPE group, both in elements under external protections (14/18 vs 3/18) and also in hair (4/6 vs 0/6). In fact, non-certified bootcovers broke during visits, resulting in viral contamination of the internal elements under them; these are consequently not suitable for using with wrinkled surfaces usually found in farm facilities. Thus, certified coveralls should be used in order to prevent contaminations, and workers and personnel of farms should be trained in their proper use. qPCR is a useful tool in the risk management of biosecurity programmes, and our results may serve as a model to evaluate different biosecurity measures.	[Diaz Cao, Jose Manuel; Prieto, Alberto; Lopez, Gonzalo; Fernandez-Antonio, Ricardo; Diaz, Pablo; Lopez, Ceferino; Remesar, Susana; Diez-Banos, Pablo; Fernandez, Gonzalo] Univ Santiago de Compostela, Fac Vet Sci, INVESAGA Grp, Dept Anim Pathol, Lugo, Spain; [Fernandez-Antonio, Ricardo] Galician Assoc Mink Breeders AGAVI, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Prieto, A (corresponding author), Univ Santiago de Compostela, Fac Vet Sci, INVESAGA Grp, Dept Anim Pathol, Lugo, Spain.	alberto.prieto@usc.es	Fernández, Pablo Díaz/J-8631-2012; Remesar, Susana/T-8577-2018; Cao, Jose Manuel Diaz/L-9217-2014; Sández, Ceferino M. López/A-6269-2010; Baños, Pablo Díez/E-1467-2012; fernandez, gonzalo/I-1644-2015	Fernández, Pablo Díaz/0000-0003-2445-1095; Remesar, Susana/0000-0002-8071-3806; Cao, Jose Manuel Diaz/0000-0002-8119-7057; Sández, Ceferino M. López/0000-0002-9151-3180; Baños, Pablo Díez/0000-0002-5236-5680; fernandez, gonzalo/0000-0002-7902-2995; Fernandez Antonio, Ricardo/0000-0002-3934-9061; Lopez Lorenzo, Gonzalo/0000-0001-8047-0413	program Consolidacio y Estructuracion de Grupos de Referencia Competitiva [GRC2015/003]	program Consolidacio y Estructuracion de Grupos de Referencia Competitiva	This work was funded by the program Consolidacio y Estructuracion de Grupos de Referencia Competitiva (GRC2015/003, Xunta de Galicia, Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allepuz A, 2007, VET REC, V160, P398, DOI 10.1136/vr.160.12.398; Allerson MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067293; [Anonymous], 2016, SUGG PRIOR RES HOR 2; Barrington GM, 2002, VET CLIN N AM-FOOD A, V18, P7, DOI 10.1016/S0749-0720(02)00005-1; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Brennan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028139; Callan RJ, 2002, VET CLIN N AM-FOOD A, V18, P57, DOI 10.1016/S0749-0720(02)00004-X; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Casanova L, 2009, J APPL MICROBIOL, V106, P1244, DOI 10.1111/j.1365-2672.2008.04093.x; Centers for Disease Control and Prevention, 2016, PROT HEALTHC PRES; Farid AH, 2012, PREV VET MED, V106, P332, DOI 10.1016/j.prevetmed.2012.03.010; Filippitzi ME, 2018, TRANSBOUND EMERG DIS, V65, P381, DOI 10.1111/tbed.12758; Ganime AC, 2015, J VIROL METHODS, V217, P24, DOI 10.1016/j.jviromet.2015.02.009; HAHN EC, 1977, ARCH VIROL, V55, P315, DOI 10.1007/BF01315053; Julian TR, 2011, APPL ENVIRON MICROB, V77, P6918, DOI 10.1128/AEM.05709-11; Kim HB, 2009, VET REC, V164, P599, DOI 10.1136/vr.164.19.599; Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029; Martin H, 2008, VET J, V177, P388, DOI 10.1016/j.tvjl.2007.06.016; Neira V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146616; Noremark M, 2016, FRONT VET SCI, V3, DOI [10.3389/fvets.2016.00046, 10.3389/fvets.2015.00054]; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Dea MA, 2008, J VIROL METHODS, V147, P61, DOI 10.1016/j.jviromet.2007.07.029; Pitkin A, 2009, CAN J VET RES, V73, P298; Prieto A, 2017, VET MICROBIOL, V204, P59, DOI 10.1016/j.vetmic.2017.04.013; Prieto A, 2014, VET MICROBIOL, V173, P355, DOI 10.1016/j.vetmic.2014.07.024; Simon-Grife M, 2013, PREV VET MED, V110, P223, DOI 10.1016/j.prevetmed.2012.11.028; Themudo GE, 2012, PREV VET MED, V107, P134, DOI 10.1016/j.prevetmed.2012.05.009; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tomas ME, 2015, JAMA INTERN MED, V175, P1904, DOI 10.1001/jamainternmed.2015.4535; Verreault D, 2010, VET MICROBIOL, V141, P224, DOI 10.1016/j.vetmic.2009.09.013; Villarroel A, 2007, JAVMA-J AM VET MED A, V230, P808, DOI 10.2460/javma.230.6.808; World Health Organization, 2014, REC US PERS PROT EQ, P25	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203144	10.1371/journal.pone.0203144	http://dx.doi.org/10.1371/journal.pone.0203144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148883	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200049
J	Borba, JVVB; Tauhata, SBF; de Oliveira, CMA; Marques, MF; Bailao, AM; Soares, CMD; Pereira, M				Verde Bastos Borba, Joyce Villa; Ferreira Tauhata, Sinji Borges; Alves de Oliveira, Cecilia Maria; Marques, Monique Ferreira; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria; Pereira, Maristela			Chemoproteomic identification of molecular targets of antifungal prototypes, thiosemicarbazide and a camphene derivative of thiosemicarbazide, in Paracoccidioides brasiliensis	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; BIOLOGICAL EVALUATION; YEAST-CELLS; EXPRESSION; PROTEIN; SPECIATION; COMPLEXES; SYNTHASE; GROWTH; VIEW	Paracoccidioidomycosis (PCM) is a neglected human systemic disease caused by species of the genus Paracoccidioides. The disease attacks the host's lungs and may disseminate to many other organs. Treatment involves amphotericin B, sulfadiazine, trimethoprim-sulfamethoxazole, itraconazole, ketoconazole, or fluconazole. The treatment duration is usually long, from 6 months to 2 years, and many adverse effects may occur in relation to the treatment; co-morbidities and poor treatment adherence have been noted. Therefore, the discovery of more effective and less toxic drugs is needed. Thiosemicarbazide (TSC) and a camphene derivative of thiosemicarbazide (TSC-C) were able to inhibit P. brasiliensis growth at a low dosage and were not toxic to fibroblast cells. In order to investigate the mode of action of those compounds, we used a chemoproteomic approach to determine which fungal proteins were bound to each of these compounds. The compounds were able to inhibit the activities of the enzyme formamidase and interfered in P. brasiliensis dimorphism. In comparison with the transcriptomic and proteomic data previously obtained by our group, we determined that TSC and TSC-C were multitarget compounds that exerted effects on the electron-transport chain and cell cycle regulation, increased ROS formation, inhibited proteasomes and peptidases, modulated glycolysis, lipid, protein and carbohydrate metabolisms, and caused suppressed the mycelium to yeast transition.	[Verde Bastos Borba, Joyce Villa; Ferreira Tauhata, Sinji Borges; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria; Pereira, Maristela] Univ Fed Goias, Inst Ciencias Biol, Lab Biol Mol, Goiania, Go, Brazil; [Alves de Oliveira, Cecilia Maria; Marques, Monique Ferreira] Univ Fed Goias, Inst Quim, Lab Prod Nat, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Pereira, M (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Lab Biol Mol, Goiania, Go, Brazil.	maristelaufg@gmail.com	Borba, Joyce V. B./S-7813-2018; Pereira, Maristela/AAT-5765-2021; de Oliveira, Cecilia M A/C-5830-2013; Bailao, Alexandre Melo/H-1272-2013	Borba, Joyce V. B./0000-0002-2663-5173; de Oliveira, Cecilia M A/0000-0003-3339-5363; Bailao, Alexandre Melo/0000-0001-7754-4047; Tauhata, Sinji/0000-0002-6617-4244	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FINEP (Financiadora de Estudos e Projetos); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work performed at Universidade Federal de Goias was supported by MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico), FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FINEP (Financiadora de Estudos e Projetos), INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica) and PRONEX (Programa de Apoio a Nucleos de Excelencia). Additionally, JVBB was supported by fellowship from CNPq.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Parente AFA, 2013, FUNGAL BIOL-UK, V117, P399, DOI 10.1016/j.funbio.2013.04.004; [Anonymous], ARG CIR CLIN EXP, V18, P197; Araujo FS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004309; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Bastos KP, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-29; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; Borges CL, 2010, FEMS YEAST RES, V10, P104, DOI 10.1111/j.1567-1364.2009.00594.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang HY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.504; Costa FG, 2015, ANTIMICROB AGENTS CH, V59, P5581, DOI 10.1128/AAC.04711-14; Cruz-Monteagudo M, 2017, DRUG DISCOV TODAY, V22, P994, DOI 10.1016/j.drudis.2017.02.004; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Dimou M, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2330-6; do Prado RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094832; Dzitko K, 2014, 1 4 DISUBSTITUTED TH, P9926, DOI [10.3390/molecules19079926, DOI 10.3390/MOLECULES19079926]; El-Gammal OA, 2014, SPECTROCHIM ACTA A, V127, P530, DOI 10.1016/j.saa.2014.02.001; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Gravi ET, 2012, MED MYCOL, V50, P81, DOI 10.3109/13693786.2011.590825; Hahn RC, 2003, MYCOSES, V46, P342; Karapandzova M, 2014, NAT PROD COMMUN, V9, P1623; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li YJ, 2009, GLYCOBIOLOGY, V19, P624, DOI 10.1093/glycob/cwp029; Liu SD, 2015, BIOCHEM J, V468, P167, DOI 10.1042/BJ20150197; Marques SA, 2013, AN BRAS DERMATOL, V88, P700, DOI 10.1590/abd1806-4841.20132463; Menezes VM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004967.pub2; Murad AM, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-82; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; Nevagi RJ, 2014, BIOORG CHEM, V54, P68, DOI 10.1016/j.bioorg.2014.04.002; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Patel SR, 2014, EUR J MED CHEM, V85, P255, DOI 10.1016/j.ejmech.2014.07.100; Prado RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00616; Rastelli G, 2015, FRONT PHARMACOL, V6, P1, DOI [10.3389/fphar.2015.00001, DOI 10.3389/FPHAR.2015.00001]; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Salomon AR, 2001, CHEM BIOL, V8, P71, DOI 10.1016/S1074-5521(00)00057-0; Santos GD, 2007, MED MYCOL, V45, P609, DOI 10.1080/13693780701502108; Scharfstein J, 2007, SCAND J IMMUNOL, V66, P128, DOI 10.1111/j.1365-3083.2007.01983.x; Serra S, 2014, EUR J MED CHEM, V82, P96, DOI 10.1016/j.ejmech.2014.05.044; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; Shikanai-Yasuda MA, 2017, REV SOC BRAS MED TRO, V50, P715, DOI 10.1590/0037-8682-0230-2017; Silva LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130703; Siwek A, 2011, MED CHEM, V7, P690, DOI 10.2174/157340611797928406; Skagia A, 2017, GENES CELLS, V22, P810, DOI 10.1111/gtc.12514; Skouloubris S, 1997, MOL MICROBIOL, V25, P989, DOI 10.1111/j.1365-2958.1997.mmi536.x; Slinski SL, 2015, PHYTOPATHOLOGY, V105, P119, DOI 10.1094/PHYTO-02-14-0027-R; Sousa-Pereira D, 2013, REV VIRTUAL QUIM, V5, P770, DOI 10.5935/1984-6835.20130055; Talevi A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00205; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Turissini DA, 2017, FUNGAL GENET BIOL, V106, P9, DOI 10.1016/j.fgb.2017.05.007; Weber SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052470; Yamaguchi MU, 2009, MOLECULES, V14, P1796, DOI 10.3390/molecules14051796; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zambuzzi-Carvalho PF, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-227	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201948	10.1371/journal.pone.0201948	http://dx.doi.org/10.1371/journal.pone.0201948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148835	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200004
J	Mori, S; Arima, N; Ito, M; Fujiyama, S; Kamo, Y; Ueki, Y				Mori, Shunsuke; Arima, Nobuyuki; Ito, Masahiro; Fujiyama, Shigetoshi; Kamo, Yasuhiro; Ueki, Yukitaka			Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment	PLOS ONE			English	Article							FATTY LIVER; RISK-FACTORS; AUTOIMMUNE HEPATITIS; PSORIATIC-ARTHRITIS; AMERICAN-COLLEGE; SCORING SYSTEM; FIBROSIS STAGE; DISEASE; PREVALENCE; CRITERIA	Objective The mechanism of liver injury with low-dose methotrexate (MTX) is incompletely understood. This study was designed to evaluate the association between non-alcoholic fatty liver disease (NAFLD) and liver injury during MTX treatment for rheumatoid arthritis (RA). Methods Between October 2014 and May 2015, we enrolled all MTX users for RA and monitored participant serum hepatic transaminase levels for 1 year. All patients had normal transaminase levels before the first MTX prescription. Using diagnostic criteria for non-alcoholic steatohepatitis (NASH), we performed histological analyses for patients presenting persistent transaminitis, defined as elevations of hepatic transaminases in four of six determinations during the follow-up period. Possible risk factors for persistent transaminitis were also examined. Results We followed 846 RA patients with a mean cumulative MTX dose of 2.48 g and identified 51 patients presenting persistent transaminitis. According to multivariate logistic regression analysis, obesity (odds ratio [OR] 3.23, p < 0.001), type 2 diabetes (OR 3.52, p = 0.001), hypercholesterolemia (OR 2.56, p = 0.004), and hyperuricemia (OR 3.52, p = 0.019), which are recognized as risk factors for NAFLD, were independently associated with a risk of persistent transaminitis. Among patients with persistent transaminitis, 42 showed fatty liver at ultrasonography. These patients had no evidence of alcoholic fatty liver, chronic viral hepatitis, autoimmune liver diseases, or hereditary liver diseases. Biopsy specimens were obtained from 32 patients, and we found that a NASH-like pattern was the most prevalent histological abnormality. There was no significant impact of MTX dose and duration on the histological severity. Conclusion Risk factors and histological findings are similar between NAFLD/NASH and liver injury during low-dose MTX treatment for RA, which suggests a strong association between both entities. NAFLD/NASH may be an underlying condition causing persistent transaminitis in MTX-treated RA patients. The results of this study illustrate the need for monitoring liver injury in RA patients with NAFLD risk factors during MTX treatment.	[Mori, Shunsuke] NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, Kumamoto, Japan; [Arima, Nobuyuki] Kumamoto Shinto Gen Hosp, Dept Pathol, Kumamoto, Japan; [Ito, Masahiro] NHO Nagasaki Med Ctr, Clin Res Ctr, Dept Pathol, Omura, Nagasaki, Japan; [Fujiyama, Shigetoshi] Kumamoto Shinto Gen Hosp, Dept Gastroenterol & Hepatol, Kumamoto, Japan; [Kamo, Yasuhiro] Sasebo Chuo Hosp, Gastrointestinal Endoscopy Ctr, Sasebo, Nagasaki, Japan; [Ueki, Yukitaka] Sasebo Chuo Hosp, Rheumat & Collagen Dis Ctr, Sasebo, Nagasaki, Japan		Mori, S (corresponding author), NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, Kumamoto, Japan.	moris@saisyunsou1.hosp.go.jp		Mori, Shunsuke/0000-0001-7972-4252	National Hospital Organization, Japan	National Hospital Organization, Japan	This study was supported by research funds from the National Hospital Organization, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2004, AM J GASTROENTEROL, V99, P1316, DOI 10.1111/j.1572-0241.2004.30444.x; Aithal GP, 2004, ALIMENT PHARM THER, V19, P391, DOI 10.1046/j.1365-2036.2004.01819.x; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Berends MAM, 2006, ALIMENT PHARM THERAP, V24, P805, DOI 10.1111/j.1365-2036.2006.03047.x; Braun J, 2011, THER ADV MUSCULOSKEL, V3, P151, DOI 10.1177/1759720X11408635; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Colli A, 2003, RADIOLOGY, V227, P89, DOI 10.1148/radiol.2272020193; Curtis JR, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2008.101378; Dawwas MF, 2014, ALIMENT PHARM THER, V40, P938, DOI 10.1111/apt.12912; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; ERICKSON AR, 1995, ARTHRITIS RHEUM, V38, P1115, DOI 10.1002/art.1780380814; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Golabi P, 2016, EXPERT REV GASTROENT, V10, P63, DOI 10.1586/17474124.2016.1099433; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv27, DOI 10.1093/rheumatology/kes084; Kent PD, 2004, J RHEUMATOL, V31, P1727; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kremer JM, 1996, J RHEUMATOL, V23, P459; KREMER JM, 1994, ARTHRITIS RHEUM-US, V37, P316, DOI 10.1002/art.1780370304; Kumada S, 2015, JPN J MED ULTRASON, V42, P201; Langman G, 2001, J GASTROEN HEPATOL, V16, P1395, DOI 10.1046/j.1440-1746.2001.02644.x; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lohse AW, 2007, HEPATOL RES, V37, pS509, DOI 10.1111/j.1872-034X.2007.00289.x; Malatjalian DA, 1996, CAN J GASTROENTEROL, V10, P369, DOI 10.1155/1996/213596; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Mori S, 2017, CLIN RHEUMATOL, V36, P2673, DOI 10.1007/s10067-017-3804-5; Nishiura T, 2005, BRIT J RADIOL, V78, P189, DOI 10.1259/bjr/75208448; Ogdie A, 2018, J INVEST DERMATOL, V138, P760, DOI 10.1016/j.jid.2017.10.024; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Quintin E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3085; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; ROENIGK HH, 1982, J AM ACAD DERMATOL, V6, P145, DOI 10.1016/S0190-9622(82)80064-9; Ros S, 2002, SCAND J RHEUMATOL, V31, P330, DOI 10.1080/030097402320817040; Rosenberg P, 2007, J HEPATOL, V46, P1111, DOI 10.1016/j.jhep.2007.01.024; Rouhi A, 2017, CLIN EXP RHEUMATOL, V35, P1029; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Schmajuk G, 2014, ARTHRIT CARE RES, V66, P1159, DOI 10.1002/acr.22294; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5; Suzuki Y, 1999, SCAND J RHEUMATOL, V28, P273; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863; Visser K, 2009, CLIN EXP RHEUMATOL, V27, P1017; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Watanabe S, 2015, J GASTROENTEROL, V50, P364, DOI 10.1007/s00535-015-1050-7; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; YAJIMA Y, 1983, TOHOKU J EXP MED, V139, P43, DOI 10.1620/tjem.139.43; Yatsuji S, 2005, J GASTROENTEROL, V40, P1130, DOI 10.1007/s00535-005-1711-z; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Yoneda M, 2013, J GASTROENTEROL, V48, P1051, DOI 10.1007/s00535-012-0704-y; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	61	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203084	10.1371/journal.pone.0203084	http://dx.doi.org/10.1371/journal.pone.0203084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142184	gold, Green Published, Green Submitted			2022-12-26	WOS:000442722500062
J	Abdelhafez, OH; Fawzy, MA; Fahim, JR; Desoukey, SY; Krischke, M; Mueller, MJ; Abdelmohsen, UR				Abdelhafez, Omnia Hesham; Fawzy, Michael Atef; Fahim, John Refaat; Desoukey, Samar Yehia; Krischke, Markus; Mueller, Martin J.; Abdelmohsen, Usama Ramadan			Hepatoprotective potential of Malvaviscus arboreus against carbon tetrachloride-induced liver injury in rats	PLOS ONE			English	Article							INDIAN MEDICINAL-PLANTS; ANTIOXIDANT ACTIVITY; CAFFEIC ACID; L.; HEPATOTOXICITY; EXTRACT; DAMAGE; GLYCOSIDES; PHENOLICS; FLOWERS	Malvaviscus arboreus Cav. is a medicinal plant belonging to family Malvaceae with both ethnomedical and culinary value; however, its phytochemical and biological profiles have been scarcely studied. Accordingly, this work was designed to explore the chemical composition and the hepatoprotective potential of M. arboreus against carbon tetrachloride (CCl4)-induced hepatotoxicity. The total extract of the aerial parts and its derived fractions (petroleum ether, dichloromethane, ethyl acetate, and aqueous) were orally administered to rats for six consecutive days, followed by injection of CCl4 (1:1 v/v, in olive oil, 1.5 ml/kg, i.p.) on the next day. Results showed that the ethyl acetate and dichloromethane fractions significantly alleviated liver injury in rats as indicated by the reduced levels of alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin (TB), and malondialdehyde (MDA), along with enhancement of the total antioxidant capacities of their livers, with the maximum effects were recorded by the ethyl acetate fraction. Moreover, the protective actions of both fractions were comparable to those of silymarin (100 mg/kg), and have been also substantiated by histopathological evaluations. On the other hand, liquid chromatography-high resolution electrospray ionization mass spectrometry (LC-HR-ESI-MS) metabolomic profiling of the crude extract of M. arboreus aerial parts showed the presence of a variety of phytochemicals, mostly phenolics, whereas the detailed chemical analysis of the most active fraction (i.e. ethyl acetate) resulted in the isolation and identification of six compounds for the first time in the genus, comprising four phenolic acids; beta-resorcylic, caffeic, protocatechuic, and 4-hydroxyphenylacetic acids, in addition to two flavonoids; trifolin and astragalin. Such phenolic principles, together with their probable synergistic antioxidant and liver-protecting properties, seem to contribute to the observed hepatoprotective potential of M. arboreus.	[Abdelhafez, Omnia Hesham] Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia, Egypt; [Fawzy, Michael Atef] Minia Univ, Fac Pharm, Dept Biochem, Al Minya, Egypt; [Fahim, John Refaat; Desoukey, Samar Yehia; Abdelmohsen, Usama Ramadan] Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya, Egypt; [Krischke, Markus; Mueller, Martin J.] Univ Wurzburg, Julius von Sachs Inst Biosci Bioctr Pharmaceut Bi, Wurzburg, Germany; [Abdelmohsen, Usama Ramadan] Univ Wurzburg, Julius von Sachs Inst Biol Sci, Dept Bot 2, Wurzburg, Germany	Deraya University; Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Minia University; University of Wurzburg; University of Wurzburg	Abdelmohsen, UR (corresponding author), Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya, Egypt.; Mueller, MJ (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biosci Bioctr Pharmaceut Bi, Wurzburg, Germany.; Abdelmohsen, UR (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biol Sci, Dept Bot 2, Wurzburg, Germany.	martin.mueller@biozentrum.uni-wuerzburg.de; usama.ramadan@mu.edu.eg	Desoukey, Samar Yehia/ABB-3317-2020; Abdelmohsen, Usama Ramadan/AAX-9874-2020; mueller, martin j/C-7616-2019; Desoukey, Samar/ABF-3565-2020	Abdelmohsen, Usama Ramadan/0000-0002-1014-6922; fawzy, michael/0000-0002-0456-9021; Fahim, John/0000-0002-2425-0819	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The author(s) received no specific funding for this work.	Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; ACHARI B, 1984, J NAT PROD, V47, P751, DOI 10.1021/np50034a047; Achyilla GS, 2003, INDIAN J PHARM, V35, P311; Akindele AJ, 2010, J ETHNOPHARMACOL, V129, P46, DOI 10.1016/j.jep.2010.02.024; Al-Rejaie SS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-136; Ali H, 2014, PHYTOMEDICINE, V21, P131, DOI 10.1016/j.phymed.2013.08.019; ARMENDARIZBORUNDA J, 1991, HEPATOLOGY, V14, P895, DOI 10.1002/hep.1840140523; Bishayee A, 2010, LIVER INT, V30, P1103, DOI 10.1111/j.1478-3231.2010.02295.x; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; CACERES A, 1990, J ETHNOPHARMACOL, V30, P55, DOI 10.1016/0378-8741(90)90017-N; Carini R, 1992, BIOCHEM PHARMACOL, V38, P2859; Cheng N, 2013, FOOD CHEM TOXICOL, V55, P234, DOI 10.1016/j.fct.2012.11.022; Choi J, 2013, ARCH PHARM RES, V36, P912, DOI 10.1007/s12272-013-0090-x; Delange DM, 2012, ANAL CHEM LETT, V2, P171; DOMINGUEZ XA, 1985, J ETHNOPHARMACOL, V13, P139, DOI 10.1016/0378-8741(85)90002-9; Eidi A, 2012, EXCLI J, V11, P495; Evans W.C, 1989, TXB PHARMACOGNOSY, P343; Ezzat Shahira M, 2016, Pharm Biol, V54, P3172, DOI 10.1080/13880209.2016.1214739; Garber J, 2010, GUIDE CARE USE LAB A, P220; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Hafez MM, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0022-y, 10.1186/S40659-015-0022-Y]; Jaeschke H., 2008, CASARETT DOULLS TOXI, P557, DOI [10.1036/0071470514, DOI 10.1036/0071470514]; Jeong CH, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-25; Jia Lu, 2011, Zhongguo Zhong Yao Za Zhi, V36, P891; Jia L, 2011, J ASIAN NAT PROD RES, V13, P907, DOI 10.1080/10286020.2011.599802; Kaisoon O, 2011, J FUNCT FOODS, V3, P88, DOI 10.1016/j.jff.2011.03.002; Lim T.K., 2014, EDIBLE MED NONMEDICI, V8, P405; MABRY TJ, 1970, SYSTEMATIC IDENTIFIC, P4; Markham K.R, 1982, TECHNIQUES FLAVONOID; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Ohtani K, 2011, Z NATURFORSCH C, V66, P31; Piazzon A, 2010, J AGR FOOD CHEM, V58, P10677, DOI 10.1021/jf101975q; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Ranawat L, 2010, J ETHNOPHARMACOL, V127, P777, DOI 10.1016/j.jep.2009.10.019; Refaat J., 2015, J MED HERBS, V5, P193, DOI [10.3233/JHD-180291, DOI 10.3233/JHD-180291]; Refaat J, 2015, MED CHEM RES, V24, P2939, DOI 10.1007/s00044-015-1342-8; Shen BD, 2015, J ETHNOPHARMACOL, V164, P46, DOI 10.1016/j.jep.2015.01.044; Shi GF, 2006, NEUROSCI LETT, V403, P206, DOI 10.1016/j.neulet.2006.02.057; Shimokawa S, 2015, NAT PROD COMMUN, V10, P451; Smith I, 1960, CHROMATOGR ELECTROPH, P1; Sofowora A, 1993, PHYTOCHEMICAL SCREEN, P270; Somasundaram A, 2010, J ETHNOPHARMACOL, V127, P555, DOI 10.1016/j.jep.2009.11.014; Soon Y. Y., 2002, SMJ Singapore Medical Journal, V43, P077; Stahl E, 1970, THIN LAYER CHROMATOG, P810, DOI DOI 10.1002/STAR.19700221110; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Syafni N, 2012, INDONES J CHEM, V12, P273, DOI 10.22146/ijc.21342; Takac Milena Jadrijevic-Mladar, 2004, Acta Pharmaceutica (Zagreb), V54, P177; Tambde GM, 2016, TAIWANIA, V61, P243, DOI 10.6165/tai.2016.61.243; Wang ML, 2012, J AGR FOOD CHEM, V60, P6620, DOI 10.1021/jf301654y; Wang Y, 2011, PHARMAZIE, V66, P445, DOI 10.1691/ph.2011.0844; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wu YH, 2007, FOOD CHEM TOXICOL, V45, P1349, DOI 10.1016/j.fct.2007.01.011; YAMADA K, 1995, PHYTOCHEMISTRY, V39, P1031, DOI 10.1016/0031-9422(95)00159-5; Yang SY, 2013, FOOD CHEM TOXICOL, V55, P92, DOI 10.1016/j.fct.2012.12.042; Yeasmin Z., 2014, DHAKA U J PHARM SCI, V13, P143, DOI [10.3329/dujps.v13i2.21892, DOI 10.3329/DUJPS.V13I2.21892]; You Y, 2010, FOOD CHEM TOXICOL, V48, P1632, DOI 10.1016/j.fct.2010.03.037; ZAMORA M, 1992, ETHNOPHARMACOLOGY, V35, P229; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhong K., 2014, J FOOD NUTR RES, V2, P349, DOI [10.12691/jfnr-2-7-4, DOI 10.12691/JFNR-2-7-4]	60	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202362	10.1371/journal.pone.0202362	http://dx.doi.org/10.1371/journal.pone.0202362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138328	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100055
J	Brown, JC				Brown, Jay C.			Control of human gene expression: High abundance of divergent transcription in genes containing both INR and BRE elements in the core promoter	PLOS ONE			English	Article							RNA-POLYMERASE-II; HUMAN GENOME; REGULATORY ELEMENTS; DNA-BINDING; IDENTIFICATION; INITIATOR; EVOLUTION; INSIGHTS; DOMAINS	Background DNA sequence elements in the core promoter can play a central role in regulation of gene expression. Core elements (e.g. INR and TATA box) are located within similar to 50bp of the transcription start site and both upstream and downstream elements are known. Although all can affect the level of gene expression, their mechanism of action has yet to be fully defined. The studies described here are focused on two core promoter elements, INR and BRE, in the human genome. The locations of the two elements were determined in a large number of human promoters and the results were interpreted in terms of overall promoter function. Results A total of 13,406 promoters were collected from the reference version of the human genome and found to contain 62,891 INR sequences and 32,290 BRE. An INR sequence was found in the core region of 1231 (9.2%) promoters and a BRE in 2592 (19.3%); 121 promoters (0.9%) have both INR and BRE elements. Counts support the view that most human promoters lack an INR or BRE element in the core promoter. Further analysis was carried out with the aligned aggregate of promoters from each chromosome. The results showed distinct INR distributions in separate chromosome groups indicating a degree of chromosome specificity to the way core promoter elements are deployed in the genome. The rare promoters with both INR and BRE elements were found to be enriched among the genes with divergent transcription. Enrichment raises the possibility that core promoter elements can have a function in chromosome organization as well as in initiation of transcription.	[Brown, Jay C.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	University of Virginia	Brown, JC (corresponding author), Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	jcb2g@virginia.edu			University of Virginia	University of Virginia	This work was funded from local sources at the University of Virginia.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Decker KB, 2013, ANNU REV MICROBIOL, V67, P113, DOI 10.1146/annurev-micro-092412-155756; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duttke SHC, 2015, TRENDS BIOCHEM SCI, V40, P127, DOI 10.1016/j.tibs.2015.01.005; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gershenzon NI, 2005, BIOINFORMATICS, V21, P1295, DOI 10.1093/bioinformatics/bti172; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ngoc LV, 2017, GENE DEV, V31, P6, DOI 10.1101/gad.293837.116; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202927	10.1371/journal.pone.0202927	http://dx.doi.org/10.1371/journal.pone.0202927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138429	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100142
J	Cooper, S; Emmott, A; McDonald, KK; Campeau, MA; Leask, RL				Cooper, Scott; Emmott, Alexander; McDonald, Karli K.; Campeau, Marc-Antoine; Leask, Richard L.			Increased MMP activity in curved geometries disrupts the endothelial cell glycocalyx creating a proinflammatory environment	PLOS ONE			English	Article							WALL SHEAR-STRESS; HEPARAN-SULFATE; ATHEROSCLEROSIS; ACTIVATION; EXPRESSION; SYNDECAN-1; CLEAVAGE; ARTERY; FLOW; MORPHOLOGY	Wall shear stress gradients (WSSGs) induce an inflammatory phenotype in endothelial cells (ECs) which is hypothesized to be mediated by mechanotransduction through the EC glycocalyx (GCX). We used a three-dimensional in vitro cell culture model with a 180 degrees curved geometry to investigate if WSSGs created by curvature can cause EC inflammation and disruption of the GCX. The hydrodynamics of the model elicited a morphological response in ECs as well as a pattern of leukocyte adhesion towards the inner wall of curvature that was attenuated with enzymatic removal of GCX components. GCX degradation was also observed in regions of curvature which corresponded to increased activity of MMPs. Together, these results support the hypothesis that the EC GCX is involved in mechano-transduction of WSSGs and that components of the GCX are regulated by MMP activity in regions of curvature.	[Cooper, Scott; Emmott, Alexander; McDonald, Karli K.; Campeau, Marc-Antoine; Leask, Richard L.] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada; [Emmott, Alexander; Leask, Richard L.] Montreal Heart Inst, Montreal, PQ, Canada	McGill University; Universite de Montreal	Leask, RL (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.; Leask, RL (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.	Richard.leask@mail.mcgill.ca		Leask, Richard/0000-0002-3649-5127	Natural Sciences and Engineering Research Council of Canada [261938-13]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by grant 261938-13 from the Natural Sciences and Engineering Research Council of Canada to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloush MM, 2014, 2 MIDDL E C BIOM ENG; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; BERGER SA, 1983, ANNU REV FLUID MECH, V15, P461, DOI 10.1146/annurev.fl.15.010183.002333; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Cooper S, 2017, ANN BIOMEDICAL ENG; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Farcas MA, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-30; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; GOODE TB, 1977, ATHEROSCLEROSIS, V27, P235, DOI 10.1016/0021-9150(77)90061-2; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; IHRCKE NS, 1993, IMMUNOL TODAY, V14, P500, DOI 10.1016/0167-5699(93)90265-M; LaMack JA, 2007, ATHEROSCLEROSIS, V195, pE35, DOI 10.1016/j.atherosclerosis.2007.04.054; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; LEWIS JC, 1982, LAB INVEST, V46, P123; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Magid R, 2003, J BIOL CHEM, V278, P32994, DOI 10.1074/jbc.M304799200; Malek AM, 1996, J CELL SCI, V109, P713; Manon-Jensen T, 2013, FEBS J, V280, P2320, DOI 10.1111/febs.12174; Marchetti M, 1996, BRIT J HAEMATOL, V93, P360, DOI 10.1046/j.1365-2141.1996.4911029.x; McDonald KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167576; MOORE JE, 1992, J BIOMECH ENG-T ASME, V114, P391, DOI 10.1115/1.2891400; Nagel T, 1999, ARTERIOSCL THROM VAS, V19, P1825, DOI 10.1161/01.ATV.19.8.1825; NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275; Ni Ghriallais R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0965; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Potter CMF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031228; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Rouleau L, 2010, ANN BIOMED ENG, V38, P2791, DOI 10.1007/s10439-010-0032-4; SMEDBY O, 1995, ARTERIOSCL THROM VAS, V15, P912, DOI 10.1161/01.ATV.15.7.912; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Wahle A, 2006, MED IMAGE ANAL, V10, P615, DOI 10.1016/j.media.2006.03.002; Wang Y, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.965.965; Wang Z, 2009, NEUROSURGERY, V65, DOI [10.1227/01.NEU.0000343541, DOI 10.1227/01.NEU.0000343541]; Wang ZJ, 2009, NEUROSURGERY, V65, P169, DOI 10.1227/01.NEU.0000343541.85713.01; Zang CB, 2000, J CANCER RES CLIN, V126, P33, DOI 10.1007/PL00008462; Zeng Y, 2014, AM J PHYSIOL-HEART C, V306, pH363, DOI 10.1152/ajpheart.00687.2013; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	52	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202526	10.1371/journal.pone.0202526	http://dx.doi.org/10.1371/journal.pone.0202526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138400	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100076
J	Iwashita, T; Uemura, S; Yoshida, K; Mita, N; Tezuka, R; Yasuda, I; Shimizu, M				Iwashita, Takuji; Uemura, Shinya; Yoshida, Kensaku; Mita, Naoki; Tezuka, Ryuichi; Yasuda, Ichiro; Shimizu, Masahito			EUS-guided hybrid rendezvous technique as salvage for standard rendezvous with intrahepatic bile duct approach	PLOS ONE			English	Article							SURGICALLY ALTERED ANATOMY; BILIARY ACCESS; DRAINAGE; STONE	EUS-guided rendezvous technique (EUS-RV) is an effective salvage technique for failed biliary cannulation during ERCP. However, it is still difficult to achieve cannulation in some cases, especially using the intrahepatic bile duct (IHBD) approach, which requires complicated guidewire manipulation. EUS-hybrid rendezvous technique (HRV) has been applied as a salvage technique for difficult guidewire placement during EUS-RV with IHBD approach. The aims of this study were to evaluate the efficacy and safety of EUS-HRV using a retrospective study. Database analysis revealed 29 patients who underwent EUS-RV for difficult biliary cannulation. Among them, 8 patients underwent EUS-HRV as a salvage technique for difficult guidewire placement during EUS-RV with the IHBD approach. In EUS-HRV, a 6-French dilator was advanced into the biliary system for better guidewire manipulation. After successful guidewire placement, the EUS scope was exchanged for a duodenoscope, keeping the guidewire and dilator in place. The EUS-placed guidewire was retrieved through the duodenoscope, followed by cannulation over the guidewire. The dilator remained at the fistula until completion of the procedure. The analysis showed that the guidewire placement and the subsequent scope exchange and deep biliary cannulation after the retrieval of the EUS-placed guidewire were successfully conducted for all 8 patients. Mild pancreatitis was recognized as an adverse event in 1 patient. The overall success rate of EUS-RV combined with EUS-HRV was improved up to 90% (26/29). Our results suggested that EUS-HRV can be an effective and safe salvage technique in cases wherein guidewire placement is difficult during EUS-RV with IHBD approach.	[Iwashita, Takuji; Uemura, Shinya; Yoshida, Kensaku; Mita, Naoki; Tezuka, Ryuichi; Yasuda, Ichiro; Shimizu, Masahito] Gifu Univ Hosp, Dept Internal Med 1, Gifu, Japan; [Yasuda, Ichiro] Univ Toyama, Dept Internal Med 3, Toyama, Japan	Gifu University; University of Toyama	Iwashita, T (corresponding author), Gifu Univ Hosp, Dept Internal Med 1, Gifu, Japan.	takuji@w7.dion.ne.jp						Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Dhir V, 2012, GASTROINTEST ENDOSC, V75, P354, DOI 10.1016/j.gie.2011.07.075; Isayama H, 2013, J HEPATO-BIL-PAN SCI, V20, P413, DOI 10.1007/s00534-012-0577-8; Itoi T, 2014, J HEPATO-BIL-PAN SCI, V21, pE86, DOI 10.1002/jhbp.165; Iwashita T, 2012, ENDOSCOPY, V44, P60, DOI 10.1055/s-0030-1256871; Iwashita T, 2017, DIGEST ENDOSC, V29, P362, DOI 10.1111/den.12800; Iwashita T, 2016, J HEPATO-BIL-PAN SCI, V23, P227, DOI 10.1002/jhbp.329; Iwashita T, 2016, GASTROINTEST ENDOSC, V83, P394, DOI 10.1016/j.gie.2015.04.043; Iwashita T, 2014, CLIN J GASTROENTEROL, V7, P94, DOI 10.1007/s12328-014-0467-5; Iwashita T, 2013, DIGEST DIS SCI, V58, P2417, DOI 10.1007/s10620-013-2645-6; Iwashita Takuji, 2012, Gastrointest Endosc Clin N Am, V22, P249, DOI 10.1016/j.giec.2012.04.018; Mallery S, 2004, GASTROINTEST ENDOSC, V59, P100, DOI 10.1016/S0016-5107(03)02300-9; Nguyen-Tang T, 2010, ENDOSCOPY, V42, P232, DOI 10.1055/s-0029-1243858; Weilert F, 2011, ENDOSCOPY, V43, P1105, DOI 10.1055/s-0030-1256961; Yang MJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008991	15	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202445	10.1371/journal.pone.0202445	http://dx.doi.org/10.1371/journal.pone.0202445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133542	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400072
J	Kauder, SE; Kuo, TC; Harrabi, O; Chen, A; Sangalang, E; Doyle, L; Rocha, SS; Bollini, S; Han, B; Sim, J; Pons, J; Wan, HI				Kauder, Steven E.; Kuo, Tracy C.; Harrabi, Ons; Chen, Amy; Sangalang, Emma; Doyle, Laura; Rocha, Sony S.; Bollini, Sangeetha; Han, Bora; Sim, Janet; Pons, Jaume; Wan, Hong, I			ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile	PLOS ONE			English	Article							REGULATORY-PROTEIN-ALPHA; ADVERSE PROGNOSTIC-FACTOR; FC-GAMMA-RIII; MACROPHAGE PLASTICITY; MEDIATED PHAGOCYTOSIS; THERAPEUTIC TARGET; TUMOR PROGRESSION; IMMUNOGLOBULIN-G; DENDRITIC CELLS; STEM-CELLS	CD47 is a widely expressed cell surface protein that functions as an immune checkpoint in cancer. When expressed by tumor cells, CD47 can bind SIRP alpha on myeloid cells, leading to suppression of tumor cell phagocytosis and other innate immune functions. CD47-SIRP alpha signaling has also been implicated in the suppression of adaptive antitumor responses, but the relevant cellular functions have yet to be elucidated. Therapeutic blockade of the CD47 pathway may stimulate antitumor immunity and improve cancer therapy. To this end, a novel CD47-blocking molecule, ALX148, was generated by fusing a modified SIRP alpha D1 domain to an inactive human IgG1 Fc. ALX148 binds CD47 from multiple species with high affinity, inhibits wild type SIRP alpha binding, and enhances phagocytosis of tumor cells by macrophages. ALX148 has no effect on normal human blood cells in vitro or on blood cell parameters in rodent and non-human primate studies. Across several murine tumor xenograft models, ALX148 enhanced the antitumor activity of different targeted antitumor antibodies. Additionally, ALX148 enhanced the antitumor activity of multiple immunotherapeutic antibodies in syngeneic tumor models. These studies revealed that CD47 blockade with ALX148 induces multiple responses that bridge innate and adaptive immunity. ALX148 stimulates antitumor properties of innate immune cells by promoting dendritic cell activation, macrophage phagocytosis, and a shift of tumor-associated macrophages toward an inflammatory phenotype. ALX148 also stimulated the antitumor properties of adaptive immune cells, causing increased T cell effector function, pro-inflammatory cytokine production, and a reduction in the number of suppressive cells within the tumor microenvironment. Taken together, these results show that ALX148 binds and blocks CD47 with high affinity, induces a broad antitumor immune response, and has a favorable safety profile.	[Kauder, Steven E.; Kuo, Tracy C.; Harrabi, Ons; Chen, Amy; Sangalang, Emma; Doyle, Laura; Rocha, Sony S.; Bollini, Sangeetha; Han, Bora; Sim, Janet; Pons, Jaume; Wan, Hong, I] ALX Oncol, Burlingame, CA 94010 USA		Sim, J; Wan, HI (corresponding author), ALX Oncol, Burlingame, CA 94010 USA.	hong@alxoncology.com						Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Ansell SM, 2016, J CLIN ONCOLOGY S, V34; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Herter S, 2014, J IMMUNOL, V192, P2252, DOI 10.4049/jimmunol.1301249; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Holland PM, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1843.1843; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kwong LS, 2014, IMMUNOLOGY, V143, P61, DOI 10.1111/imm.12290; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Liu X., 2015, NUTR CANC, P1, DOI DOI 10.1080/01635581.2015.1037961; Liu XJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0381-z; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Matlung HL, 2017, IMMUNOL REV, V276, P145, DOI 10.1111/imr.12527; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; MORGAN A, 1995, IMMUNOLOGY, V86, P319; MUNN DH, 1990, J EXP MED, V172, P231, DOI 10.1084/jem.172.1.231; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Oghumu S, 2014, IMMUNOLOGY, V143, P109, DOI 10.1111/imm.12293; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Petrova PS, 2017, CLIN CANCER RES, V23, P1068, DOI 10.1158/1078-0432.CCR-16-1700; Philips GK, 2015, INT IMMUNOL, V27, P39, DOI 10.1093/intimm/dxu095; Ring NG, 2017, P NATL ACAD SCI USA, V114, pE10578, DOI 10.1073/pnas.1710877114; Sagiv-Barfi I, 2015, P NATL ACAD SCI USA, V112, pE966, DOI 10.1073/pnas.1500712112; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Selby MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161779; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sikic BI, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3019; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Soto-Pantoja DR, 2014, CANCER RES, V74, P6771, DOI 10.1158/0008-5472.CAN-14-0037-T; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Theocharides APA, 2012, J EXP MED, V209, P1883, DOI 10.1084/jem.20120502; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Weiskopf K, 2017, EUR J CANCER, V76, P100, DOI 10.1016/j.ejca.2017.02.013; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Xiao ZY, 2015, CANCER LETT, V360, P302, DOI [10.1016/j.Canlet.2015.02.036, 10.1016/j.canlet.2015.02.036]; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Xu M., 2017, IEEE J SEL AREA COMM, P1; Yanagita T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89140; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021; Yoshida K, 2015, CANCER MED-US, V4, P1322, DOI 10.1002/cam4.478; Zaynagetdinov R, 2011, J IMMUNOL, V187, P5703, DOI 10.4049/jimmunol.1100558; Zhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153550; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	71	68	71	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201832	10.1371/journal.pone.0201832	http://dx.doi.org/10.1371/journal.pone.0201832			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133535	Green Submitted, gold, Green Published			2022-12-26	WOS:000442500400039
J	Lamirel, C; Ajasse, S; Moulignier, A; Salomon, L; Deschamps, R; Gueguen, A; Vignal, C; Cochereau, I; Lorenceau, J				Lamirel, Cedric; Ajasse, Suzon; Moulignier, Antoine; Salomon, Laurence; Deschamps, Romain; Gueguen, Antoine; Vignal, Catherine; Cochereau, Isabelle; Lorenceau, Jean			A novel method of inducing endogenous pupil oscillations to detect patients with unilateral optic neuritis	PLOS ONE			English	Article							CYCLE TIME; RESPONSES; LUMINANCE; VISION; REFLEX; DEFECT	Purpose To use and test a new method of inducing endogenously generated pupillary oscillations (POs) in patients with unilateral optic neuritis (ON), to describe a signal analysis approach quantifying pupil activity and to evaluate the extent to which POs permit to discriminate patients from control participants. Method Pupil size was recorded with an eye-tracker and converted in real time to modulate the luminance of a stimulus (a 20 E disk) presented in front of participants. With this biofeedback setting, an increasing pupil size transforms into a high luminance, entraining a pupil constriction that in turn decreases the stimulus luminance, and so on, resulting in endogenously generated POs. POs were recorded for 30 seconds in the affected eye, in the fellow eye and in binocular conditions with 22 patients having a history of unilateral ON within a period of 5 years, and with 22 control participants. Different signal analysis methods were used to quantify the power and frequency of POs. Results On average, pupil size oscillated at around 1 Hz. The amplitude of POs appears not to be a reliable marker of ON. In contrast, the frequency of POs was significantly lower, and was more variable over time, in the patients' affected eye, as compared to their fellow eye and to the binocular condition. No such differences were found in control participants. Receiver operating characteristic analyses based on the frequency and the variability of POs to classify patients and control participants gave an area under the curve of 0.82, a sensitivity of 82% (95% CI: 60%-95%) and a specificity of 77% (95% CI: 55%-92%). Conclusions The new method used to induce POs allowed characterizing the visual afferent pathway defect in ON patients with encouraging accuracy. The method was fast, easy to use, only requiring that participants look ahead, and allows testing many stimulus parameters (e.g. color, stimulus location, size, etc).	[Lamirel, Cedric; Vignal, Catherine; Cochereau, Isabelle] Fdn Ophtalmol Adolphe Rothschild, Dept Ophtalmol, Paris, France; [Lamirel, Cedric; Cochereau, Isabelle] Hop Bichat Claude Bernard, Serv Ophtalmol, Paris, France; [Ajasse, Suzon; Lorenceau, Jean] UPMC, Inst Vis, INSERM, CNRS, Paris, France; [Moulignier, Antoine; Deschamps, Romain; Gueguen, Antoine] Fdn Ophtalmol Adolphe Rothschild, Serv Neurol, Paris, France; [Salomon, Laurence] Fdn Ophtalmol Adolphe Rothschild, Unite Rech Clin, Paris, France; [Cochereau, Isabelle] Univ Paris Diderot, Paris, France	Fondation Adolphe de Rothschild; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Fondation Adolphe de Rothschild; Fondation Adolphe de Rothschild; UDICE-French Research Universities; Universite Paris Cite	Lamirel, C (corresponding author), Fdn Ophtalmol Adolphe Rothschild, Dept Ophtalmol, Paris, France.; Lamirel, C (corresponding author), Hop Bichat Claude Bernard, Serv Ophtalmol, Paris, France.	clamirel@for.paris		MOULIGNIER, Antoine/0000-0001-7566-0175	French "Agence Nationale de la Recherche" [2012-TECS-0009-01]	French "Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported by a grant from the French "Agence Nationale de la Recherche" no 2012-TECS-0009-01 to JL (http://www.agencenationale-recherche.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbur JL, 2004, CLIN NEUROPHYSIOL, V115, P2650, DOI 10.1016/j.clinph.2004.05.022; Binda P, 2014, J NEUROPHYSIOL, V112, P3046, DOI 10.1152/jn.00502.2014; Bremner FD, 2004, EYE, V18, P1175, DOI 10.1038/sj.eye.6701560; Brozou CG, 2009, EUR J OPHTHALMOL, V19, P254, DOI 10.1177/112067210901900213; Clarke RJ, 2003, J NEUROPHYSIOL, V89, P3168, DOI 10.1152/jn.01130.2002; ELLIS CJK, 1979, J NEUROL NEUROSUR PS, V42, P1008, DOI 10.1136/jnnp.42.11.1008; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gunn R, 1904, BMJ-BRIT MED J, V1904, P1285; HAMILTON W, 1983, ANN OPHTHALMOL, V15, P714; Kardon R., 2005, CLIN NEURO OPHTH, P649; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; Loewenfeld I. E., 1999, PUPIL ANATOMY PHYSL; LOWENSTEIN O, 1952, J NERV MENT DIS, V115, P121, DOI 10.1097/00005053-195201000-00001; MARTYN CN, 1986, J NEUROL NEUROSUR PS, V49, P771, DOI 10.1136/jnnp.49.7.771; MILLER SD, 1978, AM J OPHTHALMOL, V85, P635, DOI 10.1016/S0002-9394(14)77096-5; MILLER SD, 1978, BRIT J OPHTHALMOL, V62, P495, DOI 10.1136/bjo.62.7.495; Moro SI, 2007, OPHTHAL PHYSL OPT, V27, P451, DOI 10.1111/j.1475-1313.2007.00501.x; Noseda R, 2016, BRAIN, V139, P1971, DOI 10.1093/brain/aww119; SAFRAN AB, 1984, BRIT J CLIN PHARMACO, V18, pS91, DOI 10.1111/j.1365-2125.1984.tb02587.x; Schiefer U, 2012, BRIT J OPHTHALMOL, V96, P629, DOI 10.1136/bjophthalmol-2011-300776; Shindler KS, 2012, EXP EYE RES, V100, P1, DOI 10.1016/j.exer.2012.04.005; Szabadi E, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00094; Wilhelm Helmut, 2011, Handb Clin Neurol, V102, P427, DOI 10.1016/B978-0-444-52903-9.00022-4	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201730	10.1371/journal.pone.0201730	http://dx.doi.org/10.1371/journal.pone.0201730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133485	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400032
J	Nie, MZ; Bal, MS; Liu, J; Yang, ZF; Rivera, C; Wu, XR; Hoenderop, JGJ; Bindels, RJM; Marciano, DK; Wolf, MTF				Nie, Mingzhu; Bal, Manjot S.; Liu, Jie; Yang, Zhufeng; Rivera, Carolina; Wu, Xue-Ru; Hoenderop, Joost G. J.; Bindels, Rene J. M.; Marciano, Denise K.; Wolf, Matthias T. F.			Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; magnesium; endocytosis; nephrology; electrophysiology; kidney; TRPM6; uromodulin; distal tubule	TAMM-HORSFALL PROTEIN; TYPE-2 DIABETES-MELLITUS; DISTAL CONVOLUTED TUBULE; LOW SERUM MAGNESIUM; DIETARY MAGNESIUM; ATHEROSCLEROSIS-RISK; KIDNEY-DISEASE; SECONDARY HYPOCALCEMIA; MEDIATED ENDOCYTOSIS; METABOLIC SYNDROME	Up to 15% of the population have mild to moderate chronic hypomagnesemia, which is associated with type 2 diabetes mellitus, hypertension, metabolic syndrome, and chronic kidney disease. The kidney is the key organ for magnesium homeostasis, but our understanding of renal magnesium regulation is very limited. Uromodulin (UMOD) is the most abundant urinary protein in humans, and here we report that UMOD has a role in renal magnesium homeostasis. Umod-knockout (Umod(-/-)) mice excreted more urinary magnesium than WT mice and displayed up-regulation of genes promoting magnesium absorption. The majority of magnesium is absorbed in the thick ascending limb. However, both mouse strains responded similarly to the diuretic agent furosemide, indicating appropriate function of the thick ascending limb in the Umod(-/-) mice. Magnesium absorption is fine-tuned in the distal convoluted tubule (DCT) via the apical magnesium channel transient receptor potential melastatin 6 (TRPM6). We observed decreased apical Trpm6 staining in the DCT of Umod(-/-) mice. Applying biotinylation assays and whole-cell patch-clamp recordings, we found that UMOD enhances TRPM6 cell-surface abundance and current density from the extracellular space. UMOD physically interacted with TRPM6 and thereby impaired dynamin-dependent TRPM6 endocytosis. WT mice fed a low-magnesium diet had an increased urinary UMOD secretion compared with the same mice on a regular diet. Our results suggest that increased urinary UMOD secretion in low-magnesium states reduces TRPM6 endocytosis and thereby up-regulates TRPM6 cell-surface abundance to defend against further urinary magnesium losses.	[Nie, Mingzhu; Bal, Manjot S.; Liu, Jie; Rivera, Carolina; Wolf, Matthias T. F.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Yang, Zhufeng; Marciano, Denise K.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; New York University; New York University; Radboud University Nijmegen	Wolf, MTF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthias.wolf@utsouthwestern.edu	Bindels, René JM/B-9824-2013	Bindels, René JM/0000-0003-1167-1339; Wu, Xue-Ru/0000-0001-6058-6291; Wolf, Matthias/0000-0003-3577-3014; Marciano, Denise/0000-0003-0612-4664	National Institutes of Health [K08DK095994-04, R03DK111776-01, P30DK079328, R01DK009478]; Children's Health System, Dallas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK111776, R01DK099478, K08DK095994, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Health System, Dallas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08DK095994-04 (to M. T. F. W.), R03DK111776-01 (to M. T. F. W.), P30DK079328 (to M. T. F. W. and D. K. M.), and R01DK009478 (to D. K. M.) and the Children's Health System, Dallas (to M. T. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnaud MJ, 2008, BRIT J NUTR, V99, pS24, DOI 10.1017/S000711450800682X; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; BACHMANN S, 1991, RENAL PHYSIOL BIOCH, V14, P236; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; BRUNETTE MG, 1974, AM J PHYSIOL, V227, P891, DOI 10.1152/ajplegacy.1974.227.4.891; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; CHERNOW B, 1989, CHEST, V95, P391, DOI 10.1378/chest.95.2.391; Corica F, 2006, J AM COLL NUTR, V25, P210, DOI 10.1080/07315724.2006.10719534; Corre T, 2018, J AM SOC NEPHROL, V29, P335, DOI 10.1681/ASN.2017030267; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Del Gobbo LC, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-23; Delgado GE, 2017, J AM SOC NEPHROL, V28, P2201, DOI 10.1681/ASN.2016111162; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Devuyst O, 2017, NAT REV NEPHROL, V13, P525, DOI 10.1038/nrneph.2017.101; Dey R, 2015, CLIN EXP NEPHROL, V19, P1054, DOI 10.1007/s10157-015-1097-z; Elin RJ, 2010, MAGNESIUM RES, V23, pS194, DOI 10.1684/mrh.2010.0213; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Franz KB, 2004, J AM COLL NUTR, V23, p738S, DOI 10.1080/07315724.2004.10719418; Glauser A, 2000, NEPHROL DIAL TRANSPL, V15, P1580, DOI 10.1093/ndt/15.10.1580; GOODALL AA, 1980, BIOCHEM J, V189, P533, DOI 10.1042/bj1890533; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Guerrero-Romero F, 2016, J PEDIATR-US, V168, P93, DOI 10.1016/j.jpeds.2015.09.050; Han J, 2013, KIDNEY INT, V83, P733, DOI 10.1038/ki.2012.449; Haudek KC, 2010, GLYCOBIOLOGY, V20, P1199, DOI 10.1093/glycob/cwq097; Hirschler V, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22989; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Huerta MG, 2005, DIABETES CARE, V28, P1175, DOI 10.2337/diacare.28.5.1175; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kurstjens S, 2017, EUR J ENDOCRINOL, V176, P11, DOI 10.1530/EJE-16-0517; Lameris ALL, 2013, PFLUG ARCH EUR J PHY, V465, P1613, DOI 10.1007/s00424-013-1306-0; Lech M, 2012, INT J MOL SCI, V13, P10113, DOI 10.3390/ijms130810113; Lee CT, 2007, AM J PHYSIOL-RENAL, V293, pF1231, DOI 10.1152/ajprenal.00038.2007; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Leiherer A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005798; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; Lima MD, 2009, DIABETES RES CLIN PR, V83, P257, DOI 10.1016/j.diabres.2008.11.019; Liu Y, 2018, AM J PHYSIOL-RENAL, V314, pF1062, DOI 10.1152/ajprenal.00233.2017; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Nair AV, 2012, P NATL ACAD SCI USA, V109, P11324, DOI 10.1073/pnas.1113811109; Nestler A, 2014, PREGNANCY HYPERTENS, V4, P41, DOI 10.1016/j.preghy.2013.09.003; Nie MZ, 2016, J AM SOC NEPHROL, V27, P3447, DOI 10.1681/ASN.2015101100; Nio J, 2006, HISTOCHEM CELL BIOL, V126, P45, DOI 10.1007/s00418-005-0142-5; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Peters KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074355; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Pham PCT, 2014, INT J NEPHROL RENOV, V7, P219, DOI 10.2147/IJNRD.S42054; Picard N, 2005, J AM SOC NEPHROL, V16, P3602, DOI 10.1681/ASN.2004110923; Posadas-Sanchez R, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0143-3; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rebholz CM, 2016, AM J NEPHROL, V44, P381, DOI 10.1159/000450861; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Santambrogio S, 2008, BIOCHEM BIOPH RES CO, V370, P410, DOI 10.1016/j.bbrc.2008.03.099; Sarrafzadegan N, 2016, NUTRITION, V32, P409, DOI 10.1016/j.nut.2015.09.014; Schimatschek HF, 2001, MAGNESIUM RES, V14, P283; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmiedl A, 2003, MAGNESIUM RES, V16, P192; Schmitt R, 2004, HISTOCHEM CELL BIOL, V121, P319, DOI 10.1007/s00418-004-0638-4; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Tin A, 2015, KIDNEY INT, V87, P820, DOI 10.1038/ki.2014.331; Tokonami N., 2018, KIDNEY INT, VS0085-2538; Torffvit O, 2004, NEPHRON PHYSIOL, V97, pp31, DOI [DOI 10.1159/000077600, 10.1159/000077600]; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P2983, DOI 10.1093/ndt/gft358; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P879, DOI 10.1093/ndt/gfs499; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wang LJ, 2006, MOL CELL PROTEOMICS, V5, P560, DOI 10.1074/mcp.D500013-MCP200; WHANG R, 1990, JAMA-J AM MED ASSOC, V263, P3063, DOI 10.1001/jama.263.22.3063; Witkowski M, 2011, MAGNESIUM RES, V24, P163, DOI 10.1684/mrh.2011.0292; Wolf MTF, 2013, KIDNEY INT, V84, P130, DOI 10.1038/ki.2013.63; Ying WZ, 1998, KIDNEY INT, V54, P1150, DOI 10.1046/j.1523-1755.1998.00117.x	90	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16488	16502		10.1074/jbc.RA118.003950	http://dx.doi.org/10.1074/jbc.RA118.003950			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30139743	hybrid, Green Published			2022-12-26	WOS:000447833600030
J	Rangarajan, S; He, YA; Chen, YH; Kerzic, MC; Ma, BY; Gowthaman, R; Pierce, BG; Nussinov, R; Mariuzza, RA; Orban, J				Rangarajan, Sneha; He, Yanan; Chen, Yihong; Kerzic, Melissa C.; Ma, Buyong; Gowthaman, Ragul; Pierce, Brian G.; Nussinov, Ruth; Mariuzza, Roy A.; Orban, John			Peptide-MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T cell receptor (TCR); major histocompatibility complex (MHC); allosteric regulation; nuclear magnetic resonance (NMR); molecular dynamics; adaptive immunity; conformational change; T cell activation; signaling	BETA FG LOOP; ANTIGEN RECEPTOR; STRUCTURAL BASIS; CONFORMATIONAL ENTROPY; MOLECULAR-DYNAMICS; PROTEIN; RECOGNITION; ACTIVATION; COMPLEX; NMR	T cells generate adaptive immune responses mediated by the T cell receptor (TCR)-CD3 complex comprising an TCR heterodimer noncovalently associated with three CD3 dimers. In early T cell activation, alpha beta TCR engagement by peptide-major histocompatibility complex (pMHC) is first communicated to the CD3 signaling apparatus of the TCR-CD3 complex, but the underlying mechanism is incompletely understood. It is possible that pMHC binding induces allosteric changes in TCR conformation or dynamics that are then relayed to CD3. Here, we carried out NMR analysis and molecular dynamics (MD) simulations of both the alpha and beta chains of a human antiviral TCR (A6) that recognizes the Tax antigen from human T cell lymphotropic virus-1 bound to the MHC class I molecule HLA-A2. We observed pMHC-induced NMR signal perturbations in the TCR variable (V) domains that propagated to three distinct sites in the constant (C) domains: 1) the C beta FG loop projecting from the V beta/C beta interface; 2) a cluster of C beta residues near the C beta alpha A helix, a region involved in interactions with CD3; and 3) the C alpha AB loop at the membrane-proximal base of the TCR. A biological role for each of these allosteric sites is supported by previous mutational and functional studies of TCR signaling. Moreover, the pattern of long-range, ligand-induced changes in TCR A6 revealed by NMR was broadly similar to that predicted by the MD simulations. We propose that the unique structure of the TCR beta chain enables allosteric communication between the TCR-binding sites for pMHC and CD3.	[Rangarajan, Sneha; He, Yanan; Chen, Yihong; Kerzic, Melissa C.; Gowthaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Rangarajan, Sneha; Gowthaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [He, Yanan; Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Ma, Buyong; Nussinov, Ruth] NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mariuzza, RA; Orban, J (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu; jorban@umd.edu	Ma, Buyong/F-9491-2011; Pierce, Brian/AAB-8965-2022	Ma, Buyong/0000-0002-7383-719X; Pierce, Brian/0000-0003-4821-0368; Nussinov, Ruth/0000-0002-8115-6415; Gowthaman, Ragul/0000-0002-0008-6401	University of Maryland; National Institute of Standards and Technology; W.M. Keck Foundation; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129893] Funding Source: NIH RePORTER	University of Maryland; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Daniel R. Scott (National Institute of Standards and Technology) for the gift of TCR A6 expression plasmids. The NMR facility is jointly supported by the University of Maryland, the National Institute of Standards and Technology, and a grant from the W.M. Keck Foundation. All simulations were performed using the high-performance computational facilities of the Biowulf PC/Linux cluster at the National Institutes of Health, Bethesda, Maryland (https://hpc.nih.gov/systems/).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brameshuber M, 2018, NAT IMMUNOL, V19, P487, DOI 10.1038/s41590-018-0092-4; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Chavent M, 2016, STRUCTURE, V24, P337, DOI 10.1016/j.str.2015.11.008; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Goddard T.D., 2004, SPARKY 3; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; Hoffmann T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004244; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malissen B, 2015, ANNU REV IMMUNOL, V33, P539, DOI 10.1146/annurev-immunol-032414-112158; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; McLeish TCB, 2015, BIOPHYS J, V109, P1240, DOI 10.1016/j.bpj.2015.08.009; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Pierce BG, 2013, PROTEIN SCI, V22, P35, DOI 10.1002/pro.2181; Ramaprasad ASE, 2017, J AM CHEM SOC, V139, P17508, DOI 10.1021/jacs.7b09268; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; von Boehmer H, 2014, CANCER IMMUNOL RES, V2, P592, DOI 10.1158/2326-6066.CIR-14-0070; Wand AJ, 2013, CURR OPIN STRUC BIOL, V23, P75, DOI 10.1016/j.sbi.2012.11.005; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002	65	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15991	16005		10.1074/jbc.RA118.003832	http://dx.doi.org/10.1074/jbc.RA118.003832			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30135211	hybrid, Green Published			2022-12-26	WOS:000447256000020
J	Raba, DA; Rosas-Lemus, M; Menzer, WM; Li, C; Fang, X; Liang, PD; Tuz, K; Minh, DDL; Juarez, O				Raba, Daniel A.; Rosas-Lemus, Monica; Menzer, William M.; Li, Chen; Fang, Xuan; Liang, Pingdong; Tuz, Karina; Minh, David D. L.; Juarez, Oscar			Characterization of the Pseudomonas aeruginosa NQR complex, a bacterial proton pump with roles in autopoisoning resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); ubiquinone; proton pump; respiratory chain; bacterial metabolism; inhibition mechanism; quorum sensing; antibacterial compound; autotoxicity; HQNO; Na plus -NQR; quinolone; respiratory enzyme	NADH-QUINONE OXIDOREDUCTASE; NA+-TRANSLOCATING NADH; MARINE VIBRIO-ALGINOLYTICUS; UBIQUINONE-BINDING-SITE; DRIVEN ION-PUMP; NADHQUINONE OXIDOREDUCTASE; CYSTIC-FIBROSIS; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; MEMBRANE-PROTEIN	Pseudomonas aeruginosa is a Gram-negative bacterium responsible for a large number of nosocomial infections. The P. aeruginosa respiratory chain contains the ion-pumping NADH:ubiquinone oxidoreductase (NQR). This enzyme couples the transfer of electrons from NADH to ubiquinone to the pumping of sodium ions across the cell membrane, generating a gradient that drives essential cellular processes in many bacteria. In this study, we characterized P. aeruginosa NQR (Pa-NQR) to elucidate its physiologic function. Our analyses reveal that Pa-NQR, in contrast with NQR homologues from other bacterial species, is not a sodium pump, but rather a completely new form of proton pump. Homology modeling and molecular dynamics simulations suggest that cation selectivity could be determined by the exit ion channels. We also show that Pa-NQR is resistant to the inhibitor 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO). HQNO is a quinolone secreted by P. aeruginosa during infection that acts as a quorum sensing agent and also has bactericidal properties against other bacteria. Using comparative analysis and computational modeling of the ubiquinone-binding site, we identified the specific residues that confer resistance toward this inhibitor. In summary, our findings indicate that Pa-NQR is a proton pump rather than a sodium pump and is highly resistant against the P. aeruginosa-produced compound HQNO, suggesting an important role in the adaptation against autotoxicity. These results provide a deep understanding of the metabolic role of NQR in P. aeruginosa and provide insight into the structural factors that determine the functional specialization in this family of respiratory complexes.	[Raba, Daniel A.; Rosas-Lemus, Monica; Menzer, William M.; Fang, Xuan; Liang, Pingdong; Tuz, Karina; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Menzer, William M.; Li, Chen; Minh, David D. L.] IIT, Dept Chem, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Juarez, O (corresponding author), IIT, Robert A Pritzker Sci Ctr, 3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu	Fang, Xuan/CAG-5381-2022; Minh, David/A-4655-2009; Rosas-Lemus, Monica/U-4691-2019	Fang, Xuan/0000-0001-6394-4015; Minh, David/0000-0002-4802-2618; Tuz, Karina/0000-0002-1669-4612; Juarez, Oscar/0000-0002-2915-8413; Raba, Daniel/0000-0003-4334-0008; Menzer, William/0000-0001-5052-3158; Liang, Pingdong/0000-0002-8950-5755	National Institutes of Health [R15GM114781]; Illinois Institute of Technology; CONACYT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Institute of Technology; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15GM114781 (to D. D. L. M.), startup funds from the Illinois Institute of Technology (to O. J.), and CONACYT (to M. R.-L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; APELL HJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P480, DOI 10.1016/0005-2736(87)90055-1; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Babin BM, 2017, MBIO, V8, DOI 10.1128/mBio.01593-17; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2014, J BIOENERG BIOMEMBR, V46, P289, DOI 10.1007/s10863-014-9565-9; Barr HL, 2015, EUR RESPIR J, V46, P1046, DOI 10.1183/09031936.00225214; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Bucher D, 2010, BIOPHYS J, V98, pL47, DOI 10.1016/j.bpj.2010.01.064; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Cole SJ, 2014, INFECT IMMUN, V82, P2048, DOI 10.1128/IAI.01652-14; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; Crouzet M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180341; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dibrov P, 2017, CAN J PHYSIOL PHARM, V95, P595, DOI 10.1139/cjpp-2016-0505; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Fang XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186905; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Guina T, 2003, P NATL ACAD SCI USA, V100, P2771, DOI 10.1073/pnas.0435846100; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; Heikal A, 2014, MOL MICROBIOL, V91, P950, DOI 10.1111/mmi.12507; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ito T, 2017, J BIOL CHEM, V292, P7727, DOI 10.1074/jbc.M117.781393; JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl_A.19; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kamath KS, 2016, J PROTEOME RES, V15, P2152, DOI 10.1021/acs.jproteome.6b00058; Kang JW, 2007, J BIOCHEM MOL BIOL, V40, P53; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Kojima S, 1999, J BACTERIOL, V181, P1927, DOI 10.1128/JB.181.6.1927-1930.1999; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Liang PD, 2018, J BIOL CHEM, V293, P510, DOI 10.1074/jbc.M117.797209; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; MATSUSHITA K, 1984, BIOCHEMISTRY-US, V23, P4703, DOI 10.1021/bi00315a028; MATSUSHITA K, 1983, J BIOCHEM-TOKYO, V93, P1137, DOI 10.1093/oxfordjournals.jbchem.a134239; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MEUNIER B, 1995, BIOCHEMISTRY-US, V34, P1076, DOI 10.1021/bi00003a044; Minato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097083; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Moradali MF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00039; Muras V, 2016, J BACTERIOL, V198, P2307, DOI 10.1128/JB.00342-16; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Orazi G, 2017, MBIO, V8, DOI 10.1128/mBio.00873-17; PARKER VH, 1965, BIOCHEM J, V97, P658, DOI 10.1042/bj0970658; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHAFFAR BPH, 1989, MIKROCHIM ACTA, V3, P109; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SEGEL IH, 1993, ENZYME KINETICS BEHA, P957; Shea ME, 2015, BIOCHEMISTRY-US, V54, P490, DOI 10.1021/bi501266e; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; SKULACHEV VP, 1984, TRENDS BIOCHEM SCI, V9, P483, DOI 10.1016/0968-0004(84)90317-7; Steuber J, 2015, BIOL CHEM, V396, P1015, DOI 10.1515/hsz-2015-0128; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; WARREN JW, 1989, ARCH INTERN MED, V149, P1535, DOI 10.1001/archinte.149.7.1535; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182; Zemke AC, 2016, CURR BIOL, V26, pR80, DOI 10.1016/j.cub.2015.12.018; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	101	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15664	15677		10.1074/jbc.RA118.003194	http://dx.doi.org/10.1074/jbc.RA118.003194			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135204	Green Published, hybrid			2022-12-26	WOS:000446549200029
J	Carretero, GPB; Vicente, EF; Cilli, EM; Alvarez, CM; Jenssen, H; Schreier, S				Carretero, Gustavo P. B.; Vicente, Eduardo F.; Cilli, Eduardo M.; Alvarez, Carlos M.; Jenssen, Havard; Schreier, Shirley			Dissecting the mechanism of action of actinoporins. Role of the N-terminal amphipathic alpha-helix in membrane binding and pore activity of sticholysins I and II	PLOS ONE			English	Article							ANEMONE STICHODACTYLA-HELIANTHUS; CYTOLYSIN EQUINATOXIN-II; MINIPROTEIN STRUCTURE PREDICTION; SEA-ANEMONE; FORMING TOXIN; LIPID-MEMBRANES; INFRARED-SPECTROSCOPY; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; HEMOLYTIC-ACTIVITY	Actinoporins sticholysin I and sticholysin II (St I, St II) are proposed to lyse model and biomembranes via toroidal pore formation by their N-terminal domain. Based on the hypothesis that peptide fragments can reproduce the structure and function of this domain, the behavior of peptides containing St I residues 12-31 (StI(12)(-)(31)), St II residues 11-30 (StII(11)(-)(30)), and its TOAC-labeled analogue (N-TOAC-StII(11)(-)(30)) was examined. Molecular modeling showed a good match with experimental structures, indicating amphipathic alpha-helices in the same regions as in the toxins. CD spectra revealed that the peptides were essentially unstructured in aqueous solution, acquiring alpha-helical conformation upon interaction with micelles and large unilamellar vesicles (LUV) of variable lipid composition. Fluorescence quenching studies with NBD-containing lipids indicated that N-TOAC-StII(11)(-)(30)'s nitroxide moiety is located in the membranes polar head group region. Pyrene-labeled phospholipid inter-leaflet redistribution suggested that the peptides form toroidal pores, according to the mechanism of action proposed for the toxins. Binding occurred only to negatively charged LUV, indicating the importance of electrostatic interactions; in contrast the peptides bound to both negatively charged and zwitterionic micelles, pointing to a lesser influence of these interactions. In addition, differences between bilayers and micelles in head group packing and in curvature led to differences in peptide-membrane interaction. We propose that the peptides topography in micelles resembles that of the toxins in the toroidal pore. The peptides mimicked the toxins permeabilizing activity, St II peptides being more effective than StI(12)(-)(31). To our knowledge, this is the first demonstration that differences in the toxins N-terminal amphipathic alpha-helix play a role in the difference between St I and St II activities.	[Carretero, Gustavo P. B.; Schreier, Shirley] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Carretero, Gustavo P. B.; Jenssen, Havard] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Vicente, Eduardo F.] State Univ Sao Paulo, Fac Sci & Engn, Tupa, Brazil; [Cilli, Eduardo M.] State Univ Sao Paulo, Inst Chem, Araraquara, Brazil; [Alvarez, Carlos M.] Univ Havana, Ctr Prot Studies, Havana, Cuba	Universidade de Sao Paulo; Roskilde University; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidad de la Habana	Schreier, S (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	schreier@iq.usp.br	Cilli, Eduardo Maffud/K-1857-2019; Cilli, Eduardo Maffud/B-9130-2012; Schreier, Shirley/F-7001-2014; Vicente, Eduardo Festozo/Y-2439-2019; Carretero, Gustavo/M-5352-2018	Cilli, Eduardo Maffud/0000-0002-4767-0904; Cilli, Eduardo Maffud/0000-0002-4767-0904; Vicente, Eduardo Festozo/0000-0002-9154-3574; Carretero, Gustavo/0000-0001-7776-6256; Jenssen, Havard/0000-0003-0007-0335	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by grants to Shirley Schreier and to Eduardo M. Cilli from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), to Shirley Schreier and to Eduardo M. Cilli from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), to Shirley Schreier from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) through a Program between the Brazilian and Cuban Ministries of Education to support the visits of the Cuban researcher, Dr. Carlos M. Alvarez, to Havard Jenssen from Teknologi og Produktion, Det Frie Forskningsrad. Ph.D. fellowships were awarded to Gustavo P.B. Carretero and Eduardo F. Vicente by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). Gustavo P.B. Carretero was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) to do part of his doctorate in the laboratory of Dr. Havard Jenssen.	Alegre-Cebollada J, 2007, BIOPHYS J, V93, P3191, DOI 10.1529/biophysj.106.102566; Almeida PF, 2012, BBA-BIOMEMBRANES, V1818, P178, DOI 10.1016/j.bbamem.2011.07.019; Alvarez C, 2003, CHEM PHYS LIPIDS, V122, P97, DOI 10.1016/S0009-3084(02)00181-0; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1997, PROTEIN ENG, V10, P751, DOI 10.1093/protein/10.7.751; Antonini V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110824; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Atherton E, 1989, F MOC SOLID PHASE PE; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bozelli JC, 2012, CHEM PHYS LIPIDS, V165, P365, DOI 10.1016/j.chemphyslip.2011.12.005; Carretero GPB, 2018, BBA-BIOMEMBRANES, V1860, P1502, DOI 10.1016/j.bbamem.2018.05.003; Casallanovo F, 2006, BIOPOLYMERS, V84, P169, DOI 10.1002/bip.20374; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Cilli EM, 2007, TOXICON, V50, P1201, DOI 10.1016/j.toxicon.2007.07.013; de los Rios V, 1999, FEBS LETT, V455, P27, DOI 10.1016/S0014-5793(99)00846-7; de Oliveira AL, 2018, PEPTIDE SCI, V110, DOI 10.1002/bip.23097; Drechsler A, 2006, BIOCHEMISTRY-US, V45, P1818, DOI 10.1021/bi052166o; Drechsler A, 2009, EUR BIOPHYS J BIOPHY, V39, P121, DOI 10.1007/s00249-009-0445-x; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Ghosh T, 2003, BIOPHYS J, V85, P3187, DOI 10.1016/S0006-3495(03)74736-5; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Haldar S, 2011, J PHYS CHEM B, V115, P5693, DOI 10.1021/jp200255e; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Huerta V, 2001, TOXICON, V39, P1253, DOI 10.1016/S0041-0101(00)00247-6; Hunter HN, 2005, ANTIMICROB AGENTS CH, V49, P3387, DOI 10.1128/AAC.49.8.3387-3395.2005; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kumar P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010004; Lanio ME, 2001, TOXICON, V39, P187, DOI 10.1016/S0041-0101(00)00106-9; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Lopez-Castilla A, 2014, PROTEINS, V82, P1022, DOI 10.1002/prot.24475; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; MANCHENO JM, 2011, BIOCHIM BIOPHYS ACTA, V1545, P122; Manzini MC, 2014, BBA-BIOMEMBRANES, V1838, P1985, DOI 10.1016/j.bbamem.2014.04.004; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Menestrina G, 1999, BIOCHEM BIOPH RES CO, V254, P174, DOI 10.1006/bbrc.1998.9898; Miles AJ, 2008, BBA-BIOMEMBRANES, V1778, P2091, DOI 10.1016/j.bbamem.2008.04.001; Mojsoska B, 2015, PHARMACEUTICALS-BASE, V8, P366, DOI 10.3390/ph8030366; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Ros U, 2015, BIOCHIMIE, V116, P70, DOI 10.1016/j.biochi.2015.06.024; Ros U, 2013, BIOPOLYMERS, V100, P337, DOI 10.1002/bip.22211; Ros U, 2011, J BIOSCIENCES, V36, P781, DOI 10.1007/s12038-011-9156-4; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Santos TL, 2016, BIOPHYS J, V111, P2676, DOI 10.1016/j.bpj.2016.10.034; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Tanaka K, 2015, NAT COMMUN, V6; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walther TH, 2014, CURR OPIN STRUC BIOL, V27, P63, DOI 10.1016/j.sbi.2014.05.003	64	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202981	10.1371/journal.pone.0202981	http://dx.doi.org/10.1371/journal.pone.0202981			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161192	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900059
J	Lynn, H; Sun, XG; Ayshiev, D; Siegler, JH; Rizzo, AN; Karnes, JH; Garay, MG; Wang, T; Casanova, N; Camp, SM; Ellis, NA; Garcia, JGN				Lynn, Heather; Sun, Xiaoguang; Ayshiev, Djanybek; Siegler, Jessica H.; Rizzo, Alicia N.; Karnes, Jason H.; Garay, Manuel Gonzales; Wang, Ting; Casanova, Nancy; Camp, Sara M.; Ellis, Nathan A.; Garcia, Joe G. N.			Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans	PLOS ONE			English	Article							LIGHT-CHAIN-KINASE; COLORECTAL-CANCER; ENDOGENOUS RNA; GENE; EXPRESSION; MOUSE; CELLS; PROMOTER; VARIANT; 8Q24	Introduction Pseudogenes are paralogues of functional genes historically viewed as defunct due to either the lack of regulatory elements or the presence of frameshift mutations. Recent evidence, however, suggests that pseudogenes may regulate gene expression, although the functional role of pseudogenes remains largely unknown. We previously reported that MYLKP1, the pseudogene of MYLK that encodes myosin light chain kinase (MLCK), is highly expressed in lung and colon cancer cell lines and tissues but not in normal lung or colon. The MYLKP1 promoter is minimally active in normal bronchial epithelial cells but highly active in lung adenocarcinoma cells. In this study, we further validate MYLKP1as an oncogene via elucidation of the functional role of MYLKP1 genetic variants in colon cancer risk. Methods Proliferation and migration assays were performed in MYLKP/-transfected colon and lung cancer cell lines (H441, A549) and commercially-available normal lung and colon cells. Fourteen MYLKP1 SNPs (MAFs >0.01) residing within the 4 kb MYLKP1 promoter region, the core 1.4 kb of MYLKP1 gene, and a 4 kb enhancer region were selected and genotyped in a colorectal cancer cohort. MYLKP1 SNP influences on activity of MYLKP1 promoter (2kb) was assessed by dual luciferase reporter assay. Results Cancer cell lines, H441 and A549, exhibited increased MYLKP1 expression, increased MYLKP1 luciferase promoter activity, increased proliferation and migration. Genotyping studies identified two MYLKP1 SNPs (rs12490683; rs12497343) that significantly increase risk of colon cancer in African Americans compared to African American controls. Rs12490683 and rs12497343 further increase MYLKP1 promoter activity compared to the wild type MYLKP1 promoter. Conclusion MYLKP1 is a cancer-promoting pseudogene whose genetic variants differentially enhance cancer risk in African American populations.	[Lynn, Heather; Sun, Xiaoguang; Garay, Manuel Gonzales; Wang, Ting; Casanova, Nancy; Camp, Sara M.; Garcia, Joe G. N.] Univ Arizona Hlth Sci, Dept Med, Tucson, AZ 85721 USA; [Lynn, Heather; Garcia, Joe G. N.] Univ Arizona, Grad Interdisciplinary Program Physiol Sci, Tucson, AZ 85721 USA; [Ayshiev, Djanybek; Siegler, Jessica H.; Rizzo, Alicia N.] Univ Illinois, Dept Med, Chicago, IL USA; [Karnes, Jason H.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Ellis, Nathan A.] Univ Arizona Hlth Sci, Dept Cell & Mol Med, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Arizona; University of Arizona Health Sciences	Garcia, JGN (corresponding author), Univ Arizona Hlth Sci, Dept Med, Tucson, AZ 85721 USA.; Garcia, JGN (corresponding author), Univ Arizona, Grad Interdisciplinary Program Physiol Sci, Tucson, AZ 85721 USA.	skipgarcia@email.arizona.edu	Casanova, Nancy Gonzalez/L-5228-2019; Casanova, Nancy/ABA-6498-2020	Lynn, Heather/0000-0001-8259-2326; Gonzalez-Garay, Manuel/0000-0003-3412-0353	NHLBI NIH HHS [P01 HL126609, R01 HL091889] Funding Source: Medline; NIEHS NIH HHS [P30 ES006694] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL126609, R01HL091889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahuja N, 2007, ANN SURG ONCOL, V14, P411, DOI 10.1245/s10434-006-9130-9; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Cui WJ, 2010, ACTA PHARMACOL SIN, V31, P725, DOI 10.1038/aps.2010.56; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Esposito F, 2014, ONCOTARGET, V5, P8341, DOI 10.18632/oncotarget.2202; Falush D, 2003, GENETICS, V164, P1567; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Giorgi D, 2001, GENOMICS, V75, P49, DOI 10.1006/geno.2001.6571; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kessler MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12521; Khan I, 2015, ELIFE, V4, DOI [10.7554/eLife.08245, DOI 10.7554/ELIFE.08245]; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Liu JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep41179; Sayagues JM, 2016, ONCOTARGET, V7, P72908, DOI 10.18632/oncotarget.12140; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; Matsushita I, 2002, J CLIN GASTROENTEROL, V35, P29, DOI 10.1097/00004836-200207000-00008; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2011, J INVEST DERMATOL, V131, P2497, DOI 10.1038/jid.2011.232; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Purcell S, AM J HUMAN GENETICS, V81; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tan X, 2014, TUMOR BIOL, V35, P12189, DOI 10.1007/s13277-014-2527-3; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Wen YZ, 2012, RNA BIOL, V9, P27, DOI 10.4161/rna.9.1.18277; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhang H, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691418; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2; Zhou SG, 2014, J CANCER RES CLIN, V140, P1989, DOI 10.1007/s00432-014-1699-y; Zhou T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094325	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0200916	10.1371/journal.pone.0200916	http://dx.doi.org/10.1371/journal.pone.0200916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161129	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900005
J	Koussemou, M; Lorenz, K; Klotz, KN				Koussemou, Marthe; Lorenz, Kristina; Klotz, Karl-Norbert			The A(2B) adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1	PLOS ONE			English	Article							TUMOR-GROWTH INHIBITION; MEDIATED INHIBITION; PROTEIN-KINASE; CAMP; TARGET; SIGNAL; EXPRESSION; APOPTOSIS; THERAPY; CALCIUM	It was previously shown that the estrogen-receptor negative breast cancer cell line MBA-MD-231 expresses high levels of A(2B) adenosine receptors as the sole adenosine receptor subtype. These receptors couple to both, stimulation of adenylyl cyclase and a Ca2+ signal. In order to establish a potential role of A(2B) adenosine receptors in tumor growth and development MAPK signaling was investigated in these breast cancer cells. Although it is known that A(2B) adenosine receptors may stimulate MAPK it was found that in MBA-MD-231 cells ERK1/2 phosphorylation is reduced upon agonist-stimulation of A(2B) adenosine receptors. This reduction is also triggered by forskolin, but abolished by the PKA inhibitor H89, suggesting an important role for the cAMP-PKA pathway. Likewise, a role for intracellular Ca2+ was established as the Ca2+ chelator 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM) abolished the reduction of ERK1/2 phosphorylation triggered by A(2B) stimulation. It was shown that various pathways downstream from A(2B) adenosine receptors resulted in a stimulation of MAPK phosphatase-1 (MKP-1) which dephosphorylates phospho ERK1/2, and thus plays a critical role in the regulation of the phosphorylation state of ERK1/2. The reduction of ERK1/2 phosphorylation mediated by A(2B) adenosine receptors might provide an interesting approach for adjuvant treatment leading to reduced growth of certain tumors expressing the A(2B) subtype.	[Koussemou, Marthe; Lorenz, Kristina; Klotz, Karl-Norbert] Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany; [Lorenz, Kristina] Leibniz Inst Analyt Wissensch ISAS eV, Bunsen Dortmund, Germany; [Lorenz, Kristina] West German Heart & Vasc Ctr Essen, Essen, Germany	University of Wurzburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Klotz, KN (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany.	klotz@toxi.uni-wuerzburg.de	Lorenz, Kristina/F-3522-2016	Lorenz, Kristina/0000-0002-5747-2207; Klotz, Karl-Norbert/0000-0003-3553-3205				Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Fishman P, 2009, Handb Exp Pharmacol, P399, DOI 10.1007/978-3-540-89615-9_14; Fredholm B. B., 2001, PHARMACOL REV, V63, P1; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Galaz-Montoya M, 2017, J BIOL CHEM, V292, P9967, DOI 10.1074/jbc.M117.787119; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Haneda M, 1996, KIDNEY INT, V50, P384, DOI 10.1038/ki.1996.327; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Li RC, 2004, CIRC RES, V94, P759, DOI 10.1161/01.RES.0000121568.40692.97; Madi L, 2003, J BIOL CHEM, V278, P42121, DOI 10.1074/jbc.M301243200; Madi L, 2004, CLIN CANCER RES, V10, P4472, DOI 10.1158/1078-0432.CCR-03-0651; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Naviglio S, 2009, CANCER BIOL THER, V8, P1183, DOI 10.4161/cbt.8.12.8562; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Ohana G, 2001, J CELL PHYSIOL, V186, P19, DOI 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Panjehpour M, 2005, BRIT J PHARMACOL, V145, P211, DOI 10.1038/sj.bjp.0706180; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Scimeca JC, 1997, ONCOGENE, V15, P717, DOI 10.1038/sj.onc.1201231; Tuglu MM, 2018, MOL MED REP, V17, P2033, DOI 10.3892/mmr.2017.8092	27	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202914	10.1371/journal.pone.0202914	http://dx.doi.org/10.1371/journal.pone.0202914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157211	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400075
J	McNairy, ML; Jannat-Khah, D; Pape, JW; Marcelin, A; Joseph, P; Mathon, JE; Koenig, S; Wells, M; Fitzgerald, DW; Evans, A				McNairy, Margaret L.; Jannat-Khah, Deanna; Pape, Jean W.; Marcelin, Adias; Joseph, Patrice; Mathon, Jean Edward; Koenig, Serena; Wells, Martin; Fitzgerald, Daniel W.; Evans, Arthur			Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORD; ADVANCED HIV-INFECTION; SUB-SAHARAN AFRICA; TREATMENT OUTCOMES; MORTALITY; CARE; TUBERCULOSIS; AIDS; PREVENTION; IMPACT	Background Over 18 million adults have initiated life-saving antiretroviral therapy (ART) in resource-poor settings; however, mortality and lost-to-follow-up rates continue to be high among patients in their first year after treatment start. Clinical decision tools are needed to identify patients at high risk for poor outcomes in order to provide individualized risk assessment and intervention. This study aimed to develop and externally validate risk prediction tools that estimate the probability of dying or of being lost to follow-up (LTF) during the year after starting ART. Methods We used a derivation cohort of 7,031 adults age 15-70 years initiating ART from 2007 to 2013 at 6 clinics in Haiti; 242 (3.5%) had documented death and 1,521 (21.6%) were LTF at 1 year after starting ART. The following routinely collected data were used as predictors in two logistic regression models (one to predict death and another to predict LTF): age, gender, weight, CD4 count, WHO Stage, and diagnosis of tuberculosis (TB). The validation cohort consisted of 1,835 adults initiating ART at a different HIV clinic in Haiti during 2012. We assessed model discrimination by measuring the C-statistic, and measured model calibration by how closely the predicted probabilities approximated actual probabilities of the two outcomes. We derived a nomogram and a point-based risk score from the predictive models. Findings The model predicting death within the year after starting ART had a C-statistic of 0.75 (95% CI 0.74 to 0.81). There was no evidence for significant overfitting and the predictions were well calibrated. The strongest predictors of 1-year mortality were male gender, low weight, low CD4 count, advanced WHO stage, and the absence of TB. In the validation cohort, the C-statistic was 0.69 (95% CI 0.59 to 0.77). A point-based risk score for death had a C-statistic 0.73 (95% CI 0.69 to 0.76) and categorizes patients as low risk (< 2% risk of death), average risk (3-4%), and high-risk (8-10%) and very high-risk (14-19%) with likelihood ratios to be used in settings where the baseline risk is different from our study population. The model predicting LTF did not discriminate well (C-statistic 0.59). Conclusions A simple risk-score using routinely collected data can predict 1-year mortality after ART initiation for HIV-positive adults in Haiti. However, predicting lost to follow-up using routinely collected data was not as successful. The next step is to assess whether use of this risk score can identify patients who need tailored services to reduce mortality in resource-poor settings such as Haiti.	[McNairy, Margaret L.; Jannat-Khah, Deanna; Evans, Arthur] Weill Cornell Med, Div Gen Internal Med, New York, NY 10065 USA; [McNairy, Margaret L.; Fitzgerald, Daniel W.] Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA; [Pape, Jean W.; Marcelin, Adias; Joseph, Patrice; Mathon, Jean Edward] Haitian Grp Study Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena] Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA USA; [Wells, Martin] Cornell Univ, Dept Stat Sci, Ithaca, NY USA	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University	McNairy, ML (corresponding author), Weill Cornell Med, Div Gen Internal Med, New York, NY 10065 USA.; McNairy, ML (corresponding author), Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA.	mam9365@med.cornell.edu	Jannat-Khah, Deanna/L-9701-2019	Jannat-Khah, Deanna/0000-0002-1091-379X; Wells, Martin/0000-0002-9750-9529	FIC NIH HHS [D43 TW010062] Funding Source: Medline; NIAID NIH HHS [K24 AI098627] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal M, 2016, JAIDS-J ACQ IMM DEF, V73, pE33, DOI 10.1097/QAI.0000000000001117; Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Bengtson AM, 2016, AIDS CARE, V28, P1035, DOI 10.1080/09540121.2016.1144869; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brown ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092606; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Ellman T, 2015, NEW ENGL J MED, V372, P303, DOI 10.1056/NEJMp1414730; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Harrell FE, 2001, REGRESSION MODELING; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Irungu EM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1899-y; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; Koenig SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146903; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Marcelin A, 2015, STUD HEALTH TECHNOL, V216, P883, DOI 10.3233/978-1-61499-564-7-883; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; McNairy ML, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002278; McNairy ML, 2015, JAIDS-J ACQ IMM DEF, V70, pE44, DOI 10.1097/QAI.0000000000000745; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Pierre S, 2016, NEW ENGL J MED, V374, P397, DOI 10.1056/NEJMc1508934; Puttkammer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112261; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; UNAIDS, 2014, UNAIDS COUNTR REP; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2006, AN THER HIV INT AD A; World Health Organization, 2015, CONS GUID US ANT DRU; World Health Organization, 2009, RAP ADV ANT THER HIV	48	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201945	10.1371/journal.pone.0201945	http://dx.doi.org/10.1371/journal.pone.0201945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157197	gold, Green Published, Green Submitted			2022-12-26	WOS:000443071400021
J	O'Brien, TG; Kinnaird, MF; Ekwanga, S; Wilmers, C; Williams, T; Oriol-Cotterill, A; Rubenstein, D; Frank, LG				O'Brien, Timothy G.; Kinnaird, Margaret F.; Ekwanga, Steven; Wilmers, Christopher; Williams, Terrie; Oriol-Cotterill, Alayne; Rubenstein, Daniel; Frank, Laurence G.			Resolving a conservation dilemma: Vulnerable lions eating endangered zebras	PLOS ONE			English	Article							PREY; DYNAMICS; YELLOWSTONE; CARNIVORES; PREDATORS; LANDSCAPE; LIVESTOCK; WILDLIFE; ECOLOGY; NEED	When predators are removed or suppressed for generations, prey populations tend to increase and when predators are re-introduced, prey densities should fall back to pre-control levels. In cases of apparent competition where there are alternate abundant and rare prey species, rare species may decline further than expected or disappear altogether. Recently, concern about the impact of recovering predator populations on wildlife in Laikipia County, Kenya, has led to questions of whether lions (Panthera leo, IUCN Red List Vulnerable) exert top-down pressure on Grevy's zebra (Equus grevyi, IUCN Red List Endangered). We examined effects of lion predation on Plain's zebra (E. quagga, IUCN Red List Near Threatened) and Grevy's zebra populations in a 2,105 km(2) area defined by lion movements. We used line transect surveys to estimate density of Grevy's (0.71/km(2)) and Plain's (15.9/ km(2)) zebras, and satellite telemetry to measure movements for lions and both zebras. We tracked lions to potential feeding sites to estimate predation rates on zebras. We compared field-based estimates of predation rates on both zebras to random gas models of encounters that result in predation to ask if lions prey preferentially on Grevy's zebra at a sufficient rate to drive population declines. Lions preyed on Grevy's zebra significantly less than expected in 15 of 16 (94%) scenarios considered and lions preyed on Plain's zebras as expected or significantly less than expected in 15 of 16 scenarios. Population trend of Grevy's zebra indicates that the Kenya population may be stabilizing. Recruitment rate to the population has tripled since 2004, making it unlikely that lions are having an impact on Grevy's zebras. In Laikipia County, competitive displacement by livestock (Livestock: Grevy's zebra ratio = 864: 1) and interference competition for grass with Plain's zebra (Plain's zebra: Grevy's zebra ratio = 22: 1) are most likely the predominant threats to Grevy's Zebra recovery.	[O'Brien, Timothy G.] Wildlife Conservat Soc, Global Programs, Bronx, NY 10460 USA; [O'Brien, Timothy G.; Kinnaird, Margaret F.; Rubenstein, Daniel] Mpala Res Ctr, Nanyuki, Kenya; [Ekwanga, Steven; Frank, Laurence G.] Living Lions, Nanyuki, Kenya; [Wilmers, Christopher] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Williams, Terrie] Univ Calif Santa Cruz, Ctr Ocean Hlth, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Oriol-Cotterill, Alayne] Ewaso Lions, Nairobi, Kenya; [Oriol-Cotterill, Alayne] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, England; [Rubenstein, Daniel] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Frank, Laurence G.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Wildlife Conservation Society; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Oxford; Princeton University; University of California System; University of California Berkeley	O'Brien, TG (corresponding author), Wildlife Conservat Soc, Global Programs, Bronx, NY 10460 USA.; O'Brien, TG (corresponding author), Mpala Res Ctr, Nanyuki, Kenya.	tobrien@wcs.org			NSF [DBI:0963022, DBI:1255913, IOB:9874523, IIS:0705822, IBN:030923]; Chester Zoo; Cleveland Metroparks Zoo; Disney Foundation; San Francisco Zoo; Meeker Family Fund; Banovich Wildscapes Foundation; Zeitz Foundation; Donald and Maureen Green Foundation; Wildlife Conservation Society; Australian 60 Minutes	NSF(National Science Foundation (NSF)); Chester Zoo; Cleveland Metroparks Zoo; Disney Foundation; San Francisco Zoo; Meeker Family Fund; Banovich Wildscapes Foundation; Zeitz Foundation; Donald and Maureen Green Foundation; Wildlife Conservation Society; Australian 60 Minutes	Funding was provided by: NSF grants DBI:0963022, DBI:1255913, IOB:9874523, IIS:0705822 and IBN:030923, Chester Zoo, Cleveland Metroparks Zoo, Disney Foundation, San Francisco Zoo, Meeker Family Fund, Banovich Wildscapes Foundation, Zeitz Foundation, Donald and Maureen Green Foundation, the Wildlife Conservation Society, Australian 60 Minutes, Bruce Ludwig, Frank Levinson, and Cindy Calderon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Anderson JJ, 2005, ECOL MODEL, V186, P196, DOI 10.1016/j.ecolmodel.2005.01.014; Anderson TM, 2010, ECOLOGY, V91, P1519, DOI 10.1890/09-0739.1; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DENNEY RN, 1972, J RANGE MANAGE, V25, P415, DOI 10.2307/3896997; DOBSON AP, 1989, CONSERV BIOL, V3, P362, DOI 10.1111/j.1523-1739.1989.tb00242.x; ELLIOTT JP, 1977, CAN J ZOOL, V55, P1811, DOI 10.1139/z77-235; Ford AT, 2015, ECOLOGY, V96, P2705, DOI 10.1890/14-2056.1.sm; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; Frank L, 2003, WILDLIFE SOC B, V31, P309; Frank L., 2011, SMITHSONIAN CONTRIBU, V632; Georgiadis NJ, 2007, BIOL CONSERV, V137, P473, DOI 10.1016/j.biocon.2007.03.006; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; IUCN, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en2, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN2]; Kinnaird M, 2012, SAMPLE COUNT AERIAL; Kinnaird MF, 2012, CONSERVATION BIOL; Kinnaird MF, 2000, MOVE WHY ANIMALS TRA; Kruuk H., 1972, THE SPOTTED HYENA; Lotka AJ, 1924, ELEMENTS PHYS BIOL; MILLS MGL, 1992, J ANIM ECOL, V61, P693, DOI 10.2307/5624; MITANI JC, 1991, ANIM BEHAV, V42, P33, DOI 10.1016/S0003-3472(05)80603-7; Napao MI, 2016, THESIS; Ng'weno CC, 2017, J MAMMAL, V98, P1078, DOI 10.1093/jmammal/gyx040; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rubenstein D.I., 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T7950A89624491.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T7950A89624491.EN]; Rubenstein DI, 2010, ADV STUD BEHAV, V42, P231, DOI 10.1016/S0065-3454(10)42007-0; Schaller G. B., 1972, SERENGETI LION STUDY; SKELLAM JG, 1958, BIOMETRICS, V14, P385, DOI 10.2307/2527881; Springer AM, 2008, MAR MAMMAL SCI, V24, P414, DOI 10.1111/j.1748-7692.2008.00185.x; Stephens D.W., 1986, pi; Terborgh J., 2010, TROPHIC CASCADES PRE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; US Fish and Wildlife Service, 2007, REC PLAN SIERR NEV B; van Orsdal KG, 1984, AFRICAN J ECOLOGY, V22, P159; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Young TP, 2007, OECOLOGIA, V109, P98	51	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201983	10.1371/journal.pone.0201983	http://dx.doi.org/10.1371/journal.pone.0201983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157200	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400023
J	Touquet, B; Pelissier, L; Cavailles, P; Yi, W; Bellini, V; Mercier, C; Cesbron-Delauw, MF; Boumendjel, A; Aldebert, D				Touquet, Bastien; Pelissier, Leonie; Cavailles, Pierre; Yi, Wei; Bellini, Valeria; Mercier, Corinne; Cesbron-Delauw, Marie-France; Boumendjel, Ahcene; Aldebert, Delphine			High-content imaging assay to evaluate Toxoplasma gondii infection and proliferation: A multiparametric assay to screen new compounds	PLOS ONE			English	Article							INHIBITION; DRUGS	Toxoplasma gondii is an intracellular protozoan parasite widely distributed in animals and humans. Infection of host cells and parasite proliferation are essential steps in Toxoplasma pathology. The objective of this study was to develop and validate a novel automatic High Content Imaging (HCI) assay to study T. gondii infection and proliferation. We tested various fluorescent markers and strategies of image analysis to obtain an automated method providing results comparable to those from gold standard infection and proliferation assays. No significant difference was observed between the results obtained from the HCI assay and the standard assays (manual fluorescence microscopy and incorporation of [ 3 H]-uracil). We developed here a robust and time-saving assay. This automated technology was then used to screen a library of compounds belonging to four classes of either natural compounds or synthetic derivatives. Inhibition of parasite proliferation and host cell toxicity were measured in the same assay and led to the identification of one hit, a thiosemicarbazone that allows important inhibition of Toxoplasma proliferation while being relatively safe for the host cells.	[Touquet, Bastien] Univ Grenoble Alpes, CNRS UMR 5309, INSERM U1209, Inst Adv Biosci,Team Membrane Dynam Parasite Host, Grenoble, France; [Pelissier, Leonie; Aldebert, Delphine] Univ Grenoble Alpes, CNRS UMR 5525, Equipe TheREx, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France; [Pelissier, Leonie; Yi, Wei; Boumendjel, Ahcene] Univ Grenoble Alpes, CNRS UMR 5063, Dept Pharmacochim Mol, Grenoble, France; [Cavailles, Pierre] Univ Grenoble Alpes, CNRS UMR 5525, Equipe BNI, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France; [Bellini, Valeria] Univ Grenoble Alpes, CNRS UMR 5309, INSERM U1209, Inst Adv Biosci,Team Host Pathogen Interact & Imm, Grenoble, France; [Mercier, Corinne] Univ Grenoble Alpes, CNRS UMR 5525, Equipe GEM, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France; [Pelissier, Leonie] Univ Geneva, Ecole Pharm Geneve Lausanne, Sect Sci Pharmaceut, Phytochim & Prod Nat Bioactifs, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Geneva	Aldebert, D (corresponding author), Univ Grenoble Alpes, CNRS UMR 5525, Equipe TheREx, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France.	delphine.aldebert@univ-grenoble-alpes.fr	Boumendjel, Ahcene/AFN-9621-2022; Touquet, Bastien/F-4757-2019; Touquet, Bastien/AAO-9681-2020; cavaillès, pierre/R-8756-2017; Aldebert, Delphine/C-2807-2019	Touquet, Bastien/0000-0002-2619-9818; Touquet, Bastien/0000-0002-2619-9818; cavaillès, pierre/0000-0001-5559-8634; Bellini, Valeria/0000-0003-2066-9206; Aldebert, Delphine/0000-0002-4939-0367	CNRS (Centre National de la Recheche Scientifique); UGA (Universite Grenoble, Alpes); ANR (Agence Nationale pour la Recherche); Labex Arcane [ANR-11-LABX-0003-01]; Fondation pour la Recherche Medicale-;  [Labex Parafrap-ANR-11-LABX-0024-]	CNRS (Centre National de la Recheche Scientifique); UGA (Universite Grenoble, Alpes); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); Labex Arcane; Fondation pour la Recherche Medicale-(Fondation pour la Recherche Medicale); 	This work was supported by CNRS (Centre National de la Recheche Scientifique), UGA (Universite Grenoble, Alpes), ANR (Agence Nationale pour la Recherche) and Labex Arcane (ANR-11-LABX-0003-01), Fondation pour la Recherche Medicale- and Labex Parafrap-ANR-11-LABX-0024-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alday PH, 2017, DRUG DES DEV THER, V11, P273, DOI 10.2147/DDDT.S60973; Alonso-Padilla J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003493; Boccard J, 2009, EUR J PHARM SCI, V36, P254, DOI 10.1016/j.ejps.2008.09.009; Boumendjel A, 2008, J MED CHEM, V51, P2307, DOI 10.1021/jm0708331; Boveia V, 2009, USING Z FACTOR COEFF, P1; CESBRONDELAUW MF, 1989, P NATL ACAD SCI USA, V86, P7537, DOI 10.1073/pnas.86.19.7537; Dimier IH, 1997, IMMUNOL CELL BIOL, V75, P511, DOI 10.1038/icb.1997.80; Gaji RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064693; Haudecoeur R, 2011, J MED CHEM, V54, P5395, DOI 10.1021/jm200242p; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jin C, 2012, EXPERT OPIN DRUG DIS, V7, P195, DOI 10.1517/17460441.2012.660479; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Moon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061812; Nicolle E, 2011, CURR MED CHEM, V18, P2661, DOI 10.2174/092986711795933777; Nohara LL, 2010, PARASITOL INT, V59, P565, DOI 10.1016/j.parint.2010.07.007; Siqueira-Neto JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001671; Valdameri G, 2012, J MED CHEM, V55, P966, DOI 10.1021/jm201404w; Yazdanparast E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002850; Yi W, 2011, EUR J MED CHEM, V46, P4330, DOI 10.1016/j.ejmech.2011.07.003	20	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201678	10.1371/journal.pone.0201678	http://dx.doi.org/10.1371/journal.pone.0201678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157171	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400010
J	Wenzel, MA; Douglas, A; Piertney, SB				Wenzel, Marius A.; Douglas, Alex; Piertney, Stuart B.			Microbiome composition within a sympatric species complex of intertidal isopods (Jaera albifrons)	PLOS ONE			English	Article							WIDESPREAD WOLBACHIA INFECTION; BACTERIAL COMMUNITIES; REPRODUCTIVE ISOLATION; EVOLUTION; ENDOSYMBIONT; SPECIATION; DIVERSITY; PHYLOGENY; CRUSTACEA; ECOLOGY	The increasingly recognised effects of microbiomes on the eco-evolutionary dynamics of their hosts are promoting a view of the "hologenome" as an integral host-symbiont evolutionary entity. For example, sex-ratio distorting reproductive parasites such as Wolbachia are well-studied pivotal drivers of invertebrate reproductive processes, and more recent work is highlighting novel effects of microbiome assemblages on host mating behaviour and developmental incompatibilities that underpin or reinforce reproductive isolation processes. However, examining the hologenome and its eco-evolutionary effects in natural populations is challenging because microbiome composition is considerably influenced by environmental factors. Here we illustrate these challenges in a sympatric species complex of intertidal isopods (Jaera albifrons spp.) with pervasive sex-ratio distortion and ecological and behavioural reproductive isolation mechanisms. We deep-sequence the bacterial 16S rRNA gene among males and females collected in spring and summer from two coasts in north-east Scotland, and examine microbiome composition with a particular focus on reproductive parasites. Microbiomes of all species were diverse (overall 3,317 unique sequences among 3.8 million reads) and comprised mainly Proteobacteria and Bacteroidetes taxa typical of the marine intertidal zone, in particular Vibrio spp. However, we found little evidence of the reproductive parasites Wolbachia, Rickettsia, Spiroplasma and Cardinium, suggesting alternative causes of sex-ratio distortion. Notwithstanding, a significant proportion of the variance in microbiome composition among samples was explained by sex (14.1 %), nested within geographic (26.9 %) and seasonal (39.6 %) variance components. The functional relevance of this sex signal was difficult to ascertain given the absence of reproductive parasites, the ephemeral nature of the species assemblages and substantial environmental variability. These results establish the Jaera albifrons species complex as an intriguing system for examining the effects of microbiomes on reproductive processes and speciation, and highlight the difficulties associated with snapshot assays of microbiome composition in dynamic and complex environments.	[Wenzel, Marius A.; Douglas, Alex; Piertney, Stuart B.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of Aberdeen	Wenzel, MA (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	marius.wenzel@abdn.ac.uk		Wenzel, Marius Alexander/0000-0003-0093-368X; Douglas, Alex/0000-0001-6606-1058	UK Natural Environment Research Council (NERC) [NE/M015661/1]; University of Aberdeen; NERC [NE/M015661/1, NBAF010002, NBAF010003] Funding Source: UKRI	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Aberdeen; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council (NERC), grant NE/M015661/1, awarded to SBP and AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to Heather Ritchie and Laura Howell for fieldwork assistance. We acknowledge the computational support of the Maxwell HPC cluster funded by the University of Aberdeen.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Bahrndorff S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/5304028; Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierlich KC, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02574-17; BOCQUET C, 1954, SYST ZOOL, V3, P148, DOI 10.2307/2411376; Bolhuis H., 2016, MARINE MICROBIOME, P3, DOI [10.1007/978-3-319-33000-6, DOI 10.1007/978-3-319-33000-6_1, 10.1007/978-3-319-33000-6_1, DOI 10.1007/978-3-319-33000-6]; Bordenstein SR, 2007, HEREDITY, V99, P278, DOI 10.1038/sj.hdy.6800994; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Brooks AW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000225; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Chistoserdov AY, 2012, J SHELLFISH RES, V31, P449, DOI 10.2983/035.031.0205; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Esposti MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176573; Dittmer J, 2014, MOL ECOL, V23, P2619, DOI 10.1111/mec.12760; Dittmer J, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw063; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Edgar RC, 2017, UPDATING 97 BIORXIV; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fitzpatrick CR, 2018, P NATL ACAD SCI USA; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gilbert SF, 2015, NAT REV GENET, V16, P611, DOI 10.1038/nrg3982; Gromek SM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01342; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hakim JA, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw146; Hazra S., 2014, THESIS; Heuschele J, 2014, J PLANKTON RES, V36, P895, DOI 10.1093/plankt/fbu025; Hird SM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00725; Hjerde E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-616; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ishak HD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00204; Jackel R, 2013, MOL ECOL, V22, P4241, DOI 10.1111/mec.12389; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Jones M.B., 1972, Journal of exp mar Biol Ecol, V9, P231, DOI 10.1016/0022-0981(72)90035-4; JONES MB, 1971, J ZOOL, V165, P183; Kageyama D, 2017, EVOL LETT, V1, P232, DOI 10.1002/evl3.28; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kessner L, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00148-16; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Larsen AM, 2015, MICROB ECOL, V70, P534, DOI 10.1007/s00248-015-0578-7; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Mariadassou M., 2016, GITHUB REPOSITORY; Martin MO, 2010, SYMBIOSIS, V51, P97, DOI 10.1007/s13199-010-0078-y; McFall-Ngai MJ, 2014, ANNU REV MICROBIOL, V68, P177, DOI 10.1146/annurev-micro-091313-103654; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mee PT, 2015, APPL ENVIRON MICROB, V81, P6177, DOI 10.1128/AEM.01239-15; Mengoni A, 2013, ESTUAR COAST SHELF S, V131, P75, DOI 10.1016/j.ecss.2013.08.011; Merilaita S, 1997, ANIM BEHAV, V54, P769, DOI 10.1006/anbe.1996.0490; Mifsud DV, 2011, THESIS; Moisander PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138967; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Nakayama T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-35; NAYLOR E, 1966, J ANIM ECOL, V35, P209, DOI 10.2307/2697; Naylor E., 1972, BRIT MARINE ISOPODS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavloudi C, 2017, PEERJ, V5, DOI 10.7717/peerj.3687; Pennings SC, 2000, CAN J ZOOL, V78, P1918, DOI 10.1139/cjz-78-11-1918; Piertney SB, 1996, J MAR BIOL ASSOC UK, V76, P825, DOI 10.1017/S0025315400031490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ribardiere A, 2018, J EXP MAR BIOL UNPUB; Ribardiere A, 2017, ECOL EVOL, V7, P5352, DOI 10.1002/ece3.3106; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rogers EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106215; Rosenberg E, 2016, MBIO, V7, DOI 10.1128/mBio.01395-15; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; Schuelke T, 2018, MOL ECOL, V27, P1930, DOI 10.1111/mec.14539; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15; Simhadri RK, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00287-17, 10.1128/msphere.00287-17]; Smith JE, 2009, PARASITOLOGY, V136, P1901, DOI 10.1017/S0031182009991818; SOLIGNAC M, 1981, SYST ZOOL, V30, P387, DOI 10.2307/2413051; STANHOPE MJ, 1992, J CHEM ECOL, V18, P1871, DOI 10.1007/BF02751110; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sutton R, 2005, J CHEM ECOL, V31, P1865, DOI 10.1007/s10886-005-5931-8; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Venables WN., 2002, MODERN APPL STAT S 4; VEUILLE M, 1980, BIOL J LINN SOC, V13, P89, DOI 10.1111/j.1095-8312.1980.tb00072.x; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weigel BL, 2016, APPL ENVIRON MICROB, V82, P650, DOI 10.1128/AEM.02980-15; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Winters AD, 2015, CAN J MICROBIOL, V61, P72, DOI 10.1139/cjm-2014-0434; Yong HS, 2017, META GENE, V14, P6, DOI 10.1016/j.mgene.2017.07.007; Young VB, 2017, BMJ, V356; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	100	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202212	10.1371/journal.pone.0202212	http://dx.doi.org/10.1371/journal.pone.0202212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157257	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400044
J	Anand, T; Kishore, J; Isaakidis, P; Gupte, HA; Kaur, G; Kumari, S; Jha, D; Grover, S				Anand, Tanu; Kishore, Jugal; Isaakidis, Petros; Gupte, Himanshu A.; Kaur, Gurmeet; Kumari, Sneha; Jha, Diwakar; Grover, Shekhar			Integrating screening for non-communicable diseases and their risk factors in routine tuberculosis care in Delhi, India: A mixed-methods study	PLOS ONE			English	Article							DIABETES-MELLITUS	Background Evidence supports the integration of prevention and management for tuberculosis (TB) with non-communicable diseases (NCDs). Bi-directional screening for TB and diabetes mellitus (DM) is already implemented in India, a country with a dual burden of TB and NCDs. However, very limited programmatic data are available on the feasibility of adding other NCDs and their risk factors in such screening programme. Objective To assess the yield, feasibility, and acceptability of a two-stage integrated screening for NCDs and risk factors for NCDs among patients with TB >= 20 years and treated in DOTS centres of two medical colleges in Delhi, between October 2016 and March 2017. Results Amongst 403 patients screened, the prevalence of hypertension was 7% (n = 28) with 20 new cases detected and 8% for DM (n = 32) with 6 new cases diagnosed. The number needed to screen to find a new case was 20 and 63 for hypertension and DM respectively. The most frequent NCD-risk factors were inadequate vegetable (80%) and fruits (72%) intake, alcohol use (34%), use of smokeless tobacco (33%) and smoking (32%). Clustering of four or more risk factors was associated with increasing age and male sex (p<0.05). Both patients and health providers considered the screening relevant and acceptable. However, waiting time and costs involved in blood tests were considered as bothersome by the patients, while health providers perceived increased workload, inadequate medical supplies and inadequate skills and knowledge as key challenges in implementation of the screening. Conclusion Integrating screening for NCDs and their risk factors in the existing TB programme produces high yield and it is feasible and acceptable by patients and health providers provided the challenges are overcome.	[Anand, Tanu; Kaur, Gurmeet; Jha, Diwakar] Hindu Rao Hosp, North Delhi Municipal Corp Med Coll, Dept Community Med, Delhi, India; [Kishore, Jugal; Kumari, Sneha] Vardhaman Mahavir Med Coll, Dept Community Med, Delhi, India; [Kishore, Jugal; Kumari, Sneha] Safdurjung Hosp, Delhi, India; [Isaakidis, Petros] Medecins Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Gupte, Himanshu A.] Narotam Sekhsaria Fdn, Bombay, Maharashtra, India; [Grover, Shekhar] Natl Inst Canc Prevent & Res, Noida, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; Doctors Without Borders; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Anand, T (corresponding author), Hindu Rao Hosp, North Delhi Municipal Corp Med Coll, Dept Community Med, Delhi, India.		Kishore, Jugal/AAX-6160-2020	Kishore, Jugal/0000-0001-6246-5880; Gupte, Himanshu/0000-0002-6290-2419; Isaakidis, Petros/0000-0002-7881-1554; Anand, Tanu/0000-0003-2911-2332	Department for International Development (DFID),UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	Department for International Development (DFID),UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The training programme and open access publications costs were funded by the Department for International Development (DFID),UK and La Fondation Veuve Emile Metz-Tesch (Luxembourg) to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarchand Ritvik, 2015, WHO South East Asia J Public Health, V4, P130, DOI 10.4103/2224-3151.206682; Castellanos-Joya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106961; Central TB Division MoHFW, 2016, RNTCP ANN REP 2016, P77; Central TB Division MoHFW. TB India 2017, 2017, REV NAT TB CONTR PRO; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; DGHS MoHFW, 2017, NAT FRAM JOINT TB DI; DGHS MoHFW. National Programme on Prevention and Control of Diabetes, 2008, NAT PROGR PREV CONTR; Garg Ankur, 2014, J Family Med Prim Care, V3, P112, DOI 10.4103/2249-4863.137617; Gebreyohannis T, 2013, UN NEW YORK, V5, P37; Glaziou P, 2016, GLOB T B REP 2016 ME; Guessogo WR, 2016, J EXERC REHABIL, V12, P333, DOI 10.12965/jer.1632620.310; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; Harries AD, 2015, INT J TUBERC LUNG D, V19, P879, DOI 10.5588/ijtld.15.0069; Huaman MA, 2015, TROP DIS TRAVEL MED, V1, P1, DOI DOI 10.1186/S40794-015-0002-9; IIPS and MoHFW, 2016, NATL FAMILY HLTH SUR; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Khademi N, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/ijpvm.IJPVM_400_16; Kottarath M., 2015, INT J RES MED SCI, V3, P2810, DOI 10.18203/2320-6012.ijrms20150687; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Lamptey P, 2016, DISCUSSSION PAPER PR; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Luxford K, 2014, PATIENT EXP J, V1; Marak Bibha, 2016, Indian J Tuberc, V63, P123, DOI 10.1016/j.ijtb.2015.07.018; Misra A, 2009, J ASS PHYS INDIA; Mohammed S, 2015, AFR HEALTH SCI, V15, P385, DOI 10.4314/ahs.v15i2.11; Naik B, 2013, PUBLIC HEALTH ACTION, V3, pS34, DOI 10.5588/pha.13.0022; Oguntibeju O. O., 2013, ROLE FRUIT VEGETABLE, P117, DOI [10.5772/50109, DOI 10.5772/50109]; Prakash BC, 2013, PUBLIC HEALTH ACTION, V3, pS18, DOI 10.5588/pha.13.0032; Raghuraman S, 2014, N AM J MED SCI, V6, P30, DOI 10.4103/1947-2714.125863; Samal Janmejaya, 2016, J Family Med Prim Care, V5, P886, DOI 10.4103/2249-4863.201159; Seegert AB, 2017, INT J INFECT DIS, V56, P54, DOI 10.1016/j.ijid.2016.12.016; Shah B, 2010, INDIAN J MED RES, V132, P634; Sharma U, 2013, J CLIN LIPIDOL, V7, P653, DOI 10.1016/j.jacl.2013.06.003; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vasudevan U, RISE HLTH RISKS ADUL; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2015, INT PREV CONTR NONC; WHO, SECT 2 INT GUID; Workneh MH, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1378-6; World Health Organization, 2014, THE END TB STRAT; World Health Organization, WHO STEPS INSTR COR; World Health Organization, 2010, PACK ESS NONC PEN DI	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202256	10.1371/journal.pone.0202256	http://dx.doi.org/10.1371/journal.pone.0202256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138331	gold, Green Submitted, Green Published			2022-12-26	WOS:000442800100048
J	Zhang, J; Sung, L; Zhang, H; Wang, SF; Zhang, XY; Geng, AL				Zhang, Ji; Sung, Lei; Zhang, Hao; Wang, Shufang; Zhang, Xiaoyu; Geng, Anli			A novel homodimer laccase from Cerrena unicolor BBP6: Purification, characterization, and potential in dye decolorization and denim bleaching	PLOS ONE			English	Article							DIFFERENT SYNTHETIC DYES; WHITE-ROT FUNGI; BIOCHEMICAL-CHARACTERIZATION; EXTRACELLULAR LACCASE; MANGANESE PEROXIDASE; RECALCITRANT DYES; MEDIATORS; OXIDATION; FERMENTATION; INHIBITION	The white-rot fungus Cerrena unicolor BBP6 produced up to 243.4 U mL(-1) laccase. A novel laccase isoform LacA was purified; LacA is a homodimer with an apparent molecular mass of 55 kDa and an isoelectric point of 4.7. Its optimal pH was 2.5, 4.0, and 5.5 when 2, 2'-Azi-nobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS), guaiacol, and 2, 6-dimethoxyphenol (2, 6-DMP) were used as the substrates, respectively. The optimal temperature was 60 degrees C for ABTS and 80 degrees C for both guaiacol and 2, 6-DMP. LacA retained 82-92% activity when pH was greater than 4 and 42%-92% activity at or below 50 degrees C. LacA was completely inhibited by 0.1 mM L-cysteine, 1 mM Dithiothreitol, and 10 mM metal ions, Ca2+, Mg2+ and Co2+ . LacA had good affinity for ABTS, with a K-m of 49.1 mu M and a k(cat )of 3078.9 s(-1) . It decolorized synthetic dyes at 32.3-87.1%. In the presence of 1-hydroxybenzotriazole (HBT), LacA decolorized recalcitrant dyes such as Safranine (97.1%), Methylene Blue (98.9%), Azure Blue (96.6%) and simulated textile effluent (84.6%). With supplemented manganese peroxidase (MnP), Mn2+ and HBT, the purified LacA and BBP6 fermentation broth showed great potential in denim bleaching, with an up to 5-fold increase in reflectance values.	[Zhang, Ji; Zhang, Hao; Zhang, Xiaoyu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys MOE, Wuhan, Hubei, Peoples R China; [Sung, Lei; Wang, Shufang] Hebei Univ Technol, Key Lab Green Chem Technol & High Efficient Energ, Tianjin, Peoples R China; [Geng, Anli] Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore, Singapore	Huazhong University of Science & Technology; Hebei University of Technology	Zhang, XY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys MOE, Wuhan, Hubei, Peoples R China.; Wang, SF (corresponding author), Hebei Univ Technol, Key Lab Green Chem Technol & High Efficient Energ, Tianjin, Peoples R China.; Geng, AL (corresponding author), Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore, Singapore.	wangshufang@hebut.edu.cn; zhangxiaoyu@mail.hust.edu.cn; gan2@np.edu.sg	ZHANG, Haolan/HCI-3729-2022; Zhang, xiaoyu/GXA-3206-2022	Geng, Anli/0000-0002-6437-4736	Ministry of Education, Singapore [MOE2013-TIF-1-G-062]	Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was fully supported by Ministry of Education, Singapore [MOE2013-TIF-1-G-062, 2014] (AG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaie-Khouzani M, 2012, BIOCHEM ENG J, V60, P9, DOI 10.1016/j.bej.2011.09.002; Ba S, 2017, CRIT REV BIOTECHNOL, V37, P819, DOI 10.1080/07388551.2016.1261081; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Camarero S, 2008, ENVIRON SCI TECHNOL, V42, P6703, DOI 10.1021/es8008979; Chakroun H, 2010, PROCESS BIOCHEM, V45, P507, DOI 10.1016/j.procbio.2009.11.009; Chen SC, 2012, PROTEIN ENG DES SEL, V25, P761, DOI 10.1093/protein/gzs082; Claus H, 2002, APPL MICROBIOL BIOT, V59, P672, DOI 10.1007/s00253-002-1047-z; Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Fan H, 2012, J TAIWAN INST CHEM E, V43, P386, DOI 10.1016/j.jtice.2011.11.001; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Forootanfar H, 2015, BIOTECHNOL PROGR, V31, P1443, DOI 10.1002/btpr.2173; Grassi E, 2011, INT BIODETER BIODEGR, V65, P635, DOI 10.1016/j.ibiod.2011.03.007; Jaiswal N, 2014, PROCESS BIOCHEM, V49, P1196, DOI 10.1016/j.procbio.2014.04.002; Jeon JR, 2013, TRENDS BIOTECHNOL, V31, P335, DOI 10.1016/j.tibtech.2013.04.002; Jeon SJ, 2017, J MICROBIOL BIOTECHN, V27, P1120, DOI 10.4014/jmb.1701.01004; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Levin L, 2010, BIORESOURCE TECHNOL, V101, P4554, DOI 10.1016/j.biortech.2010.01.102; Lorenzo M, 2005, CHEMOSPHERE, V60, P1124, DOI 10.1016/j.chemosphere.2004.12.051; Iracheta-Cardenas MM, 2016, J ENVIRON MANAGE, V177, P93, DOI 10.1016/j.jenvman.2016.04.008; Manavalan T, 2015, CURR MICROBIOL, V70, P485, DOI 10.1007/s00284-014-0743-0; Michniewicz A, 2006, APPL MICROBIOL BIOT, V69, P682, DOI 10.1007/s00253-005-0015-9; Min KL, 2001, ARCH BIOCHEM BIOPHYS, V392, P279, DOI 10.1006/abbi.2001.2459; Mohorcic M, 2006, CHEMOSPHERE, V63, P1709, DOI 10.1016/j.chemosphere.2005.09.063; Nagai M, 2002, APPL MICROBIOL BIOT, V60, P327, DOI 10.1007/s00253-002-1109-2; Otto B, 2014, PLANTA, V240, P1225, DOI 10.1007/s00425-014-2144-9; Pezzella C, 2015, CELL MOL LIFE SCI, V72, P923, DOI 10.1007/s00018-014-1823-9; Piscitelli A, 2011, CR BIOL, V334, P789, DOI 10.1016/j.crvi.2011.06.007; Rodriguez-Couto SJS., 2012, SIGMA, V1, P10; Saratale RG, 2013, J BIOSCI BIOENG, V115, P658, DOI 10.1016/j.jbiosc.2012.12.009; Sathishkumar P, 2014, J MOL CATAL B-ENZYM, V100, P111, DOI 10.1016/j.molcatb.2013.12.008; Schlosser D, 2002, APPL ENVIRON MICROB, V68, P3514, DOI 10.1128/AEM.68.7.3514-3521.2002; Senthivelan T, 2016, BIOTECHNOL BIOPROC E, V21, P19, DOI 10.1007/s12257-015-0278-7; Si J, 2013, BIORESOURCE TECHNOL, V128, P49, DOI 10.1016/j.biortech.2012.10.085; Songulashvili G, 2015, CR BIOL, V338, P121, DOI 10.1016/j.crvi.2014.12.001; Su J, 2018, CRIT REV BIOTECHNOL, V38, P294, DOI 10.1080/07388551.2017.1354353; Sun J, 2017, MOLECULES, V22, DOI 10.3390/molecules22040673; Uzan E, 2010, J APPL MICROBIOL, V108, P2199, DOI 10.1111/j.1365-2672.2009.04623.x; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110834; Yang Y, 2011, BIOCHEM ENG J, V57, P13, DOI 10.1016/j.bej.2011.07.006; Yoshida H., 1883, J AM CHEM SOC, V43, P472, DOI [10.1039/CT8834300472, DOI 10.1039/CT8834300472]; Zhang H, 2018, PROCESS BIOCHEM, V66, P222, DOI 10.1016/j.procbio.2017.12.011; Zhuo R, 2017, BIOCHEM ENG J, V117, P62, DOI 10.1016/j.bej.2016.09.016	43	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202440	10.1371/journal.pone.0202440	http://dx.doi.org/10.1371/journal.pone.0202440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138464	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100067
J	Zhu, HQ; Sheng, K; Zhang, YL; Fang, SH; Wu, YL				Zhu, Hongqing; Sheng, Kai; Zhang, Yilong; Fang, Shuhao; Wu, Yunlong			The stage analysis and countermeasures of coal spontaneous combustion based on "five stages" division	PLOS ONE			English	Article							LOW-TEMPERATURES; MOISTURE-CONTENT; MINE FIRE; OXIDATION; MECHANISM; PROPENSITY	The "three stages" division of coal spontaneous combustion is fuzzy and lacks adequate risk and warning levels corresponding to its divisions; additionally, the targeted prevention measures for each stage have not been described. To address the shortcomings of the "three stages" division, the "five stages" division was proposed to more clearly analyze the stage changes of the spontaneous combustion of coal. The "five stages" method divides the process of the spontaneous combustion of coal into five stages, including: the latent stage, heat accumulating stage, evaporation stage, active stage, and hypoxic stage. The critical point of each stage was determined using adiabatic oxidation experiments and programmed heat experiments. As the critical point of the latent stage, the temperature of zero activation energy is approximately 55-70 degrees C. In the heat accumulating stage, the critical point is the temperature (approximately 90 degrees C) where the external moisture of coal evaporates violently while the internal moisture of coal has not yet fully evaporated. During the evaporation stage, the temperature (approximately 105 degrees C) where the internal moisture has evaporated completely represents the end of this stage and the start of the active stage (105-170 degrees C). When the oxygen concentration drops to 5%, the spontaneous combustion of coal enters the hypoxic stage. Thus, an oxygen concentration of 5% represents the critical point of the start of the hypoxic stage (above 170 degrees C). After the analysis of each stage, risk and warning levels were determined. Considering the major prevention measures of the spontaneous combustion of coal, a staged warning and disposal table was created.	[Zhu, Hongqing; Sheng, Kai; Zhang, Yilong; Fang, Shuhao; Wu, Yunlong] China Univ Min & Technol Beijing, Sch Resources & Safety Engn, Beijing, Peoples R China; [Zhu, Hongqing] China Univ Min & Technol Beijing, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology	Sheng, K (corresponding author), China Univ Min & Technol Beijing, Sch Resources & Safety Engn, Beijing, Peoples R China.	shengkai0818@163.com		Sheng, Kai/0000-0001-9875-7252	National Key R&D Program of China [2016YFC0801800]; National Natural Science Foundation of China [51704299]; Open Research Project of state Key Laboratory Cultivation Base for Gas Geology and Gas Control (Henan Polytechnic University) [WS2018A03]; Program of Beijing-funded Plan for Talents [2017000020124G011]; Open Research Project of the State Key Laboratory of coal Resources and Safe Mining (China University of Ming and Technology) [SKLCRSM17KFA10]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Project of state Key Laboratory Cultivation Base for Gas Geology and Gas Control (Henan Polytechnic University); Program of Beijing-funded Plan for Talents; Open Research Project of the State Key Laboratory of coal Resources and Safe Mining (China University of Ming and Technology)	This work was supported by the National Key R&D Program of China (Grant 2016YFC0801800) to HZ, the National Natural Science Foundation of China (Grant 51704299), the Open Research Project of state Key Laboratory Cultivation Base for Gas Geology and Gas Control (Henan Polytechnic University) (Grant WS2018A03), the Program of Beijing-funded Plan for Talents (Grant 2017000020124G011), and the Open Research Project of the State Key Laboratory of coal Resources and Safe Mining (China University of Ming and Technology) (Grant SKLCRSM17KFA10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISOY A, 1994, FUEL, V73, P281, DOI 10.1016/0016-2361(94)90126-0; [李林 Li Lin], 2010, [煤炭学报, Journal of China Coal Society], V35, P802; [李林 LI Lin], 2009, [煤炭学报, Journal of China Coal Society], V34, P505; Bateman CS, 2016, THESIS; Beamish BB, 2005, INT J COAL GEOL, V64, P133, DOI 10.1016/j.coal.2005.03.011; Cem S, 2012, MINER RESOUR ENG, V9, P421; Chatterjee RS, 2006, ISPRS J PHOTOGRAMM, V60, P113, DOI 10.1016/j.isprsjprs.2005.12.002; Chen Z, 2000, FUEL, V79, P961, DOI 10.1016/S0016-2361(99)00217-3; Clemens AH, 1996, FUEL, V75, P891, DOI 10.1016/0016-2361(96)00010-5; COLE DA, 1987, FUEL, V66, P1240, DOI 10.1016/0016-2361(87)90062-7; Deng J, 2015, FUEL, V157, P261, DOI 10.1016/j.fuel.2015.04.063; Jones JC, 1996, FUEL, V75, P1755, DOI 10.1016/S0016-2361(96)00159-7; Kim J, 2015, KOREAN J CHEM ENG, V32, P1297, DOI 10.1007/s11814-014-0331-9; Kong B, 2017, ENVIRON SCI POLLUT R, V24, P23453, DOI 10.1007/s11356-017-0209-6; Kurose R, 2001, FUEL, V80, P1457, DOI 10.1016/S0016-2361(01)00019-9; Li L, 2008, THESIS; Lu W, 2017, ENERG FUEL, V31, P882, DOI 10.1021/acs.energyfuels.6b02247; [陆伟 LU Wei], 2006, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology. Natural science], V35, P201; Lu Y, 2017, ENERG FUEL, V31, P7290, DOI 10.1021/acs.energyfuels.7b00649; Niu YH, 2007, IND SAFETY ENV PROTE, V33, P45; Qu LN., 2013, THESIS; Ren W, 2015, J CHINA COAL SOC, VA2, P401; Singh RP, 2004, J SCI IND RES INDIA, V63, P1010; Smith MA, 2005, FUEL, V84, P1161, DOI 10.1016/j.fuel.2004.12.005; Sokol E, 2010, BASIN RES, V22, P414, DOI 10.1111/j.1365-2117.2010.00462.x; Sokol EV, 2007, REV ENG GEOLOGY, V162, P373; [谭波 Tan Bo], 2013, [煤炭学报, Journal of China Coal Society], V38, P38; Tang YB, 2015, ENERG FUEL, V29, P4683, DOI 10.1021/acs.energyfuels.5b00217; Tripathi DD, 2008, FIRE TECHNOL, V44, P185, DOI 10.1007/s10694-007-0034-4; Wang, 2003, J LIAONING TU, V22, P472; Wang G, 2016, J LOSS PREVENT PROC, V44, P474, DOI 10.1016/j.jlp.2016.10.013; Wang HH, 2003, PROG ENERG COMBUST, V29, P487, DOI 10.1016/S0360-1285(03)00042-X; Wang W, 2011, J MINING SAFETY ENG, V28, P153; Xu T., 2012, THESIS; Zhang J, 2016, FUEL, V182, P80, DOI 10.1016/j.fuel.2016.05.087; Zhong X.X., 2010, J CHINA COAL SOC CHI, V35, P128; Zhou FB, 2006, INT J COAL GEOL, V67, P95, DOI 10.1016/j.coal.2005.09.006; Zhou FB, 2015, FIRE TECHNOL, V51, P325, DOI 10.1007/s10694-013-0351-8; Zhu HQ, 2013, J LOSS PREVENT PROC, V26, P236, DOI 10.1016/j.jlp.2012.11.006; [朱红青 Zhu Hongqing], 2014, [中南大学学报. 自然科学版, Journal of Central South University of Science and Technology], V45, P2845; [朱红青 Zhu Hongqing], 2014, [煤炭学报, Journal of China Coal Society], V39, P498; Zhu HQ, 2013, DISASTER ADV, V6, P219	42	7	7	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202724	10.1371/journal.pone.0202724	http://dx.doi.org/10.1371/journal.pone.0202724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138357	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100111
J	Li, CW; Jheng, BR; Chen, BS				Li, Cheng-Wei; Jheng, Bo-Ren; Chen, Bor-Sen			Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; LYTIC REACTIVATION; MEDIATED CLEAVAGE; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; UP-REGULATION; PROTEIN 1; CELLS; LATENT; EXPRESSION	Epstein-Barr virus (EBV), also known as human herpesvirus 4, is prevalent in all human populations. EBV mainly infects human B lymphocytes and epithelial cells, and is therefore associated with their various malignancies. To unravel the cellular mechanisms during the infection, we constructed interspecies networks to investigate the molecular cross-talk mechanisms between human B cells and EBV at the first (0-24 hours) and second (8-72 hours) stages of EBV infection. We first constructed a candidate genome-wide interspecies genetic-and-epigenetic network (the candidate GIGEN) by big database mining. We then pruned false positives in the candidate GIGEN to obtain the real GIGENs at the first and second infection stages in the lytic phase by their corresponding next-generation sequencing data through dynamic interaction models, the system identification approach, and the system order detection method. The real GIGENs are very complex and comprise protein-protein interaction networks, gene/microRNA (miRNA)/long non-coding RNA regulation networks, and host-virus cross-talk networks. To understand the molecular cross-talk mechanisms underlying EBV infection, we extracted the core GIGENs including host-virus core networks and host-virus core pathways from the real GIGENs using the principal network projection method. According to the results, we found that the activities of epigenetics-associated human proteins or genes were initially inhibited by viral proteins and miRNAs, and human immune responses were then dysregulated by epigenetic modification. We suggested that EBV exploits viral proteins and miRNAs, such as EBNA1, BPLF1, BALF3, BVRF1 and miR-BART14, to develop its defensive mechanism to defeat multiple immune attacks by the human immune system, promotes virion production, and facilitates the transportation of viral particles by activating the human genes NRP1 and CLIC5. Ultimately, we propose a therapeutic intervention comprising thymoquinone, valpromide, and zebularine to act as inhibitors of EBV-associated malignancies.	[Li, Cheng-Wei; Jheng, Bo-Ren; Chen, Bor-Sen] Natl Tsing Hua Univ, Lab Control & Syst Biol, Hsinchu, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Lab Control & Syst Biol, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	li, cheng-wei/Q-3338-2019; Chen, Bor-Sen/D-9114-2017	Chen, Bor-Sen/0000-0003-1644-6106; Li, Cheng-Wei/0000-0002-5883-4812	Ministry of Science and Technology of Taiwan [MOST 105-2811-E-007-041]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by the Ministry of Science and Technology of Taiwan under grant No. MOST 105-2811-E-007-041.	Adoro S, 2017, NAT IMMUNOL, V18, P780, DOI 10.1038/ni.3764; Ahsan N, 2005, J VIROL, V79, P4415, DOI 10.1128/JVI.79.7.4415-4424.2005; Albanese M, 2016, P NATL ACAD SCI USA, V113, pE6467, DOI 10.1073/pnas.1605884113; Alberghini F, 2015, IMMUNOL CELL BIOL, V93, P253, DOI 10.1038/icb.2014.116; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Baines JD, 2007, J VIROL, V81, P800, DOI 10.1128/JVI.01756-06; Bazot Q, 2018, J VIROL, V92, DOI 10.1128/JVI.01918-17; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Calderone A., 2014, NUCLEIC ACIDS RES; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; CEN H, 1994, VIRUS RES, V31, P89; Chakrabarti A, 2015, TRENDS PHARMACOL SCI, V36, P481, DOI 10.1016/j.tips.2015.04.013; Chatel G, 2012, NUCLEUS-PHILA, V3, P162, DOI 10.4161/nucl.19674; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chiu SH, 2014, J VIROL, V88, P4962, DOI 10.1128/JVI.00063-14; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Chuang HC, 2007, AM J PATHOL, V170, P1607, DOI 10.2353/ajpath.2007.061026; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; del-Toro N, 2013, NUCLEIC ACIDS RES, V41, pW601, DOI 10.1093/nar/gkt392; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Dreyfus DH., 2016, IMMUNOLOGIC RES, P1, DOI [10.1007/s12026-015-8669-6, DOI 10.1007/S12026-015-8669-6]; DYER MJS, 1990, BLOOD, V75, P709; EPSTEIN MA, 1964, LANCET, V1, P252; FAGGIONI A, 1986, SCIENCE, V232, P1554, DOI 10.1126/science.3012779; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Fu Q, 2013, J ZHEJIANG UNIV-SC B, V14, P8, DOI 10.1631/jzus.B1200189; Gomez-Suaga P, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/324521; Gorres KL, 2016, MBIO, V7, DOI 10.1128/mBio.00113-16; Granato M, 2014, J VIROL; Grimm T, 2005, BLOOD, V105, P3263, DOI 10.1182/blood-2004-07-2752; Guiboileau A, 2013, NEW PHYTOL, V199, P683, DOI 10.1111/nph.12307; Hagemeier SR, 2012, J VIROL, V86, P13360, DOI 10.1128/JVI.01850-12; Hagemeier SR, 2011, J VIROL, V85, P4318, DOI 10.1128/JVI.01856-10; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; Han L, 2015, ARCH VIROL, V160, P441, DOI 10.1007/s00705-014-2279-9; Hernando H, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r3; Hong GK, 2004, J VIROL, V78, P4983, DOI 10.1128/JVI.78.10.4983-4992.2004; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; Hsu S-D, 2010, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKQ1107; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutajulu SH, 2014, THER CLIN RISK MANAG, V10, P721, DOI 10.2147/TCRM.S47434; Ikeda M, 2009, VIROLOGY, V385, P183, DOI 10.1016/j.virol.2008.11.018; Jabara HH, 2011, INT IMMUNOL, V23, P215, DOI 10.1093/intimm/dxq474; Jang JY, 2006, CELL IMMUNOL, V241, P14, DOI 10.1016/j.cellimm.2006.07.006; Jochum S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002704; Jones K, 2010, INT J LAB HEMATOL, V32, pE169, DOI 10.1111/j.1751-553X.2008.01130.x; Jung EJ, 2007, CANCER LETT, V247, P77, DOI 10.1016/j.canlet.2006.03.022; Kalla M, 2012, J VIROL, V86, P447, DOI 10.1128/JVI.06314-11; Kamperschroer C, 2016, VIROLOGY, V488, P28, DOI 10.1016/j.virol.2015.10.025; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaur S, 2016, MOL CELL ENDOCRINOL, V419, P83, DOI 10.1016/j.mce.2015.10.002; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kenney S. C., 2007, REACTIVATION LYTIC R; Kenney SC, 2014, SEMIN CANCER BIOL, V26, P60, DOI 10.1016/j.semcancer.2014.01.002; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Key SCS, 1998, J VIROL, V72, P8485, DOI 10.1128/JVI.72.11.8485-8492.1998; Koganti S, 2015, J VIROL, V89, P5002, DOI 10.1128/JVI.00121-15; Kustatscher G, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177548; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Latsoudis H, 2017, J CELL PHYSIOL, V232, P1326, DOI 10.1002/jcp.25602; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li CW, 2016, IEEE T NEUR NET LEAR, V27, P2229, DOI 10.1109/TNNLS.2015.2475395; Li CW, 2016, ONCOTARGET, V7, P8556, DOI 10.18632/oncotarget.7388; Li HD, 2016, INT J BIOL SCI, V12, P1309, DOI 10.7150/ijbs.16564; Li J. -H., 2013, NUCLEIC ACIDS RES; Li RF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005346; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Li X, 2016, FRONTIERS MICROBIOLO, V7; Lin SJ, 2015, VIROLOGY, V481, P24, DOI 10.1016/j.virol.2015.02.015; Liu Lu, 2013, Proceedings (IEEE Int Conf Bioinformatics Biomed), P218, DOI 10.1109/BIBM.2013.6732493; Liu XQ, 2016, J VIROL, V90, P1129, DOI 10.1128/JVI.01410-15; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lu F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005339; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lv DW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006868; McCartney EM, 2013, HEPATOLOGY, V58, P1558, DOI 10.1002/hep.26496; McLaren J, 2007, J GEN VIROL, V88, P1876, DOI 10.1099/vir.0.82741-0; Meckes Jr D, 2011, J CARCINOGENE MUTA S, V11, P37; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mei SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30612; Morrison TE, 2004, J VIROL, V78, P544, DOI 10.1128/JVI.78.1.544-549.2004; Murata T, 2014, MICROBIOL IMMUNOL, V58, P307, DOI 10.1111/1348-0421.12155; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nawandar DM, 2017, J VIROL, V91, DOI 10.1128/JVI.02438-16; Noh KW, 2016, BMB REP, V49, P226, DOI 10.5483/BMBRep.2016.49.4.260; Nowag H, 2014, EBIOMEDICINE, V1, P116, DOI 10.1016/j.ebiom.2014.11.007; O'Grady T, 2014, J VIROL, V88, P1604, DOI 10.1128/JVI.02989-13; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Oughtred Rose, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top080754; Pagano M., 2018, PRINCIPLES BIOSTATIS; Park GB, 2013, J IMMUNOL, V191, P6281, DOI 10.4049/jimmunol.1203442; Patil M, 2013, CELL MOL LIFE SCI, V70, P4009, DOI 10.1007/s00018-013-1307-3; Pratt ZL, 2012, J VIROL, V86, P4380, DOI 10.1128/JVI.06966-11; Qureshi A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau103; Rao SP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-3; Rastelli J, 2008, BLOOD, V111, P1448, DOI 10.1182/blood-2007-10-117655; Renne C, 2008, LEUKEMIA RES, V32, P163, DOI 10.1016/j.leukres.2007.05.019; Rowe M, 2014, J VIROL, V88, P12065, DOI 10.1128/JVI.01431-14; Seo JS, 2008, ONCOL REP, V19, P93; Shi XN, 2018, CELL BIOL INT, V42, P53, DOI 10.1002/cbin.10866; Sivachandran N, 2010, J VIROL, V84, P11113, DOI 10.1128/JVI.01183-10; Sniderhan LF, 2009, EXP HEMATOL, V37, P1295, DOI 10.1016/j.exphem.2009.08.005; Sollner J, 2010, IMMUNOME RES, V6, P1; Strong MJ, 2015, J VIROL, V89, P10110, DOI 10.1128/JVI.01110-15; Sun CC, 2016, AGING-US, V8, P2509, DOI 10.18632/aging.101080; Tabtieng T, 2018, J VIROL, V92, DOI 10.1128/JVI.01011-17; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Whitehurst CB, 2015, MBIO, V6, DOI 10.1128/mBio.01574-15; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xiao YJ, 2017, MOL MED REP, V16, P8448, DOI 10.3892/mmr.2017.7614; Yang K, 2014, J VIROL, V88, P3815, DOI 10.1128/JVI.03175-13; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zeng LL, 2015, J BIOL CHEM, V290, P18269, DOI 10.1074/jbc.M115.640177; Zhang K, 2017, CELL REP, V21, P3445, DOI 10.1016/j.celrep.2017.11.071; Zhang Y, 2006, BRIT J CANCER, V94, P599, DOI 10.1038/sj.bjc.6602968; Zhang Y, 2016, GENETICS MOL RES GMR, V15; Zhang YW, 2015, ONCOTARGET, V6, P207, DOI 10.18632/oncotarget.2702; Zhao L, 2016, ONCOGENE; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439; Zihlif MA, 2013, INTEGR CANCER THER, V12, P257, DOI 10.1177/1534735412458827; Zimber-Strobl U, 2001, SEMIN CANCER BIOL, V11, P423, DOI 10.1006/scbi.2001.0409; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	129	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202537	10.1371/journal.pone.0202537	http://dx.doi.org/10.1371/journal.pone.0202537			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133498	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400079
J	Li, JF; Ying, YF; Xie, HY; Jin, K; Yan, HQ; Wang, S; Xu, MJ; Xu, X; Wang, X; Yang, K; Zheng, XY; Xie, LP				Li, Jiangfeng; Ying, Yufan; Xie, Haiyun; Jin, Ke; Yan, Huaqing; Wang, Song; Xu, Mingjie; Xu, Xin; Wang, Xiao; Yang, Kai; Zheng, Xiangyi; Xie, Liping			Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer	FASEB JOURNAL			English	Article						miRNA; metastasis; MEG3-DMR; DLK-DIO3 imprinted domain; urologic cancer	MESENCHYMAL TRANSITION; INHIBITS MIGRATION; CLIP-SEQ; EXPRESSION; METASTASIS; MICRORNAS; PROTEINS; INVASION; PROLIFERATION; STARBASE	Emerging evidence has elucidated that microRNAs (miRNAs) transcribed from miRNA cluster at DLK-DIO3 imprinted domain are involved in various cancers. However, as one member of this cluster, the underlying mechanisms and functions of miR-381-3p in bladder cancer (BCa) still remains elusive. Here we demonstrate that the hypermethylated status of upstream maternally expressed gene 3 divergent methylation region reduces the expression of miR-381-3p in BCa by bisulfite-sequencing PCR. In vitro and in vivo experiments indicate that overexpression of miR-381-3p significantly inhibits cell proliferation via inducing G(1) phase arrest and migration via down-regulating MET and CCNA2 induced EMT progression. CDK6/CCNA2/MET are all identified as the direct targets of miR-381-3p by bioinformatics analysis and dual-luciferase reporter assay. Furthermore, inhibition of CCNA2 mediated by miR-381-3p as the crucial biregulator not only participates in the proliferation regulation with CDK6 in cell cycle but also modulates the EMT progression via ROCK/AKT/-catenin/SNAIL pathway, which establishes an EMT circuit combined with miR-381-3p/MET/AKT/GSK-3/SNAIL pathway, and SNAIL is the last confocal target to induce EMT progression. To conclude, we propose 2 novel regulatory circuits mediated by miR-381-3p in BCa, which may assist in the development of more effective therapies against BCa in the future.Li, J., Ying, Y., Xie, H., Jin, K., Yan, H., Wang, S., Xu, M., Xu, X., Wang, X., Yang, K., Zheng, X., Xie, L. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.	[Li, Jiangfeng; Ying, Yufan; Xie, Haiyun; Jin, Ke; Yan, Huaqing; Wang, Song; Xu, Mingjie; Xu, Xin; Wang, Xiao; Yang, Kai; Zheng, Xiangyi; Xie, Liping] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Qingchun Rd 79, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zheng, XY; Xie, LP (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Qingchun Rd 79, Hangzhou 310003, Zhejiang, Peoples R China.	zheng_xy@zju.edu.cn; xielp@zju.edu.cn	Xie, li/HGE-6052-2022; Xie, Haiyun/HGD-1805-2022		National Natural Science Foundation of China [81472375, 81772744, 81702500]; Natural Science Foundation of Zhejiang Province [LY16H160012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Natural Science Foundation of China (81472375, 81772744, 81702500) and the Natural Science Foundation of Zhejiang Province (LY16H160012). Approval to conduct this study was obtained from the ethics committees of the First Affiliated Hospital, College of Medicine, Zhejiang University, in accordance with the guidelines of the Helsinki Declaration of 1975, revised in 1983. The authors declare no conflicts of interest.	Aaltomaa S, 1999, BRIT J CANCER, V80, P2001, DOI 10.1038/sj.bjc.6690634; An FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045606; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bendris N, 2014, CELL MOL LIFE SCI, V71, P4881, DOI 10.1007/s00018-014-1654-8; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Cao QH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0499-z; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Cheung CT, 2015, CARCINOGENESIS, V36, P914, DOI 10.1093/carcin/bgv069; Davidson B, 2001, GYNECOL ONCOL, V83, P249, DOI 10.1006/gyno.2001.6388; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; He XX, 2016, ONCOTARGETS THER, V9, P1231, DOI 10.2147/OTT.S99228; Kobayashi T, 2016, ASIAN J UROL, V3, P211, DOI 10.1016/j.ajur.2016.09.005; Li J., 2017, ONCOTARGET, V9, P3752, DOI DOI 10.18632/oncotarget.23365; Li JF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.331; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liang Z, 2015, MOL CELLS, V38, P130, DOI 10.14348/molcells.2015.2146; Mashal RD, 1996, CANCER RES, V56, P4159; Posadas EM, 2016, ASIAN J UROL, V3, P167, DOI 10.1016/j.ajur.2016.09.008; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Schrier BP, 2004, EUR UROL, V45, P292, DOI 10.1016/j.eururo.2003.10.006; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slaby O, 2017, BIOCHEM J, V474, P4219, DOI 10.1042/BCJ20170079; Song GL, 2016, INT J ONCOL, V49, P646, DOI 10.3892/ijo.2016.3539; Tian CY, 2017, ONCOL REP, V38, P3071, DOI 10.3892/or.2017.5956; TSAI HC, 2017, CELL DEATH DIS, V8; Wang X, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0069-6; Wang XX, 2016, MATER TODAY CHEM, V1-2, P7, DOI 10.1016/j.mtchem.2016.10.005; XIE YP, 2017, SCI REP UK, V7; Xu MJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0206-1; XU X, 2016, CELL DEATH DIS, V7; Xu X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-109; Xu X, 2013, MOL CELLS, V36, P62, DOI 10.1007/s10059-013-0044-7; Xue YB, 2017, BIOMED PHARMACOTHER, V86, P426, DOI 10.1016/j.biopha.2016.12.051; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Yuan G, 2018, ONCOL RES, V26, P1037, DOI 10.3727/096504017X15144748428127	37	45	46	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1374	1388		10.1096/fj.201800667R	http://dx.doi.org/10.1096/fj.201800667R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30138038	Bronze			2022-12-26	WOS:000457401500108
J	Wright, FA; Bonzerato, CG; Sliter, DA; Wojcikiewicz, RJH				Wright, Forrest A.; Bonzerato, Caden G.; Sliter, Danielle A.; Wojcikiewicz, Richard J. H.			The erlin2 T65I mutation inhibits erlin1/2 complex-mediated inositol 1,4,5-trisphosphate receptor ubiquitination and phosphatidylinositol 3-phosphate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol trisphosphate receptor (InsP3R); ubiquitylation (ubiquitination); phosphatidylinositol phosphatase; endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); erlin1; erlin2; mutation; phospholipid signaling; spastic paraplegia	HEREDITARY SPASTIC PARAPLEGIA; DOMAIN-CONTAINING PROTEINS; DOMINANT SENSORY ATAXIA; ENDOPLASMIC-RETICULUM; AUTOPHAGOSOME BIOGENESIS; DEGRADATION; RNF170; CELLS; MECHANISMS; DISEASE	The erlin1/2 complex is a approximate to 2-MDa endoplasmic reticulum membrane-located ensemble of the approximate to 40-kDa type II membrane proteins erlin1 and erlin2. The best defined function of this complex is to mediate the ubiquitination of activated inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and their subsequent degradation. However, it remains unclear how mutations of the erlin1/2 complex affect its cellular function and cause cellular dysfunction and diseases such as hereditary spastic paraplegia. Here, we used gene editing to ablate erlin1 or erlin2 expression to better define their individual roles in the cell and examined the functional effects of a spastic paraplegia-linked mutation to erlin2 (threonine to isoleucine at position 65; T65I). Our results revealed that erlin2 is the dominant player in mediating the interaction between the erlin1/2 complex and IP(3)Rs and that the T65I mutation dramatically inhibits this interaction and the ability of the erlin1/2 complex to promote IP3R ubiquitination and degradation. Remarkably, we also discovered that the erlin1/2 complex specifically binds to phosphatidylinositol 3-phosphate, that erlin2 binds this phospholipid much more strongly than does erlin1, that the binding is inhibited by T65I mutation of erlin2, and that multiple determinants within the erlin2 polypeptide comprise the phosphatidylinositol 3-phosphate-binding site. Overall, these results indicate that erlin2 is the primary mediator of the cellular roles of the erlin1/2 complex and that disease-linked mutations of erlin2 can affect both IP3R processing and lipid binding.	[Wright, Forrest A.; Bonzerato, Caden G.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA; [Sliter, Danielle A.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Wright, Forrest A.] Ichor Therapeut Inc, La Fayette, NY 13084 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Bonzerato, Caden/0000-0001-6380-8320	National Institutes of Health [DK107944, GM121621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK107944 and GM121621. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Saif A, 2012, ANN NEUROL, V72, P510, DOI 10.1002/ana.23641; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036; Cheng JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4207; Choy CH, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700121; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Egorova PA, 2018, FEBS J, V285, P3547, DOI 10.1111/febs.14366; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Huber MD, 2013, J CELL BIOL, V203, P427, DOI 10.1083/jcb.201305076; Inoue T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006439; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Nascimbeni AC, 2017, AUTOPHAGY, V13, P1602, DOI 10.1080/15548627.2017.1341465; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Printsev I, 2017, J MEMBRANE BIOL, V250, P379, DOI 10.1007/s00232-016-9931-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rungaldier S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178646; Rydning SL, 2018, EUR J NEUROL, V25, P943, DOI 10.1111/ene.13625; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Tian WT, 2016, CHINESE MED J-PEKING, V129, P2759, DOI 10.4103/0366-6999.193444; Tunca C, 2018, EUR J HUM GENET, V26, P745, DOI 10.1038/s41431-018-0107-5; Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wakil SM, 2013, EUR J MED GENET, V56, P43, DOI 10.1016/j.ejmg.2012.10.003; Wang GH, 2012, BIOCHEM J, V446, P415, DOI 10.1042/BJ20112050; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070	47	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15706	15714		10.1074/jbc.RA118.004547	http://dx.doi.org/10.1074/jbc.RA118.004547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135210	Green Published, hybrid			2022-12-26	WOS:000446549200032
J	Curran, AM; Scott-Boyer, MP; Kaput, J; Ryan, MF; Drummond, E; Gibney, ER; Gibney, MJ; Roche, HM; Brennan, L				Curran, Aoife M.; Scott-Boyer, Marie Pier; Kaput, Jim; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine			A proteomic signature that reflects pancreatic beta-cell function	PLOS ONE			English	Article							INSULIN; ENDORPHIN; SECRETION; GLUCAGON; HEALTHY; OBESITY; TISSUE	Aim Proteomics has the potential to enhance early identification of beta-cell dysfunction, in conjunction with monitoring the various stages of type 2 diabetes onset. The most routine method of assessing pancreatic beta-cell function is an oral glucose tolerance test, however this method is time consuming and carries a participant burden. The objectives of this research were to identify protein signatures and pathways related to pancreatic beta-cell function in fasting blood samples. Methods Beta-cell function measures were calculated for MECHE study participants who completed an oral glucose tolerance test and had proteomic data (n = 100). Information on 1,129 protein levels was obtained using the SOMAscan assay. Receiver operating characteristic curves were used to assess discriminatory ability of proteins of interest. Subsequent in vitro experiments were performed using the BRIN-BD11 pancreatic beta-cell line. Replication of findings were achieved in a second human cohort where possible. Results Twenty-two proteins measured by aptamer technology were significantly associated with beta-cell function/HOMA-IR while 17 proteins were significantly associated with the disposition index (p <= 0.01). Receiver operator characteristic curves determined the protein panels to have excellent discrimination between low and high beta-cell function. Linear regression analysis determined that beta-endorphin and IL-17F have strong associations with beta-cell function/HOMA-IR, beta = 0.039 (p = 0.005) and beta = -0.027 (p = 0.013) respectively. Calcineurin and CRTAM were strongly associated with the disposition index (beta = 0.005 and beta = 0.005 respectively, p = 0.012). In vitro experiments confirmed that IL-17F modulated insulin secretion in the BRI N-BD1 1 cell line, with the lower concentration of 10 ng/mL significantly increasing glucose stimulated insulin secretion (p = 0.043). Conclusions Early detection of compromised beta-cell function could allow for implementation of nutritional and lifestyle interventions before progression to type 2 diabetes.	[Curran, Aoife M.; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine] Ireland Univ Coll Dublin, Univ Coll Dublin, UCD Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland; [Curran, Aoife M.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine] Ireland Univ Coll Dublin, Univ Coll Dublin, FHI, Dublin, Ireland; [Scott-Boyer, Marie Pier] Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, Rovereto, Italy; [Kaput, Jim] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Roche, Helen M.] Univ Coll Dublin, Nutrigen Res Grp, UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Inst Food & Hlth, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Kaput, Jim] Vydiant Inc, Gold River, CA USA	University College Dublin; University College Dublin; University of Trento; Nestle SA; University College Dublin; University College Dublin	Brennan, L (corresponding author), Ireland Univ Coll Dublin, Univ Coll Dublin, UCD Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland.; Brennan, L (corresponding author), Ireland Univ Coll Dublin, Univ Coll Dublin, FHI, Dublin, Ireland.	lorraine.brennan@ucd.ie	Kaput, Jim/GSD-5978-2022; Kaput, Jim/AAJ-1386-2020; Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Brennan, Lorraine/0000-0002-7711-7499	Food for Health Ireland, through Enterprise Ireland [TC20130001]; Nestle Institute of Health Sciences (Lausanne, Switzerland); Department of Agriculture, Fisheries and Food [07FHRIUCD1]; "JINGO-JPI"/"ENPADASI" 2014-2016 [13F407]	Food for Health Ireland, through Enterprise Ireland; Nestle Institute of Health Sciences (Lausanne, Switzerland); Department of Agriculture, Fisheries and Food; "JINGO-JPI"/"ENPADASI" 2014-2016	This research was funded by Food for Health Ireland, through Enterprise Ireland Grant No. TC20130001 and by the Nestle Institute of Health Sciences (Lausanne, Switzerland). This work was in part funded under the Food for Health Research Initiative (NDP 2007-2013; 07FHRIUCD1) by the Department of Agriculture, Fisheries and Food (http://www.agriculture.gov.ie/). This research was also funded in part by grant number 13F407 ("JINGO-JPI"/"ENPADASI" 2014-2016).	Al-Hamodi Z, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-23; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Belongie KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182932; Beristain-Covarrubias N, 2015, IMMUN INFLAMM DIS, V3, P411, DOI 10.1002/iid3.79; Calimlioglu B, 2015, OMICS, V19, P563, DOI 10.1089/omi.2015.0088; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Curran AM, 2017, J PROTEOME RES, V16, P4122, DOI 10.1021/acs.jproteome.7b00501; Curran AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161350; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; El Ouaamari A, 2015, J PROTEOME RES, V14, P3111, DOI 10.1021/acs.jproteome.5b00587; FELDMAN M, 1983, NEW ENGL J MED, V308, P349, DOI 10.1056/NEJM198302173080701; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hathout Y, 2015, EXPERT REV PROTEOMIC, V12, P329, DOI 10.1586/14789450.2015.1064771; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Kiddle SJ, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.78; Kuo TY, 2016, J BIOL CHEM, V291, P9648, DOI 10.1074/jbc.M115.702183; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Makinen VP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004502; Maris M, 2010, J PROTEOME RES, V9, P6274, DOI 10.1021/pr100557w; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Morris C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072890; Mukherjee P, 2013, BBA-PROTEINS PROTEOM, V1834, P2226, DOI 10.1016/j.bbapap.2013.01.022; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; O'Gorman A, 2014, J CHROMATOGR B, V966, P140, DOI [10.1016/j.jchromb.2014.01.032, 10.1016/]; Moreno SO, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201600150; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; REID RL, 1981, J CLIN ENDOCR METAB, V52, P592, DOI 10.1210/jcem-52-3-592; REID RL, 1984, METABOLISM, V33, P197, DOI 10.1016/0026-0495(84)90035-0; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Riaz S, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/150176; Runau F, 2015, NUTR CLIN PRACT, V30, P363, DOI 10.1177/0884533614567337; Ryan MF, 2013, AM J CLIN NUTR, V97, P261, DOI 10.3945/ajcn.112.047936; Scott Eleanor M, 2005, Diab Vasc Dis Res, V2, P54, DOI 10.3132/dvdr.2005.009; Umeno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130971; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yarmolinsky J, 2016, SCI REP-UK, V6, DOI 10.1038/srep17714; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Yildirim C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124347; Zhang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE1433, DOI 10.1152/ajpendo.00664.2006	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202727	10.1371/journal.pone.0202727	http://dx.doi.org/10.1371/journal.pone.0202727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161145	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900041
J	Gonzalez-Mace, O; Scheu, S				Gonzalez-Mace, Odette; Scheu, Stefan			Response of Collembola and Acari communities to summer flooding in a grassland plant diversity experiment	PLOS ONE			English	Article							ORIBATID MITE; SOIL FAUNA; BIODIVERSITY; HISTORY	Flooding frequency is predicted to increase during the next decades in Europe. Therefore, it is important to understand how short-term disturbance events affect soil biota providing essential ecosystem functions and uncover factors modulating their response such as plant community composition. Here we report on the response of soil microarthropod communities (Collembola and Acari) to a severe summer flood in 2013, which affected major parts of central Europe. Collembola and Acari density and Collembola and Oribatida richness were strongly affected by the flood, but they recovered within three months. Effects of plant community composition on soil microarthropods disappeared after the flood, presumably due to homogenization of the field, but the effects of plant community were in a stage of being reasserted three months after the flood. Widespread, surface living and generalistic microarthropod species recolonized the field quickly. Prostigmata and Oribatida were more resilient or recovered to flooding than Astigmata and Gamasida. Long-term impacts, however, remain unknown and deserve further investigation.	[Gonzalez-Mace, Odette; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; University of Gottingen	Gonzalez-Mace, O (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	ogonzal@gwdg.de	Scheu, Stefan/H-7049-2015		German Science Foundation (DFG) [FOR 1451]; ETH Zurich	German Science Foundation (DFG)(German Research Foundation (DFG)); ETH Zurich(ETH Zurich)	The Jena Experiment is funded by the German Science Foundation (DFG; FOR 1451) with additional support from ETH Zurich (funds from N. Buchmann research group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FUNDAMENTALS APPL AC, DOI DOI 10.1007/978-981-10-1594-6; Bardgett RD, 2005, BIOL SOIL COMMUNITY; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Behan-Pelletier VM, 1999, AGR ECOSYST ENVIRON, V74, P411, DOI 10.1016/S0167-8809(99)00046-8; Behan-Pelletier VM, 2003, CAN J SOIL SCI, V83, P279, DOI 10.4141/S01-063; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bloschl G, 2013, HYDROL EARTH SYST SC, V17, P5197, DOI 10.5194/hess-17-5197-2013; Bokhorst S, 2017, SOIL BIOL BIOCHEM, V110, P79, DOI 10.1016/j.soilbio.2017.03.009; Chauvat M, 2003, OECOLOGIA, V137, P269, DOI 10.1007/s00442-003-1310-8; Endlweber K, 2007, BIOL FERT SOILS, V43, P741, DOI 10.1007/s00374-006-0157-7; Faraway J.J., 2014, LINEAR MODELS R; Filser J, 2002, PEDOBIOLOGIA, V46, P234, DOI 10.1078/0031-4056-00130; Fjellberg A., 1998, COLLEMBOLA FENNOSC 1; FJELLBERG A, 2007, FAUNA ENTOMOL SCAD, V42, P1; Fox J., 2014, R COMPANION APPL REG; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Hertzog LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152777; Hoffmann AA, 2008, P ROY SOC B-BIOL SCI, V275, P2473, DOI 10.1098/rspb.2008.0685; Hopkin SP, 2007, BIOL SPRINGTAILS COL; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Kaneko N, 1995, PEDOBIOLOGIA, V39, P538; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Karg W, 1993, TIERWELT DEUTSCHLAND, V59; Kaufmann R, 2002, ARCT ANTARCT ALP RES, V34, P242, DOI 10.2307/1552481; Koehler HH, 1999, AGR ECOSYST ENVIRON, V74, P395, DOI 10.1016/S0167-8809(99)00045-6; Krantz GW, 2009, MANUAL ACAROLOGY, P807; Lindberg N, 2005, APPL SOIL ECOL, V28, P163, DOI 10.1016/j.apsoil.2004.07.003; Lindberg N., 2003, SOIL FAUNA GLOBAL CH; Lindberg N, 2006, OIKOS, V114, P494, DOI 10.1111/j.2006.0030-1299.14396.x; Mace OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166349; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Makkonen M, 2011, SOIL BIOL BIOCHEM, V43, P377, DOI 10.1016/j.soilbio.2010.11.004; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; Maraun M, 2003, EUR J SOIL BIOL, V39, P85, DOI 10.1016/S1164-5563(03)00006-2; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Norton Roy A., 1994, P99; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P1158, DOI 10.1016/j.soilbio.2005.09.004; R Core Team, 2021, R LANGUAGE ENV STAT; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Ruf A, 2005, ECOTOX ENVIRON SAFE, V62, P290, DOI 10.1016/j.ecoenv.2005.03.029; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Salamon JA, 2004, OIKOS, V106, P51, DOI 10.1111/j.0030-1299.2004.12905.x; Scheu S, 2005, SOIL BIOL, V3, P253; Scheu S, 1996, BIODIVERS CONSERV, V5, P235, DOI 10.1007/BF00055833; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; SIEPEL H, 1994, BIOL FERT SOILS, V18, P263, DOI 10.1007/BF00570628; Socarras A, 2014, PASTOS FORRAJES, V37, P109; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Unger IM, 2010, ENVIRON EXP BOT, V69, P113, DOI 10.1016/j.envexpbot.2010.03.005; Visser EJW, 2005, PLANT SOIL, V274, P197, DOI 10.1007/s11104-004-1650-0; Wagner D, 2015, SOIL BIOL BIOCHEM, V89, P135, DOI 10.1016/j.soilbio.2015.07.001; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; WALLWORK J A, 1970, P283; Wallwork JA, 1980, SOIL BIOL RELATED LA, P759; Walter DE, 1999, MITES ECOLOGY EVOLUT; Weigmann G., 2006, HORNMILBEN ORIBATIDA; Williamson WM, 2007, APPL SOIL ECOL, V37, P139, DOI 10.1016/j.apsoil.2007.05.003; Wissuwa J, 2013, EUR J SOIL BIOL, V59, P8, DOI 10.1016/j.ejsobi.2013.08.002; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092; Zuur AF, 2007, STAT BIOL HEALTH, P163	64	13	13	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202862	10.1371/journal.pone.0202862	http://dx.doi.org/10.1371/journal.pone.0202862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161191	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900046
J	Seghieri, C; Calovi, M; Ferre, F				Seghieri, Chiara; Calovi, Martina; Ferre, Francesca			Proximity and waiting times in choice models for outpatient cardiological visits in Italy	PLOS ONE			English	Article							HEALTH-CARE; PATIENT CHOICE; ACCESS; EQUITY	We apply mixed logit regression to investigate patients' choice of non-emergency outpatient cardiovascular specialists in Tuscany, Italy. We focused on the effects of travel time and waiting time. Results reveal that patients prefer clinics nearby and with shorter waiting times. Differences in patient choice depend on age and socioeconomic conditions, thus confirming equity concerns in the access of non-acute services. Our results could be used to optimize the allocation of resources, reduce inequities and increase the efficiency and responsiveness of outpatient systems considering patient preferences.	[Seghieri, Chiara; Calovi, Martina; Ferre, Francesca] Scuola Super Sant Anna, Inst Management, Lab Management & Sanita, Pisa, Italy; [Calovi, Martina] Penn State Univ, Dept Geog, Geoinformat & Earth Observat Lab, University Pk, PA 16802 USA; [Calovi, Martina] Penn State Univ, Inst CyberSci, University Pk, PA 16802 USA	Scuola Superiore Sant'Anna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ferre, F (corresponding author), Scuola Super Sant Anna, Inst Management, Lab Management & Sanita, Pisa, Italy.	francesca.ferre@santannapisa.it	ferre, francesca/L-7614-2014	ferre, francesca/0000-0001-5781-517X	regional administration-Direzione Diritti di cittadinanza e coesione sociale-of Tuscany	regional administration-Direzione Diritti di cittadinanza e coesione sociale-of Tuscany	This study was supported by the regional administration-Direzione Diritti di cittadinanza e coesione sociale-of Tuscany. The authors acknowledge Professor Sabina Nuti and all researchers from Laboratorio Management e Sanita, Institute of Management, Sant'Anna School of Advances Studies, for their constant support and useful comments.	Aggarwal A, 2016, MED CARE RES REV; Akinci F., 2004, HLTH MARK Q, V22, P3, DOI DOI 10.1300/J026V22N01_02; [Anonymous], [No title captured]; [Anonymous], SANITA SALUTE TOSCAN; ARS T, 2013, RAPP CRIS EC STAT SA; Balia Silvia, 2014, Dev Health Econ Public Policy, V12, P133; Barsanti S, 2014, INT J HEALTH PLAN M, V29, pE233, DOI 10.1002/hpm.2195; Berkowitz E. N., 1981, J HEALTH CARE MARKET, V1, P25; Bevan GA, HEAL EC POLICY LAW; Boo G, 2015, ISPRS ANN PHOTO REM, VII-3, P263, DOI 10.5194/isprsannals-II-3-W5-263-2015; Boscarino J, 1982, J HLTH CARE MARK, P23; Brekke K., 2014, DEV HLTH EC PUBLIC P, V12; Briggs DJ, 2007, REMOTE SENS ENVIRON, V108, P451, DOI 10.1016/j.rse.2006.11.020; Cooper Z, 2011, ECON J, V121, pF228, DOI 10.1111/j.1468-0297.2011.02449.x; Coulter A., 2010, BMJ, V341; Dixon A, 2010, HEALTH ECON POLICY L, V5, P295, DOI 10.1017/S1744133110000058; Exworthy M, 2006, SOC POLICY ADMIN, V40, P267, DOI 10.1111/j.1467-9515.2006.00489.x; Ferre F, 2014, HEALT SYST TRANSIT, V16, P1; Fotaki M, 2007, PUBLIC ADMIN, V85, P1059, DOI 10.1111/j.1467-9299.2007.00682.x; France G, 2005, J HEALTH POLIT POLIC, V30, P169, DOI 10.1215/03616878-30-1-2-169; Gesler MW, 1989, METHODOLOGICAL ADV H; Glorioso V, 2014, HEALTH SERV RES, V49, P950, DOI 10.1111/1475-6773.12128; Hole AR, 2008, J HEALTH ECON, V27, P1078, DOI 10.1016/j.jhealeco.2007.11.006; Lane PM, 1994, HLTH CARE MARKETING; Magnussen J, 2009, NORDIC HLTH CARE SYS; Masseria C, 2010, EUR J PUBLIC HEALTH, V20, P504, DOI 10.1093/eurpub/ckq029; Ministero della salute, 2012, PIAN NAZ GOV LIST AT; Nuti S., 2016, Medical practice variations, P433; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; RisaHole Arne, 2016, ECONPAPERS; Shah J, 2010, J CLIN UROL, V3, P25, DOI 10.1016/j.bjmsu.2009.10.003; Siciliani L, 2013, OECD HLTH POLICY STU, P1; Sivey P, 2012, HEALTH ECON, V21, P444, DOI 10.1002/hec.1720; WOLINSKY FD, 1984, HOSP HEALTH SERV ADM, V29, P58	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203018	10.1371/journal.pone.0203018	http://dx.doi.org/10.1371/journal.pone.0203018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161181	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900065
J	Tsogbadrakh, B; Ju, KD; Lee, J; Han, M; Koh, J; Yu, Y; Lee, H; Yu, KS; Oh, YK; Kim, HJ; Ahn, C; Oh, KH				Tsogbadrakh, Bodokhsuren; Ju, Kyung Don; Lee, Jinho; Han, Miyeun; Koh, Junga; Yu, Yeonsil; Lee, Hajeong; Yu, Kyung-Sang; Oh, Yun Kyu; Kim, Hyo Jin; Ahn, Curie; Oh, Kook-Hwan			HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR; TGF-BETA; DIABETIC-NEPHROPATHY; METFORMIN; PROLIFERATION; INFLAMMATION; FIBROBLASTS; MECHANISM; STRESS	Background Renal fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM), which leads to progressive renal failure. Adenosine-monophosphate-activated protein kinase (AMPK) is a highly conserved kinase that plays a key role in Smad-3 signaling. Here, we examined the effect of a novel AMPK activator, HL156A, on the inhibition of renal fibrosis in in vivo and in vitro models. Methods Unilateral ureteral obstruction (UUO) was induced in male Wistar rats. Rats with UUO were administered HL156A (20mg/kg/day), and then the kidneys were harvested 10 days after ligation for further analysis. Results In the rat UUO model, HL156A attenuated ECM protein deposition. After HL156A treatment, expressions of TGF-beta 1, p-Smad3, alpha-SMA, fibronectin, and type IV collagen were suppressed, and E-cadherin expression was up-regulated. In the in vitro experiment, NRK52E cells were treated with HL156A before TGF-beta 1 stimulation. The inhibitory effects of HL156A upon the signaling pathways and markers of the epithelial-to-mesenchymal transition (EMT) were analyzed. In TGF-beta 1-treated NRK-52E cells, HL156A co-treatment inhibited the TGF-beta 1-induced Smad3 signaling pathway and EMT markers. Conclusion Taken together, the above findings suggest that HL156A, a novel AMPK activator, ameliorates renal fibrosis in vivo and in vitro.	[Tsogbadrakh, Bodokhsuren; Ju, Kyung Don; Lee, Jinho] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Han, Miyeun; Lee, Hajeong; Oh, Yun Kyu; Ahn, Curie; Oh, Kook-Hwan] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Koh, Junga; Yu, Yeonsil] Seoul Natl Univ Hosp, Dept Internal Med, Renal Div, Seoul, South Korea; [Yu, Kyung-Sang] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea; [Oh, Yun Kyu] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Kim, Hyo Jin] Dongkuk Univ, Dept Internal Med, Kyungju, South Korea; [Ahn, Curie] Seoul Natl Univ Hosp, Transplantat Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Dongguk University; Seoul National University (SNU); Seoul National University Hospital	Oh, KH (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	khoh@snu.ac.kr	Han, Miyeun/AAE-7569-2022; Oh, Yun Kyu/J-5542-2012		Hanall Biophama Co., Korea	Hanall Biophama Co., Korea	This research was funded by Hanall Biophama Co., Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Allouch S, 2017, J CELL PHYSIOL, V232, P3652, DOI 10.1002/jcp.25838; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554; Chevalier RL, 2009, KIDNEY INT, V76, P475, DOI 10.1038/ki.2009.244; Daskalopoulos EP, 2016, J MOL CELL CARDIOL, V91, P188, DOI 10.1016/j.yjmcc.2016.01.001; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Ju KD, 2016, AM J PHYSIOL-RENAL, V310, pF342, DOI 10.1152/ajprenal.00204.2015; Kim H, 2015, AM J PHYSIOL-RENAL, V308, pF226, DOI 10.1152/ajprenal.00495.2014; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Kim SI, 2012, KIDNEY RES CLIN PRAC, V31, P94, DOI 10.1016/j.krcp.2012.04.322; Kim Y, 2016, KIDNEY RES CLIN PRAC, V35, P69, DOI 10.1016/j.krcp.2016.02.004; Klahr S, 2003, KIDNEY INT, V64, pS105, DOI 10.1046/j.1523-1755.64.s87.16.x; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lan HY, 2012, KIDNEY RES CLIN PRAC, V31, P4, DOI 10.1016/j.krcp.2011.12.001; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Lieberthal W, 2016, AM J PHYSIOL-RENAL, V311, pF731, DOI 10.1152/ajprenal.00541.2015; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Lu JM, 2015, LIFE SCI, V127, P59, DOI 10.1016/j.lfs.2015.01.042; Masaki T, 2003, KIDNEY INT, V63, P1256, DOI 10.1046/j.1523-1755.2003.00874.x; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Shihab FS, 2007, CLIN J AM SOC NEPHRO, V2, P876, DOI 10.2215/CJN.02660707; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Thakur S, 2015, AM J PATHOL, V185, P2168, DOI 10.1016/j.ajpath.2015.04.014; Ueno S, 2016, J PHARMACOL SCI, V131, P110, DOI 10.1016/j.jphs.2016.04.021; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang SW, 2017, EXP THER MED, V14, P383, DOI 10.3892/etm.2017.4475; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201692	10.1371/journal.pone.0201692	http://dx.doi.org/10.1371/journal.pone.0201692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161162	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900013
J	Hoff, KE; DeBalsi, KL; Sanchez-Quintero, MJ; Longley, MJ; Hirano, M; Naini, AB; Copeland, WC				Hoff, Kirsten E.; DeBalsi, Karen L.; Sanchez-Quintero, Maria J.; Longley, Matthew J.; Hirano, Michio; Naini, Ali B.; Copeland, William C.			Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome	PLOS ONE			English	Article							POLYMERASE GAMMA-SUBUNITS; ACCESSORY SUBUNIT; DISEASE MUTATIONS; ENERGY-METABOLISM; MTDNA; PROTEIN; RECONSTITUTION; REPLICATION; MAINTENANCE; HOLOENZYME	Mutations in mitochondrial DNA (mtDNA) have been linked to a variety of metabolic, neurological and muscular diseases which can present at any time throughout life. MtDNA is replicated by DNA polymerase gamma (Pol gamma), twinkle helicase and mitochondrial single-stranded binding protein (mtSSB). The Pol gamma holoenzyme is a heterotrimer consisting of the p140 catalytic subunit and a p55 homodimeric accessory subunit encoded by the nuclear genes POLG and POLG2, respectively. The accessory subunits enhance DNA binding and promote processive DNA synthesis of the holoenzyme. Mutations in either POLG or POLG2 are linked to disease and adversely affect maintenance of the mitochondrial genome, resulting in depletion, deletions and/or point mutations in mtDNA. A homozygous mutation located at Chr17: 62492543G> A in POLG2, resulting in R182W substitution in p55, was previously identified to cause mtDNA depletion and fatal hepatic liver failure. Here we characterize this homozygous R182W p55 mutation using in vivo cultured cell models and in vitro biochemical assessments. Compared to control fibroblasts, homozygous R182W p55 primary dermal fibroblasts exhibit a two-fold slower doubling time, reduced mtDNA copy number and reduced levels of POLG and POLG2 transcripts correlating with the reported disease state. Expression of R182W p55 in HEK293 cells impairs oxidative-phosphorylation. Biochemically, R182W p55 displays DNA binding and association with p140 similar to WT p55. R182W p55 mimics the ability of WT p55 to stimulate primer extension, support steady-state nucleotide incorporation, and suppress the exonuclease function of Pol gamma in vitro. However, R182W p55 has severe defects in protein stability as determined by differential scanning fluorimetry and in stimulating function as determined by thermal inactivation. These data demonstrate that the Chr17: 62492543G> A mutation in POLG2, R182W p55, severely impairs stability of the accessory subunit and is the likely cause of the disease phenotype.	[Hoff, Kirsten E.; DeBalsi, Karen L.; Longley, Matthew J.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Sanchez-Quintero, Maria J.; Hirano, Michio; Naini, Ali B.] Columbia Univ, Dept Neurol, Med Ctr, H Houston Merritt Neuromuscular Res Ctr, New York, NY USA; [Naini, Ali B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Naini, Ali B.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, Div Personalized Genom Med, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University; Columbia University; Columbia University	Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019; SANCHEZ-QUINTERO, MARIA J/AAS-6771-2020	Copeland, William/0000-0002-0359-0953; SANCHEZ-QUINTERO, MARIA J/0000-0002-5638-2920	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES 065078]; NIH/ NICHD [5P01 HD080642-02]	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/ NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ES 065078). M.H. and A.B.N. are supported by NIH/ NICHD grant 5P01 HD080642-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brown TA, 2011, MOL CELL BIOL; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305; Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chretien D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003992; Cohen BH, 1997, POLG RELATED DISORDE; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006; DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506; Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019; Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042; Pinz KG, 2006, DNA REPAIR, V5, P121, DOI 10.1016/j.dnarep.2005.08.014; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395; Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361; Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang CK, 2012, BIOINFORMATICS, V28, P439, DOI 10.1093/bioinformatics/btr664; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Young M.J., 2013, MITOCHONDRIAL DISORD, P49; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240; Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203198	10.1371/journal.pone.0203198	http://dx.doi.org/10.1371/journal.pone.0203198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157269	gold, Green Submitted, Green Published			2022-12-26	WOS:000443071400099
J	Jarque, S; Fetter, E; Veneman, WJ; Spaink, HP; Peravali, R; Strahle, U; Scholz, S				Jarque, Sergio; Fetter, Eva; Veneman, Wouter J.; Spaink, Herman P.; Peravali, Ravindra; Straehle, Uwe; Scholz, Stefan			An automated screening method for detecting compounds with goitrogenic activity using transgenic zebrafish embryos	PLOS ONE			English	Article							THYROID-GLAND; TOXICITY TEST; FISH; EXPRESSION; DISRUPTION; POLLUTANTS; CHEMICALS; EXPOSURE; MODEL; ASSAY	The knowledge on environmentally relevant chemicals that may interfere with thyroid signaling is scarce. Here, we present a method for the screening of goitrogens, compounds that disrupt the thyroid gland function, based on the automatic orientation of zebrafish in a glass capillary and a subsequent imaging of reporter gene fluorescence in the thyroid gland of embryos of the transgenic zebrafish line tg(tg:mCherry). The tg(tg:mCherry) reporter gene indicates a compensatory upregulation of thyroglobulin, the thyroid hormone precursor, in response to inhibition of thyroid hormone synthesis. Fish embryos were exposed to a negative control compound (3,4-dichloroaniline), or a concentration series of known goitrogenic compounds (resorcinol, methimazole, potassium perchlorate, 6-propyl-2-thiouracil, ethylenethiourea, phloroglucinol, pyrazole) with maximum exposure concentration selected based on mortality and/or solubility. Exposure to 3,4-dichloroaniline decreased the fluorescence signal. All goitrogenic compounds exhibited clear concentration-dependent inductions of reporter fluorescence 1.4 to 2.6 fold above control levels. Concentration-response modelling was used to calculate goitrogenic potencies based on EC50 values. The new automated method offers an efficient screening approach for goitrogenic activity.	[Jarque, Sergio] Masaryk Univ, RECETOX, Fac Sci, Brno, Czech Republic; [Fetter, Eva; Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany; [Veneman, Wouter J.; Spaink, Herman P.] Leiden Univ, Inst Biol, Dept Anim Sci & Hlth, Leiden, Netherlands; [Peravali, Ravindra; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany	Masaryk University Brno; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leiden University; Leiden University - Excl LUMC; Helmholtz Association; Karlsruhe Institute of Technology	Scholz, S (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.	stefan.scholz@ufz.de	Spaink, Herman P./S-3586-2017; Straehle, Uwe/K-7054-2013; Scholz, Stefan/B-7776-2014	Spaink, Herman P./0000-0003-4128-9501; Scholz, Stefan/0000-0002-6990-4716; Jarque, Sergio/0000-0002-5528-9054	German Environmental Scholarship foundation; Czech Ministry of Education [LO1214]; Program of "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund [CZ.1.07/2.3.00/30.0009]; State Budget of the Czech Republic; Helmholtz Association	German Environmental Scholarship foundation; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Program of "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund; State Budget of the Czech Republic; Helmholtz Association(Helmholtz Association)	The work of Eva Fetter was supported by a scholarship of the German Environmental Scholarship foundation. Sergio Jarque was supported by the Czech Ministry of Education (LO1214) and the Program of "Employment of Newly Graduated Doctors of Science for Scientific Excellence" (Grant number CZ.1.07/2.3.00/30.0009) co-financed from European Social Fund and the State Budget of the Czech Republic. All other authors did not receive specific fundings for their contribution. We gratefully acknowledge access to the platform CITEPro (Chemicals in the Terrestrial Environment Profiler) funded by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt B, 2006, DEV DYNAM, V235, P1872, DOI 10.1002/dvdy.20831; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Demeneix B., 2014, LOSING OUR MINDS ENV; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Fetter E, 2015, REPROD TOXICOL, V57, P10, DOI 10.1016/j.reprotox.2015.04.012; Fini JB, 2007, ENVIRON SCI TECHNOL, V41, P5908, DOI 10.1021/es0704129; Freitas J, 2011, TOXICOL IN VITRO, V25, P257, DOI 10.1016/j.tiv.2010.08.013; Freitas JS, 2016, ENVIRON SCI TECHNOL, V50, P13095, DOI 10.1021/acs.est.6b04076; Haber LT, 2018, CRIT REV TOXICOL, V48, P387, DOI 10.1080/10408444.2018.1430121; ISO, 2007, 15088 ISO; Jarque S, 2014, ENVIRON RES, V135, P361, DOI 10.1016/j.envres.2014.09.022; Kah M, 2008, CHEMOSPHERE, V72, P1401, DOI 10.1016/j.chemosphere.2008.04.074; Kluver N, 2016, CHEMOSPHERE, V164, P164, DOI 10.1016/j.chemosphere.2016.08.079; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; Liu CS, 2013, CHEMOSPHERE, V93, P2327, DOI 10.1016/j.chemosphere.2013.08.026; Marchesini GR, 2006, ANAL CHEM, V78, P1107, DOI 10.1021/ac051399i; Matthiessen P, 2018, CRIT REV TOXICOL, V48, P195, DOI 10.1080/10408444.2017.1397099; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Mughal BB, 2018, ENDOCR CONNECT, V7, pR160, DOI 10.1530/EC-18-0029; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; OECD, 2012, OECD SER TEST ASS, V178; OECD, 2013, OECD 236 GUID TEST C; Opitz R, 2012, DEV BIOL, V372, P203, DOI 10.1016/j.ydbio.2012.09.011; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Paul KB, 2014, CHEM RES TOXICOL, V27, P387, DOI 10.1021/tx400310w; Raldua D, 2009, ENVIRON SCI TECHNOL, V43, P6844, DOI 10.1021/es9012454; Stefan M, 2014, P NATL ACAD SCI USA, V111, P12562, DOI 10.1073/pnas.1408821111; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h; Tonyushkina KN, 2014, J CLIN INVEST, V124, P321, DOI 10.1172/JCI70038; Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085; VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wittbrodt JN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-36	35	14	15	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203087	10.1371/journal.pone.0203087	http://dx.doi.org/10.1371/journal.pone.0203087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157258	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400088
J	Trevillyan, JM; Wong, G; Puls, R; Petoumenos, K; Emery, S; Mellett, NA; Mundra, PA; Meikle, PJ; Hoy, JF				Trevillyan, Janine M.; Wong, Gerard; Puls, Rebekah; Petoumenos, Kathy; Emery, Sean; Mellett, Natalie A.; Mundra, Piyushkumar A.; Meikle, Peter J.; Hoy, Jennifer F.		ALTAIR Study Grp	Changes in plasma lipidome following initiation of antiretroviral therapy	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TREATMENT-NAIVE; CARDIOVASCULAR-DISEASE; FATTY-ACID; HIV; EFAVIRENZ; RISK; ATAZANAVIR/RITONAVIR; INHIBITORS; POPULATION	Introduction HIV and antiretroviral therapy (ART) have been associated with increased cardiovascular disease and important changes in lipid metabolism. Advances in mass-spectrometry technology allow for the detailed assessment of individual lipid species which may illuminate the mechanisms underlying increased cardiovascular risk. We describe the change in plasma lipidome with initiation of antiretroviral therapy and compare these by regimen. Methods Plasma lipid profiling (by electrospray isonisation-tandem mass spectrometry) was performed on ARV-naive HIV positive participants randomised to one of three regimens; tenofovir/emtricitabine with efavirenz, ritonavir-boosted atazanavir (atazanavir/r) or zidovudine/abacavir. Participants (n = 115) who remained on their randomised regimen with complete samples available at baseline, week 12 and 48 were included. 306 lipid species from 22 lipid classes were analysed. Results Initiation of ART led to significant changes in lipidome which were partly dependent on the randomised regimen received. This led to significant differences in 72 lipid species and 7 classes (cholesterol ester, free cholesterol, phosphatidylcholine, GM3 ganglioside, trihexosylceramide, monohexosylceramide, and ceramides) by arm at week 48. Consistently higher lipid concentrations were seen with efavirenz compared with atazanavir/r or zidovudine/abacavir. Twelve of the lipid species and two lipid classes (cholesterol esters and ceramides) that were significantly increased in the efavirenz arm compared with the atazanavir/r or zidovudine/abacavir arms have previously been associated with future cardiovascular events in HIV positive patients. Change in HIV viral load was predictive of change in 3 lipid species. Conclusions Initiation of ART lead to significant changes in the plasma lipidome that were greatest in those receiving efavirenz.	[Trevillyan, Janine M.; Hoy, Jennifer F.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Infect Dis, Melbourne, Vic, Australia; [Wong, Gerard; Mellett, Natalie A.; Mundra, Piyushkumar A.; Meikle, Peter J.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Puls, Rebekah] UNSW Sydney, Fac Med, Sydney, NSW, Australia; [Petoumenos, Kathy; Emery, Sean] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Emery, Sean] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Hoy, Jennifer F.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	Monash University; Baker Heart and Diabetes Institute; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of Queensland; Florey Institute of Neuroscience & Mental Health	Trevillyan, JM (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Dept Infect Dis, Melbourne, Vic, Australia.	janine.trevillyan@monash.edu	Hoy, Jennifer/AAK-7968-2020; Emery, Sean/O-9122-2019; Trevillyan, Janine/AAD-1631-2019	Emery, Sean/0000-0001-6072-8309; Trevillyan, Janine/0000-0002-8660-5558; Meikle, Peter/0000-0002-2593-4665; Hoy, Jennifer/0000-0002-6948-7086; Mundra, Piyushkumar/0000-0001-7769-2939				Aberg JA, 2012, AIDS RES HUM RETROV, V28, P1184, DOI 10.1089/aid.2011.0327; Belury Martha A, 2017, Pathog Immun, V2, P376, DOI 10.20411/pai.v2i3.218; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Carey D, 2010, J ANTIMICROB CHEMOTH, V65, P1878, DOI 10.1093/jac/dkq231; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; den Boer MAM, 2006, ARTERIOSCL THROM VAS, V26, P124, DOI 10.1161/01.ATV.0000194073.87647.10; Desai M, 2015, CLIN INFECT DIS, V61, P445, DOI 10.1093/cid/civ316; El Hadri K, 2004, J BIOL CHEM, V279, P15130, DOI 10.1074/jbc.M312875200; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; Fernandez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071846; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gotti D, 2012, HIV CLIN TRIALS, V13, P245, DOI 10.1310/hct1305-245; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Kee TH, 2005, CLIN EXP PHARMACOL P, V32, P153, DOI 10.1111/j.1440-1681.2005.04166.x; Lenhard JM, 2000, ARTERIOSCL THROM VAS, V20, P2625, DOI 10.1161/01.ATV.20.12.2625; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; Martinez E, 2009, JAIDS-J ACQ IMM DEF, V51, P290, DOI 10.1097/QAI.0b013e3181aa12d5; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Oh J, 2007, LANCET INFECT DIS, V7, P787, DOI 10.1016/S1473-3099(07)70287-6; Poss J, 2011, CURR PHARM DESIGN, V17, P861, DOI 10.2174/138161211795428858; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Richmond SR, 2010, BBA-MOL CELL BIOL L, V1801, P559, DOI 10.1016/j.bbalip.2010.01.007; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Rotger M, 2013, CLIN INFECT DIS, V57, P112, DOI 10.1093/cid/cit196; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Shafran SD, 2005, HIV MED, V6, P421, DOI 10.1111/j.1468-1293.2005.00328.x; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Tarasov K, 2014, J CLIN ENDOCR METAB, V99, pE45, DOI 10.1210/jc.2013-2559; Tebas P, 2014, CLIN INFECT DIS, V59, P425, DOI 10.1093/cid/ciu234; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094810; Zhang DX, 2003, AM J PHYSIOL-HEART C, V284, pH605, DOI 10.1152/ajpheart.00697.2002	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202944	10.1371/journal.pone.0202944	http://dx.doi.org/10.1371/journal.pone.0202944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157268	Green Published, gold			2022-12-26	WOS:000443071400076
J	da Silva, HB; de Salles, EM; Lima-Mauro, EF; Sardinha, LR; Alvarez, JM; Lima, MRD				da Silva, Henrique Borges; de Salles, Erika Machado; Lima-Mauro, Eliana Faquim; Sardinha, Luiz Roberto; Alvarez, Jose Maria; D'Imperio Lima, Maria Regina			CD28 deficiency leads to accumulation of germinal-center independent IgM(+) experienced B cells and to production of protective IgM during experimental malaria	PLOS ONE			English	Article							STAGE PLASMODIUM-CHABAUDI; IN-VIVO; T-CELL; ACQUIRED-IMMUNITY; ANTIBODIES; COMPLEMENT; INDUCTION; INFECTION; RESPONSES; IMMUNOGLOBULIN	Protective immunity to blood-stage malaria is attributed to Plasmodium-specific IgG and effector-memory T helper 1 (Th1) cells. However, mice lacking the costimulatory receptor CD28 (CD28KO) maintain chronic parasitemia at low levels and do not succumb to infection, suggesting that other immune responses contribute to parasite control. We report here that CD28KO mice develop long-lasting non-sterile immunity and survive lethal parasite challenge. This protection correlated with a progressive increase of anti-parasite IgM serum levels during chronic infection. Serum IgM from chronically infected CD28KO mice recognize erythrocytes infected with mature parasites, and effectively control Plasmodium infection by promoting parasite lysis and uptake. These antibodies also recognize autoantigens and antigens from other pathogens. Chronically infected CD28KO mice have high numbers of IgM(+) plasmocytes and experienced B cells, exhibiting a germinal-center independent Fas(+)GL7(-)CD38(+)CD73(-) phenotype. These cells are also present in chronically infected C57BL/6 mice although in lower numbers. Finally, IgM(+) experienced B cells from cured C57BL/6 and CD28KO mice proliferate and produce anti-parasite IgM in response to infected erythrocytes. This study demonstrates that CD28 deficiency results in the generation of germinal-center independent IgM(+) experienced B cells and the production of protective IgM during experimental malaria, providing evidence for an additional mechanism by which the immune system controls Plasmodium infection.	[da Silva, Henrique Borges; de Salles, Erika Machado; Alvarez, Jose Maria; D'Imperio Lima, Maria Regina] Univ Sao Paulo, ICB, Dept Imunol, Sao Paulo, Brazil; [Lima-Mauro, Eliana Faquim] Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil; [Sardinha, Luiz Roberto] Inst Israelite Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [da Silva, Henrique Borges] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	Universidade de Sao Paulo; Instituto Butantan; Hospital Israelita Albert Einstein; University of Minnesota System; University of Minnesota Twin Cities	da Silva, HB; Lima, MRD (corresponding author), Univ Sao Paulo, ICB, Dept Imunol, Sao Paulo, Brazil.; da Silva, HB (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	hborgesd@umn.edu; relima@usp.br	Salles, Érika Machado/I-6001-2015; D'Império Lima, Maria Regina/I-4747-2012; Alvarez, Jose M/I-6181-2012	D'Império Lima, Maria Regina/0000-0002-4683-7709; Alvarez, Jose M/0000-0002-9711-4914; Borges da Silva, Henrique/0000-0001-9424-3326	Sao Paulo Research Foundation (FAPESP, Brazil) [2010/51150-4, 2013/07140-2, 2015/20432-8]; National Council for Scientific and Technological Development (CNPq, Brazil) [303676/2014-0, 448765/2014-4]; FAPESP [2009/08559-1]	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP, Brazil) grants, 2010/51150-4, 2013/07140-2 and 2015/20432-8 (MRDIL), and National Council for Scientific and Technological Development (CNPq, Brazil) grants, 303676/2014-0 and 448765/2014-4 (MRDIL). HBdS received a PhD fellowship from FAPESP (2009/08559-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouri RR, 2016, CELL REP, V14, P723, DOI 10.1016/j.celrep.2015.12.067; ANDERSSON J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410; Arama C, 2018, OPEN FORUM INFECT DI, P1; ATKINSON JP, 1974, J CLIN INVEST, V54, P339, DOI 10.1172/JCI107769; Barfod L, 2011, P NATL ACAD SCI USA, P1; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; Capolunghi F, 2013, IMMUNOL LETT, V152, P114, DOI 10.1016/j.imlet.2013.04.007; Chan J, 2012, J CLIN INVEST, V122; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Couper KN, 2005, PARASITE IMMUNOL, V27, P171, DOI 10.1111/j.1365-3024.2005.00760.x; D'Imperio Lima M, 1996, SCAND J IMMUNOL; da Silva HB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004598; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Fossati-Jimack L, 1999, J EXP MED, V190, P1689, DOI 10.1084/jem.190.11.1689; Gomes LR, 2014, LUPUS, V23, P1295, DOI 10.1177/0961203314546021; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARTE PG, 1983, NATURE, V302, P256, DOI 10.1038/302256a0; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; Langhorne J, 1989, Int Immunol, V1, P416, DOI 10.1093/intimm/1.4.416; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LIMA MRD, 1991, INT IMMUNOL, V3, P1207, DOI 10.1093/intimm/3.12.1207; Lugaajju A, 2017, MALARIA J, P1, DOI [10.1186/s12936-016-1650-6, DOI 10.1186/S12936-016-1650-6]; Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Muxel SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022434; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Pantaleo A, 2008, AUTOIMMUN REV, V7, P457, DOI 10.1016/j.autrev.2008.03.017; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Semblat JP, 2006, MOL BIOCHEM PARASIT, V146, P192, DOI 10.1016/j.molbiopara.2005.12.007; Snapper CM, 2012, ANN NY ACAD SCI, V1253, P92, DOI 10.1111/j.1749-6632.2011.06329.x; Stephens R, 2015, TRENDS PARASITOL, V28, P74; Stevenson L, 2015, CELL MICROBIOL, V17, P819, DOI 10.1111/cmi.12403; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Wolofsky KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002942	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202522	10.1371/journal.pone.0202522	http://dx.doi.org/10.1371/journal.pone.0202522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148845	Green Submitted, gold, Green Published			2022-12-26	WOS:000442804200013
J	Kim, JC; Ha, YJ; Tak, KH; Roh, SA; Kwon, YH; Kim, CW; Yoon, YS; Lee, JL; Park, Y; Kim, SK; Kim, SY; Cho, DH; Kim, YS				Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kwon, Yi Hong; Kim, Chan Wook; Yoon, Yong Sik; Lee, Jong Lyul; Park, Yangsoon; Kim, Seon-Kyu; Kim, Seon-Young; Cho, Dong-Hyung; Kim, Yong Sung			Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; PROGNOSTIC-FACTOR; EXPRESSION; AUTOPHAGY; COLON; GELSOLIN; GROWTH; SYNTHETASE; ACTIVATION; SUPPRESSOR	The present study aimed to identify molecules associated with lymphovascular invasion (LVI) and perineural invasion (PNI) and to examine their biological behavior in colorectal cancer (CRC). LVI- and PNI-associated molecules were identified and verified using sequential processes including (1) identification of 117 recurrence-associated genes differentially expressed on RNA-seq analysis using primary cancer tissues from 130 CRC patients with and without systemic recurrence; (2) analysis of molecules associated with LVI and PNI; (3) assessment of biological properties by measuring proliferation, anoikis, invasion/migration, epithelial-mesenchymal transition and autophagy flux; and (4) verification of disease-free survival using public datasets. Gelsolin (GSN) and 2'-5'-oligoadenylate synthetase 2 (OAS2) were associated with PNI and LVI, respectively. Invasion potential was >2-fold greater in GSN-overexpressing LoVo cells than in control cells (p<0.001-0.005), whereas OAS2-overexpressing RKO cells showed reduced invasion (p<0.001-0.005). GSN downregulated E-cadherin, beta-catenin, claudin-1 and snail, and upregulated N-cadherin and ZEB1, whereas OAS2 overexpression had the opposite effects. Several autophagy-related proteins including ATG5-12, ATG6/BECN1, ATG7 and ATG101 were downregulated in GSN-overexpressing LoVo cells, whereas the opposite pattern was observed in OAS2-overexpressing RKO cells. Patients with low GSN expression had significantly higher 5-year recurrence-free survival (RFS) rates than those with GSN overexpression (73.6% vs. 64.7%, p = 0.038), whereas RFS was longer in patients with OAS2 overexpression than in those with underexpression (73.4% vs. 63.7%, p = 0.01). In conclusion, GSN and OAS2 were positively and negatively associated with recurrence, respectively, suggesting their potential value as predictors of recurrence or therapeutic targets in CRC patients.	[Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kwon, Yi Hong; Kim, Chan Wook; Yoon, Yong Sik; Lee, Jong Lyul] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea; [Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kwon, Yi Hong; Kim, Chan Wook; Yoon, Yong Sik; Lee, Jong Lyul; Park, Yangsoon; Kim, Seon-Kyu; Kim, Seon-Young; Cho, Dong-Hyung; Kim, Yong Sung] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Park, Yangsoon] Univ Ulsan, Dept Pathol, Coll Med, Seoul, South Korea; [Kim, Seon-Kyu; Kim, Seon-Young; Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea; [Cho, Dong-Hyung] Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University	Kim, JC (corresponding author), Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea.; Kim, JC; Cho, DH; Kim, YS (corresponding author), Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea.; Kim, YS (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea.; Cho, DH (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea.	jckim@amc.seoul.kr; chodong03@gmail.com; yongsung@kribb.re.kr	Lww, Jong Lyul/W-1791-2019	Lww, Jong Lyul/0000-0002-5878-8000; Kim, Seon-Kyu/0000-0002-4176-5187	Korea Research Foundation [2016R1E1A1A02919844, 2017R1A2B1009062]; Ministry of Science, ICT, and Future Planning, Republic of Korea	Korea Research Foundation(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning, Republic of Korea	This work was supported by grants from the Korea Research Foundation (2016R1E1A1A02919844 to JCK and 2017R1A2B1009062 to SAR), Ministry of Science, ICT, and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng SF, 2002, BIOCHEM J, V366, P807, DOI 10.1042/BJ20020202; Choi UY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.110; Dan MX, 2012, MOL BIOL REP, V39, P7813, DOI 10.1007/s11033-012-1624-x; Dar AA, 2016, IMMUNOLOGY, V147, P251, DOI 10.1111/imm.12560; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Grille SJ, 2003, CANCER RES, V63, P2172; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Kim JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155160; Knijn N, 2016, AM J SURG PATHOL, V40, P103, DOI 10.1097/PAS.0000000000000518; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lacorte LM, 2015, BIOCHEM BIOPH RES CO, V457, P538, DOI 10.1016/j.bbrc.2015.01.019; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Ma XJ, 2016, TUMOR BIOL, V37, P7165, DOI 10.1007/s13277-015-4565-x; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Marino N, 2013, CANCER RES, V73, P5949, DOI 10.1158/0008-5472.CAN-13-0368; Pan HM, 2016, ONCOTARGET, V7, P21235, DOI 10.18632/oncotarget.6908; Qin WJ, 2015, ONCOTARGET, V6, P39839, DOI 10.18632/oncotarget.5674; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Sebio A, 2014, EXPERT OPIN THER TAR, V18, P611, DOI 10.1517/14728222.2014.906580; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Suren D, 2014, MED SCI MONITOR, V20, P1255, DOI 10.12659/MSM.890598; Takigawa H, 2017, NEOPLASIA, V19, P429, DOI 10.1016/j.neo.2017.02.010; Tochhawng L, 2016, ONCOTARGET, V7, P52832, DOI 10.18632/oncotarget.10451; van Wyk HC, 2017, CRIT REV ONCOL HEMAT, V112, P11, DOI 10.1016/j.critrevonc.2017.02.005; White JD, 2002, CANCER RES, V62, P1669; Xing X, 2013, BRIT J CANCER, V108, P2542, DOI 10.1038/bjc.2013.251; Yang J, 2004, LUNG CANCER-J IASLC, V46, P29, DOI 10.1016/j.lungcan.2004.03.022; Yuan H, 2017, ONCOTARGET, V8, P46565, DOI 10.18632/oncotarget.15425; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602; Zhao H, 2017, ONCOTARGET, V8, P59058, DOI 10.18632/oncotarget.19939	36	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202856	10.1371/journal.pone.0202856	http://dx.doi.org/10.1371/journal.pone.0202856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148861	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200028
J	Langfield, T; Pechey, R; Pilling, M; Marteau, TM				Langfield, Tess; Pechey, Rachel; Pilling, Mark; Marteau, Theresa M.			Impact of glass shape on time taken to drink a soft drink: A laboratory-based experiment	PLOS ONE			English	Article							CONSUMPTION; SIZE; PERCEPTION; DISEASE; WEIGHT	Background Glassware design may affect drinking behaviour for alcoholic beverages, with glass shape and size influencing drinking speed and amount consumed. Uncertainty remains both about the extent to which these effects are restricted to alcohol and the underlying mechanisms. The primary aim of the current study was to examine the effect of differently shaped glasses on time taken to drink a soft drink. The secondary aim was to develop hypotheses about mechanisms concerning micro-drinking behaviours and perceptual effects. Method In a single-session experiment, 162 participants were randomised to receive 330ml of carbonated apple juice in a glass that was either inward-sloped, straight-sided, or outward-sloped. The primary outcome measure was total drinking time. Secondary outcome measures included micro-drinking behaviours (sip size, sip duration, interval duration), and perceptual measures (midpoint bias, drink enjoyment). Results Participants drank 21.4% faster from the outward-sloped glass than from the straight-sided glass [95%CI: 0.2%,38.0%] in adjusted models. They were also 18.2% faster from the inward-sloped glass than the straight-sided glass, but this did not reach statistical significance with wide confidence intervals also consistent with slower drinking [95%CI: -3.8%, 35.6%]. Larger sips were associated with faster drinking times (Pearson's r(162) = -.45, p < .001). The direction of effects suggested sips were larger from the outward-sloped and inward-sloped glasses, compared to the straight-sided glass (15.1%, 95%CI: -4.3%,38.0%; 19.4%, 95%CI: -0.5%,43.6%, respectively). There were no significant differences between glasses in mean sip or interval duration. Bias in midpoint estimation was greater for the outward-sloped glass (12.9ml, 95%CI: 6.6ml,19.2ml) than for the straight-sided glass, although the degree of bias was not associated with total drinking time (Pearson's r(162) = 0.01, p= .87). Discussion Individuals drank a soft drink more quickly from an outward-sloped glass, relative to a straight-sided glass. Micro-drinking behaviours, such as sip size, are promising candidates for underlying mechanisms.	[Langfield, Tess; Pechey, Rachel; Pilling, Mark; Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Langfield, T (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England.	tirl2@medschl.cam.ac.uk		Langfield, Tess/0000-0003-0552-1019; Pechey, Rachel/0000-0002-6558-388X	Medical Research Council;  [MR/N013433/1]; MRC [1803821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Medical Research Council and Sackler Prize awarded to TL [MR/N013433/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043007; Bennett JW, 2009, DYSPHAGIA, V24, P152, DOI 10.1007/s00455-008-9183-y; Bland JM, 1996, BRIT MED J, V312, P1079; Cliceri D, 2018, FOOD QUAL PREFER, V64, P187, DOI 10.1016/j.foodqual.2017.09.008; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Grech A, 2015, OBES REV, V16, P1030, DOI 10.1111/obr.12311; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Hollands GJ, 2016, HEALTH PSYCHOL REV, V10, P381, DOI 10.1080/17437199.2015.1138093; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Hollands GJ, 2015, COCHRANE DATABASE SY, V14; Kampfer K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186121; Lawless HT, 2003, DYSPHAGIA, V18, P196, DOI 10.1007/s00455-002-0105-0; Maggioni E, 2015, J SENS STUD, V30, P395, DOI 10.1111/joss.12166; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Maynard OM, 2018, ALCOHOL ALCOHOLISM, V53, P12, DOI 10.1093/alcalc/agx066; MCGILL R, 2015, BMC PUBLIC HEALTH, V15; Ohkuma T, 2015, INT J OBESITY, V39, P1589, DOI 10.1038/ijo.2015.96; Olivier J, 2008, ANN ALLERG ASTHMA IM, V100, P333, DOI 10.1016/S1081-1206(10)60595-9; Pechey Rachel, 2017, BMC Res Notes, V10, P287, DOI 10.1186/s13104-017-2610-0; Pechey R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3068-z; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; Shah M, 2011, J HUM NUTR DIET, V24, P612, DOI 10.1111/j.1365-277X.2011.01210.x; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Spence C, 2017, BEVERAGES, V3, DOI 10.3390/beverages3030033; Spence C, 2015, FOOD QUAL PREFER, V39, P131, DOI 10.1016/j.foodqual.2014.07.007; Stafford LD, 2017, J PUBLIC HEALTH-HEID, V25, P147, DOI 10.1007/s10389-016-0770-3; Thaler R.H., 2021, NUDGE FINAL EDITION; Troy D, 2017, DOES GLASS SHAPE INF; Troy DM, 2017, EUR J PUBLIC HEALTH, V27, P352, DOI 10.1093/eurpub/ckw142; Van Doorn G, 2017, FOOD QUAL PREFER, V56, P201, DOI 10.1016/j.foodqual.2016.10.013; World Health Organization, 2014, GLOB STAT REP ALC HL, DOI [10.1080/17437199.2015.1138093, DOI 10.1080/17437199.2015.1138093]; Zlatevska N, 2014, J MARKETING, V78, P140, DOI 10.1509/jm.12.0303; Zupan Z, 2017, BMC Psychol, V5, P17, DOI 10.1186/s40359-017-0183-2	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202793	10.1371/journal.pone.0202793	http://dx.doi.org/10.1371/journal.pone.0202793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148889	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200024
J	Minick, SG; May, SB; Amico, KR; Cully, J; Davila, JA; Kallen, MA; Giordano, TP				Minick, Sophie G.; May, Sarah B.; Amico, K. Rivet; Cully, Jeffrey; Davila, Jessica A.; Kallen, Michael A.; Giordano, Thomas P.			Participants' perspectives on improving retention in HIV care after hospitalization: A post-study qualitative investigation of the MAPPS study	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; RANDOMIZED-TRIAL; INTERVENTION; ADHERENCE; INFORMATION; MOTIVATION; PROGRAM	Few interventions have been shown to improve retention in HIV care. We recently completed a randomized, controlled trial of a peer mentoring intervention, which failed to increase retention in care or HIV suppression. We sought to gain insight into this negative result and elicit suggestions for future interventions. We conducted semi-structured one-on-one interviews with a sub-sample of participants and all available interventionists after completion of the primary study. Interviews were coded by two researchers and thematically analyzed. Participants in the intervention arm (N = 16) reported good rapport with and benefit from peer mentoring and found the mentors helpful in facilitating the transition from hospital to out-patient clinic. Control arm participants (N = 9) reported similar emotional and social support benefits from the health educators. In both arms, ongoing challenges including completing paperwork, securing transportation, and rescheduling missed appointments were cited, along with internalized stigma and lack of will to seek care, despite the mentors' best efforts. Suggested improvements to the intervention included: more frequent contact with interventionists; additional support for mental health problems; and targeting overall health rather than a more selective focus on HIV. Mentors and health educators agreed with the participant-reported barriers and added that some participants were too sick to meaningfully participate in the intervention, while others appeared unwilling to engage with the interventionists in a meaningful way. Mentoring was highly acceptable and felt to be impactful, however it was not sufficient to overcome structural barriers or stigma and low motivation in some participants. The attention control intervention may have had an unintended positive impact. Future interventions should focus on broad aspects of health and well-being.	[Minick, Sophie G.; May, Sarah B.; Davila, Jessica A.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Minick, Sophie G.; May, Sarah B.; Cully, Jeffrey; Davila, Jessica A.; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX 77030 USA; [Amico, K. Rivet] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Cully, Jeffrey] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Kallen, Michael A.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA	Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine	Giordano, TP (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Giordano, TP (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX 77030 USA.	tpg@bcm.edu	/AAE-4700-2020	Amico, K Rivet/0000-0002-4458-6934; May, Sarah/0000-0003-1489-8053	National Institutes of Health [R01MH085527]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant number R01MH085527; T.P.G.) and the facilities and resources of the Harris Health System and the Michael E. DeBakey VA Medical Center. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health (grant number R01MH085527; T.P.G.) and the facilities and resources of Baylor College of Medicine, Harris Health System and the Michael E. DeBakey VA Medical Center.	Cully JA, 2012, AIDS PATIENT CARE ST, V26, P165, DOI 10.1089/apc.2011.0248; Doshi RK, 2015, CLIN INFECT DIS, V60, P117, DOI 10.1093/cid/ciu722; El-Sadr WM, 2017, JAMA INTERN MED, V177, P1083, DOI 10.1001/jamainternmed.2017.2158; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Fisher Jeffrey D, 2008, Curr HIV/AIDS Rep, V5, P193, DOI 10.1007/s11904-008-0028-y; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Giordano TP, 2016, CLIN INFECT DIS, V63, P678, DOI 10.1093/cid/ciw322; Giordano Thomas P, 2011, Top Antivir Med, V19, P12; Golin CE, 2006, JAIDS-J ACQ IMM DEF, V42, P42, DOI 10.1097/01.qai.0000219771.97303.0a; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Krippendorff K, 1989, CONTENT ANAL; Metsch LR, 2016, JAMA-J AM MED ASSOC, V316, P156, DOI 10.1001/jama.2016.8914; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Smith LR, 2012, AIDS PATIENT CARE ST, V26, P344, DOI 10.1089/apc.2011.0388	14	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202917	10.1371/journal.pone.0202917	http://dx.doi.org/10.1371/journal.pone.0202917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148868	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200032
J	Moore, KS; Yagci, N; van Alphen, F; Meijer, AB; 't Hoen, PAC; von Lindern, M				Moore, Kat S.; Yagci, Nurcan; van Alphen, Floris; Meijer, Alexander B.; 't Hoen, Peter A. C.; von Lindern, Marieke			Strap associates with Csde1 and affects expression of select Csde1-bound transcripts	PLOS ONE			English	Article							RNA-BINDING PROTEIN; INDUCED LEUKEMIC-CELLS; COLD-SHOCK DOMAINS; MESSENGER-RNA; TRANSLATIONAL REPRESSION; ERYTHROID-DIFFERENTIATION; INTERNAL INITIATION; GENE-EXPRESSION; UNR; ERYTHROPOIESIS	Erythropoiesis is regulated at many levels, including control of mRNA translation. Changing environmental conditions, such as hypoxia or the availability of nutrients and growth factors, require a rapid response enacted by the enhanced or repressed translation of existing transcripts. Cold shock domain protein e1 (Csde1/Unr) is an RNA-binding protein required for erythropoiesis and strongly upregulated in erythroblasts relative to other hematopoietic progenitors. The aim of this study is to identify the Csde1-containing protein complexes and investigate their role in post-transcriptional expression control of Csde1-bound transcripts. We show that Serine/Threonine kinase receptor-associated protein (Strap/Unrip), was the protein most strongly associated with Csde1 in erythroblasts. Strap is a WD40 protein involved in signaling and RNA splicing, but its role when associated with Csde1 is unknown. Reduced expression of Strap did not alter the pool of transcripts bound by Csde1. Instead, it altered the mRNA and/or protein expression of several Csde1-bound transcripts that encode for proteins essential for translational regulation during hypoxia, such as Hmbs, elF4g3 and Pabpc4. Also affected by Strap knockdown were Vim, a Gata-1 target crucial for erythrocyte enucleation, and Elav11, which stabilizes Gata-1 mRNA. The major cellular processes affected by both Csde1 and Strap were ribosome function and cell cycle control.	[Moore, Kat S.; Yagci, Nurcan; von Lindern, Marieke] Univ Amsterdam, Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Moore, Kat S.; Yagci, Nurcan; von Lindern, Marieke] Univ Amsterdam, Landsteiner Lab Amsterdam UMC, Amsterdam, Netherlands; [van Alphen, Floris; Meijer, Alexander B.] Sanquin Res, Dept Res Facil, Amsterdam, Netherlands; [Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Biomol Mass Spectrometry & Prote, Utrecht, Netherlands; ['t Hoen, Peter A. C.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen, Netherlands	University of Amsterdam; University of Amsterdam; Utrecht University; Radboud University Nijmegen	von Lindern, M (corresponding author), Univ Amsterdam, Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands.; von Lindern, M (corresponding author), Univ Amsterdam, Landsteiner Lab Amsterdam UMC, Amsterdam, Netherlands.	m.vonlindern@sanquin.nl	Hoen, Peter A 't/D-3950-2018; von Lindern, Marieke/AAH-2350-2020	Hoen, Peter A 't/0000-0003-4450-3112; Yagci, Nurcan/0000-0001-8899-6321; von Lindern, Marieke/0000-0001-6162-6320; Moore, Kat/0000-0002-5746-4098	Landsteiner Foundation for Transfusion Research (LSBR grant) [1140]; Sanquin	Landsteiner Foundation for Transfusion Research (LSBR grant); Sanquin	This project was supported by the Landsteiner Foundation for Transfusion Research (LSBR grant 1140) and by Sanquin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anderson E. C., 2015, BIOCHEM SOC T, V43; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Chang SH, 2014, P NATL ACAD SCI USA, V111, P18309, DOI 10.1073/pnas.1412172111; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Day TF, 2017, METHODS MOL BIOL, V1513, P83, DOI 10.1007/978-1-4939-6539-7_7; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; DeVilbiss AW, 2015, MOL CELL BIOL, V35, P2073, DOI 10.1128/MCB.01422-14; DeVilbiss AW, 2013, P NATL ACAD SCI USA, V110, pE3398, DOI 10.1073/pnas.1302771110; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dormoy-Raclet V, 2007, ONCOGENE, V26, P2595, DOI 10.1038/sj.onc.1210068; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Fuhrmann DC, 2015, MOL CELL BIOL, V35, P619, DOI 10.1128/MCB.01034-14; Fujishima N, 2004, INT J HEMATOL, V80, P239, DOI 10.1532/IJH97.04053; Fukao A, 2017, J BIOCHEM, V161, P309, DOI 10.1093/jb/mvw086; Gazendam RP, 2016, HAEMATOLOGICA, V101, P587, DOI 10.3324/haematol.2015.136630; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Haider SK, 2006, CANCER RES, V66, P6156, DOI 10.1158/0008-5472.CAN-05-3261; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Ho JJD, 2016, CELL REP, V14, P1293, DOI 10.1016/j.celrep.2016.01.036; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437; Ito K, 2011, PROTEIN CELL, V2, P755, DOI 10.1007/s13238-011-1092-4; JACQUEMINSABLON H, 1994, NUCLEIC ACIDS RES, V22, P2643, DOI 10.1093/nar/22.13.2643; Kamenska A, 2016, NUCLEIC ACIDS RES, V44, P6318, DOI 10.1093/nar/gkw565; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kashikar ND, 2011, CELL CYCLE, V10, P1639, DOI 10.4161/cc.10.10.15630; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kehlenbach RH, 2001, J BIOL CHEM, V276, P14524, DOI 10.1074/jbc.M011087200; Kini HK, 2014, MOL CELL BIOL, V34, P1300, DOI 10.1128/MCB.01683-13; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li X, 2014, BLOOD, V123, P1384, DOI 10.1182/blood-2013-09-526962; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Moore KS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20518-7; Paolini NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193790; Ray S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22461; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; ROSSI GB, 1967, P NATL ACAD SCI USA, V58, P1373, DOI 10.1073/pnas.58.4.1373; SANGIORGI F, 1990, DEVELOPMENT, V110, P85; Schepens B, 2007, EMBO J, V26, P158, DOI 10.1038/sj.emboj.7601468; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Stockel D, 2016, BIOINFORMATICS, V32, P1502, DOI 10.1093/bioinformatics/btv770; Tedeschi A, 2007, J CELL SCI, V120, P3748, DOI 10.1242/jcs.009308; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vargas PD, 2008, FEBS J, V275, P5947, DOI 10.1111/j.1742-4658.2008.06723.x; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040; Wurth L, 2016, CANCER CELL, V30, P694, DOI 10.1016/j.ccell.2016.10.004; Yuan GD, 2016, ONCOTARGET, V7, P16023, DOI 10.18632/oncotarget.7532; Zhang Caiguo, 2015, J Genomics, V3, P40, DOI 10.7150/jgen.11015; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215	64	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201690	10.1371/journal.pone.0201690	http://dx.doi.org/10.1371/journal.pone.0201690			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138317	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100023
J	Murray-Stewart, T; Dunworth, M; Lui, Y; Giardiello, FM; Woster, PM; Casero, RA				Murray-Stewart, Tracy; Dunworth, Matthew; Lui, Yuan; Giardiello, Francis M.; Woster, Patrick M.; Casero, Robert A., Jr.			Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies	PLOS ONE			English	Article							NF-KAPPA-B; ORNITHINE-DECARBOXYLASE; MOLECULAR-MECHANISMS; ANALOGS; GROWTH; INHIBITION; OXIDASE; DIFLUOROMETHYLORNITHINE; CHEMOPREVENTION; ACTIVATION	Curcumin, a natural polyphenol that contributes to the flavor and yellow pigment of the spice turmeric, is known for its antioxidant, anti-inflammatory, and anticarcinogenic properties. Capable of affecting the initiation, promotion, and progression of carcinogenesis through multiple mechanisms, curcumin has potential utility for both chemoprevention and chemotherapy. Previous studies demonstrated that curcumin can inhibit ornithine decarboxylase (ODC) activity in human leukemia and breast cancer cells, and pretreatment with dietary curcumin blocks carcinogen-induced ODC activity in rodent models of skin, colon, and renal cancer. The current study investigated the regulation of polyamine metabolism in human gastric and colon carcinoma cell lines in response to curcumin. Curcumin treatment significantly induced spermine oxidase (SMOX) mRNA and activity, which results in the generation of hydrogen peroxide, a source of ROS. Simultaneously, curcumin down regulated spermidine/spermine N-1-acetyltransferase (SSAT) activity and the biosynthetic enzymes ODC and S-adenosylmethionine decarboxylase (SAMDC), thereby diminishing intracellular polyamine pools. Combination treatments using curcumin with the ODC inhibitor 2-difluoromethylornithine (DFMO), an agent currently in clinical chemoprevention trials, significantly enhanced inhibition of ODC activity and decreased growth of GI cancer cell lines beyond that observed with either agent alone. Similarly, combining curcumin with the polyamine analogue bis(ethyl)norspermine enhanced growth inhibition that was accompanied by enhanced accumulation of the analogue and decreased intracellular polyamine levels beyond those observed with either agent alone. Importantly, cotreatment with curcumin permitted the lowering of the effective dose of ODC inhibitor or polyamine analogue. These studies provide insight into the polyamine-related mechanisms involved in the cancer cell response to curcumin and its potential as a chemopreventive or chemotherapeutic agent in the GI tract.	[Murray-Stewart, Tracy; Dunworth, Matthew; Lui, Yuan; Giardiello, Francis M.; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Giardiello, Francis M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Giardiello, Francis M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Woster, Patrick M.] Med Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Medical University of South Carolina	Casero, RA (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	rcasero@jhmi.edu	Stewart, Tracy Murray/B-6137-2017; Woster, Patrick M/A-5604-2010	Stewart, Tracy Murray/0000-0001-8679-6414; Woster, Patrick M/0000-0002-9471-1916; Dunworth, Matthew/0000-0002-8852-169X; Casero, Robert/0000-0001-5653-3306	National Institutes of Health [CA204345, 1R01CA134620, CA P50 CA 62924-17]; Maryland Cigarette Restitution Fund; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA204345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by National Institutes of Health (www.nih.gov) grants CA204345 (RAC and PMW), 1R01CA134620 (FMG), CA P50 CA 62924-17 (FMG), the Maryland Cigarette Restitution Fund (http://crf.maryland.gov/) (RAC), and the Samuel Waxman Cancer Research Foundation (http://www.waxmancancer.org/) (RAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiwidjaja J, 2017, EXPERT OPIN DRUG MET, V13, P953, DOI 10.1080/17425255.2017.1360279; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Babbar N, 2006, BIOCHEM J, V394, P317, DOI 10.1042/BJ20051298; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; Berrak O, 2016, BIOMED PHARMACOTHER, V77, P150, DOI 10.1016/j.biopha.2015.12.007; BEY P, 1985, J MED CHEM, V28, P1, DOI 10.1021/jm00379a001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; CASERO RA, 1989, CANCER RES, V49, P3829; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Cruz-Correa M, 2018, GASTROENTEROLOGY; Devereux W, 2003, CANCER CHEMOTH PHARM, V52, P383, DOI 10.1007/s00280-003-0662-4; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Giardiello FM, 1997, CANCER RES, V57, P199; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hahm HA, 2002, CLIN CANCER RES, V8, P684; Jobin C, 1999, J IMMUNOL, V163, P3474; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kumar G, 2016, LIFE SCI, V148, P313, DOI 10.1016/j.lfs.2016.02.022; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Liao YF, 2008, LIFE SCI, V82, P367, DOI 10.1016/j.lfs.2007.11.022; Linsalata M, 2014, INT J ONCOL, V45, P1802, DOI 10.3892/ijo.2014.2597; LoGiudice N., 2018, MED SCI BASEL, V6; LUK GD, 1984, NEW ENGL J MED, V311, P80, DOI 10.1056/NEJM198407123110202; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; Mehta K, 1997, ANTI-CANCER DRUG, V8, P470, DOI 10.1097/00001813-199706000-00010; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; Meyskens FL, 1998, JNCI-J NATL CANCER I, V90, P1212, DOI 10.1093/jnci/90.16.1212; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Murray-Stewart T, 2017, MED SCI BASEL, V5, P160, DOI [10.1016/j.biopha.2015.12.007, DOI 10.1016/J.BIOPHA.2015.12.007]; Murray-Stewart T, 2008, FEBS J, V275, P2795, DOI 10.1111/j.1742-4658.2008.06419.x; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1984, BIOCHEM J, V224, P29, DOI 10.1042/bj2240029; Perkins S, 2002, CANCER EPIDEM BIOMAR, V11, P535; Pledgie A, 2005, J BIOL CHEM, V280, P39843, DOI 10.1074/jbc.M508177200; Rao CV, 2007, ADV EXP MED BIOL, V595, P213; RAO CV, 1993, CARCINOGENESIS, V14, P2219, DOI 10.1093/carcin/14.11.2219; Reddy VK, 1998, J MED CHEM, V41, P4723, DOI 10.1021/jm980172v; Rial NS, 2009, ESSAYS BIOCHEM, V46, P111, DOI [10.1042/BSE0460008, 10.1042/bse0460008]; SEELY JE, 1983, METHOD ENZYMOL, V94, P158; Shah N, 1999, BIOCHEMISTRY-US, V38, P14763, DOI 10.1021/bi991291v; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Thomas T. J., 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P168; Tsioulias George J, 2015, Curr Pharmacol Rep, V1, P295; WAGNER AJ, 1993, CELL GROWTH DIFFER, V4, P879; Wallace HM, 2001, EUR J GASTROEN HEPAT, V13, P1033, DOI 10.1097/00042737-200109000-00006; Wang YL, 2001, CANCER RES, V61, P5370; Wu Y, 2012, BIOCHEM J, V442, P693, DOI 10.1042/BJ20111271	64	18	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202677	10.1371/journal.pone.0202677	http://dx.doi.org/10.1371/journal.pone.0202677			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138353	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100104
J	Simon, L; Funes, AK; Monclus, MA; Colombo, R; Cabrillana, ME; Lancellotti, TES; Fornes, MW				Simon, Layla; Funes, Abi K.; Monclus, Maria A.; Colombo, Regina; Cabrillana, Maria E.; Saez Lancellotti, Tania E.; Fornes, Miguel W.			Manchette-acrosome disorders and testicular efficiency decline observed in hypercholesterolemic rabbits are recovered with olive oil enriched diet	PLOS ONE			English	Article							MEDITERRANEAN DIET; MACROBRACHIUM-NIPPONENSE; METABOLIC SYNDROME; SPERMATOGENESIS; TESTIS; CHOLESTEROL; SPERMIOGENESIS; ACROFRAMOSOME; MICROTUBULES; EXPRESSION	High-fat diet is associated with hypercholesterolemia and seminal alterations in White New Zealand rabbits. We have previously reported disorders in the development of the manchette-acrosome complex during spermiogenesis and decreased testicular efficiency in hypercholesterolemic rabbits. On the other hand, olive oil incorporated into the diet improves cholesterolemia and semen parameters affected in hypercholesterolemic rabbits. In this paper, we report the recovery-with the addition of olive oil to diet-from the sub-cellular mechanisms involved in the shaping of the sperm cell and testicular efficiency altered in hypercholesterolemic rabbits. Using morphological (structural, ultra-structural and immuno-fluorescence techniques) and cell biology techniques, a reorganization of the manchette and related structures was observed when olive oil was added to the high-fat diet. Specifically, actin filaments, microtubules and lipid rafts-abnormally distributed in hypercholesterolemic rabbits-were recovered with dietary olive oil supplementation. The causes of the decline in sperm count were studied in the previous report and here in more detail. These were attributed to the decrease in the efficiency index and also to the increase in the apoptotic percentage in testis from animals under the high-fat diet. Surprisingly, the addition of olive oil to the diet avoided the sub-cellular, efficiency and apoptosis changes observed in hypercholesterolemic rabbits. This paper reports the positive effects of the olive oil addition to the diet in the recovery of testicular efficiency and normal sperm shaping, mechanisms altered by hypercholesterolemia.	[Simon, Layla; Funes, Abi K.; Monclus, Maria A.; Colombo, Regina; Cabrillana, Maria E.; Saez Lancellotti, Tania E.; Fornes, Miguel W.] Univ Nacl Cuyo, CONICET, IHEM, Mendoza, Argentina; [Monclus, Maria A.; Cabrillana, Maria E.; Saez Lancellotti, Tania E.; Fornes, Miguel W.] Univ Aconcagua, Fac Ciencias Med, Inst Invest, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Simon, L (corresponding author), Univ Nacl Cuyo, CONICET, IHEM, Mendoza, Argentina.	lsimonujam@gmail.com	Lancellotti, T Estefania Saez/AAV-4007-2020	Lancellotti, T Estefania Saez/0000-0001-8830-6482; Cabrillana, Maria Eugenia/0000-0001-6794-8603; Funes, Abi/0000-0002-6540-3324	PIP (Proyectos de Investigacion Plurianuales); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas); SECTyP UNCuyo (Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo); CIUDA (Consejo de Investigaciones de la Universidad del Aconcagua)	PIP (Proyectos de Investigacion Plurianuales); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SECTyP UNCuyo (Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo); CIUDA (Consejo de Investigaciones de la Universidad del Aconcagua)	Support was provided by PIP (Proyectos de Investigacion Plurianuales), CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) to MWF, SECTyP UNCuyo (Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo), and CIUDA (Consejo de Investigaciones de la Universidad del Aconcagua).	Almeida C, 2013, J ASSIST REPROD GEN, V30, P487, DOI 10.1007/s10815-013-9938-8; AMANN RP, 1970, FERTIL STERIL, V21, P662; Ashrafi H, 2013, AFR J TRADIT COMPLEM, V10, P277, DOI 10.4314/ajtcam.v10i2.12; Bataineh HN, 2005, SAUDI MED J, V26, P398; BERNDSTON WE, 1974, AM J ANAT, V140, P167, DOI 10.1002/aja.1001400204; Boarelli PV, 2016, J CYTOL HISTOL, V7, P412, DOI [10.4172/2157-7099.1000412, DOI 10.4172/2157-7099.1000412]; BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401, DOI 10.1530/jrf.0.0070401; BURGOS MH, 1956, J BIOPHYS BIOCHEM CY, V2, P223, DOI 10.1083/jcb.2.3.223; Casas R, 2016, J NUTR, V146, P1684, DOI 10.3945/jn.115.229476; Esener OBB, 2017, POL J VET SCI, V20, P467, DOI 10.1515/pjvs-2017-0056; Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Gotsis E, 2015, ANGIOLOGY, V66, P304, DOI 10.1177/0003319714532169; Hou CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076065; Jain A, 2015, ANDROLOGY LOS ANGEL, V4, DOI [10.4172/2167-0250.1000141, DOI 10.4172/2167-0250.1000141]; JOHNSON L, 1995, MICROSC RES TECHNIQ, V32, P385, DOI 10.1002/jemt.1070320504; JOHNSON L, 1986, J ANDROL, V7, P316; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kolodgie FD, 1996, ARTERIOSCL THROM VAS, V16, P1454, DOI 10.1161/01.ATV.16.12.1454; Lancellotti TES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052386; Li Z, 2010, INVERTEBR REPROD DEV, V54, P121, DOI 10.1080/07924259.2010.9652324; Marchiani S, 2015, MOL CELL ENDOCRINOL, V401, P12, DOI 10.1016/j.mce.2014.11.005; MOLLENHAUER HH, 1992, CELL BIOL INT REP, V16, P217, DOI 10.1016/S0309-1651(06)80123-2; Moreno RD, 2006, DEV BIOL, V293, P218, DOI 10.1016/j.ydbio.2006.02.001; MORTON D, 1986, VET PATHOL, V23, P214, DOI 10.1177/030098588602300221; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Purohit Ashok, 1999, Indian Journal of Experimental Biology, V37, P396; Richard C, 2012, BRIT J NUTR, V107, P705, DOI 10.1017/S0007114511003436; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Simon L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172994; SWIERSTRA EE, 1974, J REPROD FERTIL, V40, P113, DOI 10.1530/jrf.0.0400113; SWIERSTRA EE, 1963, J REPROD FERTIL, V5, P309, DOI 10.1530/jrf.0.0050309; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tang EI, 2016, ENDOCRINOLOGY, V157, P1644, DOI 10.1210/en.2015-1962; Wang YT, 2012, MOL BIOL REP, V39, P7591, DOI 10.1007/s11033-012-1593-0; Wei YL, 2018, GENE, V660, P28, DOI 10.1016/j.gene.2018.03.059; Whitfield M, 2015, ASIAN J ANDROL, V17, P742, DOI 10.4103/1008-682X.155536; Xu YR, 2016, GENE, V582, P97, DOI 10.1016/j.gene.2016.02.007; Yamamoto Y, 1999, HUM REPROD, V14, P1516, DOI 10.1093/humrep/14.6.1516	41	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202748	10.1371/journal.pone.0202748	http://dx.doi.org/10.1371/journal.pone.0202748			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138421	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100117
J	Tsybalova, LM; Stepanova, LA; Shuklina, MA; Mardanova, ES; Kotlyarov, RY; Potapchuk, MV; Petrov, SA; Blokhina, EA; Ravin, NV				Tsybalova, Liudmila M.; Stepanova, Liudmila A.; Shuklina, Marina A.; Mardanova, Eugenia S.; Kotlyarov, Roman Y.; Potapchuk, Marina, V; Petrov, Sergei A.; Blokhina, Elena A.; Ravin, Nikolai, V			Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine	PLOS ONE			English	Article							CD4 T-CELLS; MATRIX PROTEIN-2; EXTRACELLULAR DOMAIN; ADJUVANT ACTIVITY; FUSION PROTEIN; IN-VIVO; ANTIBODIES; FLAGELLIN; HEMAGGLUTININ; MUCOSAL	Background Influenza infection could be more effectively controlled if a multi-purpose vaccine with the ability to induce responses against most, or all, influenza A subtypes could be generated. Conserved viral proteins are a promising basis for the creation of a broadly protective vaccine. In the present study, the immunogenicity and protective properties of three recombinant proteins (vaccine candidates), comprising conserved viral proteins fused with bacterial flagellin, were compared. Methods Balb/c mice were immunized intranasally with recombinant proteins comprising either one viral protein (the ectodomain of the M2 protein, 'M2e') or two viral proteins (M2e and the hemagglutinin second subunit 'HA2' epitope) genetically fused with flagellin. Further, two different consensus variants of HA2 were used. Therefore, three experimental positives were used in addition to the negative control (Flg-his). The mucosal, humoral, and T-cell immune responses to these constructs were evaluated. Result We have demonstrated that insertion of the HA2 consensus polypeptide (aa 76-130), derived from either the first (HA2-1) or second (HA2-2) virus phylogenetic group, into the recombinant FIg4M2e protein significantly enhanced its immunogenicity and protective properties. Intranasal administration of the vaccine candidates (Flg-HA2-2-4M2e or Flg-HA2-1-4M2e) induced considerable mucosal and systemic responses directed at both the M2e-protein and, in general, the influenza A virus. However, the immune response elicited by the Flg-HA2-1-4M2e protein was weaker than the one generated by Flg-HA2-2-4M2e. These recombinant proteins containing both viral peptides provide complete protection from lethal challenge with various influenza viruses: A/H3N2; A/H2N2; and A/H5N1. Conclusion This study demonstrates that the intranasal administration of Flg-HA2-2-4M2e recombinant protein induces a strong immune response which provides broad protection against various influenza viruses. This construct is therefore a strong candidate for development as a universal vaccine.	[Tsybalova, Liudmila M.; Stepanova, Liudmila A.; Shuklina, Marina A.; Potapchuk, Marina, V; Petrov, Sergei A.] Minist Hlth Russian Federat, Dept Vaccinol, Smorodintsev Res Inst Influenza, St Petersburg, Russia; [Mardanova, Eugenia S.; Kotlyarov, Roman Y.; Blokhina, Elena A.; Ravin, Nikolai, V] Russian Acad Sci, Inst Bioengn, Res Ctr Biotechnol, Moscow, Russia	Ministry of Health of the Russian Federation; Research Center of Biotechnology RAS; Russian Academy of Sciences	Tsybalova, LM (corresponding author), Minist Hlth Russian Federat, Dept Vaccinol, Smorodintsev Res Inst Influenza, St Petersburg, Russia.	sovet@influenza.spb.ru	Blokhina, Elena/ABI-6608-2020; Ravin, Nikolai V/C-5907-2014; Kotlyarov, Roman/ABI-7582-2020; Shuklina, Marina/R-4995-2018	Kotlyarov, Roman/0000-0002-4387-2592; Shuklina, Marina/0000-0002-7550-5519	Russian Science Foundation [15-14-00043-Pi]; Russian Science Foundation [18-14-16012] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation Project No. 15-14-00043-Pi (http://rscf.ru/en) to LMT.	Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Chen SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/901817; Cho KJ, 2015, J VIROL, V89, P3700, DOI 10.1128/JVI.02576-14; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; Deng L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02725-4; Deng L, 2017, VIROLOGY, V509, P82, DOI 10.1016/j.virol.2017.06.001; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2018, MUCOSAL IMMUNOL, V11, P273, DOI 10.1038/mi.2017.14; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12780; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Guo Y, 2017, MICROBES INFECT, V19, P641, DOI 10.1016/j.micinf.2017.08.010; He WQ, 2015, J VIROL, V89, P3610, DOI 10.1128/JVI.03099-14; Herve PL, 2014, J VIROL, V88, P325, DOI 10.1128/JVI.01141-13; Honko AN, 2004, INFECT IMMUN, V72, P6676, DOI 10.1128/IAI.72.11.6676-6679.2004; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Janulikova J, 2012, ACTA VIROL, V56, P169, DOI 10.4149/av_2012_03_169; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolpe A, 2017, EXPERT REV VACCINES, V16, P123, DOI 10.1080/14760584.2017.1240041; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Lopez-Boado YS, 2005, INFECT IMMUN, V73, P7525, DOI 10.1128/IAI.73.11.7525-7534.2005; Mardanova ES, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00247; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Price GE, 2014, J VIROL, V88, P6019, DOI 10.1128/JVI.03101-13; Quinn KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184732; Schneemann A, 2012, J VIROL, V86, P11686, DOI 10.1128/JVI.01694-12; Scorza FB, 2016, VACCINE, V34, P2926, DOI 10.1016/j.vaccine.2016.03.085; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Simhadri VR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124677; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Song L, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0195-z; Stanekova Z, 2013, ANTIVIR RES, V97, P24, DOI 10.1016/j.antiviral.2012.09.008; Stepanova LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119520; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Tao WQ, 2014, NANOMEDICINE-UK, V9, P237, DOI 10.2217/nnm.13.58; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; van Doorn E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2341-9; van Doorn E, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006339, 10.1097/md.0000000000006339]; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang BZ, 2014, J CONTROL RELEASE, V178, P1, DOI 10.1016/j.jconrel.2014.01.002; Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972; Wang L, 2014, NANOMED-NANOTECHNOL, V10, P473, DOI 10.1016/j.nano.2013.08.005; Wang L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/686549; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zens KD, 2015, CURR TOP MICROBIOL, V386, P399, DOI 10.1007/82_2014_401; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhou L, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/wpsar.2017.8.1.001, 10.5365/WPSAR.2017.8.1.001]	67	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201429	10.1371/journal.pone.0201429	http://dx.doi.org/10.1371/journal.pone.0201429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138320	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100017
J	Wasitthankasem, R; Vichaiwattana, P; Siripon, N; Posuwan, N; Auphimai, C; Klinfueng, S; Thanetkongtong, N; Vuthitanachot, V; Saiyatha, S; Thongmai, C; Sochoo, S; Sukthong, P; Poovorawan, K; Tangkijvanich, P; Poovorawan, Y				Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimai, Chompoonut; Klinfueng, Sirapa; Thanetkongtong, Napha; Vuthitanachot, Viboonsak; Saiyatha, Supapith; Thongmai, Chaiwat; Sochoo, Saowakon; Sukthong, Panthip; Poovorawan, Kittiyod; Tangkijvanich, Pisit; Poovorawan, Yong			Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy	PLOS ONE			English	Article							HEPATITIS-C VIRUS; BABY BOOMERS; INFECTION; RECOMMENDATIONS	The World Health Organization aims to eliminate HCV infection worldwide by 2030. A targeted HCV screening policy is currently unavailable in Thailand, but a decrease in HCV infection has been observed in the country. However, a previous study showed that there was a higher HCV seroprevalence in adults aged between 30-64 years in the Phetchabun province (15.5%), as compared to the Khon Kaen province (3.6%). It was hypothesized that young adults had a lower rate of HCV seropositivity; this was determined by the age distribution of anti-HCV in Phetchabun and with the identification of high seroprevalence birth cohorts. In order to compare the provincial findings to the national level, anti-HCV birth cohorts were further analyzed in Khon Kaen (averaged-HCV prevalence) as well as the Thai data set that was derived from the previous literature. Thai individuals aged between 18-30 years residing in Phetchabun (n = 1453) were recruited, tested for the presence of anti-HCV antibodies and viral RNA and completed questionnaires that were designed to identify HCV exposure risks. Data was collected and compiled from previously published articles (n = 1667, age 30-64 years). The HCV seropositivity in Phetchabun by age group (18-64, at 5-year intervals) and the birth year were tabulated parallel to the Khon Kaen data set (n = 2233) in conjunction with data from the national survey 2014 (n = 5964) representing the Thai population. Factors such as age, male gender, agricultural work, blood transfusion, intravenous drug use and having a tattoo were associated with anti-HCV positivity in Phetchabun. HCV seroprevalence was less than 4.0% (ranging from 0.0-3.5%) from the age of 18-34 years. A dramatic increase of 15.1% was found in adults aged greater than or equal to 35 years, whereas, the age group in Khon Kaen and the national population with increasing prevalence of HCV were older (>= 40). The HCV seropositivity cohort accumulated for those born between 1951-1982 accounted for 71.4-100.0% of all seropositive individuals. Subsequently, new cases occurred sporadically. This finding provides evidence that there is a disproportionately high HCV seroprevalence among people born before 1983 (or aged >= 35). This cohort should be targeted for priority screening as part of the national HCV screening policy. Incorporating this birth cohort with other risk factors could improve HCV diagnostic rates, resulting in overall improvements in parallel to those given by novel antiviral treatment.	[Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimai, Chompoonut; Klinfueng, Sirapa; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand; [Thanetkongtong, Napha; Vuthitanachot, Viboonsak] Chumpare Hosp, Khon Kaen, Thailand; [Saiyatha, Supapith; Thongmai, Chaiwat] Phetchabun Prov Publ Hlth Off, Mueang Phetchabun, Phetchabun, Thailand; [Sochoo, Saowakon] Lomkao Crown Prince Hosp, Lom Kao, Phetchabun, Thailand; [Sukthong, Panthip] Lomsak Hosp, Lom Sak, Phetchabun, Thailand; [Poovorawan, Kittiyod] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Dept Biochem, Bangkok, Thailand	Chulalongkorn University; Mahidol University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Kittiyod/0000-0001-7016-7605	National Science and Technology Development Agency [P-15-50004]; National Research University Project, Office of Higher Education Commission [WCU-58-006-HR]; Thailand Research Fund [RTA5980008]; Center of Excellence in Clinical Virology [GCE 59-00930-005]; Rachadaphisek Somphot Fund for Postdoctoral Fellowship, Chulalongkorn University	National Science and Technology Development Agency; National Research University Project, Office of Higher Education Commission; Thailand Research Fund(Thailand Research Fund (TRF)); Center of Excellence in Clinical Virology; Rachadaphisek Somphot Fund for Postdoctoral Fellowship, Chulalongkorn University	This work was supported by the Research Chair Grant from the National Science and Technology Development Agency (P-15-50004), the National Research University Project, Office of Higher Education Commission (WCU-58-006-HR), The Thailand Research Fund (RTA5980008), the Center of Excellence in Clinical Virology (GCE 59-00930-005) and Rachadaphisek Somphot Fund for Postdoctoral Fellowship, Chulalongkorn University for Rujipat Wasitthankasem.	[Anonymous], 2018, NUCLEOTIDE BLAST BAS, VNucleotide BLAST; Asrani Sumeet K, 2014, Curr Gastroenterol Rep, V16, P381, DOI 10.1007/s11894-014-0381-5; Barocas JA, 2018, CLIN INFECT DIS, V67, P549, DOI 10.1093/cid/ciy098; Barocas JA, 2017, HEALTH AFFAIR, V36, P2142, DOI 10.1377/hlthaff.2017.0684; Brouard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126920; Buathong R, 2013, WEEKLY EPIDEMIOLOGIC, V44, pS47; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Ethgen O, 2017, J MED ECON, V20, P162, DOI 10.1080/13696998.2016.1232725; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/m16-2575, 10.7326/M16-2575]; Fourati S, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25058; Freiman JM, 2016, ANN INTERN MED, V165, P345, DOI 10.7326/M16-0065; Geboy AG, 2016, PUBLIC HEALTH REP, V131, P49, DOI 10.1177/00333549161310S209; Julicher P, 2018, J MED ECON, V21, P1, DOI 10.1080/13696998.2017.1369983; Lafayette CO, 2018, HCV DIAGNOSTIC RATE; Maneger Online, 2004, MANAGER ONLINE  1214; Morgan JR, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2779-9; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Thonglek N., 2017, MATICHON ONLINE 0303; Voelker R, 2012, JAMA-J AM MED ASSOC, V307, P1242, DOI 10.1001/jama.2012.337; Wasitthankasem R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196301; Wasitthankasem R, 2017, PEERJ, V5, DOI 10.7717/peerj.4008; Wasitthankasem R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177022; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764; WHO, GLOB HEP REP 2017; World Bank, 2018, BIRTH RAT CRUD 1000; World Health Organization, 2016, GUID HEP B C TEST; Worldbank, 2018, FERT RAT TOT BIRTHS	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202991	10.1371/journal.pone.0202991	http://dx.doi.org/10.1371/journal.pone.0202991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138441	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100149
J	Rauwane, ME; Odeny, DA; Millar, I; Rey, C; Rees, J				Rauwane, Molemi E.; Odeny, Damaris A.; Millar, Ian; Rey, Chrissie; Rees, Jasper			The early transcriptome response of cassava (Manihot esculenta Crantz) to mealybug (Phenacoccus manihoti) feeding	PLOS ONE			English	Article							GENE-EXPRESSION; PLANT-RESPONSES; MEDICAGO-TRUNCATULA; DIFFERENTIAL GENE; DEFENSE RESPONSES; APHID RESISTANCE; ARABIDOPSIS; IDENTIFICATION; PROTEINS; PATHOGEN	The mealybug, Phenacoccus manihoti, is a leading pest of cassava (Manihot esculenta Crantz), damaging this crop globally. Although the biological control of this mealybug using natural predators has been established, resistance breeding remains an important means of control. Understanding plant responses to insect herbivory, by determining and identifying differentially expressed genes (DEGs), is a vital step towards the understanding of molecular mechanisms of defence responses in plants and the development of resistant cultivars by gene editing. Morphological and molecular analysis confirmed the mealybug identity as Phenacoccus manihoti (Matile-Ferrero). The transcriptome response of the green mite resistant cassava genotype AR23.1 was compared to P40/1 with no known resistance at 24 and 72 hours of mealybug infestation compared to non-infested mock. A total of 301 and 206 genes were differentially expressed at 24 and 72 of mealybug infestation for AR23.1 and P40/1 genotypes respectively, using a log2 fold change and P-value <= 0.05. Gene ontology functional classification revealed an enrichment of genes in the secondary metabolic process category in AR23.1 in comparison with P40/1, while genes in the regulation of molecular function, cellular component biogenesis and electron carrier categories were more significantly enriched in P40/1 than in AR23.1. Biological pathway analysis, based on KEGG, revealed a significant enrichment of plant-pathogen interaction and plant hormonal signal transduction pathways for a cohort of up-regulated and down-regulated DEGs in both genotypes. Defence-related genes such as 2-oxogluterate, gibberellin oxidase and terpene synthase proteins were only induced in genotype AR23.1 and not in P40/1, and subsequently validated by RT-qPCR. The study revealed a difference in response to mealybug infestation in the two genotypes studied, with AR23.1 showing a higher number of differentially expressed transcripts post mealybug infestation at 24 and 72 hours. Candidate defence-related genes that were overexpressed in the AR23.1 genotype post mealybug infestation will be useful in future functional studies towards the control of mealybugs.	[Rauwane, Molemi E.; Rees, Jasper] Agr Res Council, Biotechnol Platform, Onderstepoort, South Africa; [Rauwane, Molemi E.; Rey, Chrissie] Univ Witwatersrand, Johannesburg, South Africa; [Odeny, Damaris A.] ICRISAT Nairobi, Nairobi, Kenya; [Millar, Ian] Agr Res Council, Plant Protect Res Inst, Biosystemat Div, Pretoria, South Africa	Agricultural Research Council of South Africa; University of Witwatersrand; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Agricultural Research Council of South Africa	Rauwane, ME (corresponding author), Agr Res Council, Biotechnol Platform, Onderstepoort, South Africa.; Rauwane, ME (corresponding author), Univ Witwatersrand, Johannesburg, South Africa.	rauwaneme@gmail.com	Rees, David Jasper Gilbert/AAZ-8073-2020; Rauwane, Molemi/J-8315-2019	Rees, David Jasper Gilbert/0000-0003-3321-1325; Rauwane, Molemi/0000-0001-8717-051X	Agricultural Research Council, Professional Development Programme [PDP 101105]	Agricultural Research Council, Professional Development Programme	This research was supported by the Agricultural Research Council, Professional Development Programme (PDP 101105 to J.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allie F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1006; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; [Anonymous], 2004, AZ QUANT PCR; Artico S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-854; Ballen-Taborda C, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/857986; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Beeching JR, 1998, WOUND DEFENSE RESPON, P231; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Beltran J, 2010, PLANTA, V231, P1413, DOI 10.1007/s00425-010-1144-7; Beneventi MA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-322; Bertschy C, 1997, FLA ENTOMOL, V80, P383, DOI 10.2307/3495771; Bianchi V, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat050; Bohorquez A, 2012, UNRAVELING WHITEFLY; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bricchi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046673; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Broekgaarden C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-239; Calatayud P.A., 2006, CASSAVA MEALYBUG INT; Calatayud P-A, 2009, INTERACTIONS CASSAVA; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; COCK JH, 1982, SCIENCE, V218, P755, DOI 10.1126/science.7134971; Coppola V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-515; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dixon A, 1992, P 4 TREIN S INT SOC, P83; Dowton M, 1998, MOL PHYLOGENET EVOL, V10, P354, DOI 10.1006/mpev.1998.0533; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; El-Sharkawy MA, 2003, PLANT MOL BIOL, V53, P621, DOI 10.1023/B:PLAN.0000019109.01740.c6; FAOSTAT, 2005, CASS PROD TRENDS AFR; Fregene M, 2004, PLANT MOL BIOL, V56, P563, DOI 10.1007/s11103-004-3477-8; Fregene M, 2001, EUPHYTICA, V120, P159, DOI 10.1023/A:1017565317940; Gao L, 2016, FRONT PHYSIOL, V7, P1, DOI [10.3389/fphys.2016.00001, DOI 10.3389/fphar.2016.00479]; Gao LL, 2010, NEW PHYTOL, V186, P980, DOI 10.1111/j.1469-8137.2010.03229.x; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; HERREN HR, 1991, ANNU REV ENTOMOL, V36, P257, DOI 10.1146/annurev.en.36.010191.001353; Hillocks R., 2002, CASSAVA BIOL PRODUCT, DOI DOI 10.1079/9780851995243.0000; Hillocks Rory J., 2001, P261, DOI [10.1079/9780851995243.0261, 10.1079/9780851995243.0000]; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Huang X-Z, 2015, SCI REPORTS, P5; HUTTLY AK, 1995, PLANT MOL BIOL, V27, P1043, DOI 10.1007/BF00037031; Johnson SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-456; Jorgensen K, 2011, PLANT PHYSIOL, V155, P282, DOI 10.1104/pp.110.164053; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang J, 2011, ARABIDOPSIS BOOK, V9, P1; Kawai Y, 2014, PLANT J, V78, P328, DOI 10.1111/tpj.12479; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Kumar S, 2016, PLANT BIOTECHNOL J, V14, P1438, DOI 10.1111/pbi.12508; Lenfant N, 2013, CHEM-BIOL INTERACT, V203, P266, DOI 10.1016/j.cbi.2012.09.003; Li HQ, 2018, ECONOMET REV, V37, P867, DOI 10.1080/00927872.2016.1178871; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Lin F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo S., 2016, PLANT BIOTECHNOLOGY; Lopez C, 2005, PLANT MOL BIOL, V57, P393, DOI 10.1007/s11103-004-7819-3; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Mahungu N, 2009, AFRICAN CROP SCI J, V2, P539; Mian MAR, 2008, CROP SCI, V48, P1055, DOI 10.2135/cropsci2007.06.0357; Millar IM, 2002, AFR ENTOMOL, V10, P185; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Moreno I, 2011, J VIROL METHODS, V177, P49, DOI 10.1016/j.jviromet.2011.06.013; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nweke F, 2002, CASSAVA TRANSFORMATI, P203; NWEKE FI, 1999, 17 COSCA INT I TROP; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Park SJ, 2006, PLANTA, V223, P932, DOI 10.1007/s00425-005-0148-1; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Rawat N, 2012, FUNCT INTEGR GENOMIC, V12, P249, DOI 10.1007/s10142-012-0275-2; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Roy S., 2016, PLANT SIGNAL BEHAV, V11, P1; Sethusa MT, 2014, AFR ENTOMOL, V22, P257, DOI 10.4001/003.022.0218; Staden R, 1998, BAXEVANIS ABFFOE; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Su PH, 2008, PLANT PHYSIOL, V146, P1231, DOI 10.1104/pp.107.114496; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Timm AE, 2014, ARTHROPOD-PLANT INTE, V8, P495, DOI 10.1007/s11829-014-9340-1; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Utsumi Y, 2016, J PLANT RES, V129, P711, DOI 10.1007/s10265-016-0828-x; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Venu RC, 2010, RICE, V3, P22, DOI 10.1007/s12284-010-9037-8; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wang Y., 2016, FRONT PSYCHOL, V7, P1, DOI [DOI 10.3389/FPLS.2016.00001, 10.3389/fpls.2016.00001]; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Wei XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064481; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Williams D. J., 1992, Mealybugs of Central and South America.; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Yang YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5232; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang PJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09354; Zhang X, 2008, P 14 ACM SIGKDD INT; Zhang XM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0512-5	105	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202541	10.1371/journal.pone.0202541	http://dx.doi.org/10.1371/journal.pone.0202541			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133510	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400080
J	Tafuma, TA; Mahachi, N; Dziwa, C; Marowa, P; Moga, T; Chimbidzikai, T; Muchedzi, A; Nyagura, T; Mpofu, M				Tafuma, Taurayi A.; Mahachi, Nyikadzino; Dziwa, Chengetai; Marowa, Peter; Moga, Tafara; Chimbidzikai, Tinashe; Muchedzi, Auxillia; Nyagura, Tendai; Mpofu, Mula			Time taken to link newly identified HIV positive clients to care following a home-base index case HIV testing: Experience from two provinces in Zimbabwe	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; CENTRAL MOZAMBIQUE; INTERVENTION; RETENTION; BARRIERS; ADULTS; KENYA	Background Homebased index case HIV testing (HHTC) has shown higher uptake and good yield than traditional HIV testing methods. World Health Organization has called for increased operational research to evaluate HIV care processes particularly linkage to care. In this paper, we present project results of the time taken to link newly identified PLHIV to care after HHTC in the Manicaland and Midlands provinces of Zimbabwe. Methods We retrospectively reviewed community-facility referral data from the Zimbabwe HIV Care and Treatment project for newly diagnosed PLHIV for the period March-September 2016. A referral slip was given to a client after receiving a positive HIV results and was presented and filed upon reaching a health facility. In July 2016, the project started working with trained expert clients to assist with linkage to care. Data was entered in a spreadsheet and then imported for descriptive statistical analysis with EpiInfo TM Version 7.2.0.1. Odd ratios were used to identify factors associated with linkage to care within seven days. Results Out of 1004 newly identified PLHIV between March and September 2016, 650 (64.7%) were linked to care. The median time taken to be linked to care was four days (Interquartile range 19 days). Overall, 63.1% (410) of PLHIV were linked to care within seven days of diagnosis and 85% within 30 days. PLHIV were more likely to be linked to care within seven days of diagnosis between July and September 2016 (OR = 4.1; p<0.001), a period when ZHCT started working with expert clients to support linkage to care. Conclusion HHTC resulted in almost 63% of newly diagnosed PLHIV being linked into care within seven days, and 85% within 30 days. Linkage to care within seven days was significantly associated with the period of engaging expert clients in the project. We recommend community based HIV testing programs to work with expert clients to ensure timely linkages of new PLHIV.	[Tafuma, Taurayi A.; Mahachi, Nyikadzino; Dziwa, Chengetai; Marowa, Peter; Moga, Tafara; Chimbidzikai, Tinashe; Muchedzi, Auxillia] FHI 360, Harare, Zimbabwe; [Nyagura, Tendai] USAID, Harare, Zimbabwe; [Mpofu, Mula] FHI 360, Pretoria, South Africa	United States Agency for International Development (USAID)	Tafuma, TA (corresponding author), FHI 360, Harare, Zimbabwe.	tauadd@gmail.com		Tafuma, Taurayi Adriano/0000-0001-5793-1533	United States Agency for International Development [AID-613-A-15-00009]; Zimbabwe Ministry of Health and Child Care; United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID)); Zimbabwe Ministry of Health and Child Care; United States Agency for International Development(United States Agency for International Development (USAID))	FHI360's Zimbabwe HIV Care and Treatment Project receives financial support from the United States Agency for International Development Award number AID-613-A-15-00009 and the authors are grateful for the support of the Zimbabwe Ministry of Health and Child Care. Author TN is affiliated with USAID, therefore the funder had some role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FHI360's Zimbabwe HIV Care and Treatment Project receives support from the United States Agency for International Development and the authors are grateful for the support of the Zimbabwe Ministry of Health and Child Care. The authors thank the fieldworkers and supervisors for their excellent work during the implementation of the ZHCT project in these two provinces.	Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Bigna JJR, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0179-9; Billingsley KM, 2014, INT J TROPICAL DIS H, V4, P973; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Elul B, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0549-5; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Gerdts SE, 2014, JAIDS-J ACQ IMM DEF, V66, pE37, DOI 10.1097/QAI.0000000000000081; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Kay ES, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0120-0; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Ministry of Health and Child Care The National Medicine and Therapeutics Policy Advisory Committee The AIDS and TB Directorate Ministry of Health and Child Care ., 2016, GUID ANT THER PREV T; Naik R, 2018, AIDS BEHAV, V22, P722, DOI 10.1007/s10461-017-1830-6; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; Ware NC, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20929; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; World Health Organization, 2017, GUID MAN ADV HIV DIS	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201018	10.1371/journal.pone.0201018	http://dx.doi.org/10.1371/journal.pone.0201018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133526	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400008
J	Albrett, AM; Ashby, LV; Dickerhof, N; Kettle, AJ; Winterbourn, CC				Albrett, Amelia M.; Ashby, Louisa, V; Dickerhof, Nina; Kettle, Anthony J.; Winterbourn, Christine C.			Heterogeneity of hypochlorous acid production in individual neutrophil phagosomes revealed by a rhodamine-based probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; neutrophil; oxidative stress; phagocytosis; host-pathogen interaction; hypobromous; hypochlorous	HYDROGEN-PEROXIDE; MYELOPEROXIDASE; SUPEROXIDE; BACTERIAL; CHLORINATION; PHAGOCYTOSIS; PROTEINS; CHLORAMINE; INHIBITORS; DYNAMICS	The rhodamine-based probe R19-S has been shown to react with hypochlorous acid (HOCl) to yield fluorescent R19, but not with some other oxidants including hydrogen peroxide. Here, we further examined the specificity of R19-S and used it for real-time monitoring of HOCl production in neutrophil phagosomes. We show that it also reacts rapidly with hypobromous acid, bromamines, and hypoiodous acid, indicating that R19-S responds to these reactive halogen species as well as HOCl. Hypothiocyanous acid and taurine chloramine were unreactive, however, and ammonia chloramine and dichloramine reacted only very slowly. MS analyses revealed additional products from the reaction of HOCl with R19-S, including a chlorinated species as a minor product. Of note, phagocytosis of opsonized zymosan or Staphylococcus aureus by neutrophils was accompanied by an increase in R19 fluorescence. This increase depended on NADPH oxidase and myeloperoxidase activities, and detection of chlorinated R19-S confirmed its specificity for HOCl. Using live-cell imaging to track individual phagosomes in single neutrophils, we observed considerable heterogeneity among the phagosomes in the time from ingestion of a zymosan particle to when fluorescence was first detected, ranging from 1 to >30 min. However, once initiated, the subsequent fluorescence increase was uniform, reaching a similar maximum in approximate to 10 min. Our results confirm the utility of R19-S for detecting HOCl in real-time and provide definitive evidence that isolated neutrophils produce HOCl in phagosomes. The intriguing variability in the onset of HOCl production among phagosomes identified here could influence the way they kill ingested bacteria.	[Albrett, Amelia M.; Ashby, Louisa, V; Dickerhof, Nina; Kettle, Anthony J.; Winterbourn, Christine C.] Univ Otago Christchurch, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch 8140, New Zealand; [Albrett, Amelia M.] Landcare Res, POB 69040, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Winterbourn, CC (corresponding author), Univ Otago Christchurch, Dept Pathol & Biomed Sci, POB 4345, Christchurch 8140, New Zealand.	christine.winterbourn@otago.ac.nz	Ashby, Louisa/GRN-9388-2022	Ashby, Louisa/0000-0001-8247-096X; Dickerhof, Nina/0000-0003-2269-4595; Kettle, Tony/0000-0002-8218-7766; Winterbourn, Christine/0000-0003-4160-572X	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand. The authors declare that they have no conflicts of interest with the contents of this article.	Allen Lee-Ann H., 2007, V412, P273, DOI 10.1007/978-1-59745-467-4_18; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chen XQ, 2016, NAT PROTOC, V11, P1219, DOI 10.1038/nprot.2016.062; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Coker MSA, 2008, CHEM RES TOXICOL, V21, P2334, DOI 10.1021/tx800232v; Foote JR, 2017, JOVE-J VIS EXP, DOI 10.3791/55107; Forbes LV, 2018, ANAL BIOCHEM, V544, P13, DOI 10.1016/j.ab.2017.12.022; Forbes LV, 2013, J BIOL CHEM, V288, P36636, DOI 10.1074/jbc.M113.507756; Green JN, 2017, FREE RADICAL BIO MED, V113, P363, DOI 10.1016/j.freeradbiomed.2017.10.343; Green JN, 2014, FREE RADICAL BIO MED, V77, P49, DOI 10.1016/j.freeradbiomed.2014.08.013; Heikkila R.E., 1985, HDB METHODS OXYGEN R, P387; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Jiang Q, 1997, J BIOL CHEM, V272, P32767, DOI 10.1074/jbc.272.52.32767; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; Kettle AJ, 2011, FREE RADICAL BIO MED, V51, P2190, DOI 10.1016/j.freeradbiomed.2011.09.019; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koide Y, 2011, J AM CHEM SOC, V133, P5680, DOI 10.1021/ja111470n; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Soubhye J, 2017, J MED CHEM, V60, P6563, DOI 10.1021/acs.jmedchem.7b00285; Thomas E L, 1986, Methods Enzymol, V132, P585; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Tlili A, 2011, FREE RADICAL BIO MED, V50, P438, DOI 10.1016/j.freeradbiomed.2010.11.024; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Yan Y, 2010, ANAL CHEM, V82, P9775, DOI 10.1021/ac101929q; Zhang Z, 2011, TALANTA, V85, P779, DOI 10.1016/j.talanta.2011.04.078; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zheng W, 2015, J PHARMACOL EXP THER, V353, P288, DOI 10.1124/jpet.114.221788	40	26	27	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15715	15724		10.1074/jbc.RA118.004789	http://dx.doi.org/10.1074/jbc.RA118.004789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135208	Green Published, hybrid			2022-12-26	WOS:000446549200033
J	Pule, HT; Tjelele, JT; Tedder, MJ				Pule, Hosia T.; Tjelele, Julius T.; Tedder, Michelle J.			The effects of abiotic factors in South African semi-arid grassland communities on Seriphium plumosum L density and canopy size	PLOS ONE			English	Article							WOODY PLANT ENCROACHMENT; SHRUB ENCROACHMENT; SOIL; VEGETATION; LANDSCAPE; INVASION; COVER; DESERTIFICATION; EVOLUTION; RAINFALL	Most studies suggest that multiple factors are responsible for woody plant encroachment, but are inconclusive on its causes. Woody plant encroachment is modified by local patterns of disturbance, topography, soil texture and fertility, and their relative importance and interaction strength varies among locations. We used grassland communities, Carletonville Dolomite Grassland (CDG), Rand Highveld Grassland (RHG) and abiotic factors (Soil Organic Carbon (SOC), Total nitrogen (TN), Phosphorus (P), Potassium (K), Sodium (Na), Calcium (Ca), Magnesium (Mg) and pH) to investigate habitat preferences of Seriphium plumosum L. in South African semi-arid grassland. Grassland community had a significant effect on S. plumosum density, canopy size, and on components of soil fertility (P<0.05). Slope position had a significant effect on S. plumosum density and canopy size (P< 0.05). Seriphium plumosum density was significantly lower (23 plants/50 m(2) +/- 2.39 (SE)) in CDG than in RHG (40 plants/50 m(2) +/- 4.19). By contrast, S. plumosum canopy size was significantly higher (1.39 m(2) +/- 0.11) at CDG than at the RHG (1.06 m(2) +/- 0.08). The interaction of grassland community and slope position had a significant effect on S. plumosum density and soil sodium content (P< 0.05). Bottom slope regions in RHG (59.00 plants/50 m(2) +/- 8.62) had higher S. plumosum density than bottom slope regions (19.75 plants/50 m(2) +/- 3.01) in CDG. Soil sodium content was similar in CDG slopes and higher than in RHG slopes. Seriphium plumosum density was positively related to components of soil fertility; P (r(2) = 0.1270; P 0.0036), K (r(2) = 0.0786; P 0.0237), Na (r(2) = 0.0686; P 0.0350), Ca (r(2) = 0.0681; P 0.0358), and SOC content (r(2) = 0.0669; P 0.0374). However, Seriphium plumosum canopy size did not show any relationship with components of soil fertility. This study revealed that S. plumosum density in grassland communities increased with increasing soil texture and fertility.	[Pule, Hosia T.; Tjelele, Julius T.] Agr Res Council, Anim Prod Inst, Irene, South Africa; [Pule, Hosia T.; Tedder, Michelle J.] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Scottsville, South Africa	Agricultural Research Council of South Africa; Animal Production Research Institute, Agricultural Research Council; University of Kwazulu Natal	Pule, HT (corresponding author), Agr Res Council, Anim Prod Inst, Irene, South Africa.; Pule, HT (corresponding author), Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Scottsville, South Africa.	Gpule@arc.agric.za	Tedder, Michelle/F-4633-2010; Tedder, Michelle/S-6373-2019	Tedder, Michelle/0000-0001-8021-0929; Tedder, Michelle/0000-0001-8021-0929; Pule, Hosia/0000-0001-8576-5296	South African Science Services for Climate Change and Adaptive Land Management (SASSCAL) [229]; National Research Foundation (NRF), South Africa [TTK150608118921]	South African Science Services for Climate Change and Adaptive Land Management (SASSCAL); National Research Foundation (NRF), South Africa(National Research Foundation - South Africa)	The study was funded by South African Science Services for Climate Change and Adaptive Land Management (SASSCAL), award number: ID 229 and The National Research Foundation (NRF), South Africa, award number: TTK150608118921 to JTT. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SR, 2017, SPRINGER SER ENV MAN, P25, DOI 10.1007/978-3-319-46709-2_2; Ben Wu X, 2005, LANDSCAPE ECOL, V20, P733, DOI 10.1007/s10980-005-0996-x; BENSHAHAR R, 1990, VEGETATIO, V89, P69, DOI 10.1007/BF00134435; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Bond WJ, 2000, GLOBAL CHANGE BIOL, V6, P865, DOI 10.1046/j.1365-2486.2000.00365.x; Browning DM, 2008, ECOL APPL, V18, P928, DOI 10.1890/07-1559.1; Coetzee BWT, 2008, AFR J ECOL, V46, P449, DOI 10.1111/j.1365-2028.2007.00842.x; du Toit JCO, 2012, AFR J RANGE FOR SCI, V29, P85, DOI 10.2989/10220119.2012.705325; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fensham RJ, 2005, J ECOL, V93, P596, DOI 10.1111/j.1365-2745.2005.00998.x; Getzin S, 2007, FOREST ECOL MANAG, V242, P165, DOI 10.1016/j.foreco.2007.01.009; GROVER HD, 1990, CLIMATIC CHANGE, V17, P305, DOI 10.1007/BF00138373; Hagos MG, 2005, J ARID ENVIRON, V61, P47, DOI 10.1016/j.jaridenv.2004.08.003; HANNA AY, 1982, AGRON J, V74, P999, DOI 10.2134/agronj1982.00021962007400060016x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jia JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059315; Kerley GIH, 2009, J ARID ENVIRON, V73, P651, DOI 10.1016/j.jaridenv.2009.01.001; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Koekemoer M, 2001, THESIS; Ludwig JA, 1999, LANDSCAPE ECOL, V14, P557, DOI 10.1023/A:1008112122193; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; MCAULIFFE JR, 1994, ECOL MONOGR, V64, P111, DOI 10.2307/2937038; MEA (Millennium Ecosystem Assessment), 2005, MILL EC ASS EC HUM W; Morgan JA, 2007, P NATL ACAD SCI USA, V104, P14724, DOI 10.1073/pnas.0703427104; Mucina L, 2006, VEGETATION SO AFRICA; Oba G, 2000, LANDSCAPE ECOL, V15, P535, DOI 10.1023/A:1008106625096; OCONNOR TG, 1995, OECOLOGIA, V103, P214, DOI 10.1007/BF00329083; Price JN, 2008, AUSTRAL ECOL, V33, P278, DOI 10.1111/j.1442-9993.2007.01815.x; Pugnaire FI, 2011, J ARID ENVIRON, V75, P1310, DOI 10.1016/j.jaridenv.2011.01.016; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; Roux E., 1969, GRASS STORY FRANKENW, P153; SAS Institute, 2001, SAS STAT US GGGUID V; Schlesinger WH, 1998, BIOGEOCHEMISTRY, V42, P169, DOI 10.1023/A:1005939924434; Schmidt E, 2002, TREE SHRUBS MPUMALAN; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SMITH TM, 1986, BIOTROPICA, V18, P219, DOI 10.2307/2388488; Snyman H. A., 2012, South African Journal of Plant and Soil, V29, P157, DOI 10.1080/02571862.2012.745905; Snyman HA, 2012, S AFR J BOT, V81, P34, DOI 10.1016/j.sajb.2012.05.001; Snyman HA, 2009, NEWSLETTER GRASSLAND, V9, P29; Stevens N, 2017, GLOBAL CHANGE BIOL, V23, P235, DOI 10.1111/gcb.13409; Tjelele J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117788; Tjelele JT, 2012, RANGELAND ECOL MANAG, V65, P105, DOI 10.2111/REM-D-09-00161.1; Trollope W.S.W., 1984, Ecological Studies, V48, P149; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; van Wilgen BW, 2009, S AFR J SCI, V105, P335; Walker B. H., 1982, Ecology of tropical savannas, P556; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Ward D, 2013, S AFR J BOT, V86, P141, DOI [10.1016/j.sajb.2013.02.016, 10.1007/s00442-012-2538-y]; Ward D, 2014, AFR J RANGE FOR SCI, V31, P107, DOI 10.2989/10220119.2014.914974; Whitford WG, 2020, ECOLOGY OF DESERT SYSTEMS, 2ND EDITION, P343, DOI 10.1016/B978-0-12-815055-9.00011-4; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wingley BJ, 2009, GLOBAL CHANGE BIOL, V16, P964, DOI [10.1111/j.1365-2486.2009.02030.x, DOI 10.1111/J.1365-2486.2009.02030.X]	56	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202809	10.1371/journal.pone.0202809	http://dx.doi.org/10.1371/journal.pone.0202809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161189	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900045
J	Zhao, L; Yamaguchi, Y; Shen, WJ; Morser, J; Leung, LLK				Zhao, Lei; Yamaguchi, Yasuto; Shen, Wen-Jun; Morser, John; Leung, Lawrence L. K.			Dynamic and tissue-specific proteolytic processing of chemerin in obese mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; BARIATRIC SURGERY; GENE-EXPRESSION; RECEPTOR CCRL2; SERUM CHEMERIN; FATTY LIVER; WEIGHT-LOSS; EX-VIVO; ACTIVATION	Chemerin is a chemoattractant involved in immunity as well as an adipokine, whose activity is regulated by successive proteolytic cleavages at its C-terminus. Chemerin's C-terminal sequence and its proteolytic cleavage sites are highly conserved between human and mouse, as well as in other species. We produced, purified and characterized different mouse chemerin forms. Ca2+ mobilization assay showed that the EC50 values for mchem161T and mchem157R were 135.8 +/- 158 nM and 71.2 +/- 55.4 nM, respectively, whereas mchem156S and mchem155F had a 20-fold higher potency with an EC50 of 4.6 +/- 1.8 nM and 3.6 +/- 3.0 nM, respectively, likely representing the two physiologically active forms of chemerin. No agonist activity was found for mchem154A. Similar results were obtained in a chemotaxis assay. To identify and quantify the in vivo mouse chemerin forms in biological samples, we developed specific ELISAs for mchem162K, mchem157R, mchem156S, mchem155F and mchem154A, using antibodies raised against peptides from the C-terminus of the different mouse chemerin forms. The prochemerin form, mchem162K, was the major chemerin form in plasma with its increase matching the increase of total plasma chemerin in obese mice. During the onset of obesity in high-fat diet fed mice, mchem156S was elevated in plasma. In contrast, mchem155F was the dominant form in epididymal fat extracts. Our study provides the first direct evidence that mouse chemerin undergoes extensive, dynamic and tissue-specific proteolytic processing in vivo, similar to human chemerin, underlining the importance of measuring individual chemerin forms in studies of chemerin biology in mouse models.	[Zhao, Lei; Yamaguchi, Yasuto; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Zhao, Lei; Yamaguchi, Yasuto; Shen, Wen-Jun; Morser, John; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Shen, Wen-Jun] Stanford Univ, Dept Med, Div Endocrinol, Sch Med, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Morser, J (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA.; Morser, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	jmorser@stanford.edu		Morser, John/0000-0003-3376-8692	National Heart Lung and Blood Institute [R01 HL057530]; United States Department of Veterans Affairs [I01BX001959]; Veterans Affairs [I01BX001959] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by the National Heart Lung and Blood Institute grant R01 HL057530 (https://www.nhlbi.nih.gov) to LLKL and the United States Department of Veterans Affairs grant I01BX001959 (https://www.research.va.gov/funding) to LLKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas MM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-198; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040043; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bueno AA, 2008, PFLUG ARCH EUR J PHY, V455, P701, DOI 10.1007/s00424-007-0330-3; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chang SS, 2016, OBESITY, V24, P1522, DOI 10.1002/oby.21534; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; De Henau O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164179; Dogru T, 2010, SCAND J GASTROENTERO, V45, P1000, DOI 10.3109/00365521003749826; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Einstein FH, 2008, FASEB J, V22, P3450, DOI 10.1096/fj.08-109041; Einstein FH, 2010, J GERONTOL A-BIOL, V65, P800, DOI 10.1093/gerona/glq078; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Galvez-Prieto B, 2008, J ENDOCRINOL, V197, P55, DOI 10.1677/JOE-07-0284; Ge XM, 2018, BLOOD, V131, P353, DOI 10.1182/blood-2017-07-792580; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Haberl EM, 2018, CYTOKINE, V104, P42, DOI 10.1016/j.cyto.2018.02.004; Hansen IR, 2014, BBA-MOL CELL BIOL L, V1841, P1691, DOI 10.1016/j.bbalip.2014.09.003; Helfer G, 2018, J ENDOCRINOL; Hu WC, 2011, DIABETES RES CLIN PR, V91, P159, DOI 10.1016/j.diabres.2010.11.016; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; John H, 2007, ANAL BIOCHEM, V362, P117, DOI 10.1016/j.ab.2006.12.001; Kappes A, 2000, HORM METAB RES, V32, P548, DOI 10.1055/s-2007-978684; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Rourke JL, 2014, J ENDOCRINOL, V222, P201, DOI 10.1530/JOE-14-0069; Schultz S, 2013, BIOCHEM J, V452, P271, DOI 10.1042/BJ20121880; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Toulany J, 2016, ENDOCR CONNECT, V5, P70, DOI 10.1530/EC-16-0065; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zhao L, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1615-y; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	56	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202780	10.1371/journal.pone.0202780	http://dx.doi.org/10.1371/journal.pone.0202780			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161155	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900043
J	Cesarini, E; Cerioni, L; Canonico, B; Di Sario, G; Guidarelli, A; Lattanzi, D; Savelli, D; Guescini, M; Nasoni, MG; Bigini, N; Cuppini, R; Stocchi, V; Ambrogini, P; Papa, S; Luchetti, F				Cesarini, Erica; Cerioni, Liana; Canonico, Barbara; Di Sario, Gianna; Guidarelli, Andrea; lattanzi, DaviDe; Savelli, David; Guescini, Michele; Nasoni, Maria Gemma; Bigini, Noemi; Cuppini, Riccardo; Stocchi, Vilberto; Ambrogini, Patrizia; Papa, Stefano; Luchetti, Francesca			Melatonin protects hippocampal HT22 cells from the effects of serum deprivation specifically targeting mitochondria	PLOS ONE			English	Article							ANION CHANNELS VDAC; AUTOPHAGY; APOPTOSIS; DYNAMICS; FISSION; PREVENTS; DRP1; MECHANISMS; MORPHOLOGY; MITOPHAGY	Neurons contain a high number of mitochondria, these neuronal cells produce elevated levels of oxidative stress and live for a long time without proliferation; therefore, mitochondrial homeostasis is crucial to their health. Investigations have recently focused on mitochondrial dynamics revealing the ability of these organelles to change their distribution and morphology. It is known that mitochondrial fission is necessary for the transmission of mitochondria to daughter cells during mitosis and mitochondrial fragmentation has been used as an indicator of cell death and mitochondrial dysfunction. Oxidative stress is a trigger able to induce changes in the mitochondrial network. The aim of the present study was to determine the effects of melatonin on the mitochondrial network in HT22 serum-deprived cells. Our results showed that serum deprivation increased reactive oxygen species (ROS) content, promoted the activation of plasma membrane voltage-dependent anion channels (VDACs) and affected the expression of pDRP1 and DRP1 fission proteins. Moreover, parallel increases in apoptotic and autophagic features were found. Damaged and dysfunctional mitochondria are deleterious to the cell; hence, the degradation of such mitochondria through mitophagy is crucial to cell survival. Our results suggest that melatonin supplementation reduces cell death and restores mitochondrial function through the regulation of autophagy.	[Cesarini, Erica; Cerioni, Liana; Canonico, Barbara; Di Sario, Gianna; Guidarelli, Andrea; lattanzi, DaviDe; Savelli, David; Guescini, Michele; Nasoni, Maria Gemma; Bigini, Noemi; Cuppini, Riccardo; Stocchi, Vilberto; Ambrogini, Patrizia; Papa, Stefano; Luchetti, Francesca] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy	University of Urbino	Luchetti, F (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	francesca.luchetti@uniurb.it	Guescini, Michele/L-1297-2019	Guescini, Michele/0000-0001-9372-7038; Canonico, Barbara/0000-0003-3383-715X; Di Sario, Gianna/0000-0003-1919-6050; Savelli, David/0000-0003-4686-5758				Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BENZ I, 1994, J MEMBRANE BIOL, V142, P309; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Calo L, 2013, CURR PHARM DESIGN, V19, P6848, DOI 10.2174/138161281939131127110701; Canonico B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165780; Cantoni O, 2008, METHOD ENZYMOL, V441, P73, DOI 10.1016/S0076-6879(08)01205-6; Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Chuang JI, 2016, J PINEAL RES, V61, P230, DOI 10.1111/jpi.12343; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herrera F, 2007, J NEUROCHEM, V100, P736, DOI 10.1111/j.1471-4159.2006.04228.x; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Huo XK, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12390; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Jahanban-Esfahlan R, 2017, BR J PHARM; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Luchetti F, 2007, TOXICOL IN VITRO, V21, P293, DOI 10.1016/j.tiv.2006.08.003; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Luchetti F, 2015, STEROIDS, V99, P204, DOI 10.1016/j.steroids.2015.02.008; Ma Z, 2017, CELL MOL LIFE SCI; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Purnell PR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-86; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004; Reiter RJ, 2002, J PHARM PHARMACOL, V54, P1299, DOI 10.1211/002235702760345374; Reiter RJ, 2017, CELL MOL LIFE SCI; ROBINSON J, 1970, ANAL BIOCHEM, V33, P390, DOI 10.1016/0003-2697(70)90310-6; Sanchez-Barcelo EJ, 2017, CURR MED CHEM; Sanchez-Sanchez AM, 2011, FREE RADICAL RES, V45, P1333, DOI 10.3109/10715762.2011.623700; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Steiger-Barraissoul S, 2009, APOPTOSIS, V14, P1274, DOI 10.1007/s10495-009-0396-9; Tan D.X., 2016, INT J MOL SCI, V17; Thinnes FP, 2014, MOL GENET METAB, V111, P439, DOI 10.1016/j.ymgme.2014.02.001; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang L, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12429; Xu SC, 2016, J PINEAL RES, V60, P291, DOI 10.1111/jpi.12310; Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang ZY, 2012, AUTOPHAGY, V8, P1531, DOI 10.4161/auto.21213; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	67	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203001	10.1371/journal.pone.0203001	http://dx.doi.org/10.1371/journal.pone.0203001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157259	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400081
J	Degen, J; Hovestadt, T; Storms, M; Menzel, R				Degen, Jacqueline; Hovestadt, Thomas; Storms, Mona; Menzel, Randolf			Exploratory behavior of re-orienting foragers differs from other flight patterns of honeybees	PLOS ONE			English	Article							ORIENTATION FLIGHTS; HARMONIC RADAR; SPATIAL MEMORY; COGNITIVE MAP; NAVIGATION; BEES	Honeybees, Apis mellifera, perform re-orientation flights to learn about the new surroundings of the hive when their hive is transported to a new location. Since the pattern of re-orientation flights has not yet been studied, we asked whether this form of exploratory behavior differs from the well described exploratory orientation flights performed by young honeybees before they start foraging. We also investigated whether the exploratory components of re-orientation flights differ from foraging flights and if so how. We recorded re-orientation flights using harmonic radar technology and compared the patterns and flight parameters of these flights with the first exploratory orientation flights of young honeybees and foraging flights of experienced foragers. Just as exploratory orientation flights of young honeybees, re-orientation flights can be classified into short- and long-range flights, and most short-range re-orientation flights were performed under unfavorable weather conditions. This indicates that bees adapt the flight pattern of their re-orientation and orientation flights to changing weather conditions in a similar way. Unlike exploratory orientation flights, more than one sector of the landscape was explored during a long-range re-orientation flight, and significantly longer flight durations and flight distances were observed. Thus, re-orienting bees explored a larger terrain than bees performing their first exploratory orientation flight. By displacing some bees after their first re-orientation flight, we could demonstrate that a single re-orientation flight seems to be sufficient to learn the new location of the hive. The flight patterns of re-orientation flights differed clearly from those of foraging flights. Thus, re-orientation flights represent a special exploratory behavior that is triggered by a change in the location of the hive.	[Degen, Jacqueline; Storms, Mona; Menzel, Randolf] Free Univ Berlin, Dept Biol, Berlin, Germany; [Hovestadt, Thomas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Degen, Jacqueline] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Wurzburg, Germany	Free University of Berlin; University of Wurzburg; University of Wurzburg	Degen, J (corresponding author), Free Univ Berlin, Dept Biol, Berlin, Germany.; Degen, J (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Wurzburg, Germany.	jacqueline.degen@uni-wuerzburg.de		Hovestadt, Thomas/0000-0001-7368-6013; Storms, Mona/0000-0001-8594-6572	Deutsche Forschungsgemeinschaft e.V. [Me 365/34-2]; Deutsche Forschungsgemeinschaft e.V., Collaborative Research Center [SFB 1047]	Deutsche Forschungsgemeinschaft e.V.(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft e.V., Collaborative Research Center	The experiments were supported by the Deutsche Forschungsgemeinschaft e.V. (http://www.dfg.de), grant Me 365/34-2. T.H. gratefully acknowledges financial support by the Deutsche Forschungsgemeinschaft e.V. (http://www.dfg.de), Collaborative Research Center SFB 1047 "Insect timing", Project C6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absconding Hepburn H., 2006, LIFE CYCLES SOCIAL I, P121; Agostinelli C, 2013, CIRCULAR STAT VERSIO; [Anonymous], 1927, Z VERGL PHYSIOL, V6, P221, DOI [10.1007/BF00339256, DOI 10.1007/BF00339256]; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Birke L.I.A., 1983, P1; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Capaldi EA, 1999, J EXP BIOL, V202, P1655; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Cheeseman JF, 2014, P NATL ACAD SCI USA, V111, pE4398, DOI 10.1073/pnas.1415738111; Cheeseman JF, 2014, P NATL ACAD SCI USA, V111, P8949, DOI 10.1073/pnas.1408039111; Cheung A, 2014, P NATL ACAD SCI USA, V111, pE4396, DOI 10.1073/pnas.1413581111; Degen J, 2016, CURR BIOL, V26, P2800, DOI 10.1016/j.cub.2016.08.013; Degen J, 2015, ANIM BEHAV, V102, P45, DOI 10.1016/j.anbehav.2014.12.030; DYER FC, 1993, ANIM BEHAV, V46, P813, DOI 10.1006/anbe.1993.1260; FREE J. B., 1958, BEE WORLD, V39, P109; FREE J. B., 1958, ANIMAL BEHAVIOUR, V6, P219, DOI 10.1016/0003-3472(58)90054-X; LAUGHLIN SB, 1971, Z VERGL PHYSIOL, V74, P329, DOI 10.1007/BF00297733; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2012, APIDOLOGIE, V43, P229, DOI 10.1007/s13592-012-0127-z; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Menzel R, 2010, NATURWISSENSCHAFTEN, V97, P763, DOI 10.1007/s00114-010-0690-y; Osborne JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078681; R Core Team, 2012, R LANG ENV STAT COMP; Renner M. J., 1988, INT J COMP PSYCHOL, V2, P43; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; ROBINSON GE, 1993, ANIM BEHAV, V46, P311, DOI 10.1006/anbe.1993.1192; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN, DOI [10.1007/s00114-010-0690-y, DOI 10.1007/S00114-010-0690-Y]; Wehner R, 1981, COMP PHYS EVOLUTION, VVII/ 6C, P287, DOI DOI 10.1007/978-3642-67868-4; Wiener Jan, 2011, P51; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	33	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202171	10.1371/journal.pone.0202171	http://dx.doi.org/10.1371/journal.pone.0202171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157186	Green Published, gold			2022-12-26	WOS:000443071400042
J	Geffen, N; Scholz, SM				Geffen, Nathan; Scholz, Stefan Michael			How various design decisions on matching individuals in relationships affect the outcomes of microsimulations of sexually transmitted infection epidemics	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; TRANSMISSION; PREVENTION; SIMULATION; BEHAVIOR; SPREAD; RISK	Microsimulations are increasingly used to estimate the prevalence of sexually transmitted infections (STIs). These models consist of agents which represent a sexually active population. Matching agents into sexual relationships is computationally intensive and presents modellers with difficult design decisions: how to select which partnerships between agents break up, which agents enter a partnership market, and how to pair agents in the partnership market. The aim of this study was to analyse the effect of these design decisions on STI prevalence. We compared two strategies for selecting which agents enter a daily partnership market and which agent partnerships break up: random selection in which agents are treated homogenously versus selection based on data from a large German longitudinal data set that accounts for sex, sexual orientation and age heterogeneity. We also coupled each of these strategies with one of several recently described algorithms for pairing agents and compared their speed and outcomes. Additional design choices were also considered, such as the number of agents used in the model, increasing the heterogeneity of agents' sexual behaviour, and the proportion of relationships which are casual sex encounters. Approaches which account for agent heterogeneity estimated lower prevalence than less sophisticated approaches which treat agents homogeneously. Also, in simulations with nonrandom pairing of agents, as the risk of infection increased, incidence declined as the number of agents increased. Our algorithms facilitate the execution of thousands of simulations with large numbers of agents quickly. Fast pair-matching algorithms provide a practical way for microsimulation modellers to account for varying sexual behaviour within the population they are studying. For STIs with high infection rates modellers may need to experiment with different population sizes.	[Geffen, Nathan] Univ Cape Town, Ctr Social Sci Res, Cape Town, South Africa; [Scholz, Stefan Michael] Univ Bielefeld, Dept Publ Hlth, Bielefeld, Germany; [Scholz, Stefan Michael] Leibniz Univ Hannover, Ctr Hlth Econ Res Hannover CHERH, Hannover, Germany	University of Cape Town; University of Bielefeld; Leibniz University Hannover	Geffen, N (corresponding author), Univ Cape Town, Ctr Social Sci Res, Cape Town, South Africa.	nathangeffen@gmail.com	Scholz, Stefan/W-9109-2019	Scholz, Stefan/0000-0002-8421-8829	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This paper uses data from the German Family Panel pairfam, coordinated by Josef Bruederl, Karsten Hank, Johannes Huinink, Bernhard Nauck, Franz Neyer, and Sabine Walper. pairfam is funded as long-term project by the German Research Foundation (DFG).	ALEXANDER LJ, 1949, ARCH DERMATOL SYPH, V59, P1; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Beck EC, 2015, JAIDS-J ACQ IMM DEF, V70, P186, DOI 10.1097/QAI.0000000000000733; Brookmeyer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112668; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; Burchell AN, 2011, J INFECT DIS, V204, P1723, DOI 10.1093/infdis/jir644; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; EDMONDS J, 1965, J RES NATL BUR STAND, VB 69, P125, DOI 10.6028/jres.069B.013; Escobar Erik, 2015, Online J Public Health Inform, V7, pe224, DOI 10.5210/ojphi.v7i3.6104; Geffen N, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3485; Goldhaber-Fiebert Jeremy D, 2007, Popul Health Metr, V5, P11, DOI 10.1186/1478-7954-5-11; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Huinink J, 2011, Z FAMILIENCORSCH, V23, P77; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Johnson LF, 2016, SEX TRANSM DIS, V43, P139, DOI 10.1097/OLQ.0000000000000412; Kolmogorov V, 2009, MATH PROGRAM COMPUT, V1, P43, DOI 10.1007/s12532-009-0002-8; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M., 2000, MATH POPUL STUD, V8, P109, DOI [10.1080/08898480009525478, DOI 10.1080/08898480009525478]; Nauck B., 2014, GERMAN FAMILY PANEL; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202516	10.1371/journal.pone.0202516	http://dx.doi.org/10.1371/journal.pone.0202516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157216	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400058
J	Liao, YJ; Tang, PC; Chen, YH; Chu, FH; Kang, TC; Chen, LR; Yang, JR				Liao, Yu-Jing; Tang, Pin-Chi; Chen, Yu-Hsin; Chu, Feng-Hsiang; Kang, Ting-Chieh; Chen, Lih-Ren; Yang, Jenn-Rong			Porcine induced pluripotent stem cell-derived osteoblast-like cells prevent glucocorticoid-induced bone loss in Lanyu pigs	PLOS ONE			English	Article							ANIMAL-MODELS; OSTEOGENIC DIFFERENTIATION; OSTEOPOROSIS RESEARCH; BODY-WEIGHT; FOOD-INTAKE; IN-VITRO; MINIPIGS; TURNOVER; THERAPY; CALCIUM	The application of appropriate animal models and techniques for the study of osteoporosis is important. Lanyu pigs, a local miniature breed, have been widely used in various biomedical studies in Taiwan. This study aimed to induce bone loss in Lanyu pigs and to examine whether porcine induced pluripotent stem cell (piPSC)-derived osteoblast-like cells could recover bone mass of tibiae via local cell transplantation. piPSCs were directed to differentiate into osteoblast-like cells using osteogenic medium, and differentiated cells expressed osteogenic markers and phenotypes. Twenty mature female Lanyu pigs were divided into four groups, including control (C, 1% calcium diet), treatment 1 (T1, ovariectomy + 1% calcium diet), treatment 2 (T2, ovariectomy + 0.5% calcium diet), and treatment 3 (T3, ovariectomy + 0.5% calcium diet + 1 mg/kg of prednisolone) and were subjected to bone loss induction for twelve months. Micro-CT images revealed that the lowest trabecular bone parameters, such as trabecular bone volume, thickness, separation, number, and total porosity, were detected in the T3 group. The lowest proportions of cortical bone in the proximal metaphysis, proximal diaphysis, and distal diaphysis were also found in the T3 group. These results indicate that ovariectomy, calcium restriction, and prednisolone administration can be applied to induce proper bone loss in Lanyu pigs. After bone loss induction, pigs were subjected to cell transplantation in the left tibiae and were maintained for another six months. Results showed that transplanted piPSC-derived osteoblast-like cells significantly improved trabecular bone structures at transplanted sites and maintained cortical bone structures in the proximal metaphysis. In conclusion, the therapeutic potential of piPSCderived osteoblast-like cells was confirmed via cell transplantation in the left tibiae of Lanyu pigs. These findings reveal the therapeutic potential of piPSCs for glucocorticoid-induced bone loss in pig models.	[Liao, Yu-Jing; Chen, Yu-Hsin; Chu, Feng-Hsiang; Chen, Lih-Ren; Yang, Jenn-Rong] Council Agr, Livestock Res Inst, Div Physiol, Tainan, Taiwan; [Liao, Yu-Jing; Tang, Pin-Chi] Natl Chung Hsing Univ, Dept Anim Sci, Taichung, Taiwan; [Tang, Pin-Chi] Natl Chung Hsing Univ, IEGG, Taichung, Taiwan; [Tang, Pin-Chi] Natl Chung Hsing Univ, Anim Biotechnol Ctr, Taichung, Taiwan; [Tang, Pin-Chi] Natl Chung Hsing Univ, Ctr Integrat & Evolutionary Galliformes Genom, Taichung, Taiwan; [Chen, Yu-Hsin] Natl Chiayi Univ, Dept Anim Sci, Chiayi, Taiwan; [Kang, Ting-Chieh] Council Agr, Hengchun Branch, Livestock Res Inst, Tainan, Taiwan; [Kang, Ting-Chieh] Natl Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Chen, Lih-Ren] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan	Taiwan Livestock Research Institute; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chiayi University; Taiwan Livestock Research Institute; National Pingtung University Science & Technology; National Cheng Kung University	Yang, JR (corresponding author), Council Agr, Livestock Res Inst, Div Physiol, Tainan, Taiwan.	jryang@mail.tlri.gov.tw		Liao, Yu Jing/0000-0003-0421-3268	Livestock Research Institute, Council of Agriculture [105AS-2.7.6-LI-L1]	Livestock Research Institute, Council of Agriculture	This research was supported from the grants of 105AS-2.7.6-LI-L1 by the Livestock Research Institute, Council of Agriculture.	Antebi B, 2014, CURR OSTEOPOROS REP, V12, P41, DOI 10.1007/s11914-013-0184-x; AOAC International, 2016, OFFICIAL METHODS ANA; Arpornmaeklong P, 2010, CELL REPROGRAM, V12, P377, DOI 10.1089/cell.2009.0079; Birkebaek NH, 1995, ARCH DIS CHILD, V73, P524, DOI 10.1136/adc.73.6.524; Borah B, 2002, J BONE MINER RES, V17, P1139, DOI 10.1359/jbmr.2002.17.7.1139; Bouchard GF, 1996, ADVANCES IN SWINE IN BIOMEDICAL RESEARCH, VOLS 1 AND 2, P647; Bouvard B, 2010, CLIN REV BONE MINER, V8, P15, DOI 10.1007/s12018-009-9051-9; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Creedon A, 2001, BRIT J NUTR, V86, P453, DOI 10.1079/BJN2001419; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Gao X, 2014, INT J CLIN EXP PATHO, V7, P5123; Gluer CC, 2007, BONE, V40, P645, DOI 10.1016/j.bone.2006.10.019; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Ikeda S, 2003, BONE, V33, P779, DOI 10.1016/S8756-3282(03)00263-1; Kiernan J, 2016, STEM CELL TRANSL MED, V5, P683, DOI 10.5966/sctm.2015-0231; Kim Sang-Woo, 2013, Lab Anim Res, V29, P174, DOI 10.5625/lar.2013.29.3.174; Kimmel DB, 1996, OSTEOPOROSIS, V2, P29; Larsen T, 2000, CAN J ANIM SCI, V80, P547, DOI 10.4141/A00-024; Lee JH, 2012, CLIN INTERV AGING, V7, P303, DOI 10.2147/CIA.S32513; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Li BF, 2010, ACTA ORTHOP, V81, P396, DOI 10.3109/17453674.2010.483986; Li FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147810; Liao YJ, 2018, REGEN MED; Liao YJ, 2014, J STEM CELL RES THER, V4, P208; Liu XY, 2011, EXP THER MED, V2, P977, DOI 10.3892/etm.2011.292; Liu Y, 2014, CLIN EXP MED, V14, P13, DOI 10.1007/s10238-012-0218-1; Lysdahl H, 2014, BIORESEARCH OPEN ACC, V3, P278, DOI 10.1089/biores.2014.0044; MILLER SC, 1995, BONE, V17, pS117, DOI 10.1016/8756-3282(95)00284-K; MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9; MOSEKILDE L, 1995, BONE, V17, pS343, DOI 10.1016/8756-3282(95)00312-2; RODGERS JB, 1993, BONE, V14, P369, DOI 10.1016/8756-3282(93)90166-8; SAS, 2016, US GUID STAT; Scholz-Ahrens KE, 2007, AM J PHYSIOL-ENDOC M, V293, pE385, DOI 10.1152/ajpendo.00627.2006; Seto H, 1999, BONE, V25, P687, DOI 10.1016/S8756-3282(99)00229-X; Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759; STELLON AJ, 1985, GASTROENTEROLOGY, V89, P1078, DOI 10.1016/0016-5085(85)90212-4; Sui BD, 2016, STEM CELL TRANSL MED, V5, P1238, DOI 10.5966/sctm.2015-0347; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Taiani JT, 2014, BONE, V64, P263, DOI 10.1016/j.bone.2014.04.019; Teitelbaum SL, 2010, CELL STEM CELL, V7, P553, DOI 10.1016/j.stem.2010.10.004; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Wu CY, 2007, ANIM GENET, V38, P499, DOI 10.1111/j.1365-2052.2007.01646.x	42	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202155	10.1371/journal.pone.0202155	http://dx.doi.org/10.1371/journal.pone.0202155			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157199	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400041
J	Diaz, LM; Ricaurte, J; Tovar, E; Cajiao, C; Teran, H; Grajales, M; Polania, J; Rao, I; Beebe, S; Raatz, B				Milena Diaz, Lucy; Ricaurte, Jaumer; Tovar, Eduardo; Cajiao, Cesar; Teran, Henry; Grajales, Miguel; Polania, Jose; Rao, Idupulapati; Beebe, Stephen; Raatz, Bodo			QTL analyses for tolerance to abiotic stresses in a common bean (Phaseolus vulgaris L.) population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ROOT ARCHITECTURE TRAITS; DROUGHT TOLERANCE; PLANT-GROWTH; YIELD; PHOSPHORUS; RESISTANCE; SELECTION; MAP; ACQUISITION	Common bean productivity is reduced by several abiotic stress factors like drought and low soil fertility, leading to yield losses particularly in low input smallholder farming systems in the tropics. To understand the genetics of stress tolerance, and to improve adaptation of common bean to adverse environments, the BAT 881 x G21212 population of 95 recombinant inbred lines (RILs) was evaluated under different abiotic stress conditions in 15 trials across four locations in Colombia, representing two higher altitude (Darien ,Popayan) and two lower altitude (Palmira, Quilichao) locations. Stress vs non-stress treatments showed that yields were reduced in drought trials in Palmira by 13 and 31%, respectively, and observed yield reductions in low phosphorus stress were 39% in Quilichao, 16% in Popayan, and 71% in Darien, respectively. Yield components and biomass traits were also reduced. Traits linked to dry matter redistribution from stems, leaves and pods to seed, such as pod harvest index and total non-structural carbohydrates, were found to be important factors contributing to yield in all conditions. In contrast, early maturity was correlated with improved yield only in lower altitude locations, whereas in higher altitudes delayed maturity promoted yield. Superior RILs that combine stress tolerance and high cross-location productivity were identified. Lines that showed good yield under strong stress conditions also performed well under non-stress conditions, indicating that breeder's selection can be applied for both conditions at the same time. Quantitative trait loci (QTL) analyses revealed a stable yield QTL on chromosome Pv04, detected individually in all locations, several stress treatments and in best linear unbiased predictions (BLUPs) across all trials. Furthermore, two QTL hotspots for maturity traits were identified on Pv01 and Pv08, which are the most stable QTL. The constitutive yield QTL could serve as a good candidate for marker development and could be used in marker assisted selection. Increased understanding of the physiology of abiotic stress tolerance, combined with the availability of superior germplasm and molecular tools, will aid breeding efforts for further improvement of these plant traits.	[Milena Diaz, Lucy; Ricaurte, Jaumer; Cajiao, Cesar; Grajales, Miguel; Polania, Jose; Rao, Idupulapati; Beebe, Stephen; Raatz, Bodo] Int Ctr Trop Agr CIAT, Biotechnol Unit, Cali, Valle, Colombia; [Milena Diaz, Lucy; Ricaurte, Jaumer; Cajiao, Cesar; Grajales, Miguel; Polania, Jose; Rao, Idupulapati; Beebe, Stephen; Raatz, Bodo] Int Ctr Trop Agr CIAT, Bean Program, Cali, Valle, Colombia; [Tovar, Eduardo] Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia; [Teran, Henry] DuPont Pioneer, Salinas, PR USA; [Raatz, Bodo] CIAT Int Ctr Trop Agr, Cali, Colombia; [Rao, Idupulapati] ARS, Plant Polymer Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA	Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; United States Department of Agriculture (USDA)	Raatz, B (corresponding author), Int Ctr Trop Agr CIAT, Biotechnol Unit, Cali, Valle, Colombia.; Raatz, B (corresponding author), Int Ctr Trop Agr CIAT, Bean Program, Cali, Valle, Colombia.; Raatz, B (corresponding author), CIAT Int Ctr Trop Agr, Cali, Colombia.	b.raatz@cgiar.org	Polania, Jose/Q-2745-2017	Polania, Jose/0000-0002-1186-0503; raatz, bodo/0000-0003-0556-0691	Bill & Melinda Gates Foundation [OPPGD1392, OPP1114827]; CGIAR research program on Grain Legumes; Generation Challenge Program (GCP); Tropical Legumes I (TL-I) project; BMZ-GIZ, Germany	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CGIAR research program on Grain Legumes(CGIAR); Generation Challenge Program (GCP); Tropical Legumes I (TL-I) project; BMZ-GIZ, Germany	Thanks to the Generation Challenge Program (GCP, www.generationcp.org/). And particularly its component Tropical Legume I (TL-I) project (funded by the Bill & Melinda Gates Foundation, OPPGD1392) continued by the TL3 project (http://tropicallegumes.icrisat.org/, OPP1114827). The authors also acknowledge the financial support from the CGIAR research program on Grain Legumes (http://grainlegumes.cgiar.org/), assumed by USAID (https://www.usaid.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge M. Otero, J. Molina, L. A. Lopez, R. Garcia, C. X. Rojas, C. Ceron, G. Vieira, A. Hoyos, O. Joaqui, J. Loboa, G. Mezu A, J. B. Cuasquer, M. Rivera, and F. de la Hoz for their technical support, statistical analysis and suggestions. We are grateful to the Generation Challenge Program (GCP), the Tropical Legumes I (TL-I) project (funded by the Bill & Melinda Gates Foundation), and BMZ-GIZ, Germany for financial support for SNP genotyping and field evaluation. The authors also acknowledge the financial support from the CGIAR research program on Grain Legumes. We would also like to thank all donors who supported this work through their contributions to the CGIAR Fund.	Abdel-Haleem H, 2011, THEOR APPL GENET, V122, P935, DOI 10.1007/s00122-010-1500-9; ACOSTAGALLEGOS JA, 1995, CROP SCI, V35, P199, DOI 10.2135/cropsci1995.0011183X003500010037x; Afanador L.K., 1993, ANN REP BEAN IMPROV, V36, P10; Araujo SS, 2015, CRIT REV PLANT SCI, V34, P237, DOI 10.1080/07352689.2014.898450; Asfaw A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00733; Assefa T, 2017, PLANT BREEDING, V136, P548, DOI 10.1111/pbr.12496; Assefa T, 2013, FIELD CROP RES, V148, P24, DOI 10.1016/j.fcr.2013.04.008; BASNET B, 1974, AGRON J, V66, P531, DOI 10.2134/agronj1974.00021962006600040016x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batjes N., 1997, SOIL USE MANAG; Beaver JS, 2009, EUPHYTICA, V168, P145, DOI 10.1007/s10681-009-9911-x; Beebe S., 2012, Plant Breeding Reviews, V36, P357; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; Beebe SE, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00035; Berger JD, 2011, EUPHYTICA, V180, P1, DOI 10.1007/s10681-011-0391-4; Blair M, 2008, THEOR APPL GENET, V118, P91, DOI 10.1007/s00122-008-0879-z; Blair MW, 2012, MOL BREEDING, V29, P71, DOI 10.1007/s11032-010-9527-9; Blair MW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-100; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Burt AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139450; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Cichy KA, 2009, CROP SCI, V49, P59, DOI 10.2135/cropsci2008.03.0142; Cichy KA, 2009, EUPHYTICA, V165, P257, DOI 10.1007/s10681-008-9778-2; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Da Silva DA, 2014, SCI AGR, V71, P232, DOI 10.1590/S0103-90162014000300008; Diaz LM, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0673-1; Ehlers JD, 1997, FIELD CROP RES, V53, P187, DOI 10.1016/S0378-4290(97)00031-2; Erskine W, 2011, FOOD SECUR, V3, P127, DOI 10.1007/s12571-011-0124-5; Frei A, 2005, CROP SCI, V45, P379, DOI 10.2135/cropsci2005.0379; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Kamfwa K, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0059; Kang JH, 1995, WHITE CLOVER MORPHOL, p264 ; Keller B, 2015, THEOR APPL GENET, V128, P813, DOI 10.1007/s00122-015-2472-6; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Li R, 1996, CROP SCI, V36, P617, DOI 10.2135/cropsci1996.0011183X003600030016x; Liu FL, 2004, FIELD CROP RES, V86, P1, DOI 10.1016/S0378-4290(03)00165-5; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Miklas PN, 2001, CROP SCI, V41, P309, DOI 10.2135/cropsci2001.412309x; Mukeshimana G, 2014, CROP SCI, V54, P923, DOI 10.2135/cropsci2013.06.0427; Nidhi Gupta, 2013, American Journal of Plant Sciences, V4, P21; Polania J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00296; Polania J, 2016, EUPHYTICA, V210, P17, DOI 10.1007/s10681-016-1691-5; Polania JA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00660; Porch TG, 2009, J AGRON CROP SCI, V195, P328, DOI 10.1111/j.1439-037X.2009.00375.x; Ramaekers L, 2010, FIELD CROP RES, V117, P169, DOI 10.1016/j.fcr.2010.03.001; Rao I., 2013, African Crop Science Journal, V21, P265; Rao IM, 2017, J AGR SCI-CAMBRIDGE, V155, P857, DOI 10.1017/S0021859616000915; Rao I.M., 2014, HDB PLANT CROP PHYSL, Vthird, P847, DOI [10.1201/b16675-49, DOI 10.1201/B16675-49]; Rao I.M., 2001, HDB PLANT CROP PHYSL, P583; Rao IM, 2016, ANN BOT-LONDON, V118, P593, DOI 10.1093/aob/mcw073; RAO IM, 1995, J PLANT NUTR, V18, P2135, DOI 10.1080/01904169509365052; Rao IM, 2006, ANN REPORT, P19; RCore Team, 2020, R LANG ENV STAT COMP; Resende MDV., 2002, GENETICA BIOMETRICA, P975; Rojo H, 2009, CADENAS DE MARKOV, V21, P265; Rosales-Serna R, 2004, FIELD CROP RES, V85, P203, DOI 10.1016/S0378-4290(03)00161-8; Salinas JG, 1985, METODOS QUIMICOS ANA; SAS- Institute. SAS Institute Inc, 2011, SAS 9 3 SYST OPT REF; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Thung M, 1999, INTEGRATED MANAGEMEN, P331; Trapp JJ, 2015, CROP SCI, V55, P1596, DOI 10.2135/cropsci2014.11.0792; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Urrea CA, 2009, CROP SCI, V49, P2005, DOI 10.2135/cropsci2008.12.0694; Wang J., 2014, USERS MANUAL QTL ICI; WHITE JW, 1991, EUPHYTICA, V55, P15, DOI 10.1007/BF00022554; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wortmann CS, 1998, ATLAS COMMON BEAN PR; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429; ZHANG MM, 2016, ANN BOT, P1, DOI DOI 10.1093/AOB/MCW062	73	28	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202342	10.1371/journal.pone.0202342	http://dx.doi.org/10.1371/journal.pone.0202342			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157265	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400054
J	Theart, RP; Loos, B; Powrie, YSL; Niesler, TR				Theart, Rensu P.; Loos, Ben; Powrie, Yigael S. L.; Niesler, Thomas R.			Improved region of interest selection and colocalization analysis in three-dimensional fluorescence microscopy samples using virtual reality	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; AXONAL-TRANSPORT; VISUALIZATION; DISEASE; CELLS; BETA; DNA	Although modern fluorescence microscopy produces detailed three-dimensional (3D) datasets, colocalization analysis and region of interest (ROI) selection is most commonly performed two-dimensionally (2D) using maximum intensity projections (MIP). However, these 2D projections exclude much of the available data. Furthermore, 2D ROI selections cannot adequately select complex 3D structures which may inadvertently lead to either the exclusion of relevant or the inclusion of irrelevant data points, consequently affecting the accuracy of the colocalization analysis. Using a virtual reality (VR) enabled system, we demonstrate that 3D visualization, sample interrogation and analysis can be achieved in a highly controlled and precise manner. We calculate several key colocalization metrics using both 2D and 3D derived super-resolved structured illumination-based data sets. Using a neuronal injury model, we investigate the change in colocalization between Tau and acetylated a-tubulin at control conditions, after 6 hours and again after 24 hours. We demonstrate that performing colocalization analysis in 3D enhances its sensitivity, leading to a greater number of statistically significant differences than could be established when using 2D methods. Moreover, by carefully delimiting the 3D structures under analysis using the 3D VR system, we were able to reveal a time dependent loss in colocalization between the Tau and microtubule network as an early event in neuronal injury. This behavior could not be reliably detected using a 2D based projection. We conclude that, using 3D colocalization analysis, biologically relevant samples can be interrogated and assessed with greater precision, thereby better exploiting the potential of fluorescence-based image analysis in biomedical research.	[Theart, Rensu P.; Niesler, Thomas R.] Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa; [Loos, Ben; Powrie, Yigael S. L.] Stellenbosch Univ, Dept Physiol Sci, Stellenbosch, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Niesler, TR (corresponding author), Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa.	trn@sun.ac.za	Powrie, Yigael SL/R-1094-2018	Powrie, Yigael SL/0000-0001-8044-9390; Theart, Rensu/0000-0003-0508-1690; Loos, Ben/0000-0002-5517-373X	NVIDIA corporation	NVIDIA corporation	NVIDIA corporation sponsored the GPU that was used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA J, 1992, LIFE SCI, V50, P327, DOI 10.1016/0024-3205(92)90433-P; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Comeau JWD, 2008, MOL BIOSYST, V4, P672, DOI 10.1039/b719826d; Dan P, 2003, AM J PHYSIOL-HEART C, V284, pH1295, DOI 10.1152/ajpheart.00781.2002; Demandolx D, 1997, J MICROSC-OXFORD, V185, P21, DOI 10.1046/j.1365-2818.1997.1470704.x; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Dutartre H, 1996, J CELL SCI, V109, P367; Engel K., 2006, REAL TIME VOLUME GRA; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; FOX MH, 1991, J CELL SCI, V99, P247; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Lee S., 2012, INT J ALZHEIMERS DIS; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; Lifshitz L. M., 1994, Proceedings of the IEEE Workshop on Biomedical Image Analysis (Cat. No.94TH0624-7), P166, DOI 10.1109/BIA.1994.315854; Lumkwana D, 2017, PROG NEUROBIOL, V153, P64, DOI 10.1016/j.pneurobio.2017.03.006; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Movania MM, 2013, OPENGL DEV COOKBOOK, Vfirst; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Rodriguez-Martin T, 2013, NEUROBIOL AGING, V34, P2146, DOI 10.1016/j.neurobiolaging.2013.03.015; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Theart RP, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1446-2; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; van der Voort H. T. M., 1993, Bioimaging, V1, P20, DOI 10.1002/1361-6374(199303)1:1<20::AID-BIO5>3.3.CO;2-U; VANDERVOORT HTM, 1989, J MICROSC-OXFORD, V153, P123; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037	32	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201965	10.1371/journal.pone.0201965	http://dx.doi.org/10.1371/journal.pone.0201965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157239	Green Published, gold			2022-12-26	WOS:000443071400022
J	Aguilera-Manrique, G; Marquez-Hernandez, VV; Alcaraz-Cordoba, T; Granados-Gamez, G; Gutierrez-Puertas, V; Gutierrez-Puertas, L				Aguilera-Manrique, Gabriel; Marquez-Hernandez, Veronica V.; Alcaraz-Cordoba, Tania; Granados-Gamez, Genoveva; Gutierrez-Puertas, Vanesa; Gutierrez-Puertas, Lorena			The relationship between nomophobia and the distraction associated with smartphone use among nursing students in their clinical practicum	PLOS ONE			English	Article							SOCIAL MEDIA; ADDICTION; NURSES; QUESTIONNAIRE; PHONE; WORK; PREVALENCE; VALIDATION; SETTINGS; USAGE	Background The increasing concern about the adverse effects of overuse of smartphones during clinical practicum implies the need for policies restricting smartphone use while attending to patients. It is important to educate health personnel about the potential risks that can arise from the associated distraction. Objective The aim of this study was to analyze the relationship between the level of nomophobia and the distraction associated with smartphone use among nursing students during their clinical practicum. Methods A cross-sectional study was carried out on 304 nursing students. The nomophobia questionnaire (NMP-Q) and a questionnaire about smartphone use, the distraction associated with it, and opinions about phone restriction policies in hospitals were used. Results A positive correlation between the use of smartphones and the total score of nomophobia was found. In the same way, there was a positive correlation between opinion about smartphone restriction polices with each of the dimensions of nomophobia and the total score of the questionnaire. Conclusions Nursing students who show high levels of nomophobia also regularly use their smartphones during their clinical practicum, although they also believe that the implementation of policies restricting smartphone use while working is necessary.	[Aguilera-Manrique, Gabriel; Marquez-Hernandez, Veronica V.; Alcaraz-Cordoba, Tania; Granados-Gamez, Genoveva; Gutierrez-Puertas, Vanesa; Gutierrez-Puertas, Lorena] Univ Almeria, Fac Hlth Sci, Dept Nursing Physiotherapy & Med, Almeria, Spain; [Aguilera-Manrique, Gabriel; Marquez-Hernandez, Veronica V.; Granados-Gamez, Genoveva] Univ Almeria, Res Grp Hlth Sci CTS 451, Almeria, Spain	Universidad de Almeria; Universidad de Almeria	Marquez-Hernandez, VV (corresponding author), Univ Almeria, Fac Hlth Sci, Dept Nursing Physiotherapy & Med, Almeria, Spain.; Marquez-Hernandez, VV (corresponding author), Univ Almeria, Res Grp Hlth Sci CTS 451, Almeria, Spain.	vmh380@ual.es	Márquez-Hernández, Verónica V./ABE-7896-2020; Gutiérrez-Puertas, Lorena/ABG-4135-2020; Aguilera Manrique, Gabriel/M-7347-2015	Márquez-Hernández, Verónica V./0000-0003-1163-4394; Gutiérrez-Puertas, Lorena/0000-0003-3565-7881; Gutierrez-Puertas, Vanesa/0000-0001-7580-4474; Aguilera Manrique, Gabriel/0000-0002-1945-9626				Aggarwal M., 2012, J PSYCHOL, V15, P50; Alsos OA, 2012, INT J MED INFORM, V81, P12, DOI 10.1016/j.ijmedinf.2011.09.004; Argumosa-Villar L, 2017, J ADOLESCENCE, V56, P127, DOI 10.1016/j.adolescence.2017.02.003; Arpaci I, 2019, INFORM DEV, V35, P96, DOI 10.1177/0266666917730119; Ayar D, 2018, CIN-COMPUT INFORM NU, V36, P589, DOI 10.1097/CIN.0000000000000458; Barton AJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-46; Bautista JR, 2016, INT J MED INFORM, V95, P71, DOI 10.1016/j.ijmedinf.2016.09.002; Cagan O, 2014, PROCD SOC BEHV, V114, P831, DOI 10.1016/j.sbspro.2013.12.793; Cho S, 2016, NURS EDUC TODAY, V40, P128, DOI 10.1016/j.nedt.2016.02.021; Cho S, 2015, CIN-COMPUT INFORM NU, V33, P216, DOI 10.1097/CIN.0000000000000132; Cohen TN, 2018, PERIOPER CARE OPERAT, V10, P10, DOI [10.1016/j.pcorm.2017.12.001, DOI 10.1016/J.PCORM.2017.12.001]; Flynn GAH, 2018, CIN-COMPUT INFORM NU, V36, P120, DOI 10.1097/CIN.0000000000000400; Gill PS, 2012, RISK MANAG HEALTHC P, V5, P105, DOI 10.2147/RMHP.S34813; Gokcearslan S, 2016, COMPUT HUM BEHAV, V63, P639, DOI 10.1016/j.chb.2016.05.091; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Gutierrez-Puertas L, 2016, CIN-COMPUT INFORM NU, V34, P470, DOI 10.1097/CIN.0000000000000268; Haug S, 2015, J BEHAV ADDICT, V4, P299, DOI 10.1556/2006.4.2015.037; International Telecommunications Union, MEAS INF SOC REP INT; Jones C, 2013, J CLIN NURS, V22, P1495, DOI 10.1111/jocn.12239; Junco R, 2012, COMPUT HUM BEHAV, V28, P2236, DOI 10.1016/j.chb.2012.06.031; Katz-Sidlow RJ, 2012, J HOSP MED, V7, P595, DOI 10.1002/jhm.1950; Kaur A, 2015, INT J PSYCHIAT NURS, V1, P1, DOI DOI 10.5958/2395-180X.2015.00051.1; King Anna Lucia Spear, 2014, Clin Pract Epidemiol Ment Health, V10, P28, DOI 10.2174/1745017901410010028; Kung YM, 2014, CIN-COMPUT INFORM NU, V32, P64, DOI 10.1097/CIN.0000000000000033; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee S, 2017, APPL COGNITIVE PSYCH, V31, P360, DOI 10.1002/acp.3323; Lin SC, 2013, J ADV NURS, V69, P374, DOI 10.1111/j.1365-2648.2012.06016.x; McBride DL, 2015, J ADV NURS, V71, P2020, DOI 10.1111/jan.12674; McBride DL, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4001; McBride DL, 2012, J PEDIATR NURS, V27, P275, DOI 10.1016/j.pedn.2012.02.002; McNally G, 2017, NURSE EDUC PRACT, V23, P1, DOI 10.1016/j.nepr.2016.12.004; Mobasheri M.H., 2015, BMJ INNOV, V1, P174, DOI [DOI 10.1136/BMJINNOV-2015-000062, 10.1136/bmjinnov-2015-000062]; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Polit D. F., 2012, NURSING RES GENERATI; Przybylski AK, 2013, COMPUT HUM BEHAV, V29, P1841, DOI 10.1016/j.chb.2013.02.014; Sebri I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165714; SecurEnvoy, 2012, 66 POP SUFF NOM FEAR; Sergeeva A, 2016, HEALTH INFORM J, V22, P1101, DOI 10.1177/1460458215598637; Smith T, 2011, PERFUSION-UK, V26, P375, DOI 10.1177/0267659111409969; Yildirim C, 2016, INFORM DEV, V32, P1322, DOI 10.1177/0266666915599025; Yildirim C, 2015, COMPUT HUM BEHAV, V49, P130, DOI 10.1016/j.chb.2015.02.059	41	52	53	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202953	10.1371/journal.pone.0202953	http://dx.doi.org/10.1371/journal.pone.0202953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148870	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200037
J	Kelm, NQ; Beare, JE; Yuan, FP; George, M; Shofner, CM; Keller, BB; Hoying, JB; LeBlanc, AJ				Kelm, Natia Q.; Beare, Jason E.; Yuan, Fangping; George, Monika; Shofner, Charles M.; Keller, Bradley B.; Hoying, James B.; LeBlanc, Amanda J.			Adipose-derived cells improve left ventricular diastolic function and increase microvascular perfusion in advanced age	PLOS ONE			English	Article							STROMAL-VASCULAR FRACTION; CORONARY FLOW RESERVE; STEM-CELLS; ARTERY-DISEASE; HEART-FAILURE; BLOOD-FLOW; DYSFUNCTION; RESISTANCE; RATS; ARTERIOLES	An early manifestation of coronary artery disease in advanced age is the development of microvascular dysfunction leading to deficits in diastolic function. Our lab has previously shown that epicardial treatment with adipose-derived stromal vascular fraction (SVF) preserves microvascular function following coronary ischemia in a young rodent model. Followup studies showed intravenous (i.v.) delivery of SVF allows the cells to migrate to the walls of small vessels and reset vasomotor tone. Therefore we tested the hypothesis that the i.v. cell injection of SVF would reverse the coronary microvascular dysfunction associated with aging in a rodent model. Fischer 344 rats were divided into 4 groups: young control (YC), old control (OC), old + rat aortic endothelial cells (O+EC) and old + GFP(+) SVF cells (O+SVF). After four weeks, cardiac function and coronary flow reserve (CFR) were measured via echocardiography, and hearts were explanted either for histology or isolation of coronary arterioles for vessel reactivity studies. In a subgroup of animals, microspheres were injected during resting and dobutamine-stimulated conditions to measure coronary blood flow. GFP(+) SVF cells engrafted and persisted in the myocardium and coronary vasculature four weeks following i.v. injection. Echocardiography showed age-related diastolic dysfunction without accompanying systolic dysfunction; diastolic function was improved in old rats after SVF treatment. Ultrasound and microsphere data both showed increased stimulated coronary blood flow in O+SVF rats compared to OC and O+EC, while isolated vessel reactivity was mostly unchanged. I. v.-injected SVF cells were capable of incorporating into the vasculature of the aging heart and are shown in this study to improve CFR and diastolic function in a model of advanced age. Importantly, SVF injection did not lead to arrhythmias or increased mortality in aged rats. SVF cells provide an autologous cell therapy option for treatment of microvascular and cardiac dysfunction in aged populations.	[Kelm, Natia Q.; Beare, Jason E.; Yuan, Fangping; Keller, Bradley B.; Hoying, James B.; LeBlanc, Amanda J.] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Beare, Jason E.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [George, Monika; Shofner, Charles M.; Hoying, James B.; LeBlanc, Amanda J.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Keller, Bradley B.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	LeBlanc, AJ (corresponding author), Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA.; LeBlanc, AJ (corresponding author), Univ Louisville, Dept Physiol, Louisville, KY 40292 USA.	amanda.leblanc@louisville.edu	Beare, Jason E/D-2870-2016	Beare, Jason E/0000-0003-3988-1223; LeBlanc, Amanda/0000-0003-2507-1203	National Institutes of Health [AG053585, P30 GM103507]; Jewish Heritage Fund for Excellence; Gheen's Foundation; NATIONAL INSTITUTE ON AGING [R01AG053585] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jewish Heritage Fund for Excellence; Gheen's Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (AG053585 to AJL and P30 GM103507 to UofL), Jewish Heritage Fund for Excellence and Gheen's Foundation to AJL.	Aird AL, 2015, EXP GERONTOL, V63, P18, DOI 10.1016/j.exger.2015.01.044; Anwar MA, 2013, VASC PHARMACOL, V58, P140, DOI 10.1016/j.vph.2012.10.007; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Briones AM, 2014, CURR VASC PHARMACOL, V12, P427, DOI 10.2174/1570161112666140423221319; Cheng K, 2012, CELL TRANSPLANT, V21, P1121, DOI 10.3727/096368911X627381; CHILIAN WM, 1986, AM J PHYSIOL, V251, pH779, DOI 10.1152/ajpheart.1986.251.4.H779; CZERNIN J, 1993, CIRCULATION, V88, P62, DOI 10.1161/01.CIR.88.1.62; De Barros S, 2013, MOL THER, V21, P399, DOI 10.1038/mt.2012.213; Dryer K, 2018, AM J PHYSIOL-HEART C, V314, pH1033, DOI 10.1152/ajpheart.00680.2017; Feisst V, 2015, STEM CELLS CLONING, V8, P149, DOI 10.2147/SCCAA.S64373; Ferreira RG, 2014, PERIOPERATIVE TRANSE, P90; Gir P, 2012, PLAST RECONSTR SURG, V130, P249, DOI 10.1097/PRS.0b013e318254b4d3; Gould KL, 2013, J AM COLL CARDIOL, V62, P1639, DOI 10.1016/j.jacc.2013.07.076; HACHAMOVITCH R, 1989, AM J PHYSIOL, V256, pH66, DOI 10.1152/ajpheart.1989.256.1.H66; HANLEY FL, 1984, CIRC RES, V54, P760, DOI 10.1161/01.RES.54.6.760; Hassan EA, 2015, J EQUINE VET SCI, V35, P283, DOI 10.1016/j.jevs.2015.01.016; Hill MA, 2009, TRENDS PHARMACOL SCI, V30, P363, DOI 10.1016/j.tips.2009.04.008; Hirleman Emily D, 2008, J Extra Corpor Technol, V40, P10; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsiao ST, 2013, STEM CELLS DEV, V22, P1614, DOI 10.1089/scd.2012.0602; James AW, 2012, STEM CELL TRANSL MED, V1, P510, DOI 10.5966/sctm.2012-0002; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Kitzman Dalane W., 2000, Cardiology Clinics, V18, P597, DOI 10.1016/S0733-8651(05)70164-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Larson D F, 2000, J Extra Corpor Technol, V32, P142; LeBlanc AJ, 2013, STEM CELL TRANSL MED, V2, P896, DOI 10.5966/sctm.2013-0046; Leblanc AJ, 2013, MICROCIRCULATION, V20, P365, DOI 10.1111/micc.12028; LeBlanc AJ, 2012, AM J PHYSIOL-HEART C, V302, pH973, DOI 10.1152/ajpheart.00735.2011; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053; Liu HZ, 2002, CLIN EXP PHARMACOL P, V29, P405, DOI 10.1046/j.1440-1681.2002.03676.x; Marinescu MA, 2015, JACC-CARDIOVASC IMAG, V8, P210, DOI 10.1016/j.jcmg.2014.12.008; Morris ME, 2015, STEM CELL TRANSL MED, V4, P369, DOI 10.5966/sctm.2014-0252; Neely CF, 1996, CIRCULATION, V94, P376; Nevitt C, 2016, AM J PHYSIOL-HEART C, V310, pH1842, DOI 10.1152/ajpheart.00086.2016; Pantos C, 2003, EUR J PHARMACOL, V460, P155, DOI 10.1016/S0014-2999(02)02927-8; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Rengo G, 2012, CIRC-HEART FAIL, V5, P385, DOI 10.1161/CIRCHEARTFAILURE.112.966895; Songstad NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102147; Suga H, 2014, ANN PLAS SURG, V72, P234, DOI 10.1097/SAP.0b013e318264fd6a; Taqueti VR, 2018, EUR HEART J, V39, P840, DOI 10.1093/eurheartj/ehx721; Taqueti VR, 2016, CURR OPIN CARDIOL, V31, P662, DOI 10.1097/HCO.0000000000000339; Taqueti VR, 2015, CIRCULATION, V131, P528, DOI 10.1161/CIRCULATIONAHA.114.009716; Walker EM, 2006, ANN CLIN LAB SCI, V36, P427; Yuan FP, 2006, HUM REPROD, V21, P936, DOI 10.1093/humrep/dei433; Yuill KH, 2011, ANTIOXID REDOX SIGN, V14, P1625, DOI 10.1089/ars.2010.3279; Zhao Z, 2014, AM J PHYSIOL-HEART C, V306, pH628, DOI 10.1152/ajpheart.00859.2013; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	48	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202934	10.1371/journal.pone.0202934	http://dx.doi.org/10.1371/journal.pone.0202934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142193	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500049
J	Hagstrom, H; Andreasson, A; Carlsson, AC; Jerkeman, M; Carlsten, M				Hagstrom, Hannes; Andreasson, Anna; Carlsson, Axel C.; Jerkeman, Mats; Carlsten, Mattias			Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; MASS INDEX; MULTIPLE-MYELOMA; ANTHROPOMETRIC CHARACTERISTICS; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; ALCOHOL-CONSUMPTION; CANCER-RISK; OBESITY	High body mass index (BMI) is associated with development of hematological malignancies (HMs). However, although BMI is a well-established measurement of excess weight, it does not fully reflect body composition and can sometimes misclassify individuals. This study aimed at investigating what body composition measurements had highest association with development of HM. Body composition measurements on 27,557 individuals recorded by healthcare professionals as part of the Malmo Diet and Cancer study conducted in Sweden between 1991-1996 were matched with data from national registers on cancer incidence and causes of death. Cox regression models adjusted for age and sex were used to test the association between one standard deviation increments in body composition measurements and risk of HM. During a median follow-up of 20 years, 564 persons developed an HM. Several body composition measurements were associated with risk of developing an HM, but the strongest association was found for multiple myeloma (MM). Waist circumference (HR 1.31, p = 0.04) and waist-hip ratio (HR 1.61, p = 0.05) had higher risk estimates than BMI (HR 1.18, p = 0.07) for MM. In conclusion, our study shows that measurements of abdominal adiposity better predict the risk of developing HM, particularly MM, compared to BMI.	[Hagstrom, Hannes; Andreasson, Anna] Karolinska Inst, Dept Med, Stockholm, Sweden; [Andreasson, Anna] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Andreasson, Anna] Macquarie Univ, Dept Psychol, N Ryde, NSW, Australia; [Carlsson, Axel C.] Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Carlsson, Axel C.] Uppsala Univ, Dept Med Sci, Cardiovasc Epidemiol, Uppsala, Sweden; [Jerkeman, Mats] Lund Univ, Dept Oncol, Clin Sci, Lund, Sweden; [Carlsten, Mattias] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Macquarie University; Karolinska Institutet; Uppsala University; Lund University; Karolinska Institutet	Carlsten, M (corresponding author), Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden.	mattias.carlsten@ki.se	Carlsten, Mattias/AAH-7001-2019; Hagström, Hannes/I-2036-2019	Hagström, Hannes/0000-0002-8474-1759; Carlsten, Mattias/0000-0001-9815-0012; Carlsson, Axel C/0000-0001-6113-0472				Andreasson A, 2017, CLIN GASTROENTEROL H, V15, P1294, DOI 10.1016/j.cgh.2017.02.040; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Blair CK, 2005, EPIDEMIOLOGY, V16, P691, DOI 10.1097/01.ede.0000172135.61188.2d; Britton JA, 2008, HAEMATOL-HEMATOL J, V93, P1666, DOI 10.3324/haematol.13078; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calling S, 2006, SCAND J PUBLIC HEALT, V34, P568, DOI 10.1080/14034940600595621; Cerhan JR, 2002, AM J EPIDEMIOL, V156, P527, DOI 10.1093/aje/kwf082; Chan DC, 2003, QJM-INT J MED, V96, P441, DOI 10.1093/qjmed/hcg069; Chiu BCH, 2006, CANCER EPIDEM BIOMAR, V15, P2348, DOI 10.1158/1055-9965.EPI-06-0007; Dalamaga M, 2015, HORM MOL BIOL CLIN I, V23, P5, DOI 10.1515/hmbci-2015-0016; De Ridder J, 2016, CANCER CAUSE CONTROL, V27, P291, DOI 10.1007/s10552-015-0709-y; Epstein MM, 2015, AM J EPIDEMIOL, V182, P405, DOI 10.1093/aje/kwv072; GORANSSON M, 1994, J STUD ALCOHOL, V55, P695; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hofmann JN, 2017, OBESITY, V25, P1317, DOI 10.1002/oby.21894; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Larsson SC, 2008, INT J CANCER, V122, P1418, DOI 10.1002/ijc.23176; Larsson SC, 2007, INT J CANCER, V121, P1564, DOI 10.1002/ijc.22762; Leiba M, 2016, CANCER-AM CANCER SOC, V122, P1068, DOI 10.1002/cncr.29792; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; MacInnis RJ, 2005, JNCI-J NATL CANCER I, V97, P1154, DOI 10.1093/jnci/dji209; Maskarinec G, 2008, CANCER EPIDEM BIOMAR, V17, P196, DOI 10.1158/1055-9965.EPI-07-0716; Mattisson I, 2001, EUR J CLIN NUTR, V55, P452, DOI 10.1038/sj.ejcn.1601205; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Nagel G, 2012, ANN HEMATOL, V91, P1519, DOI 10.1007/s00277-012-1489-z; National Cancer Institute, 2017, SURV EP END RES SEER; Pan SY, 2011, RECENT RESULTS CANC, V186, P135, DOI 10.1007/978-3-642-04231-7_6; Patnuk G. E., 2006, Experimental Oncology, V28, P241; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; RIBOLI E, 1992, ANN ONCOL, V3, P783, DOI 10.1093/oxfordjournals.annonc.a058097; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Tabe Y, 2004, BLOOD, V103, P1815, DOI 10.1182/blood-2003-03-0802; Teras LR, 2014, BRIT J HAEMATOL, V166, P667, DOI 10.1111/bjh.12935; Troy JD, 2010, AM J EPIDEMIOL, V171, P1270, DOI 10.1093/aje/kwq085; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Willett EV, 2006, CANCER CAUSE CONTROL, V17, P1103, DOI 10.1007/s10552-006-0042-6; Wolin KY, 2008, BRIT J CANCER, V99, P995, DOI 10.1038/sj.bjc.6604623; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; Wu HY, 2009, CHINESE J PHYSIOL, V52, P441, DOI 10.4077/CJP.2009.AMH064	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202651	10.1371/journal.pone.0202651	http://dx.doi.org/10.1371/journal.pone.0202651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138405	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100102
J	Zheng, SH; Sun, P; Liu, HM; Li, RM; Long, LL; Xu, YX; Chen, SQ; Xu, JW				Zheng, Shuhui; Sun, Peng; Liu, Haimei; Li, Runmei; Long, Lingli; Xu, Yuxia; Chen, Suiqing; Xu, Jinwen			17 beta-estradiol upregulates striatin protein levels via Akt pathway in human umbilical vein endothelial cells	PLOS ONE			English	Article							CALMODULIN-BINDING; ESTROGEN-RECEPTORS; BLOOD-PRESSURE; MIGRATION; FAMILY; ACTIVATION; MECHANISMS; DISEASES; KINASE; BRAIN	17 beta-estradiol (E2) has been shown to have beneficial effects on the cardiovascular system. We previously demonstrated that E2 increases striatin levels and inhibits migration in vascular smooth muscle cells. The objective of the present study was to investigate the effects of E2 on the regulation of striatin expression in human umbilical vein endothelial cells (HUVECs). We demonstrated that E2 increased striatin protein expression in a dose- and time-dependent manner in HUVECs. Pretreatment with ICI 182780 or the phosphatidylinositol-3 kinase inhibitor, wortmannin, abolished E2-mediated upregulation of striatin protein expression. Treatment with E2 resulted in Akt phosphorylation in a time-dependent manner. Moreover, silencing striatin significantly inhibited HUVEC migration, while striatin overexpression significantly promoted HUVEC migration. Finally, E2 enhanced HUVEC migration, which was inhibited by silencing striatin. In conclusion, our results demonstrated that E2-mediated upregulation of striatin promotes cell migration in HUVECs.	[Zheng, Shuhui; Long, Lingli; Xu, Yuxia] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou, Guangdong, Peoples R China; [Sun, Peng] Sun Yat Sen Univ, Dept Pathol, Canc Ctr, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Guangdong, Peoples R China; [Liu, Haimei; Chen, Suiqing; Xu, Jinwen] Guangzhou Univ Chinese Med, Basic Med Coll, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Li, Runmei] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Xu, JW (corresponding author), Guangzhou Univ Chinese Med, Basic Med Coll, Dept Physiol, Guangzhou, Guangdong, Peoples R China.	xujinwen@gzucm.edu.cn			National Natural Science Foundation of China [81774107]; Department of Education of Guangdong Province [yq2014045]; Guangzhou University of Chinese Medicine [QNYC20170101]; Guangdong Natural Science Foundation [2014A030310059, 2014A030313105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou University of Chinese Medicine; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (Grant No. 81774107 to J.W.X.), Department of Education of Guangdong Province (Grant No. yq2014045 to J. W.X.), Guangzhou University of Chinese Medicine (Grant No. QNYC20170101 to J.W.X.), by the Guangdong Natural Science Foundation (Grant No. 2014A030310059 to S.Z. and Grant No. 2014A030313105 to Y.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Garza AE, 2015, HYPERTENSION, V66, P674, DOI 10.1161/HYPERTENSIONAHA.115.05600; Garza AE, 2015, HYPERTENSION, V65, P211, DOI 10.1161/HYPERTENSIONAHA.114.04233; Geraldes P, 2002, ARTERIOSCL THROM VAS, V22, P1585, DOI 10.1161/01.ATV.0000035393.11854.6A; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Jiang P, 2010, J MOL ENDOCRINOL, V45, P87, DOI 10.1677/JME-09-0166; Kander MC, 2017, J CELL MOL MED, V21, P1024, DOI 10.1111/jcmm.13038; Li P, 2017, J CLIN ENDOCR METAB, V102, P594, DOI 10.1210/jc.2016-2974; Moens SJB, 2012, CIRCULATION, V126, P1993, DOI 10.1161/CIRCULATIONAHA.112.124529; Moqrich A, 1998, GENOMICS, V51, P136, DOI 10.1006/geno.1998.5342; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Nader M, 2017, CAN J PHYSL PHARM; Pojoga LH, 2012, AM J HYPERTENS, V25, P243, DOI 10.1038/ajh.2011.197; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Simoncini T, 2009, CLIMACTERIC, V12, P6, DOI 10.1080/13697130902986385; Wong MH, 2014, CANCER SCI, V105, P1526, DOI 10.1111/cas.12541; Zheng SH, 2015, GYNECOL ENDOCRINOL, V31, P618, DOI 10.3109/09513590.2015.1021325; Zheng SH, 2012, J CELL MOL MED, V16, P296, DOI 10.1111/j.1582-4934.2011.01305.x; Zheng SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022439	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202500	10.1371/journal.pone.0202500	http://dx.doi.org/10.1371/journal.pone.0202500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138337	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100072
J	Tsai, YC; Tsai, HJ; Lee, CS; Chiu, YW; Kuo, HT; Lee, SC; Chen, TH; Kuo, MC				Tsai, Yi-Chun; Tsai, Hui-Ju; Lee, Chee-Siong; Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Su-Chu; Chen, Tzu-Hui; Kuo, Mei-Chuan			The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease	PLOS ONE			English	Article							HEART-FAILURE; VOLUME OVERLOAD; HEMODIALYSIS-PATIENTS; CARDIAC BIOMARKERS; DIALYSIS; BNP; SPECTROSCOPY; MORTALITY; INFLAMMATION; ASSOCIATION	Introduction Fluid overload is one of the major characteristics and complications in patients with chronic kidney disease (CKD). N-terminal pro-brain natriuretic peptide (NT-proBNP) is related to fluid status and fluid distribution. The aim of this study is to investigate the interaction between NT-proBNP and fluid status in adverse clinical outcomes of late stages of CKD. Methods We enrolled 239 patients with CKD stages 4 +/- 5 from January 2011 to December 2011 and followed up until June 2017. Fluid status was presented as hydration status (HS) value measured by body composition monitor, while HS> 7% was defined as fluid overload. Clinical outcomes included renal outcomes (commencing dialysis and estimated glomerular filtration rate decline> 3 ml/min/1.73 m(2) /year), all-cause mortality and major adverse cardiovascular events (MACEs). Results During a mean follow-up of 3.3 +/- 2.0 years, 129(54.7%) patients commenced dialysis, 88 (37.3%) patients presented rapid renal function decline, and 48(20.3%) had MACEs or died. All patients were stratified by HS of 7% and the median of plasma NT-proBNP. The adjusted risks for commencing dialysis was significantly higher in patients with high plasma NTproBNP and HS> 7% compared to those with low plasma NT-proBNP and HS. 7%. There was a significant interaction between plasma NT-proBNP and HS in commencing dialysis (P-interaction = 0.047). Besides, patients with high plasma NT-proBNP and HS> 7% had greater risks for MACEs or all-cause mortality than others with either high plasma NTproBNP or HS>7%. Conclusion NT-proBNP and fluid overload might have a synergistic association of adverse clinical outcomes in patients with late stages of CKD.	[Tsai, Yi-Chun; Lee, Chee-Siong] Kaohsiung Med Univ Hosp, Div Gen Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Lee, Su-Chu; Kuo, Mei-Chuan] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Kuo, Mei-Chuan] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Tsai, Hui-Ju] Kaohsiung Municipal Tatung Hosp, Dept Family Med, Kaohsiung, Taiwan; [Lee, Chee-Siong] Kaohsiung Med Univ Hosp, Div Cardiol, Kaohsiung, Taiwan; [Chen, Tzu-Hui] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.; Kuo, MC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw		Kuo, Hung-Tien/0000-0002-9931-4354; lee, su-chu/0000-0002-8587-7324	Kaohsiung Medical University Hospital [KMUH106-6R26]	Kaohsiung Medical University Hospital	This study was supported by the grant from Kaohsiung Medical University Hospital (KMUH106-6R26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Bradham WS, 2014, INFLAMMATION, V37, P801, DOI 10.1007/s10753-013-9799-4; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Cheng YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079302; Crepaldi C, 2009, CONTRIB NEPHROL, V163, P1, DOI 10.1159/000223772; Desai AS, 2011, AM J KIDNEY DIS, V58, P717, DOI 10.1053/j.ajkd.2011.05.020; Eurlings LWM, 2010, J AM COLL CARDIOL, V56, P2090, DOI 10.1016/j.jacc.2010.07.030; Felker GM, 2009, AM HEART J, V158, P422, DOI 10.1016/j.ahj.2009.06.018; Fu S, 2013, CLIN INTERV AGING, V8, P409, DOI 10.2147/CIA.S42700; Goldfarb-Rumyantzev AS, 2009, NEPHRON CLIN PRACT, V113, pC270, DOI 10.1159/000235252; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Ikonomidis I, 2017, INT J CARDIOVAS IMAG, V33, P323, DOI 10.1007/s10554-016-1010-1; Kamanoa C, 2012, BLOOD PURIFICAT, V33, P37, DOI 10.1159/000333841; Khan IA, 2006, AM J CARDIOL, V97, P1530, DOI 10.1016/j.amjcard.2005.11.090; Kim SE, 2014, CLIN BIOCHEM, V47, P344, DOI 10.1016/j.clinbiochem.2014.01.025; Kojima M, 2007, J CARDIOVASC PHARM, V49, P191, DOI 10.1097/FJC.0b013e318031f07f; Lee SW, 2003, AM J KIDNEY DIS, V41, P1257, DOI 10.1016/S0272-6386(03)00358-5; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Meirovich YF, 2008, J HEART LUNG TRANSPL, V27, P31, DOI 10.1016/j.healun.2007.09.025; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Munoz-Durango N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070797; Ohashi Y, 2016, CARDIORENAL MED, V6, P337, DOI 10.1159/000447024; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Panteghini Mauro, 2004, Clin Lab, V50, P325; Provan SA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2442; Roberts MA, 2014, CLIN J AM SOC NEPHRO, V9, P1024, DOI 10.2215/CJN.08640813; Ryan TD, 2007, J AM COLL CARDIOL, V49, P811, DOI 10.1016/j.jacc.2006.06.083; Shaw SM, 2009, TRANSPL IMMUNOL, V20, P199, DOI 10.1016/j.trim.2008.08.010; Spanaus KS, 2007, CLIN CHEM, V53, P1264, DOI 10.1373/clinchem.2006.083170; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Sundqvist S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159914; Takami Y, 2004, AM J KIDNEY DIS, V44, P420, DOI 10.1053/j.ajkd.2004.05.023; Takase H, 2014, EUR J CLIN INVEST, V44, P303, DOI 10.1111/eci.12234; Tsai YC, 2015, CLIN J AM SOC NEPHRO, V10, P39, DOI 10.2215/CJN.03610414; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Vickery S, 2005, AM J KIDNEY DIS, V46, P610, DOI 10.1053/j.ajkd.2005.06.017; Wang AYM, 2008, J AM SOC NEPHROL, V19, P1643, DOI 10.1681/ASN.2008010012; Wang AYM, 2007, J AM SOC NEPHROL, V18, P321, DOI 10.1681/ASN.2005121299; Wang AYM, 2012, SEMIN DIALYSIS, V25, P326, DOI 10.1111/j.1525-139X.2012.01079.x; Wizemann V, 2008, CONTRIB NEPHROL, V161, P115, DOI 10.1159/000130423; Worster A, 2008, CLIN BIOCHEM, V41, P250, DOI 10.1016/j.clinbiochem.2007.08.008; Yasuda K, 2012, NEPHROL DIAL TRANSPL, V27, P3885, DOI 10.1093/ndt/gfs365	45	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202733	10.1371/journal.pone.0202733	http://dx.doi.org/10.1371/journal.pone.0202733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133531	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400096
J	Ednie, AR; Deng, W; Yip, KP; Bennett, ES				Ednie, Andrew R.; Deng, Wei; Yip, Kay-Pong; Bennett, Eric S.			Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy	FASEB JOURNAL			English	Article							GENE-EXPRESSION PROFILES; SIALIC-ACID; CONGENITAL DISORDERS; CHANNEL ACTIVITY; CALCIUM-BINDING; HEART-FAILURE; DISRUPTION; IDENTIFICATION; MODULATION; PROTEINS	Protein glycosylation is an essential posttranslational modification that affects a myriad of physiologic processes. Humans with genetic defects in glycosylation, which result in truncated glycans, often present with significant cardiac deficits. Acquired heart diseases and their associated risk factors were also linked to aberrant glycosylation, highlighting its importance in human cardiac disease. In both cases, the link between causation and corollary remains enigmatic. The glycosyltransferase gene, mannosyl (-1,3-)-glycoprotein -1,2-N-acetylglucosaminyltransferase (Mgat1), whose product, N-acetylglucosaminyltransferase 1 (GlcNAcT1) is necessary for the formation of hybrid and complex N-glycan structures in the medial Golgi, was shown to be at reduced levels in human end-stage cardiomyopathy, thus making Mgat1 an attractive target for investigating the role of hybrid/complex N-glycosylation in cardiac pathogenesis. Here, we created a cardiomyocyte-specific Mgat1 knockout (KO) mouse to establish a model useful in exploring the relationship between hybrid/complex N-glycosylation and cardiac function and disease. Biochemical and glycomic analyses showed that Mgat1KO cardiomyocytes produce predominately truncated N-glycan structures. All Mgat1KO mice died significantly younger than control mice and demonstrated chamber dilation and systolic dysfunction resembling human dilated cardiomyopathy (DCM). Data also indicate that a cardiomyocyte L-type voltage-gated Ca2+ channel (Ca-v) subunit (21) is a GlcNAcT1 target, and Mgat1KO Ca-v activity is shifted to more-depolarized membrane potentials. Consistently, Mgat1KO cardiomyocyte Ca2+ handling is altered and contraction is dyssynchronous compared with controls. The data demonstrate that reduced hybrid/complex N-glycosylation contributes to aberrant cardiac function at whole-heart and myocyte levels drawing a direct link between altered glycosylation and heart disease. Thus, the Mgat1KO provides a model for investigating the relationship between systemic reductions in glycosylation and cardiac disease, showing that clinically relevant changes in cardiomyocyte hybrid/complex N-glycosylation are sufficient to cause DCM and early death.Ednie, A. R., Deng, W., Yip, K.-P., Bennett, E. S. Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy.	[Ednie, Andrew R.; Bennett, Eric S.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Boonshoft Sch Med, 143 Biol Sci 2,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA; [Ednie, Andrew R.; Bennett, Eric S.] Wright State Univ, Coll Sci & Math, Dayton, OH 45435 USA; [Deng, Wei; Yip, Kay-Pong] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL USA; [Deng, Wei] Rutgers New Jersey Med Sch, Newark, NJ USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; State University System of Florida; University of South Florida; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bennett, ES (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Boonshoft Sch Med, 143 Biol Sci 2,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	eric.bennett@wright.edu	Deng, Wei/AAJ-5955-2021; Yip, Kay-Pong/H-4639-2012	Yip, Kay-Pong/0000-0003-4364-6701	National Science Foundation [IOS-1146882, IOS-1660926, CMMI-1266331]; American Heart Association [14GRNT20450148, 15POST25710010]; U.S. National Institutes of Health, National Heart, Lung, Blood Institute [1R01HL102171]	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); U.S. National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jamey Marth (University of California-Santa Barbara and Sanford Burnham Prebys Medical Discovery Institute, Santa Barbara, CA, USA) for providing the Mgat1 and LoxP-flanked mouse strain, and Dr. Beyong Cha (University of South Florida Morsani College of Medicine Lisa Muma Weitz Laboratory for Advanced Microscopy and Cell Imaging, Tampa, FL, USA), for his collection of the Ca2+ spark data. This work was supported in part by grants from the National Science Foundation (IOS-1146882, IOS-1660926, and CMMI-1266331 to E.S.B.); an American Heart Association, Greater Southeast Affiliate Grant-In-Aid (14GRNT20450148 to E.S.B.), and a Postdoctoral Fellowship (15POST25710010 to A.R.E.); and a grant from the U.S. National Institutes of Health, National Heart, Lung, Blood Institute (1R01HL102171 to E.S.B.). The authors declare no conflicts of interest.	[Anonymous], 2009, ESSENTIALS GLYCOBIOL; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bokenes J, 2005, J APPL PHYSIOL, V98, P1712, DOI 10.1152/japplphysiol.00630.2004; Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Deng W, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0574-1; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Ednie AR, 2015, J BIOL CHEM, V290, P2769, DOI 10.1074/jbc.M114.605139; Ednie AR, 2013, J MOL CELL CARDIOL, V59, P117, DOI 10.1016/j.yjmcc.2013.02.013; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Felix R, 1997, J NEUROSCI, V17, P6884; FERMINI B, 1991, AM J PHYSIOL, V260, pH735, DOI 10.1152/ajpheart.1991.260.3.H735; Footitt EJ, 2009, J INHERIT METAB DIS, V32, pS313, DOI 10.1007/s10545-009-1262-1; FRANK JS, 1977, CIRC RES, V41, P702, DOI 10.1161/01.RES.41.5.702; Fuller W, 2001, ANAL BIOCHEM, V293, P216, DOI 10.1006/abio.2001.5127; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; GANSS B, 1993, EUR J BIOCHEM, V217, P275, DOI 10.1111/j.1432-1033.1993.tb18243.x; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Heinzel FR, 2011, J MOL CELL CARDIOL, V50, P390, DOI 10.1016/j.yjmcc.2010.11.008; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hollingworth S, 2001, J GEN PHYSIOL, V118, P653, DOI 10.1085/jgp.118.6.653; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001; Jacob S, 2013, MOL CELL BIOCHEM, V377, P11, DOI 10.1007/s11010-013-1560-7; JAQUES LW, 1977, J BIOL CHEM, V252, P4533; Kaji H, 2012, J PROTEOME RES, V11, P4553, DOI 10.1021/pr300346c; Keller RS, 2001, AM J PATHOL, V158, P1079, DOI 10.1016/S0002-9440(10)64055-2; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lakdawala NK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P228, DOI 10.1161/CIRCEP.111.962050; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Liu MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060931; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marengo FD, 1998, J MOL CELL CARDIOL, V30, P127, DOI 10.1006/jmcc.1997.0579; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P657, DOI 10.1007/s10545-017-0066-y; Matsuo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111097; McCauley MD, 2011, TRENDS CARDIOVAS MED, V21, P48, DOI 10.1016/j.tcm.2012.02.004; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Nagai-Okatani C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150210; Ness TL, 2015, BIOCHEM MOL BIOL EDU, V43, P358, DOI 10.1002/bmb.20876; Nival M, 2015, J MOL CELL CARDIOL, V79, P32, DOI 10.1016/j.yjmcc.2014.10.018; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Platano D, 2000, BIOPHYS J, V78, P2959, DOI 10.1016/S0006-3495(00)76835-4; Pugach EK, 2015, J MOL CELL CARDIOL, V86, P54, DOI 10.1016/j.yjmcc.2015.06.019; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Shirokova N, 2013, J MOL CELL CARDIOL, V58, P217, DOI 10.1016/j.yjmcc.2012.12.009; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Stanley P, 2016, J MOL BIOL, V428, P3166, DOI 10.1016/j.jmb.2016.03.025; Steele EM, 2014, BIOPHYS J, V106, P566, DOI 10.1016/j.bpj.2013.12.040; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Tian Y, 2014, PROTEOM CLIN APPL, V8, P595, DOI 10.1002/prca.201400009; Tyagi, 2000, Pathophysiology, V7, P177, DOI 10.1016/S0928-4680(00)00046-8; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Wang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004133; Wang T, 2014, PROTEIN PEPTIDE LETT, V21, P976, DOI 10.2174/0929866521666140626111237; Weintraub R. G., 2017, DILATED CARDIOMYOPAT; YAMAMOTO K, 1994, J BIOCHEM, V116, P229, DOI 10.1093/oxfordjournals.jbchem.a124510; Yang S, 2015, PROTEOMICS, V15, P567, DOI 10.1002/pmic.201400151; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Yung CK, 2004, GENOMICS, V83, P281, DOI 10.1016/j.ygeno.2003.08.007	69	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1248	1261		10.1096/fj.201801057R	http://dx.doi.org/10.1096/fj.201801057R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30138037	Bronze, Green Published			2022-12-26	WOS:000457401500099
J	Fukushima, M; Dasgupta, D; Mauer, AS; Kakazu, E; Nakao, K; Malhi, H				Fukushima, Masanori; Dasgupta, Debanjali; Mauer, Amy S.; Kakazu, Eiji; Nakao, Kazuhiko; Malhi, Harmeet			StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular vesicles; exosome (vesicle); ceramide; lipid trafficking; endoplasmic reticulum (ER); endosome; lipotoxicity; lipid metabolism; hepatocyte; lipotoxicity; palmitate	PROTEIN CERT; MULTIVESICULAR ENDOSOMES; ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; FFAT MOTIF; TRAFFICKING; EXOSOMES; RELEASE; CELLS; HEPATOCYTES	Extracellular vesicles are important carriers of cellular materials and have critical roles in cell-to-cell communication in both health and disease. Ceramides are implicated in extracellular vesicle biogenesis, yet the cellular machinery that mediates the formation of ceramide-enriched extracellular vesicles remains unknown. We demonstrate here that the ceramide transport protein StAR-related lipid transfer domain 11 (STARD11) mediates the release of palmitate-stimulated extracellular vesicles having features consistent with exosomes. Using palmitate as a model of lipotoxic diseases and as a substrate for ceramide biosynthesis in human and murine liver cell lines and primary mouse hepatocytes, we found that STARD11-deficient cells release fewer extracellular vesicles. Moreover, STARD11 reciprocally regulated exosome ceramide enrichment and cellular ceramide depletion. We further observed that in STARD11 knockout cells intracellular ceramide accumulates and that this apparent inability to transfer cellular ceramide into extracellular vesicles reduces cellular viability. Using endogenous markers, we uncovered structural and functional colocalization of the endoplasmic reticulum (ER), STARD11, and multivesicular bodies. This colocalization increased following palmitate treatment, suggesting a functional association that may mediate ceramide trafficking from the ER to the multivesicular body. However, the size and number of multivesicular bodies were comparable in WT and STARD11-knockout cells. In conclusion, we propose a model of how STARD11 mediates ceramide trafficking in palmitate-treated cells and stimulates exosome biogenesis.	[Fukushima, Masanori; Dasgupta, Debanjali; Mauer, Amy S.; Kakazu, Eiji; Malhi, Harmeet] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Fukushima, Masanori; Nakao, Kazuhiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan; [Kakazu, Eiji] Tohoku Univ Hosp, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan	Mayo Clinic; Nagasaki University; Tohoku University	Malhi, H (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	malhi.harmeet@mayo.edu	Dasgupta, Debanjali/AGT-9408-2022	Dasgupta, Debanjali/0000-0001-8307-9719; Malhi, Harmeet/0000-0002-0882-4990	NIDDK, National Institutes of Health [P30DK084567, U24DK100469, UL1TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111378, U24DK100469, P30DK084567] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Gregory J. Gores for critical review of the manuscript and Dr. Kentaro Hanada for the gift of GFP-hCERT. CD63-mCherry was a gift from Dr. Mark McNiven, and CD63-GFP was from Addgene. We are also grateful to Dr. David Katzmann and Dr. Brian Davies for useful discussions and insight into MVB formation, and Courtney Hoover for outstanding administrative support. The optical microscopy core of the Mayo Clinic Center for Cell Signaling was supported by Grant P30DK084567 from the NIDDK, National Institutes of Health. The Mayo Clinic Metabolomics Core was supported by Grants U24DK100469 and UL1TR000135 from the NIDDK, National Institutes of Health.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Ghossoub R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4477; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Hirsova P, 2016, HEPATOLOGY, V64, P2219, DOI 10.1002/hep.28814; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Obata Y, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99680; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Verma VK, 2016, J HEPATOL, V64, P651, DOI 10.1016/j.jhep.2015.11.020; Zhang JD, 1999, J CELL BIOL, V145, P99, DOI 10.1083/jcb.145.1.99	37	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15277	15289		10.1074/jbc.RA118.002587	http://dx.doi.org/10.1074/jbc.RA118.002587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30139741	Green Published, hybrid			2022-12-26	WOS:000445998400027
J	Pertl-Obermeyer, H; Lackner, P; Schulze, WX; Hoepflinger, MC; Hoeftberger, M; Foissner, I; Obermeyer, G				Pertl-Obermeyer, Heidi; Lackner, Peter; Schulze, Waltraud X.; Hoepflinger, Marion C.; Hoeftberger, Margit; Foissner, Ilse; Obermeyer, Gerhard			Dissecting the subcellular membrane proteome reveals enrichment of H+ (co-) transporters and vesicle trafficking proteins in acidic zones of Chara internodal cells	PLOS ONE			English	Article							CYTOSOLIC CALCIUM TRANSIENTS; GREEN PLANT-CELLS; MODEL SYSTEM; PHOTOSYNTHETIC UTILIZATION; CHLORIDE TRANSPORT; PLASMA-MEMBRANES; BANDING-PATTERN; ATPASE ACTIVITY; V-ATPASE; CORALLINA	The Characeae are multicellular green algae with very close relationship to land plants. Their internodal cells have been the subject of numerous (electro-) physiological studies. When exposed to light, internodal cells display alternating bands of low and high pH along their surface in order to facilitate carbon uptake required for photosynthesis. Here we investigated for the first time the subcellular membrane protein composition of acidic and alkaline regions in internodal cells of Chara australis R. Br. using MS-proteomics. The identified peptides were annotated to Chara unigenes using a custom-made Chara database generated from a transcriptome analysis and to orthologous Arabidopsis genes using TAIR (The Arabidopsis Information Resource) database. Apart from providing the first public-available, functionally- annotated sequence database for Chara australis, the proteome study, which is supported by immunodetection, identified several membrane proteins associated with acidic regions that contain a high density of specific plasma membrane (PM) invaginations, the charasomes, which locally increase the membrane area to overcome diffusion limitation in membrane transport. An increased abundance of PM H+ ATPases at charasomes is consistent with their role in the acidification of the environment, but the characean PM H+ ATPase sequence suggests a different regulation compared to higher plant PM H+ ATPases. A higher abundance of H+ co-transporters in the charasome-rich, acidic regions possibly reflects enhanced uptake of ions and nutrients. The increase in mitochondrial proteins confirms earlier findings about the accumulation of cortical mitochondria in the acidic zones. The significant enrichment of clathrin heavy chains and clathrin adaptor proteins as well as other proteins involved in trafficking indicate a higher activity of membrane transport in the charasome-rich than in charasome-poor areas. New and unexpected data, for instance the upregulation and abundance of vacuolar transporters correlating with the charasome-rich, acidic cell regions account for new perspectives in the formation of charasomes.	[Pertl-Obermeyer, Heidi; Obermeyer, Gerhard] Univ Salzburg, Dept Biosci, Mol Plant Biophys & Biochem, Salzburg, Austria; [Lackner, Peter] Univ Salzburg, Dept Biosci, Bioinformat Allergens, Salzburg, Austria; [Schulze, Waltraud X.] Univ Hohenheim, Plant Syst Biol, Stuttgart, Germany; [Hoepflinger, Marion C.; Hoeftberger, Margit; Foissner, Ilse] Univ Salzburg, Dept Biosci, Plant Cell Dynam, Salzburg, Austria	Salzburg University; Salzburg University; University Hohenheim; Salzburg University	Obermeyer, G (corresponding author), Univ Salzburg, Dept Biosci, Mol Plant Biophys & Biochem, Salzburg, Austria.; Foissner, I (corresponding author), Univ Salzburg, Dept Biosci, Plant Cell Dynam, Salzburg, Austria.	ilse.foissner@sbg.ac.at; gerhard.obermeyer@sbg.ac.at	Schulze, Waltraud X/E-9800-2011; Obermeyer, Gerhard/G-4061-2013; Lackner, Peter/L-2900-2015; Pertl-Obermeyer, Heidi/I-5849-2015; Obermeyer, Gerhard/M-5942-2019	Schulze, Waltraud X/0000-0001-9957-7245; Obermeyer, Gerhard/0000-0001-8102-6322; Lackner, Peter/0000-0003-4681-6307; Pertl-Obermeyer, Heidi/0000-0001-9180-5995; Obermeyer, Gerhard/0000-0001-8102-6322; Foissner, Ilse/0000-0002-3060-1064	Austrian Science Fund FWF [P27536, P29626]; Austrian Research Fund (FWF) [P27536, P29626]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Research Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund FWF, https://www.fwf.ac.at/en/, P27536 (IF) and P29626 (GO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The project was financed by grants of the Austrian Research Fund (FWF) P27536 and P29626 to Ilse Foissner and Gerhard Obermeyer, respectively. We thank Prof. Dr. Masayoshi Maeshima (Nagoya University, Japan) for the generous gift of anti vacuolar H<SUP>+</SUP> PPase antibody, Marketa Absolonova for her help during the rapid collection and freezing of Chara cells and Ana Gimeno for technical assistance. The help of Marie Bolger and Bjorn Usadel (RWTH Aachen, Germany) with Mercator analysis is very much appreciated. We also thank Alexander Bulychev (Moscow University, Russia) for valuable discussion.	Absolonova M, 2018, PROTOPLASMA, V255, P851, DOI 10.1007/s00709-017-1191-z; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; ANDJUS PR, 1992, PLANT SCI, V82, P187, DOI 10.1016/0168-9452(92)90219-C; [Anonymous], 2012, J PROTEOME RES, V11, P5548, DOI [10.1021/pr101065j, DOI 10.1021/PR101065J]; [Anonymous], 2014, PHYSL CHARACEAN CELL; BARTON, 1965, NATURE, V205, P201; Beilby MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01052; BISSON MA, 1991, AUST J PLANT PHYSIOL, V18, P81, DOI 10.1071/PP9910081; BISSON MA, 1980, J MEMBRANE BIOL, V56, P1, DOI 10.1007/BF01869346; Braun Markus, 2007, V68, P193, DOI 10.1007/978-3-540-36832-8_9; Bulychev A, 2003, PLANTA, V218, P143, DOI 10.1007/s00425-003-1084-6; Bulychev AA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P55, DOI 10.1007/s10541-005-0051-1; Bulychev AA, 2004, J MEMBRANE BIOL, V202, P11, DOI 10.1007/s00232-004-0716-5; Cahoon B, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020080; Casanova MT, 2014, AUST SYST BOT, V27, P23, DOI 10.1071/SB13016; CHAU R, 1994, AUST J PLANT PHYSIOL, V21, P113, DOI 10.1071/PP9940113; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRAWLEY JCW, 1965, NATURE, V205, P200, DOI 10.1038/205200a0; de Vries J, 2018, P NATL ACAD SCI USA, V115, pE3471, DOI 10.1073/pnas.1719230115; de Vries J, 2018, NEW PHYTOL, V217, P1428, DOI 10.1111/nph.14975; DEBOER AH, 1989, PLANT PHYSIOL, V89, P250, DOI 10.1104/pp.89.1.250; Delwiche CF, 2015, CURR BIOL, V25, pR899, DOI 10.1016/j.cub.2015.08.029; Dettmer J, 2005, PLANT J, V41, P117, DOI 10.1111/j.1365-313X.2004.02282.x; do Amaral MN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02146; Falhof J, 2016, MOL PLANT, V9, P323, DOI 10.1016/j.molp.2015.11.002; Faraday CD, 1996, J EXP BOT, V47, P589, DOI 10.1093/jxb/47.4.589; Faulkner CR, 2005, PROTEOMICS, V5, P2866, DOI 10.1002/pmic.200401186; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foissner I, 2004, PROTOPLASMA, V224, P145, DOI 10.1007/s00709-004-0075-1; Foissner I, 2012, J MICROSC-OXFORD, V247, P10, DOI 10.1111/j.1365-2818.2011.03572.x; Foissner I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00756; Foissner I, 2014, INT REV CEL MOL BIO, V311, P307, DOI 10.1016/B978-0-12-800179-0.00006-4; FRANCESCHI VR, 1982, PLANTA, V154, P525, DOI 10.1007/BF00402996; FRANCESCHI VR, 1980, PROTOPLASMA, V104, P253, DOI 10.1007/BF01279771; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Gao CJ, 2014, TRENDS PLANT SCI, V19, P508, DOI 10.1016/j.tplants.2014.04.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoepflinger MC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00020; Hoepflinger MC, 2013, J EXP BOT, V64, P5553, DOI 10.1093/jxb/ert322; Hofmann, 1993, BIOL CHEM HOPPE SEYL, V374; HOMBLE F, 1990, J PLANT PHYSIOL, V135, P686, DOI 10.1016/S0176-1617(11)80880-1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.4, 10.1038/nplants.2014.4]; KEIFER DW, 1982, PLANT PHYSIOL, V70, P1327, DOI 10.1104/pp.70.5.1327; Klima A, 2008, PLANT CELL PHYSIOL, V49, P1508, DOI 10.1093/pcp/pcn122; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LUCAS WJ, 1986, PROTOPLASMA, V130, P5, DOI 10.1007/BF01283326; LUCAS WJ, 1981, PROTOPLASMA, V107, P255, DOI 10.1007/BF01276829; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; OECKING C, 1991, EUR J BIOCHEM, V199, P685, DOI 10.1111/j.1432-1033.1991.tb16171.x; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; Pertl H, 2005, PLANT BIOLOGY, V7, P140, DOI 10.1055/s-2005-837583; Pertl H, 2001, PLANTA, V213, P132, DOI 10.1007/s004250000483; PLIETH C, 1994, PHYSIOL PLANTARUM, V91, P205; Plieth C, 1998, PLANTA, V207, P52, DOI 10.1007/s004250050454; Plieth C, 1998, PLANTA, V207, P42, DOI 10.1007/s004250050453; PRICE GD, 1983, PROTOPLASMA, V116, P65, DOI 10.1007/BF01294232; PRICE GD, 1985, AUST J PLANT PHYSIOL, V12, P241, DOI 10.1071/PP9850241; PRICE GD, 1985, AUST J PLANT PHYSIOL, V12, P257, DOI 10.1071/PP9850257; PRINS HBA, 1989, AQUAT BOT, V34, P59, DOI 10.1016/0304-3770(89)90050-8; Ray S, 2003, AQUAT BOT, V76, P141, DOI 10.1016/S0304-3770(03)00035-4; Rudashevskaya EL, 2012, J BIOL CHEM, V287, P4904, DOI 10.1074/jbc.M111.307264; Sangha Jatinder Singh, 2010, BMC Res Notes, V3, P126, DOI 10.1186/1756-0500-3-126; Schmolzer PM, 2011, PLANT CELL PHYSIOL, V52, P1274, DOI 10.1093/pcp/pcr074; SCHNEIDER AS, 1983, BIOCHEMISTRY-US, V22, P1680, DOI 10.1021/bi00276a025; SPEAR DG, 1969, J GEN PHYSIOL, V54, P397, DOI 10.1085/jgp.54.3.397; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang X, 2017, J EXP BOT, DOI [10.1039/jxb/erx262, DOI 10.1039/JXB/ERX262]; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wood R.D., 1965, MONOGRAPH CHARACEA 1, P1; Zauber H, 2012, J PROTEOME RES, V11, P5548, DOI 10.1021/pr300413v; Zhang SY, 2016, J PLANT PHYSIOL, V193, P37, DOI 10.1016/j.jplph.2016.02.009	74	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201480	10.1371/journal.pone.0201480	http://dx.doi.org/10.1371/journal.pone.0201480			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157181	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400009
J	Conserve, DF; Muessig, KE; Maboko, LL; Shirima, S; Kilonzo, MN; Maman, S; Kajula, L				Conserve, Donaldson F.; Muessig, Kathryn E.; Maboko, Leonard L.; Shirima, Sylvia; Kilonzo, Mrema N.; Maman, Suzanne; Kajula, Lusajo			Mate Yoko Afya Yako: Formative research to develop the Tanzania HIV self-testing education and promotion (Tanzania STEP) project for men	PLOS ONE			English	Article							DAR-ES-SALAAM; YOUNG MEN; ANTIRETROVIRAL THERAPY; ACCEPTABILITY; INTERVENTION; MASCULINITY; CARE; MICROFINANCE; PREVENTION; LEADERSHIP	The purpose of this formative research, guided by the Integrated Behavioral Model, was to assess men's attitudes and personal agency towards HIV self-testing (HIVST) and confirmatory HIV testing in order to inform the development of the Tanzania STEP (Self-Testing Education and Promotion) Project, a peer-based HIV self-testing intervention for young men in Tanzania. Qualitative in-depth interviews were conducted with 23 men in Dar es Salaam, Tanzania who socialize in networks locally referred to as "camps". Men reported privacy, confidentiality, and saving time as the primary reasons for their self-testing interest. Most participants had high perceived control and self-efficacy to self-test and seek confirmatory HIV testing. Nevertheless, men reported concerns related to their ability to perform the test and the potential lack of post-test counseling. Specific recommendations for the intervention included providing HIVST education and pre-test counseling, and using mobile health (mHealth) strategies for participants to reach a healthcare professional for further assistance. The findings suggest that while HIVST is highly acceptable among men in Tanzania, future interventions will need to address the challenges that men may face with HIVST before promoting it as an alternative or supplement to facility-based HIV testing.	[Conserve, Donaldson F.; Shirima, Sylvia] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Muessig, Kathryn E.; Maman, Suzanne] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Maboko, Leonard L.] Tanzania Commiss AIDS TACAIDS, Dar Es Salaam, Tanzania; [Kilonzo, Mrema N.; Kajula, Lusajo] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat & Mental Hlth, Dar Es Salaam, Tanzania	University of South Carolina System; University of South Carolina Columbia; University of North Carolina; University of North Carolina Chapel Hill; Muhimbili University of Health & Allied Sciences	Conserve, DF (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	conserve@mailbox.sc.edu	Muessig, Kate/P-1242-2018	Conserve, Donaldson/0000-0001-8193-817X	University of North Carolina at Chapel Hill Center for AIDS Research [P30AI50410]; National Institute of Mental Health (NIMH) Grant [R01MH098690]; NIMH [K99/R00MH110343]; National Institute of Allergy and Infectious Diseases [T32 AI007001]; National Institute of Health [5R25HL105444-07];  [1UL1TR001111-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH110343, R00MH110343] Funding Source: NIH RePORTER	University of North Carolina at Chapel Hill Center for AIDS Research; National Institute of Mental Health (NIMH) Grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the University of North Carolina at Chapel Hill Center for AIDS Research (P30AI50410), National Institute of Mental Health (NIMH) Grant #R01MH098690: PI, Suzanne Maman, NIMH Grant #K99/R00MH110343: PI, Donaldson F. Conserve, a training grant from the National Institute of Allergy and Infectious Diseases #T32 AI007001, and a grant from the National Institute of Health #5R25HL105444-07. We are also grateful for the valuable contributions of Richard S. Youngblood from NC TraCS/CTSA supported by grant #1UL1TR001111-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GLOB AIDS UPD 2016; Buguzi S., 2018, THE CITIZEN; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chanda MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002442; Cherutich P., 2014, Retrovirology: Research and Treatment, V6, P23; Chikovore J, 2016, AIDS CARE, V28, P74, DOI 10.1080/09540121.2016.1178953; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21610; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Conserve D, 2016, OPEN FORUM INFECT DI; Conserve DF, 2018, AM J MENS HLTH; Conserve DF, 2017, J TELEMED TELECARE, V23, P347, DOI 10.1177/1357633X16639186; Czaicki NL, 2017, AIDS CARE, V29, P876, DOI 10.1080/09540121.2017.1287340; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Frye V, 2015, AIDS PATIENT CARE ST, V29, P617, DOI 10.1089/apc.2015.0100; Guardian T., 2018, GUARDIAN; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; ILO, 2018, TANZ LAUNCH CAMP HIV; Indravudh PP, 2018, CURR OPIN INFECT DIS, V31, P14, DOI 10.1097/QCO.0000000000000426; Iwelunmor J, 2015, AM J MENS HEALTH, V9, P193, DOI 10.1177/1557988314535235; Jennings L, 2017, ANN GLOB HEALTH, V83, P66; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21594; Joint United Nations Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Kajula L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2774-x; Kelvin EA, 2017, AIDS BEHAV, P1; Kundi GJ, 2014, ONLINE J PUBLIC HLTH, V6; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Maman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174629; Maman S, 2016, GLOB PUBLIC HEALTH, V11, P1202, DOI 10.1080/17441692.2015.1094105; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; McCoy SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1186-3; Ministry of Health CD, 2017, TANZ HIV IMP SURV 20; Montaner J, 2017, J VIRUS ERAD, V3, P97; Montauo D.E., 2015, HLTH BEHAV; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Nkuna Engetani, 2016, Open AIDS J, V10, P78, DOI 10.2174/1874613601610010078; Nyamhanga TM, 2013, TANZANIA GLOBAL HLTH, V6, P21812, DOI DOI 10.3402/GHA.V6I0.21812; Oldenburg CE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014780; Organization WH, 2013, 1 INT S SELF TEST HI; Orr N, 2017, JAIDS-J ACQ IMM DEF, V74, pS69, DOI 10.1097/qai.0000000000001204; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Perez GIP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151990; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Ratliff EA, 2013, ADV PREVENTIVE MED; Rolfe G, 2006, J ADV NURS, V53, P304, DOI 10.1111/j.1365-2648.2006.03727.x; Siu GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-33; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Spyrelis A, 2017, AIDS CARE, V29, P339, DOI 10.1080/09540121.2016.1234687; Taggart T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4387; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; van Rooyen H, 2015, J INT AIDS SOC, V18; Wang ZX, 2018, AIDS BEHAV, V22, P190, DOI 10.1007/s10461-017-1887-2; Weiser SD, 2015, AIDS, V29, P1889, DOI 10.1097/QAD.0000000000000781; Welfare MoHaS, 2013, NAT COMPR GUID HIV T; Who, 2015, FACT SHEET WHO CONS; WHO, 2015, CONSOLIDATED GUIDELI; WHO, NUMB COUNTR AD HIV S; World Health Organization, 2016, GUID HIV SELF TEST P, DOI 10665/251655/9789241549868-eng.pdf; Yamanis T, 2017, AIDS BEHAV, V21, P1171, DOI 10.1007/s10461-016-1513-8; Yamanis TJ, 2010, SOC SCI MED, V71, P1601, DOI 10.1016/j.socscimed.2010.07.039; Zanolini A, 2018, AIDS RES HUM RETROV, V34, P254, DOI [10.1089/aid.2017.0156, 10.1089/AID.2017.0156]	66	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202521	10.1371/journal.pone.0202521	http://dx.doi.org/10.1371/journal.pone.0202521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148846	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200012
J	Long, JJ; Jahn, CE; Sanchez-Hidalgo, A; Wheat, W; Jackson, M; Gonzalez-Juarrero, M; Leach, JE				Long, John J.; Jahn, Courtney E.; Sanchez-Hidalgo, Andrea; Wheat, William; Jackson, Mary; Gonzalez-Juarrero, Mercedes; Leach, Jan E.			Interactions of free-living amoebae with rice bacterial pathogens Xanthomonas oryzae pathovars oryzae and oryzicola	PLOS ONE			English	Article							ACANTHAMOEBA-CASTELLANII; COMMUNITY COMPOSITION; BIOFILM FORMATION; PLANT-GROWTH; SOIL; PROTOZOA; RHIZOSPHERE; WATER; SECRETION; GRANULES	Background Free-living amoebae (FLA) are voracious feeders, consuming bacteria and other microbes during colonization of the phytobiome. FLA are also known to secrete bacteriocidal or bacteriostatic compounds into their growth environment. Methodology and principal findings Here, we explore the impacts of co-cultivation of five FLA species, including Acanthamoeba castellanii, A. lenticulata, A. polyphaga, Dictyostelium discoideum and Vermamoeba vermiformis, on survival of two devastating bacterial pathogens of rice, Xanthomonas oryzae pathovars (pv.) oryzae and oryzicola. In co-cultivation assays, the five FLA species were either bacteriostatic or bactericidal to X. oryzae pv. oryzae and X. oryzae pv. oryzicola. Despite these effects, bacteria were rarely detected inside amoebal cells. Furthermore, amoebae did not disrupt X. oryzae biofilms. The bactericidal effects persisted when bacteria were added to a cell-free supernatant from amoebal cultures, suggesting some amoebae produce an extracellular bactericidal compound. Conclusions/Significance This work establishes novel, basal dynamics between important plant pathogenic bacteria and diverse amoebae, and lays the framework for future mechanistic studies.	[Long, John J.; Jahn, Courtney E.; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Sanchez-Hidalgo, Andrea; Wheat, William; Jackson, Mary; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol &Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Leach, JE (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	Jan.Leach@colostate.edu	Jackson, Mary/D-5345-2017	Jackson, Mary/0000-0002-9212-0258; gonzalez-juarrero, mercedes/0000-0002-4045-2365; Leach, Jan/0000-0001-7252-4397	Defense Advanced Research Projects Agency (DARPA) [DARPA-BAA-15-35]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was funded by the Defense Advanced Research Projects Agency (DARPA) under project number: DARPA-BAA-15-35. The funders had no role in study design, data collection and analysis, decision to p ublish, or preparation of the manuscript.	Benavides-Montano JA, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00593-17; Bonkowski M, 2002, SOIL BIOL BIOCHEM, V34, P1709, DOI 10.1016/S0038-0717(02)00157-8; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; Chavez-Munguia B, 2014, EXP PARASITOL, V142, P1, DOI 10.1016/j.exppara.2014.03.027; Cho JH, 2000, IUBMB LIFE, V50, P209, DOI 10.1080/152165400300001534; Clarke M, 2006, EUR J CELL BIOL, V85, P1001, DOI 10.1016/j.ejcb.2006.05.004; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Dillon A, 2009, FEMS MICROBIOL ECOL, V69, P106, DOI 10.1111/j.1574-6941.2009.00690.x; El-Etr SH, 2009, APPL ENVIRON MICROB, V75, P7488, DOI 10.1128/AEM.01829-09; Fouque E, 2015, J EUKARYOT MICROBIOL, V62, P327, DOI 10.1111/jeu.12185; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2003, ANN NY ACAD SCI, V990, P628, DOI 10.1111/j.1749-6632.2003.tb07437.x; Griffiths BS, 1999, PEDOBIOLOGIA, V43, P297; GRiSP, RICE ALMANAC; HABTE M, 1975, APPL MICROBIOL, V29, P159, DOI 10.1128/AEM.29.2.159-164.1975; HARF C, 1994, ENDOCYTOBIOSIS CELL, V10, P167; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; Kreuzer K, 2006, SOIL BIOL BIOCHEM, V38, P1665, DOI 10.1016/j.soilbio.2005.11.027; LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; MEW TW, 1993, PLANT DIS, V77, P5, DOI 10.1094/PD-77-0005; NAPOLITANO JJ, 1982, APPL ENVIRON MICROB, V44, P255, DOI 10.1128/AEM.44.1.255-257.1982; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Pagnier I, 2008, ENVIRON MICROBIOL, V10, P1135, DOI 10.1111/j.1462-2920.2007.01530.x; Plasson F., 2017, WILLAERTIA MAGNA BIO; Pradhan BB, 2012, MOL PLANT MICROBE IN, V25, P1157, DOI 10.1094/MPMI-02-12-0049-R; Riekenberg S, 2004, MOL BIOCHEM PARASIT, V138, P217, DOI 10.1016/j.molbiopara.2004.09.003; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Rosenberg K, 2009, ISME J, V3, P675, DOI 10.1038/ismej.2009.11; ROSENTHAL S, 1969, J BACTERIOL, V98, P182, DOI 10.1128/JB.98.1.182-189.1969; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Thomas V, 2010, FEMS MICROBIOL REV, V34, P231, DOI 10.1111/j.1574-6976.2009.00190.x; Verdier V, 2012, J BIOTECHNOL, V159, P320, DOI 10.1016/j.jbiotec.2011.09.020; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhou XH, 2007, ENVIRON MICROBIOL, V9, P913, DOI 10.1111/j.1462-2920.2006.01213.x	39	13	14	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202941	10.1371/journal.pone.0202941	http://dx.doi.org/10.1371/journal.pone.0202941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142182	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500052
J	Razo, CAP; Hernandez, ER; Ponce, SIR; Suazo, FM; Robbe-Austerman, S; Stuber, T; Alarcon, GJC				Angelica Perea Razo, Claudia; Rodriguez Hernandez, Elba; Ivan Roman Ponce, Sergio; Milian Suazo, Feliciano; Robbe-Austerman, Suelee; Stuber, Tod; Canto Alarcon, Germinal Jorge			Molecular epidemiology of cattle tuberculosis in Mexico through whole-genome sequencing and spoligotyping	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; POPULATION-STRUCTURE; MIRU-VNTRPLUS; COMPLEX; STRAINS; FRAMEWORK; GENOTYPES; LIVESTOCK; STRATEGY; WILDLIFE	Mycobacterium bovis infection in cattle persists in Mexico, posing a threat to human health. Control of bovine tuberculosis, through the National Program Against Bovine Tuberculosis, has led to the decrease of disease prevalence in most of the country, except for high dairy production regions. Genotyping of M. bovis has been performed mainly by spoligotyping and variable number tandem repeats (VNTR), but higher resolution power can be useful for a finer definition of the spread of the disease. Whole genome sequencing and spoligotyping was performed for a set of 322 M. bovis isolates from different sources in Mexico: Baja California, Coahuila, Estado de Mexico, Guanajuato, Hidalgo, Jalisco, Queretaro and Veracruz, from dairy and beef cattle, as well as humans. Twelve main genetic clades were obtained through WGS and genetic diversity analysis. A clear differentiation of the Baja California isolates was seen as they clustered together exclusively. However, isolates from the central states showed no specific clustering whatsoever. Although WGS proves to have higher resolving power than spoligotyping, and since there was concordance between WGS and spoligotyping results, we consider that the latter is still an efficient and practical method for monitoring bovine tuberculosis in developing countries, where resources for higher technology are scarce.	[Angelica Perea Razo, Claudia] Univ Autonoma Queretaro, Doctorado Ciencias Biol, Queretaro, Qro, Mexico; [Rodriguez Hernandez, Elba; Ivan Roman Ponce, Sergio] INIFAP, Ctr Nacl Invest Disciplinaria Fisiol & Mejoramien, Colon, Qro, Mexico; [Milian Suazo, Feliciano; Canto Alarcon, Germinal Jorge] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico; [Robbe-Austerman, Suelee; Stuber, Tod] USDA, Natl Vet Serv Labs, Univ Blvd, Ames, IA 50010 USA; [Canto Alarcon, Germinal Jorge] Fac Ciencias Nat, Queretaro, Mexico	Universidad Autonoma de Queretaro; Universidad Autonoma de Queretaro; United States Department of Agriculture (USDA)	Alarcon, GJC (corresponding author), Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico.; Alarcon, GJC (corresponding author), Fac Ciencias Nat, Queretaro, Mexico.	gcanto07@uaq.mx	ROMAN-PONCE, SERGIO IVAN/AAC-4154-2020	ROMAN-PONCE, SERGIO IVAN/0000-0002-6704-6578; Perea, Claudia/0000-0002-4863-6863				Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Amato B, 2018, TRANSBOUND EMERG DIS, V65, pe416, DOI 10.1111/tbed.12776; Andrews S., 2010, FASTQC QUALITY CONTR; Andrievskaia O, 2018, VET MICROBIOL, V214, P44, DOI 10.1016/j.vetmic.2017.12.005; Buddle B, 2014, NZ VET J, V169, P1; Cobos-Marin L, 2005, CAN J MICROBIOL, V51, P996, DOI [10.1139/w05-083, 10.1139/W05-083]; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coscolla M, 2014, SEMIN IMMUNOL, V6, P431; De Almeida Isabela Neves, 2013, BMC Res Notes, V6, P561, DOI 10.1186/1756-0500-6-561; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Djemal SE, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1314-y; Egbe NF, 2017, SCI REP, V7, P1; Sandoval-Azuara SE, 2017, INT J INFECT DIS, V63, P48, DOI 10.1016/j.ijid.2017.07.012; Ghavidel M, 2018, MICROB PATHOGENESIS, V118, P310, DOI 10.1016/j.micpath.2018.03.036; Ghebremariam MK, 2018, PLOS NEGLECT TROP D, V12, P1; Reyes JAG, 2012, PREV VET MED, V106, P1, DOI 10.1016/j.prevetmed.2012.05.008; Hasnain SE, 2015, TUBERCULOSIS, V95, P91, DOI 10.1016/j.tube.2014.12.007; Jagielski T., 2014, BioMed Research International, V2014, P645802; Jang Y, 2017, J WILDLIFE DIS, V53, P181, DOI 10.7589/2015-11-295; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kao RR, 2016, REV SCI TECH OIE, V35, P241, DOI 10.20506/rst.35.1.2430; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Lasserre M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4249-6; le Roex N, 2013, PHYSIOL GENOMICS, V45, P631, DOI 10.1152/physiolgenomics.00061.2013; Lee RS, 2016, THER ADV INFECT DIS, V3, P47, DOI 10.1177/2049936115624630; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liess M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153673; Machado A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006147; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milian-Suazo F, 2000, AM J VET RES, V61, P90, DOI 10.2460/ajvr.2000.61.90; Milian-Suazo F, 2008, PREV VET MED, V87, P261, DOI 10.1016/j.prevetmed.2008.04.004; Milian-Suazo F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155207; Milian-Suazo F, 2010, PREV VET MED, V97, P37, DOI 10.1016/j.prevetmed.2010.06.015; Vargas AN, 2016, PREV VET MED, V131, P75, DOI 10.1016/j.prevetmed.2016.07.007; Olea-Popelka F, 2017, LANCET INFECT DIS, V17, pE21, DOI 10.1016/S1473-3099(16)30139-6; Orduna P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-493; Payeur JB, 1993, MANUAL LAB METHODS V, P14; Perea Razo CA, 2017, J ANC DIS PREV REMED, V5; Perez-Guerrero L, 2008, SALUD PUBLICA MEXICO, V50, P286, DOI 10.1590/s0036-36342008000400006; Perumaalla VS, 1996, J CLIN MICROBIOL, V34, P2066, DOI 10.1128/JCM.34.9.2066-2071.1996; REYES JF, 2008, BIOMED CENTRAL, V9, DOI DOI 10.1186/1471-2105-9-496; Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440; Rodwell TC, 2010, INT J INFECT DIS, V14, pE129, DOI 10.1016/j.ijid.2009.11.037; Santillan-Flores MA, 2006, VET MICROBIOL, V115, P364, DOI 10.1016/j.vetmic.2006.02.021; SENASICA, 2016, GUI SEG EP GIC TUB B, P41; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suazo FM, 2003, PREV VET MED, V58, P1, DOI 10.1016/S0167-5877(03)00003-5; Tanaka MM, 2006, P NATL ACAD SCI USA, V103, P15266, DOI 10.1073/pnas.0603130103; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Thacker TC, 2015, VET MICROBIOL, V180, P75, DOI 10.1016/j.vetmic.2015.07.006; Thoen CO, 2016, MEDICINA-BUENOS AIRE, V76, P159; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trewby H, 2016, EPIDEMICS-NETH, V14, P26, DOI 10.1016/j.epidem.2015.08.003; Tsao K, 2014, INFECT GENET EVOL, V28, P137, DOI 10.1016/j.meegid.2014.09.025; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Yahyaoui-Azami H, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1165-6; Zumarraga MJ, 2013, RES VET SCI, V94, P9, DOI 10.1016/j.rvsc.2012.07.012	60	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201981	10.1371/journal.pone.0201981	http://dx.doi.org/10.1371/journal.pone.0201981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138365	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100033
J	Filipescu, IE; Leonardi, L; Menchetti, L; Guelfi, G; Traina, G; Casagrande-Proietti, P; Piro, F; Quattrone, A; Barbato, O; Brecchia, G				Filipescu, Iulia Elena; Leonardi, Leonardo; Menchetti, Laura; Guelfi, Gabriella; Traina, Giovanna; Casagrande-Proietti, Patrizia; Piro, Federica; Quattrone, Alda; Barbato, Olimpia; Brecchia, Gabriele			Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ENTEROTOXIGENIC ESCHERICHIA-COLI; KAPPA-B; INTESTINAL FUNCTION; CROHNS-DISEASE; MILK REPLACER; T-CELL; LIPOPOLYSACCHARIDE; EXPRESSION; ACTIVATION	Inflammatory bowel disease (IBD) is a chronic inflammatory disorder for which the current medical therapy is not completely effective. Bovine colostrum (BC) is a biological fluid rich in bioactive molecules that may have beneficial effects on several gastrointestinal disorders. The objectives of this study were to assess the preventive effects of BC supplementation in a mouse model of 2,4,6 trinitrobenzene sulfonic acid (TNBS)-induced colitis using a multidisciplinary approach. Specifically, the following parameters were evaluated: (i) disease activity index (DAI), (ii) histological score, (iii) expression levels of TLR4, anti- and pro-inflammatory cytokines, and (iv) count of some bacterial species of the intestinal microbiota. Mice received a daily suspension of BC (BC group, n = 12) or saline solution (control, CN group, n = 12) for 21 days before the intrarectal inoculation with 1% of TNBS solution. BC was well tolerated and did not induce any histological damage or clinical symptoms. After TNBS treatment, BC group showed a reduction of body weight (BW) loss (P<0.01) and histological score (P<0.05) compared to CN. Moreover, the expression levels of TLR4 (P<0.05), IL-1 beta (P<0.001), IL-8 (P<0.001), and IL-10 (P<0.001) were lower in mice administered with BC, while the concentrations of TNF-alpha did not show any differences between groups. Finally, the supplementation with BC resulted in a differential response to TNBS treatment in the bacterial count. In CN group, E. coli and Enterococci increased (P<0.001), while Anaerobes (P<0.01), Lactobacilli, and Bifidobacteria (P<0.001) reduced. Conversely, no significant changes in bacterial load were found after the inoculation of TNBS in BC pre-treated mice. This study confirms that TNBS-induced colitis model in mice is useful for studying the mechanisms involved in IBD pathogenesis and shows that pre-treatment with BC reduces the intestinal damages and clinical signs of the colitis. Molecular mechanisms and intestinal microflora could be involved in the protective effect of colostrum.	[Filipescu, Iulia Elena; Leonardi, Leonardo; Menchetti, Laura; Guelfi, Gabriella; Casagrande-Proietti, Patrizia; Quattrone, Alda; Barbato, Olimpia; Brecchia, Gabriele] Univ Perugia, Dept Vet Med, Perugia, Italy; [Traina, Giovanna] Univ Perugia, Dept Pharmaceut Sci, Perugia, Italy; [Piro, Federica] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy	University of Perugia; University of Perugia; University of Perugia	Menchetti, L (corresponding author), Univ Perugia, Dept Vet Med, Perugia, Italy.	laura.menchetti7@gmail.com	Guelfi, Gabriella/AAE-6081-2019; Traina, Giovanna/AAR-2179-2020; Menchetti, Laura/P-5172-2018	Guelfi, Gabriella/0000-0003-3695-9275; Brecchia, Gabriele/0000-0003-4750-2801; Menchetti, Laura/0000-0001-8500-7970; Piro, Federica/0000-0002-9057-2736; Quattrone, Alda/0000-0003-1147-2540				Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; An MJ, 2009, NUTR RES, V29, P275, DOI 10.1016/j.nutres.2009.03.011; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bellavia M, 2014, J BIOL REG HOMEOS AG, V28, P251; Belo A, 2006, GUT, V55, P165, DOI 10.1136/gut.2005.076752; Ben Ya'acov A, 2015, BMC GASTROENTEROL, V15, P1; Blais M, 2015, BRIT J NUTR, V113, P200, DOI 10.1017/S0007114514003481; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Bodammer P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064210; Bodammer P, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-10; Brecchia G, 2014, ANIM REPROD SCI, V147, P128, DOI 10.1016/j.anireprosci.2014.04.009; Cairangzhuoma, 2013, J DAIRY SCI, V96, P1347, DOI 10.3168/jds.2012-5701; Casagrande Proietti P, 2016, EUROMEDITERRANEAN BI, V11, P165; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Collins AM, 1991, INT ARCH ALLER A IMM, V96, P326; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Davis PF, 2007, FOOD CHEM TOXICOL, V45, P229, DOI 10.1016/j.fct.2006.07.034; Detzel CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120278; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Edberg S, 2004, CELL, V118, P229, DOI [10.1016/j.cell.2004.07.002, DOI 10.1016/J.CELL.2004.07.002]; Ek WE, 2014, ANN GASTROENTEROL, V27, P294; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Gephart SM, 2014, ADV NEONAT CARE, V14, P44, DOI 10.1097/ANC.0000000000000052; Gomes-Santos AC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/560817; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Huguet A, 2012, J ANIM SCI, V90, P1513, DOI 10.2527/jas.2011-3941; Im JP, 2011, DIGEST DIS SCI, V56, P2292, DOI 10.1007/s10620-011-1630-1; Inagaki M, 2013, J DAIRY SCI, V96, P806, DOI 10.3168/jds.2012-5847; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jones-Hall YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119441; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanwar JR, 2016, J DAIRY SCI, V99, P2488, DOI 10.3168/jds.2015-10122; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Kordjazy N., 2017, PHARM RES; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Lonnerdal B, 2013, J PAEDIATR CHILD H, V49, P1, DOI 10.1111/jpc.12104; Lopez-Posadas R, 2010, BRIT J PHARMACOL, V160, P1714, DOI 10.1111/j.1476-5381.2010.00827.x; Lord JD, 2015, WORLD J GASTROENTERO, V21, P11236, DOI 10.3748/wjg.v21.i40.11236; Lund P, 2012, EUR J CLIN NUTR, V66, P1059, DOI 10.1038/ejcn.2012.93; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McCafferty DM, 2000, AM J PHYSIOL-GASTR L, V279, pG90, DOI 10.1152/ajpgi.2000.279.1.G90; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Menchetti L, 2018, RES VET SCI, V118, P126, DOI 10.1016/j.rvsc.2018.01.024; Menchetti L, 2018, THERIOGENOLOGY, V107, P162, DOI 10.1016/j.theriogenology.2017.10.046; Menchetti Laura, 2016, Front Biosci (Schol Ed), V8, P331; Moller HK, 2011, BRIT J NUTR, V105, P44, DOI 10.1017/S0007114510003168; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Musilova S, 2014, BENEF MICROBES, V5, P273, DOI 10.3920/BM2013.0080; Nakano Taku, 2001, Acta Paediatrica Taiwanica, V42, P11; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Niewiadomski O, 2016, INTERN MED J, V46, P669, DOI 10.1111/imj.13094; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Otto W, 2011, SCAND J GASTROENTERO, V46, P862, DOI 10.3109/00365521.2011.574726; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Playford RJ, 2001, CLIN SCI, V100, P627, DOI 10.1042/CS20010015; Pontoppidan PEL, 2015, J NUTR, V145, P1472, DOI 10.3945/jn.114.203430; Poulsen ASR, 2017, BRIT J NUTR, V117, P964, DOI 10.1017/S0007114517000216; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Saito K, 2012, FUKUSHIMA J, V59, P81; Salzman N, 2008, GIMICROBIOTA ANDREGU, P67; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sponseller JK, 2015, J INFECT DIS, V211, P1334, DOI 10.1093/infdis/jiu605; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Stoy ACF, 2014, CLIN NUTR, V33, P322, DOI 10.1016/j.clnu.2013.05.013; Struff WG, 2008, INT J CLIN PHARM TH, V46, P211; Sugiharto S, 2015, BRIT J NUTR, V113, P923, DOI 10.1017/S0007114514003201; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Traina G, 2016, J BIOL REGUL HOMEOST, V30, P541; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Van Eden W, 2018, ALLERGY INFECT FRONT, V5, P1; Vegh Z, 2017, J DIGEST DIS, V18, P92, DOI 10.1111/1751-2980.12449; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wang L, 2015, MUCOSAL IMMUNOL, V8, P1297, DOI 10.1038/mi.2015.20; Warny M, 1999, GUT, V44, P212, DOI 10.1136/gut.44.2.212; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Xu ML, 2014, ARCH PHARM RES, V37, P494, DOI 10.1007/s12272-013-0255-7; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	86	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202929	10.1371/journal.pone.0202929	http://dx.doi.org/10.1371/journal.pone.0202929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138385	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100143
J	Karmacharya, D; Sherchan, AM; Dulal, S; Manandhar, P; Manandhar, S; Joshi, J; Bhattarai, S; Bhatta, TR; Awasthi, N; Sharma, AN; Bista, M; Silwal, NR; Pokharel, P; Lamichhane, RR; Sharma, N; Llewellyn, B; Wultsch, C; Kelly, MJ; Gour, D; Waite, L; Hero, JM; Hughes, J				Karmacharya, Dibesh; Sherchan, Adarsh M.; Dulal, Santosh; Manandhar, Prajwol; Manandhar, Sulochana; Joshi, Jyoti; Bhattarai, Susmita; Bhatta, Tarka R.; Awasthi, Nagendra; Sharma, Ajay N.; Bista, Manisha; Silwal, Nawa R.; Pokharel, Pravin; Lamichhane, Rom R.; Sharma, Netra; Llewellyn, Bronwyn; Wultsch, Claudia; Kelly, Marcella J.; Gour, Digpal; Waite, Lisette; Hero, Jean-Marc; Hughes, Jane			Species, sex and geo-location identification of seized tiger (Panthera tigris tigris) parts in Nepal-A molecular forensic approach	PLOS ONE			English	Article							FECAL GENETIC-ANALYSIS; CAT FELIS-CATUS; POPULATION-STRUCTURE; WILD TIGERS; MULTILOCUS GENOTYPES; ASSIGNMENT TESTS; CYTOCHROME-B; DNA ANALYSIS; CONSERVATION; ORIGIN	Tiger (Panthera tigris) populations are in danger across their entire range due to habitat loss, poaching and the demand for tiger parts. The Bengal tiger (Panthera tigris tigris) is an endangered apex predator with a population size estimated to be less than 200 in Nepal. In spite of strict wildlife protection laws, illegal trade of tiger parts is increasing; and Nepal has become one of the major sources and transit routes for poached wildlife parts. Identification of wildlife parts is often challenging for law enforcement officials due to inadequate training and lack of available tools. Here, we describe a molecular forensic approach to gain insight into illegally trafficked tiger parts seized across Nepal. We created Nepal's first comprehensive reference genetic database of wild tigers through the Nepal Tiger Genome Project (2011-2013). This database has nuclear DNA microsatellite genotype and sex profiles, including geo-spatial information, of over 60% (n = 120) of the wild tigers of Nepal. We analyzed 15 putative cases of confiscated poached tiger parts and all were confirmed to be of tiger. Ten samples were identified as male and five were female. We determined probable geo-source location for 9 of the 14 samples with 6-8 nuclear DNA microsatellite loci using inferences from four different statistical assignment methods. Six samples were assigned to Bardia National Park and one of these was an exact match to a female tiger previously profiled in our fecal DNA reference database. Two tiger samples were assigned to Shukla-phanta Wildlife Reserve and one to Chitwan National Park. We are unable to definitively assign five tiger samples which could be offspring dispersers or might have come from tiger population outside of Nepal. Our study revealed that the western region, particularly Bardia National Park, is a poaching hotspot for illegal tiger trade in Nepal. We present feasibility of using molecular forensic based evidence to incriminate criminals in a court of law in the fight against wildlife crime.	[Karmacharya, Dibesh; Sherchan, Adarsh M.; Dulal, Santosh; Manandhar, Prajwol; Manandhar, Sulochana; Joshi, Jyoti; Bhattarai, Susmita; Bhatta, Tarka R.; Awasthi, Nagendra; Sharma, Ajay N.; Bista, Manisha] Ctr Mol Dynam Nepal, Thapathali 11, Kathmandu, Nepal; [Karmacharya, Dibesh; Hughes, Jane] Griffith Univ, Sch Environm, Gold Coast, Qld, Australia; [Silwal, Nawa R.; Pokharel, Pravin] Nepal Police, Cent Invest Bur, Pillar 4, Kathmandu, Nepal; [Lamichhane, Rom R.] Minist Forest & Soil Conservat, Biodivers Sect, Kathmandu, Nepal; [Sharma, Netra; Llewellyn, Bronwyn] US Agcy Int Dev, Environm Team, Kathmandu, Nepal; [Wultsch, Claudia] Amer Nat Hist Museum, Sackler Inst Comparat Genom, New York, NY USA; [Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Gour, Digpal; Waite, Lisette] Univ Idaho, Lab Ecol Evolutionary & Conservat Genet, Moscow, ID 83843 USA; [Hero, Jean-Marc] Univ Sunshine Coast, Sch Sci & Engn, Sunshine Coast, Qld, Australia; [Hero, Jean-Marc] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	Griffith University; United States Agency for International Development (USAID); Virginia Polytechnic Institute & State University; Idaho; University of Idaho; University of the Sunshine Coast; University of Kent	Karmacharya, D (corresponding author), Ctr Mol Dynam Nepal, Thapathali 11, Kathmandu, Nepal.; Karmacharya, D (corresponding author), Griffith Univ, Sch Environm, Gold Coast, Qld, Australia.	dibesh@cmdn.org	hughes, jane m/C-5321-2008; Awasthi, Nagendra Prasad/AAE-6160-2022; Karmacharya, Dibesh/GVU-4782-2022; Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; Dulal, Dr. Santosh/0000-0002-4486-0219; Awasthi, Nagendra Prasad/0000-0001-7376-9994; Manandhar, Prajwol/0000-0002-5259-0706; Karmacharya, Dibesh/0000-0001-5093-6737; Waits, Lisette/0000-0002-1323-0812	USAID FOG [AID-367-G-11-00001]	USAID FOG(United States Agency for International Development (USAID))	This research was supported by the USAID FOG AID-367-G-11-00001 to D.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs EA, 2010, FORENSIC SCI MED PAT, V6, P180, DOI 10.1007/s12024-009-9131-7; [Anonymous], 2012, FIGHTING ILLICIT WIL; Bajimaya S, 2007, TIGER CONSERVATION A; Baker CS, 1996, MOL ECOL, V5, P671, DOI 10.1111/j.1365-294X.1996.tb00362.x; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Bhagavatula J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-48; Brown P., 2014, TRADING EXTINCTION; Budowle B, 2009, BIOTECHNIQUES, V46, P339, DOI 10.2144/000113136; Caniglia R, 2010, FORENSIC SCI INT-GEN, V4, P334, DOI 10.1016/j.fsigen.2009.10.012; DeRoe, 2015, CONSERVATION CRIME C; Dhakal M., 2018, STATUS TIGERS PREY N, DOI 10.13140/2.1.3290.2407; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellis R, 2013, TIGER BONE RHINO HOR; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gilbert M, 2015, INTEGR ZOOL, V10, P329, DOI 10.1111/1749-4877.12137; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Goodrich J., 2015, IUCN RED LIST THREAT, V2015, DOI [10.2305/IUCN.UK.2015-2.RLTS.T15955A50659951, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15955A50659951, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15955A50659951.EN, 10.2305/]; Gour DS, 2015, BIODIVERS CONSERV, V24, P2869, DOI 10.1007/s10531-015-0962-0; Gratwicke B, 2007, ENVIRON CONSERV, V34, P255, DOI 10.1017/S0376892907004079; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Gurgul A, 2010, MOL BIOL REP, V37, P2915, DOI 10.1007/s11033-009-9852-4; Hauser L, 2006, MOL ECOL, V15, P3157, DOI 10.1111/j.1365-294X.2006.03017.x; Hsieh HM, 2001, FORENSIC SCI INT, V122, P7, DOI 10.1016/S0379-0738(01)00403-0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iyengar A, 2014, J NAT CONSERV, V22, P195, DOI 10.1016/j.jnc.2013.12.001; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Karmacharya Dibesh B., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-516; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Lorenzini R, 2005, FORENSIC SCI INT, V153, P218, DOI 10.1016/j.forsciint.2005.04.032; Mainka SA, 1995, J ZOO WILDLIFE MED, V26, P193; Manel S, 2002, CONSERV BIOL, V16, P650, DOI 10.1046/j.1523-1739.2002.00576.x; Martin E.B., 2006, PACHYDERM, V41, P61; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; Mondol S, 2015, CONSERV BIOL, V29, P556, DOI 10.1111/cobi.12393; Moyle B, 2009, GLOB CRIME, V10, P124, DOI 10.1080/17440570902783921; Nagata J, 2005, CONSERV GENET, V6, P863, DOI 10.1007/s10592-005-9038-0; NTGP/CMDN, 2014, NEP TIG GEN PROJ FIN; Ogden R, 2011, MOL ECOL RESOUR, V11, P109, DOI 10.1111/j.1755-0998.2010.02954.x; Ogden Rob, 2010, Endangered Species Research, V9, P179, DOI 10.3354/esr00144; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Palomares F, 2002, MOL ECOL, V11, P2171, DOI 10.1046/j.1365-294X.2002.01608.x; Palsboll PJ, 2006, CONSERV BIOL, V20, P1284, DOI 10.1111/j.1523-1739.2006.00429.x; Palumbi SR, 1998, J HERED, V89, P459; Pariyar K, 2016, REPUBLICA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perry R, 1964, WORLD TIGER; Pervushina, 2013, REDUCED SKIN BONES R; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Qiagen, 2006, DNEASY BLOOD TISS HD; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Seidensticker J, 2010, INTEGR ZOOL, V5, P285, DOI 10.1111/j.1749-4877.2010.00214.x; Shahi P, 2016, KATHMANDU POST; Sharma R, 2008, MOL ECOL RESOUR, V8, P1480, DOI 10.1111/j.1755-0998.2008.02292.x; Singh SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174371; Sunquist M, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P19, DOI 10.1016/B978-0-8155-1570-8.00002-5; Thapa K., 2006, SITUATION ANAL BABAI; Thapa K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193495; Wan QH, 2003, FORENSIC SCI INT, V131, P75, DOI 10.1016/S0379-0738(02)00398-5; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wultsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151043; WWF, 2016, OV THREATS TIG TEXT; Wyler LS, 2013, INT ILLEGAL TRADE WI; Xu YC, 2005, FORENSIC SCI INT, V151, P45, DOI 10.1016/j.forsciint.2004.07.003; Yi- Ming L, 2000, ILLEGAL WILDLIFE TRA	76	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201639	10.1371/journal.pone.0201639	http://dx.doi.org/10.1371/journal.pone.0201639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138352	gold, Green Submitted, Green Published			2022-12-26	WOS:000442800100020
J	Klaus, J; Schutter, DJLG				Klaus, Jana; Schutter, Dennis J. L. G.			Putting focus on transcranial direct current stimulation in language production studies	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; WORD PRODUCTION; TDCS; FACILITATION; FLUENCY; INTERFERENCE; METAANALYSIS; PERFORMANCE; ACTIVATION; MODEL	Previous language production studies targeting the inferior frontal and superior temporal gyrus using anodal tDCS have provided mixed results. Part of this heterogeneity may be explained by limited target region focality of conventionally used electrode montages. We examined the focality of conventionally and alternative electrode montages. Electrical field distributions of anodal tDCS targeting IFG and pSTG were simulated in conventional setups (anodal electrode over left IFG/pSTG, reference electrode over right supraorbital region) and an alternative electrode montage in four different brains. Conventional montages showed maximum field strengths outside of the target regions. Results from alternative electrode montages showed that focality of tDCS could be improved by adjustments in electrode placement. Heterogeneity of findings of language production studies deploying conventional montages may in part be explained by diffuse electrical field distributions. Alternative montages may improve focality and provide more unequivocal results.	[Klaus, Jana; Schutter, Dennis J. L. G.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Radboud University Nijmegen	Klaus, J (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	j.klaus@donders.ru.nl	Klaus, Jana/F-4802-2016	Klaus, Jana/0000-0003-4398-8672	German Research Foundation [KL 2933/2]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (http://www.dfg.de) awarded to JK (KL 2933/2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Ehlis AC, 2016, NEUROIMAGE, V140, P134, DOI 10.1016/j.neuroimage.2015.12.047; Elsner B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009760.pub3; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Fiori V, 2014, NEUROSCIENCE, V256, P195, DOI 10.1016/j.neuroscience.2013.10.048; Galletta EE, 2015, BRAIN STIMUL, V8, P1108, DOI 10.1016/j.brs.2015.06.018; Henseler I, 2014, J COGNITIVE NEUROSCI, V26, P1403, DOI 10.1162/jocn_a_00572; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Klaus J, 2018, BRAIN COGNITION, V123, P10, DOI 10.1016/j.bandc.2018.02.007; Laakso I, 2016, NEUROIMAGE, V137, P140, DOI 10.1016/j.neuroimage.2016.05.032; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Oldrati V, 2017, CEREBELLUM, P1, DOI DOI 10.1007/S12311-015-0758-5; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Parazzini M, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/963293; Pisoni A, 2012, NEUROSCIENCE, V223, P56, DOI 10.1016/j.neuroscience.2012.07.046; Pisoni A, 2017, NEUROSCIENCE, V352, P106, DOI 10.1016/j.neuroscience.2017.03.043; Pisoni A, 2018, CEREB CORTEX, V28, P1132, DOI 10.1093/cercor/bhx021; Price AR, 2015, BRAIN STIMUL, V8, P1093, DOI 10.1016/j.brs.2015.06.013; Rahman A, 2015, PROG BRAIN RES, V222, P25, DOI 10.1016/bs.pbr.2015.09.003; Rampersad SM, 2014, IEEE T NEUR SYS REH, V22, P441, DOI 10.1109/TNSRE.2014.2308997; Sandars M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8428256; Sebastian R, 2016, NEUROREHABILITATION, V39, P141, DOI 10.3233/NRE-161346; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Turi Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep41028; Vannorsdall TD, 2016, COGN BEHAV NEUROL, V29, P11, DOI 10.1097/WNN.0000000000000086; Vannorsdall Tracy D, 2012, Front Psychiatry, V3, P73, DOI 10.3389/fpsyt.2012.00073; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Westwood SJ, 2017, NEUROPSYCHOLOGIA, V104, P234, DOI 10.1016/j.neuropsychologia.2017.07.031; Westwood SJ, 2017, CORTEX, V86, P64, DOI 10.1016/j.cortex.2016.10.016; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202730	10.1371/journal.pone.0202730	http://dx.doi.org/10.1371/journal.pone.0202730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138361	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100112
J	Oma, I; Olstad, OK; Andersen, JK; Lyberg, T; Molberg, O; Fostad, I; Fagerland, MW; Almdahi, SM; Rynning, SE; Yndestad, A; Aukrust, P; Whist, JE; Hollan, I				Oma, Ingvild; Olstad, Ole Kristoffer; Andersen, Jacqueline Kirsti; Lyberg, Torstein; Molberg, Oyvind; Fostad, Ida; Fagerland, Morten Wang; Almdahi, Sven Martin; Rynning, Stein Erik; Yndestad, Arne; Aukrust, Pal; Whist, Jon Elling; Hollan, Ivana			Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GROWTH ARREST; D-RECEPTOR; T-CELLS; ATHEROSCLEROSIS; INFLAMMATION; PARAOXONASE-2; DEFICIENCY; MICE; SMRT	Background Vitamin D has an important role in the immune system, and has been linked to rheumatoid arthritis (RA) and coronary artery disease (CAD). The exact mechanisms by which vitamin D is involved in these processes are still unclear. Therefore, we wanted to search for differences in expression of genes involved in the vitamin D receptor (VDR) activation pathway and genes that are known to alter upon vitamin D stimulation, in the aortic adventitia of CAD patients with and without RA. Methods Affymetrix microarray was used to determine gene expression profile in surgical specimens from the adventitia of the ascending aorta of CAD patients with RA (n = 8) and without RA (n = 8) from the Feiring Heart Biopsy Study. Results We identified three vitamin D associated genes that were differentially expressed between RA and non-RA patients: Growth arrest and DNA-damage-inducible protein 45 alpha (GADD45A) (FC = 1.47; p = 0.006), Nuclear Receptor Co-repressor 1 (NCOR1) (FC = 1,21; p = 0.005) and paraoxonases 2 (PON2) (FC = -1.37; p = 0.01). High expression of GADD45A in RA tissues was confirmed by real-time qRT-PCR. GADD45A expression correlated with plasma levels of 1,25(OH)(2)D-3 (r(s) = 0.69; p = 0.003). Conclusions Microarray analyses revealed higher expression of GADD45A and NCOR1; and lower expression of PON2 in the aortic adventitia of RA than non-RA patients. Further studies are needed to elucidate if and how GADD45A, NCOR1 and PON2 are involved in the development of accelerated atherosclerosis in RA. In theory, some of these factors might have proatherogenic effects whereas others might reflect an underlying vascular pathology promoting atherogenesis (such as vascular stress).	[Oma, Ingvild] Innlandet Hosp Trust, Dept Pathol, Lillehammer, Norway; [Oma, Ingvild; Yndestad, Arne; Aukrust, Pal] Univ Oslo, Inst Clin Med, Oslo, Norway; [Olstad, Ole Kristoffer; Lyberg, Torstein] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Andersen, Jacqueline Kirsti] NTNU Norwegian Univ Sci & Technol, Dept Hlth Sci Gjovik, Gjovik, Norway; [Molberg, Oyvind] Univ Oslo, Dept Rheumatol Dermatol & Infect Dis, Oslo, Norway; [Fostad, Ida] Univ Oslo, Dept Oral Biol, Oslo, Norway; [Fagerland, Morten Wang] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Almdahi, Sven Martin] Univ Hosp North Norway, Dept Cardiothorac & Vasc Surg, Tromso, Norway; [Rynning, Stein Erik] Feiring Heart Clin, Dept Cardiac Surg, Feiring, Norway; [Yndestad, Arne; Aukrust, Pal] Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Whist, Jon Elling] Innlandet Hosp Trust, Dept Med Biochem, Lillehammer, Norway; [Whist, Jon Elling; Hollan, Ivana] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway; [Hollan, Ivana] Lillehammer Hosp Rheumat Dis, Lillehammer, Norway; [Hollan, Ivana] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Hollan, Ivana] Harvard Med Sch, Boston, MA USA	Innlandet Hospital Trust; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Oslo; Innlandet Hospital Trust; Innlandet Hospital Trust; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Oma, I (corresponding author), Innlandet Hosp Trust, Dept Pathol, Lillehammer, Norway.; Oma, I (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	ingvild.oma@sykehuset-innlandet.no		Oma, Ingvild/0000-0002-0670-9753	Innlandet Hospital Trust; South-Eastern Norway Regional Health Authority; Norwegian Women's Public Health Association; Norwegian Rheumatism Association; Norwegian Association for People with Heart and Lung Diseases	Innlandet Hospital Trust; South-Eastern Norway Regional Health Authority; Norwegian Women's Public Health Association; Norwegian Rheumatism Association; Norwegian Association for People with Heart and Lung Diseases	This study was supported by the Innlandet Hospital Trust, South-Eastern Norway Regional Health Authority, the Norwegian Women's Public Health Association, the Norwegian Rheumatism Association, and the Norwegian Association for People with Heart and Lung Diseases.	Ahmed A, 2016, ARTHRITIS RHEUMATOL, V68, P1361, DOI 10.1002/art.39574; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Bonelli P, 2011, PHARMACOGENOMICS J, V11, P412, DOI 10.1038/tpj.2010.55; Bremmer F, 2012, ANTICANCER RES, V32, P341; Cutolo M, 2006, CLIN EXP RHEUMATOL, V24, P702; Cutolo M, 2009, RHEUMATOLOGY, V48, P210, DOI 10.1093/rheumatology/ken394; de Andres MC, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0748-5; Furlong CE, 2016, CHEM BIOL INTERACT; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hollan I, 2015, AUTOIMMUN REV, V14, P952, DOI 10.1016/j.autrev.2015.06.004; Hollan I, 2007, ARTHRITIS RHEUM, V56, P2072, DOI 10.1002/art.22690; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Menezes AR, 2014, CURR OPIN CARDIOL, V29, P571, DOI 10.1097/HCO.0000000000000108; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Oma I, 2017, SCAND J RHEUMATOL, V46, P198, DOI 10.3109/03009742.2016.1172664; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schottker B, 2013, AM J CLIN NUTR; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Skeoch S, 2015, NAT REV RHEUMATOL, V11, P390, DOI 10.1038/nrrheum.2015.40; Sparks JA, 2015, ARTHRITIS CARE RES; Urruticoechea-Arana A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0704-4; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605	30	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202346	10.1371/journal.pone.0202346	http://dx.doi.org/10.1371/journal.pone.0202346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138371	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100053
J	Owusu-Afriyie, O; Owiredu, WKBA; Owusu-Danquah, K; Larsen-Reindort, R; Donkor, P; Acheampong, E; Quayson, SE				Owusu-Afriyie, Osei; Owiredu, W. K. B. A.; Owusu-Danquah, Kwabena; Larsen-Reindort, Rita; Donkor, Peter; Acheampong, Emmanuel; Quayson, Solomon E.			Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana	PLOS ONE			English	Article							CYCLIN D1; PROGNOSTIC-SIGNIFICANCE; LARYNGEAL CARCINOMA; BREAST-CANCER; P53; OVEREXPRESSION; PROTEIN; SURVIVAL; EGFR; PROLIFERATION	Background Head and neck cancers include carcinomas of the oral cavity, larynx, sinonasal tract and nasopharynx. Studies on molecular expression of prognostic tumour markers in Ghana are scarce. The purpose of this study was to determine the expression of p53, p16, EGFR, Cyclin-D1 and HER2 among patients with non-oropharyngeal head and neck squamous cell carcinoma (HNSCC). Methodology Tissue microarrays from 154 histologically confirmed non-oropharyngeal HNSCC at the Komfo Anokye Teaching Hospital from 2006-2014 were constructed using duplicate cores of representative and viable areas from tumours. Expression of EGFR, p53, p16, Cyclin-D1 and HER2 was evaluated using immunohistochemistry. Results For non-oropharyngeal HNSCC, majority of the cases (66.2%; 102/154) had stage IV disease. EGFR was the most expressed molecular marker (29.4%; 25/85) followed by p53 (24.0%; 29/121), p16 (18.3%; 23/126) and Cyclin-D1 (10.0%; 12/120). HER2 was not expressed in any of the cases. There was a significantly (p = 0.022) higher expression of Cyclin-D1 in tumours of the oral cavity (19.6%; 9/46) than in those of the larynx (4.7%; 2/43) and nose (3.2%; 1/31). Tumours in stages I-III were more frequently positive for p16 (28.6%; 12/42) than tumours in stage IV (13.1%; 11/84). Conclusion Expression of p53, EGFR, p16 and Cyclin-D1 in non-oropharyngeal HNSCC in Ghana is largely similar to what has been reported in published studies from other countries.	[Owusu-Afriyie, Osei; Owiredu, W. K. B. A.; Acheampong, Emmanuel] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Owusu-Afriyie, Osei] Komfo Anokye Teaching Hosp, Sch Med Sci, Dept Pathol, Kumasi, Ghana; [Owusu-Danquah, Kwabena] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth, Dept Med Lab Technol, Kumasi, Ghana; [Larsen-Reindort, Rita] Komfo Anokye Teaching Hosp, Directorate Dent Eye Ear Nose & Throat, Kumasi, Ghana; [Donkor, Peter] KNUST, Dent Sch, Dept Maxillofacial Surg, Kumasi, Ghana; [Quayson, Solomon E.] Univ Ghana, Med Sch, Dept Pathol, Accra, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of Ghana	Owusu-Afriyie, O (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.; Owusu-Afriyie, O (corresponding author), Komfo Anokye Teaching Hosp, Sch Med Sci, Dept Pathol, Kumasi, Ghana.	ooafriyie@gmail.com	Acheampong, Emmanuel/I-9309-2019	Acheampong, Emmanuel/0000-0002-5338-3258; Owusu-Afriyie, Osei/0000-0002-7400-2952				Ang KK, 2002, CANCER RES, V62, P7350; [Anonymous], 2006, NAT CLIN GUID ED SIG; Arora S, 2012, MOL MED REP, V6, P19, DOI 10.3892/mmr.2012.889; Calys-Tagoe Benedict N L, 2014, BMC Res Notes, V7, P577, DOI 10.1186/1756-0500-7-577; Capaccio P, 1997, J LARYNGOL OTOL, V111, P622, DOI 10.1017/S0022215100138149; D'cruz A, 2013, ORAL ONCOL, V49, P872, DOI 10.1016/j.oraloncology.2013.05.010; Dissanayaka WL, 2012, OR SURG OR MED OR PA, V113, P518, DOI 10.1016/j.oooo.2011.11.001; Dong YY, 2002, CANCER LETT, V177, P13, DOI 10.1016/S0304-3835(01)00770-4; Dong YY, 2001, INT J CANCER, V95, P209, DOI 10.1002/1097-0215(20010720)95:4<209::AID-IJC1036>3.3.CO;2-I; Dong YY, 2000, CLIN CANCER RES, V6, P4253; Dragomir LP, 2012, ROM J MORPHOL EMBRYO, V53, P597; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Hewitt SM, 2014, J HISTOCHEM CYTOCHEM, V62, P693, DOI 10.1369/0022155414545224; JARES P, 1994, CANCER RES, V54, P4813; Khan AJ, 2002, CLIN CANCER RES, V8, P540; Khan H, 2015, BBA CLIN, V3, P11, DOI 10.1016/j.bbacli.2014.11.004; Kobel M, 2004, VIRCHOWS ARCH, V445, P456, DOI 10.1007/s00428-004-1095-0; Krecicki T, 2004, J LARYNGOL OTOL, V118, P676; Larsen-Reindorf R, 2014, INT J OTOLARYNGOLOGY, V3, P271, DOI DOI 10.4236/IJOHNS.2014.35050; Laryea DO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-362; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Ma BL, 2015, MOL MED REP, V12, P5246, DOI 10.3892/mmr.2015.4037; Matta A, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-6; Metindir J, 2008, EUR J GYNAECOL ONCOL, V29, P489; Metindir J, 2007, EUROPEAN J GYNAECOLO, V29, P489; Michalides R, 1996, BRIT J CANCER, V73, P728, DOI 10.1038/bjc.1996.128; Narayana A, 1998, CANCER, V82, P286, DOI 10.1002/(SICI)1097-0142(19980115)82:2<286::AID-CNCR7>3.0.CO;2-P; Nemunaitis J, 2011, HEAD NECK-J SCI SPEC, V33, P131, DOI 10.1002/hed.21364; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; NYLANDER K, 1995, CANCER, V75, P87, DOI 10.1002/1097-0142(19950101)75:1<87::AID-CNCR2820750115>3.0.CO;2-V; Obata A, 2000, INT J CANCER, V89, P187, DOI 10.1002/(SICI)1097-0215(20000320)89:2<187::AID-IJC14>3.0.CO;2-V; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Richardsen E, 2015, AM J PATHOL, V185, P2722, DOI 10.1016/j.ajpath.2015.06.013; Rivera C, 2014, INT J CLIN EXP PATHO, V7, P5968; Rodrigues PC, 2014, INT J ORAL MAX SURG, V43, P795, DOI 10.1016/j.ijom.2014.01.014; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Shiraki M, 2005, MODERN PATHOL, V18, P1482, DOI 10.1038/modpathol.3800455; Sittel C, 1999, ORAL ONCOL, V35, P583, DOI 10.1016/S1368-8375(99)00041-X; Sorbye SW, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-7; Sorbye SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047068; Walline HM, 2013, JAMA OTOLARYNGOLOGY	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202790	10.1371/journal.pone.0202790	http://dx.doi.org/10.1371/journal.pone.0202790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138436	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100127
J	Giaretta, E; Mordenti, AL; Canestrari, G; Brogna, N; Palmonari, A; Formigoni, A				Giaretta, Elisa; Mordenti, Attilio Luigi; Canestrari, Giorgia; Brogna, Nico; Palmonari, Alberto; Formigoni, Andrea			Assessment of muscle Longissimus thoracis et lumborum marbling by image analysis and relationships between meat quality parameters	PLOS ONE			English	Article							FAT-CONTENT; BEEF; CONSUMERS	The intramuscular fat (IMF), recognized by the consumer as marbling, is an important meat quality trait. The objective of this study was to validate a new method of beef marbling evaluation by image analysis. The new assessment was compared with two known marbling measurements: chemical IMF and USDA scores. Moreover, the relationship between marbling measurements and other meat quality parameters was investigated. Samples of Longissimus thoracis et lumborum (LTL) muscle were obtained from carcasses of 39 Italian crossbred heifers and 62 Angus bred heifers, that underwent two different dietary treatments. The use of various breeds and diets was chosen to obtain different intramuscular fat levels, in order to validate the use of Image J software for the analysis of different type of beef meat. The images of fresh cuts were appraised by experienced beef graders, and the samples were used to determine fat content by chemical Soxhlet extraction. Carcasses measurements according to the EUROP system, and other physical meat proprieties were also assessed. The results demonstrated that the marbling measurements obtained by computer image analysis, such as the number of marbling particles, the average particle size (mm), and the percentage of marbling particles (%), significantly (P < 0.05) correlated with USDA scores and IMF content. Moreover, the principal component analysis (PCA) showed three principal meat components, identified as 1) color, 2) fat, and 3) water release. The second principal component (PC) explained 24.94% of variance, and was positively correlated with image analysis measures, USDA score, and IMF, while negatively correlated with the Warner-Bratzler shear force (WBSF).	[Giaretta, Elisa; Mordenti, Attilio Luigi; Canestrari, Giorgia; Brogna, Nico; Palmonari, Alberto; Formigoni, Andrea] Univ Bologna, Dept Vet Med Sci DIMEVET, Bologna, Italy	University of Bologna	Giaretta, E (corresponding author), Univ Bologna, Dept Vet Med Sci DIMEVET, Bologna, Italy.	elisa.giaretta3@unibo.it	formigoni, andrea/Q-1379-2015	Giaretta, Elisa/0000-0002-0095-0554; MORDENTI, ATTILIO/0000-0002-4162-6726; FORMIGONI, ANDREA/0000-0002-8109-2482	"Lem Carni s.p.a." meat company	"Lem Carni s.p.a." meat company	The work was supported by "Lem Carni s.p.a." meat company within the project "Strategies to improve the nutritional and health characteristics of beef meat." The company was responsible for the slaughter house used for the trial. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSA, 2015, RES GUID COOK SENS E, V2nd ed; AMSA, 1991, GUID MEAT QUAL COL E; AOAC, 1990, OFFICIAL METHODS ANA, VFifteenth edn, P1058; CIE, 1978, PARIS COMM INT EL S2; Clinic J, 2017, IOP C SER EARTH ENV, V85; Gotoh T, 2009, MEAT SCI, V82, P300, DOI 10.1016/j.meatsci.2009.01.026; Gray GD, 2012, J ANIM SCI, V90, P5152, DOI 10.2527/jas.2012-5551; Hale D. A, 2010, USDA BEEF QUALITY YI; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; Indurain G, 2009, MEAT SCI, V82, P155, DOI 10.1016/j.meatsci.2009.01.005; Irie M, 2012, ASIAN AUSTRAL J ANIM, V25, P592, DOI 10.5713/ajas.2011.11204; Konarska M, 2017, MEAT SCI, V123, P67, DOI 10.1016/j.meatsci.2016.09.005; Kuchida K, 2000, J ANIM SCI, V78, P799; Lucherk LW, 2016, MEAT SCI, V122, P145, DOI 10.1016/j.meatsci.2016.08.005; Mancini RA, 2005, MEAT SCI, V71, P100, DOI 10.1016/j.meatsci.2005.03.003; Moore CB, 2010, J ANIM SCI, V88, P2464, DOI 10.2527/jas.2009-2593; Ngapo TM, 2017, MEAT SCI, V134, P34, DOI 10.1016/j.meatsci.2017.07.013; Nunes JL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S4-S6; Peciulaitiene N., 2015, Biotechnology in Animal Husbandry, V31, P73, DOI 10.2298/BAH1501073P; Picard B, 2018, PEERJ, V6, DOI 10.7717/peerj.4891; Platter WJ, 2005, J ANIM SCI, V83, P890; Polkinghorne R, 2008, AUST J EXP AGR, V48, P1351, DOI 10.1071/EA07177; Silva S, 2010, 6 INT C SIM MOD FOOD; Silva SR, 2012, WOODHEAD PUBL FOOD S, P277; SMITH GC, 1985, J FOOD QUALITY, V7, P289, DOI 10.1111/j.1745-4557.1985.tb01061.x; Tan JL, 2004, J FOOD ENG, V61, P27, DOI 10.1016/S0260-8774(03)00185-7; van Laack RLJM, 2001, J ANIM SCI, V79, P392; Yang XJ, 2006, J ANIM SCI, V84, P3251, DOI 10.2527/jas.2006-187	28	19	20	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202535	10.1371/journal.pone.0202535	http://dx.doi.org/10.1371/journal.pone.0202535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133495	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400078
J	Junaedi, DI; McCarthy, MA; Guillera-Arroita, G; Catford, JA; Burgman, MA				Junaedi, Decky, I; McCarthy, Michael A.; Guillera-Arroita, Gurutzeta; Catford, Jane A.; Burgman, Mark A.			Traits influence detection of exotic plant species in tropical forests	PLOS ONE			English	Article							CIBODAS BOTANICAL GARDEN; IMPERFECT DETECTION; MODEL; ABUNDANCE	Detecting exotic plant species is essential for invasive species management. By accounting for factors likely to affect species' detection rates (e.g. survey conditions, observer experience), detectability models can help choose search methods and allocate search effort. Integrating information on species' traits can refine detectability models, and might be particularly valuable if these traits can help improve estimates of detectability where data on particular species are rare. Analysing data collected during line transect distance sampling surveys in Indonesia, we used a multi-species hierarchical distance sampling model to evaluate how plant height, leaf size, leaf shape, and survey location influenced plant species detectability in secondary tropical rainforests. Detectability of the exotic plant species increased with plant height and leaf size. Detectability varied among the different survey locations. We failed to detect a clear effect of leaf shape on detectability. This study indicates that information on traits might improve predictions about exotic species detection, which can then be used to optimise the allocation of search effort for efficient species management. The innovation of the study lies in the multi-species distance sampling model, where the distance-detection function depends on leaf traits and height. The method can be applied elsewhere, including for different traits that may be relevant in other contexts. Trait-based multispecies distance sampling can be a practical approach for sampling exotic shrubs, herbs, or grasses species in the understorey of tropical forests.	[Junaedi, Decky, I; Burgman, Mark A.] Univ Melbourne, Sch Biosci, CEBRA, Parkville, Vic, Australia; [Junaedi, Decky, I; McCarthy, Michael A.; Guillera-Arroita, Gurutzeta; Catford, Jane A.; Burgman, Mark A.] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Junaedi, Decky, I] Indonesian Inst Sci UPI, Cibodas Bot Gardens, Cianjur, West Java, Indonesia; [Catford, Jane A.] Univ Southampton, Biol Sci, Southampton, Hants, England; [Catford, Jane A.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Burgman, Mark A.] Imperial Coll London, Fac Nat Sci, Ctr Environm Policy, South Kensington Campus, London, England	University of Melbourne; University of Melbourne; Indonesian Institute of Sciences; University of Southampton; Australian National University; Imperial College London	Junaedi, DI (corresponding author), Univ Melbourne, Sch Biosci, CEBRA, Parkville, Vic, Australia.; Junaedi, DI (corresponding author), Univ Melbourne, Sch Biosci, Parkville, Vic, Australia.; Junaedi, DI (corresponding author), Indonesian Inst Sci UPI, Cibodas Bot Gardens, Cianjur, West Java, Indonesia.	deck001@lipi.go.id	Junaedi, Decky Indrawan/AAE-1535-2019; Catford, Jane/N-1253-2019; Guillera-Arroita, Gurutzeta/F-7461-2015; Catford, Jane/B-9578-2012; McCarthy, Michael/O-5655-2014	Junaedi, Decky Indrawan/0000-0001-5846-6135; Catford, Jane/0000-0003-0582-5960; Guillera-Arroita, Gurutzeta/0000-0002-8387-5739; Catford, Jane/0000-0003-0582-5960; McCarthy, Michael/0000-0003-1039-7980; Burgman, Mark/0000-0003-0435-4829	Melbourne Research Scholarship (MRS); Centre of Excellence for Biosecurity Risk Analysis (CEBRA); Australian Research Council [DE120102221]; ARC Centre of Excellence for Environmental Decisions (CEED)	Melbourne Research Scholarship (MRS); Centre of Excellence for Biosecurity Risk Analysis (CEBRA); Australian Research Council(Australian Research Council); ARC Centre of Excellence for Environmental Decisions (CEED)(Australian Research Council)	Decky I. Junaedi is supported by a Melbourne Research Scholarship (MRS, URL: https://scholarships.unimelb.edu.au/awards/graduate-research-scholarships) and Centre of Excellence for Biosecurity Risk Analysis (CEBRA, URL: https://cebra.unimelb.edu.au/home) for his postgraduate study (living allowance, tuition, travel cost to study sites, and desk-lab supports) in University of Melbourne during the completion of this work. Jane A. Catford is supported by the Australian Research Council (DE120102221) and ARC Centre of Excellence for Environmental Decisions (CEED, URL: http://ceed.edu.au/). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DIJ thanks the managements and numerous staff members of Cibodas Botanic Gardens-LIPI, Eka Karya Bali Botanic Gardens-LIPI, Gede-Pangrango National Park (TNGGP), BKSDA Bali, Ciremai National Park (TNGC), Baturraden Botanic Gardens (Kebun Raya Baturraden), and Kuningan Botanic Gardens (Kebun Raya Kuningan) for their supports during fieldworks. The authors also thank Stuart Jones for dedicated peer review and comments on the draft manuscript. DIJ thank two anonymous reviewers (thesis external reviewers) for their constructive comments and suggestions for the manuscript improvement. DIJ is supported by a Melbourne Research Scholarship (MRS) and Centre of Excellence for Biosecurity Risk Analysis (CEBRA) during the completion of this work. We acknowledge support from the Australian Research Council (DE120102221 to JAC) and ARC Centre of Excellence for Environmental Decisions (CEED).	Amaral CH, 2015, ISPRS J PHOTOGRAMM, V108, P80, DOI 10.1016/j.isprsjprs.2015.06.009; [Anonymous], 2014, COLLINS ENGLISH DICT; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Bogich TL, 2008, J APPL ECOL, V45, P1134, DOI 10.1111/j.1365-2664.2008.01494.x; BOUXIN G, 1983, VEGETATIO, V54, P3, DOI 10.1007/BF00036075; Buckland ST, 2007, BIOMETRICS, V63, P989, DOI 10.1111/j.1541-0420.2007.00798.x; Buckland S.T., 2001, pi; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Chen GK, 2009, J ECOL, V97, P1383, DOI 10.1111/j.1365-2745.2009.01560.x; Chong KY, 2011, BIOL INVASIONS, V13, P1571, DOI 10.1007/s10530-010-9914-5; Christy MT, 2010, J APPL ECOL, V47, P106, DOI 10.1111/j.1365-2664.2009.01753.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Dawson W, 2011, DIVERS DISTRIB, V17, P1111, DOI 10.1111/j.1472-4642.2011.00796.x; Dodd AJ, 2015, DIVERS DISTRIB, V21, P151, DOI 10.1111/ddi.12262; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Ellenberg D, 1974, AIMS METHODS VEGETAT; Garrard GE, 2013, METHODS ECOL EVOL, V4, P45, DOI 10.1111/j.2041-210x.2012.00257.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Givnish T. J., 1984, Physiological ecology of plants in the wet tropics. Proceedings of an international symposium held in Oxatepec and Los Tuxtlas, Mexico, June 29 to July 6, 1983, P51; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hamzah A, 1972, MOUNTAIN FLORA JAVA; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Huebner CD, 2007, NORTHEAST NAT, V14, P183, DOI 10.1656/1092-6194(2007)14[183:DAMOIE]2.0.CO;2; Hui C, 2011, J APPL ECOL, V48, P768, DOI 10.1111/j.1365-2664.2011.01974.x; Isaac NJB, 2011, METHODS ECOL EVOL, V2, P585, DOI 10.1111/j.2041-210X.2011.00109.x; Junaedi DI, 2014, B KEBUN RAYA, V17, P1; Kellner K, 2015, WRAPPER RJAGS STREAM; Kendal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072296; Kidner C.A., 2010, INT J PLANT DEV BIOL, V4, P64, DOI DOI 10.1093/aob/mcq261; Kissa DO, 2012, FOREST ECOL MANAG, V263, P114, DOI 10.1016/j.foreco.2011.09.020; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Leung B, 2014, FRONT ECOL ENVIRON, V12, P273, DOI 10.1890/130311; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; McLellan T, 1998, SYST BIOL, V47, P264, DOI 10.1080/106351598260914; McNeely, 2001, GREAT RESHUFFLING HU; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Moore AL, 2016, METHODS ECOL EVOL; MUTAQIEN Z, 2011, BIODIVERSITAS, V12, P218; Olson CA, 2012, DETECTION PROBABILIT; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; Oo WP, 2015, FOREST ECOL MANAG, V358, P108, DOI 10.1016/j.foreco.2015.09.006; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Plummer M., 2003, P 3 INT WORKSH DISTR; Pouteau R, 2011, ECOL MODEL, V222, P2631, DOI 10.1016/j.ecolmodel.2011.04.030; Rozak AH, 2015, JURNAL PENELITIAN KE, V4, P93, DOI DOI 10.18330/JWALLACEA.2015.VOL4ISS2PP93-99; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sollmann R, 2015, METHODS ECOLOGY EVOL; Sollmann R, 2016, METHODS ECOL EVOL; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Sutomo S, 2012, BUMI LESTARI, V12; Turner KG, 2015, ECOL EVOL, V5, P3183, DOI 10.1002/ece3.1599; WERNER WL, 1986, MT RES DEV, V6, P335, DOI 10.2307/3673374; WHITMORE TC, 1998, INTRO TROPICAL RAIN; Whitten T., 1996, ECOLOGY OF JAVA BALI; Yamada I., 1975, S E ASIAN STUDIES, V13, P402, DOI [DOI 10.20495/TAK.13.3_402, 10.20495/tak.15.2_226, DOI 10.20495/TAK.15.2_226]; Zuhri M., 2013, Journal of Tropical Life Science, V3, P74	60	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202254	10.1371/journal.pone.0202254	http://dx.doi.org/10.1371/journal.pone.0202254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133512	Green Published, Green Accepted, gold			2022-12-26	WOS:000442500400062
J	Rotwein, P				Rotwein, Peter			The insulin-like growth factor 2 gene and locus in nonmammalian vertebrates: Organizational simplicity with duplication but limited divergence in fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor (IGF); genomics; gene structure; gene expression; genetics; phylogenetics; gene annotation; gene evolution; gene phylogeny; genetic database; vertebrate speciation	FACTOR SYSTEM GENES; FACTOR-II GENE; IGF-II; ALLELIC EXPRESSION; H19 GENE; MOUSE; ZEBRAFISH; EVOLUTION; GENOME; MUSCLE	The small, secreted peptide, insulin-like growth factor 2 (IGF2), is essential for fetal and prenatal growth in humans and other mammals. Human IGF2 and mouse Igf2 genes are located within a conserved linkage group and are regulated by parental imprinting, with IGF2/Igf2 being expressed from the paternally derived chromosome, and H19 from the maternal chromosome. Here, data retrieved from genomic and gene expression repositories were used to examine the Igf2 gene and locus in 8 terrestrial vertebrates, 11 ray-finned fish, and 1 lobe-finned fish representing > 500 million years of evolutionary diversification. The analysis revealed that vertebrate Igf2 genes are simpler than their mammalian counterparts, having fewer exons and lacking multiple gene promoters. Igf2 genes are conserved among these species, especially in protein-coding regions, and IGF2 proteins also are conserved, although less so in fish than in terrestrial vertebrates. The Igf2 locus in terrestrial vertebrates shares additional genes with its mammalian counterparts, including tyrosine hydroxylase (Th), insulin (Ins), mitochondrial ribosomal protein L23 (Mrpl23), and troponin T3, fast skeletal type (Tnnt3), and both Th and Mrpl23 are present in the Igf2 locus in fish. Taken together, these observations support the idea that a recognizable Igf2 was present in the earliest vertebrate ancestors, but that other features developed and diversified in the gene and locus with speciation, especially in mammals. This study also highlights the need for correcting inaccuracies in genome databases to maximize our ability to accurately assess contributions of individual genes and multigene families toward evolution, physiology, and disease.	[Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, El Paso, TX 79905 USA		Rotwein, P (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health Research [R01 DK042748-28]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grant R01 DK042748-28 (to P.R.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Amaral IPG, 2012, J EXP BIOL, V215, P3895, DOI 10.1242/jeb.068908; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Bartolomei MS, 2008, NAT GENET, V40, P932, DOI 10.1038/ng0808-932; BLUNDELL TL, 1980, NATURE, V287, P781, DOI 10.1038/287781a0; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Darling DC, 1996, GEN COMP ENDOCR, V102, P283, DOI 10.1006/gcen.1996.0071; Das R, 2015, BIOCHEM SOC T, V43, P1057, DOI 10.1042/BST20150078; DAUGHADAY WH, 1985, GEN COMP ENDOCR, V59, P316, DOI 10.1016/0016-6480(85)90384-3; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gholami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094509; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GILL G, 1994, CURR BIOL, V4, P374, DOI 10.1016/S0960-9822(00)00084-1; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; HAMPTON B, 1989, J BIOL CHEM, V264, P19155; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Kadakia R, 2016, HORM RES PAEDIAT, V85, P75, DOI 10.1159/000443500; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Koski LB, 2000, MOL REPROD DEV, V56, P345, DOI 10.1002/1098-2795(200007)56:3&lt;345::AID-MRD3&gt;3.0.CO;2-1; Kozak M, 2000, GENOMICS, V70, P396, DOI 10.1006/geno.2000.6412; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Manolio TA, 2017, CELL, V169, P6, DOI 10.1016/j.cell.2017.03.005; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Nolan CM, 2001, DEV GENES EVOL, V211, P179, DOI 10.1007/s004270000132; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Nornberg BF, 2016, GEN COMP ENDOCR, V226, P36, DOI 10.1016/j.ygcen.2015.12.017; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pierce AL, 2010, J ENDOCRINOL, V204, P331, DOI 10.1677/JOE-09-0338; Pierce AL, 2011, J ENDOCRINOL, V211, P201, DOI 10.1530/JOE-10-0456; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Quintana-Murci L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1093-y; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Richards MP, 2005, COMP BIOCHEM PHYS A, V141, P76, DOI 10.1016/j.cbpb.2005.04.006; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Rotwein P, 2018, ENDOCRINOLOGY, V159, P2288, DOI 10.1210/en.2018-00259; Rotwein P, 2018, PHYSIOL GENOMICS, V50, P425, DOI 10.1152/physiolgenomics.00030.2018; Rotwein P, 2018, J BIOL CHEM, V293, P4324, DOI 10.1074/jbc.RA117.001573; Rotwein P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189642; Schrader M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045463; Schwartz TS, 2016, INTEGR COMP BIOL, V56, P171, DOI 10.1093/icb/icw046; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Song CL, 2013, GENET MOL RES, V12, P4500, DOI 10.4238/2013.May.6.3; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; SUSSENBACH JS, 1993, ADV EXP MED BIOL, V343, P63; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; Tang SQ, 2010, ANIM BIOTECHNOL, V21, P104, DOI 10.1080/10495390903328090; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Venditti C, 2010, TRENDS ECOL EVOL, V25, P14, DOI 10.1016/j.tree.2009.06.010; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; White YAR, 2009, ENDOCRINOLOGY, V150, P4366, DOI 10.1210/en.2009-0356; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yokomine T, 2001, CYTOGENET CELL GENET, V93, P109, DOI 10.1159/000056960; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; Yuan YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00094-y	81	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15912	15932		10.1074/jbc.RA118.004861	http://dx.doi.org/10.1074/jbc.RA118.004861			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154247	hybrid, Green Published			2022-12-26	WOS:000447256000015
J	Sierra-Valdez, F; Azumaya, CM; Romero, LO; Nakagawa, T; Cordero-Morales, JF				Sierra-Valdez, Francisco; Azumaya, Caleigh M.; Romero, Luis O.; Nakagawa, Terunaga; Cordero-Morales, Julio F.			Structure-function analyses of the ion channel TRPC3 reveal that its cytoplasmic domain allosterically modulates channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; transient receptor potential channels (TRP channels); calcium channel; structural biology; electrophysiology; cryo-electron microscopy; vascular biology; neurotransmitter; GSK-1702934A; TRPC3	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; ELECTRON CRYOMICROSCOPY STRUCTURE; SYNAPTIC-TRANSMISSION; POTENTIAL CHANNELS; CEREBELLAR-ATAXIA; CALMODULIN; ACTIVATION; MUTATION; CELLS	The transient receptor potential ion channels support Ca2+ permeation in many organs, including the heart, brain, and kidney. Genetic mutations in transient receptor potential cation channel subfamily C member 3 (TRPC3) are associated with neurodegenerative diseases, memory loss, and hypertension. To better understand the conformational changes that regulate TRPC3 function, we solved the cryo-EM structures for the full-length human TRPC3 and its cytoplasmic domain (CPD) in the apo state at 5.8- and 4.0-angstrom resolution, respectively. These structures revealed that the TRPC3 transmembrane domain resembles those of other TRP channels and that the CPD is a stable module involved in channel assembly and gating. We observed the presence of a C-terminal domain swap at the center of the CPD where horizontal helices (HHs) transition into a coiled-coil bundle. Comparison of TRPC3 structures revealed that the HHs can reside in two distinct positions. Electrophysiological analyses disclosed that shortening the length of the C-terminal loop connecting the HH with the TRP helices increases TRPC3 activity and that elongating the length of the loop has the opposite effect. Our findings indicate that the C-terminal loop affects channel gating by altering the allosteric coupling between the cytoplasmic and transmembrane domains. We propose that molecules that target the HH may represent a promising strategy for controlling TRPC3-associated neurological disorders and hypertension.	[Sierra-Valdez, Francisco; Romero, Luis O.; Cordero-Morales, Julio F.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Azumaya, Caleigh M.; Nakagawa, Terunaga] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Struct Biol Ctr, Sch Med, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Vanderbilt Brain Inst, Sch Med, Nashville, TN 37232 USA	University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University; Vanderbilt University; Vanderbilt University	Cordero-Morales, JF (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.; Nakagawa, T (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Vanderbilt Brain Inst, Ctr Struct Biol,Sch Med, 702 Light Hall, Nashville, TN 37232 USA.	terunaga.nakagawa@vanderbilt.edu; jcordero@uthsc.edu		Sierra-Valdez, Francisco J/0000-0002-7803-9701; Cordero Morales, Julio/0000-0002-6505-5403; Romero, Luis/0000-0001-9855-7592	National Institutes of Health [R01 HD061543, 1-R01GM125629-01]; Vanderbilt University Trans-Institutional Program; American Heart Association [15SDG25700146]; National Institutes of Health Molecular Biophysics Training Program Grant [T32 GM008320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125629, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Trans-Institutional Program; American Heart Association(American Heart Association); National Institutes of Health Molecular Biophysics Training Program Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 HD061543, the Vanderbilt University Trans-Institutional Program, and other internal funding (to T.N.); American Heart Association Grant 15SDG25700146 and National Institutes of Health Grant 1-R01GM125629-01 (to J.C.-M.); and National Institutes of Health Molecular Biophysics Training Program Grant T32 GM008320 to Walter Chazin (to C.M.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez-Miguel I, 2017, J PHYSIOL-LONDON, V595, P1497, DOI 10.1113/JP273327; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Azumaya CM, 2018, J BIOL CHEM, V293, P10381, DOI 10.1074/jbc.RA118.003183; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Berg AP, 2007, J NEUROSCI, V27, P8845, DOI 10.1523/JNEUROSCI.0551-07.2007; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Duan J., 2018, BIORXIV282715, DOI [10.1101/282715, DOI 10.1101/282715]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Fogel BL, 2015, MOVEMENT DISORD, V30, P284, DOI 10.1002/mds.26096; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hasan R, 2017, SCI REP-UK, V7, DOI 10.1038/srep45098; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Kim Y, 2012, J NEUROSCI, V32, P11414, DOI 10.1523/JNEUROSCI.6446-11.2012; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lichtenegger M, 2018, NAT CHEM BIOL, V14, P396, DOI 10.1038/s41589-018-0015-6; Lichtenegger M, 2014, HANDB EXP PHARMACOL, V222, P67, DOI 10.1007/978-3-642-54215-2_4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Madej MG, 2018, PFLUG ARCH EUR J PHY, V470, P213, DOI 10.1007/s00424-018-2107-2; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mottl AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-104; Neuner SM, 2015, BEHAV BRAIN RES, V281, P69, DOI 10.1016/j.bbr.2014.12.018; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Santin S, 2009, NEPHROL DIAL TRANSPL, V24, P3089, DOI 10.1093/ndt/gfp229; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Sekerkova G, 2013, J NEUROSCI, V33, P19689, DOI 10.1523/JNEUROSCI.2294-13.2013; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	59	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16102	16114		10.1074/jbc.RA118.005066	http://dx.doi.org/10.1074/jbc.RA118.005066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30139744	Green Published, hybrid			2022-12-26	WOS:000447256000030
J	Kim, SY; Zhang, FM; Gong, WH; Chen, KQ; Xia, K; Liu, F; Gross, R; Wang, JM; Linhardt, RJ; Cotten, ML				Kim, So Young; Zhang, Fuming; Gong, Wanghua; Chen, Keqiang; Xia, Kai; Liu, Fei; Gross, Richard; Wang, Ji Ming; Linhardt, Robert J.; Cotten, Myriam L.			Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemotaxis; copper; glycosaminoglycan; heparin; histidine; host defense; surface plasmon resonance (SPR); antimicrobial peptide (AMP); formyl peptide receptors; piscidin	HOST-DEFENSE PEPTIDES; ACIDOPHILIC GRANULOCYTES; MOLECULAR RECOGNITION; GILTHEAD SEABREAM; BACTERIA; IMMUNE; LL-37; GLYCOSAMINOGLYCANS; INFLAMMATION; CATHELICIDIN	Phagocytic cells in fish secrete antimicrobial peptides (AMPs) such as piscidins, glycosaminoglycans such as heparin, and copper ions as first-line immune defenses. Recently, we established that Cu2+ coordination by piscidins 1 (P1) and 3 (P3) enhances their antibacterial activity against membranes and DNA. Interestingly, we noted that physicochemical similarities exist between both piscidins and other AMPs that interact with heparin and induce immune-cell chemotaxis through formyl peptide receptors (FPRs) involved in innate immunity. Thus, we postulated that P1 and P3 interact with heparin and FPRs but that these interactions distinctively depend on Cu2+. Here, we investigate the interactome potentiated by piscidins, heparin, FPR, and Cu2+. Utilizing FPR-transfected cells and neutrophils, we demonstrate that both piscidins exclusively use FPR1 and FPR2 to induce chemotaxis and that Cu2+ reduces their chemotaxis induction. P1 is more effective at activating FPR1 than P3 and other known AMP ligands. Furthermore, the expression of Fpr2 on the surface of neutrophils is down-regulated by both peptides. Copper conjugation of the peptides does not further increase down-regulation, suggesting that the conformational changes induced by the metal translate into reduced FPR efficacy without altering the binding affinity. Using surface plasmon resonance, we show that piscidin-heparin interactions are Cu2+-dependent and reduced at the acidic pH of phagosomes. Although heparin decreases the antimicrobial activity of P3-Cu2+, it does not affect bacterial killing by P1-Cu2+. Copper's effects on modulating the micromolar-range interactions of both piscidins with FPR and heparin suggest that the interactome of these distinct immune agents plays an important role in innate immunity. The interactions between diverse host-defense molecules uncovered here may help inform the design of novel therapeutics to treat immune-related diseases.	[Kim, So Young; Linhardt, Robert J.] Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Gong, Wanghua] Leidos Biomed Res Inc, Basic Res Program, Frederick, MD 21702 USA; [Chen, Keqiang; Wang, Ji Ming] NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Cotten, Myriam L.] Coll William & Mary, Dept Appl Sci, 540 Landrum Dr, Williamsburg, VA 23185 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA.; Zhang, FM (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA.; Zhang, FM; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Cotten, ML (corresponding author), Coll William & Mary, Dept Appl Sci, 540 Landrum Dr, Williamsburg, VA 23185 USA.	zhangf2@rpi.edu; linhar@rpi.edu; mcotten@wm.edu		Gross, Richard/0000-0002-5050-3162; Cotten, Myriam/0000-0002-6732-1736	National Science Foundation CAREER [CHE-0832571, MCB-1716608]; NATIONAL CANCER INSTITUTE [ZIABC010015] Funding Source: NIH RePORTER	National Science Foundation CAREER(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Science Foundation CAREER Grants CHE-0832571 and MCB-1716608 (to M. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisenbrey C, 2006, J BIOL CHEM, V281, P7708, DOI 10.1074/jbc.M513151200; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Baccari GC, 2011, INT REV CEL MOL BIO, V290, P1, DOI 10.1016/B978-0-12-386037-8.00006-5; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Bufe B, 2012, J BIOL CHEM, V287, P33644, DOI 10.1074/jbc.M112.375774; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHAO WL, 1991, J GEN APPL MICROBIOL, V37, P363, DOI 10.2323/jgam.37.363; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Chekmenev EY, 2006, J AM CHEM SOC, V128, P5308, DOI 10.1021/ja058385e; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen WF, 2015, BIOMATERIALS, V53, P1, DOI 10.1016/j.biomaterials.2015.02.069; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chuang WL, 2000, BIOCHEMISTRY-US, V39, P3542, DOI 10.1021/bi9926025; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Corminboeuf O, 2015, J MED CHEM, V58, P537, DOI 10.1021/jm501051x; Corrales J, 2010, DEV COMP IMMUNOL, V34, P331, DOI 10.1016/j.dci.2009.11.004; Crivellato E, 2015, METHODS MOL BIOL, V1220, P11, DOI 10.1007/978-1-4939-1568-2_2; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Dezfuli BS, 2012, DEV COMP IMMUNOL, V36, P174, DOI 10.1016/j.dci.2011.06.017; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; Durr M, 2002, INFECT IMMUN, V70, P6515, DOI 10.1128/IAI.70.12.6515-6517.2002; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Festa RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002887; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Flengsrud R, 2010, THROMB RES, V126, pE409, DOI 10.1016/j.thromres.2010.07.004; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hayden RM, 2015, J PHYS CHEM B, V119, P15235, DOI 10.1021/acs.jpcb.5b09685; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Jeske WP, 2007, CLIN APPL THROMB-HEM, V13, P137, DOI 10.1177/1076029606298982; Kaneider NC, 2007, THESCIENTIFICWORLDJO, V7, P1832, DOI 10.1100/tsw.2007.285; KREIL G, 1984, METHOD ENZYMOL, V106, P218; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114453; Libardo MDJ, 2017, FEBS J, V284, P3662, DOI [10.1111/febs.14262, 10.1111/febs.14263]; Lide D. R, 2004, CRC HDB CHEM PHYS RE, V85th; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Maccari F, 2015, CARBOHYD POLYM, V129, P143, DOI 10.1016/j.carbpol.2015.04.059; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Mao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083268; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mulero I, 2008, DEV COMP IMMUNOL, V32, P1531, DOI 10.1016/j.dci.2008.05.015; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Noga EJ, 2003, DRUG NEWS PERSPECT, V16, P87, DOI 10.1358/dnp.2003.16.2.829325; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park YJ, 2016, BMB REP, V49, P520, DOI 10.5483/BMBRep.2016.49.9.098; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Perrin BS, 2014, J AM CHEM SOC, V136, P3491, DOI 10.1021/ja411119m; Pundir P, 2014, MUCOSAL IMMUNOL, V7, P177, DOI 10.1038/mi.2013.37; Rakers S, 2013, J INVEST DERMATOL, V133, P1140, DOI 10.1038/jid.2012.503; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Ruangsri J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-46; Salger SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159423; Sauer RS, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-10; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Sepulcre MP, 2002, CELL TISSUE RES, V308, P97, DOI 10.1007/s00441-002-0531-1; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stoy H, 2015, GENES DIS, V2, P108, DOI 10.1016/j.gendis.2015.02.005; Sun BJ, 2007, J FISH DIS, V30, P335, DOI 10.1111/j.1365-2761.2007.00789.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Wang GS, 2013, PHARMACEUTICALS-BASE, V6, P728, DOI 10.3390/ph6060728; Weyers A, 2013, FEBS J, V280, P2285, DOI 10.1111/febs.12165; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744	76	26	27	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15381	15396		10.1074/jbc.RA118.001904	http://dx.doi.org/10.1074/jbc.RA118.001904			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30158246	hybrid, Green Published			2022-12-26	WOS:000446549200005
J	Shende, R; Wong, SSW; Rapole, S; Beau, R; Ibrahim-Granet, O; Monod, M; Guhrs, KH; Pal, JK; Latge, JP; Madan, T; Aimanianda, V; Sahu, A				Shende, Rajashri; Wong, Sarah Sze Wah; Rapole, Srikanth; Beau, Remi; Ibrahim-Granet, Oumaima; Monod, Michel; Guhrs, Karl-Heinz; Pal, Jayanta Kumar; Latge, Jean-Paul; Madan, Taruna; Aimanianda, Vishukumar; Sahu, Arvind			Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement system; complement; Aspergillus; infectious disease; inflammation; Aspergillus fumigatus; complement system; immune evasion; metalloprotease; phagocytosis	ALKALINE PROTEASE; SECRETED PROTEASES; IMMUNE EVASION; FACTOR-H; C3; BINDING; IDENTIFICATION; GENE; DEGRADATION; ACTIVATION	Innate immunity in animals including humans encompasses the complement system, which is considered an important host defense mechanism against Aspergillus fumigatus, one of the most ubiquitous opportunistic human fungal pathogens. Previously, it has been shown that the alkaline protease Alp1p secreted from A. fumigatus mycelia degrades the complement components C3, C4, and C5. However, it remains unclear how the fungal spores (i.e. conidia) defend themselves against the activities of the complement system immediately after inhalation into the lung. Here, we show that A. fumigatus conidia contain a metalloprotease Mep1p, which is released upon conidial contact with collagen and inactivates all three complement pathways. In particular, Mep1p efficiently inactivated the major complement components C3, C4, and C5 and their activation products (C3a, C4a, and C5a) as well as the pattern-recognition molecules MBL and ficolin-1, either by directly cleaving them or by cleaving them to a form that is further broken down by other proteases of the complement system. Moreover, incubation of Mep1p with human serum significantly inhibited the complement hemolytic activity and conidial opsonization by C3b and their subsequent phagocytosis by macrophages. Together, these results indicate that Mep1p associated with and released from A. fumigatus conidia likely facilitates early immune evasion by disarming the complement defense in the human host.	[Shende, Rajashri; Sahu, Arvind] Natl Ctr Cell Sci, Complement Biol Lab, SP Pune Univ Campus, Pune 411007, Maharashtra, India; [Rapole, Srikanth] Natl Ctr Cell Sci, Prote Lab, SP Pune Univ Campus, Pune 411007, Maharashtra, India; [Shende, Rajashri; Pal, Jayanta Kumar] Dr DY Patil Vidyapeeth, Dr DY Patil Biotechnol & Bioinformat Inst, Pune 411033, Maharashtra, India; [Wong, Sarah Sze Wah; Beau, Remi; Latge, Jean-Paul; Aimanianda, Vishukumar] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Wong, Sarah Sze Wah; Aimanianda, Vishukumar] Inst Pasteur, Unite Rech Mycol Mol, F-75015 Paris, France; [Ibrahim-Granet, Oumaima] Inst Pasteur, Unite Rech Cytokines & Inflammat, F-75015 Paris, France; [Monod, Michel] CHU Vaudois, Lab Mycol, Serv Dermatol, CH-1011 Lausanne, Switzerland; [Guhrs, Karl-Heinz] Leibniz Inst Aging, Fritz Lipmann Inst, D-07745 Jena, Germany; [Madan, Taruna] ICMR Natl Inst Res Reprod Hlth, Bombay 400012, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Biotechnology & Bioinformatics Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Aimanianda, V (corresponding author), Inst Pasteur, Unite Aspergillus, F-75015 Paris, France.; Sahu, A (corresponding author), Natl Ctr Cell Sci, SP Pune Univ Campus, Pune 411007, Maharashtra, India.	vkumar@pasteur.fr; arvindsahu@nccs.res.in	Aimanianda, Vishukumar/E-9204-2011; Wong, Sarah/AAX-5103-2020; Wong, Sarah/DOH-8455-2022	Aimanianda, Vishukumar/0000-0001-5813-7497; Wong, Sarah/0000-0002-9440-1774; Sahu, Arvind/0000-0003-1664-2422; Pal, Jayanta/0000-0003-1840-6458	bilateral COMASPIN grant from the Department of Science and Technology (DST) India; l'Agence Nationale de la Recherche (ANR) France; Department of Science and Technology; l'Agence Nationale de la Recherche	bilateral COMASPIN grant from the Department of Science and Technology (DST) India; l'Agence Nationale de la Recherche (ANR) France(French National Research Agency (ANR)); Department of Science and Technology(Department of Science & Technology (India)); l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by a bilateral COMASPIN grant from the Department of Science and Technology (DST) India and l'Agence Nationale de la Recherche (ANR) France (to A. S., T. M., and V. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a research fellowship from the Department of Science and Technology. A part of this work was done in partial fulfillment of the Ph.D. thesis to be submitted to the Dr. D. Y. Patil Vidyapeeth, Pune, India.; Supported by post-doctoral fellowship from the l'Agence Nationale de la Recherche.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Al-Bader N, 2016, VIRULENCE, V7, P950, DOI 10.1080/21505594.2016.1231278; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Askew DS, 2014, MYCOPATHOLOGIA, V178, P321, DOI 10.1007/s11046-014-9819-4; Beggah S, 2000, MICROBIOL-UK, V146, P2765, DOI 10.1099/00221287-146-11-2765; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Behnsen J, 2010, INFECT IMMUN, V78, P3585, DOI 10.1128/IAI.01353-09; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Braem SGE, 2015, J INNATE IMMUN, V7, P364, DOI 10.1159/000369493; Cadena J, 2016, INFECT DIS CLIN N AM, V30, P125, DOI 10.1016/j.idc.2015.10.015; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Del Tordello E, 2014, P NATL ACAD SCI USA, V111, P427, DOI 10.1073/pnas.1321556111; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Escobar N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00438; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fernandez D, 2013, ACTA CRYSTALLOGR D, V69, P1946, DOI 10.1107/S0907444913017642; Fraga TR, 2014, J INFECT DIS, V209, P876, DOI 10.1093/infdis/jit569; Gazendam RP, 2016, IMMUNOL REV, V273, P299, DOI 10.1111/imr.12454; Gresnigt MS, 2013, J IMMUNOL, V190, P5629, DOI 10.4049/jimmunol.1202601; Hartmann T, 2011, MOL MICROBIOL, V82, P917, DOI 10.1111/j.1365-2958.2011.07868.x; HECTOR RF, 1990, INFECT IMMUN, V58, P1476, DOI 10.1128/IAI.58.5.1476-1478.1990; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Heinekamp T, 2015, SEMIN IMMUNOPATHOL, V37, P141, DOI 10.1007/s00281-014-0465-1; HENWICK S, 1993, J LAB CLIN MED, V122, P27; JATONOGAY K, 1994, MOL MICROBIOL, V14, P917, DOI 10.1111/j.1365-2958.1994.tb01327.x; Jusko M, 2015, J IMMUNOL, V195, P2231, DOI 10.4049/jimmunol.1402892; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Koneru L, 2016, BIOL CHEM; KOZEL TR, 1989, INFECT IMMUN, V57, P3412, DOI 10.1128/IAI.57.11.3412-3417.1989; Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948; Lazovic Biljana, 2012, Med Arch, V66, P420, DOI 10.5455/medarh.2012.66.420-422; Lyubchenko T, 2005, J IMMUNOL, V174, P3264, DOI 10.4049/jimmunol.174.6.3264; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; MONOD M, 1991, J MED MICROBIOL, V35, P23, DOI 10.1099/00222615-35-1-23; MONOD M, 1993, INFECT IMMUN, V61, P4099, DOI 10.1128/IAI.61.10.4099-4104.1993; MONOD M, 1993, FEMS MICROBIOL LETT, V106, P39, DOI 10.1111/j.1574-6968.1993.tb05932.x; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; MOUTAOUAKIL M, 1993, J MED MICROBIOL, V39, P393, DOI 10.1099/00222615-39-5-393; Mullick J, 2005, J VIROL, V79, P12382, DOI 10.1128/JVI.79.19.12382-12393.2005; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; Paulussen C, 2017, MICROB BIOTECHNOL, V10, P296, DOI 10.1111/1751-7915.12367; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Pidde-Queiroz G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002519; Rambach G, 2005, MICROBES INFECT, V7, P1285, DOI 10.1016/j.micinf.2005.04.014; Rambach G, 2010, MOL IMMUNOL, V47, P1438, DOI 10.1016/j.molimm.2010.02.010; Rattan A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006248; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; Rosbjerg A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00473; Roy RM, 2013, MBIO, V4, DOI 10.1128/mBio.00162-13; SAHU A, 1994, J BIOL CHEM, V269, P28997; Sahu A, 1998, J IMMUNOL, V160, P5596; Schmidtchen A, 2003, MICROB PATHOGENESIS, V34, P47, DOI 10.1016/S0882-4010(02)00197-3; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Singh AK, 2006, J BIOL CHEM, V281, P23119, DOI 10.1074/jbc.M603085200; SIRAKOVA TD, 1994, INFECT IMMUN, V62, P4208, DOI 10.1128/IAI.62.10.4208-4218.1994; Svoboda E, 2015, IMMUNOL LETT, V168, P13, DOI 10.1016/j.imlet.2015.08.009; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Tsai HF, 1997, MOL MICROBIOL, V26, P175, DOI 10.1046/j.1365-2958.1997.5681921.x; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Vogl G, 2008, MOL IMMUNOL, V45, P1485, DOI 10.1016/j.molimm.2007.08.011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Warris A, 2014, J INFECTION, V69, pS36, DOI 10.1016/j.jinf.2014.07.011; WASHBURN RG, 1986, J INFECT DIS, V154, P944, DOI 10.1093/infdis/154.6.944; Wetsel RA, 2000, CONT IMMUN, V9, P113	68	20	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15538	15555		10.1074/jbc.RA117.001476	http://dx.doi.org/10.1074/jbc.RA117.001476			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139746	Green Published, hybrid			2022-12-26	WOS:000446549200019
J	Collins, M; Pellat, A; Antoni, G; Agostini, H; Labeyrie, C; Adams, D; Carbonnel, F				Collins, Michael; Pellat, Anna; Antoni, Guillemette; Agostini, Helene; Labeyrie, Celine; Adams, David; Carbonnel, Franck			Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; TRANSTHYRETIN AMYLOIDOSIS; GASTROINTESTINAL-TRACT; LIVER-TRANSPLANTATION; OCTREOTIDE; THERAPY; MANAGEMENT; DIAGNOSIS; MOTILITY; TRIAL	Introduction Familial amyloid polyneuropathy (FAP) is a genetic disease leading to the production of a variant transthyretin (TTR) or a beta variant beta 2-microglobulin. FAP may be associated with refractory diarrhoea. In this study, we assessed the efficacy and tolerance of somatostatin analogues in refractory diarrhoea associated with FAP. Methods FAP patients from the French national referral center who received somatostatin analogues for a refractory diarrhoea were retrospectively studied. We assessed remission of diarrhoea, as defined by a stool consistence of five or less on the Bristol stool scale, assessed after three to six months of follow-up. Stool frequency and continence before and after three to six months of treatment were also compared by the means of Wilcoxon and McNemar's exact tests, respectively. Results Fourteen patients treated with somatostatin analogues were evaluable. After three to six months of follow-up, 9/14 patients (64% 95%CI = [35%; 87%]) had remission of diarrhoea. This was significantly higher than a theoretical remission rate of 20% (p = 0.0004). There was a significant decrease of daily bowel movement from 6 to 2.5 per day (p = 0.002). Twelve/14 (85%) patients had incontinence at baseline vs 8/14 (57%) after three to six months of follow-up (p = 0.134). Three out of 14 patients (21%) had a severe adverse event; two patients had hypoglycaemia, and one had endocarditis due to an injection-site bacterial infection. Conclusion This study suggests that somatostatin analogues may benefit to patients with FAP and refractory diarrhoea. Approximately 20% of patients had severe adverse events, including hypoglycaemia.	[Collins, Michael; Pellat, Anna; Carbonnel, Franck] Hop Bicetre, AP HP, Dept Gastroenterol, Le Kremlin Bicetre, France; [Antoni, Guillemette] INSERM SC10 US19, Villejuif, France; [Agostini, Helene] Hop Bicetre, AP HP, Unite Rech Clin Paris Sud, Le Kremlin Bicetre, France; [Labeyrie, Celine; Adams, David; Carbonnel, Franck] French Natl Reference Ctr FAP NNERF, Le Kremlin Bicetre, France; [Labeyrie, Celine; Adams, David] Hop Bicetre, AP HP, Dept Neurol, Le Kremlin Bicetre, France; [Adams, David] Paris Sud Univ, INSERM UMR 1195, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Collins, M (corresponding author), Hop Bicetre, AP HP, Dept Gastroenterol, Le Kremlin Bicetre, France.	michael.collins@aphp.fr	Pellat, Anna/AAD-2847-2021	COLLINS, Michael/0000-0002-5785-722X				Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495; Adams D, 2016, CURR OPIN NEUROL, V29, pS14, DOI 10.1097/WCO.0000000000000289; Anan I, 1999, ACTA NEUROPATHOL, V98, P48, DOI 10.1007/s004010051050; Anan I, 2001, ACTA NEUROPATHOL, V102, P227; Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Barreiros AP, 2013, DIGEST DIS, V31, P170, DOI 10.1159/000347214; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; COMPEAN DG, 1994, AIDS, V8, P1563, DOI 10.1097/00002030-199411000-00007; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; Dyck PJ, 2017, MUSCLE NERVE, V56, P901, DOI 10.1002/mus.25563; ElSalhy M, 1997, SCAND J GASTROENTERO, V32, P849, DOI 10.3109/00365529709011190; Gertz MA, 2015, J AM COLL CARDIOL, V66, P2451, DOI 10.1016/j.jacc.2015.09.075; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; IKEDA SI, 1987, BRAIN, V110, P315, DOI 10.1093/brain/110.2.315; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Nikou GC, 2007, JCR-J CLIN RHEUMATOL, V13, P119, DOI 10.1097/RHU.0b013e3180645d2a; Nyhlin N, 1999, AMYLOID, V6, P192, DOI 10.3109/13506129909007326; Parman Y, 2016, CURR OPIN NEUROL, V29, pS3, DOI 10.1097/WCO.0000000000000288; SIMON DM, 1995, GASTROENTEROLOGY, V108, P1753, DOI 10.1016/0016-5085(95)90137-X; SOUDAH HC, 1991, NEW ENGL J MED, V325, P1461, DOI 10.1056/NEJM199111213252102; Szilagyi A, 2001, ALIMENT PHARM THERAP, V15, P1889, DOI 10.1046/j.1365-2036.2001.01114.x; Takahashi S, 2017, BRIT MED J, DOI [10.1136/bmjopen-2017-018445, DOI 10.1136/BMJOPEN-2017-018445]; Topkan E, 2006, ONCOLOGY-BASEL, V71, P354, DOI 10.1159/000108593; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wixner J, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0284-4; Wixner J, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-61; Yarandi SS, 2014, NEUROGASTROENT MOTIL, V26, P611, DOI 10.1111/nmo.12330	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201869	10.1371/journal.pone.0201869	http://dx.doi.org/10.1371/journal.pone.0201869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161158	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900014
J	Kruk, B; Liebe, R; Milkiewicz, M; Wunsch, E; Raszeja-Wyszomirska, J; Lammert, F; Milkiewicz, P; Krawczyk, M				Kruk, Beata; Liebe, Roman; Milkiewicz, Malgorzata; Wunsch, Ewa; Raszeja-Wyszomirska, Joanna; Lammert, Frank; Milkiewicz, Piotr; Krawczyk, Marcin			PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; PRIMARY SCLEROSING CHOLANGITIS; GENOME-WIDE ASSOCIATION; SUPERFAMILY MEMBER 2; GENETIC-VARIATION; STEATOSIS; RISK; FIBROSIS; SUSCEPTIBILITY; REDUCTION	Background The adiponutrin (PNPLA3) p.1148M and transmembrane 6 superfamily member 2 (TM6SF2) p.E167K variants represent major genetic risk factors for progressive liver injury in nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) and chronic viral hepatitis. The aim of this study was to find out whether these variants have a detrimental impact on the progression of chronic liver disease in patients with prolonged cholestasis induced by primary sclerosing cholangitis (PSC). Methods We prospectively recruited 178 PSC patients (112 male, age range 17-75 years, 55 with liver cirrhosis, 94 with ulcerative colitis, 48 transplanted during follow-up). PNPLA3 rs738409 and TM6SF2 rs58542926 polymorphisms were genotyped using dedicated TaqMan assays. Associations between genotypes, biochemical and clinical phenotypes were analyzed using contingency tables. Results Allele and genotype distribution of both variants were consistent with Hardy-Weinberg equilibrium. No significant differences in the genotype distribution of PNPLA3 (P = 0.90) or TM6SF2 (P = 0.72) were observed between patients with cirrhosis and patients without cirrhosis. Serum liver enzyme activities were not modified by the presence of PNPLA3 (ALT P = 0.88, AST P = 0.77) or TM6SF2 (ALT P = 0.92, AST P = 0.49) risk variants. Increasing number of risk alleles had no impact on serum liver enzyme activities, as demonstrated by a separate analysis of patients carrying 0 (n = 99), 1 (n = 64), 2 (n = 12) or 3 (n = 3) risk alleles P>0.05). No impact of PNPLA3 or TM6SF2 risk variants was detectable in patients with PSC and ulcerative colitis, and none of the variants increased the odds of transplantation. Conclusions Neither PNPLA3 nor TM6SF2 polymorphisms seem to contribute significantly towards an increased risk for deterioration of liver function in patients with PSC. These results underscore the divergent mechanisms of liver damage in cholestatic conditions as compared to metabolic and viral liver diseases.	[Kruk, Beata; Krawczyk, Marcin] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Ctr Preclin Res, Lab Metab Liver Dis, Warsaw, Poland; [Liebe, Roman; Lammert, Frank; Krawczyk, Marcin] Saarland Univ, Saarland Univ Med Ctr, Dept Med 2, Homburg, Germany; [Milkiewicz, Malgorzata] Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland; [Wunsch, Ewa; Milkiewicz, Piotr] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland; [Raszeja-Wyszomirska, Joanna; Milkiewicz, Piotr] Med Univ Warsaw, Liver & Internal Med Unit, Warsaw, Poland	Medical University of Warsaw; Universitatsklinikum des Saarlandes; Pomeranian Medical University; Pomeranian Medical University; Medical University of Warsaw	Krawczyk, M (corresponding author), Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Ctr Preclin Res, Lab Metab Liver Dis, Warsaw, Poland.; Krawczyk, M (corresponding author), Saarland Univ, Saarland Univ Med Ctr, Dept Med 2, Homburg, Germany.	marcin.krawczyk@uks.eu	Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777; Milkiewicz, Malgorzata/0000-0002-2064-0545; Liebe, Roman/0000-0002-3199-5595; Milkiewicz, Piotr/0000-0002-1817-0724				Arslanow A, 2016, LIVER INT, V36, P418, DOI 10.1111/liv.12937; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Friedrich K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058734; Goode EC, 2017, GUT; Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022; Krawczyk M, 2017, ANN HEPATOL, V16, P830, DOI 10.5604/01.3001.0010.5271; Krawczyk M, 2017, SCAND J GASTROENTERO, V52, P1407, DOI 10.1080/00365521.2017.1370009; Krawczyk M, 2017, J LIPID RES, V58, P247, DOI 10.1194/jlr.P067454; Krawczyk M, 2016, SURG OBES RELAT DIS, V12, P1838, DOI 10.1016/j.soard.2016.06.004; Krawczyk M, 2016, DIGESTION, V93, P139, DOI 10.1159/000441185; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; LEE YM, 1995, NEW ENGL J MED, V332, P924, DOI 10.1056/NEJM199504063321406; Mancina RM, 2016, INFLAMM BOWEL DIS, V22, P134, DOI 10.1097/MIB.0000000000000569; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Milano M, 2015, HEPATOLOGY, V62, P111, DOI 10.1002/hep.27811; Pirola CJ, 2015, HEPATOLOGY, V62, P1742, DOI 10.1002/hep.28142; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Vigano M, 2013, HEPATOLOGY, V58, P1245, DOI 10.1002/hep.26445; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202942	10.1371/journal.pone.0202942	http://dx.doi.org/10.1371/journal.pone.0202942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161167	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900052
J	Rooney-Varga, JN; Sterman, JD; Fracassi, E; Franck, T; Kapmeier, F; Kurker, V; Johnston, E; Jones, AP; Rath, K				Rooney-Varga, J. N.; Sterman, J. D.; Fracassi, E.; Franck, T.; Kapmeier, F.; Kurker, V; Johnston, E.; Jones, A. P.; Rath, K.			Combining role-play with interactive simulation to motivate informed climate action: Evidence from the World Climate simulation	PLOS ONE			English	Article							RISK PERCEPTION; COMMUNICATION; POLICY; PARIS; CHALLENGES; SUPPORT	Climate change communication efforts grounded in the information deficit model have largely failed to close the gap between scientific and public understanding of the risks posed by climate change. In response, simulations have been proposed to enable people to learn for themselves about this complex and politically charged topic. Here we assess the impact of a widely-used simulation, World Climate, which combines a socially and emotionally engaging role-play with interactive exploration of climate change science through the CROADS climate simulation model. Participants take on the roles of delegates to the UN climate negotiations and are challenged to create an agreement that meets international climate goals. Their decisions are entered into C-ROADS, which provides immediate feedback about expected global climate impacts, enabling them to learn about climate change while experiencing the social dynamics of negotiations. We assess the impact of World Climate by analyzing pre- and post-survey results from >2,000 participants in 39 sessions in eight nations. We find statistically significant gains in three areas: (i) knowledge of climate change causes, dynamics and impacts; (ii) affective engagement including greater feelings of urgency and hope; and (iii) a desire to learn and do more about climate change. Contrary to the deficit model, gains in urgency were associated with gains in participants' desire to learn more and intent to act, while gains in climate knowledge were not. Gains were just as strong among American participants who oppose government regulation of free markets-a political ideology that has been linked to climate change denial in the US-suggesting the simulation's potential to reach across political divides. The results indicate that World Climate offers a climate change communication tool that enables people to learn and feel for themselves, which together have the potential to motivate action informed by science.	[Rooney-Varga, J. N.; Kurker, V] Univ Massachusetts Lowell, UMass Lowell Climate Change Initiat, Lowell, MA 01854 USA; [Rooney-Varga, J. N.; Kurker, V] Univ Massachusetts Lowell, Dept Environm Earth & Atmospher Sci, Lowell, MA 01854 USA; [Sterman, J. D.] MIT, Syst Dynam Grp, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Fracassi, E.] Escuela Ingn & Gest, Inst Tecnol Buenos Aires, Buenos Aires, DF, Argentina; [Franck, T.; Johnston, E.; Jones, A. P.] Climate Interact, Washington, DC USA; [Kapmeier, F.] ESB Business Sch, Reutlingen, Germany; [Rath, K.] SageFox Consulting Grp, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell; Massachusetts Institute of Technology (MIT)	Rooney-Varga, JN (corresponding author), Univ Massachusetts Lowell, UMass Lowell Climate Change Initiat, Lowell, MA 01854 USA.; Rooney-Varga, JN (corresponding author), Univ Massachusetts Lowell, Dept Environm Earth & Atmospher Sci, Lowell, MA 01854 USA.	Juliette_RooneyVarga@uml.edu		Kapmeier, Florian/0000-0002-7567-4873	National Science Foundation [DUE-124558, ICER-1701062]; SageFox Consulting Group	National Science Foundation(National Science Foundation (NSF)); SageFox Consulting Group	Author KR is employed by SageFox Consulting Group, which provided support in the form of KR's salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of author KR are articulated in the 'author contributions' section. This work was supported by the National Science Foundation under grants DUE-124558 and ICER-1701062.	Anderson S, 2017, J ENERGY NAT RESO LA, V35, P221, DOI 10.1080/02646811.2017.1321263; Barros V.R., 2014, CLIM CHANG 2014 IMP, P688, DOI DOI 10.1017/CBO9781107415324; Bartholomew D, 2011, WILEY SER PROBAB ST, P1, DOI 10.1002/9781119970583; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chung KC, 2017, INT SYST DYN C CAMBR; Clemencon R, 2016, J ENVIRON DEV, V25, P3, DOI 10.1177/1070496516631362; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Cronin MA, 2009, ORGAN BEHAV HUM DEC, V108, P116, DOI 10.1016/j.obhdp.2008.03.003; Doherty KL, 2016, NAT CLIM CHANGE, V6, P879, DOI 10.1038/NCLIMATE3025; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Figueres C, 2017, NATURE, V546, P593, DOI 10.1038/546593a; Fischhoff B, 2007, ENVIRON SCI TECHNOL, V41, P7204, DOI 10.1021/es0726411; Gold AU, 2012, J GEOSCI ED, V60, P295, DOI [10.5408/12-324.11234011, DOI 10.5408/12-324.11234011, DOI 10.5408/12-324.1]; GOODMAN E, 2001, PEDIATRICS, V108; Goodman E, 2015, PEDIATRICS, V136, pE633, DOI 10.1542/peds.2015-1300; Halford GS, 2005, PSYCHOL SCI, V16, P70, DOI 10.1111/j.0956-7976.2005.00782.x; Harvey D, 1997, INTERGOVERNMENTAL PA; Hays R. T., 1992, MIL PSYCHOL, V4, P63, DOI DOI 10.1207/S15327876MP0402_1; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Homer J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140130; Hornsey MJ, 2016, GLOBAL ENVIRON CHANG, V39, P26, DOI 10.1016/j.gloenvcha.2016.04.003; Iyer A, 2007, PERS SOC PSYCHOL B, V33, P572, DOI 10.1177/0146167206297402; Kahan D, 2012, NATURE, V488, P255, DOI 10.1038/488255a; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kintisch E, 2015, SCIENCE, V350, P1018, DOI 10.1126/science.350.6264.1018; Kluge A, 2009, THEOR ISS ERGON SCI, V10, P489, DOI 10.1080/14639220902982192; Lattanzio R.K., 2014, INT CLIMATE CHANGE F; Ledley T.S., 2017, OXFORD RES ENCY ENV, V1, DOI [10.1093/acrefore/9780199389414.013.56, DOI 10.1093/ACREFORE/9780199389414.013.56]; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Leiserowitz A, 2011, AM TEENSKNOWLEDGE CL, P2; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; Minestere de l'education nationale, 2015, ORG SIM NEG CHANG CL; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Osgood E. E., 1957, MEASUREMENT MEANING; Pearce W, 2015, WIRES CLIM CHANGE, V6, P613, DOI 10.1002/wcc.366; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Robinson S, 2002, SIMUL MODEL PRACT TH, V10, P513, DOI 10.1016/S1569-190X(02)00117-X; Sanderson BM, 2017, NAT CLIM CHANGE, V7, P92; Shi J, 2016, NAT CLIM CHANGE, V6, P759, DOI [10.1038/NCLIMATE2997, 10.1038/nclimate2997]; Smith N, 2014, RISK ANAL, V34, P937, DOI 10.1111/risa.12140; Stage EK, 2013, SCIENCE, V340, P276, DOI 10.1126/science.1234011; Sterman J, 2012, SUSTAINABILITY SCI E; Sterman J, 2015, SIMULAT GAMING, V46, P348, DOI 10.1177/1046878113514935; Sterman J, 2012, SYST DYNAM REV, V28, P295, DOI 10.1002/sdr.1474; Sterman JD, 2008, SCIENCE, V322, P532, DOI 10.1126/science.1162574; Sterman JD, 2013, ENVIRON MODELL SOFTW, V44, P122, DOI 10.1016/j.envsoft.2012.06.004; Sterman JD, 2011, CLIMATIC CHANGE, V108, P811, DOI 10.1007/s10584-011-0189-3; Stokes B., 2015, GLOBAL CLIMATE CHANG; Sweeney LB, 2000, SYST DYNAM REV, V16, P249, DOI 10.1002/sdr.198; Tollefson J, 2017, NATURE, V546, P198, DOI 10.1038/nature.2017.22096; United Nations Secretary-General, 2021, ASS REP 6 WORK GROUP; van der Linden S, 2014, EUR J SOC PSYCHOL, V44, P430, DOI 10.1002/ejsp.2008; Weber EU, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0013; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253; Weber EU, 2010, PERSPECT PSYCHOL SCI, V5, P410, DOI 10.1177/1745691610375556	62	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202877	10.1371/journal.pone.0202877	http://dx.doi.org/10.1371/journal.pone.0202877			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161185	Green Published, gold			2022-12-26	WOS:000443388900048
J	Bastiaansen, JA; Bennik, EC; Marsman, JBC; Ormel, J; Aleman, A; Oldehinkel, AJ				Bastiaansen, Jojanneke A.; Bennik, Elise C.; Marsman, Jan Bernard C.; Ormel, Johan; Aleman, Andre; Oldehinkel, Albertine J.			Prefrontal cortex activation during a cognitive reappraisal task is associated with real-life negative affect reactivity	PLOS ONE			English	Article							FOCUSED EMOTION REGULATION; INDIVIDUAL-DIFFERENCES; NEURAL BASES; SEX-DIFFERENCES; SUPPRESSION; PREDICT; FMRI; METAANALYSIS; EXPERIENCE; AMYGDALA	The neural substrate of cognitive reappraisal has been well-mapped. Individuals who successfully downregulate negative affect (NA) by reshaping their thoughts about a potentially emotional situation show augmented activity in the prefrontal cortex (PFC), with attenuated activity in the amygdala. We performed functional neuroimaging with experience sampling to determine whether individual differences in brain activation correspond to differences in real-life NA. While being scanned, 69 female students (aged 18-25 years) were asked to perform a cognitive reappraisal task. In addition, repeated assessments (5/day, 14 days) of affect and minor events in real-life were conducted. Individual t-maps were created for an instructed downregulation contrast (downregulate negative-attend negative) and an uninstructed regulation contrast (attend negative-attend neutral). Mean beta values were extracted from a priori defined regions of interest in the bilateral amygdala and PFC and were correlated with three daily life NA measures: baseline (mean) NA, NA variability, and NA reactivity to negative events. Only one out of twelve correlations for the amygdalae was nominally significant, which did not survive correction for multiple comparisons. PFC activation in the instructed and uninstructed regulation contrasts explained approximately 10% of the variance in NA reactivity; stronger recruitment during the attend-negative condition was correlated with lower reactivity levels. The degree to which individuals spontaneously engage frontal clusters may be a critical aspect of real-life emotional reactivity. The findings of this study provide a partial external validation of the cognitive reappraisal task, suggesting that frontal brain activation during implicit task conditions may have the strongest connection with real-life behaviors.	[Bastiaansen, Jojanneke A.; Ormel, Johan; Aleman, Andre; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands; [Bastiaansen, Jojanneke A.] Friesland Mental Hlth Care Serv, Dept Educ & Res, Leeuwarden, Netherlands; [Bennik, Elise C.; Aleman, Andre] Univ Groningen, Dept Psychol, Groningen, Netherlands; [Marsman, Jan Bernard C.; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Oldehinkel, AJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands.	a.j.oldehinkel@umcg.nl	ormel, johan/AAC-5584-2019; Bastiaansen, Jojanneke/F-4849-2013	ormel, johan/0000-0002-5463-037X; Bastiaansen, Jojanneke/0000-0003-4831-6402	University Medical Center Groningen	University Medical Center Groningen	This work was supported by personal grants for excellent research from the University Medical Center Groningen to JO and AJO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkman ET, 2013, CURR DIR PSYCHOL SCI, V22, P45, DOI 10.1177/0963721412469394; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Chen SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00073-3; Csikszentmihalyi M., 1983, NEW DIRECTIONS METHO, V15, P41, DOI DOI 10.1007/978-94-017-9088-8_2; David SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23976-1; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Ehring T, 2010, EMOTION, V10, P563, DOI 10.1037/a0019010; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hoekstra H. A., 1996, HANDLEIDING NEO PERS; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Kong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097071; Koole SL, 2011, COGNITION EMOTION, V25, P389, DOI 10.1080/02699931.2010.550505; Kuppens P, 2010, J PERS SOC PSYCHOL, V99, P1042, DOI 10.1037/a0020962; Lang PJ, 2008, A8 U FLOR, DOI [10.1016/j.neuroimage.2011.10.018, DOI 10.1016/J.NEUROIMAGE.2011.10.018]; Lopez RB, 2014, PSYCHOL SCI, V25, P1337, DOI 10.1177/0956797614531492; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nikolova YS, 2012, BIOL PSYCHIAT, V72, P157, DOI 10.1016/j.biopsych.2012.03.014; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Oinonen KA, 2002, J AFFECT DISORDERS, V70, P229, DOI 10.1016/S0165-0327(01)00356-1; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Paul S, 2013, BIOL PSYCHOL, V94, P136, DOI 10.1016/j.biopsycho.2013.05.019; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Silvers JA, 2015, SOC COGN AFFECT NEUR, V10, P10, DOI 10.1093/scan/nsu016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Roekel E, 2016, J ABNORM CHILD PSYCH, V44, P999, DOI 10.1007/s10802-015-0090-z; Vanderhasselt MA, 2013, BIOL PSYCHOL, V92, P433, DOI 10.1016/j.biopsycho.2012.03.005; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Williams LE, 2009, EMOTION, V9, P847, DOI 10.1037/a0017745; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yuan JJ, 2015, COGNITION EMOTION, V29, P1042, DOI 10.1080/02699931.2014.965663; Yuan JJ, 2015, SCI CHINA LIFE SCI, V58, P480, DOI 10.1007/s11427-014-4739-6; Yuan JJ, 2009, HUM BRAIN MAPP, V30, P3676, DOI 10.1002/hbm.20796	46	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202888	10.1371/journal.pone.0202888	http://dx.doi.org/10.1371/journal.pone.0202888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142170	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500046
J	Krusi, A; Renville, F; Gurney, L; Lyons, T; Shoveller, J; Shannon, K				Krusi, Andrea; Renville, Flo; Gurney, Lulu; Lyons, Tara; Shoveller, Jean; Shannon, Kate			Positive sexuality: HIV disclosure, gender, violence and the law-A qualitative study	PLOS ONE			English	Article							SEROPOSITIVE STATUS DISCLOSURE; CRIMINAL PROSECUTIONS; SEROSTATUS DISCLOSURE; TRANSGENDER WOMEN; RISK BEHAVIORS; INFECTED WOMEN; SEX WORKERS; TRANSMISSION; PREVENTION; PARTNERS	While a growing body of research points to the shortcomings of the criminal law in governing HIV transmission, there is limited understanding of how cis and trans women living with HIV (WLWH) negotiate their sexuality and HIV disclosure in a criminalized environment. Given the ongoing criminalization of HIV non-disclosure and prevalence of gender-based violence, there is a critical need to better understand the dynamics of negotiating sexual relationships and HIV disclosure among WLWH. We conducted 64 qualitative interviews with cis and trans WLWH in Vancouver, Canada between 2015 and 2017. The interviews were conducted by three experienced researchers, including a cis and a trans WLWH using a semi-structured interview guide. Drawing on a feminist analytical framework and concepts of structural violence, the analysis sought to characterize the negotiation of sexual relationships and HIV disclosure among WLWH in a criminalized setting. For many participants their HIV diagnosis initially symbolized the end of their sexuality due to fear of rejection and potential legal consequences. WLWH recounted that disclosing their HIV status shifted the power dynamics in sexual relationships and many feared rejection, violence, and being outed as living with HIV. Participants' narratives also highlighted that male condom refusal was common and WLWH were not only subjected to the gendered interpersonal violence of male condom refusal but also to the structural violence of legislation that requires condom use but fails to account for the gendered power imbalance that shapes condom negotiation. Despite frequently being represented as a law that 'protects' women, our findings indicate that the criminalization of HIV non-disclosure constitutes a form of gendered structural violence that exacerbates risk for interpersonal violence among WLWH. In line with recommendations by, the WHO and UNAIDS these findings demonstrate the negative impacts of regulating HIV prevention through the use of criminal law for WLWH.	[Krusi, Andrea; Renville, Flo; Gurney, Lulu; Lyons, Tara; Shannon, Kate] Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Krusi, Andrea; Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Lyons, Tara] Kwantlen Polytech Univ, Surrey, BC, Canada; [Shoveller, Jean; Shannon, Kate] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Krusi, A (corresponding author), Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.; Krusi, A (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	gshi@cfenet.ubc.ca			Canadian Institutes of Health Research [384667, FDN-143349]; Michael Smith Foundation for Health Research; Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Canadian Institutes of Health Research through a Community-based Research Grant (384667) and a Foundation Grant (FDN-143349). AK is supported through a Michael Smith Foundation for Health Research Scholar Award. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS and Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2014, SEX RES SOC POLICY, V11, P39, DOI 10.1007/s13178-013-0131-8; Allard P., 2014, WOMEN HIV PREVENTION, P195; [Anonymous], 2017, CRIM JUST SYST RESP, P1; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barreto D, HIV DISCLOSURE CONSE; Bernard EJ, 2012, CRIMINALIZTION HIV N; Bernard EJ, 2016, ADV HIV JUSTICE2 BUI; Bingham B, 2014, CULT HEALTH SEX, V16, P440, DOI 10.1080/13691058.2014.888480; Borwein A, 2014, AIDS CARE, V26, P587, DOI 10.1080/09540121.2013.844763; Bourassa C, 2004, CANADIAN WOMAN STUDI, V24; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; Brady S, 2002, AIDS PATIENT CARE ST, V16, P121, DOI 10.1089/108729102317330463; Burris S., 2007, ARIZONA STATE LAW J, V2007, P1; Canadian HIV/AIDS Legal Network, 2014, CRIM LAW HIV NOND CA; CATIE, 2012, HIV CAN PRIM SERV PR; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Culhane D., 2003, AM INDIAN Q, V27, P593, DOI [10.1353/aiq.2004.0073, DOI 10.1353/AIQ.2004.0073]; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Dodds C, 2006, INT J STD AIDS, V17, P315, DOI 10.1258/095646206776790114; Dodds C, 2008, AIDS CARE, V20, P509, DOI 10.1080/09540120701867131; Dunkle KL, 2013, AM J REPROD IMMUNOL, V69, P20, DOI 10.1111/aji.12039; Farmer P.E, 2001, INFECT INEQUALITIES; Galletly CL, 2009, INT J STD AIDS, V20, P613, DOI 10.1258/ijsa.2008.008417; Galletly CL, 2012, AM J PUBLIC HEALTH, V102, P2135, DOI 10.2105/AJPH.2012.300664; GALTUNG J, 1990, J PEACE RES, V27, P291, DOI 10.1177/0022343390027003005; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; Harrington EK, 2016, CULT HEALTH SEX, V18, P453, DOI 10.1080/13691058.2015.1091507; Hastings C., 2017, HIV CRIMINALIZATION; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; HEISE LL, 1995, SOC SCI MED, V40, P931, DOI 10.1016/0277-9536(94)00165-P; Holmes C, 2015, ACME, V14, P539; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kennedy CE, 2015, J INT AIDS SOC, V18, P74, DOI 10.7448/IAS.18.6.20292; Krusi A, 2017, MED ANTHR THEORY, V4; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Loutfy M, 2014, CAN J INFECT DIS MED, V25, P135, DOI 10.1155/2014/498459; Mazanderani F, 2015, SOC SCI MED, V131, P66, DOI 10.1016/j.socscimed.2015.02.041; McGrath JW, 2014, MED ANTHROPOL, V33, P303, DOI 10.1080/01459740.2014.892483; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Moyer E, 2012, CULT HEALTH SEX, V14, pS67, DOI 10.1080/13691058.2012.662524; Mykhalovskiy E, 2004, SOC SCI MED, V59, P1059, DOI 10.1016/j.socscimed.2003.12.002; Mykhalovskiy E, 2012, CAN J LAW SOC, V27, P31, DOI 10.3138/cjls.27.1.031; O'Byrne P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-94; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Onu CC, 2017, JAIDS-J ACQ IMM DEF, V74, P52, DOI 10.1097/QAI.0000000000001135; Ostrach B, 2012, HEALTH SOCIOL REV, V21, P258, DOI 10.5172/hesr.2012.21.3.258; Otto-Salaj LL, 2010, J SEX RES, V47, P539, DOI 10.1080/00224490903216763; Palys T, 2002, SOCIOL METHODOL, V32, P1, DOI 10.1111/1467-9531.00107; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Patterson Sophie, 2016, CMAJ Open, V4, pE169, DOI 10.9778/cmajo.20150106; Patton C., 2002, GLOBALIZING AIDS, DOI [10.2105/AJPH.2014.301909, DOI 10.2105/AJPH.2014.301909]; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Quesada J, 2011, MED ANTHROPOL, V30, P339, DOI 10.1080/01459740.2011.576725; Sales JM, 2008, ARCH PEDIAT ADOL MED, V162, P432, DOI 10.1001/archpedi.162.5.432; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Siegel K, 2005, WOMEN HEALTH, V41, P63, DOI 10.1300/J013v41n04_04; Silverman JG, 2011, PERSPECT SEX REPRO H, V43, P60, DOI 10.1363/4306011; Smith LR, 2017, JAIDS-J ACQ IMM DEF, V75, P408, DOI 10.1097/QAI.0000000000001423; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Statistics Canada, 2015, AUD CORR STAT CAN 20; The Truth and Reconciliation Commission of Canada, 2015, HON TRUTH REC FUT SU; Trickey A, 2017, LANCET HIV; UNAIDS, 2007, GREAT INV PEOPL LIV; Varcoe C, 2008, JOURNAL DE LA SANTE; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P208, DOI 10.2105/AJPH.90.2.208	72	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202776	10.1371/journal.pone.0202776	http://dx.doi.org/10.1371/journal.pone.0202776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142220	gold, Green Submitted, Green Published			2022-12-26	WOS:000442722500032
J	Shahnaij, M; Latif, HA; Azmi, IJ; Amin, MB; Luna, SJ; Islam, MA; Talukder, KA				Shahnaij, Mohammad; Latif, Hasan A.; Azmi, Ishrat J.; Amin, Mohammed Badrul; Luna, Sharmin J.; Islam, Mohammad Aminul; Talukder, Kaisar Ali			Characterization of a serologically atypical Shigella flexneri Z isolated from diarrheal patients in Bangladesh and a proposed serological scheme for Shigella flexneri	PLOS ONE			English	Article							O-ANTIGEN MODIFICATION; MONOCLONAL-ANTIBODIES; DYSENTERIAE TYPE-1; GENOTYPIC CHARACTERIZATION; REPEATING-UNIT; CLONES BINDING; STRAINS; EMERGENCE; SEROTYPES; PLASMID	Background Atypical Shigella flexneri Z variant, that agglutinate with E1037 group factor specific monoclonal antisera against Shigella flexneri IV-I but not with other group or type specific antisera, has continuously being isolated in Bangladesh since 1997. Later this serotype has been reported in Indonesia, China and Argentina. Despite being a provisional serotype, continuous isolation of these strains in diverse geographical regions implicated a great necessity to study the overall characteristics of these strains. Therefore, we extensively characterized S. flexneri Z strains using various phenotypic and molecular tools. Method Of 3569 S. flexneri isolated between 1997 and 2015, 95 strains were identified as S. flexneri Z using a panel of polyvalent absorbed antisera and monoclonal antisera of S. flexneri (MASF). Of them, randomly selected 65 strains were molecular O-serotyped using multiplex PCR and characterized using different phenotypic and molecular techniques (i.e. biotyping, plasmid profile, virulence marker and PFGE) to determine relationship with other subsero-types of S. flexneri. Results All these atypical S. flexneri Z strains were agglutinated with MASF B and IV-I antisera. Concordantly, these strains were positive to opt-gene, responsible for MASF IV-I sero-positive phenotype. However, molecular O-serotyping of all 65 strains could not differentiate between Z and Yb giving similar amplification products (wzx1-5 and opt). Contrarily, MASF based serotypic scheme distinguished among Z and Yb as well as Ya. All these S. flexneri Z showed typical biochemical reaction of S. flexneri, harboured a 140 MDa virulence plasmid and virulence markers namely ipaH, ial, sen, sigA and sepA genes. Along with the virulence plasmid, small plasmids (2.6, 1.8 and 1.6 MDa) were present as core plasmid. Moreover, a middle ranged plasmid and a 4.0 MDa sized plasmid were observed in 65% and 20% strains, respectively. Analysis of PFGE on XbaI-digested chromosomal DNA of Bangladeshi strains showed that S. flexneri Z had a close relatedness with Ya and Yb but completely different than the strains of Xa, Xb, 2a and 2b. This observation was found to be unequivocal while the overall result of biotyping, plasmid profile, and virulence factors was compared. Therefore, we conclude that these atypical serotype Z isolated in Bangladesh had a clonal relationship with Ya and Yb of Bangladesh and the opt gene played an important role in serotypic switching among them. Current serotyping scheme of S. flexneri strains fails to place many such atypical strains (1c, 1c+6, 1d, type 4, and 4c) including S. flexneri Z isolated from different parts of the world. Therefore, an updated serotyping scheme for identification of subserotypes of S. flexneri has been proposed to avoid multiple naming of the same subserotype having similar agglutination pattern.	[Shahnaij, Mohammad; Latif, Hasan A.; Azmi, Ishrat J.; Amin, Mohammed Badrul; Luna, Sharmin J.; Islam, Mohammad Aminul] Int Ctr Diarrhoea Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh; [Talukder, Kaisar Ali] Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Santosh, Tangail, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Mawlana Bhashani Science & Technology University	Talukder, KA (corresponding author), Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Santosh, Tangail, Bangladesh.	katalukdar@yahoo.com	Shahnaij, Mohammad/GMX-3978-2022	Mohammad, Shahnaij/0000-0002-3693-7239; Amin, Mohammed Badrul/0000-0002-7181-6432; Talukder, Kaisar Ali/0000-0002-5538-1387	Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development (UK Aid)	Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development (UK Aid)	This research study was funded by core donors which provide unrestricted support to icddr,b for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development (UK Aid). The authors gratefully acknowledge these donors for their support and commitment to icddr,b's research efforts.	Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Azmi IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102533; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; CARLIN NIA, 1984, EUR J BIOCHEM, V139, P189, DOI 10.1111/j.1432-1033.1984.tb07993.x; CARLIN NIA, 1989, J CLIN MICROBIOL, V27, P1163, DOI 10.1128/JCM.27.6.1163-1166.1989; CARLIN NIA, 1987, INFECT IMMUN, V55, P1412, DOI 10.1128/IAI.55.6.1412-1420.1987; CARLIN NIA, 1986, INFECT IMMUN, V53, P103, DOI 10.1128/IAI.53.1.103-109.1986; Connor TR, 2015, ELIFE, V4, DOI 10.7554/eLife.07335; Das SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062029; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Edwards PR, 1972, IDENTIFICATION ENTER, P126; Gentle A, 2016, J CLIN MICROBIOL, V54, P1456, DOI 10.1128/JCM.03386-15; HAIDER K, 1989, EPIDEMIOL INFECT, V102, P421, DOI 10.1017/S0950268800030132; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KENNE L, 1977, CARBOHYD RES, V56, P363, DOI 10.1016/S0008-6215(00)83357-1; Knirel YA, 2013, GLYCOBIOLOGY, V23, P475, DOI 10.1093/glycob/cws222; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Luo X, 2012, DIAGN MICR INFEC DIS, V74, P316, DOI 10.1016/j.diagmicrobio.2012.06.022; Mao YL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-21; MUNSHI MH, 1987, LANCET, V2, P419; Noriega FR, 1999, INFECT IMMUN, V67, P782, DOI 10.1128/IAI.67.2.782-788.1999; OKADA N, 1991, MOL MICROBIOL, V5, P2171, DOI 10.1111/j.1365-2958.1991.tb02147.x; Organization, 1999, GEN PROT EST BURD SH, V99, P26; Organization WH, MAN LAB INV AC ENT I, P9; PRYAMUKHINA NS, 1988, J CLIN MICROBIOL, V26, P1147, DOI 10.1128/JCM.26.6.1147-1149.1988; Qiu S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.10.019; Qiu SF, 2011, J CLIN MICROBIOL, V49, P1148, DOI 10.1128/JCM.01946-10; Rossi O, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0061-5; SIMMONS DAR, 1987, J MED MICROBIOL, V23, P289, DOI 10.1099/00222615-23-4-289; Stagg RM, 2009, J BACTERIOL, V191, P6612, DOI 10.1128/JB.00628-09; Sun Q, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCED CLOUD AND BIG DATA (CBD), P8, DOI 10.1109/CBD.2013.3; Sun QZ, 2014, GLYCOBIOLOGY, V24, P305, DOI 10.1093/glycob/cwt115; Sun QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046095; Sun QZ, 2011, J CLIN MICROBIOL, V49, P3766, DOI 10.1128/JCM.01259-11; Talukder KA, 2003, J CLIN MICROBIOL, V41, P110, DOI 10.1128/JCM.41.1.110-117.2003; Talukder KA, 1999, J MED MICROBIOL, V48, P781, DOI 10.1099/00222615-48-8-781; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2001, J CLIN MICROBIOL, V39, P3757, DOI 10.1128/JCM.39.10.3757-3759.2001; Toapanta FR, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1439-1; van der Ploeg CA, 2015, REV ARGENT MICROBIOL, V47, P36, DOI 10.1016/j.ram.2014.11.001; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29124; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202704	10.1371/journal.pone.0202704	http://dx.doi.org/10.1371/journal.pone.0202704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142163	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500026
J	Murarka, P; Srivastava, P				Murarka, Pooja; Srivastava, Preeti			An improved method for the isolation and identification of unknown proteins that bind to known DNA sequences by affinity capture and mass spectrometry	PLOS ONE			English	Article							MOBILITY SHIFT ASSAY; CROSS-LINKING; CELL-CULTURE; AMINO-ACIDS; FORMALDEHYDE; TOOL; RNA	Transcription of a gene can be regulated at many different levels. One such fundamental level is interaction between protein and DNA. Protein(s) binds to distinct sites on the DNA, which activate, enhance or repress transcription. Despite being such an important process, very few tools exist to identify the proteins that interact with chromosome, most of which are in vitro in nature. Here, we propose an in vivo based method for identification of DNA binding protein(s) in bacteria where the DNA-protein complex formed in vivo is crosslinked by form-aldehyde. This complex is further isolated and the bound proteins are identified. The method was used to isolate promoter DNA binding proteins, which bind and regulate the dszoperon in Gordonia sp. IITR 100 responsible for biodesulfurization of organosulfurs. The promoter binding proteins were identified by MALDI ToF MS/MS and the binding was confirmed by gel shift assay. Unlike other reported in vivo methods, this improved method does not require sequence of the whole genome or a chip and can be scaled up to improve yields.	[Murarka, Pooja; Srivastava, Preeti] Indian Inst Technol, Dept Biochem Engn & Biotechnol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Srivastava, P (corresponding author), Indian Inst Technol, Dept Biochem Engn & Biotechnol, New Delhi, India.	preeti@dbeb.iitd.ac.in; preetisrivastava@hotmail.com			Department of Biotechnology, Government of India Innovative Young Biotechnologist award (DBT-IYBA) grant; CSIR	Department of Biotechnology, Government of India Innovative Young Biotechnologist award (DBT-IYBA) grant; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by the Department of Biotechnology, Government of India Innovative Young Biotechnologist award (DBT-IYBA) grant to PS. PM would like to thank CSIR for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; Butala M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp043; Carey MF, 2012, COLD SPRING HARBOR P, V2012; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FRIED MG, 1989, ELECTROPHORESIS, V10, P366, DOI 10.1002/elps.1150100515; Gade P, 2012, METHODS MOL BIOL, V809, P85, DOI 10.1007/978-1-61779-376-9_6; GILMOUR DS, 1985, MOL CELL BIOL, V5, P2009, DOI 10.1128/MCB.5.8.2009; Griffin TJ, 2001, J BIOL CHEM, V276, P45497, DOI 10.1074/jbc.R100014200; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Hudson WH, 2014, NAT REV MOL CELL BIO, V15, P749, DOI 10.1038/nrm3884; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Jaishankar J, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00230-17; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mittler G, 2008, GENOME RES; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PIDDINGTON CS, 1995, APPL ENVIRON MICROB, V61, P468, DOI 10.1128/AEM.61.2.468-475.1995; Qiu HB, 2009, J PROTEOME RES, V8, P1983, DOI 10.1021/pr8009319; Ruscher K, 2000, J BIOTECHNOL, V78, P163, DOI 10.1016/S0168-1656(00)00207-8; Sambrook J., 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sitkiewicz Izabela, 2009, BMC Microbiol, V9, P32, DOI 10.1186/1471-2180-9-32; Soufi B, 2014, METHODS MOL BIOL, V1188, P9, DOI 10.1007/978-1-4939-1142-4_2; Stefanovic D, 2003, J BIOL CHEM, V278, P42737, DOI 10.1074/jbc.M307058200; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; Wu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026217	30	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202602	10.1371/journal.pone.0202602	http://dx.doi.org/10.1371/journal.pone.0202602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138440	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100092
J	Zhang, XY; Zhang, FY; Yang, J; Yang, WY; Liu, WN; Gao, LW; Peng, ZH; Wang, Y				Zhang, Xiyan; Zhang, Fengyun; Yang, Jie; Yang, Wenyi; Liu, Weina; Gao, Liuwei; Peng, Zhihang; Wang, Yan			Prevalence of overweight and obesity among primary school-aged children in Jiangsu Province, China, 2014-2017	PLOS ONE			English	Article							CHILDHOOD OBESITY; HOUSEHOLD INCOME; UNITED-STATES; RISK; EDUCATION; ADULTS	Background Data was limited on prevalence of overweight and obesity among primary school-aged children in Jiangsu Province. We aimed to present the current situation of obesity in Jiangsu Province and explore the relationship between obesity and other common diseases in children. Methods Physical examination among children aged 7 to 14 years in Jiangsu Province was conducted since 2014, and more than one third primary schools were covered annually. The physical measurements included body height, weight, blood pressure, vision, sex, age, and so on. Results The prevalence of overweight and obesity among primary school children was 15.2% (18.7% for male students and 11.0% for female students), and 11.7% (14.5% for male students and 8.2% for female students) respectively. Obesity/overweight prevalence varied by regions. Among them the lowest prevalence was found in the southern region of Jiangsu Province, where residents had the highest average income level. Obesity group had elevated blood pressure comparing with the normal group, and obesity group especially in the male children aged 7 to 12 years had a higher prevalence of uncorrected visual acuity (UCVA) than that of normal group. Conclusion This study found that obesity/overweight prevalence differed by sex, age, and regions in Jiangsu Province. In addition, obese children were closely associated with other common disease. Further studies are needed to explore the basis of biological and statistical theories.	[Zhang, Xiyan; Zhang, Fengyun; Yang, Jie; Yang, Wenyi; Liu, Weina; Gao, Liuwei; Wang, Yan] Jiangsu Prov Ctr Dis Control & Prevent, Dept Child & Adolescent Hlth Promot, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiyan; Zhang, Fengyun; Yang, Jie; Yang, Wenyi; Liu, Weina; Gao, Liuwei; Wang, Yan] Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiyan; Zhang, Fengyun; Yang, Jie; Yang, Wenyi; Liu, Weina; Gao, Liuwei; Wang, Yan] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Wang, Y (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Child & Adolescent Hlth Promot, Nanjing, Jiangsu, Peoples R China.; Wang, Y (corresponding author), Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Wang, Y (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China.	wangyan8269@126.com			Demonstration project of comprehensive prevention and control of emerging infectious diseases [BE2015714]	Demonstration project of comprehensive prevention and control of emerging infectious diseases	This research was supported by Demonstration project of comprehensive prevention and control of emerging infectious diseases (BE2015714); http://www.jshealth.com/xxgk/sewcjz/xmzl/sbjkt/201708/t20170830_59379.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6; Barros R, 2016, CLIN NUTR; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Hu L, 2017, PLOS ONE, V12; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P1, DOI 10.3967/0895-3988.2013.01.001; Ji CY, 2008, INT J CARDIOL, V131, P1, DOI 10.1016/j.ijcard.2008.05.078; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Jin JX, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0052-9; Li CY, 2014, 2014 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS (APCCAS), P9, DOI 10.1109/APCCAS.2014.7032706; Lim LS, 2010, OPHTHALMOLOGY, V117, P993, DOI 10.1016/j.ophtha.2009.10.003; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ogden CL, 2010, NCHS DATA BRIEF, P1, DOI DOI 10.2011/01/08:1-8; Ogden CL, 2018, MMWR-MORBID MORTAL W, V67, P186, DOI 10.15585/mmwr.mm6706a3; Ogden CL, 2017, MMWR-MORBID MORTAL W, V66, P1369, DOI 10.15585/mmwr.mm6650a1; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Petersen MR, 2006, AM J EPIDEMIOL, V163, P1158, DOI 10.1093/aje/kwj162; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Wang K, 2015, PLOS ONE, V10; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Wang ZW, 2014, INT J CARDIOL, V174, P721, DOI 10.1016/j.ijcard.2014.03.117; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; You QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052668	32	12	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202681	10.1371/journal.pone.0202681	http://dx.doi.org/10.1371/journal.pone.0202681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138424	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100106
J	Zinner, D; Atickem, A; Beehner, JC; Bekele, A; Bergman, TJ; Burke, R; Dolotovskaya, S; Fashing, PJ; Gippoliti, S; Knauf, S; Knauf, Y; Mekonnen, A; Moges, A; Nguyen, N; Stenseth, NC; Roos, C				Zinner, Dietmar; Atickem, Anagaw; Beehner, Jacinta C.; Bekele, Afework; Bergman, Thore J.; Burke, Ryan; Dolotovskaya, Sofya; Fashing, Peter J.; Gippoliti, Spartaco; Knauf, Sascha; Knauf, Yvonne; Mekonnen, Addisu; Moges, Amera; Nguyen, Nga; Stenseth, Nils Chr; Roos, Christian			Phylogeography, mitochondrial DNA diversity, and demographic history of geladas (Theropithecus gelada)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; RIFT-VALLEY; BABOONS; CERCOPITHECIDAE; NEUTRALITY; ALGORITHM; SELECTION; ALIGNMENT; PATTERNS; ETHIOPIA	The large-bodied, terrestrial primates in the tribe Papionini are among the most intensely studied animals in the world, yet for some members of this tribe we know comparatively little about their evolutionary history and phylogeography. Geladas (Theropithecus gelada Ruppell, 1835), endemic primates of the Ethiopian highlands, are largely unstudied both in genetic diversity and intrageneric phylogeny. Currently, a northern and central subspecies and one isolated southern population are recognized, of which the central is classified as Least Concern, the northern as Vulnerable, and the southern is not yet assessed. The distribution and taxonomy of the subspecies remain poorly defined. Here, we estimate the mitochondrial DNA (mtDNA) diversity and phylogenetic relationships among gelada mtDNA lineages based on samples across the entire species range. We analysed 1.7 kb-long sequences of the mtDNA genome, spanning the cytochrome b gene and the hypervariable region I of the D-loop, derived from 162 faecal samples. We detected five major haplogroups or clades (south, central-1, central-2, north-1, north-2) which diverged between 0.67 and 0.43 million years ago, thus suggesting a rapid radiation, resulting in largely unresolved intrageneric phylogenetic relationships. Both, the northern and central demes contain two similarly valid haplogroups, each with little or no geographic segregation among respective haplogroups. Effective population sizes of the northern and central demes decreased during and after the last glacial maximum but remained stable for the southern deme, although on a very low level. The distribution of haplogroups within the geographic ranges of the putative gelada subspecies indicates that mtDNA sequence information does not allow reliable taxonomic inferences and thus is not sufficient for solving the taxonomic rank of the three demic populations, with the possible exception of the southern population. Nevertheless, due to the genetic differences all three populations deserve conservation efforts, in particular the smallest southern population.	[Zinner, Dietmar; Atickem, Anagaw] Leibniz Inst Primate Res, German Primate Ctr DPZ, Cognit Ethol Lab, Kellnerweg 4, Gottingen, Germany; [Atickem, Anagaw; Dolotovskaya, Sofya; Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr DPZ, Primate Genet Lab, Kellnerweg 4, Gottingen, Germany; [Beehner, Jacinta C.; Bergman, Thore J.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Beehner, Jacinta C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Bekele, Afework; Mekonnen, Addisu; Stenseth, Nils Chr] Addis Ababa Univ, Coll Nat Sci, Dept Zool Sci, Addis Ababa, Ethiopia; [Bergman, Thore J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Burke, Ryan] Univ Oxford, Dept Zool, Long Term Ecol Lab, Oxford, England; [Fashing, Peter J.; Nguyen, Nga] Calif State Univ Fullerton, Dept Anthropol & Environm Studies Program, Fullerton, CA 92634 USA; [Gippoliti, Spartaco] Soc Italiana Storia Fauna G Altobello, Viale Liegi 48A, Rome, Italy; [Knauf, Sascha; Knauf, Yvonne] Leibniz Inst Primate Res, German Primate Ctr, Infect Biol Unit, Work Grp Neglected Trop Dis, Kellnerweg 4, Gottingen, Germany; [Knauf, Yvonne] Univ Gottingen, Dept Anim Sci, Burckhardtweg 2, Gottingen, Germany; [Mekonnen, Addisu; Stenseth, Nils Chr] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Moges, Amera] Bahir Dar Univ, Coll Nat Sci, Dept Biol, Bahir Dar, Ethiopia; [Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr DPZ, Gene Bank Primates, Kellnerweg 4, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Addis Ababa University; University of Michigan System; University of Michigan; University of Oxford; California State University System; California State University Fullerton; Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Oslo; Bahir Dar University; Deutsches Primatenzentrum (DPZ)	Zinner, D (corresponding author), Leibniz Inst Primate Res, German Primate Ctr DPZ, Cognit Ethol Lab, Kellnerweg 4, Gottingen, Germany.; Roos, C (corresponding author), Leibniz Inst Primate Res, German Primate Ctr DPZ, Primate Genet Lab, Kellnerweg 4, Gottingen, Germany.; Roos, C (corresponding author), Leibniz Inst Primate Res, German Primate Ctr DPZ, Gene Bank Primates, Kellnerweg 4, Gottingen, Germany.	dzinner@gwdg.de; croos@dpz.eu	Knauf, Sascha/F-1661-2017; Bergman, Thore J/B-8196-2008; Dolotovskaya, Sofya/AAA-4050-2020; Gippoliti, Spartaco/ABG-6852-2021; Mekonnen, Addisu/U-6087-2018	Knauf, Sascha/0000-0001-5744-4946; Bergman, Thore J/0000-0002-9615-5001; Dolotovskaya, Sofya/0000-0002-1401-3764; Gippoliti, Spartaco/0000-0001-5025-7216; Mekonnen, Addisu/0000-0001-8403-1071; Zinner, Dietmar/0000-0003-3967-8014	Primate Action Fund [PAF 13-14, 64779/1000103]; Alexander von Humboldt Foundation - Georg Forster Research Awards; Margot Marsh Biodiversity Foundation; US-Norway Fulbright Foundation; University of Michigan; Primate Conservation Inc; PCI [1173, 1409]; International Primatological Society; British Ecological Society [5190-6232]; Rufford Small Grants for Nature Conservation [18192-1]; Sacramento Zoo Conservation Fund; Bronx Zoo; San Diego Zoo	Primate Action Fund; Alexander von Humboldt Foundation - Georg Forster Research Awards(Alexander von Humboldt Foundation); Margot Marsh Biodiversity Foundation; US-Norway Fulbright Foundation; University of Michigan(University of Michigan System); Primate Conservation Inc; PCI; International Primatological Society; British Ecological Society; Rufford Small Grants for Nature Conservation; Sacramento Zoo Conservation Fund; Bronx Zoo; San Diego Zoo	This research was supported by the Primate Action Fund: PAF 13-14, CI Grant 64779/1000103 (www.conservation.org) to DZ, CR; the Alexander von Humboldt Foundation - Georg Forster Research Awards (www.humboldt-foundation.de/web/home.html) to AA; Margot Marsh Biodiversity Foundation to PF; the US-Norway Fulbright Foundation (https://fulbright.no/) to PJF; the University of Michigan to JCB, TJB; the Primate Conservation Inc; PCI #1173; #1409 (www.primate.org/) to RB; the International Primatological Society (www.internationalprimatologicalsociety.org/) to RB; the British Ecological Society, 5190-6232 (www.britishecologicalsociety.org/) to A. Mekonnen; the Rufford Small Grants for Nature Conservation, 18192-1 (www.rufford.org) to A. Moges; the Sacramento Zoo Conservation Fund to JCB, TJB; the Bronx Zoo to TJB, JCB; and the San Diego Zoo to PJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu K, 2018, PRIMATES, V59, P153, DOI 10.1007/s10329-017-0640-9; Alba DM, 2014, J HUM EVOL, V76, P92, DOI 10.1016/j.jhevol.2014.06.005; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Avise John C., 2008, P5; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belay G, 1998, PRIMATES, V39, P183, DOI 10.1007/BF02557730; Belay G, 2006, BIOCHEM SYST ECOL, V34, P554, DOI 10.1016/j.bse.2006.01.004; Belmaker M, 2010, J HUM EVOL, V58, P79, DOI 10.1016/j.jhevol.2009.08.004; Bergman TJ., 2013, MAMMALS AFRICA, V2, P240; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Butynski TM, 2008, THE IUCN RED LIST OF, DOI [10.2305/IUCN.UK.2008.RLTS.T4240A10699069.en, DOI 10.2305/IUCN.UK.2008.RLTS.T4240A10699069.EN]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chala D, 2016, ECOL EVOL, V6, P8931, DOI 10.1002/ece3.2603; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; CRONIN JE, 1979, SYST ZOOL, V28, P259, DOI 10.2307/2412581; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Beaux O., 1925, ATTI SOC ITAL SCI NA, V64, P196; DELSON E, 1993, THEROPITHECUS, P157, DOI 10.1017/CBO9780511565540.006; Depaulis F, 2003, J MOL EVOL, V57, pS190, DOI 10.1007/s00239-003-0027-y; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUNBAR RIM, 1993, THEROPITHECUS, P425, DOI 10.1017/CBO9780511565540.016; Dunbar RIM, 1998, GLOB CHANGE BIOL, V4, P293, DOI 10.1046/j.1365-2486.1998.00156.x; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 2010, CONSERV GENET, V11, P661, DOI 10.1007/s10592-009-0010-2; Frost SR, 2014, J HUM EVOL, V76, P39, DOI 10.1016/j.jhevol.2014.05.003; Fu YX, 1997, GENETICS, V147, P915; Geberemedhin B, 2008, THE IUCN RED LIST OF, DOI [10.2305/IUCN.UK.2008.RLTS.T3797A10089871.en, DOI 10.2305/IUCN.UK.2008.RLTS.T3797A10089871.EN]; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gippoliti S., 2008, THE IUCN RED LIST OF, DOI [10.2305/IUCN.UK.2008.RLTS.T136849A4346820.en, DOI 10.2305/IUCN.UK.2008.RLTS.T136849A4346820.EN]; Gippoliti S, 2008, THE IUCN RED LIST OF, DOI [10.2305/IUCN.UK.2008.RLTS.T40010A10301093.en, DOI 10.2305/IUCN.UK.2008.RLTS.T40010A10301093.EN]; Gippoliti S, 2018, BIOL REV, V93, P115, DOI 10.1111/brv.12335; Gippoliti S, 2010, PRIMATES, V51, P291, DOI 10.1007/s10329-010-0202-x; Gottelli D, 2004, MOL ECOL, V13, P2275, DOI 10.1111/j.1365-294X.2004.02226.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREIG JC, 1979, S AFR J WILDL RES, V9, P57; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Groves C.P., 2001, PRIMATE TAXONOMY; Groves CP, 2017, CONSERV GENET, V18, P1247, DOI 10.1007/s10592-017-0976-0; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hill WCO, 1970, COMPARATIVE ANATOMY; IUCN SSC Antelope Specialist Group, 2016, THE IUCN RED LIST OF, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22046A50195483.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22046A50195483.EN]; IWAMOTO M, 1980, J ANTHROPOL SOC NIP, V88, P387; JABLONSKI NG, 1993, THEROPITHECUS, P209, DOI 10.1017/CBO9780511565540.008; Jablonski Nina G., 2010, P393; Jarvis A, 2008, HOLE FILLED SRTM FOR; JOLLY C J, 1972, Bulletin of the British Museum (Natural History) Geology, V22, P1; Jolly CJ, 2013, MAMMALS AFRICA, P239; Kalbitzer U, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0693-1; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Keller C, 2010, AM J PHYS ANTHROPOL, V142, P125, DOI 10.1002/ajpa.21209; Kingdon J., 1997, THE KINGDON FIELD GU; Kopp GH, 2014, J HUM EVOL, V76, P154, DOI 10.1016/j.jhevol.2014.08.003; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liedigk R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0176-1; Marino J., 2011, IUCN REDLIST THREATE, V2011, DOI [DOI 10.2305/IUCN.UK.2011-1.RLTS.T3748A10051312.EN, 10.2305/IUCN.UK.2011-1.RLTS.T3748A10051312.en]; MORI A, 1990, PRIMATES, V31, P495, DOI 10.1007/BF02382533; Neumann O, 1902, GEOGR J, V20, P373, DOI 10.2307/1775561; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nguyen N, 2016, UNPUBL FINAL REPORT; Nguyen N, 2017, AM J PHYS ANTHROPOL, V163, P14, DOI 10.1002/ajpa.23141; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Pucheran J, 1857, REV MAG ZOOL, V9, P241; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Roeder AD, 2004, MOL ECOL NOTES, V4, P761, DOI 10.1111/j.1471-8286.2004.00737.x; Ruppell E., 1835, NEUE WIRBELTHIERE ZU; Schneider-Crease I, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22684; Shotake T, 2016, ANTHROPOL SCI, V124, P157, DOI 10.1537/ase.160717; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; TAJIMA F, 1989, GENETICS, V123, P585; Ting N, 2012, ECOL EVOL, V2, P550, DOI 10.1002/ece3.98; Xue C, 2016, GENOME RES, V26, P1651, DOI 10.1101/gr.204255.116; YALDEN D W, 1977, Monitore Zoologico Italiano Supplemento, V9, P1; YALDEN DW, 1992, MAMMAL REV, V22, P115, DOI 10.1111/j.1365-2907.1992.tb00128.x; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618; Zinner D, 2013, HDB MAMMALS WORLD, V3, P550; Zinner Dietmar, 2015, Journal of East African Natural History, V104, P143; Zinner D, 2016, DEV PRIMATOL-PROG PR, P193, DOI 10.1007/978-3-319-30469-4_11; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	84	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202303	10.1371/journal.pone.0202303	http://dx.doi.org/10.1371/journal.pone.0202303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138418	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100051
J	Badin, A; Braun, F; Halloran, LJS; Maillard, J; Hunkeler, D				Badin, Alice; Braun, Fabian; Halloran, Landon J. S.; Maillard, Julien; Hunkeler, Daniel			Modelling of C/Cl isotopic behaviour during chloroethene biotic reductive dechlorination: Capabilities and limitations of simplified and comprehensive models	PLOS ONE			English	Article							RATIO MASS-SPECTROMETRY; ORGANIC CONTAMINANTS; CHLORINATED ETHENES; CARBON; FRACTIONATION; TCE; TRANSFORMATION; BIODEGRADATION; HYDROGEN; TETRACHLOROETHENE	Predicting the fate of chloroethenes in groundwater is essential when evaluating remediation strategies. Such predictions are expected to be more accurate when incorporating isotopic parameters. Although secondary chlorine isotope effects have been observed during reductive dechlorination of chloroethenes, development of modelling frameworks and simulation has thus far been limited. We have developed a novel mathematical framework to simulate the C/Cl isotopic fractionation during reductive dechlorination of chloroethenes. This framework differs from the existing state of the art by incorporating secondary isotopic effects and considering both C and Cl isotopes simultaneously. A comprehensive general model (GM), which is expected to be the closest representation of reality thus far investigated, was implemented. A less computationally intensive simplified model (SM), with the potential for use in modelling of complex reactive transport scenarios, was subsequently validated based on its comparison to GM. The approach of GM considers all isotopocules (i.e. molecules differing in number and position of heavy and light isotopes) of each chloroethene as individual species, of which each is degraded at a different rate. Both models GM and SM simulated plausible C/Cl isotopic compositions of tetrachloroethene (PCE), trichloroethene (TCE) and cis-1,2-dichloroethene (cDCE) during sequential dechlorination when using experimentally relevant kinetic and isotopic parameters. The only major difference occurred in the case where different secondary isotopic effects occur at the different non-reacting positions when PCE is dechlorinated down to cDCE. This observed discrepancy stems from the unequal Cl isotope distribution in TCE that arises due to the occurrence of differential secondary Cl isotopic effects during transformation of PCE to TCE. Additionally, these models are shown to accurately reproduce experimental data obtained during reductive dechlorination by bacterial enrichments harbouring Sulfurospirillum spp. where secondary isotope effects are known to have occurred. These findings underscore a promising future for the development of reactive transport models that incorporate isotopic parameters.	[Badin, Alice; Halloran, Landon J. S.; Hunkeler, Daniel] Univ Neuchatel, Ctr Hydrogeol & Geotherm CHYN, Neuchatel, Switzerland; [Braun, Fabian] Swiss Ctr Elect & Microtechnol CSEM, Syst Div, Neuchatel, Switzerland; [Braun, Fabian] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland; [Maillard, Julien] Ecole Polytech Fed Lausanne, Lab Environm Biotechnol, Lausanne, Switzerland	University of Neuchatel; Swiss Center for Electronics & Microtechnology (CSEM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Halloran, LJS; Hunkeler, D (corresponding author), Univ Neuchatel, Ctr Hydrogeol & Geotherm CHYN, Neuchatel, Switzerland.	landon.halloran@unine.ch; daniel.hunkeler@unine.ch		Braun, Fabian/0000-0002-0864-2804; Halloran, Landon James Szasz/0000-0002-0205-5430; Maillard, Julien/0000-0002-7498-7202	Marie Curie Initial Training Network "ADVOCATE - Advancing sustainable in situ remediation for contaminated land and groundwater"; European Commission, Marie Curie Actions [265063]; Swiss National Science Foundation [166233]; Marie Curie Initial Training Network "ADVOCATE-Advancing sustainable in situ remediation for contaminated land and groundwater" - European Commission, Marie Curie Actions [265063]; Swiss National Science Foundation (FNS/SNF) [166233]	Marie Curie Initial Training Network "ADVOCATE - Advancing sustainable in situ remediation for contaminated land and groundwater"; European Commission, Marie Curie Actions(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Initial Training Network "ADVOCATE-Advancing sustainable in situ remediation for contaminated land and groundwater" - European Commission, Marie Curie Actions; Swiss National Science Foundation (FNS/SNF)(Swiss National Science Foundation (SNSF))	AB received funding from the Marie Curie Initial Training Network "ADVOCATE - Advancing sustainable in situ remediation for contaminated land and groundwater," funded by the European Commission, Marie Curie Actions Project No. 265063 (http://www.theadvocateproject.eu/). LJSH and DH received funding from the Swiss National Science Foundation Project "Tracking reactive processes in low permeability sediments and their effect on contaminant longevity in aquifers using compound-specific isotope analysis," number 166233 (http://p3.snf.ch/Project-166233).; Christof Holliger (EPFL) is acknowledged for providing the bacterial consortia and Geraldine Buttet (EPFL) is thanked for her help with setting up microcosms. Alice Badin was supported by the Marie Curie Initial Training Network "ADVOCATE-Advancing sustainable in situ remediation for contaminated land and groundwater," funded by the European Commission, Marie Curie Actions Project No. 265063. Landon Halloran was supported in part by Swiss National Science Foundation (FNS/SNF) project number 166233.	Aeppli C, 2010, ANAL CHEM, V82, P420, DOI 10.1021/ac902445f; Aeppli C, 2009, ENVIRON SCI TECHNOL, V43, P8813, DOI 10.1021/es901481b; Atteia O, 2008, ENVIRON SCI TECHNOL, V42, P3289, DOI 10.1021/es071269m; Badin A, 2014, ENVIRON SCI TECHNOL, V48, P9179, DOI 10.1021/es500822d; Bernstein A, 2011, ANAL CHEM, V83, P7624, DOI 10.1021/ac200516c; Cretnik S, 2014, MOLECULES, V19, P6450, DOI 10.3390/molecules19056450; Cretnik S, 2013, ENVIRON SCI TECHNOL, V47, P6855, DOI 10.1021/es400107n; Elsner M, 2005, ENVIRON SCI TECHNOL, V39, P6896, DOI 10.1021/es0504587; Elsner M, 2010, J ENVIRON MONITOR, V12, P2005, DOI 10.1039/c0em00277a; Hohener P, 2016, J CONTAM HYDROL, V195, P52, DOI 10.1016/j.jconhyd.2016.11.002; Hohener P, 2010, ADV WATER RESOUR, V33, P740, DOI 10.1016/j.advwatres.2010.03.016; Hunkeler D, 2004, J CONTAM HYDROL, V74, P265, DOI 10.1016/j.jconhyd.2004.03.003; HUNKELER D, 2010, ENV ISOTOPES BIODEGR; Hunkeler D, 2011, ENVIRON SCI TECHNOL, V45, P8247, DOI 10.1021/es201415k; Hunkeler D, 2009, ENVIRON SCI TECHNOL, V43, P6750, DOI 10.1021/es900579z; Jin B, 2013, ENVIRON SCI TECHNOL, V47, P1443, DOI 10.1021/es304053h; Jin BA, 2011, ENVIRON SCI TECHNOL, V45, P5279, DOI 10.1021/es200749d; KOMPALA DS, 1984, BIOTECHNOL BIOENG, V26, P1272, DOI 10.1002/bit.260261103; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Kuder T, 2013, ENVIRON SCI TECHNOL, V47, P9668, DOI 10.1021/es400463p; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Meckenstock R. U., 2015, ENV SCI TECHNOLOGY; Meckenstock RU, 2004, J CONTAM HYDROL, V75, P215, DOI 10.1016/j.jconhyd.2004.06.003; Palau J, 2014, SCI TOTAL ENVIRON, V475, P61, DOI 10.1016/j.scitotenv.2013.12.059; Sakaguchi-Soder K, 2007, RAPID COMMUN MASS SP, V21, P3077, DOI 10.1002/rcm.3170; Shouakar-Stash O, 2003, J CONTAM HYDROL, V60, P211, DOI 10.1016/S0169-7722(02)00085-2; van Breukelen BM, 2005, ENVIRON SCI TECHNOL, V39, P4189, DOI 10.1021/es048973c; Van Breukelen BM, 2007, ENVIRON SCI TECHNOL, V41, P4004, DOI 10.1021/es0628452; Van Breukelen BM, 2017, J CONTAM HYDROL, V204, P79, DOI 10.1016/j.jconhyd.2017.07.003; Yu S, 2004, BIOTECHNOL BIOENG, V88, P451, DOI 10.1002/bit.20260	30	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202416	10.1371/journal.pone.0202416	http://dx.doi.org/10.1371/journal.pone.0202416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133496	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400070
J	Hamilton, J; Brustovetsky, T; Rysted, JE; Lin, ZH; Usachev, YM; Brustovetsky, N				Hamilton, James; Brustovetsky, Tatiana; Rysted, Jacob E.; Lin, Zhihong; Usachev, Yuriy M.; Brustovetsky, Nickolay			Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake and induction of the permeability transition pore in brain mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; calcium; mitochondrial permeability transition (MPT); mitochondrial membrane potential; cyclophilin D; ion channel; energy metabolism; respiration	RAT-KIDNEY MITOCHONDRIA; YAC128 MOUSE MODEL; HEART-MITOCHONDRIA; CA2+ UNIPORTER; NA+/CA2+ EXCHANGE; CORTICAL-NEURONS; HUNTINGTONS-DISEASE; ESSENTIAL COMPONENT; LIVER MITOCHONDRIA; RYANODINE RECEPTOR	Ca2+ influx into mitochondria is mediated by the mitochondrial calcium uniporter (MCU), whose identity was recently revealed as a 40-kDa protein that along with other proteins forms the mitochondrial Ca2+ uptake machinery. The MCU is a Ca2+-conducting channel spanning the inner mitochondrial membrane. Here, deletion of the MCU completely inhibited Ca2+ uptake in liver, heart, and skeletal muscle mitochondria. However, in brain nonsynaptic and synaptic mitochondria from neuronal somata/glial cells and nerve terminals, respectively, the MCU deletion slowed, but did not completely block, Ca2+ uptake. Under resting conditions, brain MCU-KO mitochondria remained polarized, and in brain MCU-KO mitochondria, the electrophoretic Ca2+ ionophore ETH129 significantly accelerated Ca2+ uptake. The residual Ca2+ uptake in brain MCU-KO mitochondria was insensitive to inhibitors of mitochondrial Na+/Ca2+ exchanger and ryanodine receptor (CGP37157 and dantrolene, respectively), but was blocked by the MCU inhibitor Ru360. Respiration of WT and MCU-KO brain mitochondria was similar except that for mitochondria that oxidized pyruvate and malate, Ca2+ more strongly inhibited respiration in WT than in MCU-KO mitochondria. Of note, the MCU deletion significantly attenuated but did not completely prevent induction of the permeability transition pore (PTP) in brain mitochondria. Expression level of cyclophilin D and ATP content in mitochondria, two factors that modulate PTP induction, were unaffected by MCU-KO, whereas ADP was lower in MCU-KO than in WT brain mitochondria. Our results suggest the presence of an MCU-independent Ca2+ uptake pathway in brain mitochondria that mediates residual Ca2+ influx and induction of PTP in a fraction of the mitochondrial population.	[Hamilton, James; Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,Med Sci Bldg,Rm 547, Indianapolis, IN 46202 USA; [Brustovetsky, Nickolay] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Rysted, Jacob E.; Lin, Zhihong; Usachev, Yuriy M.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa	Brustovetsky, N (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,Med Sci Bldg,Rm 547, Indianapolis, IN 46202 USA.	nbrous@iu.edu		Rysted, Jacob/0000-0001-5632-4176; Usachev, Yuriy/0000-0002-6948-4627; Brustovetsky, Nickolay/0000-0002-6564-2560	National Institutes of Health [R01 NS087068, R01 NS096246, R01 NS098772]; Indiana Traumatic Spinal Cord & Brain Injury Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096246, R01NS098772, R01NS087068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Traumatic Spinal Cord & Brain Injury Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS087068 and R01 NS096246 (to Y. U.) and R01 NS098772 (to N. B.). This study was supported in part by a grant from the Indiana Traumatic Spinal Cord & Brain Injury Research Fund (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bondarenko AI, 2014, PFLUG ARCH EUR J PHY, V466, P1411, DOI 10.1007/s00424-013-1383-0; Bondarenko AI, 2013, PFLUG ARCH EUR J PHY, V465, P997, DOI 10.1007/s00424-013-1224-1; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2016, WILEY SER NEUROPH, P3; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Chinopoulos C, 2018, NEUROCHEM INT, V117, P49, DOI 10.1016/j.neuint.2017.06.010; COX DA, 1993, J BIOL CHEM, V268, P938; COX DA, 1993, TRENDS PHARMACOL SCI, V14, P408, DOI 10.1016/0165-6147(93)90063-P; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Foskett JK, 2015, J MOL CELL CARDIOL, V78, P3, DOI 10.1016/j.yjmcc.2014.11.015; Griffiths EJ, 1999, FEBS LETT, V453, P400, DOI 10.1016/S0014-5793(99)00726-7; Hamilton J, 2015, HUM MOL GENET, V24, P4862, DOI 10.1093/hmg/ddv209; Hoyt KR, 1998, MOL PHARMACOL, V53, P742, DOI 10.1124/mol.53.4.742; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Izzo V, 2016, TRENDS CELL BIOL, V26, P655, DOI 10.1016/j.tcb.2016.04.006; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; Jung DW, 2004, ANAL BIOCHEM, V324, P258, DOI 10.1016/j.ab.2003.10.029; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; KIEDROWSKI L, 1995, MOL PHARMACOL, V47, P140; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; Li T, 2010, BBA-BIOENERGETICS, V1797, P52, DOI 10.1016/j.bbabio.2009.07.012; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; OESTREICHER AB, 1969, BIOCHIM BIOPHYS ACTA, V180, P45, DOI 10.1016/0005-2728(69)90192-3; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pellman JJ, 2015, J NEUROCHEM, V134, P652, DOI 10.1111/jnc.13165; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; PRESTIPINO G, 1993, ANAL BIOCHEM, V210, P119, DOI 10.1006/abio.1993.1160; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Schinder AF, 1996, J NEUROSCI, V16, P6125; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; SPECTOR AA, 1969, J LIPID RES, V10, P56; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2; VODYANOY I, 1993, BIOPHYS J, V65, P2097, DOI 10.1016/S0006-3495(93)81245-1; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; WHITE RJ, 1995, J NEUROSCI, V15, P1318; White RJ, 1996, J NEUROSCI, V16, P5688; WOJTCZAK AB, 1969, BIOCHIM BIOPHYS ACTA, V172, P52, DOI 10.1016/0005-2728(69)90091-7; WOJTCZAK L, 1969, BIOCHIM BIOPHYS ACTA, V191, P10, DOI 10.1016/0005-2744(69)90310-6; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	67	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15652	15663		10.1074/jbc.RA118.002926	http://dx.doi.org/10.1074/jbc.RA118.002926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30154242	Green Published, hybrid			2022-12-26	WOS:000446549200028
J	Morosov, X; Davoudi, CF; Baumgart, M; Brocker, M; Bott, M				Morosov, Xenia; Davoudi, Cedric-Farhad; Baumgart, Meike; Brocker, Melanie; Bott, Michael			The copper-deprivation stimulon of Corynebacterium glutamicum comprises proteins for biogenesis of the actinobacterial cytochrome bc(1)-aa(3) supercomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome oxidase; copper; Actinobacteria; respiratory chain; complex; respiration; CtiP; CopC; copper starvation; cytochrome aa(3); cytochrome c; protein assembly	CU-A CENTER; RESPIRATORY-CHAIN; ANAEROBIC GROWTH; PSEUDOMONAS-SYRINGAE; FERMENTING BACTERIUM; NITRATE RESPIRATION; MOLECULAR ANALYSIS; OXIDASE ACTIVITY; EXPRESSION; RESISTANCE	Aerobic respiration in Corynebacterium glutamicum involves a cytochrome bc(1)-aa(3) supercomplex with a diheme cytochrome c(1), which is the only c-type cytochrome in this species. This organization is considered as typical for aerobic Actinobacteria. Whereas the biogenesis of heme-copper type oxidases like cytochrome aa(3) has been studied extensively in -proteobacteria, yeast, and mammals, nothing is known about this process in Actinobacteria. Here, we searched for assembly proteins of the supercomplex by identifying the copper-deprivation stimulon, which might include proteins that insert copper into cytochrome aa(3). Using gene expression profiling, we found two copper starvation-induced proteins for supercomplex formation. The Cg2699 protein, named CtiP, contained 16 predicted transmembrane helices, and its sequence was similar to that of the copper importer CopD of Pseudomonas syringae in the N-terminal half and to the cytochrome oxidase maturation protein CtaG of Bacillus subtilis in its C-terminal half. CtiP deletion caused a growth defect similar to that produced by deletion of subunit I of cytochrome aa(3), increased copper tolerance, triggered expression of the copper-deprivation stimulon under copper sufficiency, and prevented co-purification of the supercomplex subunits. The secreted Cg1884 protein, named CopC, had a C-terminal transmembrane helix and contained a Cu(II)-binding motif. Its absence caused a conditional growth defect, increased copper tolerance, and also prevented co-purification of the supercomplex subunits. CtiP and CopC are conserved among aerobic Actinobacteria, and we propose a model of their functions in cytochrome aa(3) biogenesis. Furthermore, we found that the copper-deprivation response involves additional regulators besides the ECF sigma factor SigC.	[Morosov, Xenia; Davoudi, Cedric-Farhad; Baumgart, Meike; Brocker, Melanie; Bott, Michael] Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Bott, M (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, D-52425 Julich, Germany.	m.bott@fz-juelich.de	Bott, Michael/E-8004-2011; Baumgart, Meike/ABA-7414-2020; Baumgart, Meike/GWC-5464-2022	Bott, Michael/0000-0002-4701-8254; Baumgart, Meike/0000-0002-9874-1151; 	Northrhine-Westfalia (NRW) Research School BioStruct	Northrhine-Westfalia (NRW) Research School BioStruct	Supported by the Northrhine-Westfalia (NRW) Research School BioStruct.	ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Abicht HK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.607127; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Bellmann A, 2001, MICROBIOL-SGM, V147, P1765, DOI 10.1099/00221287-147-7-1765; Bengtsson J, 2004, MICROBIOL-SGM, V150, P415, DOI 10.1099/mic.0.26691-0; Binder S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r40; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; Burkovski A, 2015, CORYNEBACTERIUM GLUTAMICUM: FROM SYSTEMS BIOLOGY TO BIOTECHNOLOGICAL APPLICATIONS, P1; Castiglioni E, 1997, REV SCI INSTRUM, V68, P4288, DOI 10.1063/1.1148344; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; CHA JS, 1993, APPL ENVIRON MICROB, V59, P1671, DOI 10.1128/AEM.59.5.1671-1674.1993; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; Eggeling L., 2005, HDB CORYNEBACTERIUM, DOI 10.1201/9781420039696; EIKMANNS BJ, 1991, GENE, V102, P93, DOI 10.1016/0378-1119(91)90545-M; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frangipani E, 2008, J BACTERIOL, V190, P6706, DOI 10.1128/JB.00450-08; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Graf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34098; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hanssler Eva, 2008, P183; Hill BC, 2012, BBA-BIOENERGETICS, V1817, P948, DOI 10.1016/j.bbabio.2011.09.006; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; HUBBARD JA, 1989, ARCH MICROBIOL, V151, P300, DOI 10.1007/BF00406555; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kabus A, 2007, APPL ENVIRON MICROB, V73, P861, DOI 10.1128/AEM.01818-06; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kao WC, 2016, BBA-BIOENERGETICS, V1857, P1705, DOI 10.1016/j.bbabio.2016.07.009; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Khalfaoui-Hassani B, 2018, MBIO, V9, DOI 10.1128/mBio.00065-18; Kim MS, 2015, J BIOL CHEM, V290, P14350, DOI 10.1074/jbc.M114.624312; Kishikawa J, 2010, J BIOSCI BIOENG, V110, P42, DOI 10.1016/j.jbiosc.2009.12.006; Koch-Koerfges A, 2013, BBA-BIOENERGETICS, V1827, P699, DOI 10.1016/j.bbabio.2013.02.004; Kusumoto K, 2000, ARCH MICROBIOL, V173, P390, DOI 10.1007/s002030000161; Lewin GR, 2016, ANNU REV MICROBIOL, V70, P235, DOI 10.1146/annurev-micro-102215-095748; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Matsoso LG, 2005, J BACTERIOL, V187, P6300, DOI 10.1128/JB.187.18.6300-6308.2005; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Michel A, 2015, APPL ENVIRON MICROB, V81, P7496, DOI 10.1128/AEM.02413-15; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Nishimura T, 2007, APPL MICROBIOL BIOT, V75, P889, DOI 10.1007/s00253-007-0879-y; Nyvltova E., 2017, ENCY INORGANIC BIOIN, P1; Oertel D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123413; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sambrook J., 2001, MOL CLONING LAB MANU; Sawers RG, 2016, ADV MICROB PHYSIOL, V68, P1, DOI 10.1016/bs.ampbs.2016.02.004; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schaffer S, 2001, ELECTROPHORESIS, V22, P4404, DOI 10.1002/1522-2683(200112)22:20<4404::AID-ELPS4404>3.0.CO;2-2; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Schendzielorz G, 2014, ACS SYNTH BIOL, V3, P21, DOI 10.1021/sb400059y; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; SUGIYAMA Y, 1973, AGR BIOL CHEM TOKYO, V37, P1837, DOI 10.1080/00021369.1973.10860919; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Takeno S, 2007, APPL MICROBIOL BIOT, V75, P1173, DOI 10.1007/s00253-007-0926-8; Teramoto H, 2015, APPL MICROBIOL BIOT, V99, P3505, DOI 10.1007/s00253-015-6373-z; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Toyoda K, 2016, MOL MICROBIOL, V100, P486, DOI 10.1111/mmi.13330; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; von Wachenfeldt C, 2001, BACILLUS SUBTILIS IT, P163; Vrljic M, 1996, MOL MICROBIOL, V22, P815, DOI 10.1046/j.1365-2958.1996.01527.x; Yukawa H., 2013, CORYNEBACTERIUM GLUT	72	14	14	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15628	15640		10.1074/jbc.RA118.004117	http://dx.doi.org/10.1074/jbc.RA118.004117			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30154248	Green Published, hybrid			2022-12-26	WOS:000446549200026
J	Reijntjes, DOJ; Schubert, NMA; Pietrus-Rajman, A; van Dijk, P; Pyott, SJ				Reijntjes, Daniel O. J.; Schubert, Nick M. A.; Pietrus-Rajman, Alexander; van Dijk, Pim; Pyott, Sonja J.			Changes in spontaneous movement in response to silent gaps are not robust enough to indicate the perception of tinnitus in mice	PLOS ONE			English	Article							EXPOSURE; HEARING; RATS	Approaches to identify the perception of tinnitus in various animal models have been difficult to apply to mouse. As a result, mice have been underutilized to investigate the cellular, molecular, and genetic mechanisms underlying tinnitus. A recent study in guinea pigs identified a novel spontaneous behavior (unconditioned response), changes in movement during silent gaps, that identified a subgroup of animals presumably with tinnitus. Guinea pigs identified with tinnitus failed to ''freeze'' in response to silent gaps in sound. In the hope of developing a rapid and reliable assay for mice, we used a similar approach. C57BL/6J mice underwent three trials in which spontaneous movement was video recorded in the presence of white noise interrupted with six silent gaps. Movement metrics included velocity and body movement. Before the third trial, mice underwent either sham or noise exposure to induce hearing loss and tinnitus. Auditory brainstem responses before and after noise trauma confirmed normal hearing in sham-treated animals and hearing loss in the noise-exposed cohort. No differences in the various movement metrics were detected during the silent gaps either before or after sham/noise exposure. Variability in spontaneous movement both before and after sham/noise exposure was substantially greater in mice compared to guinea pigs. Thus, this assay is not sufficiently statistically powerful to identify changes in movement that might indicate tinnitus perception in mice. Previous observations also reported increased movement overall in guinea pigs identified as suffering tinnitus. In contrast, mice showed no statistically significant differences in movement between the three trials. Despite our results, other unconditioned (as well as conditioned) behaviors should be examined in mice to test their utility to detect changes that indicate the perception of tinnitus. Such assays are essential to accelerate the use of mouse models in tinnitus research.	[Reijntjes, Daniel O. J.; Schubert, Nick M. A.; Pietrus-Rajman, Alexander; van Dijk, Pim; Pyott, Sonja J.] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol & Head Neck Surg, Groningen, Netherlands	University of Groningen	Pyott, SJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol & Head Neck Surg, Groningen, Netherlands.	s.pyott@umcg.nl	Pyott, Sonja/AAW-8789-2020; Reijntjes, Daniël/AAH-1877-2020; Van Dijk, Pim/E-8019-2010; Schubert, Nick/D-7744-2017	Reijntjes, Daniël/0000-0002-6485-588X; Van Dijk, Pim/0000-0002-8023-7571; Schubert, Nick/0000-0003-3611-2939; Pyott, Sonja/0000-0001-7750-2437	Heinsius Houbolt Foundation; Stichting Gehoorgestoorde Kind; University of Groningen Rosalind Franklin Fellowship	Heinsius Houbolt Foundation; Stichting Gehoorgestoorde Kind; University of Groningen Rosalind Franklin Fellowship	This study was supported by the Heinsius Houbolt Foundation, the Stichting Gehoorgestoorde Kind, the University of Groningen Rosalind Franklin Fellowship to S. J. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyen K, 2015, EAR HEARING, V36, pe138, DOI 10.1097/AUD.0000000000000156; Burkard R, 2006, BRAIN RES, V1091, P27, DOI 10.1016/j.brainres.2006.02.132; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Hayes SH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00179; Heeringa AN, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00207; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; JASTREBOFF PJ, 1988, LARYNGOSCOPE, V98, P280; Longenecker RJ, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-542; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Maes IHL, 2013, EAR HEARING, V34, P508, DOI 10.1097/AUD.0b013e31827d113a; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; Mwilambwe-Tshilobo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137749; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Swain SK, 2016, J FORMOS MED ASSOC, V115, P139, DOI 10.1016/j.jfma.2015.11.011; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; von der Behrens W, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/741452; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yu H, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00158; Zeman F, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-7; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	23	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202882	10.1371/journal.pone.0202882	http://dx.doi.org/10.1371/journal.pone.0202882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157212	Green Published, gold			2022-12-26	WOS:000443071400074
J	Sylvestre, TF; Cavalcante, RD; da Silva, JD; Paniago, AMM; Weber, SS; Pauletti, BA; de Carvalho, LR; dos Santos, LD; Mendes, RP				Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; da Silva, Julhiany de Fatima; Miranda Paniago, Anamaria Mello; Weber, Simone Schneider; Pauletti, Bianca Alves; de Carvalho, Lidia Raquel; dos Santos, Lucilene Delazari; Mendes, Rinaldo Poncio			Serological proteomic biomarkers to identify Paracoccidioides species and risk of relapse	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; BRASILIENSIS; IRON	The sensitivity of the double agar gel immunodiffusion test is about 90% in patients with untreated paracoccidioidomycosis (PCM), but it is much lower in cases of relapse. In addition, serum from patients with PCM caused by Paracoccidioides lutzii, frequent in the Midwest region of Brazil, do not react with the classical antigen obtained from Pb B-339. These findings showed the need for alternative diagnostic methods, such as biological markers through proteomics. The aim of this study was to identify biomarkers for the safe identification of PCM relapse and specific proteins that could distinguish infections caused by Paracoccidioides brasiliensis from those produced by Paracoccidioides lutzii. Proteomic analysis was performed in serum from 9 patients with PCM caused by P. brasiliensis, with and without relapse, from 4 patients with PCM produced by P. lutzii, and from 3 healthy controls. The comparative evaluation of the 29 identified plasma proteins suggested that the presence of the immunoglobulin (Ig) alpha-2 chain C region and the absence of Ig heavy chain V-III TIL indicate infection by P. lutzii. In addition, the absence of complement factor B protein might be a predictor of relapse. The evaluation of these proteins in a higher number of patients should be carried out in order to validate these findings.	[Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; da Silva, Julhiany de Fatima; Mendes, Rinaldo Poncio] Univ Estadual Paulista, UNESP, Fac Med Botucatu, Botucatu, SP, Brazil; [Miranda Paniago, Anamaria Mello; Weber, Simone Schneider] Univ Fed Mato Grosso do Sul UFMS, Fac Med, Campo Grande, Brazil; [Weber, Simone Schneider] Univ Fed Amazonas UFAM, Inst Ciencias Exatas & Tecnol, Itacoatiara, Brazil; [Pauletti, Bianca Alves] CNPEM, Lab Nacl Biociencias, Campinas, SP, Brazil; [de Carvalho, Lidia Raquel] Univ Estadual Paulista, UNESP, Inst Biociencia Botucatu, Botucatu, SP, Brazil; [dos Santos, Lucilene Delazari] UNESP, CEVAP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Amazonas; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista	Sylvestre, TF (corresponding author), Univ Estadual Paulista, UNESP, Fac Med Botucatu, Botucatu, SP, Brazil.	thaty_sylvestre@hotmail.com	de Fátima da Silva, Julhiany F/F-8706-2012; Paniago, Anamaria M M/B-7747-2012; dos Santos, Lucilene Delazari/AAY-5226-2020; de Souza Cavalcante, Ricardo/D-2058-2013; Paniago, Anamaria/AGS-6094-2022; Sylvestre, Tatiane/AAV-4449-2021; Carvalho, Lidia Raquel de/C-2973-2013	de Fátima da Silva, Julhiany F/0000-0002-9675-088X; Paniago, Anamaria M M/0000-0002-8925-7712; dos Santos, Lucilene Delazari/0000-0001-5832-1825; de Souza Cavalcante, Ricardo/0000-0001-6382-2675; Paniago, Anamaria/0000-0002-8925-7712; Weber, Simone/0000-0002-4181-142X; Carvalho, Lidia Raquel de/0000-0003-0575-2263; Sylvestre, Tatiane Fernanda/0000-0002-0023-964X				Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Andres MT, 2010, ANTIMICROB AGENTS CH, V54, P4335, DOI 10.1128/AAC.01620-09; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; ARANGO R, 1988, J MED VET MYCOL, V26, P113; Batista J, 2010, MYCOSES, V53, P176, DOI 10.1111/j.1439-0507.2008.01687.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358; Casaletti L, 2017, YEAST, V34, P179, DOI 10.1002/yea.3225; Castilho DG, 2014, J PROTEOME RES, V13, P4259, DOI 10.1021/pr5002274; Del Chierico F, 2016, EXP PARASITOL, V170, P82, DOI 10.1016/j.exppara.2016.09.007; Dias-Melicio LA, 2006, MICROBIOL IMMUNOL, V50, P307, DOI 10.1111/j.1348-0421.2006.tb03798.x; Gegembauer G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002986; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kerr MA, 1990, BIOCHEM J, V271, P185; Mailhac A, 2017, J PROTEOMICS, V152, P150, DOI 10.1016/j.jprot.2016.10.017; Marques S A, 1983, Rev Inst Med Trop Sao Paulo, V25, P87; Vidal MSM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003174; Mendes Rinaldo Poncio, 2017, Open Microbiol J, V11, P224, DOI 10.2174/1874285801711010224; Mendes RP, 1994, PARACOCCIDIOIDOMYCOS, V2, P233, DOI DOI 10.1201/9781351075329-16; Otto A, 2014, INT J MED MICROBIOL, V304, P110, DOI 10.1016/j.ijmm.2013.11.007; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Putnam FR, 1984, PLASMA PROTEINS STRU, V2, P45; RESTREPO A, 1985, SABOURAUDIA, V23, P323; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Ribeiro DM, 2008, GENET MOL RES, V7, P1045, DOI 10.4238/vol7-4gmr472; Brandao RMSD, 2014, FUTURE MICROBIOL, V9, P871, DOI [10.2217/fmb.14.49, 10.2217/FMB.14.49]; Shikanai-Yasuda MA, 1997, MYCOPATHOLOGIA, V138, P65, DOI 10.1023/A:1006806615226; Singh P, 2015, WORLD J MICROB BIOT, V31, P1923, DOI 10.1007/s11274-015-1936-9; Martins LMS, 2013, FUTURE MICROBIOL, V8, P549, DOI [10.2217/FMB.13.22, 10.2217/fmb.13.22]; Sylvestre TF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002834; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Virginio ED, 2014, INT J MOL SCI, V15, P14505, DOI 10.3390/ijms150814505; WANG AC, 1977, J BIOL CHEM, V252, P7192; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202804	10.1371/journal.pone.0202804	http://dx.doi.org/10.1371/journal.pone.0202804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157221	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400070
J	van de Rijt, A				van de Rijt, Arnout			All-sense-all networks are suboptimal for sensorimotor synchronization	PLOS ONE			English	Article							AUDITORY SEQUENCES; PHASE ATTRACTION; DYNAMICS	In human groups that seek to synchronize to a common steady beat, every member can typically perceive every other member. We question whether this naturally occurring all-senseall condition is optimal for temporal coordination. We consider alternative configurations represented by directed graphs, in which individuals can only hear or see a subset of others. We identify a trade-off in the topology of such networks: While denser graphs provide stronger coupling, improving synchrony, density increases sensitivity to early taps, which produces rushing. Results from an experimental study with music conservatory students show that networks that combine short path length with low density match all-sense-all networks in synchrony while yielding a steadier beat. These findings suggest that professional teams in arts, sports, industry, and the military may improve temporal coordination by employing technology that strategically configures who can track whom.	[van de Rijt, Arnout] Univ Utrecht, Dept Sociol, Utrecht, Netherlands	Utrecht University	van de Rijt, A (corresponding author), Univ Utrecht, Dept Sociol, Utrecht, Netherlands.	a.vanderijt@uu.nl		van de Rijt, Arnout/0000-0002-4208-3452	NSF Division of Social and Economic Sciences [1340122]; NSF [1340122]	NSF Division of Social and Economic Sciences; NSF(National Science Foundation (NSF))	This research was supported by NSF Division of Social and Economic Sciences grant #1340122 to the author (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1340122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author thanks the editor and two reviewers for very helpful comments. This research was supported by NSF grant #1340122 to the author.	[Anonymous], 2004, PHYS TODAY; [Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bruggeman J, ARXIV13126809V31; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chafe C, 2010, PERCEPTION, V39, P982, DOI 10.1068/p6465; Colson JF, 2012, TEMPO ENSEMBLE PRECI; Cuijpers LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133527; Eckhardt B, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021110; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hennig H, 2014, P NATL ACAD SCI USA, V111, P12974, DOI 10.1073/pnas.1324142111; Hong H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.067105; JONES MDR, 1964, NATURE, V203, P322, DOI 10.1038/203322a0; Keller PE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0394; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; Miyake I., 1902, STUD YALE PSYCHOL LA, V10, P1; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Nowicki L., 2013, PSYCHOMUSICOLOGY, V23, P6, DOI [10.1037/a0032039, DOI 10.1037/A0032039]; Okano M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43987; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, HUM MOVEMENT SCI, V23, P389, DOI 10.1016/j.humov.2004.08.014; Repp BH, 2003, J EXP PSYCHOL HUMAN, V29, P290, DOI 10.1037/0096-1523.29.2.290; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; SISMONDO E, 1990, SCIENCE, V249, P55, DOI 10.1126/science.249.4964.55; Thomson M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18539-9; van der Steen MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00253; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; WALKER TJ, 1969, SCIENCE, V166, P891, DOI 10.1126/science.166.3907.891; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winfree AT., 1980, GEOMETRY BIOL TIME; Wing AM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1125	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202056	10.1371/journal.pone.0202056	http://dx.doi.org/10.1371/journal.pone.0202056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157192	Green Published, gold			2022-12-26	WOS:000443071400029
J	Diplock, N; Johnston, K; Mellon, A; Mitchell, L; Moore, M; Schneider, D; Taylor, A; Whitney, J; Zegar, K; Kioko, J; Kiffner, C				Diplock, Nathan; Johnston, Kate; Mellon, Antoine; Mitchell, Laura; Moore, Madison; Schneider, Daniel; Taylor, Alyssa; Whitney, Jess; Zegar, Kera; Kioko, John; Kiffner, Christian			Large mammal declines and the incipient loss of mammal-bird mutualisms in an African savanna ecosystem	PLOS ONE			English	Article							OXPECKER BUPHAGUS-ERYTHRORHYNCHUS; PRESENT ECOLOGICAL DISTRIBUTION; SEX-BIASED PARASITISM; RED-BILLED OXPECKERS; NATIONAL-PARK; BODY-SIZE; TICK PARASITISM; HOST PREFERENCE; WILDLIFE; HABITAT	Over the past half-century, large mammal populations have declined substantially throughout East Africa, mainly due to habitat loss and unsustainable direct exploitation. While it has been acknowledged that the loss of large mammals can have direct and cascading effects on community composition and ecosystem characteristics, limited quantitative work has been done on how declines of large herbivore populations impacts the abundance of mutualistic symbionts. Using a space-for-time observational approach, we quantified the large mammal community alongside the densities, host preferences and behaviors of mutualistic red-billed oxpeckers (Buphagus erythrorhynchus), and yellow-billed oxpeckers (Buphagus africanus) in northern Tanzania. At the landscape scale, mammal community composition was substantially less diverse in highly human-dominated areas when compared with more protected areas, with an observed complete loss of large wild mammal species in two study areas. Mirroring this trend, oxpecker densities were lowest in the least protected areas, and highest in fully protected areas. Using resource selection functions implemented via generalized linear models at different scales, we found that oxpeckers (1) were predominantly (67% of red-billed oxpeckers; 70% of yellow-billed oxpeckers) feeding on larger (between 500kg and 1500kg) ungulate host species within the mammal community, (2) usually preferred feeding on larger individuals (adults and males) within a specific host species population, and (3) preferred hosts that were more tolerant of their presence. In particular, cattle were especially intolerant of oxpecker presence and were relatively effective in displacing oxpeckers. We found little evidence that oxpecker feeding was parasitic across all host species; wound feeding was only observed on giraffe, comprising 6% and 4% of feeding behavior in red-billed and yellow-billed oxpeckers respectively. Thus, a loss of large-bodied and oxpecker tolerant host species is a likely explanation for declines of oxpecker populations in human dominated landscapes, which may have further cascading effects.	[Diplock, Nathan; Kioko, John; Kiffner, Christian] Sch Field Studies, Ctr Wildlife Management Studies, Karatu, Tanzania; [Johnston, Kate] Augsburg Univ, Dept Biol, Minneapolis, MN USA; [Mellon, Antoine] Southern Methodist Univ, Dept Biol Sci, Dallas, TX USA; [Mitchell, Laura] Univ Vermont, Dept Biol, Burlington, VT USA; [Moore, Madison] Franklin & Marshall Coll, Dept Biol Fdn Behav, Lancaster, PA 17604 USA; [Schneider, Daniel] Muhlenberg Coll, Dept Environm Sci, Allentown, PA 18104 USA; [Taylor, Alyssa] Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA; [Whitney, Jess] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Zegar, Kera] Univ Washington, Coll Environm, Seattle, WA 98195 USA	Augsburg University; Southern Methodist University; University of Vermont; Franklin & Marshall College; University of Massachusetts System; University of Massachusetts Amherst; University of Washington; University of Washington Seattle	Kiffner, C (corresponding author), Sch Field Studies, Ctr Wildlife Management Studies, Karatu, Tanzania.	ckiffne@gwdg.de	Kiffner, Christian/F-4088-2012	Kiffner, Christian/0000-0002-7475-9023; Diplock, Nathan/0000-0002-4208-0892	SFS	SFS	SFS supported this project through its directed research program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INT J COMPLEX SYSTEM; Attweil R. I. G., 1966, Puku, VNo. 4, P17; Barton K., 2012, MUMIN MULTIMODEL INF; Beaune D, 2013, FOREST ECOL MANAG, V295, P109, DOI 10.1016/j.foreco.2012.12.041; Bencin H, 2016, J NAT CONSERV, V34, P82, DOI 10.1016/j.jnc.2016.09.004; BEZUIDENHOUT JD, 1980, ONDERSTEPOORT J VET, V47, P51; Bourgarel M, 2002, AFR J ECOL, V40, P186, DOI 10.1046/j.1365-2028.2002.00377.x; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brashares JS, 2017, SCIENCE, V356, P136, DOI 10.1126/science.aan0499; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chritz KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32807; Cochrane EP, 2003, J TROP ECOL, V19, P579, DOI 10.1017/S0266467403003638; COHEN AS, 1993, PALEOBIOLOGY, V19, P433; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Crawley M.J., 2007, R BOOK; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Esser HJ, 2016, INT J PARASITOL-PAR, V5, P295, DOI 10.1016/j.ijppaw.2016.10.001; Essl F, 2015, DIVERS DISTRIB, V21, P534, DOI 10.1111/ddi.12312; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Galetti M, 2018, BIOL REV, V93, P845, DOI 10.1111/brv.12374; Gallivan GJ, 1997, S AFR J WILDL RES, V27, P63; Greenway JP, 1969, VEGETATION LAKE MANY, V57, P127; Grobler J.H., 1980, Koedoe, V23, P89; GROBLER JH, 1978, S AFR J WILDL RES, V8, P169; Grzeda E, 2017, PARASITOL RES, V116, P3163, DOI 10.1007/s00436-017-5633-5; Hanya G, 2013, ECOL RES, V28, P183, DOI 10.1007/s11284-012-1012-y; HUSTLER K, 1987, AFR J ECOL, V25, P241, DOI 10.1111/j.1365-2028.1987.tb01115.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kalle R, 2017, ECOL EVOL, V7, P1974, DOI 10.1002/ece3.2787; Kashoma I. P. B., 2011, Livestock Research for Rural Development, V23, P94; Keesing F, 2014, BIOSCIENCE, V64, P487, DOI 10.1093/biosci/biu059; Keesing F, 2013, ECOL APPL, V23, P1410, DOI 10.1890/12-1607.1; Kiffner C, 2016, J NAT CONSERV, V31, P29, DOI 10.1016/j.jnc.2016.02.006; Kiffner C, 2014, ANIM CONSERV, V17, P603, DOI 10.1111/acv.12131; Kiffner C, 2011, MED VET ENTOMOL, V25, P39, DOI 10.1111/j.1365-2915.2010.00929.x; Kiffner C, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2027; Kiffner C, 2015, TROP CONSERV SCI, V8, P318, DOI 10.1177/194008291500800204; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; Kiffner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113446; Kiffner C, 2013, OECOLOGIA, V173, P1009, DOI 10.1007/s00442-013-2664-1; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Kingdon J, 2012, KINGDON FIELD GUIDE; Kioko J, 2015, VET WORLD, V8, P755, DOI 10.14202/vetworld.2015.755-762; Koenig WD, 1997, EVOL ECOL, V11, P91, DOI 10.1023/A:1018439614008; Krasnov BR, 2005, OECOLOGIA, V146, P209, DOI 10.1007/s00442-005-0189-y; LIGHTFOOT CJ, 1981, S AFR J WILDL RES, V11, P41; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Manly B.F.J., 2002, RESOURCE SELECTION A; Mikula P, 2018, PEERJ, V6, DOI 10.7717/peerj.4520; Montoya JM, 2018, TRENDS ECOL EVOL, V33, P71, DOI 10.1016/j.tree.2017.10.004; Mooring MS, 2000, ANIM BEHAV, V60, P35, DOI 10.1006/anbe.2000.1461; Mooring MS, 1996, AFR J ECOL, V34, P54, DOI 10.1111/j.1365-2028.1996.tb00594.x; Morrison TA, 2016, BIOL CONSERV, V197, P53, DOI 10.1016/j.biocon.2016.02.034; Mwakitwange G, 2004, DONKEYS PEOPLE DEV, P113; MWALYOSI RBB, 1992, J APPL ECOL, V29, P581, DOI 10.2307/2404465; Ndlovu M, 2015, KOEDOE, V57, DOI 10.4102/koedoe.v57i1.1316; Nunn CL, 2011, EVOLUTION, V65, P1297, DOI 10.1111/j.1558-5646.2010.01212.x; Plantan T., 2012, AFRICAN J ECOLOGY, V51, P325, DOI DOI 10.1111/AJE.12042); Plantan T. B., 2009, THESIS; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; PRINS HHT, 1988, J BIOGEOGR, V15, P451, DOI 10.2307/2845275; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; R Core Team, 2018, R LANG ENV STAT COMP; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Ripple WJ, 2017, P NATL ACAD SCI USA, V114, P10678, DOI 10.1073/pnas.1702078114; Ripple WJ, 2017, BIOSCIENCE, V67, P197; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Robertson A, 2000, BIOL CONSERV, V92, P241, DOI 10.1016/S0006-3207(99)00069-5; Steadman DW, 2003, EARTH-SCI REV, V61, P133, DOI 10.1016/S0012-8252(02)00116-2; STUTTERHEIM CJ, 1981, S AFR J ZOOL, V16, P44; STUTTERHEIM CJ, 1982, S AFR J ZOOL, V17, P190; STUTTERHEIM IM, 1988, ONDERSTEPOORT J VET, V55, P173; Tyrberg Tommy, 2008, Oryctos, V7, P249; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Warwick BT, 2016, INT J ACAROL, V42, P12, DOI 10.1080/01647954.2015.1109708; Weeks P, 1999, ANIM BEHAV, V58, P1253, DOI 10.1006/anbe.1999.1265; Weeks P, 2000, BEHAV ECOL, V11, P154, DOI 10.1093/beheco/11.2.154; Wilson TR, 2003, LIVESTOCK PRODUCTION, V15; Wilson TR, 2015, TANZANIA SO HIGHLAND; Zimmerman DA, 1999, BIRDS KENYA NO TANZA	86	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202536	10.1371/journal.pone.0202536	http://dx.doi.org/10.1371/journal.pone.0202536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153277	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700018
J	Ma, RS; Qin, ZL; Yu, XM; Liu, S; Qu, WY; Hu, HH; Luo, D; Lu, ZB; Jiang, H				Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong			Selective ablation of the ligament of Marshall reduces ischemia and reperfusion-induced ventricular arrhythmias	PLOS ONE			English	Article							CARDIAC SYMPATHETIC DENERVATION; AUTONOMIC INNERVATION; MANAGEMENT	Cardiac sympathetic tone overdrive is a key mechanism of arrhythmia. Cardiac sympathetic nerves denervation, such as LSG ablation or renal sympathetic denervation, suppressed both the prevalence of VAs and the incidence of SCD. Accumulating evidence demonstrates the ligament of Marshall (LOM) is a key component of the sympathetic conduit between the left stellate ganglion (LSG) and the ventricles. The present study aimed to investigate the roles of the distal segment of LOM (LOMLSPV) denervation in ischemia and reperfusion (IR)induced VAs, and compared that LSG denervation. Thirty-three canines were randomly divided into group 1 (IR group, n = 11), group 2 (LOMLspv Denervation + IR, n = 9), and group 3 (LSG Denervation + IR, n = 13). Hematoxylin-Eosin (HE) and Immunohistochemistry staining revealed that LOMLSPV contained bundles of sympathetic but not parasympathetic nerves. IR increased the cardiac sympathetic tone [serum concentrations of noradrenaline (NE) and epinephrine (E)] and induced the prevalence of VAs [ventricular premature beat (VPB), salvo of VPB, ventricular tachycardia (VT), VT duration (VTD) and ventricular fibrillation (VF)]. Both LOMLSPV denervation and LSG denervation could reduce the cardiac sympathetic tone in Baseline (BS) [heart rate variability (HRV)]. Compared with group 1, LOMLSPV denervation and LSG denervation similarly reduced sympathetic tone [NE (1.39 +/- 0.068 ng/ml in group 2, 1.29 +/- 0.081 ng/ml in group 3 vs 2.32 +/- 0.17 ng/ml in group 1, P<0.05) and E (114.64 +/- 9.22 pg/ml in group 2, 112.60 +/- 9.69 pg/ml in group 3 vs 166.18 +/- 15.78 pg/ml in group 1, P<0.05),] and VAs [VT (0 +/- 3.00 in group 2, 0 +/- 1.75 in group 3 vs 8.00 +/- 11.00 in group 1, P<0.05) and VTD (0 +/- 4 s in group 2, 0 +/- 0.88s in group 3 vs 10.0 +/- 22.00s in group 1, P<0.05)] after 2h reperfusion. These findings indicated LOMLSPV denervation reduced the prevalence of VT by suppressing SNS activity. These effects are comparable to those of LSG denervation. In myocardial IR, the anti-arrhythmic effects of LOMLSPV Denervation may be related to the inhibition of the expression of NE and E.	[Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong] Wuhan Univ, Cardiovasc Res Inst, Wuhan, Hubei, Peoples R China; [Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong] Hubei Key Lab Cardiol, Wuhan, Hubei, Peoples R China; [Lu, Zhibing] Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Cardiol, Enshi City, Hubei, Peoples R China	Wuhan University; Wuhan University	Jiang, H (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China.; Jiang, H (corresponding author), Wuhan Univ, Cardiovasc Res Inst, Wuhan, Hubei, Peoples R China.; Jiang, H (corresponding author), Hubei Key Lab Cardiol, Wuhan, Hubei, Peoples R China.	414542231@qq.com			Beijing Lisheng Cardiovascular Health Foundation [LHJJ20155430]; National Natural Science Foundation of China [81270250, 81370281, 81300181]	Beijing Lisheng Cardiovascular Health Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received support from the Beijing Lisheng Cardiovascular Health Foundation (Grant number: LHJJ20155430): buying canines; The National Natural Science Foundation of China (Grants numbers: 81270250, 81370281, 81300181): buying antibody, commercial kit, consumable material, et al.	Camm AJ, 1996, EUR HEART J, V17, P354; Doshi RN, 1999, CIRCULATION, V100, P876, DOI 10.1161/01.CIR.100.8.876; Garcia-Moran E, 2013, REV ESP CARDIOL, V66, P595, DOI 10.1016/j.rec.2013.01.015; Hayase J, 2013, J CARDIOVASC ELECTR, V24, P926, DOI 10.1111/jce.12138; Huang B, 2015, EUROINTERVENTION, V11, P598, DOI 10.4244/EIJV11I5A119; Kim DT, 2000, J AM COLL CARDIOL, V36, P1324, DOI 10.1016/S0735-1097(00)00819-6; Makino M, 2006, J CARDIOVASC ELECTR, V17, P594, DOI 10.1111/j.1540-8167.2006.00375.x; Nordkamp LRAO, 2014, NETH HEART J, V22, P160, DOI 10.1007/s12471-014-0523-2; Schneider HE, 2013, CLIN RES CARDIOL, V102, P33, DOI 10.1007/s00392-012-0492-7; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; VANSTEE EW, 1978, ENVIRON HEALTH PERSP, V26, P151, DOI 10.1289/ehp.7826151; Wang Songyun, 2016, JACC Clin Electrophysiol, V2, P97, DOI 10.1016/j.jacep.2015.09.014; Wang SY, 2015, HEART RHYTHM, V12, P1628, DOI 10.1016/j.hrthm.2015.03.023; Zhao Y, 2016, HEART RHYTHM, V13, P2083, DOI 10.1016/j.hrthm.2016.07.014; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007	16	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203083	10.1371/journal.pone.0203083	http://dx.doi.org/10.1371/journal.pone.0203083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153281	Green Submitted, gold, Green Published			2022-12-26	WOS:000443001700042
J	Tornero, I; Boix, D; Bagella, S; Pinto-Cruz, C; Caria, MC; Belo, A; Lumbreras, A; Sala, J; Compte, J; Gascon, S				Tornero, Irene; Boix, Dani; Bagella, Simonetta; Pinto-Cruz, Carla; Caria, Maria Carmela; Belo, Anabela; Lumbreras, Ana; Sala, Jordi; Compte, Jordi; Gascon, Stephanie			Dispersal mode and spatial extent influence distance-decay patterns in pond metacommunities	PLOS ONE			English	Article							MEDITERRANEAN TEMPORARY PONDS; BETA DIVERSITY; ENVIRONMENTAL HETEROGENEITY; FLORISTIC VARIATION; COMMUNITY STRUCTURE; SIMILARITY; BIODIVERSITY; LIMITATION; DYNAMICS; PLANT	Assuming that dispersal modes or abilities can explain the different responses of organisms to geographic or environmental distances, the distance-decay relationship is a useful tool to evaluate the relative role of local environmental structuring versus regional control in community composition. Based on continuing the current theoretical framework on metacommunity dynamics and based on the predictive effect of distance on community similarity, we proposed a new framework that includes the effect of spatial extent. In addition, we tested the validity of our proposal by studying the community similarity among three biotic groups with different dispersal modes (macrofaunal active and passive dispersers and plants) from two pond networks, where one network had a small spatial extent, and the other network had an extent that was 4 times larger. Both pond networks have similar environmental variability. Overall, we found that environmental distance had larger effects than geographical distances in both pond networks. Moreover, our results suggested that species sorting is the main type of metacommunity dynamics shaping all biotic groups when the spatial extent is larger. In contrast, when the spatial extent is smaller, the observed distance-decay patterns suggested that different biotic groups were mainly governed by different metacommunity dynamics. While the distance-decay patterns of active dispersers better fit the trend that was expected when mass effects govern a metacommunity, passive dispersers showed a pattern that was expected when species sorting prevails. Finally, in the case of plants, it is difficult to associate their distance-decay patterns with one type of metacommunity dynamics.	[Tornero, Irene; Boix, Dani; Sala, Jordi; Compte, Jordi; Gascon, Stephanie] Univ Girona, Inst Aquat Ecol, GRECO, Girona, Spain; [Bagella, Simonetta; Caria, Maria Carmela] Univ Sassari, Dept Chem & Pharm, Sassari, Italy; [Pinto-Cruz, Carla; Belo, Anabela] Univ Evora, ICAAM, Dept Biol, Escola Ciencias & Tecnol, Evora, Portugal; [Lumbreras, Ana] Univ Evora, ICAAM, Evora, Portugal	Universitat de Girona; University of Sassari; University of Evora; University of Evora	Tornero, I (corresponding author), Univ Girona, Inst Aquat Ecol, GRECO, Girona, Spain.	irene.tornero1987@gmail.com	Pinto-Cruz, Carla/AAG-3826-2021; Boix, Dani/L-5190-2014; Caria, Maria Carmela/ABD-9019-2020; Compte, Jordi/L-9231-2014; Gascón, Stéphanie/L-7471-2014; Bagella, Simonetta/Y-8876-2019; Sala, Jordi/L-8234-2014; Tornero, Irene/AAA-4176-2021; Pinto-Cruz, Carla/H-7017-2019; Belo, Anabela Dias Ferreira/AAG-6651-2021	Pinto-Cruz, Carla/0000-0002-2818-5700; Boix, Dani/0000-0001-5468-2236; Compte, Jordi/0000-0002-2715-5518; Gascón, Stéphanie/0000-0003-1951-9083; Sala, Jordi/0000-0002-1227-8566; Tornero, Irene/0000-0001-7337-4263; Pinto-Cruz, Carla/0000-0002-2818-5700; Belo, Anabela Dias Ferreira/0000-0002-4699-3824	Ministerio de Economia y Competitividad of the Spanish Government [CGL2011-23907, CGL2016-76024-R]; Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya [2017 SGR 548]; Autonomous Region of Sardinia, Italy [CRP-24943]	Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government); Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya; Autonomous Region of Sardinia, Italy(Regione Sardegna)	This work was supported by two scientific research grants (CGL2011-23907 and CGL2016-76024-R) from the Ministerio de Economia y Competitividad of the Spanish Government (http://www.idi.mineco.gob.es/portal/site/MICINN/), the Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya (2017 SGR 548) (http://agaur.gencat.cat/) and by a scientific research grant (CRP-24943) from the Autonomous Region of Sardinia, Italy (https://www.regione.sardegna.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito S, 2013, ANN BOT-ITALY, V3, P51, DOI 10.4462/annbotrm-10242; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Ballon C, 2016, LIMNETICA, V35, P73; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Bohonak AJ, 1999, LIMNOL OCEANOGR, V44, P487, DOI 10.4319/lo.1999.44.3.0487; Briers RA, 2005, AQUAT CONSERV, V15, P549, DOI 10.1002/aqc.742; BUSH MB, 1991, J BIOGEOGR, V18, P341, DOI 10.2307/2845404; Canha P, 2010, PLANO GESTAO CHARCOS; Caramujo MJ, 2010, J LIMNOL, V69, P64, DOI 10.4081/jlimnol.2010.64; Castillo-Escriva A, 2017, FRESHWATER BIOL, V62, P1004, DOI 10.1111/fwb.12920; Chaves ML, 1999, THESIS; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cogoni A, 2009, PLANT BIOSYST, V143, pS97, DOI 10.1080/11263500903220190; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Daftologic, 2015, GOOGL MAPS AR CALC T; Damschen EI, 2008, P NATL ACAD SCI USA, V105, P19078, DOI 10.1073/pnas.0802037105; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Martins MJF, 2010, J LIMNOL, V69, P160, DOI 10.3274/JL10-69-1-15; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gan D., 2007, ANN ENV SCI, V1, P11; Girdler EB, 2008, PLANT ECOL, V198, P211, DOI 10.1007/s11258-008-9396-z; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hautala K, 2000, WATER RES, V34, P246, DOI 10.1016/S0043-1354(99)00137-2; Heino J, 2015, ECOL EVOL, V5, P1525, DOI 10.1002/ece3.1460; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Heino J, 2013, BIOL REV, V88, P166, DOI 10.1111/j.1469-185X.2012.00244.x; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hill MJ, 2017, OIKOS, V126, P1575, DOI 10.1111/oik.04266; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Horvath Z, 2016, ECOGRAPHY, V39, P726, DOI 10.1111/ecog.01685; Borthagaray AI, 2014, ECOGRAPHY, V37, P564, DOI 10.1111/j.1600-0587.2013.00366.x; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Jurasinski G, 2015, PACKAGE SIMBA; Kneitel JM, 2016, ECOLOGY, V97, P961, DOI 10.1890/15-1584.1; Konig C, 2017, GLOBAL ECOL BIOGEOGR, V26, P228, DOI 10.1111/geb.12536; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Leo P., 2011, CONSERVAZIONE HABITA, V5, P243; Logan M., 2010, BIOSTATISTICAL DESIG; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Machado M, 1999, CRUSTACEANA, V72, P591, DOI 10.1163/156854099503636; MASCAGNI A., 2011, CONSERVAZIONE HABITA, V5, P389; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; MURA G, 1986, HYDROBIOLOGIA, V134, P273, DOI 10.1007/BF00008496; Mura G, 1999, HYDROBIOLOGIA, V405, P57, DOI 10.1023/A:1003701004970; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nekola JC, 2014, ECOGRAPHY, V37, P309, DOI 10.1111/j.1600-0587.2013.00407.x; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Ptacnik R, 2010, ECOSYSTEMS, V13, P1201, DOI 10.1007/s10021-010-9380-z; Qian H, 2012, GLOBAL ECOL BIOGEOGR, V21, P341, DOI 10.1111/j.1466-8238.2011.00672.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; Rocchi S., 2011, CONSERVAZIONE HABITA, V5, P287; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Soininen J, 2007, ECOSCIENCE, V14, P146, DOI 10.2980/1195-6860(2007)14[146:NNADOP]2.0.CO;2; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Steinitz O, 2006, J BIOGEOGR, V33, P1044, DOI 10.1111/j.1365-2699.2006.01473.x; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tonkin JD, 2016, FRESHWATER BIOL, V61, P607, DOI 10.1111/fwb.12728; Tornero I, 2016, LIMNETICA, V35, P337; Tornero Irene, 2014, Boletin de la SEA, P326; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2012, ECOGRAPHY, V35, P961, DOI 10.1111/j.1600-0587.2012.07339.x; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; Warfe DM, 2013, FRESHWATER BIOL, V58, P292, DOI 10.1111/fwb.12058; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	83	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203119	10.1371/journal.pone.0203119	http://dx.doi.org/10.1371/journal.pone.0203119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153308	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700045
J	Waberski, D; Schafer, J; Bolling, A; Scheld, M; Henning, H; Hambruch, N; Schuberth, HJ; Pfarrer, C; Wrenzycki, C; Hunter, RHF				Waberski, Dagmar; Schaefer, Jana; Boelling, Alexandra; Scheld, Manon; Henning, Heiko; Hambruch, Nina; Schuberth, Hans-Joachim; Pfarrer, Christiane; Wrenzycki, Christine; Hunter, Ronald H. F.			Seminal plasma modulates the immune-cytokine network in the porcine uterine tissue and pre-ovulatory follicles	PLOS ONE			English	Article							IN-VITRO; LEUKOCYTE RECRUITMENT; ENZYME-IMMUNOASSAY; EMBRYO DEVELOPMENT; OOCYTE MATURATION; GENE-EXPRESSION; CUMULUS CELLS; OVULATION; GILTS; INSEMINATION	Evidence is emerging that the interaction between male seminal fluid and female tissues promotes fertility, pregnancy, and health of offspring. This includes the acceleration of ovulation in a species known as a spontaneous ovulator, the domestic pig. Earlier studies revealed that seminal plasma acts by a local mechanism in the female pig. The aim of the present study was to examine local short-term and mid-term effects of seminal plasma (SP) on mRNA expression of immunoregulatory genes and transcripts associated with follicle- and oocyte maturation. In the porcine animal model, effects on mRNA expression in the female tract and preovulatory follicles were examined. SP suppressed mRNA expression of Prostaglandin-Endoperoxide Synthase 2 (PTGS2) ipsilateral to the infused uterine horn which was associated with a lower presence of immune cells in the uterine epithelium and lower PTGS2 immunoreaction. Depending on the sampling time (2 h vs. 17 h) and hormonal status, SP altered significant correlative relations of mRNA expression between PTGS2 and the transcripts Tumor Necrosis Factor Alpha, Tumor Necrosis Factor Alpha-Induced Protein 6 and Pentraxin 3 in uterus, granulosa and cumulus cells. A modulatory effect of SP on the oocyte gene network comprising eight oocyte transcripts was observed: uterine exposure to SP induced positive correlations (r >0.08, p<0.05) of maturation promoting factors among each other and with cumulus cells on the side of the treated horn. In conclusion, SP orchestrates the gene network regulating the bidirectional communication between oocytes and surrounding somatic cells. The modulation of the immune-cytokine network of the female reproductive system could contribute to the previously reported SP-induced acceleration of ovulation in the porcine species.	[Waberski, Dagmar; Schaefer, Jana; Boelling, Alexandra; Henning, Heiko; Hunter, Ronald H. F.] Univ Vet Med Hannover, Unit Reprod Med Clin, Clin Pigs & Small Ruminants, Hannover, Germany; [Scheld, Manon; Hambruch, Nina; Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Schuberth, Hans-Joachim] Univ Vet Med Hannover, Immunol Unit, Hannover, Germany; [Wrenzycki, Christine] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Henning, Heiko] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Wrenzycki, Christine] Justus Liebig Univ Giessen, Fac Vet Med, Clin Obstet Gynecol & Androl Large & Small Anim, Chair Mol Reprod Med, Giessen, Giessen, Germany; [Hunter, Ronald H. F.] Ladfield, Jedburgh, Roxburghshire, Scotland	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Utrecht University; Justus Liebig University Giessen	Waberski, D (corresponding author), Univ Vet Med Hannover, Unit Reprod Med Clin, Clin Pigs & Small Ruminants, Hannover, Germany.	dagmar.waberski@tiho-hannover.de	Schuberth, Hans-Joachim/AAE-4845-2020	Hambruch, Nina/0000-0002-6592-834X; Pfarrer, Christiane/0000-0001-5282-8406	German Research Foundation (DFG) [INST 193/49-1 AOJB:567417]; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover	This study was funded by the German Research Foundation (DFG; grant number: INST 193/49-1 AOJB:567417) and its publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISCHOF RJ, 1994, J REPROD IMMUNOL, V26, P131, DOI 10.1016/0165-0378(94)90036-1; BRANNSTROM M, 1995, REPROD FERT DEVELOP, V7, P67, DOI 10.1071/RD9950067; Cahill JF, 2016, RAPID COMMUN MASS SP, V30, P611, DOI 10.1002/rcm.7477; Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; Einer-Jensen N, 2005, REPRODUCTION, V129, P9, DOI 10.1530/rep.1.00278; Field SL, 2014, MOL REPROD DEV, V81, P284, DOI 10.1002/mrd.22285; Fink Ludger, 2005, Methods Mol Biol, V293, P167; Hou J, 2016, BRIEF FUNCT GENOMICS, V15, P95, DOI 10.1093/bfgp/elv040; Jiwakanon J, 2011, ANIM REPROD SCI, V123, P210, DOI 10.1016/j.anireprosci.2010.11.016; JOCHLE W, 1975, J REPROD FERTIL, P165; Kaczmarek MM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103564; Kawashima I, 2008, REPRODUCTION, V136, P9, DOI 10.1530/REP-08-0074; LOVELL JE, 1968, AM J VET RES, V29, P609; MEYER HHD, 1990, J STEROID BIOCHEM, V35, P263, DOI 10.1016/0022-4731(90)90283-X; Mikuni M, 1998, BIOL REPROD, V59, P1077, DOI 10.1095/biolreprod59.5.1077; O'Leary S, 2006, REPRODUCTION, V132, P147, DOI 10.1530/rep.1.01119; O'Leary S, 2004, REPRODUCTION, V128, P237, DOI 10.1530/rep.1.00160; Persani L, 2014, HUM REPROD UPDATE, V20, P869, DOI 10.1093/humupd/dmu036; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRAKASH BS, 1987, J STEROID BIOCHEM, V28, P623, DOI 10.1016/0022-4731(87)90389-X; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; Richards JS, 2008, TRENDS ENDOCRIN MET, V19, P191, DOI 10.1016/j.tem.2008.03.001; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robertson SA, 2016, FERTIL STERIL, V106, P511, DOI 10.1016/j.fertnstert.2016.07.1101; Rozeboom KJ, 1998, J REPROD FERTIL, V114, P195, DOI 10.1530/jrf.0.1140195; Rozeboom KJ, 1999, J ANIM SCI, V77, P2201; Schjenken JE, 2014, REPROD DOMEST ANIM, V49, P27, DOI 10.1111/rda.12383; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuberth HJ, 2008, THERIOGENOLOGY, V70, P1174, DOI 10.1016/j.theriogenology.2008.07.020; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Soede NM, 1998, ANIM REPROD SCI, V54, P23, DOI 10.1016/S0378-4320(98)00140-7; Stinshoff H, 2014, REPROD FERT DEVELOP, V26, P502, DOI 10.1071/RD12372; Taylor U, 2009, REPROD DOMEST ANIM, V44, P180, DOI 10.1111/j.1439-0531.2007.01015.x; Waberski D, 1999, J VET MED A, V46, P431, DOI 10.1046/j.1439-0442.1999.00230.x; Waberski D, 1995, J REPROD FERTIL, V105, P247, DOI 10.1530/jrf.0.1050247; Waberski D, 1997, J REPROD FERTIL, V109, P29, DOI 10.1530/jrf.0.1090029; Waberski D, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-13; WEITZE KF, 1990, REPROD DOMEST ANIM, V25, P61, DOI 10.1111/j.1439-0531.1990.tb00682.x; Zhang DX, 2009, MOL REPROD DEV, V76, P881, DOI 10.1002/mrd.21056; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	41	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202654	10.1371/journal.pone.0202654	http://dx.doi.org/10.1371/journal.pone.0202654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153288	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700019
J	Jabbari, K; Bobbili, DR; Lal, D; Reinthaler, EM; Schubert, J; Wolking, S; Sinha, V; Motameny, S; Thiele, H; Kawalia, A; Altmuller, J; Toliat, MR; Kraaij, R; van Rooij, J; Uitterlinden, AG; Ikram, MA; Zara, F; Lehesjoki, AE; Krause, R; Zimprich, F; Sander, T; Neubauer, BA; May, P; Lerche, H; Nurnberg, P				Jabbari, Kamel; Bobbili, Dheeraj R.; Lal, Dennis; Reinthaler, Eva M.; Schubert, Julian; Wolking, Stefan; Sinha, Vishal; Motameny, Susanne; Thiele, Holger; Kawalia, Amit; Altmueller, Janine; Toliat, Mohammad Reza; Kraaij, Robert; van Rooij, Jeroen; Uitterlinden, Andre G.; Ikram, M. Arfan; Zara, Federico; Lehesjoki, Anna-Elina; Krause, Roland; Zimprich, Fritz; Sander, Thomas; Neubauer, Bernd A.; May, Patrick; Lerche, Holger; Nuernberg, Peter		EuroEPINOMICS CoGIE Consortium	Rare gene deletions in genetic generalized and Rolandic epilepsies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTISM CANDIDATE GENES; COPY NUMBER VARIATION; DE-NOVO MUTATIONS; STRUCTURAL VARIATION; DEVELOPMENTAL DELAY; PARKINSONS-DISEASE; RISK LOCI; VARIANTS; DISORDERS	Genetic Generalized Epilepsy (GGE) and benign epilepsy with centro-temporal spikes or Rolandic Epilepsy (RE) are common forms of genetic epilepsies. Rare copy number variants have been recognized as important risk factors in brain disorders. We performed a systematic survey of rare deletions affecting protein-coding genes derived from exome data of patients with common forms of genetic epilepsies. We analysed exomes from 390 European patients (196 GGE and 194 RE) and 572 population controls to identify low-frequency genic deletions. We found that 75 (32 GGE and 43 RE) patients out of 390, i.e. similar to 19%, carried rare genic deletions. In particular, large deletions (>400 kb) represent a higher burden in both GGE and RE syndromes as compared to controls. The detected low-frequency deletions (1) share genes with brain-expressed exons that are under negative selection, (2) overlap with known autism and epilepsy-associated candidate genes, (3) are enriched for CNV intolerant genes recorded by the Exome Aggregation Consortium (ExAC) and (4) coincide with likely disruptive de novo mutations from the NPdenovo database. Employing several knowledge databases, we discuss the most prominent epilepsy candidate genes and their protein-protein networks for GGE and RE.	[Jabbari, Kamel; Lal, Dennis; Motameny, Susanne; Thiele, Holger; Kawalia, Amit; Altmueller, Janine; Toliat, Mohammad Reza; Sander, Thomas; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Jabbari, Kamel] Univ Cologne, Cologne Bioctr, Inst Genet, Cologne, Germany; [Bobbili, Dheeraj R.; Krause, Roland; May, Patrick] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Lal, Dennis] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Lal, Dennis] Harvard Med Sch, Boston, MA USA; [Lal, Dennis] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lal, Dennis] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Reinthaler, Eva M.; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Schubert, Julian; Wolking, Stefan; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Sinha, Vishal] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Altmueller, Janine] Univ Cologne, Inst Human Genet, Cologne, Germany; [Kraaij, Robert; van Rooij, Jeroen; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Zara, Federico] Inst G Gaslini, Lab Neurogenet & Neurosci, Genoa, Italy; [Lehesjoki, Anna-Elina] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Neubauer, Bernd A.] Univ Giessen, Dept Neuropediat, Med Fac, Giessen, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Cologne; University of Cologne; University of Luxembourg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Helsinki; University of Cologne; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Genoa; IRCCS Istituto Giannina Gaslini; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Justus Liebig University Giessen; University of Cologne; University of Cologne	Nurnberg, P (corresponding author), Univ Cologne, Cologne Ctr Genom, Cologne, Germany.; Nurnberg, P (corresponding author), Univ Cologne, CMMC, Cologne, Germany.; Nurnberg, P (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	nuernberg@uni-koeln.de	May, Patrick/B-1238-2010; Neubauer, Bernd/AAZ-9391-2020; Zimprich, Fritz/O-1406-2019; Thiele, Holger/ABE-6792-2020; Ikram, M. Arfan/AAM-5225-2021; May, Patrick/N-1019-2019; Zara, Federico/U-3477-2017	May, Patrick/0000-0001-8698-3770; Zimprich, Fritz/0000-0002-6998-5480; Thiele, Holger/0000-0002-0169-998X; May, Patrick/0000-0001-8698-3770; Zara, Federico/0000-0001-9744-5222; Wolking, Stefan/0000-0002-1460-6623; Altmuller, Janine/0000-0003-4372-1521	EuroEPINOMICS programme (DFG grant) [LE1030/11-1, NU50/8-1, SA434/5-1]; EuroEPINOMICS programme (FWF grant) [I643-B09]; JPND Courage-PD research grant; NCER FNR grant; German Research Foundation (DFG) [FOR2715, LE1030/16-1, NU50/11-1, SA434/6-1]; Foundation Nationale de Recherche in Luxembourg (FNR grant) [INTER/DFG/17/11583046]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NOW Investments [175.010.2005.011, 911-03-012]; Netherlands Genomics Initiative (NGI)/NOW project [050-060-810]	EuroEPINOMICS programme (DFG grant); EuroEPINOMICS programme (FWF grant); JPND Courage-PD research grant; NCER FNR grant; German Research Foundation (DFG)(German Research Foundation (DFG)); Foundation Nationale de Recherche in Luxembourg (FNR grant); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NOW Investments; Netherlands Genomics Initiative (NGI)/NOW project	H.L., P.N., T.S., F.Z. received grants by the EuroEPINOMICS programme (DFG grant numbers: HL: LE1030/11-1, PN: NU50/8-1, TS: SA434/5-1, FWF grant number: FZ: I643-B09) within the EUROCORES framework of the European Science Foundation (ESF). D.R.B. and P.M. were supported by the JPND Courage-PD research grant, P.M. also from the NCER FNR grant. H.L., P.N., T.S., and R.K. received further support from the Research Unit FOR2715 funded by the German Research Foundation (DFG grant numbers: HL: LE1030/16-1, PN: NU50/11-1, TS: SA434/6-1) and the Foundation Nationale de Recherche in Luxembourg (FNR grant number: RK: INTER/DFG/17/11583046). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of genomics data for the Rotterdam Study are supported by the Netherlands Organisation of Scientific Research NOW Investments (nr. 175.010.2005.011, 911-03-012) and the Netherlands Genomics Initiative (NGI)/NOW project nr. 050-060-810 (Netherlands Consortium for Healthy Ageing; NCHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis L, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000056; Afawi Z, 2016, NEUROLOGY, V86, P713, DOI 10.1212/WNL.0000000000002404; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Bizzoca A, 2003, DEVELOPMENT, V130, P29, DOI 10.1242/dev.00183; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Buckley AW, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022749; Campbell IM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003797; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Damiano JA, 2015, EPILEPSY RES, V117, P70, DOI 10.1016/j.eplepsyres.2015.09.007; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimassi S, 2014, EPILEPSIA, V55, P370, DOI 10.1111/epi.12502; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Foa L, 2009, J NEUROCHEM, V108, P1, DOI 10.1111/j.1471-4159.2008.05726.x; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; Gau SSF, 2012, AM J MED GENET B, V159B, P710, DOI 10.1002/ajmg.b.32074; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Huttenlocher J, 2015, HUM MOL GENET, V24, P5637, DOI 10.1093/hmg/ddv277; Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942; Jabbari K, 2016, GENOMICS, V108, P31, DOI 10.1016/j.ygeno.2016.01.001; Jahn JA, 2014, EPILEPSY RES, V108, P109, DOI 10.1016/j.eplepsyres.2013.10.001; Ji TY, 2010, J HUM GENET, V55, P486, DOI 10.1038/jhg.2010.51; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kawalia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126321; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kremer PHC, 2015, J NEUROL NEUROSUR PS, V86, P524, DOI 10.1136/jnnp-2013-307276; Lal D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005226; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Leu C, 2016, CURR OPIN NEUROL, V29, P158, DOI 10.1097/WCO.0000000000000296; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JC, 2016, MOL PSYCHIATR, V21, P290, DOI 10.1038/mp.2015.40; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lupski JR, 2016, HUM GENET, V135, P591, DOI 10.1007/s00439-016-1682-6; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mahfouz A, 2015, J MOL NEUROSCI, V57, P580, DOI 10.1007/s12031-015-0641-3; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayer M, 2010, GENE EXPR PATTERNS, V10, P351, DOI 10.1016/j.gep.2010.08.002; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Miyatake S, 2015, J HUM GENET, V60, P175, DOI 10.1038/jhg.2014.124; Mulley JC, 2011, EPILEPSIA, V52, P423, DOI 10.1111/j.1528-1167.2010.02932.x; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Nicita F, 2015, ANN HUM GENET, V79, P209, DOI 10.1111/ahg.12106; Pescosolido MF, 2013, J AM ACAD CHILD PSY, V52, P414, DOI 10.1016/j.jaac.2013.01.003; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran X, 2015, NUCLEIC ACIDS RES, V43, pD893, DOI 10.1093/nar/gku943; Rasmussen MB, 2014, J MED GENET, V51, P605, DOI 10.1136/jmedgenet-2014-102535; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Reinthaler EM, 2015, ANN NEUROL, V77, P972, DOI 10.1002/ana.24395; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Scheffer IE, 2014, NAT REV NEUROL, V10, P490, DOI 10.1038/nrneurol.2014.146; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stogmann E, 2013, BRAIN, V136, P1155, DOI 10.1093/brain/awt068; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Szafranski P, 2015, EUR J HUM GENET, V23, P173, DOI 10.1038/ejhg.2014.75; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Uddin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28663; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang P, 2013, NEUROTOXICOLOGY, V37, P51, DOI 10.1016/j.neuro.2013.03.007; Wang YB, 2016, CELL REP, V16, P79, DOI 10.1016/j.celrep.2016.05.044; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhang P, 2014, GENOME, V57, P253, DOI 10.1139/gen-2014-0032; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	82	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202022	10.1371/journal.pone.0202022	http://dx.doi.org/10.1371/journal.pone.0202022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148849	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200005
J	Seroussi, E; Blum, SE; Krifucks, O; Lavon, Y; Leitner, G				Seroussi, Eyal; Blum, Shlomo E.; Krifucks, Oleg; Lavon, Yaniv; Leitner, Gabriel			Application of pancreatic phospholipase A2 for treatment of bovine mastitis	PLOS ONE			English	Article							ESCHERICHIA-COLI MASTITIS; STAPHYLOCOCCUS-AUREUS; MAMMARY-GLAND; A(2); STRATEGIES; CELLS; COWS	Recent findings have indicated that secreted phospholipases A2 (sPLA2s) have anti-inflammatory functions, including relief of symptoms in a mouse model of mastitis. This prompted us to investigate the therapeutic application of sPLA2, PLA2G1B, for bovine mastitis. Initial testing of PLA2G1B's effect on bovine mammary epithelial cell (bMEC) line PS revealed no changes in cell viability or cytokine-secretion pattern. However, when cells were first treated with lipopolysaccharide endotoxin (LPS) or live bacteria (Escherichia coli or Staphylococcus aureus), incubation with PLA2G1B significantly improved cell viability, suggesting involvement of sPLA2s in protecting membranes from lipid-peroxidation damage, rather than a bactericidal action. When PLA2G1B was applied simultaneously with LPS, a significant short-term reduction in interleukin-8 secretion was observed compared with bMECs treated only with LPS, supporting previous reports that PLA2G1B affects interleukin-8 signaling in similar cells. Following the favorable outcome of the in vitro experiments, we tested PLA2G1B in vivo by mammary infusion into infected glands. In one of a small sample (n = 4) of lactating cows chronically infected with Streptococcus dysgalactiae, a single PLA2G1B treatment completely cleared inflammation and bacteria, demonstrating its potential to cure subclinical mastitis. PLA2G1B treatment did not affect coagulase-negative staphylococci infection. These types of mastitis may involve formation of a resistant biofilm, and its elimination may relate to sPLA2s' characteristic ability to aggregate with cellular debris, facilitating their internalization by macrophages. In a bovine model of clinical mastitis based on introduction of E. colivia the streak canal, a single mammary infusion of PLA2G1B led to faster recovery to pre-infection milk-yield levels and decrease of somatic cell counts. In this case, all of sPLA2s' modes of resolving inflammation may apply, including competitive binding of the sPLA2s' receptor, the inactivation of which confers resistance to endotoxic shock. Hence, this study strongly supports further research into PLA2G1B as a cure for bovine mastitis.	[Seroussi, Eyal] ARO, Inst Anim Sci, Rishon Letsiyon, Israel; [Blum, Shlomo E.; Krifucks, Oleg; Leitner, Gabriel] Kimron Vet Inst, Natl Mastitis Reference Ctr, Dept Bacteriol, Bet Dagan, Israel; [Lavon, Yaniv] Israel Cattle Breeders Assoc, Caesarea, Israel	Kimron Veterinary Institute	Seroussi, E (corresponding author), ARO, Inst Anim Sci, Rishon Letsiyon, Israel.	seroussi@agri.huji.ac.il	Lavon, Yaniv/ABZ-1072-2022		Chief Scientist of the Israeli Ministry of Agriculture [20-11-0009]	Chief Scientist of the Israeli Ministry of Agriculture	This work was supported by a grant #20-11-0009 from The Chief Scientist of the Israeli Ministry of Agriculture.	Bar-Gal GK, 2015, VET MICROBIOL, V176, P143, DOI 10.1016/j.vetmic.2015.01.007; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; Blum S E, 2015, PLOS ONE, V10; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Gomes F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw006; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Herry V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03724-7; Kempf F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147954; Kruzel ML, 2010, INNATE IMMUN-LONDON, V16, P67, DOI 10.1177/1753425909105317; Kurz JP, 2018, THESIS, P6910; Leitner G, 2003, VET IMMUNOL IMMUNOP, V93, P159, DOI 10.1016/S0165-2427(03)00069-2; Leitner G, 2003, J VET MED B, V50, P45, DOI 10.1046/j.1439-0450.2003.00602.x; Litwinczuk Z, 2015, ANN ANIM SCI, V15, P819, DOI 10.1515/aoas-2015-0035; Mavangira V, 2018, RES VET SCI; McDougall S, 2009, VET MICROBIOL, V134, P177, DOI 10.1016/j.vetmic.2008.09.026; Murakami M, 2017, P JPN ACAD B-PHYS, V93, P677, DOI 10.2183/pjab.93.043; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Okano W, 2015, ACTA SCI VET, V43; Owens, 2004, MICROBIOLOGICAL PROC, V4th ed.; Paulrud CO, 2005, VET RES COMMUN, V29, P215, DOI 10.1023/B:VERC.0000047496.47571.41; Pyorala S, 2002, REPROD DOMEST ANIM, V37, P211, DOI 10.1046/j.1439-0531.2002.00378.x; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; SANDHOLM M, 1990, J VET PHARMACOL THER, V13, P248, DOI 10.1111/j.1365-2885.1990.tb00774.x; Seroussi E, 2013, IMMUNOGENETICS, V65, P861, DOI 10.1007/s00251-013-0738-1; Tan TL, 2017, PLOS ONE, V12; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; van den Borne BHP, 2010, J DAIRY SCI, V93, P218, DOI 10.3168/jds.2009-2567; VANKUIJK FJGM, 1987, TRENDS BIOCHEM SCI, V12, P31, DOI 10.1016/0968-0004(87)90014-4; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Zadoks R., 2009, IR VET J S4, V62, pS59; Zheng LH, 2016, FREE RADICAL BIO MED, V96, P166, DOI 10.1016/j.freeradbiomed.2016.04.022	36	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203132	10.1371/journal.pone.0203132	http://dx.doi.org/10.1371/journal.pone.0203132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148880	Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200048
J	Bae, SH; Choi, DG				Bae, Seok Hyun; Choi, Dong Gyu			Changes of corneal topographic measurements and higher-order aberrations after surgery for exotropia	PLOS ONE			English	Article							EXTRAOCULAR-MUSCLE SURGERY; LATERAL RECTUS RECESSION; STRABISMUS SURGERY; REFRACTIVE SURGERY; ASTIGMATISM; THICKNESS; CHILDREN; SYSTEM; EYE	Purpose To analyze changes in corneal topographic measurements and higher-order aberrations (HOAs) after horizontal muscle surgery for exotropia. Design Retrospective, observational study. Methods A total of 131 eyes of 121 patients who had undergone surgery for exotropia were included. The eyes with unilateral lateral rectus (ULR) or bilateral lateral rectus (BLR) recession(s) were assigned to group A, and those with unilateral lateral rectus recession & medial rectus resection (R&R) to group B. Corneal topographic measurements and HOAs were compared between the preoperative and postoperative periods using a Placido-dual Scheimpflug analyzer (Galilei 2 (TM), Ziemer, Port., Switzerland) for each group. Results In group A, simulated keratometery (sim K) was significantly changed until 3 months postoperatively relative to the preoperative value (postoperative 1 week, p = 0.017; 1 month, p = 0.037; and 3 months, p = 0.023, respectively). All steep K (steep sim K, steep-Kpost, and TCP-steep K) parameters also were significantly changed at postoperative 1 month (p<0.001, p = 0.015, p<0.001, respectively), but not at 3 months. Among the higher-order aberrations, spherical aberration (Z(4)(0)) and secondary horizontal astigmatism (Z(4)(2)) at postoperative 1 week had significantly changed from the preoperative values, as had horizontal quadrafoil (Z(4)(4)) at 1 month. However, in group B, only vertical quadrafoil (Z(4)(-4)) showed statistically significant changes, at postoperative 1 and 3 months. None of the other postoperative parameters was significantly different from the corresponding preoperative value. Conclusion Lateral rectus recession induced changes in both corneal topographic measurements and HOAs, whereas R&R did so only in HOAs. These changes might explain some patients' complaints about poor quality of vision.	[Bae, Seok Hyun] Cent Phys Examinat Off, Dept Ophthalmol, Daegu, South Korea; [Choi, Dong Gyu] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea	Hallym University	Choi, DG (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea.	eyechoi@hallym.or.kr						Al-Zeraid FM, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0205-5; Applegate RA, 1997, J REFRACT SURG, V13, P295; Brum GS, 2011, ARQ BRAS OFTALMOL, V74, P24, DOI 10.1590/S0004-27492011000100006; Campbell CE, 2004, J REFRACT SURG, V20, pS495; Charman WN, 2005, OPHTHAL PHYSL OPT, V25, P285, DOI 10.1111/j.1475-1313.2005.00297.x; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; de Paiva CS, 2003, OPHTHALMOLOGY, V110, P1102; DENIS D, 1995, OPHTHALMOLOGICA, V209, P136, DOI 10.1159/000310599; DOTTAN SA, 1988, OPHTHALMIC SURG LAS, V19, P128; Fix A, 1985, AM ORTHOPT J, V35, P59; Hainsworth DP, 1999, J AAPOS, V3, P80, DOI 10.1016/S1091-8531(99)70074-1; Jahadi Hosseini Seyed Hamid Reza, 2016, J Ophthalmic Vis Res, V11, P350; Killer HE, 1999, OPHTHALMOLOGICA, V213, P209, DOI 10.1159/000027422; KWITKO S, 1991, ARCH OPHTHALMOL-CHIC, V109, P873, DOI 10.1001/archopht.1991.01080060137042; KWITKO S, 1992, CORNEA, V11, P36, DOI 10.1097/00003226-199201000-00005; Lawless MA, 2005, CLIN EXP OPHTHALMOL, V33, P199, DOI 10.1111/j.1442-9071.2005.00994.x; Liu ZG, 1999, BRIT J OPHTHALMOL, V83, P774, DOI 10.1136/bjo.83.7.774; Marshall D, 1936, ARCH OPHTHALMOL-CHIC, V15, P1020; Menassa N, 2008, J CATARACT REFR SURG, V34, P1742, DOI 10.1016/j.jcrs.2008.06.024; Nardi M, 1997, J PEDIAT OPHTH STRAB, V34, P244; PRESLAN MW, 1992, J PEDIATR OPHTHALMOL, V29, P300; Rajavi Zhale, 2008, International Ophthalmology, V28, P83, DOI 10.1007/s10792-007-9116-z; REYNOLDS RD, 1991, AM J OPHTHALMOL, V111, P371, DOI 10.1016/S0002-9394(14)72327-X; Seo KY, 2011, YONSEI MED J, V52, P527, DOI 10.3349/ymj.2011.52.3.527; THOMPSON WE, 1980, J PEDIAT OPHTH STRAB, V17, P372; Wang XG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/140628	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202864	10.1371/journal.pone.0202864	http://dx.doi.org/10.1371/journal.pone.0202864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142210	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500043
J	Morioka, N; Tomio, J; Seto, T; Yumoto, Y; Ogata, Y; Kobayashi, Y				Morioka, Noriko; Tomio, Jun; Seto, Toshikazu; Yumoto, Yoshie; Ogata, Yasuko; Kobayashi, Yasuki			Association between local-level resources for home care and home deaths: A nationwide spatial analysis in Japan	PLOS ONE			English	Article							UNIVERSAL HEALTH-CARE; PLACE; MORTALITY; SITE	Aim Little is known about whether and how local-level resources regarding home care are associated with the prevalence of home deaths. We aimed to investigate whether geographic patterns of the resources for home care were associated with the prevalence of home deaths, taking spatial variation into consideration. Methods We conducted an ecological cross-sectional study in Japan using nationwide data in 2014. The areal unit was the municipality, the smallest administrative unit in Japan. We investigated the association between the percentage of home deaths and the resources of home care support clinics with available 24-hour-a-day functions, considering the geographic effect of neighboring municipalities by applying a geographically weighted regression model. Results The mean and standard deviation of the percentages of home deaths were 11.4% (5.0%), and those of the number of home care support clinics per 10,000 elderly population were 3.4 (3.7). The percentages of home deaths in neighboring municipalities tended to be significantly correlated (Moran's I 0.34, p<0.001). Adjusting for the number of hospital beds, total population, and the socio-economic status of municipality, the results of an ordinary least squares regression model showed a positive correlation between the percentage of home deaths and the local resources for home care support clinics per 10,000 elderly population (regression coefficient 0.15, 95% confidence interval 0.07, 0.22), while the existence of spatial autocorrelation of the residual was suggested (Moran's I of the residual 0.227, p<0.001). The geographically weighted regression model showed local regression coefficients varying across municipalities with a better model fit over the analogous ordinary least squares model (adjusted R-2 0.414 vs. 0.131). Conclusion Home deaths were more prevalent in municipalities with greater home care resources. This association was geographically varied and further strengthened in some areas.	[Morioka, Noriko; Yumoto, Yoshie; Ogata, Yasuko] Tokyo Med & Dent Univ, Dept Gerontol Nursing & Care Syst Dev, Tokyo, Japan; [Morioka, Noriko; Tomio, Jun; Kobayashi, Yasuki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Seto, Toshikazu] Univ Tokyo, Ctr Spatial Informat Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo	Morioka, N (corresponding author), Tokyo Med & Dent Univ, Dept Gerontol Nursing & Care Syst Dev, Tokyo, Japan.; Morioka, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan.	morioka.gh@tmd.ac.jp	Seto, Toshikazu/AAE-9741-2019	Seto, Toshikazu/0000-0003-0281-1790; Morioka, Noriko/0000-0001-9355-4173	JSPS KAKENHI [18K17633]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 18K17633.	Akiyama Akiko, 2007, Nihon Ronen Igakkai Zasshi, V44, P740, DOI 10.3143/geriatrics.44.740; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Chen DR, 2010, HEALTH PLACE, V16, P1248, DOI 10.1016/j.healthplace.2010.08.013; Clark CR, 2016, JAMA-J AM MED ASSOC, V316, P2363, DOI 10.1001/jama.2016.12818; Costa V, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0077-8; Dasch B, 2015, DTSCH ARZTEBL INT, V112, P496, DOI 10.3238/arztebl.2015.0496; De Roo ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093762; Ford MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146085; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Grande GE, 1998, SOC SCI MED, V47, P565, DOI 10.1016/S0277-9536(98)00115-4; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006954; Hanaoka C, 2008, SOC SCI MED, V67, P1002, DOI 10.1016/j.socscimed.2008.05.006; Hayashi T, 2011, ARCH GERONTOL GERIAT, V53, P242, DOI 10.1016/j.archger.2010.12.005; Igarashi M, 2014, PALLIATIVE CARE RES, V9, P114; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kaiser Family Foundation, 2017, 4 COUNTR SURV AG END; Kamata K, 2009, J POPULATION STUDIES, V45, P1; Kinjo K, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1961-x; Ministry of Health, VIT STAT; Ministry of Health, 2015, VIT STAT; Ministry of Health, LAB WELF; Ministry of Health Labour and Welfare, 2016, ANN HLTH LAB WELF RE; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nakaya T., 2013, GEOGRAPHICALLY WEIGH; Odoi A, 2014, SPAT SPATIO-TEMPORAL, V11, P109, DOI 10.1016/j.sste.2014.10.001; Office for National Statistics, 2015, NATL SURV BER PEOPL; Ohta Hideki, 2015, Japan Med Assoc J, V58, P6; Sauvaget C, 1996, TOHOKU J EXP MED, V180, P87, DOI 10.1620/tjem.180.87; Shepperd S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009231.pub2; Shoff C, 2012, GEOJOURNAL, V77, P331, DOI 10.1007/s10708-010-9405-3; Statistics Bureau Ministry of Internal Affairs and Communications, 2014, STAT OBS SHI KU MACH; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Tsutsui Takako, 2014, Int J Integr Care, V14, pe002; United Nations, 2015, WORLD POP AG, V2015; World Health Organization (WHO), 2015, WORLD REPORT ON AGEI; Yang Limin, 2006, BMC Palliat Care, V5, P2, DOI 10.1186/1472-684X-5-2	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201649	10.1371/journal.pone.0201649	http://dx.doi.org/10.1371/journal.pone.0201649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142197	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500004
J	Heiberg, IH; Jacobsen, BK; Nesvag, R; Bramness, JG; Reichborn-Kjennerud, T; Naess, O; Ystrom, E; Hultman, CM; Hoye, A				Heiberg, Ina H.; Jacobsen, Bjarne K.; Nesvag, Ragnar; Bramness, Jorgen G.; Reichborn-Kjennerud, Ted; Naess, Oyvind; Ystrom, Eivind; Hultman, Christina M.; Hoye, Anne			Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder	PLOS ONE			English	Article							SEVERE MENTAL-ILLNESS; ALCOHOL-USE DISORDER; FOLLOW-UP; ALL-CAUSE; DRUG-USE; INCREASING MORTALITY; PREMATURE MORTALITY; BIPOLAR DISORDER; DUAL DIAGNOSIS; RISK-FACTORS	Individuals with schizophrenia or substance use disorder have a substantially increased mortality compared to the general population. Despite a high and probably increasing prevalence of comorbid substance use disorder in people with schizophrenia, the mortality in the comorbid group has been less studied and with contrasting results. We performed a nationwide open cohort study from 2009 to 2015, including all Norwegians aged 20-79 with schizophrenia and/or substance use disorder registered in any specialized health care setting in Norway, a total of 125,744 individuals. There were 12,318 deaths in the cohort, and total, sex-, age- and cause-specific standardized mortality ratios (SMRs) were calculated, comparing the number of deaths in patients with schizophrenia, schizophrenia only, substance use disorder only or a co-occurring diagnosis of schizophrenia and substance use disorder to the number expected if the patients had the age-, sex- and calendar-year specific death rates of the general population. The SMRs were 4.9 (95% CI 4.7-5.1) for all schizophrenia patients, 4.4 (95% CI 4.2-4.6) in patients with schizophrenia without substance use disorder, 6.6 (95% CI 6.5-6.8) in patients with substance use disorder only, and 7.4 (95% CI 7.0-8.2) in patients with both schizophrenia and substance use disorder. The SMRs were elevated in both genders, in all age groups and for all considered causes of death, and most so in the youngest. Approximately 27% of the excess mortality in all patients with schizophrenia was due to the raised mortality in the subgroup with comorbid SUD. The increased mortality in patients with schizophrenia and/or substance use disorder corresponded to more than 10,000 premature deaths, which constituted 84% of all deaths in the cohort. The persistent mortality gap highlights the importance of securing systematic screening and proper access to somatic health care, and a more effective prevention of premature death from external causes in this group.	[Heiberg, Ina H.; Jacobsen, Bjarne K.; Hoye, Anne] Ctr Clin Documentat & Evaluat SKDE, Tromso, Norway; [Jacobsen, Bjarne K.] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Nesvag, Ragnar] Oslo Univ Hosp, Nydalen DPS, Oslo, Norway; [Bramness, Jorgen G.] Innlandet Hosp Trust, Norwegian Natl Advisory Unit Concurrent Subst Abu, Hamar, Norway; [Bramness, Jorgen G.; Hoye, Anne] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Reichborn-Kjennerud, Ted; Ystrom, Eivind; Hoye, Anne] Norwegian Inst Publ Hlth, Dept Mental Disorders, Oslo, Norway; [Reichborn-Kjennerud, Ted; Naess, Oyvind] Univ Oslo, Inst Clin Med, Oslo, Norway; [Naess, Oyvind] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Ystrom, Eivind] Univ Oslo, Dept Psychol, Oslo, Norway; [Ystrom, Eivind] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway; [Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hoye, Anne] Univ Hosp North Norway, Div Mental Hlth & Subst Abuse, Tromso, Norway	UiT The Arctic University of Tromso; University of Oslo; Innlandet Hospital Trust; UiT The Arctic University of Tromso; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; UiT The Arctic University of Tromso; University Hospital of North Norway	Heiberg, IH (corresponding author), Ctr Clin Documentat & Evaluat SKDE, Tromso, Norway.	ina.heiberg@skde.no	Heiberg, Ina/GPG-0958-2022; Ystrom, Eivind/C-4094-2009	Ystrom, Eivind/0000-0003-4390-6171; Heiberg, Ina H./0000-0001-7635-5826	research grant by the Regional Health Authorities in Northern Norway [PFP1236-15]	research grant by the Regional Health Authorities in Northern Norway	The study is funded by a research grant offered by the Regional Health Authorities in Northern Norway. Grant number: PFP1236-15. URL: https://helse-nord.no/. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adrian M, 2003, SUBST USE MISUSE, V38, P1575, DOI 10.1081/JA-120024230; ALLGULANDER C, 1989, AM J PUBLIC HEALTH, V79, P1006, DOI 10.2105/AJPH.79.8.1006; Arendt M, 2011, DRUG ALCOHOL DEPEN, V114, P134, DOI 10.1016/j.drugalcdep.2010.09.013; Batki SL, 2009, SCHIZOPHR RES, V107, P139, DOI 10.1016/j.schres.2008.10.016; Beary M, 2012, J PSYCHOPHARMACOL, V26, P52, DOI 10.1177/0269881112440512; Bjorkenstam C, 2014, SCHIZOPHR RES, V157, P1, DOI 10.1016/j.schres.2014.05.010; Bjorkenstam E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000778; Bogdanowicz KM, 2015, DRUG ALCOHOL DEPEN, V148, P85, DOI 10.1016/j.drugalcdep.2014.12.025; Bretteville-Jensen AL, 2015, DRUG ALCOHOL DEPEN, V147, P89, DOI 10.1016/j.drugalcdep.2014.12.002; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Correll CU, 2015, WORLD PSYCHIATRY, V14, P119, DOI 10.1002/wps.20204; Dickey B, 2002, PSYCHIATR SERV, V53, P861, DOI 10.1176/appi.ps.53.7.861; Dickman P, 2007, SAS MACRO SPLITTING; Esse K, 2011, BRAIN BEHAV, V1, P44, DOI 10.1002/brb3.7; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Frasch K, 2013, INT J SOC PSYCHIATR, V59, P757, DOI 10.1177/0020764012456803; Gale CR, 2012, ARCH GEN PSYCHIAT, V69, P823, DOI 10.1001/archgenpsychiatry.2011.2000; Hall W, 2010, ADDICTION, V105, P1332, DOI 10.1111/j.1360-0443.2010.02919.x; Hansen SS, 2000, ACTA PSYCHIAT SCAND, V102, P432, DOI 10.1034/j.1600-0447.2000.102006432.x; Hartz SM, 2014, JAMA PSYCHIAT, V71, P248, DOI 10.1001/jamapsychiatry.2013.3726; Helsedirektoratet [The Norwegian Directorate of Health], 2011, AKT PSYK HELS HELS V; Helsedirektoratet [The Norwegian Directorate of Health], 2016, AKT AVT 2015; Helsedirektoratet [The Norwegian Directorate of Health], 2010, AKT SOM SPES 2009; Helsedirektoratet [The Norwegian Directorate of Health], 2010, AKT AVT 2009; Hjorthoj C, 2017, LANCET PSYCHIAT, V4, P295, DOI 10.1016/S2215-0366(17)30078-0; Hjorthoj C, 2015, LANCET PSYCHIAT, V2, P801, DOI 10.1016/S2215-0366(15)00207-2; Hoye A, 2011, SCHIZOPHR RES, V132, P228, DOI 10.1016/j.schres.2011.07.021; Hunt GE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub3; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; Kilbourne AM, 2009, GEN HOSP PSYCHIAT, V31, P555, DOI 10.1016/j.genhosppsych.2009.07.008; Kiviniemi M, 2010, PSYCHIAT SERV, V61, P272, DOI 10.1176/ps.2010.61.3.272; Koola MM, 2012, J PSYCHIATR RES, V46, P987, DOI 10.1016/j.jpsychires.2012.04.019; Large M, 2014, AUST NZ J PSYCHIAT, V48, P418, DOI 10.1177/0004867414525838; Latalova K, 2014, NEUROPSYCH DIS TREAT, V10, P1925, DOI 10.2147/NDT.S68321; Laursen TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067133; Laursen TM, 2011, J PSYCHIATR RES, V45, P29, DOI 10.1016/j.jpsychires.2010.04.027; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Limosin F, 2007, SCHIZOPHR RES, V94, P23, DOI 10.1016/j.schres.2007.04.031; Liu NH, 2017, WORLD PSYCHIATRY, V16, P30, DOI 10.1002/wps.20384; Lumme S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152223; Maniglio R, 2009, ACTA PSYCHIAT SCAND, V119, P180, DOI 10.1111/j.1600-0447.2008.01300.x; Manrique-Garcia E, 2012, PSYCHOL MED, V42, P1321, DOI 10.1017/S0033291711002078; Maraj S, 2010, CLIN CARDIOL, V33, P264, DOI 10.1002/clc.20746; Mattisson C, 2011, DRUG ALCOHOL DEPEN, V118, P141, DOI 10.1016/j.drugalcdep.2011.03.008; Mitchell AJ, 2010, J PSYCHOPHARMACOL, V24, P69, DOI 10.1177/1359786810382056; Murthy P, 2012, CURR OPIN PSYCHIATR, V25, P194, DOI 10.1097/YCO.0b013e328351a3e0; Nesvag R, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1256-8; Nesvag R, 2015, SOC PSYCH PSYCH EPID, V50, P1267, DOI 10.1007/s00127-015-1025-2; Nielsen RE, 2013, SCHIZOPHR RES, V146, P22, DOI 10.1016/j.schres.2013.02.025; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Nyhlen A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-122; Nyhlen A, 2011, J FORENSIC LEG MED, V18, P66, DOI 10.1016/j.jflm.2011.01.003; Oiesvold T, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-13; Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737; Onyeka IN, 2014, INT J DRUG POLICY, V25, P1047, DOI 10.1016/j.drugpo.2014.07.008; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Osby U, 2016, EUR J PUBLIC HEALTH, V26, P867, DOI 10.1093/eurpub/ckv245; Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065; Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14; Reininghaus U, 2015, SCHIZOPHRENIA BULL, V41, P664, DOI 10.1093/schbul/sbu138; Roerecke M, 2013, ADDICTION, V108, P1562, DOI 10.1111/add.12231; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schmidt LM, 2011, SCHIZOPHR RES, V130, P228, DOI 10.1016/j.schres.2011.04.011; Sorensen HJ, 2005, ACTA PSYCHIAT SCAND, V111, P244, DOI 10.1111/j.1600-0447.2004.00445.x; Sorensen HJ, 2015, SCHIZOPHR RES, V162, P74, DOI 10.1016/j.schres.2015.01.018; Speyer H, 2016, WORLD PSYCHIATRY, V15, P155, DOI 10.1002/wps.20318; Statistics Netherlands, 2022, DEATHS CAUS DEATH EX; Statistics Norway, 2016, FOLK BEF; Steingrimsson S, 2016, NORD J PSYCHIAT, V70, P161, DOI 10.3109/08039488.2015.1062143; Volavka J, 2013, PSYCHIAT DANUB, V25, P24; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Walter F, 2017, JAMA PSYCHIAT, V74, P485, DOI 10.1001/jamapsychiatry.2017.0071; Westermeyer J, 2006, AM J ADDICTION, V15, P345, DOI 10.1080/10550490600860114; Westman J, 2015, ACTA PSYCHIAT SCAND, V131, P297, DOI 10.1111/acps.12330; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; Witt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055942; World Health Organization, 2004, INT STAT CLASS DIS R	82	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202028	10.1371/journal.pone.0202028	http://dx.doi.org/10.1371/journal.pone.0202028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138449	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000442800100035
J	Mutale, W; Bosomprah, S; Shankalala, P; Mweemba, O; Chilengi, R; Kapambwe, S; Chishimba, C; Mukanu, M; Chibutu, D; Heimburger, D				Mutale, Wilbroad; Bosomprah, Samuel; Shankalala, Perfect; Mweemba, Oliver; Chilengi, Roma; Kapambwe, Sharon; Chishimba, Charles; Mukanu, Mulenga; Chibutu, Daniel; Heimburger, Douglas			Assessing capacity and readiness to manage NCDs in primary care setting: Gaps and opportunities based on adapted WHO PEN tool in Zambia	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASE INTERVENTIONS; HEALTH SYSTEM INTERVENTION; CONCEPTUAL-FRAMEWORK; PACKAGE; BHOMA	Introduction Sub-Saharan Africa is experiencing an epidemiological transition as the burden of NCDs overtake communicable diseases. However, it is unknown what capacity and gaps exist at primary care level to address the growing burden of NCDs. This study aimed to assess the Zambian health system's capacity to address in NCDs, using an adapted WHO Essential Non Communicable Disease Interventions (WHO PEN) tool. Methodology This was a cross-sectional facility survey in the three districts conducted from September 2017 to October 2017. We defined facility readiness along five domains: basic equipment, essential services, diagnostic capacity, counseling services, and essential medicines. For each domain, we calculated an index as the mean score of items expressed as percentage. These indices were compared to an agreed cutoff at 70%, meaning that a facility index or district index below 70% off was considered as 'not ready' to manage NCDs at that level. All analysis were performed using Stata 15 MP. Results There appeared to be wide heterogeneity between facilities in respect of readiness to manage NCDs. Only 6 (including the three 1st level hospitals) out of the 46 facilities were deemed ready to manage NCDs. Only the first level hospitals scored a mean index higher than the 70% cut off; With regard to medications needed to manage NCDs, urban and rural health facilities were comparably equipped. However, there was evidence that calcium channel blockers (p = 0.013) and insulin (p = 0.022) were more likely to be available in urban and semi-urban health facilities compared to rural facilities. Conclusion Our study revealed gaps in primary health care capacity to manage NCDs in Zambia, with almost all health facilities failing to reach the minimum threshold. These results could be generalized to other similar districts in Zambia and the sub-region, where health systems remain focused on infectious rather than non-communicable Disease. These results should attract policy attention and potentially form the basis to review current approach to NCD care at the primary care level in Zambia and Sub-Saharan Africa.	[Mutale, Wilbroad; Shankalala, Perfect; Mweemba, Oliver; Mukanu, Mulenga; Chibutu, Daniel] Univ Zambia, Sch Publ Hlth, Lusaka, Zambia; [Bosomprah, Samuel; Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Accra, Ghana; [Kapambwe, Sharon; Chishimba, Charles] Minist Hlth, Lusaka, Zambia; [Heimburger, Douglas] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Zambia; University of Ghana; Vanderbilt University	Mutale, W (corresponding author), Univ Zambia, Sch Publ Hlth, Lusaka, Zambia.	wmutale@yahoo.com		Heimburger, Douglas/0000-0003-3551-9710; Chilengi, Roma/0000-0003-0221-9527; Mutale, Wilbroad/0000-0002-4891-6750; Bosomprah, PhD, Prof. Samuel/0000-0002-2826-3887	National Institute of Health (NIH) [R21TW010471-01]; FOGARTY INTERNATIONAL CENTER [R21TW010471] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the National Institute of Health (NIH) Grant number: R21TW010471-01 to WM.	Aantjes CJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-295; Chalkidou K, 2017, INT J HEALTH POLICY, V6, P233, DOI 10.15171/ijhpm.2016.118; Eiser JR, 2012, INT J DISAST RISK RE, V1, P5, DOI 10.1016/j.ijdrr.2012.05.002; Martinez RE, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/wpsar.2015.6.3.HYN_024, 10.5365/WPSAR.2015.6.3.HYN_024]; Garcia de Quevedo I, 2016, GLOBAL HLTH PROMOTIO; Habib SH, 2010, DIABETES METAB SYND, V4, P41, DOI 10.1016/j.dsx.2008.04.005; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MOH, 2014, 2012 ANN HLTH STAT B; Mutale W, 2017, J EVAL CLIN PRACT, V23, P439, DOI 10.1111/jep.12354; Mutale W, 2016, J EVAL CLIN PRACT, V22, P112, DOI 10.1111/jep.12160; Mutale W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093977; Organization WH, 2016, GLOBAL STATUS REPORT; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; Stringer J, 2013, BMC HLTH SERVICES, V13; Temu F, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.202.4086; WHO, 2017, NCD CHALL CURR STAT; World Health Organization, 2012, ASS NAT CAP PREV CON; World Health Organization, 2013, GLOB ACT PLAN PREV C; Zhang XH, 2016, J CLIN HYPERTENS, V18, P5, DOI 10.1111/jch.12749	20	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0200994	10.1371/journal.pone.0200994	http://dx.doi.org/10.1371/journal.pone.0200994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138318	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100011
J	Kamei, Y; Kamei, D; Tsuchiya, K; Mineshima, M; Nitta, K				Kamei, Yuiko; Kamei, Daigo; Tsuchiya, Ken; Mineshima, Michio; Nitta, Kosaku			Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL BETA-OXIDATION; DIALYSIS THERAPY GUIDELINES; NUCLEAR HORMONE-RECEPTORS; CHRONIC KIDNEY-DISEASE; JAPANESE SOCIETY; SEPTIC SHOCK; RAT-LIVER; SEPSIS; METABOLISM	Background Patients on dialysis are in a chronic carnitine-deficient state. This condition may be associated with abnormalities of the fatty acid and organic acid metabolisms. Carnitine is required for beta-oxidation of the long-chain fatty acids; therefore, carnitine deficiency decreases the efficiency of ATP synthesis and may incur death. However, the details of this association remain unknown. We examined the relationship between beta-oxidation efficiency represented by the carnitine profile and 4-year all-cause mortality in hemodialysis patients. Methods The carnitine profiles of 122 hemodialysis patients were determined by liquid chromatography- tandem mass spectrometry (LC-MS/MS). The associations between the 4-year allcause mortality and carnitine profile as well as the clinical backgrounds of the patients were investigated. A survival analysis was conducted by the Kaplan +/- Meier survival method and multivariable Cox proportional hazard analysis. The bootstrap method was performed to confirm the stability and robustness of our model. Results Of the 122 subjects analyzed, 111 were selected and 24 died during the observation period. Stepwise multivariable Cox regression demonstrated that diabetes state [Hazard ratio (95% confidence interval), 4.981 (2.107 +/- 11.77)], age [HR (95% CI), 1.052 (1.014 +/- 1.091)], and the acetylcarnitine/(palmitoylcarnitine+ octadecenoylcarnitine) [C2/(C16+ C18: 1)] ratio [HR (95% CI), 0.937 (0.904 +/- 0.971)] were independent significant factors of 4-year all-cause mortality. The bootstrap method confirmed the significance of these three factors. Conclusion The 4-year all-cause mortality negatively correlated with the C2/(C16+C18: 1) ratio. Improvement of the impaired beta-oxidation state after L-carnitine administration may ameliorate prognosis.	[Kamei, Yuiko; Kamei, Daigo; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo, Japan; [Kamei, Daigo; Mineshima, Michio] Tokyo Womens Med Univ, Kidney Ctr, Dept Blood Purificat, Tokyo, Japan; [Kamei, Daigo; Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Clin Engn, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Kamei, D (corresponding author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo, Japan.; Kamei, D (corresponding author), Tokyo Womens Med Univ, Kidney Ctr, Dept Blood Purificat, Tokyo, Japan.; Kamei, D (corresponding author), Tokyo Womens Med Univ, Dept Clin Engn, Tokyo, Japan.	Kamei-wak@umin.net	Kamei, Daigo/W-4853-2019					Afshinnia F, 2018, J AM SOC NEPHROL, V29, P295, DOI 10.1681/ASN.2017030350; Anthony Weil P., HARPERS ILLUSTRATED; Arts RJW, 2017, J LEUKOCYTE BIOL, V101, P151, DOI 10.1189/jlb.4MR0216-066R; Brealey David, 2003, Curr Infect Dis Rep, V5, P365, DOI 10.1007/s11908-003-0015-9; Chopra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021285; CLSI, 2010, NBS04 CLSI; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Evans A, 2003, AM J KIDNEY DIS, V41, pS13, DOI 10.1016/S0272-6386(03)00113-6; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30; Fornasini G, 2007, BRIT J CLIN PHARMACO, V64, P335, DOI 10.1111/j.1365-2125.2007.02926.x; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Hayashino Y, 2007, DIABETOLOGIA, V50, P1170, DOI 10.1007/s00125-007-0650-z; Higuchi T, 2016, AM J KIDNEY DIS, V67, P260, DOI 10.1053/j.ajkd.2015.09.010; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; HRYB DJ, 1979, BIOCHEM BIOPH RES CO, V87, P1200, DOI 10.1016/S0006-291X(79)80034-0; Hunter WG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003190; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kamei D, 2018, NEPHROLOGY, V23, P737, DOI 10.1111/nep.13079; Kamei D, 2017, THER APHER DIAL, V21, P43, DOI 10.1111/1744-9987.12479; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Matsumoto Y, 2000, AM J NEPHROL, V20, P201, DOI 10.1159/000013584; Murphy WJA, 2012, NEPHROL DIAL TRANSPL, V27, P304, DOI 10.1093/ndt/gfr334; Nakao T, 2015, THER APHER DIAL, V19, P40, DOI 10.1111/1744-9987.12299; NANNI G, 1985, JPEN-PARENTER ENTER, V9, P483, DOI 10.1177/0148607185009004483; Puskarich MA, 2015, ANN AM THORAC SOC, V12, P46, DOI 10.1513/AnnalsATS.201409-415OC; Reuter SE, 2009, NEPHROL DIAL TRANSPL, V24, P990, DOI 10.1093/ndt/gfn588; Ruiz M, 2017, AM J PHYSIOL-HEART C, V313, pH768, DOI 10.1152/ajpheart.00820.2016; Sakurabayashi T, 1999, AM J NEPHROL, V19, P480, DOI 10.1159/000013502; Sakurabayashi T, 2008, CIRC J, V72, P926, DOI 10.1253/circj.72.926; Schreiber Brian, 2005, Nutr Clin Pract, V20, P218, DOI 10.1177/0115426505020002218; SCHULZ H, 1994, J NUTR, V124, P165, DOI 10.1093/jn/124.2.165; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; TAKEYAMA N, 1990, AM J PHYSIOL, V259, pE498, DOI 10.1152/ajpendo.1990.259.4.E498; TAKEYAMA N, 1989, AM J PHYSIOL, V256, pE31, DOI 10.1152/ajpendo.1989.256.1.E31; Tappy L, 2007, CRIT CARE MED, V35, pS531, DOI 10.1097/01.CCM.0000278062.28122.A4; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Ueland T, 2013, INT J CARDIOL, V167, P1892, DOI 10.1016/j.ijcard.2012.04.150; Vary TC, 1999, MOL CELL BIOCHEM, V198, P113, DOI 10.1023/A:1006993910781; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Wahl P, 2016, AM J PHYSIOL-RENAL, V310, pF433, DOI 10.1152/ajprenal.00375.2015; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Watanabe Y, 2015, THER APHER DIAL, V19, P67, DOI 10.1111/1744-9987.12294; WINTER BK, 1995, BRIT J CANCER, V72, P1173, DOI 10.1038/bjc.1995.482; Wolfe RR, 1998, AM J CLIN NUTR, V67, p519S, DOI 10.1093/ajcn/67.3.519S; Wolfe RR, 2000, WORLD J SURG, V24, P639, DOI 10.1007/s002689910105; Yamamoto H., 2015, RENAL REPLACE THERAP, V3, P36, DOI [10.1186/s41100-017-0114-y, DOI 10.1186/S41100-017-0114-Y]; YAMAMOTO T, 1993, SURG TODAY, V23, P137, DOI 10.1007/BF00311231; Yoshihisa A, 2017, ESC HEART FAIL, V4, P360, DOI 10.1002/ehf2.12176	51	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201591	10.1371/journal.pone.0201591	http://dx.doi.org/10.1371/journal.pone.0201591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133480	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400026
J	Shares, BH; Busch, M; White, N; Shum, L; Eliseev, RA				Shares, Brianna H.; Busch, Melanie; White, Noelle; Shum, Laura; Eliseev, Roman A.			Active mitochondria support osteogenic differentiation by stimulating beta-catenin acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin; mitochondria; acetylation; mesenchymal stem cells (MSCs); osteoblast; osteogenesis; bone marrow mesenchymal stem cells; acetylation	MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; REGENERATION; PROGENITORS; ROLES	Bone marrow stromal (a.k.a. mesenchymal stem) cells (BMSCs) can differentiate into osteoblasts (OBs), adipocytes, or chondrocytes. As BMSCs undergo OB differentiation, they up-regulate mitochondrial oxidative phosphorylation (OxPhos). Here, we investigated the mechanism(s) connecting mitochondrial OxPhos to OB differentiation. First, we found that treating BMSC-like C3H10T1/2 cells with an OxPhos inhibitor reduces their osteogenic potential. Interestingly, ATP levels were not reduced, as glycolysis compensated for the decreased OxPhos. Thus, mitochondria support OB differentiation not only by supplying ATP, but also by other mechanisms. To uncover these mechanisms, we stimulated OxPhos in C3H10T1/2 cells by replacing media glucose with galactose and observed that this substitution increases both OxPhos and osteogenesis even in the absence of osteoinducers. beta-Catenin, an important signaling pathway in osteogenesis, was found to be responsive to OxPhos stimulation. beta-Catenin activity is maintained by acetylation, and mitochondria generate the acetyl donor acetyl-CoA, which upon entering the Krebs cycle is converted to citrate capable of exiting mitochondria. Cytosolic citrate is converted back to acetyl-CoA by ATP citrate lyase (ACLY). We found that inhibiting ACLY with SB204990 (SB) reverses the galactose-induced beta-catenin activity and OB differentiation. This suggested that acetylation is involved in beta-catenin activation after forced OxPhos stimulation, and using immunoprecipitation, we indeed detected SB-sensitive beta-catenin acetylation. Both beta-catenin acetylation and activity increased during osteoinduction coincident with OxPhos activation. These findings suggest that active mitochondria support OB differentiation by promoting beta-catenin acetylation and thus activity.	[Shares, Brianna H.; Busch, Melanie; White, Noelle; Shum, Laura; Eliseev, Roman A.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14624 USA	University of Rochester	Eliseev, RA (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14624 USA.	roman_eliseev@urmc.rochester.edu		Shum, Laura/0000-0002-0167-4133	University of Rochester Department of Orthopedics; National Institutes of Health through NIAMS [K01 AR064610, R01 AR072601]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000042]; NCATS [TL1-TR000096]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096, UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072601, K01AR064610] Funding Source: NIH RePORTER	University of Rochester Department of Orthopedics; National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the University of Rochester Department of Orthopedics as well as the National Institutes of Health through NIAMS Grants K01 AR064610 and R01 AR072601 and National Center for Advancing Translational Sciences (NCATS) Grant UL1 TR000042) (to R.A.E.) and NCATS Grant TL1-TR000096 (to L.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker N, 2015, BONE, V70, P37, DOI 10.1016/j.bone.2014.10.014; Bianco P, 2015, DEVELOPMENT, V142, P1023, DOI 10.1242/dev.102210; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cherry C, 2016, TRENDS MOL MED, V22, P391, DOI 10.1016/j.molmed.2016.03.009; Chocarro-Calvo A, 2013, MOL CELL, V49, P474, DOI 10.1016/j.molcel.2012.11.022; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Gao CX, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-13; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jing H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0231-0; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Karner CM, 2018, BONE, V115, P2, DOI 10.1016/j.bone.2017.08.008; Karner CM, 2016, J BIOL CHEM, V291, P13028, DOI 10.1074/jbc.M115.708578; Lecka-Czernik B, 2015, J BONE MINER RES, V30, P1356, DOI 10.1002/jbmr.2574; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Loeffler J, 2018, TRENDS ENDOCRIN MET, V29, P99, DOI 10.1016/j.tem.2017.11.008; Lu JL, 2016, ONCOTARGET, V7, P37471, DOI 10.18632/oncotarget.9650; Majidinia M, 2018, J CELL PHYSIOL, V233, P2937, DOI 10.1002/jcp.26042; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sandhir R, 2017, BBA-MOL BASIS DIS, V1863, P1090, DOI 10.1016/j.bbadis.2016.10.020; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Valenti MT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010041; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI [10.1158/jcr.1925.148, DOI 10.1158/JCR.1925.148]; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	32	71	74	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16019	16027		10.1074/jbc.RA118.004102	http://dx.doi.org/10.1074/jbc.RA118.004102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30150300	hybrid, Green Published			2022-12-26	WOS:000447256000022
J	Albus, A; Gold, M; Bach, JP; Burg-Roderfeld, M; Jordens, M; Kirchhein, Y; Kronimus, Y; Mengel, D; Zerr, I; Dodel, R				Albus, Alexandra; Gold, Maike; Bach, Jan-Philipp; Burg-Roderfeld, Monika; Joerdens, Marit; Kirchhein, Yvonne; Kronimus, Yannick; Mengel, David; Zerr, Inga; Dodel, Richard			Extending the functional characteristics of naturally occurring autoantibodies against beta-Amyloid, Prion Protein and alpha-Synuclein	PLOS ONE			English	Article							LY-1 B-CELLS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; INTRAVENOUS IMMUNOGLOBULIN; PEPTIDE; PATHOGENESIS; OLIGOMERS; MODELS; NEUROTOXICITY; INFLAMMATION	Background Abnormal aggregation of proteins induces neuronal cell loss in neurodegenerative disorders such as Alzheimer's Disease, Creutzfeldt-Jakob Disease and Parkinson's Disease. Specific stimuli initialize conformational changes in physiological proteins, causing intra- or extracellular protein aggregation. We and other groups have identified naturally occurring autoantibodies (nAbs) as part of the human antibody pool that are able to prevent peptide fibrillation. These nAbs show a rescue effect following exposure of toxic aggregates on neurons, and they support microglial uptake of aggregated peptides. Objective Identification of a putative common epitope among the relevant proteins beta-Amyloid, alpha-Synuclein and Prion Protein for the respective nAbs. Material and methods Binding affinity between the aforementioned proteins and nAbs was tested by Dot Blot, ELISA and SPR-technology. Furthermore, the functionality of the protein-nAbs-complexes was studied in Thioflavin-T assays and microglial uptake experiments to study dependent inhibition of protein aggregation and enhancement of Fc gamma mediated uptake by microglial cells. Results beta-Amyloid and Prion Protein fragment showed considerable binding affinity and functional efficacy for all applied nAbs. Thereby, no significant difference within the different nAbs was detected. In contrast, alpha-Synuclein was bound exclusively by nAbs-alpha-Synuclein, which was reproduced in all binding studies. Surprisingly, functional assays with alpha-Synuclein revealed no significant effect of nAbs in comparison to IVIg treatment. However, all applied nAbs as well as IVIg show a minimal functionality on the microglial uptake of alpha-Synuclein. Conclusion nAbs-A beta, nAbs-PrP possibly display comparable affinity to the same structural epitope within A beta and PrP106-126 A117V whereas the epitope recognized by nAbs-alpha-Syn is only present in alpha-Syn. The structural similarity of A beta and PrP fragment promotes the outline for an efficient antibody for the treatment of several neurodegenerative disorders and extend the functional characteristics of the investigated nAbs.	[Albus, Alexandra; Kronimus, Yannick; Dodel, Richard] Univ Duisburg Essen, Univ Hosp Essen, Chair Geriatr, Essen, Germany; [Albus, Alexandra; Gold, Maike; Bach, Jan-Philipp; Joerdens, Marit; Kirchhein, Yvonne; Kronimus, Yannick; Mengel, David; Dodel, Richard] Philipps Univ, Dept Neurol, Marburg, Germany; [Bach, Jan-Philipp] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Burg-Roderfeld, Monika] Justus Liebig Univ, Dept Hematol & Immunol, Giessen, Germany; [Zerr, Inga] Univ Goettingen, Dept Neurol, Gottingen, Germany	University of Duisburg Essen; Philipps University Marburg; RWTH Aachen University; Justus Liebig University Giessen; University of Gottingen	Dodel, R (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Chair Geriatr, Essen, Germany.; Dodel, R (corresponding author), Philipps Univ, Dept Neurol, Marburg, Germany.	richard.dodel@uk-essen.de		Albus, Alexandra/0000-0002-4897-6972; Burg-Roderfeld, Monika/0000-0003-3455-9171	Novartis; International Parkinson Fonds (Deutschland) GmbH (IPD); German Federal Ministry of Education and Research [01GI1008C]; German Federal Ministry of Education and Research (KNDD - FTLDc); JPND networks SOPHIA, BiomarkAPD and Prefrontals; EU (FAIR-PARK II); foundation of the state Baden-Wurttemberg [D.3830]; BIU (Boehringer Ingelheim University of Ulm Institute) [D.5009]	Novartis(Novartis); International Parkinson Fonds (Deutschland) GmbH (IPD); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (KNDD - FTLDc); JPND networks SOPHIA, BiomarkAPD and Prefrontals; EU (FAIR-PARK II); foundation of the state Baden-Wurttemberg; BIU (Boehringer Ingelheim University of Ulm Institute)	The DEMPARK study was funded by an unrestricted grant from Novartis and a grant from the International Parkinson Fonds (Deutschland) GmbH (IPD). The continuation of the study (LANDSCAPE) is part of the Competence Network Degenerative Dementias (KNDD), which was funded by the German Federal Ministry of Education and Research (project number 01GI1008C). The FTD study was supported by the German Federal Ministry of Education and Research (KNDD - FTLDc), the JPND networks SOPHIA, BiomarkAPD and Prefrontals, the EU (FAIR-PARK II), the foundation of the state Baden-Wurttemberg (D.3830), BIU (Boehringer Ingelheim University of Ulm Institute (D.5009)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Cattepoel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063162; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Gold M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-5; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Holodick NE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00872; Istrin G, 2006, J NEUROSCI RES, V84, P434, DOI 10.1002/jnr.20886; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kronimus Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164953; Laske C, 2014, NEW ENGL J MED, V370, P1459, DOI 10.1056/NEJMc1402193; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mengel D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.151; Morales I, 2010, NEUROIMMUNOMODULAT, V17, P202, DOI 10.1159/000258724; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Pasquali JL, 2012, ADV EXP MED BIOL, V750, P145, DOI 10.1007/978-1-4614-3461-0_11; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Roeder AM, 2013, J BIOL CHEM, V288, P27638, DOI 10.1074/jbc.M113.463273; Roettger Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067743; Roettger Y, 2013, NAT REV NEUROL, V9, P98, DOI 10.1038/nrneurol.2012.258; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shoenfeld Yehuda., 2013, AUTOANTIBODIES, V3rd; Simon D, 2014, NEUROPATH APPL NEURO, V40, P311, DOI 10.1111/nan.12066; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wang T, 2016, NEUROPHARMACOLOGY, V105, P561, DOI 10.1016/j.neuropharm.2016.02.015; Wei X, 2012, J BIOL CHEM, V287, P12858, DOI 10.1074/jbc.M111.255836; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3	43	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202954	10.1371/journal.pone.0202954	http://dx.doi.org/10.1371/journal.pone.0202954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157279	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400077
J	Moriyama, Y; Tamiya, N; Kawamura, A; Mayers, TD; Noguchi, H; Takahashi, H				Moriyama, Yoko; Tamiya, Nanako; Kawamura, Akira; Mayers, Thomas D.; Noguchi, Haruko; Takahashi, Hideto			Effect of short-stay service use on stay-at-home duration for elderly with certified care needs: Analysis of long-term care insurance claims data in Japan	PLOS ONE			English	Article							RESPITE CARE; CAREGIVERS; BURDEN; SYSTEM; HEALTH	Objective Home independence is an important issue for the elderly in many countries and cultures. The aim of this study was to examine the effect of short-stay service use on stay-at-home duration for elderly people by level of care need under the Japanese long-term care insurance system. Methods We analyzed anonymous, Ministry of Health, Labour and Welfare of Japan Long-Term Care Insurance claims data from Ibaraki Prefecture. All participants were certified as eligible for long-term care insurance and had moved into a facility under long-term care insurance after certification between April 2006 and March 2012. Data was analyzed for 2,454 participants aged 65 years or older who entered residential care at least 1 month after initial use of care services. The participants were divided into 2 groups (low- and high-care need), depending on their required level of care. Cox proportional hazard modeling was used to calculate the adjusted hazard ratio (HR) of residential care admission after initial use of care services. Results Use of short-stay services was positively correlated to delay of residential care admission compared to non-use in the low-care need group (HR; 0.834, 95% confidence interval (CI); 0.740 +/- 0.939). In the high-care need group, however, use of short-stay services was somewhat correlated with earlier admission (HR; 1.254, 95% CI; 1.084 +/- 1.451). Conclusions The results of this study show that appropriate timing short-stay service use is necessary for the elderly to stay at home longer.	[Moriyama, Yoko] Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Saitama, Japan; [Moriyama, Yoko; Tamiya, Nanako; Mayers, Thomas D.] Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Ibaraki, Japan; [Tamiya, Nanako] Univ Tsukuba, Hlth Serv Res & Dev Ctr, Ibaraki, Japan; [Kawamura, Akira; Noguchi, Haruko] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan; [Mayers, Thomas D.] Univ Tsukuba, Med English Commun Ctr, Fac Med, Ibaraki, Japan; [Takahashi, Hideto] Natl Inst Publ Hlth, Saitama, Japan	National Institute of Public Health - Japan; University of Tsukuba; University of Tsukuba; Waseda University; University of Tsukuba; National Institute of Public Health - Japan	Moriyama, Y (corresponding author), Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Saitama, Japan.; Moriyama, Y (corresponding author), Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Ibaraki, Japan.	moriyama.y.aa@niph.go.jp	Kawamura, Akira/AAX-3214-2021; Noguchi, Haruko/ABF-3059-2020	Noguchi, Haruko/0000-0002-4437-8238	Japan Society for the Promotion of Science, JSPS KAKENHI [JP16K21643]; Japan Agency for Medical Research and Development, AMED [JP18dk0110026]; Ministry of Health, Labour and Welfare [H27-seisaku-senryaku-012]	Japan Society for the Promotion of Science, JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by 1. Japan Society for the Promotion of Science, JSPS KAKENHI Grant Number JP16K21643; 2. Japan Agency for Medical Research and Development, AMED under Grant Number JP18dk0110026; 3. Ministry of Health, Labour and Welfare (H27-seisaku-senryaku-012). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DAI 5 KI TSUKUBA SHI; Arai Y, 2004, INT J GERIATR PSYCH, V19, P1205, DOI 10.1002/gps.1153; Cabinet Office in Japan, 2012, KOR KENK KANS CHOUS; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Goto M., 2003, J HLTH WELF STAT, V50, P17; Ikegami N, 2003, INT J GERIATR PSYCH, V18, P217, DOI 10.1002/gps.818; Ishizuki T, 2010, J SOCIAL WELFARE, V51, P57; Kato Gohei, 2009, BMC Geriatr, V9, P58, DOI 10.1186/1471-2318-9-58; Kim Jung-Nim, 2012, J Rural Med, V7, P6, DOI 10.2185/jrm.7.6; Kono A., 2009, RONEN SHAKAI KAGAKU, V30, P498; Kuchimura A., 2013, KOUREISHA SHOTO STEI; Kuchimura A., 2007, RYUKOKU U J GRADUATE, V15, P35; Kuzuya M, 2011, AM J GERIAT PSYCHIAT, V19, P382, DOI 10.1097/JGP.0b013e3181e9b98d; Matsuda Tomoyuki, 2013, Nihon Koshu Eisei Zasshi, V60, P586; Ministry of Health Labour and Welfare, 2010, KOK SEIK KIS CHOUS G; Neville CC, 2007, INT J MENT HEALTH NU, V16, P81, DOI 10.1111/j.1447-0349.2007.00450.x; Neville CC, 2008, COLLEGIAN, V15, P159, DOI 10.1016/j.colegn.2008.06.003; Ohwa M, 2012, J GERONTOL SOC WORK, V55, P659, DOI 10.1080/01634372.2012.670869; Salminen M, 2017, AGING CLIN EXP RES, V29, P507, DOI 10.1007/s40520-016-0530-9; Schofield HL, 1999, AUST NZ J PUBL HEAL, V23, P585, DOI 10.1111/j.1467-842X.1999.tb01541.x; SCHULZ R, 1990, J GERONTOL, V45, pP181, DOI 10.1093/geronj/45.5.P181; Tamiya N, 2001, ARCH GERONTOL GERIAT, V33, P109, DOI 10.1016/S0167-4943(01)00100-5; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Tatematsu M., 2014, J JAPAN SOC HOME EC, V65, P632; Tatematsu M, 2002, J HOME EC JAPAN, V53, P369; The project of Ministry of Health Labour and Welfare, 2011, INC NONPR ORG SUPP N; Tomita N, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-345; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Umegaki H, 2014, ARCH GERONTOL GERIAT, V58, P130, DOI 10.1016/j.archger.2013.08.010; van Exel J, 2008, HEALTH POLICY, V88, P73, DOI 10.1016/j.healthpol.2008.03.001; van Exel J, 2006, HEALTH POLICY, V78, P194, DOI 10.1016/j.healthpol.2005.11.002; Vecchio N, 2015, ASS COGNITIVE IMPAIR, DOI [10.1111/HSC.12212, DOI 10.1111/HSC.12212]; Yokozeki M, 2006, JAPANESE J SOCIAL WE, V47, P59; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	34	10	11	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203112	10.1371/journal.pone.0203112	http://dx.doi.org/10.1371/journal.pone.0203112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157253	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400090
J	Kurosaki, H; Nakahata, K; Donishi, T; Shiro, M; Ino, K; Terada, M; Kawamata, T; Kaneoke, Y				Kurosaki, Hiromichi; Nakahata, Katsutoshi; Donishi, Tomohiro; Shiro, Michihisa; Ino, Kazuhiko; Terada, Masaki; Kawamata, Tomoyuki; Kaneoke, Yoshiki			Effects of perinatal blood pressure on maternal brain functional connectivity	PLOS ONE			English	Article							WHITE-MATTER LESIONS; DEFAULT-MODE NETWORK; MAGNETIC-RESONANCE; HYPERTENSIVE ENCEPHALOPATHY; PREECLAMPSIA; PREGNANCY; PATHOGENESIS; ECLAMPSIA; SIGNAL; WOMEN	Perinatal hypertensive disorder including pre-eclampsia is a systemic syndrome that occurs in 3-5% of pregnant women. It can result in various degrees of brain damage. A recent study suggested that even gestational hypertension without proteinuria can cause cardiovascular or cognitive impairments later in life. We hypothesized that perinatal hypertension affects the brain functional connectivity (FC) regardless of the clinical manifestation of brain functional impairment. In the present study, we analyzed regional global connectivity (rGC) strength (mean cross-correlation coefficient between a brain region and all other regions) using resting-state functional magnetic resonance imaging to clarify brain FC changes associated with perinatal blood pressure using data from 16 women with a normal pregnancy and 21 pregnant women with pre-eclampsia. The rGC values in the bilateral orbitofrontal gyri were negatively correlated with diastolic blood pressure (dBP), which could not be explained by other pre-eclampsia symptoms. The strength of FC seeding at the left orbitofrontal gyrus was negatively correlated with dBP in the anterior cingulate gyri and right middle frontal gyrus. These results suggest that dBP elevation during pregnancy can affect the brain FC. Since FC is known to be associated with various brain functions and diseases, our findings are important for elucidating the neural correlate of cognitive impairments related to hypertension in pregnancy.	[Kurosaki, Hiromichi; Nakahata, Katsutoshi; Kawamata, Tomoyuki] Wakayama Med Univ, Dept Anesthesiol, Wakayama, Japan; [Donishi, Tomohiro; Kaneoke, Yoshiki] Wakayama Med Univ, Dept Syst Neurophysiol, Grad Sch, Wakayama, Japan; [Shiro, Michihisa; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan; [Nakahata, Katsutoshi] Kansai Med Univ, Dept Anesthesiol & Intens Care, Osaka, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Kansai Medical University	Kurosaki, H; Nakahata, K (corresponding author), Wakayama Med Univ, Dept Anesthesiol, Wakayama, Japan.; Nakahata, K (corresponding author), Kansai Med Univ, Dept Anesthesiol & Intens Care, Osaka, Japan.	kurosaki@wakayama-med.ac.jp; nakahatak@hirakata.kmu.ac.jp	Kawamata, Tomoyuki/AAY-6918-2020	Shiro, Michihisa/0000-0002-6661-9741	Japan Society for the Promotion of Science [24591303, 25350994]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science (24591303 and 25350994) to Y.K. and T.D.; https://kaken.nii.ac.jp/en/search/?kw=24591303, https://kaken.nii.ac.jp/en/search/?kw=25350994.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Biswal Bharat B., 2009, V489, P255, DOI 10.1007/978-1-59745-543-5_12; Bohr Iwo Jerzy, 2012, Front Psychiatry, V3, P116, DOI 10.3389/fpsyt.2012.00116; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Copel J, 2017, OBSTET GYNECOL, V130, pE210, DOI [10.1097/AOG.0000000000002355, 10.1097/AOG.0000000000002237]; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; Demirtas Ozgur, 2005, Diagn Interv Radiol, V11, P189; Donishi T, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.890; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; Fields JA, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.008; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hannesdottir K, 2009, ACTA NEUROL SCAND, V119, P261, DOI 10.1111/j.1600-0404.2008.01098.x; HAUSER RA, 1988, ARCH NEUROL-CHICAGO, V45, P1078, DOI 10.1001/archneur.1988.00520340032007; Hegarty JP, 2017, BRAIN IMAGING BEHAV, V11, P1278, DOI 10.1007/s11682-016-9604-8; Junewar V, 2014, AM J NEURORADIOL, V35, P1728, DOI 10.3174/ajnr.A3923; Kaneoke Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038131; Li Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0489-x; MENTIS MJ, 1994, STROKE, V25, P601, DOI 10.1161/01.STR.25.3.601; Narayanan A, 2010, BRAIN IMAGING BEHAV, V4, P189, DOI 10.1007/s11682-010-9098-8; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ohno Y, 2013, NEUROL MED-CHIR, V53, P513, DOI 10.2176/nmc.53.513; Osmanagaoglu MA, 2005, AUST NZ J OBSTET GYN, V45, P384, DOI 10.1111/j.1479-828X.2005.00453.x; Podymow T, 2010, HYPERTENS PREGNANCY, V29, P294, DOI 10.3109/10641950902777747; Power JD, 2017, NEUROIMAGE, V146, P609, DOI 10.1016/j.neuroimage.2016.09.038; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rolls ET, 2016, BRAIN COGNITION, V110, P4, DOI 10.1016/j.bandc.2015.07.002; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Scheinost D, 2015, HUM BRAIN MAPP, V36, P1524, DOI 10.1002/hbm.22720; Schwartz RB, 2000, RADIOLOGY, V217, P371, DOI 10.1148/radiology.217.2.r00nv44371; SCHWARTZ RB, 1992, AM J ROENTGENOL, V159, P379, DOI 10.2214/ajr.159.2.1632361; Soma-Pillay P, 2017, PREGNANCY HYPERTENS, V8, P15, DOI 10.1016/j.preghy.2017.02.001; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; Vest AR, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0395-8; Waldstein SR, 2005, ANN BEHAV MED, V29, P174, DOI 10.1207/s15324796abm2903_3; WHO Guidelines Approved by the Guidelines Review Committee, 2011, WHO REC PREV TREATM; Wiegman MJ, 2014, OBSTET GYNECOL, V123, P790, DOI 10.1097/AOG.0000000000000162; Williams K, 2003, ULTRASOUND OBST GYN, V21, P507, DOI 10.1002/uog.83; Wong NML, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00108; Yang GJ, 2014, P NATL ACAD SCI USA, V111, P7438, DOI 10.1073/pnas.1405289111; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhu DC, 2015, J CEREBR BLOOD F MET, V35, P1910, DOI 10.1038/jcbfm.2015.166	56	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203067	10.1371/journal.pone.0203067	http://dx.doi.org/10.1371/journal.pone.0203067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153298	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700040
J	Gordo, L; Oliver-Roig, A; Martinez-Pampliega, A; Elejalde, LI; Fernandez-Alcantara, M; Richart-Martinez, M				Gordo, Leire; Oliver-Roig, Antonio; Martinez-Pampliega, Ana; Iriarte Elejalde, Leire; Fernandez-Alcantara, Manuel; Richart-Martinez, Miguel			Parental perception of child vulnerability and parental competence: The role of postnatal depression and parental stress in fathers and mothers	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; INFANT VULNERABILITY; MATERNAL DEPRESSION; SELF-EFFICACY; SCALE; TRANSITION; SYMPTOMS; RISK; PSYCHOPATHOLOGY; ADAPTATION	Introduction Parents' perception that their child may be vulnerable to serious life-threatening illnesses can have negative effects on how they exercise their parenting. No studies have yet been carried out on parent's perception of their child's vulnerability, when the child has not suffered a severe illness. This study tries to analyze the relationship between parent's perception of their children's vulnerability and parental competence, and analyzes the mediating role of postnatal depression and parental stress. Method The study was carried out on mothers and fathers of full-term infants who did not have any serious illnesses. A total of 965 people (385 fathers and 580 mothers) participated in the study. Results The results revealed an association between parental perception of their child's vulnerability and parent's perception of parental competence through depression and parental stress. However, this association was different for fathers and mothers. Conclusion The variable of perception of child's vulnerability was a relevant factor to understand parental competence.	[Gordo, Leire; Martinez-Pampliega, Ana; Iriarte Elejalde, Leire] Univ Deusto, Dept Social & Dev Psychol, Bilbao, Spain; [Oliver-Roig, Antonio; Richart-Martinez, Miguel] Univ Alicante, Dept Nursing, Alicante, Spain; [Fernandez-Alcantara, Manuel] Univ Alicante, Dept Hlth Psychol, Alicante, Spain	University of Deusto; Universitat d'Alacant; Universitat d'Alacant	Oliver-Roig, A (corresponding author), Univ Alicante, Dept Nursing, Alicante, Spain.	antonio.oliver@icloud.com	Gordo, Leire/V-3016-2019; Fernández-Alcántara, Manuel/H-1406-2015; PAMPLIEGA, ANA MARTINEZ/L-5282-2014	Gordo, Leire/0000-0001-7702-5028; Fernández-Alcántara, Manuel/0000-0002-3481-8156; PAMPLIEGA, ANA MARTINEZ/0000-0001-9130-9553	General Sub-Directorate for Evaluation and Promotion of Research (Institute of Health Carlos III, ISCIII); European Regional Development Fund (FEDER) "A way to make Europe" [PI14/01549]	General Sub-Directorate for Evaluation and Promotion of Research (Institute of Health Carlos III, ISCIII); European Regional Development Fund (FEDER) "A way to make Europe"	This work was funded by the General Sub-Directorate for Evaluation and Promotion of Research (Institute of Health Carlos III, ISCIII) and co-funded by the European Regional Development Fund (FEDER) "A way to make Europe" (Project reference PI14/01549). The funders had no part in designing the study, collecting, analyzing, interpreting or influencing the writing of the data or the decision to publish.	Allen EC, 2004, PEDIATRICS, V113, P267, DOI 10.1542/peds.113.2.267; Anthony KK, 2011, CHILD HEALTH CARE, V40, P53, DOI 10.1080/02739615.2011.537938; Arbuckle JL, 2014, US GUID, P1, DOI [10.1016/j.enconman.2005.10.016, DOI 10.1016/J.ENCONMAN.2005.10.016]; BELSKY J, 1985, J MARRIAGE FAM, V47, P855, DOI 10.2307/352329; BERRY JO, 1995, J SOC PERS RELAT, V12, P463, DOI 10.1177/0265407595123009; Bloomfield Linda, 2012, Prim Health Care Res Dev, V13, P364, DOI 10.1017/S1463423612000060; Caballero-Pelaez C, 2014, 10 S NAC CAS CLIN TR, P164; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI 10.1093/jpepsy/jst049; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Doyle M, 2018, BJPSYCH ADV, V21, P5, DOI [10.1192/apt.bp.112.010900, DOI 10.1192/APT.BP.112.010900]; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.5872; Farkas-Klein C, 2008, UNIV PSYCHOL, V7, P457; Field T, 1996, CHILD PSYCHIAT HUM D, V27, P43, DOI 10.1007/BF02353445; Figueiredo B, 2011, ARCH WOMEN MENT HLTH, V14, P247, DOI 10.1007/s00737-011-0217-3; Forsyth BWC, 1996, J PEDIATR PSYCHOL, V21, P89, DOI 10.1093/jpepsy/21.1.89; Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4; Goecke TW, 2012, ARCH GYNECOL OBSTET, V286, P309, DOI 10.1007/s00404-012-2286-6; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; GREEN M, 1964, PEDIATRICS, V34, P58; Henninger WR, 2014, CHILD FAM SOC WORK, V19, P467, DOI 10.1111/cfs.12046; Hess CR, 2004, J APPL DEV PSYCHOL, V25, P423, DOI 10.1016/j.appdev.2004.06.002; Horwitz SM, 2015, INFANT MENT HEALTH J, V36, P42, DOI 10.1002/imhj.21484; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson K, 2007, ACTA PAEDIATR, V96, P227, DOI 10.1111/j.1651-2227.2007.00015.x; JOHNSTON C, 1989, J CLIN CHILD PSYCHOL, V18, P167, DOI 10.1207/s15374424jccp1802_8; Jones TL, 2005, CLIN PSYCHOL REV, V25, P341, DOI 10.1016/j.cpr.2004.12.004; Kamalifard Mahin, 2014, J Caring Sci, V3, P57, DOI 10.5681/jcs.2014.007; Karam F, 2016, ARCH WOMEN MENT HLTH, V19, P835, DOI 10.1007/s00737-016-0624-6; Kerruish NJ, 2005, J PAEDIATR CHILD H, V41, P419, DOI 10.1111/j.1440-1754.2005.00658.x; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Moon M, 2008, J GENET PSYCHOL, V169, P261, DOI 10.3200/GNTP.169.3.261-280; Ohan JL, 2000, CAN J BEHAV SCI, V32, P251, DOI 10.1037/h0087122; Oltra P., 2016, THESIS; Oronoz B, 2007, PSICOTHEMA, V19, P687; Perez-Padilla J, 2016, BEHAV PSYCHOL, V24, P51; Perren S, 2005, J PSYCHOSOM OBST GYN, V26, P173, DOI 10.1080/01674820400028407; Righetti-Veltema M, 2003, EUR CHILD ADOLES PSY, V12, P75, DOI 10.1007/s00787-003-0311-9; Saligheh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00597; Skreden M, 2012, SCAND J PUBLIC HEALT, V40, P596, DOI 10.1177/1403494812460347; Stuart S, 2008, SANTE MENT QUE, V33, P87, DOI 10.7202/019670ar; Teti DM, 2005, J DEV BEHAV PEDIATR, V26, P283, DOI 10.1097/00004703-200508000-00004; THOMASGARD M, 1995, J DEV BEHAV PEDIATR, V16, P47; Tommiska V, 2002, ARCH DIS CHILD-FETAL, V86, P161, DOI 10.1136/fn.86.3.F161; Widarsson M, 2013, SCAND J CARING SCI, V27, P839, DOI 10.1111/j.1471-6712.2012.01088.x; Wilson S, 2010, CLIN PSYCHOL REV, V30, P167, DOI 10.1016/j.cpr.2009.10.007; Yogev S., 1986, WOMEN THER, V5, P313, DOI [10.1300/J015V05N02_29, DOI 10.1300/J015V05N02_29]	47	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202894	10.1371/journal.pone.0202894	http://dx.doi.org/10.1371/journal.pone.0202894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148877	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200030
J	Beltran-Alcrudo, D; Kukielka, EA; de Groot, N; Dietze, K; Sokhadze, M; Martinez-Lopez, B				Beltran-Alcrudo, Daniel; Kukielka, Esther A.; de Groot, Nienke; Dietze, Klaas; Sokhadze, Mikheil; Martinez-Lopez, Beatriz			Descriptive and multivariate analysis of the pig sector in Georgia and its implications for disease transmission	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; RISK-FACTORS; MANAGEMENT-PRACTICES; PRODUCTION SYSTEMS; SLAUGHTER PIGS; VIRAL DISEASES; ANIMAL HEALTH; BIOSECURITY; DISTRICTS; OUTBREAKS	Background Georgia is a country in the Caucasus region with a traditional backyard and highly variable pig farming system. The practices of such sectors have seldom been described and analyzed to better understand their implication in the introduction and spread of infectious pig diseases. Moreover, the Georgian pig sector was badly hit by an epidemic of African swine fever in 2007 that quickly spread throughout the region. Materials and methods We interviewed 487 pig farmers and 116 butchers using closed questionnaires on socioeconomic issues related to pig production, husbandry practices, biosecurity, marketing and movements, and disease awareness. Surveys were conducted in four regions of Georgia and descriptive statistics were computed. Factorial analyses of mixed data and hierarchical clustering on principal components were applied to study the relationship among collected variables for both farmers and butchers. Results Results show that pig farming in Georgia is a non-professional sector, highly heterogeneous by region, characterized by smallholdings of few animals, with low inputs, outdated technologies, and poor biosecurity, which all translates into low outputs and productivity. The hierarchical clustering on principal components confirmed that there are five major production and husbandry strategies, which match the four regions where the study was conducted. Conclusions Our results are the first step to quantify biosecurity gaps and risky behaviours, develop risk profiles, and identify critical control points across the market chain where to implement mitigation measures. This study provides the baseline information needed to design realistic and sustainable prevention, surveillance and control strategies.	[Beltran-Alcrudo, Daniel] Food & Agr Org, Reg Off Europe & Cent Asia, Budapest, Hungary; [Kukielka, Esther A.; Martinez-Lopez, Beatriz] Univ Calif Davis, CADMS, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [de Groot, Nienke] Univ Utrecht, Utrecht, Netherlands; [Dietze, Klaas] Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Sokhadze, Mikheil] Natl Food Agcy, Tbilisi, Georgia; [Sokhadze, Mikheil] FAO, FAO Representat Georgia, Tbilisi, Georgia	Food & Agriculture Organization of the United Nations (FAO); University of California System; University of California Davis; Utrecht University; Friedrich Loeffler Institute	Beltran-Alcrudo, D (corresponding author), Food & Agr Org, Reg Off Europe & Cent Asia, Budapest, Hungary.	daniel.beltranalcrudo@fao.org	Lopez, Beatriz Martinez/AAE-6692-2021; Beltran-Alcrudo, Daniel/AAL-7358-2021	Beltran-Alcrudo, Daniel/0000-0002-8646-357X; de Groot, Nienke/0000-0001-9006-0071; Kukielka, Esther/0000-0002-8655-3778				Agustina KK, 2017, VET WORLD, V10, P1347, DOI 10.14202/vetworld.2017.1347-1352; Alawneh JI, 2014, PREV VET MED, V114, P73, DOI 10.1016/j.prevetmed.2014.01.020; [Anonymous], 2014, CHAPMAN HALL CRC R S; Beltran-Alcrudo D, 2008, FAO EMPRES WATCH, P1; Beltran-Alcrudo D, 2009, EMPRES WATCH, P1; Boes J, 2005, PREV VET MED, V69, P213, DOI 10.1016/j.prevetmed.2005.02.007; Boinas FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020383; Boklund A, 2004, PREV VET MED, V66, P49, DOI 10.1016/j.prevetmed.2004.08.004; Brioudes A, 2017, TRANSBOUND EMERG DIS, V64, P284, DOI 10.1111/tbed.12370; Brown AA, 2017, TRANSBOUNDARY EMERGI; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Costard S, 2009, PREV VET MED, V92, P199, DOI 10.1016/j.prevetmed.2009.08.010; DEBOER E, 1991, INT J FOOD MICROBIOL, V12, P375, DOI 10.1016/0168-1605(91)90151-E; Dione MM, 2014, PREV VET MED, V117, P565, DOI 10.1016/j.prevetmed.2014.10.012; EDELSTEN RM, 1995, REV SCI TECH OIE, V14, P655, DOI 10.20506/rst.14.3.865; Edia-Asuke AU, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-45; FAO, 2011, VAL CHAIN APPR AN DI; Farez S, 1997, REV SCI TECH OIE, V16, P65, DOI 10.20506/rst.16.1.992; Fosse J, 2009, ZOONOSES PUBLIC HLTH, V56, P429, DOI 10.1111/j.1863-2378.2008.01185.x; Herrera-Ibata DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182850; Holley RA, 2006, J ENVIRON QUAL, V35, P1170, DOI 10.2134/jeq2005.0449; HURNIK D, 1994, PREV VET MED, V20, P135, DOI 10.1016/0167-5877(94)90112-0; Jori F, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00198; Khomenko S., 2013, EMPRES WATCH, V28, P1, DOI DOI 10.1016/J.MEATSCI.2007.06.018; Khuroo MS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090253; Kukielka EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178904; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lichoti JK, 2017, PREV VET MED, V140, P87, DOI 10.1016/j.prevetmed.2017.03.005; Monger VR, 2014, PREV VET MED, V117, P222, DOI 10.1016/j.prevetmed.2014.07.005; Nantima N, 2015, TROP ANIM HEALTH PRO, V47, P589, DOI 10.1007/s11250-015-0768-9; OIE, 2008, OIE WORLD AN HLTH IN; OIE, 2007, OIE WORLD AN HLTH IN; OIE, 2007, AFR SWIN FEV ASF CON; Poolkhet C, 2016, ACTA TROP, V159, P44, DOI 10.1016/j.actatropica.2016.03.027; Probst C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170054; Rasamoelina-Andriamanivo H, 2014, ACTA TROP, V135, P10, DOI 10.1016/j.actatropica.2014.03.008; Raymond P, 2017, CAN J VET RES, V81, P162; Relun A, 2015, PREV VET MED, V121, P246, DOI 10.1016/j.prevetmed.2015.07.004; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Ruiz-Fons F, 2008, VET J, V176, P158, DOI 10.1016/j.tvjl.2007.02.017; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; Truong VM, 2014, NEW ZEAL VET J, V62, P199, DOI 10.1080/00480169.2014.888640; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004	43	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202800	10.1371/journal.pone.0202800	http://dx.doi.org/10.1371/journal.pone.0202800			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142224	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500034
J	Kim, DH				Kim, Du Hyun			Extending Populus seed longevity by controlling seed moisture content and temperature	PLOS ONE			English	Article							STORAGE; GERMINATION; CRYOPRESERVATION; MECHANISMS; VIABILITY; KINETICS; ORCHARD; TRAITS; GROWTH	The poplar species Populus davidiana and P. koreana are widely grown in plantations and as biofuel resources, but little is known about ex-situ seed conservation in poplar. To identify the optimal long-term seed storage conditions for these species, we evaluated the viability of seeds with different seed water contents (SWCs) at various storage temperatures and time periods. P. davidiana seeds with <6% SWC could be stored at room temperature (RT) for 4 weeks, while P. koreana seeds showed no storability at RT. P. davidiana seeds with 3% SWC showed 74% viability after 36 months of storage at 4 degrees C, while those with 9-18% SWC showed >89% viability after 48 months of storage at - 18 degrees C. Long-term storage at -80 degrees C was best for P. davidiana seeds with a wide range of SWCs (3-24%), with 91-98% of normal germination after 48 months of storage. However, the normal germination of P. koreana seeds with 3-24% SWC declined to <20% after 36 months of storage, even at -18 degrees C and -80 degrees C. No significant difference was observed between seeds immersed vs. not immersed in liquid nitrogen for both species. Our findings increase the possibility for longterm seed conservation for both Populus species.	[Kim, Du Hyun] Dong A Univ, Dept Life Resources Ind, Busan, South Korea	Dong A University	Kim, DH (corresponding author), Dong A Univ, Dept Life Resources Ind, Busan, South Korea.	dhimhort@dau.ac.kr			Dong-A University Research Fund	Dong-A University Research Fund	This study was financially supported by the Dong-A University Research Fund.	Annapurna D, 2005, SILVAE GENET, V54, P153, DOI 10.1515/sg-2005-0023; Asakawa S., 1980, P INT S FOR TREE SEE, P136; Ballesteros D, 2017, CRYOLETTERS, V38, P278; Benson M. K., 1972, Genet. Physiol. Note. Institute of Paper Chemistry, P4; Bonner FT, 2008, AGR HDB, P85; Daigle B. I., 2009, Native Plants Journal, V10, P48, DOI 10.2979/NPJ.2009.10.1.48; Dimitriou I, 2017, FOREST ECOL MANAG, V383, P99, DOI 10.1016/j.foreco.2016.08.022; Dreesen D. R., 2003, Native Plants Journal, V4, P118; Dussert S, 2006, CRYOLETTERS, V27, P169; FECHNER GH, 1981, CAN J FOREST RES, V11, P718, DOI 10.1139/x81-100; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Gordon JC, 2001, FOREST CHRON, V77, P217, DOI 10.5558/tfc77217-2; Gosling P., 2007, FORESTRY COMMISSION; Haggman Hely, 2008, P365, DOI 10.1007/978-0-387-72276-4_14; Hay FR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot030; Hong T.D., 1996, IPGRI TECHNICAL B, V1; International Organization on Migration, 2009, MOIST CONT DET, p[iv, 1]; Isebrands J, POPLAR CULTURE N AM; Isebrands JG, 2014, POPLARS AND WILLOWS: TREES FOR SOCIETY AND THE ENVIRONMENT, P1, DOI 10.1079/9781780641089.0000; Jin X, 2014, THESIS; Kaputska LA, 1972, THESIS; Koo YB, 2001, KOREAN J BREEDING, V33, P311; Lee WY, 2016, POPLARS SHORT ROTATI; Linington Simon H., 2001, P165; Mamo N, 2006, FOREST ECOL MANAG, V225, P320, DOI 10.1016/j.foreco.2006.01.026; Maroder HL, 2000, ANN BOT-LONDON, V86, P1017, DOI 10.1006/anbo.2000.1265; Moss EH, 1937, BOT GAZ, V99, P529; Noh ER, 1997, RES REP FOR GEN RES, V33, P1; Pence VC, 1996, SEED SCI TECHNOL, V24, P151; Popova E. V., 2012, CryoLetters, V33, P219; Popova EV, 2013, ACTA PHYSIOL PLANT, V35, P3015, DOI 10.1007/s11738-013-1334-6; Pritchard Hugh W, 2007, Methods Mol Biol, V368, P185; Singh O, 2011, ANN FOR RES, V54, P139; Slabaugh PE, 1958, 6302 ASP BIBL, V6302; Stanton Brian J., 1996, P113; Suszka J, 2014, ANN FOREST SCI, V71, P543, DOI 10.1007/s13595-014-0368-2; TAUER CG, 1979, FOREST SCI, V25, P112; Nguyen TP, 2012, PLANT PHYSIOL, V160, P2083, DOI 10.1104/pp.112.206649; Walters C, 2005, INTEGR COMP BIOL, V45, P751, DOI 10.1093/icb/45.5.751; Walters C, 1998, SEED SCI RES, V8, P223, DOI 10.1017/S096025850000413X; Walters CT, 2001, INT SOC SEED SCI BRA, P280; Wang BSP, 1982, P INT S FOR TREE SEE, P142; WARE GH, 1949, ECOLOGY, V30, P478, DOI 10.2307/1932451; Wood CB, 2003, CRYOLETTERS, V24, P17; Wyckoff G. W., 2008, AGR HDB, V727, P856, DOI DOI 10.2979/NPJ.2009.10.3.300; Zasada J. C., 1980, Tree Planters' Notes, V31, P9; ZASADA JC, 1977, SEED SCI TECHNOL, V5, P509	47	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203080	10.1371/journal.pone.0203080	http://dx.doi.org/10.1371/journal.pone.0203080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142186	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500061
J	Cascallares, G; Riva, S; Franco, DL; Risau-Gusman, S; Gleiser, PM				Cascallares, Guadalupe; Riva, Sabrina; Lorena Franco, D.; Risau-Gusman, Sebastian; Gleiser, Pablo M.			Role of the circadian clock in the statistics of locomotor activity in Drosophila	PLOS ONE			English	Article							GENE MUTATION; MELANOGASTER; RHYTHMS; BEHAVIOR; BRAIN; DISRUPTION; METABOLISM; NEURONS; CANCER; SLEEP	In many animals the circadian rhythm of locomotor activity is controlled by an endogenous circadian clock. Using custom made housing and video tracking software in order to obtain high spatial and temporal resolution, we studied the statistical properties of the locomotor activity of wild type and two clock mutants of Drosophila melanogaster. We show here that the distributions of activity and quiescence bouts for the clock mutants in light-dark conditions (LD) are very different from the distributions obtained when there are no external cues from the environment (DD). In the wild type these distributions are very similar, showing that the clock controls this aspect of behavior in both regimes (LD and DD). Furthermore, the distributions are very similar to those reported for Wistar rats. For the timing of events we also observe important differences, quantified by how the event rate distributions scale for increasing time windows. We find that for the wild type these distributions can be rescaled by the same function in DD as in LD. Interestingly, the same function has been shown to rescale the rate distributions in Wistar rats. On the other hand, for the clock mutants it is not possible to rescale the rate distributions, which might indicate that the extent of circadian control depends on the statistical properties of activity and quiescence.	[Cascallares, Guadalupe; Risau-Gusman, Sebastian; Gleiser, Pablo M.] Ctr Atom Bariloche, Stat & Interdisciplinary Phys Grp, San Carlos De Bariloche, Rio Negro, Argentina; [Riva, Sabrina; Lorena Franco, D.; Risau-Gusman, Sebastian; Gleiser, Pablo M.] Consejo Nacl Invest Cient & Tecn, Med Phys Dept, Av E Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Riva, Sabrina; Lorena Franco, D.; Risau-Gusman, Sebastian; Gleiser, Pablo M.] Ctr Atom Bariloche, Av E Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche	Gleiser, PM (corresponding author), Ctr Atom Bariloche, Stat & Interdisciplinary Phys Grp, San Carlos De Bariloche, Rio Negro, Argentina.; Gleiser, PM (corresponding author), Consejo Nacl Invest Cient & Tecn, Med Phys Dept, Av E Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.; Gleiser, PM (corresponding author), Ctr Atom Bariloche, Av E Bustillo 9500, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	gleiser@cab.cnea.gov.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220120100495]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (URL: http://www.conicet.gov.ar, grant number: PIP 11220120100495, authors who received the funding: SRG, PMG, GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Anteneodo C, 2009, CHAOS, V19, DOI 10.1063/1.3211189; Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cascallares G, 2015, PAP PHYS-LA PLATA, V7, DOI 10.4279/PIP.070005; Cascallares G, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60314-0; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Gilestro GF, 2012, NAT PROTOC, V7, P995, DOI 10.1038/nprot.2012.041; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Helfrich-Forster C, 2004, J COMP PHYSIOL A, V190, P601, DOI 10.1007/s00359-004-0527-2; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kronfeld-Schor N., 2013, P R SOC B, P280; Levi F, 2010, ANNU REV PHARMACOL, V50, P377, DOI 10.1146/annurev.pharmtox.48.113006.094626; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Menon A, 2014, CHRONOBIOL INT, V31, P433, DOI 10.3109/07420528.2013.866131; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Pfeiffenberger C, 2010, COLD SPRING HARB PRO, V5, DOI [10.1038/nature10991, DOI 10.1038/NATURE10991]; Price JL, 2004, MOL BIOL CIRCADIAN R; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reynolds AM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150085; Risau-Gusman S, 2014, J BIOL RHYTHM, V29, P401, DOI 10.1177/0748730414557865; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Spoelstra K, 2016, P NATL ACAD SCI USA, V113, P686, DOI 10.1073/pnas.1516442113; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032007; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001; Zelinski EL, 2014, NEUROSCI BIOBEHAV R, V40, P80, DOI 10.1016/j.neubiorev.2014.01.007	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202505	10.1371/journal.pone.0202505	http://dx.doi.org/10.1371/journal.pone.0202505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138403	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100074
J	Gunter, LM; Barber, RT; Wynne, CDL				Gunter, Lisa M.; Barber, Rebecca T.; Wynne, Clive D. L.			A canine identity crisis: Genetic breed heritage testing of shelter dogs	PLOS ONE			English	Article							ANIMAL CONTROL MEASURES; UNITED-STATES; DOMESTIC DOG; PIT BULL; IDENTIFICATION; ADOPTION; BITES; ATTACKS	Previous research in animal shelters has determined the breeds of dogs living in shelters by their visual appearance; however the genetic breed testing of such dogs is seldom conducted, and few studies have compared the breed labels assigned by shelter staff to the results of this testing. In the largest sampling of shelter dogs' breed identities to-date, 459 dogs at Arizona Animal Welfare League & SPCA (AAWL) in Phoenix, Arizona, and 460 dogs at San Diego Humane Society & SPCA (SDHS) in San Diego, California, were genetically tested using a commercially available product to determine their breed heritage. In our sample, genetic analyses identified 125 distinct breeds with 91 breeds present at both shelters, and 4.9% of the dogs identified as purebreds. The three most common breed signatures, in order of prevalence, American Staffordshire Terrier, Chihuahua, and Poodle, accounted for 42.5% or all breed identifications at the great grandparent level. During their stay at the shelter, dogs with pit bull-type ancestries waited longer to be adopted than other dogs. When we compared shelter breed assignment as determined by visual appearance to that of genetic testing, staff at SDHS was able to successfully match at least one breed in the genetic heritage of 67.7% of dogs tested; however their agreement fell to 10.4% when asked to identify more than one breed. Lastly, we found that as the number of pit bull-type relatives in a dog's heritage increased, so did the shelter's ability to match the results of DNA analysis. In total when we consider the complexity of shelter dog breed heritage and the failure to identify multiple breeds based on visual identification coupled with our inability to predict how these breeds then interact within an individual dog, we believe that focusing resources on communicating the physical and behavioral characteristics of shelter dogs would best support adoption efforts.	[Gunter, Lisa M.; Wynne, Clive D. L.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Barber, Rebecca T.] Arizona State Univ, Mary Lou Fulton Teachers Coll, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Gunter, LM (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	lisa.gunter@asu.edu		Barber, Rebecca/0000-0002-7987-0994; Gunter, Lisa/0000-0002-2363-7691	Mars Veterinary	Mars Veterinary	This research was supported financially by Mars Veterinary. Mars Veterinary had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support, genetic testing kits and related breed analysis were donated by Mars Veterinary (TM). Special thanks to Casey Knox for her insights related to Wisdom Panel testing. The authors thank the administration and staff of the Arizona Animal Welfare League & SPCA and the San Diego Humane Society and SPCA. Additional thanks to the student assistants that volunteered over many months in carrying out this project: Kirsten Letham, Kenji Nishimura, and Rachel Gilchrist.	American Kennel Club, 2014, BREED ID GUID; American Kennel Club, BREAK NEWS LABR RETR; APPA, 2016, PET IND MARK SIZ OWN; Banfield Pet Hospital, STAT PET HLTH 2016 R; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Brown WP, 2013, J APPL ANIM WELF SCI, V16, P2, DOI 10.1080/10888705.2013.740967; Campbell K, 2012, PET ADOPTION SPAY NE; Clarke NM, 2013, CAN VET J, V54, P145; Coile DC, 2007, HAUPPAUGE BARRONS ED; Coppinger R., 2001, DOGS STARTLING NEW U; Cornelissen JMR, 2010, VET J, V186, P292, DOI 10.1016/j.tvjl.2009.10.001; Creedon N, 2017, IRISH VET J, V70, DOI 10.1186/s13620-017-0101-1; Diesel G, 2007, ANIM WELFARE, V16, P353; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Gunter LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146857; Hoffman CL, 2014, J APPL ANIM WELF SCI, V17, P322, DOI 10.1080/10888705.2014.895904; Humane Society of the United States, PETS NUMB; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Kass PH, 2013, PEERJ, V1, DOI 10.7717/peerj.18; Koskinen MT, 2003, ANIM GENET, V34, P297, DOI 10.1046/j.1365-2052.2003.01005.x; Lepper Merry, 2002, Journal of Applied Animal Welfare Science, V5, P29, DOI 10.1207/S15327604JAWS0501_3; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lockwood R, 1997, ANTHROZOOS, V1, P2, DOI DOI 10.2752/; Mariti C., 2015, DOG BEHAV, V2, P25; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Morris KN, 2014, J APPL ANIM WELF SCI, V17, P59, DOI 10.1080/10888705.2014.856250; National Animal Interest Alliance, SURV SHELT DOG COMP; New J. C. Jr., 2000, Journal of Applied Animal Welfare Science, V3, P179, DOI 10.1207/S15327604JAWS0303_1; Olson KR, 2015, VET J, V206, P197, DOI 10.1016/j.tvjl.2015.07.019; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; PATRONEK GJ, 1995, ANTHROZOOS, V8, P31, DOI 10.2752/089279395787156455; Plomin R., 2008, BEHAV GENET; Protopopova A, 2017, ANIM WELFARE, V26, P35, DOI 10.7120/09627286.26.1.035; Protopopova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114319; Protopopova A, 2012, APPL ANIM BEHAV SCI, V142, P61, DOI 10.1016/j.applanim.2012.09.009; Rosado B, 2009, VET J, V179, P383, DOI 10.1016/j.tvjl.2008.02.002; Sacks JJ, 2000, J AM VET MED ASSOC, V217, P836, DOI 10.2460/javma.2000.217.836; SACKS JJ, 1989, JAMA-J AM MED ASSOC, V262, P1489, DOI 10.1001/jama.262.11.1489; Sacks JJ, 1996, PEDIATRICS, V97, P891; Salman M D, 1998, J Appl Anim Welf Sci, V1, P207, DOI 10.1207/s15327604jaws0103_2; Scott JP., 1965, GENETICS SOCIAL BEHA; Serpell J.A., 2014, DOMESTIC DOG COGNITI, DOI [10.1007/978-3-642-53994-7_2, DOI 10.1007/978-3-642-53994-7_2]; Siettou C, 2014, J APPL ANIM WELF SCI, V17, P136, DOI 10.1080/10888705.2014.883924; Simmons KE, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6020011; Stander MH, 2014, DOG NEWS        0411, P44; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; The American Society for the Prevention of Cruelty to Animals, 2016, SHELT INT SURR PET S; Turcsan B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172720; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Voith V.L., 2013, AM J SOCIOL RES, V3, P1729; Voith VL, 2009, J APPL ANIM WELF SCI, V12, P253, DOI 10.1080/10888700902956151; Walsh EA, 2007, P 16 ANN M INT SOC A; Weiss Emily, 2012, Animals (Basel), V2, P301, DOI 10.3390/ani2020301; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wenstrup J, 1999, J Appl Anim Welf Sci, V2, P303, DOI 10.1207/s15327604jaws0204_5	56	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202633	10.1371/journal.pone.0202633	http://dx.doi.org/10.1371/journal.pone.0202633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138476	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100099
J	Sobol, MK; Finkelstein, SA				Sobol, Magdalena K.; Finkelstein, Sarah A.			Predictive pollen-based biome modeling using machine learning	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LAST GLACIAL MAXIMUM; ARTIFICIAL NEURAL-NETWORKS; RANDOM FOREST CLASSIFIER; CLIMATE-CHANGE; LATE QUATERNARY; PHYLOGENETIC-RELATIONSHIPS; LOGISTIC-REGRESSION; SOUTHERN-AFRICA; NATIONAL-PARK	This paper investigates suitability of supervised machine learning classification methods for classification of biomes using pollen datasets. We assign modern pollen samples from Africa and Arabia to five biome classes using a previously published African pollen dataset and a global ecosystem classification scheme. To test the applicability of traditional and machine-learning based classification models for the task of biome prediction from high dimensional modern pollen data, we train a total of eight classification models, including Linear Discriminant Analysis, Logistic Regression, Naive Bayes, K-Nearest Neighbors, Classification Decision Tree, Random Forest, Neural Network, and Support Vector Machine. The ability of each model to predict biomes from pollen data is statistically tested on an independent test set. The Random Forest classifier outperforms other models in its ability correctly classify biomes given pollen data. Out of the eight models, the Random Forest classifier scores highest on all of the metrics used for model evaluations and is able to predict four out of five biome classes to high degree of accuracy, including arid, montane, tropical and subtropical closed and open systems, e.g. forests and savanna/grassland. The model has the potential for accurate reconstructions of past biomes and awaits application to fossil pollen sequences. The Random Forest model may be used to investigate vegetation changes on both long and short time scales, e.g. during glacial and interglacial cycles, or more recent and abrupt climatic anomalies like the African Humid Period. Such applications may contribute to a better understanding of past shifts in vegetation cover and ultimately provide valuable information on drivers of climate change.	[Sobol, Magdalena K.; Finkelstein, Sarah A.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada	University of Toronto	Sobol, MK (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	magdalena.sobol@mail.utoronto.ca	Finkelstein, Sarah/K-8202-2012	Finkelstein, Sarah/0000-0002-8239-399X; Sobol, Magdalena/0000-0002-2331-6388	Ontario Graduate Scholarship (OGS); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2017-06759]	Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funding to M.K. Sobol from the Ontario Graduate Scholarship (OGS) and the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST), and from a Natural Sciences and Engineering Research Council of Canada (NSERC, RGPIN-2017-06759) grant to S.A. Finkelstein.	Aguilera PA, 2010, ENVIRON MODELL SOFTW, V25, P1630, DOI 10.1016/j.envsoft.2010.04.016; Aguilera PA, 2013, STOCH ENV RES RISK A, V27, P435, DOI 10.1007/s00477-012-0676-8; Albert LP, 2017, OECOLOGIA, V184, P25, DOI 10.1007/s00442-017-3853-0; Ashley GM, 2017, AFR ARCHAEOL REV, V34, P345, DOI 10.1007/s10437-017-9260-4; Backlund M, 2000, AM J BOT, V87, P1029, DOI 10.2307/2657003; Barbacka M, 2016, PALAEOGEOGR PALAEOCL, V446, P44, DOI 10.1016/j.palaeo.2016.01.010; Bauwens M, 2009, IFAC P, P407, DOI [10.3182/20090812-3-DK-2006.0082, DOI 10.3182/20090812-3-DK-2006.0082]; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Birks H.J.B., 2012, TRACKING ENV CHANGE; Bourgeois JC, 2000, REV PALAEOBOT PALYNO, V108, P17, DOI 10.1016/S0034-6667(99)00031-7; Bourgeois JC, 2001, J GEOPHYS RES-ATMOS, V106, P5255, DOI 10.1029/2000JD900708; Braun M, 2013, QUATERN INT, V293, P114, DOI 10.1016/j.quaint.2012.03.025; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brewer S, 2008, QUATERNARY SCI REV, V27, P2303, DOI 10.1016/j.quascirev.2008.08.029; Bryant VM, 1996, PALYNOLOGY PRINCIPLE, P913; Bryant VM., 1983, ADV ARCHAEOL METH TH, V6, P191; Bubenzer O, 2007, GEOARCHAEOLOGY, V22, P607, DOI 10.1002/gea.20176; Burrough SL, 2007, PALAEOGEOGR PALAEOCL, V253, P280, DOI 10.1016/j.palaeo.2007.06.010; Calef MP, 2005, J BIOGEOGR, V32, P863, DOI 10.1111/j.1365-2699.2004.01185.x; Campbell Ian D., 1994, Palynology, V18, P5; Cao XY, 2014, REV PALAEOBOT PALYNO, V211, P87, DOI 10.1016/j.revpalbo.2014.08.007; Carter S, 1997, CITES CHECKLIST SUCC; Cerling TE, 2004, PALAEOGEOGR PALAEOCL, V206, P367, DOI 10.1016/j.palaeo.2004.01.013; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chritz KL, 2015, P NATL ACAD SCI USA, V112, P3674, DOI 10.1073/pnas.1423953112; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; Cohen AS, 2007, P NATL ACAD SCI USA, V104, P16422, DOI 10.1073/pnas.0703873104; Colgan MS, 2012, REMOTE SENS-BASEL, V4, P3462, DOI 10.3390/rs4113462; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COX DR, 1958, J R STAT SOC B, V20, P215; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daood Amar, 2016, Advances in Visual Computing. 12th International Symposium, ISVC 2016. Proceedings: LNCS 10072, P321, DOI 10.1007/978-3-319-50835-1_30; Daood A., 2016, P INT FLOR ART INT R, V2004, P26; Datema M, 2017, MAR MICROPALEONTOL, V136, P14, DOI 10.1016/j.marmicro.2017.08.003; Davis BAS, 2003, QUATERNARY SCI REV, V22, P1701, DOI 10.1016/S0277-3791(03)00173-2; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DIMBLEBY G. W., 1957, NEW PHYTOL, V56, P12, DOI 10.1111/j.1469-8137.1957.tb07446.x; Dimbley GW, 1985, PALYNOLOGY ARCHAEOLO; Douglas PMJ, 2016, ANNU REV EARTH PL SC, V44, P613, DOI 10.1146/annurev-earth-060115-012512; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Faegri K., 1975, Textbook of pollen analysis.; Ferry AJ, 2015, PROG OCEANOGR, V131, P100, DOI 10.1016/j.pocean.2014.12.001; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gajewski K, 2002, QUATERNARY SCI REV, V21, P1611, DOI 10.1016/S0277-3791(01)00152-4; Gere J., 2015, ANN RES REV BIOL, V8, P1; Gil-Romera G, 2014, J ARCHAEOL SCI, V46, P89, DOI 10.1016/j.jas.2014.02.027; Goring S, 2010, REV PALAEOBOT PALYNO, V162, P203, DOI 10.1016/j.revpalbo.2010.06.014; GUIOT J, 1990, PALAEOGEOGR PALAEOCL, V80, P49, DOI 10.1016/0031-0182(90)90033-4; GUIOT J, 1989, NATURE, V338, P309, DOI 10.1038/338309a0; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QH, 2005, ECOL MODEL, V182, P75, DOI 10.1016/j.ecolmodel.2004.07.012; Hais M, 2015, PALAEOGEOGR PALAEOCL, V438, P135, DOI 10.1016/j.palaeo.2015.07.037; Hastie T, 2009, ELEMENTS, DOI [10.2113/gselements.5.2.99, DOI 10.2113/GSELEMENTS.5.2.99]; Havinga A.J., 1984, POLLEN SPORES, V26, P541; HOLLOWAY RG, 1989, TEX J SCI, V41, P131; Holt KA, 2014, NEW PHYTOL, V203, P735, DOI 10.1111/nph.12848; Holt KA, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400032; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Hristova V, 2014, PALAEOWORLD, V23, P357, DOI 10.1016/j.palwor.2014.08.002; Hu J, 2012, COMPUT ELECTRON AGR, V88, P133, DOI 10.1016/j.compag.2012.07.008; Iversen J., 1944, GEOLOGISKA F RENINGE, V66, P463, DOI [10.1080/11035894409445689, DOI 10.1080/11035894409445689]; Iverson LR, 2001, ECOSYSTEMS, V4, P186, DOI 10.1007/s10021-001-0003-6; Izumi K, 2016, QUATERNARY SCI REV, V152, P93, DOI 10.1016/j.quascirev.2016.09.023; Jara IA, 2015, J QUATERNARY SCI, V30, P817, DOI 10.1002/jqs.2818; Jeffreys H., 1973, SCI INFERENCE; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; Jolly D, 1998, J BIOGEOGR, V25, P1007, DOI 10.1046/j.1365-2699.1998.00238.x; Kaya Y, 2013, GRANA, V52, P71, DOI 10.1080/00173134.2012.754050; Kigoshi T, 2017, QUATERN INT, V455, P126, DOI 10.1016/j.quaint.2017.05.015; Knutti R, 2003, CLIM DYNAM, V21, P257, DOI 10.1007/s00382-003-0345-1; Kotrys B, 2014, BALTICA, V27, P131, DOI 10.5200/baltica.2014.27.22; Kubitzki K, 2004, FAMILIES GENEREA VAS; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Lacourse T, 2016, REV PALAEOBOT PALYNO, V232, P140, DOI 10.1016/j.revpalbo.2016.05.005; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Li H, 2016, J CLIMATE, V29, P4327, DOI 10.1175/JCLI-D-14-00831.1; Lim S, 2016, PALAEOGEOGR PALAEOCL, V451, P197, DOI 10.1016/j.palaeo.2016.03.001; Liu R, 2017, RISK ANAL, V37, P756, DOI 10.1111/risa.12698; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Maier HR, 2000, ENVIRON MODELL SOFTW, V15, P101, DOI 10.1016/S1364-8152(99)00007-9; Mander L, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400031; Ramos-Canon AM, 2016, LANDSLIDES, V13, P671, DOI 10.1007/s10346-015-0593-2; Matouq M, 2013, J TAIBAH UNIV SCI, V7, P44, DOI 10.1016/j.jtusci.2013.04.001; Mauri A, 2015, QUATERNARY SCI REV, V112, P109, DOI 10.1016/j.quascirev.2015.01.013; Maurin O, 2010, BOT J LINN SOC, V162, P453, DOI 10.1111/j.1095-8339.2010.01027.x; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Metwally AA, 2014, PALAEOGEOGR PALAEOCL, V402, P125, DOI 10.1016/j.palaeo.2014.03.019; Moore P.D., 1991, BLACKWELL SCI PUBLI; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Naidoo L, 2012, ISPRS J PHOTOGRAMM, V69, P167, DOI 10.1016/j.isprsjprs.2012.03.005; Nakagawa T, 2002, QUATERNARY SCI REV, V21, P2099, DOI 10.1016/S0277-3791(02)00014-8; Nash DJ, 2016, QUATERNARY SCI REV, V154, P1, DOI 10.1016/j.quascirev.2016.10.012; Neumann FH, 2014, VEG HIST ARCHAEOBOT, V23, P665, DOI 10.1007/s00334-014-0445-3; Newnham RM, 2017, J QUATERNARY SCI, V32, P685, DOI 10.1002/jqs.2955; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson JS, 1983, CARBON LIVE VEGETATI, P1; Oxelman B, 1999, SYST BOT, V24, P164, DOI 10.2307/2419547; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Paull TM, 2008, PHYCOLOGIA, V47, P213, DOI 10.2216/07-17.1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peyron O, 1998, QUATERNARY RES, V49, P183, DOI 10.1006/qres.1997.1961; Porwal A, 2006, COMPUT GEOSCI-UK, V32, P1, DOI 10.1016/j.cageo.2005.03.018; Pouteau R, 2012, ECOL INFORM, V9, P37, DOI 10.1016/j.ecoinf.2012.03.003; Powers D. M, 2011, ARXIV201016061; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Russell S.J., 2016, ARTIF INTELL; Salonen JS, 2016, HOLOCENE, V26, P1040, DOI 10.1177/0959683616632881; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCOTT L, 1982, QUATERNARY RES, V17, P339, DOI 10.1016/0033-5894(82)90028-X; Scott L, 2012, QUATERNARY SCI REV, V32, P100, DOI 10.1016/j.quascirev.2011.11.010; SCOTT L, 1990, PALAEOGEOGR PALAEOCL, V76, P367, DOI 10.1016/0031-0182(90)90121-M; Scott L., 1994, Historical Biology, V9, P71; SCOTT L, 1992, J BIOGEOGR, V19, P205, DOI 10.2307/2845506; SCOTT L, 1989, PALAEOGEOGR PALAEOCL, V70, P345, DOI 10.1016/0031-0182(89)90112-0; Seppa H, 2001, HOLOCENE, V11, P527, DOI 10.1191/095968301680223486; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Tarasov PE, 2013, CLIM PAST, V9, P2759, DOI 10.5194/cp-9-2759-2013; Thomas DSG, 2003, QUATERN INT, V104, P53, DOI 10.1016/S1040-6182(02)00135-0; Timm O, 2010, J CLIMATE, V23, P2612, DOI 10.1175/2010JCLI3217.1; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Traverse, 2008, PALEOPALYNOLOGY; Trondman AK, 2015, GLOBAL CHANGE BIOL, V21, P676, DOI 10.1111/gcb.12737; Truc L, 2013, PALAEOGEOGR PALAEOCL, V386, P575, DOI 10.1016/j.palaeo.2013.06.024; Twiddle CL, 2010, REV PALAEOBOT PALYNO, V162, P621, DOI 10.1016/j.revpalbo.2010.08.003; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vapnik V, 1997, ADV NEUR IN, V9, P281; Verleysen M, 2005, ANALYSIS, V3512, P758; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860; Wang TL, 2016, FOREST ECOL MANAG, V360, P357, DOI 10.1016/j.foreco.2015.08.004; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Wu HB, 2007, CLIM DYNAM, V29, P211, DOI 10.1007/s00382-007-0231-3; Yoon H, 2011, J HYDROL, V396, P128, DOI 10.1016/j.jhydrol.2010.11.002; Zhao XQ, 2016, HOLOCENE, V26, P843, DOI 10.1177/0959683615622544	145	9	11	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202214	10.1371/journal.pone.0202214	http://dx.doi.org/10.1371/journal.pone.0202214			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138366	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100046
J	Ye, Y; Li, SL; Wang, SY				Ye, Yun; Li, Su-Liang; Wang, Sheng-Yu			Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer	PLOS ONE			English	Article							EXPRESSION PROFILE ANALYSIS; DOWN-REGULATION; TRANSCRIPTION FACTORS; MICRORNA EXPRESSION; BREAST-CANCER; PROGRESSION; SURVIVAL; TARGETS; GROWTH; IDENTIFICATION	Purpose Prostate cancer (PCa) causes a common male urinary system malignant tumour, and the molecular mechanisms of PCa are related to the abnormal regulation of various signalling pathways. An increasing number of studies have suggested that mRNAs, miRNAs, lncRNAs, and TFs could play important roles in various biological processes that are associated with cancer pathogenesis. This study aims to reveal functional genes and investigate the underlying molecular mechanisms of PCa with bioinformatics. Methods Original gene expression profiles were obtained from the GSE64318 and GSE46602 data-sets in the Gene Expression Omnibus (GEO). We conducted differential screens of the expression of genes (DEGs) between two groups using the online tool GEO2R based on the R software limma package. Interactions between differentially expressed miRNAs, mRNAs and lncRNAs were predicted and merged with the target genes. Co-expression of miRNAs, lncRNAs and mRNAs was selected to construct mRNA-miRNA-lncRNA interaction networks. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed for the DEGs. Protein-protein interaction (PPI) networks were constructed, and transcription factors were annotated. Expression of hub genes in the TCGA datasets was verified to improve the reliability of our analysis. Results The results demonstrate that 60 miRNAs, 1578 mRNAs and 61 lncRNAs were differentially expressed in PCa. The mRNA-miRNA-lncRNA networks were composed of 5 miRNA nodes, 13 lncRNA nodes, and 45 mRNA nodes. The DEGs were mainly enriched in the nuclei and cytoplasm and were involved in the regulation of transcription, related to sequence-specific DNA binding, and participated in the regulation of the PI3K-Akt signalling pathway. These pathways are related to cancer and focal adhesion signalling pathways. Furthermore, we found that 5 miRNAs, 6 lncRNAs, 6 mRNAs and 2 TFs play important regulatory roles in the interaction network. The expression levels of EGFR, VEGFA, PIK3R1, DLG4, TGFBR1 and KIT were significantly different between PCa and normal prostate tissue. Conclusion Based on the current study, large-scale effects of interrelated mRNAs, miRNAs, lncRNAs, and TFs established a new prostate cancer network. In addition, we conducted functional module analysis within the network. In conclusion, this study provides new insight for exploration of the molecular mechanisms of PCa and valuable clues for further research into the process of tumourigenesis and its development in PCa.	[Ye, Yun; Li, Su-Liang] Xian Med Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China; [Wang, Sheng-Yu] Xian Med Univ, Affiliated Hosp 1, Dept Respirat, Xian, Shaanxi, Peoples R China	Xi'an Medical University; Xi'an Medical University	Ye, Y (corresponding author), Xian Med Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China.	yeyun236@163.com		ye, yun/0000-0001-9725-2471				Afshar AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100806; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avril S, 2013, PATHOLOGE, V34, P195, DOI 10.1007/s00292-013-1878-7; Cai SW, 2015, ONCOTARGET, V6, P3904, DOI 10.18632/oncotarget.2880; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chang YT, 2018, CANCER LETT, V433, P43, DOI 10.1016/j.canlet.2018.06.029; Chawla K, 2013, BIOINFORMATICS, V29, P2519, DOI 10.1093/bioinformatics/btt432; Chen LS, 2017, J CELL BIOCHEM, V118, P4836, DOI 10.1002/jcb.26158; Daizumoto K, 2018, CANCER RES, V78, P2233, DOI 10.1158/0008-5472.CAN-17-2528; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Diboun I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-252; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Fonseca-Alves CE, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1304-0; Guo YC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040722; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hellwinkel OJC, 2008, BJU INT, V101, P1454, DOI 10.1111/j.1464-410X.2008.07540.x; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Larson SR, 2013, PROSTATE, V73, P932, DOI 10.1002/pros.22639; Lee C, 2018, CANCER LETT, V414, P205, DOI 10.1016/j.canlet.2017.11.016; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li WS, 2018, BIOMED PHARMACOTHER, V102, P1105, DOI 10.1016/j.biopha.2018.03.118; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Liu DF, 2012, ASIAN PAC J CANCER P, V13, P3313, DOI 10.7314/APJCP.2012.13.7.3313; Luo G, 2015, CELL PHYSIOL BIOCHEM, V37, P2209, DOI 10.1159/000438577; Mano R, 2016, PROSTATE CANCER P D, V19, P340, DOI 10.1038/pcan.2016.40; Mortensen MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16018; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Paraskevopoulou MD, 2016, NUCLEIC ACIDS RES, V44, pD231, DOI 10.1093/nar/gkv1270; Puhr M, 2018, CLIN CANCER RES, V24, P927, DOI 10.1158/1078-0432.CCR-17-0989; Rajpar S, 2013, CANCER J, V19, P66, DOI 10.1097/PPO.0b013e31827f123e; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sokilde R, 2014, J MOL DIAGN, V16, P106, DOI 10.1016/j.jmoldx.2013.10.001; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Song ZY, 2018, CANCER INVEST, V36, P10, DOI 10.1080/07357907.2017.1422512; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sunkel B, 2016, NUCLEIC ACIDS RES, V44, P4105, DOI 10.1093/nar/gkv1528; Tian C, 2018, AM J TRANSL RES, V10, P1562; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang BD, 2015, CLIN CANCER RES, V21, P4970, DOI 10.1158/1078-0432.CCR-14-1566; Wang JB, 2017, J CANCER RES CLIN, V143, P661, DOI 10.1007/s00432-016-2332-z; Wen JL, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0156-1; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818	54	45	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0198055	10.1371/journal.pone.0198055	http://dx.doi.org/10.1371/journal.pone.0198055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138363	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100002
J	Oshima, H; Kok, SY; Nakayama, M; Murakami, K; Voon, DCC; Kimura, T; Oshima, M				Oshima, Hiroko; Kok, Sau-Yee; Nakayama, Mizuho; Murakami, Kazuhiro; Voon, Dominic Chih-Cheng; Kimura, Takashi; Oshima, Masanobu			Stat3 is indispensable for damage-induced crypt regeneration but not for Wnt-driven intestinal tumorigenesis	FASEB JOURNAL			English	Article						colon cancer; organoids; anoikis; integrin; FAK	STEM-CELLS; EPITHELIAL-CELLS; WNT/BETA-CATENIN; COLON-CANCER; ACTIVATION; PROLIFERATION; SURVIVAL; IL-6; INFLAMMATION; PROGRESSION	Signal transducer and activator of transcription 3 (Stat3) has been shown to play a role in intestinal regeneration and colitis-associated colon carcinogenesis. However, the role of Stat3 in the Wnt-driven sporadic intestinal tumorigenesis remains poorly understood. We examined the roles of Stat3 in intestinal regeneration and tumorigenesis by organoid culture experiments using Stat3(IEC) mouse-derived intestinal epithelial cells in which Stat3 was disrupted. The regeneration of intestinal mucosa and organoid formation were significantly suppressed by Stat3 disruption, which was compensated by Wnt activation. Furthermore, once organoids were recovered, Stat3 was no longer required for organoid growth. These results indicate that Stat3 and Wnt signaling cooperatively protect epithelial cells at the early phase of intestinal regeneration. In contrast, intestinal tumorigenesis was not suppressed by Stat3 disruption in adenomatous polyposis coli (Apc)(716) and Apc(716) Tgfbr2(IEC) mice, thus indicating that Stat3 is not required for Wnt activation-driven intestinal tumorigenesis. Mechanistically, Itga5 and Itga6 were down-regulated by Stat3 disruption, and focal adhesion kinase (FAK) activation was also suppressed. Notably, FAK inhibitor suppressed the organoid formation of wild-type epithelial cells. These results indicate that Stat3 is indispensable for the survival of epithelial cells through the activation of integrin signaling and the downstream FAK pathway; however, it is not required for the Wnt signaling-activated normal or tumor epithelial cells.Oshima, H., Kok, S.-Y., Nakayama, M., Murakami, K., Voon, D. C.-C., Kimura, T., Oshima, M. Stat3 is indispensable for damage-induced crypt regeneration but not for Wnt-driven intestinal tumorigenesis.	[Oshima, Hiroko; Kok, Sau-Yee; Nakayama, Mizuho; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Oshima, Hiroko; Nakayama, Mizuho; Oshima, Masanobu] Kanazawa Univ, World Premier Int Res Ctr Initiat WPI, Nanolife Sci Inst NanoLSI, Kanazawa, Ishikawa, Japan; [Murakami, Kazuhiro] Kanazawa Univ, Canc Res Inst, Div Stem Cell Biol, Kanazawa, Ishikawa, Japan; [Voon, Dominic Chih-Cheng] Kanazawa Univ, Inst Frontier Sci Initiat InFiniti, Canc Res Core, Kanazawa, Ishikawa, Japan; [Kimura, Takashi] Hokkaido Univ, Lab Comparat Pathol, Fac Vet Med, Sapporo, Hokkaido, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Hokkaido University	Oshima, M (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan.	oshimam@staff.kanazawa-u.ac.jp	Murakami, Kazuhiro/AAC-4569-2019; Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004; Murakami, Kazuhiro/0000-0003-1759-9542; Voon, Dominic Chih-Cheng/0000-0002-2963-9305; Oshima, Hiroko/0000-0001-6855-4008; , Kok/0000-0001-5314-3521	Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) [JP17gm0410014]; AMED [JP17ck0106259]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP18H04030, JP16K07111]; Takeda Science Foundation; Mitsubishi Foundation	Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); AMED; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	The authors thank M. Watanabe, A. Tsuda, and Y. Jomen (Division of Genetics, Cancer Research Institute, Kanazawa University) for their technical assistance. This study was supported by the Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (JP17gm0410014) and AMED (JP17ck0106259); and Grants-in-Aid for Scientific Research (A) (JP18H04030) and (C) (JP16K07111) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; and Mitsubishi Foundation. The authors declare no conflicts of interest.	Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Corvinus FM, 2005, NEOPLASIA, V7, P545, DOI 10.1593/neo.04571; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Jeffery V, 2017, J IMMUNOL, V199, P304, DOI 10.4049/jimmunol.1600960; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lee J, 2012, J BIOL CHEM, V287, P18182, DOI 10.1074/jbc.M111.328831; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oshima H, 2015, CANCER RES, V75, P766, DOI 10.1158/0008-5472.CAN-14-2036; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Oudhoff MJ, 2016, DEV CELL, V37, P47, DOI 10.1016/j.devcel.2016.03.002; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Phesse TJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005411; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Roeser JC, 2015, ONCOGENE, V34, P6029, DOI 10.1038/onc.2015.98; Sakai E, 2018, CANCER RES, V78, P1334, DOI 10.1158/0008-5472.CAN-17-3303; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Takeda K, 1998, J IMMUNOL, V161, P4652; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Willson TA, 2013, INFLAMM BOWEL DIS, V19, P512, DOI 10.1097/MIB.0b013e31828028ad	42	5	5	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1873	1886		10.1096/fj.201801176R	http://dx.doi.org/10.1096/fj.201801176R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30156908	Green Published, hybrid			2022-12-26	WOS:000457296600029
J	Guha, P; Gardell, J; Darpolor, J; Cunetta, M; Lima, M; Miller, G; Espat, NJ; Junghans, RP; Katz, SC				Guha, Prajna; Gardell, Jillian; Darpolor, Josephine; Cunetta, Marissa; Lima, Matthew; Miller, George; Espat, N. Joseph; Junghans, Richard P.; Katz, Steven C.			STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; T-CELLS; IMMUNE-RESPONSE; IN-VIVO; GM-CSF; CANCER; FAS; PROMOTES; INFLAMMATION	Immunosuppressive myeloid-derived suppressor cells (MDSC) subvert antitumor immunity and limit the efficacy of chimeric antigen receptor T cells (CAR-T). Previously, we reported that the GM-CSF/JAK2/STAT3 axis drives liver-associated MDSC (L-MDSC) proliferation and blockade of this axis rescued antitumor immunity. We extended these findings in our murine liver metastasis (LM) model, by treating tumor-bearing mice with STAT3 inhibitors (STATTIC or BBI608) to further our understanding of how STAT3 drives L-MDSC suppressive function. STAT3 inhibition caused significant reduction of tumor burden as well as L-MDSC frequencies due to decrease in pSTAT3 levels. L-MDSC isolated from STATTIC or BBI608-treated mice had significantly reduced suppressive function. STAT3 inhibition of L-MDSC was associated with enhanced antitumor activity of CAR-T. Further investigation demonstrated activation of apoptotic signaling pathways in L-MDSC following STAT3 inhibition as evidenced by an upregulation of the pro-apoptotic proteins Bax, cleaved caspase-3, and downregulation of the anti-apoptotic protein Bcl-2. Accordingly, there was also a decrease of pro-survival markers, pErk and pAkt, and an increase in pro-death marker, Fas, with activation of downstream JNK and p38 MAPK. These findings represent a previously unrecognized link between STAT3 inhibition and Fas-induced apoptosis of MDSCs. Our findings suggest that inhibiting STAT3 has potential clinical application for enhancing the efficacy of CAR-T cells in LM through modulation of L-MDSC.	[Guha, Prajna; Gardell, Jillian; Darpolor, Josephine; Cunetta, Marissa; Lima, Matthew; Espat, N. Joseph; Junghans, Richard P.; Katz, Steven C.] Roger Williams Med Ctr, Dept Surg, Providence, RI 02908 USA; [Miller, George] NYU, Sch Med, New York, NY USA; [Espat, N. Joseph; Katz, Steven C.] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA	Roger Williams Medical Center; New York University; Boston University	Katz, SC (corresponding author), Roger Williams Med Ctr, Dept Surg, Providence, RI 02908 USA.; Katz, SC (corresponding author), Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA.	skatz@chartercare.org			National Institutes of Health [1K08CA160662-01A1]; NATIONAL CANCER INSTITUTE [K08CA160662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Sorrento Therapeutics, Inc. for generously preparing the CEA-Fc for anti-CEA CAR detection and Prometheus, Inc. for providing Proleukin (IL2). We also thank Dr. John Morgan and Roger Williams Medical Center Core Facility for providing us with the flow cytometry core facility. Support for this work was provided by the National Institutes of Health (1K08CA160662-01A1).	Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Burga RA, 2015, CANCER IMMUNOL IMMUN, V64, P817, DOI 10.1007/s00262-015-1692-6; Cahill MA, 1996, ONCOGENE, V13, P2087; Chipoy C, 2007, ONCOGENE, V26, P6653, DOI 10.1038/sj.onc.1210492; Condamine T, 2015, J LEUKOCYTE BIOL, V98, P913, DOI 10.1189/jlb.4RI0515-204R; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gotthardt D, 2014, BLOOD, V124, P2370, DOI 10.1182/blood-2014-03-564450; Guha P, 2017, CANCER GENE THER, V24, P114, DOI 10.1038/cgt.2016.54; Guha P, 2017, J LEUKOCYTE BIOL, V102, P201, DOI 10.1189/jlb.5HI0716-322RR; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hsu SC, 1999, J BIOL CHEM, V274, P25769, DOI 10.1074/jbc.274.36.25769; Hu XL, 2013, J BIOL CHEM, V288, P19103, DOI 10.1074/jbc.M112.434530; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Ji T, 2013, CANCER LETT, V341, P231, DOI 10.1016/j.canlet.2013.08.022; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Katz SC, 2016, CANCER GENE THER, V23, P142, DOI 10.1038/cgt.2016.14; Katz SC, 2005, HEPATOLOGY, V42, P293, DOI 10.1002/hep.20795; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Katz SC, 2009, ANN SURG ONCOL, V16, P2524, DOI 10.1245/s10434-009-0585-3; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee H, 2011, CURR TOP MICROBIOL, V344, P41, DOI 10.1007/82_2010_51; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Li YZ, 2015, P NATL ACAD SCI USA, V112, P1839, DOI 10.1073/pnas.1424171112; Liu K, 2010, WORLD J GASTRO ONCOL, V2, P399, DOI 10.4251/wjgo.v2.i11.399; Low W, 1999, ONCOGENE, V18, P3737, DOI 10.1038/sj.onc.1202702; Ma C, 2012, J LEUKOCYTE BIOL, V92, P1199, DOI 10.1189/jlb.0212059; Ma QZ, 2004, CANCER GENE THER, V11, P297, DOI 10.1038/sj.cgt.7700685; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ostrand-Rosenberg S, 2012, CANCER IMMUNOL IMMUN, V61, P1319, DOI 10.1007/s00262-012-1269-6; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Parikh N, 2004, J IMMUNOL, V173, P6220, DOI 10.4049/jimmunol.173.10.6220; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Rao L, 1997, CURR OPIN GENET DEV, V7, P52, DOI 10.1016/S0959-437X(97)80109-8; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Salmon RA, 1997, J IMMUNOL, V159, P5309; Scholz M, 2005, MED RES REV, V25, P331, DOI 10.1002/med.20025; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Thorn M, 2016, CANCER GENE THER, V23, P188, DOI 10.1038/cgt.2016.19; Toyoshima F, 1997, J CELL BIOL, V139, P1005, DOI 10.1083/jcb.139.4.1005; Turcotte S, 2014, CANCER IMMUNOL RES, V2, P530, DOI 10.1158/2326-6066.CIR-13-0180; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wittig Ilka, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P449, DOI 10.2174/156800805774912999; Wu AA, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1016700; Yang F, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.21; Ye TH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.452; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang YM, 2016, CANCER MED-US, V5, P1251, DOI 10.1002/cam4.675; Zhang YL, 2009, J IMMUNOL, V182, P3801, DOI 10.4049/jimmunol.0801548; Zhao CG, 2015, ONCOTARGET, V6, P14472, DOI 10.18632/oncotarget.3991; Zhao HF, 2015, INT J ONCOL, V47, P429, DOI 10.3892/ijo.2015.3052	76	71	76	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					533	548		10.1038/s41388-018-0449-z	http://dx.doi.org/10.1038/s41388-018-0449-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30158673				2022-12-26	WOS:000456589800006
J	Wang, LT; Wang, SN; Chiou, SS; Liu, KY; Chai, CY; Chiang, CM; Huang, SK; Yokoyama, KK; Hsu, SH				Wang, Li-Ting; Wang, Shen-Nien; Chiou, Shyh-Shin; Liu, Kwei-Yan; Chai, Chee-Yin; Chiang, Cheng-Ming; Huang, Shau-Ku; Yokoyama, Kazunari K.; Hsu, Shih-Hsien			TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer	ONCOGENE			English	Article							ZIP TRANSCRIPTION FACTOR; TUMOR PROGRESSION; BHLH FACTORS; TWIST GENE; PROTEIN; SPZ1; TRANSFORMATION; TUMORIGENESIS; CELLS; BRD4	Metastasis is the main cause of cancer mortality. However, the triggering mechanisms and regulation of epithelial-mesenchymal transition (EMT) factors in the commitment of metastasis have not been well characterized. Spermatogenic Zip 1 (SPZ1) acts as a proto-oncogene and an upstream regulator of EMT during tumorigenesis. Here we report that the HIV-1 Tat-interacting protein 60 kDa (Tip60) acetyltransferase mediates acetylation at lysine residues of SPZ1 at positions 369 and 374, and of TWIST1 at positions 73 and 76, which are required for SPZ1-TWIST1 complex formation and cancer cell migration in vitro and in vivo. Ectopic SPZ1 and TWIST1 expression, but not that of TWIST1 alone, enhanced vascular endothelial growth factor (VEGF) expression via the recruitment of bromodomain-containing protein 4 (BRD4), thus enhancing RNA-Pol II-dependent transcription and inducing metastasis. Neutralization of VEGF using humanized monoclonal antibodies such as Avastin, effectively abrogated the EMT and oncogenesis induced by the acetylated SPZ1-TWIST1 complex. Our findings highlight the importance of acetylation signaling in the SPZ1-TWIST1-BRD4 axis in the mediation of EMT and its regulation during tumor initiation and metastasis.	[Wang, Li-Ting; Liu, Kwei-Yan; Yokoyama, Kazunari K.; Hsu, Shih-Hsien] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Wang, Shen-Nien] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung 807, Taiwan; [Wang, Shen-Nien] Pingtung Hosp, Minist Hlth & Welf, Pingtung 900, Taiwan; [Chiou, Shyh-Shin] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung 807, Taiwan; [Chiou, Shyh-Shin] Kaohsiung Med Univ Hosp, Div Hematol Oncol, Kaohsiung 807, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung 807, Taiwan; [Chiang, Cheng-Ming] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Huang, Shau-Ku] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan 115, Taiwan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung 807, Taiwan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung 807, Taiwan; [Yokoyama, Kazunari K.] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan; [Hsu, Shih-Hsien] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; University of Tokyo; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yokoyama, KK; Hsu, SH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan.; Yokoyama, KK (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung 807, Taiwan.; Yokoyama, KK (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung 807, Taiwan.; Yokoyama, KK (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan.; Hsu, SH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan.	kazu@kmu.edu.tw; jackhsu@kmu.edu.tw	Yokoyama, Kazunari K./Z-1701-2019; Hsu, Shih-Hsien/D-5139-2009	Yokoyama, Kazunari K./0000-0001-8508-7587; Hsu, Shih Hsien/0000-0003-2102-0505; Chai, Chee-Yin/0000-0003-0486-9742; Wang, Li-Ting/0000-0002-3335-8055	Liver Disease Prevention & Treatment Research Foundation, Taiwan; Kaohsiung Medical University Hospital [KMUH100-0R20, KMUH106-6R33]; Ministry of Science and Technology, Taiwan [MOST-105-2314-B-037-070-MY2, MOST-106-2314-B-037-090-MY2, MOST-106-2314-B-037-017, MOST-106-2314-B-037-028, MOST-107-2314-B-037-063-MY3, MOST-107-2314-B-037-028-MY3]; National Health Research of Education [NHRI-Ex106-10416S1, NHRI-Ex107-10720-S1]; Kaohsiung Medical University grant [KMU-TP105E21, KMU-TP10500 5, KMU-DK108012]; US NIH [CA103867]; CPRIT [RP140367, RP180349]; Welch Foundation [I-1805]; NATIONAL CANCER INSTITUTE [R01CA103867] Funding Source: NIH RePORTER	Liver Disease Prevention & Treatment Research Foundation, Taiwan; Kaohsiung Medical University Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research of Education; Kaohsiung Medical University grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge support from the Liver Disease Prevention & Treatment Research Foundation, Taiwan. This work was supported in part by research grants KMUH100-0R20 and KMUH106-6R33 from the Kaohsiung Medical University Hospital, MOST-105-2314-B-037-070-MY2, MOST-106-2314-B-037-090-MY2, MOST-106-2314-B-037-017, MOST-106-2314-B-037-028, MOST-107-2314-B-037-063-MY3, MOST-107-2314-B-037-028-MY3 from the Ministry of Science and Technology, Taiwan, the National Health Research of Education (NHRI-Ex106-10416S1; NHRI-Ex107-10720-S1), Kaohsiung Medical University grant (KMU-TP105E21, KMU-TP10500 5, KMU-DK108012) and US NIH (CA103867), CPRIT (RP140367; RP180349) and Welch Foundation (I-1805).	Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Francart ME, 2018, DEV DYNAM, V247, P432, DOI 10.1002/dvdy.24506; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hsu SH, 2005, CANCER RES, V65, P4041, DOI 10.1158/0008-5472.CAN-04-3658; Hsu SH, 2004, EXP CELL RES, V294, P185, DOI 10.1016/j.yexcr.2003.10.029; Hsu SH, 2001, MECH DEVELOP, V100, P177, DOI 10.1016/S0925-4773(00)00513-X; Judes G, 2015, EPIGENOMICS-UK, V7, P1351, DOI 10.2217/epi.15.76; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Llovet JM, 2014, CANCER CELL, V25, P560, DOI 10.1016/j.ccr.2014.04.019; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Martin A, 2010, NAT CELL BIOL, V12, P924, DOI 10.1038/ncb1010-924; Mattheyses AL, 2015, METHODS MOL BIOL, V1278, P329, DOI 10.1007/978-1-4939-2425-7_20; Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tran PT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002650; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wang LT, 2017, ONCOGENE, V36, P4405, DOI 10.1038/onc.2017.69; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Zhu QQ, 2016, TUMOR BIOL, V37, P185, DOI 10.1007/s13277-015-4450-7	31	19	22	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					518	532		10.1038/s41388-018-0457-z	http://dx.doi.org/10.1038/s41388-018-0457-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30154425	Green Published, hybrid			2022-12-26	WOS:000456589800005
J	Lichner, Z; Saleeb, R; Butz, H; Ding, Q; Nofech-Mozes, R; Riad, S; Farag, M; Varkouhi, AK; dos Santos, CC; Kapus, A; Yousef, GM				Lichner, Zsuzsanna; Saleeb, Rola; Butz, Henriett; Ding, Qiang; Nofech-Mozes, Roy; Riad, Sara; Farag, Mina; Varkouhi, Amir K.; dos Santos, Claudia C.; Kapus, Andras; Yousef, George M.			Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance	FASEB JOURNAL			English	Article						kidney cancer; differential drug response; receptor tyrosine kinase inhibitor	TO-MESENCHYMAL TRANSITION; G-PROTEIN; DOWN-REGULATION; CARCINOMA; METASTASIS; SURVIVAL; DRUG; INHIBITION; EXPRESSION; VEGF	Sunitinib is the standard-of-care, first-line treatment for advanced renal cell carcinoma (RCC). Characteristics of treatment-resistant RCC have been described; however, complex tumor adaptation mechanisms obstruct the identification of significant operators in resistance. We hypothesized that resistance is a late manifestation of early, treatment-induced histomolecular alterations; therefore, studying early drug response may identify drivers of resistance. We describe an epithelioid RCC growth pattern in RCC xenografts, which emerges in sunitinib-sensitive tumors and is augmented during resistance. This growth modality is molecularly and morphologically related to the RCC spheroids that advance during in vitro treatment. Based on time-lapse microscopy, mRNA and microRNA screening, and tumor behavior-related characteristics, we propose that the spheroid and adherent RCC growth patterns differentially respond to sunitinib. Gene expression analysis indicated that sunitinib promoted spheroid formation, which provided a selective survival advantage under treatment. Functional studies confirm that E-cadherin is a key contributor to the survival of RCC cells under sunitinib treatment. In summary, we suggest that sunitinib-resistant RCC cells exist in treatment-sensitive tumors and are histologically identifiable.Lichner, Z., Saleeb, R., Butz, H., Ding, Q., Nofech-Mozes, R., Riad, S., Farag, M., Varkouhi, A. K., dos Santos, C. C., Kapus, A., Yousef, G. M. Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance.	[Lichner, Zsuzsanna; Saleeb, Rola; Butz, Henriett; Ding, Qiang; Nofech-Mozes, Roy; Riad, Sara; Farag, Mina; Varkouhi, Amir K.; dos Santos, Claudia C.; Kapus, Andras; Yousef, George M.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Varkouhi, Amir K.; dos Santos, Claudia C.] St Michaels Hosp, Viral Vector & Cell Therapy Core VICTOR, Toronto, ON, Canada; [Lichner, Zsuzsanna; Saleeb, Rola; Ding, Qiang; Yousef, George M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [dos Santos, Claudia C.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [dos Santos, Claudia C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Kapus, Andras] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Butz, Henriett] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Butz, Henriett] Semmelweis Univ HAS SE, Budapest, Hungary	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Hungarian Academy of Sciences; Semmelweis University	Yousef, GM (corresponding author), St Michaels Hosp, Dept Lab Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	yousefg@smh.ca		Kapus, Andras/0000-0002-6610-9530; Saleeb, Rola/0000-0002-1937-3101; Varkouhi, Amir Khashayar/0000-0002-1794-7546; dos Santos, Claudia/0000-0002-6446-8791	Animal Care Committee of the Keenan Research Centre; Canadian Institutes of Health Research [MOP-119606]; Kidney Foundation of Canada [KFOC130030]; Prostate Cancer Canada Movember Discovery Grants [D2013-39]; Kidney Research Scientist Core Education; National Training Program Postdoctoral Award from the Kidney Foundation of Canada	Animal Care Committee of the Keenan Research Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Prostate Cancer Canada Movember Discovery Grants; Kidney Research Scientist Core Education; National Training Program Postdoctoral Award from the Kidney Foundation of Canada	The authors are grateful for the dedicated work of Vidya Beharry (St. Michael's Hospital) regarding the immunohistochemistry stains; for the advice and support we received from the Animal Care Committee of the Keenan Research Centre; and for the animal care and handling expertise of Danielle Gifford and Alex Rivera (Keenan Research Centre for Biomedical Sciences, St. Michael's Hospital), which they have generously shared with us. The authors also thank Samantha Levin (Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada) for proofreading the manuscript and for helpful comments. This work was supported by grants from the Canadian Institutes of Health Research (MOP-119606), the Kidney Foundation of Canada (KFOC130030), and Prostate Cancer Canada Movember Discovery Grants (D2013-39). Z.L. was supported by the Kidney Research Scientist Core Education and the National Training Program Postdoctoral Award from the Kidney Foundation of Canada. The authors declare no conflicts of interest.	Adelaiye R, 2015, MOL CANCER THER, V14, P513, DOI 10.1158/1535-7163.MCT-14-0208; Berkers J, 2013, J UROLOGY, V189, P1930, DOI 10.1016/j.juro.2012.11.133; Butz H, 2018, ONCOTARGET, V9, P4661, DOI 10.18632/oncotarget.23163; Carlo MI, 2016, NAT REV UROL, V13, P420, DOI 10.1038/nrurol.2016.103; Chen GF, 2014, CELL RES, V24, P1121, DOI 10.1038/cr.2014.112; Chinello C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106684; Demetri GD, 2009, CLIN CANCER RES, V15, P5902, DOI 10.1158/1078-0432.CCR-09-0482; Dufies M, 2017, CANCER RES, V77, P1212, DOI 10.1158/0008-5472.CAN-16-3088; Ebos JML, 2014, EMBO MOL MED, V6, P1561, DOI 10.15252/emmm.201403989; Elias BC, 2015, J CELL SCI, V128, P4293, DOI 10.1242/jcs.164509; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Giuliano S, 2015, AUTOPHAGY, V11, P1891, DOI 10.1080/15548627.2015.1085742; Grunwald V, 2015, EUR UROL, V67, P952, DOI 10.1016/j.eururo.2014.12.036; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Ibragimova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077309; Larkin JMG, 2007, NAT CLIN PRACT ONCOL, V4, P470, DOI 10.1038/ncponc0901; Lawson KA, 2016, CLIN CANCER RES, V22, P5839, DOI 10.1158/1078-0432.CCR-16-0143; Lichner Z, 2015, ONCOTARGET, V6, P5567, DOI 10.18632/oncotarget.1901; Liu D, 2017, ONCOIMMUNOLOGY, V7; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; New DC, 2007, FEBS J, V274, P6025, DOI 10.1111/j.1742-4658.2007.06116.x; Ni D, 2014, CLIN CANCER RES, V20, P1779, DOI 10.1158/1078-0432.CCR-13-1687; Nikitenko LL, 2013, CLIN CANCER RES, V19, P5740, DOI 10.1158/1078-0432.CCR-13-1712; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Patyna S, 2008, TOXICOL PATHOL, V36, P905, DOI 10.1177/0192623308326151; Penzvalto Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059503; Qian CN, 2013, NAT REV UROL, V10, P300, DOI 10.1038/nrurol.2013.26; Ruan HL, 2017, INT J ONCOL, V51, P336, DOI 10.3892/ijo.2017.4010; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Stewart GD, 2015, CLIN CANCER RES, V21, P4212, DOI 10.1158/1078-0432.CCR-15-0207; Stewart K, 2014, SEMIN CELL DEV BIOL, V36, P13, DOI 10.1016/j.semcdb.2014.09.001; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tomlinson JS, 2001, CANCER RES, V61, P5231; Varna M, 2015, CLIN CANCER RES, V21, P916, DOI 10.1158/1078-0432.CCR-14-0666; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; XI W, 2017, NAT COMMUN, V8; Xiong J, 2017, ONCOTARGET, V8, P6555, DOI 10.18632/oncotarget.14149; Zhang SW, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4810734; Zhang YH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0442-8	44	3	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1347	1359		10.1096/fj.201800596R	http://dx.doi.org/10.1096/fj.201800596R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148679	Bronze			2022-12-26	WOS:000457401500106
J	Wang, CM; Gu, LY; Ruan, YL; Geng, X; Xu, M; Yang, NN; Yu, L; Jiang, YC; Zhu, C; Yang, Y; Zhou, Y; Guan, XW; Luo, WQ; Liu, Q; Dong, XZ; Yu, G; Lan, L; Tang, ZX				Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Xu, Miao; Yang, Niuniu; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Luo, Wenqin; Liu, Qin; Dong, Xinzhong; Yu, Guang; Lan, Lei; Tang, Zongxiang			Facilitation of MrgprD by TRP-A1 promotes neuropathic pain	FASEB JOURNAL			English	Article						MrgprA1; dorsal root ganglia (DRG); protein kinase A (PKA)	DORSAL-HORN NEURONS; RECEPTOR; PROTEIN; TRPA1; ITCH; MODEL; COLD; RAT; IDENTIFICATION; EXCITABILITY	Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the -alanine-induced calcium signal was attributed mostly to TRP-A1 function. We further showed that PKA serves as a downstream mediator of -alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the -alanine-induced pain behavior was increased, whereas the itching behavior was unchanged in CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the -alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.Wang, C., Gu, L., Ruan, Y., Geng, X., Xu, M., Yang, N., Yu, L., Jiang, Y., Zhu, C., Yang, Y., Zhou, Y., Guan, X., Luo, W., Liu, Q., Dong, X., Yu, G., Lan, L., Tang, Z. Facilitation of MrgprD by TRP-A1 promotes neuropathic pain.	[Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Yang, Niuniu; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, Key Lab Chinese Med Prevent & Treatment Neurol Di, Nanjing, Jiangsu, Peoples R China; [Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, State Key Lab Cultivat Base Tradit Chinese Med Qu, Nanjing, Jiangsu, Peoples R China; [Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Yu, Guang; Tang, Zongxiang] Nanjing Univ Chinese Med, Key Lab Drug Target & Drug Degenerat Dis Jiangsu, Nanjing, Jiangsu, Peoples R China; [Xu, Miao; Lan, Lei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing 210046, Jiangsu, Peoples R China; [Yang, Niuniu] Yangzhou Univ, Jiangsu Key Lab Integrated Tradit Chinese & Weste, Dept Tradit Chinese & Western Med, Yangzhou, Jiangsu, Peoples R China; [Luo, Wenqin] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Qin] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Liu, Qin] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO USA; [Liu, Qin] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing Normal University; Yangzhou University; University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Lan, L (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing 210046, Jiangsu, Peoples R China.; Yu, G (corresponding author), Nanjing Univ Chinese Med, 138 Xianlin Rd, Nanjing 210023, Jiangsu, Peoples R China.	yuguang928@126.com; lanlei@njnu.edu.cn	Luo, Wen/GRO-5989-2022; Yu, Lei/ABD-6127-2021	yang, niuniu/0000-0002-3335-3887	National Science Foundation of China [31471007, 31771163, 81600966]; Natural Science Foundation of Jiangsu Province [16KJB320005, BK20151571]; Natural Science Fund Project of Colleges in Jiangsu Province [BK20161042]; Jiangsu Keypoint Research and Invention Program [BE2017728]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project in Jiangsu Province; Hunan Cooperative Innovation Center for Molecular Target New Drug Study; Postdoctoral Science Foundation of China [M601863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Fund Project of Colleges in Jiangsu Province; Jiangsu Keypoint Research and Invention Program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project in Jiangsu Province; Hunan Cooperative Innovation Center for Molecular Target New Drug Study; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation of China Grants 31471007 and 31771163 (to Z.T.) and 81600966 (to C.W.); the Natural Science Foundation of Jiangsu Province Grants 16KJB320005 (to C.W) and BK20151571 (to G.Y.); a Natural Science Fund Project of Colleges in Jiangsu Province Grant BK20161042 (to C.W.); and Jiangsu Keypoint Research and Invention Program Grant BE2017728 (to G.Y.). The project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and sponsored by a grant from the Qing Lan Project in Jiangsu Province (to Z.T.). This work was also supported by the Hunan Cooperative Innovation Center for Molecular Target New Drug Study, and Postdoctoral Science Foundation of China (M601863). C.W. and L.G. are co-senior authors. The authors declare no conflicts of interest.	Ajit SK, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/326020; Akiyama T, 2014, NEUROSCIENCE, V266, P38, DOI 10.1016/j.neuroscience.2014.02.005; Basso L, 2017, CURR OPIN PHARMACOL, V32, P9, DOI 10.1016/j.coph.2016.10.002; Bender E, 2002, P NATL ACAD SCI USA, V99, P8573, DOI 10.1073/pnas.122016499; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Farghaly HSM, 2016, EUR J PHARMACOL, V776, P139, DOI 10.1016/j.ejphar.2016.02.046; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LaMotte RH, 2011, EXP DERMATOL, V20, P778, DOI 10.1111/j.1600-0625.2011.01367.x; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2015, HANDB EXP PHARMACOL, V226, P71, DOI 10.1007/978-3-662-44605-8_5; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Ma WY, 2005, PAIN, V113, P386, DOI 10.1016/j.pain.2004.11.018; Meents JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170097; Nightingale S, 2012, NAT REV DRUG DISCOV, V11, P101, DOI 10.1038/nrd3624; Peng JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12029; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Qu LT, 2014, BRAIN, V137, P1039, DOI 10.1093/brain/awu007; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Tetzner A, 2016, HYPERTENSION, V68, P185, DOI 10.1161/HYPERTENSIONAHA.116.07572; Trevisan G, 2016, BRAIN, V139, P1361, DOI 10.1093/brain/aww038; van Hecke O, 2014, PAIN, V155, P1907, DOI 10.1016/j.pain.2014.06.006; Veldhuis NA, 2015, PHARMACOL REV, V67, P36, DOI 10.1124/pr.114.009555; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Wang CM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0054-x; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Zhuo RG, 2014, J PHYSIOL BIOCHEM, V70, P185, DOI 10.1007/s13105-013-0292-1; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	40	35	38	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1360	1373		10.1096/fj.201800615RR	http://dx.doi.org/10.1096/fj.201800615RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148678	Green Published, Bronze			2022-12-26	WOS:000457401500107
J	Jansz, TT; Neradova, A; van Ballegooijen, AJ; Verhaar, MC; Vervloet, MG; Schurgers, LJ; van Jaarsveld, BC				Jansz, Thijs T.; Neradova, Aegida; van Ballegooijen, Adriana J.; Verhaar, Marianne C.; Vervloet, Marc G.; Schurgers, Leon J.; van Jaarsveld, Brigit C.			The role of kidney transplantation and phosphate binder use in vitamin K status	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; VASCULAR CALCIFICATION; HEMODIALYSIS; MORTALITY; SEVELAMER; SURVIVAL; DISEASE; COHORT; IMPACT	Background Cardiovascular disease is the leading cause of death in end-stage renal disease and is strongly associated with vascular calcification. Both kidney transplantation and phosphate binders may lower the risk of vascular calcification. Vascular calcification is actively inhibited by vitamin-K-dependent matrix y-carboxyglutamic acid protein (MGP). Whether kidney transplantation or phosphate binders affect vitamin K status is unknown. Therefore, we studied the influence of kidney transplantation and phosphate binder use on vitamin K status. Methods We measured plasma desphospho-uncarboxylated MGP (dp-ucMGP), a marker reflecting low vitamin K status, in a cross-sectional study of patients on hemodialysis (n = 82), peritoneal dialysis (n = 31) or who recently received a kidney transplantation (n = 36). By medication inventory, we assessed phosphate binder use. With linear regression, we assessed the influence of kidney transplantation and phosphate binder use on natural-log-transformed dp-ucMGP, adjusting for potential confounders. Results Mean age of patients was 52 +/- 13 years; 102 (68%) were male. Dp-ucMGP levels were significantly lower in kidney transplant recipients (median 689 pmol/L) compared to patients on dialysis (median 1537 pmol/L, p<0.001). Eighty-nine patients on dialysis used phosphate binders. Using any phosphate binder was not associated with dp-ucMGP levels (median 1637 pmol/L, p = 0.09) compared to no phosphate binders (median 1142 pmol/L). Twenty-six patients used sevelamer monotherapy, which was associated with higher dp-ucMGP levels (median 1740 pmol/L, p = 0.04) after adjusting for age, sex and vitamin K antagonist use. Conclusions Recent kidney transplantation is associated with lower dp-ucMGP levels suggesting improved vitamin K status after transplantation. Sevelamer monotherapy is associated with higher dp-ucMGP levels suggesting worsening of vitamin K status. Both findings warrant more attention to vitamin K status in patients on dialysis, as vitamin K is necessary for protection against vascular calcification.	[Jansz, Thijs T.; Verhaar, Marianne C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Neradova, Aegida; van Ballegooijen, Adriana J.; Vervloet, Marc G.; van Jaarsveld, Brigit C.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol & Cardiovasc Sci, ACS, Amsterdam, Netherlands; [van Ballegooijen, Adriana J.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Ballegooijen, Adriana J.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Inst, Amsterdam, Netherlands; [Schurgers, Leon J.] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [van Jaarsveld, Brigit C.] Dianet Dialysis Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Jansz, TT (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands.	t.t.jansz@umcutrecht.nl	Verhaar, Marianne/AAM-6788-2020; Schurgers, Leon/AAT-7100-2021	Verhaar, Marianne/0000-0002-3276-6428; van Jaarsveld, Brigit/0000-0001-5871-4952; Vervloet, Marc/0000-0003-4607-9415; Schurgers, Leon/0000-0001-7867-6957	Amgen; Baxter; Fresenius Medical Care; Novartis; Roche; Shire Pharmaceuticals; Wellerdieck de Goede Foundation	Amgen(Amgen); Baxter; Fresenius Medical Care; Novartis(Novartis); Roche(Roche Holding); Shire Pharmaceuticals; Wellerdieck de Goede Foundation	This work was supported by unrestricted grants from Amgen, Baxter, Fresenius Medical Care, Novartis, Roche and Shire Pharmaceuticals. T.T. Jansz was supported financially by a grant from the Wellerdieck de Goede Foundation with mediation from Friends of UMC Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Boxma PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047991; Cranenburg ECM, 2012, KIDNEY INT, V82, P605, DOI 10.1038/ki.2012.191; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Dalmeijer GW, 2013, J NUTR BIOCHEM, V24, P624, DOI 10.1016/j.jnutbio.2012.02.012; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-145; Ewing DT, 1943, J BIOL CHEM, V147, P233; Fusaro M, 2016, ENDOCRINE, V51, P333, DOI 10.1007/s12020-015-0673-z; Kaesler N, 2014, KIDNEY INT, V86, P286, DOI 10.1038/ki.2013.530; Keyzer CA, 2015, AM J KIDNEY DIS, V65, P474, DOI 10.1053/j.ajkd.2014.09.014; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Neradova A, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0560-3; Palmer SC, 2016, AM J KIDNEY DIS, V68, P691, DOI 10.1053/j.ajkd.2016.05.015; Pierce D, 2011, NEPHROL DIAL TRANSPL, V26, P1615, DOI 10.1093/ndt/gfq598; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Schnuelle P, 1998, J AM SOC NEPHROL, V9, P2135; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Schurgers LJ, 2010, CLIN J AM SOC NEPHRO, V5, P568, DOI 10.2215/CJN.07081009; Shea MK, 2011, J NUTR, V141, P1529, DOI 10.3945/jn.111.139634; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P165, DOI 10.1053/j.ajkd.2011.12.001; Takagi K, 2010, CLIN NEPHROL, V73, P30; van Ballegooijen A J, 2017, Curr Nutr Rep, V6, P197, DOI 10.1007/s13668-017-0208-8; Vervloet MC, 2017, NAT REV NEPHROL, V13, P27, DOI 10.1038/nrneph.2016.164; Westenfeld R, 2012, AM J KIDNEY DIS, V59, P186, DOI 10.1053/j.ajkd.2011.10.041; Wolf M, 2016, TRANSPLANTATION, V100, P184, DOI 10.1097/TP.0000000000000823	29	32	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203157	10.1371/journal.pone.0203157	http://dx.doi.org/10.1371/journal.pone.0203157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161193	Green Published, gold			2022-12-26	WOS:000443388900085
J	Kwon, JW; Lee, SY; Jee, D; Cho, YK				Kwon, Jin-Woo; Lee, Sun Young; Jee, Donghyun; Cho, Yang Kyung			Prognosis for ocular toxocariasis according to granuloma location	PLOS ONE			English	Article							CLINICAL EXPRESSION; CROSS-REACTIVITY; LARVA MIGRANS; CANIS; DIAGNOSIS; STANDARDIZATION; EPIDEMIOLOGY; PREVENTION; FEATURES; CHILDREN	Purpose To determine the prognosis for ocular toxocariasis (OT) according to the location of the granuloma and to identify factors associated with its recurrence within 1 year. Methods OT patients were classified according to the granuloma lesion. After grouping the patients as posterior or peripheral, we compared sex, age, intraocular pressure, best corrected visual acuity (BCVA), degree of inflammation, immunoglobulin E, eosinophil profiles, recurrence, and complications in each group. We also identified factors associated with recurrence within 1 year. Results A total of 29 (61.70%) patients had granuloma at the periphery, and 18 (38.30%) patients had granuloma around the posterior pole. There were no significant differences in ocular or systemic evaluations except the initial BCVA. The mean decimal BCVA of the posterior pole granuloma group was worse than that of the peripheral granuloma group (p = 0.042). After treatment, the mean BCVA of the posterior pole granuloma group improved significantly (p = 0.019), and the final mean BCVA was not significantly different between the groups (p = 0.673). Multiple logistic regression analyses revealed that recurrence within a year was associated with age at diagnosis (p = 0.007). Conclusions The initial BCVA of OT patients differed according to the location of the granuloma, but the BCVA after treatment was not significantly	[Kwon, Jin-Woo; Lee, Sun Young; Jee, Donghyun; Cho, Yang Kyung] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea	Catholic University of Korea	Jee, D; Cho, YK (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea.	doj087@mail.harvard.edu; yangkyeung@hanmail.net		Kwon, Jin-woo/0000-0003-2093-4284	National Research Foundation of Korea - Korean government (MSIP) [NRF-2016R1D1A1B03932606]	National Research Foundation of Korea - Korean government (MSIP)	The authors wish to acknowledge the financial support of the National Research Foundation of Korea Grant funded by the Korean government (MSIP) (No. NRF-2016R1D1A1B03932606).	Ahn SJ, 2014, ASIA PAC ALLERGY, V4, P134, DOI 10.5415/apallergy.2014.4.3.134; Ahn SJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002938; Akao N, 2007, PARASITOL INT, V56, P87, DOI 10.1016/j.parint.2007.01.009; Alm SJ, 2013, J CATARACT REFR SURG, V39, P830, DOI 10.1016/j.jcrs.2012.12.033; Bae Ki Woong, 2016, Korean J Ophthalmol, V30, P258, DOI 10.3341/kjo.2016.30.4.258; Borecka A, 2015, ANN AGR ENV MED, V22, P28, DOI 10.5604/12321966.1141364; BROWN GC, 1981, ANN OPHTHALMOL, V13, P1385; Choi D, 2012, KOREAN J PARASITOL, V50, P23, DOI 10.3347/kjp.2012.50.1.23; De Visser L, 2008, AM J OPHTHALMOL, V145, P369, DOI 10.1016/j.ajo.2007.09.020; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; Despreaux R, 2016, AM J OPHTHALMOL, V166, P162, DOI 10.1016/j.ajo.2016.03.050; GLICKMAN LT, 1993, INFECT DIS CLIN N AM, V7, P717; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jee D, 2016, OCUL IMMUNOL INFLAMM, V24, P207, DOI 10.3109/09273948.2014.994783; Jin Y, 2015, J KOREAN MED SCI, V30, P549, DOI 10.3346/jkms.2015.30.5.549; Kempen JH, 2016, AM J OPHTHALMOL, V164, P110, DOI 10.1016/j.ajo.2015.12.034; Kroten A, 2016, PARASITOL RES, V115, P205, DOI 10.1007/s00436-015-4736-0; Lee RM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003116; MARMOR M, 1987, AM J PUBLIC HEALTH, V77, P554, DOI 10.2105/AJPH.77.5.554; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Ocular toxocariasis-United States, 2009, MMWR MORBIDITY MORTA, V60, P734; Pawlowski Z, 2001, J HELMINTHOL, V75, P299, DOI 10.1017/S0022149X01000464; Perteguer MJ, 2003, ACTA TROP, V89, P85, DOI 10.1016/S0001-706X(03)00201-8; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; SCHANTZ PM, 1979, AM J TROP MED HYG, V28, P24, DOI 10.4269/ajtmh.1979.28.24; SCHANTZ PM, 1980, AM J PUBLIC HEALTH, V70, P1269, DOI 10.2105/AJPH.70.12.1269; SCHANTZ PM, 1994, J AM VET MED ASSOC, V204, P1023; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Woodhall D, 2012, OPHTHALMOLOGY, V119, P1211, DOI 10.1016/j.ophtha.2011.12.013; Woodhall DM, 2014, J PEDIATR INFECT DIS, V3, P154, DOI 10.1093/jpids/pit066	30	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202904	10.1371/journal.pone.0202904	http://dx.doi.org/10.1371/journal.pone.0202904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161178	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900049
J	Fishbein, AR; Loschner, J; Mallon, JM; Wilkinson, GS				Fishbein, Adam R.; Loeschner, Julia; Mallon, Julie M.; Wilkinson, Gerald S.			Dynamic sex-specific responses to synthetic songs in a duetting suboscine passerine	PLOS ONE			English	Article							ANTBIRD MYRMECIZA-EXSUL; TEMPORAL COORDINATION; BEHAVIOR; MECHANISMS; EVOLUTION; PLAYBACK; BIRDS; DUETS; PATTERNS; DEFENSE	Many bird species produce temporally coordinated duets and choruses, requiring the rapid integration of auditory perception and motor production. While males and females of some species are known to participate in these displays for sex-specific purposes, few studies have identified perceptual features that trigger sex-specific contributions of coordinated song. Especially little is known about perception and production in duetting suboscine passerines, which are thought to have innate songs and largely static, rather than dynamic, vocal behavior. Here, we used synthetic stimuli in a playback experiment on chestnut-backed antbirds (Myrmeciza exsul) to (1) test whether differences in song frequency (Hz) can trigger sex-specific vocal behavior in a suboscine passerine (2) test for the functions of duetting in males and females of this species, and (3) determine whether these suboscines can dynamically adjust the temporal and spectral features of their songs. We found sex-specific responses to synthetic playback manipulated in song frequency (Hz), providing evidence that in this context males sing in duets for general territory defense and females join in for mate guarding purposes. In addition, we found that the birds altered the frequency, duration, and timing of their songs depending on the frequency of the playback songs. Thus, we show that these birds integrate spectral and temporal information about conspecific songs and actively modulate their responses in sex-specific ways.	[Fishbein, Adam R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Fishbein, Adam R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Loeschner, Julia] Univ Tubingen, Inst Neurobiol, Anim Physiol, Tubingen, Germany; [Mallon, Julie M.; Wilkinson, Gerald S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Eberhard Karls University of Tubingen; University System of Maryland; University of Maryland College Park	Fishbein, AR (corresponding author), Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA.; Fishbein, AR (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	afishbei@terpmail.umd.edu	Mallon, Julie/ABB-7728-2020; Wilkinson, Gerald S./E-4424-2011	Mallon, Julie/0000-0003-3311-3792; Wilkinson, Gerald S./0000-0001-7799-8444; Loschner, Julia/0000-0002-0078-2423; Fishbein, Adam/0000-0001-5918-9256	University of Maryland Graduate School; Institute for Neurobiology at the University of Tubingen; NIDCD [T32 DC000046]; National Science Foundation [1449815]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046] Funding Source: NIH RePORTER	University of Maryland Graduate School; Institute for Neurobiology at the University of Tubingen; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the University of Maryland Graduate School and the Institute for Neurobiology at the University of Tubingen. A.F is supported by funding from NIDCD T32 DC000046 and the National Science Foundation under Grant No.1449815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Araya-Ajoy YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008137; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Dabelsteen T, 1997, ANIM BEHAV, V53, P249, DOI 10.1006/anbe.1996.0369; Dahlin CR, 2014, ETHOLOGY, V120, P1, DOI 10.1111/eth.12182; Diniz P, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01637; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Elie JE, 2010, ANIM BEHAV, V80, P597, DOI 10.1016/j.anbehav.2010.06.003; Farabaugh S.M., 1982, ACOUSTIC COMMUNICATI, V2, DOI DOI 10.2307/25063377); Fitzsimmons LP, 2008, ANIM BEHAV, V75, P1913, DOI 10.1016/j.anbehav.2007.11.006; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Hall ML, 2007, CURR BIOL, V17, pR406, DOI 10.1016/j.cub.2007.04.022; Hall ML, 2009, ADV STUD BEHAV, V40, P67, DOI 10.1016/S0065-3454(09)40003-2; Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x; Hall ML, 2000, ANIM BEHAV, V60, P667, DOI 10.1006/anbe.2000.1517; Koloff J, 2013, ETHOLOGY, V119, P462, DOI 10.1111/eth.12084; Koloff J, 2013, J ORNITHOL, V154, P51, DOI 10.1007/s10336-012-0867-6; Koloff J, 2011, ANIM BEHAV, V82, P587, DOI 10.1016/j.anbehav.2011.06.021; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Logue DM, 2008, ANIM BEHAV, V75, P1803, DOI 10.1016/j.anbehav.2007.10.036; Logue DM, 2007, ANIM BEHAV, V73, P105, DOI 10.1016/j.anbehav.2006.05.011; Logue DM, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00007; Logue DM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0103; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; Maynard DF, 2012, ANIM BEHAV, V84, P563, DOI 10.1016/j.anbehav.2012.06.008; Mennill DJ, 2008, CURR BIOL, V18, P1314, DOI 10.1016/j.cub.2008.07.073; Mennill DJ, 2005, AUK, V122, P175, DOI 10.1642/0004-8038(2005)122[0175:SDISAD]2.0.CO;2; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; Odom KJ, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00014; Odom KJ, 2017, BEHAV ECOL, V28, P1256, DOI 10.1093/beheco/arx087; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; Raposo Marcos A., 2003, Lundiana, V4, P35; Rios-Chelen AA, 2012, J EVOLUTION BIOL, V25, P2171, DOI 10.1111/j.1420-9101.2012.02597.x; Robinson W. D., 2001, Animal Biodiversity and Conservation, V24, P51; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Seddon N, 2006, BEHAV ECOL, V17, P73, DOI 10.1093/beheco/ari096; Seddon N, 2005, EVOLUTION, V59, P200; Seddon N, 2008, AM NAT, V171, P620, DOI 10.1086/587071; SIBLEY CG, 1988, AUK, V105, P409, DOI 10.1093/auk/105.3.409; Stanley CQ, 2016, ANIM BEHAV, V112, P255, DOI 10.1016/j.anbehav.2015.12.003; Stutchbury BJM, 2005, ORNITOL NEOTROP, V16, P397; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Tobias JA, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00074; Tobias JA, 2009, CURR BIOL, V19, P577, DOI 10.1016/j.cub.2009.02.036; Topp SM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1107, DOI 10.1007/s00265-007-0538-4; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; WILLIS EO, 1978, ANNU REV ECOL SYST, V9, P243, DOI 10.1146/annurev.es.09.110178.001331; Wilson DR, 2014, BIOACOUSTICS, V23, P99, DOI 10.1080/09524622.2013.827588; Wolfe JD, 2009, WILSON J ORNITHOL, V121, P556, DOI 10.1676/08-111.1; Woltmann S., 2010, THESIS; Woltmann S, 2011, WILSON J ORNITHOL, V123, P15, DOI 10.1676/10-017.1	56	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202353	10.1371/journal.pone.0202353	http://dx.doi.org/10.1371/journal.pone.0202353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157227	gold, Green Published, Green Submitted			2022-12-26	WOS:000443071400056
J	Zhang, WW; Liu, T; Cheng, K; Rummy, P				Zhang, Weiwei; Liu, Tao; Cheng, Kun; Rummy, Paul			Declining water depth delayed the breeding time of Fulica atra, not human disturbance	PLOS ONE			English	Article							POPULATION CONSEQUENCES; BIRDS; HABITAT; WETLAND; VEGETATION; PARASITISM; TERRITORY; RESPONSES; SELECTION; BEHAVIOR	Disturbances by tourists have been considered to delay the breeding time of coots. In this study, we investigated the common coot (Fulica atra) from April to June in 2008, 2009 and 2012 around the Anbanghe Nature Reserve and Daqing Longfeng wetland of Heilongjiang Province. We evaluated the correlations of four habitat factors (water depth under coots' nests, distance of nests to banks, distance of nests to human disturbance and nest coverage) to discuss the impacts of those factors on the breeding time of the coots. The water depth under the nest was significantly correlated with the coots' breeding stages in the Anbanghe wetland. In addition, we investigated the breeding dates of 56 pairs of coots and found the dates were significantly negatively correlated with the water levels under the nest for both of the wetlands. However, the breeding time (breeding stages and dates) of coots was not significantly related to the distance of the nest to disturbance, distance to the bank of the lake or the nest coverage. The LME models and GAMs that related breeding time to water level received the greatest support. For the GAM, in the group with a clear breeding date, water level was the most influential variable; in the group for which only breeding stages could be recognized, nest coverage combined with water level had a lower AICc value than water depth itself. In conclusion, we found no clear evidence to indicate that disturbances from tourism delayed the breeding time of the coots; however, the water level had a clear influence on the breeding time. We inferred that reproduction was delayed in order to wait for the improvement of habitat conditions (such as food resource and concealment). Neither water level nor disturbance impacted the reproductive output of the coots as these variables showed no clear relationships with the clutch size.	[Zhang, Weiwei; Liu, Tao] Jiangxi Agr Univ, Ctr Wildlife Resources Conservat Res, Nanchang, Jiangxi, Peoples R China; [Zhang, Weiwei; Cheng, Kun] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Heilongjiang, Peoples R China; [Rummy, Paul] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	Jiangxi Agricultural University; Northeast Forestry University - China; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Cheng, K (corresponding author), Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Heilongjiang, Peoples R China.	chengkcn@163.com		Rummy, Paul/0000-0002-8552-9848	National Natural Science Fund of China [31360521]; Science and technology project of Jiangxi Province [20132BAB214013, 2013BBG7004]; Doctoral Scientific Fund Project of Ministry of Education of China [20123603120003]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and technology project of Jiangxi Province; Doctoral Scientific Fund Project of Ministry of Education of China	Our research was supported by the National Natural Science Fund of China (No. 31360521), Science and technology project of Jiangxi Province (20132BAB214013, 2013BBG7004) and Doctoral Scientific Fund Project of Ministry of Education of China (20123603120003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; ANDERSON MG, 1978, ECOLOGY, V59, P154, DOI 10.2307/1936642; Arnold TW, 1991, THESIS; [柏祥 BAI Xiang], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1086; Bancroft GT, 2002, WATERBIRDS, V25, P265, DOI 10.1675/1524-4695(2002)025[0265:DOWBRT]2.0.CO;2; Baschuk MS, 2012, WATERBIRDS, V35, P44, DOI 10.1675/063.035.0105; BRINKHOF MWG, 1993, J ANIM ECOL, V62, P577, DOI 10.2307/5206; Brisbin I. L., 2002, BIRDS N AM; BURGER J, 1995, ENVIRON CONSERV, V22, P56, DOI 10.1017/S0376892900034081; BURGER J, 1991, ENVIRON CONSERV, V18, P158, DOI 10.1017/S0376892900021743; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CAVE AJ, 1989, ARDEA, V77, P87; Cheng K., 2008, THESIS; Conigliaro M, 2011, REND LINCEI-SCI FIS, V22, P47, DOI 10.1007/s12210-010-0113-1; De Zan LR, 2010, POL J ECOL, V58, P599; Farago S, 2012, HYDROBIOLOGIA, V697, P15, DOI 10.1007/s10750-012-1166-1; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P2023, DOI 10.1023/A:1013133308987; Fortunati L, 2011, ETHOL ECOL EVOL, V23, P165, DOI 10.1080/03949370.2010.534323; Francl KE, 2002, ENVIRON MONIT ASSESS, V73, P67, DOI 10.1023/A:1012615314061; Frid A, 2002, CONSERV ECOL, V6; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Gill JA, 2007, IBIS, V149, P9, DOI 10.1111/j.1474-919X.2007.00642.x; GOODRICH JM, 1994, BIOL CONSERV, V67, P105, DOI 10.1016/0006-3207(94)90354-9; Guan X., 2009, THESIS; Gul O, 2013, EKOLOJI, V22, P29, DOI 10.5053/ekoloji.2013.894; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Huxley J. S., 1934, British Birds, V27, P270; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jobin B, 2009, WATERBIRDS, V32, P73, DOI 10.1675/063.032.0108; KNIGHT RL, 1995, WILDLIFE RECREATIONI, P1; Li CL, 1994, WILDLIFE, V1, P15; Liley D, 2007, IBIS, V149, P82, DOI 10.1111/j.1474-919X.2007.00664.x; McNair DB, 2006, WILSON J ORNITHOL, V118, P208, DOI 10.1676/05-020.1; Moskat C, 2000, ECOGRAPHY, V23, P335, DOI 10.1034/j.1600-0587.2000.d01-1642.x; Murison G, 2007, IBIS, V149, P16, DOI 10.1111/j.1474-919X.2007.00660.x; Murkin HR, 2000, PRAIRIE WETLAND ECOLOGY, P249; Murkin HR, 1997, ECOL APPL, V7, P1144; Rek P, 2010, J ORNITHOL, V151, P163, DOI 10.1007/s10336-009-0440-0; Robel R.J., 1961, J WILDL MANAGE, V25, P436, DOI [10.2307/3798837, DOI 10.2307/3798837]; Sauvajot Raymond M., 1999, Urban Ecosystems, V2, P279, DOI 10.1023/A:1009588723665; Seabloom EW, 1998, PLANT ECOL, V138, P203, DOI 10.1023/A:1009711919757; Soderstrom B, 2001, BIODIVERS CONSERV, V10, P1839, DOI 10.1023/A:1013153427422; Uzun A, 2010, EKOLOJI, V19, P160, DOI 10.5053/ekoloji.2010.7419; van der Valk AG, 2000, PRAIRIE WETLAND ECOLOGY, P125; Wang JS, 1990, J ZOOL, V25, P24; Wang Y., 2005, J ANHUI U SCI TECHNO, V25, P27; Wen CY, 2009, J HEBEI AGR SCI, V13, P46; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xing LL, 1989, J INNERMONGOLIA U, V20, P521; Zacchei D., 2011, Lakes & Reservoirs Research and Management, V16, P281, DOI 10.1111/j.1440-1770.2011.00487.x; Zhang W., 2010, THESIS; Zhang Wei-Wei, 2011, Chinese Journal of Zoology, V46, P19; Zhang Wei-wei, 2011, Shengtaixue Zazhi, V30, P1686; Zhang Wei-wei, 2011, Journal of Forestry Research (Harbin), V22, P289, DOI 10.1007/s11676-011-0164-x; Zhao F, 2005, J NE NORM U, V39, P100	57	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202684	10.1371/journal.pone.0202684	http://dx.doi.org/10.1371/journal.pone.0202684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157235	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400068
J	Chen, GY; Wang, QY; Yang, QW; Li, ZY; Du, ZW; Ren, M; Zhao, HY; Song, Y; Zhang, GZ				Chen, Gaoyang; Wang, Qingyu; Yang, Qiwei; Li, Zhaoyan; Du, Zhenwu; Ren, Ming; Zhao, Haiyue; Song, Yang; Zhang, Guizhen			Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; CANCER; GENES; CELLS; DIFFERENTIATION; PROLIFERATION; CARCINOMA; INVASION; PLAYS	Background Osteosarcoma (OS) is a primary malignant bone tumor with a high fatality rate. Many circRNAs have been proved to play important roles in the pathogenesis of some diseases. However, the occurrence of circRNAs in OS remains little known. Methods The circular RNA (circRNA) expression file GSE96964 dataset, which included seven osteosarcoma cell lines and one control sample (osteoblast cell line), was downloaded from the Gene Expression Omnibus (GEO) database to explore the potential function of circRNAs in osteosarcoma by competing endogenous RNA (ceRNA) analysis. Three gene expression profiles of OS were downloaded from GEO database and then used for the pathway enrichment analysis, Venn analysis and protein-protein interaction (PPI) network analysis. Realtime qPCR validation and RNA interference were conducted to verify our prediction. Results Differentially expressed circRNAs between OS and control, including 8 up-regulated and 102 down-regulated circRNAs, were generated and ceRNA analysis for 5 most up-regulated or 5 most down-regulated circRNAs in OS were then performed. The pathway enrichment analysis of gene expression profiles indicated differentially expressed genes (DEGs) of three gene profiles significantly enriched in cell cycle pathway, cell adhesion molecules (CAMs) pathway, oxidative phosphorylation pathway, cytokine-cytokine receptor interaction pathway, p53 signaling pathway and proteoglycans in cancer pathway, which were critical important pathways in the pathogenesis of OS. The Venn analysis showed that 2 (one is a pseudogene) up-regulated and 39 down-regulated DEGs were co-expressed in all three gene profiles. Then PPI networks of 41 co-expressed DEGs (up- and down-regulated DEGs) were constructed to predict their functions using the GeneMANIA. The expression levels of these related RNAs also matched our predictions really well. Conclusion Ultimately, we found cell adhesion molecule 1 (CADM1) gene was not only a co-expression mRNA of the three mRNA expression profiles of OS, but also are predicted to be regulated by hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 by functioning as miRNAs `Sponge' in human osteosarcoma. These over-expressed circRNAs may result in the over expression of CADM1 which promote the development of OS. We envision this discovery of these important moleculars, incuding hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 and CADM1 may lead to further development of new concepts, thus allowing for more opportunities in diagnosis and therapy of OS.	[Chen, Gaoyang; Wang, Qingyu; Li, Zhaoyan; Du, Zhenwu; Ren, Ming; Song, Yang; Zhang, Guizhen] Jilin Univ, Hosp 2, Dept Orthoped, Changchun, Jilin, Peoples R China; [Chen, Gaoyang; Wang, Qingyu; Yang, Qiwei; Du, Zhenwu; Zhao, Haiyue; Zhang, Guizhen] Jilin Univ, Hosp 2, Res Ctr, Changchun, Jilin, Peoples R China; [Chen, Gaoyang; Wang, Qingyu; Yang, Qiwei; Li, Zhaoyan; Du, Zhenwu; Ren, Ming; Zhao, Haiyue; Song, Yang; Zhang, Guizhen] Engn Res Ctr Mol Diag & Cell Treatment Metab Bone, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Song, Y; Zhang, GZ (corresponding author), Jilin Univ, Hosp 2, Dept Orthoped, Changchun, Jilin, Peoples R China.; Zhang, GZ (corresponding author), Jilin Univ, Hosp 2, Res Ctr, Changchun, Jilin, Peoples R China.; Song, Y; Zhang, GZ (corresponding author), Engn Res Ctr Mol Diag & Cell Treatment Metab Bone, Changchun, Jilin, Peoples R China.	songyangjlu@foxmail.com; zhangguizhenjlu@163.com		Yang, Qiwei/0000-0003-0681-2184; Wang, Qingyu/0000-0002-6298-5357	National Natural Science Foundation of China [81702195]; project of application demonstration center of precision medicine for molecular diagnosis in Jilin Province (NDRC); Department of Science and Technology of Jilin Province, China [20180520125JH]; Education Department of Jilin Province, China [JJKH20170853KJ]; Bethune Youth Foundation of Jilin University, China [2015409]; Health Management Department of Jilin Province, China [20132003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of application demonstration center of precision medicine for molecular diagnosis in Jilin Province (NDRC); Department of Science and Technology of Jilin Province, China; Education Department of Jilin Province, China; Bethune Youth Foundation of Jilin University, China; Health Management Department of Jilin Province, China	This work was supported by the Project supported by the National Natural Science Foundation of China (Grant No. 81702195), the project of application demonstration center of precision medicine for molecular diagnosis in Jilin Province (2016-2018, NDRC), the Department of Science and Technology of Jilin Province, China (Grant No. 20180520125JH), the Project of Education Department of Jilin Province, China (Grant No. JJKH20170853KJ), the Project of Bethune Youth Foundation of Jilin University, China (Grant No. 2015409), the Project of Health Management Department of Jilin Province, China (Grant No. 20132003).	Abarrategi A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3631764; Bai XP, 2018, J CELL BIOCHEM, V119, P2179, DOI 10.1002/jcb.26379; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen L, 2017, ONCOGENE, V36, P4551, DOI 10.1038/onc.2017.89; Chen P, 2012, J MOL HISTOL, V43, P63, DOI 10.1007/s10735-011-9370-2; Chiappetta C, 2017, ONCOTARGET, V8, P80416, DOI 10.18632/oncotarget.19010; CLEZARDIN P, 1993, CANCER RES, V53, P4695; Dang HS, 2017, ONCOL RES, V25, P177, DOI 10.3727/096504016X14732772150343; Coelho KMDA, 2017, PATHOL RES PRACT, V213, P1067, DOI 10.1016/j.prp.2017.07.028; Deng NA, 2018, BIOCHEM BIOPH RES CO, V495, P189, DOI 10.1016/j.bbrc.2017.11.028; Deng ZM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/496193; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhondge A, 2012, ENVIRON SCI POLLUT R, V19, P4030, DOI 10.1007/s11356-012-0879-z; Duijvis NW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185097; Evola FR, 2017, FRONT PHARMACOL, V8, P1, DOI [10.3389/fphar.2017.00001, DOI 10.3389/FPHAR.2017.00001]; Guan J, 2016, EXP THER MED, V12, P2815, DOI 10.3892/etm.2016.3713; He JP, 2014, ASIAN PAC J CANCER P, V15, P5967, DOI 10.7314/APJCP.2014.15.15.5967; Helvering LM, 2005, MOL PHARMACOL, V68, P1225, DOI 10.1124/mol.105.011478; Howe JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177661; Inoue T, 2013, LIFE SCI, V92, P91, DOI 10.1016/j.lfs.2012.10.021; Islam F, 2018, EXP MOL PATHOL, V104, P98, DOI 10.1016/j.yexmp.2018.01.006; Ito A, 2012, ISLETS, V4, DOI 10.4161/isl.18675; Ito T, 2011, GENES CELLS, V16, P791, DOI 10.1111/j.1365-2443.2011.01525.x; Jin X, 2016, ONCOTARGET, V7, P66455, DOI 10.18632/oncotarget.12186; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lin YH, 2017, TRENDS MOL MED, V23, P737, DOI 10.1016/j.molmed.2017.06.004; Lindsey BA, 2017, RHEUMATOL THER, V4, P25, DOI 10.1007/s40744-016-0050-2; Liu PT, 2017, ONCOL LETT, V14, P4779, DOI 10.3892/ol.2017.6747; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22572; Liu WH, 2017, CELL PHYSIOL BIOCHEM, V43, P969, DOI 10.1159/000481650; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14088-3; Meng G, 2015, TUMOR BIOL, V36, P3009, DOI 10.1007/s13277-014-2935-4; Nikitovic D, 2008, CONNECT TISSUE RES, V49, P235, DOI 10.1080/03008200802147589; Pahl JHW, 2013, CANCER IMMUNOL IMMUN, V62, P1235, DOI 10.1007/s00262-013-1406-x; Palmini G, 2017, MOLECULES, V22, DOI 10.3390/molecules22030417; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Patop IL, 2018, CURR OPIN GENET DEV, V48, P121, DOI 10.1016/j.gde.2017.11.007; Perbal B, 2008, CLIN CANCER RES, V14, P701, DOI 10.1158/1078-0432.CCR-07-0806; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Selamat W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129634; Song YZ, 2018, BIOCHEM BIOPH RES CO, V495, P2369, DOI 10.1016/j.bbrc.2017.12.050; Sun CH, 2017, ONCOTARGET, V8, P70271, DOI 10.18632/oncotarget.20082; Tang YY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705745; Yang JX, 2016, ONCOL LETT, V12, P3075, DOI 10.3892/ol.2016.5060; Zhang W, 2016, HEPATOB PANCREAT DIS, V15, P289, DOI 10.1016/S1499-3872(16)60099-1; Zhang ZH, 2017, ENVIRONMENTAL DATA ANALYSIS: METHODS AND APPLICATIONS, P1, DOI 10.1515/9783110424904-002; Zhao MD, 2014, INT J MOL MED, V34, P1565, DOI 10.3892/ijmm.2014.1963; Zhu KP, 2017, ONCOTARGET, V8, P71881, DOI 10.18632/oncotarget.17985	51	33	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202896	10.1371/journal.pone.0202896	http://dx.doi.org/10.1371/journal.pone.0202896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153287	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700030
J	Du, J; Guo, HB; Li, Q; Forsythe, A; Chen, XH; Yu, XD				Du, Jing; Guo, Hong-Bo; Li, Qi; Forsythe, Adrian; Chen, Xu-Hui; Yu, Xiao-Dan			Genetic diversity of Lepista nuda (Agaricales, Basidiomycota) in Northeast China as indicated by SRAP and ISSR markers	PLOS ONE			English	Article							MOLECULAR MARKER; MUSHROOM EXTRACTS; ANTIOXIDANT; SYSTEMS	Lepista nuda is a popular wild edible mushroom that grows in China. In this study, we used ISSR and SRAP molecular markers to analyze the genetic diversity of 72 samples of L. nuda from eight populations in Northeast China. In total, six ISSR primers and five pairs of SRAP primers that produced clear and polymorphic banding profiles were selected for assessing L. nuda genetic diversity. The results revealed a high level of genetic variation among the 72 samples (94.4% polymorphism) but a low degree of gene flow among the populations. Among L. nuda populations, genetic distance was not correlated significantly with geographic distance. The antioxidant activity of the samples from each population was also tested and the result showed that all the selected samples had more than 60% DPPH scavenging activities. Nonetheless, the antioxidant activity diversity is not coincident with both the genetic diversity and the geographic distribution. The results indicate that ISSR and SRAP molecular markers are useful for studying the genetic diversity of L. nuda. The results also suggest that L. nuda populations in Northeast China require protection.	[Du, Jing; Guo, Hong-Bo; Li, Qi; Chen, Xu-Hui; Yu, Xiao-Dan] Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China; [Guo, Hong-Bo] Shenyang Inst Technol, Coll Life Engn, Fushun, Liaoning, Peoples R China; [Forsythe, Adrian] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Shenyang Agricultural University; Shenyang Ligong University; McMaster University	Yu, XD (corresponding author), Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China.	yuxd126@126.com	Forsythe, Adrian/P-7105-2019	Forsythe, Adrian/0000-0003-1966-9946; Yu, Xiao-Dan/0000-0001-6297-6592	National Natural Science Foundation of China [31200011, 31770014]; Natural Science Foundation of Liaoning Province Science and Technology Department [201602668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province Science and Technology Department	This study was supported by the National Natural Science Foundation of China (No. 31200011, 31770014) and the Natural Science Foundation of Liaoning Province Science and Technology Department (201602668). Dr. Yu XD received all the funding.; We are thankful to Prof. Bruce Jaffee for correcting the English. This study was supported by the National Natural Science Foundation of China (No. 31200011, 31770014) and the Natural Science Foundation of Liaoning Province Science and Technology Department (201602668).	Alvarado P, 2015, MYCOLOGIA, V107, P123, DOI 10.3852/13-369; Alves MJ, 2014, PATHOGENS, V3, P667, DOI 10.3390/pathogens3030667; Bao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18608; Beebee T., 2008, INTRO MOL ECOLOGY, V3; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Chen XH, 2013, PLANT SYST EVOL, V299, P691, DOI 10.1007/s00606-012-0744-z; Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3; Dai YuCheng, 2010, Mycosystema, V29, P1; Debnath SC, 2009, INT J FRUIT SCI, V9, P185, DOI 10.1080/15538360903005061; Geiger R., 1961, UBERARBELTETNEUAUSGA; Geiger R, 1954, LANDOLT BORNSTEIN ZA, P603; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasan HA, 2018, J FUNGI, V4, DOI 10.3390/jof4020052; Kahle D, 2013, R J, V5, P144; Kaygusuz O, 2017, CYTOTECHNOLOGY, V69, P135, DOI 10.1007/s10616-016-0045-4; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li Y., 2015, ATLAS CHINESE MACROF; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu J, 2015, J BASIC MICROB, V55, P749, DOI 10.1002/jobm.201400774; Ma DL, 2010, AFR J BIOTECHNOL, V9, P6244; Mercan N, 2006, ANN MICROBIOL, V56, P339, DOI 10.1007/BF03175028; MILLER MP, 1997, WINDOWS PROGRAM ANAL; Nylander J. A. A., 2004, MRMODELTEST V2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phillips R., 2010, MUSHROOMS OTHER FUNG; RANKER TA, 1992, HEREDITY, V69, P175, DOI 10.1038/hdy.1992.111; Rohlf FJ, 2000, NTSYS PC VERSION 2 1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez C, 2017, SYN SYST BIOTECHNO, V2, P13, DOI 10.1016/j.synbio.2016.12.001; Singer R, 1975, AGARICALES MODERN TA; Sun SJ, 2006, APPL MICROBIOL BIOT, V72, P537, DOI 10.1007/s00253-005-0299-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo CV, 2016, MOLECULES, V21, DOI 10.3390/molecules21091201; Wei HL, 2015, NO HORTICULTURE, V39, P132; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu LJ, 2015, INT J MED MUSHROOMS, V17, P1161, DOI 10.1615/IntJMedMushrooms.v17.i12.60; Yao FJ, 2018, MYCOBIOLOGY, V46, P72, DOI 10.1080/12298093.2018.1454004; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yin YG, 2014, CURR MICROBIOL, V68, P397, DOI 10.1007/s00284-013-0489-0; Yu XG, 2011, THESIS; Yu XD, 2014, MYCOSCIENCE, V55, P456, DOI 10.1016/j.myc.2014.01.007; Zeng YF, 2015, MOL ECOL, V24, P5676, DOI 10.1111/mec.13408; Zhang JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187351; Zhang QS, 2012, WORLD J MICROB BIOT, V28, P2237, DOI 10.1007/s11274-012-1031-4; Zhao MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083253; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	47	6	6	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202761	10.1371/journal.pone.0202761	http://dx.doi.org/10.1371/journal.pone.0202761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148893	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200021
J	Karageorgou, D; Imamura, F; Zhang, JY; Shi, PL; Mozaffarian, D; Micha, R				Karageorgou, Dimitra; Imamura, Fumiaki; Zhang, Jianyi; Shi, Peilin; Mozaffarian, Dariush; Micha, Renata			Assessing dietary intakes from household budget surveys: A national analysis in Bangladesh	PLOS ONE			English	Article							EXPENDITURES SURVEYS HCES; CORONARY-HEART-DISEASE; WHOLE GRAIN; RECALL DATA; CONSUMPTION; FOOD; NUTRITION; RISK; CHILDREN; WOMEN	Background Accurate national information on dietary intakes, including heterogeneity among individuals, is critical to inform health implications and policy priorities. In low- and middle-income countries, household expenditure surveys constitute the major source of food data, but with uncertain validity for individual-level intakes. Objective To investigate how individualized dietary consumption estimated from household survey data compared with individual-level 24-hr dietary recalls (24hR); and to assess potential heterogeneity by method for individualizing household intakes, dietary indicator, and individual characteristics (age, sex, education, religion, household income). Methods We evaluated data from the 2011-2012 Bangladesh Household Integrated Survey (BIHS), which included household-level consumption data (5,503 households) and individual-level dietary data based on 24hR from these households (22,173 participants). Household and 24hR estimates were standardized and harmonized for 33 dietary indicators, including 9 food groups, total energy, 8 macronutrients, and 15 micronutrients. Individual consumption was estimated from household data using two approaches, the Adult Male Equivalent (AME) and per capita (PC) approach. For each dietary indicator, differences in household vs. individual mean estimates were evaluated overall and by strata of individual characteristics, using Spearman's correlations and univariate and multivariate linear regression models. Results Individualized household estimates overestimated individual intakes from 24hR for all dietary factors using either estimation method (P<0.001 for each), except for starchy vegetables (AME: P = 0.15; PC: P = 0.85). For foods, overestimation ranged from 4% for seafood to about 240% for fruits, and for nutrients from 11% for carbohydrates and polyunsaturated fats to 55% for vitamin C, with similar overestimation for the AME and the PC method. By strata, overestimation was modestly higher in men vs. women, in children (010y) vs. adolescents (11-19y) and adults (20-44y, >= 45y), among adults of higher (>= 6y) vs. lower (<6y) education, in Muslims vs. other religions (Christians, Hindus), and for the lowest vs. all other income groups. This overestimation was notably higher in young children (0-5y) vs. all other age groups and in the lowest vs. all other income groups. Underestimation was rarely observed, for example for milk intake (-56%) in young children (0-5y). The PC approach did not capture heterogeneity in validity of estimation of different dietary factors by age, mainly in children (0-5y, 6-10y). Spearman's correlations between individualized household estimates and 24hR data were higher for the AME (0.30-0.70) than PC (0.20-0.50) approach. Findings were similar with and without multivariate regression, with proportions of variance (R-2) in 24hR intakes explained by the AME being generally greater than PC estimates, yet still low to modest. Conclusions In this national survey, established methods for estimating individual level intakes from household surveys produce overestimation of intakes of nearly all dietary indicators, with significant variation depending on the dietary factor and modest variation depending on individual characteristics. These findings suggest a need for new methods to estimate individual-level consumption from household survey estimates.	[Karageorgou, Dimitra; Zhang, Jianyi; Shi, Peilin; Mozaffarian, Dariush; Micha, Renata] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Imamura, Fumiaki] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England	Tufts University; University of Cambridge	Micha, R (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	renata.micha@tufts.edu	Imamura, Fumiaki/J-1038-2019; Mozaffarian, Dariush/ABC-2822-2020	Imamura, Fumiaki/0000-0002-6841-8396; Zhang, Jianyi/0000-0002-1501-4822	World Bank; Gates Foundation; MRC [MC_UU_12015/5] Funding Source: UKRI	World Bank(The World Bank India); Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the World Bank and Gates Foundation. The funding agencies did not contribute to design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Ahmed, 2013, BANGLADESH PARLIAMEN; [Anonymous], 2012, GUID FOOD MATCH VERS; Ansari M. N. A., 2014, International Research Journal of Social Sciences, V3, P22; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Beegle K, 2012, J DEV ECON, V98, P3, DOI 10.1016/j.jdeveco.2011.11.001; Bermudez OI, 2012, FOOD NUTR BULL, V33, pS208, DOI 10.1177/15648265120333S209; Berti PR, 2012, FOOD NUTR BULL, V33, pS163, DOI 10.1177/15648265120333S204; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bognar A., 2002, TABLES WEIGHT YIELD; Charrondiere UR, 2016, FOOD CHEM, V193, P75, DOI 10.1016/j.foodchem.2014.11.055; Christian P, 2010, J NUTR, V140, P437, DOI 10.3945/jn.109.116327; Claro RM, 2010, CAD SAUDE PUBLICA, V26, P2188, DOI 10.1590/S0102-311X2010001100020; Claro RM, 2010, CAD SAUDE PUBLICA, V26, P2168, DOI 10.1590/S0102-311X2010001100018; Coates J, 2017, FOOD POLICY, V72, P27, DOI 10.1016/j.foodpol.2017.08.010; D'Souza A., 2014, EVIDENCE BANGLADESH; Louzada MLD, 2017, FOOD POLICY, V72, P112, DOI 10.1016/j.foodpol.2017.08.017; Dary O, 2012, FOOD NUTR BULL, V33, pS190, DOI 10.1177/15648265120333S207; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; EFSA, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4071, 10.2903/j.efsa.2014.3944]; Elshenawy S, 2016, MOL CELL ENDOCRINOL, V435, P2, DOI 10.1016/j.mce.2016.07.002; Engle-Stone R, 2015, FOOD NUTR BULL, V36, P211, DOI 10.1177/0379572115587272; European Food Safety Authority, 2011, FOOD CLASS DESCR SYS; FAO, 2001, REP JOINT FAO WHO UN; FAO, 2014, INTR MIN DIETR DIV W; FAO. Food Balance Sheets, 2001, A HDB; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS170, DOI 10.1177/15648265120333S205; Foster E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169084; Friel S, 2001, PUBLIC HEALTH NUTR, V4, P1143, DOI 10.1079/PHN2001174; Global Nutrition and Policy Consortium, HOM GLOB DIET DAT; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; International Food Policy Research Institute, 2013, STAT FOOD SEC FEED F; International Household Survey Network, 008 INT HOUS SURV NE; Islam R., 2013, CONSUMPTION UNSAFE F; Jacobs K., 2002, REV POTENTIAL WAYS B; Jariseta ZR, 2012, FOOD NUTR BULL, V33, pS199, DOI 10.1177/15648265120333S208; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kaur J, 2015, J ACAD NUTR DIET, V115, P751, DOI 10.1016/j.jand.2015.01.003; Khatibzadeh S, 2016, B WORLD HEALTH ORGAN, V94, P931, DOI 10.2471/BLT.15.156323; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kothari M, 2010, NUTR UPDATE 2010; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Low MSY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009747.pub2; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Micha R, 2018, FOOD NUTR BULL, V39, P175, DOI 10.1177/0379572117752986; Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murphy S, 2012, FOOD NUTR BULL, V33, pS235, DOI 10.1177/15648265120333S213; Naska A, 2009, BRIT J NUTR, V102, P166, DOI 10.1017/S000711450809466X; Paterakis SE, 2003, PUBLIC HEALTH NUTR, V6, P571, DOI 10.1079/PHN2003469; Pereira TJ, 2015, BIOCHEM CELL BIOL, V93, P438, DOI 10.1139/bcb-2014-0141; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Sekula W, 2005, PUBLIC HEALTH NUTR, V8, P430, DOI 10.1079/PHN2004695; Shaheen N, 2013, FOOD COMPOSITION TAB; Shamah-Levy T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014371; Sichieri R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-89; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Stammers AL, 2015, EUR J CLIN NUTR, V69, P147, DOI 10.1038/ejcn.2014.204; Sununtnasuk C, 2017, FOOD POLICY, V72, P121, DOI 10.1016/j.foodpol.2017.08.018; UN, 2015, MILLENNIUM DEV GOALS; UNICEF World Health Organization World Bank Group, 2017, WORLD BANK GROUP JOI; United Nations, 2000, UN MILL DECL; United States Department of Agriculture (USDA), 2007, USDA TABL NUTR RET F, DOI DOI 10.15482/USDA.ADC/1409034; USDA Agricultural Research Service, 1975, AGR HDB, V102; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; World Food Programme, 2015, FOOD INS UND URB SLU	81	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202831	10.1371/journal.pone.0202831	http://dx.doi.org/10.1371/journal.pone.0202831			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148863	Green Published, gold			2022-12-26	WOS:000442804200027
J	Onyango, MA; Vian, T; Hirsch, I; Salvi, DD; Laing, R; Rockers, PC; Ashigbie, PG; Wirtz, VJ				Onyango, Monica Adhiambo; Vian, Taryn; Hirsch, Isabel; Salvi, Devashri D.; Laing, Richard; Rockers, Peter C.; Ashigbie, Paul G.; Wirtz, Veronika J.			Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SOCIAL-RESPONSIBILITY; AVAILABILITY; CARE	In Kenya, noncommunicable diseases (NCDs) account for 27% of all deaths. Adult Kenyans have an 18% chance of dying prematurely from cancers, diabetes, cardiovascular diseases or chronic respiratory diseases. A Novartis Access Initiative is making medicines available to treat cardiovascular diseases, diabetes, chronic respiratory diseases, and breast cancer in 30 countries, including Kenya. Little is known about patients' perceptions of access to medicines for NCDs in Kenya. The study objective was to understand patients' perceptions of access to medicines; as well as barriers and facilitators at the household, community, and healthcare system level. A baseline qualitative study was conducted in eight of 47 counties as part of an evaluation of the Novartis Access Initiative in Kenya. The 84 patients interviewed through a household survey had been diagnosed and treated for an NCD. Although medicines at government facilities were free or cheaper than those sold in private pharmacies, the availability of medicines presented a constant challenge. Patients often resorted to private pharmacies, where NCD medicines cost more than at public facilities. Participants with an NCD took their health seriously and strove to get the medicines, even under difficult circumstances. Buying NCD medicines put a strain on the household budget, especially for the lower-income participants. Some actions to overcome affordability barriers included: borrowing money, selling assets, seeking help from relatives, taking on extra work, buying partial dosages, leaving without the medicines, or resorting to non-medical alternatives. In conclusion, access to NCD medicines is a major challenge for most adults in Kenya. As a result, they engage in complex interactions between public, private facilities and pharmacies to overcome the barriers. The government should ensure well-stocked public sector pharmacies and subsidize prices of medicines for lower-income patients. Integration of industry-led access to medicine programs may help governments to obtain low cost supplies.	[Onyango, Monica Adhiambo; Vian, Taryn; Hirsch, Isabel; Salvi, Devashri D.; Laing, Richard; Rockers, Peter C.; Ashigbie, Paul G.; Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02118 USA; [Laing, Richard] Univ Western Cape, Fac Community Hlth Sci, Sch Publ Hlth, Cape Town, South Africa	Boston University; University of the Western Cape	Onyango, MA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02118 USA.	monyango@bu.edu	Vian, Taryn/H-4609-2019; Wirtz, Veornika/AAG-9712-2019; Salvi, Devashri/CAJ-3216-2022	Wirtz, Veronika J./0000-0002-0863-8768; Onyango, Monica Adhiambo/0000-0003-4998-1682; Salvi, Devashri/0000-0002-7924-1418	Sandoz International GmbH [55205062]; Novartis Access Project [55205062]	Sandoz International GmbH(Novartis); Novartis Access Project	This work received support from Sandoz International GmbH (55205062) and Novartis Access Project, Grant 55205062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Blackburn DF, 2013, PATIENT PREFER ADHER, V7, P183, DOI 10.2147/PPA.S30613; Bloom DE, 2011, GLOBAL EC BURDEN NON; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Droppert H, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0100-5; Hogerzeil HV, 2013, NEW ENGL J MED, V369, P896, DOI 10.1056/NEJMp1303723; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Ministry of Health Government of Kenya, 2014, 2013 KEN HOUS HLTH E; Mwai D., 2016, PUBLIC HLTH RES, V6, P83, DOI [10.5923/j.phr.20160603.02, DOI 10.5923/J.PHR.20160603.02]; Novozymes, 2016, NOV ENZ BIOD HDB, P1; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Rockers PC, 2017, HEALTH AFFAIR, V36, P706, DOI 10.1377/hlthaff.2016.1213; Rockers PC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013386; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; Subramanian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190113; Vedanthan R, 2015, GLOB HEART, V10, P313, DOI 10.1016/j.gheart.2015.09.003; Vialle-Valentin CE, 2015, HEALTH POLICY PLANN, V30, P1044, DOI 10.1093/heapol/czu107; Vian T, 2018, J HEALTH PSYCHOL, V23, P1895, DOI 10.1177/1359105316672922; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2014, NONC DIS COUNTR PROF	22	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201917	10.1371/journal.pone.0201917	http://dx.doi.org/10.1371/journal.pone.0201917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142218	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500006
J	Asawa, RR; Belkowski, JC; Schmitt, DA; Hernandez, EM; Babcock, AE; Lochner, CK; Baca, HN; Rylatt, CM; Steffes, IS; VanSteenburg, JJ; Diaz, KE; Doroski, DM				Asawa, Rosita R.; Belkowski, Jessica C.; Schmitt, Daniel A.; Hernandez, Elizabeth M.; Babcock, Ann E.; Lochner, Christina K.; Baca, Holly N.; Rylatt, Colleen M.; Steffes, Isaac S.; VanSteenburg, Jace J.; Diaz, Karina E.; Doroski, Derek M.			Transient cellular adhesion on poly(ethylene-glycol)-dimethacrylate hydrogels facilitates a novel stem cell bandage approach	PLOS ONE			English	Article							GLYCOL) FUMARATE) HYDROGELS; IN-VITRO; TISSUE; DIFFERENTIATION; MODULATION; CARTILAGE; PEPTIDES; TENSILE; REPAIR; SHAPE	We discovered a transient adhesion property in poly(ethylene glycol) dimethacrylate (PEG-DMA) hydrogels and employed it to develop a novel "stem cell bandage" model of cellular delivery. First, we cultured human mesenchymal stromal cells (MSCs) on the surface of PEG-DMA hydrogels with high amounts of arginine-glycine-aspartic acid (RGD) adhesive peptides (RGD++) or without RGD (RGD-). On day 1, MSCs underwent an initial adhesion to RGD- hydrogels that was not significantly different over 13 days (n = 6). In addition, cells appeared to be well spread by day 3. Significantly fewer cells were present on RGD- hydrogels on day 15 compared to day 9, suggesting that RGD- hydrogels allow for an initial cellular adhesion that is stable for multiple days, but transient over longer periods with a decrease by day 15. This initial adhesion is especially surprising considering that PEG-DMA does not contain any biological adhesion motifs and is almost chemically identical to poly (ethylene glycol) diacrylate (PEG-DA), which has been shown to be non-adhesive without RGD. We hypothesized that MSCs could be cultured on RGD- PEG-DMA hydrogels and then applied to a wound site to deliver cells in a novel approach that we refer to as a "stem cell bandage". RGD- donor hydrogels were successfully able to deliver MSCs to PEG-DMA acceptor hydrogels with high RGD content (RGD++) or low amounts of RGD (RGD+). Our novel "bandage" approach promoted cell delivery to these model surfaces while preventing cells from diffusing away. This stem cell delivery strategy may provide advantages over more common stem cell delivery approaches such as direct injections or encapsulation and thus may be valuable as an alternative tissue engineering approach.	[Asawa, Rosita R.; Belkowski, Jessica C.; Schmitt, Daniel A.; Hernandez, Elizabeth M.; Babcock, Ann E.; Lochner, Christina K.; Baca, Holly N.; Rylatt, Colleen M.; Steffes, Isaac S.; VanSteenburg, Jace J.; Diaz, Karina E.; Doroski, Derek M.] Franciscan Univ Steubenville, Dept Biol, Steubenville, OH 43952 USA	Franciscan University of Steubenville	Doroski, DM (corresponding author), Franciscan Univ Steubenville, Dept Biol, Steubenville, OH 43952 USA.	ddoroski@franciscan.edu		Asawa, Rosita/0000-0003-2758-2293				Adiguzel Z, 2017, MAT SCI ENG C-MATER, V78, P942, DOI 10.1016/j.msec.2017.04.077; [Anonymous], 2018, OIL RED STAIN KIT; [Anonymous], 2015, CHONDR DIFF AN MSC; [Anonymous], 2018, AL RED S STAIN KIT; Antony GJM, 2017, J MECH BEHAV BIOMED, V65, P857, DOI 10.1016/j.jmbbm.2016.10.011; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; De Becker A, 2016, WORLD J STEM CELLS, V8, P73, DOI 10.4252/wjsc.v8.i3.73; Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233; Hassan W, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt182; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Hiob MA, 2016, CURR OPIN BIOTECH, V40, P149, DOI 10.1016/j.copbio.2016.04.008; Horch RE, 2006, J CELL MOL MED, V10, P4, DOI 10.1111/j.1582-4934.2006.tb00286.x; Huang BJ, 2016, BIOMATERIALS, V98, P1, DOI 10.1016/j.biomaterials.2016.04.018; HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565; Hutanu D., 2014, MOD CHEM APPL, V02, P1, DOI [10.4172/2329-6798.1000132, DOI 10.4172/2329-6798.1000132]; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Kim N, 2013, KOREAN J INTERN MED, V28, P387, DOI 10.3904/kjim.2013.28.4.387; Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777; McLaughlin M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7183734; Monteiro N, 2016, J TISSUE ENG REGEN M; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Papadopoulos A, 2011, TISSUE ENG PT A, V17, P161, DOI 10.1089/ten.TEA.2010.0253; Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002; Sepantafar M, 2017, TRENDS BIOTECHNOL, V35, P1074, DOI 10.1016/j.tibtech.2017.06.015; Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027; Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193; Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402; Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p; Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259; van Rijn JM, 2016, BEST PRACT RES CL GA, V30, P281, DOI 10.1016/j.bpg.2016.03.005; Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018; Yang PJ, 2012, TISSUE ENG PT A, V18, P2365, DOI [10.1089/ten.tea.2011.0727, 10.1089/ten.TEA.2011.0727]; Yu HN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0077-2	33	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202825	10.1371/journal.pone.0202825	http://dx.doi.org/10.1371/journal.pone.0202825			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138479	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100132
J	Zhang, H; Zhou, WP; Cao, C; Zhang, WJ; Liu, GQ; Zhang, JY				Zhang, Hui; Zhou, Wenping; Cao, Chang; Zhang, Wenjing; Liu, Gangqiong; Zhang, Jinying			Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A(2) and YKL-40	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-8; PLASMA YKL-40; DISEASE; LEVEL	To test the hypothesis that combined RNA interference (RNAi) of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and YKL-40 is superior to RNAi of Lp-PLA(2) or YKL-40 alone in ameliorating atherosclerosis. A total of 120 apolipoprotein E-deficient mice (apoE(-/-)mice) were randomly divided into five groups, including the vehicle alone, scrambled RNAi, Lp-PLA(2) RNAi, YKL-40 RNAi, and combined Lp-PLA(2) and YKL-40 RNAi groups. Constrictive collars were used to induce plaque formation. Lp-PLA(2) RNAi and YKL-40 RNAi viral suspensions were transduced into carotid plaques of the mice. Carotid plaques were harvested for histological analysis four weeks after viral vector transduction. Inflammatory gene expression in the plasma and atherosclerotic plaques was determined by ELISA and real-time PCR. Four weeks after RNAi, the serum concentration and plaque mRNA expression of Lp-PLA(2) and YKL-40 were remarkably attenuated, leading to reduced inflammatory gene expression. Plaques from the Lp-PLA(2) or YKL-40 RNAi group showed lower lipid content, higher collagen content, increased fibrous cap thickness, and lower mRNA expressions of MCP-1 and MMP-8 than than those in the vehicle and scramble groups. When compared with the isolated Lp-PLA(2) or YKL-40 RNAi group, the combined Lp-PLA(2) and YKL-40 RNAi group exhibited higher collagen content and fibrous cap thickness, and lower lipid content and local inflammation. The beneficial effects of RNAi were independent of the plasma lipoprotein profile. Combined RNAi of Lp-PLA(2) and YKL-40 is superior to RNAi of Lp-PLA(2) or YKL-40 alone in ameliorating atherosclerosis.	[Zhang, Hui; Cao, Chang; Zhang, Wenjing; Liu, Gangqiong; Zhang, Jinying] Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Zhou, Wenping] Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 3, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, JY (corresponding author), Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	jyzhang@zzu.edu.cn			Natural Science Foundation of China [U1504803]; University-College Joint Cultivation Fund of Zhengzhou University [2016-BSTDJJ-19]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University-College Joint Cultivation Fund of Zhengzhou University	This study was supported by the grants from the Natural Science Foundation of China (No. U1504803) and the grants from University-College Joint Cultivation Fund of Zhengzhou University (No. 2016-BSTDJJ-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daugherty A, 2017, ARTERIOSCL THROM VAS, V37, pE131, DOI 10.1161/ATV.0000000000000062; Erdogan T, 2013, ANADOLU KARDIYOL DER, V13, P465, DOI 10.5152/akd.2013.145; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Jafari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098629; Johansen JS, 2010, CLIN CHEM, V56, P1580, DOI 10.1373/clinchem.2010.146530; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Lenglet S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/659282; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Mathiasen AB, 2011, SCAND J CLIN LAB INV, V71, P439, DOI 10.3109/00365513.2011.586470; Morris KV, 2006, GENE THER, V13, P553, DOI 10.1038/sj.gt.3302688; Mutlu LC, 2017, EUR REV MED PHARMACO, V21, P4161; Mygind ND, 2016, CARDIOVASC ENDOCRINO, V5, P21, DOI 10.1097/XCE.0000000000000073; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Thomsen SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047094; Wu S, 2014, INT J MOL SCI, V15, P22421, DOI 10.3390/ijms151222421; Zhang F, 2017, ATHEROSCLEROSIS, V261, P90, DOI 10.1016/j.atherosclerosis.2017.02.012; Zhang H, 2013, CLIN INVEST MED, V36, pE32; Zhang H, 2013, INT J MOL MED, V31, P651, DOI 10.3892/ijmm.2013.1248; Zhang H, 2012, BIOCHEM BIOPH RES CO, V427, P557, DOI 10.1016/j.bbrc.2012.09.096; Zhou W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130968	22	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202797	10.1371/journal.pone.0202797	http://dx.doi.org/10.1371/journal.pone.0202797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138439	gold, Green Submitted, Green Published			2022-12-26	WOS:000442800100129
J	Argeny, S; Tamandi, D; Scharitzer, M; Stift, A; Bergmann, M; Riss, S				Argeny, Stanislaus; Tamandi, Dietmar; Scharitzer, Martina; Stift, Anton; Bergmann, Michael; Riss, Stefan			Visceral fat area measured with computed tomography does not predict postoperative course in Crohn's disease patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ADIPOSE-TISSUE; RISK-FACTORS; BODY-COMPOSITION; CANCER-SURGERY; COMPLICATIONS; OBESITY; OUTCOMES; RESECTION; ASSOCIATION	The role of visceral fat measured by computer tomography is yet not well defined in patients with Crohn's disease. Therefore, the present study was designed to assess the impact of visceral fat area on postoperative short-term outcome and surgical characteristics. We analyzed 95 patients, who underwent intestinal resection for symptomatic Crohn's disease at an academic tertiary referral center between 2003 and 2008. Visceral fat area was measured on preoperative computed tomography scans. Postoperative morbidity was graded according to the Clavien-Dindo classification. Visceral fat area was correlated with baseline characteristics, disease phenotype and 30-day morbidity. Body mass index and age were significantly associated with a higher visceral fat area (p = 0.001). Overall 19 (20.0%) post-operative complications were observed, of whom 7 (7.4%) patients required surgical reintervention. No significant difference was found with regard to visceral fat area between patients with an uneventful and eventful postoperative course (no complications: median visceral fat area 52.0 cm(2) SD 59.7, complications: 41.3 cm(2) SD 42.8; p = 0.465). In contrast to current literature, we cannot support the role of visceral fat area for predicting postoperative course in Crohn's disease. In addition, no correlation of the visceral fat area and disease behavior was detected.	[Argeny, Stanislaus; Stift, Anton; Bergmann, Michael; Riss, Stefan] Med Univ Vienna, Dept Surg, Vienna, Austria; [Tamandi, Dietmar; Scharitzer, Martina] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Tamandi, D (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	dietmar.tamandi@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022; Scharitzer, Martina/H-3459-2016	Scharitzer, Martina/0000-0003-4427-5463; Argeny, Stanislaus/0000-0002-4342-0350				Al-Refaie WB, 2010, ANN SURG ONCOL, V17, P2264, DOI 10.1245/s10434-010-1023-2; Alves A, 2007, DIS COLON RECTUM, V50, P331, DOI 10.1007/s10350-006-0782-0; Bertin B, 2010, CURR OPIN CLIN NUTR, V13, P574, DOI 10.1097/MCO.0b013e32833cf0f4; Billioud V, 2013, J CROHNS COLITIS, V7, P853, DOI 10.1016/j.crohns.2013.01.014; Bryant RV, 2013, ALIMENT PHARM THER, V38, P213, DOI 10.1111/apt.12372; Buning C, 2015, INFLAMM BOWEL DIS, V21, P2590, DOI 10.1097/MIB.0000000000000527; Canedo J, 2010, SURG ENDOSC, V24, P1274, DOI 10.1007/s00464-009-0759-x; Cannom RR, 2009, AM SURGEON, V75, P976; Cecchini S, 2011, WORLD J SURG, V35, P415, DOI 10.1007/s00268-010-0888-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ding Z, 2016, COLORECTAL DIS, V18, P163, DOI 10.1111/codi.13128; Dong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144872; Erhayiem B, 2011, CLIN GASTROENTEROL H, V9, P684, DOI 10.1016/j.cgh.2011.05.005; Guardado J, 2016, J GASTROINTEST SURG, V20, P725, DOI 10.1007/s11605-015-3060-4; Hede P, 2015, INT J COLORECTAL DIS, V30, P1201, DOI 10.1007/s00384-015-2280-0; Khoury W, 2011, BRIT J SURG, V98, P293, DOI 10.1002/bjs.7313; Konishi T, 2006, ANN SURG, V244, P758, DOI 10.1097/01.sla.0000219017.78611.49; Li Y, 2015, COLORECTAL DIS, V17, P225, DOI 10.1111/codi.12798; Long MD, 2011, INFLAMM BOWEL DIS, V17, P2162, DOI 10.1002/ibd.21585; Malik TA, 2013, GASTROENTEROL RES, V6, P85, DOI 10.4021/gr553w; Nic Suibhne Treasa, 2013, J Crohns Colitis, V7, pe241, DOI 10.1016/j.crohns.2012.09.009; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Riss S, 2010, COLORECTAL DIS, V12, pE298, DOI 10.1111/j.1463-1318.2009.02180.x; Riss S, 2012, SURG ENDOSC, V26, P933, DOI 10.1007/s00464-011-1970-0; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Shen W, 2007, INT J OBESITY, V31, P763, DOI 10.1038/sj.ijo.0803474; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Tjeertes EEKM, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0096-7; Tzivanakis A, 2012, DIS COLON RECTUM, V55, P558, DOI 10.1097/DCR.0b013e318247c433; Watanabe J, 2014, INT J COLORECTAL DIS, V29, P343, DOI 10.1007/s00384-013-1803-9; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202220	10.1371/journal.pone.0202220	http://dx.doi.org/10.1371/journal.pone.0202220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133500	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400060
J	Leemans, EL; Willems, TP; Slump, CH; Van Der Laan, MJ; Zeebregts, CJ				Leemans, Eva L.; Willems, Tineke P.; Slump, Cornelis H.; van der Laan, Maarten J.; Zeebregts, Clark J.			Additional value of biomechanical indices based on CTa for rupture risk assessment of abdominal aortic aneurysms	PLOS ONE			English	Article							WALL STRESS; INTEROBSERVER VARIABILITY; INTRALUMINAL THROMBUS; POTENTIAL INDEX; FOLLOW-UP; MECHANICS; DIAMETER; MODELS; IMPACT	Objective Biomechanics for rupture risk prediction in abdominal aortic aneurysms (AAA) are gaining popularity. However, their clinical applicability is still doubtful as there is lack of standardization. This study evaluates the added value of biomechanical indices in rupture risk assessment. Methods This study included 175 asymptomatic, 11 sAAA and 45 ruptured aneurysms. 3D-geometries were reconstructed using computer tomography angiographies. Subsequently, finite element models were made to calculate peak wall stress (PWS), peak wall rupture index (PWRI) and the rupture risk equivalent diameter (RRED). The indices were determined with a dedicated software to facilitate standardization. Results SAAAs showed a trend towards higher PWS, PWRI and RRED compared to asymptomatic AAAs, but PWS (22.0 +/- 5.8 vs. 33.4 +/- 15.8 N/cm(2)), PWRI (0.52 +/- 0.2 vs. 1.01 +/- 0.64), and RRED (65 +/- 60 vs. 98 +/- 51 mm) were significantly (p=0.001) higher in ruptured. However, after diameter- matching no significant differences were seen. The ROC-curves for the maximum diameter and all biomechanical indices were similar but it slightly increased when diameter and biomechanical indices were combined. Conclusions This study showed no added value for biomechanical indices in AAA rupture risk assessment. Additionally, the difficulty of such an assessment increases. However, as symptomatic aneurysms show a trend towards higher biomechanical indices with similar diameters the indices may provide information about aneurysm growth and development.	[Leemans, Eva L.; van der Laan, Maarten J.; Zeebregts, Clark J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands; [Leemans, Eva L.] Univ Amsterdam, Dept Biomech Engn, Amsterdam UMC, Amsterdam, Netherlands; [Leemans, Eva L.] Univ Amsterdam, Dept Phys, Amsterdam UMC, Amsterdam, Netherlands; [Leemans, Eva L.] Univ Amsterdam, Amsterdam UMC, Radiol, Amsterdam, Netherlands; [Leemans, Eva L.; Slump, Cornelis H.] Univ Twente, MIRA Inst Biomed Engn & Tech Med, Dept Robot & Mechatron, Enschede, Netherlands; [Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, Radiol, Groningen, Netherlands	University of Groningen; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Twente; University of Groningen	Zeebregts, CJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands.	czeebregts@hotmail.com	van der Laan, Maarten/AAQ-3353-2021	Leemans, Eva/0000-0002-3640-9938				Auer M, 2010, IEEE T MED IMAGING, V29, P1022, DOI 10.1109/TMI.2009.2039579; Bluestein D, 2009, COMPUT METHOD BIOMEC, V12, P73, DOI [10.1080/10255840802176396, 10.1080/10255840903077170]; Buijs RVC, 2013, J VASC SURG, V57, P851, DOI 10.1016/j.jvs.2012.10.097; Cambria R A, 1994, Ann Vasc Surg, V8, P121, DOI 10.1007/BF02018859; de Putter S, 2006, PROC SPIE, V6143, DOI 10.1117/12.650480; Doyle B.J., 2009, VASC DIS PREV, V6, P114, DOI DOI 10.2174/1567270000906010114; Erhart P, 2015, EUR J VASC ENDOVASC, V49, P239, DOI 10.1016/j.ejvs.2014.11.010; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Gasser TC, 2014, EUR J VASC ENDOVASC, V47, P288, DOI 10.1016/j.ejvs.2013.12.018; Gasser TC, 2010, EUR J VASC ENDOVASC, V40, P176, DOI 10.1016/j.ejvs.2010.04.003; Geest JPV, 2008, ANN BIOMED ENG, V36, P921, DOI 10.1007/s10439-008-9490-3; Geest JPV, 2006, ANN NY ACAD SCI, V1085, P11, DOI 10.1196/annals.1383.046; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; Harris PL, 1997, J ENDOVASC SURG, V4, P72, DOI 10.1583/1074-6218(1997)004<0072:TNFCTO>2.0.CO;2; Heng MS, 2008, J VASC SURG, V47, P17, DOI 10.1016/j.jvs.2007.09.002; Jaakkola P, 1996, EUR J VASC ENDOVASC, V12, P230, DOI 10.1016/S1078-5884(96)80112-2; Karthikesalingam A, 2016, NEW ENGL J MED, V375, P2051, DOI 10.1056/NEJMoa1600931; Leemans EL, 2017, J ENDOVASC THER, V24, P254, DOI 10.1177/1526602816680088; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060338; Li ZY, 2008, J VASC SURG, V47, P928, DOI 10.1016/j.jvs.2008.01.006; Maier A, 2010, ANN BIOMED ENG, V38, P3124, DOI 10.1007/s10439-010-0067-6; Maier A., 2009, 11th International Congress of the IUPESM. World Congress on Medical Physics and Biomedical Engineering. Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics, P510, DOI 10.1007/978-3-642-03882-2_135; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Polzer S, 2011, EUR J VASC ENDOVASC, V41, P467, DOI 10.1016/j.ejvs.2010.12.010; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; Raghavan ML, 2000, J VASC SURG, V31, P760, DOI 10.1067/mva.2000.103971; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Reeps C, 2010, J VASC SURG, V51, P679, DOI 10.1016/j.jvs.2009.10.048; Rissland P, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005200; Scott RAP, 1998, J VASC SURG, V28, P124, DOI 10.1016/S0741-5214(98)70207-1; Scotti CM, 2007, COMPUT STRUCT, V85, P1097, DOI 10.1016/j.compstruc.2006.08.041; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Sonesson B, 1999, EUR J VASC ENDOVASC, V18, P487, DOI 10.1053/ejvs.1999.0872; Speelman L, 2007, J BIOMECH ENG-T ASME, V129, P105, DOI 10.1115/1.2401189; Speelman L, 2010, J VASC SURG, V51, P19, DOI 10.1016/j.jvs.2009.08.075; SULLIVAN CA, 1990, J VASC SURG, V11, P799, DOI 10.1067/mva.1990.19420; Teutelink A, 2012, J VASC SURG, V55, P326, DOI 10.1016/j.jvs.2011.08.012; Tierney AP, 2012, J ENDOVASC THER, V19, P100, DOI 10.1583/11-3456.1; Truijers M, 2007, EUR J VASC ENDOVASC, V33, P401, DOI 10.1016/j.ejvs.2006.10.009; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087; Wanhainen A, 2016, CIRCULATION, V134, P1141, DOI 10.1161/CIRCULATIONAHA.116.022305; Wilson KA, 2003, J VASC SURG, V37, P112, DOI 10.1067/mva.2003.40	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202672	10.1371/journal.pone.0202672	http://dx.doi.org/10.1371/journal.pone.0202672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133522	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400092
J	Khan, SI; Shihata, WA; Andrews, KL; Lee, MKS; Moore, XL; Jefferis, AM; Vinh, A; Gaspari, T; Dragoljevic, D; Jennings, GL; Murphy, AJ; Chin-Dusting, JPF				Khan, Shanzana I.; Shihata, Waled A.; Andrews, Karen L.; Lee, Man K. S.; Moore, Xiao-Lei; Jefferis, Ann-Maree; Vinh, Antony; Gaspari, Tracey; Dragoljevic, Dragana; Jennings, Garry L.; Murphy, Andrew J.; Chin-Dusting, Jaye P. F.			Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat	FASEB JOURNAL			English	Article						cyclooxygenase; cardiac hypertrophy; vascular function; renal fibrosis; prostanoids	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENDOTHELIUM-DEPENDENT CONTRACTIONS; ACUTE CORONARY SYNDROMES; ANGIOTENSIN-II; DIFFERENTIAL INHIBITION; CYCLOOXYGENASE-2; PROSTAGLANDINS; CELLS; CLOPIDOGREL; THROMBOXANE	Despite its well-known antithrombotic properties, the effect of aspirin on blood pressure (BP) and hypertension pathology is unclear. The hugely varying doses used clinically have contributed to this confusion, with high-dose aspirin still commonly used due to concerns about the efficacy of low-dose aspirin. Because prostaglandins have been shown to both promote and inhibit T-cell activation, we also explored the immunomodulatory properties of aspirin in hypertension. Although the common preclinical high dose of 100 mg/kg/d improved vascular dysfunction and cardiac hypertrophy, this effect was accompanied by indices of elevated adaptive immunity, renal T-cell infiltration, renal fibrosis, and BP elevation in stroke-prone spontaneously hypertensive rats and in angiotensin II-induced hypertensive mice. The cardioprotective effects of aspirin were conserved with a lower dose (10 mg/kg/d) while circumventing heightened adaptive immunity and elevated BP. We also show that low-dose aspirin improves renal fibrosis. Differential inhibition of the COX-2 isoform may underlie the disparate effects of the 2 doses. Our results demonstrate the efficacy of low-dose aspirin in treating a vast array of cardiovascular parameters and suggest modulation of adaptive immunity as a novel mechanism underlying adverse cardiovascular profiles associated with COX-2 inhibitors. Clinical studies should identify the dose of aspirin that achieves maximal cardioprotection with a new awareness that higher doses of aspirin could trigger undesired autoimmunity in hypertensive individuals. This work also warrants an evaluation of high-dose aspirin and COX-2 inhibitor therapy in sufferers of inflammatory conditions who are already at increased risk for cardiovascular disease.Khan, S. I., Shihata, W. A., Andrews, K. L., Lee, M. K. S., Moore, X.-L., Jefferis, A.-M., Vinh, A., Gaspari, T., Dragoljevic, D., Jennings, G. L., Murphy, A. J., Chin-Dusting, J. P. F. Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.	[Khan, Shanzana I.; Shihata, Waled A.; Andrews, Karen L.; Moore, Xiao-Lei; Jefferis, Ann-Maree; Gaspari, Tracey; Chin-Dusting, Jaye P. F.] Monash Univ, Biomed Discovery Inst, Dept Pharmacol, Clayton, Vic, Australia; [Khan, Shanzana I.; Shihata, Waled A.; Andrews, Karen L.; Lee, Man K. S.; Jefferis, Ann-Maree; Dragoljevic, Dragana; Jennings, Garry L.; Murphy, Andrew J.; Chin-Dusting, Jaye P. F.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Khan, Shanzana I.; Shihata, Waled A.; Lee, Man K. S.; Dragoljevic, Dragana] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Vinh, Antony] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Jennings, Garry L.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Monash University; Baker Heart and Diabetes Institute; Monash University; La Trobe University; University of Sydney	Khan, SI (corresponding author), Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.	shanzana.khan@monash.edu	Jennings, Garry/B-3914-2009; Gaspari, Tracey/AAD-3092-2019; Vinh, Antony/I-1563-2014	Vinh, Antony/0000-0001-8367-6134; Murphy, Andrew/0000-0001-7039-7777	National Health and Medical Research Council of Australia Program Grant; Victorian Government	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by the National Health and Medical Research Council of Australia Program Grant and in part, by the Victorian Government's Infrastructure Support Program. The authors declare no conflicts of interest.	Amin AR, 1999, CELL MOL LIFE SCI, V56, P305, DOI 10.1007/s000180050432; Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Bautista LE, 2010, CURR HYPERTENS REP, V12, P282, DOI 10.1007/s11906-010-0115-5; Bulut D, 2003, J HYPERTENS, V21, P1663, DOI 10.1097/00004872-200309000-00015; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dovizio M, 2015, BIOCHEM SOC T, V43, P707, DOI 10.1042/BST20140322; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; FRIES JF, 1993, ARCH INTERN MED, V153, P2465, DOI 10.1001/archinte.153.21.2465; Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436; Fukuda S, 2004, EXP ANIM TOKYO, V53, P67, DOI 10.1538/expanim.53.67; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hall HM, 2014, CIRC-CARDIOVASC QUAL, V7, P701, DOI 10.1161/CIRCOUTCOMES.113.000822; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; HIRSH J, 1989, CHEST, V95, pS12; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Hughson MD, 2008, AM J KIDNEY DIS, V52, P18, DOI 10.1053/j.ajkd.2008.03.023; Kanbak G, 2014, CLIN EXP HYPERTENS, V36, P1, DOI 10.3109/10641963.2013.783046; Kim Gheun-Ho, 2008, Electrolyte Blood Press, V6, P35, DOI 10.5049/EBP.2008.6.1.35; Kirkby NS, 2013, FASEB J, V27, P3938, DOI 10.1096/fj.12-215533; Kraakman MJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.31; LIVIO M, 1989, J PHARMACOL EXP THER, V248, P334; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; LORENZ RL, 1984, LANCET, V1, P1261; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; McQuay HJ, 2007, BRIT J CLIN PHARMACO, V63, P271, DOI 10.1111/j.1365-2125.2006.02723.x; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Nangaku M, 2002, KIDNEY INT, V62, P922, DOI 10.1046/j.1523-1755.2002.00519.x; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rodriguez-Iturbe B, 2012, CLIN EXP PHARMACOL P, V39, P96, DOI 10.1111/j.1440-1681.2011.05482.x; Rovati GE, 2010, TRENDS PHARMACOL SCI, V31, P102, DOI 10.1016/j.tips.2009.11.007; Sampson AK, 2014, HYPERTENSION, V64, P1376, DOI 10.1161/HYPERTENSIONAHA.114.03756; SCHARSCHMIDT L, 1986, AM J MED, V81, P30, DOI 10.1016/0002-9343(86)90906-X; Sousa T., 2014, J NEPHROL THER, V13; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007; TOHGI H, 1992, STROKE, V23, P1400, DOI 10.1161/01.STR.23.10.1400; Virdis A, 2012, EUR HEART J, V33, P2225, DOI 10.1093/eurheartj/ehr138; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; VOISIN EM, 1990, REGUL TOXICOL PHARM, V12, P107, DOI 10.1016/S0273-2300(05)80052-2; WEKSLER BB, 1983, NEW ENGL J MED, V308, P800, DOI 10.1056/NEJM198304073081402; WIENTJES MG, 1988, J PHARMACOL EXP THER, V245, P809; YAO CC, 2013, NAT COMMUN, V4; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Zhang MZ, 2015, J CLIN INVEST, V125, P4281, DOI 10.1172/JCI81550	51	6	6	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1510	1521		10.1096/fj.201701498RR	http://dx.doi.org/10.1096/fj.201701498RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30156911	Bronze			2022-12-26	WOS:000457401500118
J	Paschkowsky, S; Recinto, SJ; Young, JC; Bondar, AN; Munter, LM				Paschkowsky, Sandra; Recinto, Sherilyn Junelle; Young, Jason C.; Bondar, Ana-Nicoleta; Munter, Lisa Marie			Membrane cholesterol as regulator of human rhomboid protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						rhomboid protease; amyloid precursor protein (APP); cholesterol; cholesterol-binding protein; low-density lipoprotein (LDL); Alzheimer's disease; neurodegeneration; cholesterol pulldown; cholesterol recognition amino acid consensus sequence (CRAC); intramembrane proteolysis; large APP C-terminal fragments	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; INTRAMEMBRANE PROTEOLYSIS; DENSITY-LIPOPROTEIN; NEURONAL-ACTIVITY; CULTURED-CELLS; BETA-SECRETASE; IN-VITRO; STATINS; IDENTIFICATION	In the last decade, intramembrane proteases have gained increasing attention because of their many links to various diseases. Nevertheless, our understanding as to how they function or how they are regulated is still limited, especially when it comes to human homologues. In this regard, here we sought to unravel mechanisms of regulation of the protease rhomboid-like protein-4 (RHBDL4), one of five active human serine intramembrane proteases. In view of our recent finding that human RHBDL4 efficiently cleaves the amyloid precursor protein (APP), a key protein in the pathology of Alzheimer's disease, we used established reagents to modulate the cellular cholesterol content and analyzed the effects of this modulation on RHBDL4-mediated processing of endogenous APP. We discovered that lowering membrane cholesterol levels increased the levels of RHBDL4-specific endogenous APP fragments, whereas high cholesterol levels had the opposite effect. Direct binding of cholesterol to APP did not mediate these modulating effects of cholesterol. Instead, using homology modeling, we identified two potential cholesterol-binding motifs in the transmembrane helices 3 and 6 of RHBDL4. Substitution of the essential tyrosine residues of the potential cholesterol-binding motifs to alanine increased the levels of endogenous APP C-terminal fragments, reflecting enhanced RHBDL4 activity. In summary, we provide evidence that the activity of RHBDL4 is regulated by cholesterol likely through a direct binding of cholesterol to the enzyme.	[Paschkowsky, Sandra; Recinto, Sherilyn Junelle; Munter, Lisa Marie] McGill Univ, Dept Pharmacol & Therapeut, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada; [Paschkowsky, Sandra; Recinto, Sherilyn Junelle; Munter, Lisa Marie] McGill Univ, Cell Informat Syst Grp, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada; [Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Young, Jason C.] McGill Univ, Grp Rech Axe Sur Struct Prot, Montreal, PQ, Canada; [Bondar, Ana-Nicoleta] Free Univ Berlin, Dept Phys Theoret Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany	McGill University; McGill University	Munter, LM (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada.; Munter, LM (corresponding author), McGill Univ, Cell Informat Syst Grp, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada.	lisa.munter@mcgill.ca		Munter, Lisa/0000-0001-5736-1462; Recinto, Sherilyn Junelle/0000-0001-9632-1201	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-04645]; Canada Foundation of Innovation Leaders Opportunity Fund [CFI-LOF 32565]; Alzheimer Society of Canada Young Investigator Award [PT-58872, 17-02]; Fonds d'Innovation Pfizer-FRQS sur la Maladie d'Alzheimer et les Maladies Apparente'es [31288]; McGill Faculty of Medicine Incentive; Scottish Rite Charitable Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Freie Universitat Berlin within the Excellence Initiative of the German Research Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alzheimer Society of Canada Young Investigator Award; Fonds d'Innovation Pfizer-FRQS sur la Maladie d'Alzheimer et les Maladies Apparente'es; McGill Faculty of Medicine Incentive; Scottish Rite Charitable Foundation of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Freie Universitat Berlin within the Excellence Initiative of the German Research Foundation(German Research Foundation (DFG))	This work was supported in part by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2015-04645 (to L. M. M.); Canada Foundation of Innovation Leaders Opportunity Fund CFI-LOF 32565; Alzheimer Society of Canada Young Investigator Award PT-58872 and Research Grant 17-02; Fonds d'Innovation Pfizer-FRQS sur la Maladie d'Alzheimer et les Maladies Apparente'es no. 31288; McGill Faculty of Medicine Incentive funding; and an award from The Scottish Rite Charitable Foundation of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Received an Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award (USRA) summer student stipend.; Supported in part by the Freie Universitat Berlin within the Excellence Initiative of the German Research Foundation.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Arutyunova E, 2017, METHOD ENZYMOL, V584, P395, DOI 10.1016/bs.mie.2016.11.002; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Dusterhoft S, 2017, BBA-MOL CELL RES, V1864, P2200, DOI 10.1016/j.bbamcr.2017.04.016; Fantini J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21907; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; FERRERI K, 1992, ENDOCRINOLOGY, V131, P2059, DOI 10.1210/en.131.5.2059; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Gal Z, 2015, BBA-BIOMEMBRANES, V1848, P477, DOI 10.1016/j.bbamem.2014.11.006; Gbelcova H, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-126; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang J, 2016, EMBO J, V35, P2332, DOI 10.15252/embj.201693923; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kojro E, 2010, J ALZHEIMERS DIS, V20, P1215, DOI 10.3233/JAD-2010-091621; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2016, SEMIN CELL DEV BIOL, V60, P29, DOI 10.1016/j.semcdb.2016.06.022; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Miller LJ, 2004, ANN PHARMACOTHER, V38, P91, DOI 10.1345/aph.1D104; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Paschkowsky S, 2018, J MEMBRANE BIOL, V251, P369, DOI 10.1007/s00232-017-0008-5; Paschkowsky S, 2016, J BIOL CHEM, V291, P21903, DOI 10.1074/jbc.M116.753582; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01795-14; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Sidera C, 2005, J NEUROL SCI, V229, P269, DOI 10.1016/j.jns.2004.11.044; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2014, CELL REP, V8, P1241, DOI 10.1016/j.celrep.2014.07.039; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walder K, 2005, DIABETOLOGIA, V48, P459, DOI 10.1007/s00125-005-1675-9; Wang HZ, 2015, BIOCHEMISTRY-US, V54, P2806, DOI 10.1021/acs.biochem.5b00329; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342	57	9	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15556	15568		10.1074/jbc.RA118.002640	http://dx.doi.org/10.1074/jbc.RA118.002640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143535	hybrid, Green Published			2022-12-26	WOS:000446549200020
J	Raizada, N; Khaparde, SD; Rao, R; Kalra, A; Sarin, S; Salhotra, VS; Swaminathan, S; Khanna, A; Chopra, KK; Hanif, M; Singh, V; Umadevi, KR; Nair, SA; Huddart, S; Tripathi, R; Prakash, CHS; Saha, BK; Denkinger, CM; Boehme, C				Raizada, Neeraj; Khaparde, Sunil D.; Rao, Raghuram; Kalra, Aakshi; Sarin, Sanjay; Salhotra, Virender Singh; Swaminathan, Soumya; Khanna, Ashwani; Chopra, Kamal Kishore; Hanif, M.; Singh, Varinder; Umadevi, K. R.; Nair, Sreenivas Achuthan; Huddart, Sophie; Tripathi, Rajneesh; Prakash, C. H. Surya; Saha, B. K.; Denkinger, Claudia M.; Boehme, Catharina			Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; DIAGNOSTIC-ACCURACY; RIFAMPIN RESISTANCE; TREATMENT OUTCOMES; CHILDREN; ASSAY; METAANALYSIS	Background Diagnosis of tuberculosis (TB) in infants is challenging due to non-specific clinical presentations of the disease in this age-group and low sensitivity of widely available TB diagnostic tools, which in turn delays prompt access to TB treatment. Upfront access to Xpert/MTB RIF (Xpert) testing, a highly sensitive and specific rapid diagnostic tool, could potentially address some of these challenges. Under the current project, we assessed the utility and feasibility of applying upfront Xpert for diagnosis of tuberculosis in infants, including for testing of nonsputum specimens. Methods A high throughput lab was established in each of the four project cities, and linked to various health care providers across the city, through rapid specimen transportation and electronic reporting linkages. Free Xpert testing was offered to all infant (<2 years of age) presumptive TB cases (both pulmonary and extra-pulmonary) seeking care at public and private health facilities. Results A total of 7,994 presumptive infant TB cases were enrolled in the project from April 2014 to October 2016, detecting 465 (5.8%, CI: 5.3-6.4) TB cases. The majority (93.9%; CI: 93.4-94.4) of patient specimens were non-sputum and TB positivity was higher amongst non- sputum specimens. Further, a high proportion (5.6% CI 3.8-8.1) of infant TB cases were found to be rifampicin resistant. Covering large cities with a single lab per city over more than two years, the project demonstrated the feasibility of same-day diagnosis with upfront Xpert testing. This in turn led to prompt treatment initiation, with a two-day median turnaround time to treatment initiation. Case mortality observed in the project cohort of diagnosed TB cases was 11.0% (CI 8.4-14.1), the majority of which was pre- or early treatment mortality, in spite of prompt access to treatment for most diagnosed cases. Conclusion The current project demonstrated the feasibility of applying rapid and upfront Xpert testing for presumptive infant TB cases. Rapid TB diagnosis in turn facilitates prompt and appropriate treatment initiation. Further, levels of rifampicin resistance observed in infants TB cases highlight the additional benefit of upfront resistance testing. However, high rates of early case mortality, in spite of prompt diagnosis and treatment initiation, highlight the need for further research in infant patient pathways for overall improvement in TB care for infant populations.	[Raizada, Neeraj; Kalra, Aakshi; Sarin, Sanjay; Tripathi, Rajneesh] Fdn Innovat New Diagnost, New Delhi, India; [Khaparde, Sunil D.; Rao, Raghuram; Salhotra, Virender Singh] Govt India, Cent TB Div, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India; [Khanna, Ashwani] Govt NCT, State TB Off, New Delhi, India; [Chopra, Kamal Kishore; Hanif, M.] New Delhi TB Ctr, New Delhi, India; [Singh, Varinder] Kalawati Saran Childrens Hosp, Lady Hardinge Med Coll & Assoc, New Delhi, India; [Umadevi, K. R.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Nair, Sreenivas Achuthan] WHO, Country Off India, New Delhi, India; [Huddart, Sophie] McGill Univ, Montreal, PQ, Canada; [Prakash, C. H. Surya] Intermediate Reference Lab, Hyderabad, India; [Saha, B. K.] Intermediate Reference Lab, Kolkata, India; [Denkinger, Claudia M.; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); Lady Hardinge Medical College & Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; McGill University; Foundation For Innovative New Diagnostics	Denkinger, CM (corresponding author), Fdn Innovat New Diagnost, Geneva, Switzerland.	cdenki@gmail.com	Huddart, Sophie/AAF-8844-2020	Huddart, Sophie/0000-0001-6425-3371; Nair, Sreenivas/0000-0002-2586-6797; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The project was funded by United States Agency for International Development (USAID) under Challenge TB project to SS. FIND was responsible for implementation, training, coordination, monitoring, data analysis and writing of the report in close coordination with Central TB Division, Ministry of Health and Family Welfare, Government of India.	Adejumo OA, 2016, J TROP PEDIATRICS, V62, P131, DOI 10.1093/tropej/fmv089; Aketi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153914; Al-Ateah SM, 2012, SAUDI MED J, V33, P1100; Alvarez-Uria Gerardo, 2012, Tuberc Res Treat, V2012, P932862, DOI 10.1155/2012/932862; Bates M, 2013, LANCET INFECT DIS, V13, P36, DOI 10.1016/S1473-3099(12)70245-1; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division Ministry of Health and Family Welfare New Delhi India, 2012, NAT GUID DIAGN TREAT; Connell TG, 2011, J INFECT DIS, V204, pS1151, DOI 10.1093/infdis/jir413; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Gomez-Pastrana D, 1999, PEDIATR PULM, V28, P344; Government of India, 2018, REP 1 NAT ANT TUB DR; Harries AD, 2002, INT J TUBERC LUNG D, V6, P424; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Miller MB, 2011, J CLIN MICROBIOL, V49, P3458, DOI 10.1128/JCM.05212-11; Mpofu N, 2014, PEDIATR INFECT DIS J, V33, P1226, DOI 10.1097/INF.0000000000000523; Munoz-Sellart M, 2009, SCAND J INFECT DIS, V41, P450, DOI 10.1080/00365540902865736; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Pai Madhukar, 2014, Indian J Chest Dis Allied Sci, V56, P71; Palme IB, 2004, ACTA PAEDIATR, V93, P311, DOI 10.1080/08035250410023566; Pang Y, 2014, PEDIATR INFECT DIS J, V33, P1047, DOI 10.1097/INF.0000000000000403; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Rabie H, 2015, J INT AIDS SOC, V18, P35, DOI 10.7448/IAS.18.7.20236; Raizada N, PLOS ONE; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140375; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Raj A, 2012, IOSR J PHARM, V2, P83; Revised National Tuberculosis Control Program, 2014, STANDARD OPERATING P; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; VALLEJO JG, 1994, PEDIATRICS, V94, P1; WHO, 2017, GLOB TUB REP 2017; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	47	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202085	10.1371/journal.pone.0202085	http://dx.doi.org/10.1371/journal.pone.0202085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161142	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000443388900020
J	Sacchi, A; Tumino, N; Grassi, G; Casetti, R; Cimini, E; Sordoni, V; Ammassari, A; Antinori, A; Agrati, C				Sacchi, Alessandra; Tumino, Nicola; Grassi, Germana; Casetti, Rita; Cimini, Eleonora; Sordoni, Veronica; Ammassari, Adriana; Antinori, Andrea; Agrati, Chiara			A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry	PLOS ONE			English	Article							CANCER-PATIENTS; INFECTION; BLOOD; FREQUENCY	Myeloid derived suppressor cells (MDSC) is a heterogeneous subset of immature and mature cells of the myeloid lineage, undergoing expansion during pathologic conditions, and able to perform strong immune suppressive functions. It has been shown that cryopreservation selectively impacts the polimorphonuclear (PMN) MDSC viability and recovery, and alters the correct analysis of MDSC subsets. In laboratory practice, cryopreservation is often inevitable, in particular in multicenter studies where samples have to be shipped to a centralized laboratory. Aim of the present work was to set out a new protocol to evaluate the frequency of PMN-MDSC in thawed cells by flow-cytometry. PBMC were isolated from HIV+ patients and healthy donors, and were cryopreserved for at least ten days. After thawing, two different protocols were used: 1. standard protocol (SP) consisting of staining with the antibodies mix and then fixing with formalin 1%; 2. thawed protocol (TP) in which fixation foregoes the staining with the antibodies mix. Results showed that PMN-MDSC frequency in ex vivo PBMC evaluated by means TP was comparable to that analysed by SP, indicating that the protocol did not alter PMN-MDSC quantification in ex vivo cells. We then demonstrated that PMN-MDSC frequency in thawed PBMC tested by TP was almost identical to the frequency obtained in ex vivo cells evaluated by using SP. However, we observed that after three hours of culture post-thawing, PMN-MDSC were not assessable anymore with both SP and TP. In conclusion, we herein demonstrated that fixing PBMC soon after thawing and before antibody staining allows preservation of PMN-MDSC integrity and a reliable cells quantification. Thus, it is possible to phenotipically identify PMN-MDSC in cryopreserved PBMC, consenting adequate test precision and accuracy as well as making multicentre research more feasible.	[Sacchi, Alessandra; Tumino, Nicola; Grassi, Germana; Casetti, Rita; Cimini, Eleonora; Sordoni, Veronica; Agrati, Chiara] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol & Pharmacol Lab, Rome, Italy; [Ammassari, Adriana; Antinori, Andrea] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Sacchi, A (corresponding author), IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol & Pharmacol Lab, Rome, Italy.	alessandra.sacchi@inmi.it	Antinori, Andrea/K-7125-2016; Tumino, Nicola/Y-4761-2019; Cimini, Eleonora/K-8878-2016; Sacchi, Alessandra/K-7782-2016; Agrati, Chiara/K-8806-2016	Antinori, Andrea/0000-0003-2121-4684; Tumino, Nicola/0000-0003-3773-8829; Grassi, Germana/0000-0001-8168-8721; Cimini, Eleonora/0000-0002-2659-0868; Sacchi, Alessandra/0000-0003-4964-386X; Agrati, Chiara/0000-0002-5252-0927; Ammassari, Adriana/0000-0002-0284-0340	Italian Ministry of Health ("Ricerca Corrente")	Italian Ministry of Health ("Ricerca Corrente")(Ministry of Health, Italy)	The study was supported by grants from the Italian Ministry of Health ("Ricerca Corrente").	Boros P, 2016, HUM IMMUNOL, V77, P631, DOI 10.1016/j.humimm.2016.05.024; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; De Veirman K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00349; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; Duffy A, 2013, CANCER IMMUNOL IMMUN, V62, P299, DOI 10.1007/s00262-012-1332-3; Dumitru, 2013, CANCER IMMUNOL IMMUN, V61, P1155; Elkord E, 2009, J IMMUNOL METHODS, V347, P87, DOI 10.1016/j.jim.2009.06.001; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goh C, 2013, IMMUNOL REV, V255, P210, DOI 10.1111/imr.12084; Grutzner E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0755-y; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Schmielau J, 2001, CANCER RES, V61, P4756; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Tobin RP, 2017, J LEUKOCYTE BIOL, V102, P381, DOI 10.1189/jlb.5VMR1016-449R; Tumino N, 2017, JAIDS-J ACQ IMM DEF, V74, P575, DOI 10.1097/QAI.0000000000001283; Tumino N, 2015, AIDS, V29, P2397, DOI 10.1097/QAD.0000000000000871; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f	26	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202920	10.1371/journal.pone.0202920	http://dx.doi.org/10.1371/journal.pone.0202920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161175	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900051
J	Kong, M; Yoon, J; Ham, DI				Kong, Mingui; Yoon, Jaemoon; Ham, Don-Il			Electrophysiological function in eyes with reticular pseudodrusen according to fundus distribution	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; PREVALENCE; ELECTRORETINOGRAPHY; RISK	Reticular pseudodrusen (RPD) could be present not only in the posterior pole but extramacular area also as a confluent morphological pattern. Thus RPD can be classified by the fundus distribution for the assessment of visual prognosis. The electrophysiological function in eyes with reticular pseudodrusen (RPD), showing various fundus distribution were evaluated using full-field electroretinogram (ERG). Retinal distribution of RPD was divided into three types (localized, intermediate, and diffuse) according to the extent of involvement of retinal areas by fundus photograph montages. RPD were present with the diffuse type in 21 eyes (25.6%), with the intermediate type in 30 eyes (36.6%), and with the localized type in 31 eyes (37.8%). The average age was 74.76 +/- 4.52 (range, 65 +/- 81) years in the diffuse type, 72.47 +/- 9.13 (range, 55 +/- 91) years in the intermediate type, and 70.26 +/- 7.77 (range, 61 +/- 89) years in the localized type. The mean amplitudes of the scotopic rod response, scotopic maximal combined response, oscillatory potentials (OP), photopic cone response, and 30Hz cone flicker response were more decreased in the diffuse, intermediate, and localized types in order, except for the photopic cone a-wave response. The diffuse type showed reduced amplitudes of ERG responses than the normal control group under all testing conditions except for the photopic a-wave response, and differences were statistically significant with the age restriction and adjustment methods (Bonferroni-corrected P < 0.05). The mean implicit times of ERG responses were significantly delayed in the diffuse type in the photopic b-wave. (Bonferroni-corrected P < 0.05). Extensive retinal involvement of RPD correlates with severely reduced electrophysiological retinal function. This acquired form of decreased electrophysiological function should be regarded as different from those of hereditary retinal degeneration.	[Kong, Mingui] Hangil Eye Hosp, Incheon, South Korea; [Kong, Mingui] Catholic Kwandong Univ, Dept Ophthalmol, Coll Med, Incheon, South Korea; [Yoon, Jaemoon] Seobusan Eye Clin, Busan, South Korea; [Ham, Don-Il] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Catholic Kwandong University; Sungkyunkwan University (SKKU); Samsung Medical Center	Ham, DI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	oculus@naver.com						Alten F, 2014, GRAEF ARCH CLIN EXP, V252, P715, DOI 10.1007/s00417-013-2525-y; Alten F, 2014, INVEST OPHTH VIS SCI, V55, P6073, DOI 10.1167/iovs.13-13804; Alten F, 2012, INVEST OPHTH VIS SCI, V53, P6263, DOI 10.1167/iovs.12-10094; ARNOLD JJ, 1995, RETINA-J RET VIT DIS, V15, P183, DOI 10.1097/00006982-199515030-00001; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Flamendorf J, 2015, OPHTHALMOLOGY, V122, P2053, DOI 10.1016/j.ophtha.2015.06.023; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Lee MY, 2012, BRIT J OPHTHALMOL, V96, P1222, DOI 10.1136/bjophthalmol-2011-301207; Lois N, 2002, AM J OPHTHALMOL, V133, P341, DOI 10.1016/S0002-9394(01)01404-0; MARCUS M, 1983, ANN OPHTHALMOL, V15, P235; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; Schmitz-Valckenberg S, 2010, OPHTHALMOLOGY, V117, P1169, DOI 10.1016/j.ophtha.2009.10.044; Smith RT, 2009, AM J OPHTHALMOL, V148, P733, DOI 10.1016/j.ajo.2009.06.028; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1800, DOI 10.1097/IAE.0b013e31829c3765; Spaide RF, 2010, RETINA-J RET VIT DIS, V30, P1441, DOI 10.1097/IAE.0b013e3181ee5ce8; Steinberg JS, 2015, JAMA OPHTHALMOL, V133, P690, DOI 10.1001/jamaophthalmol.2015.0477; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P365, DOI 10.1007/BF00159171; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	24	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203146	10.1371/journal.pone.0203146	http://dx.doi.org/10.1371/journal.pone.0203146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157256	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400096
J	Martinez-Jauregui, M; Serra-Varela, MJ; Diaz, M; Sollino, M				Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Diaz, Mario; Sollino, Mario			Mitigation strategies for conserving bird diversity under climate change scenarios in Europe: The role of forest naturalization	PLOS ONE			English	Article							PLANTATION FORESTS; PINE PLANTATIONS; SPECIES RICHNESS; BIODIVERSITY; MANAGEMENT; LANDSCAPE; CONSERVATION; COMMUNITIES; ASSEMBLAGES; FUTURE	There are many possible strategies to promote naturalization in anthropogenic landscapes to mitigate global change effects. We combined large-scale databases available for continental Spain on: (1) distribution of breeding birds, (2) forest inventory stands, (3) land-use cover, (4) 18 global climate models recently developed at local scales, and (5) historical and genetically-based information on the distribution of natural versus planted pine forests, to analyze whether back to nature strategies may help to mitigate biodiversity loss due to climate change. We performed the analysis along environmental and ecological gradients of pine forests in Southern Europe. Models suggested that, naturalization strategies, in this case defined by the replacement of planted pine forests and eucalyptus forests by natural pine forests, could help to mitigate the expected loss of bird diversity due to climate change, but that mitigation efficiency will vary along environmental and ecological gradients. Maximum levels of diversity mitigation were predicted at intermediate levels of naturalization, with lower bird richness in areas where all pine forests were either planted or naturalized. Efficiency also varied spatially, given that both cold-and hot-spots of climate-driven bird diversity loss were identified. Transforming planted forest into natural forest is not a mitigation panacea, and additional regionally-adapted strategies may be identified to mitigate the expected biodiversity loss in forest ecosystems.	[Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Sollino, Mario] Natl Inst Agr & Food Res & Technol INIA, Forest Res Ctr CIFOR, Madrid, Spain; [Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Sollino, Mario] Univ Valladolid, Sustainable Forest Management Res Inst, Palencia, Spain; [Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Sollino, Mario] INIA, Palencia, Spain; [Diaz, Mario] Museo Nacl Ciencias Nat BGC MNCN CSIC, Dept Biogeog & Global Change, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Martinez-Jauregui, M (corresponding author), Natl Inst Agr & Food Res & Technol INIA, Forest Res Ctr CIFOR, Madrid, Spain.; Martinez-Jauregui, M (corresponding author), Univ Valladolid, Sustainable Forest Management Res Inst, Palencia, Spain.; Martinez-Jauregui, M (corresponding author), INIA, Palencia, Spain.	martinezmari@gmail.com	Martinez-Jauregui, Maria/AGA-8083-2022; MARTINEZ-JAUREGUI, MARIA/B-3339-2011; Soliño, Mario/A-5648-2012; Martinez-Jauregui, Maria/M-6005-2019; Diaz, Mario/C-3052-2017	Martinez-Jauregui, Maria/0000-0002-7590-822X; MARTINEZ-JAUREGUI, MARIA/0000-0002-7590-822X; Martinez-Jauregui, Maria/0000-0002-7590-822X; Diaz, Mario/0000-0002-6384-6674	Spanish Ministry of Economy and Competitiveness [RTA2013-00048-C03-01]; REMEDINAL3-CM [S2013/MAE-2719]; Spanish Ministry of Agriculture, Food and Environment	Spanish Ministry of Economy and Competitiveness(Spanish Government); REMEDINAL3-CM; Spanish Ministry of Agriculture, Food and Environment(Spanish Government)	This study is framed within the project INIA ref. RTA2013-00048-C03-01 funded by the Spanish Ministry of Economy and Competitiveness, and is a contribution to the thematic network REMEDINAL3-CM (S2013/MAE-2719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to David Sanchez de Ron, Iciar Alberdi and Javier Portoles for their collaboration during previous research stages, and to the staff of SEO/BirdLife for their work in the management of the bird atlas data. We acknowledge the Spanish Meteorological Agency (AEMET) and the Climate Research Foundation (FIC) for producing and making available the bioclimatic data. We also thank the "Scientific research for the adaptation of Pinus pinaster Ait. and Pinus halepensis Mill. to climate change" project, funded by the Spanish Ministry of Agriculture, Food and Environment. This study is framed within the project INIA ref. RTA2013-00048-C03-01 funded by the Spanish Ministry of Economy and Competitiveness, and is a contribution to the thematic network REMEDINAL3-CM (S2013/MAE-2719).	Alberdi I, 2010, ENVIRON MONIT ASSESS, V164, P649, DOI 10.1007/s10661-009-0919-4; Alia R, 2009, REGIONES PROCEDENCIA; Araujo M, 2011, IMPACTOS VULNERABILI, V2, P640; Assessment ME, 2005, EC HUM WELL BEING BI; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Calladine J, 2017, ECOLOGY CONSERVATION; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V310, P692, DOI 10.1016/j.foreco.2013.09.014; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Diaz M, 1998, J APPL ECOL, V35, P562, DOI 10.1046/j.1365-2664.1998.3540562.x; Diaz M., 2016, CURRENT LANDSCAPE EC, V1, P168, DOI [10.1007/s40823-016-0017-6, DOI 10.1007/S40823-016-0017-6]; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Gamborg C, 2003, FOREST ECOL MANAG, V179, P559, DOI 10.1016/S0378-1127(02)00553-4; Gil-Tena A, 2007, FOREST ECOL MANAG, V242, P470, DOI 10.1016/j.foreco.2007.01.080; Gjerde I, 1997, BIOL CONSERV, V79, P241, DOI 10.1016/S0006-3207(96)00093-6; Greenwood O, 2016, J APPL ECOL, V53, P885, DOI 10.1111/1365-2664.12602; Guiot J, 2016, SCIENCE, V354, P465, DOI 10.1126/science.aah5015; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huntley B., 2007, CLIMATIC ATLAS EUROP; Serra-Varela MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171549; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Luck GW, 2008, FOREST ECOL MANAG, V255, P2688, DOI 10.1016/j.foreco.2008.01.029; Martinez-Jauregui M, 2016, DIVERS DISTRIB, V22, P1255, DOI 10.1111/ddi.12488; Martinez-Jauregui M, 2016, FOREST ECOL MANAG, V376, P183, DOI 10.1016/j.foreco.2016.06.021; Martui R., 2003, ATLAS AVES REPRODUCT; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naudts K, 2016, SCIENCE, V351, P597, DOI 10.1126/science.aad7270; Navarro L., 2015, REWILDING EUROPEAN L, P3, DOI DOI 10.1007/978-3-319-12039-3_1; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Pawson SM, 2013, BIODIVERS CONSERV, V22, P1203, DOI 10.1007/s10531-013-0458-8; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; R Core Team, 2013, R LANG ENV STAT COMP; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Santana J, 2012, J APPL ECOL, V49, P632, DOI 10.1111/j.1365-2664.2012.02141.x; Stephens SS, 2007, J FOREST, V105, P307; Stocker T.F., 2013, CLIMATE CHANGE 2013, P33; Sweeney OFM, 2010, BIRD STUDY, V57, P301, DOI 10.1080/00063651003801713; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Varela E, 2018, SCI TOTAL ENVIRON, V619, P1319, DOI 10.1016/j.scitotenv.2017.11.190; Wilson MW, 2006, BIRD STUDY, V53, P225, DOI 10.1080/00063650609461437	49	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202009	10.1371/journal.pone.0202009	http://dx.doi.org/10.1371/journal.pone.0202009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157226	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400025
J	Redford, L; Alhilal, G; Needham, S; O'Brien, O; Coaker, J; Tyson, J; Amorim, LM; Middleton, I; Izuogu, O; Arends, M; Oniscu, A; Alonso, AM; Laguna, SM; Gallon, R; Sheth, H; Santibanez-Koref, M; Jackson, MS; Burn, J				Redford, Lisa; Alhilal, Ghanim; Needham, Stephanie; O'Brien, Ottie; Coaker, Julie; Tyson, John; Amorim, Leonardo Maldaner; Middleton, Iona; Izuogu, Osagi; Arends, Mark; Oniscu, Anca; Alonso, Angel Miguel; Laguna, Sira Moreno; Gallon, Richard; Sheth, Harsh; Santibanez-Koref, Mauro; Jackson, Michael S.; Burn, John			A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY DETECTION; REVISED BETHESDA GUIDELINES; COLORECTAL-CANCER PATIENTS; LYNCH-SYNDROME; RISK; IMMUNOHISTOCHEMISTRY; STRATEGIES; MUTATIONS; FRAMEWORK; ALIGNMENT	Somatic mutations in mononucleotide repeats are commonly used to assess the mismatch repair status of tumours. Current tests focus on repeats with a length above 15bp, which tend to be somatically more unstable than shorter ones. These longer repeats also have a substantially higher PCR error rate, and tests that use capillary electrophoresis for fragment size analysis often require expert interpretation. In this communication, we present a panel of 17 short repeats (length 7 - 12bp) for sequence-based microsatellite instability (MSI) testing. Using a simple scoring procedure that incorporates the allelic distribution of the mutant repeats, and analysis of two cohort of tumours totalling 209 samples, we show that this panel is able to discriminate between MMR proficient and deficient tumours, even when constitutional DNA is not available. In the training cohort, the method achieved 100% concordance with fragment analysis, while in the testing cohort, 4 discordant samples were observed (corresponding to 97% concordance). Of these, 2 showed discrepancies between fragment analysis and immunohistochemistry and one was reclassified after re-testing using fragment analysis. These results indicate that our approach offers the option of a reliable, scalable routine test for MSI.	[Redford, Lisa; Alhilal, Ghanim; Middleton, Iona; Izuogu, Osagi; Gallon, Richard; Sheth, Harsh; Santibanez-Koref, Mauro; Jackson, Michael S.; Burn, John] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Needham, Stephanie; O'Brien, Ottie] NHS Fdn Trust, Newcastle Hosp, Dept Pathol, Newcastle Upon Tyne, Tyne & Wear, England; [Needham, Stephanie; O'Brien, Ottie] NHS Fdn Trust, Newcastle Hosp, Northern Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Coaker, Julie; Tyson, John] QuantuMDx Grp ltd, Lugano Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Amorim, Leonardo Maldaner] Univ Fed Parana, Dept Genet, Lab Genet Mol Humana, Curitiba, Parana, Brazil; [Arends, Mark; Oniscu, Anca] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Alonso, Angel Miguel; Laguna, Sira Moreno] Hosp Virgen Camino, Complejo Hosp Navarra, Serv Genet Med, C Irunlarrea 4, Pamplona, Spain	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Universidade Federal do Parana; University of Edinburgh; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea	Sheth, H; Santibanez-Koref, M; Jackson, MS (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.	sheth2@newcastle.ac.uk; mauro.santibanez-koref@newcastle.ac.uk; michael.jackson@leeds.ac.uk	ALONSO, ANGEL/P-1145-2019	ALONSO, ANGEL/0000-0001-5111-310X; Jackson, Michael/0000-0001-7179-1354; Maldaner Amorim, Leonardo/0000-0001-6418-3772; Burn, John/0000-0002-9823-2322; tyson, John/0000-0002-1108-7602; Sheth, Harsh/0000-0001-9626-0971; Izuogu, Osagie/0000-0003-3116-2558	QuantuMDx Ltd.; Barbour Foundation	QuantuMDx Ltd.; Barbour Foundation	LR and HS acknowledge the funding support received from QuantuMDx Ltd. The funder provided support in the form of salaries for authors LR and HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors received grant from the Barbour Foundation as a support for the Cancer Genetics Research Programme at the Institute of Genetic Medicine, Newcastle University. The funder had no role in the study design, sample collection and data analysis, decision to publish, or preparation of the manuscript.	Ahadova A, 2018, INT J CANCER, V143, P139, DOI 10.1002/ijc.31300; Alhopuro P, 2008, P NATL ACAD SCI USA, V105, P5513, DOI 10.1073/pnas.0801213105; Ananda G, 2013, GENOME BIOL EVOL, V5, P606, DOI 10.1093/gbe/evs116; Berg KD, 2000, J MOL DIAGN, V2, P20, DOI 10.1016/S1525-1578(10)60611-3; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Boyle TA, 2014, ARCH PATHOL LAB MED, V138, P363, DOI 10.5858/arpa.2013-0159-CP; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Canard G, 2012, ANN SURG ONCOL, V19, P809, DOI 10.1245/s10434-011-2014-7; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engel C, 2012, J CLIN ONCOL, V30, P4409, DOI 10.1200/JCO.2012.43.2278; Gelman A, 2014, BAYESIAN DATA ANAL, Vxiv; Guindalini RSC, 2015, GASTROENTEROLOGY, V149, P1446, DOI 10.1053/j.gastro.2015.07.052; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Haraldsdottir S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00189; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Laiho P, 2002, CANCER RES, V62, P1166; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063056; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Mills AM, 2014, AM J SURG PATHOL, V38, P1501, DOI 10.1097/PAS.0000000000000321; Moller P, 2017, GUT, V66, P464, DOI 10.1136/gutjnl-2015-309675; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NICE, 2017, MOL TEST STRAT LYNCH; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rogers MF, 2018, BIOINFORMATICS, V34, P511, DOI 10.1093/bioinformatics/btx536; Rozen S, 2000, Methods Mol Biol, V132, P365; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Sammalkorpi H, 2007, CANCER RES, V67, P5691, DOI 10.1158/0008-5472.CAN-06-4314; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Shibata Darryl, 2006, Cancer Biomarkers, V2, P29; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Snowsill T, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI [10.3310/hta19020, 10.3310/hta18580]; Susanti S, 2018, J CLIN PATHOL, V71, P713, DOI 10.1136/jclinpath-2018-205013; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Zhang LY, 2008, J MOL DIAGN, V10, P301, DOI 10.2353/jmoldx.2008.080062; Zhu LZ, 2018, J MOL DIAGN, V20, P225, DOI 10.1016/j.jmoldx.2017.11.007	49	9	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203052	10.1371/journal.pone.0203052	http://dx.doi.org/10.1371/journal.pone.0203052			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157243	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400085
J	Skarp, S; Kamarainen, OP; Wei, GH; Jakkula, E; Kiviranta, I; Kroger, H; Auvinen, J; Lehenkari, P; Ala-Kokko, L; Mannikko, M				Skarp, Sini; Kamarainen, Olli-Pekka; Wei, Gong-Hong; Jakkula, Eveliina; Kiviranta, Ilkka; Kroger, Heikki; Auvinen, Juha; Lehenkari, Petri; Ala-Kokko, Leena; Mannikko, Minna			Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis	PLOS ONE			English	Article							ONSET GENERALIZED OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; EXPRESSION; LINKAGE; DISEASE; RISK; ARTHRITIS; ALLELES; HEALTH	Introduction Osteoarthritis (OA) is the most common degenerative joint disease and one of the major causes of disability worldwide. It is a multifactorial disorder with a significant genetic component. The heritability of OA has been estimated to be 60% for hip OA and 39% for knee OA. Genetic factors behind OA are still largely unknown. Studying families with strong history of OA, facilitates examining the co-segregation of genetic variation and OA. The aim of this study was to identify new, rare genetic factors and novel candidate genes for OA. Methods Eight patients from three Finnish families with hip and knee OA were studied using whole exome sequencing. We focused on rare exonic variants with predicted pathogenicity and variants located in active promoter or strong enhancer regions. Expression of identified candidate genes were studied in bone and cartilage tissues and the observed variants were investigated using bioinformatic analyses. Results Two rare variants co-segregated with OA in two families. In Family 8 a missense variant (c.628C>G, p.Arg210Gly) was observed in the OLIG3 gene that encodes a transcription factor known to be associated with rheumatoid arthritis and inflammatory polyarthritis. The Arg210Gly variant was estimated to be pathogenic by Polyphen-2 and Mutation taster and the locus is conserved among mammals. In Family 12 the observed variant (c.-127G>T) was located in the transcription start site of the FIP1L1 gene. FIP1L1 participates in the regulation of polyadenylation. The c.-127G>T is located in the transcription start site and may alter the DNA-binding of transcription factors. Both, OLIG3 and FIP1L1 were observed in human bone and cartilage. Conclusion The identified variants revealed novel candidate genes for OA. OLIG3 and FIP1L1 have specific roles in transcription and may effect expression of other genes. Identified variants in these genes may thus have a role in the regulatory events leading to OA.	[Skarp, Sini; Auvinen, Juha; Mannikko, Minna] Univ Oulu, Fac Med, Ctr Life Course Hlth Res, Oulu, Finland; [Skarp, Sini; Kamarainen, Olli-Pekka; Wei, Gong-Hong; Jakkula, Eveliina; Mannikko, Minna] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kiviranta, Ilkka] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland; [Kiviranta, Ilkka] Helsinki Univ Hosp, Helsinki, Finland; [Kiviranta, Ilkka] Jyvaskyla Cent Hosp, Dept Orthopaed & Traumatol, Jyvaskyla, Finland; [Kroger, Heikki] Kuopio Univ Hosp, Dept Orthopaed & Traumatol, Kuopio, Finland; [Kroger, Heikki] Univ Eastern Finland, Kuopio Musculoskeletal Res Unit, Kuopio, Finland; [Lehenkari, Petri] Univ Oulu, Med Res Ctr, Dept Anat & Cell Biol, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Med Res Ctr, Surg Clin, Oulu, Finland; [Lehenkari, Petri] Oulu Univ Hosp, Oulu, Finland; [Ala-Kokko, Leena] Connect Tissue Gene Tests, Allentown, PA USA; [Mannikko, Minna] Univ Oulu, Northern Finland Birth Cohort, Fac Med, Oulu, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Skarp, S (corresponding author), Univ Oulu, Fac Med, Ctr Life Course Hlth Res, Oulu, Finland.; Skarp, S (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	sini.skarp@oulu.fi	Skarp, Sini/AAH-2995-2021; Lehenkari, Petri/O-3009-2016	Skarp, Sini/0000-0003-2336-4221; Lehenkari, Petri/0000-0002-0055-5183; Wei, Gong-Hong/0000-0001-6546-9334	University of Oulu; Connective Tissue Gene Tests (Allentown)	University of Oulu; Connective Tissue Gene Tests (Allentown)	This study was funded by the University of Oulu (university researcher recruitment funding, MM); The Connective Tissue Gene Tests (Allentown) provided support in the form of salaries for author [LAK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of authors are articulated in the 'author contributions' section.	Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chheda H, 2017, EUR J HUM GENET, V25, P477, DOI 10.1038/ejhg.2016.205; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Gonzalez A, 2013, OSTEOARTHR CARTILAGE, V21, P1443, DOI 10.1016/j.joca.2013.07.001; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Iwasaki J, 2014, ANN HEMATOL, V93, P1473, DOI 10.1007/s00277-014-2085-1; Jakkula E, 2005, OSTEOARTHR CARTILAGE, V13, P497, DOI 10.1016/j.joca.2005.02.005; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kraatari M, 2017, SPINE, V42, P1201, DOI 10.1097/BRS.0000000000002049; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lou H, 1998, J ENDOCRINOL, V156, P401, DOI 10.1677/joe.0.1560401; Luyten FP, 2009, BONE, V44, P522, DOI 10.1016/j.bone.2008.12.006; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meulenbelt I, 2006, EUR J HUM GENET, V14, P1280, DOI 10.1038/sj.ejhg.5201704; Min JL, 2007, EUR J HUM GENET, V15, P791, DOI 10.1038/sj.ejhg.5201829; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Neame RL, 2004, ANN RHEUM DIS, V63, P1022, DOI 10.1136/ard.2003.014498; NEVANLINNA H R, 1980, Haematologia, V13, P65; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Plant D, 2012, PHARMACOGENOMICS J, V12, P128, DOI 10.1038/tpj.2010.80; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Ramos YFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103056; Reynard LN, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.4; Salem S, 2014, J CELL MOL MED, V18, P1588, DOI 10.1111/jcmm.12327; Shepherd C, 2018, ARTHRITIS RHEUMATOL; Soul J, 2018, ANN RHEUM DIS, V77; Spector TD, 1996, BRIT MED J, V312, P940; Styrkarsdottir U, 2017, NAT GENET, V49, P801, DOI 10.1038/ng.3816; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Syddall CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003557; Taipale M, 2016, OSTEOARTHR CARTILAGE, V24, P655, DOI 10.1016/j.joca.2015.10.019; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; VIKKULA M, 1993, ARTHRITIS RHEUM, V36, P401, DOI 10.1002/art.1780360317; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu Y, 2012, OSTEOARTHR CARTILAGE, V20, P1029, DOI 10.1016/j.joca.2012.05.006; Zechner D, 2007, DEV BIOL, V303, P181, DOI 10.1016/j.ydbio.2006.10.045	47	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203313	10.1371/journal.pone.0203313	http://dx.doi.org/10.1371/journal.pone.0203313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157244	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400102
J	Savo, APH; Zheng, YX; Zheng, YT; Lewbart, GA				Savo, Alison P. H.; Zheng, Yaxin; Zheng, Yuting; Lewbart, Gregory A.			Health status assessment of traumatic injury freshwater turtles	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; BIOCHEMICAL REFERENCE INTERVALS; TERRAPENE-CAROLINA-CAROLINA; BOX TURTLES; LEPIDOCHELYS-KEMPII; RESPIRATORY STATUS; CARETTA-CARETTA; NORTH-CAROLINA; HEMATOLOGY; USA	A group of injured yellow-bellied sliders (Trachemys scripta) and river cooters (Pseudemys concinna) were evaluated for a variety of health values at presentation to the NC State Turtle Rescue Team and prior to release. An i-STAT Portable Clinical Analyzer and CG8+ cartridges were used to determine venous blood gas and biochemical values, the packed cell volume (PCV) and total protein were evaluated using hematocrit tubes and high speed centrifugation, and a differential WBC percentage was determined manually with Diff-Quick stained blood smear slides. Forty-six turtles were sampled on presentation and twenty-three of those were sampled again prior to release. Blood values were analyzed for significant differences between samples collected at presentation and prior to release, as well as differences between surviving and non-surviving turtles. Five variables were identified as significantly different between presenting and recuperated samples: pH, pCO2, Glu, % heterophils, and % eosinophils. When comparing samples between turtles that survived versus those that did not, two variables were identified as being significant prognostic indicators; lactate and PCV. Identification of these significant variables can aid in determining patient prognosis and triage therapy for injured aquatic turtles.	[Savo, Alison P. H.; Lewbart, Gregory A.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Zheng, Yaxin; Zheng, Yuting] North Carolina State Univ, Dept Stat, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Lewbart, GA (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	greg_lewbart@ncsu.edu		Lewbart, Gregory/0000-0003-0716-1387	George H. Hitchings New Investigator award	George H. Hitchings New Investigator award	This work was supported in part by a George H. Hitchings New Investigator award to Alison Harrelson Savo.	Adamovicz L, 2015, J ZOO WILDLIFE MED, V46, P39, DOI 10.1638/2014-0066R.1; Anderson ET, 2011, J ZOO WILDLIFE MED, V42, P247, DOI 10.1638/2010-0217.1; Budischak SA, 2006, SOUTHEAST NAT, V5, P191, DOI 10.1656/1528-7092(2006)5[191:NHOTCB]2.0.CO;2; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Casal AB, 2009, VET REC, V164, P663, DOI 10.1136/vr.164.21.663; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Gillespie I, 2017, VET CLIN N AM-SMALL, V47, P325, DOI 10.1016/j.cvsm.2016.10.011; Harvey J.H., 2001, ATLAS VET HEMATOLOGY, P3; Heatley JJ, 2010, J EXOT PET MED, V19, P160, DOI 10.1053/j.jepm.2010.06.002; Hidalgo-Vila J, 2007, J WILDLIFE DIS, V43, P798, DOI 10.7589/0090-3558-43.4.798; Hidalgo-Vila J, 2011, J WILDLIFE DIS, V47, P201, DOI 10.7589/0090-3558-47.1.201; Hunt K. E., 2016, CONSERV PHYSIOL, V4, P1; Innis CJ, 2007, J ZOO WILDLIFE MED, V38, P425, DOI 10.1638/1042-7260(2007)38[425:HAPBAO]2.0.CO;2; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Keller Krista A., 2012, Journal of Herpetological Medicine and Surgery, V22, P99, DOI 10.5818/1529-9651-22.3.99; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Kimble SJA, 2012, J WILDLIFE DIS, V48, P799, DOI 10.7589/0090-3558-48.3.799; Li TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120796; MONTALI RJ, 1988, J COMP PATHOL, V99, P1, DOI 10.1016/0021-9975(88)90101-6; Roberts Brian K, 2016, Vet Clin North Am Exot Anim Pract, V19, P347, DOI 10.1016/j.cvex.2016.01.010; Snoddy JE, 2009, J WILDLIFE MANAGE, V73, P1394, DOI 10.2193/2008-472; Stacy NI, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot003; Steen DA, 2017, CONSERV BIOL, V31, P1333, DOI 10.1111/cobi.12926; Ultsch GR, 2006, BIOL REV, V81, P339, DOI 10.1017/S1464793106007032; Warren DE, 2008, J COMP PHYSIOL B, V178, P133, DOI 10.1007/s00360-007-0212-1; Willoughby JR, 2013, HERPETOLOGICA, V69, P186, DOI 10.1655/HERPETOLOGICA-D-12-00033R2; Wolf KN, 2008, JAVMA-J AM VET MED A, V233, P470, DOI 10.2460/javma.233.3.470	29	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202194	10.1371/journal.pone.0202194	http://dx.doi.org/10.1371/journal.pone.0202194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153271	Green Submitted, gold, Green Published			2022-12-26	WOS:000443001700009
J	Trevis, T; Gosse, M; Santarossa, N; Tabrizi, S; Russell, D; McBride, WJ				Trevis, Thomas; Gosse, Marianne; Santarossa, Nicola; Tabrizi, Sepehr; Russell, Darren; McBride, William John			Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance	PLOS ONE			English	Article							REAL-TIME PCR; MACROLIDE RESISTANCE; NONGONOCOCCAL URETHRITIS; CHLAMYDIA-TRACHOMATIS; SEXUAL-BEHAVIOR; TRICHOMONAS-VAGINALIS; RISK BEHAVIOR; MEN; TRAVELERS; INFECTION	Background Mycoplasma genitalium is a sexually transmitted infection (STI), and a common cause of non-gonococcal urethritis (NGU). There is concern regarding the rise in prevalence of M. genitalium and rates of resistance to macrolide antibiotics. International backpackers represent a unique population that may be at an increased risk of STIs. The purpose of this study was to determine the prevalence of M. genitalium and antibiotic resistance in international backpackers. Methods First void urine samples were obtained utilising opportunistic sampling from 294 non-treatment-seeking international backpackers at a variety of hostels in Cairns, Queensland Australia. Participants also answered a fixed-answer survey regarding sociodemographic characteristics and sexual risk behaviours. Samples were tested for M. genitalium, Chlamydia trachomatis and Neisseria gonorrhoeae using polymerase chain reaction (PCR). Samples positive for M. genitalium were investigated for macrolide resistance-associated mutations in the 23S rRNA genome at positions A2058G, A2058C, A2058T, A2059G and A2059C (Escherichia coli numbering). Results Of the 294 samples, 23 failed the internal control. The prevalence of M. genitalium was 1.8% (5/271, 95% confidence interval [CI] +/- 1.58), C. trachomatis was 4.1% (11/271, 95% CI +/- 2.36) and N. gonorrhoeae was not detected. Macrolide resistance-associated mutations were identified in 40% (2/5) of M. genitalium-positive samples. M. genitalium infection was associated with reporting symptoms (odds ratio [OR] 14.36, 95% CI 2.17-94.94, p < 0.05). Conclusions M. genitalium and C. trachomatis are relatively common amongst non-treatment seeking international backpackers, but may not differ from Australian population prevalence. This article provides evidence to further support the increased utilisation of M. genitalium PCR in the diagnosis of NGU, and for macrolide resistance testing for all identified M. genitalium infections.	[Trevis, Thomas; Santarossa, Nicola; McBride, William John] James Cook Univ, Cairns Hosp, Clin Sch, Cairns, Qld, Australia; [Gosse, Marianne] Norwegian Univ Sci & Technol, Fac Med, Trondheim, Norway; [Tabrizi, Sepehr] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Russell, Darren] Cairns Sexual Hlth Serv, Cairns North, Qld, Australia	James Cook University; Norwegian University of Science & Technology (NTNU); University of Melbourne	Trevis, T (corresponding author), James Cook Univ, Cairns Hosp, Clin Sch, Cairns, Qld, Australia.	thomastrevis@gmail.com	McBride, William/GQY-9084-2022	McBride, William/0000-0001-8894-533X	Cairns Sexual Health Services; James Cook University School of Medicine and Dentistry	Cairns Sexual Health Services; James Cook University School of Medicine and Dentistry	The Cairns Sexual Health Services was a major source of support for this work, providing the necessary funding and equipment required to complete the project. Further funding was sourced through the James Cook University School of Medicine and Dentistry.	Ansart S, 2009, J TRAVEL MED, V16, P79, DOI 10.1111/j.1708-8305.2008.00279.x; Australasian Society for HIV, 2018, AUSTR STI MAN GUID U; Bavastrelli M, 1998, J Travel Med, V5, P57, DOI 10.1111/j.1708-8305.1998.tb00464.x; Bissessor M, 2015, CLIN INFECT DIS, V60, P1228, DOI 10.1093/cid/ciu1162; Bradshaw CS, 2009, SEX TRANSM INFECT, V85, P432, DOI 10.1136/sti.2008.035535; Bradshaw CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003618; Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; Buhrer-Skinner M, 2009, SEX HEALTH, V6, P51, DOI 10.1071/SH08019; Cabada MM, 2011, TRAVEL MED INFECT DI, V9, P75, DOI 10.1016/j.tmaid.2011.02.002; Cabada MM, 2003, J TRAVEL MED, V10, P214, DOI 10.2310/7060.2003.40508; Cabada MM, 2002, SEX TRANSM DIS, V29, P510, DOI 10.1097/00007435-200209000-00003; Cornall AM, 2013, INT J CANCER, V133, P2253, DOI 10.1002/ijc.28228; Couldwell DL, 2013, INT J STD AIDS, V24, P822, DOI 10.1177/0956462413502008; Couldwell DL, 2015, INFECT DRUG RESISTAN, V8; Daley GM, 2014, INT J STD AIDS, V25, P475, DOI 10.1177/0956462413515196; Daley GM, 2014, SEX HEALTH, V11, P587, DOI 10.1071/SH14147; Davies SC, 2011, INT J STD AIDS, V22, P160, DOI 10.1258/ijsa.2010.010354; Davies SC, 2013, SEX HEALTH, V10, P185, DOI 10.1071/SH12136; Fischer JA, 2015, ASIA-PAC J PUBLIC HE, V27; Gesink D, 2016, CANADIAN FAMILY PHYS, V62; Gesink DC, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18203; HAWKES S, 1994, AIDS, V8, P247, DOI 10.1097/00002030-199402000-00013; HAWKES S, 1995, GENITOURIN MED, V71, P351; Henning D, 2014, INT J STD AIDS, V25, P299, DOI 10.1177/0956462413502317; Horner P, 2016, INT J STD AIDS, V27, P85, DOI 10.1177/0956462415586675; Horner P, 2014, CURR OPIN INFECT DIS, V27, P68, DOI 10.1097/QCO.0000000000000030; Horner PJ, 2011, SEX TRANSM INFECT, V87, P38, DOI 10.1136/sti.2010.044487; Horner PJ, 2002, INT J STD AIDS, V13, P667, DOI 10.1258/095646202760326408; Hughes K, 2009, SEX TRANSM INFECT, V85, P477, DOI 10.1136/sti.2009.036921; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Leung A, 2006, INT J STD AIDS, V17, P285, DOI 10.1258/095646206776790231; Lillis RA, 2011, J CLIN MICROBIOL, V49, P1990, DOI 10.1128/JCM.00129-11; Lis R, 2015, CLIN INFECT DIS, V61, P418, DOI 10.1093/cid/civ312; Lusk MJ, 2016, SEX TRANSM INFECT, V92, P175, DOI 10.1136/sextrans-2015-052332; Manhart LE, 2013, INFECT DIS CLIN N AM, V27, P779, DOI 10.1016/j.idc.2013.08.003; Manhart LE, 2011, CLIN INFECT DIS, V53, pS129, DOI 10.1093/cid/cir702; McNulty AM, 2010, SEX TRANSM INFECT, V86, P247, DOI 10.1136/sti.2009.038737; Ona Samsiya, 2016, Infect Dis Obstet Gynecol, V2016, P4513089, DOI 10.1155/2016/4513089; Rane VS, 2014, J CLIN MICROBIOL, V52, P2971, DOI 10.1128/JCM.00899-14; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Salado-Rasmussen K, 2014, CLIN INFECT DIS, V59, P24, DOI 10.1093/cid/ciu217; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Tabrizi SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156740; Tabrizi SN, 2005, SEX TRANSM DIS, V32, P199, DOI 10.1097/01.olq.0000154495.24519.bf; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Therapeutic Guidelines Limited, 2015, ETG COMPL MARCH; Tourism Australia, 2011, BACKP UNC WHAT TRAV; Trembizki E, 2017, J MED MICROBIOL, V66, P1451, DOI 10.1099/jmm.0.000584; Twin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035593; Vajdic Claire M, 2005, Sex Health, V2, P169, DOI 10.1071/SH05018; van der Veer C, 2016, SEX TRANSM INFECT, V92, P83, DOI 10.1136/sextrans-2015-052118; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; Wand H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000004; Wetmore CM, 2011, SEX TRANSM DIS, V38, P180, DOI 10.1097/OLQ.0b013e3182040de9; Whiley DM, 2004, EUR J CLIN MICROBIOL, V23, P705, DOI 10.1007/s10096-004-1170-0; Wroblewski JKH, 2006, J CLIN MICROBIOL, V44, P3306, DOI 10.1128/JCM.00553-06; Zheng HP, 2015, SEX TRANSM DIS, V42, P115, DOI 10.1097/OLQ.0000000000000241	60	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202428	10.1371/journal.pone.0202428	http://dx.doi.org/10.1371/journal.pone.0202428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153259	Green Published, Green Accepted, gold			2022-12-26	WOS:000443001700015
J	Sakai, D; Nakai, T; Hiraishi, S; Nakamura, Y; Ando, K; Naiki, M; Watanabe, M				Sakai, Daisuke; Nakai, Tomoko; Hiraishi, Shunsuke; Nakamura, Yoshihiko; Ando, Kiyoshi; Naiki, Mitsuru; Watanabe, Masahiko			Upregulation of glycosaminoglycan synthesis by Neurotropin in nucleus pulposus cells via stimulation of chondroitin sulfate N-acetylgalactosaminyltransferase 1: A new approach to attenuation of intervertebral disc degeneration	PLOS ONE			English	Article							LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS; IN-VITRO; GROWTH-FACTOR; AGGRECAN; DIFFERENTIATION; EXPRESSION; PHENOTYPE; EFFICACY; PATHWAY	It is suggested that most cases of low back pain are related to degeneration of intervertebral discs. Disc degeneration is a chronic and progressive disease and the search for effective medical treatments continues. Neurotropin is widely used in Japan and China to treat low back pain and neck-shoulder-arm syndrome. The present study aimed to investigate the effect of Neurotropin on glycosaminoglycan synthesis in nucleus pulposus cells. Cultured human nucleus pulposus cells were treated with Neurotropin every second day for two weeks. Production of glycosaminoglycan was assessed using a dimethyl-methylene blue assay and PicoGreen was used to measure DNA content. Microarray analysis, real-time PCR, and western blotting were performed to assess the biological processes related to Neurotropin-stimulated glycosaminoglycan synthesis. The results showed that the level of glycosaminoglycan normalized to DNA content was significantly upregulated by the addition of Neurotropin. Gene expression profiling showed over two-fold upregulation of 697 genes in response to Neurotropin treatment. Among these genes, ontological analysis suggested significant implication of phosphatidylinositol 3-kinase signaling, and analysis focused on this pathway demonstrated marked upregulation of angiopoietin 1 and insulin-like growth factor 1. Activation of phosphorylation of the signal transducer protein AKT was detected by western blotting. Of the genes related to sulfated glycosaminoglycan synthesis, the greatest increase in mRNA levels was observed for chondroitin sulfate N-acetylgalactosaminyltransferase 1, an enzyme initiating synthesis of chondroitin sulfate side chains attached to a core protein of aggrecan, which is a predominant disc matrix component. These findings suggest that Neurotropin may activate the phosphatidylinositol 3-kinase-AKT pathway and stimulate glycosaminoglycan synthesis through upregulation of expression of mRNA for chondroitin sulfate N-acetylgalactosaminyltransferase 1. Because there was no cytotoxic cellular growth inhibition, Neurotropin treatment might offer an accessible therapeutic strategy for intervertebral disc degeneration.	[Sakai, Daisuke; Nakai, Tomoko; Hiraishi, Shunsuke; Watanabe, Masahiko] Tokai Univ, Sch Med, Dept Orthopaed Surg Surg Sci, Isehara, Kanagawa, Japan; [Sakai, Daisuke; Nakamura, Yoshihiko; Ando, Kiyoshi] Tokai Univ, Sch Med, Res Ctr Regenerat Med & Canc Stem Cell, Isehara, Kanagawa, Japan; [Naiki, Mitsuru] Nippon Zoki Pharmaceut Co Ltd, Inst Bioact Sci, Kato, Hyogo, Japan	Tokai University; Tokai University	Sakai, D (corresponding author), Tokai Univ, Sch Med, Dept Orthopaed Surg Surg Sci, Isehara, Kanagawa, Japan.; Sakai, D (corresponding author), Tokai Univ, Sch Med, Res Ctr Regenerat Med & Canc Stem Cell, Isehara, Kanagawa, Japan.	daisakai1@gmail.com	Sakai, Daisuke/X-9164-2019	Sakai, Daisuke/0000-0003-4189-9270; Nakai, Tomoko/0000-0003-2800-8568	Nippon Zoki Pharmaceutical Company Ltd.	Nippon Zoki Pharmaceutical Company Ltd.	The authors received a research grant from Nippon Zoki Pharmaceutical Company Ltd. (http://www.nippon-zoki.co.jp/). The funder provided support in the form of a salary for an author TN and contributed to decision to publish this work. The specific role of the author is articulated in the author contributions section.	Ambs S, 1999, CANCER RES, V59, P5773; Anderson DG, 2005, SPINE, V30, pS14, DOI 10.1097/01.brs.0000175174.50235.ba; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Chothe PP, 2013, SPINE J, V13, P549, DOI 10.1016/j.spinee.2013.01.022; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; DEREUCK J, 1994, ACTA NEUROCHIR, P332; Fujita N, 2008, BIOCHEM BIOPH RES CO, V372, P367, DOI 10.1016/j.bbrc.2008.05.044; Greene MA, 2015, OSTEOARTHR CARTILAGE, V23, P949, DOI 10.1016/j.joca.2015.01.014; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jimbo K, 2005, J NEUROSURG-SPINE, V2, P589, DOI 10.3171/spi.2005.2.5.0589; Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kivitz AJ, 2013, PAIN, V154, P1009, DOI 10.1016/j.pain.2013.03.006; Krock E, 2016, J BIOL CHEM, V291, P3541, DOI 10.1074/jbc.M115.675900; Liu XB, 2008, ACTA PHARMACOL SIN, V29, P815, DOI 10.1111/j.1745-7254.2008.00811.x; Loeser RF, 2014, ARTHRITIS RHEUMATOL, V66, P2201, DOI 10.1002/art.38641; Masuguchi K, 2014, LIFE SCI, V98, P49, DOI 10.1016/j.lfs.2013.12.229; Nakai T, 2016, J ORTHOP RES, V34, P1361, DOI 10.1002/jor.23326; Nishiyama Tomoki, 2006, J Anesth, V20, P240, DOI 10.1007/s00540-006-0399-4; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; OHSHIMA H, 1995, J ORTHOPAED RES, V13, P22, DOI 10.1002/jor.1100130106; Ohtori S, 2015, SPINE J, V15, P1347, DOI 10.1016/j.spinee.2013.07.490; Okada M, 2002, INTERNAL MED, V41, P498, DOI 10.2169/internalmedicine.41.498; Okada T, 1997, ACTA PAEDIATR JAPON, V39, P690; Okazaki R, 2008, ANESTH ANALG, V107, P1064, DOI 10.1213/ane.0b013e31817e7a59; Okuda S, 2001, SPINE, V26, P2421, DOI 10.1097/00007632-200111150-00005; Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; SCHWARTZ ER, 1977, J CLIN INVEST, V60, P96, DOI 10.1172/JCI108774; Sivan SS, 2014, BBA-GEN SUBJECTS, V1840, P3181, DOI 10.1016/j.bbagen.2014.07.013; Sun Y, 2015, OSTEOARTHR CARTILAGE, V23, P1194, DOI 10.1016/j.joca.2015.02.166; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; Tao YQ, 2015, GROWTH FACTORS, V33, P326, DOI 10.3109/08977194.2015.1088532; Toda K, 2008, PAIN MED, V9, P460, DOI 10.1111/j.1526-4637.2007.00279.x; Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F; Yamazaki Y, 2011, J HEADACHE PAIN, V12, P661, DOI 10.1007/s10194-011-0382-9; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Yoshida T, 2008, J NEUROSURG-SPINE, V9, P411, DOI 10.3171/SPI.2008.9.11.411; Yoshikawa T, 2011, SPINE J M ABSTRACTS; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114071; Zhang RX, 2012, INT J COLORECTAL DIS, V27, P1645, DOI 10.1007/s00384-012-1509-4; Zhu Mengye, 2017, J Pain Res, V10, P1391, DOI 10.2147/JPR.S135037	45	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202640	10.1371/journal.pone.0202640	http://dx.doi.org/10.1371/journal.pone.0202640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148873	Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200017
J	Chen, X; Yang, YZ; Katz, SI				Chen, Xiao; Yang, Yizeng; Katz, Sharyn, I			Dexamethasone pretreatment impairs the thymidylate synthase inhibition mediated flare in thymidine salvage pathway activity in non-small cell lung cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN TUMOR-CELLS; IN-VIVO; PET; 5-FLUOROURACIL; VALIDATION; METABOLISM; EXPRESSION; TRANSPORT	Introduction Successful inhibition of thymidylate synthase (TS) by pemetrexed, a TS inhibitor, results in a reproducible transient burst or "flare" in thymidine salvage pathway activity at 2 hrs. of therapy which can be measurable with FLT-PET ([18F]fluorothymidine-positron emission tomography) in non-small cell lung cancer (NSCLC). Routine administration of dexamethasone with pemetrexed-based therapy could potentially confound this imaging approach since dexamethasone is known to inhibit expression of thymidine kinase 1, a key enzyme in the thymidine salvage pathway. Here we examine the potential impact of dexamethasone on the TS inhibition-mediated thymidine salvage pathway "flare" in NSCLC. Materials and methods In order to determine NSCLC cell line sensitivity to dexamethasone and pemetrexed, IC50 studies were performed on NSCLC cell lines H23, H1975, H460, H1299. TS inhibition-mediated "flare" in thymidine salvage pathway activity was then measured at 2hrs. of exposure to pemetrexed and cisplatin in NSCLC cells lines following using H-3-thymidine incorporation assays under the following conditions: control (no chemotherapy or dexamethasone), or treated with pemetrexed and cisplatin without dexamethasone, with 24 hrs. pre-treatment of dexamethasone or with dexamethasone administered together with chemotherapy. These conditions were chosen to model the delivery of pemetrexed-based therapy in the clinic. Results The IC50 of H23, H1975, H460, H1299 for dexamethasone and pemetrexed were 40, 5.9, 718, 362 mu M and 0.22, 0.73, 0.14 and 0.66 mu M respectively. Significant blunting of the thymidine salvage pathway "flare" is observed at 2hrs. of pemetrexed-based therapy when dexamethasone sensitive cell lines H23 and H1975 were pretreated with dexamethasone but not when dexamethasone was given together with pemetrexed therapy or in the setting of dexamethasone resistance (H460 and H1299). Conclusion 24 hr. pretreatment with dexamethasone, but not same day co-administration of dexamethasone with therapy, impairs the TS inhibition-mediated "flare" in thymidine salvage pathway activity in NSCLC.	[Chen, Xiao; Katz, Sharyn, I] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Xiao] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China; [Yang, Yizeng] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Army Medical University; University of Pennsylvania; Pennsylvania Medicine	Katz, SI (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	Sharyn.Katz@uphs.upenn.edu	Katz, Sharyn/AAK-1408-2020	Katz, Sharyn/0000-0001-9816-2291	Department of Defense, Lung Cancer Research Program, Career Development Award [W81XWH-14-1-0197]; Department of Radiology, University of Pennsylvania Perelman School of Medicine	Department of Defense, Lung Cancer Research Program, Career Development Award; Department of Radiology, University of Pennsylvania Perelman School of Medicine	This project was supported by the Department of Defense, Lung Cancer Research Program, Career Development Award, (W81XWH-14-1-0197 to S.K.), http://cdmrp.army.mil/lcrp/default; and through the Department of Radiology, University of Pennsylvania Perelman School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buxant F, 2015, MOL MED REP, V12, P4051, DOI 10.3892/mmr.2015.3920; Chen X, 2017, ONCOTARGET, V8, P82705, DOI 10.18632/oncotarget.19751; Chen X, 2017, ONCOTARGET, V8, P24213, DOI 10.18632/oncotarget.12085; Chouhan Jyoti D, 2011, J Oncol Pharm Pract, V17, P155, DOI 10.1177/1078155210367950; Elsoueidi R, 2016, J ONCOL PHARM PRACT, V22, P271, DOI 10.1177/1078155215583523; Frings V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063705; FROST GH, 1993, J BIOL CHEM, V268, P6748; Greenberg AK, 2002, AM J RESP CELL MOL, V27, P320, DOI 10.1165/rcmb.4710; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Hong YS, 2013, J NUCL MED, V54, P1209, DOI 10.2967/jnumed.112.117010; Lee SJ, 2010, BIOCHEM PHARMACOL, V80, P1528, DOI 10.1016/j.bcp.2010.08.004; McHugh C, 2018, J NUCL MED, DOI [10.2967/jnumed.117, DOI 10.2967/JNUMED.117]; McHugh CI, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0092-2; Muzi M, 2005, J NUCL MED, V46, P274; Patki M, 2014, J THORAC ONCOL, V9, P519, DOI 10.1097/JTO.0000000000000111; Perumal M, 2006, CANCER RES, V66, P8558, DOI 10.1158/0008-5472.CAN-06-0898; Plotnik DA, 2012, NUCL MED BIOL, V39, P970, DOI 10.1016/j.nucmedbio.2012.03.009; Plotnik DA, 2010, J NUCL MED, V51, P1464, DOI 10.2967/jnumed.110.076794; PRESSACCO J, 1995, CANCER RES, V55, P1505; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Wells P, 2003, JNCI-J NATL CANCER I, V95, P675, DOI 10.1093/jnci/95.9.675	22	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202384	10.1371/journal.pone.0202384	http://dx.doi.org/10.1371/journal.pone.0202384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142195	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500013
J	Fowler, DN; Webb, EB; Baldwin, FB; Vrtiska, MP; Hobson, KA				Fowler, Drew N.; Webb, Elisabeth B.; Baldwin, Frank B.; Vrtiska, Mark P.; Hobson, Keith A.			A multi-isotope (delta C-13, delta N-15, delta S-34, delta H-2) approach to establishing migratory connectivity in lesser snow geese: Tracking an overabundant species	PLOS ONE			English	Article							STABLE-ISOTOPES; HYDROGEN; WINTER; NUTRITION; ORIGINS; GROUNDS; SULFUR; BIRDS; DIETS; C-13	Expanding populations of North American midcontinent lesser snow geese (Anser caerulescens caerulescens) have potential to alter ecosystems throughout the Arctic and subarctic where they breed. Efforts to understand origins of harvested lesser snow geese to better inform management decisions have traditionally required mark-recapture approaches, while aerial photographic surveys have typically been used to identify breeding distributions. As a potential alternative, isotopic patterns that are metabolically fixed within newly grown flight feathers following summer molting could provide inferences regarding geographic breeding origin of individuals, without the need for prior capture. Our objective was to assess potential to use four stable isotopes (delta C-13, delta N-15, delta S-34, delta H-2) from feather material to determine breeding origins. We obtained newly grown flight feathers from individuals during summer banding at three Arctic and two subarctic breeding colonies in 2014 (n = 56) and 2016 (n = 45). We used linear discriminant analyses to predict breeding origins from models using combinations of stable isotopes as predictors and evaluated model accuracy when predicting colony, subregion, or subpopulation levels. We found a strong inverse relationship between delta H-2 values and increasing latitude (R-2 = 0.83), resulting in differences (F-4,F- 51 = 90.41, P < 0.0001) among sampled colonies. No differences in delta C-13 or delta N-15 were detected among colonies, although delta S-34 in Akimiski Island, Baffin Island, and Karrak Lake were more enriched (F4, 51 = 11.25, P < 0.0001). Using delta H-2 values as a predictor, discriminant analyses improved accuracy in classification level as precision decreased [model accuracy = 67% (colony), 88% (subregion), 94% (subpopulation)]. Application of the isotopic methods we describe could be used to provide an alternative monitoring method of population metrics, such as overall breeding population distribution, region-specific productivity and migratory connectivity that are informative to management decision makers and provide insight into cross-seasonal effects that may influence migratory behavior.	[Fowler, Drew N.] Univ Missouri, Sch Nat Resources, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA; [Webb, Elisabeth B.] Univ Missouri, Sch Nat Resources, US Geol Survey, Missouri Cooperat Fisheries & Wildlife Res Unit, Columbia, MO USA; [Baldwin, Frank B.] Dept Sustainable Dev, Winnipeg, MB, Canada; [Vrtiska, Mark P.] Nebraska Game & Pk Commiss, Lincoln, NE USA; [Hobson, Keith A.] Western Univ, Dept Biol, London, ON, Canada	University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; Western University (University of Western Ontario)	Fowler, DN (corresponding author), Univ Missouri, Sch Nat Resources, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA.	dnftgb@mail.missouri.edu	Hobson, Keith/Q-9306-2019	Webb, Lisa/0000-0003-3851-6056	U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission; Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research; Missouri Department of Conservation; University of Missouri; U.S. Fish and Wildlife Service; U.S. Geological Survey; Wildlife Management Institute	U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission; Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research; Missouri Department of Conservation; University of Missouri; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey); Wildlife Management Institute	Funding for this project was provided by the U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission and by Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission and by Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank R. Alisauskas, R. Brook, D. Kellett, J. Leafloor, R. Rockwell and others who collected feathers on breeding colonies for this project. Chantel Gryba prepared samples for isotope analysis and Geoff Koehler performed CNS isotope analyses at the Environment Canada Stable Isotope Laboratory in Saskatoon, SK. The Missouri Cooperative Fish and Wildlife Research Unit is jointly sponsored by the Missouri Department of Conservation, the University of Missouri, the U.S. Fish and Wildlife Service, the U.S. Geological Survey, and the Wildlife Management Institute. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	ABRAHAM K F, 1980, Wildfowl, V31, P89; Abraham K. F., 2012, ARCTIC GOOSE JOINT V; Abraham KF, 2005, GLOBAL CHANGE BIOL, V11, P841, DOI 10.1111/j.1365-2486.2005.00943.x; Alisauskas RT, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.5; Alisauskas RT, 2009, ENVIRON ECOL STAT SE, V3, P463, DOI 10.1007/978-0-387-78151-8_20; ALISAUSKAS RT, 1993, J WILDLIFE MANAGE, V57, P49, DOI 10.2307/3808999; Alisauskas RT, 2002, J WILDLIFE MANAGE, V66, P181, DOI 10.2307/3802884; Batt B., 1997, ARCTIC ECOSYSTEMS PE; Calvert AM, 2017, J WILDLIFE MANAGE, V81, P1009, DOI 10.1002/jwmg.21277; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Central Flyway Council, 2013, MAN GUID CENTR FLYW; Drake NA, 2004, EARTH SURF PROC LAND, V29, P1459, DOI 10.1002/esp.1133; Fox AD, 2009, J AVIAN BIOL, V40, P108, DOI 10.1111/j.1600-048X.2009.04720.x; Hache S, 2012, CAN J ZOOL, V90, P722, DOI 10.1139/Z2012-039; Henaux V, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00515-070105; Hill RJ, 2003, INFLUENCE BODY SIZE, V67, P530; HOBAUGH WC, 1985, J WILDLIFE MANAGE, V49, P1028, DOI 10.2307/3801390; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, PLOS ONE; Hobson KA, 2008, TERRESTIAL ECOLOGY S, V2; Hobson KA, 2015, ECOL EVOL, V5, P799, DOI 10.1002/ece3.1383; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hobson KA, 2009, J APPL ECOL, V46, P572, DOI 10.1111/j.1365-2664.2009.01651.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jonsson JE, 2015, SOUTHEAST NAT, V14, P293, DOI 10.1656/058.014.0212; Kerbes RH, 2006, TECHNICAL REPORT SER, V447; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Leafloor J. O., 2012, ARCTIC GOOSE JOINT V; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Paxton KL, 2015, J AVIAN BIOL, V46, P495, DOI 10.1111/jav.00614; Ross MV, 2017, ECOLOGY, V98, P1869, DOI 10.1002/ecy.1856; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Slattery SM, 2007, J WILDLIFE MANAGE, V71, P2230, DOI 10.2193/2005-502; Smith AD, 2005, CONDOR, V107, P547, DOI 10.1650/0010-5422(2005)107[0547:VITSIC]2.0.CO;2; Szymanski ML, 2007, J WILDLIFE MANAGE, V71, P1317, DOI 10.2193/2006-188; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Webster Michael S., 2005, P199; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	46	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203077	10.1371/journal.pone.0203077	http://dx.doi.org/10.1371/journal.pone.0203077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142189	Green Published, gold			2022-12-26	WOS:000442722500060
J	Goldammer, J; Mantziaris, C; Buschges, A; Schmidt, J				Goldammer, Jens; Mantziaris, Charalampos; Bueschges, Ansgar; Schmidt, Joachim			Calcium imaging of CPG-evoked activity in efferent neurons of the stick insect	PLOS ONE			English	Article							UNPAIRED MEDIAN NEURONS; CARAUSIUS-MOROSUS; ELECTRICAL-PROPERTIES; PATTERN GENERATION; MANDUCA-SEXTA; NEUROMODULATORY NEURONS; MOTONEURONAL ACTIVITY; SEARCHING MOVEMENTS; INTRACELLULAR CA2+; PLATEAU POTENTIALS	The stick insect is a well-established experimental animal to study the neural basis of walking. Here, we introduce a preparation that allows combining calcium imaging in efferent neurons with electrophysiological recordings of motor neuron activity in the stick insect thoracic nerve cord. The intracellular free calcium concentration in middle leg retractor coxae motor neurons and modulatory octopaminergic DUM neurons was monitored after backfilling lateral nerve nl5 that contains the axons of these neurons with the calcium indicator Oregon Green BAPTA-1. Rhythmic spike activity in retractor and protractor motor neurons was evoked by pharmacological activation of central pattern generating neuronal networks and recorded extracellularly from lateral nerves. A primary goal of this study was to investigate whether changes in the intracellular free calcium concentration observed in motor neurons during oscillatory activity depend on action potentials. We show that rhythmic spike activity in leg motor neurons induced either pharmacologically or by tactile stimulation of the animal is accompanied by a synchronous modulation in the intracellular free calcium concentration. Calcium oscillations in motor neurons do not appear to depend on calcium influx through voltage-sensitive calcium channels that are gated by action potentials because Calcium oscillations persist after pharmacologically blocking action potentials in the motor neurons. Calcium oscillations were also apparent in the modulatory DUM neurons innervating the same leg muscle. However, the timing of calcium oscillations varied not only between DUM neurons and motor neurons, but also among different DUM neurons. Therefore, we conclude that the motor neurons and the different DUM neurons receive independent central drive.	[Goldammer, Jens; Mantziaris, Charalampos; Bueschges, Ansgar; Schmidt, Joachim] Univ Cologne, Bioctr Cologne, Inst Zool, Anim Physiol, Cologne, Germany; [Goldammer, Jens] Univ Cologne, Bioctr Cologne, Inst Zool, Expt Morphol, Cologne, Germany	University of Cologne; University of Cologne	Schmidt, J (corresponding author), Univ Cologne, Bioctr Cologne, Inst Zool, Anim Physiol, Cologne, Germany.	jachim.schmidt@uni-koeln.de		Buschges, Ansgar/0000-0003-2123-1900; Mantziaris, Charalampos/0000-0003-2280-1733; Goldammer, Jens/0000-0002-5623-8339	DFG [SCHM 1084/3-1]; BMBF/NFS [CRCNS 01GQ1412]; Fellowships of the GSfBS	DFG(German Research Foundation (DFG)); BMBF/NFS; Fellowships of the GSfBS	This research was supported by DFG grant SCHM 1084/3-1 to JS, http://www.dfg.de/en/index.jsp; the BMBF/NFS (CRCNS 01GQ1412) grant to AB, https://www.bmbf.de/en/index.html; and the Fellowships of the GSfBS to JG and CM, http://www.gs-biosciences.uni-koeln.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2009, EUR J NEUROSCI, V29, P1357, DOI 10.1111/j.1460-9568.2009.06694.x; BASSLER U, 1986, PHYSIOL ENTOMOL, V11, P359, DOI 10.1111/j.1365-3032.1986.tb00426.x; BASSLER U, 1983, J EXP BIOL, V105, P127; Bassler U, 1998, BRAIN RES REV, V27, P65, DOI 10.1016/S0165-0173(98)00006-X; Baudoux S, 1998, J NEUROPHYSIOL, V79, P361, DOI 10.1152/jn.1998.79.1.361; BENNETT DL, 1995, CURR BIOL, V5, P1225, DOI 10.1016/S0960-9822(95)00243-0; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bidaye SS, 2018, J NEUROPHYSIOL, V119, P459, DOI 10.1152/jn.00658.2017; Blivis D, 2012, JOVE-J VIS EXP, DOI 10.3791/4008; Bonnot AS, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0001.2002; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; BUSCHGES A, 1995, J EXP BIOL, V198, P435; BUSCHGES A, 1989, J EXP BIOL, V144, P81; Buschges A, 2004, EUR J NEUROSCI, V19, P1856, DOI 10.1111/j.1460-9568.2004.03312.x; Buschges A, 1998, BRAIN RES, V783, P262, DOI 10.1016/S0006-8993(97)01370-X; Buschges A., 2015, E NEUROFORUM, V6, P105, DOI [10.1007/s13295-015-0017-8, DOI 10.1007/S13295-015-0017-8]; Cherniak M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00143; CHRACHRI A, 1987, NEUROSCI LETT, V77, P49, DOI 10.1016/0304-3940(87)90605-7; De Sinety R., 1901, B SOC ENTOMOL FRANCE, P255; Duch C, 2002, J NEUROPHYSIOL, V87, P1415, DOI 10.1152/jn.00524.2001; Edwards DH, 2017, NEUROBIOLOGY MOTOR C, P263; EVANS PD, 1977, NATURE, V270, P257, DOI 10.1038/270257a0; EVANS PD, 1982, J PHYSIOL-LONDON, V324, P93, DOI 10.1113/jphysiol.1982.sp014102; Fischer H, 2001, J NEUROPHYSIOL, V85, P341, DOI 10.1152/jn.2001.85.1.341; Fuchs E, 2011, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00125; Fushiki A, 2016, ELIFE, V5, DOI 10.7554/eLife.13253; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Goldammer J, 2012, J COMP NEUROL, V520, P230, DOI 10.1002/cne.22676; GOODMAN CS, 1979, J EXP BIOL, V83, P95; GRAHAM D, 1985, ADV INSECT PHYSIOL, V18, P31; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grillner S, 2015, CURR OPIN NEUROBIOL, V31, P244, DOI 10.1016/j.conb.2015.01.003; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; HALE JP, 1985, J EXP BIOL, V117, P401; Harris-Warrwick RM, 2017, NEUROBIOLOGY MOTOR C, P225; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Hinckley CA, 2015, NEURON, V87, P1008, DOI 10.1016/j.neuron.2015.08.005; Hinckley CA, 2013, ANN NY ACAD SCI, V1279, P71, DOI 10.1111/nyas.12092; HOUNSGAARD J, 1993, J PHYSIOL-LONDON, V468, P245, DOI 10.1113/jphysiol.1993.sp019769; HOYLE G, 1975, J EXP ZOOL, V193, P425, DOI 10.1002/jez.1401930321; HOYLE G, 1978, J NEUROBIOL, V9, P43, DOI 10.1002/neu.480090105; Hultborn H, 1999, PROG BRAIN RES, V123, P39, DOI 10.1016/S0079-6123(08)62842-3; Hultborn H, 2013, CURR PHARM DESIGN, V19, P4357, DOI 10.2174/1381612811319240004; Ivanov AI, 2000, J NEUROSCI, V20, P4930; Johnston RM, 1996, J NEUROPHYSIOL, V76, P3178, DOI 10.1152/jn.1996.76.5.3178; Johnston RM, 1999, J EXP BIOL, V202, P103; Kadas D, 2017, J NEUROSCI, V37, P10971, DOI 10.1523/JNEUROSCI.1064-17.2017; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Ludwar BC, 2005, J NEUROPHYSIOL, V94, P2772, DOI 10.1152/jn.00493.2005; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; McLean DL, 2011, CURR OPIN NEUROBIOL, V21, P110, DOI 10.1016/j.conb.2010.09.011; Mentel T, 2008, J INSECT PHYSIOL, V54, P51, DOI 10.1016/j.jinsphys.2007.08.010; Messutat S, 2001, CELL CALCIUM, V30, P199, DOI 10.1054/ceca.2001.0227; Mills JD, 1997, J NEUROPHYSIOL, V78, P2455, DOI 10.1152/jn.1997.78.5.2455; Oliveira EE, 2010, J NEUROPHYSIOL, V103, P2770, DOI 10.1152/jn.00963.2009; Orlovsky G, 1999, NEURAL CONTROL LOCOM; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; PITMAN RM, 1988, J EXP BIOL, V135, P95; PITMAN RM, 1975, J PHYSIOL-LONDON, V247, P511, DOI 10.1113/jphysiol.1975.sp010944; Portugues R, 2013, CURR OPIN NEUROBIOL, V23, P119, DOI 10.1016/j.conb.2012.11.001; Pulver SR, 2015, J NEUROPHYSIOL, V114, P2564, DOI 10.1152/jn.00731.2015; RYCKEBUSCH S, 1993, J NEUROPHYSIOL, V69, P1583, DOI 10.1152/jn.1993.69.5.1583; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Ryglewski S, 2012, J PHYSIOL-LONDON, V590, P809, DOI 10.1113/jphysiol.2011.222836; Schmidt J, 2001, J NEUROPHYSIOL, V85, P354, DOI 10.1152/jn.2001.85.1.354; SCHMITZ J, 1988, COMP BIOCHEM PHYS A, V91, P769, DOI 10.1016/0300-9629(88)90963-2; Simpson JH, 2018, GENETICS, V208, P1291, DOI 10.1534/genetics.117.300228; Streit AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148461; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; TSIEN RY, 1990, CELL CALCIUM, V11, P93, DOI 10.1016/0143-4160(90)90063-Z; Tuschick S., 1994, THESIS; WALZ B, 1995, J GEN PHYSIOL, V105, P537, DOI 10.1085/jgp.105.4.537; WEIDLER DJ, 1969, Z VERGL PHYSIOL, V64, P372, DOI 10.1007/BF00340433; Westmark S, 2009, J NEUROPHYSIOL, V102, P1049, DOI 10.1152/jn.91360.2008; Zwart MF, 2016, NEURON, V91, P615, DOI 10.1016/j.neuron.2016.06.031	81	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202822	10.1371/journal.pone.0202822	http://dx.doi.org/10.1371/journal.pone.0202822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142206	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500037
J	Gundersen, C; Tarasuk, V; Cheng, J; de Oliveira, C; Kurdyak, P				Gundersen, Craig; Tarasuk, Valerie; Cheng, Joyce; de Oliveira, Claire; Kurdyak, Paul			Food insecurity status and mortality among adults in Ontario, Canada	PLOS ONE			English	Article							LOW-INCOME PATIENTS; ASSISTANCE PROGRAMS; NATIONAL-HEALTH; UNITED-STATES; HOUSEHOLD; ASSOCIATION; IMPACT; FAMILIES; OUTCOMES; SAMPLE	Background Food insecurity is associated with a wide array of negative health outcomes and higher health care costs but there has been no population-based study of the association of food insecurity and mortality in high-income countries. Methods We use cross-sectional population surveys linked to encoded health administrative data. The sample is 90,368 adults, living in Ontario and respondents in the Canadian Community Health Survey (CCHS). The outcome of interest is all-cause mortality at any time after the interview and within four years of the interview. The primary variable of interest is food insecurity status, with individuals classed as "food secure", "marginally food insecure", "moderately food insecure", or "severely food insecure". We use logistic regression models to determine the association of mortality with food insecurity status, adjusting for other social determinants of health. Results Using a full set of covariates, in comparison to food secure individuals, the odds of death at any point after the interview are 1.28 (CI = 1.08, 1.52) for marginally food insecure individuals, 1.49 (CI = 1.29, 1.73) for moderately food insecure individuals, and 2.60 (CI = 2.17, 3.12) for severely food insecure individuals. When mortality within four years of the interview is considered, the odds are, respectively, 1.19 (CI = 0.95, 1.50), 1.65 (CI = 1.37, 1.98), and 2.31 (CI = 1.81, 2.93). Interpretation These findings demonstrate that food insecurity is associated with higher mortality rates and these higher rates are especially large for the most severe food insecurity category. Efforts to reduce food insecurity should be incorporated into broader public health initiatives to reduce mortality.	[Gundersen, Craig] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA; [Tarasuk, Valerie] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Cheng, Joyce; de Oliveira, Claire; Kurdyak, Paul] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [de Oliveira, Claire; Kurdyak, Paul] Inst Clin Evaluat Sci, Toronto, ON, Canada; [de Oliveira, Claire; Kurdyak, Paul] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kurdyak, Paul] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto	Gundersen, C (corresponding author), Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA.	cggunder@illinois.edu		de Oliveira, Claire/0000-0003-3961-6008; Kurdyak, Paul/0000-0001-8115-7437	Programmatic Grant in Health and Health Equity, Canadian Institutes of Health Research (CIHR) [FRN 115208]; Institute for Clinical Evaluative Sciences (ICES) - annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC)	Programmatic Grant in Health and Health Equity, Canadian Institutes of Health Research (CIHR); Institute for Clinical Evaluative Sciences (ICES) - annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC)	This research was supported by a Programmatic Grant in Health and Health Equity, Canadian Institutes of Health Research (CIHR) (FRN 115208) received by VT. The analysis was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions in this paper are those of the authors and not those of either ICES or the MOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibibula W, 2016, AIDS CARE, V28, P1577, DOI 10.1080/09540121.2016.1191613; Anema A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061277; [Anonymous], 2007, 4696 OFF NUTR POL PR, V4696; Bartfeld J., 2015, SNAP MATTERS FOOD ST; Cox J, 2017, AIDS BEHAV, V21, P792, DOI 10.1007/s10461-016-1326-9; Davison KM, 2015, SOC PSYCH PSYCH EPID, V50, P963, DOI 10.1007/s00127-015-1018-1; Ding M, 2015, J NUTR, V145, P615, DOI 10.3945/jn.114.199919; Fitzpatrick T, 2015, AM J PREV MED, V49, P161, DOI 10.1016/j.amepre.2015.02.018; Ford ES, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.130244, 10.5888/pcd10.120316e, 10.5888/pcd10.120316]; Government of Ontario, 2017, ONT BAS INC PIL; Gundersen C, 2017, AM J AGR ECON, V99, P875, DOI 10.1093/ajae/aax026; Gundersen C, 2017, EMPIR ECON, V52, P1065, DOI 10.1007/s00181-016-1191-4; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Hamelin AM, 2008, PUBLIC HEALTH NUTR, V11, P1389, DOI 10.1017/S1368980008003406; Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014; Ionescu-Ittu R, 2015, PREV MED, V70, P108, DOI 10.1016/j.ypmed.2014.11.017; Jessiman-Perreault G, 2017, SSM-POPUL HLTH, V3, P464, DOI 10.1016/j.ssmph.2017.05.013; Li N, 2016, PREV MED, V93, P151, DOI 10.1016/j.ypmed.2016.10.002; Loopstra R, 2012, CAN PUBLIC POL, V38, P497, DOI 10.3138/CPP.38.4.497; Loopstra R, 2013, CAN J PUBLIC HEALTH, V104, pE55, DOI 10.1007/BF03405655; Mcintyre L, 2016, CAN PUBLIC POL, V42, P274, DOI 10.3138/cpp.2015-069; Muldoon KA, 2013, SOC PSYCH PSYCH EPID, V48, P795, DOI 10.1007/s00127-012-0597-3; Mustard CA, 1999, HEALTH PLACE, V5, P157, DOI 10.1016/S1353-8292(99)00008-8; Park CY, 2014, J ACAD NUTR DIET, V114, P1967, DOI 10.1016/j.jand.2014.04.025; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2012, DIABETES CARE, V35, P233, DOI 10.2337/dc11-1627; Seligman HK, 2010, J HEALTH CARE POOR U, V21, P1227, DOI 10.1353/hpu.2010.0921; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Silverman J, 2015, J GEN INTERN MED, V30, P1476, DOI 10.1007/s11606-015-3351-1; Statistics Canada, CAN COMM HLTH SURV D; Statistics Canada, CAN COMM HLTH SURV C; Statistics Canada, CANADIAN COMMUNITY H; Swann CA, 2017, FOOD POLICY, V73, P1, DOI 10.1016/j.foodpol.2017.08.006; Tarasuk V, 2012, RESEARCH TO IDENTIFY; Tarasuk V, 2018, CAN J PSYCHIAT, V63, P557, DOI 10.1177/0706743717752879; Tarasuk V, 2015, CAN MED ASSOC J, V187, pE429, DOI 10.1503/cmaj.150234; Tarasuk V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1234; Tayie FA, 2009, PREV MED, V48, P480, DOI 10.1016/j.ypmed.2009.03.003; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2	39	45	46	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202642	10.1371/journal.pone.0202642	http://dx.doi.org/10.1371/journal.pone.0202642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138369	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000442800100101
J	Ohemeng, F; Ayivor, JS; Lawson, ET; Ntiamoa-Baidu, Y				Ohemeng, Fidelia; Ayivor, Jesse Sey; Lawson, Elaine Tweneboah; Ntiamoa-Baidu, Yaa			Local classifications of fever and treatment sought among populations at risk of zoonotic diseases in Ghana	PLOS ONE			English	Article							MALARIA TRANSMISSION; BEHAVIOR; LESSONS; BATS	In the past four decades, there has been an increase in the occurrence of zoonotic diseases. Some outbreaks have been devastating because of the inability of individuals and health workers to identify the diseases early. Generally, most zoonotic diseases are heralded by a fever. While fevers are common, they are often the symptoms of different diseases. This paper explores how a population at potential risk of zoonotic diseases identify fevers, and what treatments they seek when they develop fevers. The data are from focus group discussions and a survey of three communities in the Brong Ahafo, Volta and Greater Accra regions in Ghana. The quantitative data were analysed using descriptive statistics while the qualitative data were analysed using thematic analysis. The findings indicate that the perceived causes of fever differ from the traditional biomedical view. While orthodox treatment was the preferred choice for most participants, rural dwellers utilised traditional medicine more than their urban counterparts. Though there is no record of bat-borne zoonotic disease in Ghana, our findings could be used as a proxy to indicate how populations at risk of exposure might respond in the event of a spillover event from a zoonosis. We recommend that educational campaigns on zoonotic diseases should target rural dwellers, especially farmers, who may be most at risk of zoonoses.	[Ohemeng, Fidelia] Univ Ghana, Dept Sociol, Legon, Ghana; [Ayivor, Jesse Sey; Lawson, Elaine Tweneboah] Univ Ghana, Inst Environm & Sanitat Studies, Legon, Ghana; [Ntiamoa-Baidu, Yaa] Univ Ghana, Ctr African Wetlands, Legon, Ghana; [Ntiamoa-Baidu, Yaa] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana; University of Ghana	Ohemeng, F (corresponding author), Univ Ghana, Dept Sociol, Legon, Ghana.	fohemeng@ug.edu.gh		Ntiamoa-Baidu, Yaa/0000-0002-3915-3341	Ecosystem Services for Poverty Alleviation (ESPA); NERC project [NE-J00 1570-1, 192]; NERC [NE/J001422/1, NE/J001570/1] Funding Source: UKRI	Ecosystem Services for Poverty Alleviation (ESPA); NERC project(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported with funds by the Ecosystem Services for Poverty Alleviation (ESPA). NERC project no. NE-J00 1570-1, 192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Ayivor J.S., 2013, PARKS, V19, P37, DOI [10.2305/IUCN.CH.2013.PARKS-19-1.JSA.en, DOI 10.2305/IUCN.CH.2013.PARKS-19-1.JSA.EN]; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Chin RFM, 2005, ARCH DIS CHILD, V90, P66, DOI 10.1136/adc.2003.038844; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; Ghana Statistical Service, 2014, 2010 POP HOUS CENS; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Gilbert AT, 2012, AM J TROP MED HYG, V87, P206, DOI 10.4269/ajtmh.2012.11-0689; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Han HJ, 2015, VIRUS RES, V205, P1, DOI 10.1016/j.virusres.2015.05.006; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hayman DTS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025256; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Looi Lai-Meng, 2007, Malays J Pathol, V29, P63; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Mota REM, 2009, AM J TROP MED HYG, V81, P935, DOI 10.4269/ajtmh.2009.08-0361; Nonvignon J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-188; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; Nsungwa-Sabiiti J, 2004, TROP MED INT HEALTH, V9, P1191, DOI 10.1111/j.1365-3156.2004.01319.x; Ohemeng F, 2017, ANTHROZOOS, V30, P181, DOI 10.1080/08927936.2017.1310984; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Onwujekwe O, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-45; Pond BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-313; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Sarpong N, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0772-6; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Upadhyay DK, 2014, DIAGNOSIS, V1, P283, DOI 10.1515/dx-2014-0064; Wilson ML, 2015, AM J TROP MED HYG, V93, P110, DOI 10.4269/ajtmh.14-0834; Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201526	10.1371/journal.pone.0201526	http://dx.doi.org/10.1371/journal.pone.0201526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138341	gold, Green Submitted, Green Published			2022-12-26	WOS:000442800100018
J	Alkhouri, N; Johnson, C; Adams, L; Kitajima, S; Tsuruno, C; Colpitts, TL; Hatcho, K; Lawitz, E; Lopez, R; Feldstein, A				Alkhouri, Naim; Johnson, Casey; Adams, Leon; Kitajima, Sachiko; Tsuruno, Chikayuki; Colpitts, Tracey L.; Hatcho, Kazuki; Lawitz, Eric; Lopez, Rocio; Feldstein, Ariel			Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis	PLOS ONE			English	Article							MAC-2 BINDING-PROTEIN; NATURAL-HISTORY; FIBROSIS STAGE; SPECTRUM; DISEASE	Objective The race for finding effective treatments for nonalcoholic fatty liver disease (NAFLD) has been slowed down by the high screen-failure rate for including patients in trials due to the lack of a noninvasive biomarker that can identify patients with significant disease. Recently, Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) has shown promise in predicting liver fibrosis. The aims of this study were to evaluate the utility of WFA -M2BP as a biomarker to sub-classify patients with NAFLD according to their disease severity and to assess its correlation with histologic features of NAFLD. Methods Patients undergoing biopsy for clinical suspicion of NAFLD and healthy controls were included. Patients with NAFLD were classified into: NAFL, early NASH (F0-F1), fibrotic NASH (F2-F3), and NASH cirrhosis (F4). Levels of WFA(+)-M2BP in sera was measured by a HISCL (TM) M2BPGi (TM) assay kit using an automated immunoanalyzer (HISCL (TM)-800; Sysmex, Kobe, Japan). Analysis of covariance was used to assess difference in WFA(+)-M2BP between the groups and Spearman's correlation coefficients were used to assess correlation with histological features. Results Our cohort consisted of 20 healthy controls and 198 patients with biopsy-proven NAFLD divided as follows: 52 with NAFL, 62 with early NASH, 52 with fibrotic NASH, and 32 with NASH cirrhosis. WFA(+)-M2BP level was found to be significantly increased in the fibrotic NASH and NASH cirrhosis groups compared to healthy controls and those with early NAFLD after adjusting for age, gender and BMI. Furthermore, patients with NASH cirrhosis had significantly higher WFA(+)-M2BP levels (2.4[1.5, 4.2] C.0.1 (Cut-off Index)) than those with fibrotic NASH (1.2[0.79, 1.9]), p < 0.001. WFA(+) -M2BP level had moderate correlation with inflammation, ballooning and NAFLD activity score and strong correlation with fibrosis stage. Additionally, ROC curve analysis demonstrated that WFA(+) -M2BP accurately differentiated F2-4 from F0-F1. Conclusion In a large cohort of patients with the full spectrum of NAFLD, WFA(+)-M2BP levels predicted the presence of advanced disease and correlated strongly with fibrosis stage.	[Alkhouri, Naim; Lawitz, Eric] Univ Texas UT Hlth Sci Ctr, Texas Liver Inst, San Antonio, TX 78229 USA; [Johnson, Casey; Feldstein, Ariel] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Adams, Leon] Univ Western Australia, Crawley, Australia; [Colpitts, Tracey L.; Hatcho, Kazuki] Sysmex Corp R&D Ctr Amer, Lincolnshire, IL USA; [Lopez, Rocio] Cleveland Clin, Digest Dis & Surg Inst, Cleveland, OH 44106 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of Western Australia; Cleveland Clinic Foundation	Alkhouri, N (corresponding author), Univ Texas UT Hlth Sci Ctr, Texas Liver Inst, San Antonio, TX 78229 USA.	Alkhouri@txliver.com		Lopez, Ana Rocio/0000-0002-4319-420X	Sysmex	Sysmex	The study was supported by an unrestrictive grant from Sysmex. Sysmex provided HISCLTM M2BPGiTM assay kit and an automated immunoanalyzer HISCLTM-800. The funder provided support in the form of salaries for authors SK, CT, TLC, and KH; but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Alkhouri Naim, 2012, Gastroenterol Hepatol (N Y), V8, P661; Angulo P, 2015, GASTROENTEROLOGY; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Doycheva I, 2017, J CLIN GASTROENTEROL; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Goh GBB, 2016, DIGEST DIS SCI, V61, P1226, DOI 10.1007/s10620-016-4095-4; Ito K, 2017, J GASTROEN HEPATOL, V32, P1922, DOI 10.1111/jgh.13802; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lai LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174982; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nishikawa H, 2016, J VIRAL HEPATITIS, V23, P977, DOI 10.1111/jvh.12575; Nishikawa H, 2016, HEPATOL RES, V46, P1194, DOI 10.1111/hepr.12662; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305	21	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202226	10.1371/journal.pone.0202226	http://dx.doi.org/10.1371/journal.pone.0202226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161179	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900026
J	Tasse, J; Trouillet-Assant, S; Josse, J; Martins-Simoes, P; Valour, F; Langlois-Jacques, C; Badel-Berchoux, S; Provot, C; Bernardi, T; Ferry, T; Laurent, F				Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Valour, Florent; Langlois-Jacques, Carole; Badel-Berchoux, Stephanie; Provot, Christian; Bernardi, Thierry; Ferry, Tristan; Laurent, Frederic			Association between biofilm formation phenotype and clonal lineage in Staphylococcus aureus strains from bone and joint infections	PLOS ONE			English	Article							BOVINE MASTITIS; OSTEOMYELITIS; EPIDEMIOLOGY; EPIDERMIDIS; ENZYMES; DEVICE	Biofilm formation is a critical virulence factor responsible for treatment failure and chronicity in orthopaedic device-related infections (ODIs) caused by Staphylococcus aureus. Clonal lineages differ in terms of their biofilm forming capacities. The aim of this study was to investigate the correlation between the clonal complex (CC) affiliation and biofilm phenotype of 30 clinical S. aureus isolates responsible of ODI based on i) early biofilm formation using BioFilm Ring Test (R) and mature biofilm formation using crystal violet assays, ii) biofilm composition using DNase and proteinase K activity, and iii) prevention of biofilm formation by cloxacillin, teicoplanin and vancomycin using Antibiofilmogram (R) (biofilm minimal inhibitory concentration-bMIC). In terms of early biofilm formation, the CC30 strains were significantly slower than the CC5, CC15 and CC45 strains. CC45 strains produced significantly more mature biofilm than other group of strains did. The formation of biofilms was highly dependent on the presence of extracellular DNA in the CC5, CC15 and CC30 strains whereas it was mostly dependent on the presence of proteins in CC45. Finally, the CC30 group highlighted higher proportion of susceptible (bMIC < breakpoints of EUCAST guidelines) for cloxacillin, teicoplanin and vancomycin compared to the other CCs. These results demonstrate that the biofilm phenotype of clinical S. aureus isolates from ODIs is strongly related to their respective CC affiliation.	[Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Valour, Florent; Ferry, Tristan; Laurent, Frederic] Ctr Int Rech Infectiol, Pathogenie Staphylocoques, INSERM U1111, Lyon, France; [Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Valour, Florent; Langlois-Jacques, Carole; Ferry, Tristan; Laurent, Frederic] Univ Claude Bernard Lyon 1, Lyon, France; [Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Laurent, Frederic] Hosp Civils Lyon, Inst Agents Infect, Lyon, France; [Tasse, Jason; Badel-Berchoux, Stephanie; Provot, Christian; Bernardi, Thierry] BioFilm Control, St Beauzire, France; [Valour, Florent; Ferry, Tristan] Hosp Civils Lyon, Serv Malad Infect & Trop, Lyon, France; [Langlois-Jacques, Carole] Hosp Civils Lyon, Serv Biostat & Bioinformat, Lyon, France; [Langlois-Jacques, Carole] CNRS, UMR, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Tasse, J (corresponding author), Ctr Int Rech Infectiol, Pathogenie Staphylocoques, INSERM U1111, Lyon, France.; Tasse, J (corresponding author), Univ Claude Bernard Lyon 1, Lyon, France.; Tasse, J (corresponding author), Hosp Civils Lyon, Inst Agents Infect, Lyon, France.; Tasse, J (corresponding author), BioFilm Control, St Beauzire, France.	jason.tasse@chu-lyon.fr	trouillet-assant, sophie/L-9400-2014; LAURENT, Frederic/AGM-0706-2022; Ferry, Tristan/M-5108-2014	laurent, frederic/0000-0003-0609-9091; M Simoes, Patricia/0000-0001-5130-6016; JOSSE, Jerome/0000-0001-6780-9646; Badel-Berchoux, stephanie/0000-0002-7212-8199; Valour, Florent/0000-0002-1467-6162; Tasse, Jason/0000-0002-7496-7594; ferry, tristan/0000-0003-3082-7001	Fonds Unique Interministeriel 15th; Association Nationale de la Recherche et de la Technologie (ANRT); Biofilm Control through a CIFRE fellowship; 15th Fonds Unique Interministeriel (FUI) call for projects	Fonds Unique Interministeriel 15th; Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); Biofilm Control through a CIFRE fellowship; 15th Fonds Unique Interministeriel (FUI) call for projects	This work was supported by Fonds Unique Interministeriel 15th and by Association Nationale de la Recherche et de la Technologie (ANRT) and Biofilm Control through a CIFRE fellowship to JT. Biofilm Control provided support in the form of salaries for authors JT, SBB, CP, TB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was partly supported by a grant from the 15th Fonds Unique Interministeriel (FUI) call for projects.	Badel S, 2011, ENZYME MICROB TECH, V48, P248, DOI 10.1016/j.enzmictec.2010.11.003; Bardiau M, 2016, VET MICROBIOL, V185, P1, DOI 10.1016/j.vetmic.2016.01.003; Bardiau M, 2014, VET MICROBIOL, V169, P74, DOI 10.1016/j.vetmic.2013.12.010; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Cortes MF, 2015, INT J MED MICROBIOL, V305, P140, DOI 10.1016/j.ijmm.2014.11.011; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191; Elchinger PH, 2014, LETT APPL MICROBIOL, V59, P507, DOI 10.1111/lam.12305; Gbejuade HO, 2015, ACTA ORTHOP, V86, P147, DOI 10.3109/17453674.2014.966290; Grammatico-Guillon L, 2012, J HOSP INFECT, V82, P40, DOI 10.1016/j.jhin.2012.04.025; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Iyamba JML, 2011, BIOFOULING, V27, P811, DOI 10.1080/08927014.2011.604776; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545, DOI 10.1177/039139880903200903; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Lipsky BA, 2007, INFECT CONT HOSP EP, V28, P1290, DOI 10.1086/520743; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Naicker PR, 2016, MICROB PATHOGENESIS, V90, P41, DOI 10.1016/j.micpath.2015.10.023; Rao NL, 2011, PLAST RECONSTR SURG, V127, p177S, DOI 10.1097/PRS.0b013e3182001f0f; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Tasse J, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw057; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Zapotoczna M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005671	29	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0200064	10.1371/journal.pone.0200064	http://dx.doi.org/10.1371/journal.pone.0200064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161132	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900003
J	Abu Asab, N; Cuestas, JC; Montagnoli, A				Abu Asab, Nora; Carlos Cuestas, Juan; Montagnoli, Alberto			Inflation targeting or exchange rate targeting: Which framework supports the goal of price stability in emerging market economies?	PLOS ONE			English	Article							OUTPUT GROWTH; CONDITIONAL HETEROSKEDASTICITY; EMPIRICAL-EVIDENCE; MONETARY-POLICY; UNITED-KINGDOM; LONG MEMORY; UNCERTAINTY; MODEL; LINK; HETEROSCEDASTICITY	The paper investigates and compares the relationship between inflation and inflation uncertainty under inflation targeting and, alternatively, a conventional fixed exchange rate system, for a group of emerging countries. To do so we estimate GARCH in mean models and we find that there is a bi-directional relationship between inflation and inflation uncertainty under the two monetary regimes. It is also found that the fixed exchange rate regime has no impact on average inflation and inflation inertia, while inflation targeting has been successful at lowering both average inflation and inflation persistence.	[Abu Asab, Nora; Montagnoli, Alberto] Univ Sheffield, Dept Econ, Sheffield, S Yorkshire, England; [Carlos Cuestas, Juan] Jaume I Univ, Dept Econ & IEI, Castellon de La Plana, Spain; [Carlos Cuestas, Juan] Tallinn Univ Technol, Dept Econ & Finance, Tallinn, Estonia; [Carlos Cuestas, Juan] Eesti Pank, Res Unit, Tallinn, Estonia	University of Sheffield; Universitat Jaume I; Tallinn University of Technology; Bank of Estonia (Eesti Pank)	Cuestas, JC (corresponding author), Jaume I Univ, Dept Econ & IEI, Castellon de La Plana, Spain.; Cuestas, JC (corresponding author), Tallinn Univ Technol, Dept Econ & Finance, Tallinn, Estonia.; Cuestas, JC (corresponding author), Eesti Pank, Res Unit, Tallinn, Estonia.	cuestasjuancarlos@gmail.com	Cuestas, Juan Carlos/K-4270-2014; Abu Asab, Noura/W-7263-2018	Cuestas, Juan Carlos/0000-0002-7313-2157; Abu Asab, Noura/0000-0002-8114-617X	'Agencia Estatal de Investigacion' (AEI) [ECO2017-83255-C3-3-P, ECO2017-85503-R]; 'Fondo Europeo de Desarrollo Regional' (FEDER)	'Agencia Estatal de Investigacion' (AEI); 'Fondo Europeo de Desarrollo Regional' (FEDER)	JCC acknowledges the financial support from the following: the ECO2017-83255-C3-3-P and ECO2017-85503-R projects from 'Agencia Estatal de Investigacion' (AEI) and 'Fondo Europeo de Desarrollo Regional' (FEDER).	ACKLEY G, 1978, AM ECON REV, V68, P149; Baillie RT, 1996, J APPL ECONOM, V11, P23, DOI 10.1002/(SICI)1099-1255(199601)11:1<23::AID-JAE374>3.0.CO;2-M; BALL L, 1990, BROOKINGS PAP ECO AC, P215; BALL L, 1992, J MONETARY ECON, V29, P371, DOI 10.1016/0304-3932(92)90032-W; BARRO RJ, 1983, J MONETARY ECON, V12, P101, DOI 10.1016/0304-3932(83)90051-X; Batini N., 2007, MONETARY POLICY INFL, V11, P467; Bernanke BS, 1997, INFLATION TARGETING, P5893; Bernholz P., 2015, MONETARY REGIMES INF; Bhar R, 2012, ECON ANAL POLICY, V42, P305, DOI 10.1016/S0313-5926(12)50031-7; Bhar R, 2013, EMPIR ECON, V45, P1333, DOI 10.1007/s00181-012-0650-9; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Box G. E., 1970, J AM STAT ASSOC, V65, P1509, DOI [10.1080/01621459.1970.10481180, DOI 10.1080/01621459.1970.10481180]; Capistran C, 2010, J MONEY CREDIT BANK, V42, P113, DOI 10.1111/j.1538-4616.2009.00280.x; Caporale GM, 2012, EMPIR ECON, V43, P597, DOI 10.1007/s00181-011-0489-5; Caporale GM, 2009, J INT MONEY FINANC, V28, P954, DOI 10.1016/j.jimonfin.2008.09.004; CARLSON JA, 1977, ANN ECON SOC MEAS, V6, P27; Castillo P, 2012, J APPL ECON, V15, P71, DOI 10.1016/S1514-0326(12)60004-X; Chang KL, 2010, MANCH SCH, V78, P126, DOI 10.1111/j.1467-9957.2009.02162.x; Conrad C, 2005, JPN WORLD ECON, V17, P327, DOI 10.1016/j.japwor.2004.03.002; Cuestas JC, 2016, SCOT J POLIT ECON, V63, P519, DOI 10.1111/sjpe.12114; CUKIERMAN A, 1982, AM ECON REV, V72, P508; CUKIERMAN A, 1986, ECONOMETRICA, V54, P1099, DOI 10.2307/1912324; Daal E, 2005, ECON LETT, V89, P180, DOI 10.1016/j.econlet.2005.05.024; Engle, 1993, PERMANENT TRANSITORY; ENGLE RF, 1987, ECONOMETRICA, V55, P391, DOI 10.2307/1913242; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; EVANS M, 1991, J MONEY CREDIT BANK, V23, P169, DOI 10.2307/1992775; Fischer S, 1989, SHOULD NATIONS LEARN, P2815; Fountas S, 2004, MANCH SCH, V72, P221, DOI 10.1111/j.1467-9957.2004.00390.x; Fountas S, 2001, ECON LETT, V74, P77, DOI 10.1016/S0165-1765(01)00522-5; Fountas S, 2010, ECON MODEL, V27, P896, DOI 10.1016/j.econmod.2010.06.001; FRIEDMAN M, 1977, J POLIT ECON, V85, P451, DOI 10.1086/260579; GLEZAKOS C, 1984, WORLD DEV, V12, P755, DOI 10.1016/0305-750X(84)90086-X; Golob J.E., 1994, ECON REV, V79, P27; Grier KB, 2004, J APPL ECONOMET, V19, P551, DOI 10.1002/jae.763; Grier KB, 1998, J INT MONEY FINANC, V17, P671, DOI 10.1016/S0261-5606(98)00023-0; Harvey AC, 2013, DYNAMIC MODELS VOLAT; HOLLAND AS, 1995, J MONEY CREDIT BANK, V27, P827, DOI 10.2307/2077753; Hu Y, 2003, IIE WORKING PAPERS S, P03; Jiranyakul K, 2010, J ASIAN ECON, V21, P105, DOI 10.1016/j.asieco.2009.09.007; Wilson BK, 2006, J MACROECON, V28, P609, DOI 10.1016/j.jmacro.2004.11.004; Khan M, 2013, WORKING PAPERS HALSH, V00804556; KIM CJ, 1993, J BUS ECON STAT, V11, P341, DOI 10.2307/1391959; Kontonikas A, 2004, ECON MODEL, V21, P525, DOI 10.1016/j.econmod.2003.08.001; Mallik G, 2011, J ECON STUD, V38, P620, DOI 10.1108/01443581111177358; Nazar Dahmardeh, 2010, American Journal of Applied Sciences, V7, P535, DOI 10.3844/ajassp.2010.535.539; Neanidis KC, 2011, ECON LETT, V112, P26, DOI 10.1016/j.econlet.2011.03.025; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Neumann MJ, 2002, DOES INFLATION TARGE, P9577; OKUN AM, 1971, BROOKINGS PAP ECO AC, P485; PAGAN AR, 1983, REV ECON STUD, V50, P585, DOI 10.2307/2297762; POURGERAMI A, 1987, WORLD DEV, V15, P287, DOI 10.1016/0305-750X(87)90083-0; Rizvi SKA, 2009, 26 INT S MON BANK FI; Samimi AJ, 2012, UNIVERSAL J MANAGEME, V2, P57; SIDRAUSKI M, 1967, J POLIT ECON, V75, P796, DOI 10.1086/259360; STOCKMAN AC, 1981, J MONETARY ECON, V8, P387, DOI 10.1016/0304-3932(81)90018-0; Tas BKO, 2013, AUST ECON REV, V46, DOI 10.1111/1467-8462.12036; TOBIN J, 1972, AM ECON REV, V62, P1; TOBIN J, 1965, ECONOMETRICA, V33, P671, DOI 10.2307/1910352; UNGAR M, 1993, J MONEY CREDIT BANK, V25, P709, DOI 10.2307/2077800; Wachtel P, 1977, ANAL INFLATION 1965, P361; Walsh CE, 2009, INT FINANC, V12, P195, DOI 10.1111/j.1468-2362.2009.01236.x; Wright JH, 2011, AM ECON REV, V101, P1514, DOI 10.1257/aer.101.4.1514; Yeh CC, 2011, APPL ECON, V43, P2593, DOI 10.1080/00036840903299763; ZAKOIAN JM, 1994, J ECON DYN CONTROL, V18, P931, DOI 10.1016/0165-1889(94)90039-6	65	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0201798	10.1371/journal.pone.0201798	http://dx.doi.org/10.1371/journal.pone.0201798			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153258	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000443001700004
J	Jager, F; Libensek, S; Gersak, K				Jager, Franc; Libensek, Sonja; Gersak, Ksenija			Characterization and automatic classification of preterm and term uterine records	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; APPROXIMATE ENTROPY; ELECTROMYOGRAPHY; SIGNAL; PREGNANCY; DELIVERY; UTERUS; IDENTIFICATION; CONTRACTIONS; MUSCLE	Predicting preterm birth is uncertain, and numerous scientists are searching for noninvasive methods to improve its predictability. Current researches are based on the analysis of ElectroHysteroGram (EHG) records, which contain information about the electrophysiological properties of the uterine muscle and uterine contractions. Since pregnancy is a long process, we decided to also characterize, for the first time, non-contraction intervals (dummy intervals) of the uterine records, i.e., EHG signals accompanied by a simultaneously recorded external tocogram measuring mechanical uterine activity (TOCO signal). For this purpose, we developed a new set of uterine records, TPEHGT DS, containing preterm and term uterine records of pregnant women, and uterine records of non-pregnant women. We quantitatively characterized contraction intervals (contractions) and dummy intervals of the uterine records of the TPEHGT DS in terms of the normalized power spectra of the EHG and TOCO signals, and developed a new method for predicting preterm birth. The results on the characterization revealed that the peak amplitudes of the normalized power spectra of the EHG and TOCO signals of the contraction and dummy intervals in the frequency band 1.0-2.2 Hz, describing the electrical and mechanical activity of the uterus due to the maternal heart (maternal heart rate), are high only during term pregnancies, when the delivery is still far away; and they are low when the delivery is close. However, these peak amplitudes are also low during preterm pregnancies, when the delivery is still supposed to be far away (thus suggesting the danger of preterm birth); and they are also low or barely present for non-pregnant women. We propose the values of the peak amplitudes of the normalized power spectra due to the influence of the maternal heart, in an electro-mechanical sense, in the frequency band 1.0-2.2 Hz as a new biophysical marker for the preliminary, or early, assessment of the danger of preterm birth. The classification of preterm and term, contraction and dummy intervals of the TPEHGT DS, for the task of the automatic prediction of preterm birth, using sample entropy, the median frequency of the power spectra, and the peak amplitude of the normalized power spectra, revealed that the dummy intervals provide quite comparable and slightly higher classification performances than these features obtained from the contraction intervals. This result suggests a novel and simple clinical technique, not necessarily to seek contraction intervals but using the dummy intervals, for the early assessment of the danger of preterm birth. Using the publicly available TPEHG DB database to predict preterm birth in terms of classifying between preterm and term EHG records, the proposed method outperformed all currently existing methods. The achieved classification accuracy was 100% for early records, recorded around the 23rd week of pregnancy; and 96.33%, the area under the curve of 99.44%, for all records of the database. Since the proposed method is capable of using the dummy intervals with high classification accuracy, it is also suitable for clinical use very early during pregnancy, around the 23rd week of pregnancy, when contractions may or may not be present.	[Jager, Franc; Libensek, Sonja] Univ Ljubljana, Fac Comp & Informat Sci, Dept Software, Ljubljana, Slovenia; [Gersak, Ksenija] Univ Ljubljana, Fac Med, Dept Obstet & Gynecol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Jager, F (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Dept Software, Ljubljana, Slovenia.	franc.jager@fri.uni.lj.si		Gersak, Ksenija/0000-0001-9088-2382	Slovenian Research Agency (ARRS) [P3-0124]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was financed by the Slovenian Research Agency (ARRS) (https://www.arrs.gov.si/) under the research project P3-0124 Metabolic and inborn factors of reproductive health, birth II (FJ, KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2017, COMPUT BIOL MED, V85, P33, DOI 10.1016/j.compbiomed.2017.04.013; Ahmed MU, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19010002; Alamedine D, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/485684; Alexandersson A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.17; Baker PN, 2011, OBSTET 10 TEACHERS, P436; Batista AG, 2016, COMPUT BIOL MED, V76, P178, DOI 10.1016/j.compbiomed.2016.07.003; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; BLUMAN AG, 2009, ELEMENTARY STAT STEP; Borowska M, 2018, COMPUT METH PROG BIO, V153, P227, DOI 10.1016/j.cmpb.2017.10.018; Buhimschi C, 1997, OBSTET GYNECOL, V90, P102, DOI 10.1016/S0029-7844(97)83837-9; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen LL, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/7949507; Choi E, 2003, PATTERN RECOGN, V36, P1703, DOI 10.1016/S0031-3203(03)00035-9; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; de Lau H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-192; DEVEDEUX D, 1993, AM J OBSTET GYNECOL, V169, P1636, DOI 10.1016/0002-9378(93)90456-S; Diab A, 2014, P VIRT PHYS HUM C; Diab A, 2014, MED ENG PHYS, V36, P761, DOI 10.1016/j.medengphy.2014.01.009; Diab M.O., 2007, INT J COMPUT COGNIT, V5, P8; Dunne K., 2002, J MACH LEARN RES, V1, P1; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fele-Zorz G, 2008, MED BIOL ENG COMPUT, V46, P911, DOI 10.1007/s11517-008-0350-y; Fergus P, 2016, NEUROCOMPUTING, V188, P42, DOI 10.1016/j.neucom.2015.01.107; Fergus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077154; Garfield RE, 2005, BJOG-INT J OBSTET GY, V112, P103, DOI 10.1111/j.1471-0528.2005.00596.x; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hanley GE, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0857-4; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Horoba K, 2016, BIOCYBERN BIOMED ENG, V36, P610, DOI 10.1016/j.bbe.2016.08.005; Horoba K, 2016, BIOCYBERN BIOMED ENG, V36, P574, DOI 10.1016/j.bbe.2016.06.004; Howson C, 2012, BORN TOO SOON GLOBAL; Hussain AJ, 2015, NEUROCOMPUTING, V151, P963, DOI 10.1016/j.neucom.2014.03.087; Iams JD, 2003, OBSTET GYNECOL, V101, P402, DOI 10.1016/S0029-7844(02)02505-X; Idowu IO, 2015, CIT/IUCC/DASC/PICOM 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY - UBIQUITOUS COMPUTING AND COMMUNICATIONS - DEPENDABLE, AUTONOMIC AND SECURE COMPUTING - PERVASIVE INTELLIGENCE AND COMPUTING, P215, DOI 10.1109/CIT/IUCC/DASC/PICOM.2015.31; Jezewski J, 2005, PHYSIOL MEAS, V26, P753, DOI 10.1088/0967-3334/26/5/014; Jyothi R, 2016, 2016 INT C SIGN PROC, P1; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Leman H, 1999, IEEE T BIO-MED ENG, V46, P1222, DOI 10.1109/10.790499; Libensek S, 2014, THESIS; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Lucovnik M, 2011, ACTA OBSTET GYN SCAN, V90, P150, DOI 10.1111/j.1600-0412.2010.01031.x; Maner WL, 2007, ANN BIOMED ENG, V35, P465, DOI 10.1007/s10439-006-9248-8; Maner WL, 2003, OBSTET GYNECOL, V101, P1254, DOI 10.1016/S0029-7844(03)00341-7; MARQUE C, 1986, IEEE T BIO-MED ENG, V33, P1182, DOI 10.1109/TBME.1986.325698; Marque Catherine K, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS5, DOI 10.1186/1471-2393-7-S1-S5; Moslem B, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-167; Moslem B, 2010, J MED BIOL ENG, V30, P361, DOI 10.5405/jmbe.768; Newman J., 2008, PHYS LIFE SCI, DOI DOI 10.1007/978-0-387-77259-2; OLAH KS, 1994, EUR J OBSTET GYN R B, V57, P157, DOI 10.1016/0028-2243(94)90292-5; Rabotti C, 2015, ACTA PHYSIOL, V213, P406, DOI 10.1111/apha.12424; Ren P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132116; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sikora J., 2011, ARCH PERINAT MED, V17, P97; Smrdel A, 2015, PHYSIOL MEAS, V36, P341, DOI 10.1088/0967-3334/36/2/341; Terrien J, 2010, COMPUT BIOL MED, V40, P223, DOI 10.1016/j.compbiomed.2009.11.019; Verdenik I, 2001, EUR J OBSTET GYN R B, V95, P149, DOI 10.1016/S0301-2115(00)00418-8; WHITNEY AW, 1971, IEEE T COMPUT, VC 20, P1100, DOI 10.1109/T-C.1971.223410; Zhou P, 2014, PHYSIOL MEAS, V35, P45, DOI 10.1088/0967-3334/35/1/45	62	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202125	10.1371/journal.pone.0202125	http://dx.doi.org/10.1371/journal.pone.0202125			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153264	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700006
J	Chen, WL; Wang, CC; Chiang, ST; Wang, YC; Sun, YS; Wu, WT; Liou, SH				Chen, Wei-Liang; Wang, Chung-Ching; Chiang, Sheng-Ta; Wang, Ying-Chuan; Sun, Yu-Shan; Wu, Wei-Te; Liou, Saou-Hsing			The impact of occupational psychological hazards and metabolic syndrome on the 8-year risk of cardiovascular diseases-A longitudinal study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LONG WORKING HOURS; JOB STRAIN; PHYSICAL-ACTIVITY; METAANALYSIS; OBESITY; HEALTH; RECOGNITION; ASSOCIATION; OVERWEIGHT	There was little information concerning the combined effect of occupational psychosocial hazards such as long working hours, high job stress, and high fatigue on the risk of cardiovascular and cerebrovascular diseases (CVD). The aim of this study was to investigate the interaction among occupational psychosocial hazards and the impact of metabolic syndrome (MetS) on the risk of CVD among bus drivers. The Taiwan Bus Driver Cohort Study involving 1014 professional drivers was established in 2005 and comprehensively studied. The interactions among occupational psychosocial hazards and the impact of MetS on the risk of CVD were measured. A working pattern questionnaire, job stress questionnaires, the Swedish occupational fatigue inventory, the stress satisfaction offset score, biochemical measurements, and physical examinations were used to assess psychosocial hazards and the presence of metabolic syndrome. There were 707 eligible bus drivers with a mean age of 43.5years old. During the 8-years of follow-up, 77 drivers were diagnosed with CVD. Long working hours, high job stress, and high fatigue were associated with an increased risk of cardiovascular disease incidence in the multivariate analysis. There were synergistic effects among long working hours, high job stress, and high fatigue only in drivers with MetS. A combination of long working hours, high job stress, and high fatigue increased the risk of developing CVD in bus drivers with MetS.	[Chen, Wei-Liang; Wang, Chung-Ching; Chiang, Sheng-Ta; Wang, Ying-Chuan; Sun, Yu-Shan; Liou, Saou-Hsing] Triserv Gen Hosp, Natl Def Med Ctr, Dept Family & Community Med, Div Fanily Med,Div Occupat Med, Taipei, Taiwan; [Wu, Wei-Te; Liou, Saou-Hsing] Natl Inst Environm Hlth Sci, Natl Hlth Res Inst, Miaoli, Taiwan; [Liou, Saou-Hsing] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; National Defense Medical Center	Liou, SH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Family & Community Med, Div Fanily Med,Div Occupat Med, Taipei, Taiwan.; Wu, WT; Liou, SH (corresponding author), Natl Inst Environm Hlth Sci, Natl Hlth Res Inst, Miaoli, Taiwan.; Liou, SH (corresponding author), Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan.	ader.una@gmail.com; shliou@nhri.org.tw	Wu, Wei-Te/S-8189-2019	Liou, Saou-Hsing/0000-0002-6602-4414	National Health Research Institutes of Taiwan [98-EO-PP01, 99-EO-PP01, 00-EO-PP01, EO-101-PP-01, EO-102-PP-01, EO-103-PP-01]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	Funded by National Health Research Institutes of Taiwan (98-EO-PP01, 99-EO-PP01, 00-EO-PP01, EO-101-PP-01, EO-102-PP-01 and EO-103-PP-01) to Dr. Saou-Hsing Liou National Institute of Occupational Safety and Health, Japan (IOSH96-M102 and IOSH97-M102) to Dr. Saou-Hsing Liou.	Ahsberg E, 1997, INT J IND ERGONOM, V20, P121, DOI 10.1016/S0169-8141(96)00044-3; [Anonymous], 1999, OHS CANADA, V15, P10; [Anonymous], 2017, DEF MET SYNDR AD HLT; APPELS A, 1987, INT J CARDIOL, V17, P15, DOI 10.1016/0167-5273(87)90029-5; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Basu N, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0662-y; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chien TW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-478; Cohen R, 2017, AM J CARDIOL, V119, P1211, DOI 10.1016/j.amjcard.2017.01.009; Collins S, 2010, INT J OCCUP MED ENV, V23, P267, DOI 10.2478/v10001-010-0023-6; HAYANO J, 1990, CIRCULATION, V81, P1217, DOI 10.1161/01.CIR.81.4.1217; Hellerstedt WL, 1997, INT J EPIDEMIOL, V26, P575, DOI 10.1093/ije/26.3.575; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Hidaka T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153368; Jarczok MN, 2013, NEUROSCI BIOBEHAV R, V37, P1810, DOI 10.1016/j.neubiorev.2013.07.004; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2015, INT J OBESITY, V39, P1597, DOI 10.1038/ijo.2015.103; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Kouvonen A, 2005, PREV MED, V41, P532, DOI 10.1016/j.ypmed.2005.01.004; Liaw FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22750; Lin RT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00198-5; Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Moe B, 2013, OCCUP ENVIRON MED, V70, P86, DOI 10.1136/oemed-2012-100734; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Park J, 2012, IND HEALTH, V50, P17, DOI 10.2486/indhealth.MS1317; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Wu WJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010006	34	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202977	10.1371/journal.pone.0202977	http://dx.doi.org/10.1371/journal.pone.0202977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148874	Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200041
J	Zhao, ZL; Zhang, YL; Liu, LS; Hu, ZZ				Zhao, Zhilong; Zhang, Yili; Liu, Linshan; Hu, Zengzeng			The impact of drought on vegetation conditions within the Damqu River Basin, Yangtze River Source Region, China	PLOS ONE			English	Article							REMOTE-SENSING DATA; CLIMATE-CHANGE; TIBETAN PLATEAU; SOIL-MOISTURE; TREND; DESERTIFICATION; VARIABILITY; INDEX	Drought and vegetation conditions within the Damqu River Basin, part of the Yangtze River Source Region (YRSR), are assessed here using the standardized precipitation index (SPI), the standardized precipitation evapotranspiration index (SPEI), the normalized difference vegetation index (NDVI), and the leaf area index (LAI). We utilized Sen's method, least squares regression method, linear regression and Pearson's correlation analysis to study variations in drought and vegetation indices and the drought effect on vegetation between 1988 and 2015. Results reveal that droughts occurred at a 25% frequency over this period; SPI and SPEI analyses show that 1994, 1999, 2005, and 2010 were change points and that the basin was characterized by varying drought and humidity trends. Subsequent to 2010, both SPI and SPEI decreased within the basin, while 1995, 2000, 2004, and 2010 were change points for NDVI and LAI while the watershed exhibited variable trends in vegetation reduction and increase. The NDVI-annual values of 63.36% regions and the LAI-summer values of 68.39% areas within the basin were decreased during 1988 +/- 2015 and 2000 +/- 2015, respectively. Subsequent to 2010, both NDVI and LAI decreased within the basin and significant positive correlations at inter-annual and inter-summer time scales were seen in both drought and vegetation indices; drought has exerted a lag effect on vegetation as shown by significant positive correlations between annual SPI/SPEI values and following year NDVI/LAI values.	[Zhao, Zhilong; Zhang, Yili; Liu, Linshan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China; [Zhao, Zhilong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yili] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Hu, Zengzeng] Capital Univ Econ & Business, Coll Urban Econ & Publ Adm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital University of Economics & Business	Liu, LS (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China.	liuls@igsnrr.ac.cn		Liu, Linshan/0000-0002-0194-2214; zhang, yili/0000-0002-9474-1664	Key Foundation Project of Basic Work of the Ministry of Science and Technology of China [2012FY111400]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20040200]; National Natural Science Foundation of China [41671104]	Key Foundation Project of Basic Work of the Ministry of Science and Technology of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by: 1) the Key Foundation Project of Basic Work of the Ministry of Science and Technology of China (2012FY111400), to LSL [http://program.most.gov.cn/]; 2) the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA20040200), to YLZ [http://www.bmrdp.cas.cn/alzx/]; 3) National Natural Science Foundation of China (No. 41671104), to LSL [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai HY, 2015, ECOL ENG, V83, P112, DOI 10.1016/j.ecoleng.2015.06.031; Chen T, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8101069; [陈燕丽 CHEN Yanli], 2011, [遥感学报, Journal of Remote Sensing], V15, P831; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Deng LC, 2015, CHINA SCI PAPER, V10, P1822; Hao C, 2015, INT J APPL EARTH OBS, V35, P270, DOI 10.1016/j.jag.2014.09.011; [何娇楠 He Jiaonan], 2016, [山地学报, Mountain Research], V34, P19; Hua YY, 2016, ECOL INDIC, V71, P438, DOI 10.1016/j.ecolind.2016.07.036; Huang WanHua, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P50; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; IPCCWGII, 2014, CONTR IPCCS 5 ASS RE; Ivits E, 2014, REMOTE SENS-BASEL, V6, P4266, DOI 10.3390/rs6054266; Ivits E, 2014, GLOBAL CHANGE BIOL, V20, P581, DOI 10.1111/gcb.12393; Kahya E, 2004, J HYDROL, V289, P128, DOI 10.1016/j.jhydrol.2003.11.006; Li BQ, 2015, WATER-SUI, V7, P5474, DOI 10.3390/w7105474; Li XL, 2018, APPL GEOGR, V97, P176, DOI 10.1016/j.apgeog.2018.06.011; Li Y, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4182; Li Z, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4781-0; Li Z, 2015, INT J ENV RES PUB HE, V12, P7615, DOI 10.3390/ijerph120707615; Liu PL, 2017, SCI TOTAL ENVIRON, V589, P73, DOI 10.1016/j.scitotenv.2017.02.210; Liu XF, 2014, J GEOGR SCI, V24, P288, DOI 10.1007/s11442-014-1088-0; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Lu X., 1996, CHINESE GEOGR SCI, V6, P15; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Meng LK, 2016, NAT HAZARDS, V80, P1135, DOI 10.1007/s11069-015-2014-1; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Mondol MAH, 2017, ADV METEOROL, V2017, DOI 10.1155/2017/4642060; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nicholson SE, 1998, B AM METEOROL SOC, V79, P815, DOI 10.1175/1520-0477(1998)079<0815:DDASVA>2.0.CO;2; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Pan BT., 1996, J LANZHOU UNIV NAT S, V32, P108, DOI [10.13885/j.issn.0455-2059.1996.01.024, DOI 10.13885/J.ISSN.0455-2059.1996.01.024]; Pang GJ, 2017, QUATERN INT, V444, P87, DOI 10.1016/j.quaint.2016.08.038; Piao SL, 2015, GLOBAL CHANGE BIOL, V21, P1601, DOI 10.1111/gcb.12795; Pickup G, 1998, CLIMATE RES, V11, P51, DOI 10.3354/cr011051; Preethi B, 2017, CLIM DYNAM, V48, P2489, DOI 10.1007/s00382-016-3218-0; Ren XB, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080626; Shah SU, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.036005; Sheffield J, 2008, J CLIMATE, V21, P432, DOI 10.1175/2007JCLI1822.1; Smol JP, 2014, LAKES CLIMATE CHANGE; [孙鸿烈 Sun Honglie], 2012, [地理学报, Acta Geographica Sinica], V67, P3; Sun JN, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5440-9; Tabari H, 2011, J HYDROL, V396, P313, DOI 10.1016/j.jhydrol.2010.11.034; Tornros T, 2014, HYDROL EARTH SYST SC, V18, P305, DOI 10.5194/hess-18-305-2014; Tome AR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019100; Tong SQ, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/5209173; Vicente-Serrano SM, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000434.1; Vicente-Serrano SM, 2015, REMOTE SENS-BASEL, V7, P4391, DOI 10.3390/rs70404391; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; [王敏 Wang Min], 2013, [干旱区地理, Arid Land Geography], V36, P49; Wang W, 2016, INT GEOSCI REMOTE SE, P1374, DOI 10.1109/IGARSS.2016.7729351; Wu Zhifeng, 2014, Journal of Natural Disasters, V23, P94, DOI 10.13577/j.jnd.2014.0213; [徐维新 Xu Weixin], 2012, [干旱区地理, Arid Land Geography], V35, P46; YANAI MH, 1992, J METEOROL SOC JPN, V70, P319, DOI 10.2151/jmsj1965.70.1B_319; [姚檀栋 Yao Tandong], 2014, [地理科学进展, Progress in Geography], V33, P884; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; [于秀娟 Yu Xiujuan], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P66; Zeng XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141648; Zhang YJ, 2012, IEEE INFOCOM SER, P10, DOI 10.1109/INFCOM.2012.6195468; [赵静 ZHAO Jing], 2008, [世界地质, World Geology], V27, P427; Zhao ZhiLong, 2017, Journal of Resources and Ecology, V8, P67, DOI 10.5814/j.issn.1674-764x.2017.01.009; Zhao ZL, 2017, DYNAMIC WETLAND DAMQ; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/nclimate3004, 10.1038/NCLIMATE3004]	64	16	16	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202966	10.1371/journal.pone.0202966	http://dx.doi.org/10.1371/journal.pone.0202966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142183	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500055
J	Amin, MR; Yurovsky, A; Chen, YP; Skiena, S; Futcher, B				Amin, Mohammad Ruhul; Yurovsky, Alisa; Chen, Yuping; Skiena, Steve; Futcher, Bruce			Re-annotation of 12,495 prokaryotic 16S rRNA 3 ' ends and analysis of Shine-Dalgarno and anti-Shine-Dalgarno sequences	PLOS ONE			English	Article							MESSENGER-RNA; TRANSLATION INITIATION; SECONDARY STRUCTURE; SD SEQUENCES; SPECIFICITY; LEADERLESS; EXPRESSION; BACTERIA; FEATURES; OPERON	We examined 20,648 prokaryotic unique taxids with respect to the annotation of the 3' end of the 16S rRNA, which contains the anti-Shine-Dalgarno sequence. We used the sequence of highly conserved helix 45 of the 16S rRNA as a guide. By this criterion, 8,153 annotated 3' ends correctly included the anti-Shine-Dalgarno sequence, but 12,495 were foreshortened or otherwise mis-annotated, missing part or all of the anti-Shine-Dalgarno sequence, which immediately follows helix 45. We re-annotated, giving a total of 20,648 16S rRNA 3' ends. The vast majority indeed contained a consensus anti-Shine-Dalgarno sequence, embedded in a highly conserved 13 base "tail". However, 128 exceptional organisms had either a variant anti-Shine-Dalgarno, or no recognizable anti-Shine-Dalgarno, in their 16S rRNA(s). For organisms both with and without an anti-Shine-Dalgarno, we identified the Shine-Dalgarno motifs actually enriched in front of each organism's open reading frames. This showed to what extent the Shine-Dalgarno motifs correlated with anti-Shine Dalgarno motifs. In general, organisms whose rRNAs lacked a perfect anti-Shine-Dalgarno motif also lacked a recognizable Shine-Dalgarno. For organisms whose 16S rRNAs contained a perfect anti-Shine-Dalgarno motif, a variety of results were obtained. We found one genus, Alteromonas, where several taxids apparently maintain two different types of 16S rRNA genes, with different, but conserved, antiSDs. The fact that some organisms do not seem to have or use Shine-Dalgarno motifs supports the idea that prokaryotes have other robust mechanisms for recognizing start codons for translation.	[Amin, Mohammad Ruhul; Yurovsky, Alisa; Skiena, Steve] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Chen, Yuping; Futcher, Bruce] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Futcher, B (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	bfutcher@gmail.com		Futcher, Bruce/0000-0002-1012-9022; Chen, Yuping/0000-0002-9819-0230; Amin, Mohammad Ruhul/0000-0001-6540-3415	NIH [R01 GM119175-01]; NSF [DBI-1060572, DBI-1355990]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported by NIH grant R01 GM119175-01 (to BF) and NSF grants DBI-1060572 and DBI-1355990 (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolbaghaei A, 2017, G3-GENES GENOM GENET, V7, P1607, DOI 10.1534/g3.117.039305; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Burkhardt DH, 2017, ELIFE, V6, DOI [10.7554/elife.22037, 10.7554/eLife.22037]; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DESMIT MH, 1994, J MOL BIOL, V235, P173, DOI 10.1016/S0022-2836(05)80024-5; Grill S, 2002, FEMS MICROBIOL LETT, V211, P161, DOI 10.1016/S0378-1097(02)00646-8; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; Hockenberry AJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160239; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li GW, 2015, CURR OPIN MICROBIOL, V24, P66, DOI 10.1016/j.mib.2015.01.001; Lim K, 2012, MOL BIOL EVOL, V29, P2937, DOI 10.1093/molbev/mss101; Lin YH, 2008, GENE, V416, P44, DOI 10.1016/j.gene.2008.02.023; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Osada Y, 1999, BIOINFORMATICS, V15, P578, DOI 10.1093/bioinformatics/15.7.578; Osterman IA, 2013, NUCLEIC ACIDS RES, V41, P474, DOI 10.1093/nar/gks989; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Scharff LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002155; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SHINE J, 1975, EUR J BIOCHEM, V57, P221, DOI 10.1111/j.1432-1033.1975.tb02294.x; Tompa M, 1999, Proc Int Conf Intell Syst Mol Biol, P262; Tu C, 2011, P NATL ACAD SCI USA, V108, P10156, DOI 10.1073/pnas.1017679108; VANKNIPPENBERG PH, 1984, NUCLEIC ACIDS RES, V12, P2595, DOI 10.1093/nar/12.6.2595; Wei YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17918-6; WIKSTROM PM, 1992, J MOL BIOL, V224, P949, DOI 10.1016/0022-2836(92)90462-S	31	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202767	10.1371/journal.pone.0202767	http://dx.doi.org/10.1371/journal.pone.0202767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138483	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100122
J	Choudhury, GR; Daadi, MM				Choudhury, Gourav R.; Daadi, Marcel M.			Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease	PLOS ONE			English	Article							MPTP-TREATED MONKEYS; SLEEP BEHAVIOR DISORDER; ALPHA-SYNUCLEIN; CAENORHABDITIS-ELEGANS; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; SUBTHALAMIC NUCLEUS; BRAIN PATHOLOGY; ANIMAL-MODELS; CELL LOSS	Parkinson's disease is a progressive neurodegenerative disease increasingly affecting our aging population. Remarkable advances have been made in developing novel therapies to control symptoms, halt or cure the disease, ranging from physiotherapy and small molecules to cell and gene therapy. This progress was enabled by the existence of reliable animal models. The nonhuman primate model of Parkinson's disease emulates the cardinal symptoms of the disease, including tremor, rigidity, bradykinesia, postural instability, freezing and cognitive impairment. However, this model is established through the specific loss of mid-brain dopaminergic neurons, while our current knowledge reflects the reality of Parkinson's disease as a multisystem disease. Parkinson's disease involves both motor and non-motor symptoms, such as sleep disturbance, olfaction, gastrointestinal dysfunctions, depression and cognitive deficits. Some of the non-motor symptoms emerge earlier at the prodromal phase and worsen with disease progression, yet in basic and translational studies, they are rarely considered as endpoints. In this study, we set to characterize an ensemble of less described motor and non-motor dysfunctions in the marmoset MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model. We provide evidence that this animal model expresses postural head tremor and a progressive worsening of fine motor skills, movement coordination and cognitive abilities over a 6-month period. We report for the first time a non-invasive approach showing detailed analysis of daytime and nighttime sleep and circadian rhythm disturbance remarkably similar to Parkinson's disease patients. This study describes the incidence of tremors, motor and non-motor dysfunctions in a preclinical model and highlights the need for their consideration in translating effective new therapeutic approaches for Parkinson's disease.	[Choudhury, Gourav R.; Daadi, Marcel M.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA; [Daadi, Marcel M.] Univ Texas Hlth San Antonio, Res Imaging Inst, Dept Radiol, San Antonio, TX 78229 USA; [Daadi, Marcel M.] Univ Texas Hlth San Antonio, Res Imaging Inst, Dept Cell Syst, San Antonio, TX 78229 USA; [Daadi, Marcel M.] Univ Texas Hlth San Antonio, Res Imaging Inst, Dept Anat, San Antonio, TX 78229 USA	Texas Biomedical Research Institute; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Daadi, MM (corresponding author), Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA.; Daadi, MM (corresponding author), Univ Texas Hlth San Antonio, Res Imaging Inst, Dept Radiol, San Antonio, TX 78229 USA.; Daadi, MM (corresponding author), Univ Texas Hlth San Antonio, Res Imaging Inst, Dept Cell Syst, San Antonio, TX 78229 USA.; Daadi, MM (corresponding author), Univ Texas Hlth San Antonio, Res Imaging Inst, Dept Anat, San Antonio, TX 78229 USA.	mdaadi@txbiomed.org	Choudhury, Gourav Roy/L-7707-2016	Choudhury, Gourav Roy/0000-0001-8664-7638	Worth Family Fund; Perry & Ruby Stevens Charitable Foundation; Robert J., Jr., and Helen C. Kleberg Foundation; NIH primate center base grant (Office of Research Infrastructure Programs) [OD P51 OD011133]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001120]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	Worth Family Fund; Perry & Ruby Stevens Charitable Foundation; Robert J., Jr., and Helen C. Kleberg Foundation; NIH primate center base grant (Office of Research Infrastructure Programs); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Worth Family Fund, The Perry & Ruby Stevens Charitable Foundation and The Robert J., Jr., and Helen C. Kleberg Foundation, the NIH primate center base grant (Office of Research Infrastructure Programs/OD P51 OD011133), the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001120 (M.M.D.). M.M.D. is a founder of the biotech company NeoNeuron. The roles of these authors can be found in the author contributions section.	Almirall H, 1999, J NEURAL TRANSM, V106, P1125, DOI 10.1007/s007020050228; Bankiewicz KS, 2006, EXP NEUROL, V197, P363, DOI 10.1016/j.expneurol.2005.10.022; Barraud Q, 2009, EXP NEUROL, V219, P574, DOI 10.1016/j.expneurol.2009.07.019; Belaid H, 2014, J NEUROSCI, V34, P9124, DOI 10.1523/JNEUROSCI.0181-14.2014; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bergman H, 1998, MOVEMENT DISORD, V13, P29; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bjorklund A, 2010, PROG BRAIN RES, V184, P133, DOI 10.1016/S0079-6123(10)84007-5; Braak H, 1995, J NEURAL TRANSM-SUPP, P15; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chesselet Marie-Francoise, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS84, DOI 10.1016/j.parkreldis.2008.04.004; Collier TJ, 2003, EXP NEUROL, V183, P258, DOI 10.1016/S0014-4886(03)00246-2; CROSSMAN AR, 1985, NEUROPHARMACOLOGY, V24, P587, DOI 10.1016/0028-3908(85)90070-X; CROSSMAN AR, 1987, CAN J NEUROL SCI, V14, P428, DOI 10.1017/S0317167100037859; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Decamp E, 2004, EUR J NEUROSCI, V20, P1371, DOI 10.1111/j.1460-9568.2004.03586.x; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Devergnas A, 2014, NEUROBIOL DIS, V68, P156, DOI 10.1016/j.nbd.2014.04.004; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Espay AJ, 2017, NAT REV NEUROL, V13, P119, DOI 10.1038/nrneurol.2016.196; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; FORNO LS, 1986, ANN NEUROL, V20, P449, DOI 10.1002/ana.410200403; Forno Lysia S., 1993, V60, P600; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; GOMEZMANCILLA B, 1991, CLIN NEUROPHARMACOL, V14, P359, DOI 10.1097/00002826-199108000-00008; HALLIDAY GM, 1990, BRAIN RES, V510, P104, DOI 10.1016/0006-8993(90)90733-R; Hansard MJ, 2002, J PHARMACOL EXP THER, V303, P952, DOI 10.1124/jpet.102.039743; HIRSCH EC, 1987, P NATL ACAD SCI USA, V84, P5976, DOI 10.1073/pnas.84.16.5976; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Jellinger KA, 2017, INT REV NEUROBIOL, V133, P13, DOI [10.1016/bs.im.2017.05.005, 10.1016/bs.irn.2017.05.005]; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Jenner P, 2003, PARKINSONISM RELAT D, V9, P131, DOI 10.1016/S1353-8020(02)00115-3; Jenner P, 1986, ADV NEUROL, V45, P183; Kempster PA, 2007, BRAIN, V130, P2123, DOI 10.1093/brain/awm142; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; Lang AE, 2004, LANCET NEUROL, V3, P309, DOI 10.1016/S1474-4422(04)00740-9; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lang AE, 2018, MOVEMENT DISORD, V33, P660, DOI 10.1002/mds.27360; LANGSTON JW, 1984, BRAIN RES, V292, P390; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; LEES AJ, 1988, CLIN NEUROPHARMACOL, V11, P512, DOI 10.1097/00002826-198812000-00004; Marinus J, 2003, NEUROLOGY, V61, P1222, DOI 10.1212/01.WNL.0000091864.39702.1C; Masilamoni GJ, 2018, J NEURAL TRANSM, V125, P337, DOI 10.1007/s00702-017-1774-z; Masilamoni GJ, 2017, NEUROBIOL DIS, V100, P9, DOI 10.1016/j.nbd.2016.12.025; McEntire CRS, 2016, STROKE, V47, P1109, DOI 10.1161/STROKEAHA.115.012506; NAKANO I, 1984, ANN NEUROL, V15, P415, DOI 10.1002/ana.410150503; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; OHAMA E, 1976, ACTA NEUROPATHOL, V34, P311, DOI 10.1007/BF00696560; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Pavese N, 2010, EXP NEUROL, V222, P120, DOI 10.1016/j.expneurol.2009.12.021; PIFL C, 1991, NEUROSCIENCE, V44, P591, DOI 10.1016/0306-4522(91)90080-8; Politis M, 2008, EXP NEUROL, V214, P112, DOI 10.1016/j.expneurol.2008.07.021; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; RAJPUT AH, 1991, NEUROLOGY, V41, P1298, DOI 10.1212/WNL.41.8.1298; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; SCHNEIDER JS, 1990, BRAIN RES, V519, P122, DOI 10.1016/0006-8993(90)90069-N; Stocchi F, 1998, J NEUROL, V245, pS15, DOI 10.1007/PL00007731; TAYLOR JR, 1990, BRAIN, V113, P617, DOI 10.1093/brain/113.3.617; TETRUD JW, 1992, NEUROLOGY, V42, P407, DOI 10.1212/WNL.42.2.407; Titova N, 2017, INT REV NEUROBIOL, V133, P63, DOI [10.1016/bs.irn.2017.05.018, 10.1016/bs.im.2017.05.018]; Tracik F, 2001, MOVEMENT DISORD, V16, P500, DOI 10.1002/mds.1083; Verhave PS, 2011, SLEEP, V34, P1119, DOI 10.5665/SLEEP.1174; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wienecke M, 2012, J SLEEP RES, V21, P710, DOI 10.1111/j.1365-2869.2012.01027.x; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x	81	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202770	10.1371/journal.pone.0202770	http://dx.doi.org/10.1371/journal.pone.0202770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138454	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100124
J	Geyer, S; Eberhard, S; Schmidt, BMW; Epping, J; Tetzlaff, J				Geyer, Siegfried; Eberhard, Sveja; Schmidt, Bernhard Magnus W.; Epping, Jelena; Tetzlaff, Juliane			Morbidity compression in myocardial infarction 2006 to 2015 in terms of changing rates and age at occurrence: A longitudinal study using claims data from Germany	PLOS ONE			English	Article							DYNAMIC EQUILIBRIUM; LIFE EXPECTANCY; HEART-DISEASE; RISK-FACTORS; LOWER SAXONY; MORTALITY; HEALTH; TRENDS; DISABILITY; EXPANSION	Background According to James Fries morbidity compression is present if morbidity rates are decreasing to a larger extent than mortality rates. Compression also occurs if age at onset is increasing at a faster pace than age at death. These two variants of the compression hypothesis were formulated as a population concept. Compression has seldom been studied with a specific disease as application. Methods Morbidity compression was examined in terms of myocardial infarction (MI) by using German claims data covering the years 2006 to 2015. The findings are based on an annual case number of about 2 m women and men aged 18 years and older. Analyses were performed by means of proportional hazards regression and by using linear regression. Results Decreases of morbidity rates were more pronounced than those of mortality. For men, the hazard ratio for contracting MI in 2015 as compared to 2006 was hr = 0.66 and hr = 0.71 for the female population. The respective results for mortality were hr = 0.75 in men and hr = 1.0 in women. They can be interpreted in favor of morbidity compression. For the subgroup of women and men with MI, changes of onset age revealed marked gender differences. For 2015 as compared with 2006, age at MI-occurrence in men increased by 10.5 months as compared to an increase of 10.4 months for age at death. In women changes were smaller and statistically not significant. The findings referring to women have to be interpreted against the backdrop of higher onset age and higher age at death than in men. Conclusions Taken together, morbidity compression has occurred in terms of decreasing MI-rates as well as in terms of increased onset age in men. It can be concluded that both processes have led to an improvement of healthy lifetime. Decreasing morbidity rates in women are also pointing towards morbidity compression, a finding that is not complemented by changes of onset age. Our data are demonstrating that morbidity rates and age at onset may vary independently. From this perspective morbidity compression is a multi-faceted phenomenon.	[Geyer, Siegfried; Epping, Jelena; Tetzlaff, Juliane] Hannover Med Sch, Med Sociol Unit, Hannover, Germany; [Eberhard, Sveja] Local Statutory Hlth Insurance Lower Saxony AOK N, Hannover, Germany; [Schmidt, Bernhard Magnus W.] Hannover Med Sch, Clin Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Geyer, S (corresponding author), Hannover Med Sch, Med Sociol Unit, Hannover, Germany.	geyer.siegfried@mh-hannover.de	Epping, Jelena/AAE-7790-2020; Tetzlaff, Juliane/AAF-8390-2020	Tetzlaff, Juliane/0000-0001-5393-5991	Local Statutory Health Insurance of Lower Saxony (AOK Niedersachsen), Hannover	Local Statutory Health Insurance of Lower Saxony (AOK Niedersachsen), Hannover	The study was funded by a grant by the Local Statutory Health Insurance of Lower Saxony (AOK Niedersachsen), Hannover; no grant number was assigned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NB, 2017, CIRCULATION, V135, P1693, DOI 10.1161/CIRCULATIONAHA.116.026252; Bachus L, 2019, GESUNDHEITSWESEN, V81, P351, DOI 10.1055/s-0043-109860; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Beltran-Sanchez H, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24766; Beltran-Sanchez H, 2016, J EPIDEMIOL COMMUN H, V70, P1011, DOI 10.1136/jech-2015-206722; Bundesamt S, 2016, NON TRADITIONAL REF, P140; Cai LM, 2007, DEMOGRAPHY, V44, P479, DOI 10.1353/dem.2007.0022; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chaudhry SI, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001197; Chernick MR., 1999, BOOTSTRAP METHODS; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Coady SA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-705; COOK RD, 1983, BIOMETRIKA, V70, P1, DOI 10.1093/biomet/70.1.1; Crapo, 1981, VITALITY AGING IMPLI; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Dallinger G, 2013, DATENREPORT 2013 SOZ; Doblhammer G, 2012, BUNDESGESUNDHEITSBLA, V55, P448, DOI 10.1007/s00103-012-1455-x; Doblhammer G, 2001, SOC SCI MED, V52, P385, DOI 10.1016/S0277-9536(00)00141-6; Doblhammer G, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0146-x; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Finkenstadt V, 2012, NON TRADITIONAL REF; Fogel RW, 2003, AGING HLTH PUBLIC PO, P19; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; Fries James F, 2012, Curr Gerontol Geriatr Res, V2012, P420637, DOI 10.1155/2012/420637; Fries JF, 2005, AM J PREV MED, V29, P164, DOI 10.1016/j.amepre.2005.07.004; Fries JF, 2005, MILBANK Q, V83, P801, DOI 10.1111/j.1468-0009.2005.00401.x; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; FRIES JF, 1989, MILBANK Q, V67, P208, DOI 10.2307/3350138; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gerber Y, 2015, AM J MED, V128, P144, DOI 10.1016/j.amjmed.2014.09.012; Geyer S., 2015, INT ENCY SOCIAL BEHA, V4, P463; Gordo LR, 2011, APPL ECON, V43, P503, DOI 10.1080/00036840802599941; Graham P, 2004, J EPIDEMIOL COMMUN H, V58, P659, DOI 10.1136/jech.2003.014910; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Heuer T, 2015, BRIT J NUTR, V113, P1603, DOI 10.1017/S0007114515000744; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Jaunzeme J, 2013, BUNDESGESUNDHEITSBLA, V56, P447, DOI 10.1007/s00103-012-1626-9; Jonge Jd, 1999, SOC SCI MED, V50, P1317; Kreft D, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0093-1; Kuntz B, 2015, NON TRADITIONAL REF, P72; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Leggett A, 2019, J GERONTOL B-PSYCHOL, V74, P536, DOI 10.1093/geronb/gbw210; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Malki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105279; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Mardorf S, 2009, GESUNDHEIT KRANKHEIT; Marioni RE, 2014, EUR J EPIDEMIOL, V29, P211, DOI 10.1007/s10654-014-9881-8; Marioni RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050940; MARTIN CA, 1989, AM J EPIDEMIOL, V129, P655, DOI 10.1093/oxfordjournals.aje.a115182; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Molloy GJ, 2009, SOC SCI MED, V69, P223, DOI 10.1016/j.socscimed.2009.05.010; Muschik D, 2017, J PUBLIC HEALTH-HEID, V25, P19, DOI 10.1007/s10389-016-0756-1; Muschik D, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0124-6; Muschik D, 2015, INT J PUBLIC HEALTH, V60, P953, DOI 10.1007/s00038-015-0744-1; Nedkoff L, 2015, HEART LUNG CIRC, V24, P442, DOI 10.1016/j.hlc.2014.11.022; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Siegrist J, 2015, ARBEITSWELT STRESSBE; Silberman J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123910; Smolina K, 2012, CIRC-CARDIOVASC QUAL, V5, P532, DOI 10.1161/CIRCOUTCOMES.111.964700; Strazdins L, 2011, J EPIDEMIOL COMMUN H, V65, P529, DOI 10.1136/jech.2009.093732; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Tetzlaff J, 2017, INT J PUBLIC HEALTH, V62, P679, DOI 10.1007/s00038-017-0962-9; Tetzlaff J, 2017, J PUBLIC HEALTH-HEID, V25, P215, DOI 10.1007/s10389-016-0771-2; Unger R, 2011, GESUNDHEITSWESEN, V73, P292, DOI 10.1055/s-0031-1271715; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984	71	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202631	10.1371/journal.pone.0202631	http://dx.doi.org/10.1371/journal.pone.0202631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138437	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100098
J	Klyz, A; Piekarowicz, A				Klyz, Aneta; Piekarowicz, Andrzej			Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates	PLOS ONE			English	Article							FILAMENTOUS BACTERIOPHAGES; DNA VACCINES; CLASS-II; IMMUNIZATION; ANTIBODIES; BINDING; PARTICLES; RESPONSES; PEPTIDES; DISEASE	All Neisseria gonorrhoeae strains whose DNA sequences have been determined possess filamentous phage sequences representing their full genomes. The presence of filamentous phage DNA sequences in all sequenced N. gonorrhoeae strains suggest that purified phage particles might be used as a gonococcal vaccine. To test this hypothesis, we purified filamentous Ngo Phi fil phages and immunized rabbits subcutaneously. The elicited sera contained large quantities of anti-phage IgG and IgA antibodies that bound to the surface of N. gonorrhoeae cells, as shown by ELISA and flow cytometry. The elicited sera bound to the structural Ngo Phi 6fil proteins present in phage particles and to N. gonorrhoeae cells. The sera did not react with gonococcal outer membrane proteins. The sera also had bactericidal activity and blocked adhesion of gonococci to tissue culture cells. These data demonstrate that Ngo Phi fil phage particles can induce antibodies with anti-gonococcal activity and may be a candidate for vaccine development.	[Klyz, Aneta; Piekarowicz, Andrzej] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Virol, Warsaw, Poland	University of Warsaw	Klyz, A; Piekarowicz, A (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Virol, Warsaw, Poland.	aklyz@biol.uw.edu; anpiek@biol.uw.edu.pl		Klyz, Aneta/0000-0003-1172-7072	Narodowe Centrum Nauki (NCN) Poland [UMO-2014/13/B/NZ6/00245]	Narodowe Centrum Nauki (NCN) Poland	The research was funded by Narodowe Centrum Nauki (NCN) Poland (https://www.ncn.gov.pl/) Grant UMO-2014/13/B/NZ6/00245 to AP.	Afonina G, 2006, INFECT IMMUN, V74, P2224, DOI 10.1128/IAI.74.4.2224-2232.2006; Baclioglu B.K., 2014, ADV BIOSCI BIOTECH, V5, P46, DOI DOI 10.4236/ABB.2014.51008; Barney S, 2013, IMMUNOL REV, V255, DOI [10.1111/imr.12098, DOI 10.1111/IMR.12098]; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Cole JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008108; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; De Berardinis Piergiuseppe, 2004, Expert Rev Vaccines, V3, P673, DOI 10.1586/14760584.3.6.673; Eriksson F, 2007, CANCER IMMUNOL IMMUN, V56, P677, DOI 10.1007/s00262-006-0227-6; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Frenkel D, 2003, VACCINE, V21, P1060, DOI 10.1016/S0264-410X(02)00609-6; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Gaubin M, 2003, DNA CELL BIOL, V22, P11, DOI 10.1089/104454903321112451; Grabowska AM, 2000, VIROLOGY, V269, P47, DOI 10.1006/viro.2000.0185; Hashemi H, 2010, J VIROL METHODS, V163, P440, DOI 10.1016/j.jviromet.2009.11.008; Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI 10.1586/ERV.10.57; Jerse AE, 2014, VACCINE, V32, P1579, DOI 10.1016/j.vaccine.2013.08.067; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kevin AH, 2015, FRONT MICROBIOL, DOI [10.3389/fmicb.00755, DOI 10.3389/FMICB.00755]; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Lin M, 2006, J MED MICROBIOL, V55, P291, DOI 10.1099/jmm.0.46305-0; Lindquist B. H, 2006, BACTERIOPHAGES; Manoutcharian K., 2001, Current Pharmaceutical Biotechnology, V2, P217; Meyer J, 2016, MICROBIOL-SGM, V162, P268, DOI 10.1099/mic.0.000215; Parren PWHI, 1997, CHEM IMMUNOL, V65, P18; Piechucki M, 2014, J VIROL, V88, P1002, DOI [10.1128/JVI.02707-13, DOI 10.1128/JVI.02707-13]; Piekarowicz A, 2006, POL J MICROBIOL, V55, P251; Piekarowicz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22549; Price GA, 2007, VACCINE, V25, P7247, DOI 10.1016/j.vaccine.2007.07.038; Russel M, 2006, FILAMENTOUS PHAGES; Samoylova TI, 2012, J VIROL METHODS, V183, P63, DOI 10.1016/j.jviromet.2012.03.032; Sartorius R, 2011, EUR J IMMUNOL, V41, P2573, DOI 10.1002/eji.201141526; Ulivieri C, 2008, IMMUNOL LETT, V119, P62, DOI 10.1016/j.imlet.2008.04.004; Wan Y, 2005, EUR J IMMUNOL, V35, P2041, DOI 10.1002/eji.200425322; WHITE LA, 1965, APPL MICROBIOL, V13, P171, DOI 10.1128/AEM.13.2.171-174.1965	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e020243	10.1371/journal.pone.0202437	http://dx.doi.org/10.1371/journal.pone.0202437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138416	gold, Green Submitted, Green Published			2022-12-26	WOS:000442800100066
J	Krishna, V; Bachman, KE				Krishna, Vinod; Bachman, Kurtis E.			A mechanism of T cell dependent selection of antigen engaged Germinal Center B cells	PLOS ONE			English	Article							AFFINITY MATURATION; IMMUNOLOGICAL SYNAPSE; DIFFUSION; LYMPHOCYTES; DIVISION; REVEALS; BINDING; RATES	A model of B cell affinity selection is proposed, and an explanation of peripheral tolerance mechanisms through antibody repertoire editing is presented. We show that affinity discrimination between B cells is driven by a competition between obtaining T cell help and removal of B cells from the light zone, either through apoptosis or by a return to the dark zone of germinal centers. We demonstrate that this mechanism also allows for the negative selection of self reactive B cells and maintenance of B cell tolerance during the Germinal Center reaction. Finally, we demonstrate that clonal expansion upon return to the Germinal Center dark zone amplifies differences in the antigen affinity of B cells that survive the light zone.	[Krishna, Vinod; Bachman, Kurtis E.] Janssen Res & Dev LLC, Discovery Sci, Computat Biol, 1400 McKean Rd, Spring House, PA 19477 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Krishna, V (corresponding author), Janssen Res & Dev LLC, Discovery Sci, Computat Biol, 1400 McKean Rd, Spring House, PA 19477 USA.	vkrish10@its.jnj.com			Janssen Research and Development LLC	Janssen Research and Development LLC	The funder provided support in the form of salaries for authors V.K and K.E.B, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The "internal funding" provided for this work was solely in the form of salaries paid to V.K and K.E.B by Janssen Research and Development LLC, and the funders had no role in the choice of problem, study design, data collection, analysis and decision to publish or the preparation and revision of this manuscript.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; COLLINS FC, 1949, J COLL SCI IMP U TOK, V4, P425, DOI 10.1016/0095-8522(49)90023-9; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dustin ML, 2014, MOL CELL, V54, P255, DOI 10.1016/j.molcel.2014.04.001; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Gopich IV, 2013, P NATL ACAD SCI USA, V110, P19784, DOI 10.1073/pnas.1319943110; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Oprea M, 1997, J IMMUNOL, V158, P5155; SCHURR JM, 1970, BIOPHYS J, V10, P700, DOI 10.1016/S0006-3495(70)86330-5; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Smoluchowski M., 1917, Z PHYS CHEM, V92, P129, DOI [10.1515/zpch-1918-9209, DOI 10.1515/ZPCH-1918-9209]; Takahashi Y, 2009, J IMMUNOL, V190, P399; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0200241	10.1371/journal.pone.0200241	http://dx.doi.org/10.1371/journal.pone.0200241			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138347	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100006
J	Oishi, H; Tanaka, K; Watanabe, K				Oishi, Hiroyuki; Tanaka, Kanji; Watanabe, Katsumi			Feedback of action outcome retrospectively influences sense of agency in a continuous action task	PLOS ONE			English	Article							SELF-AGENCY; METACOGNITION; ATTRIBUTION; AWARENESS; GOALS	Here, we investigated whether explicit feedback on the result of the action (success or failure) modified sense of agency (SoA) in a continuous action task. Participants carried a white dot with a delay to a target square while avoiding obstacle squares. The color of the target changed unpredictably between white and blue. A trial was considered as successful or failed if the dot reached the target while it was white or blue. Thus, actions during the task resulted in almost identical experiences of successful and failed trials. After each trial, the participants reported to what extent they felt that they had been in control of the dot. The results showed that SoA was higher with shorter delay (i.e., easier control) and in the successful trials. These findings indicate that the sense of online control and the evaluation of continuous action based on feedback independently influence SoA. Particularly, the evaluation retrospectively modulated SoA.	[Oishi, Hiroyuki; Tanaka, Kanji; Watanabe, Katsumi] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Tanaka, Kanji; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Tanaka, Kanji] Japan Soc Promot Sci, Tokyo, Japan	Waseda University; University of Tokyo; Japan Society for the Promotion of Science	Tanaka, K (corresponding author), Waseda Univ, Fac Sci & Engn, Tokyo, Japan.; Tanaka, K (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan.; Tanaka, K (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	kanji.t9@gmail.com		Watanabe, Katsumi/0000-0003-1282-9994	JSPS [18H03505]; JSPS KAKENHI [JP17H00753]; CREST [JPMJCR14E4]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by JSPS Fellows to KT (18H03505) and JSPS KAKENHI Grant Number JP17H00753 and CREST (JPMJCR14E4) to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: KW is a member of PLOS	Asai T, 2015, CONSCIOUS COGN, V38, P118, DOI 10.1016/j.concog.2015.11.002; Beck B, 2017, COGNITION, V162, P54, DOI 10.1016/j.cognition.2017.02.002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Dewey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110118; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Inoue K, 2017, CONSCIOUS COGN, V48, P246, DOI 10.1016/j.concog.2016.12.003; Kawabe T., 2013, P ROYAL SOC B, V280, P1, DOI DOI 10.1098/RSPB.2013.0991; Kawabe T, 2013, CONSCIOUS COGN, V22, P407, DOI 10.1016/j.concog.2013.01.006; Kuhn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028657; Metcalfe J, 2007, J EXP PSYCHOL GEN, V136, P184, DOI 10.1037/0096-3445.136.2.184; Metcalfe J, 2013, EXP BRAIN RES, V229, P485, DOI 10.1007/s00221-012-3371-6; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Takahata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053421; van der Weiden A, 2013, J EXP PSYCHOL GEN, V142, P954, DOI 10.1037/a0030079; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Wen W, 2017, FRONT HUM NEUROSCI, V11, P1, DOI [10.3389/fnhum.2017.00001, DOI 10.3389/FNHUM.2017.00001]; Wen W, 2015, CONSCIOUS COGN, V37, P83, DOI 10.1016/j.concog.2015.08.012; Wen W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125226; Wittkopf PG, 2017, EXP BRAIN RES, V235, P1933, DOI 10.1007/s00221-017-4930-7; Zopf R, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]	28	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202690	10.1371/journal.pone.0202690	http://dx.doi.org/10.1371/journal.pone.0202690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138367	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100107
J	Dang, AK; Chaplin, NL; Murtazina, DA; Boehm, U; Clay, CM; Amberg, GC				Dang, An K.; Chaplin, Nathan L.; Murtazina, Dilyara A.; Boehm, Ulrich; Clay, Colin M.; Amberg, Gregory C.			Subplasmalemmal hydrogen peroxide triggers calcium influx in gonadotropes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; cell signaling; reactive oxygen species (ROS); NADPH oxidase; mitochondria	ARTERIAL SMOOTH-MUSCLE; PROTEIN-KINASE-C; POLYCYSTIC-OVARY-SYNDROME; NEUROENDOCRINE DYSFUNCTION; SIGNALING PATHWAYS; OXIDATIVE STRESS; HORMONE RECEPTOR; CHANNELS; MITOCHONDRIA; ACTIVATION	Gonadotropin-releasing hormone (GnRH) stimulation of its eponymous receptor on the surface of endocrine anterior pituitary gonadotrope cells (gonadotropes) initiates multiple signaling cascades that culminate in the secretion of luteinizing and follicle-stimulating hormones, which have critical roles in fertility and reproduction. Enhanced luteinizing hormone biosynthesis, a necessary event for ovulation, requires a signaling pathway characterized by calcium influx through L-type calcium channels and subsequent activation of the mitogen-activated protein kinase extracellular signal-regulated kinase (ERK). We previously reported that highly localized subplasmalemmal calcium microdomains produced by L-type calcium channels (calcium sparklets) play an essential part in GnRH-dependent ERK activation. Similar to calcium, reactive oxygen species (ROS) are ubiquitous intracellular signaling molecules whose subcellular localization determines their specificity. To investigate the potential influence of oxidant signaling in gonadotropes, here we examined the impact of ROS generation on L-type calcium channel function. Total internal reflection fluorescence (TIRF) microscopy revealed that GnRH induces spatially restricted sites of ROS generation in gonadotrope-derived alpha T3-1 cells. Furthermore, GnRH-dependent stimulation of L-type calcium channels required intracellular hydrogen peroxide signaling in these cells and in primary mouse gonadotropes. NADPH oxidase and mitochondrial ROS generation were each necessary for GnRH-mediated stimulation of L-type calcium channels. Congruently, GnRH increased oxidation within subplasmalemmal mitochondria, and L-type calcium channel activity correlated strongly with the presence of adjacent mitochondria. Collectively, our results provide compelling evidence that NADPH oxidase activity and mitochondria-derived hydrogen peroxide signaling play a fundamental role in GnRH-dependent stimulation of L-type calcium channels in anterior pituitary gonadotropes.	[Dang, An K.; Chaplin, Nathan L.; Murtazina, Dilyara A.; Clay, Colin M.; Amberg, Gregory C.] Colorado State Univ, Dept Biomed Sci, 1617 Campus Delivery, Ft Collins, CO 80523 USA; [Boehm, Ulrich] Saarland Univ, Dept Pharmacol & Toxicol, Ctr Mol Signaling PZMS, Sch Med, D-66421 Homburg, Germany	Colorado State University; Universitatsklinikum des Saarlandes	Amberg, GC (corresponding author), Colorado State Univ, Dept Biomed Sci, 1617 Campus Delivery, Ft Collins, CO 80523 USA.	Gregory.Amberg@colostate.edu		Amberg, Gregory/0000-0001-6094-1185	National Institute of Health [R01HD087347, R01HL111060, R01HD065943, F31HD078090]; Deutsche Forschungsgemeinschaft Grant [SFB894]; Colorado State University College Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065943, R01HD087347, F31HD078090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111060] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Colorado State University College Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grants R01HD087347 and R01HL111060 (to G.C.A.), R01HD065943 (to C.M.C.), and F31HD078090 (to A.K.D.); Deutsche Forschungsgemeinschaft Grant SFB894 (to U.B.); and the Colorado State University College Research Council (to G.C.A. and C.M.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Amberg GC, 2007, J PHYSIOL-LONDON, V579, P187, DOI 10.1113/jphysiol.2006.124420; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Chaplin NL, 2015, CIRC RES, V117, P1013, DOI 10.1161/CIRCRESAHA.115.306996; Chaplin NL, 2012, AM J PHYSIOL-CELL PH, V302, pC1382, DOI 10.1152/ajpcell.00222.2011; Chatzaki E, 1996, CANCER RES, V56, P2059; Dang AK, 2014, MOL ENDOCRINOL, V28, P2049, DOI 10.1210/me.2014-1208; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Edwards BS, 2016, ENDOCRINOLOGY, V157, P831, DOI 10.1210/en.2015-1575; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Imai A, 1998, J CLIN ENDOCR METAB, V83, P427, DOI 10.1210/jc.83.2.427; Kim T, 2015, ENDOCRINOLOGY, V156, P2185, DOI 10.1210/en.2014-1709; Knapp LT, 2002, J NEUROSCI, V22, P674, DOI 10.1523/JNEUROSCI.22-03-00674.2002; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; MERELLI F, 1992, ENDOCRINOLOGY, V131, P925, DOI 10.1210/en.131.2.925; Mulvaney JM, 1999, J BIOL CHEM, V274, P29796, DOI 10.1074/jbc.274.42.29796; Mulvaney JM, 2000, J BIOL CHEM, V275, P14182, DOI 10.1074/jbc.275.19.14182; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nickel A, 2014, J MOL CELL CARDIOL, V73, P26, DOI 10.1016/j.yjmcc.2014.03.011; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Roelfsema F, 2011, METABOLISM, V60, P1227, DOI 10.1016/j.metabol.2010.12.011; Roland AV, 2014, FRONT NEUROENDOCRIN, V35, P494, DOI 10.1016/j.yfrne.2014.04.002; Santo-Domingo Jaime, 2015, World J Biol Chem, V6, P310, DOI 10.4331/wjbc.v6.i4.310; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Solorzano CMB, 2012, STEROIDS, V77, P332, DOI 10.1016/j.steroids.2011.12.007; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; von Minckwitz G, 1998, BIOMED PHARMACOTHER, V52, P122, DOI 10.1016/S0753-3322(98)80090-5; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	43	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16028	16042		10.1074/jbc.RA118.001830	http://dx.doi.org/10.1074/jbc.RA118.001830			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154243	hybrid, Green Published			2022-12-26	WOS:000447256000023
J	Estrellas, KM; Chung, L; Cheug, LA; Sadtler, K; Majumdar, S; Mula, J; Wolf, MT; Elisseeff, JH; Wagner, KR				Estrellas, Kenneth M.; Chung, Liam; Cheug, Lindsay A.; Sadtler, Kaitlyn; Majumdar, Shoumyo; Mula, Jyothi; Wolf, Matthew T.; Elisseeff, Jennifer H.; Wagner, Kathryn R.			Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle; muscle regeneration; muscular dystrophy; immunology; cytokine; biomaterials; myostatin; mdx; myostatin; extracellular matrix; bioengineering; hydrogel; dystrophin; drug delivery; stem cells	SKELETAL-MUSCLE MASS; HYALURONIC-ACID; CELLS; FIBROSIS; MYOBLASTS; MICE; HYPERTROPHY; ENGRAFTMENT; STRATEGIES; HYDROGELS	Recent studies have reported that the immune system significantly mediates skeletal muscle repair and regeneration. Additionally, biological scaffolds have been shown to play a role in polarizing the immune microenvironment toward pro-myogenic outcomes. Moreover, myostatin inhibitors are known to promote muscle regeneration and ameliorate fibrosis in animal models of Duchenne muscular dystrophy (DMD), a human disease characterized by chronic muscle degeneration. Biological scaffolds and myostatin inhibition can potentially influence immune-mediated regeneration in the dystrophic environment, but have not been evaluated together. Toward this end, here we created an injectable biological scaffold composed of hyaluronic acid and processed skeletal muscle extracellular matrix. This material formed a cytocompatible hydrogel at physiological temperatures in vitro. When injected subfascially above the tibialis anterior muscles of both WT and dystrophic mdx-5(Cv) mice, a murine model of DMD, the hydrogel spreads across the entire muscle before completely degrading at 3 weeks in vivo. We found that the hydrogel is associated with CD206(+) pro-regenerative macrophage polarization and elevated anti-inflammatory cytokine expression in both WT and dystrophic mice. Co-injection of both hydrogel and myostatin inhibitor significantly increased FoxP3(+) regulatory T cell modulation and Foxp3 gene expression in the scaffold immune microenvironment. Finally, delivery of myostatin inhibitor with the hydrogel increased its bioactivity in vivo, and transplantation of immortalized human myoblasts with the hydrogel promoted their survival in vivo. This study identifies a key role for biological scaffolds and myostatin inhibitors in modulating a pro-regenerative immune microenvironment in dystrophic muscle.	[Estrellas, Kenneth M.; Wagner, Kathryn R.] Kennedy Krieger, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Estrellas, Kenneth M.; Chung, Liam; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, 400 N Broadway Rm 5031, Baltimore, MD 21231 USA; [Chung, Liam; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, 400 N Broadway Rm 5031, Baltimore, MD 21231 USA; [Cheug, Lindsay A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Sadtler, Kaitlyn] MIT, Dept Chem Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sadtler, Kaitlyn] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Majumdar, Shoumyo] Otomagnetics LLC, Rockville, MD 20852 USA; [Mula, Jyothi] NCI Frederick, NIH, Frederick, MD 21702 USA; [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, 400 N Broadway Rm 5031, Baltimore, MD 21231 USA.; Wagner, KR (corresponding author), Kennedy Krieger Inst, Ctr Genet Muscle Disorders, 707 N Broadway Rm 406, Baltimore, MD 21205 USA.	jhe@jhu.edu; wagnerk@kennedykrieger.org	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996; Estrellas, Kenneth/0000-0003-0413-6258; Wolf, Matthew/0000-0002-0328-2475	Maryland Stem Cell Research Foundation; Team Saij	Maryland Stem Cell Research Foundation; Team Saij	This work was supported by the Maryland Stem Cell Research Foundation and Team Saij. The authors declare that they have no conflicts of interest with the contents of this article.	Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Bhattacharya I, 2018, CLIN PHARM DRUG DEV, V7, P484, DOI 10.1002/cpdd.386; Bhattacharya I, 2018, J CLIN PHARMACOL, V58, P314, DOI 10.1002/jcph.1015; Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019; Bursac N, 2015, ANNU REV BIOMED ENG, V17, P217, DOI 10.1146/annurev-bioeng-071114-040640; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Campbell C, 2017, MUSCLE NERVE, V55, P458, DOI 10.1002/mus.25268; Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008; Chang CY, 2012, BIOMATERIALS, V33, P8026, DOI 10.1016/j.biomaterials.2012.07.058; Dankbar B, 2015, NAT MED, V21, P1085, DOI 10.1038/nm.3917; Dziki JL, 2016, TISSUE ENG PT A, V22, P1129, DOI 10.1089/ten.tea.2016.0340; Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062; Gaetani R, 2016, CELL TRANSPLANT, V25, P1653, DOI 10.3727/096368915X689794; Gerard C, 2012, CELL TRANSPLANT, V21, P127, DOI 10.3727/096368911X576018; Griggs RC, 2016, NEUROLOGY, V87, P2123, DOI 10.1212/WNL.0000000000003217; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Kabra H, 2015, ACS BIOMATER SCI ENG, V1, P7, DOI 10.1021/ab500021a; Larkindale J, 2014, MUSCLE NERVE, V49, P431, DOI 10.1002/mus.23942; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Li ZB, 2012, J CELL SCI, V125, P3957, DOI 10.1242/jcs.090365; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Londhe P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004633; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Moyer AL, 2011, CURR OPIN RHEUMATOL, V23, P568, DOI 10.1097/BOR.0b013e32834bac92; Muir LA, 2016, STEM CELLS DEV, V25, P1559, DOI 10.1089/scd.2016.0136; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Sadtler K, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.40; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Sahenk Z, 2011, CURR RHEUMATOL REP, V13, P199, DOI 10.1007/s11926-011-0178-6; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Serrano AL, 2017, SEMIN CELL DEV BIOL, V64, P181, DOI 10.1016/j.semcdb.2016.09.013; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; St Andre Michael, 2017, Skelet Muscle, V7, P25, DOI 10.1186/s13395-017-0141-y; Sun Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021073; Thies RS, 2001, GROWTH FACTORS, V18, P251; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Villalta SA, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1010966; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Villalta SA, 2011, J IMMUNOL, V187, P5419, DOI 10.4049/jimmunol.1101267; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wang RT, 2014, PLOS CURR, V6, P1, DOI [DOI 10.1371/CURRENTS.MD.E1E8F2BE7C94, DOI 10.1371/CURRENTS.MD.E1E8F2BE7C949F9FFE81EC6FCA1CCE6A]; Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088	54	13	13	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15594	15605		10.1074/jbc.RA118.004417	http://dx.doi.org/10.1074/jbc.RA118.004417			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139748	Green Published, hybrid			2022-12-26	WOS:000446549200023
J	Zou, Y; Uddin, MM; Padmanabhan, S; Zhu, Y; Bu, PL; Vancura, A; Vancurova, I				Zou, Yue; Uddin, Mohammad M.; Padmanabhan, Sveta; Zhu, Yan; Bu, Pengli; Vancura, Ales; Vancurova, Ivana			The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oncogene; transcription regulation; ovarian cancer; immunology; interferon; Bcl3; PD-L1	NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; ANAPLASTIC LARGE-CELL; ONCOPROTEIN BCL-3; TUMOR MICROENVIRONMENT; NEGATIVE REGULATION; CLASSICAL HODGKIN; GENE-EXPRESSION; P50 HOMODIMERS; T-LYMPHOCYTES	The proto-oncogene Bcl3 induces survival and proliferation in cancer cells; however, its function and regulation in ovarian cancer (OC) remain unknown. Here, we show that Bcl3 expression is increased in human OC tissues. Surprisingly, however, we found that in addition to promoting survival, proliferation, and migration of OC cells, Bcl3 promotes both constitutive and interferon- (IFN)-induced expression of the immune checkpoint molecule PD-L1. The Bcl3 expression in OC cells is further increased by IFN, resulting in increased PD-L1 transcription. The mechanism consists of an IFN-induced, Bcl3- and p300-dependent PD-L1 promoter occupancy by Lys-314/315 acetylated p65 NF-B. Blocking PD-L1 by neutralizing antibody reduces proliferation of OC cells overexpressing Bcl3, suggesting that the pro-proliferative effect of Bcl3 in OC cells is partly mediated by PD-L1. Together, this work identifies PD-L1 as a novel target of Bcl3, and links Bcl3 to IFN signaling and PD-L1-mediated immune escape.	[Zou, Yue; Uddin, Mohammad M.; Padmanabhan, Sveta; Zhu, Yan; Bu, Pengli; Vancura, Ales; Vancurova, Ivana] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA	Saint John's University	Vancurova, I (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	vancuroi@stjohns.edu	Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; Vancura, Ales/0000-0002-5895-1218; zou, yue/0000-0002-6999-8329	National Institutes of Health [CA202775]; NATIONAL CANCER INSTITUTE [R15CA202775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA202775 (to I. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bouillez A, 2017, ONCOGENE, V36, P4037, DOI 10.1038/onc.2017.47; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Brenne AT, 2009, EUR J HAEMATOL, V82, P354, DOI 10.1111/j.1600-0609.2009.01225.x; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang TP, 2014, BBA-MOL CELL RES, V1843, P2620, DOI 10.1016/j.bbamcr.2014.07.012; Chang TP, 2014, METHODS MOL BIOL, V1172, P329, DOI 10.1007/978-1-4939-0928-5_30; Chen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.405; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gatla HR, 2017, J BIOL CHEM, V292, P5043, DOI 10.1074/jbc.M116.771014; Ge BS, 2003, J IMMUNOL, V171, P4210, DOI 10.4049/jimmunol.171.8.4210; Gowrishankar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123410; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Huang S, 2000, CANCER RES, V60, P5334; Juvekar A, 2011, MOL CANCER RES, V9, P183, DOI 10.1158/1541-7786.MCR-10-0368; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Kim YM, 2008, J VIROL, V82, P11939, DOI 10.1128/JVI.01356-08; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Luo S, 2015, BIOCHEM BIOPH RES CO, V462, P85, DOI 10.1016/j.bbrc.2015.04.023; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Maeda T, 2018, CANCER RES, V78, P205, DOI 10.1158/0008-5472.CAN-17-1636; Maine CJ, 2014, CANCER IMMUNOL IMMUN, V63, P215, DOI 10.1007/s00262-013-1503-x; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Martin-Subero JI, 2006, BLOOD, V108, P401, DOI 10.1182/blood-2005-09-3843; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; MCKEITHAN TW, 1990, GENE CHROMOSOME CANC, V1, P247, DOI 10.1002/gcc.2870010310; McKeithan TW, 1997, GENE CHROMOSOME CANC, V20, P64, DOI 10.1002/(SICI)1098-2264(199709)20:1<64::AID-GCC10>3.0.CO;2-F; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; Nishikori M, 2005, CANCER SCI, V96, P487, DOI 10.1111/j.1349-7006.2005.00078.x; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Peng J, 2015, CANCER RES, V75, P5034, DOI 10.1158/0008-5472.CAN-14-3098; Puvvada SD, 2010, ONCOLOGY-BASEL, V78, P181, DOI 10.1159/000313697; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Thornburg NJ, 2003, CANCER RES, V63, P8293; Vancurova I, 2018, TRENDS PHARMACOL SCI, V39, P295, DOI 10.1016/j.tips.2017.11.008; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Wakefield A, 2013, CANCER RES, V73, P745, DOI 10.1158/0008-5472.CAN-12-1321; Wang VYF, 2017, MOL CELL, V67, P484, DOI 10.1016/j.molcel.2017.06.011; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Wu JH, 2016, INT J ONCOL, V49, P2471, DOI 10.3892/ijo.2016.3729; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08; Zamora R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-223; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915; Zhao H, 2016, ONCOTARGETS THER, V9, P6619, DOI 10.2147/OTT.S118184	68	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15483	15496		10.1074/jbc.RA118.004084	http://dx.doi.org/10.1074/jbc.RA118.004084			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135206	Green Published, hybrid			2022-12-26	WOS:000446549200015
J	Meester, SB; Wagenmakers, R; van den Akker-Scheek, I; Stevens, M				Meester, Sieger Bertus; Wagenmakers, Robert; van den Akker-Scheek, Inge; Stevens, Martin			Sport advice given by Dutch orthopaedic surgeons to patients after a total hip arthroplasty or total knee arthroplasty	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; AMERICAN-ASSOCIATION; RETURN; RECOMMENDATIONS; METAANALYSIS; REPLACEMENT; GUIDELINES; SOCIETY; HEALTH	Background The advice given to patients in the Netherlands regarding sport activities after total hip arthroplasty or total knee arthroplasty (THA/TKA) is currently based on the opinion of the individual orthopaedic surgeon. Aim To give an overview of the sport advice given by Dutch orthopaedic surgeons and to examine whether surgeons are familiar with the Dutch health-enhancing physical activity (PA) recommendations (NNGB). Methods 472 surgeons were selected to fill in a questionnaire regarding 40 sport activities for four patient age groups (in years): 1) THA<65, 2) THA>65, 3) TKA<65 4) TKA>65. Surgeons were also asked if they discuss the role of PA postoperatively and about their knowledge and application of the NNGB. Results There was consensus on 29 sport activities for the THA<65 group and 30 activities for the THA>65 group. In the TKA<65 group there was consensus for 33 sports activities and in the TKA>65 group for 32 activities. Amongst orthopaedic surgeons performing THAs and TKAs, respectively 77% and 79% discussed the role of PA postoperatively with their patients, and a total of 34% and 41% were familiar with the NNGB, with 33% and 34% of them giving NNGB-based advice. Conclusion Results can be used to recommend sport activities after THA/TKA. Although the majority of orthopaedic surgeons discuss the role of PA postoperatively with their patients, familiarity with health-enhancing PA recommendations is lacking.	[Meester, Sieger Bertus; van den Akker-Scheek, Inge; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Wagenmakers, Robert] Amphia Hosp Breda, Dept Orthopaed, Breda, Netherlands	University of Groningen; Amphia Hospital	Stevens, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	m.stevens@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; van den Akker-Scheek, Inge/0000-0002-1614-8419				Bates S., 2013, BRIT J SPORT MED, V47, pe3, DOI [10.1136/bjsports-2013-092558.50, DOI 10.1136/BJSPORTS-2013-092558.50]; Bradley BM, 2017, J ARTHROPLASTY, V32, P898, DOI 10.1016/j.arth.2016.09.019; Brandes M, 2011, ARTHRIT CARE RES, V63, P328, DOI 10.1002/acr.20384; Bult P, 1997, SPORT BEWEEG WIJZER; Bult P, 1994, THESIS; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Ethgen O, 2004, HLTH RELATED QUALITY; Fisher NE, 2011, INT ORTHOP, V35, P977, DOI 10.1007/s00264-010-1053-1; Gschwend N, 2000, ACTA ORTHOP SCAND, V71, P243, DOI 10.1080/000164700317411825; Kersten RFMR, 2012, PHYS THER, V92, P1109, DOI 10.2522/ptj.20110273; Klein GR, 2007, J ARTHROPLASTY, V22, P171, DOI 10.1016/j.arth.2006.09.001; Kokkinos Peter, 2012, ISRN Cardiol, V2012, P718789, DOI 10.5402/2012/718789; Laursen Mia K, 2014, Eur J Orthop Surg Traumatol, V24, P1571, DOI 10.1007/s00590-014-1442-z; Motl RW, 2010, PHYS MED REH CLIN N, V21, P299, DOI 10.1016/j.pmr.2009.12.006; Munger P, 2006, ACTA ORTHOP, V77, P567, DOI 10.1080/17453670610012629; Ollivier M, 2012, CLIN ORTHOP RELAT R, V470, P3060, DOI 10.1007/s11999-012-2362-z; Peiris CL, 2013, J PHYSIOTHER, V59, P39, DOI 10.1016/S1836-9553(13)70145-0; Pietschmann MF, 2013, INT ORTHOP, V37, P31, DOI 10.1007/s00264-012-1710-7; Schmalzried TP, 2004, CLIN ORTHOP RELAT R, P94; Schmalzried TP, 2000, CLIN ORTHOP RELAT R, P36; Seyler TM, 2006, SPORTS MED, V36, P571, DOI 10.2165/00007256-200636070-00003; Stevens M, 2012, NIEUWE HEUP KNIE HOE; Stevens M, 2012, CLIN GERIATR MED, V28, P509, DOI 10.1016/j.cger.2012.05.003; Swanson EA, 2009, J ARTHROPLASTY, V24, P120, DOI 10.1016/j.arth.2009.05.014; Trousdale RT, 1999, MAYO CLIN PROC, V74, P978; Vogel LA, 2011, SPORTS HEALTH, V3, P441, DOI 10.1177/1941738111415826; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WIDHALM R, 1990, Z ORTHOP GRENZGEB, V128, P139, DOI 10.1055/s-2008-1039489; Witjes S, 2016, SPORTS MED, V46, P269, DOI 10.1007/s40279-015-0421-9	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202494	10.1371/journal.pone.0202494	http://dx.doi.org/10.1371/journal.pone.0202494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161163	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900031
J	Ding, XT; Jiang, YP; Zhao, H; Guo, DD; He, LZ; Liu, FG; Zhou, Q; Nandwani, D; Hui, DF; Yu, JZ				Ding, Xiaotao; Jiang, Yuping; Zhao, Hong; Guo, Doudou; He, Lizhong; Liu, Fuguang; Zhou, Qiang; Nandwani, Dilip; Hui, Dafeng; Yu, Jizhu			Electrical conductivity of nutrient solution influenced photosynthesis, quality, and antioxidant enzyme activity of pakchoi (Brassica campestris L. ssp Chinensis) in a hydroponic system	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; LIGHT-INTENSITY; DIETARY NITRATE; GROWTH; NITROGEN; YIELD; FERTILIZER; CHLOROPHYLL; TOLERANCE; NUTRITION	To find an electrical conductivity (EC) in the nutrient solution used for pakchoi (Brassica campestris L. ssp. Chinensis) cultivation that optimizes the plant's physiology, growth, and quality, we conducted an experiment with eight EC treatments (from EC0 to EC9.6) in a hydroponic production system (i.e. soilless culture) under greenhouse condition in Shanghai, China. Plants biomass production, leaf photosynthesis, vegetable quality variables, tissue nitrate and nitrite contents, and antioxidant enzyme activities were measured. The results showed that very high (EC9.6) or low EC (EC0-0.6) treatments clearly decreased plants fresh weight (FW) and dry weight (DW), leaf size, leaf water content, leaf net photosynthetic rate (P-n), stomatal conductance (G(s)), transpiration rate (T-r), and taste score. Nitrite content, and antioxidant enzyme activities were low in medium EC treatments (EC1.8 and EC2.4), but high in very high or low EC treatments. Leaf relative chlorophyll, ascorbic acid, and nitrate contents increased gradually from low EC to high EC treatments, while crude fiber and soluble sugar contents decreased. Based on growth and quality criteria, the optimal EC treatment would be EC1.8 or EC2.4 for pakchoi in the hydroponic production system. Too high or too low EC would induce nutrient stress, enhance plant antioxidant enzyme activities, and suppress pakchoi growth and quality.	[Ding, Xiaotao; Jiang, Yuping; He, Lizhong; Liu, Fuguang; Zhou, Qiang; Yu, Jizhu] Shanghai Acad Agr Sci, Shanghai Dushi Green Engn Co Ltd, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China; [Ding, Xiaotao; Zhao, Hong; Guo, Doudou] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Nandwani, Dilip] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Shanghai Academy of Agricultural Sciences; Shanghai Jiao Tong University; Tennessee State University; Tennessee State University	Yu, JZ (corresponding author), Shanghai Acad Agr Sci, Shanghai Dushi Green Engn Co Ltd, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China.; Hui, DF (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA.	dhui@tnstate.edu; woloveorange2011@163.com	Guo, Doudou/M-1859-2019	Hui, Dafeng/0000-0002-5284-2897	National High-tech Research and Development Program (863 Program) [2013AA103006]; Shanghai Agriculture Applied Technology Development Program, China [T20170201]; Shanghai Science and Technology Committee Program [16DZ2282100]	National High-tech Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Agriculture Applied Technology Development Program, China; Shanghai Science and Technology Committee Program	This work was supported by the National High-tech Research and Development Program (863 Program) (2013AA103006), Shanghai Agriculture Applied Technology Development Program, China (grant no. T20170201) and Shanghai Science and Technology Committee Program (16DZ2282100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S.M., 1999, HDB PLANT CROP STRES, P285, DOI DOI 10.1201/9780824746728.CH12; Albornoz F, 2015, CHIL J AGR RES, V75, P284, DOI 10.4067/S0718-58392015000400003; Albornoz F, 2014, CHIL J AGR RES, V74, P240, DOI 10.4067/S0718-58392014000200017; Almodares A., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V6, P441; Amalfitano C, 2017, HORTIC SCI, V44, P91, DOI [10.17221/172/2015-HORTSCI, 10.17221/172/2015-hortsci]; [Anonymous], OFFICIAL METHODS ANA; Ayub M, 1999, PAKISTAN J BIOL SCI, V2, P2478; Belkhodja R, 1998, PLANT SOIL, V203, P257, DOI 10.1023/A:1004373202458; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Cartea ME, 2011, MOLECULES, V16, P251, DOI 10.3390/molecules16010251; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Conti S, 2015, SCI HORTIC-AMSTERDAM, V183, P136, DOI 10.1016/j.scienta.2014.12.003; Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5; Dietz KJ, 1997, BOOKS SOIL PLANT ENV, P951; Ding XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep35424; Domingues DS, 2012, COMPUT ELECTRON AGR, V84, P53, DOI 10.1016/j.compag.2012.02.006; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fallovo C, 2009, J SCI FOOD AGR, V89, P1682, DOI 10.1002/jsfa.3641; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gorbe E, 2010, ADV BOT RES, V53, P193, DOI 10.1016/S0065-2296(10)53006-4; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Haydon MJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00299; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; Islam S, 2001, J HORTIC SCI BIOTECH, V76, P764, DOI 10.1080/14620316.2001.11511443; Jahangir M, 2009, COMPR REV FOOD SCI F, V8, P31, DOI 10.1111/j.1541-4337.2008.00065.x; Karic L., 2005, Acta Agriculturae Slovenica, V85, P219; Kaur R, 2014, PESTIC BIOCHEM PHYS, V115, P39, DOI 10.1016/j.pestbp.2014.08.005; Khalid M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177185; Le Bot J, 1998, SCI HORTIC-AMSTERDAM, V74, P47, DOI 10.1016/S0304-4238(98)00082-X; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Lee YH, 2013, CAN J SOIL SCI, V93, P271, DOI 10.4141/cjss2012-101; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Lin KH, 2013, SCI HORTIC-AMSTERDAM, V150, P86, DOI 10.1016/j.scienta.2012.10.002; Lisiewska Z, 1996, FOOD CHEM, V57, P267, DOI 10.1016/0308-8146(95)00218-9; LONGSTRETH DJ, 1980, PLANT PHYSIOL, V65, P541, DOI 10.1104/pp.65.3.541; Mensinga Tjeert T., 2003, Toxicological Reviews, V22, P41, DOI 10.2165/00139709-200322010-00005; Morano G., 2017, Advances in Horticultural Science, V31, P25, DOI 10.13128/ahs-20722; MULLER K, 1987, PLANT SOIL, V100, P35, DOI 10.1007/BF02370931; Mullins GL, 1998, SOIL TILL RES, V45, P1, DOI 10.1016/S0167-1987(97)00069-X; Nemali KS, 2004, HORTSCIENCE, V39, P1287, DOI 10.21273/HORTSCI.39.6.1287; NIEMAN RICHARD H., 1962, BOT GAZ, V123, P279, DOI 10.1086/336163; Niinemets U, 2007, PLANT CELL ENVIRON, V30, P1052, DOI 10.1111/j.1365-3040.2007.01683.x; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; Polesskaya OG, 2004, RUSS J PLANT PHYSL+, V51, P615, DOI 10.1023/B:RUPP.0000040746.66725.77; Romero-Aranda R, 2001, PLANT SCI, V160, P265, DOI 10.1016/S0168-9452(00)00388-5; Samarakoon U. C., 2006, Tropical Agricultural Research, V18, P13; Santamaria P, 2006, J SCI FOOD AGR, V86, P10, DOI 10.1002/jsfa.2351; Savvas D., 2008, EUROP J PLANT SCI BI, V2, P45; Shannon MC, 1999, SCI HORTIC-AMSTERDAM, V78, P5, DOI 10.1016/S0304-4238(98)00189-7; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Signore A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00391; Slamic B, 2016, EMIR J FOOD AGR, V28, P398, DOI 10.9755/ejfa.2016-04-340; Smiechowska M, 2006, FOOD CHEM, V94, P366, DOI 10.1016/j.foodchem.2004.11.026; Sonneveld C, 2009, PLANT NUTRITION OF GREENHOUSE CROPS, P1, DOI 10.1007/978-90-481-2532-6; Speijers G. J. A., 1996, FOOD ADDITIVES SERIE, V35, P325; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; Stefanov M, 2016, PLANT PHYSIOL BIOCH, V101, P54, DOI 10.1016/j.plaphy.2016.01.017; Tewari RK, 2004, PLANT SCI, V166, P687, DOI 10.1016/j.plantsci.2003.11.004; vanIeperen W, 1996, J HORTIC SCI, V71, P99, DOI 10.1080/14620316.1996.11515386; Wu FB, 1998, FIELD CROP RES, V56, P309, DOI 10.1016/S0378-4290(97)00108-1; Wu M, 2008, SCI HORTIC-AMSTERDAM, V116, P122, DOI 10.1016/j.scienta.2007.11.014; Zeng HQ, 2014, PLANT SOIL, V374, P1005, DOI 10.1007/s11104-013-1907-6	65	50	52	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202090	10.1371/journal.pone.0202090	http://dx.doi.org/10.1371/journal.pone.0202090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157185	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400034
J	Hiza, H; Fenner, L; Hella, J; Kuchaka, D; Sasamalo, M; Blauenfeldt, T; Kibiki, G; Kavishe, RA; Mhimbira, F; Ruhwald, M				Hiza, Hellen; Fenner, Lukas; Hella, Jerry; Kuchaka, Davis; Sasamalo, Mohamed; Blauenfeldt, Thomas; Kibiki, Gibson; Kavishe, Reginald A.; Mhimbira, Francis; Ruhwald, Morten			Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection	PLOS ONE			English	Article							INTERLEUKIN-7; RESPONSES; BLOOD	Background A quarter of the world's population is estimated to be infected with Myobacterium tuberculosis (Mtb). Infection is detected by immune response to M. tuberculosis antigens using either tuberculin skin test (TST) and interferon gamma release (IGRA's), tests which have low sensitivity in immunocompromised. IL-7 is an important cytokine for T-cell function with potential to augment cytokine release in in-vitro assays. This study aimed to determine whether the addition of IL-7 in interferon-gamma release assays (IGRAs) improves its diagnostic performance of Mtb infection. Methods 44 cases with confirmed TB and 45 household contacts without TB were recruited and 1 ml of blood was stimulated in two separate IGRA's tube set: one set of standard Quantiferon TB gold tubes mitogen, TB antigen and TB Nil; one set of customized Quantiferon TB gold tubes with added IL-7. Following IFN-gamma and IP-10 release was determined using ELISA. Results We found that the addition of IL-7 led to significantly higher release of IFN-gamma in individuals with active TB from 4.2IU/ml (IQR 1.4 +/- 6.9IU/ml) to 5.1IU/ml (IQR 1.5 +/- 8.1IU/ml, p = 0.0057), and we found an indication of a lower release of both IFN-. and IP-10 in participants with negative tests. Conclusions In TB cases addition of IL-7 in IGRA tubes augments IFN-. but not IP-10 release, and seems to lower the response in controls. Whether IL-7 boosted IGRA holds potential over	[Hiza, Hellen; Hella, Jerry; Sasamalo, Mohamed; Mhimbira, Francis] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Fenner, Lukas; Hella, Jerry; Sasamalo, Mohamed] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas; Hella, Jerry; Sasamalo, Mohamed] Univ Basel, Basel, Switzerland; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Kuchaka, Davis; Kibiki, Gibson; Kavishe, Reginald A.] Kilimanjaro Clin Res Inst, Kilimanjaro, Tanzania; [Blauenfeldt, Thomas; Ruhwald, Morten] Statens Serum Inst, Ctr Vaccine Res, Copenhagen, Denmark; [Kibiki, Gibson] East African Hlth Res Commiss, Bujumbura, Burundi; [Kavishe, Reginald A.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll, Kilimanjaro, Tanzania	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern; Statens Serum Institut	Ruhwald, M (corresponding author), Statens Serum Inst, Ctr Vaccine Res, Copenhagen, Denmark.	moru@ssi.dk	Kuchaka, Davis/ABD-5260-2021; Hella, Jerry/I-6738-2017	Kuchaka, Davis/0000-0002-0991-703X; Hella, Jerry/0000-0003-2392-8592; Fenner, Lukas/0000-0003-3309-4835	Rudolf Geigy Foundation (Basel, Switzerland); Statens Serum Institute (Copenhagen, Denmark); European Commission H2020 program [TBVAC2020 643381]; Research Council Norway [GLOBVAC 248042/H10]	Rudolf Geigy Foundation (Basel, Switzerland); Statens Serum Institute (Copenhagen, Denmark); European Commission H2020 program; Research Council Norway(Research Council of Norway)	This work was supported by funding from the Rudolf Geigy Foundation (Basel, Switzerland) and the Statens Serum Institute (Copenhagen, Denmark). Morten Ruhwald received funding from European Commission H2020 program [grant number TBVAC2020 643381] and Research Council Norway [GLOBVAC 248042/H10]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2011, CLIN VACCINE IMMUNOL, V18, P1150, DOI 10.1128/CVI.00051-11; Arlehamn CSL, 2012, J IMMUNOL, V188, P5020, DOI 10.4049/jimmunol.1103556; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; ElKassar N, 2010, J IMMUNOTOXICOL, V7, P1, DOI 10.3109/15476910903453296; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Feske ML, 2012, METHODS MOL BIOL, V792, P229, DOI 10.1007/978-1-61779-325-7_18; Fletcher HA, 2016, T ROY SOC TROP MED H, V110, P212, DOI 10.1093/trstmh/trw016; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gao JB, 2015, INT J MOL SCI, V16, P10267, DOI 10.3390/ijms160510267; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Liu ZH, 2014, INT J CLIN EXP PATHO, V7, P870; Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mhimbira F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005342; Mikkelsen H, 2012, VET IMMUNOL IMMUNOP, V147, P69, DOI 10.1016/j.vetimm.2012.04.002; Nemes E, 2017, AM J RESP CRIT CARE, V196, P638, DOI 10.1164/rccm.201704-0817OC; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Sester M, 2015, EUR RESPIR J, V46, P1836, DOI 10.1183/13993003.01047-2015; Shmarov VA, 2016, EUR CYTOKINE NETW, V27, P102, DOI 10.1684/ecn.2016.0385; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Wang SH, 2012, J CLIN MICROBIOL, V50, P2469, DOI 10.1128/JCM.00674-12; WHO, 2016, GLOB TUB REP	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202525	10.1371/journal.pone.0202525	http://dx.doi.org/10.1371/journal.pone.0202525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157233	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400059
J	Kim, ST; Lee, YJ; Tasaki, T; Hwang, J; Kang, MJ; Yi, EC; Kim, BY; Kwon, YT				Kim, Sung Tae; Lee, Yoon Jee; Tasaki, Takafumi; Hwang, Joonsung; Kang, Min Jueng; Yi, Eugene C.; Kim, Bo Yeon; Kwon, Yong Tae			The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; TERMINAL ARGINYLATION; AUTOPHAGIC PROTEOLYSIS; MOLECULAR PRINCIPLES; STATISTICAL-MODEL; E7 ONCOPROTEIN; MICE LACKING; VE-CADHERIN; P600; MOUSE	The N-end rule pathway is a proteolytic system in which single N-terminal amino acids of proteins act as a class of degrons (N-degrons) that determine the half-lives of proteins. We have previously identified a family of mammals N-recognins (termed UBR1, UBR2, UBR4/p600, and UBR5/EDD) whose conserved UBR boxes bind N-degrons to facilitate substrate ubiquitination and proteasomal degradation via the ubiquitin-proteasome system (UPS). Amongst these N-recognins, UBR1 and UBR2 mediate ubiquitination and proteolysis of short-lived regulators and misfolded proteins. Here, we characterized the null phenotypes of UBR4-deficient mice in which the UBR box of UBR4 was deleted. We show that the mutant mice die around embryonic days 9.5-10.5 (E9.5-E10.5) associated with abnormalities in various developmental processes such as neurogenesis and cardiovascular development. These developmental defects are significantly attributed to the inability to maintain cell integrity and adhesion, which significantly correlates to the severity of null phenotypes. UBR4-loss induces the depletion of many, but not all, proteins from the plasma membrane, suggesting that UBR4 is involved in proteome-wide turnover of cell surface proteins. Indeed, UBR4 is associated with and required to generate the multivesicular body (MVB) which transiently store endocytosed cell surface proteins before their targeting to autophagosomes and subsequently lysosomes. Our results suggest that the N-recognin UBR4 plays a role in the homeostasis of cell surface proteins and, thus, cell adhesion and integrity.	[Kim, Sung Tae; Lee, Yoon Jee; Kwon, Yong Tae] Seoul Natl Univ, Prot Metab Med Res Ctr, Seoul, South Korea; [Kim, Sung Tae; Lee, Yoon Jee; Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Sung Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kim, Sung Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Tasaki, Takafumi] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa, Japan; [Hwang, Joonsung; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, World Class Inst, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea; [Kang, Min Jueng; Yi, Eugene C.] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Sch Convergence Sci & Technol, Seoul, South Korea; [Kang, Min Jueng; Yi, Eugene C.] Seoul Natl Univ, Coll Med, Coll Pharm, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa Medical University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kwon, YT (corresponding author), Seoul Natl Univ, Prot Metab Med Res Ctr, Seoul, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, BY (corresponding author), Korea Res Inst Biosci & Biotechnol, World Class Inst, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea.	bykim@kribb.re.kr; yok5@snu.ac.kr			Seoul National University (SNU) Nobel Laureates Invitation Program; National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) [NRF-2016R1A2B3011 389, NRF-2015M3A9B6073835, NRF-2014M39Ab5073938, NRF-2015-Global]; Brain Korea 21 PLUS; SNU Hospital; Bio and Medical Technology Development Program through the MSIT [2012M3A9B6055305]; R&D Convergence Program of National Research Council of Science & Technology (NST) [CAP-16-03-KRIBB]; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program [NRF-2014M39Ab5073938]; Grant for Promoted Research from Kanazawa Medical University [S2016-13, S2017-6]; JSPS KAKENHI [JP25430119, JP18K06119]	Seoul National University (SNU) Nobel Laureates Invitation Program; National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT); Brain Korea 21 PLUS; SNU Hospital; Bio and Medical Technology Development Program through the MSIT; R&D Convergence Program of National Research Council of Science & Technology (NST); Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program; Grant for Promoted Research from Kanazawa Medical University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Seoul National University (SNU) Nobel Laureates Invitation Program (http://www.snu.ac.kr), the National Research Foundation of Korea (NRF; http://www.nrf.re.kr) funded by the Ministry of Science and ICT (MSIT) (NRF-2016R1A2B3011 389 to Y.T.K., NRF-2015M3A9B6073835 to E.C.Y., NRF-2014M39Ab5073938 to B.Y.K., and NRF-2015-Global PhD Fellowship to Y.J.L.), the Brain Korea 21 PLUS (to SNU; http://bkplus.nrf.re.kr), SNU Hospital (to Y.T.K.; http://www.snuh.org), the Bio and Medical Technology Development Program (project no. 2012M3A9B6055305 to B.Y. K.) through the MSIT (http://www.msit.go.kr), the R&D Convergence Program (CAP-16-03-KRIBB) of National Research Council of Science & Technology (NST; http://www.nst.re.kr/nst), Korea Research Institute of Bioscience and Biotechnology (KRIBB; http://www.kribb.re.kr) Research Initiative Program (NRF-2014M39Ab5073938 to B.Y.K.), and Grant for Promoted Research from Kanazawa Medical University (http://www.kanazawa-med.ac.jp) (S2016-13, S2017-6 to T.T.) and by JSPS KAKENHI (https://www.jsps.go.jp) Grant Number JP25430119 and JP18K06119 (to T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim IS, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.401; An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127; Belzil C, 2014, BIOL OPEN, V3, P475, DOI 10.1242/bio.20147807; Belzil C, 2013, J BIOL CHEM, V288, P24452, DOI 10.1074/jbc.M113.483107; Bian S., 2013, NEURAL STEM CELLS; Campos EI, 2015, MOL CELL, V60, P697, DOI 10.1016/j.molcel.2015.08.005; Cha-Molstad H, 2018, AUTOPHAGY, V14, P359, DOI 10.1080/15548627.2017.1415190; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2016, AUTOPHAGY, V12, P426, DOI 10.1080/15548627.2015.1126047; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; DeMasi J, 2007, J VIROL, V81, P9419, DOI 10.1128/JVI.00422-07; Enriquez-Barreto L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00076; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Grossier JP, 2014, EMBO J, V33, P35, DOI 10.1002/embj.201385284; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim ST, 2013, AUTOPHAGY, V9, P1100, DOI 10.4161/auto.24643; Kinsella E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157079; Kischel P, 2008, NEOPLASIA, V10, P1014, DOI 10.1593/neo.08570; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Kwon YT, 1999, J BIOL CHEM, V274, P18135, DOI 10.1074/jbc.274.25.18135; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lescroart F, 2010, DEVELOPMENT, V137, P3269, DOI 10.1242/dev.050674; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Munoz-Escobar J, 2017, PROTEIN SCI, V26, P2092, DOI 10.1002/pro.3227; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Nakaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066269; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pavelka N, 2008, MOL CELL PROTEOMICS, V7, P631, DOI 10.1074/mcp.M700240-MCP200; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rybak JN, 2004, PROTEOMICS, V4, P2296, DOI 10.1002/pmic.200300780; Scheurer SB, 2005, PROTEOMICS, V5, P2718, DOI 10.1002/pmic.200401163; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shearer RF, 2018, MOL BIOL CELL, V29, P1542, DOI 10.1091/mbc.E17-04-0248; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; TAKEICHI M, 1990, NEUROSCI RES, pS92, DOI 10.1016/0921-8696(90)90036-3; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Yau RG, 2017, CELL, V171, P918, DOI 10.1016/j.cell.2017.09.040; Yoo YD, 2018, P NATL ACAD SCI USA, V115, pE2716, DOI 10.1073/pnas.1719110115; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111; Zimmerman SW, 2014, CELL TISSUE RES, V356, P261, DOI 10.1007/s00441-014-1808-x	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202260	10.1371/journal.pone.0202260	http://dx.doi.org/10.1371/journal.pone.0202260			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157281	Green Submitted, gold, Green Published			2022-12-26	WOS:000443071400047
J	Deshpande, R; Kanitkar, M; Kadam, S; Dixit, K; Chhabra, H; Bellare, J; Datar, S; Kale, VP				Deshpande, Rucha; Kanitkar, Meghana; Kadam, Sheetal; Dixit, Kadambari; Chhabra, Hemlata; Bellare, Jayesh; Datar, Savita; Kale, Vaijayanti P.			Matrix-entrapped cellular secretome rescues diabetes-induced EPC dysfunction and accelerates wound healing in diabetic mice	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE; IN-VITRO; DIFFERENTIATION; ANGIOGENESIS; REGENERATION; SCAFFOLDS; NANOFIBER; MELLITUS; DISEASE	Cellular secretory products have infinite potential, which is only recently explored for research and therapeutic applications. The present study elaborated on the formation of a unique matrix-entrapped cellular secretome (MCS), a hydrogel-like secretome produced by bone marrow-derived mononuclear cells when cultured on a three-dimensional electrospun nanofiber matrix under specific conditions. These culture conditions support the growth of a mixed population predominantly comprising of endothelial precursor cells (EPCs), along with mesenchymal stromal cells and pericytes. Interestingly, such secretome is not formed in a pure culture of EPCs on the similarly formulated matrix, suggesting that a heterotypic cell-cell interaction is essential for the formation of MCS. In addition, the specific composition of the matrix was found to be a critical necessity for the formation of MCS. Furthermore, the application of the MCS as a substrate promotes the growth of EPCs in culture. It also rescues the diabetes-induced EPC dysfunction as assessed based on the parameters, such as viability, proliferation, colony formation, cellular adhesion, chemotactic migration, and tubule formation. MCS augments the levels of eNOS-specific mRNA (Nos3) and also promotes the restoration of the SDF1/CXCR4 axis in diabetic EPCs. Notably, a topical application of MCS on diabetic wounds leads to an accelerated wound closure. Thus, the current data showed that MCS forms an excellent cell-free biomaterial in the treatment of diabetic wounds and non-healing ulcers.	[Deshpande, Rucha; Kanitkar, Meghana; Kadam, Sheetal; Dixit, Kadambari; Kale, Vaijayanti P.] Natl Ctr Cell Sci, NCCS Complex,Univ Pune Campus, Pune, Maharashtra, India; [Deshpande, Rucha; Datar, Savita] Commerce & Sci Coll, Prof Ramkrishna More Arts, Pune, Maharashtra, India; [Chhabra, Hemlata; Bellare, Jayesh] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India; [Datar, Savita] SP Coll, Dept Zool, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kale, VP (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Univ Pune Campus, Pune, Maharashtra, India.	vpkale@nccs.res.in	Kale, Vaijayanti/R-9342-2019; Bellare, Jayesh/AAO-8713-2020	Kale, Vaijayanti/0000-0001-7498-7563; Bellare, Jayesh/0000-0002-6792-8327	BRNS [2011/37B/26IBRNS/1251]; National Centre for Cell Science (NCCS)	BRNS(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); National Centre for Cell Science (NCCS)	This work is funded by BRNS, Sanction No. 2011/37B/26IBRNS/1251. The Director of National Centre for Cell Science (NCCS) also provided intramural funding to VPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Callaghan MJ, 2005, ANTIOXID REDOX SIGN, V7, P1476, DOI 10.1089/ars.2005.7.1476; Celestina Mazzotta, 2017, ARTHRITIS RES THER, V19, P27, DOI [10.1186/s13075-017-1233-0, DOI 10.1186/S13075-017-1233-0]; Cheng MF, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/513853; De Falco E, 2009, J CELL MOL MED, V13, P3405, DOI 10.1111/j.1582-4934.2009.00655.x; Dixit K., 2017, BIOMEDICAL RES J, V4, P82; Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7; Fisher MB, 2012, TISSUE ENG REGEN MED, P251; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hamed S, 2011, CARDIOVASC RES, V91, P9, DOI 10.1093/cvr/cvq412; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Hynes B, 2013, EUR HEART J, V34, P782, DOI 10.1093/eurheartj/ehr435; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kamoun EA, 2017, J ADV RES, V8, P217, DOI 10.1016/j.jare.2017.01.005; Kanitkar M, 2014, J BIOMED RES, V1, P95; Kanitkar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069960; Kimira Y, 2014, BIOCHEM BIOPH RES CO, V453, P498, DOI 10.1016/j.bbrc.2014.09.121; Kolluru GK, 2012, INT J VASCULAR MED, V918267, P30; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Loomans CJM, 2005, ANTIOXID REDOX SIGN, V7, P1468, DOI 10.1089/ars.2005.7.1468; Maekawa Y, 2011, GERIATR GERONTOL INT, V11, P510, DOI 10.1111/j.1447-0594.2011.00699.x; Makridakis M, 2013, BBA-PROTEINS PROTEOM, V1834, P2380, DOI 10.1016/j.bbapap.2013.01.032; Maltese G, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/757469; Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Oh BJ, 2010, BIOCHEM BIOPH RES CO, V398, P627, DOI 10.1016/j.bbrc.2010.06.108; Parekh N, 2017, RSC ADV, V7, P26551, DOI 10.1039/c7ra03288a; Pendharkar N, 2016, J PROTEOMICS, V132, P112, DOI 10.1016/j.jprot.2015.11.024; Rae PC, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-11; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Shimada Toshifumi, ANGIOGENESIS VASCULO; Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126; Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang X, 2016, ONCOTARGET, V7, P44941, DOI 10.18632/oncotarget.10377; Wu Danli, 2011, J Vis Exp, DOI 10.3791/3357; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yamashita K, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000045; Yamauchi M, 2016, BIOCHEMBIOPHYS RES C, V13, P845, DOI [10.1016/j.bbrc.2016.03.138, DOI 10.1016/J.BBRC.2016.03.138]; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f; Zullo JA, 2015, STEM CELL TRANSL MED, V4, P852, DOI 10.5966/sctm.2014-0111	47	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202510	10.1371/journal.pone.0202510	http://dx.doi.org/10.1371/journal.pone.0202510			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153276	Green Submitted, gold, Green Published			2022-12-26	WOS:000443001700017
J	Fortuna, ME; Vasilache, V; Ignat, M; Silion, M; Vicol, T; Patras, X; Miron, I; Lobiuc, A				Fortuna, Maria-Emiliana; Vasilache, Viorica; Ignat, Maria; Silion, Mihaela; Vicol, Tudor; Patras, Xenia; Miron, Ionel; Lobiuc, Andrei			Elemental and macromolecular modifications in Triticum aestivum L. plantlets under different cultivation conditions	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; WHEATGRASS; MANGANESE; MAGNESIUM; SYSTEMS; GROWTH; SOIL; SUPPLEMENTATION; ACCUMULATION; MECHANISMS	Young wheat plantlets (wheatgrass), represent a significant source of minerals, enzymes, vitamins, while also rich in phenolics and chlorophylls, with considerable bioactivities. As the biosynthesis of such compounds may be influenced by growth conditions, the current research assesses wheatgrass composition in soil based and hydroponic systems, using water with different elemental composition. FTIR spectroscopy did not reveal significant variations between juice and extracts cultivated in different setups. Surface elemental composition indicated higher Na, P, Si concentrations in hydroponic plants, while AAS analyses showed increased Ca and Mn in soil presence. HPLC-MS of extracts showed that soil and spring water increased chlorophyll and hydroxychlorophyll a concentrations. Phenolic contents were higher in hydroponic plants, while maximum values were recorded for spring water. Radical scavenging activity was stimulated by the use of spring water. Results indicate that wheatgrass with improved mineral and macromolecular composition may be obtained using accessible cultivation setups.	[Fortuna, Maria-Emiliana; Ignat, Maria; Silion, Mihaela; Patras, Xenia] Petru Poni Inst Macromol Chem, Iasi, Romania; [Vasilache, Viorica] Alexandru Ioan Cuza Univ, Interdisciplinary Res Dept, Field Sci, Iasi, Romania; [Ignat, Maria] Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania; [Vicol, Tudor; Patras, Xenia] Apollonia Univ, Iasi, Romania; [Miron, Ionel] Alexandru Ioan Cuza Univ, Fac Biol, Iasi, Romania; [Lobiuc, Andrei] Alexandru Ioan Cuza Univ, CERNESIM L2, Iasi, Romania; [Lobiuc, Andrei] Stefan cel Mare Univ, Fac Food Engn, Suceava, Romania	Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Apollonia University; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Stefan cel Mare University of Suceava	Vasilache, V (corresponding author), Alexandru Ioan Cuza Univ, Interdisciplinary Res Dept, Field Sci, Iasi, Romania.; Lobiuc, A (corresponding author), Alexandru Ioan Cuza Univ, CERNESIM L2, Iasi, Romania.; Lobiuc, A (corresponding author), Stefan cel Mare Univ, Fac Food Engn, Suceava, Romania.	viorica_18v@yahoo.com; andrei.lobiuc@fia.usv.ro	Ignat, Maria/AAA-2511-2022; Ignat, Maria/G-9396-2012; Silion, Mihaela/L-6048-2013; Viorica, Vasilache/A-3614-2019; Lobiuc, Andrei/I-2824-2017	Ignat, Maria/0000-0001-6884-1322; Viorica, Vasilache/0000-0002-8866-3460; 				Abdel-Aal E. M., 2008, The Open Agriculture Journal, V2, P7, DOI 10.2174/1874331500802010007; Ahmad P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00513; Akbas E, 2017, J FUNCT FOODS, V28, P19, DOI 10.1016/j.jff.2016.11.010; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Durairaj V, 2014, ASIAN PAC J TROP MED, V7, pS398, DOI 10.1016/S1995-7645(14)60265-0; Fageria NK, 2015, HDB PLANT NUTR, P127; Ghumman A, 2017, INT J FOOD SCI TECH, V52, P2191, DOI 10.1111/ijfs.13498; HEENAN DP, 1981, PLANT SOIL, V61, P447, DOI 10.1007/BF02182025; Kashudhan H, 2017, J PHARMACOGNOSY PHYT, V6, P338; Konopka I, 2012, MOLECULES, V17, P12341, DOI 10.3390/molecules171012341; Kulkarni SD, 2007, FOOD CHEM, V103, P681, DOI 10.1016/j.foodchem.2006.07.057; Kulkarni SD, 2006, FOOD CHEM, V95, P699, DOI 10.1016/j.foodchem.2005.04.006; Kulkarni SD, 2006, PHYTOTHER RES, V20, P218, DOI 10.1002/ptr.1838; Kumar Nitya, 2017, Journal of Dietary Supplements, V14, P503, DOI 10.1080/19390211.2016.1267063; Lidon FC, 2004, J PLANT PHYSIOL, V161, P1235, DOI 10.1016/j.jplph.2004.02.003; Lobiuc A, 2017, MOLECULES, V22, DOI 10.3390/molecules22122111; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Martinez-Ballesta MC, 2010, AGRON SUSTAIN DEV, V30, P295, DOI 10.1051/agro/2009022; Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008; Miller DD, 2013, FOOD SYSTEM STRATEGI, V13-06, P1; Ogutu F.O., 2017, FOOD SCI QUAL MANAG, V65, P33; Ozkose A, 2016, NOT BOT HORTI AGROBO, V44, P499, DOI 10.15835/nbha44210405; Roca M, 2016, WOODHEAD PUBL FOOD S, V295, P125, DOI 10.1016/B978-0-08-100371-8.00006-3; Salas-Perez L, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8020013; Salcedo, 2011, CHLOROPHYLL STRUCTUR, P177; Santos A. M. P., 2003, Journal of Food Technology, V1, P42; Selma MV, 2012, POSTHARVEST BIOL TEC, V63, P16, DOI 10.1016/j.postharvbio.2011.08.002; Sgherri C, 2010, FOOD CHEM, V123, P416, DOI 10.1016/j.foodchem.2010.04.058; Shenker M, 2004, J PLANT PHYSIOL, V161, P197, DOI 10.1078/0176-1617-00931; Shyam R, 2007, J ALTERN COMPLEM MED, V13, P789, DOI 10.1089/acm.2007.7137; Sinkovic L, 2015, FOOD CHEM, V166, P507, DOI 10.1016/j.foodchem.2014.06.024; Strain J.J., 2009, INTRO HUMAN NUTR, P188; Subbarao GV, 2003, CRIT REV PLANT SCI, V22, P391, DOI 10.1080/07352680390243495; Tavakkoli E, 2010, FUNCT PLANT BIOL, V37, P621, DOI 10.1071/FP09202; Tsai CC, 2013, J BIOL CHEM, V288, P17689, DOI 10.1074/jbc.M112.448381; Urbonaviciute A, 2009, ZEMDIRBYSTE, V96, P119; Verbruggen N, 2013, PLANT SOIL, V368, P87, DOI 10.1007/s11104-013-1589-0	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202441	10.1371/journal.pone.0202441	http://dx.doi.org/10.1371/journal.pone.0202441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153262	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700016
J	Yue, CY; Lu, LKY; Li, M; Zhang, QL; Ying, CM				Yue, Chao-Yan; Lu, Lou-kai-yi; Li, Meng; Zhang, Qian-Lan; Ying, Chun-Mei			Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women	PLOS ONE			English	Article							INSULIN-RESISTANCE; FOLLICULAR ARREST; MLLERIAN HORMONE; HYPERANDROGENISM; EXPRESSION; RESERVE; MARKERS; EXCESS; LEVEL; PCOS	Objective We intended to establish the threshold for anti-Mullerian hormone (AMH) in the diagnosis of polycystic ovary syndrome (PCOS) in China. Methods A total of 771 women (653 with PCOS and 118 healthy controls) were enrolled. The serum AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH), FSH/LH, prolactin, estradiol, testosterone (T), dehydroepiandrosterone sulfate (DHEA-S), sex hormone-binding globulin (SHBG), 17 alpha-OH progesterone (17 alpha-OHP), fasting insulin (INS), fasting glucose, free androgen index (FAI%) and homeostasis model assessment for insulin resistance (HOMA-IR) index were analyzed, and the diagnostic utility of AMH, LH/FSH, T and INS was established using receiver operator characteristic (ROC) curves. With AMH, LH/FSH, T and INS as independent variables, a logistic regression model was established, and the ROC curve for combined detection was fitted with the probability value of the model. Results The serum level of FSH, LH, LH/FSH, AMH, FAI%, 17 alpha-OHP, fasting INS, T, SHBG, DHEAS and HOMA-IR were altered in the PCOS patients. The best compromise between sensitivity and specificity was found at an AMH cut-off level of 8.16 ng/ml and 5.89 ng/ml for the age groups 20-29 and 30-39 years, with the corresponding area under the curve being 0.846 and 0.865 respectively. The area under the ROC curve for combined detection was 0.951, which was significantly greater than that of each index. Finally, the concentration of AMH was associated with FSH, LH, LH/FSH, T, and ovarian volume in PCOS patients. Conclusion The optimal AMH diagnostic threshold for PCOS was 8.16 ng/ml (20-29 years) and 5.89 ng/ml (30-39 years) in the Chinese population of this study. Moreover, serum AMH, LH/FSH, T and INS could be used in combination to improve the diagnostic specificity and sensitivity for the detection of PCOS.	[Yue, Chao-Yan; Lu, Lou-kai-yi; Zhang, Qian-Lan; Ying, Chun-Mei] Fudan Univ, Dept Lab Med, Obstet & Gynecol Hosp, Shanghai, Peoples R China; [Li, Meng] Fudan Univ, Dept Ultrasound, Obstet & Gynecol Hosp, Shanghai, Peoples R China	Fudan University; Fudan University	Ying, CM (corresponding author), Fudan Univ, Dept Lab Med, Obstet & Gynecol Hosp, Shanghai, Peoples R China.	ycmzh2012@163.com		Yue, Chao-yan/0000-0003-4030-0166	Shanghai Municipal Commission of Health and Family Planning [20154Y0029]	Shanghai Municipal Commission of Health and Family Planning	This work was supported by Shanghai Municipal Commission of Health and Family Planning (No. 20154Y0029).	Bako AU, 2005, REV GYNECOL PRACT, V5, P115; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; CARTER GD, 1983, ANN CLIN BIOCHEM, V20, P262, DOI 10.1177/000456328302000502; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Dewailly D, 2010, J CLIN ENDOCR METAB, V95, P4399, DOI 10.1210/jc.2010-0334; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Fraissinet A, 2017, HUM REPROD, V32, P1716, DOI 10.1093/humrep/dex239; Genuth S, 2003, DIABETES CARE, V26, P3160; Jonard S, 2004, HUM REPROD UPDATE, V10, P107, DOI 10.1093/humupd/dmh010; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Nardo LG, 2009, HUM REPROD, V24, P2917, DOI 10.1093/humrep/dep225; ORSINI LF, 1985, FERTIL STERIL, V43, P709; Pellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pierre A, 2013, HUM REPROD, V28, P762, DOI 10.1093/humrep/des460; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; Pigny P, 2016, FERTIL STERIL, V105, P1063, DOI 10.1016/j.fertnstert.2015.12.023; Piouka A, 2009, AM J PHYSIOL-ENDOC M, V296, pE238, DOI 10.1152/ajpendo.90684.2008; Romualdi D, 2016, REPROD SCI, V23, P655, DOI 10.1177/1933719115611751; Skalba P, 2011, EUR J OBSTET GYN R B, V158, P254, DOI 10.1016/j.ejogrb.2011.06.006; Speroff L., 2005, LIPPINCOTT WILLIAMS, V12, P485; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Streuli I, 2008, FERTIL STERIL, V90, P395, DOI 10.1016/j.fertnstert.2007.06.023; Stubbs SA, 2005, J CLIN ENDOCR METAB, V90, P5536, DOI 10.1210/jc.2005-0907; Weerakiet S, 2007, GYNECOL ENDOCRINOL, V23, P455, DOI 10.1080/09513590701485212; Wiweko B, 2014, J ASSIST REPROD GEN, V31, P1311, DOI 10.1007/s10815-014-0300-6; Xu J, 2018, BIOL REPROD, V98, P197, DOI 10.1093/biolre/iox181	28	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203129	10.1371/journal.pone.0203129	http://dx.doi.org/10.1371/journal.pone.0203129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153296	Green Submitted, Green Published, gold			2022-12-26	WOS:000443001700046
J	Araujo, ARD; Melo, T; Maciel, EA; Pereira, C; Morais, CM; Santinha, DR; Tavares, JF; Oliveira, H; Jurado, AS; Costa, V; Domingues, P; Domingues, MRM; Santos, MAS				Araujo, Ana Rita D.; Melo, Tania; Maciel, Elisabete A.; Pereira, Clara; Morais, Catarina M.; Santinha, Deolinda R.; Tavares, Joana F.; Oliveira, Helena; Jurado, Amalia S.; Costa, Vitor; Domingues, Pedro; Domingues, Maria Rosario M.; Santos, Manuel A. S.			Errors in protein synthesis increase the level of saturated fatty acids and affect the overall lipid profiles of yeast	PLOS ONE			English	Article							GENETIC-CODE ALTERATION; TRANSFER-RNA SYNTHETASE; MACULAR DYSTROPHY; BARTH-SYNDROME; SUPERCOMPLEX FORMATION; MYOCLONIC EPILEPSY; MITOCHONDRIAL-DNA; RESPIRATORY-CHAIN; CYTOCHROME BC(1); OXIDATIVE STRESS	The occurrence of protein synthesis errors (mistranslation) above the typical mean mistranslation level of 10(-4) is mostly deleterious to yeast, zebrafish and mammal cells. Previous yeast studies have shown that mistranslation affects fitness and deregulates genes related to lipid metabolism, but there is no experimental proof that such errors alter yeast lipid profiles. We engineered yeast strains to misincorporate serine at alanine and glycine sites on a global scale and evaluated the putative effects on the lipidome. Lipids from whole cells were extracted and analysed by thin layer chromatography (TLC), liquid chromatography-mass spectrometry(LC-MS) and gas chromatography (GC). Oxidative damage, fatty acid desaturation and membrane fluidity changes were screened to identify putative alterations in lipid profiles in both logarithmic (fermentative) and post-diauxic shift (respiratory) phases. There were alterations in several lipid classes, namely lyso-phosphatidylcholine, phosphatidic acid, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, and triglyceride, and in the fatty acid profiles, namely C16:1, C16:0, C18:1 and C18:0. Overall, the relative content of lipid species with saturated FA increased in detriment of those with unsaturated fatty acids. The expression of the OLE1 mRNA was deregulated, but phospholipid fluidity changes were not observed. These data expand current knowledge of mistranslation biology and highlight its putative roles in human diseases.	[Araujo, Ana Rita D.; Tavares, Joana F.; Santos, Manuel A. S.] Univ Aveiro, Dept Med Sci, Aveiro, Portugal; [Araujo, Ana Rita D.; Tavares, Joana F.; Santos, Manuel A. S.] Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal; [Araujo, Ana Rita D.; Melo, Tania; Maciel, Elisabete A.; Santinha, Deolinda R.; Domingues, Pedro; Domingues, Maria Rosario M.] Univ Aveiro, Mass Spectrometry Ctr, Dept Chem, QOPNA, Aveiro, Portugal; [Maciel, Elisabete A.] Univ Aveiro, Dept Biol, CESAM, Aveiro, Portugal; [Pereira, Clara; Costa, Vitor] Univ Porto, i3S, Porto, Portugal; [Pereira, Clara; Costa, Vitor] Univ Porto, IBMC, Porto, Portugal; [Pereira, Clara; Costa, Vitor] Univ Porto, Inst Ciencias Biomed Abel Salazar, Dept Biol Mol, Porto, Portugal; [Morais, Catarina M.; Jurado, Amalia S.] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal; [Oliveira, Helena] Univ Aveiro, Dept Biol, Lab Biotechnol & Cyt, CESAM, Aveiro, Portugal; [Jurado, Amalia S.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Aveiro; Universidade de Coimbra	Santos, MAS (corresponding author), Univ Aveiro, Dept Med Sci, Aveiro, Portugal.; Santos, MAS (corresponding author), Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal.; Domingues, MRM (corresponding author), Univ Aveiro, Mass Spectrometry Ctr, Dept Chem, QOPNA, Aveiro, Portugal.	mrd@ua.pt; msantos@ua.pt	Melo, Tânia/Q-6709-2018; Jurado, Amália S./AAJ-9498-2020; Oliveira, Helena/M-5068-2013; Morais, Catarina M./I-2093-2017; Domingues, Pedro/E-5202-2010; Costa, Vítor/A-2647-2008; Pereira, Clara/D-4963-2013; Domingues, Maria Rosario/K-7444-2014; Maciel, Elisabete/I-8868-2017	Melo, Tânia/0000-0002-0508-4034; Oliveira, Helena/0000-0002-4673-0696; Morais, Catarina M./0000-0002-4762-0798; Domingues, Pedro/0000-0002-8060-7675; Costa, Vítor/0000-0002-7868-4663; Pereira, Clara/0000-0002-8167-6912; Tavares, Joana/0000-0001-7083-6266; S. Jurado, Amalia/0000-0001-7095-5337; Santos, Manuel/0000-0002-0437-1146; Domingues, Maria Rosario/0000-0001-5357-3601; D. Araujo, Ana Rita/0000-0003-3729-747X; Santinha, Deolinda/0000-0001-8948-5232; Maciel, Elisabete/0000-0003-3637-6854	FCT (Fundacao para a Ciencia e a Tecnologia); European Union; QREN; POPH; FEDER; COMPETE through the iBiMED [FCT-ANR/IMI-MIC/0041/2012, PTDC/IMI-MIC/5350/2014, PTDC/BEX-BCM/2121/2014, UID/BIM/04501/2013]; COMPETE through the QOPNA research units [PTDC/QUI-BIQ/104968/2008, UID QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296]; COMPETE through the RNEM [LISBOA-01-0145-FEDER-402-022125, REDE/1504/REM/2005]; European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme [CENTRO-01-0145-FEDER-000008]; European Regional Development Fund (ERDF), through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation; FCT - Fundacao para a Ciencia e a Tecnologia [POCI-01-0145-FEDER-016390, POCI-01-0145-FEDER-007440]; FCT [SFRH/BD/78835/2011, SFRH/BD/79077/2011, SFRH/BPD/104165/2014, SFRH/BPD/111736/2015, BPD/UI51/5388/2017]; Fundo Social Europeu and Programa Operacional Potencial Humano through FCT investigator grant [IF/00889/2015]; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/104968/2008, UID/BIM/04501/2013, FCT-ANR/IMI-MIC/0041/2012] Funding Source: FCT	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); European Union(European Commission); QREN; POPH; FEDER(European Commission); COMPETE through the iBiMED; COMPETE through the QOPNA research units; COMPETE through the RNEM; European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme; European Regional Development Fund (ERDF), through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Social Europeu and Programa Operacional Potencial Humano through FCT investigator grant; Fundação para a Ciência e a Tecnologia	This work was supported by FCT (Fundacao para a Ciencia e a Tecnologia), the European Union, QREN, POPH, FEDER and COMPETE [FCT-ANR/IMI-MIC/0041/2012; PTDC/IMI-MIC/5350/2014; PTDC/BEX-BCM/2121/2014] through the iBiMED (UID/BIM/04501/2013) and QOPNA research units [PTDC/QUI-BIQ/104968/2008; UID QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296], and RNEM [LISBOA-01-0145-FEDER-402-022125 that concerns the Portuguese Mass Spectrometry Network), REDE/1504/REM/2005]. This work was also financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000008: BrainHealth 2020, and through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT - Fundacao para a Ciencia e a Tecnologia, I.P., under projects POCI-01-0145-FEDER-016390:CANCEL STEM and POCI-01-0145-FEDER-007440. Ana R. D. Araujo [SFRH/BD/78835/2011], Catarina Morais [SFRH/BD/79077/2011], Elisabete Maciel [SFRH/BPD/104165/2014], Helena Oliveira [SFRH/BPD/111736/2015], and Tania Melo [BPD/UI51/5388/2017] were supported by FCT grants. Clara Pereira was supported by Fundo Social Europeu and Programa Operacional Potencial Humano through FCT investigator grant IF/00889/2015.	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Ambasudhan R, 2004, GENOMICS, V83, P615, DOI 10.1016/j.ygeno.2003.10.004; Arnarez C, 2013, J AM CHEM SOC, V135, P3112, DOI 10.1021/ja310577u; Aued-Pimentel S, 2004, J CHROMATOGR A, V1054, P235, DOI 10.1016/j.chroma.2004.07.090; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Ballesteros M, 2001, EMBO J, V20, P5280, DOI 10.1093/emboj/20.18.5280; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Costa TLVM, 2012, CELLULAR RESPONSES G; Daum G, 1999, YEAST, V15, P601, DOI 10.1002/(SICI)1097-0061(199905)15:7<601::AID-YEA390>3.0.CO;2-N; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Epand RM, 2017, J MEMBRANE BIOL, V250, P353, DOI 10.1007/s00232-016-9909-y; Fan YQ, 2015, NUCLEIC ACIDS RES, V43, P1740, DOI 10.1093/nar/gku1404; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Gasch AP, 2007, YEAST STRESS RESPONS, P11; Geslain R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1083; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomes ACEO, 2012, THESIS; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gong J, 1996, BIOCHEMISTRY-US, V35, P14109, DOI 10.1021/bi961296h; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Higdon A, 2012, BIOCHEM J, V442, P453, DOI 10.1042/BJ20111752; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kajiwara S, 2000, APPL MICROBIOL BIOT, V53, P568, DOI 10.1007/s002530051658; Karan G, 2005, MOL VIS, V11, P657; Kim HS, 2011, BIOTECHNOL LETT, V33, P509, DOI 10.1007/s10529-010-0465-8; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Lamari F, 2013, J INHERIT METAB DIS, V36, P411, DOI 10.1007/s10545-012-9509-7; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li JX, 1998, J BIOL CHEM, V273, P6796, DOI 10.1074/jbc.273.12.6796; Loo TW, 2015, J BIOL CHEM, V290, P29389, DOI 10.1074/jbc.M115.695171; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mateus DD, 2011, MOL RECONSTRUCTION G; Mateus DD, 2013, RNA BIOL, V10, P969, DOI 10.4161/rna.24683; Miranda I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000996; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Paredes JA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-55; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Reverendo M, 2014, RNA BIOL, V11, P1199, DOI 10.4161/rna.32199; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; Schink KO, 2013, BIOESSAYS, V35, P900, DOI 10.1002/bies.201300064; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; SHEN HG, 1994, J BIOL CHEM, V269, P9424; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Shulga YV, 2012, J BIOL CHEM, V287, P35953, DOI 10.1074/jbc.M112.370155; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; Simoes JMS, 2013, PHENOTYPIC CONSEQUEN; Simoes J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00401; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	93	2	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202402	10.1371/journal.pone.0202402	http://dx.doi.org/10.1371/journal.pone.0202402			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148852	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200009
J	Ohur, I; Velamuri, M				Ohur, Ilke; Velamuri, Malathi			The gap between self-reported and objective measures of disease status in India	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LYMPHOEPITHELIOMA-LIKE CARCINOMA; EPSTEIN-BARR-VIRUS; BLOOD-PRESSURE; HEALTH; HYPERTENSION; POPULATION; MORTALITY; ADDRESS; RISK	Researchers interested in the effect of health on various life outcomes (such as employment, earnings and life satisfaction) often use self-reported health and disease status as an indicator of true, underlying health status. Self-reports appear to be reasonable measures of overall health. For example, self-assessed overall health has been found to be a reliable predictor of mortality. However, the validity of self-reports is questionable when investigating specific diseases such as diabetes and hypertension. A small and nascent body of research comparing self-reported status on certain diseases with the true status based on clinical diagnoses has found significant gaps. These validation exercises predominantly use data from high-income countries. In this paper, we use survey data from India to compare self-reports of disease prevalence to diagnostic tests conducted on the same individuals. We focus on hypertension and lung disease, two of the primary causes of death in India. We find that self-reported measures substantially understate the true disease burden for both conditions. The attenuation bias from using self-reports is over 80 percent for both diseases, and bigger than estimates from high-income countries. We test and reject the hypothesis that self-reports of the disease status are identical to the true disease status in expectation. We identify characteristics associated with false negative reporting (reporting not having the disease but testing positive for it) for both diseases. The large awareness gap between self-reports and true disease burden indicates multiple deficiencies in India's public health policy. The survey data depicts limited access to medical facilities, high levels of health illiteracy, low rates of health insurance, and other barriers related to poverty and lack of equity in the delivery of health services. These factors prevent timely intervention for managing health and controlling disease, invariably leading to morbidity and often to premature death.	[Ohur, Ilke] Univ South Australia, Sch Commerce, Adelaide, SA, Australia; [Velamuri, Malathi] Chennai Math Inst, Madras, Tamil Nadu, India	University of South Australia; Chennai Mathematical Institute	Ohur, I (corresponding author), Univ South Australia, Sch Commerce, Adelaide, SA, Australia.	ilke.onur@unisa.edu.au	PAN, ZEQIANG/X-6341-2018; Onur, Ilke/F-3868-2013	Onur, Ilke/0000-0001-5082-6298				Baker M, 2004, J HUM RESOUR, V39, P1067, DOI 10.2307/3559039; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Beniwal Sunil, 2011, J Assoc Physicians India, V59, P360; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Bloom D., 2014, LONGITUDINAL AGING S; BOUND J, 1994, J LABOR ECON, V12, P345, DOI 10.1086/298348; Castro CY, 2001, HUM PATHOL, V32, P863, DOI 10.1053/hupa.2001.26457; Cramm JM, 2015, J POPUL AGEING, V8, P245, DOI 10.1007/s12062-015-9122-2; Cutler DM, 2008, 14333 NAT BUR EC RES; Cutler DM., 2006, ED HLTH EVALUATING T; Das Shyamal Kumar, 2005, Int J Med Sci, V2, P70; Gupta R., 2017, RUHS J HLTH SCI, V2, P40; Irwin A, 2006, PLOS MED, V3, P749, DOI 10.1371/journal.pmed.0030106; Johnston DW, 2009, J HEALTH ECON, V28, P540, DOI 10.1016/j.jhealeco.2009.02.010; Johri M, 2015, J EPIDEMIOL COMMUN H, V69, P849, DOI 10.1136/jech-2014-205436; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; KPMG, 2016, POST BUDG SECT POINT; KPMG, 2015, HEALTHC IND CURR STA, V2015; Lahariya Chandrakant, 2015, Indian J Public Health, V59, P172, DOI 10.4103/0019-557X.164653; Lakoski SG, 2005, J AM COLL CARDIOL, V46, P1869, DOI 10.1016/j.jacc.2005.07.050; Lee J., 2012, LONGITUDINAL AGING S; McDade TW, 2004, CLIN CHEM, V50, P652, DOI 10.1373/clinchem.2003.029488; Mohan S, 2013, INDIAN J MED RES, V137, P627; Ngan RKC, 2002, CLIN CANCER RES, V8, P986; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Onur I, 2016, J HUM CAPITAL, V10, P520, DOI 10.1086/688898; Powdthavee N, 2010, J HUM CAPITAL, V4, P173, DOI 10.1086/657020; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Singh N, 2008, HEALTH AFFAIR, V27, P991, DOI 10.1377/hlthaff.27.4.991; Suziedelyte A, 2013, ECON LETT, V121, P163, DOI 10.1016/j.econlet.2013.07.027; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; WHO, 2014, IND AIR QUAL GUID HO; World Health Organization, 2015, GLOB TUB REP 2015; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202786	10.1371/journal.pone.0202786	http://dx.doi.org/10.1371/journal.pone.0202786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148894	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000442804200023
J	Yang, SH; Lee, TY; Ho, CA; Yang, CY; Huang, WY; Lin, YC; Nieh, S; Lin, YS; Chen, SF; Lin, FH				Yang, Shih-Hsien; Lee, Tsai-Yu; Ho, Chun An; Yang, Chin-Yuh; Huang, Wen-Yen; Lin, Yu-Chun; Nieh, Shin; Lin, Yaoh-Shiang; Chen, Su-Feng; Lin, Fu-Huang			Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma	PLOS ONE			English	Article							ALPHA-7-NICOTINIC ACETYLCHOLINE-RECEPTOR; ALDEHYDE DEHYDROGENASE 1; ORAL EPITHELIAL-CELLS; STEM-CELLS; MESENCHYMAL TRANSDIFFERENTIATION; CANCER; APOPTOSIS; ALKALOIDS; ARECA; EMT	Long-term nicotine-derived nitrosamine ketone (NNK) and arecoline exposure promotes carcinogenesis and head and neck squamous cell carcinoma (HNSCC) progression, although most associated data on the two were analyzed individually. The molecular mechanisms underlying tumor progression associated with the synergistic effects of NNK and arecoline remain unclear. We treated SCC-25 and FaDu cells with NNK and arecoline (separately or in combination) for 3 months. Comparative analysis was performed to investigate the mechanism underlying the acquisition of properties related to tumor promotion, including stemness, anti-apoptosis, and resistance to HNSCC therapeutics. Long-term exposure to NNK and arecoline resulted in an increase in cancer stem cell properties, anti-apoptosis, and the resistance to cisplatin in HNSCC. We detected abundant epidermal growth factor receptor (EGFR) expression in HNSCC cells after combined treatment with NNK and arecoline. EGFR was pivotal in inducing tumor promotion and anti-apoptosis in cancer cells by inducing pAKT and NF kappa B. Combined treatment with NNK and arecoline synergistically facilitated tumor aggressiveness via EGFR-AKT signaling. Targeting EGFR-AKT signaling may be a feasible strategy for treating HNSCC.	[Yang, Shih-Hsien] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Yang, Shih-Hsien] Natl Def Med Ctr, Dept Med Adm Off, Taipei, Taiwan; [Yang, Shih-Hsien] Triserv Gen Hosp, Beitou Branch, Taipei, Taiwan; [Lee, Tsai-Yu] Triserv Gen Hosp, Songshan Branch, Natl Def Med Ctr, Div Colon & Rectum Surg,Dept Surg, Taipei, Taiwan; [Ho, Chun An; Lin, Yu-Chun; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Ho, Chun An; Lin, Yu-Chun; Nieh, Shin] Triserv Gen Hosp, Taipei, Taiwan; [Yang, Chin-Yuh] Cheng Hsin Hosp, Dept Dent, Taipei, Taiwan; [Huang, Wen-Yen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Chen, Su-Feng] China Med Univ, Dept Dent Hyg & Sch Dent, Taichung, Taiwan; [Lin, Fu-Huang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Cheng Hsin General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; China Medical University Taiwan; National Defense Medical Center	Lin, YS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Chen, SF (corresponding author), China Med Univ, Dept Dent Hyg & Sch Dent, Taichung, Taiwan.; Lin, FH (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	yaohshiang@gmail.com; su374065@gmail.com; nolding@ms10.hinet.net	huang, wen/GXW-0661-2022		Tri-Service General Hospital [TSGH-C106-040, TSGH-C106-038]; National Science Council, Republic of China [NSC105-2320-B-039-028-MY2, NSC105-2314-B-016-028-MY2]	Tri-Service General Hospital; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was partly supported by the Tri-Service General Hospital (Grant Numbers TSGH-C106-040 and TSGH-C106-038) and the National Science Council, Republic of China (Grant Numbers NSC105-2320-B-039-028-MY2 and NSC105-2314-B-016-028-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by the Tri-Service General Hospital (Grant Numbers TSGH-C106-040 and TSGH-C106-038) and the National Science Council, Republic of China (Grant Numbers NSC105-2320-B-039-028-MY2 and NSC105-2314-B-016-028-MY2). We thank Chun An Ho for her assistance in performing some experiments in this study.	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Bai Y, 2017, EXP BIOL MED, V242, P527, DOI 10.1177/1535370216685433; Brunzell DH, 2014, ANN NY ACAD SCI, V1327, P27, DOI 10.1111/nyas.12421; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen X, 2017, ONCOL REP, V38, P2141, DOI 10.3892/or.2017.5874; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chinn SB, 2015, HEAD NECK-J SCI SPEC, V37, P317, DOI 10.1002/hed.23600; Chinn Steven B, 2012, Front Endocrinol (Lausanne), V3, P90, DOI 10.3389/fendo.2012.00090; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Chou MY, 2015, ORAL ONCOL, V51, P31, DOI 10.1016/j.oraloncology.2014.10.002; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Grando Sergei A, 2012, Handb Exp Pharmacol, P429, DOI 10.1007/978-3-642-23274-9_18; Havelek R, 2014, PHYTOMEDICINE, V21, P479, DOI 10.1016/j.phymed.2013.09.005; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang LW, 2012, TOXICOL APPL PHARM, V258, P199, DOI 10.1016/j.taap.2011.11.001; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Huang S, 2016, ONCOTARGET, V7, P38718, DOI 10.18632/oncotarget.9586; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Javed F, 2010, SCAND J PUBLIC HEALT, V38, P838, DOI 10.1177/1403494810379291; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kao SY, 2015, CHIN J DENT RES, V18, P7, DOI 10.3290/j.cjdr.a33965,PubMed:25815378; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lord GA, 2002, ADDICT BIOL, V7, P99, DOI 10.1080/13556210120091455; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Nair JJ, 2016, CURR MED CHEM, V23, P161, DOI 10.2174/0929867323666151118121124; Nair JJ, 2012, BIOORG MED CHEM LETT, V22, P6195, DOI 10.1016/j.bmcl.2012.08.005; Nieh S, 2015, HEAD NECK-J SCI SPEC, V37, P1712, DOI 10.1002/hed.23820; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Song H, 2015, ASIA-PAC J PUBLIC HE, V27, pNP47, DOI 10.1177/1010539513486921; Spindel Eliot R, 2012, Handb Exp Pharmacol, P451, DOI 10.1007/978-3-642-23274-9_19; Sun X, 2017, MAR DRUGS, V15, DOI 10.3390/md15070215; Tang J, 2013, SEMIN CANCER BIOL, V23, P533, DOI 10.1016/j.semcancer.2013.08.009; te Raa GD, 2016, BEST PRACT RES CL HA, V29, P90, DOI 10.1016/j.beha.2016.08.002; Thill M, 2011, MOL VIS, V17, P85; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Tsai LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087207; Uche FI, 2016, PHYTOTHER RES, V30, P1533, DOI 10.1002/ptr.5660; Wang TY, 2016, ONCOTARGET, V7, P84072, DOI 10.18632/oncotarget.11432; Wang W, 2012, ANN SURG ONCOL, V19, pS580, DOI 10.1245/s10434-011-2064-x; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wong HPS, 2007, TOXICOL APPL PHARM, V221, P261, DOI 10.1016/j.taap.2007.04.002; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Zhang D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-146	52	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201267	10.1371/journal.pone.0201267	http://dx.doi.org/10.1371/journal.pone.0201267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148841	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200002
J	Yan, Y; Xiao, SY; Liu, HH; Chue, P				Yan, Yuan; Xiao, Shuiyuan; Liu, Haihong; Chue, Pierre			Self-reported sexual orientation among undergraduates of 10 universities in Guangzhou, China	PLOS ONE			English	Article							MENTAL-HEALTH; US CITIES; WOMEN; GAY; DISPARITIES; DEPRESSION; BEHAVIOR; ISSUES; URBAN	Few studies have investigated the distribution of sexual orientation among Chinese university students and identified the socio-demographic factors associated with sexual orientation. For the present study, we administered a paper-based, 5-point, self-report, sexual orientation scale to a stratified, random sample of 9071 undergraduates across all 10 universities in Guangzhou Higher Education Mega Center, Guangzhou, China. Multivariable ordinal regression analysis was used to explore the relationship between demographic factors and sexual orientation. A total of 8320 respondents completed the survey. Of 8182 valid respondents, 80.6% self-reported as exclusively heterosexual, 12.6% self-reported as mostly heterosexual, 5.4% self-reported as bisexual, 0.7% self-reported as mostly homosexual, and 0.8% self-reported as exclusively homosexual. About one fifth of male students and one fourth of female students reported some degree of divergence from exclusive heterosexuality. This indicates that in China there are a large number of university students who are potentially involved in same-sex sexual attraction.	[Yan, Yuan; Xiao, Shuiyuan; Liu, Haihong] Cent S Univ, Xiangya Hosp, Mental Hlth Ctr, Changsha, Hunan, Peoples R China; [Yan, Yuan] Guangdong Univ Technol, Psychoeduc & Counseling Ctr, Guangzhou, Guangdong, Peoples R China; [Xiao, Shuiyuan] Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Chue, Pierre] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	Central South University; Guangdong University of Technology; Central South University; University of Alberta	Xiao, SY; Liu, HH (corresponding author), Cent S Univ, Xiangya Hosp, Mental Hlth Ctr, Changsha, Hunan, Peoples R China.; Xiao, SY (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn; liuhaihong9@csu.edu.cn			"CMB-CSU" Collaborative Program for Mental Health Policy Development (II) [14-188]; National Natural Science Foundation of China [81000587]	"CMB-CSU" Collaborative Program for Mental Health Policy Development (II); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by "CMB-CSU" Collaborative Program for Mental Health Policy Development (II)(Grant Number 14-188) and National Natural Science Foundation of China (Grant Number 81000587). Shuiyuan Xiao and Haihong Liu received the findings respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaert AF, 2018, J SEX RES, V55, P951, DOI 10.1080/00224499.2017.1287844; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; Eliason MJ, 2004, SUBST USE MISUSE, V39, P625, DOI 10.1081/JA-120030063; Feng YL, 2012, J ADOLESCENT HEALTH, V50, pS52, DOI 10.1016/j.jadohealth.2011.12.008; Fernando D, 2017, PREV MED, V105, P368, DOI 10.1016/j.ypmed.2017.06.013; Friedman MR, 2017, ARCH SEX BEHAV, V46, P903, DOI 10.1007/s10508-016-0863-7; Guo C, 2016, SEX HEALTH, V13, P497, DOI 10.1071/SH16041; Joseph HA, 2018, ARCH SEX BEHAV, V47, P183, DOI 10.1007/s10508-017-1052-z; Lambert EG, 2006, J HOMOSEXUAL, V50, P1, DOI 10.1300/J082v50n04_01; Lhomond B, 2014, ARCH SEX BEHAV, V43, P607, DOI 10.1007/s10508-013-0124-y; Lippa RA, 2010, ARCH SEX BEHAV, V39, P619, DOI 10.1007/s10508-008-9380-7; Lourie MA, 2017, J YOUTH ADOLESCENCE, V46, P943, DOI 10.1007/s10964-016-0553-8; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moser C, 2016, ARCH SEX BEHAV, V45, P505, DOI 10.1007/s10508-015-0625-y; Raymond HF, 2017, J ACQUIR IMMUNE DEFI; Rutter TM, 2016, J AFFECT DISORDERS, V206, P87, DOI 10.1016/j.jad.2016.07.003; Saewyc EM, 2011, J RES ADOLESCENCE, V21, P256, DOI 10.1111/j.1532-7795.2010.00727.x; Savin-Williams RC, 2016, PSYCHOL SCI PUBL INT, V17, P37, DOI 10.1177/1529100616637618; Shadaker S, 2017, JAIDS-J ACQ IMM DEF, V75, pS281, DOI [10.1097/QAI.0000000000001403, 10.1097/qai.0000000000001403]; Svallfors S, 2005, EUR SOC, V7, P255, DOI 10.1080/14616690500083493; Talley AE, 2017, ASSESSMENT, V24, P632, DOI 10.1177/1073191115617016; Talley AE, 2012, J STUD ALCOHOL DRUGS, V73, P290, DOI 10.15288/jsad.2012.73.290; VanKim NA, 2010, AM J PUBLIC HEALTH, V100, P2392, DOI 10.2105/AJPH.2009.186270; Ward Brian W, 2014, Natl Health Stat Report, P1; Zheng LJ, 2011, ARCH SEX BEHAV, V40, P533, DOI 10.1007/s10508-010-9700-6	25	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201817	10.1371/journal.pone.0201817	http://dx.doi.org/10.1371/journal.pone.0201817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142217	Green Submitted, gold, Green Published			2022-12-26	WOS:000442722500005
J	Tanabe, H; Aota, Y; Yamaguchi, Y; Kaneko, K; Imai, S; Takahashi, M; Taguri, M; Saito, T				Tanabe, Hironori; Aota, Yoichi; Yamaguchi, Yasuteru; Kaneko, Kanichiro; Imai, Sousuke; Takahashi, Masaki; Taguri, Masataka; Saito, Tomoyuki			Minodronate treatment improves low bone mass and reduces progressive thoracic scoliosis in a mouse model of adolescent idiopathic scoliosis	PLOS ONE			English	Article							CURVE PROGRESSION; MINERAL DENSITY; PINEALECTOMIZED CHICKEN; OSTEOGENESIS IMPERFECTA; CALMODULIN ANTAGONISTS; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; NATURAL-HISTORY; MICE MODEL; OSTEOPENIA	Recent studies have shown an association between osteopenia and adolescent idiopathic scoliosis (AIS) and implied that osteopenia plays a causative role in AIS development. This study aimed to determine if minodronate (MIN) treatment could prevent curve progression by increasing bone mass in a thoracic restraint (TR) mouse model, which develops causes the development of thoracic scoliosis similar to human AIS. A total of 100 young female C57BL6J mice were divided into four groups: (1) control with vehicle (CON/VEH; n = 20), (2) control with MIN (CON/MIN; n = 20), (3) TR with vehicle (TR/VEH; n = 30), or (4) TR with MIN (TR/MIN; n = 30). MIN (0.01 mg/kg/week) and vehicle were administered intraperitoneally to their respective groups. TR was performed at age 4 weeks, and the mice were sacrificed at age 9 weeks. Body weights, spine radiographs, femoral bone mineral density (BMD), serum bone marker levels, and histomorphometry of the cancellous bone of the thoracic vertebrae were analyzed. TR significantly reduced weight gain in the TR/VEH group relative to the CON/VEH group. TR also induced osteoporosis with accelerated bone resorption, as indicated by decreases in femoral BMDs and thoracic cancellous bone volume and increases in serum bone resorption marker levels and histomorphometric resorption parameters in the TR/VEH group. MIN partially improved body weight gain and improved poor bone structure relative to the TRNEH group by suppressing high bone resorption in the TR/MIN mice. MIN significantly reduced the curve magnitudes, as indicated by a 43% lower curve magnitude in the TR/MIN mice than in the TR/VEH mice (17.9 +/- 8.9 degrees vs. 31.5 +/- 13.1 degrees; p< 0.001). The administration of MIN increased bone mass and reduced the severity of scoliosis in the TR mice. MIN was suggested as a possible inhibitor of scoliosis development.	[Tanabe, Hironori; Yamaguchi, Yasuteru; Kaneko, Kanichiro; Imai, Sousuke; Saito, Tomoyuki] Yokohama City Univ, Dept Orthoped Surg, Yokohama, Kanagawa, Japan; [Aota, Yoichi] Yokohama Brain & Spine Ctr, Dept Spine & Spinal Cord, Yokohama, Kanagawa, Japan; [Takahashi, Masaki] Yokohama City Univ, Yokohama City Univ Ctr Novel & Exploratory Clin T, Yokohama, Kanagawa, Japan; [Taguri, Masataka] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Tanabe, H (corresponding author), Yokohama City Univ, Dept Orthoped Surg, Yokohama, Kanagawa, Japan.	iamhiro1978@yahoo.co.jp			JSPS KAKENHI [15K1041]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant No. 15K1041 (HT).	Ajiro Yasumitsu, 2010, Orthopedics, V33, P90, DOI 10.3928/01477447-20100104-14; Akel I, 2009, EUR SPINE J, V18, P499, DOI 10.1007/s00586-009-0912-1; Akel I, 2009, SPINE, V34, P533, DOI 10.1097/BRS.0b013e31818be0b1; Akhter MP, 2005, CALCIFIED TISSUE INT, V77, P319, DOI 10.1007/s00223-005-0072-1; Anissipour AK, 2014, J BONE JOINT SURG AM, V96A, P237, DOI 10.2106/JBJS.L.01596; Aota Y, 2013, SPINE J, V13, P1607, DOI 10.1016/j.spinee.2013.05.017; BACHRACH LK, 1990, PEDIATRICS, V86, P440; Bialo SR, 2014, CURR OSTEOPOROS REP, V12, P319, DOI 10.1007/s11914-014-0226-z; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BROOKS HL, 1975, J BONE JOINT SURG AM, V57, P968, DOI 10.2106/00004623-197557070-00015; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Cheung CSK, 2006, SPINE, V31, P330, DOI 10.1097/01.brs.0000197410.92525.10; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Demirkiran G, 2014, EUR SPINE J, V23, P455, DOI 10.1007/s00586-013-3072-2; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Ishida K., 2015, SCOLIOSIS, V10, P1, DOI DOI 10.1186/S13013-014-0026-3; Kimoto A, 2013, BONE, V55, P189, DOI 10.1016/j.bone.2013.02.013; Komori T, 2015, EUR J PHARMACOL, V759, P287, DOI 10.1016/j.ejphar.2015.03.028; Kono H, 2011, J PINEAL RES, V51, P387, DOI 10.1111/j.1600-079X.2011.00901.x; Kubota Kensuke, 2013, J Bone Joint Surg Am, V95, pe130, DOI 10.2106/JBJS.L.01381; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1924, DOI 10.1007/s00198-005-1964-7; Lu LY, 2013, MED HYPOTHESES, V80, P773, DOI 10.1016/j.mehy.2013.03.008; Machida M, 1999, SPINE, V24, P1985, DOI 10.1097/00007632-199910010-00004; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; Machida M, 2006, J PINEAL RES, V41, P1, DOI 10.1111/j.1600-079X.2005.00312.x; Machida M, 1997, SPINE, V22, P1297, DOI 10.1097/00007632-199706150-00004; Matsumoto T, 2009, OSTEOPOROSIS INT, V20, P1429, DOI 10.1007/s00198-008-0816-7; de Mendonca RGM, 2016, ORTHOP CLIN N AM, V47, P395, DOI 10.1016/j.ocl.2015.09.012; Mehler Philip S, 2011, Eat Disord, V19, P194, DOI 10.1080/10640266.2011.551636; Mente PL, 1997, SPINE, V22, P1292, DOI 10.1097/00007632-199706150-00003; Mori H, 2008, BONE, V43, P840, DOI 10.1016/j.bone.2008.07.242; Ohno K, 2011, CURR MED CHEM, V18, P220, DOI 10.2174/092986711794088335; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ramirez M, 2013, EUR SPINE J, V22, P324, DOI 10.1007/s00586-012-2465-y; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; ROGALA EJ, 1978, J BONE JOINT SURG AM, V60, P173, DOI 10.2106/00004623-197860020-00005; Sato A, 2016, BONE, V86, P53, DOI 10.1016/j.bone.2016.02.018; Schiller JR, 2010, CLIN ORTHOP RELAT R, V468, P670, DOI 10.1007/s11999-009-0884-9; Smith FM, 2002, J BONE JOINT SURG BR, V84B, P392, DOI 10.1302/0301-620X.84B3.12619; Starnes LM, 2007, GENESIS, V45, P229, DOI 10.1002/dvg.20294; Takeuchi M, 1998, CHEM PHARM BULL, V46, P1703; Tanabe H, 2017, EUR SPINE J, V26, P1600, DOI 10.1007/s00586-017-4974-1; VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129, DOI 10.3109/10520298909106985; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3	49	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202165	10.1371/journal.pone.0202165	http://dx.doi.org/10.1371/journal.pone.0202165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138335	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100043
J	Yang, HP; Qi, YL; Goley, ME; Huang, JT; Ivashuta, S; Zhang, YJ; Sparks, OC; Ma, JY; van Scoyoc, BM; Caruano-Yzermans, AL; King-Sitzes, J; Li, X; Pan, AH; Stoecker, MA; Wiggins, BE; Varagona, MJ				Yang, Heping; Qi, Youlin; Goley, Mike E.; Huang, Jintai; Ivashuta, Sergey; Zhang, Yuanji; Sparks, Oscar C.; Ma, Jiyan; van Scoyoc, Brook M.; Caruano-Yzermans, Amy L.; King-Sitzes, Jennifer; Li, Xin; Pan, Aihong; Stoecker, Martin A.; Wiggins, B. Elizabeth; Varagona, Marguerite J.			Endogenous tassel-specific small RNAs-mediated RNA interference enables a novel glyphosate-inducible male sterility system for commercial production of hybrid seed in Zea mays L.	PLOS ONE			English	Article							NUCLEAR MALE-STERILITY; PLANTS; GENE; FERTILITY; CORN; EXPRESSION; TOBACCO; MAIZE	Hybrid crops produce higher yields than their inbred parents due to heterosis. For high purity of hybrid seeds, it is critical to eliminate self-pollination. Manual or mechanical removal of male parts (such as detasseling in maize) is labor-intensive, fuel and time-consuming, and can cause physical damage to female plants, resulting in significant seed yield reductions. Many male-sterility systems either require a maintainer for male-sterile line propagation or are often affected by environmental factors. Roundup (R) Hybridization System (RHS) utilizes glyphosate to induce male sterility, which effectively eliminates the need for maintainer lines and removal of male parts for commercial hybrid seed production. The first-generation RHS (RHS1) is based on low expression of a glyphosate-insensitive 5-enolpyruvylshikimate-3-phosphate synthase (CP4 EPSPS) in pollen. This report presents the second-generation RHS (RHS2) technology built on RNA interference (RNAi) combined with CP4 EPSPS. It utilizes maize endogenous male tissue-specific small interfering RNAs (mts-siRNAs) to trigger cleavage of the CP4 EPSPS mRNA specifically in tassels, resulting in glyphosate-sensitive male cells due to lack of the CP4 EPSPS protein. Male sterility is then induced by glyphosate application at the stages critical for pollen development, and the male-sterile plants are used as the female parent to produce hybrid seed. The endogenous mts-siRNAs are conserved across maize germplasms, and the inducible male sterility was replicated in representative germplasms through introgression of a CP4 EPSPS transgene containing the mts-siRNA target sequence. This technology combines the relative simplicity and convenience of a systemic herbicide spray methodology with targeted protein expression to create an inducible male sterility system for industrial production of row crop hybrid seeds in an environmentally-independent manner.	[Yang, Heping; Qi, Youlin; Goley, Mike E.; Huang, Jintai; Ivashuta, Sergey; Zhang, Yuanji; Sparks, Oscar C.; Ma, Jiyan; van Scoyoc, Brook M.; Caruano-Yzermans, Amy L.; King-Sitzes, Jennifer; Li, Xin; Pan, Aihong; Stoecker, Martin A.; Wiggins, B. Elizabeth; Varagona, Marguerite J.] Monsanto Co, St Louis, MO 63167 USA	Monsanto	Yang, HP (corresponding author), Monsanto Co, St Louis, MO 63167 USA.	heping.yang@monsanto.com		Ma, Jiyan/0000-0001-7150-1898	Monsanto Company	Monsanto Company	This work was funded by Monsanto Company, and the funder (Monsanto) accepted no outside funding for this research represented in this manuscript. The funder provided financial support in the form of salaries and compensation for all authors, as well as logistical, scientific and regulatory support. The funder also played a role in the design, data analysis, preparation of the manuscript and the decision to publish. The specific roles of the authors are articulated in the "Author Contributions" section.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Burgess DG, 2002, PLANT J, V31, P113, DOI 10.1046/j.1365-313X.2002.01330.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang ZY, 2016, P NATL ACAD SCI USA, V113, P14145, DOI 10.1073/pnas.1613792113; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Cigan AM, 2017, PLANT BIOTECHNOL J, V15, P379, DOI 10.1111/pbi.12633; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Feng PCC, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P406; Feng PCC, 2014, PEST MANAG SCI, V70, P212, DOI 10.1002/ps.3526; Feng PCC, 2003, PESTIC BIOCHEM PHYS, V77, P83, DOI 10.1016/j.pestbp.2003.08.005; Fernandez-Cornejo J, 2004, USDA AGR INF B; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gils M, 2008, PLANT BIOTECHNOL J, V6, P226, DOI 10.1111/j.1467-7652.2007.00318.x; Heck GR, 2005, CROP SCI, V45, P329, DOI 10.2135/cropsci2005.0329; Huang JF, 2015, ACS SYM SER, V1215, P213; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kempe K, 2014, P NATL ACAD SCI USA, V111, P9097, DOI 10.1073/pnas.1402836111; Kriete G, 1996, PLANT J, V9, P809, DOI 10.1046/j.1365-313X.1996.9060809.x; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; MARIANI C, 1992, NATURE, V357, P384, DOI 10.1038/357384a0; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nawaz-ul-Rehman MS, 2007, MOL BIOTECHNOL, V36, P159, DOI 10.1007/s12033-007-0025-1; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Shukla P, 2014, FUNCT INTEGR GENOMIC, V14, P307, DOI 10.1007/s10142-014-0367-2; Singh SP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11274; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Toppino L, 2011, PLANT BIOTECHNOL J, V9, P684, DOI 10.1111/j.1467-7652.2010.00567.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Weider C, 2009, CROP SCI, V49, P77, DOI 10.2135/cropsci2007.12.0694; Wu JY, 2013, YEAST, V30, P119, DOI 10.1002/yea.2947; Wu YZ, 2016, PLANT BIOTECHNOL J, V14, P1046, DOI 10.1111/pbi.12477; Wych R. D., 1988, Corn and corn improvement. Third edition., P565; Yang HP, 2009, PLANT BIOTECHNOL J, V7, P621, DOI 10.1111/j.1467-7652.2009.00429.x; Zabaleta E, 1996, P NATL ACAD SCI USA, V93, P11259, DOI 10.1073/pnas.93.20.11259; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716	42	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202921	10.1371/journal.pone.0202921	http://dx.doi.org/10.1371/journal.pone.0202921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138445	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100140
J	Fleckenstein, J; Kruger, P; Ittner, KP				Fleckenstein, Johannes; Krueger, Peter; Ittner, Karl-Peter			Effects of single-point acupuncture (HT7) in the prevention of test anxiety: Results of a RCT	PLOS ONE			English	Article							TRIER SOCIAL STRESS; RANDOMIZED CONTROLLED-TRIAL; HEALTHY-SUBJECTS; WITHDRAWAL; RESPONSES; SYSTEM; WOMEN; RATS	Background The number of students using neuro enhancement to improve their performance and to prevent test anxiety is increasing. The acupuncture point Heart 7 (HT7) has been described as being prominent in reducing states of anxiety. Methods We conducted a randomized placebo-controlled, two-armed pilot trial to investigate the efficacy of a single-point acupuncture treatment at bilateral HT7 compared to sham laser acupuncture on test anxiety. Test anxiety was induced applying the standardised protocol of the Trier Social Stress Test. Outcome measures included saliva samples analysed for cortisol and amylase, anxiety questionnaires and heart rate variability. Results Twenty-five male subjects (age 28 +/- 5 years) were allocated to either verum acupuncture (n = 12) or sham laser acupuncture (n = 13). Cortisol peaked 20 min after the stress test (2-fold, 18.11 +/- 2 nmo1/1) and amylase 10 min after (2-fold, 259 +/- 49 U/ml) with no difference between groups. There were no differences between groups regarding either anxiety questionnaires or physiological parameters. Compared to reference data (3-fold increase in cortisol), increase in stress hormones and heart rate seemed somewhat reduced. Conclusions Acupuncture may be a possible approach for the treatment of anxiety. Due to the lack of a no control treatment group, we cannot determine the magnitude of possible specific needle effects at HT7 to promote specific effects in the neuroendocrine system. Finally this study only examines the efficacy of a single time treatment.	[Fleckenstein, Johannes] Univ Bern, Inst Complementary Med, Dept TCM Acupuncture, Personalhaus 4 Inselspital, Bern, Switzerland; [Fleckenstein, Johannes; Krueger, Peter; Ittner, Karl-Peter] Univ Hosp Regensburg, Franz Josef Str Allee 11, Regensburg, Germany; [Fleckenstein, Johannes] Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany	University of Bern; University of Regensburg; Goethe University Frankfurt	Fleckenstein, J (corresponding author), Univ Bern, Inst Complementary Med, Dept TCM Acupuncture, Personalhaus 4 Inselspital, Bern, Switzerland.; Fleckenstein, J (corresponding author), Univ Hosp Regensburg, Franz Josef Str Allee 11, Regensburg, Germany.; Fleckenstein, J (corresponding author), Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany.	johannes.fleckenstein@ikom.unibe.ch	Fleckenstein, Johannes/AAL-1315-2021	Fleckenstein, Johannes/0000-0003-3442-0380				Akimoto T, 2003, MED SCI SPORT EXER, V35, P1296, DOI 10.1249/01.MSS.0000078934.07213.25; Chan Joseph, 2002, Acupunct Med, V20, P74; de Lorent L, 2016, J ACUPUNCT MERIDIAN, V9, P191, DOI 10.1016/j.jams.2016.03.008; Diekelmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003512; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Gruner F, 2010, THESIS; Haker E, 2000, J AUTONOM NERV SYST, V79, P52, DOI 10.1016/S0165-1838(99)00090-9; Henze GI, 2017, PSYCHONEUROENDOCRINO, V75, P52, DOI 10.1016/j.psyneuen.2016.10.002; Hinz A, 2012, PSYCHOTHER PSYCH MED, V62, P52, DOI 10.1055/s-0031-1297960; Irnich D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq009; Isoyama D, 2012, ACUPUNCT MED, V30, P85, DOI 10.1136/acupmed-2011-010064; Isserstedt W, 2010, EC SOCIAL CONDITIONS; Kamody RC, 2018, BODY IMAGE, V25, P168, DOI 10.1016/j.bodyim.2018.04.003; Kim DH, 2018, NEUROSCI LETT, V664, P38, DOI 10.1016/j.neulet.2017.11.008; Kim SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081018; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klausenitz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168338; Kwong EYL, 2010, J VOICE, V24, P719, DOI 10.1016/j.jvoice.2009.05.005; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; MacPherson Hugh, 2002, Acupunct Med, V20, P22; Mandl H., 2006, HDB LERNSTRATEGIEN; Middendorff E., 2012, HOCHSCHUL INF SYST E, P11; Nedeljkovic M, 2012, PSYCHONEUROENDOCRINO, V37, P1171, DOI 10.1016/j.psyneuen.2011.12.007; Park HJ, 2011, CELL MOL NEUROBIOL, V31, P1123, DOI 10.1007/s10571-011-9718-x; Reschke-Hernandez AE, 2017, J NEUROSCI RES, V95, P106, DOI 10.1002/jnr.23851; Rizi MS, 2017, COMPLEMENT THER CLIN, V29, P136, DOI 10.1016/j.ctcp.2017.09.002; Schneider A, 2007, COMPLEMENT THER MED, V15, P255, DOI 10.1016/j.ctim.2006.12.002; Schweden TLK, 2016, J ANXIETY DISORD, V43, P99, DOI 10.1016/j.janxdis.2016.09.005; Shu Shi, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P605; So EWS, 2010, REPROD BIOMED ONLINE, V20, P814, DOI 10.1016/j.rbmo.2010.02.024; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Goyata SLT, 2016, REV BRAS ENFERM, V69, P564, DOI 10.1590/0034-7167.2016690325i; Villas-Boas JD, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/219579; VINCENT C, 1995, J ROY SOC MED, V88, P199; Wichmann S, 2017, PSYCHONEUROENDOCRINO, V77, P9, DOI 10.1016/j.psyneuen.2016.11.030; Zhao RJ, 2006, NEUROSCI LETT, V395, P28, DOI 10.1016/j.neulet.2005.10.043; Zhao ZL, 2015, NEUROSCI LETT, V597, P143, DOI 10.1016/j.neulet.2015.04.045	38	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202659	10.1371/journal.pone.0202659	http://dx.doi.org/10.1371/journal.pone.0202659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161153	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900036
J	Marino, S; Xu, JC; Zhao, Y; Zhou, NN; Zhou, YW; Dinov, ID				Marino, Simeone; Xu, Jiachen; Zhao, Yi; Zhou, Nina; Zhou, Yiwang; Dinov, Ivo D.			Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies	PLOS ONE			English	Article							ALZHEIMERS-DISEASE	The theoretical foundations of Big Data Science are not fully developed, yet. This study proposes a new scalable framework for Big Data representation, high-throughput analytics (variable selection and noise reduction), and model-free inference. Specifically, we explore the core principles of distribution-free and model-agnostic methods for scientific inference based on Big Data sets. Compressive Big Data analytics (CBDA) iteratively generates random (sub)samples from a big and complex dataset. This subsampling with replacement is conducted on the feature and case levels and results in samples that are not necessarily consistent or congruent across iterations. The approach relies on an ensemble predictor where established model-based or model-free inference techniques are iteratively applied to preprocessed and harmonized samples. Repeating the subsampling and prediction steps many times, yields derived likelihoods, probabilities, or parameter estimates, which can be used to assess the algorithm reliability and accuracy of findings via bootstrapping methods, or to extract important features via controlled variable selection. CBDA provides a scalable algorithm for addressing some of the challenges associated with handling complex, incongruent, incomplete and multi-source data and analytics challenges. Albeit not fully developed yet, a CBDA mathematical framework will enable the study of the ergodic properties and the asymptotics of the specific statistical inference approaches via CBDA. We implemented the high-throughput CBDA method using pure R as well as via the graphical pipeline environment. To validate the technique, we used several simulated datasets as well as a real neuroimaging-genetics of Alzheimer's disease case-study. The CBDA approach may be customized to provide generic representation of complex multimodal datasets and to provide stable scientific inference for large, incomplete, and multisource datasets.	[Marino, Simeone; Xu, Jiachen; Zhao, Yi; Zhou, Nina; Zhou, Yiwang; Dinov, Ivo D.] Univ Michigan, Stat Online Computat Resource, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Marino, Simeone] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Dinov, Ivo D.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dinov, Ivo D.] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dinov, ID (corresponding author), Univ Michigan, Stat Online Computat Resource, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA.; Dinov, ID (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Dinov, ID (corresponding author), Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.	statistics@umich.edu	Zhou, Nina/ABC-4458-2020; Zhou, Yiwang/AAV-9504-2021; PAN, ZEQIANG/X-6341-2018; Marino, Simeone/V-9899-2018	Zhou, Nina/0000-0002-1649-3458; Zhou, Yiwang/0000-0002-8023-205X; Marino, Simeone/0000-0002-0051-8198; ZHAO, YI/0000-0002-1600-5020	NIH [P20 NR015331, P50 NS091856, P30 DK089503, U54 EB020406, P30AG053760, P30 AG010129, K01 AG030514]; NSF [1734853, 1636840, 1416953, 0716055, 1023115]; Elsie Andresen Fiske Research Fund; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS091856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P20NR015331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG053760, K01AG030514, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Elsie Andresen Fiske Research Fund; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All the funds have been given to Ivo Dinov. This study was partially supported by NIH grants P20 NR015331, P50 NS091856, P30 DK089503, U54 EB020406, and P30AG053760, NSF grants 1734853, 1636840, 1416953, 0716055 and 1023115, and the Elsie Andresen Fiske Research Fund. Many colleagues from the Statistics Online Computational Resource (SOCR), Center for Complexity and Self-management of Chronic Disease (CSCD), Big Data Discovery Science (BDDS), and the Michigan Institute for Data Science (MIDAS) provided ideas and feedback. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI (http://www.adni-info.org) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is Rev March 26, 2012 coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514.	Agarwal R, 2014, INFORM SYST RES, V25, P443, DOI 10.1287/isre.2014.0546; Babu SK, 2017, ADV COMP C IACC 2017; Barber RF, 2015, ANN STAT, V43, P2055, DOI 10.1214/15-AOS1337; Becker RA, 1988, NEW S LANGUAGE PROGR, Vxvii; Boehmke BC, 2016, DATA WRANGLING R; Candes E, 2018, J R STAT SOC B, V80, P551, DOI 10.1111/rssb.12265; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Dai W, 2009, IEEE T INFORM THEORY, V55, P2230, DOI 10.1109/TIT.2009.2016006; Dinov ID, 2014, FRONT NEUROINFORM, P8; Dinov ID, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0117-6; Familiar B, 2017, ADV ANAL USING MACHI, P351; FOUCART S., 2013, MATH INTRO COMPRESSI; Friedman J., 2016, LASSO ELASTIC NET RE; Hastie T., 1986, STAT SCI, V1, P297; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hothorn T, 2005, COMPUT STAT DATA AN, V49, P1068, DOI 10.1016/j.csda.2004.06.019; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kapelner A., 2013, ARXIV13122171; Karatzoglou A, 2006, J STAT SOFTW, V15; Korolev IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138866; Moon SW, 2015, J ALZHEIMERS DIS, V48, P1051, DOI 10.3233/JAD-150335; Moon SW, 2015, J NEUROIMAGING, V25, P728, DOI 10.1111/jon.12252; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Polley E, 2017, PACKAGE SUPERLEARNE; Prestia A, 2013, ALZHEIMERS DEMENT, V9, P677, DOI 10.1016/j.jalz.2012.09.016; Rauhut H, 2010, THEORET FDN NUMER ME, V9, P1, DOI DOI 10.1515/9783110226157.1; Slavakis K, 2014, IEEE SIGNAL PROC MAG, V31, P18, DOI 10.1109/MSP.2014.2327238; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	36	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202674	10.1371/journal.pone.0202674	http://dx.doi.org/10.1371/journal.pone.0202674			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161148	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900038
J	Shentu, XP; Cao, ZY; Xiao, Y; Tang, G; Ochi, K; Yu, XP				Shentu, Xu-Ping; Cao, Zhen-Yan; Xiao, Yin; Tang, Gu; Ochi, Kozo; Yu, Xiao-Ping			Substantial improvement of toyocamycin production in Streptomyces diastatochromogenes by cumulative drug-resistance mutations	PLOS ONE			English	Article							BIOSYNTHETIC GENE CLUSTERS; RIBOSOMAL-PROTEIN S12; ANTIBIOTIC PRODUCTION; COELICOLOR A3(2); RNA-POLYMERASE; ACTIVATION; RPSL; DIFFERENTIATION; STRAINS; GRISEUS	Toyocamycin is a member of the nucleoside antibiotic family and has been recognized as a promising fungicide for the control of plant diseases. However, low productivity of toyocamycin remains an important bottleneck in its industrial production. Therefore, dramatic improvements of strains for overproduction of toyocamycin are of great interest in applied microbiology research. In this study, we sequentially selected for mutations for multiple drug resistance to promote the overproduction of toyocamycin by Streptomyces diastatochromogenes 1628. The triple mutant strain, SD3145 (str str par), was obtained through sequential screenings. This strain showed an enhanced capacity to produce toyocamycin (1500 mg/L), 24-fold higher than the wild type in GYM liquid medium. This dramatic overproduction was attributed at least partially to the acquisition of an rsmG mutation and increased gene expression of toyA, which encodes a LuxR-family transcriptional regulator for toyocamycin biosynthesis. The expression of toyF and toyG, probably directly involved in toyocamycin biosynthesis, was also enhanced, contributing to toyocamycin overproduction. By addition of a small amount of scandium (ScCl3 center dot 6H(2)O), the mutant strain, SD3145, produced more toyocamycin (2664 mg/L) in TPM medium, which was the highest toyocamycin level produced in shake-flask fermentation by a streptomycete so far. We demonstrated that introduction of combined drug resistance mutations into S. diastatochromogenes 1628 resulted in an obvious increase in the toyocamycin production. The triple mutant strain, SD3145, generated in our study could be useful for improvement of industrial production of toyocamycin.	[Shentu, Xu-Ping; Cao, Zhen-Yan; Xiao, Yin; Tang, Gu; Yu, Xiao-Ping] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China; [Ochi, Kozo] Hiroshima Inst Technol, Dept Life Sci, Hiroshima, Japan	China Jiliang University; Hiroshima Institute of Technology	Yu, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China.	yxp@cjlu.edu.cn		Shentu, Xuping/0000-0003-4524-0334	National Key Research and Development Program of China [2016YFF0202300]; National Natural Science Foundation of China [31401793, 31640018]; Zhejiang Provincial Programs for Science and Technology Development [2017C32006, 2018C02030]; Zhejiang Provincial Natural Science Foundation [LY12C14012]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Programs for Science and Technology Development; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Key Research and Development Program of China (2016YFF0202300), National Natural Science Foundation of China (31401793, 31640018), Zhejiang Provincial Programs for Science and Technology Development (2017C32006, 2018C02030), Zhejiang Provincial Natural Science Foundation (LY12C14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Baltz RH., 2007, MICROBE, V2, P125; Fukuda K, 2010, J BIOSCI BIOENG, V109, P459, DOI 10.1016/j.jbiosc.2009.10.017; Funane K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00188-18; Hopwood DA, 2007, STREPTOMYCES NATURE; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Hu HF, 2001, APPL ENVIRON MICROB, V67, P1885, DOI 10.1128/AEM.67.4.1885-1892.2001; Inaoka T, 2004, J BIOL CHEM, V279, P3885, DOI 10.1074/jbc.M309925200; Ma Z, 2014, J BASIC MICROB, V54, P278, DOI 10.1002/jobm.201200489; Ma Z, 2014, CURR MICROBIOL, V68, P180, DOI 10.1007/s00284-013-0461-z; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987; Ochi K, 1997, MOL GEN GENET, V256, P488; Ochi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1373, DOI 10.1271/bbb.70007; Ochi K, 2017, J ANTIBIOT, V70, P25, DOI 10.1038/ja.2016.82; Okamoto-Hosoya Y, 2000, J ANTIBIOT, V53, P1424, DOI 10.7164/antibiotics.53.1424; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shentu XP, 2016, J ANTIBIOT, V69, P406, DOI 10.1038/ja.2015.123; [申屠旭萍 Shentu Xuping], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P105; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Suzuki T, 2015, BIORESOURCE TECHNOL, V176, P156, DOI 10.1016/j.biortech.2014.10.153; Tanaka Y, 2013, J BACTERIOL, V195, P2959, DOI 10.1128/JB.00147-13; Tanaka Y, 2009, J ANTIBIOT, V62, P669, DOI 10.1038/ja.2009.97; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; Wang G, 2009, ANTIMICROB AGENTS CH, V53, P1019, DOI 10.1128/AAC.00388-08; Wang J, 2018, CURR MICROBIOL, V75, P1345, DOI 10.1007/s00284-018-1529-6; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Xu XH, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2194-1; Yu Bing, 2011, Chinese Journal of Biological Control, V27, P373	31	13	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203006	10.1371/journal.pone.0203006	http://dx.doi.org/10.1371/journal.pone.0203006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161195	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900064
J	Yang, SY; Yao, G				Yang, Shengyun; Yao, Gang			Simultaneous removal of concentrated organics, nitrogen and phosphorus nutrients by an oxygen-limited membrane bioreactor	PLOS ONE			English	Article							WASTE-WATER TREATMENT; AMMONIUM-OXIDIZING BACTERIA; ANAEROBIC METHANE OXIDATION; MICROBIAL COMMUNITY STRUCTURE; LONG-TERM OPERATION; NITRIFICATION-DENITRIFICATION; NITRITE ACCUMULATION; ARCHAEAL COMMUNITY; ANAMMOX BACTERIA; MBR	Simultaneous removal of organics, nitrogen and phosphorus was achieved in a bench-scale oxygen-limited membrane bioreactor (OLMBR). Due to the limited dissolved oxygen (similar to 0.2 mg/L equilibrium concentration) and the increased sludge concentration associated with the hollow fiber membrane, the OLMBR was endowed with an excellent performance on the removal of multi-pollutants. The optimized removal efficiencies of COD, nitrogen (N), and total phosphorus (TP) were approximately 95.5%, 90.0% and 82.6%, respectively (COD/N/P = 500:10:1, influent loading = 5.0 kg COD.m(-3).d(-1), 35 degrees C). Mass balance and bacterial community analysis indicated that the removal of organic carbon was mainly achieved by the methane production process (67.6%). Short-cut nitrification-denitrification (SCND) was observed as the primary denitrification process in the OLMBR, in which the concentrated organic compounds served as the electron donors for denitrification. Nitrosomonas was observed to be the predominant ammonium-oxidizing bacteria, while nitrite-oxidizing bacteria were almost absent in the microbial community as revealed by the high-throughput sequencing technique. In addition, Euryarchaeota and Candidatus, which were well associated with the process of denitrifying anaerobic methane oxidation, were also detected. Sludge absorption was the main route for TP removal in the OLMBR, and the production of PH3 gas also accounted for 19.4% of TP removal. This study suggested that the interception effect of hollow fiber membrane provided higher sludge concentration, therefore offering more bacteria for pollutant removal. The OLMBR can be used for simultaneous removal of highly concentrated organics and nutrients in livestock and poultry breeding wastewater.	[Yang, Shengyun; Yao, Gang] Sichuan Univ, Coll Architecture & Environm, Chengdu, Sichuan, Peoples R China	Sichuan University	Yao, G (corresponding author), Sichuan Univ, Coll Architecture & Environm, Chengdu, Sichuan, Peoples R China.	yaogang1962@163.com			science and technology bureau of Zhongshan city; Huoju industrial district of Zhongshan City, Guangdong Province	science and technology bureau of Zhongshan city; Huoju industrial district of Zhongshan City, Guangdong Province	This work was supported by the grants from the science and technology bureau of Zhongshan city and the Huoju industrial district of Zhongshan City, Guangdong Province (team project for the Langqing Membrane Company, http://www.zskj.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Arevalo J, 2013, DESALIN WATER TREAT, V51, P4839, DOI 10.1080/19443994.2013.795214; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bannert A, 2012, BIOGEOSCIENCES, V9, P3891, DOI 10.5194/bg-9-3891-2012; Beer M, 2002, FEMS MICROBIOL LETT, V207, P179, DOI 10.1016/S0378-1097(01)00561-4; Bernet N, 2001, J ENVIRON ENG, V127, P266, DOI 10.1061/(ASCE)0733-9372(2001)127:3(266); Blackall LL, 2002, ANTON LEEUW INT J G, V81, P681, DOI 10.1023/A:1020538429009; Brockmann M, 1996, WATER SCI TECHNOL, V34, P205, DOI 10.1016/S0273-1223(96)00806-2; Carvalho G, 2007, WATER RES, V41, P4383, DOI 10.1016/j.watres.2007.06.065; Coats ER, 2011, WATER ENVIRON RES, V83, P461, DOI 10.2175/106143010X12851009156402; de Almeida NM, 2011, BIOCHEM SOC T, V39, P303, DOI 10.1042/BST0390303; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fuchs W, 2003, WATER RES, V37, P902, DOI 10.1016/S0043-1354(02)00246-4; Gao DW, 2003, J ENVIRON SCI HEAL A, V38, P2933, DOI 10.1081/ESE-120025842; Hu BL, 2010, WATER RES, V44, P5014, DOI 10.1016/j.watres.2010.07.021; Hu JY, 2003, WATER RES, V37, P3463, DOI 10.1016/S0043-1354(03)00205-7; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Hu YA, 2017, ENVIRON INT, V107, P111, DOI 10.1016/j.envint.2017.07.003; Jegatheesan V, 2016, BIORESOURCE TECHNOL, V204, P202, DOI 10.1016/j.biortech.2016.01.006; JENKINS D, 1991, WATER RES, V25, P1471, DOI 10.1016/0043-1354(91)90177-R; Jenkins RO, 2000, SCI TOTAL ENVIRON, V250, P73, DOI 10.1016/S0048-9697(00)00368-5; Kartal B, 2007, SYST APPL MICROBIOL, V30, P39, DOI 10.1016/j.syapm.2006.03.004; Krzeminski P, 2017, J MEMBRANE SCI, V527, P207, DOI 10.1016/j.memsci.2016.12.010; [廖志民 Liao Zhimin], 2010, [中国给水排水, China Water & Wastewater], V26, P51; Liu FH, 2009, J APPL MICROBIOL, V106, P952, DOI 10.1111/j.1365-2672.2008.04064.x; Liu H, 2013, CHINESE J CHEM ENG, V21, P332, DOI 10.1016/S1004-9541(13)60465-6; Liu YJ, 2009, DESALINATION, V249, P445, DOI 10.1016/j.desal.2009.06.059; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Ma WW, 2017, BIORESOURCE TECHNOL, V244, P84, DOI 10.1016/j.biortech.2017.07.083; Ma Z, 2013, BIORESOURCE TECHNOL, V133, P462, DOI 10.1016/j.biortech.2013.01.023; Mutamim NSA, 2013, CHEM ENG J, V225, P109, DOI 10.1016/j.cej.2013.02.131; Neoh CH, 2016, CHEM ENG J, V283, P582, DOI 10.1016/j.cej.2015.07.060; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Pretel R, 2016, J ENVIRON MANAGE, V166, P45, DOI 10.1016/j.jenvman.2015.10.004; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Robles A, 2012, SEP PURIF TECHNOL, V100, P88, DOI 10.1016/j.seppur.2012.09.010; Roels J, 2001, BIORESOURCE TECHNOL, V79, P243, DOI 10.1016/S0960-8524(01)00032-3; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shi RJ, 2012, WATER SCI TECHNOL, V65, P254, DOI 10.2166/wst.2012.772; Smith AL, 2012, BIORESOURCE TECHNOL, V122, P149, DOI 10.1016/j.biortech.2012.04.055; Smith RV, 1997, J ENVIRON QUAL, V26, P1049, DOI 10.2134/jeq1997.00472425002600040016x; Tocchi C, 2012, WATER RES, V46, P3334, DOI 10.1016/j.watres.2012.03.032; vanLoosdrecht MCM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(96)00877-3; Virdis B, 2010, J BIOTECHNOL, V150, pS153, DOI 10.1016/j.jbiotec.2010.08.398; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang YY, 2009, BIORESOURCE TECHNOL, V100, P3506, DOI 10.1016/j.biortech.2009.02.026; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wang Y, 2016, RSC ADV, V6, P80079, DOI 10.1039/c6ra16510a; Wang ZW, 2014, J MEMBRANE SCI, V471, P258, DOI 10.1016/j.memsci.2014.08.024; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Wyffels S, 2003, J CHEM TECHNOL BIOT, V78, P412, DOI 10.1002/jctb.808; Yao S, 2017, CHEMOSPHERE, V175, P210, DOI 10.1016/j.chemosphere.2017.02.062; You HS, 2007, IEEE T SEMICONDUCT M, V20, P572, DOI 10.1109/TSM.2007.907634; Zhang XH, 2014, IERI PROC, V9, P2, DOI 10.1016/j.ieri.2014.09.032; Zhu GB, 2007, J ENVIRON SCI, V19, P1043, DOI 10.1016/S1001-0742(07)60170-3	60	3	3	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202179	10.1371/journal.pone.0202179	http://dx.doi.org/10.1371/journal.pone.0202179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161154	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900024
J	Kordyukova, M; Morgunova, V; Olovnikov, I; Komarov, PA; Mironova, A; Olenkina, OM; Kalmykova, A				Kordyukova, Maria; Morgunova, Valeriya; Olovnikov, Ivan; Komarov, Pavel A.; Mironova, Anastasia; Olenkina, Oxana M.; Kalmykova, Alla			Subcellular localization and Egl-mediated transport of telomeric retrotransposon HeT-A ribonucleoprotein particles in the Drosophila germline and early embryogenesis	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; CHROMOSOME ENDS; MULTIPLE ROLES; PIRNA PATHWAY; MELANOGASTER; EGALITARIAN; PROTEIN; TRANSCRIPTION; MACHINERY; MECHANISM	The study of the telomeric complex in oogenesis and early development is important for understanding the mechanisms which maintain genome integrity. Telomeric transcripts are the key components of the telomeric complex and are essential for regulation of telomere function. We study the biogenesis of transcripts generated by the major Drosophila telomere repeat HeT-A in oogenesis and early development with disrupted telomeric repeat silencing. In wild type ovaries, HeT-A expression is downregulated by the Piwi-interacting RNAs (piR-NAs). By repressing piRNA pathway, we show that overexpressed HeT-A transcripts interact with their product, RNA-binding protein Gag-HeT-A, forming ribonucleoprotein particles (RNPs) during oogenesis and early embryonic development. Moreover, during early stages of oogenesis, in the nuclei of dividing cystoblasts, HeT-A RNP form spherical structures, which supposedly represent the retrotransposition complexes participating in telomere elongation. During the later stages of oogenesis, abundant HeT-A RNP are detected in the cytoplasm and nuclei of the nurse cells, as well as in the cytoplasm of the oocyte. Further on, we demonstrate that HeT-A products co-localize with the transporter protein Egalitarian (Egl) both in wild type ovaries and upon piRNA loss. This finding suggests a role of Egl in the transportation of the HeT-A RNP to the oocyte using a dynein motor. Following germline piRNA depletion, abundant maternal HeT-A RNP interacts with Egl resulting in ectopic accumulation of Egl close to the centrosomes during the syncytial stage of embryogenesis. Given the essential role of Egl in the proper localization of numerous patterning mRNAs, we suggest that its abnormal localization likely leads to impaired embryonic axis specification typical for piRNA pathway mutants.	[Kordyukova, Maria; Morgunova, Valeriya; Olovnikov, Ivan; Komarov, Pavel A.; Mironova, Anastasia; Olenkina, Oxana M.; Kalmykova, Alla] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Komarov, Pavel A.] Lomonosov Moscow State Univ, Dept Biochem, Fac Biol, Moscow, Russia; [Mironova, Anastasia] Russian Acad Sci, Far Eastern Branch, Fed Sci Ctr East Asia Terr Biodivers, Vladivostok, Russia	Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences	Kalmykova, A (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.	allakalm@img.ras.ru	Mironova, Anastasia/Y-9552-2018; Kalmykova, Alla/AAG-2381-2021	Mironova, Anastasia/0000-0002-6882-1767; Morgunova, Valeriya/0000-0002-6232-7661; Komarov, Pavel/0000-0001-9482-0349	Russian Science Foundation [16-14-10167]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (16-14-10167) to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2015, TRENDS CELL BIOL, V25, P29, DOI 10.1016/j.tcb.2014.08.007; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; Cohen RS, 2005, RNA, V11, P1017, DOI 10.1261/rna.7218905; Danilevskaya ON, 1998, P NATL ACAD SCI USA, V95, P3770, DOI 10.1073/pnas.95.7.3770; Danilevskaya ON, 1997, CELL, V88, P647, DOI 10.1016/S0092-8674(00)81907-8; Danilevskaya ON, 1999, MOL CELL BIOL, V19, P873; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Dufourt J, 2014, NUCLEIC ACIDS RES, V42, P2512, DOI 10.1093/nar/gkt1184; Gao GJ, 2010, EMBO J, V29, P819, DOI 10.1038/emboj.2009.394; Garavis M, 2013, GENOME BIOL EVOL, V5, P1142, DOI 10.1093/gbe/evt079; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Kahn T, 2000, MOL CELL BIOL, V20, P7634, DOI 10.1128/MCB.20.20.7634-7642.2000; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kordyukova M, 2018, CURR OPIN GENET DEV, V49, P56, DOI 10.1016/j.gde.2018.03.002; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lopez-Panades E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128573; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Maxwell PH, 2006, NUCLEIC ACIDS RES, V34, P5498, DOI 10.1093/nar/gkl709; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Morgunova V, 2015, NUCLEIC ACIDS RES, V43, P8762, DOI 10.1093/nar/gkv775; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Navarro C, 2009, P NATL ACAD SCI USA, V106, P9691, DOI 10.1073/pnas.0903837106; Olovnikov IA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1023, DOI 10.1134/S000629791609011X; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Radion E, 2017, J MOL BIOL, V429, P3280, DOI 10.1016/j.jmb.2016.12.002; Raffa GD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00112; Rashkova S, 2002, J CELL BIOL, V159, P397, DOI 10.1083/jcb.200205039; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Ryazansky S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006731; Sanghavi P, 2016, GENETICS, V203, P415, DOI 10.1534/genetics.115.184622; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Scheibe M, 2013, GENOME RES, V23, P2149, DOI 10.1101/gr.151878.112; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Siriaco GM, 2002, GENETICS, V160, P235; Taylor MS, 2013, CELL, V155, P1034, DOI 10.1016/j.cell.2013.10.021; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; Vagin Vasily V, 2004, RNA Biol, V1, P54; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743; Zhang L, 2014, EMBO J, V33, P1148, DOI 10.1002/embj.201386940; Zhang Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006435	51	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201787	10.1371/journal.pone.0201787	http://dx.doi.org/10.1371/journal.pone.0201787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157274	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400016
J	Pfeffer, PE; Lu, H; Mann, EH; Chen, YH; Ho, TR; Cousins, DJ; Corrigan, C; Kelly, FJ; Mudway, IS; Hawrylowicz, CM				Pfeffer, Paul E.; Lu, Haw; Mann, Elizabeth H.; Chen, Yin-Huai; Ho, Tzer-Ren; Cousins, David J.; Corrigan, Chris; Kelly, Frank J.; Mudway, Ian S.; Hawrylowicz, Catherine M.			Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter	PLOS ONE			English	Article							AIR-POLLUTION; DIESEL EXHAUST; ASTHMA; PROTECTION; INDUCE; LUNG; SUPPLEMENTATION; INTERLEUKIN-8; ACTIVATION; MECHANISMS	Background Particulate matter (PM) pollutant exposure, which induces oxidative stress and inflammation, and vitamin D insufficiency, which compromises immune regulation, are detrimental in asthma. Objectives Mechanistic cell culture experiments were undertaken to ascertain whether vitamin D abrogates PM-induced inflammatory responses of human bronchial epithelial cells (HBECs) through enhancement of antioxidant pathways. Methods Transcriptome analysis, PCR and ELISA were undertaken to delineate markers of inflammation and oxidative stress; with comparison of expression in primary HBECs from healthy and asthmatic donors cultured with reference urban PM in the presence/absence of vitamin D. Results Transcriptome analysis identified over 500 genes significantly perturbed by PM-stimulation, including multiple pro-inflammatory cytokines. Vitamin D altered expression of a subset of these PM-induced genes, including suppressing IL6. Addition of vitamin D suppressed PM-stimulated IL-6 production, although to significantly greater extent in healthy versus asthmatic donor cultures. Vitamin D also differentially affected PM-stimulated GM-CSF, with suppression in healthy HBECs and enhancement in asthmatic cultures. Vitamin D increased HBEC expression of the antioxidant pathway gene G6PD, increased the ratio of reduced to oxidised glutathione, and in PM-stimulated cultures decreased the formation of 8-isoprostane. Pre-treatment with vitamin D decreased CXCL8 and further decreased IL-6 production in PM-stimulated cultures, an effect abrogated by inhibition of G6PD with DHEA, supporting a role for this pathway in the anti-inflammatory actions of vitamin D. Conclusions In a study using HBECs from 18 donors, vitamin D enhanced HBEC antioxidant responses and modulated the immune response to PM, suggesting that vitamin D may protect the airways from pathological pollution-induced inflammation.	[Pfeffer, Paul E.; Lu, Haw; Mann, Elizabeth H.; Chen, Yin-Huai; Ho, Tzer-Ren; Cousins, David J.; Corrigan, Chris; Hawrylowicz, Catherine M.] Kings Coll London, Guys Hosp, MRC, London, England; [Pfeffer, Paul E.; Lu, Haw; Mann, Elizabeth H.; Chen, Yin-Huai; Ho, Tzer-Ren; Cousins, David J.; Corrigan, Chris; Hawrylowicz, Catherine M.] Kings Coll London, Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London, England; [Pfeffer, Paul E.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London, England; [Cousins, David J.] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Cousins, David J.] Glenfield Hosp, NIHR Leicester Biomed Res Ctr Resp, Leicester, Leics, England; [Kelly, Frank J.; Mudway, Ian S.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Franklin Wilkins Bldg, London, England; [Kelly, Frank J.; Mudway, Ian S.] Kings Coll London, NIHR HPRU Hlth Impact Environm Hazards, Franklin Wilkins Bldg, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; King's College London; University of London; King's College London	Hawrylowicz, CM (corresponding author), Kings Coll London, Guys Hosp, MRC, London, England.; Hawrylowicz, CM (corresponding author), Kings Coll London, Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London, England.	catherine.hawrylowicz@kcl.ac.uk	Kelly, Frank J/C-6125-2009; Chen, Hebe/ABH-4764-2020; Hawrylowicz, Catherine/Q-8483-2017	Kelly, Frank J/0000-0003-2558-8392; Chen, Hebe/0000-0002-8890-691X; Mann, Elizabeth/0000-0001-8339-2094; Hawrylowicz, Catherine/0000-0002-2337-7463; Pfeffer, Paul/0000-0003-0369-2885; Cousins, David/0000-0003-3821-9596	Wellcome Trust [098882/Z/12/Z]; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	PEP was a Wellcome Trust Clinical Research Training Fellow and this research was supported by the Wellcome Trust (Grant 098882/Z/12/Z). This research was also supported by the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Behndig AF, 2011, THORAX, V66, P12, DOI 10.1136/thx.2010.140053; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bolcas PE, 2019, J ALLERGY CLIN IMMUN, V143, P386, DOI 10.1016/j.jaci.2018.04.042; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chambers ES, 2011, CURR ALLERGY ASTHM R, V11, P29, DOI 10.1007/s11882-010-0161-8; Chen XY, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0700-0; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; ERGER RA, 1995, AM J PHYSIOL-LUNG C, V268, pL117, DOI 10.1152/ajplung.1995.268.1.L117; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359; Gomes EC, 2011, SCAND J MED SCI SPOR, V21, pE452, DOI 10.1111/j.1600-0838.2011.01366.x; Gowers AM, 2012, RESPIROLOGY, V17, P887, DOI 10.1111/j.1440-1843.2012.02195.x; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Herr C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-31; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hosoki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126035; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; ITIN PH, 1994, ENDOCRINOLOGY, V135, P1793, DOI 10.1210/en.135.5.1793; Jacquemin B, 2015, ENVIRON HEALTH PERSP, V123, P613, DOI 10.1289/ehp.1408206; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Kent KD, 2003, IN VITRO CELL DEV-AN, V39, P388; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kim CK, 2010, RESP MED, V104, P1436, DOI 10.1016/j.rmed.2010.03.023; Lan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111599; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; Mak Judith C W, 2013, ISRN Allergy, V2013, P561831, DOI 10.1155/2013/561831; Mann EH, 2017, AM J RESP CELL MOL, V57, P355, DOI 10.1165/rcmb.2016-0409OC; Mann EH, 2014, ANN NY ACAD SCI, V1317, P57, DOI 10.1111/nyas.12410; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; MARTINEAU AR, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6583; Matthews NC, 2016, AM J RESP CELL MOL, V54, P250, DOI 10.1165/rcmb.2015-0084OC; Miller RL, 2014, J ALLERGY CLIN IMMUN, V134, P1001, DOI 10.1016/j.jaci.2014.07.064; Moore E, 2016, ANN AM THORAC SOC, V13, P1814, DOI 10.1513/AnnalsATS.201601-064OC; Morgan KA, 2017, PHOTOCH PHOTOBIO SCI, V16, P399, DOI 10.1039/c6pp00407e; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; National Institute of Standards & Technology, 2015, STAND REF MAT 1648A; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Orellano P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174050; Paine R, 2003, AM J PATHOL, V163, P2397, DOI 10.1016/S0002-9440(10)63594-8; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeffer PE, 2018, CHEST, V153, P1229, DOI 10.1016/j.chest.2017.09.005; Pfeffer PE, 2015, J ALLERGY CLIN IMMUN, V135, P824, DOI 10.1016/j.jaci.2014.09.044; Pfeffer Paul E, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS314, DOI 10.1513/AnnalsATS.201405-204AW; Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14; Rohde CM, 1999, J NUTR, V129, P2246, DOI 10.1093/jn/129.12.2246; Rosser F, 2014, AM J RESP CRIT CARE, V190, P1190, DOI 10.1164/rccm.201408-1568LE; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Sienra-Monge JJ, 2004, CLIN EXP IMMUNOL, V138, P317, DOI 10.1111/j.1365-2249.2004.02606.x; SOLOPERTO M, 1991, AM J PHYSIOL, V260, pL530, DOI 10.1152/ajplung.1991.260.6.L530; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stratford K, 2018, ENVIRON SCI TECHNOL, V52, P3054, DOI 10.1021/acs.est.7b04882; Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011; Sun J, 2014, PLACENTA, V35, P143, DOI 10.1016/j.placenta.2013.12.002; Tashakkor AY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-532; Teng Y, 2011, CHEST, V140, P108, DOI 10.1378/chest.10-2816; Vrijheid M, 2014, THORAX, V69, P876, DOI 10.1136/thoraxjnl-2013-204949; Yang X, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6470364; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhong J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45322; Zuo L, 2013, MOL IMMUNOL, V56, P57, DOI 10.1016/j.molimm.2013.04.002	72	53	54	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0200040	10.1371/journal.pone.0200040	http://dx.doi.org/10.1371/journal.pone.0200040			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157189	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400004
J	Choi, YK; Park, JH; Yun, JA; Cha, JH; Kim, Y; Won, MH; Kim, KW; Hai, KS; Kwon, YG; Kim, YM				Choi, Yoon Kyung; Park, Joon Ha; Yun, Jung-A; Cha, Jong-Ho; Kim, Yonghee; Won, Moo-Ho; Kim, Kyu-Won; Hai, Kwon-Soo; Kwon, Young-Guen; Kim, Young-Myeong			Heme oxygenase metabolites improve astrocytic mitochondrial function via a Ca2+-dependent HIF-1 alpha/ERR alpha circuit	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; ENDOTHELIAL GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; VEGF EXPRESSION; ISCHEMIC-STROKE; HIF-ALPHA; ANGIOGENESIS; BIOGENESIS; ACTIVATION; PROTEIN	Heme oxygenase-1 (HO-1) exerts beneficial effects, including angiogenesis and energy metabolism via the hypoxia-inducible factor-1 alpha (HIF-1 alpha) and peroxisome-proliferator-activating receptor-v coactivator-1 alpha (PGC-1 alpha)/estrogen-related receptor alpha (ERR alpha) pathways, respectively, in astrocytes. However, evidence of cross-talk between both pathways in HO metabolite-mediated mitochondrial biogenesis has not been well elucidated. Here, we found that HIF-1 alpha was upregulated in astrocytes after ischemic brain injury following exposure to the carbon monoxide (CO)-releasing compound CORM-2. Experiments with pharmacological inhibitors and target-specific siRNAs revealed that HIF-1 alpha levels were highly correlated with increased PGC-1 alpha and ERRa levels, which were linked to the HO metabolites CO- and bilirubin-induced activation of apical L-type Ca2+ channel and sequential Ca2+-dependent signal transduction. Moreover, HIF-1 alpha was stabilized in a proline hydroxylase-dependent manner by transient induction of intracellular hypoxia via the PGC-1 alpha/ERR alpha-induced increases in mitochondrial biogenesis and oxygen consumption. HIF-1 alpha knockdown blocked HO-1 system-mediated transcriptional expression of ERR alpha, but not of PGC-1 alpha, suggesting a possible involvement of HIF-1 alpha in ERR alpha-mediated mitochondrial biogenesis. These data suggest that the HO-1-derived metabolites, CO and bilirubin, elevate astrocytic mitochondrial function via a HIF-1 alpha/ERR alpha circuit coupled with L-type Ca2+ channel activation and PGC-1 alpha-mediated oxygen consumption. This circuit may play an important role in repairing neurovascular function after focal ischemic brain injury by stimulating mitochondrial biogenesis.	[Choi, Yoon Kyung; Kim, Yonghee] Konkuk Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea; [Park, Joon Ha; Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon, Kangwon Do, South Korea; [Yun, Jung-A; Hai, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Kangwon Do, South Korea; [Cha, Jong-Ho; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Cha, Jong-Ho; Kim, Kyu-Won] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea	Konkuk University; Kangwon National University; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Yonsei University	Choi, YK (corresponding author), Konkuk Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea.; Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Kangwon Do, South Korea.	ykchoi@konkuk.ac.kr; ymkim@kangwon.ac.kr	Choi, Yoon Kyung/AGX-0481-2022; Kim, Kyu Won/AAJ-7213-2020	Choi, Yoon Kyung/0000-0003-0242-9612; Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2017R1E1A2A01077606, 2017R1A2B3004565, 2015M3A9E6028949]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C2160]	National Research Foundation of Korea (NRF) - Korea Government (MSIP); Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2017R1E1A2A01077606 to Y.K.C., 2017R1A2B3004565 to Y.M.K., and 2015M3A9E6028949 to Y.M.K.). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C2160 to Y.K.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2017R1E1A2A01077606, 2017R1A2B3004565, and 2015M3A9E6028949). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C2160).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Choi YK, 2017, ANTIOXID REDOX SIGN, V27, P21, DOI 10.1089/ars.2016.6684; Choi YK, 2016, BIOCHEM BIOPH RES CO, V479, P297, DOI 10.1016/j.bbrc.2016.09.063; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Farshbaf MJ, 2016, NEUROMOL MED, V18, P1, DOI 10.1007/s12017-015-8370-x; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Joo HY, 2015, BIOCHEM BIOPH RES CO, V462, P294, DOI 10.1016/j.bbrc.2015.04.119; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Nada SE, 2014, MOL NEUROBIOL, V49, P945, DOI 10.1007/s12035-013-8572-x; Neary MT, 2014, J MOL CELL CARDIOL, V74, P340, DOI 10.1016/j.yjmcc.2014.06.013; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Panahian N, 1999, J NEUROCHEM, V72, P1187; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202039	10.1371/journal.pone.0202039	http://dx.doi.org/10.1371/journal.pone.0202039			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153269	gold, Green Published, Green Submitted			2022-12-26	WOS:000443001700005
J	Garcia-Arroyo, FE; Gonzaga, G; Munoz-Jimenez, I; Blas-Marron, MG; Silverio, O; Tapia, E; Soto, V; Ranganathan, N; Ranganathan, P; Vyas, U; Irvin, A; Ir, D; Robertson, CE; Frank, DN; Johnson, RJ; Sanchez-Lozada, LG				Garcia-Arroyo, Fernando E.; Gonzaga, Guillermo; Munoz-Jimenez, Itzel; Blas-Marron, Monica G.; Silverio, Octaviano; Tapia, Edilia; Soto, Virgilia; Ranganathan, Natarajan; Ranganathan, Pari; Vyas, Usha; Irvin, Anthony; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.; Johnson, Richard J.; Gabriela Sanchez-Lozada, L.			Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM URIC-ACID; CELL-PROLIFERATION; OXIDATIVE STRESS; RAT MODEL; HYPERTENSION; EXPRESSION; INTESTINE; INJURY; ABCG2	Hyperuricemia is highly prevalent and especially common in subjects with metabolic, cardiovascular and renal diseases. In chronic kidney disease, hyperuricemia is extremely common, and uric acid (UA) excretion relies on gut uricolysis by gut microbiota. Current therapy for lowering serum UA includes drugs that may produce undesired secondary effects. Therefore, this pilot study was designed to evaluate the potential of two probiotic supplements to reduce systemic uric acid concentrations. Secondary objectives were to assess whether the hypouricemic effect related to a therapeutic benefit on the hyperuricemia-induced renal damage and hypertension. Analysis of fecal microbiota was also performed. Groups of 6 rats each were followed for 5 weeks and allocated in the following treatment groups: C = Control; HU-ND = Oxonic acid-induced hyperuricemia (HU)+regular diet; HU-P = HU+placebo; HU-F1 = HU+probiotics formula 1 and HU-F2 = HU+probiotics formula 2. We confirmed that oxonic acid-induced hyperuricemia produced hypertension and renal functional and structural changes, along with modest changes in the overall composition of fecal microbiota. Both probiotic-containing diets prevented HU, elevated UA urinary excretion and intrarenal UA accumulation induced by oxonic acid. The hypouricemic effect conferred by probiotic supplementation also prevented the renal changes and hypertension caused by hyperuricemia. However, probiotic treatment did not restore the fecal microbiota. In conclusion, we demonstrated for the first time the ability of probiotics containing uricolytic bacteria to lower serum uric acid in hyperuricemic animals with beneficial consequences on blood pressure and renal disease. As probiotics supplements are innocuous for human health, we recommend clinical studies to test if probiotic supplements could benefit hyperuricemic individuals.	[Garcia-Arroyo, Fernando E.; Gonzaga, Guillermo; Munoz-Jimenez, Itzel; Blas-Marron, Monica G.; Silverio, Octaviano; Tapia, Edilia; Gabriela Sanchez-Lozada, L.] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Soto, Virgilia] INC Ignacio Chavez, Dept Pathol, Mexico City, DF, Mexico; [Ranganathan, Natarajan; Ranganathan, Pari; Vyas, Usha; Irvin, Anthony] Kibow Biotech, Newtown Sq, PA USA; [Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Johnson, Richard J.] Univ Colorado, Renal Dis & Hypertens, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sanchez-Lozada, LG (corresponding author), INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico.	lgsanchezlozada@gmail.com	Sanchez-Lozada, Laura/AAS-2104-2021	ROBERTSON, CHARLES/0000-0002-4136-4121; Tapia, Edilia/0000-0001-7955-816X; Garcia, Fernando/0000-0003-1545-9765; Vyas, Usha/0000-0002-1860-9872; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617	Kibow Biotech; Kibow Biotech, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	Kibow Biotech; Kibow Biotech, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Kibow Biotech. The funder had a role in the study design, provided the experimental diets, participated in the preparation of the manuscript and approved the final version of the manuscript. The funder (Kibow Biotech, Inc) provided support in the form of salaries for authors [NR, PR, UV, AI], manufactured all product formula for testing and completely funded the study for extending the positive in-vitro lab results to the in-vivo rat models, but did have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARELDUBEAU AM, 2014, OXIDATIVE MED CELLUL, DOI DOI 10.1155/2014/; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; De Cosmo S, 2015, CLIN J AM SOC NEPHRO, V10, P1921, DOI 10.2215/CJN.03140315; DeBosch BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5642; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ejaz AA, 2013, INT UROL NEPHROL, V45, P449, DOI 10.1007/s11255-012-0192-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feig DI, 2013, J PEDIATR-US, V162, P896, DOI 10.1016/j.jpeds.2012.12.078; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Guo Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20602; Hobbs DJ, 2010, PEDIATR NEPHROL, V25, P305, DOI 10.1007/s00467-009-1352-1; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Jin TR, 2018, AM J PHYSIOL-ENDOC M, V314, pE201, DOI 10.1152/ajpendo.00285.2017; Johnson RJ, 2018, AM J KIDNEY DIS, V71, P851, DOI 10.1053/j.ajkd.2017.12.009; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanbay M, 2017, ANGIOLOGY, V68, P132, DOI 10.1177/0003319716644395; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Komori H, 2018, BBA-BIOMEMBRANES, V1860, P973, DOI 10.1016/j.bbamem.2018.01.006; Koratala A, 2016, NEPHRON, V134, P231, DOI 10.1159/000448629; Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171; Kupferman J, 2016, AM J KIDNEY DIS, V68, P716, DOI 10.1053/j.ajkd.2016.06.012; Lanaspa MA, 2011, SEMIN NEPHROL, V31, P426, DOI 10.1016/j.semnephrol.2011.08.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li ZH, 2016, MOL MED REP, V13, P4343, DOI 10.3892/mmr.2016.5083; Mallat SG, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0684-z; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Mintz M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190997; Nacak H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-91; Nagura M, 2016, NUCLEOS NUCLEOT NUCL, V35, P550, DOI 10.1080/15257770.2016.1163379; Needell JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183786; Nycz BT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191232; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sanchez-Lozada LG, 2005, SEMIN NEPHROL, V25, P19, DOI 10.1016/j.semnephrol.2004.09.004; Sanchez-Lozada LG, 2008, NEPHROLDIALTRANSPLAN; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; Tapia E, 2016, FREE RADICAL RES, V50, P781, DOI 10.1080/10715762.2016.1174776; Trujillo J, 2013, REDOX BIOL; Vargas-Santos AB, 2017, AM J KIDNEY DIS, V70, P422, DOI 10.1053/j.ajkd.2017.01.055; Wang WQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006843; Xia X, 2016, METABOLISM, V65, P1326, DOI 10.1016/j.metabol.2016.05.009; Yano H, 2014, CLIN EXP NEPHROL, V18, P50, DOI 10.1007/s10157-013-0806-8; Zuo T, 2016, INT J CARDIOL, V224, P286, DOI 10.1016/j.ijcard.2016.09.033	55	39	45	17	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202901	10.1371/journal.pone.0202901	http://dx.doi.org/10.1371/journal.pone.0202901			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142173	Green Published, gold			2022-12-26	WOS:000442722500047
J	Yang, J; Min, KW; Kim, DH; Son, BK; Moon, KM; Wi, YC; Bang, SS; Oh, YH; Do, SI; Chae, SW; Oh, S; Kim, YH; Kwon, MJ				Yang, Jungho; Min, Kyueng-Whan; Kim, Dong-Hoon; Son, Byoung Kwan; Moon, Kyoung Min; Wi, Young Chan; Bang, Seong Sik; Oh, Young Ha; Do, Sung-Im; Chae, Seoung Wan; Oh, Sukjoong; Kim, Young Hwan; Kwon, Mi Jung			High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 MMP-9; MATRIX METALLOPROTEINASES; EXPRESSION; CARCINOMA; ANGIOGENESIS; PROGRESSION; INVASION; COLLAGEN; CELLS	Background Matrix metalloproteinase-9 (MMP-9) is associated with remodelling of the extracellular matrix and invasion in various cancers. Identifying proteins connected to high MMP-9 expression is important in explaining its mechanisms. Our study aims to shed light on genes associated with high MMP-9 expression and to discuss their clinical impact in breast cancer. Methods We evaluated 173 breast cancer cases from the Kangbuk Samsung Hospital, with 1964 cases from the Molecular Taxonomy of Breast Cancer International Consortium database serving as a validation cohort. We investigated relationships between MMP-9 expression and clinicopathological characteristics. We then used gene set enrichment analyses to detect the association of genes with MMP-9 overexpression, and performed survival analyses to determine the significance of the gene in three independent cohorts. Results High MMP-9 expression correlated with poor prognosis in univariate and multivariate analyses. Using gene set enrichment analysis, we found that tumour necrosis factor receptor superfamily member 12A (TNFRSF12A) was linked to high MMP-9 expression. In the survival analysis of three published data sets (METABRIC, GSE1456, GSE20685), high TNFRSF12A was relevant to a poor survival rate. Conclusions High levels of TNFRSF12A associated with MMP-9 overexpression may be important to explain the progression of breast cancer, and survival could be improved using therapy targeting TNFRSF12A.	[Yang, Jungho; Kim, Dong-Hoon; Do, Sung-Im; Chae, Seoung Wan] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul, South Korea; [Min, Kyueng-Whan; Oh, Young Ha] Hanyang Univ, Coll Med, Dept Pathol, Guri Hosp, Guri, Gyeonggi Do, South Korea; [Son, Byoung Kwan] Eulji Univ, Eulji Hosp, Dept Internal Med, Sch Med, Seoul, South Korea; [Moon, Kyoung Min] Univ Ulsan, Gangneung Asan Hosp, Dept Internal Med, Coll Med, Kangnung, South Korea; [Wi, Young Chan; Bang, Seong Sik] Hanyang Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Oh, Sukjoong] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Young Hwan] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Nucl Med, Sch Med, Seoul, South Korea; [Kwon, Mi Jung] Hallym Univ, Coll Med, Dept Pathol, Sacred Heart Hosp, Anyang, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Eulji University; University of Ulsan; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University	Kim, DH (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul, South Korea.; Min, KW (corresponding author), Hanyang Univ, Coll Med, Dept Pathol, Guri Hosp, Guri, Gyeonggi Do, South Korea.	kyueng@gmail.com; idavid.kim@samsung.com			Bumsuk Academic Research Fund in 2017	Bumsuk Academic Research Fund in 2017	This paper was supported by the Bumsuk Academic Research Fund in 2017.	Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Giussani M, 2015, SEMIN CANCER BIOL, V35, P3, DOI 10.1016/j.semcancer.2015.09.012; Jablonska-Trypuc A, 2016, J ENZYM INHIB MED CH, V31, P177, DOI 10.3109/14756366.2016.1161620; Jadhav U, 2004, INT J ONCOL, V25, P1407; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kodate M, 1997, PATHOL INT, V47, P461, DOI 10.1111/j.1440-1827.1997.tb04525.x; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Nart D, 2010, LIVER TRANSPLANT, V16, P621, DOI 10.1002/lt.22028; PAGE DL, 1983, HISTOPATHOLOGY, V7, P525, DOI 10.1111/j.1365-2559.1983.tb02265.x; Papathoma AS, 2000, ANTICANCER RES, V20, P2009; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Peng YP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-738; Prat A, 2014, J NATL CANC I, V106; Puzovic V, 2014, NEOPLASMA, V61, P439, DOI 10.4149/neo_2014_054; Rahko E, 2004, ANTICANCER RES, V24, P4247; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Scorilas A, 2001, BRIT J CANCER, V84, P1488, DOI 10.1054/bjoc.2001.1810; Shen ZX, 2017, ENVIRON TOXICOL PHAR, V51, P1, DOI 10.1016/j.etap.2017.02.001; Sillanpaa S, 2007, GYNECOL ONCOL, V104, P296, DOI 10.1016/j.ygyno.2006.09.004; Tabouret E, 2016, ONCOTARGET, V7, P18531, DOI 10.18632/oncotarget.7612; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Zeng ZS, 1999, CARCINOGENESIS, V20, P749, DOI 10.1093/carcin/20.5.749	26	15	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202113	10.1371/journal.pone.0202113	http://dx.doi.org/10.1371/journal.pone.0202113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142200	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500007
J	Manerba, M; Di Ianni, L; Govoni, M; Comparone, AI; Di Stefano, G				Manerba, Marcella; Di Ianni, Lorenza; Govoni, Marzia; Comparone, Anton Ietta; Di Stefano, Giuseppina			The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells	PLOS ONE			English	Article							CANCER STEM-CELLS; HEPATOCELLULAR-CARCINOMA CELLS; METABOLISM; INHIBITION; THERAPY; PATHWAY; INSULIN; GROWTH; PROLIFERATION; DIAGNOSIS	mTOR kinase and the A isoform of lactate dehydrogenase (LDH-A) are key players controlling the metabolic characteristics of cancer cells. By using cultured human breast cells as a "metabolic tumor" model, we attempted to explore the correlation between these two factors. "Metabolic tumors" are defined as neoplastic conditions frequently associated with features of the metabolic syndrome, such as hyper-insulinemia and hyper-glycemia. MCF-7 cells (a well differentiated carcinoma) and MCF-10A cells (a widely used model for studying normal breast cell transformation) were used in this study. These cells were exposed to known factors triggering mTOR activation. In both treated cultures, we evaluated the link between mTOR kinase activity and the level of LDH expression /function. Furthermore, we elaborated the metabolic changes produced in cells by the mTOR-directed LDH-A up-regulation. Interestingly, we observed that in the non-neoplastic MCF-10A culture, mTOR-directed up-regulation of LDH-A was followed by a reprogramming of cell metabolism, which showed an increased dependence on glycolysis rather than on oxidative reactions. As a consequence, lactate production appeared to be enhanced and cells began to display increased self-renewal and clonogenic power: signals suggestive of neoplastic change. Enhanced clonogenicity of cells was abolished by rapamycin treatment, and furthermore heavily reduced by LDH enzymatic inhibition. These results highlighted a mechanistic link between metabolic alterations and tumorigenesis, whereby suggesting LDH inhibition as a possible chemo-preventive measure to target the metabolic alterations driving neoplastic change.	[Manerba, Marcella; Di Ianni, Lorenza; Govoni, Marzia; Comparone, Anton Ietta; Di Stefano, Giuseppina] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy	University of Bologna	Di Stefano, G (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy.	giuseppina.distefano@unibo.it		DI STEFANO, GIUSEPPINA/0000-0003-0375-0176	University of Bologna, RFO funds; Roberto and Cornelia Pallotti's Legacy for Cancer Research	University of Bologna, RFO funds; Roberto and Cornelia Pallotti's Legacy for Cancer Research	This work was supported by the University of Bologna, RFO funds, www.unibo.it (GDS) and by Roberto and Cornelia Pallotti's Legacy for Cancer Research, www.unibo.it (GDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2015, SEMIN ONCOL, V42, pS3, DOI 10.1053/j.seminoncol.2015.01.001; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Carrasco E, 2014, EUR J CLIN INVEST, V44, P678, DOI 10.1111/eci.12276; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; De Bari L, 2010, INT J ONCOL, V37, P1607, DOI 10.3892/ijo_00000815; Duan JJ, 2016, INT J CANCER, V139, P965, DOI 10.1002/ijc.30091; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Economopoulou P, 2012, ONCOLOGIST, V17, P1394, DOI 10.1634/theoncologist.2012-0163; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Farabegoli F, 2012, EUR J PHARM SCI, V47, P729, DOI 10.1016/j.ejps.2012.08.012; Fiume L, 2014, FUTURE MED CHEM, V6, P429, DOI [10.4155/FMC.13.206, 10.4155/fmc.13.206]; Fiume L, 2011, EUR J PHARMACOL, V670, P39, DOI 10.1016/j.ejphar.2011.08.038; Gottfried E, 2012, SEMIN CANCER BIOL, V22, P335, DOI 10.1016/j.semcancer.2012.02.009; Gupta C, 2013, J MOL ENDOCRINOL, V51, P119, DOI 10.1530/JME-13-0062; Islam Monica P, 2015, Handb Clin Neurol, V132, P97, DOI 10.1016/B978-0-444-62702-5.00006-8; Liu HX, 2015, J ZHEJIANG UNIV-SC B, V16, P10, DOI 10.1631/jzus.B1400172; Manerba M, 2017, EUR J PHARM SCI, V105, P91, DOI 10.1016/j.ejps.2017.05.015; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; PAPACONSTANTINOU J, 1961, J BIOL CHEM, V236, P278; Passarella S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00407; Qu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131285; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SOULE HD, 1990, CANCER RES, V50, P6075; STRAUS DS, 1981, LIFE SCI, V29, P2131, DOI 10.1016/0024-3205(81)90482-3; Toker Alex, 2014, Advances in Biological Regulation, V55, P28, DOI 10.1016/j.jbior.2014.04.001; VARANASI UR, 1980, CANCER TREAT REP, V64, P1283; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Wang YJ, 2015, AM J PHYSIOL-CELL PH, V309, pC709, DOI 10.1152/ajpcell.00212.2015; Weichhaus M, 2012, INT J ONCOL, V41, P745, DOI 10.3892/ijo.2012.1480; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Woo YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132285; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013; Zhao Z, 2015, CANCER LETT, V358, P17, DOI 10.1016/j.canlet.2014.11.046; Zou ZP, 2015, J CELL BIOL, V211, P105, DOI 10.1083/jcb.201411128	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202588	10.1371/journal.pone.0202588	http://dx.doi.org/10.1371/journal.pone.0202588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138330	Green Published, gold			2022-12-26	WOS:000442800100089
J	Sarker, S; Lim, UT				Sarker, Souvic; Lim, Un Taek			Extract of Nicotiana tabacum as a potential control agent of Grapholita molesta (Lepidoptera: Tortricidae)	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; ORIENTAL FRUIT MOTH; PLANT-EXTRACTS; ESSENTIAL OILS; INSECTICIDAL ACTIVITY; BIOLOGICAL-ACTIVITY; GRAPHOLITA-MOLESTA; AQUEOUS EXTRACTS; NOCTUIDAE; GROWTH	Oriental fruit moth, Grapholita molesta (Busck) (Lepidoptera: Tortricidae), is an important pest of stone and pome fruits. Growers usually depend on chemical insecticides to control this pest, but demand for more environmentally-friendly means of controlling pests is increasing. At least 91 plant extracts have been reported to be effective against other lepidopterans, but their acute toxicity against G. molesta has rarely been studied. Among these 91 materials, we assessed the residual toxicity of 32 extracts against first instar larvae (< 5 h old) of G. molesta in the laboratory. Nicotiana tabacum L., used at the concentration of 2 mg/ml, showed the highest corrected mortality (92.0%) with a lethal time (LT50) value of 12.9 h. The extract was followed in its efficacy by Allium sativum L. (88.0%), Zanthoxylum piperitum (L.) De Candolle (70.0%), and Sapindus mukorossi Gaertner (65.0%), when mortality was assessed at 20 h after exposure. Against adult fruit moths (< 5 d old), N. tabacum also showed the highest corrected mortality among tested extracts, being 85 and 100% in adult females and males, respectively, at 168 h after exposure. However, there was no synergistic effect of the combined application of any of the top four extracts in either laboratory or greenhouse assays. Oviposition by G. molesta on peach twigs was reduced 85-90% when N. tabacum was applied at 4 ml/ twig compared to control (methanol), demonstrating that N. tabacum may have potential for use as a botanical insecticide against G. molesta.	[Sarker, Souvic; Lim, Un Taek] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Lim, Un Taek] Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea	Andong National University; Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.; Lim, UT (corresponding author), Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea.	utlim@andong.ac.kr		Lim, Un Taek/0000-0002-6704-0627; Sarker, Souvic/0000-0001-6346-9656	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through the Advanced Production Technology Development Program; Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [315007-03-2-HD050]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through the Advanced Production Technology Development Program; Ministry of Agriculture, Food, and Rural Affairs (MAFRA)	This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through the Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (315007-03-2-HD050) to UTL.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alim MA, 2017, FLA ENTOMOL, V100, P350, DOI 10.1653/024.100.0234; Alves DS, 2011, NEOTROP ENTOMOL, V40, P123, DOI 10.1590/S1519-566X2011000100019; Amoabeng BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078651; Arivoli S., 2013, J ENTOMOL ZOOL STUD, V1, P87, DOI DOI 10.1186/1756-3305-6-337; Barboza J, 2010, REV BIOL TROP, V58, P1; Baskaran V, 1995, TRADITIONAL PEST CON, P91; Basukriadi A, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu106; Ben Jannet H, 2001, IND CROP PROD, V14, P213, DOI 10.1016/S0926-6690(01)00086-3; Beninger CW, 2004, J CHEM ECOL, V30, P589, DOI 10.1023/B:JOEC.0000018631.67394.e5; BINDER RG, 1984, J ECON ENTOMOL, V77, P1585, DOI 10.1093/jee/77.6.1585; Bogorni PC, 2005, NEOTROP ENTOMOL, V34, P311, DOI 10.1590/S1519-566X2005000200020; Bouzouina M, 2012, BULG J AGRIC SCI, V18, P334; Brunherotto R, 2010, NEOTROP ENTOMOL, V39, P784, DOI 10.1590/S1519-566X2010000500018; Bullangpoti V, 2012, PEST MANAG SCI, V68, P1255, DOI 10.1002/ps.3291; Carrero J., 1996, LUCHAINTEGRADA PLAGA; Cloyd R., 2004, AM NURSERYMAN, V200, P41; Cox PD, 2004, J STORED PROD RES, V40, P1, DOI 10.1016/S0022-474X(02)00078-4; Dadang, 2001, Applied Entomology and Zoology, V36, P143, DOI 10.1303/aez.2001.143; de Brito EF, 2015, PESQUI AGROPECU BRAS, V50, P196, DOI 10.1590/S0100-204X2015000300002; Derbalah Aly S, 2012, ScientificWorldJournal, V2012, P639854, DOI 10.1100/2012/639854; Du J, 2015, ENVIRON ENTOMOL, V44, P1522, DOI 10.1093/ee/nvv124; Eddaya T, 2013, IND CROP PROD, V50, P325, DOI 10.1016/j.indcrop.2013.07.045; Eldefrawi M. E., 1990, SAFER INSECTICIDES D, P155; Er MK, 2009, J PEST SCI, V82, P95, DOI 10.1007/s10340-008-0223-z; Farias-Rivera LA, 2003, FLA ENTOMOL, V86, P239, DOI 10.1653/0015-4040(2003)086[0239:EOLEOT]2.0.CO;2; Figueroa-Brito R, 2011, INTERCIENCIA, V36, P752; Fouad HA, 2014, J STORED PROD RES, V57, P6, DOI 10.1016/j.jspr.2014.01.001; Freitas AF, 2014, NEOTROP ENTOMOL, V43, P446, DOI 10.1007/s13744-014-0225-x; Gallo MBC, 2006, PEST MANAG SCI, V62, P1072, DOI 10.1002/ps.1278; Ghanim NM, 2014, EGYPT J BIOL PEST CO, V24, P45; Han KyeungSik, 2001, Journal of Asia-Pacific Entomology, V4, P31, DOI 10.1016/S1226-8615(08)60099-0; Haouas D, 2010, CROP PROT, V29, P992, DOI 10.1016/j.cropro.2010.05.002; Hasheminia SM, 2011, PESTIC BIOCHEM PHYS, V99, P244, DOI 10.1016/j.pestbp.2010.12.009; Hernandez- Lambrano Ricardo, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P695; HUANG XP, 1993, ENTOMOL EXP APPL, V68, P59, DOI 10.1007/BF02380582; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Javed Iqbal, 2010, Pakistan Journal of Zoology, V42, P597; Jeong SE, 2001, J EXP BIOL, V204, P3935; Juarez ZN, 2014, NAT PROD COMMUN, V9, P895; Kanga LHB, 2003, PEST MANAG SCI, V59, P921, DOI 10.1002/ps.702; Karakoc OC, 2013, TURK ENTOMOL DERG-TU, V37, P73; Karakoc OC, 2012, TURK ENTOMOL DERG-TU, V36, P423; Kawuki RS, 2005, CROP PROT, V24, P473, DOI 10.1016/j.cropro.2004.09.017; Kraiss H, 2008, PEST MANAG SCI, V64, P660, DOI 10.1002/ps.1541; Kubo I, 2006, ADV PHYTOMED, V3, P61; Elisa GPL, 2010, AFR J BIOTECHNOL, V9, P3659; Magrini FE, 2015, IND CROP PROD, V65, P150, DOI 10.1016/j.indcrop.2014.11.032; Meriga B, 2012, ASIAN PAC J TROP MED, V5, P391, DOI 10.1016/S1995-7645(12)60065-0; Meshram P. B., 2000, Indian Forester, V126, P961; Najar-Rodriguez A, 2013, PHYSIOL ENTOMOL, V38, P63, DOI 10.1111/phen.12003; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; Noosidum A, 2014, J VECTOR ECOL, V39, P298, DOI 10.1111/jvec.12104; Salinas-Sanchez DO, 2012, FLA ENTOMOL, V95, P428, DOI 10.1653/024.095.0225; Panneerselvam A., 2013, INT J PHARM SCI REV, V18, P150; Pessoa Alciani da Silva, 2014, Arq. Inst. Biol., V81, P329, DOI 10.1590/1808-1657000962012; Trindade RCP, 2011, REV COLOMB ENTOMOL, V37, P223; Pree DJ, 1998, CAN ENTOMOL, V130, P245, DOI 10.4039/Ent130245-3; Ramos-Lopez MA, 2010, AFR J BIOTECHNOL, V9, P1359; Ramzi S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00328; Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009; Regnault-Roger C, 2004, BIOPESTICIDAS ORIGEN; RICE RE, 1972, J ECON ENTOMOL, V65, P1212, DOI 10.1093/jee/65.4.1212; Rizwan-ul-Haq M, 2010, PAK J BOT, V42, P3971; Rothschild G. H. L., 1991, TORTRICID PESTS THEI, V5, P389; SAS Institute, 2012, SAS US GUID STAT, V4th; Shalaby FF, 2013, TOXICOL ENVIRON CHEM, V95, P778, DOI 10.1080/02772248.2013.817724; Shonouda ML, 2000, J ENVIRON SCI HEAL B, V35, P347, DOI 10.1080/03601230009373275; Silva G, 2013, CHIL J AGR RES, V73, P135, DOI 10.4067/S0718-58392013000200008; Silva LB, 2009, BRAZ ARCH BIOL TECHN, V52, P653, DOI 10.1590/S1516-89132009000300018; Singh R, 2007, ENTOMOL GEN, V30, P51; So SS, 2012, ENTOMOL RES, V42, P158, DOI 10.1111/j.1748-5967.2012.00449.x; Soliman MMM, 2012, EGYPT J BIOL PEST CO, V22, P19; Soto F, 2011, REV BIOL TROP, V59, P487; SUN YP, 1960, J ECON ENTOMOL, V53, P887, DOI 10.1093/jee/53.5.887; Tambwekar KR, 2003, J PHARMACEUT BIOMED, V32, P441, DOI 10.1016/S0731-7085(03)00236-X; Tavares WD, 2013, J FOOD PROTECT, V76, P1892, DOI 10.4315/0362-028X.JFP-13-123; Tavares WD, 2009, IND CROP PROD, V30, P384, DOI 10.1016/j.indcrop.2009.07.007; Tilahun B, 2013, INT J TROP INSECT SC, V33, P256, DOI 10.1017/S1742758413000258; Trandafirescu M, 2013, ACTA HORTIC, V981, P533; Vandenborre G, 2010, J EXP BOT, V61, P1003, DOI 10.1093/jxb/erp365; Vijayalakshmi K, 1996, PLANT PEST CONTROL G, P1; Yang Chang Yeol, 2001, Korean Journal of Applied Entomology, V40, P117; Zaitoun ST, 2007, J FOOD AGRIC ENVIRON, V5, P289; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; [张志祥 Zhang Zhixiang], 2008, [植物保护, Plant Protection], V34, P34; Zhong GH, 2001, J APPL ENTOMOL, V125, P563, DOI 10.1046/j.1439-0418.2001.00590.x; Zibaee I., 2015, Arthropods, V4, P107	88	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0198302	10.1371/journal.pone.0198302	http://dx.doi.org/10.1371/journal.pone.0198302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138428	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100003
J	Wang, ZY; Yang, XM; Zhang, WG; Zhang, PX; Jiang, BG				Wang, Zhiyong; Yang, Xiaomei; Zhang, Weiguang; Zhang, Peixun; Jiang, Baoguo			Tanshinone IIA attenuates nerve structural and functional damage induced by nerve crush injury in rats	PLOS ONE			English	Article							GROWTH; RECOVERY; MICE	After peripheral nerve crush injury, the fibers of distal nerve segments gradually disintegrate, and axons regrow from the proximal nerve segment, eventually reaching the target organ. However, the axon regeneration is generally not sufficient for the recovery of neurological function, so drug therapy is necessary. In the current study, we explored the effect of Tanshinone IIA in nerve regeneration in a sciatic nerve crush injury model using Sprague Dawley rats. The rats were administered 45 mg/kg of Tanshinone IIA once daily. Motor behavior and tibialis anterior muscle mass were assessed, and histological analysis of the sciatic nerve and lumbar spinal cord were conducted. The results showed that the administration of Tanshinone IIA improved nerve growth and motor function, and resulted in a marked decrease of neuronal death. The findings of this exploratory study suggest that Tan-shinone IIA alleviates injury and boosts regeneration after nerve crush injury in a rat model of sciatic nerve injury.	[Wang, Zhiyong; Yang, Xiaomei; Zhang, Weiguang] Peking Univ, Sch Basic Med Sci, Dept Anat & Histoembryol, Beijing, Peoples R China; [Zhang, Peixun; Jiang, Baoguo] Peking Univ, Peoples Hosp, Dept Trauma & Orthoped, Beijing, Peoples R China	Peking University; Peking University	Zhang, PX (corresponding author), Peking Univ, Peoples Hosp, Dept Trauma & Orthoped, Beijing, Peoples R China.	zhangpeixun@126.com			Chinese National Key Basic Research 973 Program [2014CB542201]; Beijing Science and Technology New Star Cross Subject; National Natural Science Foundation of China [31571235, 31771322, 51373023, 21171019, 31671248, 31640045, 31571236, 81171146, 31471144, 30971526, 31100860, 31040043, 31371210, 81372044, 81401007]; Natural Science Foundation of Beijing Municipality [7162098]; Fostering Young Scholars of Peking University Health Science Center [BMU2017PY013]; Chinese National General Program of National Natural Science Fund [31571235, 31771322]; Beijing City Science & Technology New Star Cross Project [201819]	Chinese National Key Basic Research 973 Program(National Basic Research Program of China); Beijing Science and Technology New Star Cross Subject; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Fostering Young Scholars of Peking University Health Science Center; Chinese National General Program of National Natural Science Fund; Beijing City Science & Technology New Star Cross Project	This research was continuously funded by Chinese National Key Basic Research 973 Program (2014CB542201); Beijing Science and Technology New Star Cross Subject (2018); National Natural Science Foundation of China (31571235, 31771322, 51373023, 21171019, 31671248, 31640045, 31571236, 81171146, 31471144, 30971526, 31100860, 31040043, 31371210, 81372044, 81401007); Natural Science Foundation of Beijing Municipality (7162098); Fostering Young Scholars of Peking University Health Science Center (BMU2017PY013), Chinese National General Program of National Natural Science Fund (31571235, 31771322) and Beijing City Science & Technology New Star Cross Project (201819).	Chen MM, 2017, J NUTR BIOCHEM, V46, P57, DOI 10.1016/j.jnutbio.2017.04.006; Chen YL, 2012, BIOL PHARM BULL, V35, P164, DOI 10.1248/bpb.35.164; Cui Q, 2009, CURR NEUROVASC RES, V6, P117, DOI 10.2174/156720209788185641; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; Dong KN, 2009, PHYTOTHER RES, V23, P608, DOI 10.1002/ptr.2615; Gu M, 2004, J CHROMATOGR A, V1041, P239, DOI 10.1016/j.chroma.2004.04.030; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Li M, 2017, NEUROSCI LETT, V659, P18, DOI 10.1016/j.neulet.2017.08.059; Lin R, 2006, J ETHNOPHARMACOL, V108, P217, DOI 10.1016/j.jep.2006.05.004; Pang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092216; RUTISHAUSER U, 1985, J NEUROSCI RES, V13, P123, DOI 10.1002/jnr.490130109; Shen JL, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/378907; Valencia A, 2001, J NEUROSCI RES, V64, P284, DOI 10.1002/jnr.1077.abs; Wang YX, 2013, NEUROCHEM RES, V38, P538, DOI 10.1007/s11064-012-0946-3; Wang ZY, 2018, CNS NEUROSCI THER, V24, P483, DOI 10.1111/cns.12820; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066	16	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202532	10.1371/journal.pone.0202532	http://dx.doi.org/10.1371/journal.pone.0202532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138344	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100080
J	Wetzler, DE; Wightman, FF; Bucci, HA; Rinaldi, J; Caramelo, JJ; Iusem, ND; Ricardi, MM				Wetzler, Diana E.; Fuchs Wightman, Federico; Bucci, Hernan A.; Rinaldi, Jimena; Caramelo, Julio J.; Iusem, Norberto D.; Ricardi, Martiniano M.			Conformational plasticity of the intrinsically disordered protein ASR1 modulates its function as a drought stress-responsive gene	PLOS ONE			English	Article							PLANT-SPECIFIC PROTEIN; DNA-BINDING; CIRCULAR-DICHROISM; SENSOR; HELIX; POLYPEPTIDES; REGIONS; ROLES; STATE; SHOCK	Plants in arid zones are constantly exposed to drought stress. The ASR protein family (Abscisic, Stress, Ripening) -a subgroup of the late embryogenesis abundant superfamily-is involved in the water stress response and adaptation to dry environments. Tomato ASR1, as well as other members of this family, is an intrinsically disordered protein (IDP) that functions as a transcription factor and a chaperone. Here we employed different biophysical techniques to perform a deep in vitro characterization of ASR1 as an IDP and showed how both environmental factors and in vivo targets modulate its folding. We report that ASR1 adopts different conformations such as a-helix or polyproline type II in response to environmental changes. Low temperatures and low pH promote the polyproline type II conformation (PII). While NaCl increases PII content and slightly destabilizes alpha-helix conformation, PEG and glycerol have an important stabilizing effect of a-helix conformation. The binding of Zn2+ in the low micromolar range promotes a-helix folding, while extra Zn2+ results in homodimerization. The ASR1-DNA binding is sequence specific and dependent on Zn2+. ASR1 chaperone activity does not change upon the structure induction triggered by the addition of Zn2+. Furthermore, trehalose, which has no effect on the ASR1 structure by itself, showed a synergistic effect on the ASR1-driven heat shock protection towards the reporter enzyme citrate synthase (CS). These observations prompted the development of a FRET reporter to sense ASR1 folding in vivo. Its performance was confirmed in Escherichia coli under saline and osmotic stress conditions, representing a promising probe to be used in plant cells. Overall, this work supports the notion that ASR1 plasticity is a key feature that facilitates its response to drought stress and its interaction with specific targets.	[Wetzler, Diana E.; Bucci, Hernan A.; Caramelo, Julio J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Wetzler, Diana E.; Bucci, Hernan A.] Univ Buenos Aires, Inst Quim Biol, CONICET, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Fuchs Wightman, Federico; Iusem, Norberto D.; Ricardi, Martiniano M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular FBMC, Buenos Aires, DF, Argentina; [Fuchs Wightman, Federico; Iusem, Norberto D.; Ricardi, Martiniano M.] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Rinaldi, Jimena; Caramelo, Julio J.] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Rinaldi, Jimena; Caramelo, Julio J.] Consejo Nacl Invest Cient & Tecn, IIBBA, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Wetzler, DE (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.; Wetzler, DE (corresponding author), Univ Buenos Aires, Inst Quim Biol, CONICET, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina.; Ricardi, MM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular FBMC, Buenos Aires, DF, Argentina.; Ricardi, MM (corresponding author), Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina.	diana.wetzler@gmail.com; martiniano@fbmc.fcen.uba.ar		Wetzler, Diana Elena/0000-0003-2231-6690; Fuchs Wightman, Federico/0000-0003-3934-3628; Ricardi, Martiniano/0000-0002-7904-6305	Universidad de Buenos Aires, Argentina [20020130100660BA]; Agencia Nacional de Promocion Cientifica y Tenica, Argentina [PICT-2014-0502, PICT-2013-1148]	Universidad de Buenos Aires, Argentina(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tenica, Argentina	This work was funded from the Universidad de Buenos Aires, Argentina website: http://www.uba.ar grant to N.D.I. #20020130100660BA, from theAgencia Nacional de Promocion Cientifica y Tenica, Argentina (http://www.agencia.mincyt.gob.ar) grant to N.D.I. PICT-2014-0502 and to M.M.R PICT-2013-1148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenhart RA, 2014, MOL PLANT, V7, P709, DOI 10.1093/mp/sst160; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Berger J, 2016, PLANT SCI, V253, P58, DOI 10.1016/j.plantsci.2016.09.007; Boersma AJ, 2015, NAT METHODS, V12, P227, DOI [10.1038/NMETH.3257, 10.1038/nmeth.3257]; Carver JA, 2017, CELL STRESS CHAPERON, V22, P627, DOI 10.1007/s12192-017-0789-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Evers TH, 2008, PROTEIN ENG DES SEL, V21, P529, DOI 10.1093/protein/gzn029; Faller P, 2014, ACCOUNTS CHEM RES, V47, P2252, DOI 10.1021/ar400293h; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Goldgur Y, 2007, PLANT PHYSIOL, V143, P617, DOI 10.1104/pp.106.092965; Gonzalez RM, 2014, PLANTA, V239, P941, DOI 10.1007/s00425-014-2039-9; Hessels AM, 2016, ACS SENSORS, V1, P498, DOI 10.1021/acssensors.6b00078; Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468; Iturriaga G, 2008, BIOCHEM J, V410, P1, DOI [10.1042/BJ20071633, DOI 10.1042/BJ20071633]; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Lee GJ, 1995, METHOD CELL BIOL, V50, P325, DOI 10.1016/S0091-679X(08)61040-7; Li RH, 2013, BIOSCI BIOTECH BIOCH, V77, P475, DOI 10.1271/bbb.120666; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Morikawa TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22342; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Pilizota T, 2013, BIOPHYS J, V104, P2733, DOI 10.1016/j.bpj.2013.05.011; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Ricardi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041008; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Sukenik S, 2017, P NATL ACAD SCI USA, V114, P6776, DOI 10.1073/pnas.1700818114; Sun XL, 2013, PLANT CELL, V25, P38, DOI 10.1105/tpc.112.106062; TIFFANY ML, 1972, BIOPOLYMERS, V11, P2309; TIFFANY ML, 1973, BIOPOLYMERS, V12, P575, DOI 10.1002/bip.1973.360120310; TIFFANY ML, 1968, BIOPOLYMERS, V6, P1379, DOI 10.1002/bip.1968.360060911; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wetzler DE, 2009, BIOPOLYMERS, V91, P432, DOI 10.1002/bip.21146	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202808	10.1371/journal.pone.0202808	http://dx.doi.org/10.1371/journal.pone.0202808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138481	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100131
J	Baqais, AAB; Alshayeb, M				Baqais, Abdulrahman Ahmed Bobakr; Alshayeb, Mohammad			Sequence diagram refactoring using single and hybridized algorithms	PLOS ONE			English	Article							OPTIMIZATION; TAXONOMY; CODE	Data mining and search-based algorithms have been applied to various problems due to their power and performance. There have been several studies on the use of these algorithms for refactoring. In this paper, we show how search based algorithms can be used for sequence diagram refactoring. We also show how a hybridized algorithm of Kmeans and Simulated Annealing (SA) algorithms can aid each other in solving sequence diagram refactoring. Results show that search based algorithms can be used successfully in refactoring sequence diagram on small and large case studies. In addition, the hybridized algorithm obtains good results using selected quality metrics. Detailed insights on the experiments on sequence diagram refactoring reveal that the limitations of SA can be addressed by hybridizing the Kmeans algorithm to the SA algorithm.	[Baqais, Abdulrahman Ahmed Bobakr; Alshayeb, Mohammad] King Fahd Univ Petr & Minerals, Informat & Comp Sci Dept, Dhahran, Saudi Arabia	King Fahd University of Petroleum & Minerals	Alshayeb, M (corresponding author), King Fahd Univ Petr & Minerals, Informat & Comp Sci Dept, Dhahran, Saudi Arabia.	alshayeb@kfupm.edu.sa	Alshayeb, Mohammad/B-5941-2015	Alshayeb, Mohammad/0000-0001-7950-0099	King Fahd University of Petroleum and Minerals	King Fahd University of Petroleum and Minerals	All funding support received during this specific study is given by "King Fahd University of Petroleum and Minerals". No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of King Fahd University of Petroleum and Minerals in the development of this work.	Al Dallal J, 2015, INFORM SOFTWARE TECH, V58, P231, DOI 10.1016/j.infsof.2014.08.002; Al Dallal J, 2011, IEEE T SOFTWARE ENG, V37, P788, DOI 10.1109/TSE.2010.97; Alkhalid A, 2011, IET SOFTW, V5, P274, DOI 10.1049/iet-sen.2010.0070; Alkhalid A, 2011, J RES PRACT INF TECH, V43, P285; Alkhalid A, 2010, ADV ENG SOFTW, V41, P1160, DOI 10.1016/j.advengsoft.2010.08.002; Amal B, 2014, LECT NOTES COMPUT SC, V8636, P31; CHIDAMBER SR, 1994, IEEE T SOFTWARE ENG, V20, P476, DOI 10.1109/32.295895; Dias-Neto A, 2011, RELATORIOS TECNICOS; Fahad A, 2014, IEEE T EMERG TOP COM, V2, P267, DOI 10.1109/TETC.2014.2330519; Fourati R, 2011, STUD COMPUT INTELL, V364, P17; Fowler M., 2018, REFACTORING IMPROVIN; Frankel D. S., 2003, MODEL DRIVEN ARCHITE; Ghannem Adnane, 2013, Search Based Software Engineering. 5th International Symposium, SSBSE 2013. Proceedings: LNCS 8084, P96, DOI 10.1007/978-3-642-39742-4_9; Ghannem A, 2011, DETECTING MODEL REFA; Harman M, 2001, INFORM SOFTWARE TECH, V43, P833, DOI 10.1016/S0950-5849(01)00189-6; Jin L, 2005, INT C INF TECHN COD; Jourdan L, 2006, LECT NOTES COMPUT SC, V4030, P57; Kessentini M, 2011, 2011 IEEE 19 INT C P; Kessentini M, 2013, COMB MOD SEARCH BAS; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Liu J, 2010, PHYSICA A, V389, P2300, DOI 10.1016/j.physa.2010.01.042; Lung CH, 2006, J SYST SOFTWARE, V79, P1261, DOI 10.1016/j.jss.2006.02.037; Mahouachi Rim, 2013, Search Based Software Engineering. 5th International Symposium, SSBSE 2013. Proceedings: LNCS 8084, P126, DOI 10.1007/978-3-642-39742-4_11; Mahouachi R., 2013, P 15 ANN C COMP GEN, P205; Maneerat N, 2011, 8 INT JOINT C COMP S; Mens T., 2003, ELECT NOTES THEOR CO, V82, P483, DOI [10.1016/S1571-0661(05)82624-6, DOI 10.1016/S1571-0661(05)82624-6]; Merendino S, 2013, FLAIRS C; Misbhauddin M, 2012, SOFTW ENG APPL COMP, P24; Misbhauddin M, 2015, EMPIR SOFTW ENG, V20, P206, DOI 10.1007/s10664-013-9283-7; Mkaouer MW, 2014, ADV COMPUT, V92, P161, DOI 10.1016/B978-0-12-420232-0.00004-0; O'Keeffe M, 2008, J SOFTW MAINT EVOL-R, V20, P345, DOI 10.1002/smr.378; Ouni A, 2013, USE DEV HIST SOFTWAR; Ouni A, 2014, ADV COMPUT, V94, P103, DOI 10.1016/B978-0-12-800161-5.00004-9; Ouni A, 2013, AUTOMAT SOFTW ENG, V20, P47, DOI 10.1007/s10515-011-0098-8; Perim G, 2008, LECT NOTES COMPUTER, V5290; Perim GT, 2008, LECT NOTES COMPUT SC, V5290, P133, DOI 10.1007/978-3-540-88309-8_14; Rasool G, 2017, ARAB J SCI ENG, V42, P483, DOI 10.1007/s13369-016-2238-8; Rumbaugh J., 2004, UNIFIED MODELING LAN; Sahin D, 2014, ACM T SOFTW ENG METH, V24, DOI 10.1145/2675067; SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O; Simon F, 2001, FIFTH EUROPEAN CONFERENCE ON SOFTWARE MAINTENANCE AND REENGINEERING, PROCEEDINGS, P30, DOI 10.1109/CSMR.2001.914965; Sunye G., 2001, LNCS, V2185, P134, DOI DOI 10.1007/3-540-45441-1_11; Talbi EG, 2002, J HEURISTICS, V8, P541, DOI 10.1023/A:1016540724870; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	45	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202629	10.1371/journal.pone.0202629	http://dx.doi.org/10.1371/journal.pone.0202629			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133518	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400088
J	Kou, YB; Liu, QY; Liu, WL; Sun, HX; Liang, M; Kong, FY; Zhang, B; Wei, YX; Liu, ZZ; Wang, YG				Kou, Yanbo; Liu, Qingya; Liu, Wenli; Sun, Hongxiang; Liang, Ming; Kong, Fanyun; Zhang, Bo; Wei, Yanxia; Liu, Zhuanzhuan; Wang, Yugang			LIGHT/TNFSF14 signaling attenuates beige fat biogenesis	FASEB JOURNAL			English	Article						obesity; cytokine; adipocyte; browning; metabolism	NF-KAPPA-B; INSULIN-RESISTANCE; LINKING OBESITY; LIGHT; INFLAMMATION; TNFSF14; MEMBER; THERMOGENESIS; SUPERFAMILY; APOPTOSIS	The physiologic signals that regulate beige adipogenesis remain incompletely understood, especially those that limit browning and prevent overexpenditure of energy. In this study, the TNF family member cytokine lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells (LIGHT), also known as TNF super family protein 14 (TNFSF14), can inhibit adipose precursor differentiation into beige adipocytes. In acute cold stress, LIGHT deficiency in mice accelerated browning in the subcutaneous white adipose tissue (scWAT). Further experiments showed that LIGHT interacting with lymphotoxin- receptor (LTR) on adipose precursors blocked beige fat biogenesis. LTR signals attenuated the JNK pathway, which contributed to their antibeiging effect. Blocking JNK activation using a small molecular inhibitor prevented cold-induced scWAT beiging. Furthermore, LIGHT/LTR signals acted as an attenuator of white adipogenesis. LIGHT deficiency in mice promoted obesity during high-fat diet feeding. These findings identify the LIGHT axis as a regulator of adipose tissue homeostasis and suggest that LIGHT signaling functions as a mechanism to divert energy in favor of immune activation.Kou, Y., Liu, Q., Liu, W., Sun, H., Liang, M., Kong, F., Zhang, B., Wei, Y., Liu, Z., Wang, Y. LIGHT/TNFSF14 signaling attenuates beige fat biogenesis.	[Kou, Yanbo; Liu, Qingya; Liu, Wenli; Sun, Hongxiang; Liang, Ming; Kong, Fanyun; Zhang, Bo; Wei, Yanxia; Liu, Zhuanzhuan; Wang, Yugang] Xuzhou Med Univ, Jiangsu Key Lab Immun & Metab, Xuzhou, Jiangsu, Peoples R China; [Kou, Yanbo; Liu, Qingya; Liu, Wenli; Sun, Hongxiang; Liang, Ming; Kong, Fanyun; Zhang, Bo; Wei, Yanxia; Liu, Zhuanzhuan; Wang, Yugang] Xuzhou Med Univ, Lab Infect & Immun, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Wang, YG (corresponding author), Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Tongshan Rd 209, Xuzhou 221004, Jiangsu, Peoples R China.	wangyg@xzhmu.edu.cn	Liu, Qing/GWC-9222-2022; liu, qingqing/HHD-0360-2022	Wang, Yugang/0000-0002-0709-1924	National Natural Science Foundation of China [81770853, 81700774]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [KYLX14-1448]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China [16KJB310016]; Starting Foundation for Talents of Xuzhou Medical University [D2016029, 53591518]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China; Starting Foundation for Talents of Xuzhou Medical University	The authors thank Drs. Yang-Xin Fu and Mingzhao Zhu for providing critical reagents for the project. Project support was provided in part by Grants 81770853 (to Y.W.), 81700774 (to Y.K.) from the National Natural Science Foundation of China; Grant KYLX14-1448 from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in 2014; Grant 16KJB310016 from the Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China; and Grants D2016029 (to Y.W.) and 53591518 (to Y.K.) from the Starting Foundation for Talents of Xuzhou Medical University. Y.W. is a specially appointed professor by universities in Jiangsu Province. The authors declare no conflicts of interest.	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2012, CURR OPIN LIPIDOL, V23, P190, DOI 10.1097/MOL.0b013e328352dcef; Bassols J, 2010, INT J OBESITY, V34, P146, DOI 10.1038/ijo.2009.199; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Choi EK, 2014, J ENDOCRINOL, V220, P25, DOI 10.1530/JOE-13-0341; Dhall S, 2016, ADV WOUND CARE, V5, P421, DOI 10.1089/wound.2016.0687; DiSpirito JR, 2015, SEMIN IMMUNOL, V27, P315, DOI 10.1016/j.smim.2015.10.005; Goto T, 2016, CYTOKINE, V77, P107, DOI 10.1016/j.cyto.2015.11.001; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Halvorsen B, 2016, DIABETOLOGIA, V59, P2134, DOI 10.1007/s00125-016-4036-y; Krause P, 2014, GASTROENTEROLOGY, V146, P1752, DOI 10.1053/j.gastro.2014.02.010; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lim SG, 2013, CELL IMMUNOL, V285, P10, DOI 10.1016/j.cellimm.2013.08.002; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Okla M, 2018, INFLAMMATION, V41, P626, DOI 10.1007/s10753-017-0718-y; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saunders BM, 2018, IMMUNOL CELL BIOL, V96, P41, DOI 10.1111/imcb.1002; Tang HD, 2016, CANCER LETT, V370, P85, DOI 10.1016/j.canlet.2015.10.009; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tiller G, 2011, INT J OBESITY, V35, P208, DOI 10.1038/ijo.2010.126; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Wang YG, 2009, IMMUNOL REV, V229, P232, DOI 10.1111/j.1600-065X.2009.00762.x	33	12	13	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1595	1604		10.1096/fj.201800792R	http://dx.doi.org/10.1096/fj.201800792R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30148680	Bronze			2022-12-26	WOS:000457296600008
J	Pennington, ER; Sullivan, EM; Fix, A; Dadoo, S; Zeczycki, TN; DeSantis, A; Schlattner, U; Coleman, RA; Chicco, AJ; Brown, DA; Shaikh, SR				Pennington, Edward Ross; Sullivan, E. Madison; Fix, Amy; Dadoo, Sahil; Zeczycki, Tonya N.; DeSantis, Anita; Schlattner, Uwe; Coleman, Rosalind A.; Chicco, Adam J.; Brown, David A.; Shaikh, Saame Raza			Proteolipid domains form in biomimetic and cardiac mitochondrial vesicles and are regulated by cardiolipin concentration but not monolyso-cardiolipin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; membrane structure; mitochondria; cytochrome c; lipid vesicle; detergent solubilization; giant mitochondrial vesicles; giant unilamellar vesicles; lipid domains; monolyso-cardiolipin	GIANT UNILAMELLAR VESICLES; CREATINE-KINASE ISOENZYMES; LIPID RAFT MIXTURES; BARTH-SYNDROME; CYTOCHROME-C; ISCHEMIA/REPERFUSION INJURY; TETRALINOLEOYL-CARDIOLIPIN; SHOTGUN LIPIDOMICS; ALPHA-SYNUCLEIN; ENZYME-ACTIVITY	Cardiolipin (CL) is an anionic phospholipid mainly located in the inner mitochondrial membrane, where it helps regulate bioenergetics, membrane structure, and apoptosis. Localized, phase-segregated domains of CL are hypothesized to control mitochondrial inner membrane organization. However, the existence and underlying mechanisms regulating these mitochondrial domains are unclear. Here, we first isolated detergent-resistant cardiac mitochondrial membranes that have been reported to be CL-enriched domains. Experiments with different detergents yielded only nonspecific solubilization of mitochondrial phospholipids, suggesting that CL domains are not recoverable with detergents. Next, domain formation was investigated in biomimetic giant unilamellar vesicles (GUVs) and newly synthesized giant mitochondrial vesicles (GMVs) from mouse hearts. Confocal fluorescent imaging revealed that introduction of cytochrome c into membranes promotes macroscopic proteolipid domain formation associated with membrane morphological changes in both GUVs and GMVs. Domain organization was also investigated after lowering tetralinoleoyl-CL concentration and substitution with monolyso-CL, two common modifications observed in cardiac pathologies. Loss of tetralinoleoyl-CL decreased proteolipid domain formation in GUVs, because of a favorable Gibbs-free energy of lipid mixing, whereas addition of monolyso-CL had no effect on lipid mixing. Moreover, murine GMVs generated from cardiac acyl-CoA synthetase-1 knockouts, which have remodeled CL acyl chains, did not perturb proteolipid domains. Finally, lowering the tetralinoleoyl-CL content had a stronger influence on the oxidation status of cytochrome c than did incorporation of monolyso-CL. These results indicate that proteolipid domain formation in the cardiac mitochondrial inner membrane depends on tetralinoleoyl-CL concentration, driven by underlying lipid-mixing properties, but not the presence of monolyso-CL.	[Pennington, Edward Ross; Sullivan, E. Madison; Zeczycki, Tonya N.; DeSantis, Anita] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Pennington, Edward Ross; Sullivan, E. Madison; Fix, Amy; Zeczycki, Tonya N.; DeSantis, Anita] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Pennington, Edward Ross; Dadoo, Sahil; Coleman, Rosalind A.; Shaikh, Saame Raza] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Pennington, Edward Ross; Dadoo, Sahil; Coleman, Rosalind A.; Shaikh, Saame Raza] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Schlattner, Uwe] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, INSERM, U1055, Grenoble, France; [Schlattner, Uwe] Univ Grenoble Alpes, SFR Environm & Syst Biol, Grenoble, France; [Chicco, Adam J.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Brown, David A.] Virginia Tech, Corp Res Ctr, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24060 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Colorado State University; Virginia Polytechnic Institute & State University	Shaikh, SR (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu	, PEP-MX Core/AGV-4051-2022; Schlattner, Uwe/D-1267-2009	Schlattner, Uwe/0000-0003-1159-5911; Coleman, Rosalind/0000-0003-4379-3824; Zeczycki, Tonya/0000-0002-5216-1960	National Institutes of Health [R01HL123647]; University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01HL123647 (to D.B. and S.R.S.) and internal funds from the University of North Carolina, Chapel Hill (to S.R.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Beales PA, 2011, LANGMUIR, V27, P6107, DOI 10.1021/la104924c; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown DA, 2013, PHARMACOL THERAPEUT, V140, P258, DOI 10.1016/j.pharmthera.2013.07.005; Chen Q, 2006, FREE RADICAL BIO MED, V40, P976, DOI 10.1016/j.freeradbiomed.2005.10.043; Cheniour M, 2017, BBA-GEN SUBJECTS, V1861, P969, DOI 10.1016/j.bbagen.2017.02.001; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; El Khoury M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10543-3; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Fernandez MIG, 2004, ANAL BIOCHEM, V328, P174, DOI 10.1016/j.ab.2004.01.020; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; He Q, 2014, CHEM PHYS LIPIDS, V179, P75, DOI 10.1016/j.chemphyslip.2013.10.007; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Juhasz J, 2010, BIOCHEM J, V430, P415, DOI [10.1042/Bj20100516, 10.1042/BJ20100516]; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Maniti O, 2009, BIOPHYS J, V96, P2428, DOI 10.1016/j.bpj.2008.12.3911; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mitsopoulos P, 2015, MOL CELL BIOL, V35, P1838, DOI 10.1128/MCB.00047-15; Mulligan CM, 2014, J GERONTOL A-BIOL, V69, P799, DOI 10.1093/gerona/glt209; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nichols-Smith S, 2004, BBA-BIOMEMBRANES, V1663, P82, DOI 10.1016/j.bbamem.2004.02.002; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Paradies G, 2015, CLIN LIPIDOL, V10, P415, DOI 10.2217/clp.15.31; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Pennington ER, 2017, BBA-BIOMEMBRANES, V1859, P257, DOI 10.1016/j.bbamem.2016.11.012; Petrosillo G, 2005, BBA-BIOENERGETICS, V1710, P78, DOI 10.1016/j.bbabio.2005.10.003; Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2000, J BIOL CHEM, V275, P17314, DOI 10.1074/jbc.M001919200; Schlattner U, 2000, BIOL CHEM, V381, P1063, DOI 10.1515/BC.2000.131; Schlattner U, 2014, CHEM PHYS LIPIDS, V179, P32, DOI 10.1016/j.chemphyslip.2013.12.008; Schmid EM, 2015, METHOD CELL BIOL, V128, P319, DOI 10.1016/bs.mcb.2015.02.004; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Shaikh SR, 2001, BBA-BIOMEMBRANES, V1512, P317, DOI 10.1016/S0005-2736(01)00335-2; Shen Z, 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/890717, DOI 10.1155/2015/890717]; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Speer O, 2005, BIOCHEM J, V385, P445, DOI 10.1042/BJ20040386; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Sullivan EM, 2018, J BIOL CHEM, V293, P466, DOI [10.1074/jbc.m117.812834, 10.1074/jbc.M117.812834]; Sullivan EM, 2017, J NUTR BIOCHEM, V45, P94, DOI 10.1016/j.jnutbio.2017.04.004; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7	76	11	11	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15933	15946		10.1074/jbc.RA118.004948	http://dx.doi.org/10.1074/jbc.RA118.004948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30158245	Green Published, hybrid			2022-12-26	WOS:000447256000016
J	Zhang, WP; Shi, YQ; Peng, YX; Zhong, L; Zhu, S; Zhang, WB; Tang, SJ				Zhang, Wenping; Shi, Yuqiang; Peng, Yanxi; Zhong, Ling; Zhu, Shuang; Zhang, Wenbo; Tang, Shao-Jun			Neuron activity-induced Wnt signaling up-regulates expression of brain-derived neurotrophic factor in the pain neural circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; gene expression; neuron; pain; beta-catenin (B-catenin); synapse; brain-derived neurotrophic factor (BDNF)	NEUROPATHIC PAIN; PSYCHIATRIC-DISORDERS; SYNAPTIC-TRANSMISSION; NONCANONICAL PATHWAYS; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; BDNF; PATHOGENESIS	Brain-derived neurotrophic factor (BDNF) is a master regulator of synaptic plasticity in various neural circuits of the mammalian central nervous system. Neuron activity-induced BDNF gene expression is regulated through the Ca2+/CREB pathway, but other regulatory factors may also be involved in controlling BDNF levels. We report here that Wnt/-catenin signaling plays a key role in controlling neuron activity-regulated BDNF expression. Using primary cortical cultures, we show that blockade of Wnt/-catenin signaling inhibits the BDNF up-regulation that is induced by activation of the N-methyl-d-aspartic acid (NMDA) receptor and that activation of the Wnt/-catenin signaling pathway stimulates BDNF expression. In vivo, Wnt/-catenin signaling activated BDNF expression and was required for peripheral pain-induced up-regulation of BDNF in the mouse spine. We also found that conditional deletion of one copy of either Wntless (Wls) or -catenin by Nestin-Cre-mediated recombination is sufficient to inhibit the pain-induced up-regulation of BDNF. We further show that the Wnt/-catenin/BDNF axis in the spinal neural circuit plays an important role in regulating capsaicin-induced pain. These results indicate that neuron activity-induced Wnt signaling stimulates BDNF expression in the pain neural circuits. We propose that pain-induced Wnt secretion may provide an additional mechanism for intercellular coordination of BDNF expression in the neural circuit.	[Zhang, Wenping; Shi, Yuqiang; Zhang, Wenbo; Tang, Shao-Jun] Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA; [Zhu, Shuang; Zhang, Wenbo] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX 77555 USA; [Zhang, Wenping] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China; [Peng, Yanxi; Zhong, Ling] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Yanxi; Zhong, Ling] Sun Yat Sen Univ, Lab Anim Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Yanxi] Xiangnan Univ, Basic Med Dept, Chenzhou 423000, Peoples R China; [Zhong, Ling] Shenzhen Ctr ADR Monitoring, Shenzhen 518001, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Zhejiang Sci-Tech University; Sun Yat Sen University; Sun Yat Sen University	Tang, SJ (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	shtang@utmb.edu		Tang, Shao-Jun/0000-0002-6076-5481	National Institutes of Health [R01NS079166, R01DA036165, R01NS095747, R01EY026629]; NATIONAL EYE INSTITUTE [R01EY026629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095747, R01NS079166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01NS079166, R01DA036165 and R01NS095747 (to S. J. T.) and R01EY026629 (to Wenbo Zhang). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; Avila ME, 2010, J BIOL CHEM, V285, P18939, DOI 10.1074/jbc.M110.103028; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Brault V, 2001, DEVELOPMENT, V128, P1253; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Itokazu T, 2014, NEUROSCI RES, V79, P34, DOI 10.1016/j.neures.2013.12.002; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Li B, 2013, J BIOL CHEM, V288, P13610, DOI 10.1074/jbc.M112.381046; Li YC, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Shi YQ, 2013, J NEUROIMMUNE PHARM, V8, P956, DOI 10.1007/s11481-013-9474-4; Shi YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-47; Simonetti M, 2014, NEURON, V83, P104, DOI 10.1016/j.neuron.2014.05.037; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wan XZ, 2012, J NEUROSCI, V32, P3910, DOI 10.1523/JNEUROSCI.3916-11.2012; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yuan SB, 2015, PAIN, V156, P1311, DOI 10.1097/j.pain.0000000000000177; Yuan SB, 2012, J NEUROIMMUNE PHARM, V7, P904, DOI 10.1007/s11481-012-9370-3; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zhang YK, 2013, J CLIN INVEST, V123, P2268, DOI 10.1172/JCI65364; Zhu AF, 2018, CELL SIGNAL, V44, P51, DOI 10.1016/j.cellsig.2018.01.017; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	43	26	29	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15641	15651		10.1074/jbc.RA118.002840	http://dx.doi.org/10.1074/jbc.RA118.002840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139740	hybrid, Green Published			2022-12-26	WOS:000446549200027
J	Bigford, GE; Darr, AJ; Bracchi-Ricard, VC; Gao, H; Nash, MS; Bethea, JR				Bigford, Gregory E.; Darr, Andrew J.; Bracchi-Ricard, Valerie C.; Gao, Han; Nash, Mark S.; Bethea, John R.			Effects of ursolic acid on sub-lesional muscle pathology in a contusion model of spinal cord injury	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; MESSENGER-RNA EXPRESSION; BONE-MINERAL DENSITY; SYNTHASE KINASE 3; SKELETAL-MUSCLE; CARDIOVASCULAR-DISEASE; PARAPLEGIC PATIENTS; SIGNALING PATHWAYS; UBIQUITIN LIGASES; QUADRICEPS MUSCLE	Spinal Cord Injury (SCI) results in severe sub-lesional muscle atrophy and fiber type transformation from slow oxidative to fast glycolytic, both contributing to functional deficits and maladaptive metabolic profiles. Therapeutic countermeasures have had limited success and muscle-related pathology remains a clinical priority. mTOR signaling is known to play a critical role in skeletal muscle growth and metabolism, and signal integration of anabolic and catabolic pathways. Recent studies show that the natural compound ursolic acid (UA) enhances mTOR signaling intermediates, independently inhibiting atrophy and inducing hypertrophy. Here, we examine the effects of UA treatment on sub-lesional muscle mTOR signaling, catabolic genes, and functional deficits following severe SCI in mice. We observe that UA treatment significantly attenuates SCI induced decreases in activated forms of mTOR, and signaling intermediates PI3K, AKT, and S6K, and the upregulation of catabolic genes including FOXO1, MAFbx, MURF-1, and PSMD11. In addition, UA treatment improves SCI induced deficits in body and sub-lesional muscle mass, as well as functional outcomes related to muscle function, motor coordination, and strength. These findings provide evidence that UA treatment may be a potential therapeutic strategy to improve muscle-specific pathological consequences of SCI.	[Bigford, Gregory E.; Gao, Han; Nash, Mark S.] Miami Project Cure Paralysis, Miami, FL 33136 USA; [Bigford, Gregory E.; Gao, Han; Nash, Mark S.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Darr, Andrew J.] Univ Illinois, Coll Med Peoria, Dept Hlth Sci Educ, Peoria, IL USA; [Bracchi-Ricard, Valerie C.; Bethea, John R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Nash, Mark S.] Univ Miami, Miller Sch Med, Dept Rehabil Med, Miami, FL 33136 USA	University of Miami; University of Illinois System; University of Illinois Peoria; Drexel University; University of Miami	Bigford, GE (corresponding author), Miami Project Cure Paralysis, Miami, FL 33136 USA.; Bigford, GE (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.	gbigford@med.miami.edu	Bigford, Gregory/GMW-4031-2022	Bigford, Gregory/0000-0001-8990-3465	Miami Project to Cure Paralysis	Miami Project to Cure Paralysis	This work was supported by the Miami Project to Cure Paralysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 1996, PFLUG ARCH EUR J PHY, V431, P513, DOI 10.1007/BF02191897; Baldi JC, 1998, SPINAL CORD, V36, P463, DOI 10.1038/sj.sc.3100679; Bang HS, 2014, KOREAN J PHYSIOL PHA, V18, P441, DOI 10.4196/kjpp.2014.18.5.441; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; Bauman W A, 2001, J Spinal Cord Med, V24, P266; Bauman W A, 2000, Phys Med Rehabil Clin N Am, V11, P109; BAUMAN WA, 1992, PARAPLEGIA, V30, P697, DOI 10.1038/sc.1992.136; Bauman WA, 1999, ASSIST TECHNOL, V11, P88, DOI 10.1080/10400435.1999.10131993; Bauman WA, 1999, SPINAL CORD, V37, P601, DOI 10.1038/sj.sc.3100911; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRENES G, 1986, ARCH PHYS MED REHAB, V67, P445; Burnham R, 1997, SPINAL CORD, V35, P86, DOI 10.1038/sj.sc.3100364; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; Castro MJ, 1999, EUR J APPL PHYSIOL, V80, P373, DOI 10.1007/s004210050606; Chelh I, 2011, ANIMAL, V5, P278, DOI 10.1017/S1751731110001862; Chelh I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-196; Chen Y, 2006, SPINAL CORD, V44, P82, DOI 10.1038/sj.sc.3101818; Chu X, 2015, MOL NUTR FOOD RES, V59, P1491, DOI 10.1002/mnfr.201400670; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Csibi A, 2009, J BIOL CHEM, V284, P4413, DOI 10.1074/jbc.M807641200; DEARWATER SR, 1986, MED SCI SPORT EXER, V18, P541; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; Donaldson N, 2000, SPINAL CORD, V38, P680, DOI 10.1038/sj.sc.3101072; Dudley-Javoroski S, 2008, J REHABIL RES DEV, V45, P283, DOI 10.1682/JRRD.2007.02.0031; Dupont-Versteegden EE, 2000, AM J PHYSIOL-CELL PH, V279, pC1677, DOI 10.1152/ajpcell.2000.279.6.C1677; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Frey-Rindova P, 2000, SPINAL CORD, V38, P26, DOI 10.1038/sj.sc.3100905; Gael JB, 2005, PEPTIDES, V26, P1528, DOI 10.1016/j.peptides.2005.03.011; Garikipati DK, 2012, AM J PHYSIOL-REG I, V302, pR1059, DOI 10.1152/ajpregu.00523.2011; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Giangregorio L, 2006, J SPINAL CORD MED, V29, P489, DOI 10.1080/10790268.2006.11753898; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GORDON T, 1994, PHYS THER, V74, P50, DOI 10.1093/ptj/74.1.50; Gorgey AS, 2007, SPINAL CORD, V45, P304, DOI 10.1038/sj.sc.3101968; Gorgey AS, 2011, PM&R, V3, P440, DOI 10.1016/j.pmrj.2011.01.011; GRANAT MH, 1993, PARAPLEGIA, V31, P207, DOI 10.1038/sc.1993.39; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; Groah SL, 2011, J CARDIOPULM REHABIL, V31, P73, DOI 10.1097/HCR.0b013e3181f68aba; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; Jia Y, 2015, MOL NUTR FOOD RES, V59, P344, DOI 10.1002/mnfr.201400399; Jung SH, 2007, BIOCHEM J, V403, P243, DOI 10.1042/BJ20061123; KARLSSON AK, 1995, METABOLISM, V44, P52, DOI 10.1016/0026-0495(95)90289-9; Kemp Bryan J, 2005, Phys Med Rehabil Clin N Am, V16, P1, DOI 10.1016/j.pmr.2004.06.009; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Kostovski E, 2008, SPINAL CORD, V46, P559, DOI 10.1038/sc.2008.3; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JY, 2011, BIOCHEM BIOPH RES CO, V415, P632, DOI 10.1016/j.bbrc.2011.10.124; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; LEVY M, 1990, J BIOMED ENG, V12, P150, DOI 10.1016/0141-5425(90)90136-B; Liang H, 2007, ARCH PHYS MED REHAB, V88, P1198, DOI 10.1016/j.apmr.2007.05.023; LIEBER RL, 1986, DEV MED CHILD NEUROL, V28, P533; Lin CY, 2018, J NEUROTRAUM, V35, P1737, DOI 10.1089/neu.2017.5444; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; LOTTA S, 1991, PARAPLEGIA, V29, P247, DOI 10.1038/sc.1991.35; Maimoun L, 2006, SPINAL CORD, V44, P203, DOI 10.1038/sj.sc.3101832; MAKI KC, 1995, PARAPLEGIA, V33, P102, DOI 10.1038/sc.1995.24; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Modlesky CM, 2004, J APPL PHYSIOL, V96, P561, DOI 10.1152/japplphysiol.00207.2003; Moore CD, 2015, J MUSCULOSKEL NEURON, V15, P32; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; Nash Mark S, 2005, J Neurol Phys Ther, V29, P87; Nash MS, 2016, ARCH PHYS MED REHAB, V97, P1696, DOI 10.1016/j.apmr.2016.07.002; NASH MS, 1995, PARAPLEGIA, V33, P80, DOI 10.1038/sc.1995.20; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Novotny L, 2001, NEOPLASMA, V48, P241; Ogasawara R, 2013, AM J PHYSIOL-ENDOC M, V305, pE760, DOI 10.1152/ajpendo.00302.2013; Ohnishi Y, 2012, NEUROREPORT, V23, P157, DOI 10.1097/WNR.0b013e32834f4048; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; RABISCHONG E, 1992, PARAPLEGIA, V30, P467, DOI 10.1038/sc.1992.100; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; ROCHESTER L, 1995, PARAPLEGIA, V33, P437, DOI 10.1038/sc.1995.97; Rodriguez DJ, 1997, SPINAL CORD, V35, P599, DOI 10.1038/sj.sc.3100439; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; ROUND JM, 1993, J NEUROL SCI, V116, P207, DOI 10.1016/0022-510X(93)90327-U; Roy RL, 2000, MUSCLE NERVE, V23, P735, DOI 10.1002/(SICI)1097-4598(200005)23:5<735::AID-MUS11>3.0.CO;2-T; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; SaKM G, 2010, TOP SPINAL CORD INJ, V15, P1; Sanchez AMJ, 2013, INT J BIOCHEM CELL B, V45, P2158, DOI 10.1016/j.biocel.2013.06.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCELSI R, 1982, ACTA NEUROPATHOL, V57, P243, DOI 10.1007/BF00692178; Seiliez I, 2013, GEN COMP ENDOCR, V186, P9, DOI 10.1016/j.ygcen.2013.02.008; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shields RK, 1997, J APPL PHYSIOL, V82, P1499, DOI 10.1152/jappl.1997.82.5.1499; SHIELDS RK, 1995, J NEUROPHYSIOL, V73, P2195, DOI 10.1152/jn.1995.73.6.2195; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Talmadge RJ, 2002, J APPL PHYSIOL, V93, P1487, DOI 10.1152/japplphysiol.00053.2002; Thomas CK, 1997, EXP NEUROL, V148, P414, DOI 10.1006/exnr.1997.6690; TSITOURAS PD, 1995, HORM METAB RES, V27, P287, DOI 10.1055/s-2007-979961; Urso ML, 2007, J PHYSIOL-LONDON, V579, P877, DOI 10.1113/jphysiol.2006.118042; Urso ML, 2009, MED SCI SPORT EXER, V41, P1860, DOI 10.1249/MSS.0b013e3181a6458a; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wahman K, 2011, J REHABIL MED, V43, P237, DOI 10.2340/16501977-0658; Wang Zhihui, 2009, MEAS CONTROL, V19, P11, DOI DOI 10.1016/j.ejphar.2009.11.019; Wei ZJ, 2016, MOL MED REP, V14, P165, DOI 10.3892/mmr.2016.5272; Yang Y, 2014, J MOL CELL CARDIOL, V67, P103, DOI 10.1016/j.yjmcc.2013.12.018; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zlotolow S P, 1992, J Am Paraplegia Soc, V15, P158	123	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203042	10.1371/journal.pone.0203042	http://dx.doi.org/10.1371/journal.pone.0203042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157245	Green Submitted, gold, Green Published			2022-12-26	WOS:000443071400084
J	Gonzalez-Crespo, C; Serrano, E; Cahill, S; Castillo-Contreras, R; Cabaneros, L; Lopez-Martin, JM; Roldan, J; Lavin, S; Lopez-Olvera, JR				Gonzalez-Crespo, Carlos; Serrano, Emmanuel; Cahill, Sean; Castillo-Contreras, Raquel; Cabaneros, Lluis; Maria Lopez-Martin, Jose; Roldan, Joan; Lavin, Santiago; Ramon Lopez-Olvera, Jorge			Stochastic assessment of management strategies for a Mediterranean peri-urban wild boar population	PLOS ONE			English	Article							SUS-SCROFA; IBERIAN PENINSULA; RISK-ASSESSMENT; LIFE-HISTORY; ELASTICITY; ABUNDANCE; ECOSYSTEM; FOOD; MORTALITY; PRESSURE	Wild boar (Sus scrofa) population spread into urban and periurban areas has exacerbated conflicts with humans. There is a need for planned wild boar management strategies, and Population viability analysis (PVA) combined with perturbation analyses allow the assessment of the management effort of control methods. Our study aims to develop stochastic predictive models of the increasing wild boar population of the 80 km(2) peri-urban Mediterranean area of Collserola Natural Park (CNP), located near Barcelona, Spain, as well as assessing specific management measures (including reduced food availability, selective harvest, and reduction in fertility). Population parameters were estimated from previously published census and hunting data provided by the CNP and the local hunting administration. The results revealed that under the current conditions the CNP wild boar population will continue to increase. The most efficient strategy to reduce wild boar abundance was a combination of reducing supplementary anthropogenic food resources and selective removal of juvenile (<1 year) and yearling (1-2 years) wild boar. These strategies will probably be also the most efficient ones in other oversupplemented increasing wild boar populations in similar situations, although specific studies will be needed to fine-tune the best management option for each context. PVA allows the prediction of future population trends and the assessment of the efficacy and efficiency of potential management strategies before implementing management measures.	[Gonzalez-Crespo, Carlos; Serrano, Emmanuel; Castillo-Contreras, Raquel; Lavin, Santiago; Ramon Lopez-Olvera, Jorge] Univ Autonoma Barcelona UAB, Wildlife Ecol & Hlth Grp, Barcelona, Spain; [Gonzalez-Crespo, Carlos; Serrano, Emmanuel; Castillo-Contreras, Raquel; Lavin, Santiago; Ramon Lopez-Olvera, Jorge] Univ Autonoma Barcelona UAB, Serv Ecopatol Fauna Salvatge SEFaS, Dept Med & CirurgiaAnim, Fac Vet, Barcelona, Spain; [Serrano, Emmanuel] Univ Aveiro UA, Dept Biol, Aveiro, Portugal; [Serrano, Emmanuel] Univ Aveiro UA, Cesam, Aveiro, Portugal; [Cahill, Sean; Cabaneros, Lluis] Consorci Parc Nat Serra Collserola, Barcelona, Spain; [Maria Lopez-Martin, Jose] Generalitat Catalunya, Serv Terr Barcelona, Dept Agr Ramaderia Pesca & Alimentacio, Barcelona, Spain; [Roldan, Joan] Generalitat Catalunya, Forestal Catalana SA, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Universidade de Aveiro; Universidade de Aveiro	Lopez-Olvera, JR (corresponding author), Univ Autonoma Barcelona UAB, Wildlife Ecol & Hlth Grp, Barcelona, Spain.; Lopez-Olvera, JR (corresponding author), Univ Autonoma Barcelona UAB, Serv Ecopatol Fauna Salvatge SEFaS, Dept Med & CirurgiaAnim, Fac Vet, Barcelona, Spain.	Jordi.Lopez.Olvera@uab.cat	Gonzalez-Crespo, Carlos/GYV-0388-2022; Lavín, Santiago/L-5975-2014; Castillo-Contreras, Raquel/AAI-1831-2019; Contreras, Raquel Castillo/AAG-6050-2020; Martin, Josep Maria Lopez/H-8392-2015; SERRANO-FERRON, Emmanuel/J-4489-2013; Lopez Olvera, Jorge Ramon/H-8382-2015	Gonzalez-Crespo, Carlos/0000-0003-4312-0398; Lavín, Santiago/0000-0001-5655-588X; Contreras, Raquel Castillo/0000-0002-5770-7264; Martin, Josep Maria Lopez/0000-0001-8162-3960; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Lopez Olvera, Jorge Ramon/0000-0002-2999-3451	Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/B+PD/96637/2013]; University of Aveiro (Department of Biology); FCT/MEC [CESAM RU UID/AMB/50017]; FEDER within the PT2020 Partnership Agreement; Universitat Auto noma de Barcelona [13/051, 15/0174]; Municipality of Barcelona [13/051, 15/0174]; Generalitat de Catalunya (Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement) [2016FI_B 00425]; European Social Fund (ESF)	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); University of Aveiro (Department of Biology); FCT/MEC; FEDER within the PT2020 Partnership Agreement; Universitat Auto noma de Barcelona; Municipality of Barcelona; Generalitat de Catalunya (Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement); European Social Fund (ESF)(European Social Fund (ESF))	E. Serrano was supported by the Fundacao para a Ciencia e a Tecnologia (Portugal), through the postdoctoral program (SFRH/B+PD/96637/2013), and the University of Aveiro (Department of Biology) and FCT/MEC (CESAM RU UID/AMB/50017), co-financed by the FEDER within the PT2020 Partnership Agreement. This research was funded by the contracts 13/051 and 15/0174 to Jorge Ramon Lopez-Olvera between the Universitat Auto noma de Barcelona and the Municipality of Barcelona. Raquel Castillo-Contreras benefitted from a PhD grant (2016FI_B 00425) co-financed by Generalitat de Catalunya (Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement) and the European Social Fund (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Akû║akaya H.R., 1999, APPL POPULATION ECOL; Andersen MC, 2008, WILDLIFE RES, V35, P242, DOI 10.1071/WR07107; Andersen MC, 2005, HUM ECOL RISK ASSESS, V11, P1083, DOI 10.1080/10807030500278610; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Boitani L, 1985, J MOUNTAIN ECOLOGY, V3, p197 ; Bosch J, 2012, FOLIA ZOOL, V61, P138, DOI 10.25225/fozo.v61.i2.a7.2012; Braga C, 2010, EUR J WILDLIFE RES, V56, P465, DOI 10.1007/s10344-010-0373-1; Cahill S, 2012, ANIM BIODIV CONSERV, V35, P221; Cahill SL, 2012, 30 IUGB C 5 9 SEPT B; Cahill Sean, 2004, Galemys, V16, P37; Castillo-Contreras R, 2018, SCI TOTAL ENVIRON, V615, P282, DOI 10.1016/j.scitotenv.2017.09.277; Choquenot D, 2003, J ANIM ECOL, V72, P14, DOI 10.1046/j.1365-2656.2003.00676.x; Duca C, 2009, BIOL CONSERV, V142, P563, DOI 10.1016/j.biocon.2008.11.010; Fernandez-Llario P, 2000, ETHOL ECOL EVOL, V12, P335; Fernandez-Llario P, 2005, FOLIA ZOOL, V54, P240; Fernandez-Martinez M, 2012, ACTA OECOL, V43, P51, DOI 10.1016/j.actao.2012.05.006; Focardi S, 1996, FOREST ECOL MANAG, V88, P7, DOI 10.1016/S0378-1127(96)03804-2; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Fonseca C., 2004, GALEMYS, V16, P53; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Geisser H, 2004, J WILDLIFE MANAGE, V68, P939, DOI 10.2193/0022-541X(2004)068[0939:EOHFAF]2.0.CO;2; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Herrero J, 2008, ACTA THERIOL, V53, P355, DOI 10.1007/BF03195196; Hone J., 2012, APPL POPULATION COMM; Keuling O, 2017, ECOLOGY CONSERVATION, p202 ; Keuling O, 2013, EUR J WILDLIFE RES, V59, P805, DOI 10.1007/s10344-013-0733-8; Koenig WD, 2015, ECOLOGY, V96, P184, DOI 10.1890/14-0819.1; Lacy R., 2005, VORTEX10 STOCHASTIC; Lacy RC, 2015, VORTEX 10 1 MANUAL; Licoppe A, 2013, INT SURV REP INTR WO, P1; Llimona F., 2007, GALEMYS, V19, P215; Massei G, 1996, ACTA THERIOL, V41, P307, DOI 10.4098/AT.arch.96-29; Massei G, 1997, J ZOOL, V242, P394; Massei Giovanna, 2004, Galemys, V16, P135; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Massei Giovanna, 2011, Human-Wildlife Interactions, V5, P79; Mills L. S., 2013, CONSERVATION WILDLIF; Pepin KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183441; RodriguezEstevez V, 2007, ARCH ZOOTEC, V56, P25; Rosell C., 1998, BIOLOGIAIECOLOGIA SE; Rosell C., 2001, GALEMYS, V13, P1; Santos P, 2006, EUR J WILDLIFE RES, V52, P207, DOI 10.1007/s10344-005-0025-z; Serrano E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01307; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; Tenes Anna, 2007, Galemys, V19, P169; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; Vetter SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132178	54	29	30	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202289	10.1371/journal.pone.0202289	http://dx.doi.org/10.1371/journal.pone.0202289			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157225	gold, Green Published, Green Submitted			2022-12-26	WOS:000443071400049
J	Hernando, C; Hernando, C; Collado, EJ; Panizo, N; Martinez-Navarro, I; Hernando, B				Hernando, Carlos; Hernando, Carla; Joaquin Collado, Eladio; Panizo, Nayara; Martinez-Navarro, Ignacio; Hernando, Barbara			Establishing cut-points for physical activity classification using triaxial accelerometer in middle-aged recreational marathoners	PLOS ONE			English	Article							GENEA ACCELEROMETER; ENERGY-EXPENDITURE; OXYGEN-UPTAKE; RUNNERS; PARTICIPATION; INTENSITY; ATHLETE; CONTEXT; YOUTH	The purpose of this study was to establish GENEA (Gravity Estimator of Normal Everyday Activity) cut-points for discriminating between six relative-intensity activity levels in middle-aged recreational marathoners. Nighty-eight (83 males and 15 females) recreational marathoners, aged 30-45 years, completed a cardiopulmonary exercise test running on a treadmill while wearing a GENEA accelerometer on their non-dominant wrist. The breath-by-breath- <(V)over dot>O-2 data was also collected for criterion measure of physical activity categories (sedentary, light, moderate, vigorous, very vigorous and extremely vigorous). GENEA cut-points for physical activity classification was performed via Receiver Operating Characteristic (ROC) analysis. Spearman's correlation test was applied to determine the relationship between estimated and measured intensity classifications. Statistical analysis were done for all individuals, and separating samples by sex. The GENEA cut-points established were able to distinguish between all six-relative intensity levels with an excellent classification accuracy (area under the ROC curve (AUC) values between 0.886 and 0.973) for all samples. When samples were separated by sex, AUC values were 0.881-0.973 and 0.924-0.968 for males and females, respectively. The total variance in energy expenditure explained by GENEA accelerometer data was 78.50% for all samples, 78.14% for males, and 83.17% for females. In conclusion, the wrist-worn GENEA accelerometer presents a high capacity of classifying the intensity of physical activity in middle-aged recreational marathoners when examining all samples together, as well as when sample set was separated by sex. This study suggests that the triaxial GENEA accelerometers (worn on the non-dominant wrist) can be used to predict energy expenditure for running activities.	[Hernando, Carlos] Jaume I Univ, Sport Serv, Castellon de La Plana, Spain; [Hernando, Carlos] Jaume I Univ, Dept Educ, Castellon de La Plana, Spain; [Hernando, Carla] Carlos III Univ Madrid, Dept Math, Madrid, Spain; [Joaquin Collado, Eladio; Panizo, Nayara] Jaume I Univ, Fac Hlth Sci, Castellon de La Plana, Spain; [Martinez-Navarro, Ignacio] Univ Valencia, Dept Phys Educ & Sport, Valencia, Spain; [Hernando, Barbara] Jaume I Univ, Dept Med, Castellon de La Plana, Spain	Universitat Jaume I; Universitat Jaume I; Universitat Jaume I; University of Valencia; Universitat Jaume I	Hernando, C (corresponding author), Jaume I Univ, Sport Serv, Castellon de La Plana, Spain.; Hernando, C (corresponding author), Jaume I Univ, Dept Educ, Castellon de La Plana, Spain.	hernando@uji.es	Hernando, Carlos/N-2601-2019; Collado-Boira, Eladio/AAB-6001-2019; Hernando, Barbara/AAZ-7357-2021; Hernando, Barbara/AAW-9979-2021	Hernando, Carlos/0000-0001-7182-4785; Collado-Boira, Eladio/0000-0001-8062-4152; Hernando, Barbara/0000-0003-4019-2732; MARTINEZ-NAVARRO, IGNACIO/0000-0002-2942-1293	Fundacion Trinidad Alfonso; Vithas-Nisa Hospitals group	Fundacion Trinidad Alfonso; Vithas-Nisa Hospitals group	Current research was funded by Fundacion Trinidad Alfonso (https://fundaciontrinidadalfonso.org) and Vithas-Nisa Hospitals group (https://www.hospitales.nisa.es). The study funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordero MJA, 2014, NUTR HOSP, V29, P1250, DOI 10.3305/nh.2014.29.6.7410; Ahmadyar B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1254-6; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Angus SD, 2014, J SPORT SCI, V32, P31, DOI 10.1080/02640414.2013.803592; Bassett DR, 2015, MED SCI SPORT EXER, V47, P833, DOI 10.1249/MSS.0000000000000468; Boone J, 2012, SPORTS MED, V42, P511, DOI 10.2165/11599690-000000000-00000; Burrows M, 2000, SPORTS MED, V30, P281, DOI 10.2165/00007256-200030040-00004; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Dijkstra HP, 2014, BRIT J SPORT MED, V48, P523, DOI 10.1136/bjsports-2013-093222; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Esteve-Lanao J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00298; Fudge BW, 2007, MED SCI SPORT EXER, V39, P192, DOI 10.1249/01.mss.0000235884.71487.21; Gabbett TJ, 2017, BRIT J SPORT MED, V51, P1451, DOI 10.1136/bjsports-2016-097298; Hamlyn-Williams CC, 2014, BMC SPORTS SCI MED R, V6, P35, DOI [10.1186/2052-1847-6-35, DOI 10.1186/2052-1847-6-35]; Hoffman MD, 2018, SPORTS MED, V48, P243, DOI 10.1007/s40279-017-0782-3; Hoffman MD, 2015, INT J SPORT PHYSIOL, V10, P93, DOI 10.1123/ijspp.2013-0534; Hoffman MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083867; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Knechtle B, 2017, CHIN J PHYSL, V60; Mansour SG, 2017, AM J KIDNEY DIS, V70, P252, DOI 10.1053/j.ajkd.2017.01.045; Montoye AHK, 2015, MED SCI SPORT EXER, V47, P1735, DOI 10.1249/MSS.0000000000000597; MONTOYE HJ, 1983, MED SCI SPORT EXER, V15, P403; Morgan KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094532; Myers J, 2000, SPORTS MED, V30, P23, DOI 10.2165/00007256-200030010-00003; Nightingale TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126086; Pentecost C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0881-0; Phillips LRS, 2013, J SCI MED SPORT, V16, P124, DOI 10.1016/j.jsams.2012.05.013; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schaefer CA, 2014, MED SCI SPORT EXER, V46, P826, DOI 10.1249/MSS.0000000000000150; Shephard RJ, 2001, MED SCI SPORT EXER, V33, pS400, DOI 10.1097/00005768-200106001-00008; Strath SJ, 2013, CIRCULATION, DOI [10.1161/01.cir, DOI 10.1161/01.CIR]; Szabo A, 2013, J BEHAV ADDICT, V2, P249, DOI 10.1556/JBA.2.2013.4.9; Trappe S, 2007, SPORTS MED, V37, P302, DOI 10.2165/00007256-200737040-00008; Vickers AJ, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0052-y; Welch WA, 2014, MED SCI SPORT EXER, V46, P1825, DOI 10.1249/MSS.0000000000000283; Welch WA, 2013, MED SCI SPORT EXER, V45, P2012, DOI 10.1249/MSS.0b013e3182965249; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661; Zavorsky GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172121; Zhang SY, 2012, MED SCI SPORT EXER, V44, P2228, DOI 10.1249/MSS.0b013e31825e19fd; Zhang SY, 2012, MED SCI SPORT EXER, V44, P742, DOI 10.1249/MSS.0b013e31823bf95c	44	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202815	10.1371/journal.pone.0202815	http://dx.doi.org/10.1371/journal.pone.0202815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157271	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400071
J	Blackburn, NE; Mc Veigh, JG; Mc Caughan, EM; Kennedy, RD; McIntosh, SA; Wilson, IM				Blackburn, Nicole E.; Mc Veigh, Joseph G.; Mc Caughan, Eilis M.; Kennedy, Richard D.; McIntosh, Stuart A.; Wilson, Iseult M.			The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer	PLOS ONE			English	Article							BRIEF PAIN INVENTORY; ADJUVANT TREATMENT; OUTCOME MEASURES; UPPER EXTREMITY; FLAP; MORBIDITY; PERSPECTIVES; SURVIVORS; IMPACT	Introduction Current evidence suggests that patients who have latissimus dorsi (LD) breast reconstruction following mastectomy for breast cancer can experience long-term shoulder dysfunction. However, as there is no standardised assessment or follow-up period within the literature, findings are conflicting. This research aimed to investigate the impact on daily living of immediate and delayed LD breast reconstruction in women following mastectomy for breast cancer. Methods Both qualitative and quantitative methods of enquiry were used. A focus group study explored the musculoskeletal consequences of surgery as perceived by the women (n = 15) and their healthcare professionals (n =11). A questionnaire survey was administered (n = 159), including a range of outcome measures to quantify both the physical and psychosocial impact of LD breast reconstruction. Dyad interviews were also conducted in order to determine the impact of surgery on function and activities of daily living (ADL) from the woman's perspective and that of her significant other (n = 8). Results The qualitative studies highlighted a lack of preparedness and unrealistic expectations regarding functional recovery among women and their significant others'. Post-surgery it was apparent that women weighed up reduced shoulder function against survival, demonstrating resilience in their approach to coping with this adaptive way of living. The survey identified low to moderate effect on the outcomes assessed (n = 159), however, node removal significantly impacted certain aspects of quality of life (p<0.05) and disability (p = 0.04). Conclusions Breast reconstruction using the LD had an impact on shoulder function and some ADL, which impacted not only on the women but also family and significant others. Despite the functional implications associated with surgery, findings would suggest that shoulder dysfunction is not their main concern. This work identified that women and their significant other require further information to clarify expectation regarding recovery, highlighting the changing priorities of women throughout their journey from diagnosis into long-term recovery.	[Blackburn, Nicole E.] Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Blackburn, Nicole E.] UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Mc Veigh, Joseph G.] Univ Coll Cork, Coll Med & Hlth, Sch Clin Therapies, Cork, Ireland; [Mc Caughan, Eilis M.] Ulster Univ, Inst Nursing & Hlth Res, Coleraine, Londonderry, North Ireland; [Kennedy, Richard D.; McIntosh, Stuart A.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Wilson, Iseult M.] Ulster Univ, Ctr Hlth & Rehabil Technol, Inst Nursing & Hlth Res, Jordanstown, North Ireland	Queens University Belfast; University College Cork; Ulster University; Queens University Belfast; Ulster University	Blackburn, NE (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.; Blackburn, NE (corresponding author), UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland.	N.Blackburn@qub.ac.uk	McIntosh, Stuart/J-9512-2012; McVeigh, Joseph/A-5050-2018	McIntosh, Stuart/0000-0002-4123-9611; McVeigh, Joseph/0000-0003-0789-1419; Blackburn, Nicole/0000-0003-4379-6312; Wilson, Iseult M/0000-0002-5107-2843	Department of Employment and Learning, Northern Ireland; Cancer Focus Northern Ireland; Department of Employment and Learning	Department of Employment and Learning, Northern Ireland; Cancer Focus Northern Ireland; Department of Employment and Learning	We gratefully acknowledge the Department of Employment and Learning, Northern Ireland for funding the researcher's (NEB) studentship and Cancer Focus Northern Ireland for kindly funding the focus group and survey component of this research (to IMW).; This research would not have been possible without the participation of the women, their significant others and the healthcare professionals. We thank the PIs at each of the involved Trust sites and the breast care nurses and physiotherapists for their involvement in the focus groups and assistance with the recruitment for the study. We would also like to acknowledge the staff at the Northern Ireland Cancer Trials Network for their help in facilitating this research. A special thanks to the clinical research nurses at each site for their helpful contribution to the survey component of our study and to the staff from the charities and special interest groups involved in the dyad interviews. We gratefully acknowledge the Department of Employment and Learning for funding the researcher's studentship and Cancer Focus Northern Ireland for kindly funding the focus group and survey component of this research.	Adams Eike, 2010, Community Pract, V83, P18; Bodai Balazs I, 2015, Perm J, V19, P48, DOI 10.7812/TPP/14-241; Brackley PTH, 2010, J PLAST RECONSTR AES, V63, P1495, DOI 10.1016/j.bjps.2009.07.040; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Button J, 2010, J PLAST RECONSTR AES, V63, P1505, DOI 10.1016/j.bjps.2009.08.017; Castel LD, 2007, J PAIN SYMPTOM MANAG, V34, P380, DOI 10.1016/j.jpainsymman.2006.12.007; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Chow TL, 2008, SURG PRACT, V12, P35, DOI 10.1111/j.1744-1633.2008.00394.x; Chung EJ, 2013, J EXERC REHABIL, V9, P532, DOI 10.12965/jer.130079; Ciesla S., 2012, EFFECT BREAST RECONS; Collins KK, 2011, BREAST CANCER RES TR, V126, P167, DOI 10.1007/s10549-010-1077-7; De Gournay E, 2010, EJSO-EUR J SURG ONC, V36, P520, DOI 10.1016/j.ejso.2010.04.008; De Oliveira GS, 2014, BREAST J, V20, P9, DOI 10.1111/tbj.12207; Finlay L, 2006, QUALITATIVE RES ALLL; Fodor L, 2011, CHIRURGIA-BUCHAREST, V106, P485; Forthomme B, 2010, CLIN PHYSIOL FUNCT I, V30, P406, DOI 10.1111/j.1475-097X.2010.00956.x; Fraser SM, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-16; FRAULIN FOG, 1995, ANN PLAS SURG, V35, P349, DOI 10.1097/00000637-199510000-00003; Giordano S, 2011, SCAND J SURG, V100, P202, DOI 10.1177/145749691110000312; Glassey N, 2008, PLAST RECONSTR SURG, V122, P1334, DOI 10.1097/PRS.0b013e3181881ffe; Gorman JR, 2011, CANCER NURS, V34, P32, DOI 10.1097/NCC.0b013e3181e4528d; Harrington S, 2014, ARCH PHYS MED REHAB, V95, P153, DOI 10.1016/j.apmr.2013.07.022; Hunsaker FG, 2002, J BONE JOINT SURG AM, V84A, P208, DOI 10.2106/00004623-200202000-00007; Inrig T, 2012, J OCCUP REHABIL, V22, P59, DOI 10.1007/s10926-011-9323-3; Javid SH, 2017, BREAST J, V23, P127, DOI 10.1111/tbj.12707; Kelly BJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-65; Kim SH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0399-x; Kim Z, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-259; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Kumar SP, 2011, INDIAN J PALLIAT CAR, V17, P108, DOI 10.4103/0973-1075.84531; Lateef Fatimah, 2011, J Emerg Trauma Shock, V4, P163, DOI 10.4103/0974-2700.82199; Losken A, 2010, ANN PLAS SURG, V65, P17, DOI 10.1097/SAP.0b013e3181bda349; Lutringer J, 2012, ANN CHIR PLAST ESTH, V57, P567, DOI 10.1016/j.anplas.2012.04.006; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Molina Y, 2014, CLIN J ONCOL NURS, V18, P93, DOI 10.1188/14.CJON.93-101; Nelson JA, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001640; Pallant J., 2013, SPSS SURVIVAL MANUAL, V5th ed.; Parahoo K., 2014, NURSING RES PRINCIPL; Pathak A., 2012, MALAYS J ELT RES, V8, P1; Perdikis G., 2011, EPLASTY, V11, P411; Purushotham AD, 2005, J CLIN ONCOL, V23, P4312, DOI 10.1200/JCO.2005.03.228; Pusic AL, 2012, EXPERT REV PHARM OUT, V12, P149, DOI [10.1586/ERP.11.105, 10.1586/erp.11.105]; Reefy S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-171; Saint-Cyr M, 2009, PLAST RECONSTR SURG, V123, P13, DOI 10.1097/PRS.0b013e3181934838; Sajid MS, 2011, CLIN BREAST CANCER, V11, P357, DOI 10.1016/j.clbc.2011.04.006; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Senkus E., 2013, ANN ONCOLOGY, V24; Sledge GW, 2014, J CLIN ONCOL, V32, P1979, DOI 10.1200/JCO.2014.55.4139; Smith Susan L, 2014, J Adv Pract Oncol, V5, P181; Spagnola Sarah, 2003, Breast J, V9, P463, DOI 10.1046/j.1524-4741.2003.09603.x; Stout NL, 2012, CANCER-AM CANCER SOC, V118, P2191, DOI 10.1002/cncr.27476; Szychta P, 2013, BREAST, V22, P667, DOI 10.1016/j.breast.2013.01.001; Tarantino I, 2006, PLAST RECONSTR SURG, V117, P1387, DOI 10.1097/01.prs.0000207396.22527.68; Teymouri Hr, 2006, Hippokratia, V10, P153; Thiruchelvam P. T. R., 2013, BRIT MED J, V347; Tomita K., 2013, EPLASTY, V13, P206; van Huizum MA, 2016, J PLAST SURG HAND SU, V50, P202, DOI 10.3109/2000656X.2016.1151436; Winters ZE, 2016, BRIT J SURG, V103, P524, DOI 10.1002/bjs.10102; Winters ZE, 2013, BRIT J SURG, V100, P240, DOI 10.1002/bjs.8959	60	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202859	10.1371/journal.pone.0202859	http://dx.doi.org/10.1371/journal.pone.0202859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153282	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700027
J	Cerutti, F; Modesto, P; Rizzo, F; Cravero, A; Jurman, I; Costal, S; Giammarino, M; Mandola, ML; Goria, M; Radovic, S; Cattonaro, F; Acutis, PL; Peletto, S				Cerutti, Francesco; Modesto, Paola; Rizzo, Francesca; Cravero, Alessandra; Jurman, Irena; Costal, Stefano; Giammarino, Mauro; Mandola, Maria Lucia; Goria, Mariella; Radovic, Slobodanka; Cattonaro, Federica; Acutis, Pier Luigi; Peletto, Simone			The microbiota of hematophagous ectoparasites collected from migratory birds	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; TICK IXODES-RICINUS; RICKETTSIA-BELLII; MIDICHLORIA-MITOCHONDRII; INTRACELLULAR BACTERIUM; GLOBAL DISTRIBUTION; MOLECULAR-DETECTION; IXODIDAE; DNA; IDENTIFICATION	Arthropod vectors are responsible for the transmission of human pathogens worldwide. Several arthropod species are bird ectoparasites, however, no study to date has characterized their microbiota as a whole. We sampled hematophagous ectoparasites that feed on migratory birds and performed 16S rRNA gene metabarcoding to characterize their microbial community. A total of 194 ectoparasites were collected from 115 avian hosts and classified into three groups: a) Hippoboscidae diptera; b) ticks; c) other arthropods. Metabarcoding showed that endosymbionts were the most abundant genera of the microbial community, including Wolbachia for Hippoboscidae diptera, Candidatus Midichloria for ticks, Wolbachia and Arsenophonus for the other arthropod group. Genera including pathogenic species were: Rickettsia, Borrelia, Coxiella, Francisella, Bartonella, Anaplasma. Co-infection with Borrelia-Rickettsia and Anaplasma-Rickettsia was also observed. A global overview of the microbiota of ectoparasites sampled from migratory birds was obtained with the use of 16S rRNA gene metabarcoding. A novel finding is the first identification of Rickettsia in the common swift louse fly, Crataerina pallida. Given their possible interaction with pathogenic viruses and bacteria, the presence of endosymbionts in arthropods merits attention. Finally, molecular characterization of genera, including both pathogenic and symbiont species, plays a pivotal role in the design of targeted molecular diagnostics.	[Cerutti, Francesco; Acutis, Pier Luigi; Peletto, Simone] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Genet & Immunobiochim, Turin, Italy; [Modesto, Paola] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Sez Genova, Genoa, Italy; [Rizzo, Francesca; Mandola, Maria Lucia] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Lab Specialist Diagnost Mol Virol & Ovocoltura, Turin, Italy; [Cravero, Alessandra; Goria, Mariella] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Microbiol Mol & Anal Genom, Turin, Italy; [Jurman, Irena; Radovic, Slobodanka; Cattonaro, Federica] IGA Technol Serv, Udine, Italy; [Costal, Stefano] Lab Chim Camera Commercio Torino, Turin, Italy; [Giammarino, Mauro] ASL CN 1, Dept Prevent, Racconigi, CN, Italy	IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta	Peletto, S (corresponding author), Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Genet & Immunobiochim, Turin, Italy.	simone.peletto@izsto.it	Cerutti, Francesco/J-5920-2016; Rizzo, Francesca/O-7333-2019; Modesto, Paola/AAW-3642-2020; Rizzo, Francesca/GNP-1521-2022; Peletto, Simone/K-2005-2016	Cerutti, Francesco/0000-0003-0480-8296; Rizzo, Francesca/0000-0001-7659-1773; Rizzo, Francesca/0000-0001-7659-1773; Goria, Maria/0000-0001-8908-4447; Peletto, Simone/0000-0002-8684-898X	Italian Ministry of Health [IZS PLV 16/12 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health [Ricerca Corrente 2012 IZS PLV 16/12 RC]. Irena Jurman, Slobodanka Radovic and Federica Cattonaro are employed by IGA technology services. IGA technology services provided support in the form of salaries for authors IJ, SR and FC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Amore G, 2007, J MED ENTOMOL, V44, P303, DOI 10.1603/0022-2585(2007)44[303:BLIIIR]2.0.CO;2; Barbieri ARM, 2012, PATHOG GLOB HEALTH, V106, P188, DOI 10.1179/2047773212Y.0000000022; Bazzocchi C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-350; Berri M, 2000, VET MICROBIOL, V72, P285, DOI 10.1016/S0378-1135(99)00178-9; Blanco CM, 2017, TICKS TICK-BORNE DIS, V8, P90, DOI 10.1016/j.ttbdis.2016.10.003; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cossio MLT, 2015, MANUAL DIAGNOSTIC TE, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dietrich M, 2014, EMERG INFECT DIS, V20, P838, DOI 10.3201/eid2005.131088; Duron O, 2016, MICROB ECOL, V71, P761, DOI 10.1007/s00248-015-0702-8; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Elsa Jourdain, 2015, Infection Ecology & Epidemiology, V5, P29230, DOI 10.3402/iee.v5.29230; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; European Centre for Disease Prevention and Control (ECDC), 2014, IX RIC FACTSH EXP; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Finney CAM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004646; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Gerhart JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33670; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gofton AW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0958-3; Hayashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155794; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hecht JA, 2016, J MED ENTOMOL, V53, P1492, DOI 10.1093/jme/tjw111; HOOGSTRAAL H, 1963, B WORLD HEALTH ORGAN, V28, P235; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-128; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Jameson LJ, 2012, TICKS TICK-BORNE DIS, V3, P95, DOI 10.1016/j.ttbdis.2011.12.002; Lindeborg M, 2012, EMERG INFECT DIS, V18, P2095, DOI 10.3201/eid1812.120718; Machado-Ferreira E, 2016, PARASITOL RES, V115, P4691, DOI 10.1007/s00436-016-5230-z; Mariconti M, 2012, PATHOG GLOB HEALTH, V106, P391, DOI 10.1179/2047773212Y.0000000050; Martello E, 2013, TICKS TICK-BORNE DIS, V4, P518, DOI 10.1016/j.ttbdis.2013.07.002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miranda J, 2014, TICKS TICK-BORNE DIS, V5, P208, DOI 10.1016/j.ttbdis.2013.10.008; Mohanty I, 2016, J VECTOR DIS, V53, P199; Moutailler S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004539; Narasimhan S, 2015, TRENDS PARASITOL, V31, P315, DOI 10.1016/j.pt.2015.03.010; Novakova E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00526; Ogrzewalska M, 2012, TICKS TICK-BORNE DIS, V3, P254, DOI 10.1016/j.ttbdis.2012.05.003; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pintore MD, 2015, ZOONOSES PUBLIC HLTH, V62, P365, DOI 10.1111/zph.12156; Poupon MA, 2006, APPL ENVIRON MICROB, V72, P976, DOI 10.1128/AEM.72.1.976-979.2006; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skotarczak B, 2002, ANN AGR ENV MED, V9, P25; Sprong H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-41; Stuen S, 2003, ANN NY ACAD SCI, V990, P433, DOI 10.1111/j.1749-6632.2003.tb07407.x; Sumrandee C, 2014, TICKS TICK-BORNE DIS, V5, P632, DOI 10.1016/j.ttbdis.2014.04.013; Tomassone L, 2010, EXP APPL ACAROL, V52, P93, DOI 10.1007/s10493-010-9339-y; Troyo A, 2016, TICKS TICK-BORNE DIS, V7, P1128, DOI 10.1016/j.ttbdis.2016.08.009; Varela-Stokes AS, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00179; Vilcins IME, 2009, EXP APPL ACAROL, V49, P229, DOI 10.1007/s10493-009-9260-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119	60	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202270	10.1371/journal.pone.0202270	http://dx.doi.org/10.1371/journal.pone.0202270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148833	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200008
J	Kim, S; Mitterer, H; Cho, T				Kim, Sahyang; Mitterer, Holger; Cho, Taehong			A time course of prosodic modulation in phonological inferencing: The case of Korean post-obstruent tensing	PLOS ONE			English	Article							SPEECH-PERCEPTION; ASSIMILATION; RECOGNITION; WORDS; BOUNDARIES; PROMINENCE; TRACKING; STOPS	Application of a phonological rule is often conditioned by prosodic structure, which may create a potential perceptual ambiguity, calling for phonological inferencing. Three eye-tracking experiments were conducted to examine how spoken word recognition may be modulated by the interaction between the prosodically-conditioned rule application and phonological inferencing. The rule examined was post-obstruent tensing (POT) in Korean, which changes a lax consonant into a tense after an obstruent only within a prosodic domain of Accentual Phrase (AP). Results of Experiments 1 and 2 revealed that, upon hearing a derived tense form, listeners indeed recovered its underlying (lax) form. The phonological inferencing effect, however, was observed only in the absence of its tense competitor which was acoustically matched with the auditory input. In Experiment 3, a prosodic cue to an AP boundary (which blocks POT) was created before the target using an F0 cue alone (i.e., without any temporal cues), and the phonological inferencing effect disappeared. This supports the view that phonological inferencing is modulated by listeners' online computation of prosodic structure (rather than through a low-level temporal normalization). Further analyses of the time course of eye movement suggested that the prosodic modulation effect occurred relatively later in the lexical processing. This implies that speech processing involves segmental processing in conjunction with prosodic structural analysis, and calls for further research on how prosodic information is processed along with segmental information in language-specific vs. universally applicable ways.	[Kim, Sahyang] Hongik Univ, Dept English Educ, Seoul, South Korea; [Mitterer, Holger] Univ Malta, Dept Cognit Sci, Msida, Malta; [Cho, Taehong] Hanyang Univ, Hanyang Inst Phonet & Cognit Sci Language, Dept English Language & Literature, Seoul, South Korea	Hongik University; University of Malta; Hanyang University	Cho, T (corresponding author), Hanyang Univ, Hanyang Inst Phonet & Cognit Sci Language, Dept English Language & Literature, Seoul, South Korea.	tcho@hanyang.ac.kr	Mitterer, Holger/D-1908-2010	Mitterer, Holger/0000-0003-4318-0032; Cho, Taehong/0000-0002-8148-745X	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2016S1A5A2A01027109]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5A2A01027109) awarded to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5A2A01027109).	Abramson AS, 2017, J PHONETICS, V63, P75, DOI 10.1016/j.wocn.2017.05.002; Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beckman ME, 1996, LANG COGNITIVE PROC, V11, P17, DOI 10.1080/016909696387213; Cho T., 2011, CONTINUUM COMPANION, P343; Cho TH, 2007, J PHONETICS, V35, P210, DOI 10.1016/j.wocn.2006.03.003; Cho T, 2009, J PHONETICS, V37, P466, DOI 10.1016/j.wocn.2009.08.001; Cho TH, 2005, J PHONETICS, V33, P121, DOI 10.1016/j.wocn.2005.01.001; Cho TH, 2002, J PHONETICS, V30, P193, DOI 10.1006/jpho.2001.0153; Cho TH, 2001, J PHONETICS, V29, P155, DOI 10.1006/jpho.2001.0131; Christophe A, 2004, J MEM LANG, V51, P523, DOI 10.1016/j.jml.2004.07.001; Cutler A., 1987, Computer Speech and Language, V2, P133, DOI 10.1016/0885-2308(87)90004-0; Davidson L, 2016, J PHONETICS, V54, P35, DOI 10.1016/j.wocn.2015.09.003; de Jong K, 1998, J PHONETICS, V26, P283, DOI 10.1006/jpho.1998.0077; Gaskell MG, 2008, J EXP PSYCHOL HUMAN, V34, P1632, DOI 10.1037/a0011977; Gaskell MG, 1996, J EXP PSYCHOL HUMAN, V22, P144, DOI 10.1037/0096-1523.22.1.144; Gow D. W., 2007, PAPERS LAB PHONOLOGY, V9, P173; Gow DW, 2004, J MEM LANG, V51, P279, DOI 10.1016/j.jml.2004.05.004; Gow DW, 2002, J EXP PSYCHOL HUMAN, V28, P163, DOI 10.1037//0096-1523.28.1.163; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jun S.-A., 1998, PHONOLOGY, V15, P189, DOI DOI 10.1017/S0952675798003571; Jun S.-A., 2005, PROSODIC TYPOLOGY PH, P201, DOI DOI 10.1093/ACPROF:OSO/9780199249633.003.0008; Jun SA, 2000, TEXT SPEECH LANG TEC, V15, P209; Katsika A, 2016, J PHONETICS, V55, P149, DOI 10.1016/j.wocn.2015.12.003; Kim S, 2003, JAPANESE/KOREAN LINGUSITICS, VOL 11, P263; Kim S, 2017, J ACOUST SOC AM, V142, pEL362, DOI 10.1121/1.5005132; Kim S, 2013, J ACOUST SOC AM, V134, pEL19, DOI 10.1121/1.4807431; Kim S, 2012, STUD SECOND LANG ACQ, V34, P415, DOI 10.1017/S0272263112000137; Klatt D., 1975, J PHONETICS, V3, P129, DOI DOI 10.1016/S0095-4470(19)31360-9; Kuzla C., 2010, LAB PHONOLOGY, V10, P731; Kuzla C, 2007, J PHONETICS, V35, P301, DOI 10.1016/j.wocn.2006.11.001; LAHIRI A, 1991, COGNITION, V38, P245, DOI 10.1016/0010-0277(91)90008-R; McQueen JM, 2007, Q J EXP PSYCHOL, V60, P661, DOI 10.1080/17470210601183890; McQueen JM, 1995, PHONOLOGY PHONETIC E, V4, P61; Mitterer H, 2006, COGNITIVE SCI, V30, P451, DOI 10.1207/s15516709cog0000_57; Mitterer H, 2016, J PHONETICS, V54, P68, DOI 10.1016/j.wocn.2015.09.002; Mitterer H, 2013, J MEM LANG, V69, P59, DOI 10.1016/j.jml.2013.02.001; Mitterer H, 2009, J EXP PSYCHOL HUMAN, V35, P244, DOI 10.1037/a0012730; Nespor M, 1986, PROSODIC PHONOLOGY S; Ohala JJ., 1995, PHONOLOGY PHONETIC E, P41, DOI [DOI 10.1159/000262167, DOI 10.1017/CB09780511554315.004]; Pierrehumbert J., 1992, PAPERS LAB PHONOLOGY, P90, DOI DOI 10.1017/CBO9780511519918.005; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Salverda AP, 2003, COGNITION, V90, P51, DOI 10.1016/S0010-0277(03)00139-2; ShattuckHufnagel S, 1996, J PSYCHOLINGUIST RES, V25, P193, DOI 10.1007/BF01708572; SUMMERFIELD Q, 1981, J EXP PSYCHOL HUMAN, V7, P1074, DOI 10.1037/0096-1523.7.5.1074; Tanner J, 2017, LAB PHONOL, V8, DOI 10.5334/labphon.96; Tyler MD, 2009, J ACOUST SOC AM, V126, P367, DOI 10.1121/1.3129127; WIGHTMAN CW, 1992, J ACOUST SOC AM, V91, P1707, DOI 10.1121/1.402450	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202912	10.1371/journal.pone.0202912	http://dx.doi.org/10.1371/journal.pone.0202912			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148859	gold, Green Published			2022-12-26	WOS:000442804200031
J	Ranfaing, J; Dunyach-Remy, C; Lavigne, JP; Sotto, A				Ranfaing, Jeremy; Dunyach-Remy, Catherine; Lavigne, Jean-Philippe; Sotto, Albert			Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; INHIBIT ADHERENCE; PROANTHOCYANIDINS; GROWTH; VIRULENCE; BLADDER; PATHOGENESIS; ADHESION; DECREASE; IMPACT	One strategy to prevent urinary tract infections is the use of natural products such as cranberry (Vaccinium macrocarpon) and propolis. The objective of this study was to evaluate the impact of these products alone and combined on the motility and biofilm formation of a collection of representative uropathogenic Escherichia coli (UPEC). Motility was evaluated by the swarming and swimming capacity of the isolates in presence/absence of cranberry +/- propolis. Early and late biofilm formation was observed with the Biofilm Ring test (BioFilm Control) and the crystal violet method. Cranberry alone was seen to have a variable effect on motility and biofilm formation unrelated to bacterial characteristics, but a reduced motility and biofilm formation was observed for all the isolates in the presence of cranberry + propolis. These results suggest that cranberry alone doesn't work on all the E.coli strains and propolis potentiates the effect of cranberry on UPEC, representing a new strategy to prevent recurrent urinary tract infections.	[Ranfaing, Jeremy; Dunyach-Remy, Catherine; Lavigne, Jean-Philippe; Sotto, Albert] Univ Montpellier, Fac Med, French Natl Inst Hlth, Nimes, France; [Ranfaing, Jeremy; Dunyach-Remy, Catherine; Lavigne, Jean-Philippe; Sotto, Albert] Univ Montpellier, Fac Med, Med Res Unit 1047, Nimes, France; [Dunyach-Remy, Catherine; Lavigne, Jean-Philippe] Nimes Univ Hosp, Dept Microbiol, Nimes, France; [Sotto, Albert] Nimes Univ Hosp, Dept Infect Dis, Nimes, France	Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes	Lavigne, JP (corresponding author), Univ Montpellier, Fac Med, French Natl Inst Hlth, Nimes, France.; Lavigne, JP (corresponding author), Univ Montpellier, Fac Med, Med Res Unit 1047, Nimes, France.; Lavigne, JP (corresponding author), Nimes Univ Hosp, Dept Microbiol, Nimes, France.	jean.philippe.lavigne@chu-nimes.fr	Lavigne, Jean-Philippe/E-1756-2014; Sotto, Albert/AFJ-9023-2022	Lavigne, Jean-Philippe/0000-0002-9484-0304; Sotto, Albert/0000-0002-6463-9386	INSERM [U1047]; Nutrivercell SA (France); Bourse CIFRE	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Nutrivercell SA (France); Bourse CIFRE	This work was supported by INSERM (U1047). Jeremy Ranfaing's work has been funded by Nutrivercell SA (France). He was recipient of a PhD grant (Bourse CIFRE) by this company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 1998, J UROLOGY, V159, P559, DOI 10.1016/S0022-5347(01)63983-1; AVORN J, 1994, JAMA-J AM MED ASSOC, V271, P751, DOI 10.1001/jama.271.10.751; Azevedo AS, 2017, CRIT REV MICROBIOL, V43, P423, DOI [10.1080/1040841X.2016.1240656, 10.1080/1040841x.2016.1240656]; Baptista PV, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01441; Boonsai P, 2014, INT J MED SCI, V11, P327, DOI 10.7150/ijms.7373; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Cortes-Sanchez AD, 2013, MICROBIOL RES, V168, P22, DOI 10.1016/j.micres.2012.07.002; De Marco S, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/5163575; da-Silva APD, 2017, DIAGN MICR INFEC DIS, V88, P69, DOI 10.1016/j.diagmicrobio.2017.01.024; Dusane DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112093; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foo LY, 2000, J NAT PROD, V63, P1225, DOI 10.1021/np000128u; Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7; de Llano DG, 2015, INT J MOL SCI, V16, P12119, DOI 10.3390/ijms160612119; Gupta A, 2012, UROL RES, V40, P143, DOI 10.1007/s00240-011-0398-2; Gupta K, 2007, J UROLOGY, V177, P2357, DOI 10.1016/j.juro.2007.01.114; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P6852, DOI 10.1128/AEM.05561-11; Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022; Howell AB, 1998, NEW ENGL J MED, V339, P1085, DOI 10.1056/NEJM199810083391516; Howell AB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-94; Hu YX, 2016, CHEM SCI, V7, P6628, DOI 10.1039/c6sc03020c; Krueger CG, 2013, ANAL BIOANAL CHEM, V405, P4385, DOI 10.1007/s00216-013-6750-3; Lavigne JP, 2008, CLIN MICROBIOL INFEC, V14, P350, DOI 10.1111/j.1469-0691.2007.01917.x; Lavigne JP, 2016, J MED MICROBIOL, V65, P530, DOI 10.1099/jmm.0.000247; Lavigne Jean-Philippe, 2011, BMC Res Notes, V4, P522, DOI 10.1186/1756-0500-4-522; Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675; McCall J, 2013, CAN J MICROBIOL, V59, P430, DOI 10.1139/cjm-2012-0744; McLellan LK, 2016, TRENDS MOL MED, V22, P946, DOI 10.1016/j.molmed.2016.09.003; Mirzoeva OK, 1997, MICROBIOL RES, V152, P239, DOI 10.1016/S0944-5013(97)80034-1; Mitra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055492; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; O'Brien VP, 2015, CURR OPIN INFECT DIS, V28, P97, DOI 10.1097/QCO.0000000000000130; PEPELJNJAK S, 1982, PHARMAZIE, V37, P864; Prior RL, 2010, J SCI FOOD AGR, V90, P1473, DOI 10.1002/jsfa.3966; Ranfaing J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29082-6; Schwenger EM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008772.pub2; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Silverman JA, 2013, CURR UROL REP, V14, P448, DOI 10.1007/s11934-013-0354-5; SOBOTA AE, 1984, J UROLOGY, V131, P1013, DOI 10.1016/S0022-5347(17)50751-X; Sun J, 2015, J FUNCT FOODS, V17, P235, DOI 10.1016/j.jff.2015.05.016; Terlizzi ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01566; Ulrey RK, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-499; Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; Vollmerhausen TL, 2017, J PHOTOCH PHOTOBIO B, V170, P295, DOI 10.1016/j.jphotobiol.2017.04.018; Wang LS, 2016, ACS INFECT DIS, V2, P3, DOI 10.1021/acsinfecdis.5b00116; Wojnicz D, 2016, INT J FOOD SCI NUTR, V67, P1005, DOI 10.1080/09637486.2016.1211996	48	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202609	10.1371/journal.pone.0202609	http://dx.doi.org/10.1371/journal.pone.0202609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138443	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100093
J	Yano, Y; Kurebe, H; Edahiro, R; Hosono, Y; Nakatsubo, S; Nishida, K; Sawa, N; Ishijima, M; Uenami, T; Kanazu, M; Akazawa, Y; Yamaguchi, T; Mori, M				Yano, Yukihiro; Kurebe, Hiroyuki; Edahiro, Ryuya; Hosono, Yuki; Nakatsubo, Saeko; Nishida, Kohei; Sawa, Nobuyuki; Ishijima, Mikako; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yamaguchi, Toshihiko; Mori, Masahide			Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study	PLOS ONE			English	Article							RESPONSE RATES; CHEMOTHERAPY; PEMBROLIZUMAB; INHIBITORS; DOCETAXEL	Objectives The effectiveness of treatment after cessation of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) has not been well investigated. The aim of the present study was to clarify the clinical benefit of post-nivolumab treatment in such patients. Materials and methods A retrospective review was conducted on patients who received treatment after cessation of nivolumab due to disease progression or adverse events at the Toneyama National Hospital between January 2016 and April 2017. Results Among 64 patients treated with nivolumab, 26 patients received treatment after cessation of nivolumab due to disease progression (n = 21) or adverse events (n = 5). The median age of the patients was 68 years and 19 patients were male. Nineteen patients had performance status (PS) 1 or less at initiation of post-nivolumab treatment. Four, 20, and 2 patients were treated with platinum doublets, a single agent, and molecular targeting agents, respectively. Response rate, disease control rate, and median progression-free survival of first-line post-nivolumab treatment were 34.6% (9 patients), 73.1% (19 patients), and 2.8 months (95% confidence interval [CI]: 1.7-5.2), respectively. Adverse events (>= grade 3) and treatment cessation were observed in 57.7% (15 patients) and 19.2% (5 patients), respectively. There were no statistically significant differences for the majority of patient characteristics between the groups with (n = 26) and without post-nivolumab treatment. However, PS at cessation of nivolumab and post-progression survival (PPS) after cessation of nivolumab (median PPS: 12.6 vs. 1.4 months, 95% CI: 3.8-14.7 vs. 0.4-2.2) were significantly different between the groups. A multivariate Cox regression analysis showed significant correlation of PS at cessation of nivolumab (hazard ratio [HR]: 0.34, 95% CI: 0.13-0.87) and post-nivolumab treatment (HR: 0.19, 95% CI: 0.08-0.43) with prolonged PPS after nivolumab. Conclusion Median post-progression survival in patients with advanced NSCLC who received post-nivolumab treatment was approximately 1 year.	[Yano, Yukihiro; Kurebe, Hiroyuki; Edahiro, Ryuya; Hosono, Yuki; Nakatsubo, Saeko; Nishida, Kohei; Sawa, Nobuyuki; Ishijima, Mikako; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yamaguchi, Toshihiko; Mori, Masahide] Natl Hosp Org, Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan		Yano, Y (corresponding author), Natl Hosp Org, Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan.	yanoy@toneyama.go.jp						Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Grigg C, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9082; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Kogure Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135393; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Leger PD, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9084; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Li JY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/286170; Park SE, 2018, J THORAC ONCOL, V13, P106, DOI 10.1016/j.jtho.2017.10.011; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rizvi NA, 2016, J CLIN ONCOL, V34, P2969, DOI 10.1200/JCO.2016.66.9861; Roselli M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27025; Schvartsman G, 2017, LUNG CANCER, V112, P90, DOI 10.1016/j.lungcan.2017.07.034; Yoshioka H, 2017, ANN ONCOL, V28, P285, DOI 10.1093/annonc/mdw621	17	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203070	10.1371/journal.pone.0203070	http://dx.doi.org/10.1371/journal.pone.0203070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153300	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700041
J	Wei, LH; Arastoo, M; Georgiou, I; Manning, DR; Riobo-Del Galdo, NA				Wei, Lan Ho; Arastoo, Mohammad; Georgiou, Ioanna; Manning, David R.; Riobo-Del Galdo, Natalia A.			Activation of the G(i) protein-RHOA axis by non-canonical Hedgehog signaling is independent of primary cilia	PLOS ONE			English	Article							MOUSE; RECEPTOR; SUBUNIT; GTPASES; LACKING; CANCER	Primary cilia are solitary organelles that emanate from the plasma membrane during growth arrest in almost all mammalian cells. The canonical Hedgehog (HH) pathway requires trafficking of the G protein-coupled receptor SMOOTHENED (SMO) and the GLI transcription factors to the primary cilium upon binding of a HH ligand to PATCHED1. However, it is unknown if activation of the small GTPase RHOA by SMO coupling to heterotrimeric G(i) proteins, a form of non-canonical HH signaling, requires localization of SMO in the primary cilium. In this study, we compared RHOA and G i protein stimulation by activation of SMO or sphingosine 1-phosphate receptor (SIP) receptors in WT and KIF3A-deficient mouse embryonic fibroblasts that lack primary cilia. We found that activation of SMO in response to Sonic HH (SHH) or purmorphamine (PUR), a small molecule agonist of SMO, stimulates G i proteins and RHOA independently of the presence of primary cilia, similar to the effects of SIP. However, while S1 P induced a fast activation of AKT that is sensitive to the G i inhibitor pertussis toxin, HH pathway activators did not significantly activate AKT, suggesting that RHOA activation is not downstream of AKT. Our findings demonstrate that early events in some forms of non-canonical HH signaling occur in extraciliary membranes, which might be particularly relevant for actively-cycling cells, for some cancers characterized by loss of primary cilia, and in ciliopathies.	[Wei, Lan Ho] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Arastoo, Mohammad; Georgiou, Ioanna; Riobo-Del Galdo, Natalia A.] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Manning, David R.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Riobo-Del Galdo, Natalia A.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Arastoo, Mohammad] Univ Aberdeen, Scottish Biol Facil, Aberdeen, Scotland	Jefferson University; University of Leeds; University of Pennsylvania; Pennsylvania Medicine; University of Leeds; University of Aberdeen	Riobo-Del Galdo, NA (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.; Riobo-Del Galdo, NA (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	n.a.riobo-delgaldo@leeds.ac.uk	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Arastoo, Mohammad/0000-0002-0805-4949	National Institute of General Medical Sciences [2 R01 GM080396-05A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the National Institute of General Medical Sciences (2 R01 GM080396-05A1 to DRM and NARDG; https://www.nigms.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Haga Raquel B, 2016, Small GTPases, V7, P207; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Martinez-Chinchilla P, 2008, METHOD ENZYMOL, V446, P189, DOI 10.1016/S0076-6879(08)01611-X; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Teperino R, 2014, SEMIN CELL DEV BIOL, V33, P81, DOI 10.1016/j.semcdb.2014.05.007; Uschner FE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14573; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Wu FJ, 2017, CELL CHEM BIOL, V24, P252, DOI 10.1016/j.chembiol.2017.02.010; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203170	10.1371/journal.pone.0203170	http://dx.doi.org/10.1371/journal.pone.0203170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148884	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200050
J	Gong, Y; Zhang, L; Zhang, AQ; Chen, X; Gao, P; Zeng, Q				Gong, Yan; Zhang, Liang; Zhang, Aiqun; Chen, Xin; Gao, Peng; Zeng, Qiang			GATA4 inhibits cell differentiation and proliferation in pancreatic cancer	PLOS ONE			English	Article							METHYLATION; EXPRESSION; FAMILY; KRAS	Pancreatic ductal carcinoma (PDAC) is a common malignant tumor of the digestive system. GATA4 is one of the transcriptional regulatory factors, which regulates the development of endoderm-derived organs, including heart and gut. GATA4 may act as a putative tumor suppressor gene. However, the role of GATA4 in pancreatic carcinogenesis is not yet clarified. This study showed that GATA4 was highly expressed in pancreatic cancer tissues, and its expression level was positively related to the grade of pathological differentiation, suggesting that it may contribute to the progression of pancreatic neoplasia. Ectopic expression of GATA4 gene reduced cell viability and interference of GATA4 expression significantly increased the colony formation ability of pancreatic cancer cells. Furthermore, GATA4 inhibited tumor growth in xenograft mice. Agilent expression microarray profiling analysis indicated that the genes with significant levels of differential expression in GATA4 over-expressing cells were enriched in the cell differentiation process. Analysis of KEGG signaling pathway demonstrated that the regulated genes were partially enriched in MAPK and JAK-STAT signaling pathways. Re-expression of GATA4 up-regulated P53 gene expression. Our data indicate that GATA4 gene might play a role in cell proliferation and differentiation during the progression of pancreatic cancer.	[Gong, Yan; Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Inst, Beijing, Peoples R China; [Zhang, Liang; Zhang, Aiqun] Chinese Peoples Liberat Army Gen Hosp, Dept Surg, Beijing, Peoples R China; [Chen, Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Gao, Peng] Third Mil Med Univ, Daping Hosp, Ctr Hypertens & Metab Dis, Chongqing Inst Hypertens,Dept Hypertens & Endocri, Chongqing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Army Medical University	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hlth Management Inst, Beijing, Peoples R China.	zq301@126.com	Gao, Peng/AAC-1510-2020		China National Science Foundation [81201957]; Joint Project of the National Natural Science Foundation of China; Australian National Health and Medical Research Council [81561128020]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Joint Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the China National Science Foundation (No. 81201957) to YG and the Joint Project of the National Natural Science Foundation of China and the Australian National Health and Medical Research Council (No. 81561128020) to QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Chia NY, 2015, GUT, V64, P707, DOI 10.1136/gutjnl-2013-306596; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; Du YX, 2017, CANCER RES, V77, P2661, DOI 10.1158/0008-5472.CAN-16-2339; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Fu BJ, 2007, CANCER BIOL THER, V6, P1546, DOI 10.4161/cbt.6.10.4708; Guo MZ, 2006, INT J CANCER, V119, P2078, DOI 10.1002/ijc.22092; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Hua GQ, 2009, MOL CANCER RES, V7, P402, DOI 10.1158/1541-7786.MCR-08-0175; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karafin MS, 2010, INT J CLIN EXP PATHO, V3, P47; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lin QJ, 2015, WORLD J GASTROENTERO, V21, P7988, DOI 10.3748/wjg.v21.i26.7988; Lou E, 2013, PANCREAS, V42, P1218, DOI 10.1097/MPA.0000000000000007; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Muzumdar MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12685; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Sheng WW, 2017, FASEB J, V31, P2429, DOI 10.1096/fj.201601240R; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Striefler JK, 2016, PATHOL RES PRACT, V212, P726, DOI 10.1016/j.prp.2016.06.001; Takagi K, 2014, CANCER SCI, V105, P600, DOI 10.1111/cas.12382; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wen XZ, 2010, WORLD J GASTROENTERO, V16, P1201, DOI 10.3748/wjg.v16.i10.1201; Xia L, 2016, ONCOL LETT, V11, P861, DOI 10.3892/ol.2015.3974	30	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202449	10.1371/journal.pone.0202449	http://dx.doi.org/10.1371/journal.pone.0202449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142155	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500014
J	Schwedhelm, C; Knuppel, S; Schwingshackl, L; Boeing, H; Iqbal, K				Schwedhelm, Carolina; Knueppel, Sven; Schwingshackl, Lukas; Boeing, Heiner; Iqbal, Khalid			Meal and habitual dietary networks identified through Semiparametric Gaussian Copula Graphical Models in a German adult population	PLOS ONE			English	Article							NUTRIENT INTAKE; PATTERNS; BEHAVIOR; QUALITY; HEALTH	Gaussian graphical models (GGMs) are exploratory methods that can be applied to construct networks of food intake. Such networks were constructed for meal-structured data, elucidating how foods are consumed in relation to each other at meal level. Meal-specific networks were compared with habitual dietary networks using data from an EPIC-Potsdam sub-cohort study. Three 24-hour dietary recalls were collected cross-sectionally from 815 adults in 2010 +/- 2012. Food intake was averaged to obtain the habitual intake. GGMs were applied to four main meals and habitual intakes of 39 food groups to generate meal-specific and habitual dietary networks, respectively. Communities and centrality were detected in the dietary networks to facilitate interpretation. The breakfast network revealed five communities of food groups with other vegetables, sauces, bread, margarine, and sugar & confectionery as central food groups. The lunch and afternoon snacks networks showed higher variability in food consumption and six communities were detected in each of these meal networks. Among the central food groups detected in both of these meal networks were potatoes, red meat, other vegetables, and bread. Two dinner networks were identified with five communities and other vegetables as a central food group. Partial correlations at meals were stronger than on the habitual level. The meal-specific dietary networks were only partly reflected in the habitual dietary network with a decreasing percentage: 64.3% for dinner, 50.0% for breakfast, 36.2% for lunch, and 33.3% for afternoon snack. The method of GGM yielded dietary networks that describe combinations of foods at the respective meals. Analysing food consumption on the habitual level did not exactly reflect meal level intake. Therefore, interpretation of habitual networks should be done carefully. Meal networks can help understand dietary habits, however, GGMs warrant validation in other populations.	[Schwedhelm, Carolina; Knueppel, Sven; Schwingshackl, Lukas; Boeing, Heiner; Iqbal, Khalid] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Epidemiol, Nuthetal, Germany; [Schwedhelm, Carolina; Schwingshackl, Lukas; Boeing, Heiner; Iqbal, Khalid] NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schwedhelm, C (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Epidemiol, Nuthetal, Germany.; Schwedhelm, C (corresponding author), NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany.	carolina.schwedhelm@dife.de	Schwingshackl, Lukas/AAC-4119-2019; Schwedhelm, Carolina/AAE-6756-2022; Knüppel, Sven/AAI-7195-2020; Iqbal, Khalid/AAD-7112-2022	Schwingshackl, Lukas/0000-0003-3407-7594; Knüppel, Sven/0000-0001-9006-9906; Iqbal, Khalid/0000-0002-3312-4259	German Federal Ministry of Education and Research, Germany (BMBF) [01ER0808, 01EA1408A]; Open Access Fund of the Leibniz Association	German Federal Ministry of Education and Research, Germany (BMBF); Open Access Fund of the Leibniz Association	This study was funded by the German Federal Ministry of Education and Research, Germany, https://www.bmbf.de/ (BMBF, 01ER0808 and 01EA1408A). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Human Study Centre (HSC) of the German Institute of Human Nutrition Potsdam-Rehbruecke for the collection, the data hub for the processing, the participants for the provision of the data. We would also like to thank Manuela Bergman, head of the HSC, for the contribution to the study design and data generation, and Ellen Kohlsdorf for data handling and technical assistance. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], 2012, INTRO GRAPHICAL MODE; Ares G, 2007, APPETITE, V49, P148, DOI 10.1016/j.appet.2007.01.006; Arndt S, 1999, J PSYCHIAT RES, V33, P97, DOI 10.1016/S0022-3956(98)90046-2; Bishara AJ, 2012, PSYCHOL METHODS, V17, P399, DOI 10.1037/a0028087; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Camntech, 2017, ACT US MAN VERS 4 0; DeGregory KW, 2018, OBES REV, V19, P668, DOI 10.1111/obr.12667; Floegel A, 2014, INT J OBESITY, V38, P1388, DOI 10.1038/ijo.2014.39; Forbes MK, 2017, J ABNORM PSYCHOL, V126, P969, DOI 10.1037/abn0000276; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Haardorfer R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2764-z; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Hearty AP, 2007, APPETITE, V48, P1, DOI 10.1016/j.appet.2006.03.329; Hearty AP, 2008, AM J CLIN NUTR, V88, P1632, DOI 10.3945/ajcn.2008.26619; Honorio J, 2012, VARIABLE SELECTION G, P538; Iqbal K, 2017, EUR J CLIN NUTR, V71, P1312, DOI 10.1038/ejcn.2017.116; Iqbal K, 2018, EUROPEAN J NUTR; Iqbal K, 2016, J NUTR, V146, P646, DOI 10.3945/jn.115.221135; Kalinka AT, 2014, GENERATION VISUALIZA, P1; Keller K, 2014, APPETITE, V83, P63, DOI 10.1016/j.appet.2014.08.012; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Liu H., 2012, ARXIV12066488; Liu H, 2012, ANN STAT, V40, P2293, DOI 10.1214/12-AOS1037; Liu H, 2009, J MACH LEARN RES, V10, P2295; Milliron BJ, 2014, J ACAD NUTR DIET, V114, P932, DOI 10.1016/j.jand.2013.08.015; Neamat-Allah J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091586; Ocke MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013; POSNER BM, 1992, EPIDEMIOLOGY, V3, P171, DOI 10.1097/00001648-199203000-00016; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schulz M, 2008, BRIT J NUTR, V100, P942, DOI 10.1017/S0007114508966149; Schwedhelm C, 2018, AM J CLIN NUTR; Shimamura T, 2007, GENOME INFORM SER, V19, P142; Siega-Riz AM, 2014, AM J CLIN NUTR, V99, P1487, DOI 10.3945/ajcn.113.082685; Staedler N, 2015, PACKAGE NETHET; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Vainik U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144134; Voss S, 1998, Z ERNAHRUNGSWISS, V37, P227, DOI 10.1007/s003940050021; Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112; Yates L, 2015, APPETITE, V84, P299, DOI 10.1016/j.appet.2014.10.017; Zhao, 2015, PACKAGE HUGE	43	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202936	10.1371/journal.pone.0202936	http://dx.doi.org/10.1371/journal.pone.0202936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142191	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500051
J	Vangrieken, P; Al-Nasiry, S; Janssen, GMJ; Weseler, AR; Spaanderman, ME; Bast, A; Schiffers, PMH				Vangrieken, Philippe; Al-Nasiry, Salwan; Janssen, Ger M. J.; Weseler, Antje R.; Spaanderman, Marc E.; Bast, Aalt; Schiffers, Paul M. H.			The direct and sustained consequences of severe placental hypoxia on vascular contractility	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; NORMAL-PREGNANCY; PREECLAMPSIA; MECHANISMS; INHIBITORS; OXYGEN; WOMEN; HYPERTENSION; PREDICTORS; ENDOTHELIN	Introduction Preeclampsia is a major health problem in human pregnancy, severely complicating 5-8% of all pregnancies. The emerging molecular mechanism is that conditions like hypoxic stress trigger the release of placental messengers into the maternal circulation, which causes preeclampsia. Our objective was to develop an in vitro model, which can be used to further elucidate the molecular mechanisms of preeclampsia and which might be used to find a remedy. Methods Human non-complicated term placentas were collected. Placental explants were subjected to severe hypoxia and the conditioned media were added to chorionic arteries that were mounted into a myograph. Contractile responses of the conditioned media were determined, as well as effects on thromboxane-A(2) (U46619) induced contractility. To identify the vasoactive compounds present in the conditioned media, specific receptor antagonists were evaluated. Results Factors released by placental explants generated under severe hypoxia induced an increased vasoconstriction and vascular contractility to thromboxane-A(2). It was found that agonists for the angiotensin-I and endothelin-1 receptor released by placental tissue under severe hypoxia provoke vasoconstriction. The dietary antioxidant quercetin could partially prevent the acute and sustained vascular effects in a concentration-dependent manner. Discussion Both the acute vasoconstriction, as well as the increased contractility to U46619 are in line with the clinical vascular complications observed in preeclampsia. Data obtained with quercetin supports that our model opens avenues for e.g. nutritional interventions aimed at treating or preventing preeclampsia.	[Vangrieken, Philippe; Janssen, Ger M. J.; Weseler, Antje R.; Bast, Aalt; Schiffers, Paul M. H.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Al-Nasiry, Salwan; Spaanderman, Marc E.] Maastricht Univ, Dept Obstet & Gynecol, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University	Vangrieken, P (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Pharmacol & Toxicol, Maastricht, Netherlands.	p.vangrieken@maastrichtuniversity.nl	Bast, Aalt/I-7809-2013	Vangrieken, Philippe/0000-0003-0871-7789; Bast, Aalt/0000-0002-5383-2789	Nutrim Graduate Programme; Fonds gezond geboren	Nutrim Graduate Programme; Fonds gezond geboren	This study was funded by the internal source: "Nutrim Graduate Programme" and supported by the external source: "Fonds gezond geboren" (PV). There was no additional external funding received for this study.	Belfort MA, 1996, AM J OBSTET GYNECOL, V174, P687, DOI 10.1016/S0002-9378(96)70451-9; Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; BUTLER IB, 1994, TALANTA, V41, P211, DOI 10.1016/0039-9140(94)80110-X; Crocker I, 2007, PLACENTA, V28, pS4, DOI 10.1016/j.placenta.2007.01.016; Drenthen W, 2010, EUR HEART J, V31, P2124, DOI 10.1093/eurheartj/ehq200; EVERETT RB, 1978, J CLIN ENDOCR METAB, V46, P1007, DOI 10.1210/jcem-46-6-1007; George EM, 2011, AM J HYPERTENS, V24, P964, DOI 10.1038/ajh.2011.99; Geraets L, 2007, J NUTR, V137, P2190, DOI 10.1093/jn/137.10.2190; Gillham JC, 2003, EUR J OBSTET GYN R B, V109, P2, DOI 10.1016/S0301-2115(03)00044-7; Goulopoulou S, 2015, TRENDS MOL MED, V21, P88, DOI 10.1016/j.molmed.2014.11.009; Heazell AEP, 2009, REPROD BIOMED ONLINE, V18, P111, DOI 10.1016/S1472-6483(10)60432-4; Huppertz B., 2006, J REPRODUKTIONSMED E, V3, P103; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Lemkens P, 2017, HYPERTENS RES, V40, P738, DOI 10.1038/hr.2017.38; Luft FC, 2002, CURR OPIN NEPHROL HY, V11, P59, DOI 10.1097/00041552-200201000-00009; Moffett A, 2007, PLACENTA, V28, pS51, DOI 10.1016/j.placenta.2006.11.008; Morton JS, 2016, PHYSIOL REV, V96, P549, DOI 10.1152/physrev.00015.2015; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Nakimuli A, 2013, IMMUNOGENETICS, V65, P765, DOI 10.1007/s00251-013-0724-7; Newson AJ, 2008, SEMIN FETAL NEONAT M, V13, P103, DOI 10.1016/j.siny.2007.12.004; Nishikawa Y, 2000, AM J PHYSIOL-HEART C, V279, pH459, DOI 10.1152/ajpheart.2000.279.2.H459; Parets Sasha E, 2014, Biology (Basel), V3, P498, DOI 10.3390/biology3030498; PERRY IJ, 1995, BMJ-BRIT MED J, V310, P436, DOI 10.1136/bmj.310.6977.436; Pillay P, 2017, INT J NANOMED, V12, P8009, DOI 10.2147/IJN.S142732; Possomato-Vieira JS, 2016, ADV PHARMACOL, V77, P361, DOI 10.1016/bs.apha.2016.04.008; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2004, SEMIN NEPHROL, V24, P565, DOI 10.1016/j.semnephrol.2004.07.005; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Robinson NJ, 2008, LAB INVEST, V88, P293, DOI 10.1038/labinvest.3700746; Saleh Langeza, 2016, Ther Adv Cardiovasc Dis, V10, P282, DOI 10.1177/1753944715624853; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Szatanek R, 2015, INT J MOL MED, V36, P11, DOI 10.3892/ijmm.2015.2194; Tannetta D, 2017, J REPROD IMMUNOL, V119, P98, DOI 10.1016/j.jri.2016.08.008; Tannetta D, 2013, CURR HYPERTENS REP, V15, P590, DOI 10.1007/s11906-013-0395-7; Walsh S Glob. libr. women's med, 2011, GLOB LIB WOMENS MED; WALSH SW, 1985, AM J OBSTET GYNECOL, V152, P335, DOI 10.1016/S0002-9378(85)80223-4; WILKES BM, 1992, AM J PHYSIOL, V263, pE718, DOI 10.1152/ajpendo.1992.263.4.E718; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271; Zhao S, 2010, VASCULAR BIOL PLACEN	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202648	10.1371/journal.pone.0202648	http://dx.doi.org/10.1371/journal.pone.0202648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142162	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500023
J	Claes, L; Meyers, N; Schulke, J; Reitmaier, S; Klose, S; Ignatius, A				Claes, Lutz; Meyers, Nicholaus; Schuelke, Julian; Reitmaier, Sandra; Klose, Svenja; Ignatius, Anita			The mode of interfragmentary movement affects bone formation and revascularization after callus distraction	PLOS ONE			English	Article							EXPERIMENTAL TIBIAL FRACTURES; TISSUE DIFFERENTIATION; SEGMENTAL TRANSPORT; EXTERNAL FIXATION; OSTEOGENESIS; STABILITY; VASCULARIZATION; MICROMOVEMENT; MATURATION; REGENERATE	Callus distraction is sometimes associated with a delay in the maturation process and serious complications. It is believed that these complications are often caused by instability of the bone segment fixation. Typical fixation devices, such as ring-fixators, show significant deformations in all directions under external loading and muscle forces. This leads to axial compression and tension as well as shear movements in the healing area. Herein we investigated the hypothesis that the direction of interfragmentary movement after callus distraction affects the bone formation and revascularization during the maturation process. Two custom fixator systems were designed to apply a protocol of lateral callus distraction and subsequent cyclic stimulation of the regenerate tissue. One fixator system was used to apply either compressive or tensile stimulation while the other was used to apply shearing stimulation. The fixators were applied to the tibial surface of the right hind leg of sheep specimens. During lateral callus distraction, a titanium plate was elevated by 0.275 mm perpendicular to the long axis of the bone twice daily, resulting in a 5.5 mm gap at the end of the ten-day distraction phase. Following a seven-day consolidation phase, the regenerate in the gap between tibial cortex and titanium plate was stimulated once daily by cyclic movement for 120 cycles. The stimulation was applied for 18 days with amplitudes of 0.6 mm in compression (Group C) or tension (Group T), or a 1.0 mm shear amplitude (Group S). Seven weeks postoperatively the specimens were analyzed for quantity of bone formation, the presence of cartilage and fibrous tissue, and blood vessel density. There was a significantly higher blood vessel density (4.6 +/- 1.6%) in Group C than in Group T (1.2 +/- 0.4%) or Group S (1.0 +/- 0.5%) (p < 0.01). The amount of bone was significantly higher in Group C (25.6% +/- 13.0%) than in Group T (13.5 +/- 4.9%) (p < 0.05). Group S showed a similar amount of bone (14.0 +/- 10.7%) to Group T. The results show that bone formation and revascularization are dependent on the direction of interfragmentary movement and that the cyclic compression best stimulates the healing process.	[Claes, Lutz; Meyers, Nicholaus; Schuelke, Julian; Reitmaier, Sandra; Klose, Svenja; Ignatius, Anita] Univ Ulm, Ctr Musculoskeletal Res, Inst Orthoped Res & Biomech, Ulm, Germany	Ulm University	Claes, L (corresponding author), Univ Ulm, Ctr Musculoskeletal Res, Inst Orthoped Res & Biomech, Ulm, Germany.	Lutz.claes@uni-ulm.de	Ignatius, Anita/M-6012-2013; Claes, Lutz/O-4697-2014	Ignatius, Anita/0000-0002-4782-1979; 	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG 77/22-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, grant number DFG 77/22-1, awarded to LC and AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir LR, 2009, ODONTOLOGY, V97, P63, DOI 10.1007/s10266-009-0101-z; Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; Claes L, 2000, J BONE JOINT SURG BR, V82B, P142, DOI 10.1302/0301-620X.82B1.9332; Claes L, 2002, J ORTHOP RES, V20, P1099, DOI 10.1016/S0736-0266(02)00044-X; Claes L, 2005, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000150456.39608.bc; Claes L, 2010, BONE, V47, P712, DOI 10.1016/j.bone.2010.07.010; CLAES LE, 1995, CLIN BIOMECH, V10, P227, DOI 10.1016/0268-0033(95)99799-8; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Duda GN, 2002, CLIN ORTHOP RELAT R, P163; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Hente R, 2004, J ORTHOP RES, V22, P709, DOI 10.1016/j.orthres.2003.11.007; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008; Kassis B, 1996, J PEDIATR ORTHOPED, V16, P480, DOI 10.1097/01241398-199607000-00011; Leung KS, 2004, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000111889.64238.6a; Lienau J, 2005, J ORTHOP RES, V23, P639, DOI 10.1016/j.orthres.2004.09.006; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Lopez-Pliego EM, 2016, INJURY, V47, pS7, DOI 10.1016/S0020-1383(16)30600-3; Meyers N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189432; Niemeyer F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194500; Pacicca DM, 2003, BONE, V33, P889, DOI 10.1016/j.bone.2003.06.002; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; RHINELANDER FW, 1974, CLIN ORTHOP RELAT R, P34; Richards M, 1999, J BONE MINER RES, V14, P1978, DOI 10.1359/jbmr.1999.14.11.1978; Schuelke J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195466; Tuohy JL, 2014, VET SURG, V43, P903, DOI 10.1111/j.1532-950X.2014.12189.x; WEIBEL ER, 1963, LAB INVEST, V12, P131; Yang L, 2003, CLIN BIOMECH, V18, P166, DOI 10.1016/S0268-0033(02)00175-4	29	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202702	10.1371/journal.pone.0202702	http://dx.doi.org/10.1371/journal.pone.0202702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138362	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100109
J	Lawson, JS; Liu, HH; Syme, HM; Purcell, R; Wheeler-Jones, CPD; Elliott, J				Lawson, Jack S.; Liu, Hui-Hsuan; Syme, Harriet M.; Purcell, Robert; Wheeler-Jones, Caroline P. D.; Elliott, Jonathan			The cat as a naturally occurring model of renal interstitial fibrosis: Characterisation of primary feline proximal tubular epithelial cells and comparative pro-fibrotic effects of TGF-beta 1	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR-BETA; TO-MESENCHYMAL TRANSITION; ADULT HUMAN KIDNEY; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; DIABETIC-NEPHROPATHY; PRIMARY CULTURE; TISSUE	Chronic kidney disease (CKD) is common in both geriatric cats and aging humans, and is pathologically characterised by chronic tubulointerstitial inflammation and fibrosis in both species. Cats with CKD may represent a spontaneously occurring, non-rodent animal model of human disease, however little is known of feline renal cell biology. In other species, TGF-beta 1 signalling in the proximal tubular epithelium is thought to play a key role in the initiation and progression of renal fibrosis. In this study, we first aimed to isolate and characterise feline proximal tubular epithelial cells (FPTEC), comparing them to human primary renal epithelial cells (HREC) and the human proximal tubular cell line HK-2. Secondly, we aimed to examine and compare the effect of human recombinant TGF-beta 1 on cell proliferation, proapoptotic signalling and genes associated with epithelial-to-mesenchymal transition (EMT) in feline and human renal epithelial cells. FPTEC were successfully isolated from cadaverous feline renal tissue, and demonstrated a marker protein expression profile identical to that of HREC and HK-2. Exposure to TGF-beta 1 (0-10 ng/ml) induced a concentration-dependent loss of epithelial morphology and alterations in gene expression consistent with the occurrence of partial EMT in all cell types. This was associated with transcription of downstream pro-fibrotic mediators, growth arrest in FPTEC and HREC (but not HK-2), and increased apoptotic signalling at high concentrations of TGF-beta 1. These effects were inhibited by the ALK5 (TGF-beta 1R1) antagonist SB431542 (5 mu M), suggesting they are mediated via the ALK5/TGF-beta 1R11 receptor complex. Taken together, these results suggest that TGF beta 1 may be involved in epithelial cell dedifferentiation, growth arrest and apoptosis in feline CKD as in human disease, and that cats may be a useful, naturally occurring model of human CKD.	[Lawson, Jack S.; Liu, Hui-Hsuan; Purcell, Robert; Wheeler-Jones, Caroline P. D.; Elliott, Jonathan] Royal Vet Coll, Comparat Biomed Sci, London, England; [Syme, Harriet M.] Royal Vet Coll, Clin Sci & Serv, Hatfield, Herts, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Lawson, JS (corresponding author), Royal Vet Coll, Comparat Biomed Sci, London, England.	Jlawson@rvc.ac.uk		Elliott, Jonathan/0000-0002-4517-6590; Lawson, Jack/0000-0001-7993-8234	BBSRC CASE studentship - Elanco Ltd. [BB/F016891/1]	BBSRC CASE studentship - Elanco Ltd.	JSL is in receipt of a BBSRC CASE studentship co-funded by Elanco Ltd. (grant number BB/F016891/1) for which JE was the primary investigator. Elanco Ltd. played no role in the study design, in data collection, analysis and interpretation, or in the manuscript writing or submission for publication.	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bartlett PC, 2010, PREV VET MED, V94, P264, DOI 10.1016/j.prevetmed.2010.01.007; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Bland SK, 2017, VET PATHOL, V54, P490, DOI 10.1177/0300985817690213; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Brennan EP, 2012, BBA-MOL BASIS DIS, V1822, P589, DOI 10.1016/j.bbadis.2012.01.008; Chakrabarti S, 2013, VET PATHOL, V50, P147, DOI 10.1177/0300985812453176; Chakrabarti S, 2012, J VET INTERN MED, V26, P275, DOI 10.1111/j.1939-1676.2011.00874.x; Chen SC, 2011, TRANSL RES, V158, P214, DOI 10.1016/j.trsl.2011.06.002; Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, pF145, DOI 10.1152/ajprenal.00164.2016; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; DIBARTOLA SP, 1987, J AM VET MED ASSOC, V190, P1196; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Dockrell MEC, 2009, NEPHRON EXP NEPHROL, V112, pE71, DOI 10.1159/000221834; Douthwaite JA, 1999, J AM SOC NEPHROL, V10, P2109; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Elberg G, 2008, CELL TISSUE RES, V331, P495, DOI 10.1007/s00441-007-0521-4; FRANCH HA, 1995, J CELL BIOL, V129, P245, DOI 10.1083/jcb.129.1.245; Garcia-Sanchez O, 2015, CELL PHYSIOL BIOCHEM, V37, P1231, DOI 10.1159/000430246; Garcia-Sanchez O, 2014, NEPHRON EXTRA, V4, P1, DOI 10.1159/000353587; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; GEORGE MD, 1990, J BIOL CHEM, V265, P11098; Gildea John J, 2013, Methods Mol Biol, V945, P329, DOI 10.1007/978-1-62703-125-7_20; Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Huang LH, 2010, NEPHROL DIAL TRANSPL, V25, P3897, DOI 10.1093/ndt/gfq291; HUMES HD, 1991, LAB INVEST, V64, P538; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Keller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043584; Kim D, 2002, KIDNEY INT, V61, P464, DOI 10.1046/j.1523-1755.2002.00153.x; King JN, 2007, J VET INTERN MED, V21, P906, DOI 10.1892/0891-6640(2007)21[906:PFICWC]2.0.CO;2; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lawson JS, 2016, VET J, V214, P1, DOI 10.1016/j.tvjl.2016.02.004; Lever J E, 1981, Ann N Y Acad Sci, V372, P371, DOI 10.1111/j.1749-6632.1981.tb15489.x; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Marino CL, 2014, J FELINE MED SURG, V16, P465, DOI 10.1177/1098612X13511446; McLeland SM, 2015, VET PATHOL, V52, P524, DOI 10.1177/0300985814561095; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; MOLL R, 1991, LAB INVEST, V65, P74; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nowak G, 1996, AM J PHYSIOL-RENAL, V271, pF689, DOI 10.1152/ajprenal.1996.271.3.F689; Okada H, 2005, J AM SOC NEPHROL, V16, P133, DOI 10.1681/ASN.2004040339; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Quimby JM, 2013, AM J PHYSIOL-RENAL, V305, pF295, DOI 10.1152/ajprenal.00527.2012; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schmiedt CW, 2016, VET PATHOL, V53, P87, DOI 10.1177/0300985815600500; SUGAHARA K, 1984, J CELL BIOL, V99, P1541, DOI 10.1083/jcb.99.4.1541; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Syme HM, 2006, J VET INTERN MED, V20, P528, DOI 10.1892/0891-6640(2006)20[528:SOCWNO]2.0.CO;2; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Tian YC, 2002, AM J PATHOL, V160, P1619, DOI 10.1016/S0002-9440(10)61109-1; TOUTAIN H, 1991, EXP CELL RES, V194, P9, DOI 10.1016/0014-4827(91)90123-C; van Ark J, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-116; Van der Hauwaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066750; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Wynn TA, 2010, NAT MED, V16, P523, DOI 10.1038/nm0510-523; Yabuki A, 2010, RES VET SCI, V88, P294, DOI 10.1016/j.rvsc.2009.09.003; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yoshikawa M, 2010, EUR J PHARMACOL, V642, P28, DOI 10.1016/j.ejphar.2010.05.055; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	75	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202577	10.1371/journal.pone.0202577	http://dx.doi.org/10.1371/journal.pone.0202577			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138414	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100087
J	van den Heuvel, TLA; de Bruijn, D; de Korte, CL; van Ginneken, B				van den Heuvel, Thomas L. A.; de Bruijn, Dagmar; de Korte, Chris L.; van Ginneken, Bram			Automated measurement of fetal head circumference using 2D ultrasound images	PLOS ONE			English	Article							GROWTH	In this paper we present a computer aided detection (CAD) system for automated measurement of the fetal head circumference (HC) in 2D ultrasound images for all trimesters of the pregnancy. The HC can be used to estimate the gestational age and monitor growth of the fetus. Automated HC assessment could be valuable in developing countries, where there is a severe shortage of trained sonographers. The CAD system consists of two steps: First, Haar-like features were computed from the ultrasound images to train a random forest classifier to locate the fetal skull. Secondly, the HC was extracted using Hough transform, dynamic programming and an ellipse fit. The CAD system was trained on 999 images and validated on an independent test set of 335 images from all trimesters. The test set was manually annotated by an experienced sonographer and a medical researcher. The reference gestational age (GA) was estimated using the crown-rump length measurement (CRL). The mean difference between the reference GA and the GA estimated by the experienced sonographer was 0.8 +/- 2.6, -0.0 +/- 4.6 and 1.9 +/- 11.0 days for the first, second and third trimester, respectively. The mean difference between the reference GA and the GA estimated by the medical researcher was 1.6 +/- 2.7, 2.0 +/- 4.8 and 3.9 +/- 13.7 days. The mean difference between the reference GA and the GA estimated by the CAD system was 0.6 +/- 4.3, 0.4 +/- 4.7 and 2.5 +/- 12.4 days. The results show that the CAD system performs comparable to an experienced sonographer. The presented system shows similar or superior results compared to systems published in literature. This is the first automated system for HC assessment evaluated on a large test set which contained data of all trimesters of the pregnancy.	[van den Heuvel, Thomas L. A.; van Ginneken, Bram] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [van den Heuvel, Thomas L. A.; de Korte, Chris L.] Radboud Univ Nijmegen, Med Ctr, Med Ultrasound Imaging Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [de Bruijn, Dagmar] Radboud Univ Nijmegen, Dept Obstet & Gynecol, Med Ctr, Nijmegen, Netherlands; [van Ginneken, Bram] Fraunhofer MEVIS, Bremen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van den Heuvel, TLA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, Dept Radiol & Nucl Med, Nijmegen, Netherlands.; van den Heuvel, TLA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Med Ultrasound Imaging Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands.	Thomas.vandenHeuvel@radboudumc.nl	van Ginneken, Bram/A-3728-2012; de Korte, Chris L/C-1077-2008; van den Heuvel, Thomas/N-7185-2015	van Ginneken, Bram/0000-0003-2028-8972; de Korte, Chris L/0000-0002-1987-6948; van den Heuvel, Thomas/0000-0003-3736-7693	Life Sciences & Health for Development Fund [LSH14ET04]	Life Sciences & Health for Development Fund	This research was partially funded by the Life Sciences & Health for Development Fund (LSH14ET04), https://english.rvo.nl/subsidies-programmes/lsh4d. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anto EA, 2015, IEEE ENG MED BIO, P793, DOI 10.1109/EMBC.2015.7318481; Bellman R, 1952, THEORY DYNAMIC PROGR, V38, P716; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carneiro G, 2008, PROC CVPR IEEE, P133; Carneiro G, 2008, IEEE T MED IMAGING, V27, P1342, DOI 10.1109/TMI.2008.928917; Ciurte A, 2012, P CHALLENGE US BIOME, P5; Cuingnet R, 2013, I S BIOMED IMAGING, P768; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Foi A, 2012, P CHALL US BIOM MEAS, P1; Hough P.V.C., 1962, METHOD MEANS RECOGNI; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Jatmiko W, 2015, INT J SMART SENS INT, V8, P697, DOI 10.21307/ijssis-2017-779; LaGrone LN, 2012, TROP MED INT HEALTH, V17, P808, DOI 10.1111/j.1365-3156.2012.03014.x; Lienhart R, 2002, IEEE IMAGE PROC, P900; Lu W, 2008, PATTERN RECOGN, V41, P1268, DOI 10.1016/j.patcog.2007.09.006; Namburete AIL, 2018, MED IMAGE ANAL, V46, P1, DOI 10.1016/j.media.2018.02.006; Ni D, 2013, I S BIOMED IMAGING, P772; Perez-Gonzalez JL, 2015, LATIN AM C BIOMEDICA, V49, P329; Ponomarev G V, 2012, P CHALLENGE US BIOME, P17; Rueda S, 2014, IEEE T MED IMAGING, V33, P797, DOI 10.1109/TMI.2013.2276943; Ryou H, 2016, LECT NOTES COMPUT SC, V10019, P196, DOI 10.1007/978-3-319-47157-0_24; Satwika IP, 2014, INT C ADV COMP SCI I, P468, DOI 10.1109/ICACSIS.2014.7065898; Sofka M, 2014, IEEE T MED IMAGING, V33, P1054, DOI 10.1109/TMI.2014.2301936; Sorensen T, 1948, BIOLOGISKE SKRIFTER, V5, P1; Stebbing R V, 2012, P CHALLENGE US BIOME, P9; Sun C., 2012, P CHALL US BIOM MEAS, P13; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Yaqub M, 2016, IEEE J BIOMED HEALTH, V20, P1120, DOI 10.1109/JBHI.2015.2435651; Zalud I, 2009, J MATERN-FETAL NEO M, V22, P43, DOI 10.1080/14767050802415736; Zhang L, 2016, PHYS MED BIOL, V61, P1095, DOI 10.1088/0031-9155/61/3/1095	32	63	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0200412	10.1371/journal.pone.0200412	http://dx.doi.org/10.1371/journal.pone.0200412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138319	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100008
J	Gori, M; Ebranati, E; Scaltriti, E; Huedo, P; Ciceri, G; Tanzi, E; Pontello, M; Zehender, G; Pongolini, S; Bolzoni, L				Gori, Maria; Ebranati, Erika; Scaltriti, Erika; Huedo, Pol; Ciceri, Giulia; Tanzi, Elisabetta; Pontello, Mirella; Zehender, Gianguglielmo; Pongolini, Stefano; Bolzoni, Luca			High-resolution diffusion pattern of human infections by Salmonella enterica serovar Napoli in Northern Italy explained through phylogeography	PLOS ONE			English	Article							OUTBREAK; TRANSMISSION; PARATYPHI; SELECTION; SPREAD; RATES	Salmonella enterica serovar Napoli (serovar Napoli) is an emerging cause of human salmonellosis in Northern Italy. No specific reservoirs of serovar Napoli have been identified in Italy, so far. However, the environment, especially surface waters, has been hypothesized as an important source of infection based on the observation that genotypically different clusters of serovar Napoli are detected in different geographical macro-areas. To further support the hypothesis of a spatially-restricted pattern of serovar Napoli diffusion, a spatial segregation of serovar Napoli lineages should be observed also at smaller geographical scale. However, classical genotyping techniques used for Salmonella, such as pulsed-field gel electrophoresis (PFGE), did not possess enough discriminatory power to highlight spatial clustering of serovar Napoli within the macro-areas. To this purpose, we performed phylogeographical analyses based on genome-wide single nucleotide polymorphisms to test whether spatio-temporal evolution patterns of serovar Napoli in Northern Italy could be recognized with high geographical resolution, i.e. at local level. Specifically, we analyzed the local spread of the main PFGE clonal group, responsible for more than 60% of human infections in the study area, that did not show any geographical differentiation by PFGE within Northern Italy, i.e. the macro-area considered in the study. Both discrete and continuous phylogeography highlighted the existence of two main geographically-restricted clades: a Southern clade corresponding to the Po Valley and a Northern clade corresponding to the Pre-Alps area. Furthermore, the phylogeographical analyses suggested that the most probable site of origin of the clone was in an area of the Po Valley at the confluence of the Po and Ticino rivers, one of the most important Italian wetlands. These findings provide further support to the hypothesis that environmental transmission may play an important role in the ecology of serovar Napoli.	[Gori, Maria; Huedo, Pol; Pontello, Mirella] Univ Milan, Dept Hlth Sci, Milan, Italy; [Ebranati, Erika; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Scaltriti, Erika; Pongolini, Stefano; Bolzoni, Luca] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Risk Anal & Genom Epidemiol Unit, Parma, Italy; [Ciceri, Giulia; Tanzi, Elisabetta] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Tanzi, Elisabetta; Pontello, Mirella; Zehender, Gianguglielmo] Univ Milan, CRC Coordinated Res Ctr EpiSoMI, Milan, Italy	University of Milan; University of Milan; Luigi Sacco Hospital; IZS Lombardia e Emilia; University of Milan; University of Milan	Bolzoni, L (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Risk Anal & Genom Epidemiol Unit, Parma, Italy.	luca.bolzoni@izsler.it	Bolzoni, Luca/F-5061-2011; Huedo, Pol/R-4029-2016	Bolzoni, Luca/0000-0001-8523-4460; Pongolini, Stefano/0000-0002-4823-3562; Huedo, Pol/0000-0002-2933-0586; GORI, MARIA/0000-0001-6478-2791	Italian Ministry of Health 'Ricerca Corrente' [IZSLER-PRC2017001]	Italian Ministry of Health 'Ricerca Corrente'(Ministry of Health, Italy)	The study was funded by the Italian Ministry of Health 'Ricerca Corrente' Grant N. IZSLER-PRC2017001 (SP).	Andrews S, 2011, FASTQC QUALITY CONTR; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Carmeni A, 1966, Ig Mod, V59, P127; Chiari M, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0086-7; Chiari M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-42; COSTA E, 1986, ARCH VET ITAL, V37, P115; De Carli S, 2017, VET MICROBIOL, V212, P80, DOI 10.1016/j.vetmic.2017.11.001; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000094; Eikmeier D, 2018, EPIDEMIOL INFECT, V146, P423, DOI 10.1017/S0950268818000079; Eurosurveillance Editorial Team, 2015, EUROSURVEILLANCE, V20, P21021, DOI DOI 10.2807/ESE.20.04.21021-EN; Fisher IST, 2009, FOODBORNE PATHOG DIS, V6, P613, DOI 10.1089/fpd.2008.0206; Gal-Mor O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00391; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; GILL ON, 1983, LANCET, V1, P574; Graziani C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142419; Graziani C, 2011, FOODBORNE PATHOG DIS, V8, P997, DOI 10.1089/fpd.2010.0833; GREENWOOD MH, 1983, BRIT MED J, V286, P1394, DOI 10.1136/bmj.286.6375.1394; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Huedo P, 2017, FOODBORNE PATHOG DIS, V14, P148, DOI 10.1089/fpd.2016.2206; Huedo P, 2016, FOODBORNE PATHOG DIS, V13, P417, DOI 10.1089/fpd.2015.2091; Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Leekitcharoenphon P, 2016, APPL ENVIRON MICROB, V82, P2516, DOI 10.1128/AEM.03821-15; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lu X, 2017, EMERG INFECT DIS, V23, P833, DOI 10.3201/eid2305.151539; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mancini L, 2014, ANN I SUPER SANITA, V50, P96, DOI 10.4415/ANN_14_01_14; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Oggioni C, 2010, Ann Ig, V22, P327; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Sabbatucci M, 2018, EMERG INFECT DIS, V24, P562, DOI 10.3201/eid2403.171178; Shi CL, 2015, CRIT REV MICROBIOL, V41, P309, DOI 10.3109/1040841X.2013.837862; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Walker PR, 2005, GENETICS EVOLUTION, V5, P199, DOI DOI 10.1016/J.MEEGID.2004.06.011; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281; Yap KP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00270; Zhou ZM, 2014, P NATL ACAD SCI USA, V111, P12199, DOI 10.1073/pnas.1411012111; Zuliani M, 2012, EUR SCI C APPL INF D	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8								10.1371/journal.pone.0202573	http://dx.doi.org/10.1371/journal.pone.0202573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133519	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400084
J	Konar, S; Karmakar, J; Ray, A; Adhikari, S; Bandyopadhyay, TK				Konar, Saptarshi; Karmakar, Joydeep; Ray, Anirban; Adhikari, Sinchan; Bandyopadhyay, Tapas Kumar			Regeneration of plantlets through somatic embryogenesis from root derived calli of Hibiscus sabdariffa L. (Roselle) and assessment of genetic stability by flow cytometry and ISSR analysis	PLOS ONE			English	Article							IN-VITRO; SHOOT REGENERATION; CANNABINUS L.; EXPLANT; CULTURE; MARKER; PROPAGATION; FIDELITY; EXTRACT; TISSUES	Induction of somatic embryogenesis and complete plantlet regeneration from callus culture of Hibiscus sabdariffa L. var. HS4288 has been made. Leaf and root explants were cultured on Murashige and Skoog (MS) and Driver-Kuniyuki Walnut (DKW) basal media supplemented with different concentrations of synthetic auxins and cytokinins. Root explants on DKW medium supplemented with 2.26 mu M 2, 4-Dichlorophenoxyacetic acid (2, 4-D) and 4.65 mu M kinetin (KIN) induced highest percentage (70%) of embryogenic calli. Average number of globular embryos per root derived callus produced within 6 weeks of culture initiation on MS media with different plant growth regulators (PGRs) ranged from 2.27 +/- 0.12 to 8.80 +/- 0.17 and that of cotyledonary embryos ranged from 0.00 to 2.53 +/- 0.20. On DKW medium comparatively more globular embryos (2.70 +/- 0.15 to 14.53 +/- 0.23) and cotyledonary embryos (0.00 to 8.90 +/- 0.17) were produced than that of MS medium. Regeneration of complete plantlets was highest (76.67%) when embryogenic calli with mature somatic embryos were grown on DKW medium containing 2.32 mu M KIN and 2.22 mu M 6-Benzyladenine (BA). Plants were primarily hardened in humidity, temperature and light controlled chamber and finally in a greenhouse showed 70% survival ability. Different stages of somatic embryogenesis process in the root derived embryogenic calli were elaborated in detail by morphological, histological and SEM study. The data were statistically analyzed by Duncan Multiple range test (p <= 0.05) and Principal component analysis (PCA). Flow cytometry and Inter-simple sequence repeats (ISSR) marker analysis confirmed that there was no genetic variation within the regenerated plants.	[Konar, Saptarshi; Karmakar, Joydeep; Ray, Anirban; Bandyopadhyay, Tapas Kumar] Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani, W Bengal, India; [Adhikari, Sinchan] Univ Kalyani, Dept Bot, Kalyani, W Bengal, India	Kalyani University; Kalyani University	Bandyopadhyay, TK (corresponding author), Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani, W Bengal, India.	drtapaskrbandyopadhyay@gmail.com	Ray, Anirban/D-9024-2014	Ray, Anirban/0000-0001-5908-4497; ADHIKARI, SINCHAN/0000-0002-3832-8269	DST-PURSE programme	DST-PURSE programme	Financial support came from DST-PURSE programme to University of Kalyani.	Adhikari S, 2015, PLANT SYST EVOL, V301, P439, DOI 10.1007/s00606-014-1084-y; Adhikari S, 2014, SCI HORTIC-AMSTERDAM, V170, P115, DOI 10.1016/j.scienta.2014.01.015; Akindahunsi AA, 2003, J ETHNOPHARMACOL, V89, P161, DOI 10.1016/S0378-8741(03)00276-9; Akpan GA, 2000, THEOR APPL GENET, V100, P315, DOI 10.1007/s001220050041; Ali M, 2017, PROTOPLASMA, V254, P343, DOI 10.1007/s00709-016-0954-2; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Bhattacharya C, 2016, IN VITRO CELL DEV-PL, V52, P512, DOI 10.1007/s11627-016-9763-8; Bhattacharya S, 2010, SCI HORTIC-AMSTERDAM, V123, P505, DOI 10.1016/j.scienta.2009.10.011; Blair MW, 1999, THEOR APPL GENET, V98, P780, DOI 10.1007/s001220051135; Bonga JM, 2017, TREES-STRUCT FUNCT, V31, P781, DOI 10.1007/s00468-016-1509-z; Bose S, 2017, PLANT CELL TISS ORG, V129, P313, DOI 10.1007/s11240-017-1179-6; Carra A, 2012, PLANT CELL TISS ORG, V109, P373, DOI 10.1007/s11240-011-0102-9; Chen CC, 2003, J AGR FOOD CHEM, V51, P5472, DOI 10.1021/jf030065w; Da-Costa-Rocha I, 2014, FOOD CHEM, V165, P424, DOI 10.1016/j.foodchem.2014.05.002; Dam A, 2013, J PLANT BIOCHEM BIOT, V22, P348, DOI 10.1007/s13562-012-0164-8; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DRIVER JA, 1984, HORTSCIENCE, V19, P507; Faraji MH, 1999, J ETHNOPHARMACOL, V65, P231, DOI 10.1016/S0378-8741(98)00157-3; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gassama-Dia Y. K., 2004, African Journal of Biotechnology, V3, P226; Gomez-Leyva J. F., 2008, International Journal of Botany, V4, P326; Prado MJ, 2010, PLANT CELL TISS ORG, V103, P49, DOI 10.1007/s11240-010-9753-1; Joshi P, 2007, BIOL PLANTARUM, V51, P22, DOI 10.1007/s10535-007-0005-0; Kumar SS, 2016, IN VITRO CELL DEV-PL, V52, P427, DOI 10.1007/s11627-016-9785-2; Liu XM, 2012, IN VITRO CELL DEV-PL, V48, P172, DOI 10.1007/s11627-012-9429-0; Ma'arup R, 2012, SCI HORTIC-AMSTERDAM, V145, P52, DOI 10.1016/j.scienta.2012.07.028; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadlene R, 2015, FIBRES TEXT EAST EUR, V23, P23, DOI 10.5604/12303666.1167413; Nath S, 2014, CYTOM PART A, V85A, P833, DOI 10.1002/cyto.a.22489; Navarro BV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180051; Nunes S, 2018, PLANT CELL TISS ORG, V132, P71, DOI 10.1007/s11240-017-1311-7; Osman M, 2011, AUST J CROP SCI, V5, P1150; Paul S, 2011, PLANT CELL TISS ORG, V105, P271, DOI 10.1007/s11240-010-9864-8; Price HJ, METHODS GENOME ANAL; Satya P, 2013, PLANT SYST EVOL, V299, P619, DOI 10.1007/s00606-012-0748-8; SHOME A, 1981, THEOR APPL GENET, V59, P11, DOI 10.1007/BF00275767; Sie RS, 2010, AUST J CROP SCI, V4, P98; Singh RK, 2015, APPL BIOCHEM BIOTECH, V177, P207, DOI 10.1007/s12010-015-1738-4; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Thakur J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159050; Viehmannova I, 2016, PLANT CELL TISS ORG, V125, P293, DOI 10.1007/s11240-016-0949-x; Yang JL, 2010, PLANT CELL TISS ORG, V100, P49, DOI 10.1007/s11240-009-9615-x; Zhang GQ, 2011, AGR SCI CHINA, V10, P1346, DOI 10.1016/S1671-2927(11)60127-2; Zur I, 2015, PLANT CELL REP, V34, P47, DOI 10.1007/s00299-014-1686-4	45	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202324	10.1371/journal.pone.0202324	http://dx.doi.org/10.1371/journal.pone.0202324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133505	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400065
J	Li, YS; Yang, ZS; Chavko, M; Liu, B; Aderemi, OA; Simovic, MO; Dubick, MA; Cancio, LC				Li, Yansong; Yang, Zhangsheng; Chavko, Mikulas; Liu, Bin; Aderemi, Olawale A.; Simovic, Milomir O.; Dubick, Michael A.; Cancio, Leopoldo C.			Complement inhibition ameliorates blast-induced acute lung injury in rats: Potential role of complement in intracellular HMGB1-mediated inflammation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CHROMATIN PROTEIN HMGB1; GROUP BOX 1; CONTROLLED HEMORRHAGE; ANAPHYLATOXIN C3A; TISSUE-DAMAGE; ACTIVATION; RECEPTOR; CELLS; RELEASE	Background and objective Complement activation as an early and important inflammatory process contributes to multiple organ dysfunction after trauma. We have recently shown that complement inhibition by decay-accelerating factor (DAF) protects brain from blast-overpressure (BOP)-induced damage. This study was conducted to determine the effect of DAF on acute lung injury induced by BOP exposure and to elucidate its possible mechanisms of action. Methods Anesthetized adult male Sprague-Daley rats were exposed to BOP (120 kPa) from a compressed air-driven shock tube. Rats were randomly assigned to three experimental groups: 1) Control (no BOP and no DAF treatment), 2) BOP (120 kPa BOP exposure), and 3) BOP followed by treatment with rhDAF (500 mu g/kg, i.v) at 30 minutes after blast. After a recovery period of 3, 24, or 48 hours, animals were euthanized followed by the collection of blood and tissues at each time point. Samples were subjected to the assessment of cytokines and histopathology as well as for the interaction of high-mobility-group box 1 (HMGB1) protein, NF-kappa B, receptor for advanced glycation end products (RAGE), C3a, and C3aR. Results BOP exposure significantly increased in the production of systemic pro-and anti-inflammatory cytokines, and obvious pathological changes as characterized by pulmonary edema, inflammation, endothelial damage and hemorrhage in the lungs. These alterations were ameliorated by early administration of rhDAF. The rhDAF treatment not only significantlyreduced the expression levels of HMGB1, RAGE, NF-kappa B, C3a, and C3aR, but also reversed the interaction of C3a-C3aR and nuclear translocation of HMGB1 in the lungs. Conclusions Our findings indicate that early administration of DAF efficiently inhibits systemic and local inflammation, and mitigates blast-induced lung injury. The underlying mechanism might be attributed to its potential modulation of C3a-C3aR-HMGB1-transcriptional factor axis. Therefore, complement and/or HMGB1 may be potential therapeutic targets in amelioration of acute lung injury after blast injury.	[Li, Yansong; Yang, Zhangsheng; Aderemi, Olawale A.; Simovic, Milomir O.; Cancio, Leopoldo C.] US Army Inst Surg Res, Dept Multiple Organ Support Technol, San Antonio, TX 78234 USA; [Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD USA; [Liu, Bin] US Army Inst Surg Res, Dept Blood Res, San Antonio, TX USA; [Dubick, Michael A.] US Army Inst Surg Res, Dept Damage Control Resuscitat, San Antonio, TX USA	United States Department of Defense; United States Army; Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; United States Department of Defense; United States Army	Li, YS (corresponding author), US Army Inst Surg Res, Dept Multiple Organ Support Technol, San Antonio, TX 78234 USA.	yansong.li.ctr@mail.mil			Defense Medical Research and Development Program [D61_I_10_J6_82]	Defense Medical Research and Development Program	This study was supported by the Defense Medical Research and Development Program for supporting this work (grant# D61_I_10_J6_82). http://cdmrp.army.mil/dmrdp/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully thank to Dr. Saleena Adeeb and Mr. Jason Lankasky for assisting in animal blast experiments and sampling, Dr. Subrata Haldar for the editing of language issues, and the Defense Medical Research and Development Program for supporting this work (grant# D61_I_10_J6_82).	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Arbore G, 2016, EUR J IMMUNOL, V46, P1563, DOI 10.1002/eji.201546131; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cernak I., 2015, FRONTIERS NEUROENGIN; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Entezari M, 2014, REDOX BIOL, V2, P314, DOI 10.1016/j.redox.2014.01.013; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAMMERSCHMIDT DE, 1980, LANCET, V1, P947; Han Q, 2016, DNA CELL BIOL, V35, P192, DOI 10.1089/dna.2015.3003; Harris CL, 2000, IMMUNOLOGY, V100, P462, DOI 10.1046/j.1365-2567.2000.00066.x; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Howrylak JA, 2017, ANNU REV PHYSIOL, V79, P471, DOI 10.1146/annurev-physiol-021115-105229; Hubbard William Brad, 2014, Biomed Sci Instrum, V50, P92; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu XY, 2011, J SURG RES, V167, pE103, DOI 10.1016/j.jss.2009.10.021; Lucca JJD, 2013, J SURG RES, V179, P153, DOI 10.1016/j.jss.2012.10.017; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Lucca JJD, 2012, SHOCK, V38, P82, DOI 10.1097/SHK.0b013e31825a3522; Lucca JJD, 2011, J TRAUMA, V71, pS151, DOI 10.1097/TA.0b013e318221aa4c; Martinotti S, 2015, IMMUNOTARGETS THER, V4, P101, DOI 10.2147/ITT.S58064; Mellor S G, 1988, Br J Hosp Med, V39, P536; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Ruan BH, 2010, J IMMUNOL, V185, P4213, DOI 10.4049/jimmunol.1000863; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015; Sun SH, 2011, AM J RESP CELL MOL, V45, P834, DOI 10.1165/rcmb.2010-0444OC; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Tornetta MA, 1997, J IMMUNOL, V158, P5277; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Wang C, 2015, CLIN IMMUNOL, V159, P47, DOI 10.1016/j.clim.2015.04.008; Wang J, 2015, WORLD J GASTROENTERO, V21, P8314, DOI 10.3748/wjg.v21.i27.8314; Wang Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-24; Weeks C, 2007, CLIN IMMUNOL, V124, P311, DOI 10.1016/j.clim.2007.05.010; Wu FJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0485-y; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yeo JG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.69; Zhu XR, 2015, J CLIN INVEST, V125, P1098, DOI 10.1172/JCI76344	55	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202594	10.1371/journal.pone.0202594	http://dx.doi.org/10.1371/journal.pone.0202594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133517	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400085
J	Shee, K; Jiang, A; Varn, FS; Liu, S; Traphagen, NA; Owens, P; Ma, CX; Hoog, J; Cheng, C; Golub, TR; Straussman, R; Miller, TW				Shee, Kevin; Jiang, Amanda; Varn, Frederick S.; Liu, Stephanie; Traphagen, Nicole A.; Owens, Philip; Ma, Cynthia X.; Hoog, Jeremy; Cheng, Chao; Golub, Todd R.; Straussman, Ravid; Miller, Todd W.			Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer	FASEB JOURNAL			English	Article						estrogen receptor; anti-estrogen; CDK4; CDK6	BONE MORPHOGENETIC PROTEINS; CELL-PROLIFERATION; GROWTH; INHIBITORS; PALBOCICLIB; EXPRESSION; RECEPTORS; DISCOVERY; METAANALYSIS; ACTIVATION	Despite the success of approved systemic therapies for estrogen receptor (ER)-positive breast cancer, drug resistance remains common. We hypothesized that secreted factors from the human tumor microenvironment could modulate drug resistance. We previously screened a library of 297 recombinant-secreted microenvironmental proteins for the ability to confer resistance to the anti-estrogen fulvestrant in 2 ER+ breast cancer cell lines. Herein, we considered whether factors that enhanced drug sensitivity could be repurposed as therapeutics and provide leads for drug development. Screening data revealed bone morphogenic protein (BMP)4 as a factor that inhibited cell growth and synergized with approved anti-estrogens and cyclin-dependent kinase 4/6 inhibitors (CDK4/6(i)). BMP4-mediated growth inhibition was dependent on type I receptor activin receptor-like kinase (ALK)3-dependent phosphorylation (P) of mothers against decapentaplegic homolog (SMAD/P-SMAD)1 and 5, which could be reversed by BMP receptor inhibitors and ALK3 knockdown. The primary effect of BMP4 on cell fate was cell-cycle arrest, in which RNA sequencing, immunoblot analysis, and RNA interference revealed to be dependent on p21(WAF1/Cip1) upregulation. BMP4 also enhanced sensitivity to approved inhibitors of mammalian target of rapamycin complex 1 and CDK4/6 via ALK3-mediated P-SMAD1/5 and p21 upregulation in anti-estrogen-resistant cells. Patients bearing primary ER+ breast tumors, exhibiting a transcriptomic signature of BMP4 signaling, had improved disease outcome following adjuvant treatment with anti-estrogen therapy, independently of age, tumor grade, and tumor stage. Furthermore, a transcriptomic signature of BMP4 signaling was predictive of an improved biologic response to the CDK4/6(i) palbociclib, in combination with an aromatase inhibitor in primary tumors. These findings highlight BMP4 and its downstream pathway activation as a therapeutic opportunity in ER+ breast cancer.Shee, K., Jiang, A., Varn, F. S., Liu, S., Traphagen, N. A., Owens, P., Ma, C. X., Hoog, J., Cheng, C., Golub, T. R., Straussman, R., Miller, T. W. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer.	[Shee, Kevin; Jiang, Amanda; Varn, Frederick S.; Liu, Stephanie; Traphagen, Nicole A.; Cheng, Chao; Miller, Todd W.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH USA; [Cheng, Chao] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA; [Miller, Todd W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Owens, Philip] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO USA; [Owens, Philip] Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Res Med, Denver, CO USA; [Ma, Cynthia X.; Hoog, Jeremy] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Golub, Todd R.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Straussman, Ravid] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Weizmann Institute of Science	Miller, TW (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, One Med Ctr Dr,HB-7936, Lebanon, NH 03756 USA.	todd.w.miller@dartmouth.edu	Shee, Kevin/V-6803-2019	Shee, Kevin/0000-0001-5378-7650; Jiang, Amanda/0000-0002-0327-6980	U.S. National Institutes of Health National Cancer Institute [F30CA216966, R01CA211869]; U.S. National Institutes of Health National Cancer Institute (Norris Cotton Cancer Center Support Grant) [P30CA023108]; NATIONAL CANCER INSTITUTE [P30CA023108, F30CA216966, R01CA211869, R01CA200994] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002929] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health National Cancer Institute (Norris Cotton Cancer Center Support Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Genomics and Molecular Biology and Microscopy, Norris Cotton Cancer Center Shared Resources for assistance. Funding support was provided by the U.S. National Institutes of Health National Cancer Institute (Grants F30CA216966 to K.S.; R01CA211869 to T.W.M.; and Norris Cotton Cancer Center Support Grant P30CA023108). The authors declare no conflicts of interest.	ALABASTER O, 1989, CANCER RES, V49, P5638; Alarmo EL, 2013, MODERN PATHOL, V26, P10, DOI 10.1038/modpathol.2012.128; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Brama M, 2007, ENDOCR-RELAT CANCER, V14, P61, DOI 10.1677/erc.1.01307; Brubaker KD, 2004, J CELL BIOCHEM, V91, P151, DOI 10.1002/jcb.10679; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Chang SF, 2009, MOL ENDOCRINOL, V23, P1827, DOI 10.1210/me.2009-0143; Cheng C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-452; Chiu CY, 2012, MOL CANCER RES, V10, P415, DOI 10.1158/1541-7786.MCR-11-0293; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; El Bialy I, 2017, PHARM RES-DORDR, V34, P1152, DOI 10.1007/s11095-017-2147-x; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hart LS, 2017, CLIN CANCER RES, V23, P1785, DOI 10.1158/1078-0432.CCR-16-1131; Heilmann AM, 2014, CANCER RES, V74, P3947, DOI 10.1158/0008-5472.CAN-13-2923; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hosford SR, 2017, CLIN CANCER RES, V23, P2795, DOI 10.1158/1078-0432.CCR-15-2764; Huang PD, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.39; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Ketolainen JM, 2010, BREAST CANCER RES TR, V124, P377, DOI 10.1007/s10549-010-0808-0; Krishnakumar GS, 2017, INT ORTHOP, V41, P1073, DOI 10.1007/s00264-017-3471-9; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Ma CX, 2017, CLIN CANCER RES, V23, P4055, DOI 10.1158/1078-0432.CCR-16-3206; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mohedas AH, 2013, ACS CHEM BIOL, V8, P1291, DOI 10.1021/cb300655w; Na YR, 2009, CANCER SCI, V100, P2218, DOI 10.1111/j.1349-7006.2009.01301.x; Negri JM, 2009, BRIT J HAEMATOL, V147, P672, DOI 10.1111/j.1365-2141.2009.07891.x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ouyang XS, 2002, CARCINOGENESIS, V23, P721, DOI 10.1093/carcin/23.5.721; Piccart M, 2014, ANN ONCOL, V25, P2357, DOI 10.1093/annonc/mdu456; Pierard GE, 2012, J ONCOL, V2012, DOI 10.1155/2012/584219; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shee K, 2018, J EXP MED, V215, P895, DOI 10.1084/jem.20171818; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Shirai Y, 2011, AM J PATHOL, V179, P2920, DOI 10.1016/j.ajpath.2011.08.022; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Varn FS, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0086-0; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; WAKELING AE, 1991, CANCER RES, V51, P3867; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	72	11	11	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1644	1657		10.1096/fj.201801241R	http://dx.doi.org/10.1096/fj.201801241R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30161001	Green Published, Bronze			2022-12-26	WOS:000457296600012
J	Ran, YC; Zheng, AP; Thibodeau, PH				Ran, Yanchao; Zheng, Aiping; Thibodeau, Patrick H.			Structural analysis reveals pathomechanisms associated with pseudoxanthoma elasticum-causing mutations in the ABCC6 transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; X-ray crystallography; membrane protein; ABC transporter; protein misfolding; protein structure; protein stability; connective tissue; glycoprotein biosynthesis; ABCC6; connective tissue disorder; elastic fiber; pseudoxanthoma elasticum	TRANSMEMBRANE CONDUCTANCE REGULATOR; ATP-BINDING CASSETTE; CRYSTAL-STRUCTURE; ECTOPIC MINERALIZATION; IN-VIVO; DOMAIN; MUTANTS; GENE; CFTR; PROTEIN	Mutations in ABC subfamily C member 6 (ABCC6) transporter are associated with pseudoxanthoma elasticum (PXE), a disease resulting in ectopic mineralization and affecting multiple tissues. A growing number of mutations have been identified in individuals with PXE. For most of these variants, no mechanistic information is available regarding their role in normal and pathophysiologies. To assess how PXE-associated mutations alter ABCC6 biosynthesis and structure, we biophysically and biochemically evaluated the N-terminal nucleotide-binding domain. A high-resolution X-ray structure of nucleotide-binding domain 1 (NBD1) of human ABCC6 was obtained at 2.3 angstrom that provided a template on which to evaluate PXE-causing mutations. Biochemical analysis of mutations in this domain indicated that multiple PXE-causing mutations altered its structural properties. Analyses of the full-length protein revealed a strong correlation between the alterations in NBD properties and the processing and expression of ABCC6. These results suggest that a significant fraction of PXE-associated mutations located in NBD1 causes changes in its structural properties and that these mutation-induced alterations directly affect the maturation of the full-length ABCC6 protein.	[Ran, Yanchao; Zheng, Aiping; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), 450 Technol Dr, Pittsburgh, PA 15219 USA.	thibodea@pitt.edu	Zheng, Aiping/U-5313-2019	Thibodeau, Patrick/0000-0002-6790-144X	National Institutes of Health [GM122091, DK083284]; Cystic Fibrosis Foundation [THIBOD15XX0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R56DK083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM122091 and DK083284 and Cystic Fibrosis Foundation Grant THIBOD15XX0 (to P. H. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apschner A, 2014, DIS MODEL MECH, V7, P811, DOI 10.1242/dmm.015693; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bukowska MA, 2015, BIOCHEMISTRY-US, V54, P3086, DOI 10.1021/acs.biochem.5b00188; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; GOODMAN RM, 1963, MEDICINE, V42, P297, DOI 10.1097/00005792-196309000-00001; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; Hanrahan JW, 2017, CURR OPIN PHARMACOL, V34, P105, DOI 10.1016/j.coph.2017.09.016; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; Legrand A, 2017, GENET MED, V19, P909, DOI 10.1038/gim.2016.213; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Miglionico R, 2016, J BIOENERG BIOMEMBR, V48, P259, DOI 10.1007/s10863-016-9654-z; Miksch S, 2005, HUM MUTAT, V26, P235, DOI 10.1002/humu.20206; Moitra K, 2011, BIOL CHEM, V392, P29, DOI 10.1515/BC.2011.006; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Pomozi V, 2017, J INVEST DERMATOL, V137, P595, DOI 10.1016/j.jid.2016.10.035; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Ran YC, 2017, J BIOL CHEM, V292, P1559, DOI 10.1074/jbc.M116.759811; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Vernon RM, 2017, J BIOL CHEM, V292, P14147, DOI 10.1074/jbc.M116.772335; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zhao JY, 2017, J INVEST DERMATOL, V137, P2336, DOI 10.1016/j.jid.2017.06.006; Ziegler SG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1669	45	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15855	15866		10.1074/jbc.RA118.004806	http://dx.doi.org/10.1074/jbc.RA118.004806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154241	Green Published, hybrid			2022-12-26	WOS:000447256000009
J	Duan, YW; Liu, T; Zhou, Y; Dou, TY; Yang, Q				Duan, Yanwei; Liu, Tian; Zhou, Yong; Dou, Tongyi; Yang, Qing			Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; chitinase; inhibitor; protein crystallization; human; insect; -N-acetyl-D-hexosaminidase; berberine	BETA-N-ACETYLHEXOSAMINIDASE; ACIDIC MAMMALIAN CHITINASE; CELL-CYCLE ARREST; ACETYLGLUCOSAMINIDASE GENE; COMPLEXES REVEAL; RNA INTERFERENCE; NATURAL-PRODUCT; HEXOSAMINIDASE; DERIVATIVES; INHIBITORS	Berberine is a traditional medicine that has multiple medicinal and agricultural applications. However, little is known about whether berberine can be a bioactive molecule toward carbohydrate-active enzymes, which play numerous vital roles in the life process. In this study, berberine and its analogs were discovered to be competitive inhibitors of glycoside hydrolase family 20 -N-acetyl-d-hexosaminidase (GH20 Hex) and GH18 chitinase from both humans and the insect pest Ostrinia furnacalis. Berberine and its analog SYSU-1 inhibit insect GH20 Hex from O. furnacalis (OfHex1), with K-i values of 12 and 8.5 m, respectively. Co-crystallization of berberine and its analog SYSU-1 in complex with OfHex1 revealed that the positively charged conjugate plane of berberine forms - stacking interactions with Trp(490), which are vital to its inhibitory activity. Moreover, the 1,3-dioxole group of berberine binds an unexplored pocket formed by Trp(322), Trp(483), and Val(484), which also contributes to its inhibitory activity. Berberine was also found to be an inhibitor of human GH20 Hex (HsHexB), human GH18 chitinase (HsCht and acidic mammalian chitinase), and insect GH18 chitinase (OfChtI). Besides GH18 and GH20 enzymes, berberine was shown to weakly inhibit human GH84 O-GlcNAcase (HsOGA) and Saccharomyces cerevisiae GH63 -glucosidase I (ScGluI). By analyzing the published crystal structures, berberine was revealed to bind with its targets in an identical mechanism, namely via - stacking and electrostatic interactions with the aromatic and acidic residues in the binding pockets. This paper reports new molecular targets of berberine and may provide a berberine-based scaffold for developing multitarget drugs.	[Duan, Yanwei; Liu, Tian; Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China; [Duan, Yanwei; Liu, Tian; Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China; [Dou, Tongyi] Dalian Univ Technol, Sch Life Sci & Med, Panjin 124221, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Dalian University of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, T; Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China.; Liu, T; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	tianliu@dlut.edu.cn; qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022; Liu, Tian/E-2481-2012	Yang, Qing/0000-0001-8623-7532; Liu, Tian/0000-0001-9768-5496	Program for National Natural Science Funds for Distinguished Young Scholar [31425021]; National Natural Science Foundation of China [31830076, 31871959]	Program for National Natural Science Funds for Distinguished Young Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for National Natural Science Funds for Distinguished Young Scholar (Grant 31425021) and the National Natural Science Foundation of China (Grants 31830076 and 31871959). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrangi S, 2013, BIOTECHNOL ADV, V31, P1786, DOI 10.1016/j.biotechadv.2013.09.012; Andersen OA, 2005, NAT PROD REP, V22, P563, DOI 10.1039/b416660b; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chen XYL, 2018, J STORED PROD RES, V77, P156, DOI 10.1016/j.jspr.2018.04.012; da Silva AR, 2016, ANTIMICROB AGENTS CH, V60, P3551, DOI 10.1128/AAC.01846-15; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fatehi-Hassanabad Z, 2005, PHYTOTHER RES, V19, P222, DOI 10.1002/ptr.1661; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Horsch M, 1997, PHARMACOL THERAPEUT, V76, P187, DOI 10.1016/S0163-7258(97)00110-1; Iwasa K, 2000, BIOSCI BIOTECH BIOCH, V64, P1998, DOI 10.1271/bbb.64.1998; Jiang X, 2016, J CHEM INF MODEL, V56, P2413, DOI 10.1021/acs.jcim.6b00615; Jung HA, 2009, BIOL PHARM BULL, V32, P1433, DOI 10.1248/bpb.32.1433; Kim LK, 2015, P NATL ACAD SCI USA, V112, pE2891, DOI 10.1073/pnas.1507393112; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kong LD, 2001, PLANTA MED, V67, P74, DOI 10.1055/s-2001-10874; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li BB, 2017, NAT STRUCT MOL BIOL, V24, P362, DOI 10.1038/nsmb.3390; Liu JJ, 2001, CHEM BIOL, V8, P701, DOI 10.1016/S1074-5521(01)00045-X; LIU T, 2014, SCI REP UK, V4; Liu T, 2018, BIOTECHNOL ADV, V36, P1127, DOI 10.1016/j.biotechadv.2018.03.013; Liu T, 2015, FEBS LETT, V589, P110, DOI 10.1016/j.febslet.2014.11.032; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Ma C, 2013, CHEM BIOL DRUG DES, V81, P775, DOI 10.1111/cbdd.12124; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyazawa M, 2002, J SCI FOOD AGR, V82, P830, DOI 10.1002/jsfa.1112; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Qin Y, 2007, CHEM BIODIVERS, V4, P481, DOI 10.1002/cbdv.200790040; Rong S, 2013, INSECT SCI, V20, P109, DOI 10.1111/j.1744-7917.2012.01573.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Singh IP, 2013, EXPERT OPIN THER PAT, V23, P215, DOI 10.1517/13543776.2013.746314; Slamova K, 2010, BIOTECHNOL ADV, V28, P682, DOI 10.1016/j.biotechadv.2010.04.004; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Van Dyken SJ, 2017, CELL, V169, P497, DOI 10.1016/j.cell.2017.03.044; Vinetz JM, 1999, P NATL ACAD SCI USA, V96, P14061, DOI 10.1073/pnas.96.24.14061; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wiesner DL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004701; Williams LK, 2015, NAT CHEM BIOL, V11, P691, DOI [10.1038/NCHEMBIO.1865, 10.1038/nchembio.1865]; Wu Y, 2001, J BIOL CHEM, V276, P42557, DOI 10.1074/jbc.M103479200; Xi Y, 2015, INSECT MOL BIOL, V24, P601, DOI 10.1111/imb.12187; Yamasaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3078; Yang Y, 2011, CHEMBIOCHEM, V12, P457, DOI 10.1002/cbic.201000561; Yu G, 2011, J ALZHEIMERS DIS, V24, P525, DOI 10.3233/JAD-2011-101779; Zhang H, 2016, J ASIA-PAC ENTOMOL, V19, P721, DOI 10.1016/j.aspen.2016.06.012; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	65	34	38	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15429	15438		10.1074/jbc.RA118.004351	http://dx.doi.org/10.1074/jbc.RA118.004351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135205	Green Published, hybrid			2022-12-26	WOS:000446549200008
J	Liou, YS; Yang, FY; Chen, HY; Jong, GP				Liou, Yi-Sheng; Yang, Fu-Yu; Chen, Hung-Yi; Jong, Gwo-Ping			Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; RISK; THIAZOLIDINEDIONES; METFORMIN; ROSIGLITAZONE; PIOGLITAZONE; ASSOCIATION; PREVALENCE; MORTALITY	Currently, the potential risk of atrial fibrillation associated with antihyperglycemic drug use has been a topic of considerable interest. However, it remains uncertain whether different classes of antihyperglycemic drug therapy are associated with the risk of atrial fibrillation risk. Here, we investigated the association between different classes of antihyperglycemic drugs and new-onset atrial fibrillation (NAF). A case-matched study was performed based on the National Health Insurance Program in Taiwan. Patients who had NAF were considered the NAF group and were matched in a 1:4 ratio with patients without NAF, who were assigned to the non-NAF group. Patients were matched according to sex, age, diabetes mellitus duration, index date, and Charlson Comorbidity Index score. We used multivariate logistic regression controlling for potential confounders to examine the association between different classes of antihyperglycemic drug use and the risk of NAF. Overall, we identified 2,882 cases and 11,528 matched controls for the study. After adjusting for sex, age, comorbidities, and concurrent medications, users of biguanides or thiazolidinediones were at a lower risk of developing NAF when compared with non-users (odds ratio [OR] 0.81, 95% confidence interval [CI] 0.71-0.95 and OR 0.72, 95% CI 0.63-0.83, respectively). In contrast, users of insulin were at a higher risk of developing NAF than were non-users (OR 1.19, 95% CI 1.06-1.35). Sulfonylureas, glinides, a-glucosidase inhibitors, and dipeptidyl peptidase-4 inhibitors were not associated with developing the risk of NAF. In conclusion, the use of biguanides or thiazolidinediones may be associated with a low risk of NAF, whereas insulin may be associated with a significant increase in the risk of NAF in patients with type 2 diabetes mellitus during long-term follow-up. Further prospective randomized studies should investigate which specific class of antihyperglycemic drug treatment for diabetes mellitus can prevent or postpone NAF.	[Liou, Yi-Sheng] Taichung Vet Gen Hosp, Dept Family Med & Geriatr, Taipei, Taiwan; [Liou, Yi-Sheng] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Yang, Fu-Yu; Chen, Hung-Yi] China Med Univ, Inst Pharm, Taichung, Taiwan; [Chen, Hung-Yi] China Med Univ, Dept Pharm, Beigang Hosp, Touliu, Yunlin, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ Hosp, Div Internal Cardiol, Taichung, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ, Taichung, Taiwan	Taichung Veterans General Hospital; National Defense Medical Center; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Jong, GP (corresponding author), Chung Shan Med Univ Hosp, Div Internal Cardiol, Taichung, Taiwan.; Jong, GP (corresponding author), Chung Shan Med Univ, Taichung, Taiwan.	cgp8009@yahoo.com.tw		Jong, Gwo-Ping/0000-0002-7786-5497				Alves-Cabratosa L, 2016, ANN MED, V48, P119, DOI 10.3109/07853890.2016.1144930; Anglade MW, 2007, CURR MED RES OPIN, V23, P2849, DOI 10.1185/030079907X242494; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bloomgarden Z, 2016, J AM COLL CARDIOL, V67, P248, DOI 10.1016/j.jacc.2015.11.035; Calixto MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076786; Chang SH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0123-x; Chao TF, 2012, INT J CARDIOL, V156, P199, DOI 10.1016/j.ijcard.2011.08.081; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Davis TME, 1999, ARCH INTERN MED, V159, P1097, DOI 10.1001/archinte.159.10.1097; de Bock MI, 2015, DIABETES CARE, V38, pE186, DOI 10.2337/dc15-1047; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dublin S, 2010, J GEN INTERN MED, V25, P853, DOI 10.1007/s11606-010-1340-y; Fidan E, 2011, ACTA DIABETOL, V48, P297, DOI 10.1007/s00592-011-0276-y; Giannini S, 2004, J ENDOCRINOL INVEST, V27, P982, DOI 10.1007/BF03347546; Gu J, 2011, EUROPACE, V13, P1256, DOI 10.1093/europace/eur131; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hussain H, 2015, J GEN INTERN MED, V30, P833, DOI 10.1007/s11606-015-3262-1; Huxley RR, 2012, HEART, V98, P133, DOI 10.1136/heartjnl-2011-300503; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Kume O, 2011, HEART RHYTHM, V8, P278, DOI 10.1016/j.hrthm.2010.10.029; Lachin JM, 2011, CLIN J AM SOC NEPHRO, V6, P1032, DOI 10.2215/CJN.09291010; Liu T, 2008, INT J CARDIOL, V128, P129, DOI 10.1016/j.ijcard.2007.05.051; Liu T, 2014, CARDIOVASC THER, V32, P178, DOI 10.1111/1755-5922.12079; Lown M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013535; Marfella R, 2009, HEART, V95, P1020, DOI 10.1136/hrt.2009.165969; NHIR, DATABASE; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Pallisgaard JL, 2017, EUR HEART J-CARD PHA, V3, P140, DOI 10.1093/ehjcvp/pvw036; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Salman ZK, 2013, EUR J PHARMACOL, V714, P448, DOI 10.1016/j.ejphar.2013.07.002; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Vijayakumar P, 2017, DIABETES CARE, V40, P16, DOI 10.2337/dc16-1358; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yan RH, 2017, J AM HEART ASSOC, V6, DOI [10.1161/JAHA.116.004445, 10.1161/jaha.116.004445]; Yeh YH, 2011, CARDIOVASC RES, V91, P62, DOI 10.1093/cvr/cvr041; Zhang ZW, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0531-4	38	35	36	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0197245	10.1371/journal.pone.0197245	http://dx.doi.org/10.1371/journal.pone.0197245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161122	Green Submitted, gold, Green Published			2022-12-26	WOS:000443388900001
J	Pombejra, SN; Jamklang, M; Uhrig, JP; Vu, K; Gelli, A				Pombejra, Sarisa Na; Jamklang, Mantana; Uhrig, John P.; Vu, Kiem; Gelli, Angie			The structure-function analysis of the Mpr1 metalloprotease determinants of activity during migration of fungal cells across the blood-brain barrier	PLOS ONE			English	Article							PROTEOLYTIC CLEAVAGE SITES; CENTRAL-NERVOUS-SYSTEM; CRYPTOCOCCUS-NEOFORMANS; ASPERGILLUS-FUMIGATUS; MICROSPORUM-CANIS; PROTEASES; PROTEIN; FAMILY; DISSEMINATION; PATHOGENICITY	Cryptococcal meningoencephalitis, the most common form of cryptococcosis, is caused by the opportunistic fungal pathogen, Cryptococcus neoformans. Molecular strategies used by C. neoformans to invade the central nervous system (CNS) have been the focus of several studies. Recently, the role of a novel secreted metalloprotease (Mpr1) in the pathogenicity of C. neoformans was confirmed by studies demonstrating that Mpr1 mediated the migration of fungal cells into the CNS. Given this central function, the aim here was to identify the molecular determinants of Mpr1 activity and resolve their role in the migration of cryptococci across the blood-brain barrier (BBB). The Mpr1 protein belongs to an understudied group of metalloproteases of the M36 class of fungalysins unique to fungi. They are generally synthesized as propeptides with fairly long prodomains and highly conserved regions within their catalytic core. Through structure-function analysis of Mpr1, our study identified the prodomain cleavage sites of Mpr1 and demonstrated that when mutated, the prodomain appears to remain attached to the catalytic C-terminus of Mpr1 rendering a nonfunctional Mpr1 protein and an inability for cryptococci to cross the BBB. We found that proteolytic activity of Mpr1 was dependent on the coordination of zinc with two histidine residues in the active site of Mpr1, since amino acid substitutions in the HExxH motif abolished Mpr1 proteolytic activity and prevented the migration of cryptococci across the BBB. A phylogenetic analysis of Mpr1 revealed a distinct pattern likely reflecting the neurotropic nature of C. neoformans and the specific function of Mpr1 in breaching the BBB. This study contributes to a deeper understanding of the molecular regulation of Mpr1 activity and may lead to the development of specific inhibitors that could be used to restrict fungal penetration of the CNS and thus prevent cryptococcal meningoencephalitis-related deaths.	[Pombejra, Sarisa Na; Jamklang, Mantana; Uhrig, John P.; Vu, Kiem; Gelli, Angie] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; [Pombejra, Sarisa Na] Chulalongkorn Univ, Dept Microbiol, Bangkok, Thailand; [Jamklang, Mantana] Suranaree Univ Technol, Sch Preclin, Inst Sci, Nakhon Ratchasima, Thailand; [Uhrig, John P.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of California System; University of California Davis; Chulalongkorn University; Suranaree University of Technology; University of Massachusetts System; University of Massachusetts Amherst	Gelli, A (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	acgelli@ucdavis.edu	Gelli, Angie/F-1764-2018; Vu, Kiem/GQZ-3955-2022	Na Pombejra, Sarisa/0000-0002-5472-0674; Gelli, Angie/0000-0003-3351-0683	National Institute of Allergy and Infectious Diseases [AI22329]; Hartwell Foundation Individual Biomedical Research Award	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hartwell Foundation Individual Biomedical Research Award	This work was supported by National Institute of Allergy and Infectious Diseases - AI22329 Awarded to AG; https://www.niaid.nih.gov/, and the Hartwell Foundation Individual Biomedical Research Award Awarded to AG; http://thehartwellfoundation.org/2012/2012_Investigators.shtml.	Aaron PA, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12811; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Berzigotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036400; Brouta F, 2002, INFECT IMMUN, V70, P5676, DOI 10.1128/IAI.70.10.5676-5683.2002; Brouta F, 2001, MED MYCOL, V39, P269, DOI 10.1080/mmy.39.3.269.275; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Casadevall A, 2010, J CLIN INVEST, V120, P1389, DOI 10.1172/JCI42949; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; De Baets S, 2001, Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet, V66, P283; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Fernandez D, 2013, ACTA CRYSTALLOGR D, V69, P1946, DOI 10.1107/S0907444913017642; Ferraris DM, 2011, J BIOL CHEM, V286, P32475, DOI 10.1074/jbc.M111.271809; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Gebbie L, 2014, METHODS MOL BIOL, V1099, P159, DOI 10.1007/978-1-62703-715-0_14; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Heslop OD, 2011, J CLIN MICROBIOL, V49, P4405, DOI 10.1128/JCM.05028-11; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lennon FE, 2014, J BIOL CHEM, V289, P24043, DOI 10.1074/jbc.M114.554766; Lilly WW, 2008, MYCOL RES, V112, P389, DOI 10.1016/j.mycres.2007.11.013; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Liu TB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003247; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; Markaryan A, 1996, J BACTERIOL, V178, P2211, DOI 10.1128/jb.178.8.2211-2215.1996; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nagase H, 2001, CURRENT PROTOCOLS PR; Naumann TA, 2011, J BIOL CHEM, V286, P35358, DOI 10.1074/jbc.M111.279646; Nickerson NN, 2008, MOL MICROBIOL, V69, P1530, DOI 10.1111/j.1365-2958.2008.06384.x; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Polaina J, 2007, IND ENZYMES STRUCTUR, P221; Pombejra SN, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00296; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6; Santiago-Tirado FH, 2017, MBIO, V8, DOI 10.1128/mBio.02183-16; Shepherd CT, 2009, METHODS MOL BIOL, V526, P129, DOI 10.1007/978-1-59745-494-0_11; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; STARK R, 1993, J VIROL, V67, P7088, DOI 10.1128/JVI.67.12.7088-7095.1993; Tang B, 2003, BIOCHEM BIOPH RES CO, V301, P1093, DOI 10.1016/S0006-291X(03)00084-6; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; Vu K, 2014, MBIO, V5, DOI 10.1128/mBio.01101-14; Vu K, 2009, EUKARYOT CELL, V8, P1803, DOI 10.1128/EC.00240-09; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Zhang XK, 2014, MED MYCOL, V52, P36, DOI 10.3109/13693786.2013.811552	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203020	10.1371/journal.pone.0203020	http://dx.doi.org/10.1371/journal.pone.0203020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161190	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900067
J	Rmoutilova, R; Guyomarc'h, P; Veleminsky, P; Sefcakova, A; Samsel, M; Santos, F; Maureille, B; Bruzek, J				Rmoutilova, Rebeka; Guyomarc'h, Pierre; Veleminsky, Petr; Sefcakova, Alena; Samsel, Mathilde; Santos, Frederic; Maureille, Bruno; Bruzek, Jaroslav			Virtual reconstruction of the Upper Palaeolithic skull from Zlaty Kun, Czech Republic: Sex assessment and morphological affinity	PLOS ONE			English	Article							LATE-GLACIAL RECOLONIZATION; LATE PLEISTOCENE; CENTRAL-EUROPE; HUMAN FOSSILS; RELIABILITY; CALIBRATION; DIMORPHISM; EVOLUTION; SOUTHWESTERN; INFORMATION	The incomplete cranium discovered at the Zlaty kun site in the Bohemian Karst is a rare piece of skeletal evidence of human presence in Central Europe during the Late Glacial period. The relative position of cranial fragments was restored and missing parts of the cranium were virtually reconstructed using mirroring and the Thin-plate splines algorithm. The reconstruction allowed us to collect principal cranial measurements, revise a previous unfounded sex assignment and explore the specimen's morphological affinity. Visual assessment could not reliably provide a sexual diagnosis, as such methods have been developed on modern populations. Using a population-specific approach developed on cranial measurements collected from the literature on reliably sexed European Upper Palaeolithic specimens, linear discriminant analysis confirmed previous assignment to the female sex. However, caution is necessary with regard to the fact that it was assessed from the skull. The Zlaty kun specimen clearly falls within the range of Upper Palaeolithic craniometric variation. Despite the shift in cranial variation that accompanied the Last Glacial Maximum (LGM), the ZlatY kun skull exhibits a morphological affinity with the pre-LGM population. Several interpretations are proposed with regard to the complex population processes that occurred after the LGM in Europe.	[Rmoutilova, Rebeka; Bruzek, Jaroslav] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Rmoutilova, Rebeka; Guyomarc'h, Pierre; Samsel, Mathilde; Santos, Frederic; Maureille, Bruno] Univ Bordeaux, CNRS, MCC, UMR PACEA 5199, Pessac, France; [Veleminsky, Petr] Natl Museum, Dept Anthropol, Prague, Czech Republic; [Sefcakova, Alena] Nat Hist Museum, Slovak Natl Museum, Dept Anthropol, Bratislava, Slovakia	Charles University Prague; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; National Museum	Rmoutilova, R (corresponding author), Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic.; Rmoutilova, R (corresponding author), Univ Bordeaux, CNRS, MCC, UMR PACEA 5199, Pessac, France.	vejnaror@natur.cuni.cz	Santos, Frédéric/I-3565-2019; Šefčáková, Alena/ABB-6414-2021; Rmoutilova, Rebeka/S-3185-2017	Santos, Frédéric/0000-0003-1445-3871; Šefčáková, Alena/0000-0002-4957-9944; Guyomarc'h, Pierre/0000-0002-9419-9270; Rmoutilova, Rebeka/0000-0003-2426-4521; Veleminsky, Petr/0000-0003-3691-7817; Maureille, Bruno/0000-0002-7616-0073	Charles University Grant Agency [1088217]; Ministry of Culture of the Czech Republic [00023272, DKRVO 2018/17]	Charles University Grant Agency; Ministry of Culture of the Czech Republic	RR was supported by the Charles University Grant Agency, research grant GAUK No. 1088217. National Museum (00023272) obtained funding from the Ministry of Culture of the Czech Republic (DKRVO 2018/17) (PV).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Amano H, 2014, DYNAMICS LEARNING NE, V2, P161, DOI [10.1007/978-4-431-54553-8_18, DOI 10.1007/978-4-431-54553-8_18]; Amano H, 2015, AM J PHYS ANTHROPOL, V158, P185, DOI 10.1002/ajpa.22777; [Anonymous], 1980, J HUM EVOL, V9, P517; [Anonymous], 2009, ENTHESOPATHIES ACTIV; [Anonymous], 1971, CATALOGUE FOSSIL H 2; Arbour JH, 2014, METHODS ECOL EVOL, V5, P16, DOI 10.1111/2041-210X.12128; Auerbach BM, HOWELLS CRANIOMETRIC; Benazzi S, 2009, ANAT REC, V292, P1088, DOI 10.1002/ar.20933; Berg GE, 2017, FORENSIC ANTHR COMPR, P143; Blockley SPE, 2006, J QUATERNARY SCI, V21, P575, DOI 10.1002/jqs.1041; Blockley SPE, 2009, RADIOCARBON, V51, P287, DOI 10.1017/S0033822200033828; Blockley SPE, 2000, ANTIQUITY, V74, P112, DOI 10.1017/S0003598X00066199; Brauer G, 2007, VERTEBR PALEOBIOL PA, P269; Brauer G., 1988, HDB VERGLEICHENDEN B, V1, P160; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brewster C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5094; Bronk Ramsey Christopher, 2002, ARCHAEOMETRY, V44, P1, DOI DOI 10.1111/J.1475-4754.2002.TB01101.X; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Bruzek J, 2006, EARLY MODERN HUMAN E, P46; Bruzek J, 2017, AM J PHYS ANTHROPOL, V164, P440, DOI 10.1002/ajpa.23282; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Churchill SE, 1999, HUNTERS GOLDEN AGE M, P31; Cieri RL, 2014, CURR ANTHROPOL, V55, P419, DOI 10.1086/677209; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Claude J, 2013, HYSTRIX, V24, P94, DOI 10.4404/hystrix-24.1-6316; Conard NJ, 2004, NATURE, V430, P198, DOI 10.1038/nature02690; Couqueugniot H, 2000, INT J OSTEOARCHAEOL, V10, P426; D'Amore G, 2009, J HUM EVOL, V56, P537, DOI 10.1016/j.jhevol.2009.02.002; Dutailly B, 2016, THESIS; Dutailly B, TIVMI; Dutailly B, 2009, IEEE IMAGE PROC, P2505, DOI 10.1109/ICIP.2009.5413911; FRAYER DW, 1980, J HUM EVOL, V9, P399, DOI 10.1016/0047-2484(80)90050-0; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Gabor H, 2010, HUM BIOL, V82, P29, DOI 10.3378/027.082.0103; Garcia-Vazquez A, 2018, QUATERN INT, V481, P42, DOI 10.1016/j.quaint.2017.08.063; Garvin HM, 2018, J FORENSIC SCI, V63, P1243, DOI 10.1111/1556-4029.13688; Godinho RM, 2017, HUMAN REMAINS ANOTHE, P135, DOI [10.1016/B978-0-12-804602-9.00011-4, DOI 10.1016/B978-0-12-804602-9.00011-4]; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Gunther T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003703; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Hansen J, 2017, DANISH J ARCHAEOLOGY, V6, P50, DOI [10.1080/21662282.2017.1381418, DOI 10.1080/21662282.2017.1381418]; Holt BM, 2008, YEARB PHYS ANTHROPOL, V51, P70, DOI 10.1002/ajpa.20950; Hor?ek I., 2015, FORGOTTEN TIMES SPAC, P363; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Howells W. W., 1973, PAPERS PEABODY MUSEU; Howells W. W., 1989, SKULL SHAPES MAP CRA; Irish JD, 2008, J HUM EVOL, V55, P736, DOI 10.1016/j.jhevol.2008.03.007; Jelinek J, 1999, HOMINID REMAINS CZEC; Josse J, 2016, J STAT SOFTW, V70; Josse J, 2012, J SFDS, V153, P79; Katina S, 2011, ACTA MUSEI NATL PRAG, V67, P3; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kozlowski SK, 2012, QUATERN INT, V272, P288, DOI 10.1016/j.quaint.2012.02.052; Kranioti EK, 2017, FORENSIC SCI INT, V271, DOI 10.1016/j.forsciint.2016.11.018; Kukla J., 1952, CESKOSLOVENSKY KRAS, V5, P49; Kuzelka V, 1997, ANTHROPOLOGIE, VXXXV, P247; Langley NR, 2018, J FORENSIC SCI, V63, P31, DOI 10.1111/1556-4029.13534; Laznickova-Gonysevova M, 2002, ANTHROPOLOGIE, V106, P525; Lestrel PE, 2013, HOMO, V64, P247, DOI 10.1016/j.jchb.2013.05.001; Lewis CJ, 2016, J FORENSIC SCI, V61, P743, DOI 10.1111/1556-4029.13013; Loth SR, 1996, AM J PHYS ANTHROPOL, V99, P473, DOI 10.1002/(SICI)1096-8644(199603)99:3<473::AID-AJPA8>3.0.CO;2-X; Maier A, 2015, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-017-7206-8; Martin Rudolf, 1928, LEHRBUCH ANTHR SYSTE; Meiklejohn C, 2015, MESOLITHIC MISCELLAN, V23, P12; Morel P, 1993, ARCHEOLOGIE SUISSE, V16, P110; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Musil R., 2010, QUARTAR, V57, P95; Nerudova Z., 2015, FORGOTTEN TIMES SPAC, P378, DOI [10.5817/CZ.MUNI.M210-7781-2015-28, DOI 10.5817/CZ.MUNI.M210-7781-2015-28]; Orschiedt J., 2002, PAL O, V14, P241, DOI [10.4000/paleo.1504, DOI 10.4000/PALEO.1504]; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pietrusewsky M, 2012, ENCY GLOBAL ARCHAEOL, P244; Pilloud M.A., 2016, BIOL DISTANCE ANAL F; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Prosek F, 1952, CESKOSLOVENSKY KRAS, V1-2, P161; Relethford JH, 2016, BIOLOGICAL DISTANCE ANALYSIS: FORENSIC AND BIOARCHAEOLOGICAL PERSPECTIVES, P23, DOI 10.1016/B978-0-12-801966-5.00002-0; Relethford JH, 2013, ORIGINS OF MODERN HUMANS: BIOLOGY RECONSIDERED, 2ND EDITION, P321; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Ross AH, 2011, FORENSIC SCI INT, V206, DOI 10.1016/j.forsciint.2011.01.003; RUFF C, 1987, J HUM EVOL, V16, P391, DOI 10.1016/0047-2484(87)90069-8; Samsel M, 2018, MICROEVOLUTION BIOAR; Samsel M, 2017, AM J PHYS ANTHROPOL, V162, P343; Santos F, 2014, FORENSIC SCI INT, V245, DOI 10.1016/j.forsciint.2014.10.010; Schlager S., 2016, MORPHO CALCULATIONS; Schwartz J. H., 2002, HUMAN FOSSIL RECORD, V1; Side P, 2007, ARCHEOLOGIE STREDNIC, V11, P9; Skrdla P, 2015, FORGOTTEN TIMES SPAC, P395, DOI [10.5817/CZ.MUNI.M210-7781-2015-29, DOI 10.5817/CZ.MUNI.M210-7781-2015-29]; Sladek V, 2002, J HUM EVOL, V43, P787, DOI 10.1006/jhev.2002.0606; Smith FH, 1999, P NATL ACAD SCI USA, V96, P12281, DOI 10.1073/pnas.96.22.12281; SMITH FH, 1980, AM J PHYS ANTHROPOL, V53, P589, DOI 10.1002/ajpa.1330530414; SMITH FH, 1982, CURR ANTHROPOL, V23, P667, DOI 10.1086/202920; Straus Lawrence Guy, 1995, Evolutionary Anthropology, V4, P4, DOI 10.1002/evan.1360040103; Street M, 1999, ANTIQUITY, V73, P259, DOI 10.1017/S0003598X00088232; Street M, 2006, J HUM EVOL, V51, P551, DOI 10.1016/j.jhevol.2006.04.014; Street Martin, 2002, Bonner Zoologische Beitraege, V50, P269; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Svoboda J, 2000, J HUM EVOL, V38, P523, DOI 10.1006/jhev.1999.0361; SVOBODA J, 2004, DSD, V42, P161; Svoboda J. A., 2004, ARCHAOL KORRESPONDEN, V34, P463; Svoboda JA, 2002, ANTIQUITY, V76, P957, DOI 10.1017/S0003598X00091754; Svoboda JA, 2003, VE SLUZBACH ARCHEOLO, V4, P278; Terberger T, 2002, ANTIQUITY, V76, P691, DOI 10.1017/S0003598X00091134; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TRINKAUS E, 1982, AM J PHYS ANTHROPOL, V57, P27, DOI 10.1002/ajpa.1330570106; Ubelaker DH, 2017, FORENSIC SCI INT, V278, DOI 10.1016/j.forsciint.2017.06.012; VENABLES WN, 2002, MODERN APPL STAT S F; Vencl S, 1976, ARCHEOL ROZHL, V28, P424; Verpoorte A, 2004, ANTIQUITY, V78, P257, DOI 10.1017/S0003598X0011292X; Verpoorte A, 2009, QUATERN INT, V201, P77, DOI 10.1016/j.quaint.2008.05.021; Villotte S, 2007, PAL SOC M PHIL; Villotte S, 2010, J HUM EVOL, V59, P35, DOI 10.1016/j.jhevol.2010.02.001; VLCEK E, 1991, ANTHROPOLOGIE, V95, P409; Vlcek E, 1956, ANTHROPOZOIKUM, V6, P283; Vlcek E, 1957, ARCHEOL ROZHL, VIX, P305; Vlcek E, 1952, CESKOSLOVENSKY KRAS, VV, P180; Vlcek E, 1951, CASOPIS CESKYCH LEKA, V49, P1457; von Cramon-Taubadel N, 2016, BIOLOGICAL DISTANCE ANALYSIS: FORENSIC AND BIOARCHAEOLOGICAL PERSPECTIVES, P425, DOI 10.1016/B978-0-12-801966-5.00023-8; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; Walrath DE, 2004, AM J PHYS ANTHROPOL, V125, P132, DOI 10.1002/ajpa.10373; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Wisniewski A, 2017, GEOCHRONOMETRIA, V44, P16, DOI 10.1515/geochr-2015-0052; Wolpoff MH, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P273, DOI 10.1007/978-3-211-49294-9_10; Wygal BT, 2014, J WORLD PREHIST, V27, P111, DOI 10.1007/s10963-014-9075-z; Zazvorka V, 1951, CESKOSLOVENSKY KRAS, V4, P60	125	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201431	10.1371/journal.pone.0201431	http://dx.doi.org/10.1371/journal.pone.0201431			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161127	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900008
J	Grases, F; Costa-Bauza, A; Roig, J; Rodriguez, A				Grases, Felix; Costa-Bauza, Antonia; Roig, Joan; Rodriguez, Adrian			Xanthine urolithiasis: Inhibitors of xanthine crystallization	PLOS ONE			English	Article							HEREDITARY XANTHINURIA; CLASSICAL XANTHINURIA; MUTATION; IDENTIFICATION; GENE	Objective To identify in vitro inhibitors of xanthine crystallization that have potential for inhibiting the formation of xanthine crystals in urine and preventing the development of the renal calculi in patients with xanthinuria. Methods The formation of xanthine crystals in synthetic urine and the effects of 10 potential crystallization inhibitors were assessed using a kinetic turbidimetric system with a photometer. The maximum concentration tested for each compound was: 20 mg/L for 3-methylxanthine (3MX); 40 mg/L for 7-methylxanthine (7-MX), 1-methylxanthine (1-MX), theobromine (TB), theophylline, paraxanthine, and caffeine; 45 mg/L for 1-methyluric acid; 80 mg/L for 1,3-dimethyluric acid; and 200 mg/L for hypoxanthine. Scanning electron microscopy was used to examine the morphology of the crystals formed when inhibitory effects were observed. Results Only 7-MX, 3-MX, and 1-MX significantly inhibited xanthine crystallization at the tested concentrations. Mixtures of inhibitors had an additive effect rather than a synergistic effect on crystallization. Conclusion Two of the inhibitors identified here D 7-MX and 3-MX D are major metabolites of TB. In particular, after TB consumption, 20% is excreted in the urine as TB, 21.5% as 3-MX, and 36% as 7-MX. Thus, consumption of theobromine could protect patients with xanthinuria from the development of renal xanthine calculi. Clinical trials are necessary to demonstrate these effects in vivo.	[Grases, Felix; Costa-Bauza, Antonia; Roig, Joan; Rodriguez, Adrian] Univ Balearic Isl, Fac Sci, Univ Inst Hlth Sci Res IUNICS IdISBa, Lab Renal Lithiasis Res, Palma De Mallorca, Spain	Universitat de les Illes Balears	Grases, F (corresponding author), Univ Balearic Isl, Fac Sci, Univ Inst Hlth Sci Res IUNICS IdISBa, Lab Renal Lithiasis Res, Palma De Mallorca, Spain.	fgrases@uib.es	RODRIGUEZ, ADRIAN/D-6606-2019	RODRIGUEZ, ADRIAN/0000-0002-6521-4558; Grases, Felix/0000-0001-5636-9139				Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3; CARPENTER TO, 1986, J PEDIATR-US, V109, P307, DOI 10.1016/S0022-3476(86)80391-2; CRAIG WJ, 1984, J FOOD SCI, V49, P302, DOI 10.1111/j.1365-2621.1984.tb13737.x; Grases F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111184; HISATOME I, 1993, NEPHRON, V65, P578, DOI 10.1159/000187567; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Ichida K, 2012, INT J MOL SCI, V13, P15475, DOI 10.3390/ijms131115475; MATEOS FA, 1987, J CLIN INVEST, V79, P847, DOI 10.1172/JCI112893; Mraz M, 2015, UROLITHIASIS, V43, P61, DOI 10.1007/s00240-014-0734-4; Nicoletta JA, 2006, PEDIATR CLIN N AM, V53, P479, DOI 10.1016/j.pcl.2006.03.001; Peretz H, 2007, MOL GENET METAB, V91, P23, DOI 10.1016/j.ymgme.2007.02.005; Yamamoto T, 2003, METABOLISM, V52, P1501, DOI 10.1016/S0026-0495(03)00272-5	12	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0198881	10.1371/journal.pone.0198881	http://dx.doi.org/10.1371/journal.pone.0198881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157195	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400003
J	Hobbs, SJ; Nauwelaerts, S; Sinclair, J; Clayton, HM; Back, W				Hobbs, Sarah Jane; Nauwelaerts, Sandra; Sinclair, Jonathan; Clayton, Hilary M.; Back, Willem			Sagittal plane fore hoof unevenness is associated with fore and hindlimb asymmetrical force vectors in the sagittal and frontal planes	PLOS ONE			English	Article							GROUND REACTION FORCE; HORSES; LATERALITY; LAMENESS; MOTOR; KINEMATICS; BACK; LOAD; BODY; FEET	Asymmetry in forelimb dorsal hoof wall angles, termed unevenness, is associated with forelimb gait asymmetries, but compensatory mechanisms and out of plane ground reaction forces (GRFs) due to unevenness have yet to be documented. The aim of this study was therefore to investigate the effects of fore hoof unevenness on contralateral fore and hind limb force vectors patterns, in both sagittal and frontal planes. A group of n=34 riding horses were classified into four groups: hoof angle difference of more than 1.5 degrees (UNEVEN; n=27), including higher left fore (HIGH-LF; n=12), higher right fore (HIGH-RF; n=15), and hoof angle difference of less than 1.5 degrees (EVEN; n=7). Three dimensional ground reaction forces GRFs were collected during trotting. GRF summary vectors representing the magnitude (VecMag) and angular direction (VecAng) of the entire stance phase in the sagittal and the frontal plane were calculated. The effects of unevenness on GRF production were explored using linear regression, repeated measures ANOVA and statistical parametric mapping (SPM) with significance at (P<0.05). In all uneven groups, increasing unevenness affected sagittal VecAng values in the forelimbs, with more propulsive GRF in the high hoof. In the HIGH-RF group, medial GRFs were also found in the high RF hoof compared to lateral GRFs in the low LF hoof (RF VecAng: 0.97 +/- 1.64 (deg); LF VecAng: -0.64 +/- 1.19 (deg); P<0.05). In both HIGH groups, compensatory associations to increasing unevenness were only found in the RH, but also a significantly greater lateral VecAng was found in the LH (P<0.05) compared to the RH limb. No significant differences (P>0.05) were found between hindlimb pairs in the EVEN group. Unbalanced sagittal and increased frontal plane GRFs in uneven horses suggest that they have greater locomotory challenges, as the equine musculoskeletal system is not constructed to withstand movement and loading in the frontal plane as effectively as it is in the sagittal plane.	[Hobbs, Sarah Jane; Sinclair, Jonathan] Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston, Lancs, England; [Nauwelaerts, Sandra] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Nauwelaerts, Sandra] Antwerp Zoo Ctr Res & Conservat, Antwerp, Belgium; [Clayton, Hilary M.] Sport Horse Sci, Mason, MI USA; [Back, Willem] Univ Utrecht, Dept Equine Sci, Fac Vet Med, Utrecht, Netherlands; [Back, Willem] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesia Domest Anim, Ghent, Belgium	University of Central Lancashire; University of Antwerp; Utrecht University; Ghent University	Hobbs, SJ (corresponding author), Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston, Lancs, England.	sjhobbs1@uclan.ac.uk		Sinclair, Jonathan/0000-0002-2231-3732; Clayton, Hilary/0000-0002-8759-0925; Hobbs, Sarah Jane/0000-0002-1552-8647	Qualisys grant; FWO-Flanders grant; IOF grant (IOF SBO) [34424]	Qualisys grant; FWO-Flanders grant; IOF grant (IOF SBO)	This work was supported by a Qualisys grant to Sarah Jane Hobbs, an FWO-Flanders grant to Sandra Nauwelaerts and an IOF grant (IOF SBO ID 34424) to Sandra Nauwelaerts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CBG, 2008, EQUINE VET J, V40, P153, DOI 10.2746/042516408X250292; Alvarez CBG, 2007, EQUINE VET J, V39, P197, DOI 10.2746/042516407X173668; American Association of Equine Practitioners, 2017, LAM EX EV LAM HORS; Berki V, 2015, J BIOMECH, V48, P2214, DOI 10.1016/j.jbiomech.2015.03.025; Brindle RA, 2014, GAIT POSTURE, V39, P124, DOI 10.1016/j.gaitpost.2013.06.010; Clayton HM, 2017, PEERJ, V5, DOI 10.7717/peerj.3866; Colborne GR, 2016, NEW ZEAL VET J, V64, P76, DOI 10.1080/00480169.2015.1068138; Colborne GR, 2011, AM J VET RES, V72, P336, DOI 10.2460/ajvr.72.3.336; Crevier-Denoix N, 2010, EQUINE VET J, V42, P544, DOI 10.1111/j.2042-3306.2010.00202.x; Curtis SJ, 2012, C MED CHIR EQ GEN GE; DALIN G, 1985, EQUINE VET J, V17, P292, DOI 10.1111/j.2042-3306.1985.tb02501.x; Ducro B, 2009, EQUINE VET J, V49, P1439; Ducro BJ, 2009, EQUINE VET J, V41, P144, DOI 10.2746/042516408X363800; Hobbs SJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4399; Hobbs SJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2190; Hopkins S., 2014, EQUINE VET J S46, V46, P42, DOI [10.1111/evj.12267_127, DOI 10.1111/EVJ.12267_127]; Ishihara A, 2005, AM J VET RES, V66, P1805, DOI 10.2460/ajvr.2005.66.1805; Kambhampati SBS, 2007, J BIOMECH, V40, P3748, DOI 10.1016/j.jbiomech.2007.06.012; KHODADADEH S, 1986, CLIN BIOMECH, V1, P77, DOI 10.1016/0268-0033(86)90079-3; Kienapfel K, 2018, J ANIM PHYSIOL AN N, V102, pE818, DOI 10.1111/jpn.12840; Lucidi P, 2013, PHYSIOL BEHAV, V109, P8, DOI 10.1016/j.physbeh.2012.11.006; McGreevy PD, 2005, APPL ANIM BEHAV SCI, V92, P337, DOI 10.1016/j.applanim.2004.11.012; Meardon SA, 2014, J BIOMECH, V47, P2738, DOI 10.1016/j.jbiomech.2014.04.047; Morley JB, 2010, J APPL BIOMECH, V26, P205, DOI 10.1123/jab.26.2.205; Nauwelaerts S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167477; Pataky T., 2016, SPM1D; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pearce GP, 2005, AUST VET J, V83, P367, DOI 10.1111/j.1751-0813.2005.tb15636.x; PEDOTTI A, 1977, IEEE T BIO-MED ENG, V24, P456, DOI 10.1109/TBME.1977.326186; Peham C, 2004, EQUINE VET J, V36, P703, DOI 10.2746/0425164044848091; Penny W., 2007, STAT PARAMETR MAPP A, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Polk JD, 2017, GAIT POSTURE, V52, P140, DOI 10.1016/j.gaitpost.2016.11.028; TING LH, 1994, J EXP BIOL, V197, P251; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; van Heel MCV, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00064.x; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; Watson KM, 2003, EQUINE VET J, V35, P712, DOI 10.2746/042516403775696348; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Weishaupt MA, 2008, VET CLIN N AM-EQUINE, V24, P79, DOI 10.1016/j.cveq.2007.11.010; Wiggers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114836; Williams DE, 2007, ANIM BEHAV, V74, P941, DOI 10.1016/j.anbehav.2007.01.014; Wilson GH, 2009, EQUINE VET J, V41, P238, DOI 10.2746/042516409X395561	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203134	10.1371/journal.pone.0203134	http://dx.doi.org/10.1371/journal.pone.0203134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157249	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000443071400093
J	Jimeaez-Silva, CL; Carreno, MF; Ortiz-Baez, AS; Rey, LA; Villabona-Arenas, CJ; Ocazionez, RE				Jimeaez-Silva, Cinthy L.; Fernanda Carreno, Maria; Susana Ortiz-Baez, Ayda; Aida Rey, Luz; Villabona-Arenas, Christian Julian; Ocazionez, Raquel E.			Evolutionary history and spatio-temporal dynamics of dengue virus serotypes in an endemic region of Colombia	PLOS ONE			English	Article							ZIKA VIRUS; MULTIPLE INTRODUCTIONS; AMERICA; EPIDEMIOLOGY; PHYLOGENETICS; SINGAPORE; AREA	Dengue is a prevalent disease in Colombia and all dengue virus serotypes (DENV-1 to -4) co-circulate in the country since 2001. However, the relative impact of gene flow and local diversification on epidemic dynamics is unknown due to heterogeneous sampling and lack of sufficient genetic data. The region of Santander is one of the areas with the highest incidence of dengue in Colombia. To provide a better understanding of the epidemiology of dengue, we inferred DENV population dynamics using samples collected between 1998 and 2015. We used Bayesian phylogenetic analysis and included 143 new envelope gene sequences from Colombia, mainly from the region of Santander, and 235 published sequences from representative countries in the Americas. We documented one single genotype for each serotype but multiple introductions. Whereas the majority of DENV-1, DENV-2, and DENV-4 strains fell into one single lineage, DENV-3 strains fell into two distinct lineages that co-circulated. The inferred times to the most recent common ancestors for the most recent clades of DENV-1, DENV-2, and DENV-4 fell between 1977 and 1987, and for DENV-3 was around 1995. Demographic reconstructions suggested a gradual increase in viral diversity over time. A phylogeographical analysis underscored that Colombia mainly receives viral lineages and a significant diffusion route between Colombia and Venezuela. Our findings contribute to a better understanding of the viral diversity and dengue epidemiology in Colombia.	[Jimeaez-Silva, Cinthy L.; Fernanda Carreno, Maria; Susana Ortiz-Baez, Ayda; Ocazionez, Raquel E.] Univ Ind Santander, Lab Arbovirus, Ctr Invest Enfermedades Trop CINTROP, Bucaramanga, Colombia; [Aida Rey, Luz] Univ Ind Santander, Unidad Epidemiol Clin, Escuela Med, Bucaramanga, Colombia; [Villabona-Arenas, Christian Julian] Univ Montpellier, IRD, Lab TransVIHMI, Montpellier, France; [Villabona-Arenas, Christian Julian] Univ Montpellier, IBC, LIRMM, Montpellier, France	Universidad Industrial de Santander; Universidad Industrial de Santander; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier	Villabona-Arenas, CJ (corresponding author), Univ Montpellier, IRD, Lab TransVIHMI, Montpellier, France.; Villabona-Arenas, CJ (corresponding author), Univ Montpellier, IBC, LIRMM, Montpellier, France.	christian-julian.villabona-arenas@ird.fr		Carreno, Maria Fernanda/0000-0003-4294-1848; Villabona Arenas, Christian Julian/0000-0001-9928-3968; Ortiz Baez, Ayda Susana/0000-0003-0080-0633	Colombian Government: Science, Technology and Innovation Fund of Sistema General de Regalias, Santander, Casanare, Valle del Cauca [BPIN 2013000100011]	Colombian Government: Science, Technology and Innovation Fund of Sistema General de Regalias, Santander, Casanare, Valle del Cauca	This study was supported by the Colombian Government: Science, Technology and Innovation Fund of Sistema General de Regalias, Santander, Casanare, Valle del Cauca (BPIN 2013000100011).	Afreen N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004511; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Alvarez DP, 2012, DENGUE COLOMBIA EPID, P142; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340; Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006; Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866; (DANE) DAN de E, EST DEM POBL; Departamento Nacional de Planeacion (DANE), AN MOV INT VIAJ COL; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Gomez Rangel S. Y., 2008, Dengue Bulletin, V32, P126; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Instituto Nacional de Salud, INSTR INT ACC VIG PR; Villabona-Arenas CJ, 2009, TROP MED INT HEALTH, V14, P1241, DOI 10.1111/j.1365-3156.2009.02339.x; Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538; Kotaki T, 2016, INFECT GENET EVOL, V37, P88, DOI 10.1016/j.meegid.2015.11.002; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226; Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519; Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769; Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004; Ocazionez-Jimenez RE, 2013, BIOMEDICA, V33, P22, DOI 10.7705/biomedica.v33i0.717; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Ospina MC, 2010, AM J TROP MED HYG, V83, P672, DOI 10.4269/ajtmh.2010.09-0766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez G, 2014, COLECCION EC REGIONA; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; R Core team, 2015, R LANG ENV STAT COMP, V55, P275; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ramirez Clemencia, 2013, PERFIL MIGRATORIO CO; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RODRIGUEZROCHE R, 2013, BIO MED RES INT, V2013, P20, DOI DOI 10.1155/2013/690835; Santiago GA, 2012, J INFECT DIS, V206, P893, DOI 10.1093/infdis/jis426; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213; Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]; Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694; Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007; Villabona-arenas CJ, 2016, PLOS NEGLECT TROP D, P5; Villamor E, 2017, EPIDEMIOL INFECT, V145, P2961, DOI [10.1017/S0950268817002059, 10.1017/s0950268817002059]; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	63	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203090	10.1371/journal.pone.0203090	http://dx.doi.org/10.1371/journal.pone.0203090			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157270	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400089
J	de la Lama, RL; De la Puente, S; Riveros, JC				Lopez de la Lama, Rocio; De la Puente, Santiago; Carlos Riveros, Juan			Attitudes and misconceptions towards sharks and shark meat consumption along the Peruvian coast	PLOS ONE			English	Article							WORD-ASSOCIATION; CONSERVATION; SEAFOOD; BEHAVIOR	Misconceptions, lack of knowledge, and negative attitudes towards sharks act as barriers preventing actions required to tackle threats to shark populations, limiting the success of global shark conservation initiatives. Peru, a major player for the international trade of shark products, recently approved the 'National Action Plan for the Conservation and Management of Sharks, Rays and Chimaeras' (PAN-Tib); a guiding document for conservation initiatives aimed at these fishes. Within PAN-Tib, the assessment of Peruvians' current knowledge and attitudes towards sharks is listed as a research priority. Between June and October 2016, 2004 Peruvians were surveyed along the coast to characterize their (i) shark meat consumption patterns, and (ii) knowledge and attitudes towards sharks. Results suggest that shark meat consumption is extended, but not necessarily frequent, and higher in the northern regions of the country. However, 77.5% of shark meat consumers were unaware that they had eaten sharks. Although 57.6% of the participants recognized that sharks are present in Peruvian waters, only 19.4% of the surveyed population was capable of naming at least one local shark species. Moreover, Peruvians have very negative attitudes towards sharks. They fear them and view them as man-eaters, despite this, no shark attacks have ever been reported in the country. These results highlight the need to: (i) encourage sustainable shark meat consumption, and (ii) promote communication campaigns aimed at increasing knowledge about sharks, and their importance as a source of employment and food for coastal communities, as for the national economy.	[Lopez de la Lama, Rocio] Univ British Columbia, IRES, Vancouver, BC, Canada; [Lopez de la Lama, Rocio] Univ Peruana Cayetano Heredia, LEB, Lima, Peru; [De la Puente, Santiago] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Carlos Riveros, Juan] OCEANA Peru, Lima, Peru	University of British Columbia; Universidad Peruana Cayetano Heredia; University of British Columbia	de la Lama, RL (corresponding author), Univ British Columbia, IRES, Vancouver, BC, Canada.; de la Lama, RL (corresponding author), Univ Peruana Cayetano Heredia, LEB, Lima, Peru.; De la Puente, S (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	rocio.lopez@upch.pe; s.delapuente@oceans.ubc.ca		De la Puente, Santiago/0000-0002-6189-9596; Lopez de la Lama, Rocio/0000-0001-6696-5401; Riveros, Juan Carlos/0000-0003-4051-181X	Pew Charitable Trusts; Oceana Peru	Pew Charitable Trusts; Oceana Peru	This study was funded by The Pew Charitable Trusts and Oceana Peru. The funding was mainly used for field work and data collection along the Peruvian coast.	Aipanjiguly S, 2003, CONSERV BIOL, V17, P1098, DOI 10.1046/j.1523-1739.2003.01452.x; [Anonymous], 2006, CUADERNOS INVESTIGAC; [Anonymous], 590 FAO; [Anonymous], 2010, TELEGRAPH; APEGA, 2013, BOOM GAST PERUANO 20; Cardenas-Alayza S., 2017, CONSULTORIA ELABORAD; Carlucci D, 2015, APPETITE, V84, P212, DOI 10.1016/j.appet.2014.10.008; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Chirichigno N., 2001, CATA LOGO COMENTADO; Christensen V, 2014, MAR POLICY, V44, P302, DOI 10.1016/j.marpol.2013.09.022; Clemente L. E., 2010, LIBERTAD SALAVERRY; Cornejo Rodolfo, 2015, Check List, V11, P1809; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; de Andrade JC, 2016, MEAT SCI, V117, P68, DOI 10.1016/j.meatsci.2016.02.039; De la Puente S., 2017, CHARACTERIZING KNOWL; Donoghue S., 2000, J CONSUM SCI, V28, P47, DOI 10.4314/jfecs.v28i1.52784; Friedrich LA, 2014, MAR POLICY, V47, P1, DOI 10.1016/j.marpol.2014.02.003; Garla RC, 2015, MAR POLICY, V60, P128, DOI 10.1016/j.marpol.2015.06.012; Gonzalez-Pestana A., 2016, F1000RESEARCH, V3, P164, DOI DOI 10.12688/F1000RESEARCH.4412.2; Gonzalez-Pestana A, 2017, FISH B-NOAA, V115, P451, DOI 10.7755/FB.115.4.2; IMARPE, 2015, SER DIV CIENT I MAR, V1, P1; INEI, 2018, PER IND EMPL INGR DE; INEI, 2012, CONSUMO CPITA PRINCI; Jacques PJ, 2010, PROG OCEANOGR, V86, P192, DOI 10.1016/j.pocean.2010.04.001; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Lavallee D, 2011, CHUNGARA, V43, P333, DOI 10.4067/S0717-73562011000300002; Lopez de la Lama R., 2018, ORYX; Lowell B., 2015, ONE NAME ONE FISH WH, P1; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Mendo J., 2014, 201421 U BRIT COL FI, P23; MINAM, 2014, DIR GEN DIV BIOL; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; Neff C, 2015, AUST J POLIT SCI, V50, P114, DOI 10.1080/10361146.2014.989385; Pepin-Neff C., 2018, CONSERV LETT, V11, P1, DOI DOI 10.1111/C0NL.12407; Prieto G, 2015, THESIS; PRODUCE, 2014, PROGR NAC COM PESC U; PRODUCE, 2016, AN EST PESQ AC 2015; PRODUCE, 2014, 0022014PRODUCE; Roininen K, 2006, FOOD QUAL PREFER, V17, P20, DOI 10.1016/j.foodqual.2005.04.012; Rose S, 2015, MANAGEMENT RESEARCH: APPLYING THE PRINCIPLES, P1; Schultz PW, 2011, CONSERV BIOL, V25, P1080, DOI 10.1111/j.1523-1739.2011.01766.x; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; Steel BS, 2005, OCEAN COAST MANAGE, V48, P97, DOI 10.1016/j.ocecoaman.2005.01.002; Thompson TL, 2002, INT J SCI EDUC, V24, P645, DOI 10.1080/09500690110110115; Velez-Zuazo X, 2015, FISH RES, V161, P34, DOI 10.1016/j.fishres.2014.06.005; Zelezny L. C., 1999, J ENVIRON EDUC, V31, P5, DOI DOI 10.1080/00958969909598627	48	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202971	10.1371/journal.pone.0202971	http://dx.doi.org/10.1371/journal.pone.0202971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157282	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400079
J	Yoder, N; Gouaux, E				Yoder, Nate; Gouaux, Eric			Divalent cation and chloride ion sites of chicken acid sensing ion channel 1a elucidated by x-ray crystallography	PLOS ONE			English	Article							INHIBITION; RECEPTOR; PROTONS; ION-CHANNEL-1; EXPRESSION; PLASTICITY; MEMBRANE; AMYGDALA; NEURONS; FAMILY	Acid sensing ion channels (ASICs) are proton-gated ion channels that are members of the degenerin/epithelial sodium channel superfamily and are expressed throughout central and peripheral nervous systems. ASICs have been implicated in multiple physiological processes and are subject to numerous forms of endogenous and exogenous regulation that include modulation by Ca2+ and Cl- ions. However, the mapping of ion binding sites as well as a structure-based understanding of the mechanisms underlying ionic modulation of ASICs have remained elusive. Here we present ion binding sites of chicken ASIC1a in resting and desensitized states at high and low pH, respectively, determined by anomalous diffraction x-ray crystallography. The acidic pocket serves as a nexus for divalent cation binding at both low and high pH, while we observe divalent cation binding within the central vestibule on the resting channel at high pH only. Moreover, neutralization of residues positioned to coordinate divalent cations via individual and combined Glu to Gln substitutions reduced, but did not extinguish, modulation of proton-dependent gating by Ca2+. Additionally, we demonstrate that anion binding at the canonical thumb domain site is state-dependent and present a previously undetected anion site at the mouth of the extracellular fenestrations on the resting channel. Our results map anion and cation sites on ASICs across multiple functional states, informing possible mechanisms of modulation and providing a blueprint for the design of therapeutics targeting ASICs.	[Yoder, Nate; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	National Institute of General Medical Sciences [5T32DK007680]; National Institute of Neurological Disorders and Stroke [5F31NS096782, 5R01NS038631]; ARCS Foundation; Tartar Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS096782, R37NS038631, R01NS038631] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ARCS Foundation; Tartar Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this research was provided by the National Institute of General Medical Sciences (5T32DK007680, https://www.nigms.nih.gov), and the National Institute of Neurological Disorders and Stroke (5F31NS096782 to N.Y. and 5R01NS038631 to E.G., https://www.ninds.nih.gov/). Additional support was provided by ARCS Foundation (https://www.arcsfoundation.org/) and Tartar Trust fellowships. E.G. is an Investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HILLE B, 2001, ION CHANNELS EXCITAB, V18; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Lynagh T, 2017, J MED CHEM, V60, P8192, DOI 10.1021/acs.jmedchem.7b01072; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mukhopadhyay M, 2017, NEUROSCIENCE, V348, P264, DOI 10.1016/j.neuroscience.2017.02.025; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Pidoplichko VI, 2014, J NEUROSCI, V34, P3130, DOI 10.1523/JNEUROSCI.4009-13.2014; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Vullo S, 2017, P NATL ACAD SCI USA, V114, P3768, DOI 10.1073/pnas.1620560114; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574; Zuo ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04424-0	36	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202134	10.1371/journal.pone.0202134	http://dx.doi.org/10.1371/journal.pone.0202134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157194	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400038
J	Choukem, SP; Efie, DT; Djiogue, S; Kaze, FF; Mboue-Djieka, Y; Boudjeko, T; Dongo, E; Gautier, JF; Kengne, AP				Choukem, Simeon-Pierre; Efie, Derrick Tembi; Djiogue, Sefirin; Kaze, Francois F.; Mboue-Djieka, Yannick; Boudjeko, Thad; Dongo, Etienne; Gautier, Jean-Francois; Kengne, Andre-Pascal			Effects of hydroquinone-containing creams on capillary glycemia before and after serial hand washings in Africans	PLOS ONE			English	Article							BLOOD-GLUCOSE	Background Hydroquinone-containing creams cause false increases in capillary glycemia. However, the magnitude of this false increase, and the means to reverse it have not been investigated. Objective To evaluate the technical and clinical impact of hydroquinone-containing creams on capillary glycemia and investigate the efficacy of hand washing and other common practices, in reversing cream effects. Methods We included 91 participants in a quasi-experimental study in Buea, Cameroon. After determining the hydroquinone content of a cream, Caro Light, we used two glucometers with different enzymatic systems (Accu-Chek Active and OneTouch Ultra 2) to measure fasting glycemia after: initial hand washing (reference), application of 1 ml of hydroquinone-containing cream, finger swabbing with wet gauze, sanitizer application and a series of three hand washings following cream application. Reference glycemia was compared to those obtained after various interventions. Statistical significance was assessed by paired sample t-test, clinical significance by total error allowable (TEa), and clinical impact by Parke's error grid analysis. Results The mean differences in capillary glycemia (Intervention-reference) measured by Accu-Chek Active in mg/dl were 28, 27, 38, 16, 4, and -2 after cream application, finger swabbing, sanitizer application, one, two, and three hand washings respectively. Corresponding values for OneTouch Ultra2 were 41, 44, 64, 22, 5 and -5. These differences, except after two and three hand washings were both statistically (p < 0.0001) and clinically significant (TEa). After cream application, Accu-Check had 9.9% of values in Parke's Zones C-E, while OneTouch had 18.7%. Conclusion Hydroquinone-containing creams cause significant false increase in capillary glycemia irrespective of the enzymatic system of the glucometer used, and can lead to potentially wrong clinical decisions. A minimum of two hand washings is required prior to capillary glucose measurement.	[Choukem, Simeon-Pierre; Efie, Derrick Tembi] Univ Buea, Fac Hlth Sci, Dept Internal Med & Paediat, Buea, Cameroon; [Choukem, Simeon-Pierre; Efie, Derrick Tembi; Mboue-Djieka, Yannick] Hlth & Human Dev 2HD Res Network, Douala, Cameroon; [Choukem, Simeon-Pierre] Douala Gen Hosp, Dept Internal Med, Douala, Cameroon; [Djiogue, Sefirin] Univ Yaounde I, Fac Sci, Dept Anim Biol & Physiol, Yaounde, Cameroon; [Kaze, Francois F.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Subspecialties, Yaounde, Cameroon; [Boudjeko, Thad] Univ Yaounde I, Fac Sci, Dept Biochem, Yaounde, Cameroon; [Dongo, Etienne] Univ Yaounde I, Fac Sci, Dept Organ Chem, Yaounde, Cameroon; [Gautier, Jean-Francois] Univ Paris Diderot, Paris 7, Lariboisiere Hosp, AP HP,Dept Diabet Endocrinol & Nutr, Paris, France; [Kengne, Andre-Pascal] South African Med Res Council, Cape Town, South Africa; [Kengne, Andre-Pascal] Univ Cape Town, Cape Town, South Africa	University of Yaounde I; University of Yaounde I; University of Yaounde I; University of Yaounde I; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; South African Medical Research Council; University of Cape Town	Choukem, SP (corresponding author), Univ Buea, Fac Hlth Sci, Dept Internal Med & Paediat, Buea, Cameroon.; Choukem, SP (corresponding author), Hlth & Human Dev 2HD Res Network, Douala, Cameroon.; Choukem, SP (corresponding author), Douala Gen Hosp, Dept Internal Med, Douala, Cameroon.	schoukem@gmail.com	Kengne, Andre Pascal/ABB-3696-2020	DJIOGUE, Sefirin/0000-0002-3525-7047; Tembi Efie, Derrick/0000-0003-3609-809X; Choukem, Simeon Pierre/0000-0003-1399-5513; Kengne, Andre Pascal/0000-0002-5183-131X	Tseu Medical Institute, Harris Manchester College, University of Oxford, UK	Tseu Medical Institute, Harris Manchester College, University of Oxford, UK	The Health and Human Development (2HD) Research Network is supported by a Cruddas Link Fellowship (SPC), Tseu Medical Institute, Harris Manchester College, University of Oxford, UK. The authors are grateful to all participants, and to the collaborators of the Department of Organic Chemistry, Faculty of Sciences, University of Yaounde I.	Bihan H, 2011, ANN INTERN MED, V155, P649, DOI 10.7326/0003-4819-155-9-201111010-00023; Bouche CH, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3879; García Pedro López, 2007, Rev. Bras. Cienc. Farm., V43, P397, DOI 10.1590/S1516-93322007000300008; Ginsberg Barry H, 2009, J Diabetes Sci Technol, V3, P903; Harr KE, 2013, VET CLIN PATH, V42, P424, DOI 10.1111/vcp.12101; Hortensius J, 2012, DIABETES EDUCATOR, V38, P101, DOI 10.1177/0145721711427787; Hortensius J, 2011, DIABETES CARE, V34, P556, DOI 10.2337/dc10-1694; ISO, ISO STAND BLOOD GLUC; Mahoney John J, 2011, J Diabetes Sci Technol, V5, P1444; Olumide YM, 2008, INT J DERMATOL, V47, P344, DOI 10.1111/j.1365-4632.2008.02719.x; Parkes JL, 2000, DIABETES CARE, V23, P1143, DOI 10.2337/diacare.23.8.1143; Rajaratnam H, 2012, SRI LANKA J DIABETES, V1, P22; Rosindale S, 2004, J DIABETES NURS, V8, P272; Sobngwi E, 2013, DIABETES METAB, V39, pA2; Westgard, DES BIOL VAR DAT SPE	15	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202271	10.1371/journal.pone.0202271	http://dx.doi.org/10.1371/journal.pone.0202271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153255	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700010
J	Mochizuki, M; Miyagi, K; Kishigami, S				Mochizuki, Masato; Miyagi, Kodai; Kishigami, Satoshi			Optimizing treatment of tauroursodeoxycholic acid to improve embryonic development after in vitro maturation of cumulus-free oocytes in mice	PLOS ONE			English	Article							APOPTOSIS	Cumulus-free in vitro maturation (IVM) provides a powerful tool to manipulate immature oocytes, but IVM oocytes lead to poor development after fertilization. Supplementation of the culture medium with tauroursodeoxycholic acid (TUDCA), a bile acid, has been reported to improve the development of embryos derived from in vivo fertilized (IVF) embryos after in vitro culture (IVC) by attenuating endoplasmic reticulum stress. However, it remains unclear if TUDCA can improve development of IVM-IVF embryos. Here, we examined whether TUDCA treatment could improve embryonic development during or after IVM. Immature GV oocytes collected from ovaries of ICR female mice that were free from cumulus cells were subjected to IVM in alpha MEM containing 5% FBS for 16 h. TUDCA was added to the media at varying concentrations (0-1000 mu M) during IVM and IVC. TUDCA treatment during IVM reduced both MII and pronuclear (PN) rates but did not affect blastocyst rates of fertilized embryos. In contrast, TUDCA treatment during IVC significantly increased blastocyst formation rates in a concentration dependent manner. Finally, embryo transfer after TUDCA treatment revealed a significant improvement in the rates of offspring production (15% with 1000 mu M TUDCA vs. 6.0% control). These results show that treatment with 1000 mu M of TUDCA significantly can improve poor embryonic development of cumulus-free IVM-IVF embryos.	[Mochizuki, Masato; Miyagi, Kodai; Kishigami, Satoshi] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan; [Kishigami, Satoshi] Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Kishigami, S (corresponding author), Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan.; Kishigami, S (corresponding author), Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan.	skishigami@yamanashi.ac.jp		Kishigami, Satoshi/0000-0001-9447-5100	JSPS KAKENHI [17K08134, 16H02593]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant (Numbers 17K08134 to SK, 16H02593 to TW and SK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; [Anonymous], 2011, BIOL REPROD, V85, P70, DOI 10.1095/biolreprod.110.089342; Child TJ, 2002, OBSTET GYNECOL, V100, P665, DOI 10.1016/S0029-7844(02)02193-2; Dicks N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187717; Eppig JJ, 2009, HUM REPROD, V24, P922, DOI 10.1093/humrep/den466; Fonseca I, 2017, MOL NEUROBIOL, V54, P6107, DOI 10.1007/s12035-016-0145-3; Gilchrist RB, 2007, THERIOGENOLOGY, V67, P6, DOI 10.1016/j.theriogenology.2006.09.027; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Jia ZW, 2018, TOXICOL LETT, V294, P20, DOI 10.1016/j.toxlet.2018.05.007; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lin T, 2015, REPROD BIOL, V15, P101, DOI 10.1016/j.repbio.2015.01.004; Miki H, 2006, J REPROD DEVELOP, V52, P239, DOI 10.1262/jrd.17078; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; OOGA M, 2013, BIOL REPROD, V89, DOI DOI 10.1095/BI0LREPR0D.113.113258; Park HJ, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12458; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Wang DQH, 2014, WORLD J GASTROENTERO, V20, P9952, DOI 10.3748/wjg.v20.i29.9952; Yamazaki Y, 2001, ZYGOTE, V9, P277, DOI 10.1017/S0967199401001307; Zhang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040433	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202962	10.1371/journal.pone.0202962	http://dx.doi.org/10.1371/journal.pone.0202962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148855	Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200038
J	Hsu, JC; Lin, JY; Hsu, MY; Lin, PC				Hsu, Jason C.; Lin, Jia-Yu; Hsu, May-Ying; Lin, Peng-Chan			Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan	PLOS ONE			English	Article							CELL LUNG-CANCER; STAGE-III MELANOMA; UNTREATED MELANOMA; OPEN-LABEL; CHOICE CHEMOTHERAPY; COMBINED NIVOLUMAB; IPILIMUMAB; PEMBROLIZUMAB; TRIAL; SURVIVAL	Background Since 2012, several immune checkpoint inhibitors have been approved by the Taiwan FDA for various types of cancer treatment. However, none of them are covered by Taiwan National Health Insurance due to the fact that they are expensive, and there is a lack of clinical evidence as to their effectiveness. Objectives This study was aimed toward an exploration of clinical experiences with use of immune checkpoint inhibitors, including indications, prescription types, drug effectiveness, adverse drug event types, and incidence, all of which shall serve as references for future clinical drug use. Methods This is a retrospective study focusing on three immune checkpoint inhibitors (ipilimumab, nivolumab, and pembrolizumab), which are available for cancer treatment in Taiwan. We collected data from medical records for the period from January 1st, 2015 to January 12th, 2017 at National Cheng Kung University Hospital (NCKUH), a medical center in southern Taiwan, and recorded these cases until May 31st, 2017. Overall survival (OS) and progression-free survival (PFS) were estimated using the Kaplan-Meier method, and adverse drug reaction odds ratios were analyzed using a chi-square analysis. Results The 50 patients under consideration in this study had used any one of the immune checkpoint inhibitors in NCKUH. Non-small cell lung cancer (n = 24, 48%) accounted for the highest percentage, followed by hepatocellular carcinoma (n = 4, 8%). The median OS was not reached, and the PFS for all immunotherapies was 4.9 months. The median OS period and PFS for non-small cell lung cancer (NSCLC) patients were 13 and 4.9 months, respectively, which were similar to those in many clinical trials. For NSCLC patients, the OS and PFS were only 0.63 and 1.37 months for squamous cell type NSCLC, and for patients who were PD-L1 negative, the OS and PFS were only 11.53 and 2.6 months, respectively. The most common adverse events in this study included fatigue (42%), rashes (22%), nausea (20%), and fever (20%), while one patient developed severe deep venous thrombosis and tissue inflammation, which was not confirmed in previous clinical trials. Conclusions The histological subtype, the intensity of the PD-L1 expression, and the timing of treatment affected the NSCLC therapeutic results. It is recommended that clinical tests be conducted in order to enhance therapeutic effectiveness. It is expected that more testing, observation-based studies, and research results will validate their efficacy and the tolerance levels of patients.	[Hsu, Jason C.] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan; [Hsu, Jason C.] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan; [Lin, Jia-Yu; Hsu, May-Ying] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan; [Lin, Peng-Chan] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Hsu, JC (corresponding author), Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan.; Hsu, JC (corresponding author), Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan.	jasonhsu@mail.ncku.edu.tw			Taiwan Ministry of Science and Technology [MOST 104-2320-B-006-005, MOST 106-2320-B-006-039]	Taiwan Ministry of Science and Technology	Dr. Hsu was supported by Taiwan Ministry of Science and Technology grants (Grant ID: MOST 104-2320-B-006-005, MOST 106-2320-B-006-039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Calpe-Armero P, 2017, CHEMOTHERAPY, V62, P374, DOI 10.1159/000475803; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; D'Angelo SP, 2017, J CLIN ONCOL, V35, P226, DOI 10.1200/JCO.2016.67.9258; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gauvain C, 2018, LUNG CANCER, V116, P62, DOI 10.1016/j.lungcan.2017.12.008; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hui R, 2017, ANN ONCOL, V28, P874, DOI 10.1093/annonc/mdx008; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; National Institutes of Health National Cancer Institute, 2010, COMMON TERMINOLOGY C; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vokes EE, 2018, ANN ONCOL, V29, P959, DOI 10.1093/annonc/mdy041; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Xia B, 2016, IMMUNOTHERAPY-UK, V8, P279, DOI 10.2217/imt.15.123	26	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202725	10.1371/journal.pone.0202725	http://dx.doi.org/10.1371/journal.pone.0202725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142174	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500027
J	Iqbal, T; Iqbal, S; Hussain, SS; Khan, IA; Khan, HU; Rehman, A				Iqbal, Tassawar; Iqbal, Saqib; Hussain, Syed Sajid; Khan, Iftikhar Ahmed; Khan, Hikmat Ullah; Rehman, Attiqa			Fighting adult illiteracy with the help of the environmental print material	PLOS ONE			English	Article							EMERGENT LITERACY	Adult illiteracy is a major problem worldwide especially in developing countries. Adult Basic Education (ABE) programs working in this context are not very effective due to lack of motivation for the people who are not literate. The reason is inadequate learning content and content delivery methods. This situation calls for developing novel learning content and a learner-directed content delivery approach. This paper presents an exploratory study investigating the use of the Environmental Print Material (EPM) as learning content for the non-literate population of Pakistan. The EPM content is presented to the adult non-literate population in two ethnographic studies. The most frequently recognized content is selected and utilized as learning content in a Computer Assisted Learning (CAL) application. An empirical study is conducted upon two groups with 107 participants to compare the EPM-based learning content with Traditional Learning Content (TLC). As many as 54 participants participated in the experimental group (presented with EPM-based learning content), whereas 53 participants took part in the control group (presented with TLC content). The results reveal that the experimental group performed significantly better compared to the control group in recognition, pronunciation, and recall of the presented content. The meta-analysis of the results shows a large effect size of (1.05) with confidence interval in the range (0.798-1.315). The results claim that the EPM has potential to be considered as learning content in the ABE programs.	[Iqbal, Tassawar; Khan, Hikmat Ullah] COMSATS Univ Islamabad, Dept Comp Sci, Wah Campus, Wah, Pakistan; [Iqbal, Saqib] Al Ain Univ Sci & Technol, Coll Engn, Dept Software Engn & Comp Sci, Al Ain, U Arab Emirates; [Hussain, Syed Sajid; Khan, Iftikhar Ahmed; Rehman, Attiqa] COMSATS Univ Islamabad, Dept Comp Sci, Abbottabad Campus, Abbottabad, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Khan, IA (corresponding author), COMSATS Univ Islamabad, Dept Comp Sci, Abbottabad Campus, Abbottabad, Pakistan.	iftikharahmed@ciit.net.pk	Rehman, Attiqa/AAF-1123-2021; Khan, Hikmat Ullah/GZG-2251-2022; Hussain, Syed Sajid/AAS-6735-2020; Khan, Iftikhar Ahmed/Y-3798-2019; Rehman, Attiqa/AAW-3772-2020	Hussain, Syed Sajid/0000-0002-4212-8817; Khan, Iftikhar Ahmed/0000-0001-6124-1201; Iqbal, Saqib/0000-0001-8311-6129	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The research was partially supported by Higher Education Commission of Pakistan. Their URL is http://www.hec.gov.pk/english/Pages/Home.aspx. There was no additional external funding received for this study.	Aanstoos J, 2003, P 32 APPL IM PATT RE; Ahmad S, 1995, PEHLA QADAM FIRST ST; [Anonymous], 2012, TEACHER EXCELLENCE A; [Anonymous], 1988, APPEAL TRAINING MAT; [Anonymous], 2009, ED INDICATORS TECHNI; [Anonymous], 2014, IBM SPSS INTERMEDIAT; [Anonymous], 2012, WHY PAK NEEDS LIT MO; Askov E. N., 2003, EXPANDING ACCESS ADU; Burmark L., 2002, VISUAL LITERACY LEAR; Cardoso-Martins C, 2003, SCI STUD READ, V7, P335, DOI 10.1207/S1532799XSSR0704_2; Chall J, 1967, LEARNING READ GREAT; Cohen M, 2015, SUSTAINABILITY-BASEL, V7, P8709, DOI 10.3390/su7078709; Eberle A, 1980, OPINION PAPERS REPOR; EEF, 2007, KHAW LIT PROJ; Ehri LC, 1983, CRITIQUE 5 STUDIES R; Felder R.M., 1996, ASEE PRISM, V6, P18; Goodman K, 2005, WHATS WHOLE WHOLE LA; Hunt F, 2008, RES MONOGRAPH, V16; Iqbal T, 2012, THESIS; Kassow DZ, 2006, ENV PRINTN AWARENESS; Keller J. M., 1983, INSTRUCTIONAL DESIGN, P383, DOI DOI 10.1002/PFI; Khan FA, 2009, P 11 INT C INF INT W; Khan IA, 2017, TELEMAT INFORM, V34, P481, DOI 10.1016/j.tele.2016.08.015; Knowles M., 1990, ADULT LEARNER NEGLEC; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Kress G, 2001, MULTIMODAL DISCOURSE; Kuby P, 2004, J INSTRUCTIONAL PSYC, V31, P106; Kurvers J, 2009, READ WRIT, V22, P863, DOI 10.1007/s11145-008-9129-7; Lave J., 1991, SITUATED LEARNING LE; Mayer R. E., 2001, MULTIMEDIA LEARNING; McCambridge TR, 2017, DRILL AND PRACTICE; McGee LM, 1986, CHILDHOOD ED, V63, P118; Miller D, 1996, REPORTS EVALUATIVE; Nabi R, 2006, ESRA PARH READ; Neumann MM, 2012, J EARLY CHILD LIT, V12, P231, DOI 10.1177/1468798411417080; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Onyia MN, 2013, ACAD J INTERDISCIPLI, V2, P153; Park JH, 2009, EDUC TECHNOL SOC, V12, P207; Prevedel A, 2003, FOCUS BASICS, V6, P8; Pritchard A., 2009, WAYS LEARNING LEARNI, V2nd Edn; Rosen DJ, 1999, ANN REV ADULT LEARNI, V1, P304; Sabatini JP, 2001, DESIGNING MULTIMEDIA; Schlechty PC, 2004, SHAKING SCHOOLHOUSE; Selinger M, 2001, ISSUES TEACHING USIN; Shamim A, 2016, MOBILE INFORM SYSTEM, V2016; Skinner B. F., 1953, SCI HUMAN BEHAV; Sleeter C. E., 1991, POLITICS TXB, P99; Smith C, 2001, FOCUS BASICS, P1; SMITH F, 1992, PHI DELTA KAPPAN, V73, P432; Smith L., 1993, NECESSARY KNOWLEDGE; Statistics UIf, 2013, ADULT YOUTH LITERACY; Stites R, 2004, REV ADULT LEARNING L, V4, P109; Tortorella RAW, 2017, EDUC INF TECHNOL, V22, P297, DOI 10.1007/s10639-015-9445-x; Wagner D., 2005, NEW TECHNOLOGIES LIT; Wagner D. A., 2001, TECHKNOWLOGIA INT J; Wagner DA, 1998, TR9810 U PENNS NAT C; Warschauer M., 2010, EMERGING TECHNOLOGIE; Whitehurst GJ, 1998, CHILD DEV, V69, P848, DOI 10.2307/1132208	58	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201902	10.1371/journal.pone.0201902	http://dx.doi.org/10.1371/journal.pone.0201902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138404	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100029
J	Kodish, SR; Rohner, F; Beauliere, JM; Daffe, M; Ayoya, MA; Wirth, JP; Ngnie-Teta, I				Kodish, Stephen R.; Rohner, Fabian; Beauliere, Jean-Max; Daffe, Mamady; Ayoya, Mohamed Ag; Wirth, James P.; Ngnie-Teta, Ismael			Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responses	PLOS ONE			English	Article								Introduction Due to the close relationship between EVD and nutrition, the humanitarian community implemented various nutrition-specific and -sensitive interventions to stem the Ebola Virus Disease (EVD) outbreak in West Africa. Little, however, is known about stakeholder and community members' perspectives toward this response in Guinea. Therefore, we aimed to firstly understand how EVD may have influenced the nutrition situation; and secondly to assess the perceived acceptability and effectiveness of the nutrition response. Materials and methods Using 27 in-depth interviews conducted in April-May 2016, this descriptive, qualitative study had three iterative phases in an emergent design. Phase 1 explored the perceptions of 11 high-level policy and management staff. Phase 2 assessed the views of 16 community members, survivors, and front-line workers. Phase 3 compared the qualitative findings to relevant nutrition indicators from secondary data for final interpretations. A systematic, team-based coding approach using Dedoose software identified key themes during textual analysis. Results Overall, several plausible pathways through an interrelated network of bio-social factors help describe EVD impacts on the nutrition situation of Guinea. At a basic level, complex social dimensions of health, response unpreparedness, and market disruptions were perceived to be major determinants affecting the nutrition situation, especially among IYC. At an underlying level, household food security was negatively impacted, along with weakened care-seeking practices, IYC feeding practices, and coping strategies. Consequently, treatment coverage for childhood illnesses and IYC diets were negatively impacted during the outbreak. In hindsight, most participants had positive perceptions toward the overall EVD response, but described salient considerations for improving upon this nutrition response during future outbreaks. Discussion This study highlighted the complex web of inter-related factors through which EVD was perceived to impact the nutrition situation in Guinea. Considering the multi-level social and behavioral dimensions of health and nutrition is critical for effectively responding to infectious disease outbreaks.	[Kodish, Stephen R.; Rohner, Fabian; Wirth, James P.] GroundWork, Flasch, Switzerland; [Beauliere, Jean-Max; Ayoya, Mohamed Ag; Ngnie-Teta, Ismael] United Nations Childrens Fund UNICEF, Conakry, Guinea; [Daffe, Mamady] Minist Hlth, Conakry, Guinea; [Kodish, Stephen R.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Kodish, Stephen R.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kodish, SR (corresponding author), GroundWork, Flasch, Switzerland.; Kodish, SR (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.; Kodish, SR (corresponding author), Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA.	stephen.kodish@psu.edu	Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952	UNICEF	UNICEF	UNICEF funded this research project. JB, MAA, and INT, staff members of UNICEF, provided inputs related to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ACF, 2015, EFF MAL VIR EB SECT; ACF, 2015, EV IMP MAL VIR EB MV; Ansumana R, 2014, NEW ENGL J MED, V372, P2; Baize S, 2014, NEW ENGL J MED, V371, P8; Barret CB, 2010, SCIENCE, V327, P4; Beauliere JM, 2016, MALNUTRITION CASELOA; Bell M., 2008, PRINCIPLES PRACTICE, P1138; Bernard H.R., 2006, RES METHODS ANTHR, V4th; Buetow S., 2010, HLTH SERVICES RES PO, V15, P3; Burla L, 2008, NURS RES, V57, P5; Burt RS, 2005, BROKERAGE CLOSURE IN; Carrion Martin AI, 2016, INT HLTH, V8, P3, DOI [10.1093/inthealth/ihv067, DOI 10.1093/INTHEALTH/IHV067]; Cichetti DV, 1994, PSYCHOL ASSESSMENT, V6, P6; Cove S, 1993, MED ANTHROPOL, V15, P15; Creswell J. W., 2007, QUALITATIVE INQUIRY; Diallo MP, 2015, EVALUATION RAPIDE IM; Eisner E. W., 1991, ENLIGHTENED EYE QUAL; Elston JWT, 2016, J PUBLIC HEALTH-UK, V38, P673, DOI 10.1093/pubmed/fdv158; Engle PL, 2000, P NUTR SOC, V59, P25, DOI 10.1017/S0029665100000045; Evans DK, 2015, LANCET GLOB HEALTH, V3, P2; FAO, 1998, SPEC REP FAO WFP CRO; Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Hahn R. A., 2009, ANTHR PUBLIC HLTH BR; Hewlett BS, 2016, CURR ANTHROPOL, V57, P11; Heymann D. L., 2015, LANCET, V385, P2455; Mondragon NI, 2017, J HEALTH PSYCHOL, V22, P951, DOI 10.1177/1359105315620294; Kennedy SB, 2015, B WORLD HEALTH ORGAN, V93, P2, DOI 10.2471/BLT.14.151068; Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278; Kourtis AP, 2015, PEDIATR INFECT DIS J, V34, P893, DOI 10.1097/INF.0000000000000707; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; MacQueen KM, 1998, CULTURAL ANTHR METHO, V10, P5; Marshall MN, 1996, FAM PRACT, V13, P4; Maxwell J., 2004, QUALITATIVE RES DESI, DOI DOI 10.1177/1094428106290193; McMahon SA, 2016, HEALTH POLICY PLANN, V31, P1232, DOI 10.1093/heapol/czw055; Menendez C, 2015, LANCERT GLOBAL HLTH, V3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministry of Agriculture WFP FAO, 2014, IMP MAL VIR EB AGR S; Morse B, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000007; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453; Scott V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3071-4; Sociocultural Research Consultants, 2016, DED WEB APPL MAN AN; Strauss A., 1990, BASICS QUALITATIVE R; UNICEF, 2015, EB RESP; UNICEF, 1990, STRAT IMPR NUTR CHIL; UNICEF FAO WHO. Communication for Behavioural Impact (COMBI), 2012, COMM BEH IMP COMBI T, P126; UNICEF WHO CDC ENN, 2014, INF FEED CONT EB; Victora CG, 2016, LANCET, V63; WFP, EB RESP CRIS REC; WHO, 2015, WHO STRAT RESP OPT W; WHO, 2015, ONLINE REPORT; WHO, WHO SUPPL ARR GUIN S; WHO, 2015, WHO M SURV EB VIR DI; WHO UNICEF WFP, 2014, NUTR CAR CHILDR AD E, P32; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2016, CLIN CAR SURV EB VIR; Youkee D, 2016, LANCERT GLOBAL HLTH, V387	59	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202468	10.1371/journal.pone.0202468	http://dx.doi.org/10.1371/journal.pone.0202468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138407	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100068
J	Pastorek, M; Muller, P; Coates, PJ; Vojtesek, B				Pastorek, M.; Muller, P.; Coates, P. J.; Vojtesek, B.			Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition	PLOS ONE			English	Article							HUMAN-BREAST-CARCINOMA; MOLECULAR CHAPERONE; LINES; SURVIVAL; PROTEIN; CHIP; PROTEOSTASIS; ORIGIN; HSP70; HOP	Response of tumours to Hsp90 inhibitors is highly variable and their clinical effects are unpredictable, emphasising the need for a predictive marker. We postulated that sensitivity to Hsp90 inhibitors is connected to basal proteotoxic stress that makes cells dependent on Hsp90. Therefore, we assessed HSF1 as a general sensor of proteotoxic stress and correlated its activity with sensitivity to three separate small molecule Hsp90 inhibitors in seven breast cancer cell lines representing each of the different cancer subtypes. Flow cytometry was used to analyse the viability of breast cancer cell lines after Hsp90 inhibition. HSF1 activity was characterised by Ser326 phosphorylation and the transactivation capacity of HSF1 was determined by qPCR analysis of the ratios of HSF1-dependent (HOP, Hsp70) and HSF1-independent (CHIP) chaperones and cochaperone mRNAs. We show that the sensitivity of breast cancer cell lines to Hsp90 inhibition is highly variable. The basal levels of phosphorylated HSF1 also vary between cell lines and the magnitude of change in HSF1 phosphorylation after Hsp90 inhibition showed a negative correlation with sensitivity to Hsp90 inhibitors. Similarly, the basal transactivation capacity of HSF1, determined by the ratio of Hsp70 or HOP mRNA to CHIP mRNA level, is directly proportional to sensitivity to Hsp90 inhibitors. Increasing basal HSF1 activity by prior heat shock sensitised cells to Hsp90 inhibition. These results demonstrate that endogenous HSF1 activity varies between individual cancer cell lines and inversely reflects their sensitivity to Hsp90 inhibitors, suggesting that basal proteotoxic stress is an important and generalised predictor of response. Mechanistically, the data indicate that high endogenous proteotoxic stress levels sensitise to Hsp90 inhibition due to the inability to respond adequately to further proteotoxic stress. HSF1 activity therefore represents a potential biomarker for therapy with Hsp90 inhibitors, which may be useful for the rational design of future clinical studies.	[Pastorek, M.; Muller, P.; Coates, P. J.; Vojtesek, B.] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno, Czech Republic	Masaryk Memorial Cancer Institute	Vojtesek, B (corresponding author), Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno, Czech Republic.	vojtesek@mou.cz	Pastorek, Michal/R-4863-2018; Coates, Philip J/H-6854-2019; Muller, Petr/F-7762-2015; Muller, Petr/AAK-5014-2021	Pastorek, Michal/0000-0003-1987-5459; Coates, Philip J/0000-0003-1518-6306; Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Vojtesek, Borivoj/0000-0001-6194-3705	Czech Science Foundation by grant GACR [16-07321S]; Ministry of Education, Youth and Sports of the Czech Republic; National Programme of Sustainability I, project MEYS - NPS I [L01413]; Ministry of Health of the Czech Republic by the program Development of Research Organization, MH CZ - DRO (MMCI) [00209805]	Czech Science Foundation by grant GACR; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); National Programme of Sustainability I, project MEYS - NPS I; Ministry of Health of the Czech Republic by the program Development of Research Organization, MH CZ - DRO (MMCI)	MP, PJC, BV and PM were supported by the Czech Science Foundation by grant GACR 16-07321S. The work was partially supported by The Ministry of Education, Youth and Sports of the Czech Republic bybthe National Programme of Sustainability I, project MEYS - NPS I - L01413 and by the Ministry of Health of the Czech Republic by the program Development of Research Organization, MH CZ - DRO (MMCI, 00209805). There was no additional external funding received for this study.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alarcon SV, 2012, CURR MOL MED, V12, P1125, DOI 10.2174/156652412803306729; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Buffart TE, 2012, ONCOLOGIST, V17, P653, DOI 10.1634/theoncologist.2010-0379; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cheng Q, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3168; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dobbelstein M, 2014, NAT REV DRUG DISCOV, V13, P179, DOI 10.1038/nrd4201; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Jhaveri K, 2016, CLIN BREAST CANCER, V16, P276, DOI 10.1016/j.clbc.2015.11.004; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Rodrigues Loreta M, 2012, BMC Res Notes, V5, P250, DOI 10.1186/1756-0500-5-250; Ruckova E, 2012, CELL MOL BIOL LETT, V17, P446, DOI 10.2478/s11658-012-0021-8; Song CH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2557; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Trempe G L, 1976, Recent Results Cancer Res, P33; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; Zismanov V, 2014, ANTI-CANCER DRUG, V25, P998, DOI 10.1097/CAD.0000000000000140	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202758	10.1371/journal.pone.0202758	http://dx.doi.org/10.1371/journal.pone.0202758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138434	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100119
J	Chan, RCH; Lam, SSW; Fong, FLY; Chan, DTW; Lee, FWF; Sze, ETP				Chan, Roy Chi Ho; Lam, Steven Sai Wo; Fong, Fiona Long Yan; Chan, Dominic Tak Wah; Lee, Fred Wang Fat; Sze, Eric Tung Po			Optimization of protein extraction and two-dimensional gel electrophoresis profiles for the identification of Cordyceps sinensis and other similar species	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; CHINESE MEDICINE; NUCLEOSIDES; MILITARIS; MARKERS; TISSUES; FUNGI; CELLS; MS/MS; L.	Given that Chinese materia medica (CMM) is expensive and rare, people take tremendous risk to adulterate and falsify Cordyceps sinensis with counterfeit species with similar morphological features. It is thus essential to develop new methods to identify the authenticity of Cordyceps sinensis. It is hypothesized in this study that Cordyceps sinensis possesses certain protein biomarkers distinct from its counterfeits, which can be identified by proteomic technologies for authentication purposes. This is the first study that aims to optimize the conditions for extracting proteins from Cordyceps sinensis, a hybrid of fungal-animal CMM, and to compare the two-dimensional gel electrophoresis (2-DE) profiles between different Cordyceps species. Two different protein extraction buffer systems, namely, phenol/sodium dodecyl sulfate (SDS) buffer or lysis buffer, were evaluated, where the preparation using lysis buffer yielded better protein content. The results also showed that extraction with lysis buffer without pre-or post-washing of samples was the most effective protocol, with over 220% of protein yield and 819 protein spots detected on a 2-DE gel. Moreover, the results demonstrated that Cordyceps sinensis possesses protein biomarkers distinct from its counterfeits, and these biomarkers are not source-or origin-dependent, strongly supporting the feasibility of using identified biomarkers as indicators for authentication of Cordyceps species. The findings of this study warrant further investigations on the structural identification of protein biomarkers of Cordyceps species.	[Chan, Roy Chi Ho; Lam, Steven Sai Wo; Fong, Fiona Long Yan; Lee, Fred Wang Fat; Sze, Eric Tung Po] Open Univ Hong Kong, Sch Sci & Technol, Hong Kong, Hong Kong, Peoples R China; [Chan, Dominic Tak Wah] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	Hong Kong Metropolitan University; Chinese University of Hong Kong	Sze, ETP (corresponding author), Open Univ Hong Kong, Sch Sci & Technol, Hong Kong, Hong Kong, Peoples R China.	esze@ouhk.edu.hk	Sze, Eric/AAW-8946-2021	Lee, Wang-Fat/0000-0001-9665-1163	Faculty Development Scheme of the Hong Kong Research Grant Council (RGC) [UGC/FDS16/P02/14]	Faculty Development Scheme of the Hong Kong Research Grant Council (RGC)	The funding institution is Faculty Development Scheme of the Hong Kong Research Grant Council (RGC). The grant number is UGC/FDS16/P02/14. ETPS received the funding. (https://www.ugc.edu.hk/eng/rgc/index.html) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, MAR DRUGS; Au D, 2012, MICROSC RES TECHNIQ, V75, P54, DOI 10.1002/jemt.21024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho WCS, 2007, AM J CHINESE MED, V35, P911, DOI 10.1142/S0192415X07005375; Department of Health Hong Kong Special Adminstrative Region, 2010, HONG KONG CHIN MAT M; Gonzalez-Fernandez R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/932527; Holliday J, 2008, INT J MED MUSHROOMS, V10, P219, DOI 10.1615/IntJMedMushr.v10.i3.30; Hu HK, 2015, ANAL BIOANAL CHEM, V407, P8059, DOI 10.1007/s00216-015-8978-6; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Jiang T, 2015, PAK J PHARM SCI, V28, P313; Jogaiah S, 2015, INDIAN J BIOTECHNOL, V14, P532; Jordan JL, 2008, IMMUNOPHARM IMMUNOT, V30, P53, DOI [10.1080/08923970701812332, 10.1080/08923970701812332 ]; Khan MS, 2015, J PHARM BIOALLIED SC, V7, P264, DOI 10.4103/0975-7406.168022; Lakshman DK, 2008, MYCOLOGIA, V100, P867, DOI 10.3852/08-065; Lam KYC, 2015, MOLECULES, V20, P22454, DOI 10.3390/molecules201219861; Lee HH, 2015, J PHARM SCI, V23, P1; Lee J, 2016, APPL BIOCHEM BIOTECH, V180, P274, DOI 10.1007/s12010-016-2098-4; Lee S, 2015, J MICROBIOL, V53, P468, DOI 10.1007/s12275-015-5198-x; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Liu H, 2016, CAN J DIABETES, V40, P329, DOI 10.1016/j.jcjd.2016.02.001; Malafaia CB, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0062-9; Muhammad I. C., 2010, World Applied Sciences Journal, V8, P62; Pavokovic D, 2012, CROAT CHEM ACTA, V85, P177, DOI 10.5562/cca1804; Peng Y, 2016, ACTA PHARMACOL SIN, V37, P204, DOI 10.1038/aps.2015.129; Rajput R., 2016, J PROTEINS PROTEOM, V7, P187; Rastegari E, 2011, J MED PLANTS RES, V5, P3719; Sud A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/326405; Sun LW, 2011, AFR J BIOTECHNOL, V10, P17023, DOI 10.5897/AJB11.1398; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Wang DZ, 2009, HARMFUL ALGAE, V8, P685, DOI 10.1016/j.hal.2009.01.001; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Wu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029622; Xiao JH, 2012, ALTERN MED, V2012; Xie CQ, 2015, SPECTROCHIM ACTA A, V149, P971, DOI 10.1016/j.saa.2015.05.028; Yang S, 2016, FOOD NUTR RES, V60; Yoon TJ, 2008, APPL MICROBIOL BIOT, V80, P1087, DOI 10.1007/s00253-008-1607-y; Zhang JL, 2011, INT IMMUNOPHARMACOL, V11, P2251, DOI 10.1016/j.intimp.2011.09.019; Zong SY, 2015, MOLECULES, V20, P21816, DOI 10.3390/molecules201219807	38	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202779	10.1371/journal.pone.0202779	http://dx.doi.org/10.1371/journal.pone.0202779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133529	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400100
J	Gasmi, S; Bouchard, C; Ogden, NH; Adam-Poupart, A; Pelcat, Y; Rees, EE; Milord, F; Leighton, PA; Lindsay, RL; Koffi, JK; Thivierge, K				Gasmi, Salima; Bouchard, Catherine; Ogden, Nicholas H.; Adam-Poupart, Ariane; Pelcat, Yann; Rees, Erin E.; Milord, Francois; Leighton, Patrick A.; Lindsay, Robbin L.; Koffi, Jules K.; Thivierge, Karine			Evidence for increasing densities and geographic ranges of tick species of public health significance other than Ixodes scapularis in Quebec, Canada	PLOS ONE			English	Article							MOUNTAIN-SPOTTED-FEVER; AMERICAN DOG TICK; LONE STAR TICK; LYME-DISEASE; AMBLYOMMA-AMERICANUM; BORRELIA-BURGDORFERI; DERMACENTOR-VARIABILIS; POWASSAN ENCEPHALITIS; PASSIVE SURVEILLANCE; PREVENTIVE BEHAVIORS	Climate change is driving emergence and establishment of Ixodes scapularis, the main vector of Lyme disease in Quebec, Canada. As for the black-legged tick, I. scapularis Say, global warming may also favor northward expansion of other species of medically important ticks. The aims of this study were to determine (1) current diversity and abundance of ticks of public health significance other than I. scapularis, (2) sex and age of the human population bitten by these ticks (3), and the seasonal and geographic pattern of their occurrence. From 2007 to 2015, twelve tick species other than I. scapularis were submitted in the Quebec passive tick surveillance program. Of these 9243 ticks, 91.2% were Ixodes cookei, 4.1% were Dermacentor variabilis, 4.0% were Rhipicephalus sanguineus and 0.7% were Amblyomma americanum. The combined annual proportion of submitted I. cookei, D. variabilis, R. sanguineus and A. americanum ticks in passive surveillance rose from 6.1% in 2007 to 16.0% in 2015 and an annual growing trend was observed for each tick species. The number of municipalities where I. cookei ticks were acquired rose from 104 to 197 during the same period. Of the 862 people bitten by these ticks, 43.3% were I. cookei ticks removed from children aged < 10 years. These findings demonstrate the need for surveillance of all the tick species of medical importance in Quebec, particularly because climate may increase their abundance and geographic ranges, increasing the risk to the public of the diseases they transmit.	[Gasmi, Salima; Koffi, Jules K.] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Policy Integrat & Zoonoses Div, St Hyacinthe, PQ, Canada; [Gasmi, Salima; Bouchard, Catherine; Ogden, Nicholas H.; Pelcat, Yann; Rees, Erin E.; Koffi, Jules K.] Grp Rech Epidemiol Zoonoses & Sante Publ GREZOSP, St Hyacinthe, PQ, Canada; [Bouchard, Catherine; Ogden, Nicholas H.; Pelcat, Yann; Rees, Erin E.] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Adam-Poupart, Ariane; Milord, Francois] Inst Natl Sante Publ Quebec, Direct Risques Biol Sante Travail, Montreal, PQ, Canada; [Leighton, Patrick A.] Univ Montreal, Fac Vet Med, St Hyacinthe, PQ, Canada; [Lindsay, Robbin L.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada; [Thivierge, Karine] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Thivierge, Karine] McGill Univ, Fac Agr & Environm Sci, Inst Parasitol, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada	Public Health Agency of Canada; Universite de Montreal; Public Health Agency of Canada; Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Public Health Agency of Canada; Institut national de sante publique du Quebec (INSPQ); McGill University	Thivierge, K (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.; Thivierge, K (corresponding author), McGill Univ, Fac Agr & Environm Sci, Inst Parasitol, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	karine.thivierge@inspq.qc.ca			Green Fund; Fight against Climate Change of Quebec; Laboratoire de sante publique du Quebec; Public Health Agency of Canada	Green Fund; Fight against Climate Change of Quebec; Laboratoire de sante publique du Quebec; Public Health Agency of Canada	This study was funded by the Green Fund from the Minister of Sustainable Development, Environment and the Fight against Climate Change of Quebec (KT), the Laboratoire de sante publique du Quebec, and the Public Health Agency of Canada.	Aenishaenslin C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1539-2; [Anonymous], 2017, PATH SAF SHEETS INF; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; BARKER IK, 1993, J WILDLIFE DIS, V29, P416, DOI 10.7589/0090-3558-29.3.416; Barker SC, 2004, PARASITOLOGY, V129, pS15, DOI 10.1017/S0031182004005207; Bouchard C, 2015, CAN VET J, V56, P693; CAMPBELL A, 1979, ENVIRON ENTOMOL, V8, P734, DOI 10.1093/ee/8.4.734; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Clow KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189393; Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890; Cortinas R, 2013, J MED ENTOMOL, V50, P244, DOI 10.1603/ME12207; Demma LJ, 2006, ANN NY ACAD SCI, V1078, P342, DOI 10.1196/annals.1374.066; Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043; Dergousoff SJ, 2013, J MED ENTOMOL, V50, P510, DOI 10.1603/ME12193; Dergousoff SJ, 2009, APPL ENVIRON MICROB, V75, P1786, DOI 10.1128/AEM.02554-08; Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268; EstradaPena A, 2013, TICKS AND TICK-BORNE DISEASES: GEOGRAPHICAL DISTRIBUTION AND CONTROL STRATEGIES IN THE EURO-ASIA REGION, P1; Farkas M, 1990, P ENTOMOL SOC ONT; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; GARVIE MB, 1978, CAN J ZOOL, V56, P28, DOI 10.1139/z78-004; Gasmi S, 2017, Can Commun Dis Rep, V43, P194, DOI 10.14745/ccdr.v43i10a01; Gasmi S, 2016, TICKS TICK-BORNE DIS, V7, P1075, DOI 10.1016/j.ttbdis.2016.09.006; Gholam BIA, 1999, CAN MED ASSOC J, V161, P1419; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022; KOCH HG, 1982, J MED ENTOMOL, V19, P293, DOI 10.1093/jmedent/19.3.293; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Liang WC, 1999, AM J PREV MED, V17, P8, DOI 10.1016/S0749-3797(99)00040-9; Lindquist EE., 2016, HDB TICKS CANADA IXO, DOI DOI 10.3752/9780968932186; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden N H, 2015, Can Commun Dis Rep, V41, P132; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051; Phillips CB, 2001, AM J PREV MED, V20, P219, DOI 10.1016/S0749-3797(00)00315-9; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; Platts-Mills TAE, 2015, IMMUNOL ALLERGY CLIN, V35, P247, DOI 10.1016/j.iac.2015.01.009; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Rand PW, 2007, J MED ENTOMOL, V44, P1118, DOI 10.1603/0022-2585(2007)44[1118:PSIMAA]2.0.CO;2; RYDER JW, 1992, J MED ENTOMOL, V29, P525, DOI 10.1093/jmedent/29.3.525; SCHOLTEN T, 1977, CAN J PUBLIC HEALTH, V68, P494; Scott JD, 2001, J MED ENTOMOL, V38, P493, DOI 10.1603/0022-2585-38.4.493; Smith RP, 1996, J INFECT DIS, V174, P221, DOI 10.1093/infdis/174.1.221; Sonenshine D. E., 1979, Research Division Bulletin, Virginia Polytechnic Institute and State University; Sonenshine DE, 2013, BIOL TICKS, V2nd; Springer YP, 2015, AM J TROP MED HYG, V93, P875, DOI 10.4269/ajtmh.15-0330; Springer YP, 2014, J MED ENTOMOL, V51, P342, DOI 10.1603/ME13115; Thompson C, 2001, CLIN INFECT DIS, V33, P676, DOI 10.1086/322681	55	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201924	10.1371/journal.pone.0201924	http://dx.doi.org/10.1371/journal.pone.0201924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133502	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400049
J	Koch, NM; Gauthier, JA				Koch, Nicolas Mongiardino; Gauthier, Jacques A.			Noise and biases in genomic data may underlie radically different hypotheses for the position of Iguania within Squamata	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; REPTILES LIZARDS; SISTER GROUP; MORPHOLOGICAL DATA; MOLECULAR EVIDENCE; EVIDENCE CONVERGE; FOSSIL RELATIVES; ANALYSES RESOLVE; EARLY EVOLUTION; COMBINING DATA	Squamate reptiles are a major component of vertebrate biodiversity whose crown-clade traces its origin to a narrow window of time in the Mesozoic during which the main subclades diverged in rapid succession. Deciphering phylogenetic relationships among these lineages has proven challenging given the conflicting signals provided by genomic and phenomic data. Most notably, the placement of Iguania has routinely differed between data sources, with morphological evidence supporting a sister relationship to the remaining squamates (Scleroglossa hypothesis) and molecular data favoring a highly nested position alongside snakes and anguimorphs (Toxicofera hypothesis). We provide novel insights by generating an expanded morphological dataset and exploring the presence of phylogenetic signal, noise, and biases in molecular data. Our analyses confirm the presence of strong conflicting signals for the position of Iguania between morphological and molecular datasets. However, we also find that molecular data behave highly erratically when inferring the deepest branches of the squamate tree, a consequence of limited phylogenetic signal to resolve this ancient radiation with confidence. This, in turn, seems to result from a rate of evolution that is too high for historical signals to survive to the present. Finally, we detect significant systematic biases, with iguanians and snakes sharing faster rates of molecular evolution and a similarly biased nucleotide composition. A combination of scant phylogenetic signal, high levels of noise, and the presence of systematic biases could result in the misplacement of Iguania. We regard this explanation to be at least as plausible as the complex scenario of convergence and reversals required for morphological data to be misleading. We further evaluate and discuss the utility of morphological data to resolve ancient radiations, as well as its impact in combined-evidence phylogenomic analyses, with results relevant for the assessment of evidence and conflict across the Tree of Life.	[Koch, Nicolas Mongiardino; Gauthier, Jacques A.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Gauthier, Jacques A.] Yale Peabody Museum Nat Hist, New Haven, CT USA	Yale University; Yale University	Koch, NM (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	nicolas.mongiardinokoch@yale.edu		Mongiardino Koch, Nicolas/0000-0001-6317-5869	Yale Peabody Museum of Natural History	Yale Peabody Museum of Natural History	JAG gratefully acknowledges partial financial support from the Yale Peabody Museum of Natural History. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0811; Arcila D, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0020; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Bhullar B. -A. S., 2011, Bulletin of the Museum of Comparative Zoology, V160, P65; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Brown JM, 2017, SYST BIOL, V66, P517, DOI 10.1093/sysbio/syw101; Burleigh JG, 2013, PLOS CURR, V5; Caldwell MW, 1999, ZOOL J LINN SOC-LOND, V125, P115; Camargo A, 2010, MOL ECOL, V19, P3250, DOI 10.1111/j.1365-294X.2010.04722.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen MY, 2015, SYST BIOL, V64, P1104, DOI 10.1093/sysbio/syv059; Cocude-Michel M., 1963, RHYNCHOCEPHALES SAUR; Conrad JL., 2009, B AM MUS NAT HIST, V310, P1; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cummins CA, 2011, SYST BIOL, V60, P833, DOI 10.1093/sysbio/syr064; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; DEQUEIROZ A, 1995, ANNU REV ECOL SYST, V26, P657, DOI 10.1146/annurev.es.26.110195.003301; Donoghue M. J., 1992, MOL SYSTEMATICS PLAN, P340, DOI DOI 10.1007/978-1-4615-3276-715; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; Dornburg A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0837-3; Eckstut M.E. D.M., 2009, ANIMAL REPROD NEW RE, P1; Estes R., 1988, P119; Evans S.E., 2015, PALAEONTOL ELECTRON, V18, P1, DOI DOI 10.26879/519; Evans SE, 2010, NEW ASPECTS MESOZOIC, P27, DOI [DOI 10.1007/978-3-642-10311-7_2, DOI 10.1007/978-3-642-10311-7]; Evans Susan E., 2009, Palaeontologia Polonica, P179; Eyun SI, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0883-5; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Faircloth B.C., 2012, ARXIV12021215; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Fernandez R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18562-w; Fishbein M, 2001, SYST BIOL, V50, P817, DOI 10.1080/106351501753462821; Forstner MRJ, 1995, MOL PHYLOGENET EVOL, V4, P93, DOI 10.1006/mpev.1995.1010; Fox S.F., 2003, LIZARD SOCIAL BEHAV; Friedrich F, 2014, ENTOMOL SCI, V17, P1, DOI 10.1111/ens.12053; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; Gauthier J., 1988, P15; Gauthier J.A., 1988, Systematics Association Special Volume Series, P103; Gauthier JA, 1982, ROCKY MT GEOL, V21, P7; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gee H, 2003, NATURE, V425, P782, DOI 10.1038/425782a; Gilbert PS, 2015, MOL PHYLOGENET EVOL, V92, P140, DOI 10.1016/j.ympev.2015.05.027; Giribet G, 2007, EVOL BIOINFORM, V3, P341; Giribet G, 2015, ZOOL ANZ, V256, P96, DOI 10.1016/j.jcz.2015.01.003; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2002, METH TOOLS BIOSCI ME, P70; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Goremykin VV, 2010, J MOL EVOL, V71, P319, DOI 10.1007/s00239-010-9398-z; Griffith OW, 2015, J EXP ZOOL PART B, V324, P493, DOI 10.1002/jez.b.22614; Grunewald S, 2013, IEEE ACM T COMPUT BI, V10, P151, DOI 10.1109/TCBB.2013.8; Hargreaves AD, 2014, TOXICON, V92, P140, DOI 10.1016/j.toxicon.2014.10.004; Hay JM, 2010, CONSERV GENET, V11, P1063, DOI 10.1007/s10592-009-9952-7; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedges S. Blair, 2009, P383; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hillis DM, 2005, SYST BIOL, V54, P471, DOI 10.1080/10635150590946961; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Hsiou AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137523; Huang W, 2016, MOL BIOL EVOL, V33, P3314, DOI 10.1093/molbev/msw196; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Irisarri I, 2017, NAT ECOL EVOL, V1, P1370, DOI 10.1038/s41559-017-0240-5; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Jones MEH, 2009, P ROY SOC B-BIOL SCI, V276, P1385, DOI 10.1098/rspb.2008.1785; Katz LA, 2015, SYST BIOL, V64, P406, DOI 10.1093/sysbio/syu126; King N, 2017, CURR BIOL, V27, pR1081, DOI 10.1016/j.cub.2017.08.054; Kjer KM, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0363; Klopfstein S, 2017, SYST BIOL, V66, P769, DOI 10.1093/sysbio/syx051; Klopfstein S, 2015, SYST BIOL, V64, P1089, DOI 10.1093/sysbio/syv052; KLUGE AG, 1993, CLADISTICS, V9, P183, DOI 10.1111/j.1096-0031.1993.tb00217.x; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kocot KM, 2017, SYST BIOL, V66, P256, DOI 10.1093/sysbio/syw079; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kuck P, 2014, MOL PHYLOGENET EVOL, V70, P94, DOI 10.1016/j.ympev.2013.09.011; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; Kumazawa Y, 2007, GENE, V388, P19, DOI 10.1016/j.gene.2006.09.026; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lecointre G, 2005, ZOOL SCR, V34, P101, DOI 10.1111/j.1463-6409.2005.00168.x; Lee MSY, 2015, CURR BIOL, V25, pR922, DOI 10.1016/j.cub.2015.07.009; Lee MSY, 2005, ORG DIVERS EVOL, V5, P25, DOI 10.1016/j.ode.2004.05.003; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Liu Y, 2014, SYST BIOL, V63, P862, DOI 10.1093/sysbio/syu049; Longrich NR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3034; Longrich NR, 2012, P NATL ACAD SCI USA, V109, P21396, DOI 10.1073/pnas.1211526110; Longrich NR, 2012, NATURE, V488, P205, DOI 10.1038/nature11227; Losos JB, 2012, SCIENCE, V338, P1428, DOI 10.1126/science.1232455; Macey JR, 1997, MOL PHYLOGENET EVOL, V7, P272, DOI 10.1006/mpev.1997.0379; Mahler DL, 2013, SCIENCE, V341, P292, DOI 10.1126/science.1232392; McCartney J, 1802, LECT COMP ANATOMY; McMahan CD, 2015, COPEIA, V103, P525, DOI 10.1643/CH-14-015; Meloro C, 2012, J EVOLUTION BIOL, V25, P2194, DOI 10.1111/j.1420-9101.2012.02595.x; Mendes FK, 2018, SYST BIOL, V67, P158, DOI 10.1093/sysbio/syx063; Miller M. A., 2010, GAT COMP ENV WORKSH, V2010; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Mulcahy DG, 2012, MOL PHYLOGENET EVOL, V65, P974, DOI 10.1016/j.ympev.2012.08.018; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; Nixon KC, 1996, CLADISTICS, V12, P221, DOI 10.1111/j.1096-0031.1996.tb00010.x; Pagel M, 2013, BAYESTRAITS V 2 0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-91; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1_6; Pritchard AC, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170499; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Puttick MN, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2290; Pyron RA, 2017, SYST BIOL, V66, P38, DOI 10.1093/sysbio/syw068; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rage JC, 2013, PALAEOBIO PALAEOENV, V93, P517, DOI 10.1007/s12549-013-0124-x; Rambaut A., 2014, TRACER V1 6; Reddy S, 2017, SYST BIOL, V66, P857, DOI 10.1093/sysbio/syx041; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Regnault S, 2017, J MORPHOL, V278, P62, DOI 10.1002/jmor.20619; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Reyes-Velasco J, 2015, MOL BIOL EVOL, V32, P173, DOI 10.1093/molbev/msu294; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Rieppel O, 2008, ZOOL J LINN SOC-LOND, V152, P131, DOI 10.1111/j.1096-3642.2007.00337.x; Rivera-Rivera CJ, 2018, MOL PHYLOGENET EVOL, V127, P272, DOI 10.1016/j.ympev.2018.06.004; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Ronquist F., 2011, DRAFT MRBAYES VERSIO; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rouse GW, 2016, NATURE, V530, P94, DOI 10.1038/nature16545; Saint KM, 1998, MOL PHYLOGENET EVOL, V10, P259, DOI 10.1006/mpev.1998.0515; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanger TJ, 2012, EVOL DEV, V14, P231, DOI 10.1111/j.1525-142X.2012.00541.x; Schachner ER, 2014, NATURE, V506, P367, DOI 10.1038/nature12871; SCHWENK K, 1993, BRAIN BEHAV EVOLUT, V41, P124, DOI 10.1159/000113830; Schwenk K, 1988, PHYLOGENETIC RELATIO, V569, P598; Scornavacca C, 2017, SYST BIOL, V66, P112, DOI 10.1093/sysbio/syw082; Sharma PP, 2014, MOL BIOL EVOL; Shen XX, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0126; Shen XX, 2016, G3-GENES GENOM GENET, V6, P3927, DOI 10.1534/g3.116.034744; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simion P, 2017, CURR BIOL, V27, P958, DOI 10.1016/j.cub.2017.02.031; Simmons MP, 2017, CLADISTICS, V33, P488, DOI 10.1111/cla.12177; Simmons MP, 2016, MOL PHYLOGENET EVOL, V100, P424, DOI 10.1016/j.ympev.2016.04.022; Simoes TR, 2018, NATURE, V557, P706, DOI 10.1038/s41586-018-0093-3; Sites JW, 2011, ANNU REV ECOL EVOL S, V42, P227, DOI 10.1146/annurev-ecolsys-102710-145051; Skawinski T, 2017, PEERJ, V5, DOI 10.7717/peerj.3262; SOH WK, 2017, NAT PLANTS, V3; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Streicher JW, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0393; Su Z, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00011; Su Z, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0364-7; Suh A, 2016, ZOOL SCR, V45, P50, DOI 10.1111/zsc.12213; Swafford D, 2002, PAUP VERSION 4 0 PHY; Sweet S.S., 2016, CHASING FLAMINGOS TO; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tanner L.H., 2018, LATE TRIASSIC WORLD, P59, DOI [10.1007/978-3-319-68009-5_3, DOI 10.1007/978-3-319-68009-5_3]; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P., REPTILE DATABASE; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2004, P ROY SOC B-BIOL SCI, V271, pS226, DOI 10.1098/rsbl.2003.0151; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Vitt LJ, 2014, LIZARD ECOLOGY HIST; Warren DL, 2017, MOL BIOL EVOL, V34, P1016, DOI 10.1093/molbev/msw279; Wheeler QD, 2008, SYST ENTOMOL, V33, P2, DOI 10.1111/j.1365-3113.2007.00411.x; Whelan NV, 2017, NAT ECOL EVOL, V1, P1737, DOI 10.1038/s41559-017-0331-3; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wiens JJ, 2012, BIOL LETT; Wiens JJ, 2014, REPROD BIOL PHYLOGEN, P27; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wilcox TP, 2004, MOL PHYLOGENET EVOL, V31, P1101, DOI 10.1016/j.ympev.2003.11.006; Wilgenbusch JC, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1479-1; Wilkinson M, 1998, SYST BIOL, V47, P673, DOI 10.1080/106351598260662; Wright AM, 2015, J EXP ZOOL PART B, V324, P504, DOI 10.1002/jez.b.22642; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009; Zhong BJ, 2011, GENOME BIOL EVOL, V3, P1340, DOI 10.1093/gbe/evr105; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	205	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202729	10.1371/journal.pone.0202729	http://dx.doi.org/10.1371/journal.pone.0202729			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133514	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400095
J	Maas, KJ; Avanesov, M; Laqmani, A; Weinrich, J; Sauer, M; Kaul, MG; Adam, G; Regier, M; Behzadi, C				Maas, Kai-Jonathan; Avanesov, Maxim; Laqmani, Azien; Weinrich, Julius; Sauer, Markus; Kaul, Michael G.; Adam, Gerhard; Regier, Marc; Behzadi, Cyrus			Inter-and Intraobserver reproducibility of T2 relaxation times of the discus interpubicus: A feasibility study at 3 Tesla	PLOS ONE			English	Article							PROFESSIONAL FOOTBALL PLAYERS; KNEE OSTEOARTHRITIS; ARTICULAR-CARTILAGE; HEALTHY-VOLUNTEERS; GROIN INJURIES; OSTEITIS PUBIS; MRI; JOINT; DEGENERATION; DIAGNOSIS	Objective To quantify standard values of the discus interpubicus in healthy subjects and to determine reliability and repeatability using T2 relaxation time measurements at 3T. Methods 20 asymptomatic participants (10 male, 10 female; mean age: 27.3 years +/- 4.1, BMI: 22.2 +/- 1.8) underwent a 3T Magnetic Resonance Imaging (MRI) of the pelvic region in a supine position. We included sagittal and para-axial T2w sequences centred over the pubic symphysis in order to identify the complete discus interpubicus. For quantitative analysis, a multi-echo Turbo Spin Echo (TSE) sequence (including 12 echo times between 6.4 and 76.8 ms) was acquired and analysed by using an in-house developed quantification plugin tool (qMapIt) extending ImageJ. Two readers in consensus defined three central slices of the pubic symphysis with the greatest length. For each slice, both readers separately placed three regions-of-interest (ROI) covering the whole discus interpubicus. Both readers repeated the ROI placements in identical fashion after a four-week interval on the original MRI images. Statistical analysis included intraclass correlation coefficient (ICC), nonparametric Wilcoxon test, Fisher exact test and mean relaxation time in ms and 95% confidence intervals. Results T2 relaxation time analysis was performed for all 20 participants. In total, a mean relaxation time of all analysed segments for both observers was 48.6 (+/- 6.3 ms), with a mean relaxation time for observer 1 of 48.7 (+/- 6.0 ms) and for observer 2 of 48.5 ms (+/- 6.6ms). The calculated ICC comparing inter-and intrarater reproducibility was excellent in all segments (similar to 0.75). Conclusion T2 mapping of the discus interpubicus demonstrates good inter-and intrarater repeatability as well as reliability. Mean relaxation times were calculated with 48.6ms in healthy volunteers.	[Maas, Kai-Jonathan; Avanesov, Maxim; Laqmani, Azien; Weinrich, Julius; Sauer, Markus; Kaul, Michael G.; Adam, Gerhard; Regier, Marc; Behzadi, Cyrus] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Behzadi, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.	C.Behzadi@uke.de	Regier, Marc/W-5427-2019; Regier, Marc/G-8781-2018	Weinrich, Julius/0000-0002-5119-6563				Balamoody S, 2013, SKELETAL RADIOL, V42, P511, DOI 10.1007/s00256-012-1511-5; Baum T, 2013, OSTEOARTHR CARTILAGE, V21, P1474, DOI 10.1016/j.joca.2013.07.012; Behzadi C, 2018, J MAGN RESON IMAGING, V47, P372, DOI 10.1002/jmri.25757; Bittersohl B, 2012, OSTEOARTHR CARTILAGE, V20, P653, DOI 10.1016/j.joca.2012.03.011; Cha JG, 2015, RADIOLOGY, V276, P199, DOI 10.1148/radiol.15142021; Do Cha S, 2012, CLIN ORTHOP SURG, V4, P293, DOI 10.4055/cios.2012.4.4.293; Dunn TC, 2004, RADIOLOGY, V232, P592, DOI 10.1148/radiol.2322030976; Ekstrand J, 1999, SCAND J MED SCI SPOR, V9, P98; EVERITT BS, 1981, BIOMETRICS, V37, P867, DOI 10.2307/2530193; GAMBLE JG, 1986, CLIN ORTHOP RELAT R, P261; Gaudino F, 2017, EUR J RADIOL, V94, P46, DOI 10.1016/j.ejrad.2017.07.009; Gheno R, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20151002; Guermazi A, 2015, OSTEOARTHR CARTILAGE, V23, P1639, DOI 10.1016/j.joca.2015.05.026; Lefebvre G, 2017, AM J ROENTGENOL, V209, P389, DOI 10.2214/AJR.16.17244; Lo SSM, 2011, CLIN IMAG, V35, P465, DOI 10.1016/j.clinimag.2010.10.011; Lockard CA, 2017, SKELETAL RADIOL, V9, P107; Menezes-Reis R, 2016, QUANT IMAGING MED SU, V6, P402, DOI 10.21037/qims.2016.08.01; Morelli V, 2005, PRIMARY CARE, V32, P163, DOI 10.1016/j.pop.2004.11.011; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Newbould RD, 2012, J MAGN RESON IMAGING, V35, P1422, DOI 10.1002/jmri.23598; O' Connell MJ, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1790955; Omar IM, 2008, RADIOGRAPHICS, V28, P1415, DOI 10.1148/rg.285075217; Rauscher I, 2014, MAGN RESON IMAGING, V32, P1085, DOI 10.1016/j.mri.2014.05.010; Rehnitz C, 2017, J MAGN RESON IMAGING, V45, P381, DOI 10.1002/jmri.25371; Tao HY, 2018, J MAGN RESON IMAGING, V47, P69, DOI 10.1002/jmri.25745; Wang YXJ, 2015, QUANT IMAG MED SURG, V5, P858, DOI 10.3978/j.issn.2223-4292.2015.12.06; Willmott AGB, 2017, J SPORT SCI, V35, P2249, DOI 10.1080/02640414.2016.1265142; Wyatt C, 2015, ARTHRITIS RHEUMATOL, V67, P1548, DOI 10.1002/art.39074	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202698	10.1371/journal.pone.0202698	http://dx.doi.org/10.1371/journal.pone.0202698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133521	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400093
J	Yang, DX; Xiao, P; Li, Q; Fu, XL; Pan, C; Lu, D; Wen, SS; Xia, WY; He, DF; Li, H; Fang, H; Shen, YM; Xu, ZG; Lin, A; Wang, C; Yu, X; Wu, JW; Sun, JP				Yang, Duxiao; Xiao, Peng; Li, Qing; Fu, Xiaolei; Pan, Chang; Lu, Di; Wen, Shishuai; Xia, Wanying; He, Dongfang; Li, Hui; Fang, Hao; Shen, Yuemao; Xu, Zhigang; Lin, Amy; Wang, Chuan; Yu, Xiao; Wu, Jiawei; Sun, Jinpeng			Allosteric modulation of the catalytic VYD loop in Slingshot by its N-terminal domain underlies both Slingshot auto-inhibition and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; allosteric regulation; amino acid; biosensor; phosphatase; phosphorylation; serine; threonine protein kinase; cytoskeleton; assay development; auto-inhibition; bioluminescence resonance energy transfer; fluorescein arsenical hairpin binder; Slingshot; actin activation; fluorescein arsenical hairpin binder	DEPENDENT CONFORMATIONAL-CHANGES; TYROSINE-PHOSPHATASE SHP-2; PROTEIN-KINASE D1; PRE-STEADY-STATE; CRYSTAL-STRUCTURE; LIM KINASE; CELL-MIGRATION; COFILIN; RECEPTOR; GROWTH	Slingshots are phosphatases that modulate cytoskeleton dynamics, and their activities are tightly regulated in different physiological contexts. Recently, abnormally elevated Slingshot activity has been implicated in many human diseases, such as cancer, Alzheimer's disease, and vascular diseases. Therefore, Slingshot-specific inhibitors have therapeutic potential. However, an enzymological understanding of the catalytic mechanism of Slingshots and of their activation by actin is lacking. Here, we report that the N-terminal region of human Slingshot2 auto-inhibits its phosphatase activity in a noncompetitive manner. pH-dependent phosphatase assays and leaving-group dependence studies suggested that the N-terminal domain of Slingshot2 regulates the stability of the leaving group of the product during catalysis by modulating the general acid Asp(361) in the catalytic VYD loop. F-actin binding relieved this auto-inhibition and restored the function of the general acid. Limited tryptic digestion and biophysical studies identified large conformational changes in Slingshot2 after the F-actin binding. The dissociation of N-terminal structural elements, including Leu(63), and the exposure of the loop between -helix-2 and -sheet-3 of the phosphatase domain served as the structural basis for Slingshot activation via F-actin binding in vitro and via neuregulin stimulation in cells. Moreover, we designed a FlAsH-BRET-based Slingshot2 biosensor whose readout was highly correlated with the in vivo phosphatase activities of Slingshot2. Our results reveal the auto-inhibitory mechanism and allosteric activation mechanisms of a human Slingshot phosphatase. They also contribute to the design of new strategies to study Slingshot regulation in various cellular contexts and to screen for new activators/inhibitors of Slingshot activity.	[Yang, Duxiao; Xiao, Peng; Fu, Xiaolei; Pan, Chang; Lu, Di; Xia, Wanying; He, Dongfang; Sun, Jinpeng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Li, Qing; Li, Hui; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, Jinan 250012, Shandong, Peoples R China; [Xiao, Peng; Wen, Shishuai; Fang, Hao; Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China; [Xu, Zhigang] Shandong Univ, Sch Life Sci, Jinan 250003, Shandong, Peoples R China; [Lin, Amy] Duke Univ, Sch Med, Durham, NC 27705 USA; [Wu, Jiawei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Wang, Chuan] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China; [Sun, Jinpeng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Sun, Jinpeng] Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Duke University; Tsinghua University; Hebei Medical University; Peking University; Peking University	Wu, JW (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn; sunjinpeng@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020		National Natural Science Foundation of China [31470789, 31611540337, 81773704, 31471102, 31671197, 31700692]; Shandong Natural Science Fund for Distinguished Young Scholars Grant [JQ201517]; Shandong Natural Science Fund Grant [ZR2016CQ07]; Key Research and Development Program of Shandong Province Grant [2018GSF118147]; Fundamental Research Fund of Shandong University [2016JC017]; China Postdoctoral Science Foundation [2015M582082]; Program for Changjiang Scholars and Innovative Research Team in University Grant [IRT_17R68]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Fund for Distinguished Young Scholars Grant; Shandong Natural Science Fund Grant; Key Research and Development Program of Shandong Province Grant; Fundamental Research Fund of Shandong University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work is supported by National Natural Science Foundation of China Grants 31470789, 31611540337, and 81773704 (to J.-P. S.), 31471102 and 31671197 (to X. Y.), and 31700692 (to P. X.); Shandong Natural Science Fund for Distinguished Young Scholars Grant JQ201517 (to J.-P. S.), Shandong Natural Science Fund Grant ZR2016CQ07 (to P. X.); Key Research and Development Program of Shandong Province Grant 2018GSF118147 (to P. X.); Fundamental Research Fund of Shandong University Grant 2016JC017 (to J.-P. S.); China Postdoctoral Science Foundation Grant 2015M582082 (to P. X.); and the Program for Changjiang Scholars and Innovative Research Team in University Grant IRT_17R68 (to X. Y. and J.-P. S). The authors declare that they have no conflicts of interest with the contents of this article.	Almer H, 1996, J AM CHEM SOC, V118, P7921, DOI 10.1021/ja953399d; Anyatonwu G, 2010, J BIOL CHEM, V285, P25085, DOI 10.1074/jbc.M110.123208; Bielig H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004351; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Dai SP, 2004, CELL MICROBIOL, V6, P459, DOI 10.1111/j.1462-5822.2004.00375.x; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; Doppler H, 2013, J BIOL CHEM, V288, P455, DOI 10.1074/jbc.M112.397448; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Endo M, 2003, J NEUROSCI, V23, P2527; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Jung SK, 2007, PROTEINS, V68, P408, DOI 10.1002/prot.21399; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lee SY, 2017, PHARMACOL RES, V119, P422, DOI 10.1016/j.phrs.2017.03.003; Li H, 2016, CELL REP, V15, P1345, DOI 10.1016/j.celrep.2016.04.016; Li R, 2013, FEBS J, V280, P2700, DOI 10.1111/febs.12275; Li SJ, 2016, CELL RES, V26, P336, DOI 10.1038/cr.2016.14; Li TY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02401-7; Liu CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14335; Liu X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10879; Lu X, 2014, ONCOGENE, V33, P956, DOI 10.1038/onc.2013.27; Maheswaranathan M, 2011, J BIOL CHEM, V286, P35430, DOI 10.1074/jbc.M111.268284; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pan C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02333; Park H, 2013, J MOL GRAPH MODEL, V39, P65, DOI 10.1016/j.jmgm.2012.10.008; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Selden LA, 2000, BIOCHEMISTRY-US, V39, P64, DOI 10.1021/bi9914964; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Sparrow N, 2012, J NEUROSCI, V32, P5284, DOI 10.1523/JNEUROSCI.6207-11.2012; Takahashi K, 2017, BIOCHEM BIOPH RES CO, V482, P686, DOI 10.1016/j.bbrc.2016.11.095; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Torres RA, 2011, ARTERIOSCL THROM VAS, V31, P2424, DOI 10.1161/ATVBAHA.111.232769; Wang HM, 2014, CELL RES, V24, P1067, DOI 10.1038/cr.2014.99; Wang Q, 2015, ELIFE, V4, DOI 10.7554/eLife.06074; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Woo JA, 2015, CELL DEATH DIFFER, V22, P1069, DOI 10.1038/cdd.2015.41; Wu L, 1996, BIOCHEMISTRY-US, V35, P5426, DOI 10.1021/bi952885a; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao P, 2014, INT J BIOCHEM CELL B, V57, P84, DOI 10.1016/j.biocel.2014.10.004; Xu XH, 2015, MOL BIOL CELL, V26, P874, DOI 10.1091/mbc.E14-05-0982; Yamashiro Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3141; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhang K, 2016, ONCOGENE, V35, P1271, DOI 10.1038/onc.2015.184; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516	59	3	3	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16226	16241		10.1074/jbc.RA118.004175	http://dx.doi.org/10.1074/jbc.RA118.004175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30154244	Green Published, hybrid			2022-12-26	WOS:000447833600011
J	Leung, Y; Dean, RT				Leung, Yvonne; Dean, Roger Thornton			Learning unfamiliar pitch intervals: A novel paradigm for demonstrating the learning of statistical associations between musical pitches	PLOS ONE			English	Article							LEXICAL DECISION TASK; EXPECTANCY; PERCEPTION; SEQUENCES; ENCULTURATION; EXPECTATIONS; CHILDREN; INFANTS; MELODY	While mastering a musical instrument takes years, becoming familiar with a new music system requires less time and skills. In this study, we examine whether musically untrained Western listeners can incidentally learn an unfamiliar, microtonal musical scale from simply engaging in a timbre discrimination task. The experiment is comprised of an Exposure and a Test phase. During Exposure, 21 non-musicians were instructed to detect a timbre shift (TS) within short microtonal melodies, and we hypothesised that they would incidentally learn about the pitch interval structure of the microtonal scale from attending to the melodies during the task. In a follow-up Test phase, the tone before the TS was either a member (congruent) or a non-member (incongruent) of the scale. Based on our statistical manipulation of the stimuli, incongruent tones would be a better predictor of an incoming TS than the congruent tones. We therefore expect a faster response time to the shift after the participants have heard an incongruent tone. Specifically, a faster response time observed after an incongruent tone would imply participants' ability to differentiate tones from the microtonal and the diatonic scale, and reflect their learning of the microtonal pitch intervals. Results are consistent with our predictions. In investigating the learning of a microtonal scale, our study can offer directions for future research on the perception of computer music and new musical genres.	[Leung, Yvonne; Dean, Roger Thornton] Western Sydney Univ, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia	Western Sydney University	Leung, Y (corresponding author), Western Sydney Univ, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia.	yvonne.leung@unsw.edu.au	Leung, Yvonne/M-5086-2017	Leung, Yvonne/0000-0001-9110-7054; Dean, Roger Thornton/0000-0002-8859-8902	MARCS Postgraduate Scholarship; MARCS Institute for Brain, Behaviour and Development, Western Sydney University	MARCS Postgraduate Scholarship; MARCS Institute for Brain, Behaviour and Development, Western Sydney University	This work is funded by the MARCS Postgraduate Scholarship, that was granted to YL for her PhD Candidature. The funder is the MARCS Institute for Brain, Behaviour and Development, Western Sydney University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri V, 2012, MUSIC PERCEPT, V29, P297, DOI 10.1525/MP.2012.29.3.297; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, MUSIC PERCEPT, V5, P1; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; CAREY N, 1989, MUSIC THEOR SPECTRUM, V11, P187, DOI 10.1525/mts.1989.11.2.02a00030; Corrigall KA, 2014, DEVELOPMENTAL SCI, V17, P142, DOI 10.1111/desc.12100; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; CUDDY LL, 1992, PSYCHOL RES-PSYCH FO, V54, P51, DOI 10.1007/BF00937133; Cui AX, 2016, PEERJ, V4, DOI 10.7717/peerj.2399; Dean RT, 2009, LEONARDO, V42, P94, DOI 10.1162/leon.2009.42.1.94; Eerola T, 2009, MUSIC SCI, V13, P231, DOI 10.1177/102986490901300203; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Hannon EE, 2011, DEVELOPMENTAL SCI, V14, P865, DOI 10.1111/j.1467-7687.2011.01036.x; Huron D.B., 2006, SWEET ANTICIPATION M; Kinoshita S, 2003, J EXP PSYCHOL LEARN, V29, P405, DOI 10.1037/0278-7393.29.3.405; Krumhansl CL, 2010, SPRINGER HANDB AUDIT, V36, P51, DOI 10.1007/978-1-4419-6114-3_3; KRUMHANSL CL, 1992, J EXP PSYCHOL HUMAN, V18, P739, DOI 10.1037/0096-1523.18.3.739; Krumhansl CL, 1999, MUSIC PERCEPT, V17, P151; KRUMHANSL CL, 1991, ANNU REV PSYCHOL, V42, P277; KRUMHANSL CL, 1982, MEM COGNITION, V10, P243, DOI 10.3758/BF03197636; Kuhn G, 2005, J EXP PSYCHOL LEARN, V31, P1417, DOI 10.1037/0278-7393.31.6.1417; Kuhn G, 2006, Q J EXP PSYCHOL, V59, P1725, DOI 10.1080/17470210500438361; Leman M, 2000, MUSIC PERCEPT, V17, P481; Leung Y, 2018, J NEW MUSIC RES, V47, P206, DOI 10.1080/09298215.2018.1432060; Loui P, 2010, MUSIC PERCEPT, V27, P377, DOI 10.1525/mp.2010.27.5.377; LYNCH MP, 1992, PERCEPT PSYCHOPHYS, V52, P599, DOI 10.3758/BF03211696; Marmel F, 2010, J EXP PSYCHOL HUMAN, V36, P1016, DOI 10.1037/a0018735; Milne Andrew J., 2011, Mathematics and Computation in Music. Proceedings of the Third International Conference, MCM 2011, P180, DOI 10.1007/978-3-642-21590-2_14; Mullensiefen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101091; NARMOUR E, 1990, ANAL COGNITION BASIC; NEELY JH, 1989, J EXP PSYCHOL LEARN, V15, P1003, DOI 10.1037/0278-7393.15.6.1003; Ollen J. E., 2006, THESIS; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Posner M., 1975, INFORM PROCESSING CO; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Rohrmeier M., 2012, INT C MUSIC PERCEPTI, P857, DOI [10.1111/cogs.12404, DOI 10.1111/COGS.12404]; Rohrmeier M, 2011, CONSCIOUS COGN, V20, P214, DOI 10.1016/j.concog.2010.07.004; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Schellenberg EG, 2002, J EXP PSYCHOL GEN, V131, P511, DOI 10.1037//0096-3445.131.4.511; Thompson WF, 2015, MUSIC THOUGHT FEELIN; Tillmann B, 2006, EUR J COGN PSYCHOL, V18, P343, DOI 10.1080/09541440500269548; Tillmann B, 2004, J EXP PSYCHOL LEARN, V30, P1131, DOI 10.1037/0278-7393.30.5.1131; Tillmann B, 2006, PSYCHOL RES-PSYCH FO, V70, P345, DOI 10.1007/s00426-005-0222-0; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Topolinski S, 2010, CURR DIR PSYCHOL SCI, V19, P402, DOI 10.1177/0963721410388803; Trainor LJ, 2012, SPRINGER HANDB AUDIT, V42, P223, DOI 10.1007/978-1-4614-1421-6_8; Unyk AM, 1987, PSYCHOMUSICOLOGY, V7, P3, DOI [DOI 10.1037/H0094189, 10.1037/h0094189]; Wentura D, 2000, J EXP PSYCHOL LEARN, V26, P456, DOI 10.1037/0278-7393.26.2.456	51	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203026	10.1371/journal.pone.0203026	http://dx.doi.org/10.1371/journal.pone.0203026			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161174	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900070
J	Akombi, BJ; Ghimire, PR; Agho, KE; Renzaho, AM				Akombi, Blessing Jaka; Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore; Renzaho, Andre Masumbuko			Stillbirth in the African Great Lakes region: A pooled analysis of Demographic and Health Surveys	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MATERNAL SMOKING; PREGNANCY; DETERMINANTS; SURVIVAL; INDIA; COST; RISK; CARE	Background The aim of this study was to estimate the rate and predisposing factors associated with stillbirth in the African Great Lakes region (Burundi, Congo Democratic Republic, Kenya, Rwanda, Tanzania and Uganda). Methods and findings Cross-sectional data from the most recent Demographic and Health Surveys (DHS) of countries in the African Great Lakes region were used in this study. DHS from Congo Democratic Republic was not included in the analyses because data was not collected for stillbirth in the country survey. A pooled sample of 57046 pregnancies of 7+ months' duration and 1002 stillbirths were included in the final analysis. The analyses were restricted to stillbirths reported in the 5 years preceding the surveys. Stillbirth was defined as foetal death in the third trimester (>= 28 weeks' gestation). Multilevel logistic regression analyses that adjusted for cluster and survey weights were used to determine the factors associated with stillbirth in the Africa Great Lakes region. Health service variables and maternal medical condition variables were not included in the analysis because DHS do not collect data on these variables for pregnancies that did not result in a live birth. Burundi had the highest stillbirth rate per 1000 births [23% (95% CI: 20, 25)] within the region. Factors associated with stillbirth across the region were: no schooling [1.85 (95% Cl: 1.44, 2.38)] and primary education [1.64 (1.32, 2.05)], advanced maternal age [2.39 (95% CI: 1.59, 3.59)], smoking [1.99 (95% CI: 1.19, 3.32)] and drinking water from unimproved sources [1.18 (95% CI: 1.01, 1.37)]. Conclusion To achieve Every Newborn Action Plan (ENAP) stillbirth target of 12 per 1000 births or less by 2030, policy interventions to prevent stillbirth should focus on promoting community-based socio-educational programmes which encourages a healthy lifestyle especially among uneducated women in the advanced age spectrum.	[Akombi, Blessing Jaka; Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre Masumbuko] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia	Western Sydney University; Western Sydney University	Akombi, BJ (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	B.Akombi@westernsydney.edu.au	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020; Akombi-Inyang, Blessing/AAT-6507-2020; Renzaho, Andre M.N./AAH-7679-2021	Agho, Kingsley/0000-0003-4111-3207; Akombi-Inyang, Blessing/0000-0002-6410-4154; Ghimire, Pramesh/0000-0002-7902-7294; RENZAHO, ANDRE/0000-0002-6844-0833; Ghimire, Pramesh Raj/0000-0003-2816-0463				Abir T, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1410048; Afulani PA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0925-9; Badimsuguru AB, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6168; Bernis L, 2016, LANCET, V387, P703, DOI [10.1016/S0140-6736(15)00954-X, DOI 10.1016/S0140-6736(15)00954-X]; Bhutta ZA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002364; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Bjornholt SM, 2016, ACTA OBSTET GYN SCAN, V95, P1305, DOI 10.1111/aogs.13011; BRADLEY S. E. K., 2015, DHS METHODOLOGICAL R, V17; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chahande M. S., 2002, INDIAN J COMMUNITY M, V27, P106; Chakraborty N, 2003, HLTH PROMOTION INT, V18; Christou A, 2017, TROP MED INT HEALTH, V22, P294, DOI 10.1111/tmi.12828; Di Mario S, 2007, SEX TRANSM DIS, V34, pS11, DOI 10.1097/01.olq.0000258130.07476.e3; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Froen JF, 2016, LANCET, V387, P574, DOI 10.1016/S0140-6736(15)00818-1; Ghimire PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181332; Ghosh Banerjee S, TRACKING ACCESS NONS; Giri A, 2012, NEPAL MED COLL J NMC, V15, P87; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; Grossman D.S., 2017, W VIRGINIA U COLL BU, P17; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lean SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186287; Marufu TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1552-5; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) Ministry of Health (MoH) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2016, TANZ DEM HLTH SURV M; Ministry to the Presidency in charge of Good Governance and Planning [Burundi] (MPBGP) Ministry of Health Public Health and the Fight against AIDS [Burundi] (MSPLS) Institute of Statistics and Economic Studies of Burundi (ISTEEBU) and ICF, 2017, 3 DEM HLTH SURV; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Mukhopadhyay P, 2010, J HEALTH POPUL NUTR, V28, P494; National Institute of Statistics of Rwanda (NISR) [Rwanda]; Ministry of Health (MOH) [Rwanda]; and ICF International, 2015, RWAND DEM HLTH SURV; Olusanya BO, 2009, ACTA OBSTET GYN SCAN, V88, P1243, DOI 10.3109/00016340903287474; Onadeko M O, 1996, Afr J Med Med Sci, V25, P81; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Philips M, 2004, BRIT J GEN PRACT, V54, P634; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Sharma A K, 2001, Indian Pediatr, V38, P1405; Stringer EM, 2011, OBSTET GYNECOL, V117, P1151, DOI 10.1097/AOG.0b013e3182167627; Tshibumbu DD, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.1054; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; United Nations, 2016, GREAT LAK REG STRAT; USAID, GLOBAL HLTH; Varner MW, 2014, OBSTET GYNECOL, V123, P113, DOI 10.1097/AOG.0000000000000052; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; World Health Organization, 2015, MAT NEWB CHILD AD HL; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202603	10.1371/journal.pone.0202603	http://dx.doi.org/10.1371/journal.pone.0202603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157230	Green Submitted, gold, Green Published			2022-12-26	WOS:000443071400065
J	Lutz, ND; Lemes, E; Krubitzer, L; Collin, SP; Haverkamp, S; Peichl, L				Lutz, Nicolas D.; Lemes, Emina; Krubitzer, Leah; Collin, Shaun P.; Haverkamp, Silke; Peichl, Leo			The rod signaling pathway in marsupial retinae	PLOS ONE			English	Article							AII-AMACRINE CELLS; MACAQUE MONKEY RETINA; BIPOLAR CELLS; RABBIT RETINA; MAMMALIAN RETINA; MOUSE RETINA; IMMUNOCYTOCHEMICAL ANALYSIS; PHOTORECEPTOR TYPES; AMERICAN OPOSSUM; MACROPUS-EUGENII	The retinal rod pathway, featuring dedicated rod bipolar cells (RBCs) and AII amacrine cells, has been intensely studied in placental mammals. Here, we analyzed the rod pathway in a nocturnal marsupial, the South American opossum Monodelphis domestica to elucidate whether marsupials have a similar rod pathway. The retina was dominated by rods with densities of 338,000-413,000/mm. Immunohistochemistry for the RBC-specific marker protein kinase C alpha (PKC alpha) and the AII cell marker calretinin revealed the presence of both cell types with their typical morphology. This is the first demonstration of RBCs in a marsupial and of the integration of RBCs and AII cells in the rod signaling pathway. Electron microscopy showed invaginating synaptic contacts of the PKC alpha-immunoreactive bipolar cells with rods; light microscopic co-immunolabeling for the synaptic ribbon marker CtBP2 confirmed dominant rod contacts. The RBC axon terminals were mostly located in the innermost stratum S5 of the inner plexiform layer (IPL), but had additional side branches and synaptic varicosities in strata S3 and S4, with S3-S5 belonging to the presumed functional ON sublayer of the IPL, as shown by immunolabeling for the ON bipolar cell marker G.13. Triple-immunolabeling for PKC alpha, calretinin and CtBP2 demonstrated RBC synapses onto AII cells. These features conform to the pattern seen in placental mammals, indicating a basically similar rod pathway in M. domestica. The density range of RBCs was 9,900-16,600/mm(2), that of AII cells was 1,500-3,260/mm(2). The numerical convergence (density ratio) of 146-156 rods to 4.7-6.0 RBCs to 1 AII cell is within the broad range found among placental mammals. For comparison, we collected data for the Australian nocturnal dunnart Sminthopsis crassicaudata, and found it to be similar to M. domestica, with rod-contacting PKCa-immunoreactive bipolar cells that had axon terminals also stratifying in IPL strata S3-S5.	[Lutz, Nicolas D.; Haverkamp, Silke; Peichl, Leo] Max Planck Inst Brain Res, Frankfurt, Germany; [Lutz, Nicolas D.] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Lutz, Nicolas D.] Univ Tubingen, IMPRS Cognit & Syst Neurosci, Grad Training Ctr Neurosci, Tubingen, Germany; [Lemes, Emina; Haverkamp, Silke; Peichl, Leo] Goethe Univ Frankfurt, Dr Senckenbergische Anat, Inst Cellular & Mol Anat, Frankfurt, Germany; [Krubitzer, Leah] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Collin, Shaun P.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Collin, Shaun P.] Univ Western Australia, Oceans Grad Sch, Crawley, WA, Australia; [Haverkamp, Silke] Ctr Adv European Studies & Res, Dept Computat Neuroethol, Bonn, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Goethe University Frankfurt; University of California System; University of California Davis; University of Western Australia; University of Western Australia; Center of Advanced European Studies & Research (CAESAR)	Peichl, L (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.; Peichl, L (corresponding author), Goethe Univ Frankfurt, Dr Senckenbergische Anat, Inst Cellular & Mol Anat, Frankfurt, Germany.	peichl.retina@gmail.com		Lutz, Nicolas D./0000-0002-8451-2630; Lemes, Emina/0000-0002-4342-0940; Peichl, Leo/0000-0002-8141-0911	NATIONAL EYE INSTITUTE [R01EY022987] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY022987] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHNELT PK, 1995, VISUAL NEUROSCI, V12, P793, DOI 10.1017/S0952523800009366; AMMERMULLER J, 1995, J COMP NEUROL, V358, P1, DOI 10.1002/cne.903580102; Arrese CA, 2006, CURR BIOL, V16, pR193, DOI 10.1016/j.cub.2006.02.036; Arrese CA, 2003, VISUAL NEUROSCI, V20, P307, DOI 10.1017/S0952523803203096; Behrens C, 2016, ELIFE, V5, DOI 10.7554/eLife.20041; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Deeb SS, 2010, MARSUPIAL GENETICS AND GENOMICS, P403, DOI 10.1007/978-90-481-9023-2_19; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Ebeling W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086531; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; GRUNERT U, 1991, J NEUROSCI, V11, P2742; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Hunt DM, 2009, GENE, V433, P50, DOI 10.1016/j.gene.2008.12.006; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jeon YK, 2007, NEUROREPORT, V18, P1095, DOI 10.1097/WNR.0b013e3281e72afe; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; KOLB H, 1985, VISION RES, V25, P1207, DOI 10.1016/0042-6989(85)90035-5; Kuhrt H, 2017, BRAIN BEHAV EVOLUT, V89, P84, DOI 10.1159/000464097; Li YN, 2012, J COMP NEUROL, V520, P3786, DOI 10.1002/cne.23168; Massey SC, 1999, J COMP NEUROL, V411, P3; MILLS SL, 1991, J COMP NEUROL, V304, P491, DOI 10.1002/cne.903040312; Mills SL, 1999, J COMP NEUROL, V411, P19; Muller B, 2013, J NEUROSCI, V33, P1014, DOI 10.1523/JNEUROSCI.2072-12.2013; Muller LPD, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00039; Neumann S, 2013, J COMP NEUROL, V521, P709, DOI 10.1002/cne.23201; Palacios AG, 2010, J COMP NEUROL, V518, P1589, DOI 10.1002/cne.22292; Pang JJ, 2018, J COMP NEUROL, V526, P1896, DOI 10.1002/cne.24456; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Peichl L, 2000, VISUAL NEUROSCI, V17, P937, DOI 10.1017/S0952523800176138; Sakaguchi DS, 2008, BRAIN RES, V1195, P28, DOI 10.1016/j.brainres.2007.12.018; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; STERLING P, 1988, J NEUROSCI, V8, P623; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; VandeBerg John L., 1997, ILAR J, V38, P4; VANEY DI, 1991, J COMP NEUROL, V310, P154, DOI 10.1002/cne.903100203; VANEY DI, 1985, PROC R SOC SER B-BIO, V224, P475, DOI 10.1098/rspb.1985.0045; Vlahos LM, 2014, J COMP NEUROL, V522, P3423, DOI 10.1002/cne.23610; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; WASSLE H, 1993, J COMP NEUROL, V332, P407; WONG ROL, 1986, EXP BRAIN RES, V63, P102; YOUNG HM, 1991, J COMP NEUROL, V310, P139, DOI 10.1002/cne.903100202; YOUNG HM, 1990, VISUAL NEUROSCI, V5, P61, DOI 10.1017/S0952523800000079; 정세진, 2014, [Journal of Korean Ophthalmic Optics Society, 한국안광학회지], V19, P271	57	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202089	10.1371/journal.pone.0202089	http://dx.doi.org/10.1371/journal.pone.0202089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157204	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400033
J	O'Harte, FPM; Parthsarathy, V; Hogg, C; Flatt, PR				O'Harte, Finbarr P. M.; Parthsarathy, Vadivel; Hogg, Christopher; Flatt, Peter R.			Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; BODY-COMPOSITION; ADIPOSE-TISSUE; RECEPTOR; INSULIN; GLUCOSE; OBESITY; APJ; LIRAGLUTIDE	Previous studies have shown that modified apelin analogues exhibited enzyme resistance in plasma and improved circulating half-life compared to apelin-13. This study investigated the antidiabetic effects of chronic administration of stable long acting fatty acid modified apelin analogues, namely, (Lys(8)GluPAL) apelin-13 amide and pGlu(Lys(8)GluPAL) apelin-13 amide, in high-fat fed obese-diabetic mice. Male NIH Swiss mice (groups n = 8) were maintained either on a high-fat diet (45% fat) from 8 to 28 weeks old, or control mice were fed a normal diet (10% fat). When diet induced obesity-diabetes was established after high-fat feeding, mice were injected i.p. once daily with apelin analogues, liraglutide (25 nmol/kg) or saline (controls). Administration of (Lys(8)GluPAL) apelin-13 amide and pGlu(Lys(8)GluPAL) apelin-13 amide for 28 days significantly reduced food intake and decreased body weight. Non-fasting glucose was reduced (p<0.01 to p<0.001) and plasma insulin concentrations increased (p<0.01 to p<0.001). This was accompanied by enhanced insulin responses (p<0.01 to p<0.001) and significant reductions in glucose excursion after oral (p<0.01) or i.p. (p<0.01) glucose challenges and feeding. Apelin analogues also significantly improved HbA1c (p<0.01), enhanced insulin sensitivity (p<0.01), reduced triglycerides (p<0.001), increased HDL-cholesterol (p<0.01) and decreased LDL-cholesterol (p<0.01), compared to high-fat fed saline treated control mice. Cholesterol levels were decreased (p<0.01) by pGlu (Lys(8)GluPAL) apelin-13 amide and both apelin treated groups showed improved bone mineral content, reduced fat deposits and increased plasma GLP-1. Daily treatment with liraglutide mirrored many of these changes (not on bone or adipose tissue), but unlike apelin analogues increased plasma amylase. Consumption of O-2, production of CO2, respiratory exchange ratio and energy expenditure were improved by apelin analogues. These results indicate that long-term treatment with acylated analogues (Lys(8)GluPAL) apelin-13 amide and particularly pGlu(Lys(8)GluPAL) apelin-13 amide resulted in similar or enhanced therapeutic responses to liraglutide in high-fat fed mice. Fatty acid derived apelin analogues represent a new and exciting development in the treatment of obesity-diabetes.	[O'Harte, Finbarr P. M.; Parthsarathy, Vadivel; Hogg, Christopher; Flatt, Peter R.] Ulster Univ, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine, Londonderry, North Ireland; [Parthsarathy, Vadivel] Univ Derby, Coll Life & Nat Sci, Kedleston Rd, Derby, England	Ulster University; University of Derby	O'Harte, FPM (corresponding author), Ulster Univ, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine, Londonderry, North Ireland.	fpm.oharte@ulster.ac.uk		Parthsarathy, Vadivel/0000-0002-2037-7804; O'Harte, Finbarr/0000-0002-7199-4239	Department for the Economy, Northern Ireland; Invest-NI Proof of Concept [PoC518]	Department for the Economy, Northern Ireland; Invest-NI Proof of Concept	The Department for the Economy, Northern Ireland (https://www.nidirect.gov.uk/articles/department-economy-studentships, formerly DEL-NI) provided a PhD studentship to CH and FOH to perform this work. Invest-NI Proof of Concept funding (https://www.investni.com/support-for-business/proof-of-concept.html, PoC518) was secured by FOH and PRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alfarano C, 2015, INT J OBESITY, V39, P312, DOI 10.1038/ijo.2014.122; [Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]; Aring AM, 2005, AM FAM PHYSICIAN, V71, P2123; Bailey CJ, 2015, CLIN PHARMACOL THER, V98, P1532; Balistreri CR, 2010, MEDIAT INFLAMM, V80, P207, DOI [10.3389/fphys.2015.00115, DOI 10.3389/FPHYS.2015.00115]; Bertrand C, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00115; Black BL, 1998, METABOLISM, V47, P1354, DOI 10.1016/S0026-0495(98)90304-3; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Castan-Laurell I, 2008, EUR J ENDOCRINOL, V158, P905, DOI 10.1530/EJE-08-0039; Cho NH, 2018, IDF DIABETES ATLAS G; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Fournel A, 2017, GUT, V66, P258, DOI 10.1136/gutjnl-2015-310230; Gerbier R, 2017, FASEB J, V31, P687, DOI 10.1096/fj.201600784R; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Hasib A, 2017, DIABETOLOGIA, V60, P541, DOI 10.1007/s00125-016-4186-y; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Hu HL, 2016, MOL GENET METAB, V119, P20, DOI 10.1016/j.ymgme.2016.07.012; Iepsen EW, 2015, EXPERT REV CARDIOVAS, V13, P753, DOI 10.1586/14779072.2015.1054810; Irwin N, 2015, WORLD J DIABETES, V6, P1285, DOI 10.4239/wjd.v6.i15.1285; Jeon SM, 2013, J MED FOOD, V16, P133, DOI 10.1089/jmf.2012.2249; Ji QH, 2017, CLIN THER, V39, P1244, DOI 10.1016/j.clinthera.2017.03.013; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Millar P, 2017, J ENDOCRINOL, V234, P255, DOI 10.1530/JOE-17-0263; Mughal A, 2018, PHARM THER; Nauck MA, 2011, DIABETES, V60, P1561, DOI 10.2337/db10-0474; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; O'Harte FPM, 2018, PEPTIDES, V100, P219, DOI 10.1016/j.peptides.2017.12.004; O'Harte FPM, 2014, DIABETES OBES METAB, V16, P1214, DOI 10.1111/dom.12360; O'Harte FPM, 2017, BIOCHEM PHARMACOL, V146, P165, DOI 10.1016/j.bcp.2017.10.002; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Parthsarathy V, 2018, DIABETES OBES METAB, V20, P319, DOI 10.1111/dom.13068; Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497; Schinzari F, 2017, HYPERTENSION, V69, P942, DOI 10.1161/HYPERTENSIONAHA.116.08916; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thomas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032619; Valle A, 2008, J NEUROENDOCRINOL, V20, P79, DOI 10.1111/j.1365-2826.2007.01617.x; WEST DB, 1995, AM J PHYSIOL-REG I, V268, pR658, DOI 10.1152/ajpregu.1995.268.3.R658; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	52	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202350	10.1371/journal.pone.0202350	http://dx.doi.org/10.1371/journal.pone.0202350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157220	gold, Green Published, Green Submitted			2022-12-26	WOS:000443071400055
J	Szekely, P; Eguiguren, JS; Szekely, D; Ordonez-Delgado, L; Armijos-Ojeda, D; Riofrio-Guaman, ML; Cogalniceanu, D				Szekely, Paul; Sebastian Eguiguren, Juan; Szekely, Diana; Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego; Lorena Riofrio-Guaman, Maria; Cogalniceanu, Dan			A new minute Pristimantis (Amphibia: Anura: Strabomantidae) from the Andes of southern Ecuador	PLOS ONE			English	Article							FROG	We describe a new rainfrog species (Pristimantis), from the wetland complex Ona, Nabon, Saraguro and Yacuambi, in the Andes of southern Ecuador, at altitudes ranging between 3000-3400 ma.s.l. Pristimantis tiktik sp. nov. is a small frog, displaying sexual dimorphism (the males with dorsum of various shades of gray, brown, orange or green and a whitish or pinkish yellow venter; females with brownish gray or gray dorsum and a reticulated white and black venter), with SVL ranging between 19.7-20.4 mm in females (n = 3) and 16.1-18.4 mm in males (n = 6). The skin on dorsum is tuberculated, that on venter is coarsely areolate, dorsolateral folds are absent, tympanic membrane is absent but the tympanic annulus is evident, cranial crests are absent, discs on fingers just slightly expanded, heel is lacking enlarged tubercles, inner edge of tarsus is bearing a long fold, Toe V is slightly longer than Toe III and the iris coloration is bronze with fine black reticulations. The males have a large subgular vocal sac that extends onto the chest and vocal slits but lack nuptial pads. The unique advertisement call consists of long duration series of periodically repeated clicks: "tik". Molecular analyses place the new species in the recently resurrected P. orestes group, as the sister species of the assemblage that contains P. bambu, P. mazar, P. simonbolivari and an undescribed species.	[Szekely, Paul; Sebastian Eguiguren, Juan; Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego; Lorena Riofrio-Guaman, Maria] Univ Tecn Particular Loja, Dept Ciencias Biol, EcoSs Lab, Calle Marcelino Champagnat S-N, San Cayetano Alto, Loja, Ecuador; [Szekely, Paul] Assoc Chelonia Romania, Bucharest, Romania; [Szekely, Diana; Cogalniceanu, Dan] Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania; [Szekely, Diana] Univ Liege, Lab Fish & Amphibian Ethol, Behav Biol Grp, Freshwater & OCean Sci Unit ReS FOCUS, Liege, Belgium	Universidad Tecnica Particular de Loja; Ovidius University; University of Liege	Szekely, D (corresponding author), Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania.; Szekely, D (corresponding author), Univ Liege, Lab Fish & Amphibian Ethol, Behav Biol Grp, Freshwater & OCean Sci Unit ReS FOCUS, Liege, Belgium.	diana@butanescu.com	Cogalniceanu, Dan/B-7065-2011; Ordóñez-Delgado, Leonardo/AAE-3098-2019; Székely, Paul/V-8239-2017; Szekely, Diana/O-6147-2017	Cogalniceanu, Dan/0000-0003-2959-014X; Ordóñez-Delgado, Leonardo/0000-0002-4593-1728; Székely, Paul/0000-0002-9252-1596; Szekely, Diana/0000-0002-3786-3729; Armijos Ojeda, Diego/0000-0003-3685-7631; Riofrio Guaman, Maria Lorena/0000-0003-2706-4701; Eguiguren, Juan Sebastian/0000-0002-8866-4316	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, Republic of Ecuador (SENESCYT) through the Prometeo Project; SYNTHESYS [SE-TAF-4807, GBTAF-4710]; European Community-Research Infrastructure Action under the FP7 "Capacities" Specific Programme; Municipalidad de Saraguro trough the project "Inventario de areas protegidas de canton Saraguro e implementacion de un plan de conservacion de areas de interes ecologico y reforestacion con especies nativas" (PY2029)	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, Republic of Ecuador (SENESCYT) through the Prometeo Project; SYNTHESYS; European Community-Research Infrastructure Action under the FP7 "Capacities" Specific Programme; Municipalidad de Saraguro trough the project "Inventario de areas protegidas de canton Saraguro e implementacion de un plan de conservacion de areas de interes ecologico y reforestacion con especies nativas" (PY2029)	PS and DC received funding from Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, Republic of Ecuador (SENESCYT) through the Prometeo Project. Research was supported by SYNTHESYS grants: SE-TAF-4807 to PS and GBTAF-4710 to DC. The SYNTHESYS Project is financed by the European Community-Research Infrastructure Action under the FP7 "Capacities" Specific Programme. Field work was partially financed by the Municipalidad de Saraguro trough the project "Inventario de areas protegidas de canton Saraguro e implementacion de un plan de conservacion de areas de interes ecologico y reforestacion con especies nativas" (PY2029) granted to LOD.	[Anonymous], 2009, TERRESTRIAL BREEDING; [Anonymous], ANFIBIOS DEL ECUADOR; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; De Oliveira EA, 2017, ZOOKEYS, P101, DOI 10.3897/zookeys.687.13221; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2013, ZOOTAXA, V3750, P569, DOI 10.11646/zootaxa.3750.5.8; Frost D. R., 2018, AMPHIBIAN SPECIES WO; Guayasamin JM, 2013, ZOOTAXA, V3616, P345, DOI 10.11646/zootaxa.3616.4.3; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2018, MOL PHYLOGENET EVOL, V118, P145, DOI 10.1016/j.ympev.2017.09.021; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jorge Brito M., 2017, Papeis Avulsos de Zoologia (Sao Paulo), V57, P177, DOI 10.11606/0031-1049.2017.57.15; Katoh K, 2017, BRIEF BIOINFORM, DOI [DOI 10.1093/BIB/BBX108, 10.1093/bib/bbx108]; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kohler G., 2012, COLOR CATALOGUE FIEL; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lehr E, 2007, COPEIA, P140, DOI 10.1643/0045-8511(2007)7[140:TNSOEA]2.0.CO;2; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; LYNCH J D, 1979, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Rodrigues ASL, 2010, BIOSCIENCE, V60, P798, DOI 10.1525/bio.2010.60.10.6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teran-Valdez A, 2010, ZOOTAXA, P53; Toledo LF, 2015, ACTA ETHOL, V18, P87, DOI 10.1007/s10211-014-0194-4; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Zwickl DJ., 2006, GENETIC ALGORITHM AP	35	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202332	10.1371/journal.pone.0202332	http://dx.doi.org/10.1371/journal.pone.0202332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157209	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400052
J	Tack, ILMM; Nimmegeers, P; Akkermans, S; Logist, F; Van Impe, JFM				Tack, Ignace L. M. M.; Nimmegeers, Philippe; Akkermans, Simen; Logist, Filip; Van Impe, Jan F. M.			A low-complexity metabolic network model for the respiratory and fermentative metabolism of Escherichia coli	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; LISTERIA-MONOCYTOGENES; ANAEROBIC FERMENTATION; GENOME SEQUENCE; MICROBIAL LAG; GROWTH-RATE; PH; TEMPERATURE; ACID; MAINTENANCE	Over the last decades, predictive microbiology has made significant advances in the mathematical description of microbial spoiler and pathogen dynamics in or on food products. Recently, the focus of predictive microbiology has shifted from a (semi-) empirical population-level approach towards mechanistic models including information about the intracellular metabolism in order to increase model accuracy and genericness. However, incorporation of this subpopulation-level information increases model complexity and, consequently, the required run time to simulate microbial cell and population dynamics. In this paper, results of metabolic flux balance analyses (FBA) with a genome-scale model are used to calibrate a low-complexity linear model describing the microbial growth and metabolite secretion rates of Escherichia coli as a function of the nutrient and oxygen uptake rate. Hence, the required information about the cellular metabolism (i.e., biomass growth and secretion of cell products) is selected and included in the linear model without incorporating the complete intracellular reaction network. However, the applied FBAs are only representative for microbial dynamics under specific extracellular conditions, viz., a neutral medium without weak acids at a temperature of 37 degrees C. Deviations from these reference conditions lead to metabolic shifts and adjustments of the cellular nutrient uptake or maintenance requirements. This metabolic dependency on extracellular conditions has been taken into account in our low-complex metabolic model. In this way, a novel approach is developed to take the synergistic effects of temperature, pH, and undissociated acids on the cell metabolism into account. Consequently, the developed model is deployable as a tool to describe, predict and control E. coli dynamics in and on food products under various combinations of environmental conditions. To emphasize this point, three specific scenarios are elaborated: (i) aerobic respiration without production of weak acid extracellular metabolites, (ii) anaerobic fermentation with secretion of mixed acid fermentation products into the food environment, and (iii) respiro-fermentative metabolic regimes in between the behaviors at aerobic and anaerobic	[Tack, Ignace L. M. M.; Nimmegeers, Philippe; Akkermans, Simen; Logist, Filip; Van Impe, Jan F. M.] Katholieke Univ Leuven, BioTeC, Dept Chem Engn, Ghent, Belgium	KU Leuven	Van Impe, JFM (corresponding author), Katholieke Univ Leuven, BioTeC, Dept Chem Engn, Ghent, Belgium.	jan.vanimpe@kuleuven.be	Nimmegeers, Philippe/ABD-4568-2020; Logist, Filip/AAG-4210-2020; Nimmegeers, Philippe/AAG-1512-2020; Akkermans, Simen/F-7549-2018	Nimmegeers, Philippe/0000-0002-2086-7694; Logist, Filip/0000-0001-8621-7531; Akkermans, Simen/0000-0003-2904-0439; Van Impe, Jan/0000-0002-5904-1638	Agency for Innovation by Science and Technology (IWT) [IWT SB-111565]; Research Foundation Flanders (FWO) [FWO-G.0930.13, FWO KAN2013,1.5.189.13]; KU Leuven Research Fund [PFV/10/002]; Knowledge Platform (SCORES4CHEM) of the KU Leuven Industrial Research Fund [KP/09/005]; Belgian Program on Interuniversity Poles of Attraction; Belgian Federal Science Policy Office (IAP Phase VII - 19 DYSCO)	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); KU Leuven Research Fund(KU Leuven); Knowledge Platform (SCORES4CHEM) of the KU Leuven Industrial Research Fund; Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Belgian Federal Science Policy Office (IAP Phase VII - 19 DYSCO)(Belgian Federal Science Policy Office)	The research of I.L.M.M. Tack is funded by PhD grant IWT SB-111565 of the Agency for Innovation by Science and Technology (IWT, https://www.vlaio.be/nl). In addition, this work is supported by projects FWO-G.0930.13 and FWO KAN2013,1.5.189.13 of the Research Foundation Flanders (FWO, https://www.vlaio.be/nl), project PFV/10/002 (Center of Excellence OPTEC - Optimization in Engineering) of the KU Leuven Research Fund (https://www.kuleuven.be/english/research/support/if), Knowledge Platform KP/09/005 (SCORES4CHEM) of the KU Leuven Industrial Research Fund (https://www.kuleuven.be/english/research/iof), and the Belgian Program on Interuniversity Poles of Attraction, initiated by the Belgian Federal Science Policy Office (IAP Phase VII - 19 DYSCO, https://www.belspo.be).	ALAM KY, 1989, J BACTERIOL, V171, P6213, DOI 10.1128/jb.171.11.6213-6217.1989; [Anonymous], 1994, ILJ, V23, DOI DOI 10.1016/0168-1605(94)90157-0; Baka M, 2013, FOOD CONTROL, V29, P328, DOI 10.1016/j.foodcont.2012.04.022; Banerjee C, 2016, BIOTECHNOL J, V11, P303, DOI 10.1002/biot.201500284; Baweja M, 2016, FRONTIER DISCOVERIES, P207, DOI DOI 10.1007/978-81-322-2610-9_13; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bernaerts K, 2002, INT J FOOD MICROBIOL, V73, P145, DOI 10.1016/S0168-1605(01)00645-6; Biryukova IV, 2010, RUSS J GENET+, V46, P308, DOI 10.1134/S1022795410030075; BLACKWOOD AC, 1956, J BACTERIOL, V72, P497, DOI 10.1128/JB.72.4.497-499.1956; Buchanan RL, 1998, J FOOD PROTECT, V61, P1531, DOI 10.4315/0362-028X-61.11.1531; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Clomburg JM, 2011, BIOTECHNOL BIOENG, V108, P867, DOI 10.1002/bit.22993; COLE MB, 1990, J APPL BACTERIOL, V69, P63, DOI 10.1111/j.1365-2672.1990.tb02912.x; Coroller L, 2005, INT J FOOD MICROBIOL, V100, P167, DOI 10.1016/j.ijfoodmicro.2004.10.014; Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P319, DOI 10.1016/j.ijfoodmicro.2004.11.017; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; DiezGonzalez F, 1997, MICROBIOL-UK, V143, P1175, DOI 10.1099/00221287-143-4-1175; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Eklund T, 1989, MECH ACTION FOOD PRE, P160; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Ferrier R, 2013, APPL ENVIRON MICROB, V79, P5870, DOI 10.1128/AEM.01311-13; Ginovart M, 2002, J THEOR BIOL, V214, P305, DOI 10.1006/jtbi.2001.2466; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HEIJNEN JJ, 1981, BIOTECHNOL BIOENG, V23, P739, DOI 10.1002/bit.260230407; Higgins TE, 1970, J BACTERIOL, V101, P885, DOI 10.1128/JB.101.3.885-891.1970; Hinshelwood, 1946, CHEM KINETICS BACTER; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ihssen J, 2007, MICROBIOL-SGM, V153, P2052, DOI 10.1099/mic.0.2006/002006-0; Ingraham J. L., 1996, ESCHERICHIA COLI SAL, V2, P1570; Jiang GRJ, 2001, MICROBIOL-SGM, V147, P2437, DOI 10.1099/00221287-147-9-2437; Jin Qi, 2002, Nucleic Acids Research, V30, P4432, DOI 10.1093/nar/gkf566; KAREL SF, 1989, BIOTECHNOL BIOENG, V34, P337, DOI 10.1002/bit.260340308; Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7; Leistner L, 2000, INT J FOOD MICROBIOL, V55, P181, DOI 10.1016/S0168-1605(00)00161-6; MATJAN F, 1989, J BACTERIOL, V171, P342, DOI 10.1128/jb.171.1.342-348.1989; Monod J., 1942, ACTUALITES SCI IND; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Pharkya P, 2003, BIOTECHNOL BIOENG, V84, P887, DOI 10.1002/bit.10857; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Prats C, 2006, J THEOR BIOL, V241, P939, DOI 10.1016/j.jtbi.2006.01.029; Presser KA, 1997, APPL ENVIRON MICROB, V63, P2355, DOI 10.1128/AEM.63.6.2355-2360.1997; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Sanchez AM, 2005, METAB ENG, V7, P229, DOI 10.1016/j.ymben.2005.03.001; Scheibe TD, 2009, MICROB BIOTECHNOL, V2, P274, DOI 10.1111/j.1751-7915.2009.00087.x; SCHULZE KL, 1964, ARCH MIKROBIOL, V48, P1, DOI 10.1007/BF00406595; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Standaert A. R., 2004, 9 IFAC S COMP APPL B, V9, P183; Stephanopoulos G. N., 1998, METAB ENG, P115, DOI [10.1016/b978-012666260-3/50005-4, DOI 10.1016/B978-012666260-3/50005-4]; Stling O C, 1993, J APPL BACTERIOL, V75, P18, DOI [10.1111/j.1365-2672.1993.tb03402.x, DOI 10.1111/J.1365-2672.1993.TB03402.X]; STOKES JL, 1949, J BACTERIOL, V57, P147, DOI 10.1128/JB.57.2.147-158.1949; Swinnen IAM, 2005, INT J FOOD MICROBIOL, V100, P85, DOI 10.1016/j.ijfoodmicro.2004.10.022; Tack ILMM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02509; TARMY EM, 1968, J BIOL CHEM, V243, P2587; terSteeg PF, 1995, FOOD MICROBIOL, V12, P471, DOI 10.1016/S0740-0020(95)80132-4; Trinh CT, 2009, APPL ENVIRON MICROB, V75, P6696, DOI 10.1128/AEM.00670-09; Valero A, 2006, EUR FOOD RES TECHNOL, V224, P91, DOI 10.1007/s00217-006-0293-1; van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5; Van Derlinden E, 2009, QUANTIFYING MICROBIA; VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993; Varma A, 1993, J THEOR BIOL, V1993, P4; Verhulst AJ, 2011, FOOD MICROBIOL, V28, P656, DOI 10.1016/j.fm.2010.07.014; WALLACE RJ, 1986, FEMS MICROBIOL LETT, V37, P317, DOI 10.1016/0378-1097(86)90427-1; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4&lt;203::AID-BIT1&gt;3.0.CO;2-#]; ZWIETERING MH, 1992, J FOOD PROTECT, V55, P973, DOI 10.4315/0362-028X-55.12.973	73	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202565	10.1371/journal.pone.0202565	http://dx.doi.org/10.1371/journal.pone.0202565			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157229	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400062
J	Li, HZ; Hai, Y; Lim, SY; Toledo, N; Crecente-Campo, J; Schalk, D; Li, L; Omange, RW; Dacoba, TG; Liu, LR; Abul Kashem, M; Wan, YM; Liang, BH; Li, QS; Rakasz, E; Schultz-Darken, N; Alonso, MJ; Plummer, FA; Whitney, JB; Luo, M				Li, Hongzhao; Hai, Yan; Lim, So-Yon; Toledo, Nikki; Crecente-Campo, Jose; Schalk, Dane; Li, Lin; Omange, Robert W.; Dacoba, Tamara G.; Liu, Lewis R.; Abul Kashem, Mohammad; Wan, Yanmin; Liang, Binhua; Li, Qingsheng; Rakasz, Eva; Schultz-Darken, Nancy; Alonso, Maria J.; Plummer, Francis A.; Whitney, James B.; Luo, Ma			Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; SIMIAN IMMUNODEFICIENCY; HIV-1 INFECTION; VIRAL PROTEASE; ISOTYPE DIVERSIFICATION; IMMUNE-RESPONSES; PROCESSING SITES; IGG ANTIBODIES; NANOPARTICLES	HIV mutates rapidly and infects CD4(+) T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4(+) T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p<0.0001). The effect of the mucosal antibody responses in protection from repeated low dose pathogenic SIVmac251 challenges is being evaluated.	[Li, Hongzhao; Hai, Yan; Toledo, Nikki; Omange, Robert W.; Liu, Lewis R.; Abul Kashem, Mohammad; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Lim, So-Yon; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Crecente-Campo, Jose; Dacoba, Tamara G.; Alonso, Maria J.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Campus Vida, Santiago De Compostela, Spain; [Schalk, Dane; Schultz-Darken, Nancy] Wisconsin Natl Primate Res Ctr, Sci Protocol Implementat Unit, Madison, WI USA; [Li, Lin; Liang, Binhua; Plummer, Francis A.; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Wan, Yanmin; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE USA; [Liang, Binhua] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Rakasz, Eva] Wisconsin Natl Primate Res Ctr, Immunol Serv Unit, Madison, WI USA; [Whitney, James B.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	University of Manitoba; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade de Santiago de Compostela; Public Health Agency of Canada; University of Nebraska System; University of Nebraska Lincoln; University of Manitoba; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Luo, M (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca	, yanmin/GQH-2789-2022; Alonso, Maria Jose/K-3893-2014; Rakasz, Eva G/H-9197-2019; Campo, Crecente/AAA-2646-2019; Liang, Binhua/ABN-9806-2022; Omange, Were/F-1454-2016	, yanmin/0000-0001-5027-9423; Campo, Crecente/0000-0002-8630-5010; Kashem, Mohammad/0000-0002-6472-3676; Omange, Were/0000-0002-0421-110X; Dacoba, Tamara/0000-0003-0770-6340; liang, binhua/0000-0002-1108-6407	National Institute of Allergy and Infectious Diseases [R01AI111805]; Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative; National Microbiology Laboratory of Canada; Office of the Director, National Institutes of Health [P51OD011106]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NIH [R01AI111805]; CIHR/CHVI; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111805] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative(Canadian Institutes of Health Research (CIHR)); National Microbiology Laboratory of Canada; Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/CHVI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the following funding awarded to ML: a National Institute of Allergy and Infectious Diseases grant, with grant number: R01AI111805 and URL: https://www.niaid.nih.gov/; a Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant (no grant number available), with URL: http://www.cihr-irsc.gc.ca/e/42458.html; and funding from National Microbiology Laboratory of Canada (no grant number available), with URL: https://www.nml-lnm.gc.ca/index-eng.htm. Research reported in this publication was supported in part by the Office of the Director, National Institutes of Health under Award Number P51OD011106 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank staff at Wisconsin National Primate Research Center Scientific Protocol Implementation Unit and Immunology Services Unit for important technical support. We recognize Dr. Stuart Shapiro, NIH Vaccine Research Program, and Dr. Matthew Gilmour, National Microbiology Laboratory of Canada, for important support and discussion. This work was supported by a NIH grant (R01AI111805), a CIHR/CHVI bridging grant and funding from National Microbiology Laboratory of Canada.	Adamson CS, 2009, EXPERT OPIN THER TAR, V13, P895, DOI 10.1517/14728220903039714; Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; [Anonymous], 2003, AIDS Alert, V18, P43; [Anonymous], 2007, Nature, V449, P390; [Anonymous], 2003, AIDS ALERT, V18, P3; Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225; Carias AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005885; Chen YX, 2014, VACCINES, V2, P138, DOI 10.3390/vaccines2010138; Correia-Pinto JF, 2013, INT J PHARMACEUT, V440, P27, DOI 10.1016/j.ijpharm.2012.04.047; Craig L, 1998, J MOL BIOL, V281, P183, DOI 10.1006/jmbi.1998.1907; de Oliveira T, 2003, J VIROL, V77, P9422, DOI 10.1128/JVI.77.17.9422-9430.2003; French MA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00780; French MA, 2013, VACCINES, V1, P328, DOI 10.3390/vaccines1030328; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; French MA, 2010, AIDS, V24, P1983, DOI 10.1097/QAD.0b013e32833c1ce0; He T, 2016, J IMMUNOL, V197, P4535, DOI 10.4049/jimmunol.1601539; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Hope TJ, 2018, NAT MED, V24, P384, DOI 10.1038/nm.4534; Joag VR, 2016, MUCOSAL IMMUNOL, V9, P1, DOI 10.1038/mi.2015.28; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Lema D, 2014, SCAND J IMMUNOL, V80, P1, DOI 10.1111/sji.12184; Li HZ, 2018, BIOINFORMATION, V14, P48, DOI 10.6026/97320630014048; Li HZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186079; Li HZ, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0174-7; Li HZ, 2017, J MED PRIMATOL, V46, P137, DOI 10.1111/jmp.12300; Lin SW, 2007, VACCINE, V25, P2187, DOI 10.1016/j.vaccine.2006.11.044; Lu S, 1996, J VIROL, V70, P3978, DOI 10.1128/JVI.70.6.3978-3991.1996; Lu S, 1997, VACCINE, V15, P920, DOI 10.1016/S0264-410X(96)00282-4; Lu S, 2010, CURR HIV RES, V8, P622, DOI 10.2174/157016210794088290; Luo M, 2013, VACCINE, V31, P3000, DOI 10.1016/j.vaccine.2013.04.057; Luo M, 2012, J VIROL, V86, P1166, DOI 10.1128/JVI.05721-11; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; McCarthy M, 2003, LANCET, V361, P755, DOI 10.1016/S0140-6736(03)12669-4; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Nguyen M, 2006, JAIDS-J ACQ IMM DEF, V42, P412, DOI 10.1097/01.qai.0000222289.97825.35; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Pandrea I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005384; Paolicelli P, 2010, NANOMEDICINE-UK, V5, P843, DOI [10.2217/nnm.10.69, 10.2217/NNM.10.69]; Pavot V, 2014, AIDS, V28, P1701, DOI 10.1097/QAD.0000000000000308; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Plotkin SA, 2010, HUM VACCINES, V6, P159; Policicchio BB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005879; Policicchio BB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190908; Prego C, 2005, J CONTROL RELEASE, V101, P151, DOI 10.1016/j.jconrel.2004.07.030; Prego C, 2010, VACCINE, V28, P2607, DOI 10.1016/j.vaccine.2010.01.011; Racine T, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0179-2; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Routy JP, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0164-9; Ruprecht RM, 2017, CURR OPIN HIV AIDS, V12, P222, DOI 10.1097/COH.0000000000000369; Schell JB, 2015, VIROLOGY, V476, P405, DOI 10.1016/j.virol.2014.12.027; Sheng ZZ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004940; Stieh DJ, 2016, CELL HOST MICROBE, V19, P529, DOI 10.1016/j.chom.2016.03.005; Stieh DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004440; Sunshine JE, 2015, J VIROL, V89, P10303, DOI 10.1128/JVI.01876-15; Tatsis N, 2007, VIROLOGY, V367, P156, DOI 10.1016/j.virol.2007.05.028; Tebit DM, 2012, CURR HIV RES, V10, P3, DOI 10.2174/157016212799304689; Tjiam MC, 2016, AIDS, V30, P2757, DOI 10.1097/QAD.0000000000001242; Tjiam MC, 2015, J IMMUNOL, V194, P5320, DOI 10.4049/jimmunol.1402918; Tobio M, 1998, PHARMACEUT RES, V15, P270, DOI 10.1023/A:1011922819926; Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514; Vaccari M, 2010, EXPERT REV VACCINES, V9, P997, DOI [10.1586/erv.10.104, 10.1586/ERV.10.104]; Vicente S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062500; Vila A, 2004, J AEROSOL MED, V17, P174, DOI 10.1089/0894268041457183; Vila A, 2004, EUR J PHARM BIOPHARM, V57, P123, DOI 10.1016/j.ejpb.2003.09.006; Whitney JB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-96; Whitney JB, 2002, J VIROL, V76, P8958, DOI 10.1128/JVI.76.17.8958-8962.2002; Willyard C, 2010, NATURE, V466, pS8, DOI 10.1038/nature09238	77	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202997	10.1371/journal.pone.0202997	http://dx.doi.org/10.1371/journal.pone.0202997			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153293	Green Published, gold			2022-12-26	WOS:000443001700037
J	Ojansivu, M; Mishra, A; Vanhatupa, S; Juntunen, M; Larionova, A; Massera, J; Miettinen, S				Ojansivu, Miina; Mishra, Ayush; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Massera, Jonathan; Miettinen, Susanna			The effect of S53P4-based borosilicate glasses and glass dissolution products on the osteogenic commitment of human adipose stem cells	PLOS ONE			English	Article							BIOACTIVE GLASS; IN-VITRO; CONTROLLABLE DEGRADATION; BONE REGENERATION; GROWTH-FACTORS; 3D CULTURE; TISSUE; DIFFERENTIATION; SCAFFOLDS; BORATE	Despite the good performance of silicate bioactive glasses in bone regeneration, there is considerable potential to enhance their properties by chemical modifications. In this study, S53P4-based borosilicate glasses were synthesized and their dissolution profile was studied in simulated body fluid by assessing pH change, ion release and conversion to hydroxyapatite. The viability, proliferation, attachment, osteogenesis and endothelial marker expression of human adipose stem cells (hASCs) was evaluated upon direct culture on glass discs and in the extract medium. This is the first study evaluating cell behavior in response to borosilicate glasses based on S53P4 (commercially available as BonAlive (R)). Replacing silicate with borate in S53P4 increased the glass reactivity. Despite the good viability of hASCs under all conditions, direct culture of cells on borosilicate discs and in undiluted extract medium reduced cell proliferation. This was accompanied with changes in cell morphology. Regarding osteogenic commitment, alkaline phosphatase activity was significantly reduced by the borosilicate glass discs and extracts, whereas the expression of osteogenic markers RUNX2a, OSTERIX, DLX5 and OSTEOPONTIN was upregulated. There was also a borosilicate glass-induced increase in osteocalcin protein production. Moreover, osteogenic supplements containing borosilicate extracts significantly increased the mineral production in comparison to the osteogenic medium control. Interestingly, borosilicate glasses stimulated the expression of endothelial markers vWF and PECAM-1. To conclude, our results reveal that despite reducing hASC proliferation, S53P4-based borosilicate glasses and their dissolution products stimulate osteogenic commitment and upregulate endothelial markers, thus supporting their further evaluation for regenerative medicine.	[Ojansivu, Miina; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Miettinen, Susanna] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Ojansivu, Miina; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Miettinen, Susanna] Univ Tampere, BioMediTech Inst, Tampere, Finland; [Ojansivu, Miina; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Miettinen, Susanna] Tampere Univ Hosp, Sci Ctr, Tampere, Finland; [Mishra, Ayush; Massera, Jonathan] Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland; [Mishra, Ayush; Massera, Jonathan] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University	Ojansivu, M (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.; Ojansivu, M (corresponding author), Univ Tampere, BioMediTech Inst, Tampere, Finland.; Ojansivu, M (corresponding author), Tampere Univ Hosp, Sci Ctr, Tampere, Finland.	miinaojansivu@hotmail.com		Massera, Jonathan/0000-0002-1099-8420; Ojansivu, Miina/0000-0002-5493-3530; Miettinen, Susanna/0000-0002-0647-9556	TEKES, the Finnish Funding Agency for Innovation; Academy of Finland [275427]; Jane and Aatos Erkko Foundation; Tampere University Hospital; Doctoral Programme in Biomedicine and Biotechnology	TEKES, the Finnish Funding Agency for Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Tampere University Hospital; Doctoral Programme in Biomedicine and Biotechnology	This study was supported by TEKES, the Finnish Funding Agency for Innovation (https://www.businessfinland.fi/en/), Academy of Finland (grant number #275427; http://www.aka.fi/en), Jane and Aatos Erkko Foundation (https://jaes.fi/en/), the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (http://www.pshp.fi/en-US/Hospital_District), and the Doctoral Programme in Biomedicine and Biotechnology (http://www.uta.fi/med/en/MED_doctoral_programme.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SF, 2012, J MATER SCI-MATER M, V23, P789, DOI 10.1007/s10856-011-4531-0; Balasubramanian P, 2018, J EUR CERAM SOC, V38, P855, DOI 10.1016/j.jeurceramsoc.2017.11.001; Benderdour M, 1998, J TRACE ELEM MED BIO, V12, P2, DOI 10.1016/S0946-672X(98)80014-X; Bi LX, 2012, J BIOMED MATER RES A, V100A, P3267, DOI 10.1002/jbm.a.34272; Blair HC, 2017, TISSUE ENG PART B-RE, V23, P268, DOI [10.1089/ten.TEB.2016.0454, 10.1089/ten.teb.2016.0454]; Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008; Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679; Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433; Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768; Durand LAH, 2014, J MATER CHEM B, V2, P7620, DOI 10.1039/c4tb01043d; Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013; Fu QA, 2010, J BIOMED MATER RES A, V95A, P164, DOI 10.1002/jbm.a.32824; Fu QA, 2010, J BIOMED MATER RES A, V95A, P172, DOI 10.1002/jbm.a.32823; Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032; Gu YF, 2014, MAT SCI ENG C-MATER, V36, P294, DOI 10.1016/j.msec.2013.12.023; Gu YF, 2013, ACTA BIOMATER, V9, P9126, DOI 10.1016/j.actbio.2013.06.039; Hakki SS, 2010, J TRACE ELEM MED BIO, V24, P243, DOI 10.1016/j.jtemb.2010.03.003; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Hench LL, 1971, J BIOMED MATER RES S, V5, P117, DOI [10.1002/jbm.820050611, DOI 10.1002/JBM.820050611]; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z; Jones Julian R, 2015, Acta Biomater, V23 Suppl, pS53, DOI 10.1016/j.actbio.2015.07.019; Kargozar S, 2018, TRENDS BIOTECHNOL, V36, P430, DOI 10.1016/j.tibtech.2017.12.003; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015; Ledieu A, 2004, J NON-CRYST SOLIDS, V343, P3, DOI 10.1016/j.jnoncrysol.2004.06.006; Leu A, 2008, PHARM RES-DORDR, V25, P1222, DOI 10.1007/s11095-007-9508-9; Li X, 2016, J BIOMED MATER RES B, V104, P323, DOI 10.1002/jbm.b.33391; Lian J B, 1995, Iowa Orthop J, V15, P118; Lindfors NC, 2010, J BIOMED MATER RES B, V94B, P157, DOI 10.1002/jbm.b.31636; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Lynch MP, 1998, J CELL BIOCHEM, V68, P31; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615; Marklein RA, 2016, STEM CELLS, V34, P935, DOI 10.1002/stem.2322; Massera J, 2011, J NON-CRYST SOLIDS, V357, P3623, DOI 10.1016/j.jnoncrysol.2011.06.037; Massera J, 2014, J MATER SCI-MATER M, V25, P657, DOI 10.1007/s10856-013-5120-1; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; McCullen SD, 2010, TISSUE ENG PT A, V16, P1971, DOI [10.1089/ten.tea.2009.0691, 10.1089/ten.TEA.2009.0691]; Modglin VC, 2013, J MATER SCI-MATER M, V24, P1191, DOI 10.1007/s10856-013-4875-8; Monfoulet LE, 2014, TISSUE ENG PT A, V20, P1827, DOI [10.1089/ten.tea.2013.0500, 10.1089/ten.TEA.2013.0500]; Ojansivu M, 2018, EUR CELLS MATER, V35, P54, DOI 10.22203/eCM.v035a05; Ojansivu M, 2015, ACTA BIOMATER, V21, P190, DOI 10.1016/j.actbio.2015.04.017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabiee SM, 2015, CERAM INT, V41, P7241, DOI 10.1016/j.ceramint.2015.02.140; Sandor GK, 2014, STEM CELL TRANSL MED, V3, P530, DOI 10.5966/sctm.2013-0173; Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927; Tirkkonen L, 2013, EUR CELLS MATER, V25, P144, DOI 10.22203/eCM.v025a10; Waselau M, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412467789; Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503; Ying XZ, 2011, BIOL TRACE ELEM RES, V144, P306, DOI 10.1007/s12011-011-9094-x; Zhang J, 2015, BIOMED MATER, V10; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202740	10.1371/journal.pone.0202740	http://dx.doi.org/10.1371/journal.pone.0202740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153295	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700024
J	Brabazon, F; Bermudez, S; Shaughness, M; Khayrullina, G; Byrnes, KR				Brabazon, Fiona; Bermudez, Sara; Shaughness, Michael; Khayrullina, Guzal; Byrnes, Kimberly R.			The effects of insulin on the inflammatory activity of BV2 microglia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE DEMENTIA; MILD COGNITIVE IMPAIRMENT; NITRIC-OXIDE SYNTHASE; NADPH OXIDASE; BRAIN-INJURY; CELL-DEATH; IN-VITRO; ACTIVATION; NEUROTOXICITY; EXPRESSION	Microglia are the macrophages of the central nervous system (CNS), which function to monitor and maintain homeostasis. Microglial activation occurs after CNS injury, infection or disease. Prolonged microglial activation is detrimental to the CNS as they produce nitric oxide (NO), reactive oxygen species (ROS) and pro-inflammatory cytokines, resulting in neuronal cell dysfunction and death. Microglial activation is implicated in the neurological deficits following traumatic brain injury (TBI) and Alzheimer's disease. Intranasal insulin administration is a promising treatment of Alzheimer's disease and TBI. However, the exact effect of insulin on microglia is currently unclear. The goal of this study was therefore to examine the effect of insulin administration on activated microglia. The microglial cell line BV2 were exposed to a pro-inflammatory stimulus, lipopolysaccharide (LPS), followed by insulin administration. Outcome measures were conducted at 24 hours after treatment. In vitro assays quantified NO and ROS production. Western blot, immunocytochemistry and phagocytosis assay further examined the effect of insulin on microglial activity. Insulin treatment significantly reduced NO, ROS and TNF alpha production and increased phagocytic activity. Insulin treatment also significantly reduced iNOS expression, but had no significant effect on any other M1 or M2 macrophage polarization marker examined. These data suggest that insulin has very specific effects to reduce pro-inflammatory or chemoattractant properties of microglia, and this may be one mechanism by which insulin has beneficial effects in CNS injury or neurodegenerative conditions.	[Brabazon, Fiona; Shaughness, Michael; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Bermudez, Sara; Khayrullina, Guzal; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA.; Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.; Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu		Byrnes, Kimberly/0000-0002-7501-7734; Brabazon, Fiona/0000-0003-1642-808X	Uniformed Services University of the Health Sciences Student Grant [T0-70-3278]; NIH/NINDS grant [1R01NS073667-01A1]	Uniformed Services University of the Health Sciences Student Grant; NIH/NINDS grant	This study was funded by the Uniformed Services University of the Health Sciences Student Grant T0-70-3278 to FB and NIH/NINDS grant number 1R01NS073667-01A1 to KRB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dandona P, 2010, DIABETES CARE, V33, P2416, DOI 10.2337/dc10-0929; Engelhardt JF, 2001, ANTIOXID REDOX SIGN, V3, P341, DOI 10.1089/15230860152408997; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Kim WK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072108; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; Kumar A, 2014, FREE RADICAL BIO MED, V73, P51, DOI 10.1016/j.freeradbiomed.2014.04.014; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morris JK, 2012, CURR NEUROL NEUROSCI, V12, P520, DOI 10.1007/s11910-012-0297-0; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orihuela R, 2015, BR J PHARM, DOI 10.1111/bph.13139; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spielman LJ, 2015, CURR ALZHEIMER RES, V12, P684, DOI 10.2174/1567205012666150710104428; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stevens RB, 1997, J IMMUNOL, V159, P5329; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068	43	22	25	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201878	10.1371/journal.pone.0201878	http://dx.doi.org/10.1371/journal.pone.0201878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148836	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200003
J	Pena-Peniche, A; Ruvalcaba-Ortega, I; Rojas-Soto, O				Pena-Peniche, Alexander; Ruvalcaba-Ortega, Irene; Rojas-Soto, Octavio			Climate complexity in the migratory cycle of Ammodramus bairdii	PLOS ONE			English	Article							SPECIES DISTRIBUTION; GRASSLAND BIRDS; HABITAT USE; VEGETATION STRUCTURE; POPULATION-DYNAMICS; DISTRIBUTION MODEL; ECOLOGICAL NICHES; ENVELOPE MODELS; DISTRIBUTIONS; EVOLUTION	One way to understand the ecology of bird migration is to analyze how birds use their ecological niche during their annual cycle. Ammodramus bairdii is a grassland specialist sparrow that breeds in southern Canada and the northern U.S.A. and winters in the Chihuahuan Desert. A continuous and alarming decrease of its populations has been observed over the last 50 years, and studying its seasonal distribution and associated climatic niches could help improve strategies for its conservation. We analyzed the temporal use of its Grinnellian niche (GN)-set of environmental conditions under which a species can establish and persist; in this case the climatic attributes-. We modeled the GN for the reproductive and winter seasons and projected them onto each other (inter-prediction), and also onto transient migratory periods. To measure niche breadth and their overlap, minimum convex polygons (MCP) were calculated for the climatic space. The niches of each of the two seasons were tested for similarity using the PCA axes of climatic variables. The geographic areas with optimal, suboptimal and marginal conditions were identified, based on the distance to the centroid of the GN. The models for each season revealed no geographic inter-prediction among them, with the exception of winter to migratory seasons. The niche breadth of the winter was greater than that of the reproductive season, with an overlap of 22.47% and 45.18%, respectively. The similarity analyses showed a value of zero between seasons. The climate conditions for the records during the migratory months corresponded with suboptimal and marginal conditions of the sparrow's winter niche. These results suggest that A. bairdii uses different climate conditions within ecological niches of each season during its migratory cycle.	[Pena-Peniche, Alexander; Rojas-Soto, Octavio] Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico; [Ruvalcaba-Ortega, Irene] UANL, Fac Ciencias Biol, Lab Biol Conservac & Desarrollo Sustentable, Ciudad Univ, San Nicolas De Los Garza, Nuevo Leon, Mexico	Instituto de Ecologia - Mexico; Universidad Autonoma de Nuevo Leon	Rojas-Soto, O (corresponding author), Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico.	octavio.rojas@inecol.mx		Rojas-Soto, Octavio/0000-0002-0201-1454; Pena-Peniche, Alexander/0000-0002-8518-5002; Ruvalcaba-Ortega, Irene/0000-0001-8309-7618	Consejo Nacional de Ciencia y Tecnologia [371044/250334]; Consejo Nacional de Ciencia y Tecnologia Project [CB-2013-01-222920]; Universidad Autonoma de Nuevo Leon [PAICYT CN375-15]; Mexico's National Science and Technology Council (CONACYT, Consejo Nacional de Ciencia y Tecnologia) [371044/250334]; CONACYT [CB-2013-01-222920]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia Project; Universidad Autonoma de Nuevo Leon; Mexico's National Science and Technology Council (CONACYT, Consejo Nacional de Ciencia y Tecnologia); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This reasearch was supported by the Consejo Nacional de Ciencia y Tecnologia, the award of a scholarship (No. 371044/250334); to APP; the Consejo Nacional de Ciencia y Tecnologia Project No. CB-2013-01-222920; to IRC; and the Universidad Autonoma de Nuevo Leon (PAICYT CN375-15); to IRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Instituto de Ecologia A. C. for logistical support and to Mexico's National Science and Technology Council (CONACYT, Consejo Nacional de Ciencia y Tecnologia) for the award of a scholarship to APP (No. 371044/250334). Funding for this project was provided by CONACYT (Project No. CB-2013-01-222920) and the Universidad Autonoma de Nuevo Leon (PAICYT CN375-15). Juan Cervantes-Pasqualli advised us on the use of scripts in R. The Conservation Biology and Sustainable Development Lab (Laboratorio de Biologia de Conservacion y Desarrollo Sustentable) at the Universidad Autonoma de Nuevo Leon and the Integrated Monitoring for Bird Conservation Regions (Monitoreo Integrado en Regiones para la Conservacion de Aves provided record localities. We are especially grateful to two anonymous reviewers. For valuable feedback that improved this manuscript.	Ahlering MA, 2009, AUK, V126, P799, DOI 10.1525/auk.2009.08154; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bairlein F, 2003, BIRD STUDY, V50, P243, DOI 10.1080/00063650309461317; Barve N, 2008, TOOL PARTIAL ROC VER; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cardador L, 2014, DIVERS DISTRIB, V20, P515, DOI 10.1111/ddi.12156; Carroll C, 1999, CONSERV BIOL, V13, P1344, DOI 10.1046/j.1523-1739.1999.98364.x; Cartwright B. W., 1937, Transactions of the Canadian Institute, V21, P153; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; Culp LA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1565; Davis SK, 1998, WILSON BULL, V110, P262; Davis SK, 1999, WILSON BULL, V111, P389; DECHANT J. A., 2002, EFFECTS MANAGEMENT P, V125, P1; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; Dinerstein E, 2001, NATURE, V376; EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714; Engler JO, 2017, J AVIAN BIOL, V48, P1483, DOI 10.1111/jav.01248; Engler JO, 2014, J ORNITHOL, V155, P657, DOI 10.1007/s10336-014-1049-5; ESRI (Environmental Systems Research Institute), 1999, ARCVIEW GIS V 3 2; Eyres A, 2017, J AVIAN BIOL, V48, P1517, DOI 10.1111/jav.01308; Fletcher RJ, 2006, J WILDLIFE MANAGE, V70, P145, DOI 10.2193/0022-541X(2006)70[145:CDPFDS]2.0.CO;2; Frans VF, 2018, METHODS ECOL EVOL, V9, P98, DOI 10.1111/2041-210X.12847; GAUTHREAUX SA, 1991, AM ZOOL, V31, P187; Gomez C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2458; Green M.T., 2002, BIRDS N AM, DOI [10.2173/bna.638, DOI 10.2173/BNA.638]; Grinnell J., 1917, Auk Cambridge Mass, V34; Gschweng M, 2012, J APPL ECOL, V49, P803, DOI 10.1111/j.1365-2664.2012.02170.x; Guisande C, 2006, TRATAMIENDO DE DATOS; Hahn S, 2013, OECOLOGIA, V173, P1217, DOI 10.1007/s00442-013-2726-4; Heglund PJ, 2005, CONDOR, V107, P193, DOI 10.1650/7806; Heikkinen RK, 2006, DIVERS DISTRIB, V12, P502, DOI 10.1111/j.1366-9516.2006.00284.x; Herkert J. R., 1996, MANAGEMENT MIDWESTER, P89; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hostetler JA, 2015, AUK, V132, P433, DOI 10.1642/AUK-14-211.1; Hoyt A.C., 2002, ENDANGER SPECIES B, V27, P16; Hufkens K, 2016, NAT CLIM CHANGE, V6, P710, DOI [10.1038/nclimate2942, 10.1038/NCLIMATE2942]; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hutto R.L., 1985, P455; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Igl LD, 1999, CONDOR, V101, P771, DOI 10.2307/1370064; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Joseph L, 2003, J BIOGEOGR, V30, P925, DOI 10.1046/j.1365-2699.2003.00841.x; Joseph L, 2000, P ACAD NAT SCI PHILA, V150, P293; Joseph L., 1996, ECOTROPICA, V2, P185; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Laube I, 2015, J BIOGEOGR, V42, P1896, DOI 10.1111/jbi.12565; Lemoine N, 2003, CONSERV BIOL, V17, P577, DOI 10.1046/j.1523-1739.2003.01389.x; Liminana R, 2015, ORYX, V49, P329, DOI 10.1017/S0030605313001075; Lira-Noriega A, 2014, EVOLUTION, V68, P1082, DOI 10.1111/evo.12343; Lloyd P, 1998, AUK, V115, P404; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luce R, 2003, SPECIES ASSESSMENT B; Macias-Duarte A, 2011, WINTERING GRASSLAND, P164; Macias-Duarte A, 2009, AUK, V126, P896, DOI 10.1525/auk.2009.08251; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Manthey JD, 2015, ENDANGER SPECIES RES, V26, P201, DOI 10.3354/esr00646; Marini MA, 2013, J ORNITHOL, V154, P393, DOI 10.1007/s10336-012-0903-6; Marini MA, 2010, BIOL CONSERV, V143, P102, DOI 10.1016/j.biocon.2009.09.009; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Martinez-Guerrero JH, 2011, AGROCIENCIA-MEXICO, V45, P441; Martinez-Meyer E, 2004, P ROY SOC B-BIOL SCI, V271, P1151, DOI 10.1098/rspb.2003.2564; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Monroe AP, 2014, AM MIDL NAT, V171, P97, DOI 10.1674/0003-0031-171.1.97; Moore F. R, 2000, STUD AVIAN BIOL, V20, P133; Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Norris DR, 2007, CONDOR, V109, P535; Pateiro-Lopez B, 2010, J STAT SOFTW, V34, P1; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perez-Moreno H, 2016, ECOL EVOL, V6, P2022, DOI 10.1002/ece3.1973; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; Pool DB, 2012, 1RGJV1101 RMBO; Pool DB, 2014, BIOL CONSERV, V170, P274, DOI 10.1016/j.biocon.2013.12.019; Quintero I, 2013, GLOBAL ECOL BIOGEOGR, V22, P422, DOI 10.1111/geb.12001; RAPPOLE JH, 1994, AUK, V111, P652; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Rising J, 2014, HDB BIRDS WORLD ALIV; Rising J.D., 2010, GUIDE IDENTIFICATION; Ruiz-Sanchez A, 2015, J AVIAN BIOL, V46, P516, DOI 10.1111/jav.00531; Rushing CS, 2016, ECOLOGY, V97, P1218, DOI 10.1890/15-1259.1; Ruth JM, 2014, SOUTHWEST NAT, V59, P199, DOI 10.1894/F07-GDS-13.1; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Sauer JR, 2017, N AM BREEDING BIRD S, DOI [10.1111/jav.00319, DOI 10.1111/JAV.00319]; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Soberon J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175138; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Somveille M, 2015, GLOBAL ECOL BIOGEOGR, V24, P664, DOI 10.1111/geb.12298; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Sutter B, 2005, J FIELD ORNITHOL, V76, P345, DOI 10.1648/0273-8570-76.4.345; Sutter GC, 1995, ECOSCIENCE, V2, P344, DOI 10.1080/11956860.1995.11682302; Swanson DL, 2009, J FIELD ORNITHOL, V80, P351, DOI 10.1111/j.1557-9263.2009.00241.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tobon-Sampedro A, 2015, BIRD CONSERV INT, V25, P489, DOI 10.1017/S0959270914000501; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290; Travers SE, 2015, WILSON J ORNITHOL, V127, P43, DOI 10.1676/14-033.1; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Urena-Aranda CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131452; Vickery PD, 2001, AUK, V118, P11, DOI 10.1642/0004-8038(2001)118[0011:RAIGBR]2.0.CO;2; Voelker G, 2004, CONDOR, V106, P910, DOI 10.1650/7500; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; White R., 2000, PILOT ANAL GLOBAL EC, DOI 10.1021/es0032881; Wiggings DA, 2006, BAIRDS SPARROW AMMOD; Williams HM, 2017, J AVIAN BIOL, V48, P1624, DOI 10.1111/jav.01476; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x; Zink RM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603133	138	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202678	10.1371/journal.pone.0202678	http://dx.doi.org/10.1371/journal.pone.0202678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148886	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200019
J	Raghu, D; Christodoulides, JA; Christophersen, M; Liu, JL; Anderson, GP; Robitaille, M; Byers, JM; Raphael, MP				Raghu, Deepa; Christodoulides, Joseph A.; Christophersen, Marc; Liu, Jinny L.; Anderson, George P.; Robitaille, Michael; Byers, Jeff M.; Raphael, Marc P.			Nanoplasmonic pillars engineered for single exosome detection	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; EXTRACELLULAR VESICLES; CANCER; BIOMARKERS; RESOLUTION; BIOSENSOR; CELLS	Exosomes are secreted nanovesicles which incorporate proteins and nucleic acids, thereby enabling multifunctional pathways for intercellular communication. There is an increasing appreciation of the critical role they play in fundamental processes such as development, wound healing and disease progression, yet because of their heterogeneous molecular content and low concentrations in vivo, their detection and characterization remains a challenge. In this work we combine nano- and microfabrication techniques for the creation of nanosensing arrays tailored toward single exosome detection. Elliptically-shaped nanoplasmonic sensors are fabricated to accommodate at most one exosome and individually imaged in real time, enabling the label-free recording of digital responses in a highly multiplexed geometry. This approach results in a three orders of magnitude sensitivity improvement over previously reported real-time, multiplexed platforms. Each nanosensor is elevated atop a quartz nanopillar, minimizing unwanted nonspecific substrate binding contributions. The approach is validated with the detection of exosomes secreted by MCF7 breast adenocarcinoma cells. We demonstrate the increasingly digital and stochastic nature of the response as the number of subsampled nanosensors is reduced from four hundred to one.	[Raghu, Deepa; Christodoulides, Joseph A.; Robitaille, Michael; Byers, Jeff M.; Raphael, Marc P.] Naval Res Lab, Mat Sci & Technol Div, Washington, DC 20375 USA; [Christophersen, Marc] Naval Res Lab, Space Sci Div, Washington, DC 20375 USA; [Liu, Jinny L.; Anderson, George P.] Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA; [Raghu, Deepa] Sigma Aldrich Corp, BioReliance, Rockville, MD USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; Merck KGaA; MilliporeSigma	Raphael, MP (corresponding author), Naval Res Lab, Mat Sci & Technol Div, Washington, DC 20375 USA.	marc.raphael@nrl.navy.mil		Robitaille, Michael/0000-0002-8445-7205	Naval Research Laboratory's Institute for Nanoscience; Office of the Assistant Secretary of Defense for Research & Engineering (Vannevar Bush Award); National Research Council Research Postdoc Associateship Award	Naval Research Laboratory's Institute for Nanoscience(United States Department of Defense); Office of the Assistant Secretary of Defense for Research & Engineering (Vannevar Bush Award); National Research Council Research Postdoc Associateship Award	This work was supported by the Naval Research Laboratory's Institute for Nanoscience, the Office of the Assistant Secretary of Defense for Research & Engineering (Vannevar Bush Award), and a National Research Council Research Postdoc Associateship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Daaboul GG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37246; Dahlin AB, 2006, ANAL CHEM, V78, P4416, DOI 10.1021/ac0601967; Di Noto G, 2016, BIOSENS BIOELECTRON, V77, P518, DOI 10.1016/j.bios.2015.09.061; Di Noto G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00517; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Im H, 2009, ANAL CHEM, V81, P2854, DOI 10.1021/ac802276x; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Li JT, 2009, BIOMED CIRC SYST C, P9, DOI 10.1109/BIOCAS.2009.5372096; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Paolini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23550; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raphael MP, 2015, PLASMONICS, V10, P1649, DOI 10.1007/s11468-015-9969-3; Raphael MP, 2013, BIOPHYS J, V105, P602, DOI 10.1016/j.bpj.2013.06.022; Raphael MP, 2013, BIOPHYS J, V104, P30, DOI 10.1016/j.bpj.2012.11.3821; Raphael MP, 2012, ANAL CHEM, V84, P1367, DOI 10.1021/ac2023266; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smith ZJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28533; Su J, 2015, ACS PHOTONICS, V2, P1241, DOI 10.1021/acsphotonics.5b00142; Thakur A, 2017, BIOSENS BIOELECTRON, V94, P400, DOI 10.1016/j.bios.2017.03.036; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Witwer KW, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1396823; Yoshioka Y, 2014, NAT COMMUN, P5, DOI [10.1038/ncomms4591WOS:000335220400009, DOI 10.1038/NCOMMS459125230337]	32	43	43	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202773	10.1371/journal.pone.0202773	http://dx.doi.org/10.1371/journal.pone.0202773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142169	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500031
J	Hallali, E; Kokou, F; Chourasia, TK; Nitzan, T; Con, P; Harpaz, S; Mizrahi, I; Cnaani, A				Hallali, Eyal; Kokou, Fotini; Chourasia, Tapan Kumar; Nitzan, Tali; Con, Pazit; Harpaz, Sheenan; Mizrahi, Itzhak; Cnaani, Avner			Dietary salt levels affect digestibility, intestinal gene expression, and the microbiome, in Nile tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; APPARENT DIGESTIBILITY; FUNCTIONAL-PROPERTIES; PEPTIDE TRANSPORTERS; ABSORPTION; GROWTH; ACCLIMATION; BACTERIA; FRESH	Nile tilapia (Oreochromis niloticus) is the world's most widely cultured fish species. Therefore, its nutritional physiology is of great interest from an aquaculture perspective. Studies conducted on several fish species, including tilapia, demonstrated the beneficial effects of dietary salt supplementation on growth; however, the mechanism behind these beneficial effects is still not fully understood. The fish intestine is a complex system, with functions, such as nutrient absorption, ion equilibrium and acid-base balance that are tightly linked and dependent on each other's activities and products. Ions are the driving force in the absorption of feed components through pumps, transporters and protein channels. In this study, we examined the impact of 5% increase in dietary NaCl on protein, lipid, ash and dry matter digestibility, as well as on the expression of intestinal peptide transporters (PepTs) and ion pumps (Na+/K+-ATPase, V-H+-ATPase, N+/H+-Exchanger) in Nile tilapia. In addition, effects on the gut microbiome were evaluated. Our results show that dietary salt supplementation significantly increased digestibility of all measured nutritional components, peptide transporters expression and ion pumps activity. Moreover, changes in the gut microbial diversity were observed, and were associated with lipid digestibility and Na+/K+-ATPase expression.	[Hallali, Eyal; Kokou, Fotini; Chourasia, Tapan Kumar; Nitzan, Tali; Con, Pazit; Harpaz, Sheenan; Cnaani, Avner] Agr Res Org, Inst Anim Sci, Rishon Leziyyon, Israel; [Hallali, Eyal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Kokou, Fotini; Mizrahi, Itzhak] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Bar Ilan University; Ben Gurion University	Cnaani, A (corresponding author), Agr Res Org, Inst Anim Sci, Rishon Leziyyon, Israel.	avnerc@agri.gov.il	Chourasia, Tapan Kumar/GNW-4226-2022	Chourasia, Tapan Kumar/0000-0003-1638-2720; Kokou, Fotini/0000-0002-3675-3835; Cnaani, Avner/0000-0003-0097-8693	Chief Scientist of the Ministry of Agriculture and Rural Development [356-5469, 356-0672]; BARD (US-Israel Binational Agricultural Research and Development) [IS-4800-15]	Chief Scientist of the Ministry of Agriculture and Rural Development; BARD (US-Israel Binational Agricultural Research and Development)(US-Israel Binational Science Foundation)	This research was supported by grants 356-5469 and 356-0672 from the Chief Scientist of the Ministry of Agriculture and Rural Development and grant IS-4800-15 from BARD (US-Israel Binational Agricultural Research and Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rhman AM, 2009, FISH SHELLFISH IMMUN, V27, P175, DOI 10.1016/j.fsi.2009.03.020; Austreng E, 2000, AQUACULTURE, V188, P65, DOI 10.1016/S0044-8486(00)00336-7; Bakke AM, 2011, FISH PHYSIOL, V30, P57, DOI 10.1016/S1546-5098(10)03002-5; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chourasia TK, 2018, COMP BIOCHEM PHYS A, V218, P16, DOI 10.1016/j.cbpa.2018.01.004; Clements KD, 2014, MOL ECOL, V23, P1891, DOI 10.1111/mec.12699; Cnaani A, 2012, ISR J AQUACULT-BAMID, V64; Cnaani A, 2010, AQUAC RES, V41, P1545, DOI 10.1111/j.1365-2109.2009.02438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Con P, 2017, FRONT PHYSL FRONTIER, V8, P57, DOI [10.3389/fphys.2017.00057, DOI 10.3389/FPHYS.2017.00057]; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Fontainhas-Fernandes A, 2000, FISH PHYSIOL BIOCHEM, V23, P307, DOI 10.1023/A:1011156806524; Friedman N, 2017, ENVIRON MICROBIOL, V19, P174, DOI 10.1111/1462-2920.13551; GANAPATHY V, 1985, AM J PHYSIOL, V249, pG153, DOI 10.1152/ajpgi.1985.249.2.G153; GATLIN DM, 1992, PROG FISH CULT, V54, P220, DOI 10.1577/1548-8640(1992)054&lt;0220:EODSCO&gt;2.3.CO;2; Goddard JS, 2001, AQUACULTURE, V194, P93, DOI 10.1016/S0044-8486(00)00499-3; Grosell M, 2009, J EXP BIOL, V212, P1684, DOI 10.1242/jeb.027730; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; Grosell M, 2011, FISH PHYSIOL, V30, P135, DOI 10.1016/S1546-5098(10)03004-9; Harpaz S, 2005, AQUACULTURE, V248, P315, DOI 10.1016/j.aquaculture.2005.03.007; Hatlen B, 2015, AQUACULTURE, V435, P301, DOI 10.1016/j.aquaculture.2014.10.008; Hawkings GS, 2004, J EXP BIOL, V207, P905, DOI 10.1242/jeb.00844; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Jimoh W. A., 2010, International Journal of Fisheries and Aquaculture, V2, P102; Lee SM, 2002, AQUACULTURE, V207, P79, DOI 10.1016/S0044-8486(01)00751-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margheritis E, 2013, COMP BIOCHEM PHYS A, V166, P285, DOI 10.1016/j.cbpa.2013.06.027; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nakajima M, 2016, AQUACULTURE, V460, P1, DOI 10.1016/j.aquaculture.2016.04.003; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Nengas I., 1995, Aquaculture Research, V26, P185, DOI 10.1111/j.1365-2109.1995.tb00901.x; Nitzan T, 2017, AQUACULTURE, V472, P71, DOI 10.1016/j.aquaculture.2016.01.020; Romano A, 2006, PHYSIOL GENOMICS, V24, P207, DOI 10.1152/physiolgenomics.00227.2005; Sangaletti R, 2009, PFLUG ARCH EUR J PHY, V459, P47, DOI 10.1007/s00424-009-0700-0; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Sun H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01558; Terova G, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-17; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; Verri T, 2003, FEBS LETT, V549, P115, DOI 10.1016/S0014-5793(03)00759-2; Verri T, 2017, J COMP PHYSIOL B, V187, P395, DOI 10.1007/s00360-016-1044-7; Verri T, 2011, BIOL LETTERS, V7, P597, DOI 10.1098/rsbl.2010.1164; Wang Y, 2011, AQUAC RES, V42, P1170, DOI 10.1111/j.1365-2109.2010.02705.x	45	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202351	10.1371/journal.pone.0202351	http://dx.doi.org/10.1371/journal.pone.0202351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138368	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100054
J	Heinemann, F; Birk, G; Schoenberger, T; Stierstorfer, B				Heinemann, Fabian; Birk, Gerald; Schoenberger, Tanja; Stierstorfer, Birgit			Deep neural network based histological scoring of lung fibrosis and inflammation in the mouse model system	PLOS ONE			English	Article							PULMONARY-FIBROSIS	Preclinical studies of novel compounds rely on quantitative readouts from animal models. Frequently employed readouts from histopathological tissue scoring are time consuming, require highly specialized staff and are subject to inherent variability. Recent advances in deep convolutional neural networks (CNN) now allow automating such scoring tasks. Here, we demonstrate this for the case of the Ashcroft fibrosis score and a newly developed inflammation score to characterize fibrotic and inflammatory lung diseases. Sections of lung tissue from mice exhibiting a wide range of fibrotic and inflammatory states were stained with Masson trichrome. Whole slide scans using a 20x objective were acquired and cut into smaller tiles of 512x512 pixels. The tiles were subsequently classified by specialized CNNs, either an "Ashcroft fibrosis CNN" or an "inflammation CNN". For the Ashcroft fibrosis score the CNN was fine-tuned by using 14000 labelled tiles. For the inflammation score the CNN was trained with 3500 labelled tiles. After training, the Ashcroft fibrosis CNN achieved an accuracy of 79.5% and the inflammation CNN an accuracy of 80.0%. An error analysis revealed that misclassifications are almost exclusively with neighboring scores, which reflects the inherent ambiguity of parts of the data. The variability between two experts was found to be larger than the variability between the CNN classifications and the ground truth. The CNN generated Ashcroft score was in very good agreement with the score of a pathologist (r(2) = 0.92). Our results demonstrate that costly and time consuming scoring tasks can be automated and standardized with deep learning. New scores such as the inflammation score can be easily developed with the approach presented here.	[Heinemann, Fabian; Birk, Gerald; Schoenberger, Tanja; Stierstorfer, Birgit] Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res, Biberach, Germany	Boehringer Ingelheim	Heinemann, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res, Biberach, Germany.	fabian.heinemann@boehringer-ingelheim.com		Heinemann, Fabian/0000-0002-9710-7351				Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Canziani A ., 2016, ARXIV160507678; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Chollet F., 2015, KERAS PYTHON DEEP LE; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gilhodes JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170561; Hakansson HF, 2012, PULM PHARMACOL THER, V25, P399, DOI 10.1016/j.pupt.2012.08.001; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Maglogiannis I, 2008, IEEE T INF TECHNOL B, V12, P42, DOI 10.1109/TITB.2006.888702; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; REDMON J, 2017, PROC CVPR IEEE, DOI [DOI 10.1109/CVPR.2017.690, 10.1109/CVPR.2017.690]; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Seger S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193057; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Tasoulis SK, 2012, IFIP INT C ART INT A; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang D., 2016, ARXIV PREPRINT ARXIV; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008	30	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202708	10.1371/journal.pone.0202708	http://dx.doi.org/10.1371/journal.pone.0202708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138413	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100110
J	Ivert, T; Malmstrom, H; Hammar, N; Carlsson, AC; Wandell, PE; Holzmann, MJ; Jungner, I; Arnlov, J; Walldius, G				Ivert, Torbjorn; Malmstrom, Hakan; Hammar, Niklas; Carlsson, Axel C.; Wandell, Per E.; Holzmann, Martin J.; Jungner, Ingmar; Arnlov, Johan; Walldius, Goran			Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; RISK-FACTORS; SERUM-CHOLESTEROL; APOLIPOPROTEIN-B; HEART-DISEASE; A-I; MEN; PREVENTION; MANAGEMENT	Background The long-term trajectories of lipid and glucose levels in subjects who experience a major cardiovascular (CV) event at a young age has not been well studied. Our objective was to investigate lipid, lipoprotein, apolipoprotein (apo), and glucose levels in individuals experiencing a CV event before 50 years of age. Methods and findings A first CV event [non-fatal myocardial infarction (MI), coronary revascularisation, or CV related death] before age 50 was recorded in 2,939 (cumulative incidence 1.2% in males and 0.3% in females) of 361,353 individuals included in the prospective Swedish AMORIS (Apolipoprotein-related MOrtality RISk) study with health examinations 1985-1996 and follow-up through 2011. In a nested case-control analysis, cases with a CV event were matched to randomly selected controls. Population risk factor trajectories were calculated up to 20 years prior to an event. Total cholesterol (TC), triglyceride (TG), and glucose levels were higher in cases than in controls as early as 20 years prior to the event with differences increasing over time. Low density lipoprotein, apoB, and the apoB/apoA-1 ratio were higher and increased over time, while HDL and apoA-1 were lower in cases compared to controls. The odds ratio was 2.5 (95% confidence interval 1.6-3.7) for TC >= 5 mmol/L and TG >= 1.7 mmol/L in cases versus controls. The adjusted population-attributable fractions including lipids, glucose, diabetes, smoking, hypertension, and obesity indicated that about 50% of CV events before age 50 may be associated with elevated lipid and glucose levels. Conclusions Elevated TC, TG, LDL, apoB, and glucose levels and high apoB/apo A-1 ratio documented two decades before a CV event in subjects younger than 50 years may account for about half of CV events before age 50, which calls for early recognition and possibly treatment of modifiable CV risk factors in young individuals.	[Ivert, Torbjorn] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Ivert, Torbjorn] Karolinska Univ Hosp, Heart & Vasc Theme, Stockholm, Sweden; [Malmstrom, Hakan; Hammar, Niklas; Jungner, Ingmar; Walldius, Goran] Karolinska Inst, Inst Environm Med, Unit Epidemiol, Stockholm, Sweden; [Malmstrom, Hakan] Swedish Orphan Biovitrum Sobi, Biostat Data Management & Med Writing Res & Dev, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca, Global Med Affairs, Med Evidence & Observat Res, Molndal, Sweden; [Carlsson, Axel C.; Wandell, Per E.; Arnlov, Johan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Huddinge, Sweden; [Carlsson, Axel C.] Uppsala Univ Hosp, Dept Med Sci, Uppsala, Sweden; [Holzmann, Martin J.] Karolinska Univ Hosp, Dept Emergency Med, Huddinge, Sweden; [Holzmann, Martin J.] Karolinska Inst, Dept Internal Med, Solna, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; AstraZeneca; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Dalarna University	Ivert, T (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Ivert, T (corresponding author), Karolinska Univ Hosp, Heart & Vasc Theme, Stockholm, Sweden.	torbjorn.ivert@ki.se	Ärnlöv, Johan/AAF-2746-2019	Ärnlöv, Johan/0000-0002-6933-4637; Carlsson, Axel C/0000-0001-6113-0472; Ivert, Torbjorn/0000-0002-4052-7574; Wandell, Per/0000-0001-5169-2965	Gunnar and Ingmar Jungner Foundation [671-97-14421]	Gunnar and Ingmar Jungner Foundation	The Gunnar and Ingmar Jungner Foundation is a non-commercial foundation with a primary goal to fund laboratory medicine and medical research. This foundation has contributed to the establishment of the AMORIS cohort at Karolinska Institutet and also provided a nonrestricted grant to the Institute of Environmental Medicine, Karolinska Institutet for research based on this cohort. The foundation has not made any claims or suggestions as to the contents of this research or had any influence on the work on the current manuscript. The chair of the foundation, Associate Professor Ingmar Jungner, is co-author of this manuscript based on his expertise in laboratory medicine. The foundation was registered in Stockholm, Sweden 1998-03-02 (No. 671-97-14421) (GW).	BERGSTRAND R, 1982, EUR HEART J, V3, P130, DOI 10.1093/oxfordjournals.eurheartj.a061274; BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891; Carlsson AC, 2016, HEART; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8; Jungner I, 1998, CLIN CHEM, V44, P1641; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Krogsboll L, 2012, BMJ-BRIT MED J, V345, pe7191, DOI DOI 10.1136/BMJ.E7191; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Malmstrom H, 2018, DIABETES OBES METAB, V20, P1419, DOI 10.1111/dom.13241; Mukherjee D, 2003, AM J CARDIOL, V92, P1465, DOI 10.1016/j.amjcard.2003.08.062; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Piepoli MF, 2016, EUR J PREV CARDIOL, V23, pNP1, DOI 10.1177/2047487316653709; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rothman KJ, 1988, MODERN EPIDEMIOLOGY, V2nd; Schiele F, 2017, EUR J PREV CARDIOL, V24, P88, DOI 10.1177/2047487317706586; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tracy RE, 1995, AM J MED SCI, V310, pS37, DOI 10.1097/00000441-199512000-00007; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Vallejo-Vaz AJ, 2015, ATHEROSCLEROSIS, V243, P257, DOI 10.1016/j.atherosclerosis.2015.09.021; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 2017, INT J EPIDEMIOL, V46, P1103, DOI 10.1093/ije/dyw333; Walldius G, 2012, LIPOPROTEINS - ROLE IN HEALTH AND DISEASES, P95, DOI 10.5772/47869; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201972	10.1371/journal.pone.0201972	http://dx.doi.org/10.1371/journal.pone.0201972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138379	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100031
J	Mapa, MST; Le, VQ; Wimalasena, K				Mapa, Mapa S. T.; Le, Viet Q.; Wimalasena, Kandatege			Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4 ' I-MPP+	PLOS ONE			English	Article							VITRO DOPAMINERGIC TOXINS; RAPID COLORIMETRIC ASSAY; 4-(4-(DIMETHYLAMINO)PHENYL)-1-METHYLPYRIDINIUM APP(+); INHIBITION; 1-METHYL-4-PHENYLPYRIDINIUM; NEUROTOXIN; TRANSPORTER; APOPTOSIS; LIVER; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	The discovery that 1 -methyl-4-phenylpyridinium (MPP+) selectively destroys dopaminergic neurons and causes Parkinson's disease (PD) symptoms in mammals has strengthened the environmental hypothesis of PD. The current model for the dopaminergic toxicity of MPP+ is centered on its uptake into dopaminergic neurons, accumulation into the mitochondria, inhibition of the complex-I leading to ATP depletion, increased reactive oxygen species (ROS) production, and apoptotic cell death. However, some aspects of this mechanism and the details of the cellular and mitochondrial accumulation of MPP+ are still poorly understood. The aim of this study was to characterize a structural and functional MPP+ mimic which is suitable to study the cellular distribution and mitochondrial uptake of MPP+ in live cells and use it to identify the molecular details of these processes to advance the understanding of the mechanism of the selective dopaminergic toxicity of MPP+. Here we report the characterization of the fluorescent MPP+ derivative, 1-methyl-4-(4'-iodophenyl)pyridinium (4'I-MPP+), as a suitable candidate for this purpose. Using this novel probe, we show that cytosolic/mitochondrial Ca2+ play a critical role through the sodium-calcium exchanger (NCX) in the mitochondrial and cellular accumulation of MPP+ suggesting for the first time that MPP+ and related mitochondrial toxins may also exert their toxic effects through the perturbation of Ca2+ homeostasis in dopaminergic cells. We also found that the specific mitochondrial NCX (mNCX) inhibitors protect dopaminergic cells from the MPP+ and 4'I-MPP+ toxicity, most likely through the inhibition of the mitochondrial uptake, which could potentially be exploited for the development of pharmacological agents to protect the central nervous system (CNS) dopaminergic neurons from PD-causing environmental toxins.	[Mapa, Mapa S. T.; Le, Viet Q.; Wimalasena, Kandatege] Wichita State Univ, Dept Chem, Wichita, KS 67208 USA; [Le, Viet Q.] Rochester Inst Technol, Natl Tech Inst Deaf, Dept Sci & Math, Rochester, NY 14623 USA	Wichita State University; Rochester Institute of Technology	Wimalasena, K (corresponding author), Wichita State Univ, Dept Chem, Wichita, KS 67208 USA.	kandatege.wimalasena@wichita.edu						AIUCHI T, 1988, NEUROCHEM INT, V12, P525, DOI 10.1016/0197-0186(88)90038-1; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKEMEIER KM, 1994, MOL CELL BIOCHEM, V139, P33, DOI 10.1007/BF00944201; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Dai XQ, 2007, MOL PHARMACOL, V72, P1576, DOI 10.1124/mol.107.037150; DAVEY GP, 1992, BIOCHEM J, V288, P439, DOI 10.1042/bj2880439; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Davis SE, 2012, J NEUROSCI, V32, P13582, DOI 10.1523/JNEUROSCI.0809-12.2012; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; EPHARDT H, 1991, J PHYS CHEM-US, V95, P6792, DOI 10.1021/j100171a011; Finichiu PG, 2013, J BIOENERG BIOMEMBR, V45, P165, DOI 10.1007/s10863-012-9493-5; FREI B, 1986, FEBS LETT, V198, P99, DOI 10.1016/0014-5793(86)81192-9; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; FRITZ RR, 1985, FEBS LETT, V186, P224, DOI 10.1016/0014-5793(85)80713-4; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; George JL, 2009, CURR NEUROPHARMACOL, V7, P9, DOI 10.2174/157015909787602814; GLUCK MR, 1994, J BIOL CHEM, V269, P3167; Haenisch B, 2010, N-S ARCH PHARMACOL, V381, P33, DOI 10.1007/s00210-009-0479-8; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Jacob TJC, 1996, AM J PHYSIOL-CELL PH, V271, pC703, DOI 10.1152/ajpcell.1996.271.3.C703; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Joshi DC, 2011, JOVE-J VIS EXP, DOI 10.3791/2704; Kadigamuwa CC, 2016, CHEM RES TOXICOL, V29, P1468, DOI 10.1021/acs.chemrestox.6b00138; Kadigamuwa CC, 2015, J NEUROCHEM, V135, P755, DOI 10.1111/jnc.13201; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Kamalian L, 2015, TOXICOL IN VITRO, V29, P732, DOI 10.1016/j.tiv.2015.02.011; Karpowicz RJ, 2013, ACS CHEM NEUROSCI, V4, P858, DOI 10.1021/cn400038u; LeBel CP, 1992, CHEM RES TOXICOL, V5, DOI [10.1111/j.1471-4159.2006.04025.x, DOI 10.1111/J.1471-4159.2006.04025.X]; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Martel F, 1999, EUR J PHARMACOL, V379, P211, DOI 10.1016/S0014-2999(99)00501-4; Mohanakumar KP, 2002, NEUROSCI RES COMMUN, V30, P35, DOI 10.1002/nrc.10015; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Nicolau SM, 2009, J PHARMACOL EXP THER, V330, P844, DOI 10.1124/jpet.109.154765; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Oubrahim H, 2001, P NATL ACAD SCI USA, V98, P9505, DOI 10.1073/pnas.181319898; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; RAMSAY RR, 1986, J BIOL CHEM, V261, P7585; RAMSAY RR, 1991, J NEUROCHEM, V56, P1184, DOI 10.1111/j.1471-4159.1991.tb11409.x; Seki S, 2002, CIRC J, V66, P390, DOI 10.1253/circj.66.390; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; Solis E, 2012, J BIOL CHEM, V287, P8852, DOI 10.1074/jbc.M111.267757; Sonsalla Patricia K, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS116, DOI 10.1016/j.parkreldis.2008.04.008; Tretter L, 1998, MOL PHARMACOL, V53, P734, DOI 10.1124/mol.53.4.734; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Wilson JN, 2014, ACS CHEM NEUROSCI, V5, P296, DOI 10.1021/cn400230x; Wimalasena DS, 2008, J MED CHEM, V51, P760, DOI 10.1021/jm070875p; Xu Q, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00496-6; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N	54	18	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0197946	10.1371/journal.pone.0197946	http://dx.doi.org/10.1371/journal.pone.0197946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138351	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100001
J	Latulippe, J; Lotito, D; Murby, D				Latulippe, Joe; Lotito, Derek; Murby, Donovan			A mathematical model for the effects of amyloid beta on intracellular calcium	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; INOSITOL 1,4,5-TRISPHOSPHATE; CA2+ RELEASE; OSCILLATIONS; RECEPTOR; RYANODINE; DYSREGULATION; HOMEOSTASIS; ASTROCYTES	The accumulation of Alzheimer's disease (AD) associated Amyloid beta (A beta) oligomers can trigger aberrant intracellular calcium (Ca2+) levels by disrupting the intrinsic Ca2+ regulatory mechanism within cells. These disruptions can cause changes in homeostasis levels that can have detrimental effects on cell function and survival. Although studies have shown that A beta can interfere with various Ca2+ fluxes, the complexity of these interactions remains elusive. We have constructed a mathematical model that simulates Ca2+ patterns under the influence of A beta. Our simulations shows that A beta can increase regions of mixed-mode oscillations leading to aberrant signals under various conditions. We investigate how A beta affects individual flux contributions through inositol triphosphate (IP3) receptors, ryanodine receptors, and membrane pores. We demonstrate that controlling for the ryanodine receptor's maximal kinetic reaction rate may provide a biophysical way of managing aberrant Ca2+ signals. The influence of a dynamic model for IP3 production is also investigated under various conditions as well as the impact of changes in membrane potential. Our model is one of the first to investigate the effects of A beta on a variety of cellular mechanisms providing a base modeling scheme from which further studies can draw on to better understand Ca2+ regulation in an AD environment.	[Latulippe, Joe; Murby, Donovan] Norwich Univ, Math Dept, Northfield, VT 05663 USA; [Lotito, Derek] Norwich Univ, Chem & Biochem Dept, Northfield, VT USA		Latulippe, J (corresponding author), Norwich Univ, Math Dept, Northfield, VT 05663 USA.	jlatulip@norwich.edu			Norwich University; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	Norwich University; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. Part of this study was also funded by a Faculty Development grant from Norwich University.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Abramov AY, 2003, J NEUROSCI, V23, P5088; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; [Anonymous], 2017, MATLAB 2017B; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Breslin K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006151; Briggs CA, 2017, BIOCHEM BIOPH RES CO, V483, P988, DOI 10.1016/j.bbrc.2016.09.088; Briggs CA, 2013, NEUROBIOL AGING, V34, P1632, DOI 10.1016/j.neurobiolaging.2012.12.013; Brons M, 2015, MATH POPUL STUD, V22, P71, DOI 10.1080/08898480.2014.925344; Chakroborty S, 2014, EUR J PHARMACOL, V739, P83, DOI 10.1016/j.ejphar.2013.11.012; Costa RO, 2012, AGING CELL, V11, P823, DOI 10.1111/j.1474-9726.2012.00848.x; Dallerac G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00159; De Caluwe J, 2013, J THEOR BIOL, V331, P12, DOI 10.1016/j.jtbi.2013.04.015; Dehkordy SR, 2014, P ICEE EL ENG 22 IR; Del Prete D, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-21; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2013, J NEUROSCI, V33, P3824, DOI 10.1523/JNEUROSCI.4367-12.2013; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Desroches M, 2012, SIAM REV, V54, P211, DOI 10.1137/100791233; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; DOEDEL EJ, 1981, P 10 MAN C NUM MATH, P265; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Dupont G., 2016, MODELS CALCIUM SIGNA; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Fall CP., 2002, COMPUTATIONAL CELL B; Favre CJ, 1996, J BIOL CHEM, V271, P14925, DOI 10.1074/jbc.271.25.14925; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harvey E, 2011, J NONLINEAR SCI, V21, P639, DOI 10.1007/s00332-011-9096-z; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; KEENER J., 2009, MATH PHYSL CELLULAR; Keizer J, 1996, BIOPHYS J, V71, P3477, DOI 10.1016/S0006-3495(96)79543-7; Kenny A, 2018, J COMPUT NEUROSCI, V44, P97, DOI 10.1007/s10827-017-0671-7; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; LeBeau AP, 2000, J NEUROSCI, V20, P9290; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Liang JY, 2015, BIOSYSTEMS, V134, P1, DOI 10.1016/j.biosystems.2015.05.003; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MANNINEN T, 2018, FRONT COMPUT NEUROSC, V12, DOI DOI 10.3389/FNC0M.2018.00014; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; OTHMER HG, 1993, NATO ADV SCI INST SE, V259, P277; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Popugaeva E, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00029; Ries M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00160; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Ripoli C, 2013, NEUROBIOL AGING, V34, P1032, DOI 10.1016/j.neurobiolaging.2012.06.027; Seifert G, 2018, BRAIN RES BULL, V136, P26, DOI 10.1016/j.brainresbull.2016.12.002; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shtifman A, 2010, NEUROBIOL AGING, V31, P2080, DOI 10.1016/j.neurobiolaging.2008.11.003; Sibille J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004137; Sims CE, 1998, J BIOL CHEM, V273, P4052, DOI 10.1074/jbc.273.7.4052; Sneyd J, 2003, BIOPHYS J, V85, P1392, DOI 10.1016/S0006-3495(03)74572-X; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tang J, 2016, COMMUN NONLINEAR SCI, V32, P262, DOI 10.1016/j.cnsns.2015.08.019; Ullah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137357	74	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202503	10.1371/journal.pone.0202503	http://dx.doi.org/10.1371/journal.pone.0202503			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133494	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400076
J	Weckel, A; Ahamada, D; Bellais, S; Mehats, C; Plainvert, C; Longo, M; Poyart, C; Fouet, A				Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes			The N-terminal domain of the R28 protein promotes emm28 group A Streptococcus adhesion to host cells via direct binding to three integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus pyogenes (S pyogenes); host-pathogen interaction; infection; adhesion; integrin; protein-protein interaction	GROUP-B STREPTOCOCCUS; ALPHA-C-PROTEIN; SURFACE-PROTEINS; GENOME SEQUENCE; COLONIZATION; EXPRESSION; IDENTIFICATION; RECEPTOR; GLYCOSAMINOGLYCAN; INTERNALIZATION	Group A Streptococcus (GAS) is a human-specific pathogen responsible for a wide range of diseases, ranging from superficial to life-threatening invasive infections, including endometritis, and autoimmune sequelae. GAS strains express a vast repertoire of virulence factors that varies depending on the strain genotype, and many adhesin proteins that enable GAS to adhere to host cells are restricted to some genotypes. GAS emm28 is the third most prevalent genotype in invasive infections in France and is associated with gyneco-obstetrical infections. emm28 strains harbor R28, a cell wall-anchored surface protein that has previously been reported to promote adhesion to cervical epithelial cells. Here, using cellular and biochemical approaches, we sought to determine whether R28 supports adhesion also to other cells and to characterize its cognate receptor. We show that through its N-terminal domain, R28(Nt), R28 promotes bacterial adhesion to both endometrial-epithelial and endometrial-stromal cells. R28(Nt) was further subdivided into two domains, and we found that both are involved in cell binding. R28(Nt) and both subdomains interacted directly with the laminin-binding alpha 3 beta 1, alpha 6 beta 1, and alpha 6 beta 4 integrins; interestingly, these bindings events did not require divalent cations. R28 is the first GAS adhesin reported to bind directly to integrins that are expressed in most epithelial cells. Finally, R28(Nt) also promoted binding to keratinocytes and pulmonary epithelial cells, suggesting that it may be involved in supporting the prevalence in invasive infections of the emm28 genotype.	[Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes] Inst Cochin, INSERM, U1016, Paris, France; [Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes] CNRS, UMR 8104, Paris, France; [Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes] Univ Paris 05, UMR S1016, Paris, France; [Plainvert, Celine; Poyart, Claire; Fouet, Agnes] Ctr Natl Reference Streptocoques, F-75014 Paris, France; [Plainvert, Celine; Poyart, Claire] Hop Univ Paris Ctr, AP HP, Inst Cochin, F-75014 Paris, France; [Bellais, Samuel] Bioaster, 28 Rue Dr Roux, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fouet, A (corresponding author), Inst Cochin, 22 Rue Mech, F-75014 Paris, France.	agnes.fouet@inserm.fr	Mehats, Celine/D-8650-2017	Fouet, Agnes/0000-0001-7715-9157; Mehats, Celine/0000-0002-3677-2024; Weckel, Antonin/0000-0002-5085-0551	European Regional Development Fund (ERDF) through the Operational Programme for Competitiveness Factors and Employment 2007-2013; Canceropole Ile de France	European Regional Development Fund (ERDF) through the Operational Programme for Competitiveness Factors and Employment 2007-2013; Canceropole Ile de France(Region Ile-de-France)	We thank Wassim El Nemer, Julie Guignot, and Cecile Arrieumerlou for helpful discussions and Philippe Glaser for sequencing and providing the relevant contigs of the Delta R28 strain. We thank Cedric Broussard (LC-MS supervision and in-gel protein digestion); Evangeline Bennana (proteomics data collection, analysis, and reporting), Marjorie Leduc (LIMS management); and Francois Guillonneau, Philippe Chafey, and Patrick Mayeux (proteomics expertise and experimental design) from the 3P5 proteomics facility of the Universite Paris Descartes, Sorbonne Paris Cite and the Imag'IC facility, both at the Cochin Institute. We thank the Margottin-Pique team for access to the TECAN plate reader. The Orbitrap Fusion mass spectrometer was acquired with funds from the European Regional Development Fund (ERDF) through the Operational Programme for Competitiveness Factors and Employment 2007-2013 and from the Canceropole Ile de France.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Auperin TC, 2005, J BIOL CHEM, V280, P18245, DOI 10.1074/jbc.M412391200; BAKER CJ, 1977, J INFECT DIS, V135, P392, DOI 10.1093/infdis/135.3.392; Baron MJ, 2007, J BIOL CHEM, V282, P10526, DOI 10.1074/jbc.M608279200; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bessen DE, 2016, CURR OPIN INFECT DIS, V29, P295, DOI 10.1097/QCO.0000000000000262; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bolduc GR, 2007, MICROBIOL-SGM, V153, P4039, DOI 10.1099/mic.0.2007/009134-0; Bolduc GR, 2002, CELL MICROBIOL, V4, P751, DOI 10.1046/j.1462-5822.2002.00227.x; Brouwer S, 2016, FEBS LETT, V590, P3739, DOI 10.1002/1873-3468.12254; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; FALCIONI R, 1994, EXP CELL RES, V210, P113, DOI 10.1006/excr.1994.1017; Gallotta M, 2014, INFECT IMMUN, V82, P2890, DOI 10.1128/IAI.00064-14; Gherardi G, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00059; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hamzaoui N, 2004, CELL MICROBIOL, V6, P817, DOI 10.1111/j.1462-5822.2004.00391.x; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Koller T, 2010, J MED MICROBIOL, V59, P442, DOI 10.1099/jmm.0.013581-0; Kong FR, 2002, J CLIN MICROBIOL, V40, P620, DOI 10.1128/JCM.40.2.620-626.2002; Lachenauer CS, 2000, P NATL ACAD SCI USA, V97, P9630, DOI 10.1073/pnas.97.17.9630; LESSEY BA, 1994, FERTIL STERIL, V62, P497; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Linke C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.376434; Longo M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00750-15; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Lynskey NN, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006493; Nobbs AH, 2015, INFECT GENET EVOL, V33, P361, DOI 10.1016/j.meegid.2014.09.018; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Rezcallah MS, 2005, CELL MICROBIOL, V7, P645, DOI 10.1111/j.1462-5822.2004.00497.x; Rohde M, 2016, STREPTOCOCCUS PYOGEN, P1; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Six A, 2015, MOL MICROBIOL, V97, P1209, DOI 10.1111/mmi.13097; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Stalhammar-Carlemalm M, 2000, J INFECT DIS, V182, P142, DOI 10.1086/315693; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wastfelt M, 1996, J BIOL CHEM, V271, P18892, DOI 10.1074/jbc.271.31.18892; Werner J, 2012, INNATE IMMUN-LONDON, V18, P55, DOI 10.1177/1753425910392934	60	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16006	16018		10.1074/jbc.RA118.004134	http://dx.doi.org/10.1074/jbc.RA118.004134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30150299	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000447256000021
J	Whittal, A; Kaviani, M; Graf, R; Humphreys, G; Navabi, A				Whittal, Alexander; Kaviani, Mina; Graf, Robert; Humphreys, Gavin; Navabi, Alireza			Allelic variation of vernalization and photoperiod response genes in a diverse set of North American high latitude winter wheat genotypes	PLOS ONE			English	Article							FLOWERING TIME; SPRING WHEAT; KOLMOGOROV-SMIRNOV; PPD-D1; BARLEY; TRAITS; ADAPTABILITY; ADAPTATION; REGULATOR; NORMALITY	The major physiological determinants of wheat (Triticum aestivum L.) phenology in a given area are a response to vernalization temperature and day length, which are at least in part, regulated by the allelic variation at the vernalization (VRN) and photoperiod (PPD) loci, respectively. Characterization of the existing genetic variation for plant phenology in winter wheat can assist breeding programs improve adaptation to local environments and to optimize wheat phenology for the changing climate. The objectives of this research were to characterize the allelic variation at the major VRNand PPD loci in a diverse panel of high latitude winter wheat genotypes (n = 203) and to associate the allelic variation with phenologic, agronomic and adaptation traits. The panel was genotyped using allele-specific markers at vernalization (VRN-A1, VRN-B1, VRN-D1 and VRN-B3) and photoperiod (PPD-A1, PPDB1, and PPD-D1) loci and phenotyped for agronomically-important traits. Though photoperiod sensitivity was more prevalent, most of the variation in the phenology of the winter wheat panel was explained by allelic variation at PPD-D1, PPD-A1, and the interaction between these loci. While a typical high latitude winter wheat genotype is one that carries winter alleles at all major VRN loci and photoperiod sensitive alleles at the major PPD loci, in lower latitudes where winters are milder, the presence of one or two photoperiod insensitive alleles seems to contribute to higher yield and wider adaptation.	[Whittal, Alexander; Kaviani, Mina; Navabi, Alireza] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [Graf, Robert] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Humphreys, Gavin] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada	University of Guelph; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Navabi, A (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON, Canada.	anavabi@uoguelph.ca	Kaviani, Mohammad Javad/T-9205-2019	Kaviani, Mina/0000-0002-5426-7208; Graf, Robert/0000-0003-0922-5049	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Grain Farmers of Ontario; SeCan National Scientific and Engineering Research Council of Canada (NSERC)	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Grain Farmers of Ontario; SeCan National Scientific and Engineering Research Council of Canada (NSERC)	Funded by Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Grain Farmers of Ontario, SeCan National Scientific and Engineering Research Council of Canada (NSERC).	ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Cane K, 2013, CROP PASTURE SCI, V64, P100, DOI 10.1071/CP13086; Chen H, 2016, EUPHYTICA, V208, P377, DOI 10.1007/s10681-015-1615-9; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; DARLING DA, 1957, ANN MATH STAT, V28, P823, DOI 10.1214/aoms/1177706788; DAVIDSON JL, 1985, AUST J AGR RES, V36, P347, DOI 10.1071/AR9850347; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dyck JA, 2004, CROP SCI, V44, P1976, DOI 10.2135/cropsci2004.1976; Fjellheim S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00431; Foulkes MJ, 2004, EUPHYTICA, V135, P63, DOI 10.1023/B:EUPH.0000009542.06773.13; Fowler DB, 2001, PLANT PHYSIOL, V127, P1676, DOI 10.1104/pp.010483; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Grogan SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152852; Guedira M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154242; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Iqbal M, 2006, CAN J PLANT SCI, V86, P995, DOI 10.4141/P06-002; Iqbal M, 2007, CROP SCI, V47, P1031, DOI 10.2135/cropsci2006.09.0618; Kamran A, 2013, CROP SCI, V53, P84, DOI 10.2135/cropsci2012.05.0313; Karsai I, 2006, PLANT BREEDING, V125, P468, DOI 10.1111/j.1439-0523.2006.01266.x; Kiss T, 2017, CEREAL RES COMMUN; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langer SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00537; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; MCMASTER GS, 1988, AGR FOREST METEOROL, V43, P1, DOI 10.1016/0168-1923(88)90002-0; Milec Z, 2013, EUPHYTICA, V192, P371, DOI 10.1007/s10681-013-0863-9; Miralles DJ, 2000, ANN BOT-LONDON, V85, P655, DOI 10.1006/anbo.2000.1121; Nakamichi N, 2015, PLANT CELL PHYSIOL, V56, P594, DOI 10.1093/pcp/pcu181; Procunier J. D., 1990, Barley Genetics Newsletter, V20, P74; PUGSLEY AT, 1972, EUPHYTICA, V21, P547, DOI 10.1007/BF00039355; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shcherban AB, 2015, PLANT BREEDING, V134, P49, DOI 10.1111/pbr.12223; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Worland AJ, 1996, EUPHYTICA, V89, P49, DOI 10.1007/BF00015718; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yang FP, 2009, EUPHYTICA, V165, P445, DOI 10.1007/s10681-008-9745-y; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang XF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00470	49	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203068	10.1371/journal.pone.0203068	http://dx.doi.org/10.1371/journal.pone.0203068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161188	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900074
J	Mattern, T; Putz, K; Garcia-Borboroglu, P; Ellenberg, U; Houston, DM; Long, R; Luthi, B; Seddon, PJ				Mattern, Thomas; Puetz, Klemens; Garcia-Borboroglu, Pablo; Ellenberg, Ursula; Houston, David M.; Long, Robin; Luethi, Benno; Seddon, Philip J.			Marathon penguins - Reasons and consequences of long-range dispersal in Fiordland penguins / Tawaki during the premoult period	PLOS ONE			English	Article							NEW-ZEALAND; PRE-MOLT; SUBTROPICAL FRONT; WINTER MIGRATION; SOUTHERN-OCEAN; HABITAT; CONSERVATION; BIRDS; ATTACHMENT; SEABIRDS	Migratory species often roam vast distances bringing them into contact with diverse conditions and threats that could play significant roles in their population dynamics. This is especially true if long-range travels occur within crucial stages of a species' annual life-cycle. Crested penguins, for example, usually disperse over several hundreds of kilometres after completing the energetically demanding breeding season and in preparation for the costly annual moult. A basic understanding of crested penguins' pre-moult dispersal is therefore paramount in order to be able to assess factors affecting individual survival. The Fiordland penguin, or Tawaki, the only crested penguin species breeding on the New Zealand mainland, is currently one of the least studied and rarest penguin species in the world. We successfully satellite tracked the pre-moult dispersal of 17 adult Tawaki from a single colony located in the species' northern breeding distribution. Over the course of 8-10 weeks the penguins travelled up to 2,500 km away from their breeding colony, covering total swimming distances of up to 6,800 km. During outbound travels all penguins headed south-west within a well-defined corridor before branching out towards two general trip destinations. Birds leaving in late November travelled towards the Subtropical Front some 800 km south of Tasmania, whereas penguins that left in December headed further towards the subantarctic front. Using K-select analysis we examined the influence of oceanographic factors on the penguins' dispersal. Water depth, surface current velocity and sea level anomalies had the greatest influence on penguin movements at the subantarctic Front, while sea surface temperature and chlorophyll a concentration were key for birds travelling to the subtropical front. We discuss our findings in the light of anthropogenic activities (or lack thereof) in the regions visited by the penguins as well as the potential consequences of Tawaki pre-moult dispersal for the species' breeding distribution on the New Zealand mainland.	[Mattern, Thomas] Univ Otago, Dept Zool, Dunedin, New Zealand; [Mattern, Thomas; Garcia-Borboroglu, Pablo; Ellenberg, Ursula; Seddon, Philip J.] Global Penguin Soc, Marcos Zar 2716, RA-9120 Puerto Madryn, Chubut, Argentina; [Puetz, Klemens] Antarctic Res Trust, Oste Hamme Kanal 10, Bremervorde, Germany; [Garcia-Borboroglu, Pablo] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Blvd Brown 2825, Puerto Madryn, Chubut, Argentina; [Ellenberg, Ursula] La Trobe Univ, Dept Ecol Environm & Evolut, Melbourne, Vic, Australia; [Houston, David M.] Dept Conservat, Sci & Policy Grp, Auckland, New Zealand; [Long, Robin] West Coast Penguin Trust, Hokitika, New Zealand; [Luethi, Benno] Antarctic Res Trust, Zoo Zurich, Zurichbergstr 221, Zurich, Switzerland	University of Otago; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); La Trobe University	Mattern, T (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.; Mattern, T (corresponding author), Global Penguin Soc, Marcos Zar 2716, RA-9120 Puerto Madryn, Chubut, Argentina.	t.mattern@eudyptes.net	Seddon, Philip/G-8659-2011; Mattern, Thomas/AAJ-6325-2020; Ellenberg, Ursula/AAF-7317-2020	Seddon, Philip/0000-0001-9076-9566; Mattern, Thomas/0000-0003-0745-8180; Ellenberg, Ursula/0000-0002-3100-6742; Puetz, Klemens/0000-0003-1375-2669	Antarctic Research Trust; Global Penguin Society; Ornithological Society New Zealand; JS Watson Trust; Forest Bird Southland	Antarctic Research Trust; Global Penguin Society; Ornithological Society New Zealand; JS Watson Trust; Forest Bird Southland	Devices and data acquisition costs were covered by the Antarctic Research Trust to TM. This study was funded through grants by the Global Penguin Society, Ornithological Society New Zealand (Birds NZ Research grant), the JS Watson Trust and Forest & Bird Southland to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; [Anonymous], 2014, R LANG ENV STAT COMP; BANNASCH R, 1994, J EXP BIOL, V194, P83; Berthold P, 2001, J ORNITHOL, V142, P148, DOI 10.1007/BF01651453; Berthold P, 1996, CONTROL BIRD MIGRATI; Beyer HL, 2010, GEOSPATIAL MODELLING; BirdLife International, 2016, EUD PACH IUCN RED LI, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22697776A93638571.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22697776A93638571.EN]; Bon C, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0057-2; Bostock HC, 2015, PALEOCEANOGRAPHY, V30, P824, DOI 10.1002/2014PA002652; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carter L, 2009, DEV EARTH ENV SCI, V8, P85, DOI 10.1016/S1571-9197(08)00004-9; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Crawford R, 2017, ENDANGER SPECIES RES, V34, P373, DOI 10.3354/esr00869; Croxall J. P., 1999, Marine Ornithology, V27, P1; Davis LS., 2003, PENGUINS; Dehnhard N, 2011, POLAR BIOL, V34, P1763, DOI 10.1007/s00300-011-1026-x; Dinica V, 2017, J SUSTAIN TOUR, V25, P1811, DOI 10.1080/09669582.2015.1115512; Ellenberg U, 2015, NEW ZEAL J ECOL, V39, P231; ESRI, 2011, ARCGIS DESKT REL 10; Falla RA, 1954, NOTORNIS, V5, P212; Fayet AL, 2016, BEHAV ECOL, V27, P1061, DOI 10.1093/beheco/arw013; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P321; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Hartin CA, 2014, GEOPHYS RES LETT, V41, P519, DOI 10.1002/2013GL058728; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hiscock JA, 2014, NEW ZEAL J ECOL, V38, P124; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Jaeger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016484; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Kooyman GL, 2000, MAR ECOL PROG SER, V204, P269, DOI 10.3354/meps204269; Kooyman GL, 2004, MAR ECOL PROG SER, V267, P281, DOI 10.3354/meps267281; Le Quere C, 2016, BIOGEOSCIENCES, V13, P4111, DOI 10.5194/bg-13-4111-2016; Long R, 2014, FIORDLAND CRESTED PE; Lowther AD, 2014, ANTARCT SCI, V26, P533, DOI 10.1017/S0954102014000170; Ludynia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050429; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Mattern T, 2017, TAWAKI PROJECT FIELD, DOI [10.13140/RG.2.2.31050.77760, DOI 10.13140/RG.2.2.31050.77760]; Mattern T, 2017, PEERJ, V5, DOI 10.7717/peerj.3272; Mattern T, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P153; Mattern T, 2009, EMU, V109, P204, DOI 10.1071/MU08001; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Meyer S, 2015, MAR BIOL, V162, P1587, DOI 10.1007/s00227-015-2695-8; Morgenthaler A, 2018, POLAR BIOL, V41, P1041, DOI 10.1007/s00300-018-2264-y; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; Norris DR, 2007, CONDOR, V109, P535; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Price R, 2016, FUNDING CUT IS NOT C; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Putz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097164; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; Ramos R, 2017, DIVERS DISTRIB, V23, P794, DOI 10.1111/ddi.12569; Ramos R, 2015, J BIOGEOGR, V42, P1651, DOI 10.1111/jbi.12541; Robertson HA, 2017, NZ THREAT CLASSIF SE, V19; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Smith RO, 2013, DEEP-SEA RES PT I, V76, P13, DOI 10.1016/j.dsr.2013.02.007; Thiebot JB, 2014, IBIS, V156, P511, DOI 10.1111/ibi.12151; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; van Heezik Y.M., 1989, Notornis, V36, P151; VANHEEZIK Y, 1990, NEW ZEAL J ZOOL, V17, P543, DOI 10.1080/03014223.1990.10422952; WARHAM J, 1974, IBIS, V116, P1, DOI 10.1111/j.1474-919X.1974.tb00220.x; Whitehead TO, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2794-6; Whitehead TO, 2017, MAR ECOL PROG SER, V565, P227, DOI 10.3354/meps12017; Wienecke B, 2004, POLAR BIOL, V27, P83, DOI 10.1007/s00300-003-0574-0; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1989, J FIELD ORNITHOL, V60, P104; Wood S.N., 2017, GEN ADDITIVE MODELS; Worthy Trevor H., 1997, New Zealand Natural Sciences, V23, P71	78	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0198688	10.1371/journal.pone.0198688	http://dx.doi.org/10.1371/journal.pone.0198688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157174	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400002
J	Musa, A; Tripathi, S; Kandhavelu, M; Dehmer, M; Emmert-Streib, F				Musa, Aliyu; Tripathi, Shailesh; Kandhavelu, Meenakshisundaram; Dehmer, Matthias; Emmert-Streib, Frank			Harnessing the biological complexity of Big Data from LINCS gene expression signatures	PLOS ONE			English	Article							CONNECTIVITY MAP; CELL-GROWTH; TARGET; CHALLENGES; RESPONSES	Gene expression profiling using transcriptional drug perturbations are useful for many biomedical discovery studies including drug repurposing and elucidation of drug mechanisms (MoA) and many other pharmacogenomic applications. However, limited data availability across cell types has severely hindered our capacity to progress in these areas. To fill this gap, recently, the LINCS program generated almost 1.3 million profiles for over 40,000 drug and genetic perturbations for over 70 different human cell types, including meta information about the experimental conditions and cell lines. Unfortunately, Big Data like the ones generated from the ongoing LINCS program do not enable easy insights from the data but possess considerable challenges toward their analysis. In this paper, we address some of these challenges. Specifically, first, we study the gene expression signature profiles from all cell lines and their perturbagents in order to obtain insights in the distributional characteristics of available conditions. Second, we investigate the differential expression of genes for all cell lines obtaining an understanding of condition dependent differential expression manifesting the biological complexity of perturbagents. As a result, our analysis helps the experimental design of follow-up studies, e.g., by selecting appropriate cell lines.	[Musa, Aliyu; Tripathi, Shailesh; Emmert-Streib, Frank] Tampere Univ Technol, Dept Signal Proc, Predict Med & Data Analyt Lab, Tampere, Finland; [Musa, Aliyu; Kandhavelu, Meenakshisundaram; Emmert-Streib, Frank] Tampere Univ Technol, Fac Biomed Sci & Engn, Mol Signaling Lab, Tampere, Finland; [Tripathi, Shailesh; Dehmer, Matthias] Univ Appl Sci Upper Austria, Steyr, Austria; [Kandhavelu, Meenakshisundaram] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland; [Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria	Tampere University; Tampere University; Tampere University	Emmert-Streib, F (corresponding author), Tampere Univ Technol, Dept Signal Proc, Predict Med & Data Analyt Lab, Tampere, Finland.; Emmert-Streib, F (corresponding author), Tampere Univ Technol, Fac Biomed Sci & Engn, Mol Signaling Lab, Tampere, Finland.	frank.emmert-streib@tut.fi	Emmert-Streib, Frank/AAF-2878-2020; Kandhavelu, Meenakshisundaram/AAZ-7503-2021; PAN, ZEQIANG/X-6341-2018; Trpathi, Shailesh/T-2123-2017	Emmert-Streib, Frank/0000-0003-0745-5641; Kandhavelu, Meenakshisundaram/0000-0002-4986-055X; Musa, Aliyu/0000-0003-1217-2638	Austrian Science Funds [P26142]	Austrian Science Funds(Austrian Science Fund (FWF))	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P26142).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Butcher RA, 2005, CURR OPIN CHEM BIOL, V9, P25, DOI 10.1016/j.cbpa.2004.10.009; Cayrefourcq L, 2015, CANCER RES, V75, P892, DOI 10.1158/0008-5472.CAN-14-2613; Duan QN, 2014, NUCLEIC ACIDS RES, V42, pW449, DOI 10.1093/nar/gku476; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emmert-Streib F, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00015; Emmert-Streib F, 2013, PEERJ, V1, DOI 10.7717/peerj.10; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Finley SD, 2015, DRUG DISCOV TODAY, V20, P187, DOI 10.1016/j.drudis.2014.09.026; Hafner M, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.166; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinkelmann K, 2008, DESIGN ANAL EXPT INT; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Keenan AB, 2018, CELL SYST, V6, P13, DOI 10.1016/j.cels.2017.11.001; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kibble M, 2015, NAT PROD REP, V32, P1249, DOI 10.1039/c5np00005j; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019750; Lim RG, 2017, CELL REP, V19, P1365, DOI 10.1016/j.celrep.2017.04.021; Lincscloud, 2014, LINCS L1000 R TOOLS; Liu CL, 2015, MOL BIOSYST, V11, P714, DOI 10.1039/c4mb00677a; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Musa A, 2018, BRIEF BIOINFORM, V19, P506, DOI 10.1093/bib/bbw112; Niepel M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01383-w; Nigsch F, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-2; Ong E, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1981-5; Pan W, 2002, GENOME BIOL, V3; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Simoes RD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-324; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Vidovic D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00342; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201937	10.1371/journal.pone.0201937	http://dx.doi.org/10.1371/journal.pone.0201937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157183	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400020
J	Ali, M; Ali, SI; Kim, D; Hur, T; Bang, J; Lee, S; Kang, BH; Hussain, M				Ali, Maqbool; Ali, Syed Imran; Kim, Dohyeong; Hur, Taeho; Bang, Jaehun; Lee, Sungyoung; Kang, Byeong Ho; Hussain, Maqbool			uEFS: An efficient and comprehensive ensemble-based feature selection methodology to select informative features	PLOS ONE			English	Article							ALGORITHMS; RANKING	Feature selection is considered to be one of the most critical methods for choosing appropriate features from a larger set of items. This task requires two basic steps: ranking and filtering. Of these, the former necessitates the ranking of all features, while the latter involves filtering out all irrelevant features based on some threshold value. In this regard, several feature selection methods with well-documented capabilities and limitations have already been proposed. Similarly, feature ranking is also nontrivial, as it requires the designation of an optimal cutoff value so as to properly select important features from a list of candidate features. However, the availability of a comprehensive feature ranking and a filtering approach, which alleviates the existing limitations and provides an efficient mechanism for achieving optimal results, is a major problem. Keeping in view these facts, we present an efficient and comprehensive univariate ensemble-based feature selection (uEFS) methodology to select informative features from an input dataset. For the uEFS methodology, we first propose a unified features scoring (UFS) algorithm to generate a final ranked list of features following a comprehensive evaluation of a feature set. For defining cutoff points to remove irrelevant features, we subsequently present a threshold value selection (TVS) algorithm to select a subset of features that are deemed important for the classifier construction. The uEFS methodology is evaluated using standard benchmark datasets. The extensive experimental results show that our proposed uEFS methodology provides competitive accuracy and achieved (1) on average around a 7% increase in f-measure, and (2) on average around a 5% increase in predictive accuracy as compared with state-of-the-art methods.	[Ali, Maqbool; Ali, Syed Imran; Kim, Dohyeong; Hur, Taeho; Bang, Jaehun; Lee, Sungyoung] Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, Gyeonggi, South Korea; [Ali, Maqbool; Kang, Byeong Ho] Univ Tasmania, Sch Engn & ICT, Hobart, Tas, Australia; [Hussain, Maqbool] Sejong Univ, Dept Software, Seoul, Gyeonggi, South Korea	Kyung Hee University; University of Tasmania; Sejong University	Lee, S (corresponding author), Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, Gyeonggi, South Korea.	sylee@oslab.khu.ac.kr	Kang, Byeong Ho/J-7907-2014; Lee, Sungyoung/AAK-7257-2020	Kang, Byeong Ho/0000-0003-3476-8838; , Maqbool/0000-0002-4107-7122	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) [IITP-2017-0-01629]; Institute for Information & Communications Technology Promotion (IITP) - Korean government (MSIT) [2017-0-00655]	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center); Institute for Information & Communications Technology Promotion (IITP) - Korean government (MSIT)	This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2017-0-01629) supervised by the IITP (Institute for Information & Communications Technology Promotion). This work was supported by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korean government (MSIT) (No. 2017-0-00655).	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Ahmad A, 2005, PATTERN RECOGN LETT, V26, P43, DOI 10.1016/j.patrec.2004.08.015; Ali M, 2017, DOCUMENTATION UFS FE; Ali M, 2017, UFS UNIFIED FEATURES; Ali M, 2018, IEEE ACCESS, V6, P15587, DOI 10.1109/ACCESS.2018.2817022; Ali M, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P382, DOI 10.1109/ICMLA.2013.78; Ali S., 2012, INT J COMPUT APPL, P1, DOI [DOI 10.1109/ICET.2012.6375420, 10.1109/ICET.2012.6375420]; Altidor W, 2011, STABILITY ANAL FEATU; Altidor W, 2011, HANDBOOK OF DATA INTENSIVE COMPUTING, P349, DOI 10.1007/978-1-4614-1415-5_13; Attik M, 2006, LECT NOTES COMPUT SC, V3971, P1359; Belanche L.A., 2011, ARXIV11012320; Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Chen Y, 2006, LECT NOTES COMPUT SC, V4318, P153; Das S., 2001, ICML, P74; Dhote Y, 2015, INT CONF COMPUT INTE, P1375, DOI 10.1109/CICN.2015.267; Doraisamy S., 2008, P ISMIR, P331; Grigorev A, 2014, RULE BASED CLASSIFIE; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Humphrey M., 1998, Intelligent Data Analysis, V2, DOI 10.1016/S1088-467X(98)00029-8; Jong K, 2004, LECT NOTES ARTIF INT, V3202, P267; Joshi R., 2018, ACCURACY PRECISION R; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; LIU H, 2005, SYSTEMS MAN CYBERN A, V17, P491, DOI DOI 10.1109/TKDE; Liu Z, ED TECHN COMP SCI ET, V1; Lutu PEN, 2010, EXPERT SYST APPL, V37, P602, DOI 10.1016/j.eswa.2009.06.031; Makrehchi M., 2007, FEATURE RANKING TEXT; McLachlan G.J., 2005, ANAL MICROARRAY GENE, V422; Novakovic Jasmina, 2016, YUGOSLAV J OPERATION, V21; Onan A, 2017, J INF SCI, V43, P25, DOI 10.1177/0165551515613226; Osanaiye O, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0623-3; Pratt R., 2012, 2012 IEEE PES Innovative Smart Grid Technologies (ISGT), DOI 10.1109/ISGT.2012.6175820; Rokach L, 2006, STUD COMPUT INTELL, V23, P295; Sadeghi S, 2013, INT J ARTIF INTELL T, V22, DOI 10.1142/S0218213013500103; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Santana LEA, 2007, IEEE IJCNN, P643, DOI 10.1109/IJCNN.2007.4371032; Sarkar C, 2014, APPL ARTIF INTELL, V28, P243, DOI 10.1080/08839514.2014.883903; Seijo-Pardo B, 2017, KNOWL-BASED SYST, V118, P124, DOI 10.1016/j.knosys.2016.11.017; Sharma A., 2012, IJCA SPECIAL ISSUE A, V3, P15; Slavkov I, 2010, JMLR WORKSH CONF PRO, V8, P122; Stoean R, 2013, ANN UNIV CRAIOVA-MAT, V40, P100; Tuv E, 2006, IEEE IJCNN, P2181; Wang GT, 2013, J ARTIF INTELL RES, V47, P1, DOI 10.1613/jair.3831; Whiteson S, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P1225; Williams G., 2010, CROSS VALIDATION DAT; Yousefpour A, 2017, EXPERT SYST APPL, V75, P80, DOI 10.1016/j.eswa.2017.01.009	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202705	10.1371/journal.pone.0202705	http://dx.doi.org/10.1371/journal.pone.0202705			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153294	Green Published, Green Accepted, gold			2022-12-26	WOS:000443001700022
J	Eickel, K; Porter, DA; Sohner, A; Maass, M; Ludemann, L; Gunther, M				Eickel, Klaus; Porter, David Andrew; Soehner, Anika; Maass, Marc; Luedemann, Lutz; Guenther, Matthias			Simultaneous multislice acquisition with multi-contrast segmented EPI for separation of signal contributions in dynamic contrast-enhanced imaging	PLOS ONE			English	Article							ARTERIAL INPUT FUNCTION; PERFUSION MRI; DCE-MRI; CANCER; MODEL; T-1	We present a method to efficiently separate signal in magnetic resonance imaging (MRI) into a base signal S0, representing the mainly T1 -weighted component without T2*-relaxation, and its T2*-weighted counterpart by the rapid acquisition of multiple contrasts for advanced pharmacokinetic modelling. This is achieved by incorporating simultaneous multislice (SMS) imaging into a multi-contrast, segmented echo planar imaging (EPI) sequence to allow extended spatial coverage, which covers larger body regions without time penalty. Simultaneous acquisition of four slices was combined with segmented EPI for fast imaging with three gradient echo times in a preclinical perfusion study. Six female domestic pigs, German-landrace or hybrid-form, were scanned for 11 minutes respectively during administration of gadolinium-based contrast agent. Influences of reconstruction methods and training data were investigated. The separation into T1- and T2*-dependent signal contributions was achieved by fitting a standard analytical model to the acquired multi-echo data. The application of SMS yielded sufficient temporal resolution for the detection of the arterial input function in major vessels, while anatomical coverage allowed perfusion analysis of muscle tissue. The separation of the MR signal into T1- and T2*-dependent components allowed the correction of susceptibility related changes. We demonstrate a novel sequence for dynamic contrast-enhanced MRI that meets the requirements of temporal resolution (Delta t< 1.5 s) and image quality. The incorporation of SMS into multi-contrast, segmented EPI can overcome existing limitations of dynamic contrast enhancement and dynamic susceptibility contrast methods, when applied separately. The new approach allows both techniques to be combined in a single acquisition with a large spatial coverage.	[Eickel, Klaus; Guenther, Matthias] Univ Bremen, Bermen, Germany; [Eickel, Klaus; Guenther, Matthias] Fraunhofer MEVIS, Bremen, Germany; [Eickel, Klaus; Guenther, Matthias] mediri GmbH, Heidelberg, Germany; [Porter, David Andrew] Univ Glasgow, Glasgow, Lanark, Scotland; [Soehner, Anika; Luedemann, Lutz] Univ Hosp Essen, Essen, Germany; [Maass, Marc] Evangel Krankenhaus Wesel, Wesel, Germany	University of Bremen; University of Glasgow; University of Duisburg Essen	Eickel, K (corresponding author), Univ Bremen, Bermen, Germany.; Eickel, K (corresponding author), Fraunhofer MEVIS, Bremen, Germany.; Eickel, K (corresponding author), mediri GmbH, Heidelberg, Germany.	klaus.eickel@rub.de	Porter, David A/AAN-8501-2020	Porter, David A/0000-0001-8436-6904; Eickel, Klaus/0000-0002-5700-2029	Deutsche Forschungsgemeinschaft (DFG) [LU 844/8-1]; MRC [MR/N003403/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Lutz Ludemann received Grant No. LU 844/8-1 from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Klaus Eickel and Matthias Gunther were/are employees of mediri GmbH, Heidelberg, Germany, as well as Fraunhofer MEVIS, Bremen, Germany. The funders provided support in the form of salaries for authors [K.E., M.G.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baish JW, 2000, CANCER RES, V60, P3683; Barth M, 2016, MAGN RESON MED, V75, P63, DOI 10.1002/mrm.25897; Breuer F, 2015, CAIPIRINHA REV, P8; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Castillo M, 2014, RADIOLOGY, V273, pS111, DOI 10.1148/radiol.14140130; Cauley SF, 2014, MAGN RESON MED, V72, P93, DOI 10.1002/mrm.24898; d'Arcy JA, 2002, NMR BIOMED, V15, P174, DOI 10.1002/nbm.755; Deshmane A, 2012, J MAGN RESON IMAGING, V36, P55, DOI 10.1002/jmri.23639; Eichner C, 2014, MAGN RESON MED, V72, P770, DOI 10.1002/mrm.24960; Eickel K, 2016, P INT SOC MAG RESON, V3244; Essig M, 2013, AM J ROENTGENOL, V200, P24, DOI 10.2214/AJR.12.9543; FEINBERG DA, 1994, MAGNET RESON MED, V32, P535, DOI 10.1002/mrm.1910320418; Feinberg DA., 2011, PLOS ONE, DOI [10.1371/annotation/d9496d01-8c5d-4d24-8287-94449ada5064, DOI 10.1371/ANNOTATION/D9496D01-8C5D-4D24-8287-94449ADA5064]; Heid O, 2000, US Patent, Patent No. 6043651A; Heilmann M, 2007, MAGN RESON MATER PHY, V20, P193, DOI 10.1007/s10334-007-0082-2; Hennel F, 1997, CONCEPT MAGNETIC RES, V9, P43, DOI 10.1002/(SICI)1099-0534(1997)9:1<43::AID-CMR4>3.0.CO;2-N; Hindel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170841; Hindel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128060; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Jackson A, 2005, DYNAMIC CONTRAST ENH, DOI [10.1007/b137553, DOI 10.1007/B137553]; Jahng GH, 2014, KOREAN J RADIOL, V15, P554, DOI 10.3348/kjr.2014.15.5.554; Kershaw LE, 2010, MAGN RESON MED, V64, P1772, DOI 10.1002/mrm.22573; Kistler M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2930; Ludemann L, 2009, ANN BIOMED ENG, V37, P749, DOI 10.1007/s10439-009-9645-x; Markwardt CB, 2009, ASTR SOC P, V411, P251; Miyati T, 1997, J MAGN RESON IMAGING, V7, P230, DOI 10.1002/jmri.1880070136; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mugler JP, 1996, MAGNET RESON MED, V36, P306, DOI 10.1002/mrm.1910360218; Newbould RD, 2007, MAGN RESON MED, V58, P70, DOI 10.1002/mrm.21255; Newton AT, 2016, AM J NEURORADIOL, V37, P1237, DOI 10.3174/ajnr.A4700; Polimeni JR, 2012, P INT SOC MAGN RESON, V20, P2222; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Sauerbrey A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/390506; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sourbron S, 2009, MAGN RESON MED, V62, P672, DOI 10.1002/mrm.22042; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Vonken EJPA, 2000, MAGNET RESON MED, V43, P820, DOI 10.1002/1522-2594(200006)43:6<820::AID-MRM7>3.0.CO;2-F; YOUNG IR, 1984, BRIT MED BULL, V40, P139, DOI 10.1093/oxfordjournals.bmb.a071960	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202673	10.1371/journal.pone.0202673	http://dx.doi.org/10.1371/journal.pone.0202673			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153275	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000443001700020
J	Popescu, DC; Huang, H; Singhal, NK; Shriver, L; McDonough, J; Clements, RJ; Freeman, EJ				Popescu, Daniela C.; Huang, He; Singhal, Naveen K.; Shriver, Leah; McDonough, Jennifer; Clements, Robert J.; Freeman, Ernest J.			Vitamin K enhances the production of brain sulfatides during remyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; CUPRIZONE MODEL; DEMYELINATION; METABOLISM; RATS; SKELETAL; MYELIN; MOUSE; MICE	Multiple sclerosis (MS) is a devastating neurological disease, which is characterized by multifocal demyelinating lesions in the central nervous system. The most abundant myelin lipids are galactosylceramides and their sulfated form, sulfatides, which together account for about 27% of the total dry weight of myelin. In this study we investigated the role of vitamin K in remyelination, by using an animal model for MS, the cuprizone model. Demyelination was induced in C57BI6/J mice, by feeding them a special diet containing 0.3% cuprizone (w/w) for 6 weeks. After 6 weeks, cuprizone was removed from the diet and mice were allowed to remyelinate for either 1 or 3 weeks, in the absence or presence of vitamin K(i.p phylloquinone, 2mg, three times per week). Vitamin K enhanced the production of total brain sulfatides, after both 1 week and 3 weeks of remyelination (n = 5, P-values were <0.0001), when compared with the control group. To determine whether or not there is a synergistic effect between vitamins K and D for the production of brain sulfatides, we employed a similar experiment as above. Vitamin K also increased the production of individual brain sulfatides, including d18:1/18:0, d18:1/20:0, d18:1/24:0, and d18:1/24:1 after 3 weeks of remyelination, when compared to the control group. In addition, vitamin D enhanced the production of total brain sulfatides, as well as d18:1/18:0, d18:1/24:0, and d18:1/24:1 sulfatides after 3 weeks of remyelination, but no synergistic effect between vitamins K and D for the production of total brain sulfatides was observed.	[Popescu, Daniela C.] Kent State Univ, Dept Biol Sci, Geauga Campus, Burton, OH 44021 USA; [Huang, He; Shriver, Leah] Univ Akron, Dept Chem & Biol, Akron, OH 44325 USA; [Singhal, Naveen K.; McDonough, Jennifer; Clements, Robert J.; Freeman, Ernest J.] Kent State Univ, Dept Biol Sci, Kent Campus, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Geauga; University System of Ohio; University of Akron; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Popescu, DC (corresponding author), Kent State Univ, Dept Biol Sci, Geauga Campus, Burton, OH 44021 USA.	dpopescu@kent.edu		Singhal, Naveen Kumar/0000-0003-4336-7331; Popescu, Daniela/0000-0002-9603-1084	National Multiple Sclerosis Society Pilot Grant [PP3372]; Kent State University, Geauga campus	National Multiple Sclerosis Society Pilot Grant; Kent State University, Geauga campus	This work was supported by National Multiple Sclerosis Society Pilot Grant PP3372 (D.C. P.) and by Kent State University, Geauga campus (D.C.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Binder MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017727; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; CONKERTON EJ, 1995, J AM OIL CHEM SOC, V72, P963, DOI 10.1007/BF02542075; Crivello NA, 2010, J NUTR BIOCHEM, V21, P1083, DOI 10.1016/j.jnutbio.2009.09.005; Denisova NA, 2005, NUTR REV, V63, P111, DOI 10.1111/j.1753-4887.2005.tb00129.x; Eckhardt M, 2007, J NEUROSCI, V27, P9009, DOI 10.1523/JNEUROSCI.2329-07.2007; Ferland G, 2012, ADV NUTR, V3, P204, DOI 10.3945/an.111.001784; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Haffa A, 2000, J BONE MINER RES, V15, P872, DOI 10.1359/jbmr.2000.15.5.872; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Iwamoto J, 2003, BONE, V33, P557, DOI 10.1016/S8756-3282(03)00249-7; Kidd PM, 2010, ALTERN MED REV, V15, P199; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Ludwin SK, 2006, J NEUROPATH EXP NEUR, V65, P305, DOI 10.1097/01.jnen.0000225024.12074.80; LUDWIN SK, 1978, LAB INVEST, V39, P597; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Martinez-Gardeazabal J, 2017, BBA-BIOMEMBRANES, V1859, P1548, DOI 10.1016/j.bbamem.2017.02.011; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mugoni V, 2013, NAT PROTOC, V8, P2337, DOI 10.1038/nprot.2013.139; Nystad AE, 2014, APMIS, V122, P1178, DOI 10.1111/apm.12281; Ropper AH, 2006, NEW ENGL J MED, V354, P965, DOI 10.1056/NEJMe068002; Sachs HH, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551955; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Sundaram KS, 1996, J NUTR, V126, P2746; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Taraboletti A, 2017, BIOCHEMISTRY-US, V56, P1518, DOI 10.1021/acs.biochem.6b01072; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203057	10.1371/journal.pone.0203057	http://dx.doi.org/10.1371/journal.pone.0203057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148869	Green Submitted, gold, Green Published			2022-12-26	WOS:000442804200043
J	Poulsen, ASR; Luise, D; Curtasu, MV; Sugiharto, S; Canibe, N; Trevisi, P; Leuridsen, C				Poulsen, Ann-Sofie Riis; Luise, Diana; Curtasu, Mihai Victor; Sugiharto, Sugiharto; Canibe, Nuria; Trevisi, Paolo; Leuridsen, Charlotte			Effects of alpha-(1,2)-fucosyltransferase genotype variants on plasma metabolome, immune responses and gastrointestinal bacterial enumeration of pigs pre- and post- weaning	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; INTESTINAL EPITHELIUM; POSTWEANING DIARRHEA; FUT1 GENE; GUT; PORCINE; MICROBIOTA; EXPRESSION; PIGLETS; SUSCEPTIBILITY	In pigs, the alpha-(1,2) fucosyltransferase (FUT1) gene has been highlighted for its properties in controlling the intestinal expression of enterotoxigenic E. coli (ETEC) F18 receptors; a pathogen causing edema disease and post-weaning diarrhoea. In this study, we hypothesized that pigs with different genotypes (ETEC F18 resistant (FUT1(AA)) versus susceptible (FUT1(AG))) differed in following systemic and enteric responses: growth performance, plasma metabolic profiles, expression of candidate genes for intestinal mucosal homeostasis and immunity, number of selected bacteria and the concentration of short-chain fatty acids (SCFA) in faeces and digesta in piglets pre and post-weaning, and on the ETEC F18 adherence ex vivo. Genotype had the strongest impact on plasma metabolomic profile on day 7 and 28 of age. FUT1(AG) piglets had higher level of N-methyl-2-pyrrolidinone, hippuric acid, oxindole, and 3-oxo-5-beta-chol-7-en-24-oic acid on day 7, and a higher level of guanosine on day 28 than that in the FUT1(AA) piglets. FUT1(AA) piglets had a higher level of betaine on day 7 and 3-methylguanine on day 28. On day 34 of age, the FUT1(AA) pigs had higher levels of S-2-hydroxyglutarate, L-phenylalanine, tauroursodeoxycholic acid and an undetermined PC/LysoPC, while Ile Glu Phe Gly peptide and genistein 5-O-glucuronide, and PC (18:0/0:0) were at higher levels in the FUT1(AG) piglets. FUT1 genotype did not affect the growth performance and expression of candidate genes. FUT1(AG) piglets had a higher number of haemolytic bacteria in faeces and in digesta than that in FUT1(AA) at 34 days of age. The colonic acetic acid concentration was highest in FUT1(AG) piglets. FUT1 genotype may influence not only the expression of E. coli F18 receptors but could potentially impact the gut homeostasis and metabotype of piglets pre and post-weaning. Further investigations on the relation between FUT1 genotype and these aspects including the intestinal commensal microbiota will expand the knowledge on factors affecting the intestinal ecosystem.	[Poulsen, Ann-Sofie Riis; Curtasu, Mihai Victor; Canibe, Nuria; Leuridsen, Charlotte] Aarhus Univ, Fac Sci & Technol, Dept Anim Sci, Tjele, Denmark; [Luise, Diana; Trevisi, Paolo] Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Sugiharto, Sugiharto] Diponegoro Univ, Fac Anim & Agr Sci, Semarang, Central Java, Indonesia	Aarhus University; University of Bologna; Diponegoro University	Leuridsen, C (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Anim Sci, Tjele, Denmark.	charlotte.lauridsen@anis.au.dk	Luise, Diana/AAR-6903-2020	Luise, Diana/0000-0001-7864-7822; Canibe, Nuria/0000-0002-5424-9974; Curtasu, Mihai Victor/0000-0001-9823-6692	Graduate School of Science and Technology, Aarhus University, Denmark; COST (European Cooperation in Science and Technology) [FA1401]	Graduate School of Science and Technology, Aarhus University, Denmark; COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	Funding for the experimental work and paper drafting was made possible through a Ph.D.-scholarship obtained from the Graduate School of Science and Technology, Aarhus University, Denmark, for main author Ann-Sofie Riis Poulsen, and a Short Term Scientific Mission grant for main author Diana Luise from the COST Action FA1401 (PiGutNet), supported by COST (European Cooperation in Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is based upon work from COST Action FA1401, supported by COST (European Cooperation in Science and Technology). The authors would like to thank laboratory technicians Trine Poulsen and Karin Durup, technicians Mette Lykkegaard and Karin Johansen and the staff of SB32 at the Department of Animal Science for their skilful technical assistance during the course of the experiment. The authors want to thank Scientist Lone Bruhn Madsen, and research professor Christian Bendixen at Department of Molecular Biology and Genetics for FUT1 genotyping the animals.	ARMSTRONG MD, 1955, P SOC EXP BIOL MED, V90, P675; Bao WB, 2008, J ANIM BREED GENET, V125, P427, DOI 10.1111/j.1439-0388.2008.00722.x; Bao WB, 2012, GENE, V497, P336, DOI 10.1016/j.gene.2012.01.035; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellaver B, 2015, PURINERG SIGNAL, V11, P571, DOI 10.1007/s11302-015-9475-2; Bian GR, 2016, ENVIRON MICROBIOL, V18, P1566, DOI 10.1111/1462-2920.13272; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Canibe N, 2008, LIVEST SCI, V114, P251, DOI 10.1016/j.livsci.2007.05.002; Chen LM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01688; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Ciccarelli R, 1999, GLIA, V25, P93, DOI 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N; Curtis CD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-9; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Daly K, 2014, BRIT J NUTR, V111, pS30, DOI 10.1017/S0007114513002274; Domino SE, 2001, MOL CELL BIOL, V21, P8336, DOI 10.1128/MCB.21.24.8336-8345.2001; Francis DH, 2002, J SWINE HEALTH PROD, V10, P171; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frydendahl K, 2003, VET MICROBIOL, V93, P39, DOI 10.1016/S0378-1135(02)00348-6; Halekoh U, 2014, J STAT SOFTW, V59, P1; HAN K, 1992, BIOTECHNOL BIOENG, V39, P663, DOI 10.1002/bit.260390611; Henry S, 1996, GLYCOCONJUGATE J, V13, P985, DOI 10.1007/BF01053194; Hesselager MO, 2016, GLYCOBIOLOGY, V26, P607, DOI 10.1093/glycob/cww009; Holdeman L. V, 1977, ANAEROBE LAB MANUAL, V4th; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HOU CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI DOI 10.1186/2049-1891-6-1; Hurd EA, 2005, GLYCOBIOLOGY, V15, P1002, DOI 10.1093/glycob/cwi089; Ingerslev AK, 2015, J PROTEOME RES, V14, P3095, DOI 10.1021/acs.jproteome.5b00039; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Meijerink E, 2000, IMMUNOGENETICS, V52, P129, DOI 10.1007/s002510000263; Meijerink E, 1997, MAMM GENOME, V8, P736, DOI 10.1007/s003359900556; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Plaza-Diaz J, 2014, WORLD J GASTROENTERO, V20, P15632, DOI 10.3748/wjg.v20.i42.15632; POON K, 1995, DRUG METAB DISPOS, V23, P255; Schopper D, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0002-3; SLIFIERZ MJ, 2015, BMC MICROBIOL, V15, DOI DOI 10.1186/S12866-015-0344-5; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stokes CR, 2004, ANIM RES, V53, P325, DOI 10.1051/animres:2004020; Sugiharto, 2012, J ANIM SCI, V90, P397, DOI [10.2527/jas.53924, 10.2527/jas53924]; Sugiharto S, 2015, BRIT J NUTR, V113, P923, DOI 10.1017/S0007114514003201; Sugiharto S, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-17; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Vogeli P, 1996, ANIM GENET, V27, P321; Wang JJ, 2012, ANTIOXID REDOX SIGN, V17, P282, DOI 10.1089/ars.2011.4381; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BA, 2005, ANIM RES, V54, P191, DOI 10.1051/animres:2005011; Williams HRT, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-108	55	15	16	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202970	10.1371/journal.pone.0202970	http://dx.doi.org/10.1371/journal.pone.0202970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148866	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200040
J	Sato, Y; Toida, T; Nakagawa, H; Iwakiri, T; Nishizono, R; Kikuchi, M; Fujimoto, S				Sato, Yuji; Toida, Tatsunori; Nakagawa, Hideto; Iwakiri, Takashi; Nishizono, Ryuzoh; Kikuchi, Masao; Fujimoto, Shouichi			Diminishing dry weight is strongly associated with all-cause mortality among long-term maintenance prevalent dialysis patients	PLOS ONE			English	Article							SURVIVAL	Objectives To investigate the relationship between dry weight (DW) change and survival in long-term maintenance prevalent dialysis patients. Methods We conducted a prospective data collection study with retrospective analysis of the registered data. Patients were followed up for 5 years (1-year observation of DW changes and subsequent 4-year follow-up). The outcome was all-cause mortality. The predictors were 1-year DW change rates. The hazard ratios (HRs) for all-cause mortality were calculated using multivariable Cox regression analysis, fully adjusted for age, sex, basal kidney disease, dialysis vintage, current smoking, past cardiovascular events, serum albumin, DW at enrollment, serum creatinine, mean predialysis systolic blood pressure, and cardiothoracic ratio or 1-year cardiothoracic ratio change rate. Propensity score (PS) analysis was also conducted using the same covariates of Cox regression analysis. Results In total, 899 dialysis patients (mean dialysis vintage: 101.2 months) were followed up, and 180 deaths were recorded, of which 90 were of cardiovascular origin. Each 2% decrement of DW showed adjusted HR, and the 95% confidence interval was 1.24 [1.16-1.33]. According to the 1-year DW change rate, participants were divided into five groups (group A, >=+3%; group B, +1 to +2.9%; group C, -0.9 to +0.9%; group D, -2.9 to -1.0%; and group E, <=-3%). For survival curves based on grouping, group B had the best and group E had the worst survival rate (p<0.01, log-rank test). Therefore, we set group B as a reference; adjusted risks for death of groups D and E were 2.16 [1.23-3.79] and 2.66 [1.54-4.58], respectively. However, this relation was blunted in patients of heavier DW. The PS-matched cohort showed a poorer prognosis in patients with diminishing DW divided by DW change rate at -0.635% (mean value of DW change rate). Conclusion In the long-term maintenance hemodialysis cohort, 1-year DW decrement, especially <=-3.0%, was significantly associated with all-cause mortality, and cardiovascular diseaserelated death was prominent in these patients.	[Sato, Yuji; Nakagawa, Hideto; Iwakiri, Takashi] Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan; [Toida, Tatsunori; Fujimoto, Shouichi] Univ Miyazaki, Fac Med, Dept Hemovasc Med & Artificial Organs, Miyazaki, Japan; [Nishizono, Ryuzoh; Kikuchi, Masao] Univ Miyazaki, Fac Med, Dept Internal Med, Div Circulatory & Body Fluid Regulat, Miyazaki, Japan	University of Miyazaki; University of Miyazaki; University of Miyazaki	Sato, Y (corresponding author), Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan.	ysato@med.miyazaki-u.ac.jp						Badve SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114897; Bonanni A, 2011, INT J ENV RES PUB HE, V8, P1631, DOI 10.3390/ijerph8051631; Cabezas-Rodriguez I, 2013, CLIN J AM SOC NEPHRO, V8, P1725, DOI 10.2215/CJN.10951012; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; London GM, 2000, J AM SOC NEPHROL, V11, P778, DOI 10.1681/ASN.V114778; Nanri A, 2010, INT J OBESITY, V34, P348, DOI 10.1038/ijo.2009.234; Saito I, 2009, J EPIDEMIOL COMMUN H, V63, P447, DOI 10.1136/jech.2008.082065; Sato Y, 2017, THER APHER DIAL, V21, P287, DOI 10.1111/1744-9987.12512; Sato Y, 2016, CLIN J AM SOC NEPHRO, V11, P840, DOI 10.2215/CJN.09830915; Tanaka Y, 2015, BLOOD PURIFICAT, V40, P332, DOI 10.1159/000441582; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Yotsueda R, 2017, AM J KIDNEY DIS, V70, P84, DOI 10.1053/j.ajkd.2016.11.026	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203060	10.1371/journal.pone.0203060	http://dx.doi.org/10.1371/journal.pone.0203060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148875	Green Submitted, Green Published, gold			2022-12-26	WOS:000442804200045
J	Chung, SM; Moon, JS; Yoon, JS; Won, KC; Lee, HW				Chung, Seung Min; Moon, Jun Sung; Yoon, Ji Sung; Won, Kyu Chang; Lee, Hyoung Woo			Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; ACID LEVELS; CARDIOVASCULAR MORTALITY; INSULIN-RESISTANCE; HEALTH; METAANALYSIS; POPULATION; NEPHROLITHIASIS; FEATURES; DISEASE	Introduction Low urine pH (UpH) and high serum uric acid are considered evidence of metabolic disorders. The effect of low UpH on the development of metabolic syndrome (MetS) is less clear than that of high serum uric acid. We investigated the association between low UpH on the development of MetS and its components: central obesity, dyslipidemia, hypertension, and dysglycemia. Methods Two studies were conducted based on 2 datasets. The cross-sectional study included 14,511 subjects aged 19-80 years, based on the Korea National Health and Nutrition Examination Survey in 2013-2015. The retrospective cohort study included 3,453 subjects aged 19-80 years without MetS at the first checkup, who underwent at least 3 health checkups at a single tertiary hospital between 2011 and 2017. UpH was measured using an automatic urine analyzer in the range of 5.0-9.0 at first visit. Results In the cross-sectional study, low UpH (= 5.0) was associated with the prevalence of MetS (odds ratio [OR] = 1.480, 95% confidence interval [CI] 1.334-1.643, p<0.001), particularly central obesity, dyslipidemia, and dysglycemia (OR ranges 1.282-1.422, p<0.001, all). In the retrospective cohort study, compared with the highest UpH subgroup, the lowest UpH subgroup (= 5.0) was associated with higher risk of MetS development (hazard ratio = 1.394, 95% CI 1.096-1.772, p=0.007). The incident risk of MetS increased from the highest to lowest UpH subgroups (p for trend = 0.020), among which dyslipidemia and dysglycemia increased (p for trend <0.01, all). Conclusion Low UpH can be used as a surrogate marker of MetS and affects the development of MetS, associative with the increase of dyslipidemia and dysglycemia in those without MetS. If UpH is <= 5.0, efforts to prevent metabolic disorders are warranted.	[Chung, Seung Min; Moon, Jun Sung; Yoon, Ji Sung; Won, Kyu Chang; Lee, Hyoung Woo] Yeungnam Coll Med, Dept Internal Med, Div Endocrinol & Metab, Daegu, South Korea		Moon, JS; Won, KC (corresponding author), Yeungnam Coll Med, Dept Internal Med, Div Endocrinol & Metab, Daegu, South Korea.	mjs7912@yu.ac.kr; kcwon@med.yu.ac.kr	Chung, Seung Min/AAM-3135-2020	Chung, Seung Min/0000-0003-3336-7557; Moon, Jun Sung/0000-0003-1569-3068; Won, Kyu Chang/0000-0001-5945-3395	Basic Science Research Program though the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1A2B1008877, NRF-2017R1C1B1003429]	Basic Science Research Program though the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by Basic Science Research Program though the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1A2B1008877 and NRF-2017R1C1B1003429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Billiet Laura, 2014, ISRN Rheumatol, V2014, P852954, DOI 10.1155/2014/852954; Bobulescu IA, 2008, AM J PHYSIOL-RENAL, V294, pF1315, DOI 10.1152/ajprenal.00550.2007; Capolongo G, 2011, UROL RES, V39, P367, DOI 10.1007/s00240-011-0365-y; Cho YH, 2014, J RES MED SCI, V19, P599; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hara S, 2012, METABOLISM, V61, P281, DOI 10.1016/j.metabol.2011.06.026; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Kanbara A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-39; Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712; Kraut JA, 2016, AM J KIDNEY DIS, V67, P307, DOI 10.1053/j.ajkd.2015.08.028; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee YJ, 2014, INTERN MED J, V44, P1210, DOI 10.1111/imj.12588; Li M, 2014, ATHEROSCLEROSIS, V232, P265, DOI 10.1016/j.atherosclerosis.2013.11.051; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Maalouf NM, 2007, CLIN J AM SOC NEPHRO, V2, P883, DOI 10.2215/CJN.00670207; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Odden MC, 2014, AM J KIDNEY DIS, V64, P550, DOI 10.1053/j.ajkd.2014.04.024; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Otsuki M, 2011, ENDOCR J, V58, P363, DOI 10.1507/endocrj.K10E-319; Rendina D, 2014, J NEPHROL, V27, P371, DOI 10.1007/s40620-014-0085-9; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Shimodaira M, 2017, MED PRIN PRACT, V26, P433, DOI 10.1159/000481624; Sun DJY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089696; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105125, 10.1371/journal.pone.0114259]; Welch AA, 2008, BRIT J NUTR, V99, P1335, DOI 10.1017/S0007114507862350; Wiederkehr MR, 2011, CLIN REV BONE MINER, V9, P207, DOI 10.1007/s12018-011-9106-6; Wong YV, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/570674; Yadav D, 2015, ATHEROSCLEROSIS, V241, P271, DOI 10.1016/j.atherosclerosis.2015.04.797; Yamanishi Hachiro, 2014, Rinsho Byori, V62, P692; Yuan HP, 2015, J CLIN ENDOCR METAB, V100, P4198, DOI 10.1210/jc.2015-2527; Yun SH, 2013, J NUTR, V46	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202757	10.1371/journal.pone.0202757	http://dx.doi.org/10.1371/journal.pone.0202757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142166	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500028
J	Cox, F; van der Fits, L; Abbink, P; Larocca, RA; van Huizen, E; Saeland, E; Verhagen, J; Peterson, R; Tolboom, J; Kaufmann, B; Schuitemaker, H; Barouch, DH; Zahn, R				Cox, Freek; van der Fits, Leslie; Abbink, Peter; Larocca, Rafael A.; van Huizen, Ella; Saeland, Eirikur; Verhagen, Janneke; Peterson, Rebecca; Tolboom, Jeroen; Kaufmann, Baerbel; Schuitemaker, Hanneke; Barouch, Dan H.; Zahn, Roland			Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge	PLOS ONE			English	Article							VACCINE PLATFORMS; IMMUNOGENICITY; INFECTION; SAFETY	In 2015, there was a large outbreak of Zika virus (ZIKV) in Brazil. Despite its relatively mild impact on healthy adults, ZIKV infection during pregnancy has been associated with severe birth defects. Currently, there is no ZIKV vaccine available, but several vaccine candidates based on the ZIKV membrane (M) and envelope (Env) structural proteins showed promising results in preclinical and clinical studies. Here, the immunogenicity and protective efficacy of a non-replicating adenoviral vector type 26 (Ad26) that encodes the ZIKV M-Env antigens (Ad26. ZIKV. M-Env) was evaluated in mice and non-human primates (NHP). Ad26. ZIKV. M-Env induced strong and durable cellular and humoral immune responses in preclinical models. Humoral responses were characterized by Env-binding and ZIKV neutralizing antibody responses while cellular responses were characterized by ZIKV reactive CD4(+) and CD8(+) T cells. Importantly, a single immunization with a very low dose of 4x10(7) vp of Ad26. ZIKV. M-Env protected mice from ZIKV challenge. In NHP, a single immunization with a typical human dose of 1x10(11) vp of Ad26. ZIKV. M-Env also induced Env-binding and ZIKV neutralizing antibodies and Env and M specific cellular immune responses that associated with complete protection against viremia from ZIKV challenge as measured in plasma and other body fluids. Together these data provide the rationale to progress the Ad26. ZIKV. M-Env candidate vaccine to clinical testing.	[Cox, Freek; van der Fits, Leslie; van Huizen, Ella; Saeland, Eirikur; Verhagen, Janneke; Tolboom, Jeroen; Kaufmann, Baerbel; Schuitemaker, Hanneke; Zahn, Roland] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Abbink, Peter; Larocca, Rafael A.; Peterson, Rebecca; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Zahn, R (corresponding author), Janssen Vaccines & Prevent BV, Leiden, Netherlands.	RZahn@its.jnj.com	Zahn, Roland/ABE-8779-2021; Barouch, Dan/Y-3918-2019; Assumpcao Larocca, Rafael/H-1655-2015	Assumpcao Larocca, Rafael/0000-0002-9995-1804; Cox, Freek/0000-0001-9857-7382	Janssen Vaccines & Prevention B.V.	Janssen Vaccines & Prevention B.V.	The authors received no specific funding for this work. Janssen Vaccines & Prevention B.V. provided support in the form of salaries for authors FC, LVDF, EVH, ES, JV, JT, BK, HS AND RZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880; Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Gaudinski M. R, 2017, LANCET; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Martinot AJ, 2018, CELL; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Modjarrad K, 2017, LANCET; Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Song G, 2018, MOL CELL PROTEOMICS, V17, P349, DOI 10.1074/mcp.RA117.000310; Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426; Tebas P, 2017, N ENGL J MED; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; Vellinga J, 2014, HUM GENE THER, V25, P318, DOI 10.1089/hum.2014.007; Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x; Waldorf KMA, 2018, NAT MED; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	41	37	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202820	10.1371/journal.pone.0202820	http://dx.doi.org/10.1371/journal.pone.0202820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142207	gold, Green Published, Green Submitted			2022-12-26	WOS:000442722500036
J	Fujihara, M; Yamamizu, K; Comizzoli, P; Wildt, DE; Songsasen, N				Fujihara, Mayako; Yamamizu, Kohei; Comizzoli, Pierre; Wildt, David E.; Songsasen, Nucharin			Retinoic acid promotes in vitro follicle activation in the cat ovary by regulating expression of matrix metalloproteinase 9	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; ASCORBIC-ACID; SURVIVAL; GROWTH; CELLS; DOG	Retinoic acid (RA) facilitates tissue morphogenesis by regulating matrix matalloproteinase (MMPs) expression. Our objective was to examine the influence of RA on in vitro development of follicles enclosed within domestic cat ovarian tissues. Ovarian cortices from 9 prepubertal and 13 adult cats were incubated for 7 d in medium containing 0 (control), 1 or 5 mu M RA and then analyzed for viability. Cortices from additional three animals of each age group were cultured in the same condition and follicle morphology, stage and size were histologically evaluated. In a separate study, cortices from 14 donors (7 prepubertal; 7 adult cats) were incubated in 0 or 5 mu M RA for 7 d and assessed for (1) MMP1, 2, 3, 7, 9 and TIMP1 expression by qPCR and (2) protein expression of MMP9 by immunohistochemistry. Donor age did not influence follicle response to RA. Collective data from both age groups revealed that percentages of primordial follicles in 5 mu M RA treatment were lower (P < 0.05; 40.5 +/- 4.5%) than in fresh cortices (66.7 +/- 5.3%) or controls (60.1 +/- 4.0%) with 1 mu M-RA treatment producing intermediate (56.3 +/- 4.0%) results. Proportion of primary follicles in 5 mu M RA (21.7 +/- 3.3%) was higher than in fresh cortices (4.9 +/- 2.9%) and controls (9.0 +/- 2.8%) with 1 mu M-RA treatment producing an intermediate value (13.8 +/- 2.0%). Furthermore, proportion of secondary follicles increased after 7 d in the presence of 5 mu M RA (9.5 +/- 2.7%) compared to other groups (fresh, 1.9 +/- 0.8%; control, 2.6 +/- 1.1%; 1 mu M RA, 2.5 +/- 0.2%). MMP9 transcript and protein were upregulated, whereas MMP7 mRNA was suppressed by 5 mu M-RA treatment compared to fresh counterparts. RA did not impact MMP1, 2, 3, 13 or TIMP1 expression. In summary, RA activated cat primordial follicle growth likely via a mechanism related to upregulation of MMP9 and down-regulation of MMP7 transcripts.	[Fujihara, Mayako; Comizzoli, Pierre; Wildt, David E.; Songsasen, Nucharin] Smithsonian Conservat Biol Inst, Ctr Species Survival, Natl Zool Pk, Front Royal, VA 22630 USA; [Fujihara, Mayako] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Yamamizu, Kohei] NIA, Lab Genet, NIH, Baltimore, MD 21224 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fujihara, M (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Natl Zool Pk, Front Royal, VA 22630 USA.; Fujihara, M (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.	fujihara.mayako.22e@st.kyoto-u.ac.jp	Fujihara, Mayako/N-9965-2019	Fujihara, Mayako/0000-0001-5477-2653	National Institute of Health [R56OD018304]; Smithsonian's Competitive Grant for Sciences; Overseas Research Fellowship from the Japanese Society for the Promotion of Science; RPD Research Fellowship from the Japanese Society for the Promotion of Science [15J40107]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smithsonian's Competitive Grant for Sciences; Overseas Research Fellowship from the Japanese Society for the Promotion of Science; RPD Research Fellowship from the Japanese Society for the Promotion of Science	This study was supported by the National Institute of Health (R56OD018304) and by the Smithsonian's Competitive Grant for Sciences to NS and by an Overseas Research Fellowship and RPD Research Fellowship (15J40107) from the Japanese Society for the Promotion of Science to MF.	Abidin FZ, 2015, ORGANOGENESIS, V11, P122, DOI 10.1080/15476278.2015.1093267; Al-Alem L, 2015, REPRODUCTION, V150, pR55, DOI 10.1530/REP-14-0546; Axel DI, 2001, CARDIOVASC RES, V49, P851, DOI 10.1016/S0008-6363(00)00312-6; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Chaffin CL, 1999, BIOL REPROD, V61, P14, DOI 10.1095/biolreprod61.1.14; Chambaut-Guerin AM, 2000, J NEUROCHEM, V74, P508, DOI 10.1046/j.1471-4159.2000.740508.x; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fujihara M, 2016, REPROD DOMEST ANIM, V51, P717, DOI 10.1111/rda.12736; Fujihara M, 2012, REPROD DOMEST ANIM, V47, P102, DOI 10.1111/rda.12022; Fujihara M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115089; Gao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150831; Ii M, 2006, EXP BIOL MED, V231, P20; Ikeda S, 2005, J REPROD DEVELOP, V51, P23, DOI 10.1262/jrd.51.23; Meinel S, 2015, HORM MOL BIOL CLIN I, V24, P91, DOI 10.1515/hmbci-2015-0028; Murray AA, 2001, REPRODUCTION, V121, P89, DOI 10.1530/rep.0.1210089; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pauli SA, 2013, REPROD SCI, V20, P1116, DOI 10.1177/1933719113477487; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Songsasen N, 2012, REPROD DOMEST ANIM, V47, P13, DOI 10.1111/rda.12067; Tagler D, 2014, BIOTECHNOL BIOENG, V111, P1417, DOI 10.1002/bit.25181; Wildt DE, 2010, FELIDS EX SITU MANAG	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202759	10.1371/journal.pone.0202759	http://dx.doi.org/10.1371/journal.pone.0202759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142172	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500029
J	Alonso, S; Stange, MK; Beta, C				Alonso, Sergio; Stange, Mai Ke; Beta, Carsten			Modeling random crawling, membrane deformation and intracellular polarity of motile amoeboid cells	PLOS ONE			English	Article							SIGNALING SYSTEM; ACTIN CYTOSKELETON; EXCITABLE NETWORKS; PIP3 WAVES; CHEMOTAXIS; DICTYOSTELIUM; DYNAMICS; TRANSDUCTION; INHIBITION; MECHANISMS	Amoeboid movement is one of the most widespread forms of cell motility that plays a key role in numerous biological contexts. While many aspects of this process are well investigated, the large cell-to-cell variability in the motile characteristics of an otherwise uniform population remains an open question that was largely ignored by previous models. In this article, we present a mathematical model of amoeboid motility that combines noisy bistable kinetics with a dynamic phase field for the cell shape. To capture cell-to-cell variability, we introduce a single parameter for tuning the balance between polarity formation and intracellular noise. We compare numerical simulations of our model to experiments with the social amoeba Dictyostelium discoideum. Despite the simple structure of our model, we found close agreement with the experimental results for the center-of-mass motion as well as for the evolution of the cell shape and the overall intracellular patterns. We thus conjecture that the building blocks of our model capture essential features of amoeboid motility and may serve as a starting point for more detailed descriptions of cell motion in chemical gradients and confined environments.	[Alonso, Sergio] Univ Politecn Cataluna, Dept Phys, Barcelona, Spain; [Stange, Mai Ke; Beta, Carsten] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany	Universitat Politecnica de Catalunya; University of Potsdam	Alonso, S (corresponding author), Univ Politecn Cataluna, Dept Phys, Barcelona, Spain.	s.alonso@upc.edu	Alonso, Sergio/L-6177-2014; Alonso, Sergio/GVR-8346-2022	Alonso, Sergio/0000-0002-3989-8757; Stange, Maike/0000-0001-7161-1405	Ministerio Economia (SPAIN) [FIS-2014-55365-P, RYC-2012-11265]; Deutsche Forschungsgemeinschaft (Germany) [SFB 1294]	Ministerio Economia (SPAIN); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG))	SA was supported by Ministerio Economia (SPAIN) FIS-2014-55365-P and RYC-2012-11265. MS and CB were supported by Deutsche Forschungsgemeinschaft (Germany) SFB 1294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037213; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Aranson IS, 2016, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-319-24448-8_1; Aranson IS, 2016, PHYSICAL MODELS OF C; Artemenko Y, 2014, CELL MOL LIFE SCI, V71, P3711, DOI 10.1007/s00018-014-1638-8; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; Beta C, 2017, ANNU REV CONDEN MA P, V8, P239, DOI 10.1146/annurev-conmatphys-031016-025210; Bodeker HU, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/28005; Boettinger WJ, 2002, ANNU REV MATER RES, V32, P163, DOI 10.1146/annurev.matsci.32.101901.155803; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bray D, 2001, CELL MOVEMENTS MOL M; Byrne KM, 2016, CELL SYST, V2, P38, DOI 10.1016/j.cels.2016.01.003; Camley BA, 2014, P NATL ACAD SCI USA, V111, P14770, DOI 10.1073/pnas.1414498111; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; d'Alessandro J, 2017, NAT PHYS, V13, P999, DOI 10.1038/NPHYS4180; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Dreher A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055007; Driscoll MK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002392; Driscoll MK, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055001; Folch R, 1999, PHYS REV E, V60, P1724, DOI 10.1103/PhysRevE.60.1724; Gerhardt M, 2014, J CELL SCI, V127, P4507, DOI 10.1242/jcs.156000; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Gole L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026901; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Knoch F, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/4/046002; Kulawiak DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005239; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Lober J, 2014, SOFT MATTER, V10, P1365, DOI 10.1039/c3sm51597d; Maeda Y, 2005, INT REV CYTOL, V244, P287, DOI 10.1016/S0074-7696(05)44007-3; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; Makarava N, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042703; Miao YC, 2017, NAT CELL BIOL, V19, P329, DOI 10.1038/ncb3495; Mogilner A, 2012, SCIENCE, V336, P175, DOI 10.1126/science.1216380; Moure A, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042423; Nagel O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113382; Najem S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.034702; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Nichols JME, 2015, CURR OPIN CELL BIOL, V36, P7, DOI 10.1016/j.ceb.2015.06.005; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pedersen JN, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.062401; Pons AJ, 2010, NATURE, V464, P85, DOI 10.1038/nature08862; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; POTEL MJ, 1979, J CELL SCI, V36, P281; Rappel Wouter-Jan, 2017, Curr Opin Syst Biol, V3, P43, DOI 10.1016/j.coisb.2017.03.005; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x; Shao DY, 2012, P NATL ACAD SCI USA, V109, P6851, DOI 10.1073/pnas.1203252109; Shao DY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.108104; Shi CJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003122; Shi CJ, 2013, WIRES SYST BIOL MED, V5, P631, DOI 10.1002/wsbm.1230; Shibata T, 2013, BIOPHYS J, V105, P2199, DOI 10.1016/j.bpj.2013.09.024; Shibata T, 2012, J CELL SCI, V125, P5138, DOI 10.1242/jcs.108373; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Tang M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6175; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; Tweedy L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02606; Van Haastert PJM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001708; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; VARNUM B, 1986, DEV BIOL, V113, P218, DOI 10.1016/0012-1606(86)90124-7; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Ziebert F, 2012, J R SOC INTERFACE, V9, P1084, DOI 10.1098/rsif.2011.0433	73	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201977	10.1371/journal.pone.0201977	http://dx.doi.org/10.1371/journal.pone.0201977			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138392	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100032
J	Paparini, S; Nutland, W; Rhodes, T; Nguyen, V; Anderson, J				Paparini, Sara; Nutland, Will; Rhodes, Tim; Vinh-Kim Nguyen; Anderson, Jane			DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS PREP; GAY MEN; INFECTION; LONDON; SCIENCE; MSM	Pre-exposure prophylaxis (PrEP) with antiretroviral medication is an effective, evidence-based option for HIV prevention. In England, issues of cost-effectiveness and of responsibility for commissioning prevention services have so far led National Health Service (NHS) England to decide not to commission PrEP. Given the significant lag between the awareness of PrEP efficacy and the opportunity to obtain PrEP through traditional health care routes, many gay and other men who have sex with men (MSM) have turned to DIY PrEP', purchasing generic formulations of PrEP for themselves on the internet or via other alternative routes. However, there is very little research on DIY PrEP practices and no qualitative study with DIY PrEP users in the UK. A formative qualitative study was conducted in 2017 to inform the development of an intervention (PrEP Club) to support DIY PrEP users and improve the safety and experience of this prevention strategy. Focus groups were held with 20 MSM who are based in London and are obtaining PrEP through means other than clinical trials, to explore their accounts of sourcing and using PrEP and the experiential meanings of these. In this article, we report findings from this first, formative study and present the different practices involved in finding out about PrEP, buying it and ascertaining legitimacy of sellers and products. We reflect on the uncertainties participants described related to actually using PrEP, including deciding on drug dosing and monitoring their health. Finally, we present the results of the discussions participants had about the kind of support they had received, the help they would have liked, and their views on proposed interventions to support DIY PrEP users, such as PrEP Club.	[Paparini, Sara; Vinh-Kim Nguyen] Grad Inst Int & Dev Studies, Dept Anthropol & Sociol Dev, Geneva, Switzerland; [Nutland, Will; Rhodes, Tim] London Sch Hyg & Trop Med, Fac Publ Hlth Policy, Dept Social & Environm Hlth Res, London, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, London, England	University of London; London School of Hygiene & Tropical Medicine	Paparini, S (corresponding author), Grad Inst Int & Dev Studies, Dept Anthropol & Sociol Dev, Geneva, Switzerland.	sara.paparini@graduateinstitute.ch	Anderson, Jane/A-1632-2012; Rhodes, Tim/DNJ-9679-2022	Anderson, Jane/0000-0001-5294-8707; Rhodes, Tim/0000-0003-2400-9838; Paparini, Sara/0000-0002-1909-2481	European Research Council ERC [CoG 617930]; Independent Social Research Foundation (ISRF); Flexible Grant for Small Groups Award; Small Group as part of the same ISRF Award	European Research Council ERC(European Research Council (ERC)); Independent Social Research Foundation (ISRF); Flexible Grant for Small Groups Award; Small Group as part of the same ISRF Award	SP and VKN are funded by the European Research Council ERC CoG 617930 (https://erc.europa.eu/). Direct research costs related to this study were funded by the Independent Social Research Foundation (ISRF) with a Flexible Grant for Small Groups Award (http://www.isrf.org/). The Award was granted to SP in September 2016, in collaboration with TR, VKN and JA. WN has received consultancy funding from the Small Group as part of the same ISRF Award.	Aghaizu A, 2013, SEX TRANSM INFECT, V89, P207, DOI 10.1136/sextrans-2012-050648; Aloysius I, 2017, J VIRUS ERAD, V3, P218; [Anonymous], 2017, ELIMINATION HIV TRAN; Brisson J, 2018, GLOB PUBLIC HEALTH, V13, P1382, DOI 10.1080/17441692.2017.1373139; Brisson J, 2017, CULT HEALTH SEX, V19, P1066, DOI 10.1080/13691058.2017.1291994; British HIV Association and British Association for Sexual Health and HIV, 2017, CONS VERS BHIVA BASH; Brown AE, 2017, EURO SURVEILLANCE, V22; Caceres CF, 2015, J INT AIDS SOC, V18, P5, DOI [10.7448/IAS.18.4.19949, 10.7448/IAS.18.4.20527]; Caceres CF, 2016, J INT AIDS SOC, V19; Cain M, 2017, GUARDIAN; Castro DR, 2017, HIV MED, V18, P308, DOI 10.1111/hiv.12419; Collins SP, 2017, INT J SEX HEALTH, V29, P55, DOI 10.1080/19317611.2016.1206051; Dean T, 2015, SEXUALITIES, V18, P224, DOI 10.1177/1363460715569137; Frankis J, 2014, HIV MED, V15, P16; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Green J, 2014, QUALITATIVE METHODS; Greenhough B, 2017, HLTH GEOGRAPHIES CRI; Hill A, 2017, J VIRUS ERAD, V3, P200; Keogh P, 2015, AIDS CARE, V27, P796, DOI 10.1080/09540121.2014.989484; Koester K, 2017, CULT HEALTH SEX, V19, P1301, DOI 10.1080/13691058.2017.1310927; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Mazanderani F, 2018, BIOSOCIETIES, V13, P232, DOI 10.1057/s41292-017-0066-z; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; Nguyen VK, 2017, INCIDENCE SEXUALLY T; Nwokolo N, 2017, LANCET HIV, V4, pE482, DOI 10.1016/S2352-3018(17)30181-9; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Quet M, 2017, THEOR CULT SOC; Sigma Research, 2011, SIGM PAN INS BLAST 6; Slawson N, 2016, GUARDIAN; Spieldenner A, 2016, J HOMOSEXUAL, V63, P1685, DOI 10.1080/00918369.2016.1158012; Strudwick P, 2017, BUZZFEED; THNG C, 2012, HIV MED S1, V13, P84; Wang X, 2018, HIV MED, V19, P1, DOI 10.1111/hiv.12528; Young I, 2016, SOCIOL HEALTH ILL, V38, P411, DOI 10.1111/1467-9566.12372; Young I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005717; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zablotska IB, 2013, JAIDS-J ACQ IMM DEF, V62, P334, DOI 10.1097/QAI.0b013e31827e854a	39	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202830	10.1371/journal.pone.0202830	http://dx.doi.org/10.1371/journal.pone.0202830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138482	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000442800100135
J	Plazanet, M; Tasseva, J; Bartolini, P; Taschin, A; Torre, R; Combes, C; Rey, C; Di Michele, A; Verezhak, M; Gourrier, A				Plazanet, Marie; Tasseva, Jordanka; Bartolini, Paolo; Taschin, Andrea; Torre, Renato; Combes, Christele; Rey, Christian; Di Michele, Alessandro; Verezhak, Mariana; Gourrier, Aurelien			Time-domain THz spectroscopy of the characteristics of hydroxyapatite provides a signature of heating in bone tissue	PLOS ONE			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; ORGANIC-MATTER; TEMPERATURE; SCAFFOLDS; DYNAMICS; BEHAVIOR	Because of the importance of bone in the biomedical, forensic and archaeological contexts, new investigation techniques are constantly required to better characterize bone ultrastructure. In the present paper, we provide an extended investigation of the vibrational features of bone tissue in the 0.1-3 THz frequency range by time-domain THz spectroscopy. Their assignment is supported by a combination of X-ray diffraction and DFT-normal modes calculations. We investigate the effect of heating on bone tissue and synthetic calcium-phosphates compounds with close structure and composition to bone mineral, including stoichiometric and non-stoichiometric hydroxyapatite (HA), tricalcium phosphate, calcium pyrophosphate and tetracalcium phosphate. We thus demonstrate that the narrow vibrational mode at 2.1 THz in bone samples exposed to thermal treatment above 750 degrees C arises from a lattice mode of stoichiometric HA. This feature is also observed in the other synthetic compounds, although weaker or broader, but is completely smeared out in the non-stoichiometric HA, close to natural bone mineral composition, or in synthetic poorly crystalline HA powder. The THz spectral range therefore provides a clear signature of the crystalline state of the investigated bone tissue and could, therefore be used to monitor or identify structural transitions occurring in bone upon heating.	[Plazanet, Marie; Verezhak, Mariana; Gourrier, Aurelien] Univ Grenoble Alpes, CNRS, LIPhy, Grenoble, France; [Plazanet, Marie; Di Michele, Alessandro] Univ Perugia, Dipartimento Fis & Geol, Perugia, Italy; [Tasseva, Jordanka; Bartolini, Paolo; Taschin, Andrea; Torre, Renato] Univ Firenze, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy; [Tasseva, Jordanka; Bartolini, Paolo; Taschin, Andrea; Torre, Renato] Univ Firenze, Dip Fis & Astron, Sesto Fiorentino, Italy; [Combes, Christele; Rey, Christian] Univ Toulouse, CIRIMAT, CNRS, INPT ENSIACET, Toulouse, France; [Tasseva, Jordanka] Ist Nazl Fis Nucl, Naples, Italy; [Tasseva, Jordanka] CNR, Ist Nazl Ott, Pozzuoli, Italy; [Verezhak, Mariana] Paul Scherrer Inst, Villigen, Switzerland	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Perugia; University of Florence; University of Florence; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Plazanet, M; Gourrier, A (corresponding author), Univ Grenoble Alpes, CNRS, LIPhy, Grenoble, France.; Plazanet, M (corresponding author), Univ Perugia, Dipartimento Fis & Geol, Perugia, Italy.	marie.plazanet@univ-grenoble-alpes.fr; aurelien.gourrier@univ-grenoble-alpes.fr	de la Torre, Rafael/D-3561-2018; Torre, Renato/G-6313-2012	de la Torre, Rafael/0000-0002-6765-1866; Bartolini, Paolo/0000-0002-5447-9868; Di Michele, Alessandro/0000-0002-0357-2608; Verezhak, Mariana/0000-0001-6897-8476; COMBES, Christele/0000-0001-5009-1973; Gourrier, Aurelien/0000-0001-9526-5746; Torre, Renato/0000-0003-3182-9906; Plazanet, Marie/0000-0002-7041-8299	Regione Toscana [POR-CROFSE-UNIFI-26]; Ente Cassa di Risparmio Firenze [2016-0866]; ECs Seventh Framework Programme [284464]; program Laserlab (Laserlab-Europe) [H2020 EC-GA (654148)]; Ph.D. program of the Nanosciences Foundation of Grenoble (France)	Regione Toscana(Regione Toscana); Ente Cassa di Risparmio Firenze; ECs Seventh Framework Programme(European Commission); program Laserlab (Laserlab-Europe); Ph.D. program of the Nanosciences Foundation of Grenoble (France)	We thank the ILL for the use of computational cluster and VASP 5.4 licence. This work was partially funded by Regione Toscana, prog. POR-CROFSE-UNIFI-26 and by Ente Cassa di Risparmio Firenze, prog. 2016-0866, and by the ECs Seventh Framework Programme, Grant Agreement No. 284464 (RT). TD-THz measurements were supported by the program Laserlab (i.e. Laserlab-Europe, H2020 EC-GA (654148)). M. Verezhak acknowledges support from the Ph.D. program of the Nanosciences Foundation of Grenoble (France). There was no additional external funding received for this study.	ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3; BADDOURHADJEAN R, 1995, CHEM PHYS, V197, P81, DOI 10.1016/0301-0104(95)00155-H; Bessou M, 2012, APPL OPTICS, V51, P6738, DOI 10.1364/AO.51.006738; Bhat SS, 2014, CRYST GROWTH DES, V14, P3131, DOI 10.1021/cg5004269; BOUDIN S, 1993, ACTA CRYSTALLOGR C, V49, P2062, DOI 10.1107/S0108270193005608; Chadefaux C, 2009, J NANO RES-SW, V8, P157, DOI 10.4028/www.scientific.net/JNanoR.8.157; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COWLEY ER, 1973, PHYS REV B, V8, P4795, DOI 10.1103/PhysRevB.8.4795; De Aza PN, 1997, CHEM MATER, V9, P15; DICKENS B, 1973, ACTA CRYSTALLOGR B, V29, P2046, DOI 10.1107/S0567740873006102; Ellingham STD, 2016, J FORENSIC SCI, V61, P153, DOI 10.1111/1556-4029.12855; Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016; Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206; Gourrier A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176179; Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.0.CO;2-B; Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033; HEUGHEBA.JC, 1970, B SOC CHIM FR, P2923; HUGHES JM, 1989, AM MINERAL, V74, P870; Jacob S, 2010, J THERM ANAL CALORIM, V100, P897, DOI 10.1007/s10973-009-0373-0; Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014; Jung E, 2012, BIOMED OPT EXPRESS, V3, P1110, DOI 10.1364/BOE.3.001110; Kalsbeek N, 2006, STUD CONSERV, V51, P123, DOI 10.1179/sic.2006.51.2.123; Karhanek D, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/26/265006; Kim SM, 2013, P PROG EL RES S, P434; Lebon M, 2008, ANAL BIOANAL CHEM, V392, P1479, DOI 10.1007/s00216-008-2469-y; Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039; Mizuno M, 2013, J BIOL PHYS, V39, P123, DOI 10.1007/s10867-012-9290-8; Mkukuma LD, 2004, CALCIFIED TISSUE INT, V75, P321, DOI 10.1007/s00223-004-0199-5; Nasiri-Tabrizi B, 2014, J IND ENG CHEM, V20, P245, DOI 10.1016/j.jiec.2013.03.041; Niakan A, 2015, CERAM INT, V41, P3024, DOI 10.1016/j.ceramint.2014.10.138; Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001; Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P487, DOI 10.1007/s002239900372; Piga G, 2008, J ARCHAEOL SCI, V35, P2171, DOI 10.1016/j.jas.2008.02.003; Piga G, 2016, INT J SPECTROSC, DOI 10.1155/2016/4810149; Piga G, 2013, J ARCHAEOL SCI, V40, P778, DOI 10.1016/j.jas.2012.07.004; Rey C., 2011, COMPREHENSIVE BIOMAT, V1, P187, DOI [DOI 10.1016/B978-0-08-055294-1.00178-1, 10.1016/B978-0-08-055294-1.00178-1]; Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7; Schuetz R, 2015, MOLECULES, V20, P5835, DOI 10.3390/molecules20045835; Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017; Sofronia AM, 2014, MAT SCI ENG C-MATER, V43, P153, DOI 10.1016/j.msec.2014.07.023; Stringer MR, 2005, PHYS MED BIOL, V50, P3211, DOI 10.1088/0031-9155/50/14/001; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; Taschin A., 2017, ACTA IMEKO, V6, P12, DOI [10.21014/acta_imeko.v6i3.447, DOI 10.21014/ACTA_IMEKO.V6I3.447]; Taschin A, 2018, MEASUREMENT, V118, P282, DOI 10.1016/j.measurement.2017.05.074; Tasseva J, 2017, ANALYST, V142, P42, DOI 10.1039/c6an02113a; Taylor MG, 2001, PHYS CHEM CHEM PHYS, V3, P1514, DOI 10.1039/b005666i; Taylor MG, 1999, PHYS CHEM CHEM PHYS, V1, P3141, DOI 10.1039/a902511a; Thompson TJU, 2011, PALAEOGEOGR PALAEOCL, V299, P168, DOI 10.1016/j.palaeo.2010.10.044; Thompson TJU, 2009, J ARCHAEOL SCI, V36, P910, DOI 10.1016/j.jas.2008.11.013; Verezhak M, 2018, ACTA BIOMATER, V73, P500, DOI 10.1016/j.actbio.2018.04.004; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Yashima M, 2003, J SOLID STATE CHEM, V175, P272, DOI 10.1016/S0022-4596(03)00279-2; Yatongchai C, 2015, J INFRARED MILLIM TE, V36, P81, DOI 10.1007/s10762-014-0103-y; Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201745	10.1371/journal.pone.0201745	http://dx.doi.org/10.1371/journal.pone.0201745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138314	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000442800100024
J	Yurovsky, A; Amin, MR; Gardin, J; Chen, YP; Skiena, S; Futcher, B				Yurovsky, Alisa; Amin, Mohammad Ruhul; Gardin, Justin; Chen, Yuping; Skiena, Steve; Futcher, Bruce			Prokaryotic coding regions have little if any specific depletion of Shine-Dalgarno motifs	PLOS ONE			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; SECONDARY STRUCTURE; TRANSLATION; SEQUENCE; INITIATION; LEADERLESS; EXPRESSION; BACTERIA; OPERON	The Shine-Dalgarno motif occurs in front of prokaryotic start codons, and is complementary to the 3' end of the 16S ribosomal RNA. Hybridization between the Shine-Dalgarno sequence and the anti-Shine-Dalgarno region of the16S rRNA (CCUCCU) directs the ribo-some to the start AUG of the mRNA for translation. Shine-Dalgarno-like motifs (AGGAGG in E. coli) are depleted from open reading frames of most prokaryotes. This may be because hybridization of the 16S rRNA at Shine-Dalgarnos inside genes would slow translation or induce internal initiation. However, we analyzed 128 species from diverse phyla where the 16S rRNA gene(s) lack the anti-Shine-Dalgarno sequence, and so the 16S rRNA is incapable of interacting with Shine-Dalgarno-like sequences. Despite this lack of an anti-Shine-Dalgarno, half of these species still displayed depletion of Shine-Dalgarno-like sequences when analyzed by previous methods. Depletion of the same G-rich sequences was seen by these methods even in eukaryotes, which do not use the Shine-Dalgarno mechanism. We suggest previous methods are partly detecting a non-specific depletion of G-rich sequences. Alternative informatics approaches show that most prokaryotes have only slight, if any, specific depletion of Shine-Dalgarno-like sequences from open reading frames. Together with recent evidence that ribosomes do not pause at ORF-internal Shine-Dalgarno motifs, these results suggest the presence of ORF-internal Shine-Dalgarno-like motifs may be inconsequential, perhaps because internal regions of prokaryotic mRNAs may be structurally "shielded" from translation initiation.	[Yurovsky, Alisa; Amin, Mohammad Ruhul; Skiena, Steve] SUNY Stony Brook, Dept Comp Sci, New York, NY USA; [Gardin, Justin; Chen, Yuping; Futcher, Bruce] SUNY Stony Brook, Dept Mol Genet & Microbiol, New York, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Futcher, B (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, New York, NY 11794 USA.	bfutcher@gmail.com		Futcher, Bruce/0000-0002-1012-9022; Amin, Mohammad Ruhul/0000-0001-6540-3415; Gardin, Justin/0000-0001-8495-6728; Chen, Yuping/0000-0002-9819-0230	NIH [R01 GM119175-01]; NSF [DBI-1060572, DBI-1355990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01 GM119175-01 (to BF) and NSF grants DBI-1060572 and DBI-1355990 (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Borg A, 2015, J MOL BIOL, V427, P1835, DOI 10.1016/j.jmb.2014.10.027; Burkhardt DH, 2017, ELIFE, V6, DOI [10.7554/elife.22037, 10.7554/eLife.22037]; Chadani Y, 2016, P NATL ACAD SCI USA, V113, pE829, DOI 10.1073/pnas.1520560113; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DESMIT MH, 1994, J MOL BIOL, V235, P173, DOI 10.1016/S0022-2836(05)80024-5; Diwan GD, 2016, GENOME BIOL EVOL, V8, P1722, DOI 10.1093/gbe/evw107; Grill S, 2002, FEMS MICROBIOL LETT, V211, P161, DOI 10.1016/S0378-1097(02)00646-8; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Li GW, 2015, CURR OPIN MICROBIOL, V24, P66, DOI 10.1016/j.mib.2015.01.001; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lim K, 2012, MOL BIOL EVOL, V29, P2937, DOI 10.1093/molbev/mss101; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Mohammad F, 2016, CELL REP, V14, P686, DOI 10.1016/j.celrep.2015.12.073; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Sakai H, 2001, J MOL EVOL, V52, P164, DOI 10.1007/s002390010145; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Scharff LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002155; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SHINE J, 1975, EUR J BIOCHEM, V57, P221, DOI 10.1111/j.1432-1033.1975.tb02294.x; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; Tompa M, 1999, Proc Int Conf Intell Syst Mol Biol, P262; WIKSTROM PM, 1992, J MOL BIOL, V224, P949, DOI 10.1016/0022-2836(92)90462-S; Yang CY, 2016, G3-GENES GENOM GENET, V6, P3467, DOI 10.1534/g3.116.032227	32	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202768	10.1371/journal.pone.0202768	http://dx.doi.org/10.1371/journal.pone.0202768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138485	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100123
J	Chapartegui-Gonzalez, I; Lazaro-Diez, M; Bravo, Z; Navas, J; Icardo, JM; Ramos-Vivas, J				Chapartegui-Gonzalez, Itziar; Lazaro-Diez, Maria; Bravo, Zaloa; Navas, Jesus; Icardo, Jose M.; Ramos-Vivas, Jose			Acinetobacter baumannii maintains its virulence after long-time starvation	PLOS ONE			English	Article							DRY SURFACES; BIOFILM FORMATION; INANIMATE SURFACES; IN-VITRO; SURVIVAL; CONTAMINATION; INFECTIONS; CYTOTOXICITY; DESICCATION; ENVIRONMENT	Acinetobacter baumannii is a cause of healthcare-associated infections. Although A. baumannii is an opportunistic pathogen, its infections are notoriously difficult to treat due to intrinsic and acquired antimicrobial resistance, often limiting effective therapeutic options. A. baumannii can survive for long periods in the hospital environment, particularly on inanimate surfaces. Such environments may act as a reservoir for cross-colonization and infection outbreaks and should be considered a substantial factor in infection control practices. Moreover, clothing of healthcare personnel and gadgets may play a role in the spread of nosocomial bacteria. A link between contamination of hospital surfaces and A. baumannii infections or between its persistence in the environment and its virulence has not yet been established. Bacteria under stress (i.e., long-term desiccation in hospital setting) could conserve factors that favor infection. To investigate whether desiccation and/or starvation may be involved in the ability of certain strains of A. baumannii to retain virulence factors, we have studied five well-characterized clinical isolates of A. baumannii for which survival times were determined under simulated hospital conditions. Despite a considerable reduction in the culturability over time (up to 88% depending on strain and the condition tested), some A. baumannii strains were able to maintain their ability to form biofilms after rehydration, addition of nutrients, and changing temperature. Also, after long-term desiccation, several clinical strains were able to grow in the presence of non-immune human serum as fine as their non-stressed homologs. Furthermore, we also show that the ability of bacterial strains to kill Galleria mellonella larvae does not change although A. baumannii cells were stressed by long-term starvation (up to 60 days). This means that A. baumannii can undergo a rapid adaptation to both the temperature shift and nutrients availability, conditions that can be easily found by bacteria in a new patient in the hospital setting.	[Chapartegui-Gonzalez, Itziar; Lazaro-Diez, Maria; Bravo, Zaloa; Navas, Jesus; Ramos-Vivas, Jose] Inst Invest Valdecilla IDIVAL, Santander, Spain; [Chapartegui-Gonzalez, Itziar; Lazaro-Diez, Maria; Ramos-Vivas, Jose] Hosp Univ Marques Valdecilla, Serv Microbiol, Santander, Spain; [Lazaro-Diez, Maria; Ramos-Vivas, Jose] Inst Salud Carlos III, REIF, Madrid, Spain; [Navas, Jesus] Univ Cantabria, Dept Biol Mol, Santander, Spain; [Icardo, Jose M.] Univ Cantabria, Dept Anat & Biol Celular, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Instituto de Salud Carlos III; Universidad de Cantabria; Universidad de Cantabria	Ramos-Vivas, J (corresponding author), Inst Invest Valdecilla IDIVAL, Santander, Spain.; Ramos-Vivas, J (corresponding author), Hosp Univ Marques Valdecilla, Serv Microbiol, Santander, Spain.; Ramos-Vivas, J (corresponding author), Inst Salud Carlos III, REIF, Madrid, Spain.	jvivas@idival.org	Lázaro-Díez, María/AAA-1529-2020; Chapartegui-González, Itziar/AAC-2709-2022; Icardo, Jose Manuel/ABH-5431-2020; Ramos-Vivas, J/G-3643-2016	Lázaro-Díez, María/0000-0002-6098-8052; Chapartegui-González, Itziar/0000-0001-7878-4499; Icardo, Jose Manuel/0000-0001-9543-2444; Ramos-Vivas, J/0000-0001-8795-519X	Spanish Instituto de Salud Carlos III, Spain [PI16/01103]; Plan Nacional de I+D+i 2008-2011; Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases - European Development Regional Fund "A way to achieve Europe" [REIPI RD12/0015]; Instituto de Investigacion Sanitaria Valdecilla IDIVAL [PREVAL16/05]; Universidad de Cantabria [PREVAL16/05]; Instituto de Salud Carlos III, Spain [PI16/01103]	Spanish Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Plan Nacional de I+D+i 2008-2011; Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases - European Development Regional Fund "A way to achieve Europe"; Instituto de Investigacion Sanitaria Valdecilla IDIVAL; Universidad de Cantabria; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	Research in our laboratory is supported by the Spanish Instituto de Salud Carlos III, Spain (grant PI16/01103 to Jose Ramos-Vivas) and the Plan Nacional de I+D+i 2008-2011 and Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015) - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.L.-D. holds a contract from the Instituto de Investigacion Sanitaria Valdecilla IDIVAL and Universidad de Cantabria (PREVAL16/05). J.R-V. holds a Miguel Servet II contract for Young Researchers from the Instituto de Salud Carlos III, Spain. The authors thank Dr. Fidel Madrazo (Electron Microscopy Unit, Technology Support Services, IDIVAL) for helping with confocal microscopy and Dr. Miguel Santibanez for his assistance with the statistics used in this report. Research in our laboratory is supported by the Instituto de Salud Carlos III, Spain (grant PI16/01103) and the Plan Nacional de I+D+i 2008-2011 and Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015) - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF.	Bassetti M, 2015, CURR OPIN CRIT CARE, V21, P402, DOI 10.1097/MCC.0000000000000235; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Bravo Z, 2018, J HOSP INFECT, V98, P74, DOI 10.1016/j.jhin.2017.07.031; Bravo Z, 2016, ARCH MICROBIOL, V198, P399, DOI 10.1007/s00203-016-1200-1; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; D'Agata EMC, 1999, J CLIN MICROBIOL, V37, P3065; Dancer SJ, 2014, CLIN MICROBIOL REV, V27, P665, DOI 10.1128/CMR.00020-14; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Garnacho-Montero J, 2015, EXPERT REV ANTI-INFE, V13, P769, DOI 10.1586/14787210.2015.1032254; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jawad A, 1998, J HOSP INFECT, V39, P235, DOI 10.1016/S0195-6701(98)90263-8; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Lazaro-Diez M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04870-8; Lazaro-Diez M, 2016, MICROBES INFECT, V18, P559, DOI 10.1016/j.micinf.2016.05.002; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Munoz-Price LS, 2012, AM J INFECT CONTROL, V40, pE245, DOI 10.1016/j.ajic.2012.03.032; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Remuzgo-Martinez S, 2015, APPL ENVIRON MICROB, V81, P3306, DOI 10.1128/AEM.00088-15; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Rosales-Reyes R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182899; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Russotto V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0120-5; Sanchez-Larrayoz AF, 2017, J IMMUNOL, V199, P2803, DOI 10.4049/jimmunol.1700877; Saun TJ, 2018, J BURN CARE RES, V39, P1029, DOI 10.1097/BCR.0000000000000626; Shamsizadeh Z, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0653-4; Shimose LA, 2016, INFECT CONT HOSP EP, V37, P777, DOI 10.1017/ice.2016.69; Subashchandrabose S, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00013-15; Vila-Farres X, 2015, J ANTIMICROB CHEMOTH, V70, P2981, DOI 10.1093/jac/dkv244; Vivas J, 2004, APPL ENVIRON MICROB, V70, P2702, DOI 10.1128/AEM.70.5.2702-2708.2004; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Wong D, 2017, CLIN MICROBIOL REV, V30, P409, DOI 10.1128/CMR.00058-16	35	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201961	10.1371/journal.pone.0201961	http://dx.doi.org/10.1371/journal.pone.0201961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133491	gold, Green Submitted, Green Published			2022-12-26	WOS:000442500400053
J	Li, JJ; Guo, HL; Wang, Y; Zong, JQ; Chen, JB; Li, DD; Li, L; Wang, JJ; Liu, JX				Li, Jianjian; Guo, Hailin; Wang, Yi; Zong, Junqin; Chen, Jingbo; Li, Dandan; Li, Ling; Wang, Jingjing; Liu, Jianxiu			High-throughput SSR marker development and its application in a centipedegrass (Eremochloa ophiuroides (Munro) Hack.) genetic diversity analysis	PLOS ONE			English	Article							SEQUENCE REPEAT MARKERS; AMPLIFIED POLYMORPHISM; LINKAGE MAP; TRANSCRIPTOME; EST; TRANSFERABILITY; WHEAT; IDENTIFICATION; CONSTRUCTION; REGISTRATION	Centipedegrass (Eremochloa ophiuroides (Munro) Hack.) is a perennial, warm-season C4 grass species that shows great potential for use as a low-maintenance turfgrass species in tropical and subtropical regions. However, limited genetic and genomic information is available for this species, which has impeded systematic studies on the enhancement of its turf quality and resistance against biotic and abiotic stress. In this study, Illumina HiSeq high-throughput sequencing technology was performed to generate centipedegrass transcriptome sequences. A total of 352,513 assembled sequences were used to search for simple sequence repeat (SSR) loci, and 64,470 SSR loci were detected in 47,638 SSR containing sequences. The tri-nucleotides were the most frequent repeat motif, followed by di-nucleotides, tetra-nucleotides hexnucleotides, and pentanucleotides. A total of 48,061 primer pairs were successfully designed in the flanking sequences of the SSRs, and 100 sets of primers were randomly selected for the initial validation in four centipedegrass accessions. In total, 56 (56.0%) of the 100 primer pairs tested successfully amplified alleles from all four centipedegrass accessions, while 50 were identified as polymorphic markers and were then used to assess the level of genetic diversity among 43 centipedegrass core collections. The genetic diversity analysis exhibited that the number of alleles (Na) per locus ranged from 3 to 13, and the observed heterozygosity (Ho) ranged from 0.17 to 0.83. The polymorphism information content (PIC) value of the markers ranged from 0.15 to 0.78, and the genetic distances (coefficient Nei72) between the accessions varied from 0.07 to 0.48. The UPGMA-based dendrogram clustered all 43 core collections into two main groups and six subgroups, which further validated the effectiveness of these newly developed SSR markers. Hence, these newly developed SSR markers will be valuable and potentially useful for future genetic and genomic studies of E. ophiuroides.	[Li, Jianjian; Guo, Hailin; Wang, Yi; Zong, Junqin; Chen, Jingbo; Li, Dandan; Li, Ling; Wang, Jingjing; Liu, Jianxiu] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Mem Sun Yat Sen, Nanjing Bot Garden, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences	Liu, JX (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, Mem Sun Yat Sen, Nanjing Bot Garden, Nanjing, Jiangsu, Peoples R China.	turfuni@aliyun.com	wang, jing/GVT-8700-2022; zong, Junqin/J-4141-2014; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022	Li, Jianjian/0000-0001-6732-282X; Chen, Jingbo/0000-0001-8113-7823	Scientific Facility Project of Jiangsu Province, China [BM2015019-1]; Jiangsu Provincial Natural Science Foundation [BK20171327]	Scientific Facility Project of Jiangsu Province, China; Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was financially supported by Grants from the Scientific Facility Project of Jiangsu Province, China (Grant No. BM2015019-1), and Jiangsu Provincial Natural Science Foundation (Grant No. BK20171327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bushman BS, 2011, THEOR APPL GENET, V123, P119, DOI 10.1007/s00122-011-1571-2; Chen HG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123176; DICKENS R, 1981, AGRON J, V73, P674, DOI 10.2134/agronj1981.00021962007300040025x; Ding YJ, 2015, BIOCHEM SYST ECOL, V63, P183, DOI 10.1016/j.bse.2015.10.008; Du FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061337; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo HaiLin, 2014, Acta Agrestia Sinica, V22, P203; Guo R, 2014, MOL BREEDING, V34, P1733, DOI 10.1007/s11032-014-0134-z; Guo YW, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.07.0074; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; HANNA WW, 1995, CROP SCI, V35, P332, DOI 10.2135/cropsci1995.0011183X003500020007x; HANNA WW, 1978, CROP SCI, V18, P835, DOI 10.2135/cropsci1978.0011183X001800050038x; Hanna WW, 1997, CROP SCI, V37, P1017, DOI 10.2135/cropsci1997.0011183X003700030074x; Harris-Shultz KR, 2012, CROP SCI, V52, P383, DOI 10.2135/cropsci2011.03.0151; He XD, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0820-3; Hirata M, 2006, THEOR APPL GENET, V113, P270, DOI 10.1007/s00122-006-0292-4; Hirata M, 2012, GRASSL SCI, V58, P28, DOI 10.1111/j.1744-697X.2011.00238.x; Hodel RGJ, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600024; Huang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00496; Iniguez-Luy FL, 2008, THEOR APPL GENET, V117, P977, DOI 10.1007/s00122-008-0837-9; Islam M. Anowarul, 2005, Grassland Science, V51, P183, DOI 10.1111/j.1744-697X.2005.00014.x; Jia XP, 2015, GENES GENOM, V37, P77, DOI 10.1007/s13258-014-0231-8; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kubik C, 2011, MOL ECOL RESOUR, V11, P872, DOI 10.1111/j.1755-0998.2011.03006.x; Kuleung C, 2004, THEOR APPL GENET, V108, P1147, DOI 10.1007/s00122-003-1532-5; Lee EM, 2013, RADIAT PHYS CHEM, V91, P108, DOI 10.1016/j.radphyschem.2013.06.010; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu MX, 2008, IN VITRO CELL DEV-PL, V44, P100, DOI 10.1007/s11627-008-9115-4; Liu MX, 2012, PLANT CELL TISS ORG, V109, P557, DOI 10.1007/s11240-012-0122-0; Liu MingXi, 2012, Acta Prataculturae Sinica, V21, P126; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083549; Luo JH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01655; Milla-Lewis SR, 2012, GENET RESOUR CROP EV, V59, P1517, DOI 10.1007/s10722-011-9780-8; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nie G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00801; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Scully BT, 2012, J PLANT REGIST, V6, P246, DOI 10.3198/jpr2012.02.0082crc; Studer B, 2008, MOL BREEDING, V21, P533, DOI 10.1007/s11032-007-9148-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsuruta Shin-Ichi, 2005, Grassland Science, V51, P249, DOI 10.1111/j.1744-697X.2005.00033.x; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang PL, 2017, PLANT MOL BIOL REP, V35, P215, DOI 10.1007/s11105-016-1017-8; Wang PL, 2014, SCI HORTIC-AMSTERDAM, V176, P97, DOI 10.1016/j.scienta.2014.06.031; Wang XW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4878-4; Wang XW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01350; Watson L., 1992, The grass genera of the world.; Xiao Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0384-2; Xie Y, 2015, PLANT SOIL, V390, P307, DOI 10.1007/s11104-015-2391-y; Xuan JiPing, 2003, Acta Prataculturae Sinica, V12, P110; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139775; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Yeh F. POPGENE, 1999, POPGENE VERSION 132, DOI DOI 10.1590/S1415-47572003000300014; Zhang J, 2018, J APPL PHYCOL, V30, P2101, DOI 10.1007/s10811-017-1354-5; Zheng Y.C, 2009, SHRINKAGE BEHAV GEOP; Zheng YQ, 2013, SCI HORTIC-AMSTERDAM, V156, P86, DOI 10.1016/j.scienta.2013.03.030; Zhou XJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2743-x; Zhu YQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00687	65	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202605	10.1371/journal.pone.0202605	http://dx.doi.org/10.1371/journal.pone.0202605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133524	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400087
J	Mekonnen, FA; Ambaw, YA; Neri, GT				Mekonnen, Fantahun Ayenew; Ambaw, Yohannes Abere; Neri, Genanew Timerga			Socio-economic determinants of anemia in pregnancy in North Shoa Zone, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; WOMEN	Background Globally, anemia in pregnancy increases maternal, fetal and neonatal mortality and morbidity. According to 2011 Ethiopian Demographic and Health Survey, 22% of pregnant women in Ethiopia were reported to be anemic. However, since the Ethiopian population is diverse with regard to culture, religion and other characteristics, this evidence may not represent the condition in our study area. So, we aimed to determine the prevalence of anemia and its associated factors among women receiving Antenatal Care (ANC) in Debre Berhan Town Hospitals and Clinics. Methods We conducted an institution based cross sectional study among women receiving ANC at hospitals and clinics in Debre Berhan Town, Ethiopia from September to November, 2013. Antenatal care providers in the respective health facilities collected the data by interview and observation using closed and open-ended questions. We computed frequencies and percentages to describe the data. We performed bivariate and multivariable binary logistic regression analyses to identify factors associated with anemia in pregnancy. STATA version 12 was used to carry out the analyses. Results A total of 295 participants completed the study, with a response rate of 89%. This study demonstrated a 10% prevalence of anemia out of which 64.3%, 32% and 4% of the respondents were with mild, moderate and severe anemia respectively. Anemia was statistically significantly associated with education and occupation. Conclusion The prevalence of anemia in our study area is lower than previous studies' findings. Literacy and job status of the women were predictors of anemia in pregnancy. Since this study was conducted on women who had an opportunity to visit health facilities, it is more valuable to conduct community based research to better understand the problem in the study area and thus propose future deliverable.	[Mekonnen, Fantahun Ayenew] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Amhara Regional, Ethiopia; [Ambaw, Yohannes Abere] Bahir Dar Univ, Inst Med & Hlth Sci, Bahir Dar, Amhara Regional, Ethiopia; [Neri, Genanew Timerga] Debre Berhan Univ, Coll Computat & Nat Sci, Dept Stat, Debre Berhan, Amhara Regional, Ethiopia	University of Gondar; Bahir Dar University	Mekonnen, FA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Amhara Regional, Ethiopia.	ayenewf@yahoo.com	Mekonnen, Fantahun Ayenew/HDN-9515-2022		Debre Berhan University	Debre Berhan University	This work was supported by Debre Berhan University (www.dbu.edu.et).	Agarwal KN, 2001, BRIT J NUTR, V85, pS147, DOI 10.1079/BJN2000307; Ahmad N, 2010, AUSTRALAS MED J, V3, P276, DOI 10.4066/AMJ.2010.286; Ayoya MA, 2006, FOOD NUTR BULL, V27, P3, DOI 10.1177/156482650602700101; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Belachew Tefera, 2006, Ethiop Med J, V44, P211; Central Statistical Agency (CSA), 2011, FOOD KNOWL SURV 2011; Dim Cyril C, 2007, MedGenMed, V9, P11; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940; James DCS, 2004, ETHNIC HEALTH, V9, P349, DOI 10.1080/1355785042000285375; Khatod L, 2013, INT J RECENT TRENDS, V1, P27; Kisioglu NN, 2004, BIOMED RES, V16, P11; Lee GR, 1993, WINTROBES CLIN HEMAT, P1; Mondal B., 2006, J HUM ECOL, V14, P27; Msuya Sia E, 2011, Tanzan J Health Res, V13, P33; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; VITERI FE, 1994, ADV EXP MED BIOL, V352, P127; WHO, 2002, RED RISKS PROM HLTH; World Health Organization, 2008, WHO GLOBAL DATABASE; Xiong X, 2003, INT J GYNECOL OBSTET, V83, P159, DOI [10.1016/S0020-7292(03)00214-5, 10.1016/s0020-7292(03)00214-5]	20	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202734	10.1371/journal.pone.0202734	http://dx.doi.org/10.1371/journal.pone.0202734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133527	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400097
J	Thapa, S; Abdulrahman, B; Abdelaziz, DH; Lu, L; Ben Aissa, M; Schatzl, HM				Thapa, Simrika; Abdulrahman, Basant; Abdelaziz, Dalia H.; Lu, Li; Ben Aissa, Manel; Schatzl, Hermann M.			Overexpression of quality control proteins reduces prion conversion in prion-infected cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; ER quality control; endoplasmic reticulum stress (ER stress); infection; lentivirus; bovine spongiform encephalopathy; Creutzfeldt-Jakob disease; neurodegeneration; scrapie	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; SECRETORY PATHWAY; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; SCRAPIE; NEUROTOXICITY; TRANSLOCATION; ACCUMULATION; DYSFUNCTION	Prion diseases are fatal infectious neurodegenerative disorders in humans and other animals and are caused by misfolding of the cellular prion protein (PrPC) into the pathological isoform PrPSc. These diseases have the potential to transmit within or between species, including zoonotic transmission to humans. Elucidating the molecular and cellular mechanisms underlying prion propagation and transmission is therefore critical for developing molecular strategies for disease intervention. We have shown previously that impaired quality control mechanisms directly influence prion propagation. In this study, we manipulated cellular quality control pathways in vitro by stably and transiently overexpressing selected quality control folding (ERp57) and cargo (VIP36) proteins and investigated the effects of this overexpression on prion propagation. We found that ERp57 or VIP36 overexpression in persistently prion-infected neuroblastoma cells significantly reduces the amount of PrPSc in immunoblots and prion-seeding activity in the real-time quaking-induced conversion (RT-QuIC) assay. Using different cell lines infected with various prion strains confirmed that this effect is not cell type- or prion strain-specific. Moreover, de novo prion infection revealed that the overexpression significantly reduced newly formed PrPSc in acutely infected cells. ERp57-overexpressing cells significantly overcame endoplasmic reticulum stress, as revealed by expression of lower levels of the stress markers BiP and CHOP, accompanied by a decrease in PrP aggregates. Furthermore, application of ERp57-expressing lentiviruses prolonged the survival of prion-infected mice. Taken together, improved cellular quality control via ERp57 or VIP36 overexpression impairs prion propagation and could be utilized as a potential therapeutic strategy.	[Thapa, Simrika; Abdulrahman, Basant; Abdelaziz, Dalia H.; Lu, Li; Ben Aissa, Manel; Schatzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Thapa, Simrika; Abdulrahman, Basant; Abdelaziz, Dalia H.; Lu, Li; Ben Aissa, Manel; Schatzl, Hermann M.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada; [Abdulrahman, Basant; Abdelaziz, Dalia H.] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo 11795, Egypt; [Schatzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Schatzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University; University of Wyoming; University of Wyoming	Schatzl, HM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hschaetz@ucalgary.ca		Abdulrahman, Basant/0000-0002-4970-6835; Schatzl, Hermann/0000-0003-4972-8740	NINDS, National Institutes of Health [R01 NS076853-01A1]; Alberta Innovates - Health Solutions [201300003, 201600010, 201610675, 20160740]; Killam Trusts grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates - Health Solutions; Killam Trusts grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS076853-01A1 (to H. M. S.); Alberta Innovates - Health Solutions Grants 201300003 and 201600010 (to H. M. S.), 201610675 (to S. T.), and 20160740 (to B. A.); and Killam Trusts grant (to S. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelaziz DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11235-8; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Castillo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136620; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fullekrug J, 1999, J CELL SCI, V112, P2813; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Hamdan N, 2017, J CELL BIOL, V216, P2295, DOI 10.1083/jcb.201612165; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Kim JY, 2014, JOVE-J VIS EXP, DOI 10.3791/51863; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Nyfeler B, 2003, BIOCHEM BIOPH RES CO, V304, P599, DOI 10.1016/S0006-291X(03)00634-X; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Orru CD, 2015, MBIO, V6, DOI 10.1128/mBio.02451-14; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Park KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44723; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Schmitz M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28711; Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Tatzelt A, 2004, AMYLOID, V11, P162, DOI 10.1080/1350-612040000723; Torres M, 2015, J BIOL CHEM, V290, P23631, DOI 10.1074/jbc.M114.635565; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wang HP, 2015, TOXICOL APPL PHARM, V283, P157, DOI 10.1016/j.taap.2014.12.019; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; 2004, CONTRIB MICROBIOL, V11, P33, DOI DOI 10.1159/000077061	64	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16069	16082		10.1074/jbc.RA118.002754	http://dx.doi.org/10.1074/jbc.RA118.002754			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154245	hybrid, Green Published			2022-12-26	WOS:000447256000026
J	Gray, CL; Messer, LC; Rappazzo, KM; Jagai, JS; Grabich, SC; Lobdell, DT				Gray, Christine L.; Messer, Lynne C.; Rappazzo, Kristen M.; Jagai, Jyotsna S.; Grabich, Shannon C.; Lobdell, Danelle T.			The association between physical inactivity and obesity is modified by five domains of environmental quality in US adults: A cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; BUILT ENVIRONMENT; ISCHEMIC-STROKE; RISK; OVERWEIGHT; NEIGHBORHOOD; PREVENTION; HEALTH; TIME	Physical inactivity is a primary contributor to the obesity epidemic, but may be promoted or hindered by environmental factors. To examine how cumulative environmental quality may modify the inactivity-obesity relationship, we conducted a cross-sectional study by linking county-level Behavioral Risk Factor Surveillance System data with the Environmental Quality Index (EQI), a composite measure of five environmental domains (air, water, land, built, sociodemographic) across all U.S. counties. We estimated the county-level association (N = 3,137 counties) between 2009 age-adjusted leisure-time physical inactivity (LTPIA) and 2010 age-adjusted obesity from BRFSS across EQI tertiles using multi-level linear regression, with a random intercept for state, adjusted for percent minority and rural-urban status. We modelled overall and sex-specific estimates, reporting prevalence differences (PD) and 95% confidence intervals (CI). In the overall population, the PD increased from best (PD = 0.341 (95% CI: 0.287, 0.396)) to worst (PD = 0.645 (95% CI: 0.599, 0.690)) EQI tertile. We observed similar trends in males from best (PD = 0.244 (95% CI: 0.194, 0.294)) to worst (PD = 0.601 (95% CI: 0.556, 0.647)) quality environments, and in females from best (PD = 0.446 (95% CI: 0.385, 0.507)) to worst (PD = 0.655 (95% CI: 0.607, 0.703)). We found that poor environmental quality exacerbates the LTPIA-obesity relationship. Efforts to improve obesity through LTPIA may benefit from considering this relationship.	[Gray, Christine L.] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Gray, Christine L.; Grabich, Shannon C.] US EPA, Oak Ridge Inst Sci & Educ, Human Studies Facil, Chapel Hill, NC USA; [Messer, Lynne C.] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Rappazzo, Kristen M.; Lobdell, Danelle T.] US EPA, Natl Hlth & Environm Effects Res Lab, Human Studies Facil, Chapel Hill, NC 27514 USA; [Jagai, Jyotsna S.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL USA; [Grabich, Shannon C.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; Oregon Health & Science University; Portland State University; United States Environmental Protection Agency; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lobdell, DT (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Human Studies Facil, Chapel Hill, NC 27514 USA.	lobdell.danelle@epa.gov		Rappazzo, Kristen/0000-0002-9939-0883; Gray, Christine/0000-0002-0751-1626	Office of Research and Development at the U.S. Environmental Protection Agency [EP12D000264, EP09D000003, EP17D000079, EP17D000063]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER	Office of Research and Development at the U.S. Environmental Protection Agency; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Research and Development at the U.S. Environmental Protection Agency (contracts EP12D000264, EP09D000003 and EP17D000079 to LCM, contract EP17D000063 to JSJ, and appointment of CLG to the Research Participation Program, administered through the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Environmental Protection Agency; epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Centers for Disease Control and Prevention (CDC), 2009, BEH RISK FACT SURV S; Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276; Donaldson EA, 2015, PREV MED, V74, P117, DOI 10.1016/j.ypmed.2015.02.013; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Eyler AA, 2016, J PHYS ACT HEALTH, V13, P207, DOI 10.1123/jpah.2015-0010; Flowers EP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3050-9; Gaalema DE, 2014, J CARDIOPULM REHABIL, V34, P248, DOI 10.1097/HCR.0000000000000059; Ghosh-Dastidar B, 2014, AM J PREV MED, V47, P587, DOI 10.1016/j.amepre.2014.07.005; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawkes C, 2009, NUTR REV, V67, P333, DOI 10.1111/j.1753-4887.2009.00206.x; Heo M, 2010, OBESITY, V18, P2030, DOI 10.1038/oby.2009.400; Hines F, 1970, 272 USDA EC RES SERV; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Jian Y, 2017, ENVIRON HEALTH PERSP, V125, P355, DOI 10.1289/EHP119; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; Jones SA, 2015, PREV MED, V78, P17, DOI 10.1016/j.ypmed.2015.05.028; Kaczynski AT, 2007, LEISURE SCI, V29, P315, DOI 10.1080/01490400701394865; Kelishadi R, 2013, J OBES, V2013, DOI 10.1155/2013/208392; Keum N, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/dju428, 10.1093/jnci/djv088]; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Ladabaum U, 2014, AM J MED, V127, P717, DOI 10.1016/j.amjmed.2014.02.026; Langlois PH, 2010, J RURAL HEALTH, V26, P164, DOI 10.1111/j.1748-0361.2010.00278.x; Lee RE, 2015, AM J HEALTH PROMOT, V29, P210, DOI 10.4278/ajhp.130403-QUAN-148; Leskinen T, 2009, INT J OBESITY, V33, P1211, DOI 10.1038/ijo.2009.170; Li WY, 2016, OBESITY, V24, P2593, DOI 10.1002/oby.21630; Lobdell D. T, 2014, EPA600R14304; Lobdell DT, 2011, AM J PUBLIC HEALTH, V101, pS277, DOI 10.2105/AJPH.2011.300184; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luben TJ, 2009, HEALTH PLACE, V15, P863, DOI 10.1016/j.healthplace.2009.02.006; Messer LC, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-39; Messer LC, 2010, ANN EPIDEMIOL, V20, P32, DOI 10.1016/j.annepidem.2009.09.006; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335; Nguyen NT, 2011, OBES SURG, V21, P351, DOI 10.1007/s11695-010-0335-4; Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pierannunzi C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-49; Popkin BM, 2011, EMBO REP, V12, P11, DOI 10.1038/embor.2010.200; Richardson AS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3959-z; Roberts JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090143; SAS Institute Inc, 2013, SAS STAT SOFTW VERS; Schulz A, 2013, J URBAN HEALTH, V90, P872, DOI 10.1007/s11524-013-9793-z; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; U.S. Centers for Disease Control and Prevention, 2016, AD OB CAUS CONS; USDA, 2003, RUR URB CONT COD; van der Sande MAB, 2001, B WORLD HEALTH ORGAN, V79, P321; Van Dyck D, 2015, HEALTH PLACE, V36, P65, DOI 10.1016/j.healthplace.2015.09.007; von Hippel P, 2014, AM J PUBLIC HEALTH, V104, P1287, DOI 10.2105/AJPH.2013.301838; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wen M, 2012, HEALTH PLACE, V18, P1314, DOI 10.1016/j.healthplace.2012.09.002; Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001; World Health Organization, 2018, OB OV FACT SHEET 311; Xu YQ, 2015, HEALTH PLACE, V34, P19, DOI 10.1016/j.healthplace.2015.03.010; Yang QH, 2015, AM J PREV MED, V48, P58, DOI 10.1016/j.amepre.2014.09.014; Yatsuya H, 2010, J EPIDEMIOL, V20, P347, DOI 10.2188/jea.JE20090186; Yatsuya H, 2010, STROKE, V41, P417, DOI 10.1161/STROKEAHA.109.566299	66	27	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203301	10.1371/journal.pone.0203301	http://dx.doi.org/10.1371/journal.pone.0203301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161196	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900105
J	Wettmann, L; Bonny, M; Kruse, K				Wettmann, Lukas; Bonny, Mike; Kruse, Karsten			Effects of geometry and topography on Min-protein dynamics	PLOS ONE			English	Article							DIVISION SITE SELECTION; TO-POLE OSCILLATIONS; ESCHERICHIA-COLI; CELL-DIVISION; SELF-ORGANIZATION; PATTERN-FORMATION; RAPID POLE; IN-VITRO; MEMBRANE; BINDING	In the rod-shaped bacterium Escherichia coli, the center is selected by the Min-proteins as the site of cell division. To this end, the proteins periodically translocate between the two cell poles, where they suppress assembly of the cell division machinery. Ample evidence notably obtained from in vitro reconstitution experiments suggests that the oscillatory pattern results from self-organization of the proteins MinD and MinE in presence of a membrane. A mechanism built on cooperative membrane attachment of MinD and persistent MinD removal from the membrane induced by MinE has been shown to be able to reproduce the observed Min-protein patterns in rod-shaped E. coliand on flat supported lipid bilayers. Here, we report our results of a numerical investigation of patterns generated by this mechanism in various geoemtries. Notably, we consider the dynamics on membrane patches of different forms, on topographically structured lipid bilayers, and in closed geometries of various shapes. We find that all previously described patterns can be reproduced by the mechanism. However, it requires different parameter sets for reproducing the patterns in closed and in open geometries.	[Wettmann, Lukas; Bonny, Mike; Kruse, Karsten] Univ Saarland, Theoret Phys, Saarbrucken, Germany; [Kruse, Karsten] Univ Geneva, Dept Biochem, NCCR Chem Biol, Geneva, Switzerland; [Kruse, Karsten] Univ Geneva, Dept Theoret Phys, NCCR Chem Biol, Geneva, Switzerland	Saarland University; University of Geneva; University of Geneva	Kruse, K (corresponding author), Univ Saarland, Theoret Phys, Saarbrucken, Germany.; Kruse, K (corresponding author), Univ Geneva, Dept Biochem, NCCR Chem Biol, Geneva, Switzerland.; Kruse, K (corresponding author), Univ Geneva, Dept Theoret Phys, NCCR Chem Biol, Geneva, Switzerland.	Karsten.Kruse@unige.ch	Kruse, Karsten/GOG-8298-2022	Kruse, Karsten/0000-0001-8665-2349	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 1027]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 1027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiranashvili A, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/9/093049; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; Caspi Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19271; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2007, PHYS BIOL, V4, P38, DOI 10.1088/1478-3975/4/1/005; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Halatek J, 2014, P NATL ACAD SCI USA, V111, pE1817, DOI 10.1073/pnas.1220971111; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Park KT, 2017, P NATL ACAD SCI USA, V114, P7497, DOI 10.1073/pnas.1707385114; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Petrasek Z, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043023; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Schweizer J, 2012, P NATL ACAD SCI USA, V109, P15283, DOI 10.1073/pnas.1206953109; Sengupta S, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056003; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Varma A, 2008, J BACTERIOL, V190, P2106, DOI 10.1128/JB.00720-07; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113; Walsh JC, 2016, AIMS BIOPHYS, V3, P119, DOI 10.3934/biophy.2016.1.119; Walsh JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128148; Wettmann L, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0039; Wettmann L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0111; Wu FB, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156724; Wu FB, 2015, NAT NANOTECHNOL, V10, P719, DOI [10.1038/NNANO.2015.126, 10.1038/nnano.2015.126]; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949; Zieske K, 2014, FEBS LETT, V588, P2545, DOI 10.1016/j.febslet.2014.06.026; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	54	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203050	10.1371/journal.pone.0203050	http://dx.doi.org/10.1371/journal.pone.0203050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161173	Green Published, gold, Green Submitted			2022-12-26	WOS:000443388900073
J	Yang, HW; Kim, HJ; Park, JH; Shin, JM; Lee, HM				Yang, Hyun-Woo; Kim, Hwee-Jin; Park, Joo-Hoo; Shin, Jae-Min; Lee, Heung-Man			Apigenin alleviates TGF-beta 1-induced nasal mucosa remodeling by inhibiting MAPK/NF-kappa B signaling pathways in chronic rhinosinusitis	PLOS ONE			English	Article							INFLAMMATION; FLAVONOIDS; FIBROBLAST; POLYPOSIS; GROWTH; ASTHMA; BETA	Background Chronic rhinosinusitis is involved in tissue remodeling of nasal mucosa such as nasal myofibroblast differentiation and extracellular matrix production. Apigenin (4',5,7-trihydroxyflavone) is a bioflavonoid compound and has anti-tissue remodeling characteristics. The aims of this study were to evaluate the effect of apigenin on TGF-beta 1-induced myofibroblast differentiation and extracellular matrix accumulation and to determine the underlying mechanism. Methods Nasal fibroblasts and ex vivo nasal inferior turbinate tissues were stimulated with TGF-beta 1 with or without apigenin. The expression levels of a-SMA, fibronectin and collagen type I were determined by real-time PCR, western blot and immunocytochemical staining. Mitogen-activated protein kinase (MAPK) phosphorylation induced by TGF-beta 1 were determined by western blot analysis. The transcriptional activity of NF-kappa B was measured by luciferase assay. Migration effects of fibroblasts were evaluated by wound scratch and transwell migration assay. Contractile activity was determined by collagen gel contraction assay. Results The expression levels of alpha-SMA, fibronectin, and collagen type I significantly increased in TGF-beta 1-stimulated nasal fibroblasts. In TGF-beta 1-stimulated nasal fibroblasts, apigenin inhibited the expressions of alpha-SMA, fibronectin, and collagen type I. Inhibitors of MAPK (p-38, JNK) and NF-kappa B blocked the expression of alpha-SMA, fibronectin and collagen type I. Apigenin suppressed the activation of MAPK (p-38, JNK) and NF-kappa B induced by TGF-beta 1 treatment. Apigenin also inhibited the functional activity of fibroblasts by reducing the migration and collagen contractile activities. Conclusions These results suggests the possible use of apigenin as a chronic rhinosinusitis therapeutic agent which can suppress tissue remodeling in nasal mucosa.	[Yang, Hyun-Woo; Kim, Hwee-Jin; Park, Joo-Hoo; Lee, Heung-Man] Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Guro Hosp, Coll Med, IVD Support Ctr, Seoul, South Korea; [Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Guro Hosp, Coll Med, IVD Support Ctr, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	lhman146@gmail.com		park, joo hoo/0000-0002-3221-640X	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1512]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512).	Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; Chen L, 2016, EXP THER MED, V11, P230, DOI 10.3892/etm.2015.2885; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Gonzalez ACD, 2016, AN BRAS DERMATOL, V91, P614, DOI 10.1590/abd1806-4841.20164741; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Jun JB, 2010, RHEUMATOL INT, V30, P1695, DOI 10.1007/s00296-009-1285-9; Kim DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139945; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li L., 2016, INFORM DOCUMENTATION, V2, P63; Li RR, 2010, IMMUNOPHARM IMMUNOT, V32, P364, DOI 10.3109/08923970903420566; Lim HN, 2007, SYNTHESIS-STUTTGART, P3376, DOI 10.1055/s-2007-990809; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082373; Nabavi SM, 2015, ANTI-CANCER AGENT ME, V15, P728, DOI 10.2174/1871520615666150304120643; Ricupero DA, 2001, FEBS LETT, V506, P15, DOI 10.1016/S0014-5793(01)02737-5; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shukla S, 2014, CARCINOGENESIS, V35, P452, DOI 10.1093/carcin/bgt316; Sim GS, 2007, ARCH PHARM RES, V30, P290, DOI 10.1007/BF02977608; Tos M, 2010, NASAL POLYPOSIS: PATHOGENESIS, MEDICAL AND SURGICAL TREATMENT, P53, DOI 10.1007/978-3-642-11412-0_7; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Wang J, 2014, INFLAMMATION, V37, P2085, DOI 10.1007/s10753-014-9942-x; Wojcik KA, 2013, PHARMACOL REP, V65, P164, DOI 10.1016/S1734-1140(13)70974-5; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	28	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201595	10.1371/journal.pone.0201595	http://dx.doi.org/10.1371/journal.pone.0201595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161164	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900011
J	Yu, DS; He, J; Zhang, EM; Wang, P; Liu, DP; Hou, YD; Zhang, HM; Wei, KF; Gou, FX; Zhan, HJ; Li, W; Wei, JC				Yu, Deshan; He, Jian; Zhang, Enmin; Wang, Peng; Liu, Dongpeng; Hou, Yadong; Zhang, Huimin; Wei, Kongfu; Gou, Faxiang; Zhan, Huijuan; Li, Wei; Wei, Jianchun			Investigation and source-tracing of an anthrax outbreak in Gansu Province, China	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; EPIDEMIOLOGY	Anthrax is an endemic disease in China. Cases are reported every year, especially in the northwestern areas. In August 2016, an outbreak of 21 cutaneous anthrax cases was reported in Min County, Gansu Province, China. In this study, the general characteristics of the anthrax outbreak are described. Two molecular typing methods, canonical single-nucleotide polymorphism (canSNP) and multiple-locus variable-number tandem repeat analysis with 15 markers (MLVA15), were used to investigate the possible source of transmission and to identify the genetic relationship among the strains/samples isolated in this outbreak as well as previous isolates. In this outbreak, all patients were infected through contact with diseased livestock or contaminated animal products. Livestock had been introduced into the local area shortly before the outbreak from Gannan Prefecture (in Gansu Province), Sichuan and Qinghai Provinces. In the molecular typing analysis, there were two canSNP subgroups found in Gansu, A.Br.001/002 and A.Br.Ames, and five MLVA15 genotypes were observed. The strains collected from the anthrax outbreak in Min County in 2016 belonged to the A. Br.001/002 canSNP subgroup and the MLVA15-28 and MLVA15-30 genotype. Strains previously isolated from Sichuan, Inner Mongolia and Maqu County (in Gannan Prefecture, Gansu Province) were clustered with these outbreak-related strains/samples according to the MLVA15-30 genotype. The MLVA15-28 genotype was found in strains isolated from Gansu and Xinjiang in previous studies. Combining the epidemiological investigation and molecular typing results, we conclude that the patients in this outbreak were infected by a local pathogen present in the adjoining area of Gansu, Sichuan and Qinghai Provinces.	[Yu, Deshan; He, Jian; Wang, Peng; Liu, Dongpeng; Zhang, Huimin; Wei, Kongfu; Gou, Faxiang] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Zhang, Enmin; Zhan, Huijuan; Li, Wei; Wei, Jianchun] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Enmin; Zhan, Huijuan; Li, Wei; Wei, Jianchun] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Enmin; Zhan, Huijuan; Li, Wei; Wei, Jianchun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Hou, Yadong] Min Cty Ctr Dis Control & Prevent, Minxian, Gansu, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wei, JC (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.; Wei, JC (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Wei, JC (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	weijianchun@icdc.cn			National Science and Technology Mega-Projects of China [2012ZX1004208, 2012ZX10004215]; National Priority Development Project on Key Science Instrument [2012YQ09019706]	National Science and Technology Mega-Projects of China; National Priority Development Project on Key Science Instrument	This work was supported by National Science and Technology Mega-Projects of China (2012ZX1004208 and 2012ZX10004215, www.most.gov.cn) and National Priority Development Project on Key Science Instrument (2012YQ09019706, www.caiq.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P677; Chen WJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004637; Dauphin LA, 2012, J CLIN MICROBIOL, V50, P3960, DOI 10.1128/JCM.02076-12; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; Jung KH, 2012, J VET SCI, V13, P385, DOI 10.4142/jvs.2012.13.4.385; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Li S, 2015, EUR J CLIN MICROBIOL, V34, P89, DOI 10.1007/s10096-014-2195-7; Li Y, 2017, EMERG INFECT DIS, V23, P14, DOI 10.3201/eid2301.150947; Mao LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157496; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Tan ZM, 2014, AM J TROP MED HYG, V91, P574, DOI 10.4269/ajtmh.13-0633; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; WHO, 2008, ANTHRAX HUMANS ANIMA; [姚光海 Yao Guanghai], 2014, [中国人兽共患病学报, Chinese Journal of Zoonoses], V30, P871; Zhou W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135777	19	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203267	10.1371/journal.pone.0203267	http://dx.doi.org/10.1371/journal.pone.0203267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161194	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900098
J	Favero, V; Sakuma, S; Alccayhuaman, KAA; Benedetto, GA; Bengazi, F; Botticelli, D				Favero, Vittorio; Sakuma, Shigeru; Alccayhuaman, Karol Ali Apaza; Alejandro Benedetto, Guillermo; Bengazi, Franco; Botticelli, Daniele			Healing at sites prepared using different drilling protocols. An experimental study in the tibiae of sheep	PLOS ONE			English	Article							HYDROPHOBIC IMPLANT SURFACES; SINUS FLOOR ELEVATION; HEAT-GENERATION; IN-VITRO; BONE-FORMATION; TITANIUM IMPLANTS; DENTAL IMPLANTS; SINGLE-DRILL; IRRIGATION; SPEED	The aim of the experiment was to study the healing at implants installed in site prepared in bone type 1 using different rotation speeds and cooling strategies. The tibiae of twelve sheep were used as experimental sites. Two implant sites were prepared in each tibia using drills either at a high or a mixed speed under irrigation. At the mixed-speed sites, 60 rpm without irrigation were applied for the last drill, the countersink and during implant installation. Biopsies representing the healing after 1, 2, and 6 weeks were obtained and ground sections were prepared. At the histological analyses, after 1 week of healing, no new bone was found at both high- and mixed-speed sites. After 2 weeks of healing, small amounts of newly formed bone were observed in the cortical layer, reaching percentages of 3.6 +/- 3.0% at the mixed-speed sites, and of 2.2 +/- 1.5% at the high-speed sites. An irrelevant quantity of new bone was seen in the marrow compartments of a few specimens. After 6 weeks of healing, new bone was found in higher quantity, reaching in the cortical compartment 66.9 +/- 6.8% and 67.3 +/- 17.7% at the mixed- and high-speed sites, respectively. The respective percentages in the marrow compartment were 23.2 +/- 13.0% and 30.6 +/- 29.2%. No statistically significant differences between high- and mixed-speed groups were found. It was concluded that the use of the last drill and the installation of the implant with or without irrigation yielded similar bone healing and osseointegration.	[Favero, Vittorio] Univ Verona, Unit Maxillofacial Surg & Dent, Verona, Italy; [Sakuma, Shigeru; Alccayhuaman, Karol Ali Apaza; Bengazi, Franco; Botticelli, Daniele] Ariminum Odontol, ARDEC Acad, Rimini, Italy; [Alejandro Benedetto, Guillermo] Univ Buenos Aires, Fac Odontol, Buenos Aires, DF, Argentina; [Bengazi, Franco; Botticelli, Daniele] Univ Med Sci, Fac Dent, Havana, Cuba	University of Verona; University of Buenos Aires	Alccayhuaman, KAA (corresponding author), Ariminum Odontol, ARDEC Acad, Rimini, Italy.	caroline7_k@hotmail.com	Botticelli, Daniele/ABF-6494-2020; Apaza Alccayhuaman, Karol Ali/AAD-3583-2022	Botticelli, Daniele/0000-0003-2804-1632; Apaza Alccayhuaman, Karol Ali/0000-0003-4565-5222	BTI Biotechnology Institute, Vitoria-Gasteiz (AAlava), Spain; ARDEC Academy, Ariminum Odontologica s.r.l., Rimini, Italy	BTI Biotechnology Institute, Vitoria-Gasteiz (AAlava), Spain; ARDEC Academy, Ariminum Odontologica s.r.l., Rimini, Italy	BTI Biotechnology Institute, Vitoria-Gasteiz (AAlava), Spain, provided funds to Ariminum Odontologica s.r.l., Rimini, Italy to cover part of the costs. The remaining costs were covered by ARDEC Academy, Ariminum Odontologica s.r.l., Rimini, Italy.	Abboud M, 2015, CLIN IMPLANT DENT R, V17, pE472, DOI 10.1111/cid.12273; Barrak I, 2017, IMPLANT DENT, V26, P541, DOI 10.1097/ID.0000000000000607; Bogovic V, 2016, P I MECH ENG H, V230, P907, DOI 10.1177/0954411916660737; Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x; Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P35, DOI 10.1034/j.1600-0501.2003.140105.x; Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P1, DOI 10.1034/j.1600-0501.2003.140101.x; Botticelli D, 2017, CLIN ORAL IMPLAN RES, V28, P742, DOI 10.1111/clr.12872; Bulloch SE, 2012, INT J ORAL MAX IMPL, V27, P1456; Caneva M, 2015, CLIN ORAL IMPLAN RES, V26, P293, DOI 10.1111/clr.12475; Caroprese M, 2017, CLIN ORAL IMPLAN RES, V28, P1030, DOI 10.1111/clr.12913; Cordioli G, 1997, INT J ORAL MAX IMPL, V12, P186; De Santis E, 2017, CLIN ORAL IMPLAN RES, V28, P503, DOI 10.1111/clr.12825; Delgado-Ruiz RA, 2018, CLIN ORAL INVEST, V22, P349, DOI 10.1007/s00784-017-2119-x; Ercoli C, 2004, INT J ORAL MAX IMPL, V19, P335; Favero R, 2016, CLIN IMPLANT DENT R, V18, P369, DOI 10.1111/cid.12311; Favero R, 2016, CLIN ORAL IMPLAN RES, V27, P203, DOI 10.1111/clr.12591; Flanagan D, 2014, J ORAL IMPLANTOL, V40, P174, DOI 10.1563/AAID-JOI-D-13-00261; Gaspar J, 2013, ACTA MEDICA PORT, V26, P231; Gehrke SA, 2018, CLIN ORAL IMPLAN RES, V29, P772, DOI 10.1111/clr.12827; Guazzi P, 2015, EUR J ORAL IMPLANTOL, V8, P283; Iyer S, 1997, INT J PROSTHODONT, V10, P536; Iyer S, 1997, INT J PROSTHODONT, V10, P411; Koo KT, 2015, J ORAL IMPLANTOL, V41, pE19, DOI 10.1563/AAID-JOI-D-13-00151; Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x; Lucchiari N, 2016, CLIN IMPLANT DENT R, V18, P182, DOI 10.1111/cid.12246; MATTHEWS LS, 1972, J BONE JOINT SURG AM, VA 54, P297, DOI 10.2106/00004623-197254020-00008; Morelli F, 2015, CLIN ORAL IMPLAN RES, V26, P300, DOI 10.1111/clr.12487; Oh HJ, 2017, INT J ORAL MAX IMPL, V32, P483, DOI 10.11607/jomi.4819; Pellicer-Chover H, 2017, MED ORAL PATOL ORAL, V22, pE730, DOI 10.4317/medoral.21694; Rossi F, 2014, CLIN ORAL IMPLAN RES, V25, P124, DOI 10.1111/clr.12097; Russell WMS, 1959, PRINCIPLES HUMAN EXP; Sannino G, 2015, INT J ORAL MAX IMPL, V30, P351, DOI 10.11607/jomi.3747; Scala A, 2012, CLIN ORAL IMPLAN RES, V23, P175, DOI 10.1111/j.1600-0501.2011.02227.x; Scarano A, 2011, CLIN IMPLANT DENT R, V13, P319, DOI 10.1111/j.1708-8208.2009.00209.x; Schweikert MT, 2016, CLIN IMPLANT DENT R, V18, P439, DOI 10.1111/cid.12330; Sener BC, 2009, CLIN ORAL IMPLAN RES, V20, P294, DOI 10.1111/j.1600-0501.2008.01643.x; Sindel A, 2017, MED ORAL PATOL ORAL, V22, pE506, DOI 10.4317/medoral.21880; Stelzle F, 2014, CLIN ORAL IMPLAN RES, V25, pE140, DOI 10.1111/clr.12077; Strbac GD, 2014, CLIN ORAL IMPLAN RES, V25, P665, DOI 10.1111/clr.12032; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Tehemar SH, 1999, INT J ORAL MAX IMPL, V14, P127; Trisi P, 2014, CLIN ORAL IMPLAN RES, V25, P696, DOI 10.1111/clr.12127; Yacker M J, 1996, Int J Oral Maxillofac Implants, V11, P634; Yeniyol S, 2013, OR SURG OR MED OR PA, V116, P550, DOI 10.1016/j.oooo.2013.07.001	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202957	10.1371/journal.pone.0202957	http://dx.doi.org/10.1371/journal.pone.0202957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157237	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400078
J	Komatsu, Y; Kasahara, K; Inoue, T; Lee, ST; Muratani, T; Yano, H; Kirita, T; Mikasa, K				Komatsu, Yuko; Kasahara, Kei; Inoue, Takashi; Lee, Sang-Tae; Muratani, Tetsuro; Yano, Hisakazu; Kirita, Tadaaki; Mikasa, Keiichi			Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; PREVALENCE	Objectives To identify risk factors and clinical outcomes in patients with bacteremia due to extended-spectrum beta-lactamase (ESBL) or carbapenemase-producing Escherichia coli, as well as to determine the prevalence and genetic background of such isolates. Methods Case control study was performed with patients with E. coli bacteremia between January 2008 and May 2013 (n = 115) at a tertiary university hospital in Japan. Cases had ESBL-producing E. coli (ESBL-EC) whereas controls had non-ESBL-producing E. coli (non-ESBL-EC) isolates. A retrospective chart review was performed to identify risk factors and clinical outcomes. Isolates were characterized by antimicrobial susceptibility testing, polymerase chain reaction analysis for beta-lactamase genes, and multi-locus sequence typing. Results Of 115 unique cases of E. coli bacteremia, 30 (26.1%) were due to ESBL-EC and three (2.6%) were due to carbapenemase-producing E. coli. All three carbapenemase-producing E. coli isolates were IMP-6 and concurrently produced ESBL (ESBL/IMP-6-EC). ESBL-EC isolates showed multidrug resistance. Of the ESBL-EC isolates, CTX-M-27 was the most prevalent (33.3%), followed by CTX-M-14 (30%). Multi-locus sequence typing revealed that 19 (63.3%) isolates were ST131. The multivariate analysis identified nursing home-associated infections and antibiotic administration in the preceding 30 days as risk factors for ESBL-EC bacteremia. The 14-day mortality non-ESBL-EC, ESBL-EC, and ESBL/IMP-6-EC was 4.7% (4/85), 20% (6/30), and 66.7% (2/3), respectively. Conclusions CTX-M-27, CTX-M-14, and ST131 were the most prevalent ESBL-EC isolates from bacteremic patients in a Japanese hospital. Further studies with larger sample sizes are warranted to investigate the clinical significance of ESBL-EC and ESBL/IMP-6-EC.	[Komatsu, Yuko; Kasahara, Kei; Lee, Sang-Tae; Mikasa, Keiichi] Nara Med Univ, Ctr Infect Dis, Nara, Japan; [Komatsu, Yuko; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Nara, Japan; [Inoue, Takashi] Nara Med Univ, Inst Clin & Translat Sci, Nara, Japan; [Muratani, Tetsuro] Hibiki AMR Lab, Fukuoka, Japan; [Muratani, Tetsuro] Kyurin Corp, Dept Clin Lab, Fukuoka, Fukuoka, Japan; [Yano, Hisakazu] Nara Med Univ, Dept Microbiol & Infect Dis, Nara, Japan	Nara Medical University; Nara Medical University; Nara Medical University; Nara Medical University	Kasahara, K (corresponding author), Nara Med Univ, Ctr Infect Dis, Nara, Japan.	kassan@naramed-u.ac.jp		Lee, Sang-Tae/0000-0003-1265-5509				CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Denis B, 2015, INT J INFECT DIS, V39, P1, DOI 10.1016/j.ijid.2015.07.010; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Institute CaLS, 2009, 19 INF SM, V29, P76; Ishii Y, 2017, J INFECT CHEMOTHER, V23, P583, DOI 10.1016/j.jiac.2017.06.009; Matsumura Y, 2013, CLIN MICROBIOL INFEC, V19, P161, DOI 10.1111/j.1469-0691.2012.03762.x; Matsumura Y, 2016, EMERG INFECT DIS, V22, P1900, DOI 10.3201/eid2211.160519; McKinnell JA, 2016, INFECT CONT HOSP EP, V37, P1485, DOI 10.1017/ice.2016.215; Nakamura A, 2016, J INFECT CHEMOTHER, V22, P102, DOI 10.1016/j.jiac.2015.11.001; Namikawa H, 2017, INTERNAL MED, V56, P1807, DOI 10.2169/internalmedicine.56.7702; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Ohno Y, 2017, J INFECT CHEMOTHER, V23, P224, DOI 10.1016/j.jiac.2016.12.013; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P180, DOI 10.1111/j.1469-0691.2007.01884.x; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Willemsen I, 2015, INFECT CONT HOSP EP, V36, P394, DOI 10.1017/ice.2014.76; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Yamamoto N, 2017, J HOSP INFECT, V97, P212, DOI 10.1016/j.jhin.2017.07.015; Yano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064359; Yano H, 2012, ANTIMICROB AGENTS CH, V56, P4554, DOI 10.1128/AAC.00617-12	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202276	10.1371/journal.pone.0202276	http://dx.doi.org/10.1371/journal.pone.0202276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157275	Green Submitted, gold, Green Published			2022-12-26	WOS:000443071400048
J	Leonska-Duniec, A; Cieszczyk, P; Jastrzebski, Z; Jazdzewska, A; Lulinska-Kuklik, E; Moska, W; Ficek, K; Niewczas, M; Maciejewska-Skrendo, A				Leonska-Duniec, Agata; Cieszczyk, Pawel; Jastrzebski, Zbigniew; Jazdzewska, Aleksandra; Lulinska-Kuklik, Ewelina; Moska, Waldemar; Ficek, Krzysztof; Niewczas, Marta; Maciejewska-Skrendo, Agnieszka			The polymorphisms of the PPARD gene modify post-training body mass and biochemical parameter changes in women	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; MESSENGER-RNA EXPRESSION; CORONARY-ARTERY-DISEASE; PEROXISOME-PROLIFERATOR; SKELETAL-MUSCLE; RISK-FACTORS; ENDURANCE; PPARGC1A; DELTA+294T/C; ASSOCIATION	In this study we examined the genotype distribution of the PPARD rs2267668, rs2016520, and rs1053049 alleles in a group of women, before and after the completion of a 12-week training program. There were two significant genotype x training interactions resulting in decreases of total cholesterol (Chol) through training in rs2267668 G allele carriers and significant increases of triglyceride (TGL) levels in rs2267668 AA homozygotes. Carriers of rs2016520 PPARD C allele exhibited a significant decrease in Chol through training with an accompanying decrease in TGL. There was also overrepresentation of PPARD rs1053049 TT homozygotes in the group with higher post-training TGL levels. Moreover (rs2267668/rs2016520/rs1053049) G/C/T haplotype displayed smaller post-training body mass decrease, suggesting that harboring this specific G/C/T haplotype is unfavorable for achieving the desired training-induced body mass changes. On the other hand, the G/C/C haplotype was significantly associated with post-training increase in fat free mass (FFM) and with lower levels of Chol as well as TGL as observed in the blood of the participants in response to applied training. This observation constitutes the second important finding of the study, implying that when specific training-induced biochemical changes are taken into account, some individuals may benefit from carrying the G/C/C haplotype.	[Leonska-Duniec, Agata] Szczecin Univ, Fac Phys Culture & Hlth Promot, Szczecin, Poland; [Leonska-Duniec, Agata; Cieszczyk, Pawel] Gdansk Univ Phys Educ & Sport, Fac Phys Educ, Gdansk, Poland; [Jastrzebski, Zbigniew; Jazdzewska, Aleksandra; Lulinska-Kuklik, Ewelina; Moska, Waldemar; Maciejewska-Skrendo, Agnieszka] Gdansk Univ Phys Educ & Sport, Fac Tourism & Recreat, Gdansk, Poland; [Ficek, Krzysztof] Jerzy Kukuczka Acad Phys Educ Katowice, Fac Physiotherapy, Katowice, Poland; [Niewczas, Marta] Univ Rzeszow, Fac Phys Educ, Rzeszow, Poland	University of Szczecin; Gdansk University of Physical Education & Sport; Gdansk University of Physical Education & Sport; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; University of Rzeszow	Cieszczyk, P (corresponding author), Gdansk Univ Phys Educ & Sport, Fac Phys Educ, Gdansk, Poland.	cieszczyk@poczta.onet.pl	Cieszczyk, Pawel/AFK-4645-2022; Krzysztof, Ficek/X-3529-2018; Cieszczyk, Pawel/AAG-3328-2022; Moska, Waldemar/S-9944-2017	Cieszczyk, Pawel/0000-0002-7735-7580; Krzysztof, Ficek/0000-0002-3027-9984; Cieszczyk, Pawel/0000-0002-7735-7580; Moska, Waldemar Piotr/0000-0002-7177-8376; Niewczas, Marta/0000-0002-2687-3243; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Jastrzebski, Zbigniew/0000-0003-2006-125X; Leonska-Duniec, Agata/0000-0001-6787-3760; Jazdzewska, Aleksandra/0000-0002-7518-855X; Lulinska, Ewelina/0000-0002-1021-8885; Moska, Waldemar/0000-0003-4323-0765	National Science Centre of Poland [2012/07/B/NZ7/01155]	National Science Centre of Poland(National Science Centre, Poland)	The study was supported by National Science Centre of Poland (No. 2012/07/B/NZ7/01155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Aberle J, 2006, INT J OBESITY, V30, P1709, DOI 10.1038/sj.ijo.0803345; Aberle Jens, 2006, Int J Med Sci, V3, P108; Akhmetov I I, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P837; Burch LR, 2010, J CLIN ENDOCR METAB, V95, P1830, DOI 10.1210/jc.2009-1201; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Eynon N, 2009, EXP PHYSIOL, V94, P1147, DOI 10.1113/expphysiol.2009.049668; Gouni-Berthold L, 2005, ATHEROSCLEROSIS, V183, P336, DOI 10.1016/j.atheroscelerosis.2005.03.016; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Hautala AJ, 2007, AM J PHYSIOL-HEART C, V292, pH2498, DOI 10.1152/ajpheart.01092.2006; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Jguirim-Souissi I, 2010, GENET MOL RES, V9, P1326, DOI 10.4238/vol9-3gmr831; Karpe F, 2009, CURR OPIN LIPIDOL, V20, P333, DOI 10.1097/MOL.0b013e32832dd4b1; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Leonska-Duniec A, 2016, BIOL SPORT, V33, P207, DOI 10.5604/20831862.1201052; Leonska-Duniec A, 2018, J SPORT HEALTH SCI, V7, P459, DOI 10.1016/j.jshs.2016.08.013; Lundell K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-70; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Maciejewska-Karlowska A, 2014, SCAND J MED SCI SPOR, V24, pE148, DOI 10.1111/sms.12126; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Miao L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-145; Nikitin AG, 2010, HEART VESSELS, V25, P229, DOI 10.1007/s00380-009-1159-9; Nilsson E, 2007, J PHYSIOL-LONDON, V584, P1011, DOI 10.1113/jphysiol.2007.140673; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Pilegaard H, 2008, J APPL PHYSIOL, V104, P1264, DOI 10.1152/japplphysiol.90346.2008; Polimanti R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160654; Robitaille J, 2007, INT J OBESITY, V31, P411, DOI 10.1038/sj.ijo.0803450; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Shin HD, 2004, DIABETES, V53, P847, DOI 10.2337/diabetes.53.3.847; Skogsberg J, 2003, J INTERN MED, V254, P597, DOI 10.1111/j.1365-2796.2003.01236.x; Skogsberg J, 2000, INT J MOL MED, V6, P73; Stefan N, 2007, J CLIN ENDOCR METAB, V92, P1827, DOI 10.1210/jc.2006-1785; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thamer C, 2008, J CLIN ENDOCR METAB, V93, P1497, DOI 10.1210/jc.2007-1209; Vanttinen M, 2005, DIABETES, V54, P3587, DOI 10.2337/diabetes.54.12.3587; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202557	10.1371/journal.pone.0202557	http://dx.doi.org/10.1371/journal.pone.0202557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157214	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400061
J	Zhang, N; Wu, YZ; Huang, ZL; Zhang, CZ; Zhang, LF; Cai, QR; Shen, XG; Jiang, HX; Ding, HZ				Zhang, Nan; Wu, Yuzhi; Huang, Zilong; Zhang, Chuanzhen; Zhang, Longfei; Cai, Qinren; Shen, Xiangguang; Jiang, Hongxia; Ding, Huanzhong			Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model	PLOS ONE			English	Article							MUTANT SELECTION WINDOW; EFFLUX-MEDIATED RESISTANCE; TOPOISOMERASE-IV; DYNAMIC-MODEL; DNA GYRASE; QUINOLONE; PHARMACOKINETICS; FLUOROQUINOLONES; MUTATIONS; MOXIFLOXACIN	Mycoplasma gallisepticum is a serious pathogen for poultry that causes chronic respiratory disease in chickens. Increased embryonic mortality, as well as reduced weight gain and egg production have been found in infected chickens, which can lead to considerable economic losses in poultry production. Increased antibiotic resistance compromises the use of tetracyclines, macrolides and quinolones in the farm environment. In the present study, danofloxacin concentrations were simulated below the MIC99, between the MIC99 and MPC (the mutant prevention concentration), and above the MPC in an in vitro dynamic model against M. gallisepticum. The relationship between the simulated danofloxacin pharmacokinetics, pharmacodynamics (PK/PD) parameters and development of resistance for M. gallisepticum was explored based on the available data obtained from various dosing regimens in the in vitro model. Danofloxacin concentration, counts of viable cell and susceptibility were determined during the experiment. The mutations in gyrA, gyrB, parC and parE as well as efflux pumps were examined. The MIC of danofloxacin against M. gallisepticum was increased when drug concentrations were between the lower and upper boundaries of the mutant selection window. The upper boundary of the selection window in vitro was estimated as a C-max/MPC value of 1. The lower boundary was estimated as C-max/MPC value of 0.05. Both in terms of the MIC and resistance frequency, M. gallisepticum resistance was developed when danofloxacin concentrations fell inside the mutant selection window (ratios of C-max to MPC between 0.05 and 1). The single mutation in gyrA (Ser-83! Arg) was found in all mutants, while double mutations in gyrA and parC (Ala-64! Ser) were observed only in the mutant with the highest MIC. In addition, no change of susceptibility in the mutants was observed in the presence of reserpine and carbonyl cyanide 3-chlorophenylhydrazone (CCCP). This suggested that ATP-binding cassette superfamily (ABC transporter) and major facilitator superfamily (MFS transporter) did not play a role in danofloxacin efflux.	[Zhang, Nan] Foshan Univ, Sch Life Sci & Engn, Foshan, Peoples R China; [Zhang, Nan; Wu, Yuzhi; Huang, Zilong; Zhang, Chuanzhen; Zhang, Longfei; Cai, Qinren; Shen, Xiangguang; Ding, Huanzhong] South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Guangdong, Peoples R China; [Cai, Qinren; Jiang, Hongxia] Zhuhai Entry Exit Inspect & Quarantine Bur, Tech Ctr Inspect & Quarantine, Zhuhai, Peoples R China	Foshan University; South China Agricultural University	Ding, HZ (corresponding author), South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Guangdong, Peoples R China.	hzding@scau.edu.cn		Zhang, Chuan-Zhen/0000-0001-7029-0021	National Key Research and Development Program of China [2016YFD0501300/2016YFD0501310]; Special Program for Science and Technology Development of Gaungdong Province [2015A020209130]	National Key Research and Development Program of China; Special Program for Science and Technology Development of Gaungdong Province	This study is supported financially by National Key Research and Development Program of China (2016YFD0501300/2016YFD0501310) and Special Program for Science and Technology Development of Gaungdong Province (2015A020209130).	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Bebear CM, 1999, ANTIMICROB AGENTS CH, V43, P954, DOI 10.1128/AAC.43.4.954; Bebear CM, 1998, ANTIMICROB AGENTS CH, V42, P2304, DOI 10.1128/AAC.42.9.2304; BRADBURY JM, 1994, AVIAN PATHOL, V23, P105, DOI 10.1080/03079459408418978; Cui JC, 2006, J INFECT DIS, V194, P1601, DOI 10.1086/508752; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Ferguson NA, 2003, AVIAN DIS, V47, P523, DOI 10.1637/6059; Ferran AA, 2009, ANTIMICROB AGENTS CH, V53, P3384, DOI 10.1128/AAC.01347-08; Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003; FRIIS C, 1993, AM J VET RES, V54, P1122; GREENBERGOFRATH N, 1993, APPL ENVIRON MICROB, V59, P547, DOI 10.1128/AEM.59.2.547-551.1993; HANNAN PCT, 1989, RES VET SCI, V46, P202, DOI 10.1016/S0034-5288(18)31146-9; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; Hooper D.C., 2003, QUINOLONE ANTIMICROB, V3rd ed., P41, DOI [10.1128/9781555817817.ch3, DOI 10.1128/9781555817817.CH3]; Hooper DC, 1998, CLIN INFECT DIS, V27, pS54, DOI 10.1086/514923; Join-Lamberti OF, 2001, ANTIMICROB AGENTS CH, V45, P571, DOI 10.1128/AAC.45.2.571-576.2001; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Kenny GE, 1999, ANTIMICROB AGENTS CH, V43, P2493, DOI 10.1128/AAC.43.10.2493; Kleven S., 1989, SUMMARY DISCUSSIONS; Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x; Lauerman, 1998, MYCOPLASMA PCR ASSAY; Levisohn S, 2000, REV SCI TECH OIE, V19, P425, DOI 10.20506/rst.19.2.1232; Ley DH, 1997, EMERG INFECT DIS, V3, P375, DOI 10.3201/eid0303.970318; Liang BB, 2011, ANTIMICROB AGENTS CH, V55, P2409, DOI 10.1128/AAC.00975-10; Lu T, 2003, J ANTIMICROB CHEMOTH, V52, P61, DOI 10.1093/jac/dkg268; LYNCH MJ, 1994, J AGR FOOD CHEM, V42, P289, DOI 10.1021/jf00038a012; Marquez B, 2005, PHYTOCHEMISTRY, V66, P1804, DOI 10.1016/j.phytochem.2005.06.008; McKellar QA, 1998, BIOPHARM DRUG DISPOS, V19, P123, DOI 10.1002/(SICI)1099-081X(199803)19:2<123::AID-BDD89>3.0.CO;2-G; Meletiadis J, 2012, ANTIMICROB AGENTS CH, V56, P403, DOI 10.1128/AAC.00662-11; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2595, DOI 10.1128/AAC.44.10.2595-2599.2000; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; RAZIN S, 1970, J BACTERIOL, V102, P306, DOI 10.1128/JB.102.2.306-310.1970; Reinhardt AK, 2002, ANTIMICROB AGENTS CH, V46, P590, DOI 10.1128/AAC.46.2.590-593.2002; Ricci V, 2003, J ANTIMICROB CHEMOTH, V52, P605, DOI 10.1093/jac/dkg418; Scheffer GL, 2002, J CLIN PATHOL, V55, P332, DOI 10.1136/jcp.55.5.332; Schrickx JA, 2007, BRIT J PHARMACOL, V150, P463, DOI 10.1038/sj.bjp.0706974; Zeng Z, 2011, J VET PHARMACOL THER, V34, P101, DOI 10.1111/j.1365-2885.2010.01223.x; Zhang BX, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0297-1; Zhang N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00926; Zhang N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169134; Zhang N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00653; Zhao XL, 2001, CLIN INFECT DIS, V33, pS147, DOI 10.1086/321841; Zinner SH, 2003, J ANTIMICROB CHEMOTH, V52, P616, DOI 10.1093/jac/dkg401; Zinner SH, 2008, J ANTIMICROB CHEMOTH, V61, P629, DOI 10.1093/jac/dkm542	46	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202070	10.1371/journal.pone.0202070	http://dx.doi.org/10.1371/journal.pone.0202070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157201	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400030
J	Gmel, AI; Druml, T; Portele, K; von Niederhausern, R; Neuditschko, M				Gmel, Annik Imogen; Druml, Thomas; Portele, Katrin; von Niederhausern, Rudolf; Neuditschko, Markus			Repeatability, reproducibility and consistency of horse shape data and its association with linearly described conformation traits in Franches-Montagnes stallions	PLOS ONE			English	Article							GENETIC-PARAMETERS; GEOMETRIC MORPHOMETRICS; EQUINE CONFORMATION; POPULATION	Linear description (LD) of conformation traits was introduced in horse breeding to minimise subjectivity in scoring. However, recent studies have shown that LD traits show essentially the same problems as traditionally scored traits, such as data converging around the mean value with very small standard deviations. To improve the assessment of conformation traits of horses, we investigated the application of the recently described horse shape space model based upon 403 digitised photographs of 243 Franches-Montagnes (FM) stallions and extracted joint angles based on specific landmark triplets. Repeatability, reproducibility and consistency of the resulting shape data and joint angles were assessed with Procrustes ANOVA (Rep) and intra-class correlation coefficients (ICC). Furthermore, we developed a subjective score to classify the posture of the horses on each photograph. We derived relative warp scores (PCs) based upon the digitised photos conducting a principal component analysis (PCA). The PCs of the shapes and joint angles were compared to the posture scores and to the linear description data using linear mixed effect models including significant posture scores as random factors. The digitisation process was highly repeatable and reproducible for the shape (Rep = 0.72-0.99, ICC = 0.99). The consistency of the shape was limited by the age and posture (p < 0.05). The angle measurements were highly repeatable within one digitiser. Between digitisers, we found a higher variability of ICC values (ICC = 0.054-0.92), indicating digitising error in specific landmarks (e.g. shoulder point). The posture scores were highly repeatable (Fleiss' kappa = 0.713-0.857). We identified significant associations (p(x(2)) < 0.05) with traits describing the withers height, shoulder length and incline, overall leg conformation, walk and trot step length. The horse shape data and angles provide additional information to explore the morphology of horses and therefore can be applied to improve the knowledge of the genetic architecture of LD traits.	[Gmel, Annik Imogen; Portele, Katrin; von Niederhausern, Rudolf; Neuditschko, Markus] Agroscope Swiss Natl Stud Farm, Avenches, Switzerland; [Gmel, Annik Imogen] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Druml, Thomas; Neuditschko, Markus] Vet Univ Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Portele, Katrin] Vet Univ Vienna, Equine Sci Fac, Vienna, Austria; [Portele, Katrin] Vet Univ Vienna, Messerli Res Inst, Vienna, Austria	Swiss Federal Research Station Agroscope; University of Bern; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Gmel, AI (corresponding author), Agroscope Swiss Natl Stud Farm, Avenches, Switzerland.; Gmel, AI (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	annik.gmel@agroscope.admin.ch	Gmel, Annik Imogen/AAO-3076-2020	Gmel, Annik Imogen/0000-0002-6259-2377; Druml, Thomas/0000-0002-2777-4669; Portele, Katrin/0000-0001-6963-3568	Swiss Federal Office for Agriculture (FOAG) [625000469]	Swiss Federal Office for Agriculture (FOAG)	This study was funded by the Swiss Federal Office for Agriculture (FOAG) under the contract number 625000469. The funding payed the salary of Annik Gmel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2014, GEOMORPH R PACKAGE S; Anderson TM, 2004, EQUINE VET J, V36, P563, DOI 10.2746/0425164044864507; Bignon O, 2005, J ARCHAEOL SCI, V32, P375, DOI 10.1016/j.jas.2004.02.016; Bromiley PA, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0061-1; Burren A, 2015, ZUCHTERISCHE AUSWERT; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Druml T, 2015, ANIMAL, P1, DOI [10.1017/S1751731114002602, DOI 10.1017/S1751731114002602]; Druml T, 2016, ARCH ANIM BREED, V59, P309, DOI 10.5194/aab-59-309-2016; Duensing J, 2014, J EQUINE VET SCI, V34, P360, DOI 10.1016/j.jevs.2013.09.002; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Gamer M, 2012, IRR R PACKAGE VARIOU; Institut franc E ais du cheval et de l'e A quitation IFCE Les Haras du Pin, 2018, APPR MOD ALL CHEV QU; KOENEN EPC, 1995, LIVEST PROD SCI, V43, P85, DOI 10.1016/0301-6226(95)00010-I; Kristjansson T, 2013, LIVEST SCI, V158, P12, DOI 10.1016/j.livsci.2013.09.019; Kropatsch WG, 2015, PHANOTYPISIERUNG SCH, P93; Kuznetsova A, 2016, LMERTEST R PACKAGE T; Lefcheck JS, 2016, PIECEWISESEM R PACKA; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olsson EG, 2000, LIVEST PROD SCI, V65, P81, DOI 10.1016/S0301-6226(99)00176-1; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Pfammatter M., 2017, SYSTEME DESCRIPTION; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; R Core Team, 2017, R LANGUAGE ENV STAT; Rohlf F.J., 2016, TPSDIG2 DIGITIZE LAN; Rohlf FJ, 2016, TPS UTILITY PROGRAM; Samore AB, 1997, LIVEST PROD SCI, V52, P105, DOI 10.1016/S0301-6226(97)00143-7; Sanchez MJ, 2017, EQUINE VET J, V49, P196, DOI 10.1111/evj.12569; Schroderus E, 2010, J ANIM BREED GENET, V127, P395, DOI 10.1111/j.1439-0388.2010.00856.x; Seetah K, 2014, J ARCHAEOL SCI, V41, P904, DOI 10.1016/j.jas.2013.10.022; Smythe R.H., 1957, WHAT MAKES GOOD HORS; THOMPSON JR, 1981, J DAIRY SCI, V64, P1610, DOI 10.3168/jds.S0022-0302(81)82733-6; Viklund A, 2008, ANIMAL, V2, P1832, DOI 10.1017/S1751731108003030; Viklund A, 2018, J ANIM BREED GENET, V135, P62, DOI 10.1111/jbg.12311; Weller R, 2006, EQUINE VET J, V38, P616, DOI 10.2746/042516406X150394; Weller R, 2006, EQUINE VET J, V38, P610, DOI 10.2746/042516406X150367; Wolak ME, 2015, ICC R PACKAGE FACILI; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	38	9	9	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202931	10.1371/journal.pone.0202931	http://dx.doi.org/10.1371/journal.pone.0202931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148872	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200034
J	AlRuthia, Y; Alkofide, H; Alosaimi, FD; Alkadi, H; Alnasser, A; Aldahash, A; Basalamah, A; Alarfaj, M				AlRuthia, Yazed; Alkofide, Hadeel; Alosaimi, Fahad Dakheel; Alkadi, Hisham; Alnasser, Albandari; Aldahash, Aliah; Basalamah, Arwa; Alarfaj, Maryam			Translation and cultural adaptation of Glasgow Antipsychotic Side-effects Scale (GASS) in Arabic	PLOS ONE			English	Article							SELF-RATING SCALE; HEALTH LITERACY; MEDICATION NONADHERENCE; 1ST-EPISODE SCHIZOPHRENIA; MENTAL-DISORDERS; ADHERENCE; VALIDATION; CLOZAPINE; TRENDS; PATIENT	Background In view of a constant increase in the number of patients treated with antipsychotic medications, the problem of nonadherence to the prescribed treatment becomes particularly relevant. Since one of the major contributors to the nonadherence is the presence of side effects of the drugs being used, the availability of tools for assessment of adverse reactions is of great importance. Objective The objective of the present work was to develop an Arabic language version of the Glasgow Antipsychotic Side-effect Scale (GASS). Methods After confirming the accuracy of translation, the questionnaire was given to 100 patients in two psychiatric centers in Saudi Arabia. Results The Cronbach's alpha (0.793) indicated a good reliability of the survey. The mean GASS score was 19.09, indicating absent or mild side effects of antipsychotics, but 46% of patients experienced moderate, and 25% experienced severe side effects. An analysis of the correlation between patients' characteristics and side effects revealed the presence of a positive relationship between the side effects and health literacy. Conclusions It is expected that the Arabic-GASS will benefit Arabic-speaking psychiatric patients by helping them to express their concerns about side effects of antipsychotics. The collected results also document the importance of patients' health literacy in achieving high-quality healthcare.	[AlRuthia, Yazed; Alkofide, Hadeel; Alnasser, Albandari; Aldahash, Aliah; Basalamah, Arwa; Alarfaj, Maryam] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia; [Alosaimi, Fahad Dakheel] King Saud Univ, Coll Med, Dept Psychiat, Riyadh, Saudi Arabia; [Alkadi, Hisham] King Saud Univ, Arab Linguist Inst, Dept Teacher Training, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University	AlRuthia, Y (corresponding author), King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.	yazeed@ksu.edu.sa		Aldahash, Aliah/0000-0002-3240-2958; AlRuthia, Yazed/0000-0002-0029-5924	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	The authors acknowledge financial support from the College of Pharmacy Research Center and the Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumatar HJ, 2013, J GEN INTERN MED, V28, P1469, DOI 10.1007/s11606-013-2466-5; Al Sayah F, 2013, J GEN INTERN MED, V28, P444, DOI 10.1007/s11606-012-2241-z; Al-Jumaili AA, 2015, RES SOC ADMIN PHARM, V11, P803, DOI 10.1016/j.sapharm.2015.02.002; Al-Ruthia YS, 2017, SAUDI PHARM J, V25, P1015, DOI 10.1016/j.jsps.2017.04.003; Alosaimi FD, 2016, NEUROPSYCH DIS TREAT, V12, P897, DOI 10.2147/NDT.S100405; Barbui C, 2009, PSYCHOPATHOLOGY, V42, P311, DOI 10.1159/000232973; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Bauer AM, 2013, J GEN INTERN MED, V28, P1181, DOI 10.1007/s11606-013-2402-8; Brown E, 2015, J PSYCHIATR MENT HLT, V22, P192, DOI 10.1111/jpm.12186; Burton Simon C, 2005, J Psychiatr Pract, V11, P369, DOI 10.1097/00131746-200511000-00003; Carbon M, 2014, DIALOGUES CLIN NEURO, V16, P505; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DAY JC, 1995, BRIT J PSYCHIAT, V166, P650, DOI 10.1192/bjp.166.5.650; DiBonaventura M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-20; Exeter D, 2009, AUST NZ J PSYCHIAT, V43, P1131, DOI 10.3109/00048670903279879; Fan JH, 2016, DIABETES EDUCATOR, V42, P199, DOI 10.1177/0145721715624969; Gee SH, 2017, THER ADV PSYCHOPHARM, V7, P79, DOI 10.1177/2045125316677027; Green AI, 2006, SCHIZOPHR RES, V86, P234, DOI 10.1016/j.schres.2006.06.021; Gualano MR, 2014, PSYCHIAT SERV, V65, P1226, DOI 10.1176/appi.ps.201300510; Hynes C, 2015, SCHIZOPHR RES, V168, P505, DOI 10.1016/j.schres.2015.07.052; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Jonsdottir H, 2010, J CLIN PSYCHOPHARM, V30, P169, DOI 10.1097/JCP.0b013e3181d2191e; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kane JM, 2013, WORLD PSYCHIATRY, V12, P216, DOI 10.1002/wps.20060; Knapp M, 2004, BRIT J PSYCHIAT, V184, P509, DOI 10.1192/bjp.184.6.509; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Lang Kathleen, 2013, J Med Econ, V16, P997, DOI 10.3111/13696998.2013.816310; Lang Kathleen, 2011, J Med Econ, V14, P217, DOI 10.3111/13696998.2011.562265; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lindquist LA, 2012, J GEN INTERN MED, V27, P173, DOI 10.1007/s11606-011-1886-3; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; McCann TV, 2008, J PSYCHIATR MENT HLT, V15, P622, DOI 10.1111/j.1365-2850.2008.01277.x; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; Miller Brian J, 2011, Clin Psychopharmacol Neurosci, V9, P45, DOI 10.9758/cpn.2011.9.2.45; Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21; Mosher HJ, 2012, J HEALTH COMMUN, V17, P241, DOI 10.1080/10810730.2012.712611; Negi R., 2007, ROYAL COLL PSYCH GEN; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Ostini R, 2014, INT J CLIN PHARM-NET, V36, P36, DOI 10.1007/s11096-013-9895-4; Patel M.X., 2007, PSYCHIATRY, V6, P357, DOI [DOI 10.1016/J.MPPSY.2007.06.003, https://doi.org/10.1016/j.mppsy.2007.06.003]; Qureshi Naseem Akhtar, 2013, Neuropsychiatr Dis Treat, V9, P1121, DOI 10.2147/NDT.S48782; Sahni S, 2016, INDIAN J MED RES, V144, P696, DOI 10.4103/ijmr.IJMR_279_15; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; Slota C, 2015, OPTOMETRY VISION SCI, V92, P537, DOI 10.1097/OPX.0000000000000574; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Stomski NJ, 2016, AUST NZ J PSYCHIAT, V50, P399, DOI 10.1177/0004867415608244; Sun SX, 2007, CURR MED RES OPIN, V23, P2305, DOI 10.1185/030079907X226050; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Valenstein M, 2006, J CLIN PSYCHIAT, V67, P1542, DOI 10.4088/JCP.v67n1008; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Waddell L, 2008, J PSYCHOPHARMACOL, V22, P238, DOI 10.1177/0269881107087976; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Yusufi B, 2007, INT CLIN PSYCHOPHARM, V22, P238, DOI 10.1097/YIC.0b013e32819f8f17	53	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201225	10.1371/journal.pone.0201225	http://dx.doi.org/10.1371/journal.pone.0201225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138349	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100014
J	Biterova, E; Ignatyev, A; Uusimaa, J; Hinttala, R; Ruddock, LW				Biterova, Ekaterina; Ignatyev, Alexander; Uusimaa, Johanna; Hinttala, Reetta; Ruddock, Lloyd W.			Structural analysis of human NHLRC2, mutations of which are associated with FINCA disease	PLOS ONE			English	Article							STRUCTURE REFINEMENT; DENSITY MODIFICATION; PROTEIN; DOMAIN; MODEL; PREDICTION; MACROMOLECULES; SCATTERING; SYSTEM; SERVER	NHLRC2 (NHL repeat-containing protein 2) is an essential protein. Mutations of NHLRC2, including Asp148Tyr, have been recently associated with a novel FINCA disease (fibrosis, neurodegeneration, cerebral angiomatosis), which is fatal in early childhood. To gain insight into the mechanisms of action of this essential protein, we determined the crystal structure of the Trx-like and NHL repeat beta-propeller domains of human NHLRC2 to a resolution of 2.7 A. The structure reveals two domains adjacent to each other that form a cleft containing a conserved CCINC motif. A SAXS structure of full-length NHLRC2 reveals that the non-conserved C-terminal domain does not pack against the N-terminal domains. Analysis of the surface properties of the protein identifies an extended negative electrostatic potential in the surface of the cleft formed by the two domains, which likely forms a binding site for a ligand or interaction partner(s). Bioinformatics analysis discovers homologs across a range of eukaryotic and prokaryotic species and conserved residues map mostly to the adjacent surfaces of the Trx-like and beta-propeller domains that form the cleft, suggesting both that this forms the potential functional site of NHLRC2 and that the function is conserved across species. Asp148 is located in the Trx-like domain and is not conserved across species. The Asp148Tyr mutation destabilizes the structure of the protein by 2 degrees C. The NHLRC2 structure, the first of any of its homologs, provides an important step towards more focused structure-function studies of this essential protein.	[Biterova, Ekaterina; Ignatyev, Alexander; Ruddock, Lloyd W.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Biterova, Ekaterina; Ignatyev, Alexander; Uusimaa, Johanna; Hinttala, Reetta; Ruddock, Lloyd W.] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Biterova, Ekaterina; Uusimaa, Johanna; Hinttala, Reetta] Univ Oulu, PEDEGO Res Unit, Oulu, Finland; [Biterova, Ekaterina; Uusimaa, Johanna; Hinttala, Reetta] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Biterova, Ekaterina; Uusimaa, Johanna; Hinttala, Reetta] Oulu Univ Hosp, Oulu, Finland; [Uusimaa, Johanna] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Ruddock, LW (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.; Ruddock, LW (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.	lloyd.ruddock@oulu.fi		Hinttala, Reetta/0000-0002-7642-4008; Ruddock, Lloyd/0000-0002-6247-686X	Academy of Finland [266457, 272573, 266498, 303996]; Biocenter Oulu	Academy of Finland(Academy of Finland); Biocenter Oulu	This work was supported by the Academy of Finland (http://www.aka.fi/en; grant numbers 266457 and 272573 (LWR), 266498 and 303996 (RH)) and Biocenter Oulu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abicht HK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.607127; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Brooks MD, 2013, P NATL ACAD SCI USA, V110, pE2733, DOI 10.1073/pnas.1305443110; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chim N, 2010, J MOL BIOL, V396, P1211, DOI 10.1016/j.jmb.2009.12.060; Chufan EE, 2009, STRUCTURE, V17, P965, DOI 10.1016/j.str.2009.05.008; D'Arcy A, 2014, ACTA CRYSTALLOGR F, V70, P1117, DOI 10.1107/S2053230X14015507; Di Matteo A, 2010, PROTEINS, V78, P2213, DOI 10.1002/prot.22733; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goldstone D, 2005, ACTA CRYSTALLOGR A, V61, pC267, DOI 10.1107/S0108767305088586; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Ha NC, 2000, NAT STRUCT BIOL, V7, P147; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Long JT, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4250480; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; Malnoe A, 2018, PLANT CELL, V30, P196, DOI 10.1105/tpc.17.00536; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishi K, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0006-7; Onoa B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101470; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polkoff K., 2017, REPROD FERT DEVELOP, V29, P212; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tocchini C, 2015, SEMIN CELL DEV BIOL, V47-48, P52, DOI 10.1016/j.semcdb.2015.10.017; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uusimaa J, 2018, ACTA NEUROPATHOL, V135, P727, DOI 10.1007/s00401-018-1817-z; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195	52	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202391	10.1371/journal.pone.0202391	http://dx.doi.org/10.1371/journal.pone.0202391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138417	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100060
J	Ziegler, AL; Pridgen, TA; Mills, JK; Gonzalez, LM; Van Landeghem, L; Odle, J; Blikslager, AT				Ziegler, Amanda L.; Pridgen, Tiffany A.; Mills, Juliana K.; Gonzalez, Liara M.; Van Landeghem, Laurianne; Odle, Jack; Blikslager, Anthony T.			Epithelial restitution defect in neonatal jejunum is rescued by juvenile mucosal homogenate in a pig model of intestinal ischemic injury and repair	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR-BETA; BARRIER FUNCTION; PORCINE ILEUM; NECROTIZING ENTEROCOLITIS; CELL RESTITUTION; ANIMAL-MODELS; GLIAL-CELLS; RECOVERY; MIGRATION	Intestinal ischemic injury results sloughing of the mucosal epithelium leading to host sepsis and death unless the mucosal barrier is rapidly restored. Volvulus and neonatal necrotizing enterocolitis (NEC) in infants have been associated with intestinal ischemia, sepsis and high mortality rates. We have characterized intestinal ischemia/repair using a highly translatable porcine model in which juvenile (6-8-week-old) pigs completely and efficiently restore barrier function by way of rapid epithelial restitution and tight junction re-assembly. In contrast, separate studies showed that younger neonatal (2-week-old) pigs exhibited less robust recovery of barrier function, which may model an important cause of high mortality rates in human infants with ischemic intestinal disease. Therefore, we aimed to further refine our repair model and characterize defects in neonatal barrier repair. Here we examine the defect in neonatal mucosal repair that we hypothesize is associated with hypomaturity of the epithelial and subepithelial compartments. Following jejunal ischemia in neonatal and juvenile pigs, injured mucosa was stripped from seromuscular layers and recovered ex vivo while monitoring transepithelial electrical resistance (TEER) and H-3-mannitol flux as measures of barrier function. While ischemia-injured juvenile mucosa restored TEER above control levels, reduced flux over the recovery period and showed 93 +/- 4.7% wound closure, neonates exhibited no change in TEER, increased flux, and a 11 +/- 23.3% increase in epithelial wound size. Scanning electron microscopy revealed enterocytes at the wound margins of neonates failed to assume the restituting phenotype seen in restituting enterocytes of juveniles. To attempt rescue of injured neonatal mucosa, neonatal experiments were repeated with the addition of exogenous prostaglandins during ex vivo recovery, ex vivo recovery with full thickness intestine, in vivo recovery and direct application of injured mucosal homogenate from neonates or juveniles. Neither exogenous prostaglandins, intact seromuscular intestinal layers, nor in vivo recovery enhanced TEER or restitution in ischemia-injured neonatal mucosa. However, ex vivo exogenous application of injured juvenile mucosal homogenate produced a significant increase in TEER and enhanced histological restitution to 80 +/- 4.4% epithelial coverage in injured neonatal mucosa. Thus, neonatal mucosal repair can be rescued through direct contact with the cellular and non-cellular milieu of ischemia-injured mucosa from juvenile pigs. These findings support the hypothesis that a defect in mucosal repair in neonates is due to immature repair mechanisms within the mucosal compartment. Future studies to identify and rescue specific defects in neonatal intestinal repair mechanisms will drive development of novel clinical interventions to reduce mortality in infants affected by intestinal ischemic injury.	[Ziegler, Amanda L.; Pridgen, Tiffany A.; Mills, Juliana K.; Gonzalez, Liara M.; Blikslager, Anthony T.] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Van Landeghem, Laurianne] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [Odle, Jack] North Carolina State Univ, Coll Agr & Life Sci, Dept Anim Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Blikslager, AT (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.	Anthony_Blikslager@ncsu.edu	Ziegler, Amanda/AAA-3189-2020; Odle, Jack/O-4459-2019; Ariel, Pablo/AGJ-4118-2022; Odle, Jack/K-9660-2017	Ziegler, Amanda/0000-0003-4450-0536; Gonzalez, Liara/0000-0003-3972-2812; Odle, Jack/0000-0003-4965-2096; Blikslager, Anthony/0000-0002-0867-7310	National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UNC CGIBD Large Animal Models Core [P30 DK034987]; National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UNC CGIBD Basic Science Research Training Fellowship [NIH T32 5T32DK007737-22]; United States Department of Agriculture, National Institute of Food and Agriculture, Animal Health Project [1007263]; North Carolina State University College of Veterinary Medicine, Intramural Grant 2017; North Carolina State University College of Veterinary Medicine, Comparative Medicine Institute, Translational Pharmacology and Physiology Seed Grant CMI TPP 2017; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007737, P30DK034987] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019911] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UNC CGIBD Large Animal Models Core; National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UNC CGIBD Basic Science Research Training Fellowship; United States Department of Agriculture, National Institute of Food and Agriculture, Animal Health Project; North Carolina State University College of Veterinary Medicine, Intramural Grant 2017; North Carolina State University College of Veterinary Medicine, Comparative Medicine Institute, Translational Pharmacology and Physiology Seed Grant CMI TPP 2017; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UNC CGIBD Large Animal Models Core, P30 DK034987 (to ATB); by National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UNC CGIBD Basic Science Research Training Fellowship, NIH T32 5T32DK007737-22 (to ALZ); by United States Department of Agriculture, National Institute of Food and Agriculture, Animal Health Project 1007263 (to ATB); by North Carolina State University College of Veterinary Medicine, Intramural Grant 2017 (to ATB); and by North Carolina State University College of Veterinary Medicine, Comparative Medicine Institute, Translational Pharmacology and Physiology Seed Grant CMI TPP 2017 (to ALZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; ARGENZIO RA, 1993, GASTROENTEROLOGY, V104, P440, DOI 10.1016/0016-5085(93)90412-6; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Blikslager AT, 2002, GUT, V50, P615, DOI 10.1136/gut.50.5.615; Blikslager AT, 1997, J CLIN INVEST, V100, P1928, DOI 10.1172/JCI119723; Blikslager AT, 2001, AM J PHYSIOL-GASTR L, V281, pG375, DOI 10.1152/ajpgi.2001.281.2.G375; Blikslager AT, 1999, AM J PHYSIOL-GASTR L, V276, pG28, DOI 10.1152/ajpgi.1999.276.1.G28; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Coquenlorge S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25203; Cossais F, 2016, AM J PHYSIOL-GASTR L, V310, pG941, DOI 10.1152/ajpgi.00232.2015; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Goggins BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00272; Gonzalez LM, 2015, AM J PHYSIOL-GASTR L, V308, pG63, DOI 10.1152/ajpgi.00112.2013; Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465; Gookin JL, 2003, AM J PHYSIOL-GASTR L, V285, pG967, DOI 10.1152/ajpgi.00532.2002; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; Huygelen V, 2014, J ANIM SCI, V92, P3398, DOI 10.2527/jas.2014-7742; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; Jacobi SK, 2012, J NUTR, V142, P1266, DOI 10.3945/jn.111.150995; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kirk AD, 2003, IMMUNOL REV, V196, P176, DOI 10.1046/j.1600-065X.2003.00081.x; Lee Henry Chong, 2012, J Emerg Med, V43, pe49, DOI 10.1016/j.jemermed.2011.06.135; Lefebvre O, 1999, DEV BIOL, V210, P135, DOI 10.1006/dbio.1999.9270; Li QR, 2009, J CELL MOL MED, V13, P4061, DOI 10.1111/j.1582-4934.2009.00975.x; Lotz MM, 1997, AM J PATHOL, V150, P747; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Luu Y, 2010, INT J BIOCHEM CELL B, V42, P996, DOI 10.1016/j.biocel.2010.03.001; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; MESSINEO A, 1992, J PEDIATR SURG, V27, P1343, DOI 10.1016/0022-3468(92)90293-G; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Neunlist M, 2007, AM J PHYSIOL-GASTR L, V292, pG231, DOI 10.1152/ajpgi.00276.2005; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Rhoads JM, 2004, GUT, V53, P514, DOI 10.1136/gut.2003.027540; Riegler M, 1996, GASTROENTEROLOGY, V111, P28, DOI 10.1053/gast.1996.v111.pm8698221; Rothkotter HJ, 2002, HUM EXP TOXICOL, V21, P533, DOI 10.1191/0960327102ht293oa; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schellekens DHSM, 2017, WORLD J GASTROENTERO, V23, P8452, DOI 10.3748/wjg.v23.i48.8452; SEASHORE JH, 1994, ARCH PEDIAT ADOL MED, V148, P43, DOI 10.1001/archpedi.1994.02170010045009; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Van Landeghem L, 2011, AM J PHYSIOL-GASTR L, V300, pG976, DOI 10.1152/ajpgi.00427.2010; Watkins DJ, 2013, SEMIN PEDIATR SURG, V22, P83, DOI 10.1053/j.sempedsurg.2013.01.004; Xiao WD, 2014, MOL NEUROBIOL, V50, P274, DOI 10.1007/s12035-014-8730-9; Xie H, 1998, J CELL SCI, V111, P615; Young Christopher M, 2011, J Pediatr, V158, pe25, DOI 10.1016/j.jpeds.2010.11.009; Ziegler A, 2016, CELL MOL GASTROENTER, V2, P716, DOI 10.1016/j.jcmgh.2016.09.003	54	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0200674	10.1371/journal.pone.0200674	http://dx.doi.org/10.1371/journal.pone.0200674			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138372	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100009
J	Brunner, I; Fischer, M; Ruthi, J; Stierli, B; Frey, B				Brunner, Ivano; Fischer, Moira; Ruethi, Joel; Stierli, Beat; Frey, Beat			Ability of fungi isolated from plastic debris floating in the shoreline of a lake to degrade plastics	PLOS ONE			English	Article							POLYESTER POLYURETHANE; MICROBIAL-DEGRADATION; MARINE-ENVIRONMENT; GREAT-LAKES; FAIRY RINGS; BIODEGRADATION; MICROPLASTICS; POLYETHYLENE; INGESTION; ENZYMES	Plastic waste in the environment is a significant threat due to its resistance to biological processes. Here we report the ability of fungal strains found on floating plastic debris to degrade plastics. In particular, we wanted to know which fungi grow on plastic debris floating in the shoreline, whether these fungi have the ability to degrade plastics, whether the plastic-degrading fungi can degrade other complex C-polymers such as lignin, and whether lignin-degraders vice versa can also break down plastics. Overall, more than a hundred fungal strains were isolated from plastic debris of the shoreline of Lake Zurich, Switzerland, and grouped morphologically. Representative strains of these groups were then selected and genetically identified, altogether twelve different fungal species and one species of Oomycota. The list of fungi included commonly occurring saprotrophic fungi but also some plant pathogens. These fungal strains were then used to test the ability to degrade polyethylene and polyurethane. The tests showed that none of the strains were able to degrade polyethylene. However, four strains were able to degrade polyurethane, the three litter-saprotrophic fungi Cladosporium cladosporioides, Xepiculopsis graminea, and Penicillium griseofulvum and the plant pathogen Leptosphaeria sp. A series of additional fungi with an origin other than from plastic debris were tested as well. Here, only the two litter-saprotrophic fungi Agaricus bisporus and Marasmius oreades showed the capability to degrade polyurethane. In contrast, wood-saprotrophic fungi and ectomycorrhizal fungi were unable to degrade polyurethane. Overall, it seems that in majority only a few litter-saprotrophic fungi, which possess a wide variety of enzymes, have the ability to degrade polyurethane. None of the fungi tested was able to degrade polyethylene.	[Brunner, Ivano; Fischer, Moira; Ruethi, Joel; Stierli, Beat; Frey, Beat] Swiss Fed Inst Forest Snow & Landscape Res WSL, Forest Soils & Biogeochem, Birmensdorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Brunner, I (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Forest Soils & Biogeochem, Birmensdorf, Switzerland.	ivano.brunner@wsl.ch	Brunner, Ivano L./J-8661-2014; Frey, Beat/AAE-1745-2022	Brunner, Ivano L./0000-0003-3436-995X; Frey, Beat/0000-0002-6391-3574; Ruthi, Joel/0000-0002-0568-9551				Abbas HK, 2002, PHYTOCHEMISTRY, V59, P309, DOI 10.1016/S0031-9422(01)00464-2; Alvarez-Barragan J, 2016, APPL ENVIRON MICROB, V82, P5225, DOI 10.1128/AEM.01344-16; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Banani H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2347-x; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barratt SR, 2003, J APPL MICROBIOL, V95, P78, DOI 10.1046/j.1365-2672.2003.01961.x; Bennett JW, 1998, J BIOTECHNOL, V66, P101, DOI 10.1016/S0168-1656(98)00133-3; Bhardwaj H, 2013, J POLYM ENVIRON, V21, P575, DOI 10.1007/s10924-012-0456-z; Biffinger JC, 2015, POLYM DEGRAD STABIL, V120, P178, DOI 10.1016/j.polymdegradstab.2015.06.020; Bonanomi G, 2012, J VEG SCI, V23, P236, DOI 10.1111/j.1654-1103.2011.01353.x; Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Boyette CD, 2002, BIOCONTROL SCI TECHN, V12, P75, DOI 10.1080/09583150120093031; BREITENBACH J, 1986, PILZE SCHWEIZ, V2; Brunner I, 2011, GEOBIOLOGY, V9, P266, DOI 10.1111/j.1472-4669.2011.00274.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caspar J, 2015, CHEMBIOCHEM, V16, P570, DOI 10.1002/cbic.201402453; Chen Y, 2016, MYCOSPHERE, V7, P64, DOI 10.5943/mycosphere/7/1/7; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Crous PW, 2007, STUD MYCOL, P33, DOI 10.3114/sim.2007.58.02; Davison P, 2011, MAR ECOL PROG SER, V432, P173, DOI 10.3354/meps09142; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; De Tender CA, 2015, ENVIRON SCI TECHNOL, V49, P9629, DOI 10.1021/acs.est.5b01093; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Driedger AGJ, 2015, J GREAT LAKES RES, V41, P9, DOI 10.1016/j.jglr.2014.12.020; EDWARDS PJ, 1984, J ECOL, V72, P505, DOI 10.2307/2260062; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Ernst M, 2003, MOL PLANT MICROBE IN, V16, P580, DOI 10.1094/MPMI.2003.16.7.580; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Filella M, 2018, FRONT ENV SCI-SWITZ, V6, DOI 10.3389/fenvs.2018.00001; FISHER RF, 1977, SOIL BIOL BIOCHEM, V9, P239, DOI 10.1016/0038-0717(77)90028-1; Garnica S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw045; Ghosh SK, 2013, ENVIRON SCI POLLUT R, V20, P4339, DOI 10.1007/s11356-013-1706-x; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Gourmelon G., VITAL SIGNS, V2015, P1; Gramss G, 2005, J BASIC MICROB, V45, P41, DOI 10.1002/jobm.200410459; Gramss G, 1998, MYCOL RES, V102, P67, DOI 10.1017/S095375629700436X; Grover A., 2015, INT J ENV SCI, V5, P1091, DOI DOI 10.6088/IJES.2014050100103; Isola D, 2016, FUNGAL DIVERS, V76, P75, DOI 10.1007/s13225-015-0342-9; Jambeck JR, 2015, SCIENCE, V347, P468, DOI [10.1126/science.347.6221.468, DOI 10.1126/SCIENCE.347.6221.468]; Kale SK, 2015, J BIOTECHNOL TECHNOL, V6, P952; Koelmans AA, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa9500; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Loredo-Trevi?o A., 2011, ADV BIOSCI BIOTECHNO, V2, P52, DOI DOI 10.4236/ABB.2011.22009; Meyer Vera, 2016, Fungal Biol Biotechnol, V3, P6, DOI 10.1186/s40694-016-0024-8; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Nechwatal J, 2008, HYDROBIOLOGIA, V613, P109, DOI 10.1007/s10750-008-9476-z; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Pathak VM, 2017, BIORESOUR BIOPROCESS, V4, DOI 10.1186/s40643-017-0145-9; Patyshakuliyeva A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-663; Perdomo H, 2013, MYCOLOGIA, V105, P398, DOI 10.3852/12-137; PlasticsEurope, 2015, PLAST FACTS 2015 AN; PRESTON N. C., 1948, TRANS BRIT MYCOL SOC, V31, P271; Raghavendra VB., 2016, INT J CURR RES, V8, P34753; Restrepo-Florez JM, 2014, INT BIODETER BIODEGR, V88, P83, DOI 10.1016/j.ibiod.2013.12.014; Rime T, 2015, MOL ECOL, V24, P1091, DOI 10.1111/mec.13051; Rungjindamai N, 2012, CRYPTOGAMIE MYCOL, V33, P319, DOI 10.7872/crym.v33.iss3.2012.319; Russell JR, 2011, APPL ENVIRON MICROB, V77, P6076, DOI 10.1128/AEM.00521-11; Sangale M. K., 2012, Journal of Bioremediation and Biodegradation, V3, P1000164; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wieczorek AM, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00039; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Yamada-Onodera K, 2001, POLYM DEGRAD STABIL, V72, P323, DOI 10.1016/S0141-3910(01)00027-1; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zbyszewski M, 2014, J GREAT LAKES RES, V40, P288, DOI 10.1016/j.jglr.2014.02.012	69	55	62	16	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202047	10.1371/journal.pone.0202047	http://dx.doi.org/10.1371/journal.pone.0202047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133489	gold, Green Published			2022-12-26	WOS:000442500400057
J	Gummesson, A; Stromberg, U; Schmidt, C; Kullberg, J; Angeras, O; Lindgren, S; Hjelmgren, O; Toren, K; Rosengren, A; Fagerberg, B; Brandberg, J; Bergstrom, G				Gummesson, Anders; Stromberg, Ulf; Schmidt, Caroline; Kullberg, Joel; Angeras, Oskar; Lindgren, Stefan; Hjelmgren, Ola; Toren, Kjell; Rosengren, Annika; Fagerberg, Bjorn; Brandberg, John; Bergstrom, Goran			Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HEPATIC STEATOSIS; SUBCLINICAL ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ASSOCIATION; CALCIUM; CT; QUANTIFICATION; OBESITY	Objectives This study aims to estimate the relationship between non-alcoholic fatty liver disease (NAFLD) and measures of atherosclerotic cardiovascular disease (ASCVD), and to determine to what extent such relationships are modified by metabolic risk factors. Methods The study was conducted in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot cohort (n = 1015, age 50-64 years, 51.2% women). NAFLD was defined as computed tomography liver attenuation <= 40 Hounsfield Units, excluding other causes of liver fat. Coronary artery calcification score (CACS) was assessed using the Agatston method. Carotid plaques and intima media thickness (IMT) were measured by ultrasound. Metabolic status was based on assessments of glucose homeostasis, serum lipids, blood pressure and inflammation. A propensity score model was used to balance NAFLD and non NAFLD groups with regards to potential confounders and associations between NAFLD status and ASCVD variables in relation to metabolic status were examined by logistic and generalized linear regression models. Results NAFLD was present in 106 (10.4%) of the subjects and strongly associated with obesity-related traits. NAFLD was significantly associated with CACS after adjustment for confounders and metabolic risk factors (OR 1.77, 95% CI 1.07-2.94), but not with carotid plaques and IMT. The strongest association between NAFLD and CACS was observed in subjects with few metabolic risk factors (n = 612 [60% of all] subjects with 0-1 out of 7 predefined metabolic risk factors; OR 5.94, 95% CI 2.13-16.6). Conclusions NAFLD was independently associated with coronary artery calcification but not with measures of carotid atherosclerosis in this cohort. The association between NAFLD and CACS was most prominent in the metabolically healthy subjects.	[Gummesson, Anders] Sahlgrens Univ Hosp, Dept Clin Pathol & Genet, Gothenburg, Sweden; [Gummesson, Anders; Schmidt, Caroline; Angeras, Oskar; Hjelmgren, Ola; Rosengren, Annika; Fagerberg, Bjorn; Bergstrom, Goran] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Stromberg, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Hlth Metr Unit, Gothenburg, Sweden; [Kullberg, Joel] Uppsala Univ, Dept Surg Sci, Sect Radiol, Uppsala, Sweden; [Kullberg, Joel] Antaros Med, Molndal, Sweden; [Angeras, Oskar] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Lindgren, Stefan] Lund Univ, Univ Hosp Sickle, Dept Clin Sci, Gastroenterol Div, Malmo, Sweden; [Hjelmgren, Ola; Bergstrom, Goran] Sahlgrens Univ Hosp, Clin Physiol, Gothenburg, Sweden; [Toren, Kjell] Univ Gothenburg, Sahlgrenska Acad, Sect Occupat & Environm Med, Gothenburg, Sweden; [Brandberg, John] Sahlgrens Univ Hosp, Dept Radiol, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Uppsala University; Sahlgrenska University Hospital; Lund University; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Gummesson, A (corresponding author), Sahlgrens Univ Hosp, Dept Clin Pathol & Genet, Gothenburg, Sweden.; Gummesson, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden.	anders.gummesson@vgregion.se	Kullberg, Joel/ABE-3997-2021	Bergstrom, Goran/0000-0003-4289-5722; Gummesson, Anders/0000-0003-0024-960X	Swedish Heart and Lung Foundation; Swedish Research Council; Sahlgrenska Academy at University of Gothenburg; Region Vastra Gotaland	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska Academy at University of Gothenburg; Region Vastra Gotaland	The main funding body of The Swedish CArdioPulmonary bioImage Study (SCAPIS) is the Swedish Heart and Lung Foundation (www.hjart-lungfonden.se). In addition, the SCAPIS Pilot study received support from the Swedish Research Council (www.vr.se), the Sahlgrenska Academy at University of Gothenburg (sahlgrenska.gu.se) and Region Vastra Gotaland (www.vgregion.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Al Rifai M, 2015, ATHEROSCLEROSIS, V239, P629, DOI 10.1016/j.atherosclerosis.2015.02.011; Alluri K, 2015, ATHEROSCLEROSIS, V239, P109, DOI 10.1016/j.atherosclerosis.2014.12.040; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; Cai J, 2015, INT J CLIN EXP MED, V8, P7673; Chatrath H, 2012, SEMIN LIVER DIS, V32, P22, DOI 10.1055/s-0032-1306423; Chhabra R, 2013, MAYO CLIN PROC, V88, P1259, DOI 10.1016/j.mayocp.2013.06.025; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Deprez FC, 2013, J CARDIOVASC COMPUT, V7, P58, DOI 10.1016/j.jcct.2012.11.006; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dick TJM, 2013, ATHEROSCLEROSIS, V226, P208, DOI 10.1016/j.atherosclerosis.2012.10.040; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Fargion S, 2014, WORLD J GASTROENTERO, V20, P13306, DOI 10.3748/wjg.v20.i37.13306; FITZPATRICK LA, 1994, J CLIN INVEST, V94, P1597, DOI 10.1172/JCI117501; Gavin JR, 1999, DIABETES CARE, V22, pS5; Idilman IS, 2015, J DIABETES, V7, P279, DOI 10.1111/1753-0407.12172; Kang MK, 2015, YONSEI MED J, V56, P1288, DOI 10.3349/ymj.2015.56.5.1288; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Kim HC, 2009, ATHEROSCLEROSIS, V204, P521, DOI 10.1016/j.atherosclerosis.2008.09.012; Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992; Kramer H, 2017, AM J ROENTGENOL, V208, P92, DOI 10.2214/AJR.16.16565; Kullberg J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08925-8; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Liu Jichuan, 2012, J RADIO ENG, V42, p[7, 45], DOI DOI 10.1016/J.ATHER0SCLER0SIS.2012.07.042; Loffroy R, 2015, QUANT IMAG MED SURG, V5, P754, DOI 10.3978/j.issn.2223-4292.2015.10.08; Madan SA, 2015, EUR J GASTROEN HEPAT, V27, P1237, DOI 10.1097/MEG.0000000000000429; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Osawa K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131138; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Petit JM, 2009, J CLIN ENDOCR METAB, V94, P4103, DOI 10.1210/jc.2009-0541; Puchner SB, 2015, RADIOLOGY, V274, P693, DOI 10.1148/radiol.14140933; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schmidt C, 1999, CLIN PHYSIOL, V19, P45; Schmidt C, 2009, ATHEROSCLEROSIS, V205, P284, DOI 10.1016/j.atherosclerosis.2008.11.025; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Sung KC, 2012, DIABETES CARE, V35, P2359, DOI 10.2337/dc12-0515; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Tomizawa N, 2016, INT J CARDIOVAS IMAG, V32, pS73, DOI 10.1007/s10554-016-0847-7; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; VanWagner LB, 2014, ATHEROSCLEROSIS, V235, P599, DOI 10.1016/j.atherosclerosis.2014.05.962; Wainwright P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030367; Wallenfeldt K, 2001, J INTERN MED, V250, P492, DOI 10.1046/j.1365-2796.2001.00917.x; Xia MF, 2016, ALIMENT PHARM THER, V43, P631, DOI 10.1111/apt.13521; Xu X, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0141-z; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	51	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202666	10.1371/journal.pone.0202666	http://dx.doi.org/10.1371/journal.pone.0202666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133541	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400090
J	Lal, S; Scarinci, N; Perez, PL; Cantero, MD; Cantiello, HF				Lal, Sumit; Scarinci, Noelia; Perez, Paula L.; del Rocio Cantero, Maria; Cantiello, Horacio F.			Lipid bilayer-atomic force microscopy combined platform records simultaneous electrical and topological changes of the TRP channel polycystin-2 (TRPP2)	PLOS ONE			English	Article							CATION CHANNEL; ION CHANNELS; CRYOELECTRON MICROSCOPY; REVEALS; CRYOMICROSCOPY; DISEASE; RECONSTRUCTION; BIOMOLECULES; RESOLUTION; DOMAIN	Ion channels are transmembrane proteins that mediate ion transport across biological membranes. Ion channel function is traditionally characterized by electrical parameters acquired with techniques such as patch-clamping and reconstitution in lipid bilayer membranes (BLM) that provide relevant information such as ionic conductance, selectivity, and gating properties. High resolution structural information of ion channels however, requires independent technologies, of which atomic force microscopy (AFM) is the only one that provides topological features of single functional channel proteins in their native environments. To date practically no data exist on direct correlations between electrical features and topological parameters from functional single channel complexes. Here, we report the design and construction of a BLM reconstitution microchamber that supports the simultaneous recording of electrical currents and AFM imaging from single channel complexes. As proof-of-principle, we tested the technique on polycystin-2 (PC2, TRPP2), a TRP channel family member from which we had previously elucidated its tetrameric topology by AFM imaging, and single channel currents by the BLM technique. The experimental setup provided direct structural-functional correlates from PC2 single channel complexes that disclosed novel topological changes between the closed and open sub-conductance states of the functional channel, namely, an inverse correlation between conductance and height of the channel. Unexpectedly, we also disclosed intrinsic PC2 mechanosensitivity in response to external forces. The platform provides a suitable means of accessing topological information to correlate with ion channel electrical parameters essential to understand the physiology of these transmembrane proteins.	[Lal, Sumit; Cantiello, Horacio F.] Massachusetts Gen Hosp, Nephrol Div, Charlestown, MA USA; [Lal, Sumit; Cantiello, Horacio F.] Massachusetts Gen Hosp, Electrophysiol Core, Charlestown, MA 02149 USA; [Scarinci, Noelia; Perez, Paula L.; del Rocio Cantero, Maria; Cantiello, Horacio F.] IMSaTeD UNSE CONICET, Lab Canales Ion, Inst Multidisciplinario Salud Tecnol & Desarrollo, Santiago Del Estero, Argentina; [Cantiello, Horacio F.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Cantiello, HF (corresponding author), Massachusetts Gen Hosp, Electrophysiol Core, Charlestown, MA 02149 USA.; Cantiello, HF (corresponding author), IMSaTeD UNSE CONICET, Lab Canales Ion, Inst Multidisciplinario Salud Tecnol & Desarrollo, Santiago Del Estero, Argentina.; Cantiello, HF (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	hcantiello@yahoo.com.ar	Scarinci, Noelia/CAF-4813-2022	Cantiello, Horacio/0000-0001-7973-0804; Cantero, Maria del Rocio/0000-0002-9690-8413	NIDDK National Institute of Diabetes and Digestive and Kidney Diseases, USA ARRA American Recovery and Reinvestment Act, USA Award [1R01DK077079]; FONCyT Fondo para la Investigacion Cientifica y Tecnologica, Argentina PICT Proyecto de Investigacion Cientifica y Tecnologica, Argentina 2013 [1411]	NIDDK National Institute of Diabetes and Digestive and Kidney Diseases, USA ARRA American Recovery and Reinvestment Act, USA Award; FONCyT Fondo para la Investigacion Cientifica y Tecnologica, Argentina PICT Proyecto de Investigacion Cientifica y Tecnologica, Argentina 2013	Funded by NIDDK National Institute of Diabetes and Digestive and Kidney Diseases, USA ARRA American Recovery and Reinvestment Act, USA Award #1R01DK077079. FONCyT Fondo para la Investigacion Cientifica y Tecnologica, Argentina PICT Proyecto de Investigacion Cientifica y Tecnologica, Argentina 2013 #1411.	Allen MJ, 2011, J BIOL CHEM, V286, P22139, DOI 10.1074/jbc.M111.240002; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Barrera NP, 2008, PFLUG ARCH EUR J PHY, V456, P199, DOI 10.1007/s00424-007-0381-5; Cheng YF, 2009, ANNU REV BIOCHEM, V78, P723, DOI 10.1146/annurev.biochem.78.070507.140543; Chiu W, 2005, STRUCTURE, V13, P363, DOI 10.1016/j.str.2004.12.016; Cohn EJ, 1943, PROTEINS AMINO ACIDS; Frank J, 2009, Q REV BIOPHYS, V42, P139, DOI 10.1017/S0033583509990059; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Geisse NA, 2002, J MEMBRANE BIOL, V189, P83, DOI 10.1007/s00232-002-1005-9; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Katan AJ, 2011, CELL, V147, P979, DOI 10.1016/j.cell.2011.11.017; Korepanova A, 2009, PROTEIN EXPRES PURIF, V65, P38, DOI 10.1016/j.pep.2008.12.006; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Miller C., 1986, ION CHANNEL RECONSTI; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Muller DJ, 1997, BIOPHYS J, V73, P1633, DOI 10.1016/S0006-3495(97)78195-5; Neher E, 1995, SINGLE CHANNEL RECOR; Nilius B, 2006, MOL CELL, V22, P297, DOI 10.1016/j.molcel.2006.04.015; Ovalle-Garcia E, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2776356; Quist AP, 2007, LANGMUIR, V23, P1375, DOI 10.1021/la062187z; Rees DC, 2000, J BIOL CHEM, V275, P713, DOI 10.1074/jbc.275.2.713; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; Sumino A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01063; Watanabe H, 2009, CIRC J, V73, P419, DOI 10.1253/circj.CJ-08-1153; White JPM, 2010, ANESTHESIOLOGY, V112, P729, DOI 10.1097/ALN.0b013e3181ca3179; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202029	10.1371/journal.pone.0202029	http://dx.doi.org/10.1371/journal.pone.0202029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133487	Green Submitted, gold, Green Published			2022-12-26	WOS:000442500400056
J	Lin, CM; Cheng, CJ; Yang, SS; Tseng, MH; Yen, MT; Sung, CC; Lin, SH				Lin, Chien-Ming; Cheng, Chih-Jen; Yang, Sung-Sen; Tseng, Min-Hua; Yen, Ming-Tso; Sung, Chih-Chien; Lin, Shih-Hua			Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain	FASEB JOURNAL			English	Article						Cullin 3; Kelch-like 3; PHAII; with-no-lysine kinases	DISEASE-CAUSING MUTATIONS; FAMILIAL HYPERKALEMIC HYPERTENSION; NA-CL COTRANSPORTER; KELCH-LIKE 3; BLOOD-PRESSURE; KNOCKIN MOUSE; ION-TRANSPORT; WNK4; KINASE; UBIQUITINATION	The Kelch-like 3 (KLHL3) mutations contributed to the most common causative genes in patients with pseudohypoaldosteronism type II (PHAII); however, the molecular mechanisms of PHAII-causing mutations in BTB domain of KLHL3in vivo have not been investigated. We generated and analyzed Klhl3 knock-in (KI) mice carrying a missense M131V mutation in the BTB domain (corresponding to human KLHL3 M78V mutation). Klhl3(M131V/+) KI mice exhibited typical PHAII phenotype with an exaggerated diuretic response to hydrochlorothiazide. Their kidney tissues showed an unchanged KLHL3, decreased cullin 3 (Cul3), and increased with-no-lysine kinases (WNKs) WNK1 and WNK4 along with an enhanced downstream ste20-related proline/alanine-rich kinase/oxidative stress response kinase 1-N(K)CC phosphorylation. Their Cul3 protein in the cytosol of distal convoluted tubule cells was also significantly attenuated on immunogold-labeling electron microscopy. In microdissected renal tubules, Klhl3(M131V/+) KI mice expressed high levels of Wnk4 mRNA in the distal nephron. In vitro coimmunoprecipitation showed the KLHL3 BTB domain mutation retained intact interaction with WNKs but reduced binding to Cul3, thus leading to the increased abundance of total WNKs. In summary, Klhl3(M131V/+) KI mice feature typical PHAII with a simultaneous increase of WNK1 and WNK4 through the impaired KLHL3 BTB domain binding to Cul3.Lin, C.-M., Cheng, C.-J., Yang, S.-S., Tseng, M.-H., Yen, M.-T., Sung, C.-C., Lin, S.-H. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.	[Lin, Chien-Ming; Yang, Sung-Sen; Tseng, Min-Hua; Yen, Ming-Tso; Sung, Chih-Chien; Lin, Shih-Hua] Triserv Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Chien-Ming] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pediat, Taipei, Taiwan; [Cheng, Chih-Jen; Yang, Sung-Sen; Sung, Chih-Chien; Lin, Shih-Hua] Triserv Gen Hosp, Natl Def Med Ctr, Div Nephrol, Dept Med, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan; [Tseng, Min-Hua] Chang Gung Mem Hosp, Div Pediat Nephrol, Dept Pediat, Taoyuan, Taiwan; [Yen, Ming-Tso] Cathay Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Cathay General Hospital	Lin, SH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Div Nephrol, Dept Med, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	l521116@ndmctsgh.edu.tw	Cheng, Chih-Jen/AAM-3305-2021		Ministry of Science and Technology (MOST) [103-2314-B-016-010-MY3, 104-2314-B-016-023-MY3, 107-2314-B-016-064-MY3]; Research Fund of Tri-Service General Hospital (TSGH) [C105-110, C106-091, C106-007-S03, C107-015]; Teh-Tzer Study Group for Human Medical Research Foundation	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Research Fund of Tri-Service General Hospital (TSGH); Teh-Tzer Study Group for Human Medical Research Foundation	The authors thank the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, and the Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine. The authors thank T.-H. Chang, C.-C. Huang, W.-S. Lee, and M.-H. Chen (Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center) for their technical assistance. This work was supported in part by a grant from the Ministry of Science and Technology (MOST; 103-2314-B-016-010-MY3, 104-2314-B-016-023-MY3, and 107-2314-B-016-064-MY3), the Research Fund of Tri-Service General Hospital (TSGH; C105-110, C106-091, C106-007-S03, and C107-015), and the Teh-Tzer Study Group for Human Medical Research Foundation. The authors declare no conflicts of interest.	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Bergaya S, 2011, HYPERTENSION, V58, P439, DOI 10.1161/HYPERTENSIONAHA.111.172429; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Cheng CJ, 2015, AM J PHYSIOL-RENAL, V308, pF437, DOI 10.1152/ajprenal.00493.2013; Chiga M, 2011, J CELL SCI, V124, P1391, DOI 10.1242/jcs.084111; Ellison D. H., 2011, GENEREVIEWS, P1993; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Hadchouel J, 2006, J AM SOC NEPHROL, V17, P208, DOI 10.1681/ASN.2005030314; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Huang CL, 2015, PFLUG ARCH EUR J PHY, V467, P2235, DOI 10.1007/s00424-015-1708-2; Ishizawa K, 2016, BIOCHEM BIOPH RES CO, V480, P745, DOI 10.1016/j.bbrc.2016.10.127; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Lee YR, 2010, EMBO J, V29, P1748, DOI 10.1038/emboj.2010.62; Lin MY, 2011, J CELL BIOL, V193, P985, DOI 10.1083/jcb.201103015; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; McCormick JA, 2014, J CLIN INVEST, V124, P4723, DOI 10.1172/JCI76126; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Mori Y, 2015, BIOCHEM J, V472, P33, DOI 10.1042/BJ20150500; Mori Y, 2013, BIOCHEM BIOPH RES CO, V439, P30, DOI 10.1016/j.bbrc.2013.08.035; Murthy M, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12850; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Pathare G, 2013, AM J PHYSIOL-RENAL, V305, pF1513, DOI 10.1152/ajprenal.00440.2013; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Sasaki E, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00508-16; Schumacher FR, 2015, EMBO MOL MED, V7, P1285, DOI 10.15252/emmm.201505444; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Sohara E, 2016, NEPHROL DIAL TRANSPL, V31, P1417, DOI 10.1093/ndt/gfv259; Susa K, 2017, BIOCHEM BIOPH RES CO, V491, P727, DOI 10.1016/j.bbrc.2017.07.121; Susa K, 2014, HUM MOL GENET, V23, P5052, DOI 10.1093/hmg/ddu217; Susa K, 2012, CLIN EXP NEPHROL, V16, P530, DOI 10.1007/s10157-012-0590-x; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Uchida S, 2014, BIOL CELL, V106, P45, DOI 10.1111/boc.201300069; Vidal-Petiot E, 2013, P NATL ACAD SCI USA, V110, P14366, DOI 10.1073/pnas.1304230110; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu GJ, 2013, FEBS LETT, V587, P1717, DOI 10.1016/j.febslet.2013.04.032; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Yang SS, 2013, J AM SOC NEPHROL, V24, P1587, DOI 10.1681/ASN.2012070742; Yang SS, 2010, HUM MUTAT, V31, P1304, DOI 10.1002/humu.21364; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Yang SS, 2010, ENDOCRINOLOGY, V151, P1829, DOI 10.1210/en.2009-0951	48	8	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1051	1061		10.1096/fj.201801023R	http://dx.doi.org/10.1096/fj.201801023R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148674				2022-12-26	WOS:000457401500083
J	Roehrkasse, AM; Booe, JM; Lee, SM; Warner, ML; Pioszak, AA				Roehrkasse, Amanda M.; Booe, Jason M.; Lee, Sang-Min; Warner, Margaret L.; Pioszak, Augen A.			Structure-function analyses reveal a triple beta-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); molecular pharmacology; peptide hormone; fluorescence anisotropy; X-ray crystallography; protein engineering; receptor structure-function; signal transduction; cardioprotection; class B GPCR; receptor activity-modifying protein; vasodilation	GENE-RELATED PEPTIDE; ACTIVITY-MODIFYING PROTEINS; CRYO-EM STRUCTURE; CLASS-B GPCR; CALCITONIN-RECEPTOR; EXTRACELLULAR DOMAIN; ECTODOMAIN COMPLEX; COUPLED-RECEPTOR; OXIDATIVE STRESS; N-GLYCOSYLATION	The cardioprotective vasodilator peptide adrenomedullin 2/intermedin (AM2/IMD) and the related adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) signal through three heterodimeric receptors comprising the calcitonin receptor-like class B G protein-coupled receptor (CLR) and a variable receptor activity-modifying protein (RAMP1, -2, or -3) that determines ligand selectivity. The CGRP receptor (RAMP1:CLR) favors CGRP binding, whereas the AM(1) (RAMP2:CLR) and AM(2) (RAMP3:CLR) receptors favor AM binding. How AM2/IMD binds the receptors and how RAMPs modulate its binding is unknown. Here, we show that AM2/IMD binds the three purified RAMP-CLR extracellular domain (ECD) complexes with a selectivity profile that is distinct from those of CGRP and AM. AM2/IMD bound all three ECD complexes but preferred the CGRP and AM(2) receptor complexes. A 2.05 angstrom resolution crystal structure of an AM2/IMD antagonist fragment-bound RAMP1-CLR ECD complex revealed that AM2/IMD binds the complex through a unique triple beta-turn conformation that was confirmed by peptide and receptor mutagenesis. Comparisons of the receptor-bound conformations of AM2/IMD, AM, and a high-affinity CGRP analog revealed differences that may have implications for biased signaling. Guided by the structure, enhanced-affinity AM2/IMD antagonist variants were developed, including one that discriminates the AM(1) and AM(2) receptors with similar to 40-fold difference in affinities and one stabilized by an intramolecular disulfide bond. These results reveal differences in how the three peptides engage the receptors, inform development of AM2/IMD-based pharmacological tools and therapeutics, and provide insights into RAMP modulation of receptor pharmacology.	[Roehrkasse, Amanda M.; Booe, Jason M.; Lee, Sang-Min; Warner, Margaret L.; Pioszak, Augen A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Pioszak, AA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	augen-pioszak@ouhsc.edu		Lee, Sangmin/0000-0002-7262-159X	National Institutes of Health [P20GM103640, DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640, R01GM104251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Debbie Hay for helpful discussions and for sharing plasmids expressing the alanine-substituted full-length CLR and RAMP1 variants. We thank Spencer Anderson for assistance with remote data collection at LS-CAT beamline 21-ID-G of the Advanced Photon Source, Argonne National Laboratory. Use of the crystal-imaging microscope was supported by National Institutes of Health Grant P20GM103640. The Advanced Photon Source is a United States Department of Energy facility operated under Contract DE-AC02-06CH11357. Use of LS-CAT sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Barbash S, 2017, P NATL ACAD SCI USA, V114, P12015, DOI 10.1073/pnas.1713074114; Bell D, 2016, PEPTIDES, V76, P19, DOI 10.1016/j.peptides.2015.12.003; Bell D, 2016, PEPTIDES, V76, P1, DOI 10.1016/j.peptides.2015.12.005; Booe JM, 2018, MOL PHARMACOL, V93, P355, DOI 10.1124/mol.117.110916; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Buhlmann N, 2000, FEBS LETT, V486, P320, DOI 10.1016/S0014-5793(00)02259-6; Chauhan M, 2005, BIOCHEMISTRY-US, V44, P782, DOI 10.1021/bi049153f; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; Duddy WJ, 2004, PROTEIN SCI, V13, P3051, DOI 10.1110/ps.04920904; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flahaut M, 2003, BIOCHEMISTRY-US, V42, P10333, DOI 10.1021/bi0347508; Gujer R, 2001, BIOCHEMISTRY-US, V40, P5392, DOI 10.1021/bi002497v; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hill HE, 2013, PROTEIN EXPRES PURIF, V88, P107, DOI 10.1016/j.pep.2012.11.019; Hirose T, 2011, HYPERTENS RES, V34, P1327, DOI 10.1038/hr.2011.131; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jia YX, 2006, EUR J PHARMACOL, V549, P117, DOI 10.1016/j.ejphar.2006.07.054; Kamitani S, 2001, BBA-MOL CELL RES, V1539, P131, DOI 10.1016/S0167-4889(01)00100-8; Korner C, 2014, PEPTIDES, V62, P49, DOI 10.1016/j.peptides.2014.09.022; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Lee SM, 2017, BIOCHEMISTRY-US, V56, P3380, DOI 10.1021/acs.biochem.7b00256; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Lei SF, 2018, J BIOL CHEM, V293, P9370, DOI 10.1074/jbc.RA118.003278; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Lv Y, 2016, J BIOL CHEM, V291, P23390, DOI 10.1074/jbc.M116.735563; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moad HE, 2013, PROTEIN SCI, V22, P1775, DOI 10.1002/pro.2377; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata S, 2017, DRUG DEVELOP RES, V78, P129, DOI 10.1002/ddr.21383; Nilsson C, 2016, EUR J PHARMACOL, V773, P24, DOI 10.1016/j.ejphar.2016.01.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Takahashi K, 2011, J MOL NEUROSCI, V43, P182, DOI 10.1007/s12031-010-9413-2; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Taylor MM, 2005, BRAIN RES, V1045, P199, DOI 10.1016/j.brainres.2005.03.034; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Wang LJ, 2018, ARTERIOSCL THROM VAS, V38, P398, DOI 10.1161/ATVBAHA.117.310317; Watkins HA, 2013, BRIT J PHARMACOL, V169, P143, DOI 10.1111/bph.12118; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218; Watkins HA, 2012, DRUG DISCOV TODAY, V17, P1006, DOI 10.1016/j.drudis.2012.05.005; Weston C, 2016, J BIOL CHEM, V291, P21925, DOI 10.1074/jbc.M116.751362; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolley MJ, 2017, BIOCHEM PHARMACOL, V142, P96, DOI 10.1016/j.bcp.2017.07.005; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Yang JH, 2009, REGUL PEPTIDES, V158, P19, DOI 10.1016/j.regpep.2009.05.012; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhang SY, 2018, BRIT J PHARMACOL, V175, P1230, DOI 10.1111/bph.13814; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016	62	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15840	15854		10.1074/jbc.RA118.005062	http://dx.doi.org/10.1074/jbc.RA118.005062			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30139742	hybrid, Green Published			2022-12-26	WOS:000447256000008
J	Chiba, Y; Suto, W; Sakai, H				Chiba, Yoshihiko; Suto, Wataru; Sakai, Hiroyasu			Augmented Pla2g4c/Ptgs2/Hpgds axis in bronchial smooth muscle tissues of experimental asthma	PLOS ONE			English	Article							IVC PHOSPHOLIPASE A(2); BETA(2)-ADRENERGIC RECEPTOR DESENSITIZATION; NF-KAPPA-B; AIRWAY HYPERRESPONSIVENESS; TNF-ALPHA; TRANSCRIPTIONAL REGULATION; LUNG INFLAMMATION; CD38 EXPRESSION; CELLS; RELEASE	Rationale Augmented smooth muscle contractility of the airways is one of the causes of airway hyperresponsiveness in asthmatics. However, the mechanism of the altered properties of airway smooth muscle cells is not well understood. Objectives To identify differentially expressed genes (DEGs) related to the bronchial smooth muscle (BSM) hypercontractility in a murine asthma model. Methods The ovalbumin (OA)-sensitized mice were repeatedly challenged with aerosolized OA to induce asthmatic reaction. Transcriptomic profiles were generated by microarray analysis of BSM tissues from the OA-challenged and control animals, and KEGG (Kyoto Encyclopedia of Genes and Genomes) Pathway Analysis was applied. Measurements and main results Tension study showed a BSM hyperresponsiveness to acetylcholine (ACh) in the OA-challenged mice. A total of 770 genes were differentially expressed between the OA-challenged and control animals. Pathway analysis showed a significant change in arachidonic acid (AA) metabolism pathway in BSM tissues of the OA-challenged mice. Validation of DEGs by quantitative RT-PCR showed a significant increase in PLA 2 group 4c (Pla2g4c)/C0X-2 (Ptgs2)/PGD(2) synthase 2 (Hpgds) axis. PGD(2) level in bronchoalveolar fluids of the OAchallenged mice was significantly increased. A 24-h incubation of BSM tissues with PGD(2) caused a hyperresponsiveness to ACh in naive control mice. Conclusions AA metabolism is shifted towards PGD(2) production in BSM tissues of asthma. Increased PGD(2) level in the airways might be a cause of the BSM hyperresponsiveness in asthma.	[Chiba, Yoshihiko; Suto, Wataru] Hoshi Univ, Sch Pharm, Dept Physiol & Mol Sci, Tokyo, Japan; [Sakai, Hiroyasu] Hoshi Univ, Sch Pharm, Dept Analyt Pathophysiol, Tokyo, Japan	Hoshi University; Hoshi University	Chiba, Y (corresponding author), Hoshi Univ, Sch Pharm, Dept Physiol & Mol Sci, Tokyo, Japan.	chiba@hoshi.ac.jp		Chiba, Yoshihiko/0000-0002-7342-4491; Sakai, Hiroyasu/0000-0002-4501-2836	Japan Society for the Promotion of Science (JSPS) [15K08248]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aid for Scientific Research (C) Grant Number 15K08248 (YC) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMOUR CL, 1988, PROSTAGLANDINS, V35, P959, DOI 10.1016/0090-6980(88)90119-0; Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Bickford JS, 2012, BIOCHEM J, V442, P127, DOI 10.1042/BJ20111269; BJORCK T, 1992, AM REV RESPIR DIS, V145, P1087; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Calzetta L, 2014, AM J RESP CELL MOL, V50, P493, DOI 10.1165/rcmb.2013-0119OC; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng Z, 2017, ONCOTARGET, V8, P67933, DOI 10.18632/oncotarget.18913; Chiba Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-4; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; Clarke DL, 2009, PULM PHARMACOL THER, V22, P426, DOI 10.1016/j.pupt.2008.12.003; Comer BS, 2015, AM J RESP CELL MOL, V52, P438, DOI 10.1165/rcmb.2014-0129OC; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; Damera G, 2009, AM J PHYSIOL-LUNG C, V296, pL674, DOI 10.1152/ajplung.90585.2008; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Ishimura Masakazu, 2006, Allergol Int, V55, P403, DOI 10.2332/allergolint.55.403; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jude JA, 2012, AM J RESP CELL MOL, V47, P427, DOI 10.1165/rcmb.2012-0025OC; Jude JA, 2012, AM J PHYSIOL-LUNG C, V303, pL460, DOI 10.1152/ajplung.00041.2012; Kato Y, 1999, J IMMUNOL, V162, P7470; Lambert JA, 2015, AM J PHYSIOL-LUNG C, V309, pL1394, DOI 10.1152/ajplung.00353.2015; Lortie K, 2018, AM J RESP CELL MOL, V58, P79, DOI 10.1165/rcmb.2017-0008OC; Lucas KK, 2004, BBA-MOL CELL BIOL L, V1636, P213, DOI 10.1016/j.bbalip.2003.12.009; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; Martin JG, 2000, EUR RESPIR J, V16, P349, DOI 10.1034/j.1399-3003.2000.16b25.x; Morin C, 2013, CLIN EXP ALLERGY, V43, P1071, DOI 10.1111/cea.12162; Morin C, 2008, AM J RESP CELL MOL, V38, P192, DOI 10.1165/rcmb.2007-0232OC; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Murakami M, 2003, BIOCHEM J, V372, P695, DOI 10.1042/BJ20030061; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; OMINI C, 1986, J AUTON PHARMACOL, V6, P181, DOI 10.1111/j.1474-8673.1986.tb00643.x; Paez-Cortez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074469; Pickard RT, 1999, J BIOL CHEM, V274, P8823, DOI 10.1074/jbc.274.13.8823; Rumzhum NN, 2016, ALLERGY, V71, P387, DOI 10.1111/all.12810; Rumzhum NN, 2016, AM J RESP CELL MOL, V54, P128, DOI 10.1165/rcmb.2014-0443OC; Sanak M, 2016, ALLERGY ASTHMA IMMUN, V8, P481, DOI 10.4168/aair.2016.8.6.481; Santus P, 2016, EXPERT OPIN INV DRUG, V25, P1083, DOI 10.1080/13543784.2016.1212838; Seow CY, 1998, AM J RESP CRIT CARE, V158, pS179, DOI 10.1164/ajrccm.158.supplement_2.13tac160; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Sun MY, 2016, BIOL CHEM, V397, P507, DOI 10.1515/hsz-2015-0298; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Sutcliffe A, 2012, AM J RESP CRIT CARE, V185, P267, DOI 10.1164/rccm.201107-1281OC; Sutcliffe AM, 2009, BRIT J PHARMACOL, V157, P436, DOI 10.1111/j.1476-5381.2009.00143.x; TAMAOKI J, 1987, J APPL PHYSIOL, V63, P1396, DOI 10.1152/jappl.1987.63.4.1396; TAMAOKI J, 1993, PROSTAGLANDINS, V45, P363, DOI 10.1016/0090-6980(93)90113-L; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Underwood KW, 1998, J BIOL CHEM, V273, P21926, DOI 10.1074/jbc.273.34.21926; Vanaudenaerde BM, 2007, AM J TRANSPLANT, V7, P76, DOI 10.1111/j.1600-6143.2006.01586.x; Yamabayashi C, 2012, AM J RESP CELL MOL, V47, P170, DOI 10.1165/rcmb.2011-0350OC; Zaslona Z, 2015, CHEST, V148, P1300, DOI 10.1378/chest.15-1029; Zhou WS, 2016, J IMMUNOL, V197, P1577, DOI 10.4049/jimmunol.1501063	54	9	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202623	10.1371/journal.pone.0202623	http://dx.doi.org/10.1371/journal.pone.0202623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161143	gold, Green Submitted, Green Published			2022-12-26	WOS:000443388900034
J	Malfacini, D; Simon, K; Trapella, C; Guerrini, R; Zaveri, NT; Kostenis, E; Calo, G				Malfacini, Davide; Simon, Katharina; Trapella, Claudio; Guerrini, Remo; Zaveri, Nurulain T.; Kostenis, Evi; Calo, Girolamo			NOP receptor pharmacological profile - A dynamic mass redistribution study	PLOS ONE			English	Article							NOCICEPTIN/ORPHANIN FQ RECEPTOR; PROTEIN-COUPLED RECEPTOR; LABEL-FREE; IN-VITRO; OPIOID RECEPTOR; ORL1 RECEPTOR; SELECTIVE ANTAGONIST; BINDING REGION; HIGH-AFFINITY; LIVING CELLS	The Nociceptin/Orphanin FQ (N/OFQ) peptide NOP receptor is coupled to pertussis toxin (PTX)-sensitive G proteins (G(i/o)) whose activation leads to the inhibition of both cAMP production and calcium channel activity, and to the stimulation of potassium currents. The label free dynamic mass redistribution (DMR) approach has been demonstrated useful for investigating the pharmacological profile of G protein-coupled receptors. Herein, we employ DMR technology to systematically characterize the pharmacology of a large panel of NOP receptor ligands. These are of peptide and non-peptide nature and display varying degrees of receptor efficacy, ranging from full agonism to pure antagonism. Using Chinese hamster ovary (CHO) cells expressing the human NOP receptor we provide rank orders of potency for full and partial agonists as well as apparent affinities for selective antagonists. We find the pharmacological profile of NOP receptor ligands to be similar but not identical to values reported in the literature using canonical assays for G(i/o)-coupled receptors. Our data demonstrate that holistic label-free DMR detection can be successfully used to investigate the pharmacology of the NOP receptor and to characterize the cellular effects of novel NOP receptor ligands.	[Malfacini, Davide; Simon, Katharina; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Sect Pharmacol, Dept Med Sci, Ferrara, Italy; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Natl Inst Neurosci, Ferrara, Italy; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, LTTA, Ferrara, Italy; [Zaveri, Nurulain T.] Astraea Therapeut LLC, Mountain View, CA USA	University of Bonn; University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Malfacini, D (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany.; Malfacini, D (corresponding author), Univ Ferrara, Sect Pharmacol, Dept Med Sci, Ferrara, Italy.; Malfacini, D (corresponding author), Univ Ferrara, Natl Inst Neurosci, Ferrara, Italy.	dmalfaci@uni-bonn.de	Trapella, Claudio/I-2128-2012	Trapella, Claudio/0000-0002-6666-143X; Malfacini, Davide/0000-0003-4562-9550	5x1000 Giovani Ricercatori (University of Ferrara, IT); German Academic Exchange Service (DAAD) Short-Term Grants, 2015; FAR grant	5x1000 Giovani Ricercatori (University of Ferrara, IT); German Academic Exchange Service (DAAD) Short-Term Grants, 2015; FAR grant	This work was supported by 5x1000 Giovani Ricercatori (University of Ferrara, IT) and German Academic Exchange Service (DAAD) Short-Term Grants, 2015 to DM. Both funders provided support in the form of salary for DM. This work was also supported by a FAR grant to GC (University of Ferrara, IT). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2016, METHODS, V92, P64, DOI 10.1016/j.ymeth.2015.08.018; Bes B, 2003, BIOCHEM BIOPH RES CO, V310, P992, DOI 10.1016/j.bbrc.2003.09.113; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; Calo G, 1998, BRIT J PHARMACOL, V125, P373, DOI 10.1038/sj.bjp.0702087; Calo' G, 2000, BRIT J PHARMACOL, V129, P1183, DOI 10.1038/sj.bjp.0703169; Calo G, 2018, PEPTIDES, V99, P195, DOI 10.1016/j.peptides.2017.10.004; Calo' G, 2013, ACS SYM SER, V1131, P275; Camarda V, 2009, N-S ARCH PHARMACOL, V379, P599, DOI 10.1007/s00210-009-0396-x; Carter RL, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.24; Chan JSC, 1998, J NEUROCHEM, V71, P2203; Chang SD, 2015, MOL PHARMACOL, V88, P502, DOI 10.1124/mol.115.099150; Christensen HB, 2017, J PHARMACOL TOX MET, V88, P72, DOI 10.1016/j.vascn.2017.07.003; Deng HY, 2013, J PHARMACOL TOX MET, V68, P323, DOI 10.1016/j.vascn.2013.07.005; Dooley CT, 1997, J PHARMACOL EXP THER, V283, P735; Eichel K, 2018, NATURE, V557, P381, DOI 10.1038/s41586-018-0079-1; Fang Y, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-24; Ferrari F, 2016, EUR J PHARMACOL, V793, P1, DOI 10.1016/j.ejphar.2016.10.025; Ferrie AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00033; Gestwicki JE, 2002, J AM CHEM SOC, V124, P14922, DOI 10.1021/ja027184x; Goto Y, 2006, J MED CHEM, V49, P847, DOI 10.1021/jm0509851; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Grundmann M, 2015, METHODS MOL BIOL, V1272, P199, DOI 10.1007/978-1-4939-2336-6_14; Guerrini R, 1997, J MED CHEM, V40, P1789, DOI 10.1021/jm970011b; Guerrini R, 1998, BRIT J PHARMACOL, V123, P163, DOI 10.1038/sj.bjp.0701640; Guerrini R, 2014, BIOORGAN MED CHEM, V22, P3703, DOI 10.1016/j.bmc.2014.05.005; Homberg JR, 2009, NEUROSCIENCE, V163, P308, DOI 10.1016/j.neuroscience.2009.06.021; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P81, DOI 10.1016/B978-0-12-374585-9.00005-0; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lee MY, 2014, ASSAY DRUG DEV TECHN, V12, P361, DOI 10.1089/adt.2014.590; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Lieb S, 2016, PHARMACOL RES, V114, P13, DOI 10.1016/j.phrs.2016.10.010; Lieb S, 2016, PHARMACOL RES, V108, P65, DOI 10.1016/j.phrs.2016.04.026; Madeddu P, 1999, HYPERTENSION, V33, P914, DOI 10.1161/01.HYP.33.3.914; Mahmoud S, 2010, MOL PHARMACOL, V77, P804, DOI 10.1124/mol.109.062208; Malfacini D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132865; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Marti M, 2013, BRIT J PHARMACOL, V168, P863, DOI 10.1111/j.1476-5381.2012.02219.x; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Miller RL, 2015, STRUCTURE, V23, P2291, DOI 10.1016/j.str.2015.07.024; Morse M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-17; Morse M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025643; Mouledous L, 2000, J BIOL CHEM, V275, P29268, DOI 10.1074/jbc.M004971200; Mustazza C, 2011, MED RES REV, V31, P605, DOI 10.1002/med.20197; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nishi M, 1997, EMBO J, V16, P1858, DOI 10.1093/emboj/16.8.1858; Okada K, 2000, BIOCHEM BIOPH RES CO, V278, P493, DOI 10.1006/bbrc.2000.3822; Ozaki S, 2000, EUR J PHARMACOL, V402, P45, DOI 10.1016/S0014-2999(00)00520-3; Ozawa A, 2015, J NEUROSCI, V35, P11682, DOI 10.1523/JNEUROSCI.5122-14.2015; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rizzi A, 2015, BRIT J PHARMACOL, V172, P3661, DOI 10.1111/bph.13150; Rizzi A, 2014, BRIT J PHARMACOL, V171, P4138, DOI 10.1111/bph.12799; Rizzi A, 1999, EUR J PHARMACOL, V385, pR3, DOI 10.1016/S0014-2999(99)00730-X; Rizzi A, 2001, N-S ARCH PHARMACOL, V363, P161, DOI 10.1007/s002100000358; Rizzi A, 2007, PEPTIDES, V28, P1240, DOI 10.1016/j.peptides.2007.04.020; Rover S, 2000, J MED CHEM, V43, P1329, DOI 10.1021/jm991129q; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Spagnolo B, 2007, J PHARMACOL EXP THER, V321, P961, DOI 10.1124/jpet.106.116764; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Tang WW, 2017, RSC ADV, V7, P43005, DOI 10.1039/c7ra07927c; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Toll L, 2016, PHARMACOL REV, V68, P419, DOI 10.1124/pr.114.009209; Tran E, 2012, ASSAY DRUG DEV TECHN, V10, P37, DOI 10.1089/adt.2011.0392; Trapella C, 2009, BIOORGAN MED CHEM, V17, P5080, DOI 10.1016/j.bmc.2009.05.068; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Witkin JM, 2014, PHARMACOL THERAPEUT, V141, P283, DOI 10.1016/j.pharmthera.2013.10.011; Yung LY, 1999, J PHARMACOL EXP THER, V288, P232; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848; Zaveri NT, 2016, J MED CHEM, V59, P7011, DOI 10.1021/acs.jmedchem.5b01499	74	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203021	10.1371/journal.pone.0203021	http://dx.doi.org/10.1371/journal.pone.0203021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161182	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900068
J	Trevisi, P; Priori, D; Jansman, AJM; Luise, D; Koopmans, SJ; Hynonen, U; Palva, A; Van Der Meulen, J; Bosi, P				Trevisi, Paolo; Priori, Davide; Jansman, Alfons J. M.; Luise, Diana; Koopmans, Sietse-Jan; Hynonen, Ulla; Palva, Airi; Van Der Meulen, Jan; Bosi, Paolo			Molecular networks affected by neonatal microbial colonization in porcine jejunum, luminally perfused with enterotoxigenic Escherichia coli, F4ac fimbria or Lactobacillus amylovorus	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; VANIN INHIBITORS; BARRIER FUNCTION; DENDRITIC CELLS; REGIII-GAMMA; WEANED PIGS; PIGLETS; GUT; EXPRESSION; INFECTION	The development of an early complex gut microbiota may play an important role in the protection against intestinal dysbiosis later in life. The significance of the developed microbiota for gut barrier functionality upon interaction with pathogenic or beneficial bacteria is largely unknown. The transcriptome of differently perfused jejunal loops of 12 caesarian-derived pigs, neonatally associated with microbiota of different complexity, was studied. Piglets received pasteurized sow colostrum at birth (d0), a starter microbiota (Lactobacillus amylovorus (LAM), Clostridium glycolicum, and Parabacteroides) on d1-d3, and a placebo inoculant (simple association, SA) or an inoculant consisting of sow's diluted feces (complex association, CA) on d3-d4. On d 26-37, jejunal loops were perfused for 8 h with either enterotoxigenic Escherichia coli F4 (ETEC), purified F4 fimbriae, LAM or saline control (CTRL). Gene expression of each intestinal loop was analyzed by Affymetrix Porcine Gene 1.1_ST array strips. Gene Set Enrichment Analysis was performed on expression values. Compared to CTRL, 184 and 74; 2 and 139; 2 and 48 gene sets, were up- and down-regulated by ETEC, F4 and LAM, respectively. ETEC up-regulated networks related to inflammatory and immune responses, RNA processing, and mitosis. There was a limited overlap in up-regulated gene sets between ETEC and F4 fimbriae. LAM down-regulated genes related to inflammatory and immune responses, as well as to cellular compound metabolism. In CA pigs, 57 gene sets were up-regulated by CA, while 73 were down-regulated compared to SA. CA up-regulated gene sets related to lymphocyte modulation and to cellular defense in all loop perfusions. In CA pigs, compared to SA pigs, genes for chemokine and cytokine activity and for response to external stimuli were down-regulated in ETEC-perfused loops and up-regulated in CTRL. The results highlight the importance of the nature of neonatal microbial colonization in the response to microbial stimuli later in life.	[Trevisi, Paolo; Priori, Davide; Luise, Diana; Bosi, Paolo] Univ Bologna, DISTAL, Bologna, Italy; [Jansman, Alfons J. M.; Koopmans, Sietse-Jan; Van Der Meulen, Jan] Wageningen UR Livestock Res, Wageningen, Netherlands; [Hynonen, Ulla; Palva, Airi] Univ Helsinki, Dept Vet Biosci, Div Microbiol & Epidemiol, Helsinki, Finland	University of Bologna; Wageningen University & Research; University of Helsinki	Bosi, P (corresponding author), Univ Bologna, DISTAL, Bologna, Italy.	paolo.bosi@unibo.it	Luise, Diana/AAR-6903-2020	van der Meulen, Jan/0000-0002-9451-2335; Hynonen, Ulla/0000-0002-2002-7804; BOSI, PAOLO/0000-0002-0755-8002; Luise, Diana/0000-0001-7864-7822	European Union [227549]	European Union(European Commission)	This research was funded by the European Union, Interplay project, Grant agreement no. 227549. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekiaris V, 2014, IMMUNOL REV, V260, P86, DOI 10.1111/imr.12194; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Canani RB, 2011, CURR OPIN GASTROEN, V27, P8, DOI 10.1097/MOG.0b013e32833fd48a; Danabassis MS, 2006, THESIS; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; Elizondo-Salazar JA, 2009, J DAIRY SCI, V92, P4565, DOI 10.3168/jds.2009-2188; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ghose Romi, 2004, Nucl Recept, V2, P4, DOI 10.1186/1478-1336-2-4; Goc J, 2015, INT IMMUNOL; Godden S, 2006, J DAIRY SCI, V89, P3476, DOI 10.3168/jds.S0022-0302(06)72386-4; Gronke K, 2015, NATURE, V528, P488, DOI 10.1038/nature16325; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; HOWELL S, 1992, BIOCHEM J, V284, P595, DOI 10.1042/bj2840595; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jansen PAM, 2013, ANTIMICROB AGENTS CH, V57, P4794, DOI 10.1128/AAC.00603-13; Jansen PAM, 2013, ACS CHEM BIOL, V8, P530, DOI 10.1021/cb3006424; Jansman AJM, 2012, J ANIM SCI, V90, P433, DOI 10.2527/jas.53850; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaskow BJ, 2012, BIOCHEM BIOPH RES CO, V417, P653, DOI 10.1016/j.bbrc.2011.11.099; Kiers JL, 2006, RES VET SCI, V81, P274, DOI 10.1016/j.rvsc.2005.12.007; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Konstantinov SR, 2008, FEMS MICROBIOL ECOL, V66, P599, DOI 10.1111/j.1574-6941.2008.00517.x; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; Koopmans SJ, 2016, 41 ANIMAL NUTR RES F, P16; Kraan CTMV, 2012, HUM IMMUNOL, V73, P912, DOI 10.1016/j.humimm.2012.06.004; Kumar A, 2014, AM J PHYSIOL-CELL PH, V307, pC1084, DOI 10.1152/ajpcell.00194.2014; Lalles JP, 2011, J ANIM PHYSIOL AN N, V95, P478, DOI 10.1111/j.1439-0396.2010.01075.x; Laycock G, 2012, VET IMMUNOL IMMUNOP, V149, P216, DOI 10.1016/j.vetimm.2012.07.004; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Loos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041041; Luo Y, 2015, VET RES, V46, DOI 10.1186/s13567-015-0264-2; NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F; Niewold TA, 2005, VET IMMUNOL IMMUNOP, V105, P317, DOI 10.1016/j.vetimm.2005.02.010; Niewold TA, 2010, VET MICROBIOL, V141, P110, DOI 10.1016/j.vetmic.2009.08.014; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Orrhage K, 1999, ACTA PAEDIATR, V88, P47; Oshida K, 2015, NUCL RECEPTOR SIGNAL, V13; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Priori D, 2016, J ANIM SCI, V94, P592, DOI 10.2527/jas.2015-9948; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016; Rothkotter HJ, 1999, SCAND J IMMUNOL, V50, P31; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Snoeck V, 2008, VET IMMUNOL IMMUNOP, V124, P29, DOI 10.1016/j.vetimm.2006.10.014; Soler L, 2015, VET IMMUNOL IMMUNOP, V167, P51, DOI 10.1016/j.vetimm.2015.07.006; Trevisi P, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0213-1; Trevisi P, 2017, ITAL J ANIM SCI, V16, P101, DOI 10.1080/1828051X.2016.1260499; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780	53	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202160	10.1371/journal.pone.0202160	http://dx.doi.org/10.1371/journal.pone.0202160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161141	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900022
J	Amnie, AG				Amnie, Asrat Genet			An impact evaluation of two rounds of mass drug administration on the prevalence of active trachoma: A clustered cross sectional survey	PLOS ONE			English	Article							NIGERIA	Introduction We investigated the impact of two round of mass drug administration on trachoma prevalence in Plateau and Nasarawa States of Nigeria. The mass drug administration was conducted as a component of the SAFE Strategy, a combination of interventions recommended for the global elimination of blinding trachoma. Methods The study consisted of a two-stage cross-sectional clustered sample survey in which 3990 people from 793 households were screened for clinical signs of trachoma. Results Of the total 3990 people examined, 1530 were children, of which 808 (53%) were boys and 704 (47%) were girls. The impact of intervention as measured by the changes in overall prevalence of follicular trachoma were as follows: At baseline the overall prevalence of follicular trachoma among children 1 +/- 9 years of age was 6.4%, 95% CI [5.8, 7.0]; the overall prevalence of trachomatous trichiasis in the total population was 0.20%, 95% CI [0.16, 0.25]. At follow up, the overall prevalence of follicular trachoma among children 1 +/- 9 years of age was 3.4%, 95% CI [1.9, 4.9]; the overall prevalence of trachomatous trichiasis in the total population was 0.20%, 95% CI [0.00, 0.05]. The highest statistically significant reduction (96%) in follicular trachoma prevalence was observed in Doma Local Government Area of Nasarawa State from baseline prevalence of 13.6%, 95% CI [9.7, 17.5] to follow-up prevalence of 0.5%, 95% CI [0.0, 1.5] and the lowest reduction (58%) in follicular trachoma prevalence was observed in Langtang North Local Government Area of Plateau State from baseline prevalence of 15.8%, 95% CI [9.3, 22.3] to 6.6%, 95% CI [1.6, 11.6], (p< 0.05). Conclusion A significant reduction in the overall prevalence of follicular trachoma was achieved after two rounds of mass drug administration. In the absence of significant activities pertaining to facial cleanliness and environmental sanitation components of the SAFE strategy in the intervention areas, the observed deep reductions in prevalence could mainly be attributed to mass drug administration. Therefore, two rounds of mass azithromycin administration may be as effective as guideline-recommended three or more rounds in reducing active trachoma prevalence but findings should be replicated in more robustly designed studies.	[Amnie, Asrat Genet] CUNY, Eugenio Maria de Hostos Community Coll, Dept Educ, Hlth Educ Unit, New York, NY 10021 USA	City University of New York (CUNY) System	Amnie, AG (corresponding author), CUNY, Eugenio Maria de Hostos Community Coll, Dept Educ, Hlth Educ Unit, New York, NY 10021 USA.	aamnie@hostos.cuny.edu						[Anonymous], 2013, SAS COMP PROGR VERS; [Anonymous], 2013, MICROSOFT EXCEL; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Emerson PM, 2006, B WORLD HEALTH ORGAN, V84, P613, DOI 10.2471/BLT.05.28696; Hopkins DR, 2008, ANN NY ACAD SCI, V1136, P45, DOI 10.1196/annals.1425.015; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001600; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x; King JD, 2010, BRIT J OPHTHALMOL, V94, P14, DOI 10.1136/bjo.2009.165282; King JD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002732; Kyari F, 2009, INVEST OPHTH VIS SCI, V50, P2033, DOI 10.1167/iovs.08-3133; Mariotti SP, 2008, BRIT J OPHTHALMOLOGY; Mathew AA, 2009, DRUGS, V69, P953, DOI 10.2165/00003495-200969080-00002; Means AR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005085; Ngondi J, 2008, T ROY SOC TROP MED H, V102, P432, DOI 10.1016/j.trstmh.2008.02.014; Oswald .WE, 2017, B WORLD HEALTH ORGAN, V95, P250, DOI [10.2471/BLT.16.177758, 10.2471/blt.16.177758]; Rabiu M, 2012, COCHRANE LIB, DOI [10.1002/14651858.CD010274, DOI 10.1002/14651858.CD010274]; Rabiu MM, 2011, MIDDLE EAST AFR J OP, V18, P115, DOI 10.4103/0974-9233.80699; Roba AA, 2011, J EPIDEMIOL COMMUN H, V65, P626, DOI 10.1136/jech.2009.094763; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; The Carter Center, 2010, SUMM P 11 ANN TRACH; The World Health Organization, 2006, TRACH CONTR GUID PRO, P34; WHO, 2016, GUID TREATM CHLAM TR; World Health Organization, 2008, HUM RES HLTH COUNTR; World Health Organization, 2008, PREV BLINDN VIS IMP	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201911	10.1371/journal.pone.0201911	http://dx.doi.org/10.1371/journal.pone.0201911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157193	Green Published, gold			2022-12-26	WOS:000443071400019
J	Brun, C; Gagne, M; McCabe, CS; Mercier, C				Brun, Clementine; Gagne, Martin; McCabe, Candida S.; Mercier, Catherine			Motor and sensory disturbances induced by sensorimotor conflicts during passive and active movements in healthy participants	PLOS ONE			English	Article							ONE ARM; VISUAL FEEDBACK; INCONGRUENCE; SYMPTOMS; POSITION; DISPLACEMENT; INFORMATION; INTEGRATION; VOLUNTEERS; PERCEPTION	Sensorimotor conflict induces both sensory and motor disturbances, but the specific factors playing a role in conflict-induced disturbances are still misunderstood. For example, we still do not know the role played by motor intention (vs. a purely visuo-proprioceptive conflict) or the influence of specific types of incongruent visual feedback. The objective of this study was threefold: 1- to compare the effect of passive and active movement during sensorimotor conflict on sensory disturbances measured with a questionnaire; 2- to compare the effect of three incongruent visual feedback conditions on sensory and motor (mediolateral drift and movement amplitude) disturbances; 3- to test whether conflict-induced sensory and motor disturbances were stable over time. 20 healthy participants realized active or passive cyclic upper limb movements while viewing either congruent or incongruent visual feedback about their movement using a robotized exoskeleton combined with 2D virtual reality interface. First, results showed that in condition of conflict, participants reported higher sensory disturbances during active movements compared to passive movements (p = 0.034), suggesting that the efference copy reinforces the conflict between vision and proprioception. Second, the three conditions of incongruence in the active condition induced similar sensory (all p>0.45) and motor disturbances (medio-lateral drift: all p>0.59 and amplitude: all p>0.25), suggesting that conflict induced motor disturbances could be related more to the observation of another movement rather than to a detection of conflict between motor intention and sensory feedback. Finally, both sensory and motor disturbances were stable over time (all ICCs between 0.76 and 0.87), demonstrating low variability within participants. Overall, our results suggest that the efference copy is more involved in sensory disturbances than in motor disturbances, suggesting that they might rely on independent processes.	[Brun, Clementine; Gagne, Martin; Mercier, Catherine] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Brun, Clementine; Mercier, Catherine] Laval Univ, Dept Rehabil, Quebec City, PQ, Canada; [McCabe, Candida S.] Royal United Hosp NHS Fdn Trust, Bath, Avon, England; [McCabe, Candida S.] Univ West England, Bristol, Avon, England; [McCabe, Candida S.] Florence Nightingale Fdn, London, England	Laval University; Laval University; University of West England	Mercier, C (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Mercier, C (corresponding author), Laval Univ, Dept Rehabil, Quebec City, PQ, Canada.	Catherine.mercier@rea.ulaval.ca		Mercier, Catherine/0000-0002-2037-6916	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 355896-2012]; Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS); Centre thematique de recherche en neurosciences (CTRN); Faculte de medecine de l'Universite Laval; Fonds de Recherche Quebec - Nature et Technologies (FRQNT); Fonds de recherche Quebec-Sante (FRQS) [29251]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS); Centre thematique de recherche en neurosciences (CTRN); Faculte de medecine de l'Universite Laval; Fonds de Recherche Quebec - Nature et Technologies (FRQNT); Fonds de recherche Quebec-Sante (FRQS)	We thank Nicolas Robitaille, eng. Ph.D. for his help in the development of the task and technical support. This study was supported by a Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC, RGPIN 355896-2012, www.nserc-crsng.gc.ca). C. Brun was supported by fellowships from Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS, www.cirris.ulaval.ca), from Centre thematique de recherche en neurosciences (CTRN, www.neuro.ulaval.ca), from the Faculte de medecine de l'Universite Laval (www.fmed.ulaval.ca) and from the Fonds de Recherche Quebec - Nature et Technologies (FRQNT, www.frqnt.gouv.qc.ca). C. Mercier is supported by a salary award from Fonds de recherche Quebec-Sante (FRQS, no. 29251, www.frqs.gouv.qc.ca).	Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; Brun C, 2015, NEUROSCIENCE, V310, P268, DOI 10.1016/j.neuroscience.2015.09.052; Brun C, 2015, NEUROSCIENCE, V285, P343, DOI 10.1016/j.neuroscience.2014.11.036; Brun C, SENSORY DISTUR UNPUB; Brun C, 2017, FRONT INTEGR NEUROSC, V11, P1, DOI [10.3389/fnint.2017.00001, DOI 10.3389/FNINT.2017.00001]; Chancel M, 2016, EXP BRAIN RES, V234, P1, DOI [10.1007/s00221-015-4432-4, DOI 10.1007/S00221-015-4432-4]; Coslett HB, 2008, BEHAV NEUROL, V19, P117, DOI 10.1155/2008/972542; Daenen L, 2012, PAIN PHYSICIAN, V15, P405; Daenen L, 2012, RHEUMATOLOGY, V51, P1492, DOI 10.1093/rheumatology/kes050; Daenen L, 2010, RHEUMATOLOGY, V49, P1281, DOI 10.1093/rheumatology/keq067; De Kooning M, 2017, PAIN PRACT, V17, P156, DOI 10.1111/papr.12439; Don S, 2017, PAIN PRACT, V17, P115, DOI 10.1111/papr.12456; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Foell J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00310; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Gullaud-Toussaint L, 2003, PSYCHOL RES-PSYCH FO, V67, P291, DOI 10.1007/s00426-002-0129-y; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Howell DC, 2008, FUNDAMENTALS STAT BE; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; Katayama O, 2016, J PAIN RES, V9, P1197, DOI 10.2147/JPR.S122564; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; LAJOIE Y, 1992, NEUROLOGY, V42, P1104, DOI 10.1212/WNL.42.5.1104; Laufer Y, 2001, Physiother Res Int, V6, P65, DOI 10.1002/pri.215; McCabe CS, 2007, RHEUMATOLOGY, V46, P1587, DOI 10.1093/rheumatology/kem204; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; McCabe CS, 2000, LANCET, V355, P318, DOI 10.1016/S0140-6736(05)72316-3; Metral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080360; Miall RC, 2007, EXP BRAIN RES, V176, P432, DOI 10.1007/s00221-006-0626-0; Moseley GL, 2006, RHEUMATOLOGY, V45, P196, DOI 10.1093/rheumatology/kei119; Roussel NA, 2015, MOTOR CONTROL, V19, P271, DOI 10.1123/ijsnem.2013-0074; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203206	10.1371/journal.pone.0203206	http://dx.doi.org/10.1371/journal.pone.0203206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157264	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400100
J	Hunt, EA; Evans, TC; Tanner, NA				Hunt, Eric A.; Evans, Thomas C., Jr.; Tanner, Nathan A.			Single-stranded binding proteins and helicase enhance the activity of prokaryotic argonautes in vitro	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; DEPENDENT AMPLIFICATION; BACTERIAL ARGONAUTE; SILENCING COMPLEX; DEFENSE SYSTEMS; SLICER ACTIVITY; PIWI PROTEIN; GUIDE-DNA; RNA	Prokaryotic argonautes are a unique class of nucleic acid-guided endonucleases putatively involved in cellular defense against foreign genetic elements. While their eukaryotic homologs and Cas protein counterparts require single-stranded RNAs as guides, some prokaryotic argonautes are able to utilize short single-stranded DNAs as guides for sequence-specific endonuclease activity. Many complications currently prevent the use of prokaryotic argonautes for in vivo gene-editing applications; however, they do exhibit potential as a new class of in vitro molecular tools if certain challenges can be overcome, specifically the limitations on substrate accessibility which leads to unequal levels of activity across a broad palate of substrates and the inability to act on double-stranded DNA substrates. Here we demonstrate the use of accessory factors, including thermostable single-stranded DNA binding proteins and UvrD-like helicase, in conjunction with prokaryotic argonautes to significantly improve enzymatic activity and enable functionality with a broader range of substrates, including linear double-stranded DNA substrates. We also demonstrate the use of Thermus thermophilus argonaute with accessory factors as a programmable restriction enzyme to generate long, unique single-stranded overhangs from linear double-stranded substrates compatible with downstream ligation.	[Hunt, Eric A.; Evans, Thomas C., Jr.; Tanner, Nathan A.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Tanner, NA (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	tanner@neb.com		Hunt, Eric/0000-0002-6891-8294	New England Biolabs, Inc.; New England Biolabs	New England Biolabs, Inc.; New England Biolabs	This project was funded internally by New England Biolabs, Inc. (http://www.neb.com). Eric A. Hunt, Thomas C. Evans Jr., and Nathan A. Tanner are employees of New England Biolabs, a manufacturer and vendor of molecular biology reagents. All authors were employees of New England Biolabs at the time the work was performed. New England Biolabs funded the work and paid the salaries of all authors. Members of New England Biolabs is not on the author list had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Azlan A, 2016, J GENET GENOMICS, V43, P481, DOI 10.1016/j.jgg.2016.06.002; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Enghiad B, 2017, ACS SYNTH BIOL, V6, P752, DOI 10.1021/acssynbio.6b00324; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Goldmeyer J, 2007, J MOL DIAGN, V9, P639, DOI 10.2353/jmoldx.2007.070012; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Greenough L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv899; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hegge JW, 2017, NAT REV MICROBIOL, V434, P356; Hiramatsu Y, 1997, GENE, V199, P77, DOI 10.1016/S0378-1119(97)00349-1; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Javidi-Parsijani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177444; Jeon JH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.208101; Klein M, 2017, SEMIN CELL DEV BIOL, V65, P20, DOI 10.1016/j.semcdb.2016.05.017; Koonin EV, 2017, ANNU REV MICROBIOL, V71, P233, DOI 10.1146/annurev-micro-090816-093830; Koonin EV, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0177-2; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lapinaite A, 2018, P NATL ACAD SCI USA, V115, P3368, DOI 10.1073/pnas.1717725115; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; LILLEY DMJ, 1988, TRENDS GENET, V4, P111, DOI 10.1016/0168-9525(88)90099-6; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Meyer R, 1990, MICROBIOL REV; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Olszewski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126563; OSHIMA RG, 1992, BIOTECHNIQUES, V13, P188; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rapley Ralph, 1994, Molecular Biotechnology, V2, P295, DOI 10.1007/BF02745882; Richard DJ, 2004, NUCLEIC ACIDS RES, V32, P1065, DOI 10.1093/nar/gkh259; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Sheu-Gruttadauria J, 2017, J MOL BIOL, V429, P2619, DOI 10.1016/j.jmb.2017.07.018; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sunghyeok Y, 2017, DNA DEPENDENT RNA CL; Swarts DC, 2017, MOL CELL, V65, P985, DOI 10.1016/j.molcel.2017.01.033; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124880; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tanner NA, REDUCING TEMPLATE IN; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Tsai Y, 2017, AMPLIFICATION FREE C; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Willkomm S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.35; Willkomm Sarah, 2015, Life-Basel, V5, P538, DOI 10.3390/life5010538; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zander A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.34; Zhang JC, 2014, NUCLEIC ACIDS RES, V42, P3821, DOI 10.1093/nar/gkt1316; Zhang YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09063-x; Zhu LZ, 2017, PROG BIOPHYS MOL BIO, V128, P39, DOI 10.1016/j.pbiomolbio.2016.09.008; Zhu LZ, 2016, J PHYS CHEM B, V120, P2709, DOI 10.1021/acs.jpcb.5b12426	64	10	12	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203073	10.1371/journal.pone.0203073	http://dx.doi.org/10.1371/journal.pone.0203073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157272	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400086
J	Marchenkov, AM; Petrova, DP; Morozov, AA; Zakharova, YR; Grachev, MA; Bondar, AA				Marchenkov, Artyom M.; Petrova, Darya P.; Morozov, Alexey A.; Zakharova, Yulia R.; Grachev, Michael A.; Bondar, Alexander A.			A family of silicon transporter structural genes in a pennate diatom Synedra ulna subsp danica (Kutz.) Skabitsch	PLOS ONE			English	Article							GENOME; ACUS; DATABASE; PROTEIN; MARINE; CYCLE	Silicon transporters (SIT) are the proteins, which capture silicic acid in the aquatic environment and direct it across the plasmalemma to the cytoplasm of diatoms. Diatoms utilize silicic acid to build species-specific ornamented exoskeletons and make a significant contribution to the global silica cycle, estimated at 240 +/- 40 Tmol a year. Recently SaSIT genes of the freshwater araphid pennate diatom Synedra acus subsp. radians are found to be present in the genome as a cluster of two structural genes (SaSIT-TD and SaSIT-TRI) encoding several concatenated copies of a SIT protein each. These structural genes could potentially be transformed into "mature" SIT proteins by means of posttranslational proteolytic cleavage. In the present study, we discovered three similar structural SuSIT genes in the genome of a closely related freshwater diatom Synedra ulna subsp. danica. Structural gene SuSIT1 is identical to structural gene SuSIT2, and the two are connected by a non-coding nucleotide DNA sequence. All the putative "mature" SITs contain conserved amino acid motifs, which are believed to be important in silicon transport. The data obtained suggest that the predicted "mature" SIT proteins may be the minimal units necessary for the transport of silicon is S. ulna subsp. danica. The comparative analysis of all available multi-SITs has allowed us to detect two conservative motifs YQXDXVYL and DXDID, located between the "mature" proteins. Aspartic acid-rich DXDID motif can, in our opinion, serve as a proteolysis site during the multi-SIT cleavage. The narrow distribution of the distances between CMLD and DXDID motifs can serve as additional evidence to the conservation of their function.	[Marchenkov, Artyom M.; Petrova, Darya P.; Morozov, Alexey A.; Zakharova, Yulia R.; Grachev, Michael A.] Russian Acad Sci, Limnol Inst, Dept Cell Ultrastruct, Siberian Branch, Irkutsk, Russia; [Bondar, Alexander A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Genom Core Facil, Siberian Branch, Novosibirsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Petrova, DP (corresponding author), Russian Acad Sci, Limnol Inst, Dept Cell Ultrastruct, Siberian Branch, Irkutsk, Russia.	daryapetr@lin.irk.ru	Morozov, Alexey Anatolievich/J-4630-2018; Bondar, Alexander/AAA-7087-2020; Marchenkov, Artyom M/J-4652-2018	Morozov, Alexey Anatolievich/0000-0003-1925-0045; Bondar, Alexander/0000-0001-9181-0487; Marchenkov, Artyom M/0000-0002-4820-9394	FASO Russia [0345-2015-0031, AAAA-A15-115122810221-8, 0345-2016-0005, AAAA-A16-116122110068-5]	FASO Russia	This study was supported by government projects (FASO Russia) "Molecular and Cell Biology" (0345-2015-0031, state registration No AAAA-A15-115122810221-8) (MAG) and (FASO Russia) "Experimental studies of genomes and proteomes" (0345-2016-0005, state registration No AAAA-A16-116122110068-5) (MAG).	Alverson AJ, 2007, LIMNOL OCEANOGR, V52, P1420, DOI 10.4319/lo.2007.52.4.1420; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Basu S, 2017, NEW PHYTOL, V215, P140, DOI 10.1111/nph.14557; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bukhtiyarova L. N., 2006, ALGOLOGIA, V16, P280; Carlisle E.M., 1981, P69; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Durak GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10543; Durkin CA, 2012, LIMNOL OCEANOGR, V57, P1619, DOI 10.4319/lo.2012.57.6.1619; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frings PJ, 2016, CHEM GEOL, V425, P12, DOI 10.1016/j.chemgeo.2016.01.020; Galachyants YP, 2015, DOKL BIOCHEM BIOPHYS, V461, P84, DOI 10.1134/S1607672915020064; Grachev MA, 2002, MOL BIOL+, V36, P534, DOI 10.1023/A:1019860628910; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hastings PJ, 2010, GENES-BASEL, V1, P427, DOI 10.3390/genes1030427; Hildebrand M, 2003, PROG ORG COAT, V47, P256, DOI 10.1016/S0300-9440(03)00142-5; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iler, 1979, CHEM SILICA SOLUBILI; JACOBS JD, 1992, MOL GEN GENET, V233, P302, DOI 10.1007/BF00587592; Kang LK, 2015, MAR BIOL, V162, P1511, DOI 10.1007/s00227-015-2687-8; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Knight MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11926; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Korunes KL, 2017, MOL ECOL, V26, P351, DOI 10.1111/mec.13736; Kulikovskiy M, 2016, FOTTEA, V16, P34, DOI 10.5507/fot.2015.011; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Likhoshway Ye V, 2006, Dokl Biol Sci, V408, P256, DOI 10.1134/S001249660603015X; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Marchenkov AM, 2016, DOKL BIOCHEM BIOPHYS, V471, P407, DOI 10.1134/S1607672916060089; Marron AO, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2543; Mock T, 2017, NATURE, V541, P536, DOI 10.1038/nature20803; Monroe J.S., 2011, CHANGING EARTH EXPLO, V6th; Mukherjee S, 2017, NUCLEIC ACIDS RES, V45, pD446, DOI 10.1093/nar/gkw992; Petrova DP, 2007, DOKL BIOCHEM BIOPHYS, V417, P295, DOI 10.1134/S1607672907060014; Pondaven P, 2000, NATURE, V405, P168, DOI 10.1038/35012046; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sapriel G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007458; Sherbakova TA, 2005, MOL BIOL+, V39, P269, DOI 10.1007/s11008-005-0038-4; Skabichevskii AP, 1960, PLANCTONIC DIATOMS F; Skabichevskii AP, 1959, URSS, V12, p46 ; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sutton JN, 2018, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00112; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2015, PLANT CELL, V27, P162, DOI 10.1105/tpc.114.135194; Thamatrakoln K, 2007, EUKARYOT CELL, V6, P271, DOI 10.1128/EC.00235-06; Thamatrakoln K, 2006, J PHYCOL, V42, P822, DOI 10.1111/j.1529-8817.2006.00233.x; Thompson A.S., 1988, CULTURE COLLECTION A; Traller JC, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0670-3; Treguer P, 2018, NAT GEOSCI, V11, P27, DOI 10.1038/s41561-017-0028-x; Treguer PJ, 2013, ANNU REV MAR SCI, V5, P477, DOI 10.1146/annurev-marine-121211-172346; Wil liams D.M., 1987, DIATOM RES, V2, P267, DOI DOI 10.1080/0269249X.1987.9705004; ZUCKERKANDL EMILE, 1965, P97	56	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203161	10.1371/journal.pone.0203161	http://dx.doi.org/10.1371/journal.pone.0203161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157241	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400098
J	Bosschieter, J; Bach, S; Bijnsdorp, IV; Segerink, LI; Rurup, WF; van Splunter, AP; Bahce, I; Novianti, PW; Kazemier, G; van Moorselaar, RJA; Steenbergen, RDM; Nieuwenhuijzen, JA				Bosschieter, J.; Bach, S.; Bijnsdorp, I., V; Segerink, L., I; Rurup, W. F.; van Splunter, A. P.; Bahce, I; Novianti, P. W.; Kazemier, G.; van Moorselaar, R. J. A.; Steenbergen, R. D. M.; Nieuwenhuijzen, J. A.			A protocol for urine collection and storage prior to DNA methylation analysis	PLOS ONE			English	Article							EDTA	Background Urine poses an attractive non-invasive means for obtaining liquid biopsies for oncological diagnostics. Especially molecular analysis on urinary DNA is a rapid growing field. However, optimal and practical storage conditions that result in preservation of urinary DNA, and in particular hypermethylated DNA (hmDNA), are yet to be determined. Aim To determine the most optimal and practical conditions for urine storage that result in adequate preservation of DNA for hmDNA analysis. Methods DNA yield for use in methylation analysis was determined by quantitative methylation specific PCR (qMSP) targeting the ACTB and RASSF1A genes on bisulfite modified DNA. First, DNA yield (ACTB qMSP) was determined in a pilot study on urine samples of healthy volunteers using two preservatives (Ethylenediaminetetraacetic acid (EDTA) and Urine Conditioning Buffer, Zymo Research) at four different temperatures (room temperature (RT), 4 degrees C, -20 degrees C, -80 degrees C) for four time periods (1, 2, 7, 28 days). Next, hmDNA levels (RASSF1A qMSP) in stored urine samples of patients suffering from bladder cancer (n = 10) or non-small cell lung cancer (NSCLC; n = 10) were measured at day 0 and 7 upon storage with and without the addition of 40mM EDTA and/ or 20 mu l/ml Penicillin Streptomycin (PenStrep) at RT and 4 degrees C. Results In the pilot study, DNA for methylation analysis was only maintained at RT upon addition of preserving agents. In urine stored at 4 degrees C for a period of 7 days or more, the addition of either preserving agent yielded a slightly better preservation of DNA. When urine was stored at -20 degrees C or -80 degrees C for up to 28 days, DNA was retained irrespective of the addition of preserving agents. In bladder cancer and NSCLC samples stored at RT loss of DNA was significantly less if EDTA was added compared to no preserving agents (p<0.001). Addition of PenStrep did not affect DNA preservation (p>0.99). Upon storage at 4 degrees C, no difference in DNA preservation was found after the addition of preserving agents (p = 0.18). The preservation of methylated DNA (RASSF1A) was strongly correlated to that of unmethylated DNA (ACTB) in most cases, except when PCR values became inaccurate. Conclusions Addition of EDTA offers an inexpensive preserving agent for urine storage at RT up to seven days allowing for reliable hmDNA analysis. To avoid bacterial overgrowth PenStrep can be added without negatively affecting DNA preservation.	[Bosschieter, J.; Bijnsdorp, I., V; van Moorselaar, R. J. A.; Nieuwenhuijzen, J. A.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Urol, Med Ctr, Amsterdam, Netherlands; [Bach, S.; Kazemier, G.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Med Ctr, Amsterdam, Netherlands; [Segerink, L., I; Rurup, W. F.] Univ Twente, BIOS Lab Chip Grp, Enschede, Netherlands; [van Splunter, A. P.; Novianti, P. W.; Steenbergen, R. D. M.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Pathol & Mol Biol, Med Ctr, Amsterdam, Netherlands; [Bahce, I] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Pulmonol, Med Ctr, Amsterdam, Netherlands; [Novianti, P. W.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Twente; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Bosschieter, J (corresponding author), Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Urol, Med Ctr, Amsterdam, Netherlands.	j.bosschieter@vumc.nl	Segerink, Loes/L-8229-2018; Bahce, Idris/AAZ-5501-2021	Bahce, Idris/0000-0002-1111-608X; Steenbergen, Renske/0000-0002-2327-9839; Bach, Sander/0000-0003-1711-6619; Nieuwenhuijzen, Jakko/0000-0002-8977-5501	Edli Foundations	Edli Foundations	Part of this research was funded by Edli Foundations.	Barra GB, 2015, CLIN BIOCHEM, V48, P976, DOI 10.1016/j.clinbiochem.2015.02.014; Bryzgunova OE, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-3-48-54; Cannas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006985; Cerchietti L, 2017, J CLIN ONCOL, V35, P793, DOI 10.1200/JCO.2016.71.0616; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Clozel T, 2013, CANCER DISCOV, V3, P1002, DOI 10.1158/2159-8290.CD-13-0117; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hubers AJ, 2014, LUNG CANCER, V84, P127, DOI 10.1016/j.lungcan.2014.01.019; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Milde A, 1999, INT J LEGAL MED, V112, P209, DOI 10.1007/s004140050237; Reckamp KL, 2016, J THORAC ONCOL, V11, P1690, DOI 10.1016/j.jtho.2016.05.035; Uijterwaal MH, 2016, GYNECOL ONCOL, V143, P135, DOI 10.1016/j.ygyno.2016.07.089; van Kessel KEM, 2017, J UROLOGY, V197, P590, DOI 10.1016/j.juro.2016.09.118; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilting SM, 2016, ONCOTARGET, V7, P43805, DOI 10.18632/oncotarget.9698; Yokoi K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040735	16	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0200906	10.1371/journal.pone.0200906	http://dx.doi.org/10.1371/journal.pone.0200906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142219	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500002
J	Jung, H; Kim, JY; Kim, KB; Chae, YC; Hahn, Y; Kim, JW; Seo, SB				Jung, Hyeonsoo; Kim, Ji-Young; Kim, Kee-Beom; Chae, Yun-Cheol; Hahn, Yoonsoo; Kim, Jung-Woong; Seo, Sang-Beom			Deacetylase activity-independent transcriptional activation by HDAC2 during TPA-induced HL-60 cell differentiation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; H3K9 METHYLTRANSFERASE G9A; TRANS-RETINOIC ACID; VALPROIC ACID; B-CELLS; PAX5 EXPRESSION; CANCER; GENE; LSD1; THERAPY	The human myeloid leukemia cell line HL-60 differentiate into monocytes following treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA). However, the mechanism underlying the differentiation of these cells in response to TPA has not been fully elucidated. In this study, we performed ChIP-seq profiling of RNA Pol II, HDAC2, Acetyl H3 (AcH3), and H3K27me3 and analyzed differential chromatin state changes during TPA-induced differentiation of HL-60 cells. We focused on atypically active genes, which showed enhanced H3 acetylation despite increased HDAC2 recruitment. We found that HDAC2 positively regulates the expression of these genes in a histone deacetylase activity-independent manner. HDAC2 interacted with and recruited paired box 5 (PAX5) to the promoters of the target genes and regulated HL-60 cell differentiation by PAX5-mediated gene activation. Taken together, these data elucidated the specific-chromatin status during HL-60 cell differentiation following TPA exposure and suggested that HDAC2 can activate transcription of certain genes through interactions with PAX5 in a deacetylase activity-independent pathway.	[Jung, Hyeonsoo; Kim, Ji-Young; Kim, Kee-Beom; Chae, Yun-Cheol; Hahn, Yoonsoo; Kim, Jung-Woong; Seo, Sang-Beom] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul, South Korea	Chung Ang University	Seo, SB (corresponding author), Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul, South Korea.	sangbs@cau.ac.kr	Kim, Kee-Beom/AAG-9225-2022; Kim, Kee-Beom/AFL-8804-2022	Kim, Kee-Beom/0000-0003-0132-8924; Kim, Kee-Beom/0000-0003-0132-8924; Seo, Sang Beom/0000-0003-4709-6022	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1A4A1008035, NRF-2017R1A2B4004407]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1A4A1008035 and NRF-2017R1A2B4004407).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baijun Fang QL., 2015, J LEUKEMIA, V03, DOI [10.4172/2329-6917.1000168, DOI 10.4172/2329-6917.1000168]; Beguelin W, 2015, LEUKEMIA, V29, P1684, DOI 10.1038/leu.2015.57; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Blagitko-Dorfs N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075258; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; COLLINS SJ, 1987, BLOOD, V70, P1233; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Jung H, 2017, SCI REP-UK, V7, DOI 10.1038/srep46182; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kim KB, 2015, NUCLEIC ACIDS RES, V43, P3509, DOI 10.1093/nar/gkv183; Kimbrel EA, 2009, BLOOD, V114, P4804, DOI 10.1182/blood-2009-04-217794; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Kupsa T, 2012, BIOMED PAP, V156, P291, DOI 10.5507/bp.2012.108; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Miccadei S, 2005, ONCOGENE, V24, P6993, DOI 10.1038/sj.onc.1208861; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Ramirez RN, 2017, CELL SYST, V4, P416, DOI 10.1016/j.cels.2017.03.005; Ray D, 2013, BLOOD, V122, P759, DOI 10.1182/blood-2013-02-482497; Rucker FG, 2016, EPIGENETICS-US, V11, P517, DOI 10.1080/15592294.2016.1187350; Savickiene J, 2012, CELL MOL BIOL LETT, V17, P501, DOI 10.2478/s11658-012-0024-5; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Son HJ, 2012, MOL CELL BIOL, V32, P3681, DOI 10.1128/MCB.00673-12; Tegla CA, 2015, EXP MOL PATHOL, V98, P328, DOI 10.1016/j.yexmp.2015.03.011; Tiacci E, 2004, CANCER RES, V64, P7399, DOI 10.1158/0008-5472.CAN-04-1865; Verma M., 2018, EPIGENETICS AGING LO, P439, DOI DOI 10.1016/B978-0-12-811060-7.00021-8; Vlaicu SI, 2013, IMMUNOL RES, V56, P109, DOI 10.1007/s12026-012-8381-8	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202935	10.1371/journal.pone.0202935	http://dx.doi.org/10.1371/journal.pone.0202935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142192	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500050
J	Luttrull, JK; Sinclair, SH; Elmann, S; Glaser, BM				Luttrull, Jeffrey K.; Sinclair, Stephen H.; Elmann, Solly; Glaser, Bert M.			Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; HEAT-SHOCK PROTEINS; DEGENERATION; EYE; PHOTOCOAGULATION; PROGRESSION; BURDEN; METAANALYSIS; EXPRESSION; RESPONSES	Purpose To determine the incidence of new choroidal neovascularization (CNV) in eyes with dry age-related macular degeneration (AMD) following subthreshold diode micropulse laser (SDM). Method In an observational retrospective cohort study, the records of all patients active in the electronic medical records database were reviewed to identify eyes with dry AMD treated with SDM. Identified eyes were classified by simplified AREDS categories, and analyzed for the primary endpoint of new CNV after treatment. Results The EMR revealed SDM was offered to 373/392 (95%) patients with dry AMD and elected by 363/373 (97%) between 2008-2017. Follow up was available for 354/363 patients (547 eyes, 98%) (range 6-108 mos., avg. 22). CNV risk factors included age (median 84 years, 67%> 80); reticular pseudodrusen (214 eyes, 39%); AREDS category (78% category 3 and 4); and fellow eye CNV (128 eyes, 23%). New CNV developed in 9/547 eyes (1.6%, annualized rate 0.87%). Visual acuity was unchanged. There were no adverse treatment effects. Summary In a review of a large group of eyes with exceptionally high-risk AMD, SDM was followed by a very low incidence of new CNV. If confirmed by further study, SDM would offer a new and highly effective treatment to reduce the risk of vision loss from AMD.	[Sinclair, Stephen H.] Drexel Univ, Sch Med, Philadelphia, PA 19104 USA; [Elmann, Solly; Glaser, Bert M.] Natl Retina Inst, Towson, MD USA	Drexel University		office@venturacountyretina.com		Luttrull, Jeffrey K/0000-0002-4475-3237				Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 1993, Arch Ophthalmol, V111, P1189; Baldwin Robert L., 2007, J MOL BIOL, P283; Basso FG, 2015, PHOTOCHEM PHOTOBIOL, V91, P952, DOI 10.1111/php.12445; Beckham JT, 2008, THESIS; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Boyers LN, 2015, JAMA OPHTHALMOL, V133, P25, DOI 10.1001/jamaophthalmol.2014.3527; Brader HS, 2016, SEMIN OPHTHALMOL, V31, P30, DOI 10.3109/08820538.2015.1114837; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Caballero S, 2017, INVEST OPHTH VIS SCI, V58, P5164, DOI 10.1167/iovs.16-20736; Chen GH, 2016, RETINA-J RET VIT DIS, V36, P2059, DOI 10.1097/IAE.0000000000001053; Chen X, 2014, PLOS ONE, V9; Chhablani J, 2018, SURV OPHTHALMOL, V63, P307, DOI 10.1016/j.survophthal.2017.09.008; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Department of Health and Human Services Offices of the Inspector General, 2012, OEI031000360 DEP HLT; Dias JRD, 2018, OPHTHALMOLOGY, V125, P255, DOI 10.1016/j.ophtha.2017.08.030; Dudeja V, 2009, GUT, V58, P1000, DOI 10.1136/gut.2007.140194; ELLENBERG SS, 1993, BRIT J CANCER, V68, P457, DOI 10.1038/bjc.1993.369; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Flaxel C, 2007, RETINA-J RET VIT DIS, V27, P629, DOI 10.1097/01.iae.0000249561.02567.fd; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Guymer RH, 2014, CLIN EXP OPHTHALMOL, V42, P466, DOI 10.1111/ceo.12247; Hattenbach LO, 2005, OPHTHALMIC RES, V37, P341, DOI 10.1159/000088263; Inagaki K, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/729792; Iwami H, 2014, EXP EYE RES, V124, P37, DOI 10.1016/j.exer.2014.04.014; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kern K, 2018, EXP EYE RES, V170, P117, DOI 10.1016/j.exer.2018.02.013; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Klein R, 2002, AJO, V137, P486; Kolomeyer AM, 2014, SURV OPHTHALMOL, V59, P134, DOI 10.1016/j.survophthal.2013.09.004; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lavinsky D, 2016, INVEST OPHTH VIS SCI, V57, P2488, DOI 10.1167/iovs.15-18981; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Lu RC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435203; Lund DJ, 2014, HEALTH PHYS, V106, P505, DOI 10.1097/HP.0b013e3182a2a837; Luttrull JK, 2018, EYE, V32, P1099, DOI 10.1038/s41433-018-0017-3; Luttrull JK, 2016, INVEST OPHTH VIS SCI, V57, P265, DOI 10.1167/iovs.15-18163; Luttrull JK, 2015, RETINA-J RET VIT DIS, V35, P1184, DOI 10.1097/IAE.0000000000000458; Luttrull JK, 2014, RETINA-J RET VIT DIS, V34, P2010, DOI 10.1097/IAE.0000000000000177; Luttrull JK, 2012, CURR DIABETES REV, V8, P274, DOI 10.2174/157339912800840523; Luttrull JK, 2012, RETINA-J RET VIT DIS, V32, P375, DOI 10.1097/IAE.0b013e3182206f6c; Luttrull JK, 2005, BRIT J OPHTHALMOL, V89, P74, DOI 10.1136/bjo.2004.051540; Luttrull JK, 2018, GLAUCOMA RES CLIN AD; Maguire MG, 2013, OPHTHALMOLOGY, V120, P2035, DOI 10.1016/j.ophtha.2013.03.017; Mitchell P, 2011, PHARMACOECONOMICS, V29, P107, DOI 10.2165/11585520-000000000-00000; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Scott IU, 2014, JAMA OPHTHALMOL, V132, P535, DOI 10.1001/jamaophthalmol.2014.93; Smith RT, 2006, INVEST OPHTH VIS SCI, V47, P5495, DOI 10.1167/iovs.05-1318; Solomon SD, 2009, RETINA-J RET VIT DIS, V29, P1080, DOI 10.1097/IAE.0b013e3181b1baeb; Soubrane G, 2007, ARCH OPHTHALMOL-CHIC, V125, P1249, DOI 10.1001/archopht.125.9.1249; Sramek C, 2011, INVEST OPHTH VIS SCI, V52, P1780, DOI 10.1167/iovs.10-5917; Srivastava K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151060; van Teijlingen ER, 2001, J ADV NURS, V34, P289, DOI 10.1046/j.1365-2648.2001.01757.x; Virgili G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006537.pub3; Wang HB, 2016, MOL VIS, V22, P189; Wang Q, 2016, INT J OPHTHALMOL-CHI, V9, P298, DOI 10.18240/ijo.2016.02.23; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Xu QB, 2012, AM J PHYSIOL-HEART C, V302, pH506, DOI 10.1152/ajpheart.00646.2011; Zhou Q, 2016, OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2016.02.043, DOI 10.1016/J.OPHTHA.2016.02043]	67	10	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202097	10.1371/journal.pone.0202097	http://dx.doi.org/10.1371/journal.pone.0202097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138455	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100039
J	Faisal, M; Abu Bakar, M; Sarwar, A; Adeel, M; Batool, F; Malik, KI; Jamshed, A; Hussain, R				Faisal, Muhammad; Abu Bakar, Muhammad; Sarwar, Albash; Adeel, Mohammad; Batool, Fatima; Malik, Kashif Iqbal; Jamshed, Arif; Hussain, Raza			Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT)	PLOS ONE			English	Article							TUMOR THICKNESS; NECK DISSECTION; CANCER; HEAD; INVOLVEMENT; MANAGEMENT; SURVIVAL; MOUTH; FLOOR	Background The new AJCC staging system (8th edition) incorporates depth of invasion to stage oral cancers. It is a recognized predictor for neck nodal metastasis and local recurrence, the associated risk is not well defined. The aim of this study was to explore the risk of occult neck nodal metastasis and local recurrence in relation to depth in early stage squamous cell carcinoma of oral tongue. Methods We have evaluated records of 179 patients with early tongue cancer treated in our unit from 2006-2015 with a mean age of 57.92 +/- 11.93 years. Treatment modalities used were surgery (26%), surgery followed by radiotherapy (64%) and chemo-radiation (10%). Neck dissection was ipsilateral in 94% and bilateral in 6% of the patients. Patients were grouped according to the AJCC cut off points in 8th edition for depth; group A: 1-5 mm (35%), group B: 6-10 mm (47%) and group C: > 10 mm (18%). Results Risk of local recurrence and nodal metastasis for Group A was 15% (10/63) and 23% (15/63), group B 20% (17/84) and 34% (29/84), and group C 40% (13/32) and 53% (17/32). Conclusions Depth more than 10 mm is associated with significantly increased risk of recurrence and nodal metastasis. Elective neck dissection should be a consideration for tumors having depth less than 5mm.	[Faisal, Muhammad; Sarwar, Albash; Adeel, Mohammad; Malik, Kashif Iqbal; Hussain, Raza] Shaukat Khanum Mem Canc Hosp & Res Ctr, Dept Surg Oncol, Lahore, Pakistan; [Abu Bakar, Muhammad] Shaukat Khanum Mem Canc Hosp & Res Ctr, Dept Canc Registry & Clin Data Management, Lahore, Pakistan; [Batool, Fatima; Jamshed, Arif] Shaukat Khanum Mem Canc Hosp & Res Ctr, Dept Radiat Oncol, Lahore, Pakistan	Shaukat Khanum Memorial Cancer Hospital & Research Centre; Shaukat Khanum Memorial Cancer Hospital & Research Centre; Shaukat Khanum Memorial Cancer Hospital & Research Centre	Faisal, M (corresponding author), Shaukat Khanum Mem Canc Hosp & Res Ctr, Dept Surg Oncol, Lahore, Pakistan.	maxfas@live.com	Faisal, Muhammad/AAM-6214-2020	Faisal, Muhammad/0000-0001-6564-0410				Ahmed F, 1990, Bangladesh Med Res Counc Bull, V16, P17; Amin MB, 2017, AJCC CANC STAGING MA; Asakage T, 1998, CANCER, V82, P1443, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A; Balasubramanian D, 2014, ORAL ONCOL, V50, P1165, DOI 10.1016/j.oraloncology.2014.09.012; Boyle P, 2008, WORLD CANC REPORT; FAKIH AR, 1989, AM J SURG, V158, P309, DOI 10.1016/0002-9610(89)90122-0; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Foschini MP, 2013, INT J SURG PATHOL, V21, P133, DOI 10.1177/1066896912471851; Frech S, 2009, ANTICANCER RES, V29, P1675; Gosselin B.J., 2015, MALIGNANT TUMOURS MO; Gourin CG, 2008, LARYNGOSCOPE, V118, P1191, DOI 10.1097/MLG.0b013e31816e2eb7; Huang SH, 2009, CANCER-AM CANCER SOC, V115, P1489, DOI 10.1002/cncr.24161; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Keski-Santti H, 2006, ORAL ONCOL, V42, P96, DOI 10.1016/j.oraloncology.2005.06.018; Kowalski LP, 1998, OTOLARYNG CLIN N AM, V31, P621, DOI 10.1016/S0030-6665(05)70076-1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Melchers LJ, 2012, ORAL ONCOL, V48, P337, DOI 10.1016/j.oraloncology.2011.11.007; O-charoenrat P, 2003, ORAL ONCOL, V39, P386, DOI 10.1016/S1368-8375(02)00142-2; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; SPIRO RH, 1986, AM J SURG, V152, P345, DOI 10.1016/0002-9610(86)90302-8; WEISS MH, 1994, ARCH OTOLARYNGOL, V120, P699; Yii NW, 1999, CLIN OTOLARYNGOL, V24, P75, DOI 10.1046/j.1365-2273.1999.00224.x	22	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202632	10.1371/journal.pone.0202632	http://dx.doi.org/10.1371/journal.pone.0202632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133515	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400089
J	Liu, XJ; Zhang, N; Liu, Y; Liu, L; Zeng, QX; Yin, MX; Wang, YX; Song, DQ; Deng, HB				Liu, Xiaojia; Zhang, Na; Liu, Yang; Liu, Lu; Zeng, Qingxuan; Yin, Mingxiao; Wang, Yanxiang; Song, Danqing; Deng, Hongbin			MPB, a novel berberine derivative, enhances lysosomal and bactericidal properties via TGF--activated kinase 1-dependent activation of the transcription factor EB	FASEB JOURNAL			English	Article						lysosome; bacterial eradication; c-Jun N-terminal protein kinase; AMP-activated protein kinase	UBIQUITIN-DEPENDENT KINASE; CELLULAR CLEARANCE; AUTOPHAGY; TAK1; TFEB; INNATE; BIOGENESIS; PHOSPHORYLATION; ANTIBIOTICS; INFECTIONS	Lysosome has a crucial role in clearance of endocytosed pathogens from the cell. Small molecules that can boost lysosome function and bactericidal ability to cope with subsequent infection are urgently needed. Here, we report that MPB, a novel berberine derivative, induced lysosome-based degradation and clearance of methicillin-resistant Staphylococcus aureus and enteroinvasive Escherichia coli in macrophages. MPB caused nuclear translocation of transcription factor EB (TFEB), which boosted expression of lysosome genes. TFEB silencing repressed the MPB-mediated enhancements in degradation and bacterial eradication. MPB switched on TFEB nuclear translocation by coupling 2 parallel signaling pathways. MPB-triggered JNK activation led to 14-3-3 being released from TFEB, which, in turn, caused TFEB nuclear translocation. In addition, MPB induced AMPK activation and subsequent inhibition of mechanistic target of rapamycin activity, which also contributed to TFEB nuclear translocation. Importantly, genetical or pharmaceutical inhibition of TGF--activated kinase 1 (TAK1) reduced MPB action remarkably. MPB acted through TAK1 at lysine 158 to activate JNK and AMPK and, thus, induced TFEB-dependent bactericidal activity in macrophages. Therefore, our study reveals a novel mechanism by which MPB controls JNK and AMPK phosphorylation cascades to activate lysosomal function and bactericidal activity via TAK1 K158-dependent manner, which may offer insight into novel therapeutic strategies to control bacterial infection.Liu, X., Zhang, N., Liu, Y., Liu, L., Zeng, Q., Yin, M., Wang, Y., Song, D., Deng, H. MPB, a novel berberine derivative, enhances lysosomal and bactericidal properties via TGF--activated kinase 1-dependent activation of the transcription factor EB.	[Liu, Xiaojia; Zhang, Na; Liu, Yang; Liu, Lu; Zeng, Qingxuan; Yin, Mingxiao; Wang, Yanxiang; Song, Danqing; Deng, Hongbin] Chinese Acad Med Sci, Inst Med Biotechnol, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China; [Liu, Xiaojia; Zhang, Na; Liu, Yang; Liu, Lu; Zeng, Qingxuan; Yin, Mingxiao; Wang, Yanxiang; Song, Danqing; Deng, Hongbin] Peking Union Med Coll, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Song, DQ; Deng, HB (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China.; Song, DQ; Deng, HB (corresponding author), Peking Union Med Coll, 1 Tian Tan Xi Li, Beijing 100050, Peoples R China.	songdanqingsdq@hotmail.com; hdeng@imb.pumc.edu.cn	Deng, Hongbin/AAN-3603-2020	Deng, Hongbin/0000-0002-4398-8819	National Natural Science Foundation of China [81773782, 81473248]; Chinese Academy of Medical Sciences Major Collaborative Innovation Project [2016-12M-1-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Major Collaborative Innovation Project	The authors thank Dr. Jianhua Yang (Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA) for kindly providing TAK1 (WT, K34R, K72R, and K209R) plasmids. This work was supported by grants from National Natural Science Foundation of China (Grants 81773782 and 81473248), and the Chinese Academy of Medical Sciences Major Collaborative Innovation Project (Grant 2016-12M-1-011). The authors declare no conflicts of interest.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bewley MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001262; Carroll B, 2017, BIOCHEM J, V474, P1453, DOI 10.1042/BCJ20160780; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Deng HB, 2011, INT J BIOCHEM CELL B, V43, P409, DOI 10.1016/j.biocel.2010.11.011; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fisher RA, 2017, NAT REV MICROBIOL, V15, P453, DOI 10.1038/nrmicro.2017.42; Heathcote HR, 2016, BIOCHEM J, V473, P4681, DOI 10.1042/BCJ20160211; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim SH, 2017, AUTOPHAGY, V13, P1767, DOI 10.1080/15548627.2017.1356977; Kim W, 2018, NATURE, V556, P103, DOI 10.1038/nature26157; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Larrosa M, 2012, MOL CELL PROBE, V26, P121, DOI 10.1016/j.mcp.2012.03.001; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Liu L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41862; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Ploper D, 2015, PHARMACOL RES, V99, P36, DOI 10.1016/j.phrs.2015.04.006; Powers JH, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k587; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Saberi B, 2014, HEPATOLOGY, V59, P1543, DOI 10.1002/hep.26625; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Vega-Rubin-de-Celis S, 2017, AUTOPHAGY, V13, P464, DOI 10.1080/15548627.2016.1271514; Visvikis O, 2014, IMMUNITY, V40, P896, DOI 10.1016/j.immuni.2014.05.002; Vural A, 2016, J IMMUNOL, V196, P846, DOI 10.4049/jimmunol.1501595; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YX, 2018, EUR J MED CHEM, V143, P1858, DOI 10.1016/j.ejmech.2017.10.078; Wang YX, 2017, MOLECULES, V22, DOI 10.3390/molecules22081257; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8; Zhang N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0309-3; Zhong KL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005823; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	59	11	11	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1468	1481		10.1096/fj.201801198R	http://dx.doi.org/10.1096/fj.201801198R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30161000				2022-12-26	WOS:000457401500115
J	Kim, JJ; Kim, T; Lee, H; Byun, SS; Lee, SE; Choe, G; Hong, SK				Kim, Jung Jun; Kim, Taejin; Lee, Hakjong; Byun, Seok-Soo; Lee, Sang Eun; Choe, Gheeyoung; Hong, Sung Kyu			Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience	PLOS ONE			English	Article							ULTRASOUND FUSION BIOPSY; FOCAL THERAPY; CLINICAL-SIGNIFICANCE; MRI; LATERALITY; CONSENSUS; ACCURACY	Hemi-ablation of prostate cancer (PCa) requires an accurate prediction of laterality. Recently, multi-parametric magnetic resonance imaging (mpMRI) has recently been increasingly used to enhance clinical staging and characterization of tumor foci. Thus, we tried to investigate the real-life accuracy of combinatory approach of using both transrectal ultrasound (TRUS)-guided prostatic biopsy and mpMRI in predicting the laterality of PCa. We reviewed the records of 335 men who were suspected of having unilateral PCa on multi (>= 12)-core TRUS-guided biopsy and preoperative mpMRI and subsequently had undergone radical prostatectomy (RP) at our institution. Based on the analysis of pathologic outcomes from RP, the performance of the combinatory approach in predicting the pathological laterality of PCa was evaluated. Pathology was classified to be unfavorable when showing a Gleason pattern of 4/5 or pT3/N1 features. Significant cancer was defined as non-organconfined disease, having a Gleason pattern of 4/5, or showing a cancer volume of >= 0.5 mL. Among the 335 unilateral lobes not suspected to harbor tumor from either the TRUS biopsy or mpMRI, the actual absence rate of malignancy was only 13.7% from a pathologic analysis of RP specimens. Even among the 115 D'Amico low-risk group, the absence rate of malignancy was only 26.1% in unilateral lobes not suspected to harbor tumor. Among the 335 lobes, unfavorable pathology and significant cancer were not observed in 36.1% and 30.7%, respectively. The absence rates of unfavorable pathology and significant cancer among the D'Amico low risk group were 56.5% and 47.8%, respectively. Meanwhile, the absence rate of dominant Gleason pattern 4 or 5 was 74.9% among the 335 total subjects. Our real-life clinical experience showed that the combination of multi-core TRUS-guided biopsy and mpMRI did not provide reliable accuracy in the prediction of true unilaterality of PCa.	[Kim, Jung Jun; Kim, Taejin; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea; [Lee, Hakjong] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Byun, Seok-Soo; Hong, Sung Kyu] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea; [Choe, Gheeyoung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.; Hong, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	skhong@snubh.org		Hong, Sung Kyu/0000-0002-8344-6774				Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Ahmed HU, 2012, LANCET ONCOL, V13, P622, DOI 10.1016/S1470-2045(12)70121-3; Baco E, 2015, EUR UROL, V67, P787, DOI 10.1016/j.eururo.2014.08.077; Bahn D, 2012, EUR UROL, V62, P55, DOI 10.1016/j.eururo.2012.03.006; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P577, DOI 10.1167/iovs.15-18972; Branger N, 2017, BJU INT, V119, P449, DOI 10.1111/bju.13657; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cordeiro ER, 2012, BJU INT, V110, P1228, DOI 10.1111/j.1464-410X.2012.11262.x; de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Feijoo ERC, 2016, EUR UROL, V69, P214, DOI 10.1016/j.eururo.2015.06.018; Filson CP, 2016, CANCER-AM CANCER SOC, V122, P884, DOI 10.1002/cncr.29874; Jeldres C, 2008, EUR UROL, V54, P1306, DOI 10.1016/j.eururo.2007.11.057; Jeong CW, 2012, UROLOGY, V79, P1322, DOI 10.1016/j.urology.2012.01.080; Kawakami Satoru, 2006, Int J Clin Oncol, V11, P127, DOI 10.1007/s10147-005-0547-0; Le JD, 2015, EUR UROL, V67, P569, DOI 10.1016/j.eururo.2014.08.079; Matsuoka Y, 2016, BJU INT, V117, P94, DOI 10.1111/bju.12901; Meiers I, 2007, UROLOGY, V70, P3, DOI 10.1016/j.urology.2007.06.1129; Tran M, 2016, BJU INT, V117, P48, DOI 10.1111/bju.13090; Mouraviev V, 2007, CANCER, V110, P906, DOI 10.1002/cncr.22858; Numao N, 2012, BJU INT, V109, P665, DOI 10.1111/j.1464-410X.2011.10427.x; Polascik TJ, 2009, CANCER, V115, P2104, DOI 10.1002/cncr.24258; Radtke JP, 2016, EUR UROL, V70, P846, DOI 10.1016/j.eururo.2015.12.052; Rosenkrantz AB, 2012, J UROLOGY, V187, P2032, DOI 10.1016/j.juro.2012.01.074; STAMEY TA, 1993, CANCER, V71, P933, DOI 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L; Thompson JE, 2014, J UROLOGY, V192, P67, DOI 10.1016/j.juro.2014.01.014; Valerio M, 2014, EUR UROL, V66, P732, DOI 10.1016/j.eururo.2013.05.048; van den Bos W, 2014, EUR UROL, V65, P1078, DOI 10.1016/j.eururo.2014.01.001; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Zhang K, 2017, ASIAN J UROL, V4, P86, DOI 10.1016/j.ajur.2016.08.010	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202872	10.1371/journal.pone.0202872	http://dx.doi.org/10.1371/journal.pone.0202872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157232	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400072
J	Lequeux, BD; Ahumada-Sempoal, MA; Lopez-Perez, A; Reyes-Hernandez, C				Lequeux, Bertrand D.; Ahumada-Sempoal, Miguel-Angel; Lopez-Perez, Andres; Reyes-Hernandez, Cristobal			Coral connectivity between equatorial eastern Pacific marine protected areas: A biophysical modeling approach	PLOS ONE			English	Article							POPULATION CONNECTIVITY; TROPICAL PACIFIC; LARVAL DISPERSAL; REEF RECOVERY; CO2 SYSTEM; OCEAN; DYNAMICS; GULF; TEHUANTEPEC; ARCHIPELAGO	There are many marine protected areas (MPAs) containing coral reef aggregations in the eastern Pacific region. However, the connectivity of corals between MPAs is still poorly known, especially in the Marine Conservation Corridor of the Eastern Tropical Pacific (MCCETP). Here, we assess the potential connectivity of corals across equatorial eastern Pacific MPAs through a Lagrangian particle-tracking algorithm coupled offline with an ocean-circulation numerical model. Connectivity metrics and graph theory were used to analyze the networks and highlight those MPAs that are critical for maintaining the connectivity of corals across the region. Our results show that the equatorial eastern Pacific MPAs form a relatively well-connected network, at least 40% of coral larvae released per year end up within the boundaries of an MPA. MPAs like Malpelo and Gorgona islands included in the MCCETP were found to be critical for connectivity of corals because of their high between-ness centrality and potential role as stepping-stones between coastal MPAs and offshore MPAs such as the Galapagos Islands. Two pelagic larval duration (PLD) scenarios (40 and 130 days) indicate a quasi-unidirectional larval flow from coastal MPAs toward oceanic MPAs, where the only resilient MPAs (Coiba and Malpelo islands) depend mostly on subsidiary recruitment from MPAs located along the coast of Costa Rica, Panama and Colombia. In the two PLD scenarios, Cocos Island maintains a very low resilience potential. Our results indicate the imperative need to include coastal MPAs in the MCCETP network initiative, since connectivity and resilience of coral reefs in the equatorial eastern Pacific region rely heavily on coastal MPAs.	[Lequeux, Bertrand D.] Univ Mar, Program Marine Biol, Ciudad Univ S-N, San Pedro Pochutla, Oaxaca, Mexico; [Ahumada-Sempoal, Miguel-Angel; Reyes-Hernandez, Cristobal] Univ Mar, Ciudad Univ S-N, San Pedro Pochutla, Oaxaca, Mexico; [Lopez-Perez, Andres] Univ Autonoma Metropolitana, Unidad Iztapalapa, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico	Ahumada-Sempoal, MA (corresponding author), Univ Mar, Ciudad Univ S-N, San Pedro Pochutla, Oaxaca, Mexico.	ahumada@angel.umar.mx	Lopez-Perez, Andres/U-1151-2017; Lopez-Perez, Andres/GPJ-9537-2022; Reyes-Hernandez, Cristobal/GPP-4329-2022	Lopez-Perez, Andres/0000-0003-1246-7401; Lopez-Perez, Andres/0000-0003-1246-7401; Reyes-Hernandez, Cristobal/0000-0002-9064-7136; Ahumada-Sempoal, Miguel-Angel/0000-0003-3465-3643; Lequeux, Bertrand Didier/0000-0002-3617-3806				Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Andrello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068564; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Baums IB, 2012, MOL ECOL, V21, P5418, DOI 10.1111/j.1365-294X.2012.05733.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Chapa-Balcorta C, 2015, J GEOPHYS RES-OCEANS, V120, P7752, DOI 10.1002/2015JC011249; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crowder LB, 2000, B MAR SCI, V66, P799; da Silva AM., 1994, ATLAS SURFACE MARINE; Debreu L, 2012, OCEAN MODEL, V49-50, P1, DOI 10.1016/j.ocemod.2012.03.003; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Glynn PW, 2015, CORAL REEFS, V34, P421, DOI 10.1007/s00338-015-1280-4; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2003, LATIN AMERICAN CORAL REEFS, P449, DOI 10.1016/B978-044451388-5/50020-5; Glynn PW, 2017, CORAL REEF WORLD COR; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Guzman HM, 2008, ENVIRON CONSERV, V35, P46, DOI 10.1017/S0376892908004542; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; Guzman HM, 2001, B MAR SCI, V69, P133; Alvarado JJ, 2017, CORAL REEFS WORLD, V8, P565, DOI 10.1007/978-94-017-7499-4_21; Karstensen J, 2009, PERU CHILE CURRENT S, P85; Lessios HA, 2017, CORAL REEFS WORLD, V8, P477, DOI 10.1007/978-94-017-7499-4_16; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Lopez-Perez A, 2016, MAR ECOL-EVOL PERSP, V37, P679, DOI 10.1111/maec.12337; Lopez-Perez RA, 2012, MAR ECOL-EVOL PERSP, V33, P407, DOI 10.1111/j.1439-0485.2011.00505.x; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Manzello DP, 2017, CORAL REEFS WORLD, V8, P517, DOI 10.1007/978-94-017-7499-4_18; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/s1463-5003(00)00013-5; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Peven P, 2007, ENVIRON MODELL SOFTW, V23, P660; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; Romero-Torres M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27644-2; Sale PF, 2010, PRESERVING REEF CONN; Santiago-Garcia MW, 2014, PROG OCEANOGR, V123, P64, DOI 10.1016/j.pocean.2014.02.002; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Tay YC, 2012, AQUAT BIOL, V15, P283, DOI 10.3354/ab00433; TRASVINA A, 1995, J GEOPHYS RES-OCEANS, V100, P20649, DOI 10.1029/95JC01283; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Veron J, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2014.00081; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wood S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12571; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101	51	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202995	10.1371/journal.pone.0202995	http://dx.doi.org/10.1371/journal.pone.0202995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157276	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400080
J	Lee, TM; Chang, NC; Lin, SZ				Lee, Tsung-Ming; Chang, Nen-Chung; Lin, Shinn-Zong			Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium	PLOS ONE			English	Article							POTASSIUM CHANNEL AGONISTS; NERVE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; HYPOMAGNESEMIA; PROTEIN; MG2+; ATP; PEROXYNITRITE; SUPEROXIDE; ACTIVATION	The long-term use of proton pump inhibitors (PPIs) has been shown to increase the risk of cardiovascular mortality, however the molecular mechanisms are unknown. Superoxide has been implicated in the regulation of nerve growth factor (NGF), a mediator of sympathetic innervation. The purpose of this study was to determine whether PPIs increase ventricular arrhythmias through magnesium-mediated superoxide production in infarcted rats. Male Wistar rats were randomly assigned to receive vehicle, omeprazole, omeprazole + magnesium sulfate, or famotidine treatment for 4 weeks starting 24 hours after the induction of myocardial infarction by ligating the coronary artery. Increased myocardial superoxide and nitrotyrosine levels were noted post-infarction, in addition to a significant upregulation of NGF expression on mRNA and protein levels. Sympathetic hyperinnervation after infarction was confirmed by measuring myocardial norepinephrine and immunofluorescent analysis. Compared with the vehicle, omeprazole-treated infarcted rats had significantly reduced myocardial magnesium content, increased oxidant production, and increased sympathetic innervation, which in turn increased ventricular arrhythmias. These effects were prevented by the coadministration of magnesium sulfate. In an in vivo study, an omeprazole-induced increase in NGF was associated with a superoxide pathway, which was further confirmed by an ex vivo study showing the attenuation of NGF levels after coadministration of the superoxide scavenger Tiron. Magnesium sulfate did not further attenuate NGF levels compared with omeprazole + Tiron. Our results indicate that the long-term administration of PPIs was associated with reduced tissue magnesium content and increased myocardial superoxide production, which exacerbated ventricular arrhythmias after infarction. Magnesium may be a potential target for PPI-related arrhythmias after infarction.	[Lee, Tsung-Ming] China Med Univ, An Nan Hosp, Cardiovasc Inst, Tainan, Taiwan; [Lee, Tsung-Ming] China Med Univ, Dept Med, Taichung, Taiwan; [Lee, Tsung-Ming; Chang, Nen-Chung] Taipei Med Univ, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lin, Shinn-Zong] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Lin, SZ (corresponding author), Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien, Taiwan.	shinnzong@yahoo.com.tw	Lin, Shinn-Zong/AAX-2379-2020		An-Nan Hospital [ANHRF106-07]; Ministry of Science and Technology, Taiwan [MOST-106-2314-B-039-049]	An-Nan Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants of An-Nan Hospital (ANHRF106-07, TML) and Ministry of Science and Technology (MOST-106-2314-B-039-049, TML), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; BENGHEDALIA D, 1975, BRIT J NUTR, V33, P87, DOI 10.1079/BJN19750011; Broeren MAC, 2009, ANN INTERN MED, V151, P755, DOI 10.7326/0003-4819-151-10-200911170-00016; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Cernak I, 2000, MAGNESIUM RES, V13, P29; Colangelo AM, 1998, P NATL ACAD SCI USA, V95, P10920, DOI 10.1073/pnas.95.18.10920; DAHLSTRO.A, 1965, J ANAT, V99, P677; Eshraghi T, 2015, MAGNESIUM RES, V28, P32, DOI 10.1684/mrh.2015.0380; Ferdinandy P, 2006, BRIT J PHARMACOL, V148, P1, DOI 10.1038/sj.bjp.0706693; Food and Drug Administration, 2011, FDA SAF COMM LOW MAG; HAIGNEY MCP, 1995, CIRCULATION, V92, P2190, DOI 10.1161/01.CIR.92.8.2190; HERRE JM, 1988, J AM COLL CARDIOL, V11, P414, DOI 10.1016/0735-1097(88)90110-6; Howden CW, 2000, J CLIN GASTROENTEROL, V30, P29, DOI 10.1097/00004836-200001000-00006; Kang CS, 2009, AM J PHYSIOL-HEART C, V296, pH1949, DOI 10.1152/ajpheart.00903.2008; Kim S, 2015, AM J THER, V22, P14, DOI 10.1097/MJT.0b013e31829c4c71; Kuzniar A, 2003, BIOMETALS, V16, P349, DOI 10.1023/A:1020632505289; Landi SN, 2018, GASTROENTEROLOGY; Lee TM, 2004, CARDIOVASC RES, V63, P109, DOI 10.1016/j.cardiores.2004.03.009; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; Lee TM, 2014, FREE RADICAL BIO MED, V77, P71, DOI 10.1016/j.freeradbiomed.2014.08.022; Lee TM, 2011, FREE RADICAL BIO MED, V50, P1461, DOI 10.1016/j.freeradbiomed.2011.01.031; Lee TM, 2010, CARDIOVASC RES, V85, P137, DOI 10.1093/cvr/cvp286; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02101-8; MASUMOTO N, 1992, BIOCHEM BIOPH RES CO, V182, P906, DOI 10.1016/0006-291X(92)91818-B; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Park SH, 2015, KIDNEY RES CLIN PRAC, V34, P98, DOI 10.1016/j.krcp.2015.03.001; Pehar M, 2006, FREE RADICAL BIO MED, V41, P1632, DOI 10.1016/j.freeradbiomed.2006.08.010; Perazella MA, 2013, KIDNEY INT, V83, P553, DOI 10.1038/ki.2012.462; Perez-de-Arce K, 2005, BIOCHEM BIOPH RES CO, V338, P1103, DOI 10.1016/j.bbrc.2005.10.053; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; REINHART RA, 1991, J AM COLL CARDIOL, V17, P651, DOI 10.1016/S0735-1097(10)80179-2; SEGAWA K, 1987, Gastroenterologia Japonica, V22, P413; Sener-Muratoglu G, 2001, DIGEST DIS SCI, V46, P318, DOI 10.1023/A:1005652815921; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SPARROW MP, 1964, BIOCHIM BIOPHYS ACTA, V90, P425, DOI 10.1016/0304-4165(64)90215-6; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tamura M, 2001, BBA-BIOMEMBRANES, V1510, P270, DOI 10.1016/S0005-2736(00)00358-8; Thongon N, 2016, PFLUG ARCH EUR J PHY, V468, P1809, DOI 10.1007/s00424-016-1905-7; VRACKO R, 1990, LAB INVEST, V63, P490; WEGLICKI WB, 1994, CIRC RES, V74, P1009, DOI 10.1161/01.RES.74.5.1009; Westermaier Thomas, 2013, Exp Transl Stroke Med, V5, P6, DOI 10.1186/2040-7378-5-6; Xia QG, 2001, CARDIOVASC RES, V49, P110, DOI 10.1016/S0008-6363(00)00227-3; Yepuri G, 2016, CIRC RES, V118, pE36, DOI 10.1161/CIRCRESAHA.116.308807	45	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202979	10.1371/journal.pone.0202979	http://dx.doi.org/10.1371/journal.pone.0202979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153299	Green Submitted, Green Published, gold			2022-12-26	WOS:000443001700034
J	Moreno-Padilla, M; Fernandez-Serrano, MJ; del Paso, GAR				Moreno-Padilla, Maria; Jose Fernandez-Serrano, Maria; Reyes del Paso, Gustavo A.			Risky decision-making after exposure to a food-choice task in excess weight adolescents: Relationships with reward-related impulsivity and hunger	PLOS ONE			English	Article							BODY-MASS INDEX; SENSATION SEEKING; TAKING PROPENSITY; BEHAVIOR; BRAIN; OBESITY; DISINHIBITION; OVERWEIGHT; INCREASES; ADULTHOOD	Objective To assess the effects of exposure to a food-choice task (appetizing versus healthy food) on risky decision-making by excess versus normal weight adolescents. We also analyzed the influence of food visualization on hunger levels, as well as group differences in food choices and impulsivity. Methods Fifty-six adolescents (aged 13 +/- 18 years) classified as excess (n = 27) or normal (n = 29) weight participated in the study. Risky-decision-making was assessed through the Balloon Analogue Risk Task, which was administered before and after a food-choice task. We also evaluated impulsivity traits through the UPPS-P Scale, and subjective hunger levels with a visual analogue scale. Results Adolescents with excess weight showed enhanced risky decision-making after the foodchoice task compared to normal weight adolescents, as well as increased hunger levels. Furthermore, excess weight adolescents made more appetizing choices, and showed greater scores for Positive Urgency and Sensation Seeking. Reward-related impulsivity measures were positively associated with the number of appetizing choices in the foodchoice task. Several associations were found between impulsivity measures, hunger levels and risk-taking variables. Conclusions Excess weight adolescents increased their risky-decision-making after food exposure and this augmentation was associated with the increase in hunger levels. Increased hunger levels and risk-taking after food exposure could lead to overeating. Alterations in decision-making caused by food signals may be a long-term risk factor for the development of obesity in adulthood. In modern societies, with the high availability and continuous exposure to food cues, decision-making may be a crucial factor in maintain healthy eating habits in adolescents.	[Moreno-Padilla, Maria; Jose Fernandez-Serrano, Maria; Reyes del Paso, Gustavo A.] Univ Jaen, Dept Psychol, Jaen, Spain	Universidad de Jaen	Moreno-Padilla, M (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	maria.moreno@uiaen.es	Reyes del Paso, Gustavo A./G-4179-2011; PADILLA, MARÍA M/Z-1050-2018; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Serrano, M Josefa Fernández/V-3124-2019	Reyes del Paso, Gustavo A./0000-0002-2188-8673; Serrano, M Josefa Fernández/0000-0002-6158-237X; MORENO PADILLA, MARIA/0000-0002-4751-8283				[Anonymous], [No title captured]; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; BALL SA, 1994, J CONSULT CLIN PSYCH, V62, P1053, DOI 10.1037/0022-006X.62.5.1053; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Brogan A, 2011, J PSYCHOSOM RES, V70, P89, DOI [10.1016/j.jbtep.2013.09.009, DOI 10.1016/J.JBTEP.2013.09.009]; Candido A., 2012, TRASTORNOS ADICTIVOS, V14, P73, DOI DOI 10.1016/S1575-0973(12)70048-X; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cooper ML, 2000, J PERS, V68, P1059, DOI 10.1111/1467-6494.00126; Cosenza M, 2017, J GAMBL STUD, V33, P383, DOI 10.1007/s10899-016-9623-9; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; Del Boca FK, 2004, J CONSULT CLIN PSYCH, V72, P155, DOI 10.1037/0022-006X.72.2.155; Delgado-Rico E, 2012, OBESITY, V20, P1604, DOI 10.1038/oby.2012.47; Doolan KJ, 2015, P NUTR SOC, V74, P37, DOI 10.1017/S002966511400144X; Epstein LH, 2006, APPETITE, V46, P22, DOI 10.1016/j.appet.2005.04.006; Ernst M, 2009, NEUROSCI BIOBEHAV R, V33, P367, DOI 10.1016/j.neubiorev.2008.10.009; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; GRAY JA, 1987, THE PSYCHOLOGY OF FE; Hanson KL, 2014, J PSYCHOPHARMACOL, V28, P1080, DOI 10.1177/0269881114550352; Jones JD, 2016, J CLIN EXP NEUROPSYC, V38, P709, DOI 10.1080/13803395.2016.1156652; Fernandez-Serrano MJ, 2011, PSYCHOPHARMACOLOGY, V217, P331, DOI 10.1007/s00213-011-2288-2; Koritzky G, 2012, APPETITE, V59, P289, DOI 10.1016/j.appet.2012.05.020; Lane SD, 2000, DRUG ALCOHOL DEPEN, V60, P179, DOI 10.1016/S0376-8716(99)00155-6; Lee H, 2011, J ADOLESCENT HEALTH, V49, P601, DOI 10.1016/j.jadohealth.2011.04.019; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Loeber S, 2013, APPETITE, V71, P32, DOI 10.1016/j.appet.2013.07.008; Macchi R, 2017, APPETITE, V116, P442, DOI 10.1016/j.appet.2017.05.031; MacPherson L, 2010, ALCOHOL CLIN EXP RES, V34, P1400, DOI 10.1111/j.1530-0277.2010.01223.x; Millar L, 2014, OBESITY, V22, pE96, DOI 10.1002/oby.20665; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Nazarbol N, 2015, BIOMED PHARM J, V8, P729, DOI DOI 10.13005/BPJ/776; Nederkoorn C, 2010, HEALTH PSYCHOL, V29, P389, DOI 10.1037/a0019921; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/0743558403258860; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Velazquez-Sanchez C, 2014, NEUROPSYCHOPHARMACOL, V39, P2463, DOI 10.1038/npp.2014.98; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2015, TRENDS NEUROSCI, V38, P345, DOI 10.1016/j.tins.2015.04.002; Werthmann J, 2015, P NUTR SOC, V74, P99, DOI 10.1017/S0029665114001451; Werthmann J, 2014, J BEHAV THER EXP PSY, V45, P136, DOI 10.1016/j.jbtep.2013.09.009; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Yeomans MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137626; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65; Zuckerman M, 1986, NIDA Res Monogr, V74, P59	56	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202994	10.1371/journal.pone.0202994	http://dx.doi.org/10.1371/journal.pone.0202994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142187	Green Submitted, gold, Green Published			2022-12-26	WOS:000442722500057
J	Brinkman-Stoppelenburg, A; Witkamp, FE; van Zuylen, L; van der Rijt, CCD; van der Heide, A				Brinkman-Stoppelenburg, Arianne; Witkamp, Frederika E.; van Zuylen, Lia; van der Rijt, Carin C. D.; van der Heide, Agnes			Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study	PLOS ONE			English	Article							OF-LIFE CARE; RANDOMIZED CONTROLLED-TRIAL; BEREAVED RELATIVES; CANCER-PATIENTS; FAMILY-MEMBERS; END; OUTCOMES; INTERVENTION; HEALTH; IMPACT	Purpose Involvement of palliative care experts improves the quality of life and satisfaction with care of patients who are in the last stage of life. However, little is known about the relation between palliative care expert involvement and quality of dying (QOD) in the hospital. We studied the association between palliative care team (PCT) consultation and QOD in the hospital as experienced by relatives. Methods We conducted a secondary analysis of data from a prospective study among relatives of patients who died from cancer in a university hospital and compared characteristics and QOD of patients for whom the PCT was or was not consulted. Results 175 out of 343 (51%) relatives responded to the questionnaire. In multivariable linear regression PCT was associated with a 1.0 point better QOD (95% CI 0.07-1.96). In most of the subdomains of QOD, we found a non-significant trend towards a more favorable outcome for patients for whom the PCT was consulted. Patients for whom the PCT was consulted had more often discussed their preferences for medical treatment, had more often been aware of their imminent death and had more often been at peace with their imminent death. Further, patients for whom the PCT was consulted and their relatives had more often been able to say goodbye. Relatives had also more often been present at the moment of death when a PCT had been consulted. Conclusion For patients dying in the hospital, palliative care consultation is associated with a favorable QOD.	[Brinkman-Stoppelenburg, Arianne; Witkamp, Frederika E.; van der Heide, Agnes] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Witkamp, Frederika E.] Rotterdam Univ Appl Sci, Fac Nursing, Rotterdam, Netherlands; [Witkamp, Frederika E.] Rotterdam Univ Appl Sci, Ctr Expertise Care Innovat, Rotterdam, Netherlands; [van Zuylen, Lia; van der Rijt, Carin C. D.] Erasmus MC, Canc Inst, Dept Med Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Brinkman-Stoppelenburg, A (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	a.brinkman-stoppelenburg@erasmusmc.nl	Solari, Alessandra/AAO-1741-2021; Van der Rijt, Carin C.D./CAF-8390-2022	Solari, Alessandra/0000-0001-9930-7579; Van der Rijt, Carin C.D./0000-0001-5996-1242; Stoppelenburg, Arianne/0000-0001-6377-1599; van Zuylen, Lia/0000-0002-7142-7605	Erasmus MC Medical Research Committee [2007-7208]; Tom and Josephine Rijckes Legacy Foundation	Erasmus MC Medical Research Committee; Tom and Josephine Rijckes Legacy Foundation	This study was financially supported by grants from the Erasmus MC Medical Research Committee (grant number 2007-7208 to FEW) and the Tom and Josephine Rijckes Legacy Foundation to FEW; neither had any involvement in the study or publication. The study was conducted independent from the funders. All authors have full access to all the data (including statistical reports and tables) in the study and take responsibility for the integrity of the data and the accuracy of the analysis.	Addington-Hall JM, 2009, PALLIATIVE MED, V23, P190, DOI 10.1177/0269216309102525; Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Blinderman CD, 2015, NEW ENGL J MED, V373, P2549, DOI 10.1056/NEJMra1411746; Brinkman-Stoppelenburg A, 2015, SUPPORT CARE CANCER, V23, P2899, DOI 10.1007/s00520-015-2655-3; Cantin B, 2009, J PALLIAT CARE, V25, P92, DOI 10.1177/082585970902500203; Casarett D, 2008, J AM GERIATR SOC, V56, P593, DOI 10.1111/j.1532-5415.2007.01610.x; Chou WC, 2013, SUPPORT CARE CANCER, V21, P1973, DOI 10.1007/s00520-013-1733-7; Costantini M, 2014, LANCET, V383, P226, DOI 10.1016/S0140-6736(13)61725-0; Curtis JR, 2011, AM J RESP CRIT CARE, V183, P348, DOI 10.1164/rccm.201006-1004OC; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Glavan BJ, 2008, CRIT CARE MED, V36, P1138, DOI 10.1097/CCM.0b013e318168f301; Hales S, 2008, ARCH INTERN MED, V168, P912, DOI 10.1001/archinte.168.9.912; Hales S, 2014, J PAIN SYMPTOM MANAG, V48, P839, DOI 10.1016/j.jpainsymman.2013.12.240; Higginson IJ, 2005, CLIN GERIATR MED, V21, P45, DOI 10.1016/j.cger.2004.08.003; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; Jongen Joost L M, 2011, BMJ Support Palliat Care, V1, P322, DOI 10.1136/bmjspcare-2011-000087; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P3, DOI 10.1016/j.ygyno.2013.10.025; Penrod JD, 2006, J PALLIAT MED, V9, P855, DOI 10.1089/jpm.2006.9.855; Perrin KO, 2015, CRIT CARE NURSE, V35, P44, DOI 10.4037/ccn2015357; Sasahara T, 2014, J PAIN SYMPTOM MANAG, V47, P579, DOI 10.1016/j.jpainsymman.2013.04.009; Sasahara T, 2010, PALLIAT SUPPORT CARE, V8, P49, DOI 10.1017/S1478951509990708; Seale C, 1997, SOC SCI MED, V45, P477, DOI 10.1016/S0277-9536(96)00379-6; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Van Scoy LJ, 2016, DEATH STUD, V40, P486, DOI 10.1080/07481187.2016.1181121; Wentlandt K, 2012, J CLIN ONCOL, V30, P4380, DOI 10.1200/JCO.2012.44.0248; Witkamp FE., 2015, INT J PALLIATIVE CAR, V2015, P1, DOI [10.1155/2015/623890, DOI 10.1155/2015/623890]; Witkamp FE, 2015, J PAIN SYMPTOM MANAG, V49, P203, DOI 10.1016/j.jpainsymman.2014.06.013; Witkamp FE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-115; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	33	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201191	10.1371/journal.pone.0201191	http://dx.doi.org/10.1371/journal.pone.0201191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138316	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100013
J	Qiu, LN; Pan, YH; Zhang, WW; Gong, AJ				Qiu, Lina; Pan, Yuhong; Zhang, Weiwei; Gong, Aijun			Application of a functionalized ionic liquid extractant tributylmethylammonium dibutyldiglycolamate ([A336][BDGA]) in light rare earth extraction and separation	PLOS ONE			English	Article							SOLVENT-EXTRACTION; DIGLYCOLAMIDES; LANTHANIDES; TODGA; ALIQUAT-336; BEHAVIOR; RESINS	A type of functionalized ionic liquid extractant, tributylmethylammonium dibutyldiglycolamate ([A336][BDGA]), was synthesized, and its extraction ability of light rare earth elements, namely, La(III), Ce(III), Pr(III) and Nd(III), was compared with that of other functionalized ionic liquid extractants, including tributylmethylammonium dioctyldiglycolamate and diglycolic amide extractants N,N,N,N-tetrabutyl-3-oxapentane-diamide (TBDGA) and N,N,N,N-tetraoctyl-3-oxapentane-diamide (TODGA). The study of extraction behavior indicated that the ionic liquids exhibited better extraction properties than the amides under lower acidity conditions. The effects of the pH and concentration of the extractant on the extraction behavior of [A336][BDGA] on light rare earths were determined. A separation strategy of mixed light rare earths was investigated by means of extraction chromatography using [A336][BDGA] as the stationary phase. As a result, nearly pure La(III), Ce(III), Pr(III) and Nd(III) were obtained, respectively. A new strategy of separating mixed light rare earths was established by means of extraction chromatography. The stationary phase of [A336][BDGA] was used in this strategy. The four rare earths elements, La(III), Ce(III), Pr(III) and Nd(III), achieved baseline separation.	[Qiu, Lina; Pan, Yuhong; Gong, Aijun] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China; [Qiu, Lina; Zhang, Weiwei; Gong, Aijun] Univ Sci & Technol Beijing, Beijing Key Lab Sci & Applicat Funct Mol & Crysta, Beijing, Peoples R China; [Zhang, Weiwei] Univ Sci & Technol Beijing, Basic Expt Ctr Nat Sci, Beijing, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing; University of Science & Technology Beijing	Gong, AJ (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China.; Gong, AJ (corresponding author), Univ Sci & Technol Beijing, Beijing Key Lab Sci & Applicat Funct Mol & Crysta, Beijing, Peoples R China.	gongaijun5661@ustb.edu.cn			Chinese National Natural Science Foundation [51701016]; National Key Research and Development Program of China [2017YFF0106006]; Beijing Municipal Natural Science Foundation [8172033]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This study was financially supported by Chinese National Natural Science Foundation (No. 51701016) (LQ), National Key Research and Development Program of China (No. 2017YFF0106006) (AG), Beijing Municipal Natural Science Foundation (CN) (No. 8172033) (AG).	Aly HF, 2007, SOLVENT EXTR ION EXC, V25, P205, DOI [10.1080/07306290601169352, DOI 10.1080/07306290601169352]; Ansari SA, 2009, SEP PURIF TECHNOL, V66, P118, DOI 10.1016/j.seppur.2008.11.019; Ansari SA, 2012, CHEM REV, V112, P1751, DOI 10.1021/cr200002f; Atanassova A, 2002, HYDROMETALLURGY, V63, P41; Belova VV, 2012, J MOL LIQ, V172, P144, DOI 10.1016/j.molliq.2012.04.012; Bose RSC, 2014, SEP SCI TECHNOL, V49, P2338, DOI 10.1080/01496395.2014.927886; Gujar RB, 2015, SEP PURIF TECHNOL, V141, P229, DOI 10.1016/j.seppur.2014.11.038; Gujar RB, 2011, J RADIOANAL NUCL CH, V288, P621, DOI 10.1007/s10967-011-0982-5; Guo L, 2014, ACS SUSTAIN CHEM ENG, V2, P1968, DOI 10.1021/sc400541b; Lucas J, 2015, RARE EARTHS: SCIENCE, TECHNOLOGY, PRODUCTION AND USE, P1, DOI 10.1016/B978-0-444-62735-3.00001-2; Mahanty BN, 2014, J HAZARD MATER, V275, P146, DOI 10.1016/j.jhazmat.2014.04.059; Mikkola JP, 2006, GREEN CHEM, V8, P250, DOI 10.1039/b512819f; Mohapatra PK, 2014, RSC ADV, V4, P10412, DOI 10.1039/c3ra43280g; Mowafy EA, 2007, SOLVENT EXTR ION EXC, V25, P205, DOI 10.1080/07366290601169352; Mowafy EA, 2014, SEP PURIF TECHNOL, V128, P18, DOI 10.1016/j.seppur.2014.03.005; Panja S, 2012, SEP PURIF TECHNOL, V96, P289, DOI 10.1016/j.seppur.2012.06.015; Rout A, 2014, IND ENG CHEM RES, V53, P6500, DOI 10.1021/ie404340p; Rout A, 2012, SEP PURIF TECHNOL, V95, P26, DOI 10.1016/j.seppur.2012.04.020; Sasaki Y, 2001, SOLVENT EXTR ION EXC, V19, P91, DOI 10.1081/SEI-100001376; Sun XQ, 2015, RSC ADV, V5, P49500, DOI 10.1039/c5ra05884h; Sun XQ, 2012, CHEM REV, V112, P2100, DOI 10.1021/cr200193x; Sun XQ, 2010, TALANTA, V81, P1877, DOI 10.1016/j.talanta.2010.03.041; Sun XQ, 2010, AICHE J, V56, P989, DOI 10.1002/aic.12039; Wang CZ, 2014, DALTON T, V43, P8713, DOI 10.1039/c4dt00032c; Wang XL, 2006, J CHEM TECHNOL BIOT, V81, P761, DOI 10.1002/jctb.1532; Xie F, 2014, MINER ENG, V56, P10, DOI 10.1016/j.mineng.2013.10.021; Yang HL, 2011, CHINESE J ANAL CHEM, V39, P1561, DOI 10.3724/SP.J.1096.2011.01561; [朱文彬 Zhu Wenbin], 2014, [核化学与放射化学, Journal of Nuclear and Radiochemistry], V36, P24	28	6	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201405	10.1371/journal.pone.0201405	http://dx.doi.org/10.1371/journal.pone.0201405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138315	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100016
J	Yoshioka, K; Provedor, E; Manne-Goehler, J				Yoshioka, Kota; Provedor, Ezequiel; Manne-Goehler, Jennifer			The resilience of Triatoma dimidiata: An analysis of reinfestation in the Nicaraguan Chagas disease vector control program (2010-2016)	PLOS ONE			English	Article							PERIDOMESTIC POPULATIONS; PYRETHROID INSECTICIDES; LATIN-AMERICA; RISK-FACTORS; TRANSMISSION; INFESTATION; REDUVIIDAE; SURVEILLANCE; MANAGEMENT; GUATEMALAN	Background The control of Triatoma dimidiata, a major vector of Chagas disease, was believed to eliminate Trypanosoma cruzitransmission in Central America. This vector was known for its ability to repeatedly reinfest human dwellings even after initial insecticide spraying. Current vector control programs assume that community-based surveillance can maintain low levels of infestation over many years, despite a lack of evidence in the literature to corroborate this assumption. This study aims to evaluate long-term reinfestation risk in the Nicaraguan vector control program from 2010 to 2016. Methods We collected data from a cohort of 395 houses in Pueblo Nuevo, Nicaragua. Primary data were collected through a field survey to assess post-intervention levels of T. dimidiata house infestation in 2016, two years after the large-scale insecticide spraying. We obtained secondary data from the records about past infestation levels and control activities between 2010 and 2015. Multilevel mixed-effects logistic regression analyses were used to identify factors associated with post-intervention house infestation. Results The control program effectively reduced the infestation level from 2010 to 2014. Community-based surveillance was introduced in 2013; however, post-intervention infestation in 2016 had nearly reached pre-intervention levels in rural villages. Post-intervention house infestation was positively associated with poor wall construction, roofing tiles piled in the peri-domestic areas or the presence of dogs. Interestingly, the odds of post-intervention house infestation were one-fifth less when villagers sprayed their own houses regularly. Past infestation levels and the intensity of government-led insecticide spraying did not explain post-intervention house infestation. Conclusions The vector control program failed to offer sustained reductions in T. dimidiata house infestation. This experience would suggest that community-based surveillance is an insufficient approach to suppressing T. dimidiata house infestation over many years. This study provides evidence to suggest that control policies for T. dimidiata should be reconsidered throughout Central America.	[Yoshioka, Kota] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Yoshioka, Kota] Harvard TH Chan Sch Publ Hlth, Publ Hlth Program, Boston, MA 02115 USA; [Provedor, Ezequiel] Univ Nacl Autonoma Nicaragua Managua, Fac Reg Multidisciplinaria Esteli, Managua, Esteli, Nicaragua; [Manne-Goehler, Jennifer] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Manne-Goehler, Jennifer] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Nagasaki University; Harvard University; Harvard T.H. Chan School of Public Health; Universidad Nacional Autonoma de Nicaragua - Managua; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Yoshioka, K (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.; Yoshioka, K (corresponding author), Harvard TH Chan Sch Publ Hlth, Publ Hlth Program, Boston, MA 02115 USA.	koy501@mail.harvard.edu		Yoshioka, Kota/0000-0001-8463-4913; Manne-Goehler, Jennifer/0000-0001-9295-0035	Japan Society for the Promotion of Science (JSPS) [JP15K19247]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was initially funded by Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/english/e-grants/) Grant-in-Aid for Young Scientists - KAKENHI Grant Number JP15K19247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bustamante DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104599; Bustamante DM, 2007, GEOSPATIAL HEALTH, V1, P199, DOI 10.4081/gh.2007.268; Zamora DMB, 2015, AM J TROP MED HYG, V93, P97, DOI 10.4269/ajtmh.14-0596; Castillo-Neyra R, 2015, PREV VET MED, V120, P349, DOI 10.1016/j.prevetmed.2015.04.014; Cecere MC, 2006, J MED ENTOMOL, V43, P902, DOI 10.1603/0022-2585(2006)43[902:CTOEOP]2.0.CO;2; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P277, DOI 10.1590/0074-0276140362; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; Pessoa GCD, 2015, REV SOC BRAS MED TRO, V48, P380, DOI 10.1590/0037-8682-0081-2015; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Gomez-Palacio A, 2015, INFECT GENET EVOL, V36, P15, DOI 10.1016/j.meegid.2015.08.035; Gurevitz JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002158; Gurtler RE, 2004, B WORLD HEALTH ORGAN, V82, P196; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Hashimoto K, 2006, AM J TROP MED HYG, V75, P226, DOI 10.4269/ajtmh.2006.75.2.0750226; Hashimoto K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003974; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; King RJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001035; Mancero Bucheli T, 2011, HIST INICIATIVA SUBR; Manne J, 2012, AM J TROP MED HYG, V86, P446, DOI 10.4269/ajtmh.2012.11-0052; Bustamante DM, 2009, CAD SAUDE PUBLICA, V25, pS83, DOI 10.1590/S0102-311X2009001300008; Pereira PCM, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-34; Melgar S, 2007, MEM I OSWALDO CRUZ, V102, P221, DOI 10.1590/S0074-02762007005000001; Ministerio de Salud, 2013, MAN PROC PREV CONTR; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Monroy C, 2009, CAD SAUDE PUBLICA, V25, pS168, DOI 10.1590/S0102-311X2009001300016; Monroy Carlota, 1998, Medical Entomology and Zoology, V49, P195; Mougabure-Cueto G, 2015, ACTA TROP, V149, P70, DOI 10.1016/j.actatropica.2015.05.014; Nakagawa J, 2003, ANN TROP MED PARASIT, V97, P289, DOI 10.1179/000349803235001895; Nieto-Sanchez C, 2015, MEM I OSWALDO CRUZ, V110, P299, DOI 10.1590/0074-02760140472; Parra-Henao G, 2015, AM J TROP MED HYG, V92, P193, DOI 10.4269/ajtmh.14-0273; Ponce C, 1999, MEM I OSWALDO CRUZ, V94, P417, DOI 10.1590/S0074-02761999000700082; Ramsey JM, 2003, J MED ENTOMOL, V40, P912, DOI 10.1603/0022-2585-40.6.912; Rassi A, 2017, MEM I OSWALDO CRUZ, V112, P224, DOI 10.1590/0074-02760160334; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Salvatella R, 2014, MEM I OSWALDO CRUZ, V109, P122, DOI 10.1590/0074-0276140338; Schofield C, 2001, FIELD TEST EV INS IN; Schofield CJ, 1997, PARASITOL TODAY, V13, P141, DOI 10.1016/S0169-4758(97)89811-0; Stevens L, 2015, J MED ENTOMOL, V52, P419, DOI 10.1093/jme/tjv002; Weeks ENI, 2013, B ENTOMOL RES, V103, P634, DOI 10.1017/S000748531300014X; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; Yoshioka K, 2017, INFECT DIS POVERTY, P6; Yoshioka K, 2015, AM J TROP MED HYG, V93, P1231, DOI 10.4269/ajtmh.15-0403; Yoshioka K, 2011, REV PANAM SALUD PUBL, V30, P439, DOI 10.1590/S1020-49892011001100006; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P379, DOI 10.1590/S0074-02762006000400006	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202949	10.1371/journal.pone.0202949	http://dx.doi.org/10.1371/journal.pone.0202949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138377	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100145
J	Huang, ZQ; Liang, N; Damdimopoulos, A; Fan, RR; Treuter, E				Huang, Zhiqiang; Liang, Ning; Damdimopoulos, Anastasius; Fan, Rongrong; Treuter, Eckardt			G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages	FASEB JOURNAL			English	Article						nuclear receptor corepressor complex; LXR; RAW264; 7; THP1	HISTONE DEACETYLASE 3; NF-KAPPA-B; TRANSCRIPTIONAL REPRESSION; ABCA1; ATHEROSCLEROSIS; ACTIVATION; ABCG1; LXR; BACTERIAL; OBESITY	Macrophages play important roles in linking alterations of cholesterol metabolism and inflammation to the development of atherosclerosis. Previous studies have identified several positive and negative crosstalk mechanisms that connect cholesterol efflux and inflammation at the transcriptional level. Of particular relevance is that the expression of ATP-binding cassette transporter A1 (Abca1), a main regulator of cholesterol efflux, can be induced by oxysterol receptor LXR agonists but also by bacterial endotoxins, such as LPS, that activate TLR4 signaling. However, the extent to which these pathways influence each other has remained incompletely understood. We investigated the possible role of the transcriptional coregulator G protein pathway suppressor 2 (GPS2) in LPS-induced Abca1 expression and cholesterol efflux in mouse and human macrophages. To activate Abca1, GPS2 cooperates with the LPS-inducible NF-B subunit p65, but not with LXRs nor with corepressor complex subunits that otherwise cooperate with GPS2 to repress proinflammatory gene expression. Overall, our work identifies a regulatory chromatin component of crosstalk mechanisms between cholesterol efflux and inflammation that specifically affects ABCA1. Because GPS2 expression is down-regulated in some humans with obese and type 2 diabetes, the macrophage GPS-2/ABC-A1 pathway could be altered and contribute to atherogenesis.Huang, Z., Liang, N., Damdimopoulos, A., Fan, R., Treuter, E. G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages.	[Huang, Zhiqiang; Liang, Ning; Damdimopoulos, Anastasius; Fan, Rongrong; Treuter, Eckardt] Karolinska Inst, Dept Biosci & Nutr, Ctr Innovat Med CIMED, Huddinge, Sweden	Karolinska Institutet	Fan, RR; Treuter, E (corresponding author), Karolinska Inst, Dept Biosci & Nutr, NEO, S-14183 Huddinge, Sweden.	rongrong.fan@ki.se; eckardt.treuter@ki.se	Fan, Rongrong/N-3446-2017	Fan, Rongrong/0000-0002-5707-1497; Liang, Ning/0000-0002-7848-2893; Treuter, Eckardt/0000-0002-4147-8989; Huang, Zhiqiang/0000-0001-5208-008X	Center for Innovative Medicine (CIMED) at the Karolinska Institutet; Swedish Research Council; Swedish Cancer Society; Swedish Diabetes Foundation; Novo Nordisk Foundation; European Foundation for the Study of Diabetes (EFSD)/Lilly research fellowship; CSC [201206170053]	Center for Innovative Medicine (CIMED) at the Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Diabetes Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes (EFSD)/Lilly research fellowship; CSC	The authors thank all members of the laboratory for scientific discussions and materials. The study was supported by grants from the Center for Innovative Medicine (CIMED) at the Karolinska Institutet, the Swedish Research Council, the Swedish Cancer Society, the Swedish Diabetes Foundation, and the Novo Nordisk Foundation (to E.T.); a European Foundation for the Study of Diabetes (EFSD)/Lilly research fellowship (to R.F.); and CSC doctoral scholarship File 201206170053 (to Z.H.). The authors declare no conflicts of interest.	Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Cederquist CT, 2017, MOL METAB, V6, P125, DOI 10.1016/j.molmet.2016.10.007; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Emmett MJ, 2017, NATURE, V546, P544, DOI 10.1038/nature22819; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Gerbod-Giannone MC, 2006, P NATL ACAD SCI USA, V103, P3112, DOI 10.1073/pnas.0510345103; Gillespie MA, 2015, EMBO J, V34, P1244, DOI 10.15252/embj.201489819; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kaplan R, 2002, J LIPID RES, V43, P952; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Libby P, 2016, CIRC RES, V118, P531, DOI 10.1161/CIRCRESAHA.116.308334; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Maurya MR, 2013, J LIPID RES, V54, P2525, DOI 10.1194/jlr.M040212; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park SH, 2012, ARTERIOSCL THROM VAS, V32, P2869, DOI 10.1161/ATVBAHA.112.254573; Phillips MC, 2018, J LIPID RES, V59, P749, DOI 10.1194/jlr.R082313; Pollack RM, 2016, DIABETES CARE, V39, pS244, DOI 10.2337/dcS15-3015; Pothineni NVK, 2017, EUR HEART J, V38, P3195, DOI 10.1093/eurheartj/ehx362; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Sallam T, 2018, NAT MED, V24, P304, DOI 10.1038/nm.4479; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Thompson PA, 2010, J LIPID RES, V51, P2672, DOI 10.1194/jlr.M007435; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Treuter E, 2017, FEBS LETT, V591, P2959, DOI 10.1002/1873-3468.12850; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Westerterp M, 2018, CIRCULATION, V138, P898, DOI 10.1161/CIRCULATIONAHA.117.032636; Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	48	9	9	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1631	1643		10.1096/fj.201801123R	http://dx.doi.org/10.1096/fj.201801123R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30153049	hybrid			2022-12-26	WOS:000457296600011
J	Avenarius, MR; Jung, JY; Askew, C; Jones, SM; Hunker, KL; Azaiez, H; Rehman, AU; Schraders, M; Najmabadi, H; Kremer, H; Smith, RJH; Geleoc, GSG; Dolan, DF; Raphael, Y; Kohrman, DC				Avenarius, Matthew R.; Jung, Jae-Yun; Askew, Charles; Jones, Sherri M.; Hunker, Kristina L.; Azaiez, Hela; Rehman, Atteeq U.; Schraders, Margit; Najmabadi, Hossein; Kremer, Hannie; Smith, Richard J. H.; Geleoc, Gwenaelle S. G.; Dolan, David F.; Raphael, Yehoash; Kohrman, David C.			Grxcr2 is required for stereocilia morphogenesis in the cochlea	PLOS ONE			English	Article							PLANAR CELL POLARITY; AUDITORY HAIR-CELLS; PROTEIN-STRUCTURE PREDICTION; NONSYNDROMIC HEARING-LOSS; MOUSE INNER-EAR; SENSORY TRANSDUCTION; DEVELOPMENTAL ACQUISITION; SECONDARY STRUCTURE; GENE-EXPRESSION; USHER-SYNDROME	Hearing and balance depend upon the precise morphogenesis and mechanosensory function of stereocilia, the specialized structures on the apical surface of sensory hair cells in the inner ear. Previous studies of Grxcr1 mutant mice indicated a critical role for this gene in control of stereocilia dimensions during development. In this study, we analyzed expression of the paralog Grxcr2 in the mouse and evaluated auditory and vestibular function of strains carrying targeted mutations of the gene. Peak expression of Grxcr2 occurs during early postnatal development of the inner ear and GRXCR2 is localized to stereocilia in both the cochlea and in vestibular organs. Homozygous Grxcr2 deletion mutants exhibit significant hearing loss by 3 weeks of age that is associated with developmental defects in stereocilia bundle orientation and organization. Despite these bundle defects, the mechanotransduction apparatus assembles in relatively normal fashion as determined by whole cell electrophysiological evaluation and FM1-43 uptake. Although Grxcr2 mutants do not exhibit overt vestibular dysfunction, evaluation of vestibular evoked potentials revealed subtle defects of the mutants in response to linear accelerations. In addition, reduced Grxcr2 expression in a hypomorphic mutant strain is associated with progressive hearing loss and bundle defects. The stereocilia localization of GRXCR2, together with the bundle pathologies observed in the mutants, indicate that GRXCR2 plays an intrinsic role in bundle orientation, organization, and sensory function in the inner ear during development and at maturity.	[Avenarius, Matthew R.; Jung, Jae-Yun; Hunker, Kristina L.; Dolan, David F.; Raphael, Yehoash; Kohrman, David C.] Univ Michigan, Kresge Hearing Res Inst, Sch Med, Dept Otolaryngol, 1301 E Ann St, Ann Arbor, MI 48109 USA; [Avenarius, Matthew R.; Kohrman, David C.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Askew, Charles] Univ Virginia, Neurosci Grad Program, Charlottesville, VA USA; [Askew, Charles; Geleoc, Gwenaelle S. G.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Jones, Sherri M.] East Carolina Univ, Dept Commun Sci & Disorders, Greenville, NC USA; [Azaiez, Hela; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Iowa City, IA USA; [Rehman, Atteeq U.] NIDCD, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD USA; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Hearing & Genes Div, Nijmegen, Netherlands; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Avenarius, Matthew R.] Nationwide Childrens Hosp, Inst Genom Med, Columbus, OH USA; [Jung, Jae-Yun] Dankook Univ, Dept Otolaryngol Head & Neck Surg, Cheonan, South Korea; [Askew, Charles] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC USA; [Jones, Sherri M.] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia; Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; East Carolina University; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Dankook University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Nebraska System; University of Nebraska Lincoln	Kohrman, DC (corresponding author), Univ Michigan, Kresge Hearing Res Inst, Sch Med, Dept Otolaryngol, 1301 E Ann St, Ann Arbor, MI 48109 USA.; Kohrman, DC (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	dkohrman@umich.edu	Kremer, Hannie/F-5126-2010; Azaiez, Hela/AAQ-7011-2020; Najmabadi, Hossein/P-8182-2017; Rehman, Atteeq/AAG-8342-2020	Kremer, Hannie/0000-0002-0841-8693; Azaiez, Hela/0000-0002-2863-6970; Geleoc, Gwenaelle/0000-0002-2825-6521; Avenarius, Matthew/0000-0001-9516-5163; Askew, Charles/0000-0002-6131-6602; Smith, Richard/0000-0003-1201-6731	NIH-NIDCD [DC003049, DC005188, DC006443, DC008853, DC002842, DC000011]; Margaret G. Bertsch Endowed Research Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011, P30DC005188, R01DC006443, R01DC003049, R01DC008853, R01DC002842] Funding Source: NIH RePORTER	NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Margaret G. Bertsch Endowed Research Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by NIH-NIDCD grants DC003049 (DCK), DC005188 (DCK and YR), DC006443 (SMJ), DC008853 (GSGG), DC002842 (RJHS), and DC000011 (MRA) and by the Margaret G. Bertsch Endowed Research Fund (DCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arany ZP, 2008, CURR PROTOC HUM GENE, DOI DOI 10.1002/0471142905.HG1110S58; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Bartles JR, 1996, J CELL SCI, V109, P1229; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beyer LA, 2000, J NEUROCYTOL, V29, P227, DOI 10.1023/A:1026515619443; Bonthuis PJ, 2015, CELL REP, V12, P979, DOI 10.1016/j.celrep.2015.07.017; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dallos P., 1973, AUDITORY PERIPHERY, P548; Daudet N, 2002, CELL MOTIL CYTOSKEL, V53, P326, DOI 10.1002/cm.10092; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Erven A, 2002, EUR J NEUROSCI, V16, P1433, DOI 10.1046/j.1460-9568.2002.02213.x; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Friedman TB, 2011, ADV OTO-RHINO-LARYNG, V70, P56, DOI 10.1159/000322473; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2012, J NEUROSCI, V32, P2762, DOI 10.1523/JNEUROSCI.3635-11.2012; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Gurtler N, 2004, J MOL MED, V82, P775, DOI 10.1007/s00109-004-0597-1; Horwitz GC, 2011, J NEUROSCI, V31, P16814, DOI 10.1523/JNEUROSCI.3064-11.2011; Imtiaz A, 2014, HUM MUTAT, V35, P618, DOI 10.1002/humu.22545; Jagger D, 2011, HUM MOL GENET, V20, P466, DOI 10.1093/hmg/ddq493; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Jones SM, 1999, HEARING RES, V135, P56, DOI 10.1016/S0378-5955(99)00090-8; Jones TA, 1999, HEARING RES, V136, P75, DOI 10.1016/S0378-5955(99)00110-0; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Lu XW, 2016, WIRES DEV BIOL, V5, P85, DOI 10.1002/wdev.202; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; McGee DJ, 2006, J BIOL CHEM, V281, P3290, DOI 10.1074/jbc.M506139200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Meyers JR, 2003, J NEUROSCI, V23, P4054; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Mustapha M, 2009, J NEUROSCI, V29, P1212, DOI 10.1523/JNEUROSCI.4957-08.2009; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Noguchi S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.112; Odeh H, 2004, AUDIOL NEURO-OTOL, V9, P303, DOI 10.1159/000080701; Odeh H, 2010, AM J HUM GENET, V86, P148, DOI 10.1016/j.ajhg.2010.01.016; OSBORNE MP, 1991, SCANNING MICROSCOPY, V5, P555; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Papadopoulos JS, 2007, CONSTRAINT BASED MUL; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Raphael Y, 2001, HEARING RES, V151, P237, DOI 10.1016/S0378-5955(00)00233-1; Rida PCG, 2009, SEMIN CELL DEV BIOL, V20, P978, DOI 10.1016/j.semcdb.2009.02.007; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sabag Adi D., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Scheffer DI, 2015, GENE EXPRESSION MOUS; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Sipe CW, 2011, DEVELOPMENT, V138, P3441, DOI 10.1242/dev.065961; SOBKOWICZ HM, 1995, J NEUROCYTOL, V24, P633, DOI 10.1007/BF01179815; Steel KP, 1995, ANNU REV GENET, V29, P675; Van Laer L, 2003, EAR HEARING, V24, P275, DOI 10.1097/01.AUD.0000079805.04016.03; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Xia JH, 2002, J HUM GENET, V47, P635, DOI 10.1007/s100380200098; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng QY, 2001, HEARING RES, V154, P45, DOI 10.1016/S0378-5955(01)00215-5; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	96	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201713	10.1371/journal.pone.0201713	http://dx.doi.org/10.1371/journal.pone.0201713			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157177	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400011
J	Edwards, HA; Schroeder, J; Dugdale, HL				Edwards, Hannah A.; Schroeder, Julia; Dugdale, Hannah L.			Gender differences in authorships are not associated with publication bias in an evolutionary journal	PLOS ONE			English	Article							DOUBLE-BLIND; WOMEN; PATTERNS; OUTCOMES; SCIENCE; JOB	The loss of talented women from senior academic positions has partly resulted from a lower number of published papers and the accompanying reduced visibility of female compared to male scientists. The reasons for these gender-differences in authorship is unclear. One potential reason is a bias in the editorial and review process of scientific journals. We investigated whether patterns of authorship and editorial outcome were biased according to gender and geographic location in the Journal of Evolutionary Biology. Such potential bias may contribute to inequality in the field. We found patterns of gender differences in authorship, but this was unrelated to the editorial decision of whether to publish the manuscript. Female first-authors (the lead role) were six times less likely to be named as the corresponding author than male first-authors, and female first-authors were more likely to be displaced as corresponding authors by female co-authors than were male first-authors. We found an under-representation of female first-and last-authors compared to baseline populations of members of the European Society for Evolutionary Biology (which publishes the Journal of Evolutionary Biology) and of Evolutionary Biology faculty at the world top-10 universities for the Life Sciences. Also, manuscripts from Asia were five times more likely to be rejected on the final decision, independent of gender. Overall our results suggest that the peer review processes we investigated at the Journal of Evolutionary Biology are predominately genderneutral, but not neutral to geographic location. Editorial gender-bias is thus unlikely to be a contributing factor to differences in authorship in this journal.	[Edwards, Hannah A.; Dugdale, Hannah L.] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Schroeder, Julia] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	University of Leeds; Imperial College London	Edwards, HA (corresponding author), Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	hannah.a.edwards@outlook.com	Schroeder, Julia/B-1436-2010; Dugdale, Hannah L/C-7138-2008	Schroeder, Julia/0000-0002-4136-843X; Dugdale, Hannah L/0000-0001-8769-0099	European Society of Evolutionary Biology (ESEB); JEB (the society journal for the ESEB); JEB; ESEB Equal Opportunities Fund 2017	European Society of Evolutionary Biology (ESEB); JEB (the society journal for the ESEB); JEB; ESEB Equal Opportunities Fund 2017	HAE was supported by a (sic)1000 European Society of Evolutionary Biology (ESEB) Equal Opportunities Fund 2017. The editorial office of the Journal of Evolutionary Biology, the society journal for the ESEB, provided data on the reviewing requests and publication decisions of manuscripts submitted to the journal between January 2012 and February 2016.; We thank Mike Ritchie, former Editor-in-Chief of the JEB (the society journal for the ESEB), and Lianne Baker, Managing Editor of the JEB, for their support and for providing data on the reviewing requests and publication decisions of manuscripts submitted to the journal. We also thank Ute Friedrich from the ESEB office for providing membership data and three anonymous reviewers for their constructive comments. HAE was supported by the ESEB Equal Opportunities Fund 2017.	Ali J, 2010, J YOUNG PHARM, V2, P3, DOI [10.4103/0975-1483.62205, 10.4103/0975-1483.51868]; Amrein K, 2011, GENDER MED, V8, P378, DOI 10.1016/j.genm.2011.10.007; [Anonymous], 2015, SHE FIGURES 2015 EUR; Barrett SCH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2553; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake-Beard S, 2011, J SOC ISSUES, V67, P622, DOI 10.1111/j.1540-4560.2011.01717; BLANK RM, 1991, AM ECON REV, V81, P1041; Bonnet X. R., 2004, J WOM MINOR SCI ENG, V10, P353; Burgman M, 2015, CONSERV BIOL, V29, P1255, DOI 10.1111/cobi.12589; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Cho AH, 2014, PEERJ, V2, DOI 10.7717/peerj.542; Cole J. R., 1984, ADV MOTIVATION ACHIE, V2, P217; Committee on Science Engineering and Public Policy (COSE-PUP), 2007, BIAS BARR FULF POT W; Damschen EI, 2005, FRONT ECOL ENVIRON, V3, P212, DOI 10.2307/3868465; Dugdale HL, 2011, TRENDS ECOL EVOL, V26, P622, DOI 10.1016/j.tree.2011.07.005; Fox CW, 2017, FUNCT ECOL, V31, P270, DOI 10.1111/1365-2435.12665; Fox CW, 2016, FUNCT ECOL, V30, P140, DOI 10.1111/1365-2435.12529; Fox CW, 2016, FUNCT ECOL, V30, P126, DOI 10.1111/1365-2435.12587; Fyfe A, 2018, TIME HIGHER ED  0212; Garcia-Carpintero E, 2010, SCIENTOMETRICS, V84, P799, DOI 10.1007/s11192-010-0199-3; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Grod ON, 2010, FRONT ECOL ENVIRON, V8, P187, DOI 10.1890/090048; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heckenberg A, 2010, WIEN KLIN WOCHENSCHR, V122, P141, DOI 10.1007/s00508-010-1302-8; Herrera AJ, 1999, NATURE, V397, P467, DOI 10.1038/17194; Kamalski J, 2011, RISE ASIA RES PROFIL; Knapp S, 2005, TRENDS ECOL EVOL, V20, P55, DOI 10.1016/j.tree.2004.11.016; Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784; Long MT, 2015, GASTROINTEST ENDOSC, V81, P1440, DOI 10.1016/j.gie.2015.01.032; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P177, DOI 10.1890/12.WB.011; Mason M. A., 2004, DO BABIES MATTER 2; Mauleon E, 2013, SCIENTOMETRICS, V95, P87, DOI 10.1007/s11192-012-0824-4; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Morton MJ, 2007, J NATL MED ASSOC, V99, P764; Moss-Racusin CA, 2010, PSYCHOL WOMEN QUART, V34, P186, DOI 10.1111/j.1471-6402.2010.01561.x; Pasterkamp G, 2007, SCIENTOMETRICS, V70, P153, DOI 10.1007/s11192-007-0109-5; R Development Core Team, 2017, R LANG ENV STAT COMP; Rammstedt B, 2001, Z PADAGOG PSYCHOL, V15, P207, DOI 10.1024//1010-0652.15.34.207; Roberts SG, 2016, J LANG EVOL, V1, P163, DOI 10.1093/jole/lzw009; Schroeder J, 2013, J EVOLUTION BIOL, V26, P2063, DOI 10.1111/jeb.12198; Shah Deepika N, 2013, Digit J Ophthalmol, V19, P50, DOI 10.5693/djo.01.2013.07.002; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; Sieverding M, 2003, Z SOZIALPSYCHOL, V34, P147, DOI 10.1024//0044-3514.34.3.147; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; Topaz CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161357; Uzun A, 2004, SCIENTOMETRICS, V61, P457, DOI 10.1023/B:SCIE.0000045121.26810.35; Valian V., 1999, WHY SO SLOW ADV WOME, V1 1st; Wais K, 2016, GENDERIZER GENDER PR; Webb TJ, 2008, TRENDS ECOL EVOL, V23, P351, DOI 10.1016/j.tree.2008.03.003; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Willett Peter, 2013, International Journal of Knowledge Content Development & Technology, V3, P5, DOI 10.5865/IJKCT.2013.3.1.005	53	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201725	10.1371/journal.pone.0201725	http://dx.doi.org/10.1371/journal.pone.0201725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157231	Green Published, gold			2022-12-26	WOS:000443071400012
J	Nilsson, E; King, SE; McBirney, M; Kubsad, D; Pappalardo, M; Beck, D; Sadler-Riggleman, I; Skinner, MK				Nilsson, Eric; King, Stephanie E.; McBirney, Margaux; Kubsad, Deepika; Pappalardo, Michelle; Beck, Daniel; Sadler-Riggleman, Ingrid; Skinner, Michael K.			Vinclozolin induced epigenetic transgenerational inheritance of pathologies and sperm epimutation biomarkers for specific diseases	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; DNA METHYLATION; READ ALIGNMENT; ADIPOSE-TISSUE; EXPOSURE; OBESITY; CLASSIFICATION; INDUCTION; PACKAGE; GENES	Exposure to vinclozolin has been shown to induce the epigenetic transgenerational inheritance of increased susceptibility to disease, and to induce transgenerational changes to the epigenome. In the current study, gestating F0 generation rats were exposed to vinclozolin, and the subsequent F1, F2 and transgenerational F3 generations were evaluated for diseases and pathologies. F1 and F2 generation rats exhibited few abnormalities. However, F3 generation rats showed transgenerational increases in testis, prostate, and kidney disease, changes in the age of puberty onset in males, and an increased obesity rate in females. Overall there was an increase in the rate of animals with disease, and in the incidence of animals with multiple diseases. The objective of the current study was to analyze the sperm epigenome of F3 generation rats with specific abnormalities and compare them to rats without those abnormalities, in an effort to find epigenetic biomarkers of transgenerational disease. Unique signatures of differential DNA methylation regions (DMRs) in sperm were found that associated with testis disease, prostate disease and kidney disease. Confounding factors identified were the presence of multiple diseases in the analysis and the limited number of animals without disease. These results further our understanding of the mechanisms governing epigenetic transgenerational inheritance, and may lead in the future to the use of epigenetic biomarkers that will help predict an individual's susceptibility for specific diseases.	[Nilsson, Eric; King, Stephanie E.; McBirney, Margaux; Kubsad, Deepika; Pappalardo, Michelle; Beck, Daniel; Sadler-Riggleman, Ingrid; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020	King, Stephanie Evelyn/0000-0002-0970-6355; Kubsad, Deepika/0000-0002-3830-1808	John Templeton Foundation [50183]; NIH [ES012974]	John Templeton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a John Templeton Foundation (50183) (https://www.templeton.org/) grant to MKS and NIH (ES012974) (https://www.nih.gov/) grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baker TR, 2014, MOL CELL ENDOCRINOL, V398, P36, DOI 10.1016/j.mce.2014.08.011; Ben Maamar M, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy010; Berger A, 2016, REPROD TOXICOL, V60, P39, DOI 10.1016/j.reprotox.2015.12.004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Bruner-Tran KL, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138370; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Carvan MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176155; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Knecht AL, 2017, TOXICOL APPL PHARM, V329, P148, DOI 10.1016/j.taap.2017.05.033; Kress A, 2017, J INSECT PHYSIOL, V99, P113, DOI 10.1016/j.jinsphys.2017.04.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leroux S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0292-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Manikkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102091; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McBirney M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184306; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Pocar P, 2017, TOXICOL APPL PHARM, V322, P113, DOI 10.1016/j.taap.2017.03.008; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Santi D, 2017, ANDROLOGY-US, V5, P695, DOI 10.1111/andr.12379; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; Schuster A, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw001; Shnorhavorian M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170085; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0178-0; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P1, DOI 10.1016/j.mce.2014.07.017; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592; 2000, ARCH INTERN MED, V160, P898	72	50	50	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202662	10.1371/journal.pone.0202662	http://dx.doi.org/10.1371/journal.pone.0202662			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157260	gold, Green Published, Green Submitted			2022-12-26	WOS:000443071400067
J	Yi, Y; Li, FJ; Zhang, MW; Yuan, Y; Zhu, M; Guo, WS; Zhu, XK; Li, CY				Yi, Yuan; Li, Fujian; Zhang, Mingwei; Yuan, Yi; Zhu, Min; Guo, Wenshan; Zhu, Xinkai; Li, Chunyan			Is there a nitrogen fertilizer threshold emitting less N2O with the prerequisite of high wheat production?	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; USE EFFICIENCY; CROPPING SYSTEMS; OXIDE EMISSIONS; RICE PRODUCTION; GRAIN PRODUCTION; EASTERN CHINA; MANAGEMENT; REGION; SOILS	Excessive use of synthetic nitrogen (N) fertilizer and lower nitrogen use efficiency (NUE) are threatening the wheat production in the middle and lower reaches of Yangtze River. Excess input of N fertilizers also results in severe environmental pollution, climate change and biodiversity loss. However, the study on reasonable nitrogen application and NUE improvement with the prerequisite of stable and high yield remains unexplored. In our study, the four different levels of nitrogen were applied to find out the nitrogen threshold which could be both friendly to environment and promise the stable and high yield. The experiment was carried out in Yangzhou University (Yangzhou, China). The wheat cultivar Yangmai 23 was selected as the research material. The four nitrogen levels were as follows: 0, 189, 229.5, and 270 kg ha(-1). The results showed that the grain yield under the application of 229.5 kg ha(-1) N was as high as that under 270 kg ha(-1) N level, with the observation of 20.3% increase in agronomic efficiency. The N2O emission of 229.5 kg ha(-1) N application was as low as that of 189 kg ha(-1) N, but the grain yield and agronomic efficiency were significantly higher (11.9%) under 229.5 kg ha(-1) treatment than the lower one. Taken together, this indicated the nitrogen level at 229.5 kg ha(-1) could be identified as the fertilizer threshold, which will be beneficial for the future fieldwork.	[Yi, Yuan; Li, Fujian; Zhang, Mingwei; Zhu, Min; Guo, Wenshan; Zhu, Xinkai; Li, Chunyan] Yangzhou Univ, Wheat Res Inst, Coinnovat Ctr Modern Prod Technol Grain Crops, Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China; [Yuan, Yi] Zhenjiang Agrotech Extens Stn 97, Zhenjiang City, Jiangsu, Peoples R China	Yangzhou University	Guo, WS; Zhu, XK (corresponding author), Yangzhou Univ, Wheat Res Inst, Coinnovat Ctr Modern Prod Technol Grain Crops, Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China.	guows@yze.edu.cn; xkzhu@yzu.edu.cn		yi, yuan/0000-0002-8795-6261	National Key Research and Development Program of China - Ministry of Science and Technology of the People's Republic of China [2016YFD0300107]; National Natural Science Foundation of China by the committee of National Natural Science Foundation of China [31771711]; Science and Technology Innovation Group of Yangzhou University; Innovation Program of Jiangsu Province [CX(16)1001]; Yangzhou Science Foundation for Excellent Youths - Yangzhou Science and Technology Bureau [YZ2017098]	National Key Research and Development Program of China - Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China by the committee of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Group of Yangzhou University; Innovation Program of Jiangsu Province; Yangzhou Science Foundation for Excellent Youths - Yangzhou Science and Technology Bureau	This work was supported by the National Key Research and Development Program of China (2016YFD0300107), which was funded by the Ministry of Science and Technology of the People's Republic of China (http://www.most.gov.cn/) and the receiver is Li CY. It was also supported by the National Natural Science Foundation of China (31771711), which was provided by the committee of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) with the receiver Guo WS. In addition, it was sponsored by Science and Technology Innovation Group of Yangzhou University (2016) with the receiver Zhu XK. It was also funded by the Innovation Program of Jiangsu Province (CX(16)1001) with the receiver Li CY. It was also supported by the Yangzhou Science Foundation for Excellent Youths (YZ2017098), which was funded by the Yangzhou Science and Technology Bureau (http://kjj.yangzhou.gov.cn/yzkjj/index.shtml) with the receiver Li CY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Chem A, 1980, OFFICIAL METHODS ANA; Chen J, 2011, AGR ECOSYST ENVIRON, V142, P195, DOI 10.1016/j.agee.2011.05.005; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; Dobermann A, 2002, PLANT SOIL, V247, P153, DOI 10.1023/A:1021197525875; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; European Environmental Agency, 2013, ANN EUR UN GREENH GA, DOI [10.2800/92220, DOI 10.2800/92220]; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Grant B, 2004, CLIMATIC CHANGE, V65, P315, DOI 10.1023/B:CLIM.0000038226.60317.35; Gray V, 2010, S AFR GEOGR J, V92, P86; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo Q, 2013, SPAN J AGRIC RES, V11, P980, DOI 10.5424/sjar/2013114-4373; Jia XC, 2014, AGR WATER MANAGE, V137, P92, DOI 10.1016/j.agwat.2014.02.010; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Kahrl F, 2010, ENVIRON SCI POLICY, V13, P688, DOI 10.1016/j.envsci.2010.07.006; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kumar A, 2015, J PURE APPL MICROBIO, V9, P1487; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Li CS, 2006, J ENVIRON QUAL, V35, P1554, DOI 10.2134/jeq2005.0208; Li CS, 2001, NUTR CYCL AGROECOSYS, V60, P159, DOI 10.1023/A:1012642201910; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Lu R, 1999, SOIL AGROCHEMISTRY A, V15; Ma L, 2014, LAND USE POLICY, V37, P52, DOI 10.1016/j.landusepol.2013.01.008; Manna MC, 2005, FIELD CROP RES, V93, P264, DOI 10.1016/j.fcr.2004.10.006; Meng QF, 2012, AGR ECOSYST ENVIRON, V146, P93, DOI 10.1016/j.agee.2011.10.015; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Nouriyani H, 2012, RES CROP, V13, P439; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Raun WR, 2002, AGRON J, V94, P815; Richard B, 2011, ENVIRON PLANN A, V43, P431, DOI [10.1007/978-94-007-6208-4_2, DOI 10.1007/978-94-007-6208-4_2]; Roelcke M, 2004, PEDOSPHERE, V14, P449; Roelcke M, 2002, NUTR CYCL AGROECOSYS, V63, P255, DOI 10.1023/A:1021115218531; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Sheoran P, 2016, INT J PLANT PROD, V10, P109; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Solomon S, 2007, CLIMATE CHANGE 2007, V18, P95; Tian HQ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044020; Wang DJ, 2004, ENVIRON GEOCHEM HLTH, V26, P221, DOI 10.1023/B:EGAH.0000039584.35434.e0; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yan J, 2009, SOILS; Yao ZS, 2010, PLANT SOIL, V327, P315, DOI 10.1007/s11104-009-0056-4; Zhang JH, 2013, PEDOSPHERE, V23, P59, DOI 10.1016/S1002-0160(12)60080-0; Zhao X, 2009, PLANT SOIL, V319, P225, DOI 10.1007/s11104-008-9865-0; Zheng J, 2000, RICE WHEAT CROPPING; Zhu XinKai, 2003, Agricultural Sciences in China, V2, P609; Zou JW, 2009, GLOBAL CHANGE BIOL, V15, P229, DOI 10.1111/j.1365-2486.2008.01775.x	55	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202343	10.1371/journal.pone.0202343	http://dx.doi.org/10.1371/journal.pone.0202343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153270	Green Published, Green Submitted, gold			2022-12-26	WOS:000443001700014
J	Cavazzana, A; Rohrborn, A; Garthus-Niegel, S; Larsson, M; Hummel, T; Croy, I				Cavazzana, Annachiara; Rohrborn, Anja; Garthus-Niegel, Susan; Larsson, Maria; Hummel, Thomas; Croy, Ilona			Sensory-specific impairment among older people. An investigation using both sensory thresholds and subjective measures across the five senses	PLOS ONE			English	Article							AGE-RELATED-CHANGES; ODOR DISCRIMINATION; HEARING IMPAIRMENT; VISUAL IMPAIRMENT; VISION IMPAIRMENT; ADULTS; HEALTH; TASTE; LIFE; DECLINE	Age-related sensory impairment is a slow and gradual progress, which affects multiple modalities. Two contradictory hypotheses exist about the age-related decline of sensory thresholds. The common factor theory assumes one underlying factor-which accounts for the loss of several sensory modalities simultaneously-and the specific factor theory predicts that the sensory decline is uncorrelated between different modalities. In this study, we aimed to explore whether (i) there is a common factor of sensory thresholds in older people, (ii) older people assume that sensory decline in one modality also affects other modalities, (iii) there is a relation between sensory threshold and the subjective assessment of sensory function. This was accomplished by collecting both threshold measures and self-reported ratings for smell, hearing, taste, vision, and touch function in a group of 104 older people (mean age: 67.2 years; SD: 9.85; range: 50-100 years). Results indicated that there was no common factor of sensory thresholds, hence an impairment in one modality did not necessarily imply a shortfall in other modalities. In contrast, our results suggested one or two common factor(s) for the participants' ratings. Participants who reported a diminished function in one sense tended to generalize this rating to the other senses as well. The correspondence between subjective ratings and sensory thresholds was relatively good for vision and audition, although no correlations were observed for the other domains. These findings have implications for clinicians, suggesting that subjective measures should be combined with sensory threshold measurements when evaluating sensory dysfunction. Also, these data convey a positive message for older people and their physicians by showing that loss in one sensory modality does not necessarily generalize to losses across all sensory modalities.	[Cavazzana, Annachiara; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Cavazzana, Annachiara; Larsson, Maria] Stockholm Univ, Dept Psychol, Gosta Ekman Lab, Stockholm, Sweden; [Rohrborn, Anja; Garthus-Niegel, Susan; Croy, Ilona] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Fac Med, Dresden, Germany; [Garthus-Niegel, Susan] Norwegian Inst Publ Hlth, Dept Child Hlth, Oslo, Norway	Technische Universitat Dresden; Stockholm University; Technische Universitat Dresden; Norwegian Institute of Public Health (NIPH)	Cavazzana, A (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.; Cavazzana, A (corresponding author), Stockholm Univ, Dept Psychol, Gosta Ekman Lab, Stockholm, Sweden.	annachiara.cavazzana@gmail.com		Croy, Ilona/0000-0002-0361-5559	Deutsche Froschungsgemeinschaft [DFG HU 411/18-1]; Swedish Foundation for Humanities and Social Sciences [M14-0375:1]; Open Access Publishing Funds of the SLUB / TU Dresden	Deutsche Froschungsgemeinschaft(German Research Foundation (DFG)); Swedish Foundation for Humanities and Social Sciences; Open Access Publishing Funds of the SLUB / TU Dresden	This research was supported by a grant from the Deutsche Froschungsgemeinschaft (http://www.dfg.de) to TH (DFG HU 411/18-1) and by the The Swedish Foundation for Humanities and Social Sciences (https://rio.jrc.ec.europa.eu/en/organisations/swedish-foundation-humanities-and-social-sciences) to ML (M14-0375:1). We acknowledge support by the Open Access Publishing Funds of the SLUB / TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bazargan M, 2001, J GERONTOL B-PSYCHOL, V56, pP268, DOI 10.1093/geronb/56.5.P268; Berardi A, 2001, EXP AGING RES, V27, P19, DOI 10.1080/03610730126014; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bourque P, 2007, CAN J NURS RES, V39, P154; Bowden JL, 2013, AGE, V35, P1077, DOI 10.1007/s11357-012-9429-3; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Caban AJ, 2005, AM J PUBLIC HEALTH, V95, P1940, DOI 10.2105/AJPH.2004.056671; CAUNA N, 1958, J ANAT, V92, P1; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Chou KL, 2008, J AFFECT DISORDERS, V106, P191, DOI 10.1016/j.jad.2007.05.028; Correia C, 2016, J AM GERIATR SOC, V64, P306, DOI 10.1111/jgs.13955; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Cruickshanks Karen J., 2012, Seminars in Hearing, V33, P217, DOI 10.1055/s-0032-1315720; Decorps J, 2014, AGEING RES REV, V13, P90, DOI 10.1016/j.arr.2013.12.003; Deshpande N, 2008, NEUROBIOL AGING, V29, P765, DOI 10.1016/j.neurobiolaging.2006.12.002; Doty RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00020; Farage MA, 2008, AGING CLIN EXP RES, V20, P195; Fischer ME, 2009, OPHTHAL EPIDEMIOL, V16, P346, DOI 10.3109/09286580903312236; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fozard J.L., 1990, HDB PSYCHOL AGING, V3, P143; Fukunaga A, 2005, J GERONTOL A-BIOL, V60, P109, DOI 10.1093/gerona/60.1.109; Gadkaree SK, 2016, DOES SENSORY FUNCTIO, V2016; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GILMORE MM, 1989, PERCEPT PSYCHOPHYS, V46, P555, DOI 10.3758/BF03208152; Guergova S, 2011, AGEING RES REV, V10, P80, DOI 10.1016/j.arr.2010.04.009; Heft MW, 2017, J ORAL REHABIL, V44, P327, DOI 10.1111/joor.12488; Heft MW, 2014, AGE, V36, P1, DOI 10.1007/s11357-013-9536-9; Heine C, 2004, AGEING SOC, V24, P113, DOI 10.1017/S0144686X03001491; Hofer SM, 2003, PSYCHOL AGING, V18, P285, DOI 10.1037/0882-7974.18.2.285; Hofer SM, 2006, MULTIVARIATE BEHAV R; HOLLAND CA, 1992, APPL COGNITIVE PSYCH, V6, P217, DOI 10.1002/acp.2350060304; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Humes LE, 2009, ATTEN PERCEPT PSYCHO, V71, P860, DOI 10.3758/APP.71.4.860; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2011, INT J PSYCHOPHYSIOL, V80, P69, DOI 10.1016/j.ijpsycho.2011.01.012; Kaneda H, 2000, CHEM SENSES, V25, P331, DOI 10.1093/chemse/25.3.331; Keller BK, 1999, J AM GERIATR SOC, V47, P1319, DOI 10.1111/j.1532-5415.1999.tb07432.x; Khil L, 2015, OTOLARYNG HEAD NECK, V153, P364, DOI 10.1177/0194599815588913; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; Lin YH, 2005, J PERIPHER NERV SYST, V10, P269, DOI 10.1111/j.1085-9489.2005.10305.x; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Liu ZY, 2016, ARCH GERONTOL GERIAT, V62, P30, DOI 10.1016/j.archger.2015.10.011; Lupsakko T, 2002, INT J GERIATR PSYCH, V17, P808, DOI 10.1002/gps.689; Mueller C, 2003, RHINOLOGY, V41, P2; Muthen LK., 2017, MPLUS, VEight; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; PAUSE M, 1989, BRAIN, V112, P1599, DOI 10.1093/brain/112.6.1599; Pinto JM, 2017, J AM GERIATR SOC, V65, P2587, DOI 10.1111/jgs.15031; Pinto JM, 2014, J GERONTOL B-PSYCHOL, V69, pS144, DOI 10.1093/geronb/gbu102; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Ro T, 2009, EXP BRAIN RES, V195, P135, DOI 10.1007/s00221-009-1759-8; Roth Thomas Nicolas, 2015, Handb Clin Neurol, V129, P357, DOI 10.1016/B978-0-444-62630-1.00020-2; Schiffman SS, 2009, ANN NY ACAD SCI, V1170, P725, DOI 10.1111/j.1749-6632.2009.03924.x; SCHLAUCH RS, 1990, J ACOUST SOC AM, V88, P732, DOI 10.1121/1.399776; Schubert CR, 2017, J GERONTOL A-BIOL, V72, P710, DOI 10.1093/gerona/glw036; Seubert J, 2017, PREVALENCE CORRELATE, P1; STEVENS JC, 1995, CHEM SENSES, V20, P451, DOI 10.1093/chemse/20.4.451; Stevens JC, 1998, J GERONTOL B-PSYCHOL, V53, pP263, DOI 10.1093/geronb/53B.4.P263; Stuart Meg, 2003, BMC Geriatr, V3, P1, DOI 10.1186/1471-2318-3-1; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Wallhagen MI, 2001, J AM GERIATR SOC, V49, P1086, DOI 10.1046/j.1532-5415.2001.49213.x; Warren DE, 2013, INVEST OPHTH VIS SCI, V54, P5778, DOI 10.1167/iovs.13-12032; Wegener BA, 2015, CHEM SENSES, V40, P667	71	47	49	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202969	10.1371/journal.pone.0202969	http://dx.doi.org/10.1371/journal.pone.0202969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148857	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200039
J	Oda, Y; Sasaki, H; Miura, T; Takanashi, T; Furuya, Y; Yoshinari, M; Yajima, Y				Oda, Yukari; Sasaki, Hodaka; Miura, Tadashi; Takanashi, Takuya; Furuya, Yoshitaka; Yoshinari, Masao; Yajima, Yasutomo			Bone marrow stromal cells from low-turnover osteoporotic mouse model are less sensitive to the osteogenic effects of fluvastatin	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; IN-VITRO; SIMVASTATIN; EXPRESSION; STATINS; SAMP6; MICE; OSTEOCALCIN; INHIBITION; HYDROGEL	This study aimed to investigate the effects of fluvastatin on the differentiation of bone marrow stromal cells (BMSCs) into osteoblasts in senescence-accelerated mouse prone 6 (SAMP6) compared with that in the normal senescence-accelerated-resistant mouse (SAMR1) model. SAMP strains arose spontaneously from the AKR/J background and display shortened life span and an array of signs of accelerated aging, compared with control SAMR strains. The dose effects of fluvastatin were also evaluated. BMSCs were cultured with/without fluvastatin (0 mu M, 0.1 mu M, 0.5 mu M, and 1.0 mu M). WST-1-based colorimetry was performed to evaluate cell proliferation. To evaluate cell differentiation, gene expression levels of bmp2 and runx2 were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR), and protein expression levels were determined using enzyme-linked immunosorbent assay (BMP2) and immunofluorescence staining (BMP2 and Runx2). Alkaline phosphatase (ALP) activity assay and histochemical detection were determined; the effect of noggin, a BMP-specific antagonist, was examined using ALP histochemical detection. To assess for mature osteogenic marker, gene expression levels of bglap2 were determined by qRT-PCR and mineralization was determined by alizarin red staining. RhoA activity was also examined by Western blotting. In SAMP6, BMP2, Runx2 and Bglap2 mRNA and protein expressions were significantly increased by fluvastatin, and ALP activity was increased by BMP2 action. RhoA activity was also inhibited by fluvastatin. The concentration of fluvastatin sufficient to increase BMP2 and Runx2 expression and ALP activity was 0.5 mu M in SAMP6 and 0.1 mu M in SAMR1. In conclusion, the present study revealed that fluvastatin promoted BMSC differentiation into osteoblasts by RhoA-BMP2 pathway in SAMP6. BMSCs of SAMP6 are less sensitive to the osteogenic effects of fluvastatin than SAMR1.	[Oda, Yukari; Sasaki, Hodaka; Miura, Tadashi; Yoshinari, Masao; Yajima, Yasutomo] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan; [Oda, Yukari; Sasaki, Hodaka; Takanashi, Takuya; Furuya, Yoshitaka; Yajima, Yasutomo] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College	Oda, Y (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan.; Oda, Y (corresponding author), Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan.	takahashiyukari@tdc.ac.jp		Oda, Yukari/0000-0003-3419-9217				Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x; Auer J, 2002, CURR MED CHEM, V9, P1831, DOI 10.2174/0929867023369024; Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031; Beppu K, 2013, CLIN IMPLANT DENT R, V15, P217, DOI 10.1111/j.1708-8208.2011.00350.x; Bryant S Ross, 2002, J Can Dent Assoc, V68, P97; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004; Duque G, 2008, J AM GERIATR SOC, V56, P935, DOI 10.1111/j.1532-5415.2008.01764.x; Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Horiuchi N, 2006, ORAL DIS, V12, P85, DOI 10.1111/j.1601-0825.2005.01172.x; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kasai S, 2004, J BONE MINER METAB, V22, P207, DOI 10.1007/s00774-003-0471-1; Kupcsik L, 2009, J CELL MOL MED, V13, P4465, DOI 10.1111/j.1582-4934.2008.00545.x; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Moriyama Y, 2008, CLIN ORAL IMPLAN RES, V19, P600, DOI 10.1111/j.1600-0501.2007.01508.x; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; O'Sullivan RP, 2012, EXP HEMATOL, V40, P499, DOI 10.1016/j.exphem.2012.01.019; Ohira T, 2015, J HARD TISSUE BIOL, V24, P147, DOI 10.2485/jhtb.24.147; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; PARFITT AM, 1995, J BONE MINER RES, V10, P466; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Ruiz-Gaspa S, 2007, J CELL BIOCHEM, V101, P1430, DOI 10.1002/jcb.21259; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; Silva MJ, 2004, J BIOMECH, V37, P1639, DOI 10.1016/j.jbiomech.2004.02.018; Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6; Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202857	10.1371/journal.pone.0202857	http://dx.doi.org/10.1371/journal.pone.0202857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142209	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500041
J	Wysocki, MA; Tseng, ZJ				Wysocki, M. Aleksander; Tseng, Z. Jack			Allometry predicts trabecular bone structural properties in the carnivoran jaw joint	PLOS ONE			English	Article							R PACKAGE	Because overall cranial morphology-biomechanics linkage in carnivorans is significantly influenced by both feeding and non-feeding ecological variables, whole-skull mechanical performance measures may be less sensitive to feeding ecology than regional characteristics within the skull. The temporomandibular joint could be one regional characteristic that is highly sensitive to feeding ecology considering that this joint is used in prey capture, food processing, and experiences compressive loading during mastication. Through 3D model construction, 3D printing, and compression tests, morphological and mechanical performance measures were determined for the temporomandibular joint trabecular bone structure of 40 species representative of the phylogenetic and ecology diversity of Carnivora. Remarkably, the results indicate that relative fill volume, relative structural complexity, elastic modulus, and relative maximum compressive strength of trabecular bone structure are not significantly related to phylogeny or ecology. The results reveal that morphological and mechanical performance attributes of trabecular bone structure are primarily influenced by body size, and that positive centroid size allometry and positive body mass allometry are present for structural complexity. The lack of feeding ecological signal in dorso-ventral compressive loading of temporomandibular joint models indicates that carnivoran temporomandibular joint trabecular structures may not undergo significant differential remodeling as an evolutionary response to different mechanically demanding feeding tasks.	[Wysocki, M. Aleksander; Tseng, Z. Jack] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Grad Program Computat Cell Biol Anat & Pathol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wysocki, MA (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Grad Program Computat Cell Biol Anat & Pathol, Buffalo, NY 14260 USA.	research.wysocki@gmail.com			National Science Foundation [DEB-1257572]	National Science Foundation(National Science Foundation (NSF))	This project is funded by National Science Foundation grant DEB-1257572 to Z.J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alexander R., 1983, ANIMAL MECH; [Anonymous], 2018, MESQUITE MODULAR SYS; [Anonymous], 2018, 3D SYST VISIJET M2R; Askeland D. R., 2013, SCI ENG MAT; Beaulieu J, 2014, OUWIE ANAL EVOLUTION, P1; Boughner JC, 2017, J EXP ZOOL PART B, V328, P321, DOI 10.1002/jez.b.22734; Diaz-Uriarte R, 2005, PHYLOGR FUNCTIONS PH; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey KB, 2005, J BIOMECH, V38, P2143, DOI 10.1016/j.jbiomech.2005.06.007; Herring SW, 2001, CELLS TISSUES ORGANS, V169, P193, DOI 10.1159/000047882; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Orme D., 2013, CAPER PACKAGE COMP A, V5, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasitschniak- Arts M, 1995, MAMMALIAN SPECIES, P1; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Ravosa MJ, 2007, J EXP BIOL, V210, P628, DOI 10.1242/jeb.02683; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ryan TM, 2010, AM J PHYS ANTHROPOL, V141, P583, DOI 10.1002/ajpa.21178; Schlager S, 2017, MORPHO RVCG SHAPE AN, P217; Team RC, 2014, R LANG ENV STAT COMP; Tseng ZJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5441; van Ruijven LJ, 2007, J BIOMECH, V40, P1211, DOI 10.1016/j.jbiomech.2006.06.004	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202824	10.1371/journal.pone.0202824	http://dx.doi.org/10.1371/journal.pone.0202824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142221	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500038
J	Khan, AS; Georges, K; Rahaman, S; Abdela, W; Adesiyun, AA				Khan, Anisa S.; Georges, Karla; Rahaman, Saed; Abdela, Woubit; Adesiyun, Abiodun A.			Prevalence and serotypes of Salmonella spp. on chickens sold at retail outlets in Trinidad	PLOS ONE			English	Article							WHOLE-CARCASS RINSE; ANTIMICROBIAL RESISTANCE; SAMPLING METHODS; BROILER CARCASSES; RAW POULTRY; NECK SKIN; MICROBIOLOGICAL QUALITY; ESCHERICHIA-COLI; COMMERCIAL EGG; SEROVARS	Background This cross-sectional study determined the prevalence of Salmonella spp. and their sero-types on dressed chicken sold at retail outlets in Trinidad. The study also investigated the risk factors for contamination of dressed carcasses by Salmonella spp. at cottage poultry processor outlets where chickens are slaughtered and processed for sale. Methods A total of 133 dressed, whole chickens and 87 chicken parts from 44 cottage poultry processors and 36 dressed, whole chickens and 194 chicken parts from 46 supermarket outlets were randomly collected throughout the country. Isolation and identification of Salmonella spp. were performed using standard bacteriological techniques. Serotyping was performed by a regional reference laboratory. Results The prevalence of Salmonella spp. in chicken carcasses sampled from cottage poultry processors and supermarkets was 20.5% and 8.3% respectively (p <0.001). The frequency of isolation of Salmonella spp. at cottage poultry processors was 22.4%, 23.0%, 7.1%, and 10.0% for non-chilled whole chicken, non-chilled chicken parts, chilled whole chicken and chilled chicken parts respectively. Fresh, non-chilled chicken (22.6%) yielded a higher frequency of isolation of Salmonella spp. than chilled chickens (8.3%). For supermarket samples, the frequency of isolation of Salmonella spp. was 19.0%, 8.1%, 0.0% and 7.6% for chilled whole chickens, chill chicken parts, frozen whole chicken and frozen chicken parts respectively. The swab method of sampling yielded a statistically significantly (p = 0.029) higher frequency (3.2%) of Salmonella spp. than the rinse method (1.6%). The predominant serotypes isolated were Kentucky (30.9%) and Javiana (22.7%). Use of chilled water-bath to cool carcasses was the only risk factor significantly (p = 0.044) associated with isolation of Salmonella spp. Conclusion Raw chicken carcasses purchased from cottage poultry processors pose a significantly higher risk of contamination with Salmonella spp. than those sold at supermarkets.	[Khan, Anisa S.; Georges, Karla; Adesiyun, Abiodun A.] Univ West Indies, Fac Med Sci, Sch Vet Med, St Augustine, Trinidad Tobago; [Rahaman, Saed] Minist Hlth, Vet Publ Hlth Unit, Port Of Spain, Trinidad Tobago; [Abdela, Woubit] Tuskegee Univ, Dept Pathobiol, Coll Vet Med Nursing & Allied Hlth, Tuskegee, AL 36088 USA	University West Indies Mona Jamaica; University West Indies Saint Augustine; Tuskegee University	Adesiyun, AA (corresponding author), Univ West Indies, Fac Med Sci, Sch Vet Med, St Augustine, Trinidad Tobago.	Abiodun.Adesiyun@sta.uwi.edu	Georges, Karla/AAN-5536-2020	Adesiyun, Abiodun/0000-0001-9470-9421	University of the West Indies, St. Augustine Campus Research and Publication Fund Committee [2660-457522]	University of the West Indies, St. Augustine Campus Research and Publication Fund Committee	This work is supported by the University of the West Indies, St. Augustine Campus Research and Publication Fund Committee [Research grant #2660-457522] awarded to the primary author Anisa Khan and Abiodun Adewale Adesiyun, for Anisa Khan's Master of Philosophy (M.Phil.) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesiyun A, 2005, EPIDEMIOL INFECT, V133, P1049, DOI 10.1017/S0950268805004565; Adesiyun A. A., 1994, Bulletin of Animal Health and Production in Africa, V42, P167; Ahmed T. A., 2013, Pakistan Journal of Nutrition, V12, P121; Aimey V, 2013, PREV VET MED, V110, P489, DOI 10.1016/j.prevetmed.2012.12.009; Alali WQ, 2012, J FOOD PROTECT, V75, P1469, DOI 10.4315/0362-028X.JFP-12-080; Alvarez-Fernandez E, 2012, INT J FOOD MICROBIOL, V153, P281, DOI 10.1016/j.ijfoodmicro.2011.11.011; Andrews W, 1992, FAO Food Nutr Pap, V14, P1; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; Bada-Alambedji R, 2006, BRAZ J MICROBIOL, V37, P510, DOI 10.1590/S1517-83822006000400020; Badhe SR, 2013, INDIAN J ANIM RES, V47, P262; Bae DH, 2013, J VET MED SCI, V75, P1193, DOI 10.1292/jvms.13-0093; Barbour EK, 2015, J INFECT DEV COUNTR, V9, P1, DOI 10.3855/jidc.5065; Basler C, 2016, EMERG INFECT DIS, V22, P1705, DOI 10.3201/eid2210.150765; Betancor L, 2010, J CLIN MICROBIOL, V48, P2413, DOI 10.1128/JCM.02137-09; Bohara M. S., 2017, International Journal of Life Sciences and Technology (IJLST), V10, P79; Bourassa DV, 2015, J FOOD PROTECT, V78, P1938, DOI 10.4315/0362-028X.JFP-15-189; Caribbean Public Health Agency, 2013, STAT PUBL HLTH CAR R; Cason JA, 2010, POULTRY SCI, V89, P2038, DOI 10.3382/ps.2009-00478; Chuah LO, 2018, FOOD RES INT, V105, P743, DOI 10.1016/j.foodres.2017.11.066; Cox NA, 2014, J FOOD PROTECT, V77, P493, DOI 10.4315/0362-028X.JFP-13-320; Cox NA, 2010, J FOOD PROTECT, V73, P976, DOI 10.4315/0362-028X-73.5.976; Curtello S., 2013, British Microbiology Research Journal, V3, P461; Davies PR, 2000, J APPL MICROBIOL, V89, P169, DOI 10.1046/j.1365-2672.2000.01101.x; Donado-Godoy P, 2014, J FOOD PROTECT, V77, P227, DOI 10.4315/0362-028X.JFP-13-276; Dookeran M.M., 2012, J AGR BIODIVERS RES, V1, P78; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Foley SL, 2013, MICROBIOL MOL BIOL R, V77, P582, DOI 10.1128/MMBR.00015-13; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Galarneau KD, 2015, POULTRY SCI, V94, P461, DOI 10.3382/ps/pev001; Gill CO, 2005, J FOOD PROTECT, V68, P2718, DOI 10.4315/0362-028X-68.12.2718; Giombelli A, 2013, J FOOD PROTECT, V76, P1330, DOI 10.4315/0362-028X.JFP-13-004; Gorski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034722; Hardy B, 2013, J FOOD SCI, V78, pM1232, DOI 10.1111/1750-3841.12212; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Huda N, 2016, INT J POULT SCI, V15, P111, DOI [10.3923/ijps.2016.111.120, DOI 10.3923/IJPS.2016.111.120]; James C, 2006, INT J REFRIG, V29, P847, DOI 10.1016/j.ijrefrig.2005.08.003; Jarquin C, 2015, J FOOD PROTECT, V78, P1642, DOI 10.4315/0362-028X.JFP-15-117; Lamas A, 2016, POULTRY SCI, V95, P2097, DOI 10.3382/ps/pew150; Line JE, 2001, J FOOD PROTECT, V64, P982, DOI 10.4315/0362-028X-64.7.982; Lyle CH, 2015, J S AFR VET ASSOC, V86, DOI [10.4102/jsava.v86i1.1292, 10.4102/JSAVA.V86I1.1292]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McEvoy M, 2005, J FOOD PROTECT, V68, P34, DOI 10.4315/0362-028X-68.1.34; Meldrum RJ, 2007, J FOOD PROTECT, V70, P1937, DOI 10.4315/0362-028X-70.8.1937; Moe AZ, 2017, J FOOD PROTECT, V80, P947, DOI [10.4315/0362-028X.JFP-16-407, 10.4315/0362-028x.jfp-16-407]; MORRIS GK, 1970, APPL MICROBIOL, V19, P795, DOI 10.1128/AEM.19.5.795-799.1970; Nidaullah H, 2017, VET WORLD, V10, P286, DOI 10.14202/vetworld.2017.286-292; Padungtod P, 2006, INT J FOOD MICROBIOL, V108, P346, DOI 10.1016/j.ijfoodmicro.2005.11.020; Palumbo SA, 1999, FOOD MICROBIOL, V16, P459, DOI 10.1006/fmic.1998.0259; Park SH, 2014, FOOD MICROBIOL, V38, P250, DOI 10.1016/j.fm.2013.10.002; Rivera-Perez W, 2014, J FOOD PROTECT, V77, P2031, DOI 10.4315/0362-028X.JFP-14-052; Rodrigo S, 2006, J FOOD PROTECT, V69, P1096, DOI 10.4315/0362-028X-69.5.1096; Sarlin LL, 1998, POULTRY SCI, V77, P1253, DOI 10.1093/ps/77.8.1253; Schonenbrucher V, 2008, INT J FOOD MICROBIOL, V123, P61, DOI 10.1016/j.ijfoodmicro.2007.11.064; Simmons M, 2003, J FOOD PROTECT, V66, P446, DOI 10.4315/0362-028X-66.3.446; Smith DP, 2012, POULTRY SCI, V91, P2017, DOI 10.3382/ps.2011-01985; Ta YT, 2014, J FOOD PROTECT, V77, P57, DOI 10.4315/0362-028X.JFP-13-221; Ta YT, 2012, J FOOD PROTECT, V75, P1851, DOI 10.4315/0362-028X.JFP-12-130; Thomas A., 2006, Tropicultura, V24, P135; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; VANPOUCKE LSG, 1990, APPL ENVIRON MICROB, V56, P924, DOI 10.1128/AEM.56.4.924-927.1990; Vinueza-Burgos C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159567; WHO, 2009, MICR RISK ASS SER, V19; Yang BW, 2014, J FOOD PROTECT, V77, P894, DOI 10.4315/0362-028X.JFP-13-439; Yang BW, 2011, J FOOD PROTECT, V74, P1724, DOI 10.4315/0362-028X.JFP-11-215; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001	65	35	36	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202108	10.1371/journal.pone.0202108	http://dx.doi.org/10.1371/journal.pone.0202108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138324	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100040
J	Ribeiro, GF; de Goes, CG; Onorio, DS; de Campos, CBL; Morais, FV				Ribeiro, Giselle Ferreira; de Goes, Caroline Gonsalves; Onorio, Diego Santos; Ladeira de Campos, Claudia Barbosa; Morais, Flavia Villaca			Autophagy in Paracoccidioides brasiliensis under normal mycelia to yeast transition and under selective nutrient deprivation	PLOS ONE			English	Article							ISOLATED RAT HEPATOCYTES; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; MAGNAPORTHE-ORYZAE; ASEXUAL DIFFERENTIATION; ASPERGILLUS-NIDULANS; NITROGEN STARVATION; MURINE MACROPHAGES; CARBON-STARVATION; GLYOXYLATE CYCLE	Paracoccidioides spp. is a thermally dimorphic fungus endemic to Latin America and the etiological agent of paracoccidioidomycosis (PCM), a granulomatous disease acquired through fungal propagule inhalation by its mammalian host. The infection is established after successful mycelia to yeast transition in the host pulmonary alveoli. The challenging environment inside the host exposes the fungus to the need of adaptation in order to circumvent nutritional, thermal, oxidative, immunological and other stresses that can directly affect their survival. Considering that autophagy is a response to abrupt environmental changes and is induced by stress conditions, this study hypothesizes that this process might be crucially involved in the adaptation of Paracoccidioides spp. to the host and, therefore, it is essential for the proper establishment of the disease. By labelling autophagous vesicles with monodansylcadaverine, autophagy was observed as an early event in cells during the normal mycelium to yeast transition, as well as in yeast cells of P. brasiliensis under glucose deprivation, and under either rapamycin or 3-methyladenine (3-MA). Findings in this study demonstrated that autophagy is triggered in P. brasiliensis during the thermal-induced mycelium to yeast transition and by glucose-limited conditions in yeasts, both of which modulated by rapamycin or 3-MA. Certainly, further genetic and in vivo analyses are needed in order to finally address the contribution of autophagy for adaptation. Yet, our data propose that autophagy possibly plays an important role in Paracoccidioides brasiliensis virulence and pathogenicity.	[Ribeiro, Giselle Ferreira; de Goes, Caroline Gonsalves; Onorio, Diego Santos; Morais, Flavia Villaca] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Lab Biol Celular & Mol Fungos, Sao Jose Dos Campos, SP, Brazil; [Ladeira de Campos, Claudia Barbosa] Univ Fed Sao Paulo, UNIFESP, Inst Ciencia & Tecnol, Lab Bioquim Biol Celular & Mol Fungos, Sao Jose Dos Campos, SP, Brazil	Universidade do Vale do Paraiba; Universidade Federal de Sao Paulo (UNIFESP)	Morais, FV (corresponding author), Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Lab Biol Celular & Mol Fungos, Sao Jose Dos Campos, SP, Brazil.	flavia@univap.br	Morais, Flavia V/C-7330-2011; Campos, Claudia B.L./I-4802-2018	Morais, Flavia V/0000-0001-8576-9684; 	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) [2012/ 02138-7]	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP, http://www.fapesp.br/), grant 2012/ 02138-7. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; An ZY, 2014, AUTOPHAGY, V10, P1702, DOI 10.4161/auto.32122; Arruda DC, 2015, ANTIMICROB AGENTS CH, V59, P7214, DOI 10.1128/AAC.00512-15; Bartoszewska M, 2011, ANTIOXID REDOX SIGN, V14, P2271, DOI 10.1089/ars.2010.3528; Bermejo C, 2013, BIOCHEM J, V452, P489, DOI 10.1042/BJ20121736; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Campos CBL, 2008, EUKARYOT CELL, V7, P1856, DOI 10.1128/EC.00110-08; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Conway MK, 2012, G3-GENES GENOM GENET, V2, P1003, DOI 10.1534/g3.112.002808; Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5; Deng YZ, 2010, AUTOPHAGY, V6, P455, DOI 10.4161/auto.6.4.11736; Deng YZ, 2009, AUTOPHAGY, V5, P33, DOI 10.4161/auto.5.1.7175; Derengowski LS, 2008, MED MYCOL, V46, P125, DOI 10.1080/13693780701670509; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dong B, 2009, AUTOPHAGY, V5, P946, DOI 10.4161/auto.5.7.9161; Eltschinger S, 2016, TRENDS CELL BIOL, V26, P148, DOI 10.1016/j.tcb.2015.10.003; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gontijo FD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177461; Gonzalez S, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00061; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim Y, 2011, BIOTECHNOL BIOENG, V108, P2705, DOI 10.1002/bit.23223; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Krohn NG, 2014, G3-GENES GENOM GENET, V4, P49, DOI 10.1534/g3.113.008607; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lima PD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002855; Liu XH, 2007, AUTOPHAGY, V3, P472, DOI 10.4161/auto.4339; Liu XH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40018; Liu XH, 2011, RES MICROBIOL, V162, P756, DOI 10.1016/j.resmic.2011.06.011; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lopez-Berges MS, 2010, PLANT CELL, V22, P2459, DOI 10.1105/tpc.110.075937; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; Lv WY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11640-z; Madden T, 2002, NCBI HDB; Martinez R, 2015, REV INST MED TROP SP, V57, P11, DOI 10.1590/S0036-46652015000700004; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nadal M, 2010, MOL PLANT PATHOL, V11, P463, DOI [10.1111/J.1364-3703.2010.00620.X, 10.1111/j.1364-3703.2010.00620.x]; NCBI (National Center for Biotechnology Information), BAS LOC AL SEARCH TO; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030052; Parente-Rocha JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137619; Pasquier B, 2016, CELL MOL LIFE SCI, V73, P985, DOI 10.1007/s00018-015-2104-y; Pollack JK, 2008, BIOTECHNOL BIOENG, V100, P458, DOI 10.1002/bit.21779; Pollack JK, 2009, FUNGAL GENET BIOL, V46, P1, DOI 10.1016/j.fgb.2008.10.010; Queiroz-Telles F, 2011, SEMIN RESP CRIT CARE, V32, P764, DOI 10.1055/s-0031-1295724; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani M, 2011, BIOMED RES-TOKYO, V32, P379, DOI 10.2220/biomedres.32.379; Stipanuk MH, 2009, NUTR REV, V67, P677, DOI 10.1111/j.1753-4887.2009.00252.x; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Tavares AH, 2015, FUNGAL GENET BIOL, V81, P98, DOI 10.1016/j.fgb.2014.01.008; Taylor R, 2012, AUTOPHAGY, V8, P1300, DOI 10.4161/auto.20681; Teixeira MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004397; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wang C, 2016, PHARMACOL RES, V105, P164, DOI 10.1016/j.phrs.2016.01.028; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Weisman R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0006-2016; Wirth M, 2013, SEMIN CANCER BIOL, V23, P301, DOI 10.1016/j.semcancer.2013.05.007; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Ying SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26376; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906	75	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202529	10.1371/journal.pone.0202529	http://dx.doi.org/10.1371/journal.pone.0202529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138387	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100078
J	Lino, ADD; Vianna, D; Oishi, JC; Souza, MVC; Ruffoni, LD; Marin, CT; de Avo, LRD; Perez, SED; Rodrigues, GJ; Tirapegui, J; Shiguemoto, GE				de Souza Lino, Anderson Diogo; Vianna, Daiana; Oishi, Jorge Camargo; Campos Souza, Markus Vinicius; Ruffoni, Leandro Dias; Marin, Cecilia Tardivo; da Silva de Avo, Lucimar Retto; de Andrade Perez, Sergio Eduardo; Rodrigues, Gerson Jhonatan; Tirapegui, Julio; Shiguemoto, Gilberto Eiji			Resistance training and caloric restriction prevent systolic blood pressure rise by improving the nitric oxide effect on smooth muscle and morphological changes in the aorta of ovariectomized rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; OXIDATIVE STRESS; MATRIX METALLOPROTEINASE-2; ENDOTHELIAL FUNCTION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; EXERCISE; ESTROGEN; ARTERY; HYPERTROPHY	In this study, we investigated the effects of resistance training (RT), caloric restriction (CR), and the association of both interventions in aortic vascular reactivity and morphological alterations, matrix metalloproteinase-2 (MMP-2) activity, insulin resistance and systolic blood pressure (SBP) in ovariectomized rats. Fifty female Holtzman rats were subjected to ovariectomy and Sham surgery and distributed into the following groups: Sham-sedentary, ovariectomized-sedentary, ovariectomized-resistance training, ovariectomized-caloric restriction, and ovariectomized-resistance training and caloric restriction groups. RT and 30% CR protocols were performed for 13 weeks. Analyses were conducted to evaluate the following: acetylcholine and sodium nitroprusside-induced relaxation of aortic rings, MMP-2 activity, insulin tolerance test, highlighting of the aorta wall cross-sectional area by hematoxylin-eosin stain, aorta vessel remodeling and SBP. We observed that ovariectomy decreased the potency of dependent and independent endothelium relaxation and MMP-2 activity, prevented insulin resistance, promoted aorta vessel remodeling in the cross-sectional area, and promoted the media-to-lumen ratio, the collagen content, and the alteration of the structure and elastic fibers of the vessel. The effects of the ovariectomy could contribute to SBP increases. However, the association of exercise and diet improved the relaxation potency in dependent and independent endothelium relaxation, elevated MMP-2 activity, ameliorate insulin sensitivity, increased the aorta cross-sectional area and media-to-lumen ratio, decreased collagen content and promoted histological parameters of the aorta vessel wall, preventing the increase of SBP. Conclusion: Our study revealed that the RT and CR separately, and even associatively, improved vascular function, activated MMP-2, and produced a beneficial hypertrophic remodeling, preventing the elevation of SBP in ovariectomized rats.	[de Souza Lino, Anderson Diogo; Marin, Cecilia Tardivo; de Andrade Perez, Sergio Eduardo; Shiguemoto, Gilberto Eiji] Fed Univ Sao Carlos UFSCar, Interinst Postgrad Program Physiol Sci, Ctr Biol & Hlth Sci, Lab Exercise Physiol,Dept Physiol Sci, Sao Carlos, SP, Brazil; [Vianna, Daiana; Tirapegui, Julio] Univ Sao Paulo, Dept Food & Expt Nutr, Lab Nutr Biochem, Sao Paulo, Brazil; [Oishi, Jorge Camargo; Rodrigues, Gerson Jhonatan] Fed Univ Sao Carlos UFSCar, Ctr Biol & Hlth Sci, Interinst Postgrad Program Physiol Sci, Dept Physiol Sci,Lab Pharmacol, Sao Carlos, SP, Brazil; [Campos Souza, Markus Vinicius] Univ Fed Triangulo Mineiro, Dept Sports Sci, Postgrad Program Phys Educ, Phys Educ Course, Uberaba, Brazil; [Ruffoni, Leandro Dias] Fed Univ Sao Carlos UFSCar, Interinst Postgrad Program Physiol Sci, Ctr Biol & Hlth Sci, Lab Neuroendocrinol,Dept Physiol Sci, Sao Carlos, SP, Brazil; [da Silva de Avo, Lucimar Retto] Fed Univ Sao Carlos UFSCar, Ctr Biol & Hlth Sci, Med Dept, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Federal do Triangulo Mineiro; Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Shiguemoto, GE (corresponding author), Fed Univ Sao Carlos UFSCar, Interinst Postgrad Program Physiol Sci, Ctr Biol & Hlth Sci, Lab Exercise Physiol,Dept Physiol Sci, Sao Carlos, SP, Brazil.	gileiji@gmail.com	Lino, Anderson Diogo de Souza/ABB-3159-2021; Lino, Anderson/AAC-7543-2019; Rodrigues, Gerson J/J-1987-2016; Stefanadis, Christodoulos/ABH-2232-2020	Lino, Anderson/0000-0002-0834-7098; Rodrigues, Gerson J/0000-0002-1896-9536; Stefanadis, Christodoulos/0000-0001-5974-6454	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/21087-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2012/21087-4) (JT), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; The author's wish to thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2012/21087-4), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Asikainen TM, 2004, SPORTS MED, V34, P753, DOI 10.2165/00007256-200434110-00004; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Bryan NS, 2009, FRONT BIOSCI-LANDMRK, V14, P1, DOI 10.2741/3228; Castro MM, 2012, NITRIC OXIDE-BIOL CH, V26, P162, DOI 10.1016/j.niox.2012.01.009; Chen CH, 2017, MENOPAUSE, V24, P617, DOI 10.1097/GME.0000000000000811; Coutinho T, 2014, CAN J CARDIOL, V30, P756, DOI 10.1016/j.cjca.2014.03.020; Dao HH, 2001, J HYPERTENS, V19, P1965, DOI 10.1097/00004872-200111000-00006; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; Florian M, 2004, STEROIDS, V69, P637, DOI 10.1016/j.steroids.2004.05.016; Flues K, 2010, MATURITAS, V65, P267, DOI 10.1016/j.maturitas.2009.11.007; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163; Gielen S, 2001, CIRCULATION, V103, pE1; Higashi Y, 2004, PHARMACOL THERAPEUT, V102, P87, DOI 10.1016/j.pharmthera.2004.02.003; Homer KL, 2000, BRIT J PHARMACOL, V131, P673, DOI 10.1038/sj.bjp.0703613; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Horta PP, 2005, LIFE SCI, V77, P3336, DOI 10.1016/j.lfs.2005.05.044; Huang A, 2005, CIRC RES, V96, P376, DOI 10.1161/01.RES.0000155332.17783.26; Janus A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3634948; Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112; Lam KK, 2009, AM J HYPERTENS, V22, P27, DOI 10.1038/ajh.2008.306; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Laurent S, 2015, CIRC RES, V116, P1007, DOI 10.1161/CIRCRESAHA.116.303596; Leite RD, 2010, INT J SPORTS MED, V31, P761, DOI 10.1055/s-0030-1263117; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Marques CMM, 2006, MENOPAUSE, V13, P87, DOI 10.1097/01.gme.0000191209.13115.46; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mayet J, 2003, HEART, V89, P1104, DOI 10.1136/heart.89.9.1104; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Pedroso JAB, 2014, CELL BIOCHEM FUNCT, V32, P326, DOI 10.1002/cbf.3017; Posa A, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/787063; Prasannarong M, 2012, BBA-MOL BASIS DIS, V1822, P1051, DOI 10.1016/j.bbadis.2012.02.018; Prestes J, 2009, APPL PHYSIOL NUTR ME, V34, P700, DOI 10.1139/H09-059; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sherratt MJ, 2009, AGE, V31, P305, DOI 10.1007/s11357-009-9103-6; Shiguemoto GE, 2012, SCAND J MED SCI SPOR, V22, P607, DOI 10.1111/j.1600-0838.2010.01284.x; Tatchum-Talom R, 2002, AM J PHYSIOL-HEART C, V282, pH491, DOI 10.1152/ajpheart.00589.2001; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8; Wu J, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-162; Wycherley TP, 2008, DIABETES OBES METAB, V10, P1062, DOI 10.1111/j.1463-1326.2008.00863.x; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zervoudaki A, 2004, AM J HYPERTENS, V17, P273, DOI 10.1016/j.amjhyper.2003.11.007; Zervoudaki A, 2003, J HUM HYPERTENS, V17, P119, DOI 10.1038/sj.jhh.1001518; Zhang YL, 2000, HYPERTENSION, V36, P970, DOI 10.1161/01.HYP.36.6.970	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201843	10.1371/journal.pone.0201843	http://dx.doi.org/10.1371/journal.pone.0201843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133537	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400040
J	Hewitt, MJ; Hourston, M; McDonald, JI				Hewitt, Matthew J.; Hourston, Mathew; McDonald, Justin, I			A long way from home: Biosecurity lessons learnt from the impact of La Nina on the transportation and establishment of tropical portunid species	PLOS ONE			English	Article							TEMPERATE WESTERN-AUSTRALIA; EL-NINO; NORTHEAST PACIFIC; RANGE EXPANSION; MUD CRABS; FUTURE; ESTUARIES; FREQUENCY; EVENTS; OCEAN	Marine ecosystems can be modified and shaped by irregular interannual variations in oceanic current patterns and temperatures, such as El Nino and La Nina. These large scale oceanic events have also been shown to influence environmental stressors such as invasive marine species (IMS). Our study indicates that there is a causative link between these climatic events, and atypical detections of native and IMS. Significant La Nina events between 1970 and 2014 were associated with sightings of tropical crab species in temperate waters following a lag period of 18 +/- 24 months from the onset of the event. We identified a total of 72 records of six tropical portunid crabs species (from both Charybdis and Scylla) in temperate waters of south-western Australia following these La Nina events, based on reports in published scientific literature, grey literature and museum records, as well as citizen science networks such as FishWatch and PestWatch apps. We suggest that La Nina conditions facilitated transportation and temporary establishment of crab larvae from their native tropical habitat to temperate regions. As the strength of La Nina events is likely to increase into the future due to the escalating effects of climate change, it is likely that there will be a growth in associated atypical establishment events of IMS. Consequently, biosecurity managers will need to reprioritise resources in order to accommodate the potential impacts of these large scale oceanic events as part of their surveillance programmes.	[Hewitt, Matthew J.; McDonald, Justin, I] Aquat Biosecur Surveillance, Dept Primary Ind & Reg Dev, Perth, WA, Australia; [Hourston, Mathew] Dept Primary Ind & Reg Dev, Sci & Resource Assessments Div, Bycatch & Harvest Strategies, Perth, WA, Australia		Hewitt, MJ (corresponding author), Aquat Biosecur Surveillance, Dept Primary Ind & Reg Dev, Perth, WA, Australia.	Matthew.Hewitt@dpird.wa.gov.au		Hewitt, Matthew/0000-0003-1008-2583	Department of Primary Industries and Regional Development, Government of Western Australia	Department of Primary Industries and Regional Development, Government of Western Australia	This study was funded by the Department of Primary Industries and Regional Development, Government of Western Australia (www.dpird.wa.gov.au). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Museum Sydney, 2014, CHAR CHAR FER; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Caputi N., 2014, MARINE HEAT WAVE W A; Cashin P, 2015, IMF WORKING PAPER, DOI [10.2139/ssrn.2643965, DOI 10.2139/SSRN.2643965]; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Connolly SR, 1999, LIMNOL OCEANOGR, V44, P466, DOI 10.4319/lo.1999.44.2.0466; Davie PJ, 2002, CRUSTACEA MALACOSTRA; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Galil BS, 2007, MAR POLLUT BULL, V55, P314, DOI 10.1016/j.marpolbul.2006.11.008; Gopurenko D, 2003, MAR FRESHWATER RES, V54, P833, DOI 10.1071/MF03033; Hallett CS, 2018, REG ENVIRON CHANGE, V18, P1357, DOI 10.1007/s10113-017-1264-8; Hourston M, 2015, MANAG BIOL INVASION, V6, P243, DOI 10.3391/mbi.2015.6.3.03; Jones DS, 1990, W FISHERIES MAGAZINE, P30; Kangas MI, 2006, 2002038 FRDC; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Lenanton R. C., 2009, Journal of the Royal Society of Western Australia, V92, P111; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Lluch-Belda D, 2005, FISH OCEANOGR, V14, P458, DOI 10.1111/j.1365-2419.2005.00347.x; Lovell S, 2006, 52 AGR RES EC REV; Marbuah G., 2014, Diversity, V6, P500; McDonald JI, 2012, AQUAT INVASIONS, V7, P483, DOI 10.3391/ai.2012.7.4.005; Ng P.K.L., 1998, P1045; Occhipinti-Ambrogi A, 2003, MAR POLLUT BULL, V46, P542, DOI 10.1016/S0025-326X(02)00363-6; Paavola M, 2005, ESTUAR COAST SHELF S, V64, P738, DOI 10.1016/j.ecss.2005.03.021; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pearce A., 2011, MARINE HEAT WAVE W A; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Petersen C, 2006, BIOL INVASIONS, V8, P565, DOI 10.1007/s10530-005-0160-1; Poore Gary C.B., 2004, pi; Preisler Rikke K., 2009, V204, P587, DOI 10.1007/978-3-540-79236-9_33; Ruscoe IM, 2004, AQUACULTURE, V238, P239, DOI 10.1016/j.aquaculture.2004.05.030; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Smale DA, 2012, BIOL INVASIONS, V14, P1325, DOI 10.1007/s10530-011-0167-8; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; SUMPTON W, 1990, B MAR SCI, V46, P425; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trivedi J.N., 2012, Arthropods, V1, P129; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; Wee DPC, 1995, RAFFLES B ZOOLOGY, V43; Wilkinson C, 1999, AMBIO, V28, P188; Yamada SB, 2010, BIOL INVASIONS, V12, P1791, DOI 10.1007/s10530-009-9589-y	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202766	10.1371/journal.pone.0202766	http://dx.doi.org/10.1371/journal.pone.0202766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133520	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400098
J	Maritan, M; Veggi, D; Cozzi, R; Dello Iacono, L; Bartolini, E; Lo Surdo, P; Maruggi, G; Spraggon, G; Bottomley, MJ; Malito, E				Maritan, Martina; Veggi, Daniele; Cozzi, Roberta; Dello Iacono, Lucia; Bartolini, Erika; Lo Surdo, Paola; Maruggi, Giulietta; Spraggon, Glen; Bottomley, Matthew J.; Malito, Enrico			Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; H-BINDING-PROTEIN; SECONDARY STRUCTURE; ANTIGEN NHBA; FAB NC6.8; PREDICTION; DOMAIN; PROPENSITIES; MENINGITIS; STABILITY	Neisserial heparin binding antigen (NHBA) is one of three main recombinant protein antigens in 4CMenB, a vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B. NHBA is a surface-exposed lipoprotein composed of a predicted disordered N-terminal region, an arginine-rich region that binds heparin, and a C-terminal domain that folds as an anti-parallel beta-barrel and that upon release after cleavage by human proteases alters endothelial permeability. NHBA induces bactericidal antibodies in humans, and NHBA-specific antibodies elicited by the 4CMenB vaccine contribute to serum bactericidal activity, the correlate of protection. To better understand the structural bases of the human antibody response to 4CMenB vaccination and to inform antigen design, we used X-ray crystallography to elucidate the structures of two C-terminal fragments of NHBA, either alone or in complex with the Fab derived from the vaccine-elicited human monoclonal antibody 5H2, and the structure of the unbound Fab 5H2. The structures reveal details on the interaction between an N-terminal beta-hairpin fragment and the beta-barrel, and explain how NHBA is capable of generating cross-reactive antibodies through an extensive conserved conformational epitope that covers the entire C-terminal face of the beta-barrel. By providing new structural information on a vaccine antigen and on the human immune response to vaccination, these results deepen our molecular understanding of 4CMenB, and might also aid future vaccine design projects.	[Maritan, Martina; Veggi, Daniele; Cozzi, Roberta; Dello Iacono, Lucia; Bartolini, Erika] GSK, Siena, Italy; [Lo Surdo, Paola; Maruggi, Giulietta; Bottomley, Matthew J.; Malito, Enrico] GSK, Rockville, MD 20850 USA; [Spraggon, Glen] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Maritan, Martina] Univ Milan, Milan, Italy	GlaxoSmithKline; GlaxoSmithKline; Novartis; University of Milan	Malito, E (corresponding author), GSK, Rockville, MD 20850 USA.	enrico.x.malito@gsk.com	Iacono, Lucia Dello/AAG-3478-2020	Iacono, Lucia Dello/0000-0003-2867-283X	GlaxoSmithKline Biologicals SA; Novartis/GSK Academy PhD Fellowship	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); Novartis/GSK Academy PhD Fellowship	This study was sponsored by GlaxoSmithKline Biologicals SA. The funder provided support in the form of salaries for authors DV, RC, EB, PLS, GM, MJB, and EM, and also provided support in the form of research material, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. During this project, MM held a Novartis/GSK Academy PhD Fellowship registered at the University of Padova, Italy.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Bricogne G., 2016, BUSTER VERSION 2 11; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Casellato A, 2014, CELL MICROBIOL, V16, P925, DOI 10.1111/cmi.12250; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Deller MC, 2016, ACTA CRYSTALLOGR F, V72, P72, DOI 10.1107/S2053230X15024619; Domina M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160702; Donnarumma D, 2015, FASEB J, V29, P2260, DOI 10.1096/fj.14-263954; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Giuliani M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22057-7; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Keskin O, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-31; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konar M, 2015, P NATL ACAD SCI USA, V112, P14823, DOI 10.1073/pnas.1507829112; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Malito E, 2016, BIOCHEM J, V473, P4699, DOI 10.1042/BCJ20160806; Malito E, 2014, P NATL ACAD SCI USA, V111, P17128, DOI 10.1073/pnas.1419686111; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Maritan M, 2017, ACTA CRYSTALLOGR F, V73, P305, DOI 10.1107/S2053230X17006021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; O'Ryan M, 2014, DRUGS, V74, P15, DOI 10.1007/s40265-013-0155-7; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Partridge E, 2017, VACCINE, V35, P4236, DOI 10.1016/j.vaccine.2017.06.020; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Sotriffer CA, 1998, J MOL BIOL, V278, P301, DOI 10.1006/jmbi.1998.1684; Sotriffer CA, 2000, BIOPHYS J, V79, P614, DOI 10.1016/S0006-3495(00)76320-X; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Sundberg EJ, METHODS MOL BIOL EPI, V524, P23; Toneatto D, 2017, EXPERT REV VACCINES, V16, P433, DOI 10.1080/14760584.2017.1308828; Tsutakawa SE, 2007, J STRUCT BIOL, V158, P214, DOI 10.1016/j.jsb.2006.09.008; Vacca I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162878; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Wang RYR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022060; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	54	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201922	10.1371/journal.pone.0201922	http://dx.doi.org/10.1371/journal.pone.0201922			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133484	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400048
J	Scarff, JM; Seldina, YI; Vergis, JM; Ventura, CL; O'Brien, AD				Scarff, Jennifer M.; Seldina, Yuliya, I; Vergis, James M.; Ventura, Christy L.; O'Brien, Alison D.			Expression and contribution to virulence of each polysaccharide capsule of Bacillus cereus strain G9241	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TOXIN GENES; ADP-RIBOSYLTRANSFERASE; INHALATION ANTHRAX; MOLECULAR-CLONING; IDENTIFICATION; BIOSYNTHESIS; ORGANIZATION; PATHOGEN; PROMOTER	Bacillus cereus strain G9241 was isolated from a patient with pneumonia who had an anthrax-like illness. Like Bacillus anthracis, the virulence of G9241 is dependent on two large plasmids. In G9241 those plasmids are pBCXO1 and pBC210. There is a multi-gene capsule locus on each of these virulence plasmids, and both capsules are produced by G9241 in vitro and in mice. The hasACB operon on pBCXO1 is responsible for production of a hyaluronic acid (HA) capsule. The locus on pBC210 encodes a putative tetrasaccharide (TS) capsule that assembles in a Wzy-dependent manner. We found that the pBC210 capsule locus is transcribed as two operons and identified the promoter regions responsible for transcription. We constructed isogenic mutants to assess the role of genes in the two TS capsule operons in production of the capsule. Spores of strains deficient in production of either the HA or TS capsule were inoculated subcutaneously or intranasally into A/J and C57BL/6 mice to determine the lethal dose 50% of each bacterial mutant by each route of infection. The loss of the HA capsule attenuated G9241 more than the loss of the TS capsule for both infection routes in both mouse strains. Overall, our data further characterize the unique TS capsule on pBC210 and demonstrate that the two capsules do not have the same impact on virulence of G9241.	[Scarff, Jennifer M.; Seldina, Yuliya, I; Vergis, James M.; Ventura, Christy L.; O'Brien, Alison D.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	O'Brien, AD (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	alison.obrien@usuhs.edu	Scarff, Jennifer/M-7594-2019	Scarff, Jennifer/0000-0001-5419-5534	Biological Defense Research Directorate of the Naval Medical Research Center [HU0001-15-2-0030, HU0001-16-2-0066]; National Institute of Allergy and Infectious Diseases [R21 AI111101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111101] Funding Source: NIH RePORTER	Biological Defense Research Directorate of the Naval Medical Research Center; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by awards HU0001-15-2-0030 and HU0001-16-2-0066 (ADO) from the Biological Defense Research Directorate of the Naval Medical Research Center and R21 AI111101 (ADO) from the National Institute of Allergy and Infectious Diseases. The opinions and assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense, the Department of the Navy, the Uniformed Services University of the Health Sciences, or the National Institutes of Health.	AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; Antonation KS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004923; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brezillon C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003455; CINADER B, 1964, J EXP MED, V120, P897, DOI 10.1084/jem.120.5.897; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; Gee JE, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00469-14; Gilbreath JJ, 2012, J BACTERIOL, V194, P6490, DOI 10.1128/JB.01226-12; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lessard PA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-15; MAKINO S, 1988, MOL MICROBIOL, V2, P371, DOI 10.1111/j.1365-2958.1988.tb00041.x; Marston CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156987; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Munoz R, 1997, MOL MICROBIOL, V25, P79, DOI 10.1046/j.1365-2958.1997.4341801.x; Oh SY, 2011, MOL MICROBIOL, V80, P455, DOI 10.1111/j.1365-2958.2011.07582.x; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Pena-Gonzalez A, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00181-17, 10.1128/genomea.00181-17]; ROBERTSON DL, 1986, GENE, V44, P71, DOI 10.1016/0378-1119(86)90044-2; Sau S, 1997, J BACTERIOL, V179, P1614, DOI 10.1128/jb.179.5.1614-1621.1997; Scarff JM, 2016, MOL MICROBIOL, V102, P545, DOI 10.1111/mmi.13478; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Simon NC, 2013, BIOCHEMISTRY-US, V52, P2309, DOI 10.1021/bi300692g; Sue D, 2006, J CLIN MICROBIOL, V44, P3426, DOI 10.1128/JCM.00873-06; TIPPETTS MT, 1988, J BACTERIOL, V170, P2263, DOI 10.1128/jb.170.5.2263-2266.1988; Vergis JM, 2013, CLIN VACCINE IMMUNOL, V20, P56, DOI 10.1128/CVI.00550-12; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; VODKIN MH, 1983, CELL, V34, P693, DOI 10.1016/0092-8674(83)90402-6; Wen ZS, 2015, INFECT IMMUN, V83, P1957, DOI 10.1128/IAI.02944-14; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wilson MK, 2011, INFECT IMMUN, V79, P3012, DOI 10.1128/IAI.00205-11; Wright AM, 2011, ARCH PATHOL LAB MED, V135, P1447, DOI 10.5858/2011-0362-SAIR.1; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	38	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202701	10.1371/journal.pone.0202701	http://dx.doi.org/10.1371/journal.pone.0202701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133532	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400094
J	Skrzypczak-Pietraszek, E; Reiss, K; Zmudzki, P; Pietraszek, J				Skrzypczak-Pietraszek, Ewa; Reiss, Katarzyna; Zmudzki, Pawet; Pietraszek, Jacek			Enhanced accumulation of harpagide and 8-O-acetyl-harpagide in Melittis melissophyllum L. agitated shoot cultures analyzed by UPLC-MS/MS	PLOS ONE			English	Article							HAIRY ROOT CULTURES; HARPAGOPHYTUM-PROCUMBENS; METHYL JASMONATE; SALICYLIC-ACID; BIOSYNTHESIS; IRIDOIDS; PLANTS; HARPAGOSIDE; ELICITATION; METABOLITE	Harpagide and its derivatives have valuable medicinal properties, such as anti-inflammatory, analgesic and potential antirheumatic effects. There is the demand for searccultures and the enhancement of their accumulation by means of medium supplementation with elicitors and precursor.hing plant species containing these iridoids or developing biotechnological methods to obtain the compounds. The present study investigated the effects of methyl jasmonate (MeJa, 50 mu M), ethephon (Eth, 50 mu M) and L-phenylalanine (L-Phe, 2.4 g/L of medium), added to previously selected variant of Murashige and Skoog medium (supplemented with plant growth regulators: 6-benzylaminopurine 1.0 mg/L, alpha-naphthaleneacetic acid 0.5 mg/L, gibberellic acid 0.25 mg/L) on the accumulation of harpagide and 8-O-acetyl-harpagide in Melittis melissophyllum L. agitated shoot cultures. Plant material was harvested 2 and 8 days after the supplementation. Iridoids were quantitatively analyzed by the UPLC-MS/MS method in extracts from the biomass and the culture medium. It was found that all of the variants caused an increase in the accumulation of harpagide. In the biomass harvested after 2 days, the highest harpagide content of 247.3 mg/100 g DW was found for variant F (L-Phe and Eth), and the highest 8-O-acetyl-harpagide content of 138 mg/100 g DW for variant E (L-Phe and MeJa). After 8 days, in some variants, a portion of the metabolites was released into the culture medium. Considering the total amount of the compounds (in the biomass and medium), the highest accumulation of harpagide, amounting to 619 mg/100 g DW, was found in variant F, and the highest amount of 8-O-acetyl-harpagide, of 255.4 mg/100 g DW, was found in variant H (L-Phe, MeJa, Eth) when harvested on the 8th day. These amounts were, respectively, 24.7 and 4.8 times higher than in the control culture, and were, respectively, 15 and 6.7 times higher than in the leaves of the soil-grown plant. The total amount of the two iridoids was highest for variant F (0.78% DW) and variant H (0.68% DW) when harvested on the 8th day. The results indicate that the agitated shoot cultures of M. melissophyllum can be a rich source of harpagide and 8-O-acetyl-harpagide, having a potential practical application. To the best of our knowledge we present for the first time the results of the quantitative UPLC-MS/MS analysis of harpagide and 8-O-acetyl-harpagide in M. melissophyllum shoot	[Skrzypczak-Pietraszek, Ewa; Reiss, Katarzyna] Jagiellonian Univ, Coll Med, Fac Pharm, Chair & Dept Pharmaceut Bot, Krakow, Poland; [Zmudzki, Pawet] Jagiellonian Univ, Coll Med, Fac Pharm, Chair Pharmaceut Chem, Krakow, Poland; [Pietraszek, Jacek] Cracow Univ Technol, Fac Mech Engn, Dept Software Engn & Appl Stat, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Cracow University of Technology	Skrzypczak-Pietraszek, E (corresponding author), Jagiellonian Univ, Coll Med, Fac Pharm, Chair & Dept Pharmaceut Bot, Krakow, Poland.	ewa.skrzypczak-pietraszek@uj.edu.pl	Pietraszek, Jacek/C-8500-2012; Skrzypczak-Pietraszek, Ewa/K-7579-2013; Żmudzki, Paweł/A-3728-2013	Pietraszek, Jacek/0000-0003-2851-1606; Skrzypczak-Pietraszek, Ewa/0000-0001-8222-0047; Żmudzki, Paweł/0000-0003-3594-1241	Jagiellonian University Collegium Medicum [K/ZDS/005618/2017]	Jagiellonian University Collegium Medicum	This work was supported by statute scientific grant number K/ZDS/005618/2017 funded by Jagiellonian University Collegium Medicum (http://www.cm-uj.krakow.pl/) for Ewa Skrzypczak-Pietraszek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, EUROPEAN PHARMACOPOE, P1335; Arora R, 2010, MEDICINAL PLANT BIOTECHNOLOGY, pXI; Bae KH, 2006, BIOTECHNOL LETT, V28, P1163, DOI 10.1007/s10529-006-9071-1; Bairu MW, 2011, S AFR J BOT, V77, P479, DOI 10.1016/j.sajb.2010.09.009; Ball P. W., 1972, FLORA EUROPAEA, V3, P143; DAMTOFT S, 1994, PHYTOCHEMISTRY, V35, P621, DOI 10.1016/S0031-9422(00)90574-0; DAMTOFT S, 1993, PHYTOCHEMISTRY, V33, P1089, DOI 10.1016/0031-9422(93)85028-P; Espinosa-Leal CA, 2018, PLANTA, V248, P1, DOI 10.1007/s00425-018-2910-1; Georgiev M, 2006, ENG LIFE SCI, V6, P593, DOI 10.1002/elsc.200620160; Georgiev MI, 2007, APPL MICROBIOL BIOT, V74, P1175, DOI 10.1007/s00253-007-0856-5; Georgiev MI, 2013, PHYTOCHEMISTRY, V92, P8, DOI 10.1016/j.phytochem.2013.04.009; Georgiev V, 2009, Z NATURFORSCH C, V64, P219; Giri CC, 2016, PLANT CELL TISS ORG, V126, P1, DOI 10.1007/s11240-016-0985-6; Grabkowska R, 2010, ACTA PHYSIOL PLANT, V32, P665, DOI 10.1007/s11738-009-0445-6; Guarrera PM, 2005, FITOTERAPIA, V76, P1, DOI 10.1016/j.fitote.2004.09.006; Hidalgo D, 2017, ENG LIFE SCI, V17, P413, DOI 10.1002/elsc.201600167; Hinkelman K., 2008, DESIGN ANAL EXPT, V1; Hochberg Y., 1987, MULTIPLE COMP PROCED; Idolo M, 2010, J ETHNOPHARMACOL, V127, P379, DOI 10.1016/j.jep.2009.10.027; Jang HR, 2016, HORTIC ENVIRON BIOTE, V57, P79, DOI 10.1007/s13580-016-0111-z; John R, 2018, PHYSIOL MOL BIOL PLA, V24, P275, DOI 10.1007/s12298-018-0506-7; Karuppusamy S, 2009, J MED PLANTS RES, V3, P1222; Kim JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187622; Krishnan SRS, 2018, IND CROP PROD, V114, P173, DOI 10.1016/j.indcrop.2018.01.069; Kuzma L, 2009, ENZYME MICROB TECH, V44, P406, DOI 10.1016/j.enzmictec.2009.01.005; Lee EJ, 2015, PLANT CELL TISS ORG, V120, P1, DOI [10.1007/s11240-014-0567-4, 10.1007/s11240-014-0467-7]; Ludwig-Muller J, 2008, PROCESS BIOCHEM, V43, P15, DOI 10.1016/j.procbio.2007.10.006; Maggi F, 2011, CHEM BIODIVERS, V8, P2057, DOI 10.1002/cbdv.201000365; Maggi F, 2011, CHEM BIODIVERS, V8, P325, DOI 10.1002/cbdv.201000262; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nartop P., PLANT METABOLITES RE; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; Parenti C, 2016, NAT PROD RES, V30, P1248, DOI 10.1080/14786419.2015.1052069; Piatczak E, 2016, ACTA BIOL CRACOV BOT, V58, P57, DOI 10.1515/abcsb-2016-0004; Piatczak E, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-2011-8; Rahimi S, 2015, APPL MICROBIOL BIOT, V99, P6987, DOI 10.1007/s00253-015-6806-8; Sagare AP, 2001, BIOL PHARM BULL, V24, P1311, DOI 10.1248/bpb.24.1311; Sampaio-Santos MI, 2001, J BRAZIL CHEM SOC, V12, P144; SCARPATI MARIA LUISA, 1967, RIC SCI, V37, P840; SCARPATI ML, 1965, TETRAHEDRON LETT, P3439; Scarpati ML, 1967, GAZZ CHIM ITAL, V97, P211; Sesterhenn K, 2007, PLANT CELL REP, V26, P365, DOI 10.1007/s00299-006-0233-3; SKRZYPCZAK L, 1994, ACTA SOC BOT POL, V63, P173, DOI 10.5586/asbp.1994.023; Skrzypczak-Pietraszek E, 2000, PHARMAZIE, V55, P768; Skrzypczak-Pietraszek E, 2005, ACTA PHYSIOL PLANT, V27, P79, DOI 10.1007/s11738-005-0039-x; Skrzypczak-Pietraszek E, 2018, ENG LIFE SCI, V18, P287, DOI 10.1002/elsc.201800003; Skrzypczak-Pietraszek E, 2017, PHYTOCHEM LETT, V20, P443, DOI 10.1016/j.phytol.2017.01.009; Skrzypczak-Pietraszek E, 2014, CHEM BIODIVERS, V11, P562, DOI 10.1002/cbdv.201300148; Skrzypczak-Pietraszek E, 2014, ACTA BIOCHIM POL, V61, P47; Skrzypczak-Pietraszek E, 2012, J PHARMACEUT BIOMED, V66, P154, DOI 10.1016/j.jpba.2012.03.037; Smetanska I, 2008, ADV BIOCHEM ENG BIOT, V111, P187, DOI 10.1007/10_2008_103; Szopa A, 2018, APPL MICROBIOL BIOT, V102, P945, DOI 10.1007/s00253-017-8640-7; Venditti A, 2016, NAT PROD RES, V30, P218, DOI 10.1080/14786419.2015.1040792; Venditti A, 2016, NAT PROD COMMUN, V11, P1631; Zaheer M, 2017, RES CHEM INTERMEDIAT, V43, P2433, DOI 10.1007/s11164-016-2771-9; Zaheer M, 2016, NAT PROD RES, V30, P1542, DOI 10.1080/14786419.2015.1054823; Zaheer M, 2015, PLANT CELL TISS ORG, V122, P553, DOI 10.1007/s11240-015-0787-2	57	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202556	10.1371/journal.pone.0202556	http://dx.doi.org/10.1371/journal.pone.0202556			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133513	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400082
J	Baker, JR; Vuppusetty, C; Colley, T; Hassibi, S; Fenwick, PS; Donnelly, LE; Ito, K; Barnes, PJ				Baker, Jonathan R.; Vuppusetty, Chaitanya; Colley, Thomas; Hassibi, Shyreen; Fenwick, Peter S.; Donnelly, Louise E.; Ito, Kazuhiro; Barnes, Peter J.			MicroRNA-570 is a novel regulator of cellular senescence and inflammaging	FASEB JOURNAL			English	Article						COPD; miRNA; cell cycle; epithelial cells; inflammation	OXIDATIVE STRESS; MOLECULAR-MECHANISMS; PREMATURE SENESCENCE; DNA-DAMAGE; P38 MAPK; DISEASE; SIRT1; INHIBITOR; PROTEIN; COPD	Diseases of accelerated aging often occur together (multimorbidity), and their prevalence is increasing, with high societal and health care costs. Chronic obstructive pulmonary disease (COPD) is one such condition, in which one half of patients exhibit 4 age-related diseases. Diseases of accelerated aging share common molecular pathways, which lead to the detrimental accumulation of senescent cells. These senescent cells no longer divide but release multiple inflammatory proteins, known as the senescence-associated secretory phenotype, which may perpetuate and speed disease. Here, we show that inhibiting miR-570-3p, which is increased in COPD cells, reverses cellular senescence by restoring the antiaging molecule sirtuin-1. MiR-570-3p is induced by oxidative stress in airway epithelial cells through p38 MAP kinase-c-Jun signaling and drives senescence by inhibiting sirtuin-1. Inhibition of elevated miR-570-3p in COPD small airway epithelial cells, using an antagomir, restores sirtuin-1 and suppresses markers of cellular senescence (p16(INK4a), p21(Waf1), and p27(Kip1)), thereby restoring cellular growth by allowing progression through the cell cycle. MiR-570-3p inhibition also suppresses the senescence-associated secretory phenotype (matrix metalloproteinases-2/9, C-X-C motif chemokine ligand 8, IL-1, and IL-6). Collectively, these data suggest that inhibiting miR-570-3p rejuvenates cells via restoration of sirtuin-1, reducing many of the abnormalities associated with cellular senescence.Baker, J. R., Vuppusetty, C., Colley, T., Hassibi, S., Fenwick, P. S., Donnelly, L. E., Ito, K., Barnes, P. J. MicroRNA-570 is a novel regulator of cellular senescence and inflammaging.	[Baker, Jonathan R.; Vuppusetty, Chaitanya; Colley, Thomas; Hassibi, Shyreen; Fenwick, Peter S.; Donnelly, Louise E.; Ito, Kazuhiro; Barnes, Peter J.] Imperial Coll London, Airway Dis Sect, Natl Heart & Lung Inst, London, England	Imperial College London	Barnes, PJ (corresponding author), Imperial Coll London, NHLI, Dovehouse St, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019	Barnes, Peter/0000-0002-5122-4018	British Lung Foundation [JFRG17-7]; Wellcome Trust Programme Grant [093080/Z/10/Z]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London	British Lung Foundation; Wellcome Trust Programme Grant(Wellcome Trust); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London	The authors thank Prof. Jim Hogg (University of British Columbia, Vancouver, BC, Canada) for kindly providing peripheral lung tissue samples and Dr. Andriana I. Papaioannou (Sismanogleio Hospital, Athens, Greece) for providing the sputum samples. This work was funded by the British Lung Foundation Grant (JFRG17-7), Wellcome Trust Programme Grant (093080/Z/10/Z), and supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The authors declare no conflicts of interest.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aoshiba K, 2012, EUR RESPIR J, V39, P1368, DOI 10.1183/09031936.00050211; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep35871; Baraldo S, 2007, CHEST, V132, P1733, DOI 10.1378/chest.06-2819; Barnes PJ, 2017, ANNU REV PHYSIOL, V79, P517, DOI 10.1146/annurev-physiol-022516-034314; Barnes PJ, 2015, EUR RESPIR J, V45, P790, DOI 10.1183/09031936.00229714; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Barnes PJ, 2011, AM J RESP CRIT CARE, V184, P866, DOI 10.1164/rccm.201108-1436ED; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Booton R, 2014, CHEST, V146, P193, DOI 10.1378/chest.13-2736; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao L, 2013, BRAZ J MED BIOL RES, V46, P659, DOI 10.1590/1414-431X20132903; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Choi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115787; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Ding Lily, 2004, COPD, V1, P191, DOI 10.1081/COPD-120039810; Donohue JF, 2006, THORAX, V61, P461, DOI 10.1136/thx.2005.053058; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Guo W, 2015, TUMOR BIOL, V36, P9049, DOI 10.1007/s13277-015-3644-3; Hayakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116480; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hesselbach K, 2017, EPIGENETICS-US, V12, P779, DOI 10.1080/15592294.2017.1356555; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Renda T, 2008, EUR RESPIR J, V31, P62, DOI 10.1183/09031936.00036707; Roff AN, 2014, AM J CLIN EXP IMMUNO, V3, P68; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090022; Siganaki M, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-46; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; To M, 2011, CHEST, V140, P76, DOI 10.1378/chest.10-1608; Tong XD, 2015, INT J CLIN EXP PATHO, V8, P2829; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhang R, 2014, J NEUROL SCI, V338, P57, DOI 10.1016/j.jns.2013.12.017; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	58	42	44	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1605	1616		10.1096/fj.201800965R	http://dx.doi.org/10.1096/fj.201800965R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30156909	Green Published, hybrid			2022-12-26	WOS:000457296600009
J	Brandt, SC; Ellinger, B; van Nguyen, T; Thi, QD; Van Nguyen, G; Baschien, C; Yurkov, A; Hahnke, RL; Schafer, W; Gand, M				Brandt, Sophie C.; Ellinger, Bernhard; van Nguyen, Thuat; Quyen Dinh Thi; Giang Van Nguyen; Baschien, Christiane; Yurkov, Andrey; Hahnke, Richard L.; Schaefer, Wilhelm; Gand, Martin			A unique fungal strain collection from Vietnam characterized for high performance degraders of bioecological important biopolymers and lipids	PLOS ONE			English	Article							PENICILLIUM-CITRINUM; ASPERGILLUS-FUMIGATUS; XYLANASE PRODUCTION; FUSARIUM-OXYSPORUM; PURIFICATION; TRICHODERMA; LIPASE; IDENTIFICATION; ENDO-1,4-BETA-XYLANASE; BIODIVERSITY	Fungal strains are abundantly used throughout all areas of biotechnology and many of them are adapted to degrade complex biopolymers like chitin or lignocellulose. We therefore assembled a collection of 295 fungi from nine different habitats in Vietnam, known for its rich biodiversity, and investigated their cellulase, chitinase, xylanase and lipase activity. The collection consists of 70 isolates from wood, 55 from soil, 44 from rice straw, 3 found on fruits, 24 from oil environments (butchery), 12 from hot springs, 47 from insects as well as 27 from shrimp shells and 13 strains from crab shells. These strains were cultivated and selected by growth differences to enrich phenotypes, resulting in 211 visually different fungi. DNA isolation of 183 isolates and phylogenetic analysis was performed and 164 species were identified. All were subjected to enzyme activity assays, yielding high activities for every investigated enzyme set. In general, enzyme activity corresponded with the environment of which the strain was isolated from. Therefore, highest cellulase activity strains were isolated from wood substrates, rice straw and soil and similar substrate effects were observed for chitinase and lipase activity. Xylanase activity was similarly distributed as cellulase activity, but substantial activity was also found from fungi isolated from insects and shrimp shells. Seven strains displayed significant activities against three of the four tested substrates, while three degraded all four investigated carbon sources. The collection will be an important source for further studies. Therefore representative strains were made available to the scientific community and deposited in the public collection of the Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig.	[Brandt, Sophie C.; van Nguyen, Thuat; Schaefer, Wilhelm; Gand, Martin] Univ Hamburg, Dept Mol Phytopathol, Hamburg, Germany; [Ellinger, Bernhard] Fraunhofer Inst Mol Biol & Appl Ecol IME, Dept ScreeningPort, Hamburg, Germany; [Quyen Dinh Thi] Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam; [Giang Van Nguyen] Vietnam Natl Univ Agr, Fac Biotechnol, Hanoi, Vietnam; [Baschien, Christiane; Yurkov, Andrey; Hahnke, Richard L.] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany; [Gand, Martin] Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Germany	University of Hamburg; Fraunhofer Gesellschaft; Vietnam Academy of Science & Technology (VAST); Vietnam National University of Agriculture (VNUA); Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Justus Liebig University Giessen	Gand, M (corresponding author), Univ Hamburg, Dept Mol Phytopathol, Hamburg, Germany.; Gand, M (corresponding author), Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Germany.	martin.gand@lcb.chemie.uni-giesssen.de	Yurkov, Andrey M./E-7854-2011; Gand, Martin/ABE-4962-2020	Yurkov, Andrey M./0000-0002-1072-5166; Gand, Martin/0000-0001-8211-691X; Ellinger, Bernhard/0000-0001-5703-3901	German federal ministry BMBF [03A0150B]	German federal ministry BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by the German federal ministry BMBF under contract No. 03A0150B within the framework of Bioeconomy International 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fatah OM, 2012, BRAZ J MICROBIOL, V43, P1, DOI 10.1590/S1517-83822012000100001; Aleku GA, 2017, NAT CHEM, V9, P961, DOI [10.1038/nchem.2782, 10.1038/NCHEM.2782]; [Anonymous], 2004, HOTSPOTS REVISITED E; [Anonymous], 2010, COLD SPRING HARB PRO; Archer DB, 2008, ADV BIOCHEM ENG BIOT, V111, P99, DOI 10.1007/10_2007_094; Bagewadi Z.K., 2016, BIOTECH, V3, P6, DOI [10.1007/s13205-016-0489-4, DOI 10.1007/S13205-016-0489-4]; Baker RA, 1996, TRENDS FOOD SCI TECH, V7, P279, DOI 10.1016/0924-2244(96)10030-3; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barbi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116264; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; BEDFORD MR, 1991, POULTRY SCI, V70, P1571, DOI 10.3382/ps.0701571; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bennett JW, 1998, J BIOTECHNOL, V66, P101, DOI 10.1016/S0168-1656(98)00133-3; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bommarius AS, 2005, BIOCATALYSIS, P159; Bormann J, 2014, GESUNDE PFLANZ, V66, P23, DOI 10.1007/s10343-013-0312-7; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Breuil C, 1984, ENZYME MICROB TECHNO, V7; Butt MS, 2008, FOOD TECHNOL BIOTECH, V46, P22; Cantrell SA, 2011, MYCOLOGIA, V103, P1161, DOI 10.3852/11-108; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chambergo FS, 2016, APPL MICROBIOL BIOT, V100, P2567, DOI 10.1007/s00253-016-7305-2; Cherif S, 2011, LIPIDS HLTH DIS, V10; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; da Silva LRC, 2011, BRAZ J MICROBIOL, V42, P49, DOI 10.1590/S1517-83822011000100007; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Danso D, 2018, APPL ENV MICROBIOL; DAR RA, 2013, ADV ENZYME RES, V1, P91, DOI DOI 10.4236/AER.2013.14010; de Alencar Guimaraes NC, 2013, SPRINGERPLUS, V2, P380, DOI DOI 10.1186/2193-1801-2-380; de Maria PD, 2005, J MOL CATAL B-ENZYM, V37, P36, DOI 10.1016/j.molcatb.2005.09.001; De Queiroz JS, 2013, VIETNAM TROPICAL FOR; Dhiman TR, 2002, ANIM FEED SCI TECH, V101, P115, DOI 10.1016/S0377-8401(02)00177-3; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Druzhinina IS, 2012, FEMS MICROBIOL LETT, V337, P1, DOI 10.1111/j.1574-6968.2012.02665.x; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Ferguson BA, 2003, CAN J FOREST RES, V33, P612, DOI 10.1139/x03-065; Ferrari AR, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-37; Garvey M, 2013, TRENDS BIOTECHNOL, V31, P581, DOI 10.1016/j.tibtech.2013.06.006; Ghoshal G, 2014, CHEM BIOCHEM ENG Q, V28, P399, DOI 10.15255/CABEQ.2013.1885; Ghoshal G, 2012, CHEM BIOCHEM ENG Q, V26, P61; Goker M, 2011, STAND GENOMIC SCI, V4, P63, DOI 10.4056/sigs.1533840; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hwang HT, 2014, BIOTECHNOL BIOENG, V111, P639, DOI 10.1002/bit.25162; Jaafaru M.I., 2013, ISRN MICROBIOL, V2013, P2013, DOI DOI 10.1155/2013/283423; Jaklitsch WM, 2015, STUD MYCOL, P1, DOI 10.1016/j.simyco.2014.11.001; Jung WJ, 2006, PROTEIN EXPRES PURIF, V45, P125, DOI 10.1016/j.pep.2005.06.016; Karthik N, 2014, INDIAN J EXP BIOL, V52, P1025; Kelly SA, 2018, CHEM REV, V118, P349, DOI 10.1021/acs.chemrev.7b00437; Kim SK, 2010, SOURCES PRODUCTION C; Kwon Hyuk Woo, 2007, Mycobiology, V35, P162, DOI 10.4489/MYCO.2007.35.3.162; LEACH J, 1982, J GEN MICROBIOL, V128, P1719; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lombard L, 2015, STUD MYCOL, P189, DOI 10.1016/j.simyco.2014.12.002; Lu Y, 2009, GLYCOCONJUGATE J, V26, P525, DOI 10.1007/s10719-008-9203-z; Mai C, 2004, APPL MICROBIOL BIOT, V63, P477, DOI 10.1007/s00253-003-1411-7; MASE T, 1995, BIOSCI BIOTECH BIOCH, V59, P1771, DOI 10.1271/bbb.59.1771; Matny ON, 2015, ADV PLANTS AGR RES, V2, P1; Mayordomo I, 2000, J AGR FOOD CHEM, V48, P105, DOI 10.1021/jf9903354; Mirzaakhmedov SY, 2007, CHEM NAT COMPD+, V43, P594, DOI 10.1007/s10600-007-0199-6; Mohsenzadeh A, 2017, CHEMBIOENG REV, V4, P75, DOI 10.1002/cben.201600025; Morita T, 2011, BIOSCI BIOTECH BIOCH, V75, P1597, DOI 10.1271/bbb.110036; MUELLER GM, 2004, BIODIVERSITY FUNGI I, P1; Omumasaba CA, 2001, J GEN APPL MICROBIOL, V47, P53, DOI 10.2323/jgam.47.53; PING S, 1948, IND ENG CHEM, V40, P1202; Pscheidt B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-25; Quintanilla D, 2015, ADV BIOCHEM ENG BIOT, V149, P29, DOI 10.1007/10_2015_309; REYES F, 1989, FEMS MICROBIOL LETT, V65, P83, DOI 10.1016/0378-1097(89)90370-4; Ribeiro LFC, 2014, BRIT BIOTECHNOLOGY J, V4, P30, DOI DOI 10.9734/BBJ/2014/6066; Richards E, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0203s27; Robert V, 2013, IMA FUNGUS, V4, P371, DOI 10.5598/imafungus.2013.04.02.16; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Ruijter GJG, 2002, MYCOTA, V10, P213; Rush CL, 2010, CHEM BIOL, V17, P1275, DOI 10.1016/j.chembiol.2010.07.018; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; SHEPPARD PO, 1994, GENE, V150, P163, DOI 10.1016/0378-1119(94)90878-8; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Sreenath HK, 1996, J FERMENT BIOENG, V81, P18, DOI 10.1016/0922-338X(96)83113-8; Steinecke F, 1983, EXPT BIOL; Su GD, 2010, APPL MICROBIOL BIOT, V86, P1493, DOI 10.1007/s00253-009-2382-0; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tanaka H, 2005, J BIOSCI BIOENG, V100, P623, DOI 10.1263/jbb.100.623; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; VONTIGERSTROM RG, 1989, CAN J MICROBIOL, V35, P511, DOI 10.1139/m89-079; Wakiyama M, 2008, J BIOSCI BIOENG, V105, P367, DOI 10.1263/jbb.105.367; Walia A, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-016-0584-6; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; WONG KKY, 1992, CRIT REV BIOTECHNOL, V12, P413, DOI 10.3109/07388559209114234; Zhao ZP, 2013, APPL MICROBIOL BIOT, V97, P10003, DOI 10.1007/s00253-013-4767-3; Zheng YB, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-50	99	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202695	10.1371/journal.pone.0202695	http://dx.doi.org/10.1371/journal.pone.0202695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161149	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900039
J	Kamel, NA; El-tayeb, WN; El-Ansary, MR; Mansour, MT; Aboshanab, KM				Kamel, Noha A.; El-tayeb, Wafaa N.; El-Ansary, Mona R.; Mansour, Mohamed T.; Aboshanab, Khaled M.			Phenotypic screening and molecular characterization of carbapenemase-producing Gram-negative bacilli recovered from febrile neutropenic pediatric cancer patients in Egypt	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; BLUE-CARBA TEST; ACUTE-LEUKEMIA; MULTIPLEX PCR; ENTEROBACTERIACEAE; SPREAD; OXA-48; ASSAY	Aim Infections with carbapenem-resistant Gram-negative bacteria (GNB) are among the most frequent complications in the immunocompromised cancer patients because of their considerable morbidity and mortality. Therefore, the aim of the current study was to characterize the prevalence of carbapenemase-producing GNB recovered from febrile neutropenic pediatric cancer patients in Egypt. Methods Standard methods were used for identification, sensitivity testing (Kirby-Bauer and broth microdilution method according to CLSI guidelines). Standard methods were applied for both phenotypic and genotypic detection of the carbapenemase-producing GNB. Results A total of 185 GNB were recovered from different clinical specimens, Escherichia (E.) coli (86; 46.48%), followed by Klebsiella spp. (71; 38.37%), Acinetobacter (A.) baumannii (7; 3.78%) and others including Pseudomonas spp., Enterobacter (Ent.) cloacae and Proteus spp. (21; 11.35%). It is a matter of concern that 116 out of 171 enterobacterial isolates (94.15%) showed resistance to three or more antimicrobial classes and were considered multidrug resistant. Additionally, the rate of carbapenem-resistance displayed a worrisome trend as 113 out of 171 enterobacterial isolates (66.08%) and 12 out of 14 non fermenting bacilli (85.71%) showed resistance pattern to at least one of the tested carbapenems. After performing a series of phenotypic tests for initial screening of potential carbapenemase producers, molecular characterization to the 29 extracted plasmids were subjected to PCR using 5 common carbapenemase primers). The results revealed that bla(OXA-48) was the most prevalent 17 (58.62%), followed by bla(NDM) 8(27.58%), then bla(VIM) 3 (10.3%) and bla(KPC) 2 (6.89%). Conclusion These results are an alarming threat to public health that calls for urgent application of antimicrobial stewardship programs along with routine surveillance for controlling outbreaks.	[Kamel, Noha A.; El-tayeb, Wafaa N.] Misr Int Univ, Fac Pharm, Dept Microbiol, Cairo, Egypt; [El-Ansary, Mona R.] Modern Univ Technol & Informat, Dept Biochem, Cairo, Egypt; [Mansour, Mohamed T.] Cairo Univ, Childrens Canc Hosp 57357, Dept Virol & Immunol, Cairo, Egypt; [Aboshanab, Khaled M.] Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Misr International University; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University	Aboshanab, KM (corresponding author), Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt.	aboshanab2012@pharma.asu.edu.eg	Aboshanab, Khaled/L-9848-2019	Eltayeb, Wafaa N/0000-0002-5309-1917; Aboshanab, Khaled/0000-0002-7608-850X; El-Ansary, Mona/0000-0002-7904-7914; Ahmed Kamel, Noha/0000-0001-7703-6579				AlTamimi M, 2017, SAUDI J BIOL SCI, V24, P155, DOI 10.1016/j.sjbs.2016.07.004; [Anonymous], SDF, DOI DOI 10.1128/CMR.00117-13; [Anonymous], 2011, MANUAL CLIN MICROBIO; [Anonymous], 2017, EGYPTIAN J MED MICRO; [Anonymous], 2018, INFECT DIS; [Anonymous], 2013, J CLIN MICROBIOL, DOI DOI 10.1128/JCM.01634-13; Averbuch D, 2017, INFECTION, V45, P327, DOI 10.1007/s15010-017-0988-1; Bakthavatchalam YD, 2016, J GLOB INFECT DIS, V8, P41, DOI 10.4103/0974-777X.176149; Bochennek K, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2015.110; Boutal H, 2018, J ANTIMICROB CHEMOTH, V73, P909, DOI 10.1093/jac/dkx521; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cattaneo C, 2018, ANN HEMATOL, P1, DOI [10.1007/s00277-017-3149-9, DOI 10.1007/S00277-017-3149-9]; Chavda KD, 2016, ANTIMICROB AGENTS CH, V60, P6957, DOI 10.1128/AAC.01458-16; CLSI, 2017, PERFORMANCE STANDARD, V26; Dortet L, 2017, EUROSURVEILLANCE, V22, P10, DOI [10.2807/1560-7917.ES.2017.22.6.30461, 10.2807/1560-7917.es.2017.22.6.30461]; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Gauthier L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170769; Holt J., 1994, BERGEYS MANUAL DETER; Islas-Munoz B, 2018, INT J INFECT DIS, V71, P59, DOI 10.1016/j.ijid.2018.03.022; Koroska F, 2017, J CLIN MICROBIOL, V55, P877, DOI 10.1128/JCM.01929-16; Kuo FC, 2017, J MICROBIOL IMMUNOL, V50, P507, DOI 10.1016/j.jmii.2015.08.013; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nastro M, 2017, J CHEMOTHERAPY, V29, P150, DOI 10.1080/1120009X.2016.1201272; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pasteran F, 2015, J CLIN MICROBIOL, V53, P1996, DOI 10.1128/JCM.03026-14; Patel J.B., 2015, PERFORMANCE STANDARD; Pires J, 2013, J CLIN MICROBIOL, V51, P4281, DOI 10.1128/JCM.01634-13; Poirel L, 2013, INT J ANTIMICROB AG, V41, P90, DOI 10.1016/j.ijantimicag.2012.08.015; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Pournaras S, 2013, J CLIN MICROBIOL, V51, P2986, DOI 10.1128/JCM.00901-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Ramana K V, 2013, J Nat Sci Biol Med, V4, P346, DOI 10.4103/0976-9668.117009; Safdar A, 2011, CLIN INFECT DIS, V53, P798, DOI 10.1093/cid/cir492; Sambrook J., 2001, MOL CLONING LAB MANU; Sherry N, 2018, EXPERT REV ANTI-INFE, V21, P1; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Yao JF, 2017, CHINESE MED J-PEKING, V130, P2076, DOI 10.4103/0366-6999.213411	39	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202119	10.1371/journal.pone.0202119	http://dx.doi.org/10.1371/journal.pone.0202119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157188	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400037
J	Nomura, K; Fujiwara, A; Iwasaki, Y; Nishiki, I; Matsuura, A; Ozaki, A; Sudo, R; Tanaka, H				Nomura, Kazuharu; Fujiwara, Atushi; Iwasaki, Yuki; Nishiki, Issei; Matsuura, Aiko; Ozaki, Akiyuki; Sudo, Ryusuke; Tanaka, Hideki			Genetic parameters and quantitative trait loci analysis associated with body size and timing at metamorphosis into glass eels in captive-bred Japanese eels (Anguilla japonica)	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FRESH-WATER EELS; NORTHERN KYUSHU; EVOLUTION; LARVAE; MAPS; LEPTOCEPHALI; AQUACULTURE; DISPERSAL; MIGRATION	The Japanese eel (Anguilla japonica) is among the most important aquaculture fish species in Eastern Asia. The present study aimed to identify the genetic parameters underlying body size and the timing at metamorphosis from leptocephali to glass eels in captive-bred Japanese eels, with the intent to foster sustainable development. Larvae from a partly factorial cross (14 sires x 11 dams) were reared until the point of metamorphosis into glass eels. In these organisms, we observed moderate heritability and mild genetic correlations among traits related to body size (h(2) = 0.16 +/- 0.33) and timing at metamorphosis (h(2) = 0.36 +/- 0.41). In an F1 full-sib family, quantitative trait loci (QTL) mapping for these traits identified one significant (genome-wide P < 0.05) and five suggestive QTLs (chromosome-wide P < 0.05). These results suggest that in the Japanese eel, metamorphic traits exhibit a polygenic genetic structure comprising many QTLs with small effects. In addition, we updated the genetic linkage map for the Japanese eel and integrated it with our newly constructed de novo genome assembly. The information and tools generated from this study will contribute to the development of freshwater eel genetics and genomics.	[Nomura, Kazuharu; Ozaki, Akiyuki; Sudo, Ryusuke; Tanaka, Hideki] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Fujiwara, Atushi; Iwasaki, Yuki; Nishiki, Issei; Matsuura, Aiko] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Iwasaki, Yuki] Natl Inst Genet, Mishima, Shizuoka, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nomura, K (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan.	nomurak@affrc.go.jp		nomura, kazuharu/0000-0002-0459-9992	Ministry of Agriculture, Forestry, and Fisheries (MAFF), Government of Japan; Bio-oriented Technology Research Advancement Institution (NARO)	Ministry of Agriculture, Forestry, and Fisheries (MAFF), Government of Japan; Bio-oriented Technology Research Advancement Institution (NARO)	This work was supported in part by a Grant-in-Aid for "Development of Sustainable Aquaculture Technology Independent of Wild Fishery Resources" from the Ministry of Agriculture, Forestry, and Fisheries (MAFF), Government of Japan and "The special scheme project on advanced research and development for next-generation technology" from the Project of the Bio-oriented Technology Research Advancement Institution (NARO).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashton DT, 2017, MOL ECOL, V26, P1465, DOI 10.1111/mec.13965; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Fierst JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00220; Gilmoura R, 2015, ASREML USER GUIDE, P2005; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Iwasaki Y, 2016, GENE, V576, P644, DOI 10.1016/j.gene.2015.10.015; Jansen HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07650-6; Kagawa H, 2005, FISH PHYSIOL BIOCHEM, V31, P193, DOI 10.1007/s10695-006-0024-3; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Kawakami Y, 1998, FISHERIES SCI, V64, P235, DOI 10.2331/fishsci.64.235; Kawakami Y, 1999, B MAR SCI, V64, P315; Koh ICC, 2017, AQUACULTURE, V473, P487, DOI 10.1016/j.aquaculture.2017.03.011; Kuroki M, 2014, CAN J ZOOL, V92, P749, DOI 10.1139/cjz-2013-0303; Laugen AT, 2005, GENET RES, V86, P161, DOI 10.1017/S0016672305007810; Leander NJ, 2013, ANGUILLA JAPONICA A, V52, P1, DOI [10.1186/1810-522X-52-30, DOI 10.1186/1810-522X-52-30]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masuda Y, 2011, NIPPON SUISAN GAKK, V77, P416, DOI 10.2331/suisan.77.416; Miller MJ, 2017, CAN J FISH AQUAT SCI, V74, P958, DOI 10.1139/cjfas-2016-0281; Nomura K, 2006, AQUACULTURE, V257, P53, DOI 10.1016/j.aquaculture.2006.03.011; Nomura K, 2004, FISHERIES SCI, V70, P247, DOI 10.1111/j.1444-2906.2003.00798.x; Nomura K, 2011, AQUACULTURE, V310, P329, DOI 10.1016/j.aquaculture.2010.11.006; Ohta H, 2017, AQUACULTURE, V479, P150, DOI 10.1016/j.aquaculture.2017.05.044; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; Page RB, 2013, GENOME BIOL EVOL, V5, P1716, DOI 10.1093/gbe/evt123; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pavey SA, 2017, MOL ECOL RESOUR, V17, P806, DOI 10.1111/1755-0998.12608; Sekino M, 2012, CONSERV GENET RESOUR, V4, P275, DOI 10.1007/s12686-011-9523-3; Shiraishi H, 2015, MARKET DYNAMICS ANAL; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; TABETA O, 1987, NIPPON SUISAN GAKK, V53, P1727; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2001, PRODUCTION LEPTOCEPH, P51; Tanaka H, 2015, FISHERIES SCI, V81, P11, DOI 10.1007/s12562-014-0821-z; Tang HB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0573-1; Tsukamoto K, 2002, CAN J FISH AQUAT SCI, V59, P1989, DOI 10.1139/F02-165; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Voss SR, 2012, HEREDITY, V109, P293, DOI 10.1038/hdy.2012.41; Wang CH, 2000, FISH RES, V46, P191, DOI 10.1016/S0165-7836(00)00146-6; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0	46	6	6	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201784	10.1371/journal.pone.0201784	http://dx.doi.org/10.1371/journal.pone.0201784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157280	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400015
J	Singh, S; Fatima, Z; Ahmad, K; Hameed, S				Singh, Shweta; Fatima, Zeeshan; Ahmad, Kamal; Hameed, Saif			Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism	PLOS ONE			English	Article							ABC MULTIDRUG TRANSPORTERS; PROTEIN-STRUCTURE; I-TASSER; RESISTANCE; MECHANISMS; ANTIBACTERIAL; MITOCHONDRIA; HOMEOSTASIS; DISRUPTION; INHIBITORS	Among the several mechanisms of multidrug resistance (MDR), overexpression of drug efflux pumps CaCdr1p and CaMdr1p belonging to ATP binding cassette (ABC) and major facilitator superfamily (MFS) respectively remain the predominant mechanisms of candidal infections. Therefore inhibiting or modulating the function of these transporters continues to draw attention as effective strategy to combat MDR. We have previously reported the antifungal potential of Geraniol (Ger), a natural monoterpenoid from Palmarosa oil, against Candida albicans. Herein, we explored the fungicidal nature of Ger. The Rhodamine 6G (R6G) and Nile red accumulation confirms the specific effect on CaCdr1p. Mechanistic insights with Candida cells overexpressing CaCdr1p and CaMdr1p revealed that Ger specifically modulates CaCdr1p activity. Kinetic studies further unraveled the competitive inhibition of Ger for R6G efflux as evident from increased apparent Km without affecting V-max value. The effect of Ger on CaCdr1p was substantiated by molecular docking analyses, which depicted in-silico binding affinity of Ger with CaCdr1p and explored that Ger binds to the active site of CaCdr1p with higher binding energy. Although RT-PCR and western blot revealed no change in expressions of CDR1 and CaCdr1p, confocal microscopy images however depicted CaCdr1p mislocalization in presence of Ger. Interestingly, Ger was synergistic (FICI<0.5) with fluconazole (FLC) which is a well known antifungal drug. Furthermore, Ger sensitizes the FLC sensitive and resistant clinical matched pair of isolates Gu4/Gu5 and led to abrogated R6G efflux and depleted ergosterol. Furthermore, Rhodamine B labeling demonstrates altered mitochondrial potential with Ger which suggest possible linkage of dysfunctional mitochondria with CaCdr1p activity. We also estimated phenotypic virulence marker extracellular phospholipase activity which was considerably diminished along with inhibited cell adherence and biofilm biomass. Lastly, antifungal efficacy of Ger was demonstrated by enhanced survival of Caenorhabditis elegans model and negligible hemolytic activity (20%). Together, modulation of efflux pump activity by Ger and FLC synergism represent a promising approach for combinatorial treatment of candidiasis.	[Singh, Shweta; Fatima, Zeeshan; Hameed, Saif] Amity Univ Haryana, Amity Inst Biotechnol, Gurugram, Manesar, India; [Ahmad, Kamal] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India	Jamia Millia Islamia	Fatima, Z; Hameed, S (corresponding author), Amity Univ Haryana, Amity Inst Biotechnol, Gurugram, Manesar, India.	drzeeshanfatima@gmail.com; saifhameed@yahoo.co.in		ahmad, kamal/0000-0003-1744-6554				Ahmad K, 2017, LETT DRUG DES DISCOV, V14, P488, DOI 10.2174/1570180814666161214114322; [Anonymous], 2008, M27A3 NAT COMM CLIN; Ansari MA, 2018, BIOCHEM BIOPH RES CO, V495, P560, DOI 10.1016/j.bbrc.2017.11.064; Ansari MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162465; Ansari MA, 2016, MICROB PATHOGENESIS, V98, P140, DOI 10.1016/j.micpath.2016.07.004; Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200; Baghel P, 2017, BBA-BIOMEMBRANES, V1859, P1778, DOI 10.1016/j.bbamem.2017.05.011; Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Berkow EL, 2017, INFECT DRUG RESIST, V10, P237, DOI 10.2147/IDR.S118892; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Franz R, 1999, MYCOSES, V42, P453, DOI 10.1046/j.1439-0507.1999.00498.x; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Garcia-Gomes AS, 2012, MED MYCOL, V50, P26, DOI 10.3109/13693786.2011.578156; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gu WR, 2016, ANTIMICROB AGENTS CH, V60, P6179, DOI 10.1128/AAC.03046-15; Guo XL, 2008, J APPL MICROBIOL, V104, P831, DOI 10.1111/j.1365-2672.2007.03617.x; Hameed Saif, 2013, Int J Microbiol, V2013, P240209, DOI 10.1155/2013/240209; Karacaer Z, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.398.4960; Lacka I, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00783; Misra LN, 2013, J ETHNOPHARMACOL, V148, P74, DOI 10.1016/j.jep.2013.03.069; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114; Nim S, 2016, PLANTA MED, V82, P1180, DOI 10.1055/s-0042-106169; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad R., 2006, Infectious Disorders - Drug Targets, V6, P69, DOI 10.2174/187152606784112164; Prasad R, 2002, ADV MICROB PHYSIOL, V46, P155, DOI 10.1016/S0065-2911(02)46004-3; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Qu Y, 2012, EUKARYOT CELL, V11, P532, DOI 10.1128/EC.05292-11; Repasky M.P., 2007, CURR PROTOC HUM GENE, V18, P1; Reungpatthanaphong P, 2003, J BIOCHEM BIOPH METH, V57, P1, DOI 10.1016/S0165-022X(03)00032-0; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sharma M, 2011, ANTIMICROB AGENTS CH, V55, P4834, DOI 10.1128/AAC.00344-11; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Singh S., 2017, FRONT ANTIINFECT DRU, V7, P1; Singh S, 2016, REV SOC BRAS MED TRO, V49, P465, DOI 10.1590/0037-8682-0190-2016; Singh S, 2016, ARCH MICROBIOL, V198, P459, DOI 10.1007/s00203-016-1205-9; Singh Shweta, 2015, Infez Med, V23, P211; Sun WW, 2017, INT J ANTIMICROB AG, V50, P399, DOI 10.1016/j.ijantimicag.2017.03.015; Szczepaniak J, 2017, INT J ANTIMICROB AG, V50, P171, DOI 10.1016/j.ijantimicag.2017.01.044; Tanwar Jyoti, 2014, Interdiscip Perspect Infect Dis, V2014, P541340, DOI 10.1155/2014/541340; Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13; Tong YJ, 2016, SYN SYST BIOTECHNO, V1, P158, DOI 10.1016/j.synbio.2016.10.001; Tran-Nguyen VK, 2017, CURR MED CHEM, V24, P3242, DOI 10.2174/0929867324666170523102244; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xie F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33687; Yamamoto S, 2005, BIOCHEM BIOPH RES CO, V330, P622, DOI 10.1016/j.bbrc.2005.03.009; Yan HB, 2014, FEMS YEAST RES, V14, P614, DOI 10.1111/1567-1364.12148; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yousuf S, 2011, MED MYCOL, V49, P444, DOI 10.3109/13693786.2010.539629; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079671	59	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203079	10.1371/journal.pone.0203079	http://dx.doi.org/10.1371/journal.pone.0203079			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157240	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400087
J	Spindler, J; Zandi, S; Pfister, IB; Gerhardt, C; Garweg, JG				Spindler, Jan; Zandi, Souska; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.			Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BIOMARKERS; EXPRESSION; CHEMOKINE; ANGIOGENESIS; INFLAMMATION; RANIBIZUMAB; PROGRESSION; MECHANISMS; SENESCENCE	Purpose To identify disease-specific cytokine profile differences in the aqueous humor (AH) (other than the vascular endothelial growth factor) between patients with dry and treated wet age-related macular degeneration (AMD) and healthy controls. Methods This retrospective study drew on a case-series of patients diagnosed with dry AMD (n=25) and treated wet AMD (n=19), as well as on healthy controls (no systemic therapy; n=20) undergoing phacoemulsification or vitrectomy. Samples of AH and serum were collected in parallel at the beginning of surgery. The levels of 43 cytokines were simultaneously determined using the Bio-Plex (R) multiplex beads system. Differences between the three groups were statistically compared using the Kruskal-Wallis H-Test after applying the Bonferroni correction for multiple comparisons (p<0.0012). Results The concentrations of three cytokines were elevated in the AH of patients with dry AMD (CXCL6; p=0.00067) and treated wet AMD (CXCL5, CXCL6, MIG/XCXL; all p<0.001) relative to those in the healthy controls. No other differences between the three groups were identified. The AH levels of seven cytokines (16%), including CXCL6, ranged below the lower limit of quantitation of the assay. Without the correction for multiple comparisons (p<0.05), the levels of 31 of the 43 cytokines in the AH of patients with AMD would have differed significantly from those in the control. The systemic cytokine profiles (serum) were similar in all three groups. Conclusions No systematic differences in the AH cytokine environment were identified between patients with dry AMD and those with treated wet AMD. This finding might indicate that AMD is either the result of a persistent imbalance in the physiological tissue milieu, or that the localized process induces no significant change in the cytokine environment of the anterior ocular segment.	[Spindler, Jan; Zandi, Souska; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.] Swiss Eye Inst, Bern, Switzerland; [Spindler, Jan; Zandi, Souska; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.] Berner Augenklin Lindenhofspital, Bern, Switzerland; [Spindler, Jan; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.] Univ Bern, Bern, Switzerland	University of Bern	Garweg, JG (corresponding author), Swiss Eye Inst, Bern, Switzerland.; Garweg, JG (corresponding author), Berner Augenklin Lindenhofspital, Bern, Switzerland.; Garweg, JG (corresponding author), Univ Bern, Bern, Switzerland.	garweg@swiss-eye-institute.com		Zandi, Souska/0000-0001-9351-4278	Scientific Funds of the Lindenhof Foundation	Scientific Funds of the Lindenhof Foundation	The manuscript was partially funded by a grant from the Scientific Funds of the Lindenhof Foundation without commercial interests. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bauer ME, 2016, MECH AGEING DEV, V158, P27, DOI 10.1016/j.mad.2016.01.001; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Camelo S, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/532487; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Cao SJ, 2013, AM J OPHTHALMOL, V156, P1176, DOI 10.1016/j.ajo.2013.08.003; Cha DM, 2013, INVEST OPHTH VIS SCI, V54, P7038, DOI 10.1167/iovs.13-12730; Chaudhary V, 2016, CAN J OPHTHALMOL, V51, P302, DOI 10.1016/j.jcjo.2016.04.020; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Danis RP, 2015, CLIN OPHTHALMOL, V9, P2159, DOI 10.2147/OPTH.S92359; Falk MK, 2014, INVEST OPHTH VIS SCI, V55, P4050, DOI 10.1167/iovs.14-14107; Fauser S, 2016, BRIT J OPHTHALMOL, V100, P1494, DOI 10.1136/bjophthalmol-2015-308264; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; FRASCA D, 2016, BIOGERONTOLOGY, V17, P7, DOI [DOI 10.1007/S10522-015-9578-8, 10.1007/s10522-015-9578-8]; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Gallenga CE, 2014, INFLAMM RES, V63, P105, DOI 10.1007/s00011-013-0684-2; Garweg JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182571; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hong HS, 2015, WOUND REPAIR REGEN, V23, P268, DOI 10.1111/wrr.12264; Hooks JJ, 2008, J IMMUNOL, V180, P3789, DOI 10.4049/jimmunol.180.6.3789; Huang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173716; Jonas JB, 2007, OPHTHAL RES, V39, P139, DOI 10.1159/000102935; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe381, DOI 10.1111/j.1755-3768.2012.02414.x; Juel HB, 2012, INVEST OPHTH VIS SCI, V53, P8472, DOI 10.1167/iovs.12-9963; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Knickelbein Jared E, 2015, Int Ophthalmol Clin, V55, P63, DOI 10.1097/IIO.0000000000000073; Kutty RK, 2015, CYTOKINE, V74, P335, DOI 10.1016/j.cyto.2015.03.016; Torres KCL, 2018, EXP GERONTOL, V103, P47, DOI 10.1016/j.exger.2017.12.006; Lin Tony, 2013, Cytokine, V62, P369, DOI 10.1016/j.cyto.2013.03.027; Liu F, 2016, MOL VIS, V22, P352; Ma YG, 2018, TRANSL RES, V191, P15, DOI 10.1016/j.trsl.2017.10.001; Machado-Silva W, 2016, J STROKE CEREBROVASC, V25, P2851, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.047; Marquioni-Ramella MD, 2015, PHOTOCH PHOTOBIO SCI, V14, P1560, DOI 10.1039/c5pp00188a; Marshall A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172821; Martinez-Cengotitabengoa M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122022; Miao H, 2012, MOL VIS, V18, P574; Miller Jr R. G, 1981, SIMULTANEOUS STAT IN, P67; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Nassar K, 2015, GRAEF ARCH CLIN EXP, V253, P699, DOI 10.1007/s00417-014-2738-8; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Parmar T, 2016, INVEST OPHTH VIS SCI, V57, P3257, DOI 10.1167/iovs.15-18993; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Rutar M, 2016, ADV EXP MED BIOL, V854, P11, DOI 10.1007/978-3-319-17121-0_2; Sakamoto S, 2017, BR J OPHTHALMOL; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Sharma R, 2014, NUTR RES, V34, P968, DOI 10.1016/j.nutres.2014.09.006; Shen DF, 2011, INVEST OPHTH VIS SCI, V52, P2897, DOI 10.1167/iovs.10-6114; Shevchenko A V, 2016, Vestn Oftalmol, V132, P8, DOI 10.17116/oftalma201613228-13; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Shurin GV, 2007, CYTOKINE, V39, P123, DOI 10.1016/j.cyto.2007.06.006; Shwu-Jiuan S, 2012, TAIWAN J OPHTHALMOLO, V2, P51, DOI [10.1016/j.tjo.2012.02.002, DOI 10.1016/J.TJO.2012.02.002]; Silvestre JS, 2000, CIRC RES, V87, P448; van der Kraan P, 2017, GERONTOLOGY, V63, P29, DOI 10.1159/000448711; Ventura Maria Teresa, 2017, Clin Mol Allergy, V15, P21, DOI 10.1186/s12948-017-0077-0; Wuyts A, 2000, BIOCHEMISTRY-US, V39, P14549, DOI 10.1021/bi0011227; Zandi S, 2016, INVEST OPHTH VIS SCI, V57, P6320, DOI 10.1167/iovs.16-20657; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zehetner C, 2014, INVEST OPHTH VIS SCI, V55, P337, DOI 10.1167/iovs.13-12978; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078	69	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203337	10.1371/journal.pone.0203337	http://dx.doi.org/10.1371/journal.pone.0203337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157273	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400103
J	Yuan, AL; Ricks, CB; Bohm, AK; Lun, XQ; Maxwell, L; Safdar, S; Bukhari, S; Gerber, A; Sayeed, W; Bering, EA; Pedersen, H; Chan, JA; Shen, YQ; Marra, M; Kaplan, DR; Mason, W; Goodman, LD; Ezhilarasan, R; Kaufmann, AB; Cabral, M; Robbins, SM; Senger, DL; Cahill, DP; Sulman, EP; Cairncross, JG; Blough, MD				Yuan, Alice L.; Ricks, Christian B.; Bohm, Alexandra K.; Lun, Xueqing; Maxwell, Lori; Safdar, Shahana; Bukhari, Shazreh; Gerber, Amanda; Sayeed, Wajid; Bering, Elizabeth A.; Pedersen, Haley; Chan, Jennifer A.; Shen, Yaoqing; Marra, Marco; Kaplan, David R.; Mason, Warren; Goodman, Lindsey D.; Ezhilarasan, Ravesanker; Kaufmann, Ascher B.; Cabral, Matthew; Robbins, Steve M.; Senger, Donna L.; Cahill, Daniel P.; Sulman, Erik P.; Cairncross, J. Gregory; Blough, Michael D.			ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts	PLOS ONE			English	Article							ADP-RIBOSE POLYMERASE; MISMATCH REPAIR-DEFICIENT; BASE EXCISION-REPAIR; ADJUVANT TEMOZOLOMIDE; MSH6 MUTATIONS; CLINICAL-TRIAL; GLIOBLASTOMA; INHIBITOR; MGMT; THERAPY	Background Temozolomide (TMZ) is active against glioblastomas (GBM) in which the O6-methylguanine-DNA methyltransferase (MGMT) gene is silenced. However, even in responsive cases, its beneficial effect is undermined by the emergence of drug resistance. Here, we tested whether inhibition of poly (ADP-ribose) polymerase-1 and -2 (PARP) enhanced the effectiveness of TMZ. Methods Using patient derived brain tumor initiating cells (BTICs) and orthotopic xenografts as models of newly diagnosed and recurrent high-grade glioma, we assessed the effects of TMZ, ABT-888, and the combination of TMZ and ABT-888 on the viability of BTICs and survival of tumor-bearing mice. We also studied DNA damage repair, checkpoint protein phosphorylation, and DNA replication in mismatch repair (MMR) deficient cells treated with TMZ and TMZ plus ABT-888. Results Cells and xenografts derived from newly diagnosed MGMT methylated high-grade gliomas were sensitive to TMZ while those derived from unmethylated and recurrent gliomas were typically resistant. ABT-888 had no effect on the viability of BTICs or tumor bearing mice, but co-treatment with TMZ restored sensitivity in resistant cells and xenografts from newly diagnosed unmethylated gliomas and recurrent gliomas with MSH6 mutations. In contrast, the addition of ABT-888 to TMZ had little sensitizing effect on cells and xenografts derived from newly diagnosed methylated gliomas. In a model of acquired TMZ resistance mediated by loss of MMR gene MSH6, re-sensitization to TMZ by ABT-888 was accompanied by persistent DNA strand breaks, re-engagement of checkpoint kinase signaling, and interruption of DNA synthesis. Conclusion In laboratory models, the addition of ABT-888 to TMZ overcame resistance to TMZ.	[Yuan, Alice L.; Bohm, Alexandra K.; Lun, Xueqing; Maxwell, Lori; Safdar, Shahana; Bukhari, Shazreh; Gerber, Amanda; Sayeed, Wajid; Bering, Elizabeth A.; Pedersen, Haley; Chan, Jennifer A.; Robbins, Steve M.; Senger, Donna L.; Cairncross, J. Gregory; Blough, Michael D.] Univ Calgary, Clark H Smith Brain Tumour Ctr, Calgary, AB, Canada; [Yuan, Alice L.; Bohm, Alexandra K.; Lun, Xueqing; Maxwell, Lori; Safdar, Shahana; Bukhari, Shazreh; Gerber, Amanda; Sayeed, Wajid; Bering, Elizabeth A.; Pedersen, Haley; Chan, Jennifer A.; Robbins, Steve M.; Senger, Donna L.; Cairncross, J. Gregory; Blough, Michael D.] Univ Calgary, Charbonneau Canc Inst, Calgary, AB, Canada; [Ricks, Christian B.; Goodman, Lindsey D.; Ezhilarasan, Ravesanker; Kaufmann, Ascher B.; Sulman, Erik P.] MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA; [Sayeed, Wajid; Robbins, Steve M.; Senger, Donna L.; Cairncross, J. Gregory] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Shen, Yaoqing; Marra, Marco] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Kaplan, David R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kaplan, David R.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Mason, Warren] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Cabral, Matthew] MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX USA; [Cahill, Daniel P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Cairncross, J. Gregory; Blough, Michael D.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Cairncross, J. Gregory] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Texas System; UTMD Anderson Cancer Center; University of Calgary; University of Calgary; British Columbia Cancer Agency; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; University of Calgary; University of Calgary	Blough, MD (corresponding author), Univ Calgary, Clark H Smith Brain Tumour Ctr, Calgary, AB, Canada.; Blough, MD (corresponding author), Univ Calgary, Charbonneau Canc Inst, Calgary, AB, Canada.; Blough, MD (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	mdblough@ucalgary.edu	Marra, Marco A/B-5987-2008; Ezhilarasan, Ravesanker/AAC-9750-2022	Marra, Marco A/0000-0001-7146-7175; Senger, Donna/0000-0003-2403-3395; Robbins, Stephen/0000-0001-7475-1665; Goodman, Lindsey/0000-0002-9255-3811; Ezhilarasan, Ravesanker/0000-0002-1353-8307; Sulman, Erik/0000-0003-4933-9120	Terry Fox Research Institute and Foundation (CA); Alberta Cancer Foundation; Genome Canada; Alberta Innovates Health Solutions; family of Clark H. Smith; Burroughs Wellcome Career Award	Terry Fox Research Institute and Foundation (CA); Alberta Cancer Foundation; Genome Canada(Genome Canada); Alberta Innovates Health Solutions; family of Clark H. Smith; Burroughs Wellcome Career Award(Burroughs Wellcome Fund)	This work was supported by the Terry Fox Research Institute and Foundation (CA), the Alberta Cancer Foundation, Genome Canada, Alberta Innovates Health Solutions all to MDB, and the family of Clark H. Smith. DPC is the recipient of a Burroughs Wellcome Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; Balvers RK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0427-y; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blough MD, 2010, NEURO-ONCOLOGY, V12, P756, DOI 10.1093/neuonc/noq032; Butowski NA, 2006, J CLIN ONCOL, V24, P1273, DOI 10.1200/JCO.2005.04.7522; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cheng CL, 2005, MOL CANCER THER, V4, P1364, DOI 10.1158/1535-7163.MCT-05-0128; Clarke MJ, 2009, MOL CANCER THER, V8, P407, DOI 10.1158/1535-7163.MCT-08-0854; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; del Alcazar CRG, 2016, MOL CANCER RES, V14, P928, DOI 10.1158/1541-7786.MCR-16-0125; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Gupta SK, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv369; Gupta SK, 2014, CLIN CANCER RES, V20, P3730, DOI 10.1158/1078-0432.CCR-13-3446; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Huambachano O, 2011, J BIOL CHEM, V286, P7149, DOI 10.1074/jbc.M110.175190; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Kelly JJP, 2010, NEURO-ONCOLOGY, V12, P745, DOI 10.1093/neuonc/noq031; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Lemasson B, 2016, NEOPLASIA, V18, P82, DOI 10.1016/j.neo.2015.11.014; Liu L, 1999, CLIN CANCER RES, V5, P2908; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Nguyen SA, 2014, CLIN CANCER RES, V20, P4894, DOI 10.1158/1078-0432.CCR-13-1856; Palma JP, 2009, CLIN CANCER RES, V15, P7277, DOI 10.1158/1078-0432.CCR-09-1245; Robins HI, 2016, J NEURO-ONCOL, V126, P309, DOI 10.1007/s11060-015-1966-z; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su JM, 2014, NEURO-ONCOLOGY, V16, P1661, DOI 10.1093/neuonc/nou103; Tentori L, 2003, CLIN CANCER RES, V9, P5370; Tentori L, 2002, GLIA, V40, P44, DOI 10.1002/glia.10113; Tentori L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-151; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; van den Bent MJ, 2007, NEUROL CLIN, V25, P1089, DOI 10.1016/j.ncl.2007.07.013; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Yip S, 2013, CLIN CANCER RES, V19, P4543, DOI 10.1158/1078-0432.CCR-13-1821; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	43	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202860	10.1371/journal.pone.0202860	http://dx.doi.org/10.1371/journal.pone.0202860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153289	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700028
J	Choi, SM; Sum, RKW; Leung, EFL; Ng, RSK				Choi, Siu Ming; Sum, Raymond Kim Wai; Leung, Elean Fung Lin; Ng, Robert Siu Kuen			Relationship between perceived physical literacy and physical activity levels among Hong Kong adolescents	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; EUROPEAN ADOLESCENTS; GENDER-DIFFERENCES; IPAQ-A; SCHOOL; ASSOCIATIONS; FITNESS; PERFORMANCE; CHILDREN; AGE	This study explores the relationship between the perceived physical literacy (PL) and physical activity (PA) levels of Hong Kong adolescents by using a cross-sectional study design. A total of 1,945 adolescents aged between 12 and 18, (1,028 male and 917 female) with a mean age of 14.98 (+/- 1.65 years), took part in this study. A Perceived Physical Literacy Instrument (PPLI) and an International Physical Activity Questionnaire for Adolescents (IPAQ-A) were distributed to the participants within the first 15 minutes of PE lessons at their schools. The correlation between perceived PL and PA levels was low but significant (r = 0.227, p < 0.01), as was the correlation between the attributes of PL and PA intensity and the domains of PA (r = 0.067-0.292, p < 0.01). A significant linear equation was computed (F (3, 1941) = 35.679, p < 0.01), with an R-2 of 0.052. The metabolic equivalent (MET) minutes representing participants' predicted PA levels were -5490 + 366.1 (sense of self and self-confidence) + 221.866 (self-expression and communication with others) + 287.748 (knowledge and understanding). Looking at individual factors, the correlation between perceived PL and PA levels showed no significant difference across gender (r(male) = 0.234; r(female) = 0.198) but showed a significant difference across grade level (r(junior) = 0.302; r (senior) = 0.197), school bands (r(band 1) = 0.31; r(band 2) = 0.263; r(band 3) = 0.191) and socio-economic status (SES) (r(low) = 0.225; r(medium) = 0.35; r(high) = 0.191). The relationship between perceived PL and PA levels was significantly low but was closely related to the recreational PA, including individual factors such as gender, grade levels, school band and SES. Future studies could focus on school-based PA intervention programmes for perceived PL and the relationship between perceived PL and objective PA levels.	[Choi, Siu Ming; Sum, Raymond Kim Wai] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China; [Leung, Elean Fung Lin; Ng, Robert Siu Kuen] Chinese Univ Hong Kong, Phys Educ Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Sum, RKW (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China.	kwsum@cuhk.edu.hk	Choi, Siu Ming/AAY-3451-2021; Sum, Raymond/ABA-1210-2020; Choi, Siu Ming/P-3418-2018	Choi, Siu Ming/0000-0002-0716-699X; Sum, Raymond/0000-0002-4051-9945; Choi, Siu Ming/0000-0002-0716-699X	Chinese University of Hong Kong [4058033]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded by the direct grant for research (Grant Number: 4058033) of the Chinese University of Hong Kong (http://www.orkts.cuhk.edu.hk/research-and-funding/overview). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, QUALITY PHYS ED POLI; Booth M, 2000, Res Q Exerc Sport, V71 Suppl 2, P114, DOI 10.1080/02701367.2000.11082794; Castelli DM, 2014, PREV MED, V66, P95, DOI 10.1016/j.ypmed.2014.06.007; Census and Statistics Department (CSD), 2013, HONG KONG MONTHLY DI; Census and Statistics Department (CSD), 2016, HONG KONG 2016 POP C; Corbin CB, 2016, RES Q EXERCISE SPORT, V87, P14, DOI 10.1080/02701367.2016.1124722; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curriculum Development Council (CDC), 2002, PHYS ED KEY LEARN AR; Dmitruk A., 2014, Polish Journal of Sport and Tourism, V21, P240; Education Bureau (EDB), 2017, GEN INF SEC SCH PLAC; Edwards JU, 2011, J SCHOOL HEALTH, V81, P65, DOI 10.1111/j.1746-1561.2010.00562.x; Edwards LC, 2017, SPORTS MED, V47, P113, DOI 10.1007/s40279-016-0560-7; Field A, 2013, DISCOVERING STAT USI; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Giblin S, 2014, SPORTS MED, V44, P1177, DOI 10.1007/s40279-014-0205-7; Ha AS, 2010, SPORT EDUC SOC, V15, P331, DOI 10.1080/13573322.2010.493313; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541, DOI 10.1123/jpah.7.4.541; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hui SC, 2004, J PHYS ACT HEALTH, V1; Ingram DK, 2000, MED SCI SPORT EXER, V32, P1623; Keegan R., 2013, GETTING AUSTR MOVING; Keeley T.J.H., 2009, INT REV SPORT EXER P, V2, P198, DOI [10.1080/17509840903233822, DOI 10.1080/17509840903233822]; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Lloyd M, 2010, PEDIATR EXERC SCI, V22, P176, DOI 10.1123/pes.22.2.176; Longmuir PE, 2016, RES Q EXERCISE SPORT, V87, P28, DOI 10.1080/02701367.2016.1124671; Ottevaere C, 2011, J SCI MED SPORT, V14, P317, DOI 10.1016/j.jsams.2011.02.008; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Srikanth S, 2015, J EARLY ADOLESCENCE, V35, P353, DOI 10.1177/0272431614530807; Sum RKW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155610; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; United Nations Educational Scientific and Cultural Organization (UNESCO), 2013, WORLD WID SURV SCH P; USDHHS, 2008, PHYS ACT GUID AM; Vickerman P, 2010, PHYS LITERACY LIFECO; Vilhjalmsson R, 2003, SOC SCI MED, V56, P363, DOI 10.1016/S0277-9536(02)00042-4; Whitehead M., 2001, European Journal of Physical Education, V6, P127; Whitehead M., 2006, PE MATTERS, V1, P6; Whitehead M., 2013, INT COUNCIL SPORT SC, V65, P29; Whitehead M., 2016, INT PHYS LITERACY AS; Whitehead M., 2010, PHYS LITERACY, DOI DOI 10.4324/9780203881903; Whitehead M., 2013, J SPORT SCI PHYS ED, P52; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	43	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203105	10.1371/journal.pone.0203105	http://dx.doi.org/10.1371/journal.pone.0203105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148876	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200047
J	Fitzpatrick, KR; Cucak, A; McLoon, LK				Fitzpatrick, Krysta R.; Cucak, Anja; McLoon, Linda K.			Changing muscle function with sustained glial derived neurotrophic factor treatment of rabbit extraocular muscle	PLOS ONE			English	Article							LATERAL RECTUS MUSCLE; GROWTH-FACTOR-I; MYOSIN HEAVY; SKELETAL-MUSCLE; ADULT-RABBIT; MOTOR UNIT; NEUROMUSCULAR-JUNCTION; CONTRACTILE PROPERTIES; OCULOMOTOR NEURONS; GENE-EXPRESSION	Recent microarray and RNAseq experiments provided evidence that glial derived neurotrophic factor (GDNF) levels were decreased in extraocular muscles from human strabismic subjects compared to age-matched controls. We assessed the effect of sustained GDNF treatment of the superior rectus muscles of rabbits on their physiological and morphological characteristics, and these were compared to naive control muscles. Superior rectus muscles of rabbits were implanted with a sustained release pellet of GDNF to deliver 2 mu g/day, with the contralateral side receiving a placebo pellet. After one month, the muscles were assessed using in vitro physiological methods. The muscles were examined histologically for alteration in fiber size, myosin expression patterns, neuromuscular junction size, and stem cell numbers and compared to age-matched naive control muscles. GDNF resulted in decreased force generation, which was also seen on the untreated contralateral superior rectus muscles. Muscle relaxation times were increased in the GDNF treated muscles. Myofiber mean cross-sectional areas were increased after the GDNF treatment, but there was a compensatory increase in expression of developmental, neonatal, and slow tonic myosin heavy chain isoforms. In addition, in the GDNF treated muscles there was a large increase in Pitx2-positive myogenic precursor cells. One month of GDNF resulted in significant extraocular muscle adaptation. These changes are interesting relative to the decreased levels of GDNF in the muscles from subjects with strabismus and preliminary data in infant non-human primates where sustained GDNF treatment produced a strabismus. These data support the view that GDNF has the potential for improving eye alignment in subjects with strabismus.	[Fitzpatrick, Krysta R.; Cucak, Anja; McLoon, Linda K.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [McLoon, Linda K.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McLoon, LK (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.; McLoon, LK (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	mcloo001@umn.edu		McLoon, LInda/0000-0001-9714-4681	NIH from the National Eye Institute [R01EY15313, P30 EY11375]; Minnesota Lions Foundation; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY015313] Funding Source: NIH RePORTER	NIH from the National Eye Institute; Minnesota Lions Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH R01EY15313 (LKM) and NIH P30 EY11375 from the National Eye Institute, the Minnesota Lions Foundation, and an unrestricted grant to the Department of Ophthalmology and Visual Neurosciences from Research to Prevent Blindness, Inc. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAOGLU MN, 2015, INVEST OPHTH VIS SCI, V56; Agarwal AB, 2016, INVEST OPHTH VIS SCI, V57, P5576, DOI 10.1167/iovs.16-20294; Ahn AN, 2003, J PHYSIOL-LONDON, V549, P877, DOI 10.1113/jphysiol.2002.038018; Altick AL, 2012, INVEST OPHTH VIS SCI, V53, P5168, DOI 10.1167/iovs.12-9785; Anderson BC, 2008, INVEST OPHTH VIS SCI, V49, P221, DOI 10.1167/iovs.07-0600; Baumgartner BJ, 1998, J NEUROSCI RES, V54, P766, DOI 10.1002/(SICI)1097-4547(19981215)54:6<766::AID-JNR4>3.0.CO;2-A; Belair EL, 2005, J PHYSIOL-LONDON, V569, P163, DOI 10.1113/jphysiol.2005.094805; Chen J, 2004, INVEST OPHTH VIS SCI, V45, P3538, DOI 10.1167/iovs.04-0393; Chen J, 2003, MOL CELL NEUROSCI, V24, P41, DOI 10.1016/S1044-7431(03)00098-8; Christiansen SP, 2010, INVEST OPHTH VIS SCI, V51, P5646, DOI 10.1167/iovs.10-5523; Glat MJ, 2016, J MOL NEUROSCI, V58, P39, DOI 10.1007/s12031-015-0648-9; Goldberg SJ, 1998, J NEUROSCI, V18, P10629; Goldberg SJ, 1997, MUSCLE NERVE, V20, P1229, DOI 10.1002/(SICI)1097-4598(199710)20:10<1229::AID-MUS4>3.0.CO;2-E; Harandi VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109833; Hebert SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058405; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HUGHES A, 1982, J COMP NEUROL, V204, P151, DOI 10.1002/cne.902040205; JOHNSON BD, 1994, J APPL PHYSIOL, V77, P481, DOI 10.1152/jappl.1994.77.1.481; Kallestad KM, 2011, EXP CELL RES, V317, P873, DOI 10.1016/j.yexcr.2011.01.018; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Li TA, 2011, PFLUG ARCH EUR J PHY, V461, P373, DOI 10.1007/s00424-011-0925-6; Li T, 2010, INVEST OPHTH VIS SCI, V51, P2479, DOI 10.1167/iovs.09-4414; LOWEY S, 1993, J BIOL CHEM, V268, P20414; Mantilla CB, 2004, MUSCLE NERVE, V29, P381, DOI 10.1002/mus.10558; McLoon LK, 2006, J AAPOS, V10, P424, DOI 10.1016/j.jaapos.2006.06.011; McLoon LK, 2018, INVEST OPHTH VIS SCI, V59, P322, DOI 10.1167/iovs.17-23003; McLoon LK, 2016, INVEST OPHTH VIS SCI, V57, P6070, DOI 10.1167/iovs.16-19739; McLoon LK, 2011, J APPL PHYSIOL, V111, P1178, DOI 10.1152/japplphysiol.00368.2011; McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P3866, DOI 10.1167/iovs.03-0223; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; McLoon LK, 2016, INVEST OPHTH VIS SCI, V57, P1395; Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050; NELSON AG, 1994, AM J PHYSIOL, V266, pC919, DOI 10.1152/ajpcell.1994.266.4.C919; Nelson KR, 2016, INVEST OPHTH VIS SCI, V57, P5834, DOI 10.1167/iovs.16-19679; Park JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090245; PATTON JF, 1990, EUR J APPL PHYSIOL O, V60, P222, DOI 10.1007/BF00839163; Pawlikowski B, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0067-1; PULLELA M, 2015, INVEST OPHTH VIS SCI, V56; Pullela M, 2016, INVEST OPHTH VIS SCI, V57, P6040, DOI 10.1167/iovs.16-20481; REISER PJ, 1988, DEV BIOL, V129, P400, DOI 10.1016/0012-1606(88)90387-9; Rubinstein NA, 2000, INVEST OPHTH VIS SCI, V41, P3391; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Seale Patrick, 2000, Cell, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sendtner M, 1998, CYTOKINE GROWTH F R, V9, P1, DOI 10.1016/S1359-6101(97)00033-6; Steljes TPV, 1999, J NEUROBIOL, V41, P295, DOI 10.1002/(SICI)1097-4695(19991105)41:2<295::AID-NEU11>3.0.CO;2-W; Suzuki H, 1998, NEUROSCI LETT, V257, P165, DOI 10.1016/S0304-3940(98)00817-9; Thalhammer A, 2014, NEUROPHARMACOLOGY, V78, P23, DOI 10.1016/j.neuropharm.2013.03.015; Verma Mayank, 2017, Curr Ophthalmol Rep, V5, P207, DOI 10.1007/s40135-017-0141-4; WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618; Willoughby CL, 2015, INVEST OPHTH VIS SCI, V56, P3467, DOI 10.1167/iovs.15-16852; Willoughby CL, 2015, INVEST OPHTH VIS SCI, V56, P3484, DOI 10.1167/iovs.15-16761; Yang LX, 2004, NEUROSCIENCE, V128, P497, DOI 10.1016/j.neuroscience.2004.06.067; Zwick M, 2001, EXP NEUROL, V171, P342, DOI 10.1006/exnr.2001.7753	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202861	10.1371/journal.pone.0202861	http://dx.doi.org/10.1371/journal.pone.0202861			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142211	gold, Green Published, Green Submitted			2022-12-26	WOS:000442722500042
J	van Rijssen, TJ; Mohabati, D; Dijkman, G; Theelen, T; de Jong, EK; van Dijk, EHC; Boon, CJF				van Rijssen, Thomas J.; Mohabati, Daniel; Dijkman, Greet; Theelen, Thomas; de Jong, Eiko K.; van Dijk, Elon H. C.; Boon, Camiel J. F.			Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy	PLOS ONE			English	Article							FOVEAL PHOTORECEPTOR LAYER; THICKNESS; DENSITY; SEGMENT	Purpose To assess parameters on optical coherence tomography (OCT), and their correlation with best-corrected visual acuity (BCVA) in patients with non-resolving central serous chorioretinopathy (CSC). Methods For 25 non-resolving CSC patients treated with photodynamic therapy (PDT), the thickness of retinal layers was assessed on the foveal spectral-domain (SD) OCT scan. Evaluated OCT parameters included the central retinal thickness (CRT), defined as the internal limiting membrane (ILM) to ellipsoid zone (EZ) distance, and the second band thickness (SBT), defined as the EZ to hyperreflective subretinal accumulation distance. Integrity of the external limiting membrane (ELM) and the EZ bands was also determined. These parameters, along with BCVA and CRT measured automatically by SD-OCT device software were obtained before PDT, after PDT, and at final visit. After Bonferroni correction, a p-value <0.007 was considered statistically significant. Results Twenty-five patients could be included at last visit before PDT and first visit after PDT. At final visit, 24 patients could be included, since 1 patients was lost to follow-up. Mean CRT was 112 mu m at last visit before PDT, 118 mu m at first visit after PDT (p = 0.030), and 127 mu m at final visit (p<0.001 compared to baseline). Mean SBT was 74 mu m, 26 mu m (p<0.001 compared to baseline), and 21 mu m (p<0.001 compared to baseline), respectively. Mean BCVA in Early Treatment of Diabetic Retinopathy Study letters was 79 at baseline, 85 at first visit after PDT (p = 0.005 compared to baseline), and 87 at final visit (p = 0.001 compared to baseline). BCVA had an estimated correlation of beta = 0.103 (p = 0.114) with CRT, beta = -0.051 (p = 0.014) with SBT, beta = 0.615 (p = 0.600) with the integrity of the ELM, and beta = 4.917 with the integrity of the EZ (p = 0.001). Conclusions In non-resolving CSC patients treated with half-dose PDT, the CRT increased at final visit in comparison to the last visit before PDT. The continuity of the EZ on SD-OCT was positively correlated with BCVA. We propose that the distance between ILM and EZ should be used as a reliable CRT measurement in non-resolving CSC patients treated with half-dose PDT.	[van Rijssen, Thomas J.; Mohabati, Daniel; Dijkman, Greet; van Dijk, Elon H. C.; Boon, Camiel J. F.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Theelen, Thomas; de Jong, Eiko K.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Ophthalmol, Med Ctr, Nijmegen, Netherlands; [Boon, Camiel J. F.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Boon, CJF (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.; Boon, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.	c.j.f.boon@lumc.nl	Theelen, Thomas/A-3192-2012; Boon, CJF/P-7534-2014	Theelen, Thomas/0000-0001-9067-1171; Boon, CJF/0000-0002-6737-7932	Macula Fonds; Retina Netherlands, BlindenPenning; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Rotterdamse Stichting Blindenbelangen, Stichting Leids Oogheelkundig Ondersteuningsfonds; Haagse Stichting Blindenhulp; Gisela Thier Fellowship of Leiden University; VENI grant of Netherlands Organization for Scientific Research (NWO)	Macula Fonds; Retina Netherlands, BlindenPenning; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Rotterdamse Stichting Blindenbelangen, Stichting Leids Oogheelkundig Ondersteuningsfonds; Haagse Stichting Blindenhulp; Gisela Thier Fellowship of Leiden University; VENI grant of Netherlands Organization for Scientific Research (NWO)	This research was supported by the following foundations: Macula Fonds (http://maculafonds.nl/), Retina Netherlands, BlindenPenning (http://www.blinden-penning.nl/), Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (http://www.anvvb.nl/), and Landelijke Stichting voor Blinden en Slechtzienden (https://www.lsbs.nl/), which contributed through UitZicht (https://www.uitzicht.nl/), as well as Rotterdamse Stichting Blindenbelangen, Stichting Leids Oogheelkundig Ondersteuningsfonds (http://stichtingloof.nl/), and Haagse Stichting Blindenhulp (http://www.blindenhulp.nl/). Prof. Camiel J.F. Boon was supported by a Gisela Thier Fellowship of Leiden University, and a VENI grant of Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arf S, 2016, INT OPHTHALMOLOGY; Breukink MB, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0939-z; Cakir B, 2016, GRAEF ARCH CLIN EXP, V254, P2151, DOI 10.1007/s00417-016-3373-3; Cheng C, 2016, RETINA-J RET VIT DIS, V36, P717, DOI 10.1097/IAE.0000000000000757; Choi KE, 2017, RETINA-J RET VIT DIS, V37, P568, DOI 10.1097/IAE.0000000000001170; Daruich A, 2015, PROG RETIN EYE RES, V48, P82, DOI 10.1016/j.preteyeres.2015.05.003; de Jong EK, 2015, OPHTHALMOLOGY, V122, P562, DOI 10.1016/j.ophtha.2014.09.026; Dhirani NA, 2017, CLIN OPHTHALMOL, V11, DOI 10.2147/OPTH.S151933; Furuta M, 2009, OPHTHALMOLOGICA, V223, P28, DOI 10.1159/000161880; Ghadiali Q, 2016, RETINA-J RET VIT DIS, V36, P611, DOI 10.1097/IAE.0000000000000748; Haga F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181479; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Lai FHP, 2016, AM J OPHTHALMOL, V170, P91, DOI 10.1016/j.ajo.2016.07.026; Matsumoto H, 2008, AM J OPHTHALMOL, V145, P162, DOI 10.1016/j.ajo.2007.08.024; Nakamura T, 2016, GRAEF ARCH CLIN EXP, V254, P2347, DOI 10.1007/s00417-016-3403-1; Ohkuma Y, 2013, GRAEF ARCH CLIN EXP, V251, P1909, DOI 10.1007/s00417-013-2289-4; Ojima Y, 2007, OPHTHALMOLOGY, V114, P2197, DOI 10.1016/j.ophtha.2007.02.015; Ojima Y, 2010, JPN J OPHTHALMOL, V54, P55, DOI 10.1007/s10384-009-0766-4; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Salehi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011841.pub2; Sayanagi K, 2009, OPHTHALMOLOGY, V116, P947, DOI 10.1016/j.ophtha.2008.11.002; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tao LW, 2016, CLIN EXP OPHTHALMOL, V44, P422, DOI 10.1111/ceo.12685; Tzekov R, 2006, INVEST OPHTH VIS SCI, V47, P377, DOI 10.1167/iovs.05-0838; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wang M, 2005, ACTA OPHTHALMOL SCAN, V83, P691, DOI 10.1111/j.1600-0420.2005.00582.x; Williamson TH, 2013, EYE, V27, P1063, DOI 10.1038/eye.2013.136; Yalcinbayir O, 2014, RETINA-J RET VIT DIS, V34, P705, DOI 10.1097/IAE.0000000000000001; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002	32	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202549	10.1371/journal.pone.0202549	http://dx.doi.org/10.1371/journal.pone.0202549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142176	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500019
J	Vedrine, M; Berthault, C; Leroux, C; Reperant-Ferter, M; Gitton, C; Barbey, S; Rainard, P; Gilbert, FB; Germon, P				Vedrine, Megane; Berthault, Camille; Leroux, Cindy; Reperant-Ferter, Maryline; Gitton, Christophe; Barbey, Sarah; Rainard, Pascal; Gilbert, Florence B.; Germon, Pierre			Sensing of Escherichia coli and LPS by mammary epithelial cells is modulated by O-antigen chain and CD14	PLOS ONE			English	Article							COMPLEMENT FRAGMENT C5A; BOVINE MASTITIS; INTRAMAMMARY INFECTIONS; INFLAMMATORY CYTOKINES; STAPHYLOCOCCUS-AUREUS; POLYACRYLAMIDE GELS; SIGNALING PATHWAYS; REDUCES SEVERITY; KAPPA-B; LIPOPOLYSACCHARIDE	Escherichia coli is one of the major pathogens causing mastitis in dairy cattle. Yet, the factors which mediate the ability for E. coli to develop in the bovine mammary gland remain poorly elucidated. In a mouse model, infections induced by the reference mastitis E. coli P4 showed a strong colonisation of the mammary gland, while this strain had a low stimulating power on cells of the PS bovine mammary epithelial cell line. In order to understand if such a reduced response contributes to the severity of infection, a library of random mutants of P4 strain was screened to identify mutants inducing stronger response of PS cells. Among hyper-stimulating mutants, six were altered in genes involved in biosynthesis of lipopolysaccharide (LPS) and had lost their O-polysaccharide region, suggesting that the presence of O-antigen impairs the response of PS cells to LPS. Using purified smooth (S) and rough (R) fractions of LPS, we showed that the R-LPS fraction induced a stronger response from PS cells than the smooth LPS fraction. Biological activity of the S-LPS fraction could be restored by the addition of recombinant bovine CD14 (rbCD14), indicating a crucial role of CD14 in the recognition of S-LPS by Mammary Epithelial Cells (MEC). When S-LPS and R-LPS were injected in udder quarters of healthy lactating cows, an inflammation developed in all infused quarters, but the S-LPS induced a more intense pro-inflammatory response, possibly in relation to sizeable concentrations of CD14 in milk. Altogether, our results demonstrate that the O-antigen modulates the pro-inflammatory response of MEC to LPS, that SLPS and R-LPS trigger different responses of MEC and that these responses depend on the presence of CD14.	[Vedrine, Megane; Berthault, Camille; Leroux, Cindy; Reperant-Ferter, Maryline; Gitton, Christophe; Rainard, Pascal; Gilbert, Florence B.; Germon, Pierre] Univ Francois Rabelais Tours, ISP UMR 1282, INRA, Nouzilly, France; [Barbey, Sarah] INRA, UE Domaine Expt Pin Au Haras 0326, Le Pin Au Haras, France	INRAE; INRAE	Germon, P (corresponding author), Univ Francois Rabelais Tours, ISP UMR 1282, INRA, Nouzilly, France.	pierre.germon@inra.fr	GERMON, Pierre/M-5264-2019	GERMON, Pierre/0000-0003-3078-876X	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation; project KOlimastIR of the Animal Health and Welfare (ANIHWA) Era-Net; GISA metaprogram (RUMINFLAME project)	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation; project KOlimastIR of the Animal Health and Welfare (ANIHWA) Era-Net; GISA metaprogram (RUMINFLAME project)	M. Vedrine was recipient of a grant from the Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation. This work has been supported by the project KOlimastIR of the Animal Health and Welfare (ANIHWA) Era-Net (www.anihwa.eu) and by grants from the GISA metaprogram (RUMINFLAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bougarn S, 2011, J DAIRY SCI, V94, P2425, DOI 10.3168/jds.2010-3859; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; CARROLL EJ, 1964, AM J VET RES, V25, P720; de Barros JPP, 2015, J LIPID RES, V56, P1363, DOI 10.1194/jlr.D059725; Dosogne H, 2002, INFLAMM RES, V51, P201, DOI 10.1007/PL00000293; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eckersall PD, 2001, VET REC, V148, P35, DOI 10.1136/vr.148.2.35; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Han Y, 2014, VET MICROBIOL, V172, P486, DOI 10.1016/j.vetmic.2014.05.029; HILL AW, 1981, RES VET SCI, V31, P107, DOI 10.1016/S0034-5288(18)32532-3; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Horvath DJ, 2016, J BACTERIOL, V198, P964, DOI 10.1128/JB.00664-15; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2006, VET RES, V37, P219, DOI 10.1051/vetres:2005051; Lee JW, 2003, VET RES, V34, P307, DOI 10.1051/vetres:2003006; Lee JW, 2003, INFECT IMMUN, V71, P4034, DOI 10.1128/IAI.71.7.4034-4039.2003; LINTON AH, 1984, BRIT VET J, V140, P368, DOI 10.1016/0007-1935(84)90128-3; LINTON AH, 1979, J APPL BACTERIOL, V46, P585, DOI 10.1111/j.1365-2672.1979.tb00859.x; Lopez-Meza JE, 2009, RES VET SCI, V87, P59, DOI 10.1016/j.rvsc.2008.12.005; MCDERMOTT CM, 1991, J DAIRY SCI, V74, P1227, DOI 10.3168/jds.S0022-0302(91)78278-7; Molenaar AJ, 2009, BIOMARKERS, V14, P26, DOI 10.1080/13547500902730714; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; REEVES P, 1995, TRENDS MICROBIOL, V3, P381, DOI 10.1016/S0966-842X(00)88983-0; Rendueles O, 2014, ISME J, V8, P1275, DOI 10.1038/ismej.2013.238; Ridley BL, 2000, GLYCOBIOLOGY, V10, P1013, DOI 10.1093/glycob/10.10.1013; Riollet C, 2000, CLIN DIAGN LAB IMMUN, V7, P161, DOI 10.1128/CDLI.7.2.161-167.2000; Roosen S, 2004, MAMM GENOME, V15, P834, DOI 10.1007/s00335-004-2387-z; Roussel P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178285; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; Shuster DE, 1997, INFECT IMMUN, V65, P3286, DOI 10.1128/IAI.65.8.3286-3292.1997; Spears PA, 2000, MOL MICROBIOL, V36, P1425, DOI 10.1046/j.1365-2958.2000.01963.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Swanson K, 2004, INFECT IMMUN, V72, P7311, DOI 10.1128/IAI.72.12.7311-7314.2004; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Wang JJ, 2016, J DAIRY SCI, V99, P3016, DOI 10.3168/jds.2015-10330; Wells SJ, 1998, J DAIRY SCI, V81, P3029, DOI 10.3168/jds.S0022-0302(98)75867-9; Zanoni I, 2012, IMMUNOL LETT, V142, P41, DOI 10.1016/j.imlet.2011.12.002	56	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202664	10.1371/journal.pone.0202664	http://dx.doi.org/10.1371/journal.pone.0202664			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142177	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500024
J	Ajong, AB; Njotang, PN; Kenfack, B; Essi, MJ; Yakum, MN; Lballa, FBS; Mbu, ER				Ajong, Atem Bethel; Njotang, Philip Nana; Kenfack, Bruno; Essi, Marie Jose; Yakum, Martin Ndinakie; Lballa, Francklin Brice Soung; Mbu, Enow Robinson			Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon	PLOS ONE			English	Article								Introduction Meeting targets of the Sustainable Development Goals in the domain of maternal health and the Family Planning 2020 commitments for Cameroon requires an increased use of modern contraception. Long acting reversible contraceptives (LARCs) are methods which have been proven highly efficient with contraceptive failure rates of less than 1%. The objective of this survey was to determine the contraceptive method mix in the Biyem-Assi Health District and identify factors associated to the use of LARCs. Methodology A cross-sectional community-based study was conducted from March 2015 to April 2015 targeting current female contraceptive users of childbearing age in the Biyem-Assi Health District. A multistep cluster sampling was used and data collected by trained surveyors using a pretested and validated questionnaire. Data were analysed using the statistical software Epi-Info version 3.5.4. Logistic regressions were used to identify associations between the use of LARCs and selected covariates and the strength of association measured with the odds ratio. Results A total of 437 eligible women were included in the survey. Their mean age was 26.7 +/- 5.8 years and 45.8% were in a union. The contraceptive method mix decreased in this order; male condoms (76.0%), female condoms (7.6%), oral contraceptive pills (5.0%), implants (4.6%), and intrauterine devices (3.4%) giving us a LARC rate of 8%. Only 54.0% and 46.9% of the participants reported to be knowledgeable of the implant and intrauterine device respectively. Their contraceptive choices were determined principally by perceived efficiency and accessibility. The major factor significantly associated to LARC use was the number of living children above 2 (AOR = 3.90[1.53-9.94], p-value = 0.004). Though not statistically significant, associations were found between LARC use and other factors like marital status, level of education, religion and future fertility desire. Conclusion The rate of use of LARCs is still very low among these women. The number of living children is significantly associated with the use of LARCs. The local family planning policy makers should intensify sensitization on the benefits and side effects of modern contraception and LARCs in order to create more awareness and improve contraceptive uptake.	[Ajong, Atem Bethel; Njotang, Philip Nana; Mbu, Enow Robinson] Univ Yaounde I, Fac Med & Biomed Sci, Dept Obstet & Gynaecol, Yaounde, Cameroon; [Njotang, Philip Nana] Yaounde Cent Hosp, Obstet & Gynaecol Unit, Yaounde, Cameroon; [Kenfack, Bruno; Lballa, Francklin Brice Soung] Univ Dschang, Fac Sci, Dept Biomed Sci, Dschang, Cameroon; [Essi, Marie Jose] Univ Yaounde I, Fac Med & Biomed Sci, Dept Publ Hlth, Yaounde, Cameroon; [Yakum, Martin Ndinakie] Meilleur Acces Soins Sante, Yaounde, Cameroon; [Lballa, Francklin Brice Soung] Global Fund, MC CCAM, Bamenda, Cameroon; [Mbu, Enow Robinson] Minist Publ Hlth, Directorate Family Hlth, Yaounde, Cameroon	University of Yaounde I; University of Yaounde I	Ajong, AB (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Dept Obstet & Gynaecol, Yaounde, Cameroon.	christrah@yahoo.fr	Yakum, Martin/R-5738-2019	Yakum, Martin/0000-0003-3149-2020; Ajong, Atem Bethel/0000-0002-5513-2110; SOUNG IBALLA, Francklin Brice/0000-0001-7182-6254				Ajong AB, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0283-9; Akam E, 2005, DOCUMENTS DANALYSE; Bulto GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-46; Dockalova B, 2016, SUSTAINABLE DEV GOAL, P1; Earsido A, 2015, J PREG CHILD HLTH, V2, P1; Gebeyehu WA, TRENDS DETERMINANTS; Getinet S., 2014, GREENER J EPIDEMIOL, V2, P23, DOI [10.15580/GJEPH.2014.1.070514294, DOI 10.15580/GJEPH.2014.1.070514294]; Gudaynhe SW, 2014, GLOB J MED RES E, V14, P8; Institut National de la Statistique(INS) et ICF, 2011, ENQ DEM SANT IND MUL, P99; National Institute of Statistics/UNDP, 2008, COUNTR REP PROGR ACH; Sahilemichael A., 2015, W ETHIOPIA J WOMENS, V4, P1; Seiber EE, 2007, INT FAM PLAN PERSPEC, V33, P117, DOI 10.1363/3311707; Tebeje B., 2017, J WOMENS HLTH CARE, V6, P1, DOI [10.4172/2167-0420.1000351, DOI 10.4172/2167-0420.1000351]; Teferra AS., 2015, SCI J PUBLIC HLTH, V3, P143, DOI DOI 10.11648/J.SJPH; Warriner IK., 2006, PREVENTING UNSAFE AB	15	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202967	10.1371/journal.pone.0202967	http://dx.doi.org/10.1371/journal.pone.0202967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138474	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100147
J	Furlong, LAM; Rolle, U				Furlong, Laura-Anne M.; Rolle, Udo			Injury incidence in elite youth field hockey players at the 2016 European Championships	PLOS ONE			English	Article							SPORTS INJURIES; PROFESSIONAL FOOTBALL; HIGH-SCHOOL; PREVENTION; EPIDEMIOLOGY; SURVEILLANCE; SEVERITY; PATTERNS; SEASONS; HEAD	Despite being an essential consideration when deciding rule changes, injury prevention strategies, and athlete development models, there is little epidemiological data of U18 field hockey player injuries-something explicitly referred to in the 2015 International Olympic Committee's Consensus Statement on Youth Athlete Development. The aim of this study was to quantify incidence and characteristics of injuries in elite youth field hockey players during a major international tournament. Standardized reporting forms detailing time, location on pitch, mechanism and anatomical location of injury were completed for new musculo-skeletal conditions resulting in a time stoppage by the umpire and where a player was noticeably affected by an injury for up to 20 s regardless of time stoppage. Injury incidence was 1.35 and 2.20 injuries/match or 53 and 86 injuries per 1000 player match hours for boys (B) and girls (G) respectively; girls were over three times more likely to have a minor injury. Most injuries were contusions due to being hit by the ball or stick (B: 12, G: 27), with high numbers of injuries to the torso (B: 8) and head/face (G: 7). Injuries during the penalty corner (B: 3, G: 4) were to the lower limb and hand, and boys were less likely to wear facial protection (B: 65.9%, G: 86.4%). Results form an essential initial dataset of injuries in U18 field hockey players. Current reporting protocols under-report injuries and must be addressed by the international governing body. The high number of head/face injuries, particularly in females, requires further investigation.	[Furlong, Laura-Anne M.] Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Furlong, Laura-Anne M.] Natl Ctr Sport & Exercise Med East Midlands, Loughborough, Leics, England; [Rolle, Udo] Univ Hosp Frankfurt, Dept Pediat Surg & Pediat Urol, Theodor Stern Kai 7, Frankfurt, Germany; [Rolle, Udo] Federat Int Hockey FIH Hlth & Safety Panel, Lausanne, Switzerland	Loughborough University; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Furlong, LAM (corresponding author), Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.; Furlong, LAM (corresponding author), Natl Ctr Sport & Exercise Med East Midlands, Loughborough, Leics, England.	L.A.M.Furlong@lboro.ac.uk	Rolle, Udo/AAI-7424-2020; Furlong, Laura-Anne/GQZ-6977-2022	Rolle, Udo/0000-0002-1268-6092; Furlong, Laura-Anne/0000-0002-7303-4434				Barboza SD, 2018, SCAND J MED SCI SPOR, V28, P1708, DOI 10.1111/sms.13065; Barboza SD, 2018, SPORTS MED, V48, P849, DOI 10.1007/s40279-017-0839-3; Bengtsson H, 2013, BRIT J SPORT MED, V47, P743, DOI 10.1136/bjsports-2013-092383; Bergeron MF, 2015, BRIT J SPORT MED, V49, P843, DOI 10.1136/bjsports-2015-094962; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; CLARKE KS, 1980, AM J SPORT MED, V8, P187, DOI 10.1177/036354658000800308; Dick R, 2007, J ATHL TRAINING, V42, P211; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Goldberg AS, 2007, SPORTS MED, V37, P265, DOI 10.2165/00007256-200737030-00005; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Hendrickson CD, 2008, CLIN J SPORT MED, V18, P399, DOI 10.1097/JSM.0b013e318188b89d; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; MARTIN RK, 1987, AM J SPORT MED, V15, P603, DOI 10.1177/036354658701500614; MCLAIN LG, 1989, PEDIATRICS, V84, P446; Peterson L, 2000, AM J SPORT MED, V28, pS51; Phillips LH, 2000, BRIT J SPORT MED, V34, P133, DOI 10.1136/bjsm.34.2.133; Powell JW, 1999, J ATHL TRAINING, V34, P277; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P71; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Stracciolini A, 2014, AM J SPORT MED, V42, P965, DOI 10.1177/0363546514522393; Theilen TM, 2016, BRIT J SPORT MED, V50, P657, DOI 10.1136/bjsports-2015-094847; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; ZARICZNYJ B, 1980, AM J SPORT MED, V8, P318, DOI 10.1177/036354658000800504	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201834	10.1371/journal.pone.0201834	http://dx.doi.org/10.1371/journal.pone.0201834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138463	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100026
J	Swanston, T; Varney, TL; Kozachuk, M; Choudhury, S; Bewer, B; Coulthard, I; Keenleyside, A; Nelson, A; Martin, RR; Stenton, DR; Cooper, DML				Swanston, Treena; Varney, Tamara L.; Kozachuk, Madalena; Choudhury, Sanjukta; Bewer, Brian; Coulthard, Ian; Keenleyside, Anne; Nelson, Andrew; Martin, Ronald R.; Stenton, Douglas R.; Cooper, David M. L.			Franklin expedition lead exposure: New insights from high resolution confocal x-ray fluorescence imaging of skeletal microstructure	PLOS ONE			English	Article							ARCHAEOLOGICAL BONE; ARCTIC EXPEDITION; ZINC; IDENTIFICATION; TISSUES; CREW	In the summer of 1845, under the command of Sir John Franklin, 128 officers and men aboard Royal Navy ships HMS Erebus and HMS Terrorsailed into Lancaster Sound and entered the waters of Arctic North America. The goal of this expedition was to complete the discovery of a northwest passage by navigating the uncharted area between Barrow Strait and Simpson Strait. Franklin and his crew spent the first winter at Beechey Island, where three crewmen died and were buried. In September 1846, the ships became stranded in ice off the northwest coast of King William Island, where they remained until April 1848. At that time, the crew, reduced to 105, deserted the ships and retreated south along the island's western and southern shores in a desperate attempt to reach the mainland and via the Back River, to obtain aid at a Hudson's Bay Company Post. Sadly, not one individual survived. Previous analyses of bone, hair, and soft tissue samples from expedition remains found that crewmembers' tissues contained elevated lead (Pb) levels, suggesting that Pb poisoning may have contributed to their demise; however, questions remain regarding the timing and degree of exposure and, ultimately, the extent to which the crewmembers may have been impacted. To address this historical question, we investigated three hypotheses. First, if elevated Pb exposure was experienced by the crew during the expedition, we hypothesized that those sailors who survived longer (King William Island vs. Beechey Island) would exhibit more extensive uptake of Pb in their bones and vice versa. Second, we hypothesized that Pb would be elevated in bone microstructural features forming at or near the time of death compared with older tissue. Finally, if Pb exposure played a significant role in the failure of the expedition we hypothesized that bone samples would exhibit evidence of higher and more sustained uptake of Pb than that of a contemporary comparator naval population from the 19th century. To test these hypotheses, we analyzed bone and dental remains of crew members and compared them against samples derived from the Royal Navy cemetery in Antigua. Synchrotron-based high resolution confocal X-ray fluorescence imaging was employed to visualize Pb distribution within bone and tooth microstructures at the micro scale. The data did not support our first hypothesis as Pb distribution within the samples from the two different sites was similar. Evidence of Pb within skeletal microstructural features formed near the time of death lent support to our second hypothesis but consistent evidence of a marked elevation in Pb levels was lacking. Finally, the comparative analysis with the Antigua samples did not support the hypothesis that the Franklin sailors were exposed to an unusually high level of Pb for the time period. Taken all together our skeletal microstructural results do not support the conclusion that Pb played a pivotal role in the loss of Franklin and his crew.	[Swanston, Treena] MacEwan Univ, Dept Anthropol Econ & Polit Sci, Edmonton, AB, Canada; [Swanston, Treena] MacEwan Univ, Dept Biol Sci, Edmonton, AB, Canada; [Varney, Tamara L.] Lakehead Univ, Dept Anthropol, Thunder Bay, ON, Canada; [Kozachuk, Madalena; Nelson, Andrew; Martin, Ronald R.] Western Univ, Dept Chem, London, ON, Canada; [Choudhury, Sanjukta; Cooper, David M. L.] Univ Saskatchewan, Dept Anat Physiol & Pharmacol, Saskatoon, SK, Canada; [Bewer, Brian; Coulthard, Ian] Canadian Light Source, Saskatoon, SK, Canada; [Keenleyside, Anne] Trent Univ, Dept Anthropol, Peterborough, ON, Canada; [Nelson, Andrew] Western Univ, Dept Anthropol, London, ON, Canada; [Stenton, Douglas R.] Univ Waterloo, Dept Anthropol, Waterloo, ON, Canada	Lakehead University; Western University (University of Western Ontario); University of Saskatchewan; University of Saskatchewan; Trent University; Western University (University of Western Ontario); University of Waterloo	Swanston, T (corresponding author), MacEwan Univ, Dept Anthropol Econ & Polit Sci, Edmonton, AB, Canada.; Swanston, T (corresponding author), MacEwan Univ, Dept Biol Sci, Edmonton, AB, Canada.	swanstont@macewan.ca	Varney, Tamara/J-3144-2019; Nelson, Andrew J/B-9090-2015	Nelson, Andrew/0000-0001-6398-7314; Cooper, David/0000-0002-3175-9170	U.S. DOE [DE-AC02-06CH11357]; Canadian Light Source; Social Sciences and Humanities Research Council (SSHRC) [430-2014-1796]; Canada Research Chairs program	U.S. DOE(United States Department of Energy (DOE)); Canadian Light Source; Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs)	This research used resources of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory and was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357, and the Canadian Light Source and its funding partners. The micro-CT scanning analysis was done using the facilities of Sustainable Archaeology at Western University. This research was supported by a Social Sciences and Humanities Research Council (SSHRC) Insight Grant (#430-2014-1796). DMLC is supported by the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMY R, 1986, CAN MED ASSOC J, V135, P115; Battersby W, 2008, J HAKLUYT SOC, V2015, P1; Bayliss R, 2002, J ROY SOC MED, V95, P151, DOI 10.1258/jrsm.95.3.151; Beattie O, 1985, FRANKLIN ERA CANADIA, P131, DOI [10.1016/0305-4403(91)90048-T, DOI 10.1016/0305-4403(91)90048-T]; Beattie O., 1981, LOCATION ANAL HUMAN; Choudhury S, 2017, J ANAL ATOM SPECTROM, V32, P527, DOI 10.1039/c6ja00297h; Choudhury S, 2016, ARCHAEOMETRY, V58, P207, DOI 10.1111/arcm.12232; Christensen JR, 2017, J ARCHAEOL SCI-REP, V16, P430, DOI 10.1016/j.jasrep.2016.11.042; Cyriax R.J., 1939, J FRANKLINS LAST ARC; FARRER KTH, 1993, J ARCHAEOL SCI, V20, P399, DOI 10.1006/jasc.1993.1024; GAMBLIN C, 1994, APPL RADIAT ISOTOPES, V45, P1035, DOI 10.1016/0969-8043(94)90173-2; Giffin KL, 2017, INT J OSTEOARCHAEOL, V27, P672, DOI 10.1002/oa.2589; Hall DF, 1858, CF HALL COLLECTION 1; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Hernberg S, 2000, AM J IND MED, V38, P244, DOI 10.1002/1097-0274(200009)38:3<244::AID-AJIM3>3.3.CO;2-6; Keenleyside A, 1996, J ARCHAEOL SCI, V23, P461, DOI 10.1006/jasc.1996.0042; Keenleyside A, 1997, ARCTIC, V50, P36; KOWAL W, 1990, NATURE, V343, P319, DOI 10.1038/343319b0; KOWAL W, 1991, J ARCHAEOL SCI, V18, P193, DOI 10.1016/0305-4403(91)90048-T; KOWAL WA, 1989, INT J ENVIRON AN CH, V35, P119, DOI 10.1080/03067318908028385; Martin RR, 2013, APPL PHYS A-MATER, V111, P23, DOI 10.1007/s00339-013-7579-5; Mays S, 2016, INT J OSTEOARCHAEOL, V26, P778, DOI 10.1002/oa.2479; Mays S, 2015, INT J OSTEOARCHAEOL, V25, P334, DOI 10.1002/oa.2305; Millar K, 2017, J ARCHAEOL SCI-REP, V13, P286, DOI 10.1016/j.jasrep.2017.03.046; Millar K, 2016, POLAR REC, V52, P423, DOI 10.1017/S0032247416000176; Millar K, 2015, POLAR REC, V51, P224, DOI 10.1017/S0032247413000867; Montgomery J, 2010, J ROMAN ARCHAEOLOG S, p[78, 199]; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Owen R., 1978, THE FATE OF FRANKLIN; Parks Canada, FRANKL EXP; Pemmer B, 2013, BONE, V57, P184, DOI 10.1016/j.bone.2013.07.038; Rae J., 1855, J ROYAL GEOGRAPHICAL, V25, P246, DOI DOI 10.2307/1798121; Schroeder H.E., 1986, THE PERIODONTIUM, P23, DOI DOI 10.1007/978-3-642-71261-6_4; Schwatka F, 1965, LONG ARCTIC SEARCH N; Stenton DR, 2017, ARCTIC, V70, P203, DOI 10.14430/arctic4649; Stenton DR, 2015, ARCTIC, V68, P32, DOI 10.14430/arctic4454; Swanston T, AM ASS PHYS ANTHR AA; Swanston T, 2012, J ARCHAEOL SCI, V39, P2409, DOI 10.1016/j.jas.2012.01.041; Taichman RS, 2017, ARCTIC, V70, P25, DOI 10.14430/arctic4629; Varney T, 2011, P 23 INT C CAR ARCH; Woodman David C., 1991, UNRAVELLING FRANKLIN; Yamamoto T, 2016, JPN DENT SCI REV, V52, P63, DOI 10.1016/j.jdsr.2016.04.002	42	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202983	10.1371/journal.pone.0202983	http://dx.doi.org/10.1371/journal.pone.0202983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138435	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100148
J	Whitfield-Cargile, CM; Chamoun-Emanuelli, AM; Cohen, ND; Richardson, LM; Ajami, NJ; Dockery, HJ				Whitfield-Cargile, Canaan M.; Chamoun-Emanuelli, Ana M.; Cohen, Noah D.; Richardson, Lauren M.; Ajami, Nadim J.; Dockery, Hannah J.			Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL-TRACT; NSAID ENTEROPATHY; ACID PRODUCTION; GUT MICROBIOTA; INJURY; PHENYLBUTAZONE; FIROCOXIB; COMMUNITY; BACTERIA	Non-steroidal anti-inflammatory drugs (NSAIDs) are routinely used in both veterinary and human medicine. Gastrointestinal injury is a frequent adverse event associated with NSAID use and evidence suggests that NSAIDs induce gastrointestinal microbial imbalance (i.e., dysbiosis) in both animals and people. It is unknown, however, whether cyclooxygenase (COX)-2-selective NSAIDs induce dysbiosis, or if this phenomenon occurs in horses administered any class of NSAIDs. Therefore, our objectives were to determine whether the composition and diversity of the fecal microbiota of adult horses were altered by NSAID use, and whether these effects differed between non-selective and COX-2-selective NSAIDs. Twenty-five adult horses were randomly assigned to 1 of 3 groups: control (n = 5); phenylbutazone (n = 10); or, firocoxib (n = 10). Treatments were administered for 10 days. Fecal samples were collected every 5 days for 25 days. DNA was extracted from feces and the 16S rRNA gene amplified and sequenced to determine the composition of the microbiota and the inferred metagenome. While the fecal microbiota profile of the control group remained stable over time, the phenylbutazone and firocoxib groups had decreased diversity, and alteration of their microbiota profiles was most pronounced at day 10. Similarly, there were clear alterations of the inferred metagenome at day 10 compared to all other days, indicating that use of both non-selective and selective COX inhibitors resulted in temporary alterations of the fecal microbiota and inferred metagenome. Dysbiosis associated with NSAID administration is clinically relevant because dysbiosis has been associated with several important diseases of horses including abdominal pain (colic), colitis, enteric infections, and laminitis.	[Whitfield-Cargile, Canaan M.; Chamoun-Emanuelli, Ana M.; Cohen, Noah D.; Richardson, Lauren M.; Dockery, Hannah J.] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Ajami, Nadim J.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Baylor College of Medicine	Whitfield-Cargile, CM (corresponding author), Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	cwhitfield@cvm.tamu.edu		Chamoun-Emanuelli, Ana/0000-0001-5314-7266; Whitfield-Cargile, Canaan/0000-0002-9743-8783	Department of Large Animal Clinical Sciences at Texas A&M University, College of Veterinary Medicine & Biomedical Sciences, College Station, TX; Link Equine Research Endowment	Department of Large Animal Clinical Sciences at Texas A&M University, College of Veterinary Medicine & Biomedical Sciences, College Station, TX; Link Equine Research Endowment	This work was graciously funded by a grant from the Department of Large Animal Clinical Sciences at Texas A&M University, College of Veterinary Medicine & Biomedical Sciences, College Station, TX, and the Link Equine Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Becker JC, 2004, BRIT J CLIN PHARMACO, V58, P587, DOI 10.1111/j.1365-2125.2004.02198.x; Beretta C, 2005, PHARMACOL RES, V52, P302, DOI 10.1016/j.phrs.2005.04.004; Bray JR, 1957, ECOL MONOGR, V27, P24; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cox S, 2013, VET J, V198, P382, DOI 10.1016/j.tvjl.2013.07.035; Dalby AB, 2006, APPL ENVIRON MICROB, V72, P6707, DOI 10.1128/AEM.00378-06; Dastidar SG, 2000, INT J ANTIMICROB AG, V14, P249, DOI 10.1016/S0924-8579(99)00159-4; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dougal K., 2013, IDENTIFICATION CORE, V8, DOI [10.1371/journal.pone.0077660, DOI 10.1371/JOURNAL.PONE.0077660]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166523; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fox S, 2013, W VET C LAS NV; GLINSKY MJ, 1976, J ANIM SCI, V42, P1465, DOI 10.2527/jas1976.4261465x; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Hagiwara Mari, 2004, Journal of Medical Investigation, V51, P43, DOI 10.2152/jmi.51.43; Handa O, 2014, FREE RADICAL RES, V48, P1095, DOI 10.3109/10715762.2014.928411; Hotz-Behofsits C, 2010, SCAND J GASTROENTERO, V45, P822, DOI 10.3109/00365521003797205; Hu HH, 2005, JAVMA-J AM VET MED A, V226, P414, DOI 10.2460/javma.2005.226.414; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Koga H, 1999, AM J PHYSIOL-GASTR L, V276, pG576, DOI 10.1152/ajpgi.1999.276.3.G576; Kvaternick V, 2007, J VET PHARMACOL THER, V30, P208, DOI 10.1111/j.1365-2885.2007.00840.x; Lanas A, 2009, GASTROENTEROL CLIN N, V38, P333, DOI 10.1016/j.gtc.2009.03.007; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lau JT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0327-7; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Matsui H, 2011, J CLIN BIOCHEM NUTR, V48, P107, DOI 10.3164/jcbn.10-79; Mayo SA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12725; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; Mohsen A, 2015, AM J EPIDEMIOL INFEC, V3, P1, DOI [10.12691/ajeid-3-1-1, DOI 10.12691/AJEID-3-1-1]; Montalto M, 2013, J GASTROENTEROL, V48, P689, DOI 10.1007/s00535-012-0648-2; Mukherjee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01126-3; Omatsu T, 2010, J GASTROENTEROL, V45, P692, DOI 10.1007/s00535-010-0213-9; Orsini JA, 2012, AM J VET RES, V73, P664, DOI 10.2460/ajvr.73.5.664; Rigottier-Gois L, 2013, ISME J, V7, P1256, DOI 10.1038/ismej.2013.80; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers MAM, 2016, INFLUENCE NONSTEROID, V22, DOI [10.1016/j.cmi.2015.10.003, DOI 10.1016/J.CMI.2015.10.003]; Scarpignato C, 2010, GASTROENTEROL CLIN N, V39, P433, DOI 10.1016/j.gtc.2010.08.010; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Syer SD, 2015, J GASTROENTEROL, V50, P387, DOI 10.1007/s00535-014-1032-1; Syer Stephanie D, 2014, Curr Gastroenterol Rep, V16, P377, DOI 10.1007/s11894-014-0377-1; Tomita T, 2014, J PHYSIOL PHARMACOL, V65, P435; TOUTAIN PL, 1994, J VET PHARMACOL THER, V17, P459, DOI 10.1111/j.1365-2885.1994.tb00278.x; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Tucker CM, 2017, BIOL REV, V92, P698, DOI 10.1111/brv.12252; Uejima M, 1996, MICROBIOL IMMUNOL, V40, P553, DOI 10.1111/j.1348-0421.1996.tb01108.x; Wallace JL, 2013, WORLD J GASTROENTERO, V19, P1861, DOI 10.3748/wjg.v19.i12.1861; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Weese JS, 2015, EQUINE VET J, V47, P641, DOI 10.1111/evj.12361; Weese JS, 2001, EQUINE VET J, V33, P403, DOI 10.2746/042516401776249534; Whitfield-Cargile CM, 2016, GUT MICROBES, V7, P246, DOI 10.1080/19490976.2016.1156827; Whitfield-Cargile CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136586; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Xiao X, 2017, SCI REP-UK, V7, DOI 10.1038/srep40317; Yin Z, 2014, CHEM BIOL, V21, P481, DOI 10.1016/j.chembiol.2014.02.009	72	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202527	10.1371/journal.pone.0202527	http://dx.doi.org/10.1371/journal.pone.0202527			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138339	Green Submitted, Green Published, gold			2022-12-26	WOS:000442800100077
J	Whitmill, A; Kim, S; Rojas, V; Gulraiz, F; Afreen, K; Jain, M; Singh, M; Park, IW				Whitmill, Amanda; Kim, Seongcheol; Rojas, Vivian; Gulraiz, Fahad; Afreen, Kazi; Jain, Mamta; Singh, Meharvan; Park, In-Woo			Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN HEPATOCELLULAR-CARCINOMA; ACID-COA LIGASE-4; RNA REPLICATION; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; HUMAN HEPATOCYTES; INFECTED PATIENTS; LIPID-METABOLISM	To elucidate HIV-1 co-infection-induced acceleration of HCV liver disease and identify stage-specific molecular signatures, we applied a new high-resolution molecular screen, the Affymetrix GeneChip Human Transcriptome Array (HTA2.0), to HCV-mono- and HIV/HCV-co-infected liver specimens from subjects with early and advanced disease. Out of 67,528 well-annotated genes, we have analyzed the functional and statistical significance of 75 and 28 genes expressed differentially between early and advanced stages of HCV mono- and HIV/HCV co-infected patient liver samples, respectively. We also evaluated the expression of 25 and 17 genes between early stages of mono- and co-infected liver tissues and between advanced stages of mono- and co-infected patient's samples, respectively. Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC). Our qRT-PCR analysis of the four genes in patient liver specimens supported the microarray data. Protein products of each gene were detected in the endoplasmic reticulum (ER) where HCV replication takes place, and the genes' expression significantly altered replicability of HCV in the subgenomic replicon harboring regulatory genes of the JFH1 strain of HCV in Huh7.5.1. With respect to three well-known transferrable HIV-1 viral elements-Env, Nef, and Tat-Nef uniquely augmented replicon expression, while Tat, but not the others, substantially modulated expression of the candidate genes in hepatocytic cells. Combinatorial expression of these cellular and viral genes in the replicon cells further altered replicon expression. Taken together, these results showed that HIV-1 viral proteins can exacerbate liver pathology in the co-infected patients by disparate molecular mechanisms-directly or indirectly dysregulating HCV replication, even if lack of association of HCV load and end-stage liver disease in hemophilic patients were reported, and modulating expression of hepatocellular genes critical for disease progression. These findings also provide major insights into development of stage-specific hepatocellular biomarkers for improved diagnosis and prognosis of HCV-mediated liver disease.	[Whitmill, Amanda] Univ Texas Southwestern Med Sch, Green Ctr Reprod Biol Sci, Dept Obstet & Gynecol, Dallas, TX USA; [Kim, Seongcheol; Singh, Meharvan] Univ North Texas Hlth Sci Ctr, Pharmacol & Neurosience, Ft Worth, TX USA; [Rojas, Vivian; Gulraiz, Fahad; Afreen, Kazi; Park, In-Woo] Univ North Texas Hlth Sci Ctr, Microbiol Immunol & Genet, Ft Worth, TX 76107 USA; [Jain, Mamta] Univ Texas Southwestern Med Sch, Div Infect Dis, Dallas, TX USA		Park, IW (corresponding author), Univ North Texas Hlth Sci Ctr, Microbiol Immunol & Genet, Ft Worth, TX 76107 USA.	inwoo.park@unthsc.edu		Jain, Mamta/0000-0003-2292-6544; Rojas, Vivian/0000-0001-6721-6349; PARK, IN-WOO/0000-0002-2066-474X	NIH/NIDDK [R01 DK099055]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099055] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by NIH/NIDDK R01 DK099055.	Abbate I, 2004, AIDS, V18, P691, DOI 10.1097/00002030-200403050-00015; Altavilla G, 2000, AM J PATHOL, V157, P1081, DOI 10.1016/S0002-9440(10)64622-6; BANERJEE R, 1992, AIDS, V6, P1127, DOI 10.1097/00002030-199210000-00010; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bruno R, 2002, AM J GASTROENTEROL, V97, P1598, DOI 10.1111/j.1572-0241.2002.05817.x; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Budhu A, 2007, CARCINOGENESIS, V28, P1552, DOI 10.1093/carcin/bgm075; Cao Y, 2001, CANCER RES, V61, P8429; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Daar ES, 2001, J ACQ IMMUN DEF SYND, V26, P466, DOI 10.1097/00126334-200104150-00011; DebRoy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070062; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Flynn JK, 2012, J INFECT DIS, V206, P1568, DOI 10.1093/infdis/jis544; Frahm Jennifer L, 2011, J Proteomics Bioinform, V4, P129; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fromentin R, 2011, J GEN VIROL, V92, P587, DOI 10.1099/vir.0.028746-0; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Goedert JJ, 2001, J INFECT DIS, V184, P1202, DOI 10.1086/323665; Gonzalez SA, 2008, J VIRAL HEPATITIS, V15, P331, DOI 10.1111/j.1365-2893.2007.00949.x; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Gulsen M, 2005, J GASTROEN HEPATOL, V20, P1448, DOI 10.1111/j.1440-1746.2005.03891.x; Hajer GR, 2007, HEART, V93, P216, DOI 10.1136/hrt.2006.093971; Hammer GP, 2003, SEX TRANSM DIS, V30, P919, DOI 10.1097/01.OLQ.0000091152.31366.E6; HOUSSET C, 1990, RES VIROLOGY, V141, P153, DOI 10.1016/0923-2516(90)90017-D; Israelow B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6408; Jang JY, 2011, J HEPATOL, V54, P612, DOI 10.1016/j.jhep.2010.07.042; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Klett EL, 2013, J BIOL CHEM, V288, P21618, DOI 10.1074/jbc.M113.481077; Kottilil S, 2009, HEPATOLOGY, V50, P34, DOI 10.1002/hep.23055; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kuch EM, 2014, BBA-MOL CELL BIOL L, V1841, P227, DOI 10.1016/j.bbalip.2013.10.018; Kuntzen T, 2008, AIDS, V22, P203, DOI 10.1097/QAD.0b013e3282f3553b; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Li SQ, 2015, J SURG RES, V193, P255, DOI 10.1016/j.jss.2014.06.055; Lin CJF, 2008, BIOCHEM BIOPH RES CO, V375, P315, DOI 10.1016/j.bbrc.2008.07.154; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Maloberti PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015540; Martensen PM, 2001, EUR J BIOCHEM, V268, P5947, DOI 10.1046/j.0014-2956.2001.02545.x; Mohsen AH, 2002, GUT, V51, P601, DOI 10.1136/gut.51.4.601; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Park IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099545; Park IW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075648; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Pyeon D, 2016, VIRUS RES, V223, P161, DOI 10.1016/j.virusres.2016.07.009; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; de Carvalho SCR, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-37; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Roe Barbara, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000847; Rosenberg PM, 2002, AM J GASTROENTEROL, V97, P478, DOI 10.1111/j.1572-0241.2002.05459.x; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Rubbia-Brandt L, 2004, GUT, V53, P406, DOI 10.1136/gut.2003.018770; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; SCHMITT MP, 1990, RES VIROLOGY, V141, P143, DOI 10.1016/0923-2516(90)90016-C; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; SHERMAN KE, 1993, J CLIN MICROBIOL, V31, P2679, DOI 10.1128/JCM.31.10.2679-2682.1993; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Shrivastava S, 2016, HEPATOL INT, V10, P937, DOI 10.1007/s12072-016-9733-6; STEFFAN AM, 1992, P NATL ACAD SCI USA, V89, P1582, DOI 10.1073/pnas.89.5.1582; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; Tantawy MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106392; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Thibault PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089971; Thibault PA, 2013, VIROLOGY, V436, P179, DOI 10.1016/j.virol.2012.11.007; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; vantWout AB, 1998, J VIROL, V72, P488; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; VOGEL J, 1991, CANCER RES, V51, P6686; WEISS A, 1984, J IMMUNOL, V133, P123; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045200; Zubiete-Franco I, 2016, J HEPATOL, V64, P409, DOI 10.1016/j.jhep.2015.08.037	103	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202524	10.1371/journal.pone.0202524	http://dx.doi.org/10.1371/journal.pone.0202524			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138348	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100075
J	Jeng, CJ; Hsieh, YT; Yang, CM; Yang, CH; Lin, CL; Wang, IJ				Jeng, Chi-Juei; Hsieh, Yi-Ting; Yang, Chung-May; Yang, Chang-Hao; Lin, Cheng-Li; Wang, I-Jong			Development of diabetic retinopathy after cataract surgery	PLOS ONE			English	Article							BLOOD-AQUEOUS BARRIER; MACULAR EDEMA; RISK-FACTORS; NATURAL-HISTORY; STATIN USE; PHACOEMULSIFICATION; PROGRESSION; LENS; PREVALENCE; EXTRACTION	This study explored whether cataract surgery precipitates diabetic retinopathy (DR) development in diabetic patients without previous DR. Patients with the diagnosis of type II diabetes but without DR were selected from the Longitudinal Health Insurance Database 2000. Patients who received cataract surgery between January 1, 2000, and December 31, 2010, were included in the case group, and the control group was matched to the case group by age, sex, and index year. The postoperative incidence rates of nonproliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR), and diabetic macular edema (DME) were the main outcomes studied and were adjusted by age, sex, comorbidities, and statin, fibrate, angiotensin-converting-enzyme inhibitor (ACEI), oral hypoglycemic agents (OHA), and insulin use. In our cohort, patients who had dyslipidemia and used statins were more likely to undergo cataract surgery. Among diabetic patients without previous DR, patients receiving cataract surgery had a higher risk of NDPR development (adjusted hazard ratio = 1.48, 95% confidence interval = 1.15-1.91). No statistical difference was observed in PDR or DME development between operative and nonoperative groups. In additional stratified analyses, female sex, older age, comorbidities, surgery within 5 years, statin, ACEI, OHA, and insulin use increased the risk of NPDR development. In an adjusted Cox regression model, cataract surgery, OHA and insulin use were found to be risk factors for NPDR development. Cataract surgery with complications increased post-operative risks for NPDR were even higher, and the significant influence from cataract surgery persisted 5 years after surgery.	[Jeng, Chi-Juei] Taipei Med Univ, Dept Ophthalmol, Shuang Ho Hosp, New Taipei, Taiwan; [Jeng, Chi-Juei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Jeng, Chi-Juei; Hsieh, Yi-Ting; Yang, Chung-May; Yang, Chang-Hao; Wang, I-Jong] Natl Taiwan Univ Hosp, Sch Med, Dept Ophthalmol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ, Management Off Hlth Data, Taichung, Taiwan; [Wang, I-Jong] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	Taipei Medical University; Shuang Ho Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Sch Med, Dept Ophthalmol, Taipei, Taiwan.; Lin, CL (corresponding author), China Med Univ, Management Off Hlth Data, Taichung, Taiwan.; Wang, IJ (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	orangechengli@gmail.com; ijong@ms8.hinet.net	Yang, Chung-May/AAV-3737-2020; Yang, Chang-Hao/AAR-3759-2021	YANG, CHANG-HAO/0000-0002-4328-8716; YANG, CHUNG-MAY/0000-0003-4082-420X; Wang, I-Jong/0000-0002-3045-0614	Ministry of Health and Welfare [MOHW107-TDU-B-212-123004]; China Medical University Hospital, Academia Sinica Stroke Biosignature Project [BM10701010021]; Minister of Science and Technology Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); China Medical University Hospital, Academia Sinica Stroke Biosignature Project; Minister of Science and Technology Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by Ministry of Health and Welfare, MOHW107-TDU-B-212-123004, Cheng-Li Lin; China Medical University Hospital, Academia Sinica Stroke Biosignature Project, BM10701010021, Cheng-Li Lin; Minister of Science and Technology Clinical Trial Consortium for Stroke, MOST 106-2321-B-039-005-, Cheng-Li Lin; Tseng-Lien Lin Foundation, Taichung, Taiwan, Cheng-Li Lin; Katsuzo and Kiyo Aoshima Memorial Funds, Japan, Cheng-Li Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar J J, 1984, J Am Intraocul Implant Soc, V10, P433; BENSON WE, 1993, OPHTHALMOLOGY, V100, P730; Biro Z, 2010, EYE, V24, P639, DOI 10.1038/eye.2009.164; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Chew EY, 1999, ARCH OPHTHALMOL-CHIC, V117, P1600; Chu LQ, 2013, MOL VIS, V19, P2418; Chung J, 2002, J CATARACT REFR SURG, V28, P626, DOI 10.1016/S0886-3350(01)01142-7; Dong N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/126984; DONNELLY CA, 1995, BRIT J OPHTHALMOL, V79, P1036, DOI 10.1136/bjo.79.11.1036; Dowler JGF, 1999, OPHTHALMOLOGY, V106, P663, DOI 10.1016/S0161-6420(99)90148-3; FERGUSON VMG, 1992, BRIT J OPHTHALMOL, V76, P453, DOI 10.1136/bjo.76.8.453; Hauser D, 2004, J CATARACT REFR SURG, V30, P428, DOI 10.1016/S0886-3350(03)00579-0; Henricsson M, 1997, DIABETIC MED, V14, P123, DOI 10.1002/(SICI)1096-9136(199702)14:2<123::AID-DIA306>3.0.CO;2-U; Henricsson M, 1996, BRIT J OPHTHALMOL, V80, P789, DOI 10.1136/bjo.80.9.789; Hong T, 2009, OPHTHALMOLOGY, V116, P1510, DOI 10.1016/j.ophtha.2009.03.003; JAFFE GJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P745; Jingi AM, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0213-3; Klein B E, 1995, Ophthalmic Epidemiol, V2, P49, DOI 10.3109/09286589509071451; Klein BEK, 2006, JAMA-J AM MED ASSOC, V295, P2752, DOI 10.1001/jama.295.23.2752; KLEIN BEK, 1985, OPHTHALMOLOGY, V92, P1191; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P295, DOI 10.1016/S0002-9394(14)71170-5; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KODAMA T, 1993, GRAEF ARCH CLIN EXP, V231, P439, DOI 10.1007/BF02044228; Krepler K, 2002, GRAEF ARCH CLIN EXP, V240, P735, DOI 10.1007/s00417-002-0530-7; KUCHLE M, 1995, AM J OPHTHALMOL, V119, P111; Laron Zvi, 2008, Archives of Physiology and Biochemistry, V114, P11, DOI 10.1080/13813450801928356 ; Liu L, 2015, INT J ENV RES PUB HE, V12, P7899, DOI 10.3390/ijerph120707899; Liu Y, 2004, EYE, V18, P900, DOI 10.1038/sj.eye.6701349; Mittra RA, 2000, ARCH OPHTHALMOL-CHIC, V118, P912; MORIARTY AP, 1994, AM J OPHTHALMOL, V117, P768, DOI 10.1016/S0002-9394(14)70320-4; Nemet AY, 2010, EYE, V24, P1352, DOI 10.1038/eye.2010.34; Ostri C, 2011, J CATARACT REFR SURG, V37, P2006, DOI 10.1016/j.jcrs.2011.05.030; POLLACK A, 1992, BRIT J OPHTHALMOL, V76, P228, DOI 10.1136/bjo.76.4.228; Rim THT, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-4; Romero-Aroca P, 2006, J CATARACT REFR SURG, V32, P1438, DOI 10.1016/j.jcrs.2006.03.039; Sabanayagam C, 2011, INVEST OPHTH VIS SCI, V52, P2397, DOI 10.1167/iovs.10-6373; Squirrell D, 2002, BRIT J OPHTHALMOL, V86, P565, DOI 10.1136/bjo.86.5.565; Tan JSL, 2007, AM J OPHTHALMOL, V143, P687, DOI 10.1016/j.ajo.2006.11.027; Ting DSW, 2016, CLIN EXP OPHTHALMOL, V44, P260, DOI 10.1111/ceo.12696; Tsujikawa A, 1997, JPN J OPHTHALMOL, V41, P319, DOI 10.1016/S0021-5155(97)00071-3; Wagner T, 1996, GER J OPHTHALMOL, V5, P79; Wang SX, 2016, INT J CLIN EXP MED, V9, P8874; Wang SY, 2017, OPHTHALMOLOGY, V124, P424, DOI 10.1016/j.ophtha.2016.10.031; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; Yu SD, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004180; Zaczek A, 1999, ACTA OPHTHALMOL SCAN, V77, P726; Zhang Wenbo, 2011, J Cardiovasc Dis Res, V2, P96, DOI 10.4103/0975-3583.83035	48	15	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202347	10.1371/journal.pone.0202347	http://dx.doi.org/10.1371/journal.pone.0202347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133506	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400067
J	Kienberger, K; Riera-Buch, M; Schonemann, AM; Bartsch, V; Halbauer, R; Prieto, L				Kienberger, Karen; Riera-Buch, Marta; Schonemann, Alexandre M.; Bartsch, Vanessa; Halbauer, Roland; Prieto, Laura			First description of the life cycle of the jellyfish Rhizostoma luteum (Scyphozoa: Rhizostomeae)	PLOS ONE			English	Article							CNIDARIA SCYPHOZOA; SETTLEMENT PREFERENCES; NORTH-SEA; BLOOMS; REPRODUCTION; VARIABILITY; HISTORY; WATERS; EVOLUTION; PODOCYSTS	Jellyfish blooms are a significant environmental problem that is increasing and may be influenced by anthropocentric practices such as overfishing, pollution, eutrophication, translocation, climate change, and ocean acidification. Many jellyfish have unknown life cycles leading to these blooms. We describe for the first time, the life cycle of scyphozoan jellyfish Rhizostoma luteum from the planula to the young medusa stages, based on laboratory observations. We also provide a preliminary assessment of temperature related to life stages. Comparisons were made with early life history stages of its sibling species Rhizostoma pulmo and Rhizostoma octopus. The life cycle of R. luteum follows the general pattern of metagenesis of scyphozoans. Scyphistoma culture was maintained in filtered seawater at 17-17.5 degrees C, salinity 37 and light photoperiod (12: 12 h light: dark). Scyphistomae were exposed to an experimental temperature descent for two days to test their survival capacity under severe winter conditions. Only one asexual reproduction mode was observed, which is employed for propagation, consisting of podocyst formation with excystment, subsequent development of scyphistoma, strobilation and liberation of viable ephyra. The development of the ephyra to metaephyra was photodocumented, reaching the metaephyra stage in approximately 21-25 days. Young medusae grow rapidly and maturity was reached after a 3-month post-liberation period with a mean bell diameter of 13.27 +/- 2.26 cm and wet weight of 181.53 +/- 53 g. The life cycle of R. luteum resembles that of its congeners, with the distinction that it has the unique features of being a brooding species (internal fertilisation with subsequent release of planulae) and under the conditions tested, the predominantly strobilation type observed was monodisc, and not polydisc as with the other two species in the genus Rhizostoma. As R. luteum shows sufficient requisite to form blooms if environmental circumstances change, it is important to understand its life cycle.	[Kienberger, Karen; Riera-Buch, Marta; Schonemann, Alexandre M.; Prieto, Laura] CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Grp Ecosyst Oceanog, Cadiz, Spain; [Bartsch, Vanessa; Halbauer, Roland] Vienna Zoo, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Kienberger, K (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Grp Ecosyst Oceanog, Cadiz, Spain.	kienberger@correo.ugr.es	Prieto, Laura/B-3986-2009	Prieto, Laura/0000-0003-4704-7757; Kienberger, Karen/0000-0002-8213-7451; Schonemann, Alexandre M/0000-0003-2316-8570	project Med2CA [CTM2016-75487-R]; project Forzamientos fisicos en la proliferacion costera de organismos gelatinosos [2017301072]; project Convenio Govern de les Illes Baleares/SOCIB/CSIC: "Deteccion de medusas en el mar Balear y su relacion con las condiciones ambientales: hacia el desarrollo de un sistema de prediccion preoperacional"; Rotary Foundation; Rotary Club Geneve-Lac; Geneve-International, Switzerland; University of Granada (Spain); European Social Fund of UE	project Med2CA; project Forzamientos fisicos en la proliferacion costera de organismos gelatinosos; project Convenio Govern de les Illes Baleares/SOCIB/CSIC: "Deteccion de medusas en el mar Balear y su relacion con las condiciones ambientales: hacia el desarrollo de un sistema de prediccion preoperacional"; Rotary Foundation; Rotary Club Geneve-Lac; Geneve-International, Switzerland; University of Granada (Spain); European Social Fund of UE	This work was financially supported by projects Med2CA (CTM2016-75487-R),"Forzamientos fisicos en la proliferacion costera de organismos gelatinosos" (2017301072) and Convenio Govern de les Illes Baleares/SOCIB/CSIC: "Deteccion de medusas en el mar Balear y su relacion con las condiciones ambientales: hacia el desarrollo de un sistema de prediccion preoperacional". KK has received financial assistance from a PhD fellowship from the Rotary Foundation (District 1990), Rotary Club Geneve-Lac and Geneve-International, Switzerland. The Vienna Zoo (Austria) has provided a research grant and the University of Granada (Spain) a travel grant to KK. The Program of "GarantoAa Juvenil" from the CSIC funded by European Social Fund of UE supported MR-BA.	Adler L, 2009, MAR BIOL, V156, P1411, DOI 10.1007/s00227-009-1181-6; Arai MN, 2009, HYDROBIOLOGIA, V616, P241, DOI 10.1007/s10750-008-9588-5; Arai MN., 1997, FUNCTIONAL BIOL SCYP, P169; Astorga D, 2012, HYDROBIOLOGIA, V690, P141, DOI 10.1007/s10750-012-1036-x; Boero F., 2013, STUD REV GEN FISH CO, V92, P53; CALDER DR, 1982, BIOL BULL, V162, P149, DOI 10.2307/1540810; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; Cargo D. G., 1971, Tulane Stud Zool Bot, V17, P31; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Dawson MN, 2009, HYDROBIOLOGIA, V616, P193, DOI 10.1007/s10750-008-9591-x; Ding GW., 1981, J FISH CHINA, V5, P93; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Fuentes V, 2011, MAR BIOL, V158, P2247, DOI 10.1007/s00227-011-1730-7; Grenacher H, 1876, ABHANDLUNGEN SENCKEN, V10; Helm RR, 2018, BIOL REV, V93, P1228, DOI 10.1111/brv.12393; Holst S., 2008, THESIS; Holst S, 2007, MAR BIOL, V151, P1695, DOI 10.1007/s00227-006-0594-8; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Holst S, 2012, MAR BIOL, V159, P2707, DOI 10.1007/s00227-012-2028-0; Kawahara M, 2006, MAR ECOL PROG SER, V307, P161, DOI 10.3354/meps307161; Kienberger K, 2018, MAR BIODIVERS, V48, P1455, DOI 10.1007/s12526-017-0637-z; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; Kuhl H., 1972, OCEAN MAR BIOL ANN R, V10, P225; Lilley MKS, 2009, J MAR BIOL ASSOC UK, V89, P39, DOI 10.1017/S0025315408002439; LOTAN A, 1992, MAR BIOL, V112, P237, DOI 10.1007/BF00702467; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P51, DOI 10.2989/025776187784522621; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Mayer A. G., 1910, MEDUSAE OF THE WORLD; NOAA National Oceanic and Atmospheric Administration, COASTWATCH SST; Paspaleff G. W., 1938, Arbeiten der Biologischen Meeresstation Varna, V7, P1; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; Prieto L, 2013, MAR BIOL, V160, P3241, DOI 10.1007/s00227-013-2293-6; Prieto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013793; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, HYDROBIOLOGIA, V690, P169, DOI 10.1007/s10750-012-1047-7; Russell FS., 1970, PELAGIC SCYPHOZOA SU, P284; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; Schiariti A, 2008, MAR BIOL, V156, P1, DOI 10.1007/s00227-008-1050-8; Schiariti A, 2014, MAR ECOL PROG SER, V510, P241, DOI 10.3354/meps10798; Schiariti A, 2012, MAR BIOL RES, V8, P255, DOI 10.1080/17451000.2011.616897; STIASNY G., 1936, ARQ MUS BOCAGE, V7, P1; STIASNY G., 1931, ZOOL MEDEDEEL [LEIDEN], V14, P137; Straehler-Pohl I, 2010, HYDROBIOLOGIA, V645, P3, DOI 10.1007/s10750-010-0226-7; Straehler-Pohl I., 2009, THESIS; Straehler-Pohl I, 2017, FRONTIERS ECOLOGICAL, P17; Straehler-Pohl I, 2011, ZOOTAXA, P1; Thein H, 2012, HYDROBIOLOGIA, V690, P157, DOI 10.1007/s10750-012-1045-9; Vargas JM, 2003, J MARINE SYST, V38, P205, DOI 10.1016/S0924-7963(02)00240-3	51	12	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202093	10.1371/journal.pone.0202093	http://dx.doi.org/10.1371/journal.pone.0202093			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133536	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400058
J	Gui, Y; Li, JZ; Lu, QM; Feng, Y; Wang, MJ; He, WC; Yang, JW; Dai, CS				Gui, Yuan; Li, Jianzhong; Lu, Qingmiao; Feng, Ye; Wang, Mingjie; He, Weichun; Yang, Junwei; Dai, Chunsun			Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; Yes-associated protein (YAP); fibroblast; fibrosis; cell signaling; Rictor	EPITHELIAL-MESENCHYMAL TRANSITION; ORGAN SIZE CONTROL; CELL SELF-RENEWAL; HIPPO PATHWAY; MYOFIBROBLAST TRANSITION; RENAL FIBROSIS; PROTEIN YAP; MTOR; GROWTH; DISEASE	Our previously published study demonstrated that mammalian target of rapamycin complex 2 (mTORC2) signaling mediates TGF1-induced fibroblast activation. However, the underlying mechanisms for mTORC2 in stimulating fibroblast activation remain poorly understood. Here, we found that TGF1 could stimulate mTORC2 and Yap/Taz activation in NRK-49F cells. Blocking either mTORC2 or Yap/Taz signaling diminished TGF1-induced fibroblast activation. In addition, blockade of mTORC2 could down-regulate the expression of Yap/Taz, connective tissue growth factor (CTGF), and ankyrin repeat domain 1 (ANKRD1). Overexpression of constitutively active Taz (Taz-S89A) could restore fibroblast activation suppressed by PP242, an mTOR kinase inhibitor in NRK-49F cells. In mouse kidneys with unilateral ureter obstructive (UUO) nephropathy, both mTORC2 and Yap/Taz were activated in the interstitial myofibroblasts. Ablation of Rictor in fibroblasts/pericytes or blockade of mTOR signaling with PP242 attenuated Yap/Taz activation and UUO nephropathy in mice. Together, this study uncovers that targeting mTORC2 retards fibroblast activation and kidney fibrosis through suppressing Yap/Taz activation.	[Gui, Yuan; Li, Jianzhong; Lu, Qingmiao; Feng, Ye; Wang, Mingjie; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China	Nanjing Medical University	Dai, CS (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	daichunsun@njmu.edu.cn			National Science Foundation of China [81570611/H0503, 81770675/H0503, 81700589]; Science Foundation of Jiangsu Province [BK20140048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province	This work was supported by National Science Foundation of China Grants 81570611/H0503 and 81770675/H0503 (to D. C.) and 81700589 (to J. L.) and Science Foundation of Jiangsu Province Grant BK20140048 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Artinian N, 2015, J BIOL CHEM, V290, P19387, DOI 10.1074/jbc.M115.656587; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Feng Y, 2018, J AM SOC NEPHROL, V29, P182, DOI 10.1681/ASN.2017040391; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kocalis HE, 2014, MOL METAB, V3, P394, DOI 10.1016/j.molmet.2014.01.014; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kramann R, 2017, J AM SOC NEPHROL, V28, P776, DOI 10.1681/ASN.2016030297; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Piersma B, 2015, AM J PATHOL, V185, P3326, DOI 10.1016/j.ajpath.2015.08.011; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ren JF, 2017, J PATHOL, V242, P488, DOI 10.1002/path.4921; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sciarretta S, 2015, CELL REP, V11, P125, DOI 10.1016/j.celrep.2015.03.010; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	47	29	31	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16364	16375		10.1074/jbc.RA118.004073	http://dx.doi.org/10.1074/jbc.RA118.004073			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30154246	hybrid, Green Published			2022-12-26	WOS:000447833600020
J	Hudson, DM; Archer, M; King, KB; Eyre, DR				Hudson, David M.; Archer, Marilyn; King, Karen B.; Eyre, David R.			Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; glycation; diabetes; mass spectrometry (MS); post-translational modification (PTM); tendon; extracellular matrix	RAT TAIL TENDON; MECHANICAL-PROPERTIES; NONENZYMATIC GLYCOSYLATION; ARTICULAR-CARTILAGE; MAILLARD REACTION; ACHILLES-TENDON; AGE; PROTEIN; IDENTIFICATION; ACCUMULATION	Nonenzymatic glycation of collagen has long been associated with the progressive secondary complications of diabetes. How exactly such random glycations result in impaired tissues is still poorly understood. Because of the slow turnover rate of most fibrillar collagens, they are more susceptible to accumulate time-dependent glycations and subsequent advanced glycation end-products. The latter are believed to include cross-links that stiffen host tissues. However, diabetic animal models have also displayed weakened tendons with reduced stiffness. Strikingly, not a single experimentally identified specific molecular site of glycation in a collagen has been reported. Here, using targeted MS, we have identified partial fructosyl-hydroxylysine glycations at each of the helical domain cross-linking sites of type I collagen that are elevated in tissues from a diabetic mouse model. Glycation was not found at any other collagen lysine residues. Type I collagen in mouse tendons is cross-linked intermolecularly by acid-labile aldimine bonds formed by the addition of telopeptide lysine aldehydes to hydroxylysine residues at positions 1(I)Lys(87), 1(I)Lys(930), 2(I)Lys(87), and 2(I)Lys(933) of the triple helix. Our data reveal that site-specific glycations of these specific lysines may significantly impair normal lysyl oxidase-controlled cross-linking in diabetic tendons. We propose that such N-linked glycations can hinder the normal cross-linking process, thus altering the content and/or placement of mature cross-links with the potential to modify tissue material properties.	[Hudson, David M.; Archer, Marilyn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [King, Karen B.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Hudson, DM (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	dmhudson@uw.edu			National Institutes of Health Grant (NIAMS) [AR037318]; National Institutes of Health Grant (NICHD) [HD070394]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIAMS); National Institutes of Health Grant (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants (NIAMS) AR037318 (to D. E.) and (NICHD) HD070394 (to D. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDREASSEN TT, 1981, BIOCHIM BIOPHYS ACTA, V677, P313, DOI 10.1016/0304-4165(81)90101-X; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; BRENNAN M, 1989, J BIOL CHEM, V264, P20947; BRENNAN M, 1989, J BIOL CHEM, V264, P20953; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Collier TA, 2016, BIOPHYS CHEM, V218, P42, DOI 10.1016/j.bpc.2016.09.003; Collier TA, 2015, MATRIX BIOL, V48, P78, DOI 10.1016/j.matbio.2015.06.001; Connizzo BK, 2014, ANN BIOMED ENG, V42, P1880, DOI 10.1007/s10439-014-1031-7; Dai ZY, 2008, J PROTEOME RES, V7, P2756, DOI 10.1021/pr700874a; de Oliveira RR, 2011, ANN BIOMED ENG, V39, P1528, DOI 10.1007/s10439-011-0247-z; EYRE D, 1987, METHOD ENZYMOL, V144, P115; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fessel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110948; Fox AJS, 2011, J ORTHOP RES, V29, P880, DOI 10.1002/jor.21327; Frolov A, 2006, J MASS SPECTROM, V41, P1459, DOI 10.1002/jms.1117; Frolov A, 2010, ANAL BIOANAL CHEM, V397, P2349, DOI 10.1007/s00216-010-3810-9; GALESKI A, 1977, J BIOMECH, V10, P775, DOI 10.1016/0021-9290(77)90091-4; Gautieri A, 2014, MATRIX BIOL, V34, P89, DOI 10.1016/j.matbio.2013.09.004; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; HAUT RC, 1992, J BIOMECH, V25, P163, DOI 10.1016/0021-9290(92)90273-4; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Hudson DM, 2017, J PERIODONTAL RES, V52, P1042, DOI 10.1111/jre.12475; Hudson DM, 2017, J BIOL CHEM, V292, P3877, DOI 10.1074/jbc.M116.762245; IBERG N, 1986, J BIOL CHEM, V261, P3542; JAMES VJ, 1991, DIABETES, V40, P391, DOI 10.2337/diabetes.40.3.391; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; MCLENNAN S, 1986, DIABETIC MED, V3, P141, DOI 10.1111/j.1464-5491.1986.tb00725.x; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; REISER KM, 1992, J BIOL CHEM, V267, P24207; Saxena AK, 1999, BIOCHEM BIOPH RES CO, V260, P332, DOI 10.1006/bbrc.1999.0898; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; Snedeker Jess G, 2014, Muscles Ligaments Tendons J, V4, P303; Soboleva A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122677; Stolarczyk A, 2018, CLIN EXP PHARMACOL P, V45, P619, DOI 10.1111/1440-1681.12939; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; WATKINS NG, 1985, J BIOL CHEM, V260, P629; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	48	24	25	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15620	15627		10.1074/jbc.RA118.004829	http://dx.doi.org/10.1074/jbc.RA118.004829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143533	Green Published, hybrid			2022-12-26	WOS:000446549200025
J	Lin, JB; Cui, X; Dai, XY; Chen, YJ; Mo, L				Lin, Jiabao; Cui, Xuan; Dai, Xiaoying; Chen, Yajue; Mo, Lei			Neural correlates of creative insight: Amplitude of low-frequency fluctuation of resting-state brain activity predicts creative insight	PLOS ONE			English	Article							SUPERIOR FRONTAL GYRUS; CHUNK DECOMPOSITION; CHINESE CHARACTERS; ANGULAR GYRUS; FMRI; EEG; LOCALIZATION; SUBDIVISIONS; NEUROSCIENCE; FLEXIBILITY	Creative insight has attracted much attention across cultures. Although previous studies have explored the neural correlates of creative insight by functional magnetic resonance imaging (fMRI), little is known about intrinsic resting-state brain activity associated with creative insight. In the present study, we used amplitude of low-frequency fluctuation (ALFF) as an index in resting-state fMRI (rs-fMRI) to identify brain regions involved in individual differences in creative insight, which was measured by the response time of creative Chinese character chunk decomposition. Our results showed that ALFF in the superior frontal gyrus (SFG) positively predicted creative insight, while ALFF in the middle cingulate cortex/insula cortex (MCC/IC), superior temporal gyrus/angular gyrus (STG/AG), anterior cingulate cortex/caudate nucleus (ACC/CN), and culmen/declive (CU/DC) negatively predicted creative insight. Moreover, these findings indicate that spontaneous brain activity in multiple regions related to breaking mental sets, solutions exploring, evaluation of novel solutions, forming task-related associations, and emotion experience contributes to creative insight. In conclusion, the present study provides new evidence to further understand the cognitive processing and neural correlates of creative insight.	[Lin, Jiabao; Cui, Xuan; Dai, Xiaoying; Chen, Yajue; Mo, Lei] South China Normal Univ, Ctr Studies Psychol Applicat, Sch Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Jiabao; Cui, Xuan; Dai, Xiaoying; Chen, Yajue; Mo, Lei] South China Normal Univ, Guangdong Prov Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Sch Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Guangdong Prov Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.	molei@m.scnu.edu.cn			National Social Science Foundation of China [14ZDB159]; Key Institute of Humanities and Social Sciences, Ministry of Education, China [16JJD880025]	National Social Science Foundation of China; Key Institute of Humanities and Social Sciences, Ministry of Education, China(Ministry of Education, China)	This work was supported by grants from the National Social Science Foundation of China (Grant NO.14ZDB159 URL:http://www.npopss-cn.gov.cn/) and Project of the Key Institute of Humanities and Social Sciences, Ministry of Education, China (Grant NO.16JJD880025 URL:https://www.sinoss.net/). The funders had no role in study design, data collection and analysis,	AMABILE TM, 1988, RES ORGAN BEHAV, V10, P123; Chavez RA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00351; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bowden EM, 2007, METHODS, V42, P87, DOI 10.1016/j.ymeth.2006.11.007; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; DREU CKW, 2011, SOCIAL PSYCHOL PERSO, V2, P72, DOI DOI 10.1177/1948550610381789; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith C, 2001, NEUROPSYCHOLOGIA, V39, P1367, DOI 10.1016/S0028-3932(01)00124-5; Goldman-Rakic P S, 1987, COMPREHENSIVE PHYSL; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Huang FR, 2015, NEUROIMAGE, V113, P122, DOI 10.1016/j.neuroimage.2015.03.030; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kershaw TC, 2004, J EXP PSYCHOL LEARN, V30, P3, DOI 10.1037/0278-7393.30.1.3; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Knoblich G, 1999, J EXP PSYCHOL LEARN, V25, P1534, DOI 10.1037/0278-7393.25.6.1534; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Kounios J, 2009, CURR DIR PSYCHOL SCI, V18, P210, DOI 10.1111/j.1467-8721.2009.01638.x; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Kumari V, 2004, J NEUROSCI, V24, P10636, DOI 10.1523/JNEUROSCI.3206-04.2004; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Luo J, 2006, BRAIN RES BULL, V70, P430, DOI 10.1016/j.brainresbull.2006.07.005; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Ollinger M, 2008, EXP PSYCHOL, V55, P269, DOI 10.1027/1618-3169.55.4.269; Ohlsson S., 1992, ADV PSYCHOL THINKING, V1, DOI DOI 10.1017/CB09780511780295; Pernet CR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-67; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; Rose JE, 2011, BIOL PSYCHIAT, V70, P794, DOI 10.1016/j.biopsych.2011.05.031; SCOTT WA, 1962, SOCIOMETRY, V25, P405, DOI 10.2307/2785779; Seger CA, 2006, NEUROSCIENTIST, V12, P285, DOI 10.1177/1073858405285632; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Smith S. M., 1995, GETTING OUT MENTAL R; Sternberg R. J, 1995, NATURE INSIGHT; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tang XC, 2016, CEREB CORTEX, V26, P2991, DOI 10.1093/cercor/bhv113; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Webb ME, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01424; Wu LL, 2013, HUM BRAIN MAPP, V34, P1173, DOI 10.1002/hbm.21501; Wu LL, 2009, BRAIN RES, V1296, P104, DOI 10.1016/j.brainres.2009.08.023; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang WJ, 2016, CREATIVITY RES J, V28, P67, DOI 10.1080/10400419.2016.1125274; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhao Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082503, 10.1371/journal.pone.0059351]; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009	60	5	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203071	10.1371/journal.pone.0203071	http://dx.doi.org/10.1371/journal.pone.0203071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161187	Green Published, Green Submitted, gold			2022-12-26	WOS:000443388900075
J	Miyara, M; Charuel, JL; Mudumba, S; Wu, A; Ghillani-Dalbin, P; Amoura, Z; Burlingame, RW; Musset, L				Miyara, Makoto; Charuel, Jean-Luc; Mudumba, Sasi; Wu, Alice; Ghillani-Dalbin, Pascale; Amoura, Zahir; Burlingame, Rufus W.; Musset, Lucile			Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; POINT-OF-CARE; CLASSIFICATION CRITERIA; RHEUMATIC-DISEASES; AMERICAN-COLLEGE; ANTIBODIES	A novel technology, photonic ring immunoassay (PRI), for detecting 12 autoantibodies simultaneously in whole blood in less than 15 minutes was evaluated by comparing results from 235 clinically diagnosed patients with standard laboratory tests. The overall agreement was greater than 91% for 10 of the 12 assays, with positive percent agreement greater than 89% for 9 of the assays and negative percent agreement greater than 91% for 10 of them. Thus, the clinical sensitivities and specificities were similar for the 2 methods. In addition, 199 normal blood donors were tested on the ANA 12 PRI, yielding specificities greater than 97.5% for all assays. This proof of concept study shows that this new system is suitable for point of care testing for clinically useful autoantibodies, allowing the doctor to have test results in minutes rather than days.	[Miyara, Makoto; Charuel, Jean-Luc; Ghillani-Dalbin, Pascale; Musset, Lucile] Hop La Pitie Salpetriere, AP HP, Immunol Dept, Paris, France; [Miyara, Makoto; Amoura, Zahir] Sorbonne Univ, CIMI, INSERM U1135, Paris, France; [Mudumba, Sasi; Wu, Alice; Burlingame, Rufus W.] Genalyte Inc, San Diego, CA USA; [Amoura, Zahir] Hop Pitie Salpetriere Hosp, AP HP, Serv Med Interne 2, Inst E3M,Ctr Reference Natl Lupus & Syndrome Anti, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Miyara, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Immunol Dept, Paris, France.; Miyara, M (corresponding author), Sorbonne Univ, CIMI, INSERM U1135, Paris, France.	makoto.miyara@aphp.fr	Miyara, Makoto/P-4491-2017	Miyara, Makoto/0000-0001-8743-8846	Genalyte Inc.	Genalyte Inc.	Funding for the study (materials, arrays etc.) was provided by Genalyte Inc. SM, AW and RB are Genalyte Inc employees. The funder provided support in the form of salaries for authors SM, AW and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Amigues JM, 1996, J RHEUMATOL, V23, P2055; Bhansing KJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4562; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Fritzler MJ, 1996, MOL BIOL REP, V23, P133, DOI 10.1007/BF00351161; Goddard GZ, 2017, IMMUNOL RES, V65, P363, DOI 10.1007/s12026-016-8846-2; Iqbal M, 2010, IEEE J SEL QUANTUM E, V16; Konstantinov KN, 2013, AUTOIMMUN HIGHLIGHTS, V4, P55, DOI 10.1007/s13317-013-0052-9; Luchansky MS, 2010, BIOSENS BIOELECTRON, V26, P1283, DOI 10.1016/j.bios.2010.07.010; Mahler M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/315179; Mudumba S, 2017, J IMMUNOL METHODS; Pasoto SG, 2014, EXPERT REV CLIN IMMU, V10, P1493, DOI 10.1586/1744666X.2014.966692; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pisetsky DS, 2016, NAT REV RHEUMATOL, V12, P102, DOI 10.1038/nrrheum.2015.151; Respaldiza N, 2006, SCAND J RHEUMATOL, V35, P290, DOI 10.1080/03009740600588376; Rubin RL, 2016, BIOSENS BIOELECTRON, V83, P306, DOI 10.1016/j.bios.2016.04.048; Scholz J, 2015, CLIN CHEM LAB MED, V53, P1991, DOI 10.1515/cclm-2015-0083; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; SMEENK R, 1990, CLIN RHEUMATOL, V9, P63, DOI 10.1007/BF02205553; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; WERLE E, 1992, LUPUS, V1, P369, DOI 10.1177/096120339200100606; Willems P, 2018, CLIN CHEM LAB MED	24	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202736	10.1371/journal.pone.0202736	http://dx.doi.org/10.1371/journal.pone.0202736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161159	gold, Green Published, Green Submitted			2022-12-26	WOS:000443388900042
J	Guerra, TJ; Messeder, JVS; Arruda, AAJ; Fuzessy, LF; Dayrell, RLC; Neves, FS; Silveira, FAO				Guerra, Tadeu J.; Messeder, Joao V. S.; Arruda, Andre A. J.; Fuzessy, Lisieux F.; Dayrell, Roberta L. C.; Neves, Frederico S.; Silveira, Fernando A. O.			Handling by avian frugivores affects diaspore secondary removal	PLOS ONE			English	Article							SEED DISPERSAL EFFECTIVENESS; FRUIT-EATING BIRDS; GUT PASSAGE; MICONIA MELASTOMATACEAE; PLANT INTERACTIONS; MICROHABITAT USE; ANTS; GERMINATION; PREDATION; TROPIDURIDAE	The balance between the costs and benefits of fleshy fruit production depends on the feeding behavior of their seed dispersers, which might effectively disperse seeds to farther areas or drop beneath parent plants some diaspores they handle during frugivory bouts. Nevertheless, the consequences of variation in fruit handling by primary seed dispersers on the secondary removal of diaspores remains poorly understood. We conducted a field study to determine how variation in fruit handling by avian frugivores affects short-term secondary removal of Miconia irwinii (Melastomataceae) diaspores by the ground-dwelling fauna in campo rupestre vegetation, southeastern Brazil. We conducted factorial experiments manipulating: (1) different outcomes of primary fruit/seed removal by birds, (2) distances of diaspore deposition from conspecifics, and (3) the access of ants and vertebrates to diaspores. We showed that secondary removal of diaspores was highly variable at the population scale, with an overall low removal rate by the ground-dwelling fauna (13% seeds, 19% fruits). However, we found that gut-passed seeds embedded in bird feces were less removed than seeds expelled from fruits. Gut-passed seeds were more likely to be removed by ant species acting as secondary dispersers, whereas pulp-free seeds dropped by birds were likely to interact with potential seed predators, including ants and rodents. We found no clear effect of dispersal from parent plant vicinity on seed removal, but fruit removal was significantly higher near parent plants. Partially defleshed fruits were more removed than intact fruits. The removal of fruits by ant and vertebrate rescuers, including lizards and birds, might reduce the costs of interactions with less effective dispersers that drop partially defleshed fruits under parent plants. Our study highlights that variation in fruit handling by primary avian seed dispersers mediate subsequent interactions among discarded diaspores and ground-dwelling animals, potentially affecting final seed fates. Moreover, we argue that escape-related benefits of dispersal can be contingent on how primary dispersers handle and discard seeds.	[Guerra, Tadeu J.; Messeder, Joao V. S.; Arruda, Andre A. J.; Fuzessy, Lisieux F.; Dayrell, Roberta L. C.; Silveira, Fernando A. O.] Univ Fed Minas Gerais Belo Horizonte, Dept Bot, Belo Horizonte, MG, Brazil; [Neves, Frederico S.] Univ Fed Minas Gerais Belo Horizonte, Dept Biol Geral, Belo Horizonte, MG, Brazil		Guerra, TJ (corresponding author), Univ Fed Minas Gerais Belo Horizonte, Dept Bot, Belo Horizonte, MG, Brazil.	guerra.tj@gmail.com	Arruda, André/ABC-2514-2021; Neves, Frederico/E-5777-2013; Fuzessy, Lisieux/G-2488-2017; Guerra, Tadeu J./O-2320-2013; Dayrell, Roberta LC/L-7063-2016; Messeder, João Vitor S/F-2809-2019	Arruda, André/0000-0001-8894-2585; Neves, Frederico/0000-0002-2691-3743; Fuzessy, Lisieux/0000-0001-9599-9782; Guerra, Tadeu J./0000-0003-1247-365X; Dayrell, Roberta LC/0000-0002-4770-9100; Messeder, João Vitor S/0000-0001-9161-0274; Silveira, Fernando/0000-0001-9700-7521	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG [APQ00382-17]; CAPES; FAPEMIG; FAO Silveira; CNPq	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAO Silveira; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG (Grant#: APQ00382-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also that TJ Guerra, AJ Arruda, LF Fuzessy and RLC Dayrell received scholarships from CAPES, JVS Messeder received a scholarship from FAPEMIG and FAO Silveira and FS Neves received a research productivity grant from CNPq.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Bates D, 2014, DRUG INF J, V35, P1215; Bieber AGD, 2013, ECOSCIENCE, V20, P85, DOI 10.2980/20-1-3573; Brito VLG, 2017, PLANT BIOLOGY, V19, P806, DOI 10.1111/plb.12591; BYRNE MM, 1993, VEGETATIO, V108, P363; Camargo PHSA, 2016, OECOLOGIA, V181, P507, DOI 10.1007/s00442-016-3571-z; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Christianini AV, 2007, J TROP ECOL, V23, P343, DOI 10.1017/S0266467407004087; Christianini AV, 2010, J ECOL, V98, P573, DOI 10.1111/j.1365-2745.2010.01653.x; Christianini AV, 2009, OECOLOGIA, V160, P735, DOI 10.1007/s00442-009-1349-2; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Costa FV, 2015, SOCIOBIOLOGY, V62, P228; Costa FV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167161; Crawley M. J., 2013, R BOOK; Dalling JW, 1998, J TROP ECOL, V14, P705, DOI 10.1017/S0266467498000492; Palacio RD, 2016, BIOTROPICA, V48, P349, DOI 10.1111/btp.12290; Duncan RS, 2002, ECOLOGY, V83, P2630, DOI 10.1890/0012-9658(2002)083[2630:DHSBSR]2.0.CO;2; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Filogonio R, 2010, IHERINGIA SER ZOOL, V100, P336, DOI 10.1590/S0073-47212010000400008; Fornara DA, 2005, J TROP ECOL, V21, P79, DOI 10.1017/S026646740400197X; Fricke EC, 2016, OECOLOGIA, V181, P905, DOI 10.1007/s00442-016-3612-7; Fricke EC, 2013, ECOL LETT, V16, P1031, DOI 10.1111/ele.12134; Gallegos SC, 2014, J ECOL, V102, P659, DOI 10.1111/1365-2745.12226; Genrich CM, 2017, OIKOS, V126, P361, DOI 10.1111/oik.03825; Goldenberg R, 2013, PHYTOTAXA, V106, P1, DOI 10.11646/phytotaxa.106.1.1; Gomes VGN, 2014, PLANT BIOLOGY, V16, P315, DOI 10.1111/plb.12063; Guerra TJ, 2011, J NAT HIST, V45, P1101, DOI 10.1080/00222933.2011.552800; Guerra TJ, 2017, OECOLOGIA, V185, P233, DOI 10.1007/s00442-017-3943-z; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KASPARI M, 1993, OECOLOGIA, V95, P81, DOI 10.1007/BF00649510; Labecca, 2012, ORNITOL NEOTROP, V23, P9; Leal IR, 1998, BIOTROPICA, V30, P170, DOI 10.1111/j.1744-7429.1998.tb00052.x; Lessa LG, 2013, ACTA BOT BRAS, V27, P519, DOI 10.1590/S0102-33062013000300009; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Lima MHC, 2013, BIOTROPICA, V45, P217, DOI 10.1111/j.1744-7429.2012.00910.x; Loiselle BA, 1999, ECOLOGY, V80, P330, DOI 10.1890/0012-9658(1999)080[0330:DOMSBF]2.0.CO;2; MAGNUSSON WE, 1987, J TROP ECOL, V3, P277, DOI 10.1017/S0266467400002169; Maruyama PK, 2013, J TROP ECOL, V29, P99, DOI 10.1017/S0266467413000138; Murakami T, 1997, J ETHOL, V15, P17, DOI 10.1007/BF02767322; Noss CF, 2014, SOUTHEAST NAT, V13, P475, DOI 10.1656/058.013.0308; Silveira FAO, 2012, PLANT ECOL EVOL, V145, P350, DOI 10.5091/plecevo.2012.706; Orivel J, 2018, BIOTROPICA, V50, P641, DOI 10.1111/btp.12539; Pan Y, 2016, INTEGR ZOOL, V11, P191, DOI 10.1111/1749-4877.12189; Pietczak C, 2013, HERPETOL J, V23, P75; Pizo MA, 1999, CAN J ZOOL, V77, P1595, DOI 10.1139/cjz-77-10-1595; RCore Team, 2020, R LANG ENV STAT COMP; ROBERTS JT, 1986, ECOLOGY, V67, P1046, DOI 10.2307/1939827; Sahley CT, 2016, J TROP ECOL, V32, P125, DOI 10.1017/S0266467416000043; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Santos AMO, 2017, SEED SCI RES, V27, P65, DOI 10.1017/S0960258517000071; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Silveira FAO, 2012, SEED SCI RES, V22, P37, DOI 10.1017/S0960258511000286; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; STILES FG, 1993, VEGETATIO, V108, P57; TRAVESET A, 1994, EVOL ECOL, V8, P618, DOI 10.1007/BF01237845; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Van Sluys M, 2004, J HERPETOL, V38, P606, DOI 10.1670/218-03N; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004	61	11	11	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202435	10.1371/journal.pone.0202435	http://dx.doi.org/10.1371/journal.pone.0202435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157261	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400057
J	Zhang, J; Jiang, Y; Wang, Y; Guo, YL; Long, H; Deng, GB; Chen, Q; Xuan, P				Zhang, Jie; Jiang, Yun; Wang, Ying; Guo, Yuanlin; Long, Hai; Deng, Guangbing; Chen, Qian; Xuan, Pu			Molecular markers and cytogenetics to characterize a wheat-Dasypyrum villosum 3V (3D) substitution line conferring resistance to stripe rust	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; F-SP TRITICI; CHROMOSOMAL-ABERRATIONS; CEREAL EYESPOT; GENUS SECALE; HETEROCHROMATIN; IDENTIFICATION; REARRANGEMENTS; SEQUENCES; CHROMATIN	Dasypyrum villosum has been used as a valuable gene resource for disease resistances, yield increase and quality improvement in wheat. A novel wheat-D. villosum alien introgression line CD-3 was generated through hybridization between the common wheat Chinese Spring (CS) and a CS-D. villosum 3V addition line having considerably high stripe rust resistance, which enable the characterization of a potential new stripe rust resistance gene (s) derived from D. villosum. The results of non-denaturing fluorescent in situ hybridization (ND-FISH) showed that CD-3 contained 42 chromosomes, including a 3V chromosome pair, and the absence of both of the 3D chromosomes. PCR-based Landmark Unique Gene (PLUG) molecular marker analysis supported results from the FISH analysis, revealing CD-3 was a wheat-D. villosum 3V (3D) disomic substitution line. Resistant test of stripe rust on 52 plants of F2 generation (CD-3/CS), CD-3, CS and D. villosum have been conducted at seedling stage. 7 plants of F2 generation possessing two 3V chromosomes exhibited high resistance to stripe rust as CD-3 and D. villosum, 10 plants carrying one 3V chromosome and 35 plants without 3V chromosome were susceptive to stripe rust as CS. The result implied the high stripe rust resistance of CD-3 should be controlled by recessive gene(s) originating from D. villosum. To rapidly detect chromosome 3V in the genetic background of wheat, we developed a novel Sequence Characterized Amplified Region (SCAR) marker specific for 3V chromosome based on the sequence of a grain size-related gene DvGS5 in D. villosum, an orthologue of TaGS5 from wheat. The SCAR marker was designated DvGS5-1443, which could successfully amplify a unique 3V-specific fragment in CD-3 and D. villosum, suggesting that this SCAR marker could facilitate targeting the chromosome 3V in the genetic background of wheat for wheat improvement.	[Zhang, Jie; Jiang, Yun; Wang, Ying; Guo, Yuanlin; Chen, Qian] Sichuan Acad Agr Sci, Inst Biotechnol & Nucl Technol Res, Chengdu, Sichuan, Peoples R China; [Zhang, Jie] Minist Agr, Key Lab Wheat Biol & Genet Improvement Southweste, Chengdu, Sichuan, Peoples R China; [Long, Hai; Deng, Guangbing] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Xuan, Pu] Sichuan Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Chengdu, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS); Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan Academy of Agricultural Sciences (SAAS)	Xuan, P (corresponding author), Sichuan Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Chengdu, Sichuan, Peoples R China.	xuanpu@hotmail.com	Guo, Yuan-Lin/K-4887-2019	Guo, Yuan-Lin/0000-0002-7159-0189	National Key R&D Program of China [2016YFD0102101, 2016YFD0102002]; Foundation for Excellent Thesis of Sichuan Academy of Agricultural Sciences [2017LWJJ-001]; Sichuan Wheat Breeding Community [2016NYZ0030]; Project of Innovation Ability Improvement, Sichuan Province [2016ZYPZ-004]; Applied Basic Research Programs of Science and Technology Department, Sichuan Province (Key Project) [2018JY0629]	National Key R&D Program of China; Foundation for Excellent Thesis of Sichuan Academy of Agricultural Sciences; Sichuan Wheat Breeding Community; Project of Innovation Ability Improvement, Sichuan Province; Applied Basic Research Programs of Science and Technology Department, Sichuan Province (Key Project)	This work was supported by National Key R&D Program of China (No. 2016YFD0102101, http://www.most.gov.cn/), YG received the funding; National Key R&D Program of China (No2016YFD0102002, http://www.most.gov.cn/), HL received the funding; Foundation for Excellent Thesis of Sichuan Academy of Agricultural Sciences (No. 2017LWJJ-001, http://www.chinawestagr.com/), JZ received the funding; Sichuan Wheat Breeding Community (No. 2016NYZ0030, http://www.scst.gov.cn/), YG received the funding; Project of Innovation Ability Improvement, Sichuan Province (No. 2016ZYPZ-004, http://www.sccz.gov.cn/new_web/new_index.jsp), YG received the funding; Applied Basic Research Programs of Science and Technology Department, Sichuan Province (Key Project) grant 2018JY0629 to YG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; Arzani A, 2016, CRIT REV PLANT SCI, V35, P146, DOI 10.1080/07352689.2016.1245056; Bariana H, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0528-1; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Bizzarri M, 2009, P 53 IT SOC AGR GEN, P16; CHEN PD, 1995, THEOR APPL GENET, V91, P1125, DOI 10.1007/BF00223930; Chen PD, 2013, MOL BREEDING, V31, P477, DOI 10.1007/s11032-012-9804-x; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Danilova TV, 2017, THEOR APPL GENET, V130, P549, DOI 10.1007/s00122-016-2834-8; Danilova TV, 2012, CHROMOSOMA, V121, P597, DOI 10.1007/s00412-012-0384-7; De Pace C, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P185, DOI 10.1007/978-3-642-14228-4_4; Dong ZZ, 2017, THEOR APPL GENET, V130, P2127, DOI 10.1007/s00122-017-2946-9; Fu SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10552; Fu SL, 2013, J GENET GENOMICS, V40, P413, DOI 10.1016/j.jgg.2013.05.005; Fu SL, 2010, J GENET, V89, P489, DOI 10.1007/s12041-010-0070-6; Gradzielewska A, 2006, EUPHYTICA, V152, P441, DOI 10.1007/s10681-006-9245-x; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; He H., 2017, BIORXIV, DOI [10.1101/177857, DOI 10.1101/177857]; He HG, 2018, MOL PLANT, V11, P879, DOI 10.1016/j.molp.2018.03.004; Huang DaHui, 2007, Agricultural Sciences in China, V6, P513, DOI 10.1016/S1671-2927(07)60077-7; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kato A, 2004, P NATL ACAD SCI USA, V101, P13554, DOI 10.1073/pnas.0403659101; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Li GR, 2014, CYTOGENET GENOME RES, V143, P280, DOI 10.1159/000366051; Li GR, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0217-0; Li Q, 2011, THEOR APPL GENET, V122, P189, DOI 10.1007/s00122-010-1435-1; LINE RF, 1995, PLANT DIS, V79, P1254; Line RF, 1992, US DEP AGR TECH B, P1968; Liu Shou-Bin, 2003, Acta Genetica Sinica, V30, P350; MCINTOSH RA, 2001, CATALOGUE GENE SYMBO; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; PUMPHREY M, 2008, P 11 INT WHEAT GEN S; Randhawa MS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0270-0; Roebbelen G, 1978, ADV PLANT BREEDING S, V9, P1; SEARS ER, 1953, AM J BOT, V40, P168, DOI 10.2307/2438774; Sears ER, 1939, GENETICS, V24, P509; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Tang ZuQiang, 2007, Journal of Agricultural Biotechnology, V15, P799; Uslu E, 1998, EUPHYTICA, V103, P203, DOI 10.1023/A:1018340018838; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Wang SS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01166; Xiang C, 2016, PHYTOPATHOLOGY, V106, P1186, DOI 10.1094/PHYTO-01-16-0045-FI; Xing L, 2018, MOL PLANT, V11, P847; Yildirim A, 1998, GENOME, V41, P1, DOI 10.1139/gen-41-1-1; Yildirim A, 2000, PLANT DIS, V84, P40, DOI 10.1094/PDIS.2000.84.1.40; Zhang J, 2017, GENETICA, V145, P371, DOI 10.1007/s10709-017-9972-z; Zhang J, 2015, INT J MOL SCI, V16, P29787, DOI 10.3390/ijms161226134; Zhang J, 2013, J GENET, V92, P103, DOI 10.1007/s12041-013-0218-2; Zhang QP, 2005, EUPHYTICA, V145, P317, DOI 10.1007/s10681-005-1743-8; Zhang RQ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0549-9; Zhang RQ, 2016, THEOR APPL GENET, V129, P1975, DOI 10.1007/s00122-016-2753-8; Zhang RQ, 2015, THEOR APPL GENET, V128, P2415, DOI 10.1007/s00122-015-2596-8; Zhao WC, 2010, EUPHYTICA, V175, P343, DOI 10.1007/s10681-010-0177-0; Zheng SG, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1828-6	56	10	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202033	10.1371/journal.pone.0202033	http://dx.doi.org/10.1371/journal.pone.0202033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157196	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400028
J	Inomata, M; Horie, T; Into, T				Inomata, Megumi; Horie, Toshi; Into, Takeshi			OmpA-like proteins of Porphyromonas gingivalis contribute to serum resistance and prevent Toll-like receptor 4-mediated host cell activation	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; MANNOSE-BINDING LECTIN; CYSTEINE PROTEINASES; INNATE IMMUNITY; COMPLEMENT; LIPOPOLYSACCHARIDE; GINGIPAINS; PERIODONTITIS; PROTEASE; OPSONOPHAGOCYTOSIS	Porphyromonas gingivalis possesses various abilities to evade and disrupt host immune responses, by which it acts as an important periodontal pathogen. P. gingivalis produces outer membrane protein A (OmpA)-like proteins (OmpALPs), Pgm6 and Pgm7, as major O-linked glycoproteins, but their pathological roles in P. gingivalis infection are largely unknown. Here, we report that OmpALP-deficient strains of P. gingivalis show an enhanced stimulatory activity in coculture with host cells. Such an altered ability of the OmpALP-deficient strains was found to be due to their impaired survival in coculture and the release of LPS from dead bacterial cells to stimulate Toll-like receptor 4 (TLR4). Further analyses revealed that the OmpALP-deficient strains were inviable in serum-containing media although they grew normally in the bacterial medium. The wild-type strain was able to grow in 90% normal human serum, while the OmpALP-deficient strains did not survive even at 5%. The OmpALP-deficient strains did not survive in heat-inactivated serum, but they gained the ability to survive and grow in proteinase K-treated serum. Of note, the sensitivity of the OmpALP-deficient strains to the bactericidal activity of human beta-defensin 3 was increased as compared with the WT. Thus, this study suggests that OmpALPs Pgm6 and Pgm7 are important for serum resistance of P. gingivalis. These proteins prevent bacterial cell destruction by serum and innate immune recognition by TLR4; this way, P. gingivalis may adeptly colonize serum-containing gingival crevicular fluids and subgingival environments.	[Inomata, Megumi; Horie, Toshi; Into, Takeshi] Asahi Univ, Sch Dent, Div Oral Infect & Hlth Sci, Dept Oral Microbiol,Mizuho Ku, Gifu, Japan	Asahi University	Inomata, M; Into, T (corresponding author), Asahi Univ, Sch Dent, Div Oral Infect & Hlth Sci, Dept Oral Microbiol,Mizuho Ku, Gifu, Japan.	inomata@dent.asahi-u.ac.jp; into@dent.asahi-u.ac.jp		Inomata, Megumi/0000-0003-2409-2694	 [15K11094];  [17K17114];  [26462803]	; ; 	This work was supported by Grant-in-Aid for Scientific Research (C), 15K11094 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15K11094/) to MI; Grant-in-Aid for Young Scientists (B), 17K17114, (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K17114/) to TH; Grant-in-Aid for Scientific Research (C) 26462803, (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26462803/) to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Brown L J, 1993, Periodontol 2000, V2, P57; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dasanayake Ananda P, 2003, Dent Clin North Am, V47, P115, DOI 10.1016/S0011-8532(02)00056-3; DEMOT R, 1994, MOL MICROBIOL, V12, P333; GANT VA, 1993, J MED MICROBIOL, V39, P147, DOI 10.1099/00222615-39-2-147; Genco R, 2002, J AM DENT ASSOC, V133, p14S, DOI 10.14219/jada.archive.2002.0375; Gorr SU, 2012, FRONT ORAL BIOL, V15, P84, DOI 10.1159/000329673; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Hajishengallis G, 2008, J IMMUNOL, V181, P4141, DOI 10.4049/jimmunol.181.6.4141; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Horie T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163974; Inomata M, 2007, MICROBES INFECT, V9, P1500, DOI 10.1016/j.micinf.2007.08.005; Inomata M, 2010, EUR J ORAL SCI, V118, P574, DOI 10.1111/j.1600-0722.2010.00775.x; Into T, 2006, CLIN EXP IMMUNOL, V145, P545, DOI 10.1111/j.1365-2249.2006.03156.x; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Iwami J, 2007, ORAL MICROBIOL IMMUN, V22, P356, DOI 10.1111/j.1399-302X.2007.00363.x; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; Maisetta G, 2003, ANTIMICROB AGENTS CH, V47, P3349, DOI 10.1128/AAC.47.10.3349-3351.2003; Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; McCrudden MTC, 2013, J CLIN PERIODONTOL, V40, P933, DOI 10.1111/jcpe.12141; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Murakami Y, 2014, INFECT IMMUN, V82, P4563, DOI 10.1128/IAI.02069-14; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Ogawa T, 2002, EUR J IMMUNOL, V32, P2543, DOI 10.1002/1521-4141(200209)32:9<2543::AID-IMMU2543>3.0.CO;2-2; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30936; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Potempa M, 2008, J IMMUNOL, V181, P5537, DOI 10.4049/jimmunol.181.8.5537; Scannapleco FA, 1999, J PERIODONTAL RES, V34, P340, DOI 10.1111/j.1600-0765.1999.tb02263.x; SCHENKEIN HA, 1977, J PERIODONTOL, V48, P772, DOI 10.1902/jop.1977.48.12.772; Slaney JM, 2006, INFECT IMMUN, V74, P5352, DOI 10.1128/IAI.00304-06; SUNDQVIST G, 1985, J MED MICROBIOL, V19, P85, DOI 10.1099/00222615-19-1-85; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Wilensky A, 2015, J INNATE IMMUN, V7, P127, DOI 10.1159/000365970; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202791	10.1371/journal.pone.0202791	http://dx.doi.org/10.1371/journal.pone.0202791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153274	gold, Green Submitted, Green Published			2022-12-26	WOS:000443001700026
J	Young, CR; Kaida, A; Kabakyenga, J; Muyindike, W; Musinguzi, N; Martin, JN; Hunt, PW; Bangsberg, DR; Haberer, JE; Matthews, LT				Young, Cynthia R.; Kaida, Angela; Kabakyenga, Jerome; Muyindike, Winnie; Musinguzi, Nicholas; Martin, Jeffrey N.; Hunt, Peter W.; Bangsberg, David R.; Haberer, Jessica E.; Matthews, Lynn T.			Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda	PLOS ONE			English	Article							DAR-ES-SALAAM; PRIMARY-CARE; RISK-FACTORS; TANZANIA; AUDIT	Background Intimate partner violence (IPV) is a significant global health problem. Women who experience IPV have increased HIV incidence, reduced antiretroviral adherence, and a lower likelihood of viral load suppression. There is a lack of evidence regarding how to effectively identify and support women living with HIV (WLWH) experiencing IPV, including uncertainty whether universal or targeted screening is most appropriate for lower-resourced settings. We examined physical and sexual IPV prevalence and correlates among WLWH in Uganda to understand the burden of IPV and factors that could help identify women at risk. Methods We utilized data from women receiving ART and enrolled in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort study between 2011 and 2015. Bloodwork and interviewer-administered questionnaires were completed every 4 months. IPV was assessed annually or with any new pregnancy. Multivariate models assessed independent socio-demographic and clinical factors correlated with IPV, at baseline and follow-up visits. Results 455 WLWH were included. Median age was 36 years, 43% were married, and median follow-up was 2.8 years. At baseline 131 women (29%) reported any experience of past or current IPV. In the adjusted models, being married was associated with a higher risk of baseline IPV (ARR 2.33, 95% CI 1.13-4.81) and follow-up IPV (ARR 2.43, 95% CI 1.334.45). Older age (ARR 0.96, 95% CI 0.94-0.99) and higher household asset index score (ARR 0.81, 95% CI 0.68-0.96) were associated with lower risk of IPV during follow-up. Conclusion There was a high prevalence of physical and sexual IPV amongst WLWH, and many women experienced both types of violence. These findings suggest the need for clinic-based screening for IPV. If universal screening is not feasible, correlates of having experienced IPV can inform targeted approaches.	[Young, Cynthia R.] Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA; [Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Kabakyenga, Jerome] Mbarara Univ Sci & Technol, Maternal Newborn & Child Hlth Inst, Mbarara, Uganda; [Muyindike, Winnie] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Musinguzi, Nicholas] Mbarara Univ Sci & Technol, Global Hlth Collaborat, Mbarara, Uganda; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hunt, Peter W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bangsberg, David R.] Portland State Univ, Sch Publ Hlth, Oregon Hlth & Sci Univ, Portland, OR USA; [Haberer, Jessica E.; Matthews, Lynn T.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.; Matthews, Lynn T.] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Simon Fraser University; Mbarara University of Science & Technology; Mbarara University of Science & Technology; Mbarara University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Portland State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Young, CR (corresponding author), Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA.	cyoung2@bwh.harvard.edu	Hunt, Peter W./P-2976-2017; Muyindike, Winnie/W-2892-2019; Haberer, Jessica/AAH-7976-2019	Hunt, Peter W./0000-0002-4571-4870; Haberer, Jessica/0000-0001-5845-3190	National Institutes of Health [R21 HD069194, R01 MH054907, K23 MH095655, P30 AI027763, U01 CA066529, T32 AI007433]; Sullivan Family Foundation; Global Women's Health Fellowship at the Connor's Center for Women's Health and Gender Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sullivan Family Foundation; Global Women's Health Fellowship at the Connor's Center for Women's Health and Gender Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the National Institutes of Health (R21 HD069194, R01 MH054907, K23 MH095655, P30 AI027763, U01 CA066529, T32 AI007433), the Sullivan Family Foundation, and the Global Women's Health Fellowship at the Connor's Center for Women's Health and Gender Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], 2013, WORLD FACTB 2013 14; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Bair-Merritt MH, 2014, AM J PREV MED, V46, P188, DOI 10.1016/j.amepre.2013.10.001; Bolton P, 2000, CROSS CULTURAL ASSES; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Folayan MO, 2016, PLOS ONE, V11, P16; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Hampanda KM, 2016, SOC SCI MED, V153, P123, DOI 10.1016/j.socscimed.2016.02.011; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Joyner K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-399; Joyner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029540; Joyner K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000254; Kayibanda JF, 2012, JAIDS-J ACQ IMM DEF, V59, P300, DOI 10.1097/QAI.0b013e31823dc634; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Kouyoumdjian FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081044; Kouyoumdjian FG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-566; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Machtinger EL, 2015, WOMEN HEALTH ISS, V25, P193, DOI 10.1016/j.whi.2015.03.008; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Ministry of Health, 2016, CONS GUID PREV TREAT; O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3; Organization WH, 2010, PREV INT PARTN SEX V, DOI [10.1136/ip.2010.029629, DOI 10.1136/IP.2010.029629]; Rees K, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24588; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; WHO, 2005, MULT STUD WOM HLTH D; WHO, 2013, RESPONDING INTIMATE; WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395	38	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202992	10.1371/journal.pone.0202992	http://dx.doi.org/10.1371/journal.pone.0202992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148854	Green Published, gold, Green Submitted			2022-12-26	WOS:000442804200042
J	Daer, R; Barrett, CM; Melendez, EL; Wu, JQ; Tekel, SJ; Xu, J; Dennison, B; Muller, R; Haynes, KA				Daer, Rene; Barrett, Cassandra M.; Melendez, Ernesto Luna; Wu, Jiaqi; Tekel, Stefan J.; Xu, Jimmy; Dennison, Brady; Muller, Ryan; Haynes, Karmella A.			Characterization of diverse homoserine lactone synthases in Escherichia coli	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; ACYL CARRIER PROTEIN; PHOTOBACTERIUM-FISCHERI; CELL COMMUNICATION; QUORUM; LUXR; BACTERIAL; GENES; AUTOINDUCER; EXPRESSION	Quorum sensing networks have been identified in over one hundred bacterial species to date. A subset of these networks regulate group behaviors, such as bioluminescence, virulence, and biofilm formation, by sending and receiving small molecules called homoserine lactones (HSLs). Bioengineers have incorporated quorum sensing pathways into genetic circuits to connect logical operations. However, the development of higher-order genetic circuitry is inhibited by crosstalk, in which one quorum sensing network responds to HSLs produced by a different network. Here, we report the construction and characterization of a library of ten synthases including some that are expected to produce HSLs that are incompatible with the Lux pathway, and therefore show no crosstalk. We demonstrated their function in a common lab chassis, Escherichia coli BL21, and in two contexts, liquid and solid agar cultures, using decoupled Sender and Receiver pathways. We observed weak or strong stimulation of a Lux receiver by longer-chain or shorter-chain HSL-generating Senders, respectively. We also considered the under-investigated risk of unintentional release of incompletely deactivated HSLs in biological waste. We found that HSL-enriched media treated with bleach were still bioactive, while autoclaving deactivates LuxR induction. This work represents the most extensive comparison of quorum signaling synthases to date and greatly expands the bacterial signaling toolkit while recommending practices for disposal based on empirical, quantitative evidence.	[Daer, Rene; Barrett, Cassandra M.; Tekel, Stefan J.; Haynes, Karmella A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Melendez, Ernesto Luna] Arizona State Univ, Sch Mol Sci, Tempe, AZ USA; [Wu, Jiaqi] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Wu, Jiaqi; Xu, Jimmy; Dennison, Brady; Muller, Ryan] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Xu, Jimmy] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ USA; [Muller, Ryan] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Haynes, KA (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	karmella.haynes@asu.edu		Haynes, Karmella/0000-0002-5975-577X; Muller, Ryan/0000-0002-8868-7841	Integrated DNA Technologies (IDT); iGEM Headquarters; Western Alliance to Expand Student Opportunities (WAESO) [NSF HRD 1401190]; School of Molecular Sciences at Arizona State University; School of Biological and Health Systems Engineering at Arizona State University; NIH NCI [K01CA188164]; ARCS Foundation; NSF CBET [1404084]; Ira A. Fulton School of Engineering at Arizona State University; NATIONAL CANCER INSTITUTE [K01CA188164] Funding Source: NIH RePORTER	Integrated DNA Technologies (IDT); iGEM Headquarters; Western Alliance to Expand Student Opportunities (WAESO); School of Molecular Sciences at Arizona State University; School of Biological and Health Systems Engineering at Arizona State University; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ARCS Foundation; NSF CBET(National Science Foundation (NSF)); Ira A. Fulton School of Engineering at Arizona State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Most of the work reported here was presented at the 2016 International Genetically Engineered Machines (iGEM) Competition by the Arizona State University (ASU) 2016 iGEM team. The authors thank Integrated DNA Technologies (IDT, http://idtdna.com), iGEM Headquarters (http://igem.org), the Western Alliance to Expand Student Opportunities (WAESO, NSF HRD 1401190, https://mge-p1000.asu.edu/waeso/), the School of Molecular Sciences at Arizona State University, and the School of Biological and Health Systems Engineering at Arizona State University for their support of the undergraduate co-authors. KAH was supported by the NIH NCI (K01CA188164, http://www.nih.gov). RMD was supported by the ARCS Foundation (https://www.arcsfoundation.org/) and NSF CBET (1404084, http://nsf.gov). CMB is supported by the Ira A. Fulton School of Engineering at Arizona State University.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; [Anonymous], PSYCEXTRA DATASET, DOI [10.1037/e545922006-001, DOI 10.1037/E545922006-001]; BALAGADDE FK, 2008, MOL SYST BIOL, P4; Brochardt SA, 2001, APPL ENVIRON MICROB, V67, P3174, DOI 10.1128/AEM.67.7.3174-3179.2001; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Chen Y, 2015, SCIENCE, V349, P986, DOI 10.1126/science.aaa3794; Cox RS, 2018, J INTEGR BIOINFORMAT, V15, DOI 10.1515/jib-2018-0001; da Silva DP, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00052; Davis R. M., 2015, FRONT BIOENG BIOTECH, V3, P1, DOI DOI 10.12970/2311-1755.2015.03.01.1); Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Eberl L, 1999, SYST APPL MICROBIOL, V22, P493, DOI 10.1016/S0723-2020(99)80001-0; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Golberg K, 2011, MICROB ECOL, V61, P783, DOI 10.1007/s00248-011-9848-1; Gould TA, 2006, J BACTERIOL, V188, P773, DOI 10.1128/JB.188.2.773-783.2006; Grant PK, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156590; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Hudaiberdiev S, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00020; Ji WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057482; KAPLAN HB, 1987, P NATL ACAD SCI USA, V84, P6639, DOI 10.1073/pnas.84.19.6639; Kimura N, 2014, VIRULENCE, V5, P433, DOI 10.4161/viru.27850; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Knight T., 2003, IDEMPOTENT VECTOR DE, DOI [10.21236/ada457791, DOI 10.21236/ADA457791, 10.21236/ADA457791]; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; Lewenza S, 2002, CAN J MICROBIOL, V48, P707, DOI 10.1139/W02-068; Lindemann A, 2011, P NATL ACAD SCI USA, V108, P16765, DOI 10.1073/pnas.1114125108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Marketon MM, 2002, J BACTERIOL, V184, P5686, DOI 10.1128/JB.184.20.5686-5695.2002; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Nasuno E, 2012, APPL ENVIRON MICROB, V78, P8067, DOI 10.1128/AEM.01442-12; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Puskas A, 1997, J BACTERIOL, V179, P7530, DOI 10.1128/jb.179.23.7530-7537.1997; ROCK CO, 1982, J BIOL CHEM, V257, P10759; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Sanchez-Contreras M, 2007, PHILOS T R SOC B, V362, P1149, DOI 10.1098/rstb.2007.2041; Scott SR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.83; Scott SR, 2016, ACS SYNTH BIOL, V5, P969, DOI 10.1021/acssynbio.5b00286; Shong J, 2013, ACS CHEM BIOL, V8, P789, DOI 10.1021/cb3006402; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tashiro Y, 2016, J GEN APPL MICROBIOL, V247, P18; von Bodman SB, 2003, J BACTERIOL, V185, P7001, DOI 10.1128/JB.185.23.7001-7007.2003; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Wang BJ, 2013, BIOSENS BIOELECTRON, V40, P368, DOI 10.1016/j.bios.2012.08.011; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wu FQ, 2014, CHEM BIOL, V21, P1629, DOI 10.1016/j.chembiol.2014.10.008; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	54	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202294	10.1371/journal.pone.0202294	http://dx.doi.org/10.1371/journal.pone.0202294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138364	Green Submitted, gold, Green Published			2022-12-26	WOS:000442800100050
J	Foncy, J; Esteve, A; Degache, A; Colin, C; Collet, X; Cau, JC; Vieu, C; Trevisiol, E; Malaquin, L				Foncy, Julie; Esteve, Aurore; Degache, Amelie; Colin, Camille; Collet, Xavier; Cau, Jean-Christophe; Vieu, Christophe; Trevisiol, Emmanuelle; Malaquin, Laurent			Dynamic inking of large-scale stamps for multiplexed microcontact printing and fabrication of cell microarrays	PLOS ONE			English	Article							PROTEIN; ARRAYS	Microcontact printing has become a versatile soft lithography technique used to produce molecular micro- and nano-patterns consisting of a large range of different biomolecules. Despite intensive research over the last decade and numerous applications in the fields of biosensors, microarrays and biomedical applications, the large-scale implementation of microcontact printing is still an issue. It is hindered by the stamp-inking step that is critical to ensure a reproducible and uniform transfer of inked molecules over large areas. This is particularly important when addressing application such as cell microarray manufacturing, which are currently used for a wide range of analytical and pharmaceutical applications. In this paper, we present a large-scale and multiplexed microcontact printing process of extracellular matrix proteins for the fabrication of cell microarrays. We have developed a microfluidic inking approach combined with a magnetic clamping technology that can be adapted to most standard substrates used in biology. We have demonstrated a significant improvement of homogeneity of printed protein patterns on surfaces larger than 1 cm(2) through the control of both the flow rate and the wetting mechanism of the stamp surface during microfluidic inking. Thanks to the reproducibility and integration capabilities provided by microfluidics, we have achieved the printing of three different adhesion proteins in one-step transfer. Selective cell adhesion and cell shape adaptation on the produced patterns were observed, showing the suitability of this approach for producing on-demand large-scale cell microarrays.	[Foncy, Julie; Esteve, Aurore; Colin, Camille; Collet, Xavier; Vieu, Christophe; Trevisiol, Emmanuelle; Malaquin, Laurent] Univ Toulouse, INSA, CNRS, LAAS, Toulouse, France; [Degache, Amelie; Cau, Jean-Christophe] Innopsys, Parc Activites Activestre, Carbonne, France	Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse	Malaquin, L (corresponding author), Univ Toulouse, INSA, CNRS, LAAS, Toulouse, France.	laurent.malaquin@laas.fr	MALAQUIN, LAURENT/B-4852-2016	MALAQUIN, LAURENT/0000-0003-4791-3352	Agence nationale pour la recherche (ANR) LABCOM program [ANR-13-LAB2-0009-01]	Agence nationale pour la recherche (ANR) LABCOM program	Agence nationale pour la recherche (ANR) www.agence-nationale-recherche.fr LABCOM program: ANR-13-LAB2-0009-01	Angres B, 2004, EUR CELLS MATER, V7, P40; Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.3.CO;2-D; Buhl M, 2015, IMMOBILIZATION ENZYM, P26; Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015; Cau JC, 2013, MICROELECTRON ENG, V110, P207, DOI 10.1016/j.mee.2013.03.164; Cerf A, 2009, MICROELECTRON ENG, V86, P1419, DOI 10.1016/j.mee.2009.01.057; Crozatier C, 2006, MICROELECTRON ENG, V83, P910, DOI 10.1016/j.mee.2006.01.015; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Filipponi L, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0036-4; Fredonnet J, 2013, MICROELECTRON ENG, V111, P379, DOI 10.1016/j.mee.2013.03.118; Hu SH, 2018, LANGMUIR, V34, P1750, DOI 10.1021/acs.langmuir.7b02935; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Lalo H, 2009, MICROELECTRON ENG, V86, P1428, DOI 10.1016/j.mee.2008.11.088; LeDuc P, 2002, METHOD CELL BIOL, V69, P385, DOI 10.1016/S0091-679X(02)69024-7; Lin YA, 2010, LANGMUIR, V26, P12803, DOI 10.1021/la1017888; Malaquin L, 2007, LANGMUIR, V23, P11513, DOI 10.1021/la700852c; Rickman DS, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng109; Ricoult SG, 2012, J NEUROSCI METH, V208, P10, DOI 10.1016/j.jneumeth.2012.04.016; Santhanam V, 2004, NANO LETT, V4, P41, DOI 10.1021/nl034851r; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Tan CP, 2010, NANO LETT, V10, P719, DOI 10.1021/nl903968s; Xia YN, 1996, J ELECTROCHEM SOC, V143, P1070, DOI 10.1149/1.1836585; Yarmush ML, 2009, ANNU REV BIOMED ENG, V11, P235, DOI 10.1146/annurev.bioeng.10.061807.160502	23	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202531	10.1371/journal.pone.0202531	http://dx.doi.org/10.1371/journal.pone.0202531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138342	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100079
J	Hsieh, YC; Jeng, WJ; Huang, CH; Teng, W; Chen, WT; Chen, YC; Lin, SM; Tai, DI; Lin, CY; Sheen, IS				Hsieh, Yi-Chung; Jeng, Wen-Juei; Huang, Chien-Hao; Teng, Wei; Chen, Wei-Ting; Chen, Yi-Cheng; Lin, Shi-Ming; Tai, Dar-In; Lin, Chun-Yen; Sheen, I-Shyan			Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis	PLOS ONE			English	Article							REAL-WORLD EFFECTIVENESS; SUSTAINED VIROLOGICAL RESPONSE; RITONAVIR-BOOSTED PARITAPREVIR; ACUTE LIVER-FAILURE; VIRUS-INFECTION; PLUS RIBAVIRIN; DASABUVIR; THERAPY; OMBITASVIR; SAFETY	Background and aim Hepatic decompensation is a severe on-treatment adverse event for chronic hepatitis C treated with paritaprevir/ritonavir/ombitasvir and dasabuvir (PrOD). Till now, few papers regarding on-treatment hepatic decompensation have been reported. The study aims to analyze the general feature and predictive factors of on-treatment hepatic decompensation in hepatitis C virus (HCV) genotype 1b-infected patients with advanced fibrosis and compensated cirrhosis who receive treatment with PrOD. Methods A real-word cohort enrolled 189 HCV genotype 1b patients with advanced fibrosis and compensated cirrhosis treated with 12-week PrOD. Clinical and laboratory data were analyzed between patients with and without on-treatment hepatic decompensation. Results The sustained virologic response rate at 12 weeks after treatment was 97.3% in HCV subtype 1 b patients with advanced fibrosis and cirrhosis. On-treatment hyperbilirubinemia (total bilirubin >2 mg/dL) occurred in 27 (14.3%) patients, and the incidence of the increase of total and direct form bilirubin was significantly different during treatment between patients with Child-Turcotte-Pugh score 5 and score 6. Five (18.5%) hyperbilirubinemia patients progressed to hepatic decompensation. Older age (adjusted OR: 1.2, 95% CI: 1.0-1.4) and albumin <= 3.6 g/dL (adjusted OR: 10.4, 95% CI: 1.3-81.2) may be two predictors for ontreatment hepatic decompensation by multivariate analysis. Conclusions PrOD is an effective direct-acting antiviral agent for antiviral therapy in HCV genotype 1 b patients with advanced fibrosis and cirrhosis. Hyperbilirubinemia is possibly the early warning feature of on-treatment hepatic decompensation. This serious adverse event of on-treatment hepatic decompensation is not common. Older age and low baseline albumin level may be predictive factors.	[Hsieh, Yi-Chung; Jeng, Wen-Juei; Huang, Chien-Hao; Teng, Wei; Chen, Wei-Ting; Chen, Yi-Cheng; Lin, Shi-Ming; Tai, Dar-In; Lin, Chun-Yen; Sheen, I-Shyan] Chang Gung Mem Hosp, Linkou Med Ctr, Dept HepatoGastroenterol, Div Hepatol, Taoyuan, Taiwan; [Jeng, Wen-Juei; Huang, Chien-Hao; Chen, Yi-Cheng; Lin, Shi-Ming; Tai, Dar-In; Lin, Chun-Yen; Sheen, I-Shyan] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan; [Jeng, Wen-Juei; Lin, Shi-Ming] Change Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Lin, Chun-Yen; Sheen, I-Shyan] Chang Gung Univ, Dept HepatoGastroenterol, Chang Gung Mem Hosp, Linkou Med Ctr,Sch Med,Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, CY; Sheen, IS (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept HepatoGastroenterol, Div Hepatol, Taoyuan, Taiwan.; Lin, CY; Sheen, IS (corresponding author), Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan.; Lin, CY; Sheen, IS (corresponding author), Chang Gung Univ, Dept HepatoGastroenterol, Chang Gung Mem Hosp, Linkou Med Ctr,Sch Med,Coll Med, Taoyuan, Taiwan.	chunyenlin@gmail.com; happy95kevin@gmail.com	Zixuan, Huang/ABI-3557-2020	Lin, Chun-Yen/0000-0003-3007-3190	Chang Gung Memory Research Grant [CORPG3G0631]	Chang Gung Memory Research Grant	This study was supported by the Chang Gung Memory Research Grant CORPG3G0631. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD- IDSA, 2017, REC TEST MAN TREAT H; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, 2021, HCV GUID REC TEST MA; Asahina Y, 2016, HEPATOL RES, V46, P129, DOI 10.1111/hepr.12645; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Buzas C, 2017, J GASTROINTEST LIVER, V26, P93, DOI 10.15403/jgld.2014.1121.261.vir; Chan HLY, 2017, J GASTROEN HEPATOL, V32, P1230, DOI 10.1111/jgh.13663; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/m16-2575, 10.7326/M16-2575]; Flisiak R, 2016, ALIMENT PHARM THER, V44, P946, DOI 10.1111/apt.13790; Fofiu C, 2017, J GASTROINTEST LIVER, V26, P94, DOI 10.15403/jgld.2014.1121.261.pak; Forns X, 2015, LIVER INT, V35, P2358, DOI 10.1111/liv.12931; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hoofnagle JH, 2016, J HEPATOL, V64, P763, DOI 10.1016/j.jhep.2016.01.007; Ippolito AM, 2017, DIGEST LIVER DIS, V49, P1022, DOI 10.1016/j.dld.2017.03.025; Liu CH, 2018, J GASTROEN HEPATOL, V33, P710, DOI 10.1111/jgh.13912; Lubel J, 2017, ANTIVIR THER, V22, P699, DOI 10.3851/IMP3168; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Masetti M, 2016, J GASTROINTEST LIVER, V25, P559, DOI [15403/jgld.2014.1121.254.tti, 10.15403/jgld.2014.1121.254.tti]; Nahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009; Poordad F, 2017, J HEPATOL, V67, P700, DOI 10.1016/j.jhep.2017.06.011; Preda CM, 2018, LIVER INT, V38, P602, DOI 10.1111/liv.13550; Sezaki H, 2017, LIVER INT, V37, P1325, DOI 10.1111/liv.13384; Smith MA, 2015, DRUG DES DEV THER, V9, P6083, DOI 10.2147/DDDT.S80226; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wedemeyer H, 2017, J VIRAL HEPATITIS, V24, P936, DOI 10.1111/jvh.12722; Weil C, 2018, J VIRAL HEPATITIS, V25, P144, DOI 10.1111/jvh.12800; WHO, 2016, MYANM NATL SIMPL TRE	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202777	10.1371/journal.pone.0202777	http://dx.doi.org/10.1371/journal.pone.0202777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138456	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100125
J	Tokai, N; Yoshida, S; Kotani, T; Yoshikawa, A; Kimura, Y; Fujiki, Y; Matsumura, Y; Takeuchi, T; Makino, S; Arawaka, S				Tokai, Nao; Yoshida, Shuzo; Kotani, Takuya; Yoshikawa, Ayaka; Kimura, Yuko; Fujiki, Youhei; Matsumura, Yoko; Takeuchi, Tohru; Makino, Shigeki; Arawaka, Shigeki			Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis	PLOS ONE			English	Article							DISEASE-ACTIVITY; CLASSIFICATION; TOCILIZUMAB; REMISSION; SYNOVITIS; EFFICACY; CRITERIA; MMP-3; SCORE	Objective The aim of this study was to clarify whether serum matrix metalloproteinase 3 (MMP-3) levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs (bDMARDs) in patients with rheumatoid arthritis (RA). Methods Forty three patients with RA were treated with iguratimod as add-on therapy to bDMARDs. They were classified into remission and non-remission groups at 24 weeks of iguratimod therapy. Remission was defined as a state with a disease activity score (DAS) <2.6 in 28 joints (termed DAS remission) and total power Doppler ultrasound (US) score <3 (termed US remission). The serum MMP-3 levels at baseline and at 12 weeks were compared between these two groups. Results There were no significant differences in the serum MMP-3 levels at baseline between the DAS and US remission groups and the non-remission group. The serum MMP-3 levels at 12 weeks in the US remission group were significantly lower than those in the non-remission group. The ratios of the serum MMP-3 levels at baseline to those at 12 weeks in both the DAS and US remission groups were significantly lower than those in the non-remission group. An MMP-3 ratio <0.86 was determined as the cut-off value to predict US remission at 24 weeks. Conclusion Our findings suggest that the ratios of the serum MMP-3 levels at baseline to those at 12 weeks could be used to predict remission in RA patients who are administered iguratimod as an add-on to bDMARDs.	[Tokai, Nao; Kotani, Takuya; Yoshikawa, Ayaka; Kimura, Yuko; Fujiki, Youhei; Takeuchi, Tohru; Makino, Shigeki; Arawaka, Shigeki] Osaka Med Coll, Dept Internal Med 4, Takatsuki, Osaka, Japan; [Yoshida, Shuzo] Arisawa Gen Hosp, Dept Internal Med, Hirakata, Osaka, Japan; [Matsumura, Yoko] Osaka Med Coll, Cent Lab, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Kotani, T (corresponding author), Osaka Med Coll, Dept Internal Med 4, Takatsuki, Osaka, Japan.; Yoshida, S (corresponding author), Arisawa Gen Hosp, Dept Internal Med, Hirakata, Osaka, Japan.	in1307@osaka-med.ac.jp; in1242@osaka-med.ac.jp						Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; FOSANG AJ, 1995, BIOCHEM J, V310, P337, DOI 10.1042/bj3100337; Fukae J, 2014, RHEUMATOLOGY, V53, P586, DOI 10.1093/rheumatology/ket311; GLYNN L E, 1963, Bull Rheum Dis, V14, P323; Hammer HB, 2011, ANN RHEUM DIS, V70, P1995, DOI 10.1136/ard.2011.152926; HARDWICKE J, 1952, CLIN SCI, V11, P333; Hattori Y, 2017, CLIN RHEUMATOL; Hattori Y, 2018, MOD RHEUMATOL, V28, P242, DOI 10.1080/14397595.2017.1354431; Hattori Y, 2018, MOD RHEUMATOL, V28, P119, DOI 10.1080/14397595.2017.1317320; Iwamoto T, 2014, ARTHRIT CARE RES, V66, P1576, DOI 10.1002/acr.22303; Kanbe K, 2015, CLIN MED INSIGHTS-AR, V8, P25, DOI 10.4137/CMAMD.S22155; Kaneshiro S, 2017, MOD RHEUMATOL, V27, P42, DOI 10.1080/14397595.2016.1181315; Kishimoto T., 2005, ANNU REV IMMUNOL, V23, P1, DOI [10.1146/annurev.immunol.23.021704.115806, DOI 10.1146/ANNUREV.IMMUNO0L.23.021704.115806]; Kubo S, 2016, ANN RHEUM DIS, V75, P1321, DOI 10.1136/annrheumdis-2015-207784; Nishino A, 2018, ARTHRITIS CARE RES; Ribbens C, 2000, J RHEUMATOL, V27, P888; Shiozawa K, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0948-7; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Urata Y, 2012, ANN RHEUM DIS, V71, P534, DOI 10.1136/annrheumdis-2011-200108; Yamanaka H, 2000, ARTHRITIS RHEUM, V43, P852, DOI 10.1002/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7; Yokoe I, 2011, MOD RHEUMATOL, V21, P710, DOI 10.1007/s10165-011-0474-z; Yoshikawa A, 2017, MOD RHEUMATOL, V27, P162, DOI 10.3109/14397595.2014.954742	24	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202601	10.1371/journal.pone.0202601	http://dx.doi.org/10.1371/journal.pone.0202601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138480	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100091
J	Xu, W; Rao, Q; An, YB; Li, MY; Zhang, ZT				Xu, Wei; Rao, Quan; An, Yongbo; Li, Mengyi; Zhang, Zhongtao			Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma	PLOS ONE			English	Article							HEPATIC RESECTION; EXPRESSION; INVASION; PROLIFERATION; METAANALYSIS; MULTICENTER; ANTIGEN; PROTEIN; BENEFIT; MARKER	The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liver Cancer (BCLC) staging system and prognosis of patients with hepatocellular carcinoma (HCC). We downloaded 4 gene expression datasets from the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo), and screened for genes that were differentially expressed between HCC and normal liver tissues, using significance analysis of the microarray algorithm. We used a weighted gene co-expression network analysis (WGCNA) to identify hub genes that correlate with BCLC staging, functional enrichment analysis to associate hub genes with their functions, protein-protein interaction network analysis to identify interactions among hub genes, UALCAN analysis to assess gene expression levels based on tumour stage, and survival analyses to clarify the effects of hub genes on patients' overall survival (OS). We identified 50 relevant hub genes using WGCNA; among them, 13 genes (including TIGD5, C8ORF33, NUDCD1, INSB8, and STIP1) correlated with OS and BCLC staging. Significantly enriched gene ontology biological process terms included RNA processing, non-coding RNA processing and phosphodiester bond hydrolysis, and 6 genes were found to interact with 10 or more hub genes. We identified several candidate biomarkers that correlate with BCLC staging and OS of HCC. These genes might be used for prognostic assessment and selection of HCC patients for surgery, especially those with intermediate or advanced disease.	[Xu, Wei; Rao, Quan; An, Yongbo; Li, Mengyi; Zhang, Zhongtao] Capital Med Univ, Beijing Friendship Hosp, Beijing Key Lab Canc Invas & Metastasis Res, Dept Gen Surg,Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China	Capital Medical University	Zhang, ZT (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Beijing Key Lab Canc Invas & Metastasis Res, Dept Gen Surg,Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China.	zhangzht@ccmu.edu.cn						Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bhandare MS, 2018, LANGENBECK ARCH SURG, V403, P37, DOI 10.1007/s00423-017-1640-3; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen ZB, 2017, BIOCHEM BIOPH RES CO, V493, P365, DOI 10.1016/j.bbrc.2017.09.016; Cheng L, 2013, GENOMICS, V102, P323, DOI 10.1016/j.ygeno.2013.05.004; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Federico A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050936; Grinchuk OV, 2018, MOL ONCOL, V12, P89, DOI 10.1002/1878-0261.12153; Haase M, 2016, GENE, V575, P171, DOI 10.1016/j.gene.2015.08.063; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang K, 2018, CANCER CONTROL, V25, DOI 10.1177/1073274817744658; Jianyong Lei, 2014, Medicine (Baltimore), V93, pe180, DOI 10.1097/MD.0000000000000180; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kokudo T, 2016, J HEPATOL, V65, P938, DOI 10.1016/j.jhep.2016.05.044; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45646; Li J, 2017, ONCOTARGET, V8, P96027, DOI 10.18632/oncotarget.21630; Li WH, 2009, CHINESE MED J-PEKING, V122, P15, DOI 10.3760/cma.j.issn.0366-6999.2009.01.004; Liu W, 2015, J GASTROINTEST SURG, V19, P1271, DOI 10.1007/s11605-015-2811-6; Qi XS, 2015, ONCOTARGET, V6, P18715, DOI 10.18632/oncotarget.4134; Sakabe T, 2017, ANTICANCER RES, V37, P4881, DOI 10.21873/anticanres.11897; Shao P, 2017, FEBS OPEN BIO, V7, P1696, DOI 10.1002/2211-5463.12310; Simpson HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141906; Suemori K, 2008, CANCER SCI, V99, P1414, DOI 10.1111/j.1349-7006.2008.00823.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tada T, 2017, CANCER SCI, V108, P1414, DOI 10.1111/cas.13257; Vitale A, 2015, J HEPATOL, V62, P617, DOI 10.1016/j.jhep.2014.10.037; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; Weiler SME, 2017, GASTROENTEROLOGY, V152, P2037, DOI 10.1053/j.gastro.2017.02.018; Woo HG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00991-w; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Xu W, 2017, ONCOTARGET, V8, P110406, DOI 10.18632/oncotarget.22779; Xu W, 2017, ASIA-PAC J CLIN ONCO, V13, pE321, DOI 10.1111/ajco.12585; Yamaguchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085750; Yang MR, 2016, EUR REV MED PHARMACO, V20, P4248; Zheng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37070	39	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202763	10.1371/journal.pone.0202763	http://dx.doi.org/10.1371/journal.pone.0202763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138346	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100121
J	Serra, T; Oldham, C; Colomer, J				Serra, Teresa; Oldham, Carolyn; Colomer, Jordi			Local hydrodynamics at edges of marine canopies under oscillatory flows	PLOS ONE			English	Article							SEAGRASS POSIDONIA-OCEANICA; SEDIMENT RESUSPENSION; DRAG FORCES; WAVE; TURBULENCE; MEADOWS; MODEL; QUANTIFICATION; STIFFNESS; HABITATS	Canopy fragmentation increases both spatial heterogeneity and patch edges which, in turn, is then likely to modify the local hydrodynamics in the canopy. The orientation of the edge versus the wave and current field is also expected to play an important role in determining wave attenuation and sheltering at the edge of a canopy. We investigated the effect a longitudinal edge (i.e. with its main axis aligned to wave direction) of a simulated canopy has on local edge hydrodynamics. The effect that both canopy density and flexibility have on the hydrodynamics was studied. Flexible plants reduced the wave velocity and the turbulent kinetic energy with distance into the canopy and this attenuation increased as the density of the canopy increased. Compared to flexible plants, an edge of rigid plants produced a higher wave velocity attenuation coupled with an increase in the turbulent kinetic energy with distance into the canopy despite having the same canopy density. This greater wave attenuation at the edge coincided with the shifting of the associated mean current that, in turn, produced an increase in the turbulent kinetic energy at the edge in the canopy. The effect was accentuated when the canopy density increased. The wave velocity attenuation was a linear function of the canopy cover. While flexible plants reduced the turbulent kinetic energy following a linear function of the canopy cover, rigid canopies increased the turbulent kinetic energy following a linear function of the canopy cover. In the case of the flexible vegetation, the lengths of both the inner and outer canopy boundary layers increased as the canopy cover increased.	[Serra, Teresa; Colomer, Jordi] Univ Girona, Dept Phys, Girona, Spain; [Oldham, Carolyn] Univ Western Australia, Dept Civil Environm & Min Engn, Perth, WA, Australia	Universitat de Girona; University of Western Australia	Serra, T (corresponding author), Univ Girona, Dept Phys, Girona, Spain.	teresa.serra@udg.edu	Serra, Teresa/L-9279-2014; Colomer, Jordi/Y-5386-2018	Serra, Teresa/0000-0002-6075-5849; Colomer, Jordi/0000-0002-9330-0269; Oldham, Carolyn/0000-0003-2968-6889	University of Girona fund [MPCUdG2016]; University of Western Australia; Ministerio de Economoia y Competitividad grant [CGL2017-86515-P]	University of Girona fund; University of Western Australia; Ministerio de Economoia y Competitividad grant	Work was supported by the University of Girona funding MPCUdG2016, www.udg.edu, http://research-repository.uwa.edu.au/en/persons/carolyn-oldham(e820ea56-699d-4fb8-97a8-e919b1549c9d).html, and Study Leave Grant from The University of Western Australia to Dr. Teresa Serra, and Ministerio de Economoia y Competitividad grant CGL2017-86515-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MP, 2016, LIMNOL OCEANOGR, V61, P1937, DOI 10.1002/lno.10319; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson ME, 2014, COAST ENG, V83, P82, DOI 10.1016/j.coastaleng.2013.10.004; Boudouresque C.F., 2012, RAMOGE PUBLICATION, P1, DOI DOI 10.1007/S10750-015-2333-Y; BOUDOURESQUE CF, 1985, ANN I OCEANOGR PARIS, V61, P27; Bouma TJ, 2007, CONT SHELF RES, V27, P1020, DOI 10.1016/j.csr.2005.12.019; Bouma TJ, 2009, MAR ECOL PROG SER, V388, P293, DOI 10.3354/meps08130; Bouma TJ, 2014, COAST ENG, V87, P147, DOI 10.1016/j.coastaleng.2013.11.014; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; Bradley K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000951; Carr J, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001103; Colomer J, 2017, MAR ECOL PROG SER, DOI [10.3354/meps12328, DOI 10.3354/MEPS12328]; Coulombier T, 2012, ESTUAR COAST SHELF S, V101, P64, DOI 10.1016/j.ecss.2012.02.014; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P97, DOI 10.3354/meps067097; Guillen JE, 2013, J SEA RES, V83, P65, DOI 10.1016/j.seares.2013.04.012; El Allaoui N, 2015, J HYDROL, V531, P840, DOI 10.1016/j.jhydrol.2015.10.041; Folkard AM, 2005, LIMNOL OCEANOGR, V50, P1592, DOI 10.4319/lo.2005.50.5.1592; Fredriksen S, 2010, MAR BIOL RES, V6, P189, DOI 10.1080/17451000903042461; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Gera A, 2013, J ECOL, V101, P1053, DOI 10.1111/1365-2745.12109; Ghisalberti M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000871; Granata TC, 2001, MAR ECOL PROG SER, V218, P95, DOI 10.3354/meps218095; Green MO, 2014, REV GEOPHYS, V52, P77, DOI 10.1002/2013RG000437; Hansen JCR, 2012, MAR ECOL PROG SER, V448, P271, DOI 10.3354/meps09225; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Hendriks IE, 2011, ESTUAR COAST, V34, P60, DOI 10.1007/s12237-010-9309-y; Horinouchi M, 2007, J EXP MAR BIOL ECOL, V350, P111, DOI 10.1016/j.jembe.2007.06.015; Infantes E, 2012, MAR ECOL PROG SER, V456, P63, DOI 10.3354/meps09754; Jones BL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150596; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; Lefebvre A, 2010, CONT SHELF RES, V30, P1783, DOI 10.1016/j.csr.2010.08.006; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI [10.1029/2004JC002711, 10.1029/2004JC002788]; Luhar M, 2013, J GEOPHYS RES-OCEANS, V118, P1955, DOI 10.1002/jgrc.20162; Luhar M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006345; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; Morris EP, 2008, LIMNOL OCEANOGR, V53, P1531, DOI 10.4319/lo.2008.53.4.1531; Nepf HM, 1997, LIMNOL OCEANOGR, V42, P1735, DOI 10.4319/lo.1997.42.8.1735; Nepf HM, 1999, WATER RESOUR RES; Neumeier U, 2005, ESTUAR COAST SHELF S, V63, P489, DOI 10.1016/j.ecss.2004.12.009; Neumeier U, 2004, J COASTAL RES, V20, P435, DOI 10.2112/1551-5036(2004)020[0435:FRAASP]2.0.CO;2; Neumeier U, 2006, J COASTAL RES, P433; Nezu I, 2002, J VISUAL-JAPAN, V5, P77, DOI 10.1007/BF03182606; Orlins JJ, 2003, EXP FLUIDS, V34, P662, DOI [10.1007/s00348-003-0595-z, 10.1007/S00348-003-0595-Z]; Paul M, 2012, MAR ECOL PROG SER, V444, P31, DOI 10.3354/meps09489; Paul M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006797; Paul M, 2016, COAST ENG, V117, P70, DOI 10.1016/j.coastaleng.2016.07.004; Pergent G, 2014, MEDITERR MAR SCI, V15, P462, DOI 10.12681/mms.621; Pujol D, 2013, CONT SHELF RES, V66, P9, DOI 10.1016/j.csr.2013.06.012; Pujol D, 2013, J HYDROL, V486, P281, DOI 10.1016/j.jhydrol.2013.01.024; Pujol D, 2010, CONT SHELF RES, V30, P1019, DOI 10.1016/j.csr.2010.02.014; Ricart AM, 2015, MAR POLLUT BULL, V100, P476, DOI 10.1016/j.marpolbul.2015.09.032; Robbins BD, 1994, SEAGRASS LANDSCAPES, P301, DOI [10.1016/0169-5347(94)90041-8, DOI 10.1016/0169-5347(94)90041-8]; Ros A, 2016, THESIS; Ros A, 2014, CONT SHELF RES, V91, P220, DOI 10.1016/j.csr.2014.10.004; Serra T, 2016, PLOS ONE, V11, P1, DOI [10.1371/journal.pone.0152624, DOI 10.1371/JOURNAL.PONE.0152624]; Serra T, 2015, J HYDOLOGY, V114, P1; Tanner JE, 2005, AUSTRAL ECOL, V30, P210, DOI 10.1111/j.1442-9993.2005.01438.x; Vacchi M, 2012, ESTUAR COAST SHELF S, V97, P58, DOI 10.1016/j.ecss.2011.11.024; White BL, 2003, J FLUID MECH, V487, P43, DOI 10.1017/S0022112003004579; White BL, 2008, WATER RESOUR RES, P44	62	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201737	10.1371/journal.pone.0201737	http://dx.doi.org/10.1371/journal.pone.0201737			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133481	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400034
J	Drews, HJ; Wiesner, CD; Bethke-Jaenicke, C; Weinhold, SL; Baier, PC; Goder, R				Drews, Henning Johannes; Wiesner, Christian Dirk; Bethke-Jaenicke, Christina; Weinhold, Sara Lena; Baier, Paul Christian; Goeder, Robert			Slow-wave sleep predicts long-term social functioning in severe mental illness	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; SCHIZOPHRENIA; MEMORY; CONSOLIDATION; DISORDERS; DEFICITS; OUTCOMES	Sleep's relevance for long-term social functioning in psychiatric disorders has been widely overlooked so far. Here, we investigate social functioning in a transdiagnostic sample of 31 patients with severe mental illness, namely schizophrenia (n = 15) or major depression (n = 16), in relation to their polysomnographic sleep characteristics 6 (+/- 2.4) years earlier. In addition, cognitive performance at follow-up and clinical characteristics (i.e., severity of disorder-related symptoms and number of hospitalizations between baseline and follow-up) are assessed. Multiple regression analysis results in a model with slow-wave sleep (SWS) and number of hospitalizations as significant predictors accounting for 50% (R-2 = 0.507; p<0.001) of the variance in social functioning. SWS remains a significant predictor of long-term social functioning throughout a series of refining analyses which also identify baseline functioning as an additional significant predictor, whereas diagnosis is non-significant. Also, the effect of SWS on social functioning is not mediated by number of hospitalizations as assessed by a bootstrapped mediation analysis. We thus conclude that duration of slow-wave sleep is a powerful predictor of long-term social outcome in psychiatric disorders. Also, we discuss the relevance of verbal memory, symptom severity, and diagnostic category for social functioning. Future studies should test this finding by using a prospective design, a bigger sample, optimized predictor variables, and a more diverse set of diagnoses. Moreover, it should be explored whether or not treating sleep disturbances in psychiatric illnesses independently improves long-term social functioning.	[Drews, Henning Johannes; Bethke-Jaenicke, Christina; Weinhold, Sara Lena; Baier, Paul Christian; Goeder, Robert] Christian Albrechts Univ Kiel, Dept Psychiat & Psychotherapy, Kiel, Schleswig Holst, Germany; [Wiesner, Christian Dirk] Christian Albrechts Univ Kiel, Dept Psychol, Kiel, Schleswig Holst, Germany	University of Kiel; University of Kiel	Drews, HJ (corresponding author), Christian Albrechts Univ Kiel, Dept Psychiat & Psychotherapy, Kiel, Schleswig Holst, Germany.	henning.drews@uksh.de	Baier, Paul Christian/H-7919-2014	Weinhold, Sara Lena/0000-0002-7606-3492; Drews, Henning Johannes/0000-0002-9929-3194	Dpt. of Psychiatry and Psychotherapy, Christian-Albrechts-University, Kiel and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	Dpt. of Psychiatry and Psychotherapy, Christian-Albrechts-University, Kiel and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	The present study was funded by own resources of the Dpt. of Psychiatry and Psychotherapy, Christian-Albrechts-University, Kiel and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Baglioni C, 2016, PSYCHOL BULL, V142, P969, DOI 10.1037/bul0000053; Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014; Bryson G, 2003, J NERV MENT DIS, V191, P87, DOI 10.1097/01.NMD.0000050937.06332.3C; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Feld GB, 2017, CURR OPIN NEUROBIOL, V44, P20, DOI 10.1016/j.conb.2017.02.012; Fusar-Poli P, 2010, J PSYCHIATR RES, V44, P294, DOI 10.1016/j.jpsychires.2009.08.016; Giugiario M, 2012, SOC PSYCH PSYCH EPID, V47, P553, DOI 10.1007/s00127-011-0367-7; Goder R, 2008, PHARMACOPSYCHIATRY, V41, P92, DOI 10.1055/s-2007-1004592; Goder R, 2004, J PSYCHIATR RES, V38, P591, DOI 10.1016/j.jpsychires.2004.04.005; Goder R, 2011, J SLEEP RES, V20, P544, DOI 10.1111/j.1365-2869.2011.00914.x; Goldman M, 1996, SCHIZOPHR RES, V21, P65, DOI 10.1016/0920-9964(96)00021-7; Gonzalez-Ortega I, 2013, PSYCHIAT RES, V206, P8, DOI 10.1016/j.psychres.2012.08.025; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 2016, J CLIN PSYCHIAT, V77, P8, DOI 10.4088/JCP.14074su1c.02; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Harvey AG, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1690-9; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Hayes A. F., 2012, PROCESS VERSATILE CO; Helmstaedter C, 1990, Schweiz Arch Neurol Psychiatr (1985), V141, P21; Hofer A, 2007, PHARMACOPSYCHIATRY, V40, P1, DOI 10.1055/s-2007-958520; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krystal AD, 2012, NEUROL CLIN, V30, P1389, DOI 10.1016/j.ncl.2012.08.018; Lee RSC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058176; Leger D, 2018, SLEEP MED REV; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Nordt C, 2007, SOC SCI MED, V65, P1420, DOI 10.1016/j.socscimed.2007.05.024; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Raven F, 2018, SLEEP MED REV, V39, P3, DOI 10.1016/j.smrv.2017.05.002; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sanchez-Torres AM, 2017, SCHIZOPHR RES, V179, P30, DOI 10.1016/j.schres.2016.10.002; Sara SJ, 2017, J NEUROSCI, V37, P457, DOI 10.1523/JNEUROSCI.0297-16.2017; Simonsen C, 2010, J INT NEUROPSYCH SOC, V16, P771, DOI 10.1017/S1355617710000573; STRAUSS JS, 1972, ARCH GEN PSYCHIAT, V27, P739; WHO, 2013, EUR MENT HLTH ACT PL; Woo YS, 2016, CLIN PSYCHOPHARM NEU, V14, P1, DOI 10.9758/cpn.2016.14.1.1	38	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202198	10.1371/journal.pone.0202198	http://dx.doi.org/10.1371/journal.pone.0202198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157190	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400043
J	Landman, C; Grill, JP; Mallet, JM; Marteau, P; Humbert, L; Le Balc'h, E; Maubert, MA; Perez, K; Chaara, W; Brot, L; Beaugerie, L; Sokol, H; Thenet, S; Rainteau, D; Seksik, P; Quevrain, E				Landman, Cecilia; Grill, Jean-Pierre; Mallet, Jean-Maurice; Marteau, Philippe; Humbert, Lydie; Le Balc'h, Eric; Maubert, Marie-Anne; Perez, Kevin; Chaara, Wahiba; Brot, Loic; Beaugerie, Laurent; Sokol, Harry; Thenet, Sophie; Rainteau, Dominique; Seksik, Philippe; Quevrain, Elodie		St Antoine IBD Network	Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RESONANCE MASS-SPECTROMETRY; ACTIVE ULCERATIVE-COLITIS; LINEAR ION-TRAP; FECAL MICROBIOTA; CROHNS-DISEASE; PSEUDOMONAS-AERUGINOSA; FAECALIBACTERIUM-PRAUSNITZII; ELECTROSPRAY-IONIZATION; CONTROLLED-TRIAL	Background and aims N-acyl homoserine lactones (AHLs), which are autoinducer quorum-sensing molecules involved in the bacterial communication network, also interact with eukaryotic cells. Searching for these molecules in the context of inflammatory bowel disease (IBD) is appealing. The aims of our study were to look for AHL molecules in faecal samples from healthy subjects (HS) and IBD patients to correlate AHL profiles with the microbiome and investigate the effect of AHLs of interest on epithelial cells. Methods Using mass spectrometry, we characterised AHL profiles in faecal samples from HS (n = 26) and IBD patients in remission (n = 24) and in flare (n = 25) and correlated the presence of AHLs of interest with gut microbiota composition obtained by real-time qPCR and 16S sequencing. We synthesised AHLs of interest to test the inflammatory response after IL1 beta stimulation and paracellular permeability on Caco-2 cells. Results We observed 14 different AHLs, among which one was prominent. This AHL corresponded to 3-oxo-C12:2 and was found significantly less frequently in IBD patients in flare (16%) and in remission (37.5%) versus HS (65.4%) (p = 0.001). The presence of 3-oxo-C12:2 was associated with significantly higher counts of Firmicutes, especially Faecalbacterium prausnitzii, and lower counts of Escherichia coli. In vitro, 3-oxo-C12:2 exerted an anti-inflammatory effect on Caco-2 cells. Interestingly, although 3-oxo-C12, the well-known AHL from Pseudomonas aeruginosa, increased paracellular permeability, 3-oxo-C12:2 did not. Conclusions We identified AHLs in the human gut microbiota and discovered a new and prominent AHL, 3-oxo-C12:2, which correlates with normobiosis and exerts a protective effect on gut epithelial cells.	[Landman, Cecilia; Grill, Jean-Pierre; Mallet, Jean-Maurice; Marteau, Philippe; Humbert, Lydie; Le Balc'h, Eric; Maubert, Marie-Anne; Perez, Kevin; Brot, Loic; Beaugerie, Laurent; Sokol, Harry; Rainteau, Dominique; Seksik, Philippe; Quevrain, Elodie] Sorbonne Univ, PSL Univ, Ecole Normale Super, CNRS,INSERM,AP HP,Hop St Antoine,Lab Biomol,LBM, Paris, France; [Chaara, Wahiba] Sorbonne Univ, INSERM, i3, Paris, France; [Thenet, Sophie] Sorbonne Univ, PSL Univ, Ctr Rech Cordeliers, Paris, France	Arts et Metiers Institute of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Universite Paris Cite	Seksik, P (corresponding author), Sorbonne Univ, PSL Univ, Ecole Normale Super, CNRS,INSERM,AP HP,Hop St Antoine,Lab Biomol,LBM, Paris, France.	philippe.seksik@aphp.fr	Thenet, Sophie/GQY-5726-2022; SEKSIK, Philippe/ABE-2962-2020; Mallet, Jean-Maurice/H-2113-2011; Perez, Kevin/AAM-3763-2021; Sokol, Harry/E-2290-2019; sokol, harry/ABA-8991-2020	Thenet, Sophie/0000-0002-0336-2942; Mallet, Jean-Maurice/0000-0001-8570-9542; Perez, Kevin/0000-0002-1802-185X; Sokol, Harry/0000-0002-2914-1822; sokol, harry/0000-0002-2914-1822; philippe, marteau/0000-0002-7621-6719	Biocodex; ECCO (European Crohn's and Colitis Organization); Association Francois Aupetit; Fondation pour la recherche medicale; SNFGE (Societe nationale francaise de gastroenterologie)	Biocodex; ECCO (European Crohn's and Colitis Organization); Association Francois Aupetit; Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); SNFGE (Societe nationale francaise de gastroenterologie)	This study was supported by grants from Biocodex https://www.snfge.org/content/bourse-biocodex (CL), ECCO (European Crohn's and Colitis Organization) https://www.ecco-ibd.eu/science/fellowships-and-grants.html (PS), the Association Francois Aupetit https://www.afa.asso.fr/categorie/la-recherche/bourses-de-recherche.html (CL), Fondation pour la recherche medicale https://www.frm.org/chercheurs/les-appels-doffre/programme-espoirs-de-la-recherche (ELB, CL) and SNFGE (Societe nationale francaise de gastroenterologie) https://www.snfge.org/content/fare-nouvelles-modalites-pour-lappel-projet (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand X, 2001, INTENS CARE MED, V27, P1263, DOI 10.1007/s001340100979; Boehm D, 2009, INFLAMM BOWEL DIS, V15, P93, DOI 10.1002/ibd.20582; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Cataldi TRI, 2008, J MASS SPECTROM, V43, P82, DOI 10.1002/jms.1275; Cataldi TRI, 2011, RAPID COMMUN MASS SP, V25, P1817, DOI 10.1002/rcm.5054; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Chakrabarti S, 2003, PROTEIN ENG, V16, P271, DOI 10.1093/proeng/gzg031; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Derwa Y, 2017, ALIMENT PHARM THER, V46, P389, DOI 10.1111/apt.14203; Doberva M, 2015, AQUAT MICROB ECOL, V74, P107, DOI 10.3354/ame01734; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Eum SY, 2014, AM J PHYSIOL-GASTR L, V306, pG992, DOI 10.1152/ajpgi.00016.2014; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Glucksam-Galnoy Y, 2013, J IMMUNOL, V191, P337, DOI 10.4049/jimmunol.1300368; Hawver LA, 2016, FEMS MICROBIOL REV, V40, P738, DOI 10.1093/femsre/fuw014; Holm A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00309; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karban A, 2007, DIGEST DIS SCI, V52, P2707, DOI 10.1007/s10620-006-9700-5; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mitchell RJ, 2011, BMB REP, V44, P1, DOI 10.5483/BMBRep.2011.44.1.1; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; MOSS CW, 1989, J CLIN MICROBIOL, V27, P1467, DOI 10.1128/JCM.27.7.1467-1470.1989; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235; Pigneur B, 2016, MUCOSAL IMMUNOL, V9, P1360, DOI 10.1038/mi.2016.67; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Quigley EMM, 2016, CURR OPIN GASTROEN, V32, P74, DOI 10.1097/MOG.0000000000000243; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Soares JA, 2011, CURR OPIN MICROBIOL, V14, P188, DOI 10.1016/j.mib.2011.01.006; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Sokol H, 2014, DIGEST DIS, V32, P10, DOI 10.1159/000367820; Swearingen MC, 2013, J BACTERIOL, V195, P173, DOI 10.1128/JB.01341-12; Teplitski M, 2011, CHEM REV, V111, P100, DOI 10.1021/cr100045m; Teshima CW, 2017, CLIN GASTROENTEROL H, V15, P1413, DOI 10.1016/j.cgh.2017.02.028; Varela E, 2013, ALIMENT PHARM THER, V38, P151, DOI 10.1111/apt.12365; Vikstrom E, 2009, EXP CELL RES, V315, P313, DOI 10.1016/j.yexcr.2008.10.044	46	24	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202587	10.1371/journal.pone.0202587	http://dx.doi.org/10.1371/journal.pone.0202587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157234	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400063
J	Fu, LY; Wang, XX; Wu, X; Li, B; Huang, LL; Li, BB; Du, QF; Wang, PX				Fu, Li-Ying; Wang, Xiao-Xiao; Wu, Xiao; Li, Bo; Huang, Ling-Ling; Li, Bing-Bing; Du, Qing-Feng; Wang, Pei-Xi			Association between obesity and sickness in the past two weeks among middle-aged and elderly women: A cross-sectional study in Southern China	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CHRONIC DISEASES; OVERWEIGHT; MORTALITY; DEPRESSION; PREVALENCE; WEIGHT; COHORT	Objectives Sickness situation in the past two weeks, an indicator of health service needs, is an increasing major health concern. However, data on the relationship between obesity and two-week morbidity in the female population, particularly in middle-aged and elderly women, is sparse. The present study aimed to examine the association between obesity and two-week morbidity among middle-aged and elderly women in Southern China, and to explore the independent contributions of socio-demographic variables, health-related factors, and obesity to two-week morbidity. Methods In total, 2364 middle-aged and elderly women were included in this cross-sectional, community-based survey. Obesity was assessed using body mass index (BMI). The outcome variable was sickness situation over the past two weeks (two-week morbidity). Clustered logistic regression was applied to analyze the independent contribution of obesity to two-week morbidity. Results Approximately 14.6% of participants experienced sickness in the past two weeks. Obesity (odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.02-2.12) was significantly associated with two-week morbidity and its independent contribution accounted for 3.7%, lower than that of socio-demographic variables (73.7%) and health-related factors(22.6%). Conclusions Some degree of correlation was observed between obesity and two-week morbidity among middle-aged and elderly women in Southern China, which can be used as a reference for health-related decision-making.	[Fu, Li-Ying; Wang, Xiao-Xiao; Wu, Xiao; Li, Bo; Huang, Ling-Ling; Li, Bing-Bing; Wang, Pei-Xi] Henan Univ, Sch Nursing & Hlth, Inst Chron Dis Risks Assessment, Kaifeng, Henan, Peoples R China; [Fu, Li-Ying; Du, Qing-Feng; Wang, Pei-Xi] Southern Med Univ, Nanhai Hosp, Gen Practice Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Xiao-Xiao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Nursing Dept, Wuhan, Hubei, Peoples R China; [Wang, Pei-Xi] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China	Henan University; Southern Medical University - China; Huazhong University of Science & Technology; Guangzhou Medical University	Wang, PX (corresponding author), Henan Univ, Sch Nursing & Hlth, Inst Chron Dis Risks Assessment, Kaifeng, Henan, Peoples R China.; Du, QF; Wang, PX (corresponding author), Southern Med Univ, Nanhai Hosp, Gen Practice Ctr, Guangzhou, Guangdong, Peoples R China.; Wang, PX (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China.	nhyyqk@126.com; 18317856338@163.com			Science and Technology Program of Guangzhou [201607010136]; Guangzhou 121 Talents program	Science and Technology Program of Guangzhou; Guangzhou 121 Talents program	This work was supported by the Science and Technology Program of Guangzhou [201607010136] and the Guangzhou 121 Talents program to PXW.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Barcelos-Ferreira R, 2013, J AFFECT DISORDERS, V150, P616, DOI 10.1016/j.jad.2013.02.024; Center for Health Statistics and Information the Ministry of Health of China, 2009, REP NAT HLTH SERV SU; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen J, 2016, CHINESE MED CLIN, V16, P1573; Chen L., 2016, THESIS; Cohen YC, 1999, J CLIN EPIDEMIOL, V52, P1031, DOI 10.1016/S0895-4356(99)00079-7; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Ferrie JE, 2007, OBESITY, V15, P1554, DOI 10.1038/oby.2007.184; Gazmararian JA, 2015, J OBES, V2015, DOI 10.1155/2015/298698; Gong YL, 2002, HLTH SERVICE REASEAR; Hajek A, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0081-5; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; Huang X, 2015, INT J ENV RES PUB HE, V12, P13209, DOI 10.3390/ijerph121013209; Jing MJ, 2015, J PSYCHOSOM RES, V79, P288, DOI 10.1016/j.jpsychores.2015.05.009; Khongsdier R, 2005, BRIT J NUTR, V93, P101, DOI 10.1079/BJN20041316; Korpela K, 2013, SCAND J PUBLIC HEALT, V41, P25, DOI 10.1177/1403494812468965; Lin YY, 2017, J PUBLIC HLTH PREVEN, V28, P133; Liu L., 2018, HLTH EC RES, P39, DOI [10.14055/j.cnki.33-1056/f.20180109.010, DOI 10.14055/J.CNKI.33-1056/F.20180109.010]; Mao Y, 2013, CHINESE MED J-PEKING, V126, P2510, DOI 10.3760/cma.j.issn.0366-6999.20123001; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Qin XZ, 2016, HEALTH ECON, V25, P1291, DOI 10.1002/hec.3217; Roos E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4997-x; Roos E, 2015, EUR J PUBLIC HEALTH, V25, P263, DOI 10.1093/eurpub/cku087; Rossi AP, 2017, J GERONTOL A-BIOL, V72, P1098, DOI 10.1093/gerona/glw203; Salguero A, 2011, ARCH GERONTOL GERIAT, V53, P152, DOI 10.1016/j.archger.2010.10.005; Song T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2238-8; Tian DP, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0330-z; Wardell S, 2015, CAN RESPIR J, V22, P23, DOI 10.1155/2015/938930; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; World Health Organization, GLOBAL STATUS REPORT; Xu LT, 2016, CHINESE COMMUNITY PH, V32, P184; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3; Zhu Yan-Bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P687; 何利平, 2017, [中国卫生统计, Chinese Journal of Health Statistics], V34, P104; 高忠飞, 2016, [中国卫生统计, Chinese Journal of Health Statistics], V33, P800	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203034	10.1371/journal.pone.0203034	http://dx.doi.org/10.1371/journal.pone.0203034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153292	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700038
J	Gao, X; Yang, X; Noll, L; Shi, XR; Worley, J; Allard, M; Brown, E; Nagaraja, TG; Meng, JH				Gao, Xin; Yang, Xun; Noll, Lance; Shi, Xiaorong; Worley, Jay; Allard, Marc; Brown, Eric; Nagaraja, T. G.; Meng, Jianghong			Whole genome shotgun sequencing revealed highly polymorphic genome regions and genes in Escherichia coli O157:H7 isolates collected from a single feedlot	PLOS ONE			English	Article							UNITED-STATES; OUTBREAK DATA; O157-H7; VIRULENCE; CATTLE; INFECTION; MICROBIOLOGY; EPIDEMIOLOGY; SURVEILLANCE; PREVALENCE	Escherichia coli serotype O157:H7 continues to pose a serious health threat to human beings. Cattle, a major reservoir of the pathogen, harbor E. coli O157:H7 in their gastrointestinal tract and shed variable concentrations of E. coli O157:H7 into the environment. Genetic characterization of cattle-shed E. coli O157 strains is of interest to the livestock industry, food business, and public health community. The present study applied whole genome shotgun sequencing (WGS) and single nucleotide variant (SNV) calling to characterize 279 cattle-shed E. coli O157:H7 strains isolated from a single feedlot located in southwestern region of the US. More than 4,000 SNVs were identified among the strains and the resultant phylogenomic tree revealed three major groups. Using the Sakai strain genome as reference, more than 2,000 SNVs were annotated and a detailed SNV map generated. Results clearly revealed highly polymorphic loci along the E. coli O157:H7 genome that aligned with the prophage regions and highly variant genes involved in processing bacterial genetic information. The WGS data were further profiled against a comprehensive virulence factor database (VFDB) for virulence gene identification. Among the total 285 virulence genes identified, only 132 were present in all the strains. There were six virulence genes unique to single isolates. Our findings suggested that the genome variations of the E. coli O157:H7 were mainly attributable to dynamics of certain phages, and the bacterial strains have variable virulence gene profiles, even though they came from a single cattle population, which may explain the differences in pathogenicity, host prevalence, and transmissibility by E. coli O157:H7.	[Gao, Xin; Yang, Xun; Worley, Jay; Meng, Jianghong] Univ Maryland, Ctr Food Safety & Secur Syst, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Noll, Lance; Shi, Xiaorong; Nagaraja, T. G.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Allard, Marc; Brown, Eric] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); Kansas State University; US Food & Drug Administration (FDA)	Meng, JH (corresponding author), Univ Maryland, Ctr Food Safety & Secur Syst, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA.	jmeng@umd.edu		Worley, Jay/0000-0002-5923-1159	National Institute of Food and Agriculture, U. S. Department of Agriculture [2012-68003-30155]; Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland	National Institute of Food and Agriculture, U. S. Department of Agriculture(United States Department of Agriculture (USDA)); Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland	This material is based upon work that is supported by the National Institute of Food and Agriculture (https://nifa.usda.gov/), U. S. Department of Agriculture, under award number 2012-68003-30155 and in part by the Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland (http://jifsan.umd.edu/).	Ambroise J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-413; Amigo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127710; Avery LM, 2005, J APPL MICROBIOL, V98, P814, DOI 10.1111/j.1365-2672.2004.02524.x; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Bankevich A, 2012, JCOMPUTBIOL, V19; Beutin L, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; Callaway TR, 2006, FOODBORNE PATHOG DIS, V3, P234, DOI 10.1089/fpd.2006.3.234; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chui HX, 2015, J CLIN MICROBIOL, V53, P2480, DOI 10.1128/JCM.00593-15; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Dallman TJ, 2015, CLIN INFECT DIS, V61, P305, DOI 10.1093/cid/civ318; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Eppinger M, 2011, APPL ENVIRON MICROB, V77, P2916, DOI 10.1128/AEM.02554-10; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hirvonen JJ, 2012, J CLIN MICROBIOL, V50, P3586, DOI 10.1128/JCM.01754-12; Holmes A, 2015, J CLIN MICROBIOL, V53, P3565, DOI 10.1128/JCM.01066-15; Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Laing C, 2008, APPL ENVIRON MICROB, V74, P6606, DOI 10.1128/AEM.00985-08; LeJeune JT, 2001, APPL ENVIRON MICROB, V67, P3053, DOI 10.1128/AEM.67.7.3053-3057.2001; Leung KT, 2004, FEMS MICROBIOL ECOL, V47, P111, DOI 10.1016/S0168-6496(03)00254-X; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Manges AR, 2015, FOODBORNE PATHOG DIS, V12, P302, DOI 10.1089/fpd.2014.1860; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Mayo B, 2014, CURR GENOMICS, V15, P293, DOI 10.2174/1389202915666140616233211; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Reinstein S, 2007, J FOOD PROTECT, V70, P2555, DOI 10.4315/0362-028X-70.11.2555; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Ronholm J, 2016, CLIN MICROBIOL REV, V29, P837, DOI 10.1128/CMR.00056-16; Rusconi B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00985; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Trees E, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00718-14; Vernozy-Rozand C, 2004, APPL ENVIRON MICROB, V70, P2556, DOI 10.1128/AEM.70.4.2556-2559.2004; WELLS JG, 1983, J CLIN MICROBIOL, V18, P512, DOI 10.1128/JCM.18.3.512-520.1983; Worley JN, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00734-17; Yang SC, 2017, ARCH MICROBIOL, V199, P811, DOI 10.1007/s00203-017-1393-y; Zhang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33235; Zhou MX, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-32; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	54	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202775	10.1371/journal.pone.0202775	http://dx.doi.org/10.1371/journal.pone.0202775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153286	Green Published, gold, Green Submitted			2022-12-26	WOS:000443001700025
J	Kumari, S; Kumar, M; Khandelwal, NK; Kumari, P; Varma, M; Vishwakarma, P; Shahi, G; Sharma, S; Lynn, AM; Prasad, R; Gaur, NA				Kumari, Sonam; Kumar, Mohit; Khandelwal, Nitesh Kumar; Kumari, Priya; Varma, Mahendra; Vishwakarma, Poonam; Shahi, Garima; Sharma, Suman; Lynn, Andrew M.; Prasad, Rajendra; Gaur, Naseem A.			ABC transportome inventory of human pathogenic yeast Candida glabrata: Phylogenetic and expression analysis	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG-RESISTANCE; AZOLE RESISTANCE; SACCHAROMYCES-CEREVISIAE; FLUCONAZOLE RESISTANCE; CASSETTE PROTEIN; GENE FAMILY; EVOLUTION; ALBICANS; COMPLEX	ATP-binding cassette (ABC) is one of the two major superfamilies of transporters present across the evolutionary scale. ABC superfamily members came to prominence due to their ability to extrude broad spectrum of substrates and to confer multi drug resistance (MDR). Overexpression of some ABC transporters in clinical isolates of Candida species was attributed to the development of MDR phenotypes. Among Candida species, Candida glabrata is an emerging drug resistant species in human fungal infections. A comprehensive analysis of such proteins in C. glabrata is required to untangle their role not only in MDR but also in other biological processes. Bioinformatic analysis of proteins encoded by genome of human pathogenic yeast C. glabrata identified 25 putative ABC protein coding genes. On the basis of phylogenetic analysis, domain organization and nomenclature adopted by the Human Genome Organization (HUGO) scheme, these proteins were categorized into six subfamilies such as Pleiotropic Drug Resistance (PDR)/ABCG, Multi Drug Resistance (MDR)/ABCB, Multi Drug Resistance associated Protein (MRP)/ABCC, Adrenoleukodystrophy protein (ALDp)/ABCD, RNase L Inhibitor (RLI)/ABCE and Elongation Factor 3 (EF3)/ABCF. Among these, only 18 ABC proteins contained transmembrane domains (TMDs) and were grouped as membrane proteins, predominantly belonging to PDR, MDR, MRP, and ALDp subfamilies. A comparative phylogenetic analysis of these ABC proteins with other yeast species revealed their orthologous relationship and pointed towards their conserved functions. Quantitative real time PCR (qRT-PCR) analysis of putative membrane localized ABC protein encoding genes of C. glabrata confirmed their basal expression and showed variable transcriptional response towards antimycotic drugs. This study presents first comprehensive overview of ABC superfamily proteins of a human fungal pathogen C. glabrata, which is expected to provide an important platform for in depth analysis of their physiological relevance in cellular processes and drug resistance.	[Kumari, Sonam; Kumar, Mohit; Khandelwal, Nitesh Kumar; Kumari, Priya; Varma, Mahendra; Gaur, Naseem A.] Int Ctr Genet Engn & Biotechnol, Yeast Biofuel Grp, New Delhi, India; [Kumar, Mohit; Shahi, Garima; Sharma, Suman; Prasad, Rajendra] Amity Univ Gurgaon, Amity Inst Integrat Sci & Hlth, Gurgaon, Haryana, India; [Vishwakarma, Poonam; Lynn, Andrew M.] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi	Gaur, NA (corresponding author), Int Ctr Genet Engn & Biotechnol, Yeast Biofuel Grp, New Delhi, India.; Prasad, R (corresponding author), Amity Univ Gurgaon, Amity Inst Integrat Sci & Hlth, Gurgaon, Haryana, India.	rprasad@amity.ggn.amity.edu; naseem@icgeb.res.in	Khandelwal, Nitesh Kumar/AAX-6273-2021	Khandelwal, Nitesh Kumar/0000-0002-6319-8048; Varma, Mahendra/0000-0003-0271-4958; Gaur, Naseem/0000-0002-1224-8789; Sharma, Suman/0000-0003-3398-3245	Department of Biotechnology DBT [BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, BT/PR14117/BRB/10/1420/2015]; DST [SR/S2/RJN-07/2012]; DBT [BT/PR10684/PBD/26/403/2013, BT/PB/Centre/03/2011]	Department of Biotechnology DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India)	The work has been supported in parts by grants to R.P. from the Department of Biotechnology DBT [No. BT/01/CEIB/10/III/02], DBT [No. BT/PR7392/MED/29/652/2012] and DBT [No. BT/PR14117/BRB/10/1420/2015] and in parts by grants to N.A.G. by DST Ramanujan Fellowship grant [SR/S2/RJN-07/2012], DBT grants [No. BT/PR10684/PBD/26/403/2013] and DBT [No. BT/PB/Centre/03/2011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Ben-Ami R, 2016, MBIO, V7, DOI 10.1128/mBio.00655-16; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Brun S, 2004, SOCIETY, P1788, DOI [10.1128/AAC.48.5.1788, DOI 10.1128/AAC.48.5.1788]; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Dean M, 2001, J LIPID RES, V42, P1007; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jeong CB, 2017, AQUAT TOXICOL, V183, P144, DOI 10.1016/j.aquatox.2016.12.022; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Khandelwal NK, 2018, J BIOL CHEM, V293, P412, DOI [10.1074/jbc.M117.807032, 10.1074/jbc.m117.807032]; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Khunweeraphong N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11794-w; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Liu HY, 2001, J BIOL CHEM, V276, P7541, DOI 10.1074/jbc.M009112200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miyazaki H, 1998, ANTIMICROB AGENTS CH, V42, P1695, DOI 10.1128/AAC.42.7.1695; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Nagi M, 2013, J INFECT CHEMOTHER, V19, P138, DOI 10.1007/s10156-012-0531-3; Nakayama H, 1998, MICROBIOL-UK, V144, P2407, DOI 10.1099/00221287-144-9-2407; Nakayama H, 2007, J ANTIMICROB CHEMOTH, V60, P1264, DOI 10.1093/jac/dkm321; Oxman DA, 2010, J ANTIMICROB CHEMOTH, V65, P1460, DOI 10.1093/jac/dkq136; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Prasad R, 2016, FUNGAL GENET BIOL, V93, P25, DOI 10.1016/j.fgb.2016.05.008; Prasad R, 2015, EUKARYOT CELL, V14, P1154, DOI 10.1128/EC.00137-15; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Rai V, 2006, BIOCHEMISTRY-US, V45, P14726, DOI 10.1021/bi061535t; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Samaranayake YH, 2013, J MED MICROBIOL, V62, P303, DOI 10.1099/jmm.0.044123-0; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Schmidt P, 2008, PROTEOMICS, V8, P534, DOI 10.1002/pmic.200700845; Schwarzmuller T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004211; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; Slomka M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0271-3; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Tian LX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3706-6; Torelli R, 2008, MOL MICROBIOL, V68, P186, DOI 10.1111/j.1365-2958.2008.06143.x; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Vale-Silva L, 2013, INFECT IMMUN, V81, P1709, DOI 10.1128/IAI.00074-13; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Vernon RM, 2017, J BIOL CHEM, V292, P14147, DOI 10.1074/jbc.M116.772335; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Whaley SG, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02173; Whaley SG, 2016, CURRENT INFECT DIS R, V18, P19, DOI [10.1007/s11908-016-0525-x, DOI 10.1007/S11908-016-0525-X]; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Xiong J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16724	72	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202993	10.1371/journal.pone.0202993	http://dx.doi.org/10.1371/journal.pone.0202993			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153284	Green Submitted, Green Published, gold			2022-12-26	WOS:000443001700036
J	Konno, S; Banno, T; Takagi, H; Honda, S; Toyota, T				Konno, Shota; Banno, Taisuke; Takagi, Hideaki; Honda, Satoshi; Toyota, Taro			Irreversible aggregation of alternating tetra- block-like amphiphile in water	PLOS ONE			English	Article							STATE NMR-SPECTROSCOPY; MAGIC-ANGLE; X-RAY; MODEL; PROTEINS; BACTERIORHODOPSIN; KINETICS; BEHAVIOR; SYSTEM	As a frontier topic of soft condensed matter physics, irreversible aggregation has drawn attention for a better understanding of the complex behavior of biomaterials. In this study, we have described the synthesis of an artificial amphiphilic molecule, an alternating tetrablock-like amphiphile, which was able to diversify its aggregate structure in water. The aggregated state of its aqueous dispersion was obtained by slow evaporation of the organic solvent at room temperature, and it collapsed irreversibly at - 50 degrees C. By using a cryo-transmission electron microscope and a differential scanning calorimeter, it was revealed that two types of molecular nanostructures were formed and developed into submicro- and micrometer-sized fibrils in the aggregated material.	[Konno, Shota; Honda, Satoshi; Toyota, Taro] Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Banno, Taisuke] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa, Japan; [Takagi, Hideaki] High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki, Japan	University of Tokyo; Keio University; High Energy Accelerator Research Organization (KEK)	Toyota, T (corresponding author), Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	cttoyota@mail.ecc.u-tokyo.ac.jp	Honda, Satoshi/E-9072-2016; Banno, Taisuke/AAB-3702-2019	Honda, Satoshi/0000-0001-5289-5078; Takagi, Hideaki/0000-0003-3389-7945	KAKENHI of Japan Society for the Promotion of Science [16K14074, 16H04032]; Izumi Science and Technology Foundation	KAKENHI of Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Izumi Science and Technology Foundation(Izumi Science and Technology Foundation)	This work was partially supported by KAKENHI of Japan Society for the Promotion of Science (Grant Numbers 16K14074 S.H. and 16H04032 T.T.) [see https://www.jsps.go.jp/]and the Izumi Science and Technology Foundation (S.H.) [see http://www.izumi-zaidan.jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work benefited from fruitful discussions with Prof. Hideki Seto (High Energy Accelerator Research Organization, KEK, Japan), Dr. Taku Ogura (Lion Corp., Japan) and Prof. Atsushi Ikeda (The University of Tokyo, Japan). Synchrotron radiation-SAXS measurements were performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2016PF-02 H.T.). Cryo-TEM measurements were conducted under the approval of the Advanced Characterization Nanotechnology Platform of the University of Tokyo, supported by the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Proposal No. A-16-UT-0225 S.H.). The authors acknowledge Ms. Misuzu Konishi and Mr. Hiroshi Ohki (Mettler-Toledo Japan) for support with DSC measurements and Dr. Shunji Yunoki and Mr. Hirosuke Hatayama (Tokyo Metropolitan Industrial Technology Research Institute) for support with DMA. This work was partially supported by KAKENHI of Japan Society for the Promotion of Science (Grant Numbers 16K14074 S.H. and 16H04032 T.T.) and the Izumi Science and Technology Foundation (S.H.).	Bedard AC, 2013, ACS CATAL, V3, P773, DOI 10.1021/cs400050g; Berthelot J.-M, 2012, COMPOSITE MAT MECH B; Bourriot S, 1999, FOOD HYDROCOLLOID, V13, P43, DOI 10.1016/S0268-005X(98)00068-X; Corezzi S, 2010, J PHYS CHEM B, V114, P3769, DOI 10.1021/jp911165b; Craievich A.F., 2002, Mat. Res., V5, P1, DOI 10.1590/S1516-14392002000100002; Fameau AL, 2011, ANGEW CHEM INT EDIT, V50, P8264, DOI 10.1002/anie.201102115; Gennes P. G. D., 1990, INTRO POLYM DYNAMICS; GREST GS, 1985, PHYS REV B, V32, P3014, DOI 10.1103/PhysRevB.32.3014; He JT, 2017, CARBOHYD POLYM, V164, P364, DOI 10.1016/j.carbpol.2017.01.080; Helvig S, 2015, AIMS BIOPHYS, V2, P116, DOI 10.3934/biophy.2015.2.116; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; HIGUCHI WI, 1963, J PHARM SCI, V52, P49, DOI 10.1002/jps.2600520110; Hu ZB, 2010, SOFT MATTER, V6, P2115, DOI 10.1039/b921150k; Igarashi N, 2011, J PHYS CONF SER, V272, DOI 10.1088/1742-6596/272/1/012026; Ikkala O, 2004, CHEM COMMUN, P2131, DOI 10.1039/b403983a; Knyazev A, 2011, CHEM-EUR J, V17, P14663, DOI 10.1002/chem.201101182; Lee CY, 2005, LANGMUIR, V21, P5134, DOI 10.1021/la0472302; Lee MJ, 2015, PROC SPIE, V9565, DOI 10.1117/12.2187818; Liu JQ, 2012, J MATER CHEM, V22, P12435, DOI 10.1039/c2jm31218b; Mezzenga R, 2005, NAT MATER, V4, P729, DOI 10.1038/nmat1496; Mushi NE, 2016, CHEMSUSCHEM, V9, P989, DOI 10.1002/cssc.201501697; Pavisic R, 2010, EUR J PHARM BIOPHARM, V76, P357, DOI 10.1016/j.ejpb.2010.09.006; Pham KN, 2002, SCIENCE, V296, P104, DOI 10.1126/science.1068238; Prasad V, 2003, FARADAY DISCUSS, V123, P1, DOI 10.1039/b211107c; Ravula T, 2017, ANGEW CHEM INT EDIT, V56, P11466, DOI 10.1002/anie.201705569; Rest C, 2015, CHEM SOC REV, V44, P2543, DOI 10.1039/c4cs00497c; Royall CP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.258302; SAEKI S, 1976, POLYMER, V17, P685, DOI 10.1016/0032-3861(76)90208-1; Saito H, 2007, BBA-BIOMEMBRANES, V1768, P3145, DOI 10.1016/j.bbamem.2007.08.026; SCHAEFER J, 1976, J AM CHEM SOC, V98, P1031, DOI 10.1021/ja00420a036; Shih WY, 1999, J AM CERAM SOC, V82, P616, DOI 10.1111/j.1151-2916.1999.tb01809.x; Shimizu N, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952937; Trappe V, 2004, CURR OPIN COLLOID IN, V8, P494, DOI 10.1016/j.cocis.2004.01.002; Wang AD, 2014, SOFT MATTER, V10, P3362, DOI 10.1039/c3sm53214c; Winter R, 2002, BBA-PROTEIN STRUCT M, V1595, P160, DOI 10.1016/S0167-4838(01)00342-9; WU CH, 1994, J MAGN RESON SER A, V109, P270, DOI 10.1006/jmra.1994.1169; Xuan Y, 2004, MACROMOLECULES, V37, P7301, DOI 10.1021/ma0497761; Zaccarelli E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/323101; Zhang H, 2016, RSC ADV, V6, P9186, DOI 10.1039/c5ra25437j; Zhang RC, 2017, ACCOUNTS CHEM RES, V50, P1105, DOI 10.1021/acs.accounts.7b00082; Zhou YL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02579-w	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202816	10.1371/journal.pone.0202816	http://dx.doi.org/10.1371/journal.pone.0202816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148887	Green Published, Green Submitted, gold			2022-12-26	WOS:000442804200025
J	Chong, WT; Tang, CP; Cheah, YK; Lajis, AFB; Dian, NLHM; Kanagaratnam, S; Lai, OM				Chong, Wai-Ting; Tang, Chin-Ping; Cheah, Yoke-Kqueen; Lajis, Ahmad Firdaus B.; Dian, Noor Lida Habi Mat; Kanagaratnam, Sivaruby; Lai, Oi-Ming			Optimization of process parameters in preparation of tocotrienol-rich red palm oil-based nanoemulsion stabilized by Tween80-Span 80 using response surface methodology	PLOS ONE			English	Article							HIGH-PRESSURE HOMOGENIZATION; FOOD-GRADE MICROEMULSIONS; NANO-EMULSION FORMATION; IN-WATER NANOEMULSIONS; ALPHA-TOCOPHEROL; PHASE-BEHAVIOR; SPONTANEOUS EMULSIFICATION; ULTRASONIC EMULSIFICATION; PROPYLENE-GLYCOL; REQUIRED HLB	Red palm oil (RPO) is a natural source of Vitamin E (70-80% tocotrienol). It is a potent natural antioxidant that can be used in skin-care products. Its antioxidant property protects skin from inflammation and aging. In our work, a tocotrienol-rich RPO-based nanoemulsion formulation was optimized using response surface methodology (RSM) and formulated using high pressure homogenizer. Effect of the concentration of three independent variables [surfactant (5-15 wt%), co-solvent (10-30 wt%) and homogenization pressure (500-700 bar)] toward two response variables (droplet size, polydispersity index) was studied using central composite design (CCD) coupled to RSM. RSM analysis showed that the experimental data could be fitted into a second-order polynomial model and the coefficients of multiple determination (R-2) is 0.9115. The optimized formulation of RPO-based nanoemulsion consisted of 6.09 wt% mixed surfactant [Tween 80/Span 80 (63: 37, wt)], 20 wt% glycerol as a co-solvent via homogenization pressure (500 bar). The optimized tocotrienol-rich RPO-based nanoemulsion response values for droplet size and polydispersity index were 119.49nm and 0.286, respectively. The actual values of the formulated nanoemulsion were in good agreement with the predicted values obtained from RSM, thus the optimized compositions have the potential to be used as a nanoemulsion for cosmetic formulations.	[Chong, Wai-Ting; Lajis, Ahmad Firdaus B.; Lai, Oi-Ming] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Tang, Chin-Ping] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Technol, Serdang, Selangor, Malaysia; [Cheah, Yoke-Kqueen] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Dian, Noor Lida Habi Mat; Kanagaratnam, Sivaruby] Malaysian Palm Oil Board, Prot & Food Technol Unit, Kajang, Selangor, Malaysia; [Lai, Oi-Ming] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Malaysian Palm Oil Board; Universiti Putra Malaysia	Lai, OM (corresponding author), Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia.; Lai, OM (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Serdang, Selangor, Malaysia.	omlai@upm.edu.my	Tan, Chin-Ping/A-8130-2008; Lajis, Ahmad Firdaus B./T-7088-2018; Lajis, Ahmad Firdaus B./AAD-3717-2020	Tan, Chin-Ping/0000-0003-4177-4072; Lajis, Ahmad Firdaus B./0000-0003-2766-8986; Lajis, Ahmad Firdaus B./0000-0003-2766-8986	Universiti Putra Malaysia, Malaysia (Putra Grant-Putra Graduate Initiative) [9622900]	Universiti Putra Malaysia, Malaysia (Putra Grant-Putra Graduate Initiative)	This project was financially supported by Universiti Putra Malaysia, Malaysia (Putra Grant-Putra Graduate Initiative, Grant No.: 9622900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta E, 2009, CURR OPIN COLLOID IN, V14, P3, DOI 10.1016/j.cocis.2008.01.002; Ali A, 2016, INT J PHARMACEUT, V500, P291, DOI 10.1016/j.ijpharm.2016.01.035; Anarjan N, 2010, FOOD CHEM, V123, P477, DOI 10.1016/j.foodchem.2010.05.036; Aramaki K, 1999, LANGMUIR, V15, P6226, DOI 10.1021/la9900573; Ayeleso A. O., 2012, African Journal of Biotechnology, V11, P8275; Benichou A, 2001, J DISPER SCI TECHNOL, V22, P269, DOI 10.1081/DIS-100105214; Bergstrom M, 2000, LANGMUIR, V16, P7173, DOI 10.1021/la000397k; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bouchemal K, 2004, INT J PHARM, V280, P241, DOI 10.1016/j.ijpharm.2004.05.016; Cavalli R, 1996, J DISPER SCI TECHNOL, V17, P717, DOI 10.1080/01932699608943535; Chaturvedi PA, 2000, PLANT FOOD HUM NUTR, V55, P147, DOI 10.1023/A:1008197931085; Che HL, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/357609; Cheong JN, 2008, J FOOD ENG, V89, P204, DOI 10.1016/j.jfoodeng.2008.04.018; Choo YM, 1993, PORIM INF SER, V11; Choo YM, 1995, PALM OIL DEV, V22, P1; Chu BS, 2007, J AM OIL CHEM SOC, V84, P1053, DOI 10.1007/s11746-007-1132-7; Edem DO, 2009, EUR J SCI RES, P32; Eqbal Dauqan, 2011, American Journal of Applied Sciences, V8, P407; Fan YR, 2010, COLLOID SURFACE A, V366, P120, DOI 10.1016/j.colsurfa.2010.05.034; Fanun M, 2007, J DISPER SCI TECHNOL, V28, P1244, DOI 10.1080/01932690701528159; Floury J, 2003, J FOOD ENG, V58, P227, DOI 10.1016/S0260-8774(02)00372-2; Floury J., 2000, Innovative Food Science & Emerging Technologies, V1, P127, DOI 10.1016/S1466-8564(00)00012-6; Fu ZS, 2010, FUEL, V89, P2838, DOI 10.1016/j.fuel.2010.05.031; Garti N, 2001, J AGR FOOD CHEM, V49, P2552, DOI 10.1021/jf001390b; Genot C, 2013, WOODHEAD PUBL FOOD S, V252, P150, DOI 10.1533/9780857098863.2.150; GENSLER HL, 1991, NUTR CANCER, V15, P97, DOI 10.1080/01635589109514117; Gharibzahedi SMT, 2013, FOOD BIOPROCESS TECH, V6, P456, DOI 10.1007/s11947-011-0763-8; Gutierrez JM, 2008, CURR OPIN COLLOID IN, V13, P245, DOI 10.1016/j.cocis.2008.01.005; Hatanaka J, 2010, INT J PHARMACEUT, V396, P188, DOI 10.1016/j.ijpharm.2010.06.017; He J, 2016, INT J PSYCHOL, V51, P445, DOI 10.1002/ijop.12263; Hecht LL, 2011, LANGMUIR, V27, P2279, DOI 10.1021/la104480s; Hsieh CW, 2012, J OLEO SCI, V61, P483, DOI 10.5650/jos.61.483; Izquierdo P, 2005, J COLLOID INTERF SCI, V285, P388, DOI 10.1016/j.jcis.2004.10.047; Izquierdo P, 2004, LANGMUIR, V20, P6594, DOI 10.1021/la049566h; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Keck CM, 2006, EUR J PHARM BIOPHARM, V62, P3, DOI 10.1016/j.ejpb.2005.05.009; Kommuru TR, 2001, INT J PHARM, V212, P233, DOI 10.1016/S0378-5173(00)00614-1; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; Lee Junsoo, 2000, Journal of Food Composition and Analysis, V13, P45, DOI 10.1006/jfca.1999.0845; Li PH, 2012, ULTRASON SONOCHEM, V19, P192, DOI 10.1016/j.ultsonch.2011.05.017; Li QH, 2005, FOOD CHEM, V92, P701, DOI 10.1016/j.foodchem.2004.08.042; Lietz G, 2001, AM J CLIN NUTR, V74, P501; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; Maindarkar SN, 2013, CHEM ENG SCI, V89, P102, DOI 10.1016/j.ces.2012.12.001; Mao LK, 2009, FOOD TECHNOL BIOTECH, V47, P336; Mba OI, 2015, FOOD BIOSCI, V10, P26, DOI 10.1016/j.fbio.2015.01.003; McClements D. J., 2015, Food emulsions: principles, practices, and techniques; McClements DJ, 2018, ADV COLLOID INTERFAC, V251, P55, DOI 10.1016/j.cis.2017.12.001; McClements DJ, 2011, CRIT REV FOOD SCI, V51, P285, DOI 10.1080/10408398.2011.559558; McClements DJ, 2011, SOFT MATTER, V7, P2297, DOI 10.1039/c0sm00549e; Meganathan P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111682; Mohan S, 1997, J COLLOID INTERF SCI, V192, P1, DOI 10.1006/jcis.1997.5012; Morales D, 2003, LANGMUIR, V19, P7196, DOI 10.1021/la0300737; Nagendran B., 2000, Food and Nutrition Bulletin, V21, P189; Niemann B, 2010, J COLLOID INTERF SCI, V342, P361, DOI 10.1016/j.jcis.2009.10.066; Oguntibeju OO, 2009, BRIT J BIOMED SCI, V66, P216, DOI 10.1080/09674845.2009.11730279; Orafidiya LO, 2002, INT J PHARMACEUT, V237, P241, DOI 10.1016/S0378-5173(02)00051-0; Peh HY, 2016, PHARMACOL THERAPEUT, V162, P152, DOI 10.1016/j.pharmthera.2015.12.003; Petrovic LB, 2010, J COLLOID INTERF SCI, V342, P333, DOI 10.1016/j.jcis.2009.10.077; Pey CM, 2006, COLLOID SURFACE A, V288, P144, DOI 10.1016/j.colsurfa.2006.02.026; Pinheiro-Santana HMF, 1998, SOC BRAS CIENC E; Poletto FS, 2009, J NANOSCI NANOTECHNO, V9, P4933, DOI 10.1166/jnn.2009.1270; PORRETTA S, 1995, FOOD CHEM, V52, P35, DOI 10.1016/0308-8146(94)P4178-I; Preetz C, 2010, EUR J PHARM SCI, V39, P141, DOI 10.1016/j.ejps.2009.11.009; Qian C, 2011, FOOD HYDROCOLLOID, V25, P1000, DOI 10.1016/j.foodhyd.2010.09.017; Rao J, 2012, FOOD HYDROCOLLOID, V29, P326, DOI 10.1016/j.foodhyd.2012.04.008; Rebolleda S, 2015, FOOD CHEM, V167, P16, DOI 10.1016/j.foodchem.2014.06.097; Saberi AH, 2013, FOOD RES INT, V54, P812, DOI 10.1016/j.foodres.2013.08.028; Scamehorn JF, 1986, ANAL CHEM, V58, p1250A, DOI [10.1021/BK-1986-0311, DOI 10.1021/BK-1986-0311]; Schmidts T, 2010, COLLOID SURFACE A, V372, P48, DOI 10.1016/j.colsurfa.2010.09.025; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Shi AM, 2011, CARBOHYD POLYM, V83, P1604, DOI 10.1016/j.carbpol.2010.10.011; Shibata A, 2010, J AGR FOOD CHEM, V58, P7013, DOI 10.1021/jf100691g; Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004; Sole I, 2006, COLLOID SURFACE A, V288, P138, DOI 10.1016/j.colsurfa.2006.02.013; Sun MH, 2011, DRUG DEV IND PHARM, V37, P986, DOI 10.3109/03639045.2011.553618; SUNDRAM K, 1992, BRIT J NUTR, V68, P677, DOI 10.1079/BJN19920125; Sundram K, 2003, ASIA PAC J CLIN NUTR, V12, P355; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Tan SF, 2016, ULTRASON SONOCHEM, V29, P299, DOI 10.1016/j.ultsonch.2015.09.015; Uskokovic V, 2005, SURF REV LETT, V12, P239, DOI 10.1142/S0218625X05007001; Wang LJ, 2009, J COLLOID INTERF SCI, V330, P443, DOI 10.1016/j.jcis.2008.10.077; Wooster TJ, 2008, LANGMUIR, V24, P12758, DOI 10.1021/la801685v; Yaghmur A, 2002, COLLOID SURFACE A, V209, P71, DOI 10.1016/S0927-7757(02)00168-1; Yamada Y, 2008, J NUTR SCI VITAMINOL, V54, P117, DOI 10.3177/jnsv.54.117; Yuan Y, 2008, FOOD RES INT, V41, P61, DOI 10.1016/j.foodres.2007.09.006	86	32	33	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202771	10.1371/journal.pone.0202771	http://dx.doi.org/10.1371/journal.pone.0202771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142164	Green Published, gold, Green Submitted			2022-12-26	WOS:000442722500030
J	Ferreira, GBS; Scheutz, M; Boyd, SK				Ferreira, Giordano B. S.; Scheutz, Matthias; Boyd, Sunny K.			Mate choice strategies in a spatially-explicit model environment	PLOS ONE			English	Article							FEMALE BARKING TREEFROGS; MALE CALLING BEHAVIOR; GRAY TREE FROGS; HYLA-VERSICOLOR; MATING PREFERENCES; ADVERTISEMENT CALLS; NEOTROPICAL FROG; SEXUAL SELECTION; SPRING PEEPER; LARGE MALES	Decisions about the choice of a mate can greatly impact both individual fitness and selection processes. We developed a novel agent-based model to investigate two common mate choice rules that may be used by female gray treefrogs (Hyla versicolor). In this model environment, female agents using the minimum-threshold strategy found higher quality mates and traveled shorter distances on average, compared with female agents using the best-of-n strategy. Females using the minimum-threshold strategy, however, incur significant lost opportunity costs, depending on the male population quality average. The best-of-n strategy leads to significant female:female competition that limits their ability to find high quality mates. Thus, when the sex ratio is 0.8, best-of-5 and best-of-2 strategies yield mates of nearly identical quality. Although the distance traveled by females in the mating task varied depending on male spatial distribution in the environment, this did not interact with female choice for the best-of-n or minimum-threshold strategies. By incorporating empirical data from the frogs in this temporally- and spatially-explicit model, we thus show the emergence of novel interactions of common decision-making rules with realistic environmental variables.	[Ferreira, Giordano B. S.; Scheutz, Matthias] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Boyd, Sunny K.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	Tufts University; University of Notre Dame	Boyd, SK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	boyd.1@nd.edu	Boyd, Sunny/C-6711-2014	Boyd, Sunny/0000-0002-8982-6524; Scheutz, Matthias/0000-0002-0064-2789	National Science Foundation [0725187, 1257777, 1257815]; Direct For Biological Sciences [1257777] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors gratefully acknowledge the support of the National Science Foundation, https://www.nsf.gov/ (IOS # 0725187 to MS and SKB; #1257777 to SKB; and #1257815 MS and GBSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Backwell PRY, 1996, BEHAV ECOL SOCIOBIOL, V38, P407, DOI 10.1007/s002650050258; Bateson M, 2002, ANIM BEHAV, V63, P587, DOI 10.1006/anbe.2001.1925; Beckage N., 2009, P 2009 COGN SCI C PP, V31, P2365; Beckers OM, 2004, J COMP PHYSIOL A, V190, P869, DOI 10.1007/s00359-004-0542-3; Bee MA, 2007, BEHAV ECOL SOCIOBIOL, V61, P955, DOI 10.1007/s00265-006-0324-8; Bee MA, 2012, CURR OPIN NEUROBIOL, V22, P301, DOI 10.1016/j.conb.2011.12.014; Bertorelle G, 1997, ETHOLOGY, V103, P999; Bertram S, 1996, COPEIA, P729, DOI 10.2307/1447540; Bush SL, 2002, ANIM BEHAV, V63, P7, DOI 10.1006/anbe.2001.1880; Carter N, 2015, ECOL MODEL, V312, P347, DOI 10.1016/j.ecolmodel.2015.06.008; Castellano S, 2012, BEHAV PROCESS, V90, P261, DOI 10.1016/j.beproc.2012.02.010; Castellano S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1109, DOI 10.1007/s00265-009-0756-z; Cheng R, 2014, COMPUT STRUCT BIOTEC, V10, P8, DOI 10.1016/j.csbj.2014.05.002; Collins EJ, 2006, BEHAV ECOL, V17, P799, DOI 10.1093/beheco/arl008; Deb R, 2014, BEHAV ECOL, V25, P967, DOI 10.1093/beheco/aru072; Dechaume-Moncharmont FX, 2016, ANIM BEHAV, V114, P249, DOI 10.1016/j.anbehav.2016.02.019; Dubois F, 2004, BEHAV ECOL SOCIOBIOL, V56, P228, DOI 10.1007/s00265-004-0780-y; Ellis BJ, 1999, TEACH PSYCHOL, V26, P118, DOI 10.1207/s15328023top2602_8; FELLERS GM, 1979, ANIM BEHAV, V27, P107, DOI 10.1016/0003-3472(79)90131-3; FELLERS GM, 1979, COPEIA, P286, DOI 10.2307/1443416; Fiske P, 1998, BEHAV ECOL, V9, P328, DOI 10.1093/beheco/9.4.328; Gerhardt HC, 2008, J EXP BIOL, V211, P2609, DOI 10.1242/jeb.019612; GERHARDT HC, 1988, ANIM BEHAV, V36, P1247, DOI 10.1016/S0003-3472(88)80090-3; Gerhardt HC, 1996, BEHAV ECOL, V7, P7, DOI 10.1093/beheco/7.1.7; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; GERHARDT HC, 1978, J EXP BIOL, V74, P59; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; GODWIN GJ, 1983, HERPETOLOGICA, V39, P141; Grafe TU, 1997, ANIM BEHAV, V53, P1103, DOI 10.1006/anbe.1996.0427; Greenfield MD, 2000, ETHOLOGY, V106, P331, DOI 10.1046/j.1439-0310.2000.00525.x; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hobel G, 2014, BEHAVIOUR, V151, P741, DOI 10.1163/1568539X-00003167; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Hutchinson JMC, 2005, BIOL REV, V80, P73, DOI 10.1017/S1464793104006554; Hutchinson JMC, 2004, J THEOR BIOL, V231, P129, DOI 10.1016/j.jtbi.2004.06.009; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1997, BEHAV ECOL SOCIOBIOL, V40, P51, DOI 10.1007/s002650050315; KALICK SM, 1986, J PERS SOC PSYCHOL, V51, P673, DOI 10.1037/0022-3514.51.4.673; Krause J, 2002, LIVING GROUPS; Kuczynski MC, 2016, BEHAV PROCESS, V124, P74, DOI 10.1016/j.beproc.2015.11.020; Lea AM, 2015, SCIENCE, V349, P964, DOI 10.1126/science.aab2012; Leary CJ, 2004, BEHAV ECOL, V15, P313, DOI 10.1093/beheco/arh015; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; Luttbeg B, 2002, ANIM BEHAV, V63, P805, DOI 10.1006/anbe.2001.1979; Molnar PK, 2008, P R SOC B, V275, P217, DOI 10.1098/rspb.2007.1307; MORRIS MR, 1989, BEHAV ECOL SOCIOBIOL, V25, P275, DOI 10.1007/BF00300054; MORRIS MR, 1991, J ZOOL, V223, P371, DOI 10.1111/j.1469-7998.1991.tb04771.x; Murphy CG, 1996, ANIM BEHAV, V51, P881, DOI 10.1006/anbe.1996.0092; Murphy CG, 2002, BEHAV ECOL, V13, P472, DOI 10.1093/beheco/13.4.472; Murphy CG, 2008, J COMP PSYCHOL, V122, P264, DOI 10.1037/0735-7036.122.3.264; Myhre LC, 2012, AM NAT, V179, P741, DOI 10.1086/665651; Parris KM, 2002, ECOL MODEL, V156, P213, DOI 10.1016/S0304-3800(02)00170-9; Pfennig KS, 2000, BEHAV ECOL SOCIOBIOL, V48, P69, DOI 10.1007/s002650000205; R Development Core Team, 2014, R LANG ENV STAT COMP; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Roff DA, YEAR EVOLUTIONARY BI, P1, DOI [10.1186/1471-2148-13-1, DOI 10.1186/1471-2148-13-1]; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Scheutz M, 2005, P AG DIR SIM ADS 05; Scheutz M, 2005, EVALUATIONS ALIFE SI, P35; Scheutz M, LECT NOTES ARTIFICIA, P618; Scheutz M, 2013, IEEE SYMP ART LIFE, P113, DOI 10.1109/ALIFE.2013.6602439; Scheutz MJ, 2004, COGNITIVE SCI, V28, P559, DOI 10.1016/j.cogsci.2004.03.001; Schwartz JJ, 2004, ANIM BEHAV, V68, P533, DOI 10.1016/j.anbehav.2003.09.016; Schwartz JJ, 2002, BEHAV ECOL SOCIOBIOL, V53, P9, DOI 10.1007/s00265-002-0542-7; Schwartz JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P443, DOI 10.1007/s002650100317; Smaldino P, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.2030; SULLIVAN BK, 1990, COPEIA, P1146, DOI 10.2307/1446500; SULLIVAN BK, 1992, ANIM BEHAV, V44, P733, DOI 10.1016/S0003-3472(05)80299-4; Svensson EI, 2004, AM NAT, V163, P726, DOI 10.1086/383592; TAIGEN TL, 1985, J COMP PHYSIOL B, V155, P163, DOI 10.1007/BF00685209; The ABC Research Group, 1999, SIMPLE HEURISTICS MA, P287, DOI DOI 10.1111/.1745-9125.2010.00223.X; Tito MB, 1999, HORM BEHAV, V36, P166, DOI 10.1006/hbeh.1999.1540; Todd PM, 2007, EUR J OPER RES, V177, P1317, DOI 10.1016/j.ejor.2005.04.005; WAGNER WE, 1992, COPEIA, P647, DOI 10.2307/1446140; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; Wiegmann DD, 2013, CURR ZOOL, V59, P184, DOI 10.1093/czoolo/59.2.184; Wiegmann DD, 2010, J THEOR BIOL, V262, P596, DOI 10.1016/j.jtbi.2009.08.033; Witte K, 2001, ETHOLOGY, V107, P685, DOI 10.1046/j.1439-0310.2001.00715.x; Wollerman L, 1999, ANIM BEHAV, V57, P529, DOI 10.1006/anbe.1998.1013	89	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202680	10.1371/journal.pone.0202680	http://dx.doi.org/10.1371/journal.pone.0202680			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138426	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100105
J	Hernandez, G; Dima, AL; Pont, A; Garin, O; Marti-Pastor, M; Alonso, J; Van Ganse, E; Laforest, L; de Bruin, M; Mayoral, K; Ferrer, M				Hernandez, Gimena; Dima, Alexandra L.; Pont, Angels; Garin, Olatz; Marti-Pastor, Marc; Alonso, Jordi; Van Ganse, Eric; Laforest, Laurent; de Bruin, Marijn; Mayoral, Karina; Ferrer, Montse		ASTRO-LAB Grp	Impact of asthma on women and men: Comparison with the general population using the EQ-5D-5L questionnaire	PLOS ONE			English	Article							QUALITY-OF-LIFE; WELL-CONTROLLED ASTHMA; SF-36 HEALTH SURVEY; SWEDISH-POPULATION; REFERENCE-VALUES; SPANISH VERSION; CARE; SYMPTOMS; VALIDITY; DISEASE	Background The aim was to evaluate the impact of asthma on patients' Health-Related Quality of Life (HRQoL) by comparing asthmatic women and men with reference norms, to examine the factors which contributed to an impaired HRQoL, and to identify groups at higher risk. Methods Cross-sectional evaluation of 222 primary care patients with persistent asthma (18-40 years old). HRQoL impact was estimated with the EuroQol-5 Dimensions (EQ-5D), which allows calculating Quality-Adjusted Life-Years (QALYs) by applying society preferences. Participants self-completed the EQ-5D questionnaire online. Telephonic interviews collected information on medication and adherence, and administered the Asthma Control Questionnaire. Severity markers included asthma-related comorbidity, previous oral cortico-steroids course prescription, and inhaled corticosteroids daily dose. After bivariate analyses, multiple linear regression models were constructed to examine the relations between HRQoL asthma impact and socio-demographic and clinical variables, using as dependent variable the deviation from general population-based EQ-5D reference norms. Results Deviation from the EQ-5D index norms was moderate in most age/gender groups (-0.1, which corresponds to 0.6 standard deviations), while it was large in women aged 18-24 years (-0.18, corresponding to 1.1 standard deviations). In regression models, a poor asthma control was the only factor independently associated to HRQoL impact in both women and men beta -0.18 (p<0.001) and -0.15 (p = 0.01) respectively. Translating these beta coefficients to QALYs, they are interpretable as 66 fewer days of full health per year in women with uncontrolled asthma and 55 for men, compared with those with controlled asthma. Conclusion Persistent asthma has a moderately negative HRQoL impact on patients of both genders, and the youngest women have been identified as a high risk group which merits further research. We identified asthma control as the major contributor to impaired HRQoL in patients, regardless of their gender, suggesting that asthma HRQoL impact could be alleviated by achieving a good control of symptoms.	[Hernandez, Gimena; Pont, Angels; Garin, Olatz; Marti-Pastor, Marc; Alonso, Jordi; Mayoral, Karina; Ferrer, Montse] IMIM Hosp Mar Med Res Inst, Hlth Serv Res Grp, Barcelona, Spain; [Hernandez, Gimena; Marti-Pastor, Marc; Ferrer, Montse] Univ Autonoma Barcelona, Dept Paediat Obstet & Gynaecol & Prevent Med, Barcelona, Spain; [Hernandez, Gimena; Pont, Angels; Garin, Olatz; Marti-Pastor, Marc; Alonso, Jordi; Ferrer, Montse] CIBERESP, CIBER Epidemiol & Salud PUbl, Madrid, Spain; [Dima, Alexandra L.; de Bruin, Marijn] Univ Amsterdam, Amsterdam Sch Commun Res ASCoR, Amsterdam, Netherlands; [Garin, Olatz; Alonso, Jordi; Mayoral, Karina] Pompeu Fabra Univ UPF, Barcelona, Spain; [Van Ganse, Eric; Laforest, Laurent] Claude Bernard Univ Lyon1, HESPER Unit, PEL, Lyon, France; [Van Ganse, Eric; Laforest, Laurent] CHU Lyon, Croix Rousse Hosp, Resp Med, Lyon, France; [de Bruin, Marijn] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Amsterdam; Pompeu Fabra University; CHU Lyon; University of Aberdeen	Garin, O; Ferrer, M (corresponding author), IMIM Hosp Mar Med Res Inst, Hlth Serv Res Grp, Barcelona, Spain.; Ferrer, M (corresponding author), Univ Autonoma Barcelona, Dept Paediat Obstet & Gynaecol & Prevent Med, Barcelona, Spain.; Garin, O; Ferrer, M (corresponding author), CIBERESP, CIBER Epidemiol & Salud PUbl, Madrid, Spain.	ogarin@imim.es; mferrer@imim.es	Garin, Olatz/K-5468-2013; Hernandez, Gimena/B-1571-2015; Pont, Angels/B-1368-2015; Ferrer, Montse/A-5510-2010; Dima, Alexandra Lelia/H-4823-2019; de Bruin, Marijn/X-8418-2018; Ortiz, Karina Mayoral/AAD-3735-2021; Alonso, Jordi/A-5514-2010	Garin, Olatz/0000-0001-6193-0779; Hernandez, Gimena/0000-0001-5319-3465; Pont, Angels/0000-0002-0602-552X; Ferrer, Montse/0000-0001-9867-7391; Dima, Alexandra Lelia/0000-0002-3106-2242; de Bruin, Marijn/0000-0003-3100-6803; Ortiz, Karina Mayoral/0000-0002-7904-4422; Alonso, Jordi/0000-0001-8627-9636; Marti Pastor, Marc/0000-0001-6189-2178	European Union Seventh Framework Programme FP7 (ASTROLAB project) [EC HEALTH-F5-2011-282593]; Instituto de Salud Carlos III FEDER [PI12/00772]; DIUE of Generalitat de Catalunya [2014 SGR 748]	European Union Seventh Framework Programme FP7 (ASTROLAB project); Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos III); DIUE of Generalitat de Catalunya(Generalitat de Catalunya)	Financial support for this study was provided by the European Union Seventh Framework Programme FP7 (ASTROLAB project EC HEALTH-F5-2011-282593) to EVG, Instituto de Salud Carlos III FEDER (PI12/00772) to JA, and DIUE of Generalitat de Catalunya (2014 SGR 748) to MF. The funding agreement ensures the authors' independence in designing the study, interpreting the data, writing and publishing the report.	Alonso J, 1998, MED CLIN-BARCELONA, V111, P410; ALONSO J, 1990, AM J PUBLIC HEALTH, V80, P704, DOI 10.2105/AJPH.80.6.704; Belloch A, 2003, J ASTHMA, V40, P945, DOI 10.1081/JAS-120024595; Bohmer MM, 2016, J ASTHMA, P1; Borenstein M., 2009, INTRO META ANAL, P21, DOI DOI 10.1002/9780470743386.CH4; Braido F, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0374-z; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Celant N, 2014, SANTE A EUROPE A ENN; Chen H, 2007, J ALLERGY CLIN IMMUN, V120, P396, DOI 10.1016/j.jaci.2007.04.040; Chevalier J, 2013, EUR J HEALTH ECON, V14, P57, DOI 10.1007/s10198-011-0351-x; Demoly P, 2010, EUR RESPIR REV, V19, P150, DOI 10.1183/09059180.00002110; Dima AL, 2017, PSYCHOL HEALTH, V32, P1288, DOI 10.1080/08870446.2017.1290248; Dima AL, 2016, J ALLER CL IMM-PRACT, V4, P868, DOI 10.1016/j.jaip.2016.04.020; Doz M, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-15; Ford ES, 2003, CHEST, V123, P119, DOI 10.1378/chest.123.1.119; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Golicki D, 2015, ADV CLIN EXP MED, V24, P139, DOI 10.17219/acem/38137; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hung MC, 2015, J OCCUP REHABIL, V25, P387, DOI 10.1007/s10926-014-9547-0; Hunger M, 2012, QUAL LIFE RES, V21, P1205, DOI 10.1007/s11136-011-0024-3; Jansson SA, 2016, RESP MED, V120, P64, DOI 10.1016/j.rmed.2016.09.019; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Konig HH, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-47; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Laforest L, 2006, J ALLERGY CLIN IMMUN, V117, P1404, DOI 10.1016/j.jaci.2006.03.007; McClure NS, 2017, VALUE HEALTH, V20, P644, DOI 10.1016/j.jval.2016.11.015; McTaggart-Cowan HM, 2008, QUAL LIFE RES, V17, P453, DOI 10.1007/s11136-008-9309-6; Michelson H, 2000, ACTA ONCOL, V39, P477; Mishoe S C, 2001, Respir Care, V46, P1236; Rasanen P, 2006, INT J TECHNOL ASSESS, V22, P235, DOI 10.1017/S0266462306051051; Rosenzweig JRC, 2004, RESP MED, V98, P1157, DOI 10.1016/j.rmed.2004.04.001; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, pS67; Sobota A, 2011, AM J HEMATOL, V86, P92, DOI 10.1002/ajh.21896; Stavem K, 2000, EPILEPSIA, V41, P85, DOI 10.1111/j.1528-1157.2000.tb01510.x; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; Tan NC, 2012, PRIM CARE RESP J, V21, P90, DOI 10.4104/pcrj.2012.00003; Uchmanowicz B, 2016, PATIENT PREFER ADHER, V10, P579, DOI 10.2147/PPA.S103043; Uchmanowicz B, 2016, PATIENT PREFER ADHER, V10, P345, DOI 10.2147/PPA.S101898; Van Ganse E, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.40; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Zein JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157301	42	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202624	10.1371/journal.pone.0202624	http://dx.doi.org/10.1371/journal.pone.0202624			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138415	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100095
J	Klein, C; Metz, SI; Elmer, S; Jancke, L				Klein, Carina; Metz, Silvana Iris; Elmer, Stefan; Jancke, Lutz			The interpreter's brain during rest - Hyperconnectivity in the frontal lobe	PLOS ONE			English	Article							RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; SPANISH-ENGLISH BILINGUALS; ANTERIOR CINGULATE CORTEX; VERBAL WORKING-MEMORY; BROCAS AREA; PREFRONTAL CORTEX; CORTICAL THICKNESS; EEG-ALPHA; FUNCTIONAL-ORGANIZATION; LANGUAGE REPRESENTATION	Language in its highest complexity is a unique human faculty with simultaneous translation being among the most demanding language task involving both linguistic and executive functions. In this context, bilingually grown up individuals as well as simultaneous interpreters (SIs) represent appropriate groups for studying expertise-related neural adaptations in the human brain. The present study was performed to examine if a domain-specific neural network activation pattern, constituted by brain regions involved in speech processing as well as cognitive control mechanisms can be detected during a task-free resting state condition. To investigate this, electroencephalographic (EEG) data were recorded from 16 SIs and 16 age and gender-matched multilingual control subjects. Graph-theoretical network analyses revealed interhemispheric hyperconnectivity between the ventral part of the prefrontal cortex (pars opercularis and pars triangularis) and the dorsolateral prefrontal cortex (DLPFC) in language experts compared to multilingual controls in the alpha frequency range. This finding suggests that the high cognitive demands placed on simultaneous interpreting lead to an increased neural communication between prefrontal brain regions essentially engaged in supporting executive control-a neural fingerprint that is even detectable during rest.	[Klein, Carina; Metz, Silvana Iris; Elmer, Stefan; Jancke, Lutz] Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, INAPIC, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Dynam Hlth Aging, URPP, Zurich, Switzerland; [Jancke, Lutz] King Abdulaziz Univ, Dept Special Educ, Jeddah, Saudi Arabia	University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; King Abdulaziz University	Klein, C (corresponding author), Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland.	carina.klein@uzh.ch	Elmer, Stefan/F-7840-2011	Elmer, Stefan/0000-0003-1721-450X; Klein, Carina/0000-0003-0159-1079	Swiss National Science Foundation (SNSF) [320030B_138668]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This research was supported by the Swiss National Science Foundation (SNSF, Grant No 320030B_138668 granted to Lutz Jancke. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; Ackermann H, 2010, BRAIN STRUCT FUNCT, V214, P419, DOI 10.1007/s00429-010-0257-x; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; [Anonymous], 1989, MANUAL ADV MEASURES; Babiloni C, 2004, NEUROIMAGE, V22, P57, DOI 10.1016/j.neuroimage.2003.09.028; Balconi M, 2013, NEUROSCI BULL, V29, P381, DOI 10.1007/s12264-013-1309-z; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Becker M, 2016, NEUROIMAGE, V134, P250, DOI 10.1016/j.neuroimage.2016.03.079; Berger H, 1933, ARCH PSYCHIAT NERVEN, V98, P231, DOI 10.1007/BF01814645; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Blumenfeld RS, 2011, J COGNITIVE NEUROSCI, V23, P257, DOI 10.1162/jocn.2010.21459; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bornkessel-Schlesewsky I, 2013, BRAIN LANG, V125, P60, DOI 10.1016/j.bandl.2013.01.010; Braun U, 2015, P NATL ACAD SCI USA, V112, P11678, DOI 10.1073/pnas.1422487112; Brodmann K, 1909, VERGLEICHENDE LOKALI; Burzynska AZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00566; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Christoffels IK, 2006, J MEM LANG, V54, P324, DOI 10.1016/j.jml.2005.12.004; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Duan XJ, 2014, BRAIN RES, V1558, P33, DOI 10.1016/j.brainres.2014.02.033; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Eickhoff SB, 2009, PHILOS T R SOC A, V367, P2399, DOI 10.1098/rsta.2008.0287; ELMER S, 2016, FRONT HUM NEUROSCI, V10, DOI DOI 10.3389/FNHUM.2010.00060; Elmer S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00491; Elmer S, 2014, J COGNITIVE NEUROSCI, V26, P2356, DOI 10.1162/jocn_a_00632; Elmer S, 2014, CORTEX, V54, P179, DOI 10.1016/j.cortex.2014.02.014; Elmer S, 2013, CORTEX, V49, P2812, DOI 10.1016/j.cortex.2013.03.007; Elmer S, 2012, CEREB CORTEX, V22, P650, DOI 10.1093/cercor/bhr142; Elmer S, 2011, HUM BRAIN MAPP, V32, P2064, DOI 10.1002/hbm.21169; Elmer S, 2010, BRAIN RES, V1317, P147, DOI 10.1016/j.brainres.2009.12.052; Fallani FD, 2010, BRAIN TOPOGR, V23, P214, DOI 10.1007/s10548-010-0133-2; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Festman J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00115; Festman J, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-5; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Friederici AD, 2006, CORTEX, V42, P472, DOI 10.1016/S0010-9452(08)70380-0; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GALE A, 1971, PSYCHON SCI, V23, P99; Goldstein S., 2013, HDB EXECUTIVE FUNCTI; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P, 2014, CURR OPIN NEUROBIOL, V28, P136, DOI 10.1016/j.conb.2014.07.013; Hernandez AE, 2000, BRAIN LANG, V73, P421, DOI 10.1006/brln.1999.2278; Hernandez AE, 2001, NEUROIMAGE, V14, P510, DOI 10.1006/nimg.2001.0810; Hernandez AE, 2009, BRAIN LANG, V109, P133, DOI 10.1016/j.bandl.2008.12.005; Hervais-Adelman A, 2017, NEUROPSYCHOLOGIA, V98, P212, DOI 10.1016/j.neuropsychologia.2017.01.008; Hervais-Adelman A, 2015, NEUROIMAGE, V114, P264, DOI 10.1016/j.neuroimage.2015.03.072; Hirota T, 2001, NEUROPSYCHOBIOLOGY, V44, P108, DOI 10.1159/000054927; Jancke L, 2011, J NEUROPSYCHOL, V5, P178, DOI 10.1111/j.1748-6653.2011.02004.x; Jancke L., 2006, BROCAS REGION, P218; Jin SH, 2014, J NEUROPHYSIOL, V111, P1455, DOI 10.1152/jn.00585.2013; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Klein C, 2016, HUM BRAIN MAPP, V37, P536, DOI 10.1002/hbm.23045; Klein C, 2016, BRAIN TOPOGR, V29, P67, DOI 10.1007/s10548-015-0433-7; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kurth F, 2017, J NEUROSCI RES, V95, P626, DOI 10.1002/jnr.23898; Langer N, 2013, CORTEX, V49, P2424, DOI 10.1016/j.cortex.2013.01.008; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lehmann D, 2006, J PHYSIOLOGY-PARIS, V99, P29, DOI 10.1016/j.jphysparis.2005.06.005; Lehrl S., 1991, THEORIE MESSUNG GEIS; Lehrl S., 1977, MEHRFACHWAHL WORTSCH; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; Mayhew SD, 2013, NEUROIMAGE, V76, P362, DOI 10.1016/j.neuroimage.2013.02.070; Miller EK, 1996, J NEUROSCI, V16, P5154; Morales J, 2013, J EXP CHILD PSYCHOL, V114, P187, DOI 10.1016/j.jecp.2012.09.002; Moreno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094169; Mulert C, 2001, NEUROIMAGE, V13, P589, DOI 10.1006/nimg.2000.0727; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Otero T. M., 2014, HDB EXECUTIVE FUNCTI, P29, DOI DOI 10.1007/978-1-4614-8106-5_3; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pascual-Marqui R. D, 2007, ARXIV07111455; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; PASCUALMARQUI RD, 2007, ARXIV07061776V3; Pizzagalli D, 2000, CLIN NEUROPHYSIOL, V111, P521, DOI 10.1016/S1388-2457(99)00252-7; Polunina AG, 2012, CURRENT TRENDS NEURO, V6, P51; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1999, BRAIN, V122, P2221, DOI 10.1093/brain/122.12.2221; Rinne JO, 2000, NEUROSCI LETT, V294, P85, DOI 10.1016/S0304-3940(00)01540-8; Rodriguez-Fornells A, 2006, LANG LEARN, V56, P133, DOI 10.1111/j.1467-9922.2006.00359.x; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Sadaghiani S, 2013, NEUROIMAGE, V80, P379, DOI 10.1016/j.neuroimage.2013.04.100; Sammler D, 2015, CURR BIOL, V25, P3079, DOI 10.1016/j.cub.2015.10.009; Santi A, 2012, NEUROPSYCHOLOGIA, V50, P821, DOI 10.1016/j.neuropsychologia.2012.01.017; SCHLAEPFER TE, 1995, PSYCHIAT RES-NEUROIM, V61, P129, DOI 10.1016/0925-4927(95)02634-A; Seeck M, 1998, ELECTROEN CLIN NEURO, V106, P508, DOI 10.1016/S0013-4694(98)00017-0; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Strelnikov KN, 2006, NEUROIMAGE, V29, P1127, DOI 10.1016/j.neuroimage.2005.08.021; Tan B, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/976365; Thompson CK, 1999, BRAIN LANG, V67, P169, DOI 10.1006/brln.1999.2052; Turkeltaub PE, 2010, BRAIN LANG, V114, P1, DOI 10.1016/j.bandl.2010.03.008; Tyler LK, 2011, BRAIN, V134, P415, DOI 10.1093/brain/awq369; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Vikingstad EM, 2000, J NEUROL SCI, V175, P17, DOI 10.1016/S0022-510X(00)00269-0; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	123	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202600	10.1371/journal.pone.0202600	http://dx.doi.org/10.1371/journal.pone.0202600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138477	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000442800100090
J	Patton, SR; Russell, MB; Windmuller-Campione, MA; Frelich, LE				Patton, Stephanie R.; Russell, Matthew B.; Windmuller-Campione, Marcella A.; Frelich, Lee E.			Quantifying impacts of white-tailed deer (Odocoileus virginianus Zimmerman) browse using forest inventory and socio-environmental datasets	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; BORRELIA-BURGDORFERI; LYME-DISEASE; TICK ABUNDANCE; BALSAM FIR; DENSITY; REDUCTION; GROWTH; MICE; REGENERATION	Elevated population levels of white-tailed deer (Odocoileus virginianus Zimmerman) can drastically alter forest ecosystems and negatively impact society through human interactions such as deer vehicle collisions. It is currently difficult to estimate deer populations at multiple scales ranging from stand, county, state, and regional levels. This presents a challenge as natural resource managers develop silvicultural prescriptions and forest management practices aimed at successfully regenerating tree species in the face of deer browsing. This study utilized measurements of deer browse impact from the new tree regeneration indicator developed by the United States Department of Agriculture Forest Service Forest Inventory and Analysis (FIA) program. Seedling and sapling abundance and other plot-level characteristics were analyzed across three states (Michigan, Minnesota, and Wisconsin) in the Great Lakes Region of the United States. Socio-environmental datasets (Lyme disease cases, deer vehicle collisions, and deer density estimates) were used in conjunction with FIA data to determine their predictive power in estimating deer browse impacts by county. Predictions from random forests models indicate that using Lyme disease case reports, the number of deer-vehicle collisions, deer density estimates, and forest inventory information correctly predicted deer browse impact 70-90% of the time. Deer-vehicle collisions per county ranked highly important in the random forests for predicting deer browse impacts in all three states. Lyme disease cases ranked high in importance for the Lake States combined and for Minnesota and Wisconsin, separately. Results show the effectiveness of predicting deer browse impacts using a suite of freely available forest inventory and other socio-environmental information.	[Patton, Stephanie R.; Russell, Matthew B.; Windmuller-Campione, Marcella A.; Frelich, Lee E.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Patton, SR (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	att0373@umn.edu	Russell, Matthew/P-5078-2019	Russell, Matthew/0000-0002-7044-9650; Frelich, Lee/0000-0002-9052-7070	Minnesota Agricultural Experiment Station [MIN-42-063, MIN-42-068]; University of Minnesota Office of the Vice President for Research [23024]	Minnesota Agricultural Experiment Station; University of Minnesota Office of the Vice President for Research(University of Minnesota System)	This work was supported by the Minnesota Agricultural Experiment Station (www.maes.umn.edu, projects MIN-42-063 and MIN-42-068) and the University of Minnesota Office of the Vice President for Research (www.research.umn.edu, Grant-in-Aid #23024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams K, 2009, QUALITY DEER MANAGEM; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; ANDERSON JF, 1987, APPL ENVIRON MICROB, V53, P892, DOI 10.1128/AEM.53.4.892-894.1987; ANDERSON JF, 1984, YALE J BIOL MED, V57, P627; Bacon RM, 2008, MORBIDITY MORTALITY, V57; Bechtold W.A., 2005, ENHANCED FOREST INVE, P85, DOI [10.2737/SRS-GTR-80, DOI 10.2737/SRS-GTR-80]; Bradshaw L, 2016, FOREST ECOL MANAG, V375, P1, DOI 10.1016/j.foreco.2016.05.019; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Callan R, 2013, J ECOL, V101, P837, DOI 10.1111/1365-2745.12095; Churski M, 2017, NEW PHYTOL, V214, P158, DOI 10.1111/nph.14345; Cornett MW, 2000, BIOL CONSERV, V93, P359, DOI 10.1016/S0006-3207(99)00129-9; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DECALESTA DS, 1994, J WILDLIFE MANAGE, V58, P711, DOI 10.2307/3809685; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; DUFFY DC, 1994, J MED ENTOMOL, V31, P152, DOI 10.1093/jmedent/31.1.152; ESRI, 2011, ARCGIS DESKT REL 10; Frelich L.E., 2002, FOREST DYNAMICS DIST; FRELICH LE, 1985, BIOL CONSERV, V34, P99, DOI 10.1016/0006-3207(85)90103-X; Frerker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115843; Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Goodwin BJ, 2001, VECTOR-BORNE ZOONOT, V1, P129, DOI 10.1089/153036601316977732; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Hothorn T, 2010, FOREST ECOL MANAG, V260, P1416, DOI 10.1016/j.foreco.2010.07.019; Jenkins LH, 2014, BIOL CONSERV, V175, P119, DOI 10.1016/j.biocon.2014.04.022; Kilpatrick HJ, 2014, J MED ENTOMOL, V51, P777, DOI 10.1603/ME13232; Knapp KK, 2005, STATEWIDE UPPER MIDW; Knight TM, 2009, NAT AREA J, V29, P110, DOI 10.3375/043.029.0202; Kuiters AT, 2002, BIOL CONSERV, V105, P65, DOI 10.1016/S0006-3207(01)00204-X; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; MCSHEA W J, 1992, Virginia Journal of Science, V43, P177; McWilliams WH, 2015, REGNERATION INDICATO; Nuttle T, 2014, J ECOL, V102, P221, DOI 10.1111/1365-2745.12175; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld Richard S., 1998, Integrative Biology, V1, P178, DOI 10.1002/(SICI)1520-6602(1998)1:5<178::AID-INBI3>3.0.CO;2-C; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; Palik BJ, 2015, FOREST ECOL MANAG, V337, P20, DOI 10.1016/j.foreco.2014.10.033; R Core Team, 2021, R LANGUAGE ENV STAT; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Raynor JL, 2016, CAUSAL IMPACT INCREA; Ripple William J., 2010, P141; RISENHOOVER KL, 1987, CAN J FOREST RES, V17, P357, DOI 10.1139/x87-062; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Russell MB, 2017, FOREST ECOL MANAG, V384, P26, DOI 10.1016/j.foreco.2016.10.038; Russell MB, 2017, CAN J FOREST RES, DOI [10.1139/cjfr-2017-0049, DOI 10.1139/CJFR-2017-0049]; Schutz M, 2003, FOREST ECOL MANAG, V181, P177, DOI 10.1016/S0378-1127(03)00131-2; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Stearns F.W., 1997, LAKE STATES REGIONAL; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; THOMPSON ID, 1993, CAN J FOREST RES, V23, P1388, DOI 10.1139/x93-175; TILGHMAN NG, 1989, J WILDLIFE MANAGE, V53, P524, DOI 10.2307/3809172; Waller DM, 2013, FOREST ECOL MANAG, V304, P296, DOI 10.1016/j.foreco.2013.05.011; Walters BF, 2008, WHITE TAILED DEER DE; Warren RJ, 1997, WILDLIFE SOC B, V25, P213; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043; WILSON ML, 1990, MED VET ENTOMOL, V4, P151, DOI 10.1111/j.1365-2915.1990.tb00273.x	60	10	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0201334	10.1371/journal.pone.0201334	http://dx.doi.org/10.1371/journal.pone.0201334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138322	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100015
J	Don, CG; Smiesko, M				Don, Charleen G.; Smiesko, Martin			Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HUMAN CYTOCHROME-P450 2D6; SUBSTRATE-SPECIFICITY; NATURAL VARIANT; ACTIVE-SITE; BINDING; PROTEIN; P450S; INHIBITOR; DOCKING	Characterization of cytochrome P450 2D6 (CYP2D6) and the impact of the major identified allelic variants on the activity of one of the most dominating drug-metabolising enzymes is essential to increase drug safety and avoid adverse reactions. Microsecond molecular dynamics simulations have been performed to capture the dynamic signatures of this complex enzyme and five allelic variants with diverse enzymatic activity. In addition to the apo simulations, three substrates (bufuralol, veliparib and tamoxifen) and two inhibitors (prinomastat and quinidine) were included to explore their influence on the structure and dynamical features of the enzyme. Our results indicate that the altered enzyme activity can be attributed to changes in the hydrogen bonding network within the active site, and local structural differences in flexibility, position and shape of the binding pocket. In particular, the increased (CYP2D6*53) or the decreased (CYP2D6*17) activity seems to be related to a change in dynamics of mainly the BC loop due to a modified hydrogen bonding network around this region. In addition, the smallest active site volume was found for CYP2D6*4 (no activity). CYP2D6*2 (normal activity) showed no major differences in dynamic behaviour compared to the wild-type.	[Don, Charleen G.; Smiesko, Martin] Univ Basel, Dept Pharmaceut Sci, Mol Modeling Grp, Basel, Switzerland	University of Basel	Smiesko, M (corresponding author), Univ Basel, Dept Pharmaceut Sci, Mol Modeling Grp, Basel, Switzerland.	martin.smiesko@unibas.ch	Smieško, Martin/K-8233-2019	Smieško, Martin/0000-0003-2758-2680; Don, Charleen/0000-0002-1257-3274				Abduljalil K, 2010, CLIN PHARMACOL THER, V88, P643, DOI 10.1038/clpt.2010.137; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barnaba Carlo, 2017, F1000Res, V6, P662, DOI 10.12688/f1000research.11015.1; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berka K, 2012, J INORG BIOCHEM, V110, P46, DOI 10.1016/j.jinorgbio.2012.02.010; Bermudez M, 2016, DRUG DISCOV TODAY, V21, P1799, DOI 10.1016/j.drudis.2016.07.001; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Caudle KE, 2017, GENET MED, V19, P215, DOI 10.1038/gim.2016.87; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; de Graaf C, 2006, J MED CHEM, V49, P2417, DOI 10.1021/jm0508538; de Graaf C, 2007, CURR DRUG METAB, V8, P59, DOI 10.2174/138920007779315062; de Waal PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108607; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Flanagan JU, 2004, BIOCHEM J, V380, P353, DOI 10.1042/BJ20040062; Fukuyoshi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152946; Gaedigk A, 2016, GENET MED, V18, P1167, DOI 10.1038/gim.2016.80; Han KM, 2013, PSYCHIAT INVEST, V10, P286, DOI 10.4306/pi.2013.10.3.286; Handa K, 2014, DRUG METAB PHARMACOK, V29, P52, DOI 10.2133/dmpk.DMPK-13-RG-044; He ZX, 2015, DRUG METAB REV, V47, P470, DOI 10.3109/03602532.2015.1101131; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hochleitner J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08404-0; Ito Y, 2008, J MOL GRAPH MODEL, V26, P947, DOI 10.1016/j.jmgm.2007.07.004; Klein K, 2007, DRUG METAB DISPOS, V35, P1247, DOI 10.1124/dmd.107.015149; Li XF, 2011, DRUG METAB DISPOS, V39, P1161, DOI 10.1124/dmd.110.037820; Martiny VY, 2015, BIOINFORMATICS, V31, P3930, DOI 10.1093/bioinformatics/btv486; McLaughlin LA, 2005, J BIOL CHEM, V280, P38617, DOI 10.1074/jbc.M505974200; McMasters DR, 2007, J MED CHEM, V50, P3205, DOI 10.1021/jm0700060; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P708, DOI 10.1038/clpt.2011.27; Navratilova V, 2016, J PHYS CHEM B, V120, P11205, DOI 10.1021/acs.jpcb.6b10108; Oprea TI, 1997, P NATL ACAD SCI USA, V94, P2133, DOI 10.1073/pnas.94.6.2133; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; Paine MJI, 2003, J BIOL CHEM, V278, P4021, DOI 10.1074/jbc.M209519200; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Panicco P, 2011, ANAL CHEM, V83, P2179, DOI 10.1021/ac200119b; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Reed JR, 2012, PHARMACOL THERAPEUT, V133, P299, DOI 10.1016/j.pharmthera.2011.11.009; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; Santos R, 2010, J CHEM INF MODEL, V50, P146, DOI 10.1021/ci900293e; Sasahara K, 2015, BIOORGAN MED CHEM, V23, P5459, DOI 10.1016/j.bmc.2015.07.043; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shiraishi T, 2002, DRUG METAB DISPOS, V30, P1201, DOI 10.1124/dmd.30.11.1201; Smiesko M, 2013, J CHEM INF MODEL, V53, P1415, DOI 10.1021/ci400098y; Smith G, 1998, BIOCHEM J, V331, P783, DOI 10.1042/bj3310783; Stingl J, 2015, J INTERN MED, V277, P167, DOI 10.1111/joim.12317; Sundermann A, 2013, PROTEIN SCI, V22, P1183, DOI 10.1002/pro.2307; Suvarna B S, 2009, Kathmandu Univ Med J (KUMJ), V7, P172; Teh LK, 2012, DRUG METAB PHARMACOK, V27, P55, DOI 10.2133/dmpk.DMPK-11-RV-121; Venhorst J, 2000, DRUG METAB DISPOS, V28, P1524; Visscher KM, 2015, PROTEINS, V83, P445, DOI 10.1002/prot.24741; Wang A, 2015, J BIOL CHEM, V290, P5092, DOI 10.1074/jbc.M114.627661; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wooller SK, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160180; Yu AM, 2002, J PHARMACOL EXP THER, V303, P1291, DOI 10.1124/jpet.102.039891; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074	56	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202534	10.1371/journal.pone.0202534	http://dx.doi.org/10.1371/journal.pone.0202534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133539	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400077
J	Lipina, C; Walsh, SK; Mitchell, SE; Speakman, JR; Wainwright, CL; Hundal, HS				Lipina, Christopher; Walsh, Sarah K.; Mitchell, Sharon E.; Speakman, John R.; Wainwright, Cherry L.; Hundal, Harinder S.			GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues	FASEB JOURNAL			English	Article						endocannabinoid; cannabinoid receptor; skeletal muscle; liver; adipogenesis	CARDIOMETABOLIC RISK-FACTORS; CANNABINOID RECEPTOR GPR55; ENDOCANNABINOID LEVELS; GLUCOSE-UPTAKE; POTENTIAL ROLE; MUSCLE; OBESITY; IDENTIFICATION; STIMULATION; ACTIVATION	Emerging evidence indicates that G-protein coupled receptor 55 (GPR55), a nonclassic receptor of the endocannabinoid system that is activated by L--lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function and energy metabolism. We examined how GPR55 deficiency and modulation affects insulin signaling in skeletal muscle, adipose tissue, and liver alongside expression analysis of proteins implicated in insulin action and energy metabolism. We show that GPR55-null mice display decreased insulin sensitivity in these tissues, as evidenced by reduced phosphorylation of PKB/Akt and its downstream targets, concomitant with increased adiposity and reduced physical activity relative to wild-type counterparts. Impaired tissue insulin sensitivity coincided with reduced insulin receptor substrate-1 abundance in skeletal muscle, whereas in liver and epididymal fat it was associated with increased expression of the 3-phosphoinoistide lipid phosphatase, phosphatase and tensin homolog. In contrast, GPR55 activation enhanced insulin signaling in cultured skeletal muscle cells, adipocytes, and hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myotubes. Sustained GPR55 antagonism in 3T3-L1 adipocytes enhanced expression of proteins implicated in lipogenesis and promoted triglyceride accumulation. Our findings identify GPR55 as a positive regulator of insulin action and adipogenesis and as a potential therapeutic target for countering obesity-induced metabolic dysfunction and insulin resistance.Lipina, C., Walsh, S. K., Mitchell, S. E., Speakman, J. R., Wainwright, C. L., Hundal, H. S. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.	[Lipina, Christopher; Hundal, Harinder S.] Univ Dundee, Sch Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland; [Walsh, Sarah K.; Wainwright, Cherry L.] Robert Gordon Univ, Ctr Cardiometab Hlth Res, Aberdeen, Scotland; [Mitchell, Sharon E.; Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	University of Dundee; Robert Gordon University; University of Aberdeen; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Hundal, HS (corresponding author), Univ Dundee, Sch Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	Walsh, Sarah/ABF-2490-2020	Walsh, Sarah K/0000-0002-9936-5303	Biotechnology and Biological Sciences Research Council (BBSRC); Diabetes UK; BBSRC [BB/S00033X/1, BB/N003500/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and Diabetes UK. The authors declare no conflicts of interest.	Abdulla H, 2016, DIABETOLOGIA, V59, P44, DOI 10.1007/s00125-015-3751-0; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arifin SA, 2016, METABOLITES, V6, DOI 10.3390/metabo6010006; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; Bjursell M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167965; Caldwell MD, 2013, BRIT J PHARMACOL, V169, P834, DOI 10.1111/bph.12136; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Diaz-Arteaga A, 2012, DIABETES OBES METAB, V14, P234, DOI 10.1111/j.1463-1326.2011.01515.x; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Gupta A, 2016, J BIOL CHEM, V291, P18465, DOI 10.1074/jbc.M116.727750; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Kargl J, 2013, J PHARMACOL EXP THER, V346, P54, DOI 10.1124/jpet.113.204180; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kotsikorou E, 2013, BIOCHEMISTRY-US, V52, P9456, DOI 10.1021/bi4008885; Lanuti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126839; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee Mak-Soon, 2016, Prev Nutr Food Sci, V21, P62, DOI [10.3746/pnf.2016.21.1.62, 10.3746/pnf.2016.21.1.57]; Lingerfelt MA, 2017, BIOCHEMISTRY-US, V56, P473, DOI 10.1021/acs.biochem.6b01013; Lipina C, 2016, AGING CELL, V15, P325, DOI 10.1111/acel.12438; Lipina C, 2010, DIABETES, V59, P375, DOI 10.2337/db09-0979; Liu B, 2016, DIABETES OBES METAB, V18, P1263, DOI 10.1111/dom.12780; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; Meadows A, 2016, INT J OBESITY, V40, P417, DOI 10.1038/ijo.2015.209; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Petitet F, 2006, CHEM BIOL DRUG DES, V67, P252, DOI 10.1111/j.1747-0285.2006.00370.x; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tuduri E, 2017, J MOL ENDOCRINOL, V58, pR191, DOI 10.1530/JME-16-0253; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Walsh SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108999; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yang Hyewon, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P297, DOI 10.1515/jbcpp-2015-0080; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Zhang P, 2012, BIOMED PHARMACOTHER, V66, P485, DOI 10.1016/j.biopha.2012.04.004	53	37	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1299	1312		10.1096/fj.201800171R	http://dx.doi.org/10.1096/fj.201800171R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30148676	Green Published, hybrid			2022-12-26	WOS:000457401500103
J	Duranti, S; Vivo, V; Zini, I; Milani, C; Mangifesta, M; Anzalone, R; Mancabelli, L; Viappiani, A; Cantoni, AM; Barocelli, E; van Sinderen, D; Bertoni, S; Turroni, F				Duranti, Sabrina; Vivo, Valentina; Zini, Irene; Milani, Christian; Mangifesta, Marta; Anzalone, Rosaria; Mancabelli, Leonardo; Viappiani, Alice; Cantoni, Anna Maria; Barocelli, Elisabetta; van Sinderen, Douwe; Bertoni, Simona; Turroni, Francesca			Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusion injury	PLOS ONE			English	Article							REPERFUSION INJURY; GUT; INFLAMMATION; ISCHEMIA; IDENTIFICATION; PROBIOTICS; MICROBIOTA; BACTERIA; ASSAY; PCR	Mesenteric ischemia/reperfusion is a clinical emergency with high morbidity and mortality due to the transient reduction of blood supply to the bowel. In recent years, the critical contribution of gut microbiome to human health and proper gastrointestinal functions has gradually emerged. In the current study, we investigated the protective effects of five days supplementation with Bifidobacterium bifidum PRL2010 in a murine model of gut ischemia/reperfusion. Our findings indicate that animals pretreated with B. bifidum PRL2010 showed lower neutrophil recruitment in the lungs, remarkably reduced bacterial translocation and decreased transcription levels of TNFalpha and IL-10 both in liver and kidneys, at the same time increasing those of IL-12 in kidneys. Inhibiting the adhesion of pathogenic bacteria and boosting host innate immunity responses are among the possible protective mechanisms enacted by the probiotic. These results demonstrate that short-period treatment with B. bifidum PRL2010 is a potential strategy to dampen remote organ injury due to mesenteric ischemia/reperfusion.	[Duranti, Sabrina; Milani, Christian; Anzalone, Rosaria; Mancabelli, Leonardo; Viappiani, Alice; Barocelli, Elisabetta; Turroni, Francesca] Univ Parma, Dept Chem Sci Life Sci & Environm Sustainabil, Lab Probiogen, Parma, Italy; [Vivo, Valentina; Zini, Irene; Bertoni, Simona] Univ Parma, Food & Drug Dept, Parma, Italy; [Mangifesta, Marta] GenProbio Srl, Parma, Italy; [Cantoni, Anna Maria] Univ Parma, Dept Vet Sci, Parma, Italy; [van Sinderen, Douwe] Natl Univ Ireland, APC Microbiome Inst, Cork, Ireland; [van Sinderen, Douwe] Natl Univ Ireland, Sch Microbiol, Biosci Inst, Cork, Ireland; [Turroni, Francesca] Univ Parma, Microbiome Res Hub, Parma, Italy	University of Parma; University of Parma; University of Parma; University College Cork; University College Cork; University of Parma	Bertoni, S (corresponding author), Univ Parma, Food & Drug Dept, Parma, Italy.	simona.bertoni@uni.it	Bertoni, Simona/AAJ-8961-2020; mangifesta, marta/AAW-1521-2020; Mancabelli, Leonardo/AAV-5147-2021; Turroni, Francesca/K-9660-2016; Milani, Christian/ABA-8160-2020; Van Sinderen, Douwe/A-6778-2015; Duranti, Sabrina/AAI-7916-2020	mangifesta, marta/0000-0002-0933-1071; Mancabelli, Leonardo/0000-0002-1744-2214; Turroni, Francesca/0000-0001-5363-0231; Van Sinderen, Douwe/0000-0003-1823-7957; Duranti, Sabrina/0000-0002-7724-5669	GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [SFI/12/RC/2273]	GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	We thank GenProbio srl for financial support of the Laboratory of Probiogenomics. The funder provided support in the form of salaries for L.M., M.M. and A.V. and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DvS is a member of The APC Microbiome Institute funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant number SFI/12/RC/2273). Part of this research was conducted using the High Performance Computing (HPC) facility of the University of Parma.	Aviello G, 2017, BRIT J PHARMACOL, V174, P1704, DOI 10.1111/bph.13428; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Batt RM, 1996, J SMALL ANIM PRACT, V37, P261, DOI 10.1111/j.1748-5827.1996.tb02376.x; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bertoni S, 2018, DRUG DISCOV TODAY, V23, P1416, DOI 10.1016/j.drudis.2018.05.034; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Carver TW, 2016, CRIT CARE CLIN, V32, P155, DOI 10.1016/j.ccc.2015.11.001; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Duranti S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw191; Fedorak RN, 2015, CLIN GASTROENTEROL H, V13, P928, DOI 10.1016/j.cgh.2014.10.031; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Gueimonde M, 2004, APPL ENVIRON MICROB, V70, P4165, DOI 10.1128/AEM.70.7.4165-4169.2004; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Milani C, 2017, ISME J, V11, P2834, DOI 10.1038/ismej.2017.138; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Moore-Olufemi SD, 2005, SHOCK, V23, P258, DOI 10.1097/01.shk.0000155195.17687.00; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pires Ana L.G., 2003, J. Pediatr. (Rio J.), V79, P329, DOI 10.1590/S0021-75572003000400011; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Serafini F, 2013, ANAEROBE, V21, P9, DOI 10.1016/j.anaerobe.2013.03.003; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Turroni F, 2016, ISME J, V10, P1656, DOI 10.1038/ismej.2015.236; Turroni F, 2014, APPL ENVIRON MICROB, V80, P730, DOI 10.1128/AEM.03313-13; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Turroni F, 2011, APPL ENVIRON MICROB, V77, P8578, DOI 10.1128/AEM.06352-11; Wang HG, 2013, BRIT J NUTR, V109, P1990, DOI 10.1017/S0007114512004308	33	13	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202670	10.1371/journal.pone.0202670	http://dx.doi.org/10.1371/journal.pone.0202670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161157	Green Submitted, Green Published, gold			2022-12-26	WOS:000443388900037
J	Nemeh, F; Humberstone, J; Yates, MJ; Reeve, RA				Nemeh, Fiona; Humberstone, Judi; Yates, Mark J.; Reeve, Robert A.			Non-symbolic magnitudes are represented spatially: Evidence from a non-symbolic SNARC task	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PARIETAL CORTEX; NUMERICAL ASSOCIATIONS; VISUOSPATIAL ABILITIES; MENTAL REPRESENTATION; COMPARATIVE JUDGMENTS; RESPONSE SELECTION; NUMBER MAGNITUDE; SINGLE-DIGIT; SPACE	A core proposition in numerical cognition is numbers are represented spatially. Evidence for this proposition comes from the "spatial numerical association of response codes" effect (SNARC) in which faster responses are made by the left/right hand judging whether one of a pair of Arabic digits is smaller/larger than the other. Less is known if a similar SNARC effect exists for non-symbolic magnitudes; and research that has been conducted used stimuli which could be translated into symbolic terms. To overcome this limitation, we employed a referent-to-target judgment paradigm in which a referent dot array (n = 30 dots) was follow by a second array of dots (e.g., n = 45 or 15 dots)-participants judged if the second array contained fewer or more dots than the referent array. Dot arrays with fewer dots were judged more quickly with the left hand compared to the right hand (i.e., a SNARC effect). Not all participants demonstrated a SNARC effect, however. Neither visuospatial working memory nor math ability was associated with the presence/absence of a non-symbolic SNARC effect. Implications of the non-symbolic SNARC effect for accounts of numerical cognition are discussed.	[Nemeh, Fiona; Humberstone, Judi; Reeve, Robert A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Yates, Mark J.] Columbia Univ, Dept Neurol Surg, New York, NY USA	University of Melbourne; Columbia University	Reeve, RA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	r.reeve@unimelb.edu.au		Nemeh, Fiona/0000-0001-9412-1732	Australian Government Research Training Program (RTP) Scholarship	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was supported by an Australian Government Research Training Program (RTP) Scholarship to Ms Fiona Nemeh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalric M, 2016, P NATL ACAD SCI USA, V113, P4909, DOI 10.1073/pnas.1603205113; Bachot J., 2005, PSYCHOL SCI, V47, P172, DOI DOI 10.1016/0010-0277(92)90049-N; Beecham R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005543; Beran MJ, 2017, BEHAV BRAIN SCI, V40, P17, DOI 10.1017/S0140525X16002065; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Burr DC, 2017, BEHAV BRAIN SCI, V40, P18, DOI 10.1017/S0140525X16002077; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Chew CS, 2016, J EXP CHILD PSYCHOL, V152, P173, DOI 10.1016/j.jecp.2016.07.001; Cipora K, 2016, PSYCHOL RES-PSYCH FO, V80, P710, DOI 10.1007/s00426-015-0677-6; Cipora K, 2013, Q J EXP PSYCHOL, V66, P1974, DOI 10.1080/17470218.2013.772215; Cornu V, 2016, WORKSH DOM GEN DOM S, DOI 10993/28747; Crollen V, 2015, J EXP CHILD PSYCHOL, V132, P84, DOI 10.1016/j.jecp.2014.12.006; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene Stanislas, 2011, SPACE TIME NUMBER BR; Dowker A, 2008, DEVELOPMENTAL SCI, V11, P650, DOI 10.1111/j.1467-7687.2008.00713.x; Fattorini E, 2015, CORTEX, V73, P298, DOI 10.1016/j.cortex.2015.09.007; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2006, CORTEX, V42, P1066, DOI 10.1016/S0010-9452(08)70218-1; Fischer MH, 2010, BRAIN COGNITION, V72, P333, DOI 10.1016/j.bandc.2009.10.010; Fischer MH, 2004, EXP PSYCHOL, V51, P91, DOI 10.1027/1618-3169.51.2.91; FISCHER MH, 2005, PSYCHOL SCI, V47, P22; Formoso J, 2017, SPAN J PSYCHOL, V20, DOI 10.1017/sjp.2017.23; Gebuis T, 2017, BEHAV BRAIN SCI, V40, P23, DOI 10.1017/S0140525X16002107; Gebuis T, 2016, ACTA PSYCHOL, V171, P17, DOI 10.1016/j.actpsy.2016.09.003; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gevers W, 2006, ACTA PSYCHOL, V122, P221, DOI 10.1016/j.actpsy.2005.11.004; Gevers W, 2006, EXP PSYCHOL, V53, P58, DOI 10.1027/1618-3169.53.1.58; Gevers W, 2010, J EXP PSYCHOL GEN, V139, P180, DOI 10.1037/a0017688; Gibson LC, 2016, J EXP CHILD PSYCHOL, V150, P301, DOI 10.1016/j.jecp.2016.05.009; Gray SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094428; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Holmes KJ, 2011, BRAIN COGNITION, V77, P315, DOI 10.1016/j.bandc.2011.07.002; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Huber S, 2015, RES DEV DISABIL, V43-44, P32, DOI 10.1016/j.ridd.2015.06.003; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Keus IM, 2005, COGNITIVE BRAIN RES, V24, P48, DOI 10.1016/j.cogbrainres.2004.12.005; Krause F, 2014, J COGNITIVE NEUROSCI, V26, P768, DOI 10.1162/jocn_a_00518; Leibovich T, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000960; Lourenco SF, 2017, BEHAV BRAIN SCI, V40, P29, DOI 10.1017/S0140525X16002156; Macnamara A, 2018, EXP BRAIN RES, V236, P335, DOI 10.1007/s00221-017-5154-6; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Mitchell T, 2012, Q J EXP PSYCHOL, V65, P1945, DOI 10.1080/17470218.2012.673631; Myers T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01646; Nishimura A, 2009, PSYCHON B REV, V16, P666, DOI 10.3758/PBR.16.4.666; Nuerk HC, 2005, EXP PSYCHOL, V52, P187, DOI 10.1027/1618-3169.52.3.187; Odic D, 2017, BEHAV BRAIN SCI, V40, P34, DOI 10.1017/S0140525X1600220X; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patro K, 2012, J EXP CHILD PSYCHOL, V111, P534, DOI 10.1016/j.jecp.2011.09.006; Paul JM, 2016, LEARN INSTR, V42, P113, DOI 10.1016/j.learninstruc.2016.01.011; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; Reynvoet B, 1999, COGNITION, V72, P191, DOI 10.1016/S0010-0277(99)00048-7; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rusconi E., 2006, COGNITION, V99, P113, DOI [10. 1016/j. cognition. 2005. 01. 004, DOI 10.1016/J.C0GNITI0N.2005.01.004]; Schwarz W, 2006, EXP PSYCHOL, V53, P4, DOI 10.1027/1618-3169.53.1.4; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Sella F, 2016, TRENDS NEUROSCI EDUC, V5, P20, DOI 10.1016/j.tine.2016.02.002; Shaki S, 2005, PSYCHON B REV, V12, P931, DOI 10.3758/BF03196788; Shaki S, 2012, J EXP PSYCHOL HUMAN, V38, P515, DOI 10.1037/a0026729; Shaki S, 2011, J CROSS CULT PSYCHOL, V42, P639, DOI 10.1177/0022022111406100; Tosto MG, 2017, DEV PSYCHOL, V53, P1924, DOI 10.1037/dev0000331; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Viarouge A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095756; Vicario CM, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00016; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Zhou XL, 2016, EXP PSYCHOL, V63, P169, DOI 10.1027/1618-3169/a000324	70	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203019	10.1371/journal.pone.0203019	http://dx.doi.org/10.1371/journal.pone.0203019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161171	Green Published, gold			2022-12-26	WOS:000443388900066
J	Abd El Kader, NA; Farghali, HA; Abu-Seida, AM; Salem, NY; Khattab, MS				Abd El Kader, Naglaa A.; Farghali, Haithem A.; Abu-Seida, Ashraf M.; Salem, Noha Y.; Khattab, Marwa S.			Evaluation of chromocystoscopy in the diagnosis of cystitis in female donkeys	PLOS ONE			English	Article							CHROMOENDOSCOPY; MANAGEMENT; ENDOSCOPY; HORSES; TRACT	Early detection of cystitis in equine is essential to improve the prognosis and outcome of therapy. However, the conventional white light endoscopy is not sufficiently accurate for this purpose. Hence, this study evaluated chromoendoscopy as a recent diagnostic tool for cystitis in female donkeys. For this purpose, 5 apparently normal donkeys (control group) and 5 female donkeys with cystitis (diseased group) were used. Physical and rectal examinations, urine analysis, white light cystoscopy, methylene blue-based chromoendoscopy and histopathology were performed in all animals. Turbid urine exhibiting an alkaline pH and a significant (P = .02) increase in the numbers of RBCs and WBCs was observed in the diseased group compared to the control one. In the control group, white light cystoscopy showed a smooth pale pink glistening mucosa with two openings of the ureters and visible submucosal blood vessels. During chromocystoscopy, faint bluish discoloration of the mucosal surface with clearly visible submucosal blood vessels was detectable. These findings were correlated with the histopathological findings of the biopsies collected from the urinary bladder. In the diseased group, white-light cystoscopy showed clearly visible blood vessels, mildly hyperaemic mucosa in focal or diffuse forms and small vesicle formation. Chromocystoscopy revealed dark bluish oedematous and irregular mucosa either in a focal form or a diffuse form (marbled appearance) with deeply stained submucosal blood vessels. Histopathologically, the urothelium was hyperplastic with squamous metaplasia and the lamina propria was infiltrated with few leukocytes and congested blood vessels. Small bluish dots representing the absorbed methylene blue dye were seen in the inflamed areas against the lightly stained mucosa of the bladder. Severe diffuse necrotic cystitis was also seen with bacterial aggregations on the surface. Gram's staining revealed both gram positive bacilli and Gram positive coccobacilli. In conclusion, chromoendoscopy is a helpful tool for early diagnosis of cystitis in female donkeys and enables targeted biopsies, which improves the prognosis and outcome of therapy.	[Abd El Kader, Naglaa A.; Farghali, Haithem A.; Abu-Seida, Ashraf M.] Cairo Univ, Fac Vet Med, Dept Surg Anaesthesiol & Radiol, Giza, Egypt; [Salem, Noha Y.] Cairo Univ, Fac Vet Med, Dept Internal Med & Infect Dis, Giza, Egypt; [Khattab, Marwa S.] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt; [Abd El Kader, Naglaa A.; Farghali, Haithem A.; Abu-Seida, Ashraf M.; Salem, Noha Y.; Khattab, Marwa S.] Cairo Univ, Fac Vet Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Abu-Seida, AM (corresponding author), Cairo Univ, Fac Vet Med, Dept Surg Anaesthesiol & Radiol, Giza, Egypt.; Abu-Seida, AM (corresponding author), Cairo Univ, Fac Vet Med, Giza, Egypt.	ashrafseida@cu.edu.eg	Abu-Seida, A.M./F-7771-2011; Farghali, Haithem/AAH-8288-2021	Abu-Seida, A.M./0000-0001-5466-2016; Salem, Noha/0000-0002-3376-8695; Khattab, Marwa/0000-0002-8068-6094; Ali Mohamed Ahmed Farghali, Haithem/0000-0002-3311-1335				Boeriu AM, 2009, J GASTROINTEST LIVER, V18, P109; Divers TJ, 2006, LARGE ANIMAL INTERNA, P937; Frye MA, 2006, VET CLIN N AM-EQUINE, V22, P497, DOI 10.1016/j.cveq.2006.03.004; Higgens AG, 2006, EQUINE MANUAL, P123; JOHNSON PJ, 1987, J AM VET MED ASSOC, V191, P973; Kida M, 2003, ENDOSCOPY, V35, P590; Kiesslich R, 2001, ENDOSCOPY, V33, P1001, DOI 10.1055/s-2001-18932; Kim C, 2011, OPT LETT, V36, P3599, DOI 10.1364/OL.36.003599; Knottenbelt DC, 2006, THE EQUINE MANUAL; Kumas C, 2014, J EQUINE VET SCI, V34, P329, DOI 10.1016/j.jevs.2013.07.003; Martov A. G., 2015, Urologiya (Moscow), P55; Nessa K, 2014, J ENAM MED COLL, V4, P39; Onmaz AC, 2013, KAFKAS UNIV VET FAK, V19, pA203, DOI 10.9775/kvfd.2012.7656; Pohl J, 2011, GUT, V60, P485, DOI 10.1136/gut.2010.229534; Pohl J, 2010, AM J GASTROENTEROL, V105, P2350, DOI 10.1038/ajg.2010.280; Ratiu Nadia, 2005, Rom J Gastroenterol, V14, P239; Rendle DI, 2008, VET REC, V162, P783, DOI 10.1136/vr.162.24.783; Schott H.C., 2004, EQUINE INTERNAL MED; Schott HC, 1997, URINARY TRACT EQUINE, P187; Sellon DC., 2004, EQUINE INTERNAL MED; Sellors John, 2003, Asian Pac J Cancer Prev, V4, P277; Sprayberry K., 2004, ATLAS EQUINE ENDOSCO, P169; Squinas SC, 2013, CAN VET J, V54, P690; Sullins KE, 1988, COMP CONT EDUC PRACT, V4, P339; Suvarna SK, 2012, BANCROFTS THEORY PRA, P234; Tatsuta M, 1985, GASTROENTEROL ENDOSC, V27, P924; Traub-Dargatz JL, 1987, VET CLIN N AM-EQUINE, V3, P585; Trivedi PJ, 2013, QJM-INT J MED, V106, P117, DOI 10.1093/qjmed/hcs186; YOSHIDA S, 1981, JPN J CLIN ONCOL, V11, P495; YOSHIDA S, 1984, JPN J CLIN ONCOL, V14, P225	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202596	10.1371/journal.pone.0202596	http://dx.doi.org/10.1371/journal.pone.0202596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157228	Green Published, gold, Green Submitted			2022-12-26	WOS:000443071400064
J	Zhao, M; Yuan, MM; Yuan, L; Huang, LL; Liao, JH; Yu, XL; Su, C; Chen, YH; Yang, YY; Yu, H; Xu, DX				Zhao, Mei; Yuan, Man Man; Yuan, Li; Huang, Li Li; Liao, Jian Hong; Yu, Xiao Ling; Su, Chang; Chen, Yuan Hua; Yang, Yu Ying; Yu, Huan; Xu, De Xiang			Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice	PLOS ONE			English	Article							HIGH-FAT DIET; HEPATIC INSULIN-RESISTANCE; FED ICR MICE; HOMOCYSTEINE-THIOLACTONE; METHYL DONOR; MODEL; RATS; HYPERHOMOCYSTEINEMIA; DIFFERENTIATION; GLYCOGEN	Previous studies have shown that folate levels were decreased in patients with type 2 diabetes (T2D) and further lowered in T2D patients with cognitive impairment. However, whether folate deficiency could cause T2D and subsequent cognitive dysfunction is still unknown. The present study aimed to explore the effects of chronic folate deficiency (CFD) on glucose and lipid metabolism and cognitive function in mice. Seven-week-old mice were fed with either a CFD or control diet for 25 weeks. Serum folate was significantly reduced, whereas serum total homocysteine was significantly increased in the CFD group. Moreover, CFD induced obesity after a 6-week diet treatment, glucose intolerance and insulin resistance after a 16-week-diet treatment. In addition, CFD reduced the hepatic p-Akt/Akt ratio in response to acute insulin administration. Moreover, CFD increased serum triglyceride levels, upregulated hepatic Acct and Fasn mRNA expression, and downregulated hepatic Cd36 and ApoB mRNA expression. After a 24-week diet treatment, CFD induced anxietyrelated activities and impairment of spatial learning and memory performance. This study demonstrates that folate deficiency could induce obesity, glucose and lipid metabolism disorders and subsequent cognitive dysfunction.	[Zhao, Mei; Yuan, Man Man; Yuan, Li; Huang, Li Li; Liao, Jian Hong; Yu, Xiao Ling; Su, Chang; Yang, Yu Ying; Yu, Huan] Anhui Med Univ, Sch Nursing, Hefei, Anhui, Peoples R China; [Zhao, Mei; Chen, Yuan Hua; Xu, De Xiang] Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Anhui, Peoples R China; [Chen, Yuan Hua] Anhui Med Univ, Dept Histol & Embryol, Hefei, Anhui, Peoples R China; [Xu, De Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Anhui, Peoples R China; [Yuan, Man Man] Anhui Med Univ, Sch Int Educ, Hefei, Anhui, Peoples R China; [Yuan, Li] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhao, M (corresponding author), Anhui Med Univ, Sch Nursing, Hefei, Anhui, Peoples R China.; Zhao, M (corresponding author), Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Anhui, Peoples R China.	zhaomei@ahmu.edu.cn		Zhao, Mei/0000-0003-3530-0233	National Natural Science Foundation of China [81671471, 81630084]; Key University Science Research Project of Anhui Provincial [KJ2016A360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Anhui Provincial	This project was supported by National Natural Science Foundation of China (81671471 and 81630084) and Key University Science Research Project of Anhui Provincial (KJ2016A360).	Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Al-Maskari Masoud Y, 2012, Nutrition, V28, pe23, DOI 10.1016/j.nut.2012.01.005; Araujo JR, 2015, AGEING RES REV, V22, P9, DOI 10.1016/j.arr.2015.04.005; Aydin O, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1020-6; Berglund SK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2809-3; Bernardo A, 2007, NEUROBIOL AGING, V28, P1195, DOI 10.1016/j.neurobiolaging.2006.05.035; Bharathselvi M, 2016, INDIAN J MED RES, V143, P756, DOI 10.4103/0971-5916.192026; Champier J, 2012, NUTR RES, V32, P124, DOI 10.1016/j.nutres.2011.12.012; Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859; Choi Sun-Il, 2012, Lab Anim Res, V28, P155, DOI 10.5625/lar.2012.28.3.155; Dekel Y, 2009, LAB ANIMAL, V38, P55, DOI 10.1038/laban0209-55; Demakakos P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175827; EVENSON A, 1946, J BACTERIOL, V51, P513, DOI 10.1128/JB.51.4.513-521.1946; Fu L, 2017, PHYSIOL BEHAV, V179, P333, DOI 10.1016/j.physbeh.2017.07.017; Geijselaers SLC, 2015, LANCET DIABETES ENDO, V3, P75, DOI 10.1016/S2213-8587(14)70148-2; Helm S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00161; Hong SM, 2017, BRIT J NUTR, V118, P1078, DOI 10.1017/S0007114517003087; Hrncic D, 2016, CAN J PHYSIOL PHARM, V94, P1074, DOI 10.1139/cjpp-2015-0581; Hsu HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077931; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kang S, 2017, NEUROPHARMACOLOGY, V113, P467, DOI 10.1016/j.neuropharm.2016.10.029; Kim Ji Eun, 2017, Lab Anim Res, V33, P171, DOI 10.5625/lar.2017.33.2.171; Liu XJ, 2015, ENDOCRINOLOGY, V156, P2103, DOI 10.1210/en.2014-2037; Liu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114780; Liu ZX, 2016, MOL MED REP, V14, P1323, DOI 10.3892/mmr.2016.5393; Macklin L, 2017, EXP GERONTOL, V88, P9, DOI 10.1016/j.exger.2016.12.019; Najib S, 2005, J MOL ENDOCRINOL, V34, P119, DOI 10.1677/jme.1.01581; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Niedowicz DM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-64; Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Palta P, 2018, J GERONTOL A-BIOL, V73, P123, DOI 10.1093/gerona/glx076; Rector RS, 2013, HEPATOLOGY, V57, P2213, DOI 10.1002/hep.26285; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shea TB, 2004, J ALZHEIMERS DIS, V6, P269; Sickmann HM, 2015, METAB BRAIN DIS, V30, P335, DOI 10.1007/s11011-014-9546-z; Sironi AM, 2011, CURR PHARM DESIGN, V17, P3074, DOI 10.2174/138161211798157720; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang D, 2017, MOL CELL ENDOCRINOL, V443, P72, DOI 10.1016/j.mce.2017.01.006; Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010; Wee AKH, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0208-3; Wierzbicki Anthony S, 2007, Diab Vasc Dis Res, V4, P143; Yu XQ, 2014, POULTRY SCI, V93, P2596, DOI 10.3382/ps.2014-04027; Yuan HD, 2012, BIOMOL THER, V20, P220, DOI 10.4062/biomolther.2012.20.2.220; Zhang F, 2017, J DAIRY SCI, V100, P1618, DOI 10.3168/jds.2016-11870; Zhang HS, 2005, PHARMACOLOGY, V74, P57, DOI 10.1159/000083684; Zhang ZH, 2015, EXP ANIM TOKYO, V64, P435, DOI 10.1538/expanim.14-0086; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672; Zheng MY, 2014, J CLIN BIOCHEM NUTR, V54, P122, DOI 10.3164/jcbn.13-89; Zheng YQ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0223-5; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	53	16	16	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202910	10.1371/journal.pone.0202910	http://dx.doi.org/10.1371/journal.pone.0202910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153273	gold, Green Submitted, Green Published			2022-12-26	WOS:000443001700031
J	Jin, S; Lee, MY				Jin, Solee; Lee, Mi-Young			The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; HUMAN KERATINOCYTES; PROTEIN EXPRESSION; MAMMALIAN TARGET; CELLS; AKT; MACROPHAGES; SUPPRESSION; ACTIVATION	In this study, we investigated the anti-microbial, anti-inflammatory, and anti-lipogenic effects of hemp (Cannabis sativa L.) seed hexane extracts, focusing on the Propionibacterium acnes-triggered inflammation and lipogenesis. Hemp seed hexane extracts (HSHE) showed anti-microbial activity against P. acnes. The expression of iNOS, COX-2, and the subsequent production of nitric oxide and prostaglandin increased after infection of P. acnes in HaCaT cells, however, upon treating with HSHE, their expressions were reduced. P. acnes induced expressions of IL-1 beta and IL-8 were also reduced. HSHE exerted anti-inflammatory effects by regulating NF-kappa B and MAPKs signaling and blunting the translocation of p-NF-kappa B to the nucleus in P. acnes-stimulated HaCaT cells. Moreover, P. acnes-induced phosphorylation of ERK and JNK, and their downstream targets c-Fos and c-Jun, was also inhibited by HSHE. In addition, the transactivation of AP-1 induced by P. acnes infection was also downregulated by HSHE. Notably, HSHE regulated inflammation and lipid biosynthesis via regulating AMPK and AKT/FoxO1 signaling in IGF-1-induced inflammation and lipogenesis of sebocytes. In addition, HSHE inhibited 5-lipoxygenase level and P. acnes-induced MMP-9 activity, and promoted collagen biosynthesis in vitro. Thus, HSHE could be utilized to treat acne vulgaris, through its anti-microbial, anti-inflammatory, anti-lipogenic, and collagen-promoting properties.	[Jin, Solee; Lee, Mi-Young] SoonChunHyang Univ, Coll Med Sci, Dept Med Sci, Asan, Chungnam, South Korea; [Lee, Mi-Young] SoonChunHyang Univ, Coll Med Sci, Dept Med Biotechnol, Asan, Chungnam, South Korea	Soonchunhyang University; Soonchunhyang University	Lee, MY (corresponding author), SoonChunHyang Univ, Coll Med Sci, Dept Med Sci, Asan, Chungnam, South Korea.; Lee, MY (corresponding author), SoonChunHyang Univ, Coll Med Sci, Dept Med Biotechnol, Asan, Chungnam, South Korea.	miyoung@sch.ac.kr			Soonchunhyang University	Soonchunhyang University	This work was supported by Soonchunhyang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Soonchunhyang University.	Al-Mariri A, 2013, IRAN J MED SCI, V38, P44; Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Badowski M, 2017, CANCER CHEMOTH PHARM, V80, P441, DOI 10.1007/s00280-017-3387-5; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Byrum RS, 1999, J IMMUNOL, V163, P6810; Chang CS, 2010, INFLAMMATION, V33, P46, DOI 10.1007/s10753-009-9157-8; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Deferne J.L, 1996, J INT HEMP ASS, V3, P4; Dhupal M, 2017, MOL CELL TOXICOL, V13, P115, DOI 10.1007/s13273-017-0012-y; Gao YL, 2012, TOXICOL IN VITRO, V26, P1, DOI 10.1016/j.tiv.2011.09.019; Ge YJ, 2012, J BIOL CHEM, V287, P43928, DOI 10.1074/jbc.R112.406942; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hirayama K, 2002, J COMP PATHOL, V127, P249, DOI 10.1053/jcpa.2002.0590; Jeon YM, 2015, LIFE SCI, V124, P56, DOI 10.1016/j.lfs.2014.12.029; Jeong JW, 2017, MOL CELL TOXICOL, V13, P405, DOI 10.1007/s13273-017-0045-2; Jeong M, 2014, J ETHNOPHARMACOL, V154, P745, DOI 10.1016/j.jep.2014.04.052; Jung JY, 2014, ACTA DERM-VENEREOL, V94, P521, DOI 10.2340/00015555-1802; Kim JH, 2016, MOL CELL TOXICOL, V12, P53, DOI 10.1007/s13273-016-0008-z; Kim M, 2015, ARCH BIOCHEM BIOPHYS, V583, P79, DOI 10.1016/j.abb.2015.07.007; Kim SY, 2015, INT J MOL MED, V35, P1042, DOI 10.3892/ijmm.2015.2098; Ko JW, 2017, MOL CELL TOXICOL, V13, P295, DOI 10.1007/s13273-017-0033-6; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee H, 2016, MOL CELL TOXICOL, V12, P337, DOI 10.1007/s13273-016-0038-6; Lee H, 2016, MOL CELL TOXICOL, V12, P273, DOI 10.1007/s13273-016-0032-z; Lee NR, 2016, MOL CELL TOXICOL, V12, P371, DOI 10.1007/s13273-016-0041-y; Leizer C., 2000, Journal of Nutraceuticals, Functional & Medical Foods, V2, P35, DOI 10.1300/J133v02n04_04; Levy LL, 2012, AM J CLIN DERMATOL, V13, P331, DOI 10.2165/11631410-000000000-00000; Luo Q, 2017, MOL CELL BIOCHEM, V428, P129, DOI 10.1007/s11010-016-2923-7; McCusker MM, 2010, CLIN DERMATOL, V28, P440, DOI 10.1016/j.clindermatol.2010.03.020; Nissen L, 2010, FITOTERAPIA, V81, P413, DOI 10.1016/j.fitote.2009.11.010; Ottaviani M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/858176; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park JY, 2014, EVID-BASED COMPL ALT, V2014, P11; Ryu AR, 2017, PHOTODIAGN PHOTODYN, V20, P71, DOI 10.1016/j.pdpdt.2017.08.002; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sato T, 2012, J DERMATOL, V39, P774, DOI 10.1111/j.1346-8138.2012.01525.x; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Shibata M, 2009, J INVEST DERMATOL, V129, P375, DOI 10.1038/jid.2008.237; Tsai HH, 2013, J DERMATOL SCI, V69, P122, DOI 10.1016/j.jdermsci.2012.10.009; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170599; Won J, 2016, MOL CELL TOXICOL, V12, P37, DOI 10.1007/s13273-016-0006-1; Wu WJ, 2015, INT J MOL MED, V35, P1734, DOI 10.3892/ijmm.2015.2187; Yoon JY, 2013, J INVEST DERMATOL, V133, P429, DOI 10.1038/jid.2012.292; Zhang JH, 2016, DRUG DES DEV THER, V10, P1829, DOI 10.2147/DDDT.S104602; Zouboulis CC, 2010, EXP DERMATOL, V19, P148, DOI 10.1111/j.1600-0625.2009.00929.x; Zouboulis CC, 2009, DERM-ENDOCRINOL, V1, P188, DOI 10.4161/derm.1.3.8368; Zuardi AW, 2006, REV BRAS PSIQUIATR, V28, P153, DOI 10.1590/S1516-44462006000200015	48	19	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202933	10.1371/journal.pone.0202933	http://dx.doi.org/10.1371/journal.pone.0202933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148860	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200035
J	Ma, DJ; Park, UC; Kim, ET; Yu, HG				Ma, Dae Joong; Park, Un Chul; Kim, Ei Tae; Yu, Hyeong Gon			Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SPECTRAL-DOMAIN; ANGIOGRAPHY; THICKNESS; EYES; VASCULATURE; VERTEPORFIN	Purpose This study evaluated changes in choroidal vascularity after half-fluence photodynamic therapy (HF-PDT) in patients with central serous chorioretinopathy (CSC) using swept-source optical coherence tomography (SS-OCT) en face imaging. Methods This retrospective comparative case series included 50 eyes of 25 patients with unilateral CSC who underwent HF-PDT and 50 age-and sex-matched normal healthy control eyes. En face SS-OCT images of the choriocapillaris, Sattler's layer, and Haller's layer were converted into binary images. The vascular proportions were defined as the percentage of the area of vascular lumen against the area of the 3.0-mm-diameter circular area. The main outcome measures were the vascular proportions before HF-PDT and at 6 weeks, 6 months, and 12 months after HF-PDT. Results At baseline, the vascular proportions in the CSC eyes were significantly greater than those in the control eyes in all layers (choriocapillaris: 51.8%+/- 15.5% vs. 41.3 +/- 18.7%, P = 0.018; Sattler's: 58.6% +/- 13.4% vs. 49.7% +/- 15.7%, P = 0.017; Haller's: 65.3% +/- 15.3% vs. 53.0% +/- 13.4%, P= 0.001). In the CSC eyes, the vascular proportion in the choriocapillaris significantly decreased at 6 weeks (36.6% +/- 16.9%, P< 0.001), 6 months (34.0% +/- 12.3%, P< 0.001), and 12 months (34.8% +/- 17.6%, P< 0.001) after HF-PDT compared with baseline. The vascular proportions in Sattler's and Haller's layers did not show a significant decrease at 6 weeks (Sattler's: 49.7% +/- 17.3%, P = 0.052 and Haller's: 58.3% +/- 12.9%, P= 0.558) but decreased significantly at 6 months (Sattler's: 48.9% +/- 12.4%, P< 0.001 and Haller's: 57.7% +/- 15.7%, P= 0.027) and 12 months after HF-PDT from the baseline values (Sattler's: 45.8% +/- 10.4%, P< 0.001 and Haller's: 56.8% +/- 15.7%, P< 0.001). Conclusion After HF-PDT, the choriocapillaris showed the earliest decrease in vascular proportion of en face images, Sattler's and Haller's layers showed later decreases. The temporal differences in the response of each layer may reflect the pathophysiology of CSC and the therapeutic mechanism of HF-PDT.	[Ma, Dae Joong; Park, Un Chul; Kim, Ei Tae; Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Ma, Dae Joong; Park, Un Chul; Yu, Hyeong Gon] Seoul Natl Univ Hosp, Retinal Degenerat Res Lab, Biomed Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Yu, HG (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Yu, HG (corresponding author), Seoul Natl Univ Hosp, Retinal Degenerat Res Lab, Biomed Res Inst, Seoul, South Korea.	hgonyu@snu.ac.kr		MA, DAE JOONG/0000-0001-9322-5898; Yu, Hyeong Gon/0000-0002-1795-202X				Agrawal R, 2016, RETINA-J RET VIT DIS, V36, P1646, DOI 10.1097/IAE.0000000000001040; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chan SY, 2016, RETINA-J RET VIT DIS, V36, P2051, DOI 10.1097/IAE.0000000000001064; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Dansingani KK, 2016, RETINA-J RET VIT DIS, V36, P499, DOI 10.1097/IAE.0000000000000742; Donald J, 1967, AM J OPHTHALMOL, V63, DOI [10.1016/0002-9394(67)90027-X, DOI 10.1016/0002-9394(67)90027-X]; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Hua R, 2014, PHOTODIAGN PHOTODYN, V11, P565, DOI 10.1016/j.pdpdt.2014.07.002; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Izumi T, 2017, BRIT J OPHTHALMOL, V101, P433, DOI 10.1136/bjophthalmol-2016-308921; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Kim YT, 2011, EYE, V25, P1635, DOI 10.1038/eye.2011.258; Kuroda Y, 2016, AM J OPHTHALMOL, V169, P199, DOI 10.1016/j.ajo.2016.06.043; Manayath GJ, 2018, RETINA-J RET VIT DIS, V38, P1195, DOI 10.1097/IAE.0000000000001665; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; MARMOR MF, 1988, GRAEF ARCH CLIN EXP, V226, P548, DOI 10.1007/BF02169203; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Mori K, 1999, OPHTHALMOLOGY, V106, P1384, DOI 10.1016/S0161-6420(99)00729-0; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Reibaldi M, 2010, AM J OPHTHALMOL, V149, P307, DOI 10.1016/j.ajo.2009.08.026; Salehi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011841.pub2; Schlotzer-Schrehardt U, 2002, GRAEF ARCH CLIN EXP, V240, P748, DOI 10.1007/s00417-002-0517-4; Shin JY, 2011, RETINA-J RET VIT DIS, V31, P119, DOI 10.1097/IAE.0b013e3181e378f2; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Su GL, 2017, CLIN OPHTHALMOL, V11, P889, DOI 10.2147/OPTH.S135479; Tsujikawa A, 2010, RETINA-J RET VIT DIS, V30, P801, DOI 10.1097/IAE.0b013e3181c72068; Yang LH, 2013, ACTA OPHTHALMOL, V91, pE358, DOI 10.1111/aos.12059	30	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202930	10.1371/journal.pone.0202930	http://dx.doi.org/10.1371/journal.pone.0202930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148858	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200033
J	Tran, VN; Dasagrandhi, C; Truong, VG; Kim, YM; Kang, HW				Van Nam Tran; Dasagrandhi, Chakradhar; Van Gia Truong; Kim, Young-Mog; Kang, Hyun Wook			Antibacterial activity of Staphylococcus aureus biofilm under combined exposure of glutaraldehyde, near-infrared light, and 405-nm laser	PLOS ONE			English	Article							ANTIMICROBIAL PHOTODYNAMIC THERAPY; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; IN-VITRO; GOLD NANOPARTICLES; RESISTANCE; EFFICACY; AGENTS; DECONTAMINATION; DISINFECTION	Healthcare-associated infections have increasingly become problematic in the endoscopic procedures resulting in several severe diseases such as carbapenem-resistant Enterobacteriaceae (CRE)-related infections, pneumonia, and bacteremia. Especially, some bacterial strains are resistant to traditional antimicrobials. Therefore, the necessity of developing new antibiotics or management to deal with bacterial infections has been increasing. The current study combined a low concentration of glutaraldehyde (GTA) with near-infrared (NIR) light and 405-nm laser to entail antibacterial activity on Staphylococcus aureus biofilm. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and colony forming unit (CFU) counting were used to quantify the viable cells while fluorescent and scanning electron microscopic images were used to qualitatively evaluate the cell membrane integrity and structural deformation, respectively. Practically, S. aureus biofilm was highly susceptible (7% cell viability and 6.8-log CFU/cm(2) bacterial reduction for MTT assay and CFU analysis, respectively) to the combination of GTA (0.1%), NIR light (270 J/cm(2)), and 405-nm laser (288 J/cm(2)) exposure. GTA could form either DNA-protein or protein-protein crosslinks to inhibit DNA and protein synthesis. The NIR light induced the thermal damage on protein/ enzymes while 405-nm laser could induce reactive oxygen species (ROS) to damage the bacterial membrane. Thus, the proposed technique may be a feasible modality for endoscope cleaning to prevent any secondary infection in the healthcare industry.	[Van Nam Tran; Van Gia Truong; Kang, Hyun Wook] Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea; [Dasagrandhi, Chakradhar] Pukyong Natl Univ, Marine Integrated Bion Res Ctr, Busan, South Korea; [Kim, Young-Mog] Pukyong Natl Univ, Dept Food Sci & Technol, Busan, South Korea; [Kang, Hyun Wook] Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol, Busan, South Korea	Pukyong National University; Pukyong National University; Pukyong National University; Pukyong National University	Kang, HW (corresponding author), Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea.; Kim, YM (corresponding author), Pukyong Natl Univ, Dept Food Sci & Technol, Busan, South Korea.; Kang, HW (corresponding author), Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol, Busan, South Korea.	ymkim@pknu.ac.kr; wkang@pukyong.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1017]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1017).; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1017).	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Abreu AC, 2013, J ANTIMICROB CHEMOTH, V68, P2718, DOI 10.1093/jac/dkt281; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Astafyeva LG, 2012, OPT SPECTROSC+, V112, P642, DOI 10.1134/S0030400X12040030; Aumeran C, 2012, J CLIN MICROBIOL, V50, P938, DOI 10.1128/JCM.06221-11; Bruenke J, 2016, MACROMOL BIOSCI, V16, P647, DOI 10.1002/mabi.201500266; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotton P., 2003, PRACTICAL GASTROINTE; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Gao Q, 2017, ACTA BIOMATER, V51, P112, DOI 10.1016/j.actbio.2017.01.061; Gu HW, 2003, NANO LETT, V3, P1261, DOI 10.1021/nl034396z; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Ha JW, 2015, APPL ENVIRON MICROB, V81, P2, DOI 10.1128/AEM.01862-14; Ha JW, 2013, APPL ENVIRON MICROB, V79, P6568, DOI 10.1128/AEM.02249-13; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hu DF, 2017, ACS NANO, V11, P9330, DOI 10.1021/acsnano.7b04731; Ju EG, 2013, CHEM COMMUN, V49, P9048, DOI 10.1039/c3cc45290e; Juan MR, 2015, GASTROENTEROL NURS, V38, P70, DOI 10.1097/SGA.0000000000000092; Kim SY, 2011, CLIN ENDOSC, V44, P109, DOI 10.5946/ce.2011.44.2.109; Kim SH, 2016, RSC ADV, V6, P61482, DOI 10.1039/c6ra08196g; Kim SH, 2015, ACS APPL MATER INTER, V7, P15600, DOI 10.1021/acsami.5b04321; Kovaleva J, 2013, CLIN MICROBIOL REV, V26, P231, DOI 10.1128/CMR.00085-12; Krespi YP, 2011, AM J OTOLARYNG, V32, P198, DOI 10.1016/j.amjoto.2010.01.010; Kumar A, 2015, J PHOTOCH PHOTOBIO B, V149, P37, DOI 10.1016/j.jphotobiol.2015.05.005; Lei WX, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600767; Li M, 2017, RSC ADV, V7, P40734, DOI 10.1039/c7ra06073d; Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]; MACLEAN M, 2009, J APPL ENV MICROBIOL, V75, P1932, DOI DOI 10.1128/AEM.01892-08; Maillard JY, 2002, J APPL MICROBIOL, V92, p16S, DOI 10.1046/j.1365-2672.92.5s1.3.x; Marion-Ferey K, 2003, J HOSP INFECT, V53, P64, DOI 10.1053/jhin.2002.1320; Martinez SR, 2016, RSC ADV, V6, P101023, DOI 10.1039/c6ra19670e; Mattheis C, 2013, MACROMOL BIOSCI, V13, P242, DOI 10.1002/mabi.201200217; MCGUCKEN PV, 1973, J APPL BACTERIOL, V36, P419, DOI 10.1111/j.1365-2672.1973.tb04123.x; Mirzaie M, 2016, PHOTODIAGN PHOTODYN, V14, P115, DOI 10.1016/j.pdpdt.2016.03.005; Murdoch LE, 2012, SCI WORLD J, DOI 10.1100/2012/137805; Pajkos A, 2004, J HOSP INFECT, V58, P224, DOI 10.1016/j.jhin.2004.06.023; Park SB, 2013, CLIN ENDOSC, V46, P403, DOI 10.5946/ce.2013.46.4.403; Pineau L, 2008, J HOSP INFECT, V68, P171, DOI 10.1016/j.jhin.2007.10.021; Pires RH, 2013, ANTIMICROB AGENTS CH, V57, P2417, DOI 10.1128/AAC.01308-12; Psaltikidis EM, 2014, COGITARE ENFERMAGEM, V19; Ramakrishnan P, 2016, TOXICOL IN VITRO, V33, P54, DOI 10.1016/j.tiv.2016.02.011; Rutala WA, 2013, AM J INFECT CONTROL, V41, pS2, DOI 10.1016/j.ajic.2012.11.005; Saravanan R, 2014, BIOTECHNOL BIOENG, V111, P37, DOI 10.1002/bit.25003; Su YJ, 2017, POLYM CHEM-UK, V8, P3788, DOI 10.1039/c7py00528h; Su YJ, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601173; Traba C, 2015, BIOFOULING, V31, P39, DOI 10.1080/08927014.2014.995643; USA- Environmental Protection Agency, 2012, DIS US HARD SURF EFF; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Venkatesan N, 2015, FUTURE MICROBIOL, V10, P1743, DOI 10.2217/fmb.15.69; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wu MC, 2013, ACS NANO, V7, P1281, DOI 10.1021/nn304782d; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P146, DOI 10.1111/j.1574-695X.2011.00858.x; Zhang J, 2018, J HAZARD MATER, V342, P121, DOI 10.1016/j.jhazmat.2017.07.053; Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843	57	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202821	10.1371/journal.pone.0202821	http://dx.doi.org/10.1371/journal.pone.0202821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148865	gold, Green Published, Green Submitted			2022-12-26	WOS:000442804200026
J	Kim, HN; Han, K; Song, SW; Lee, JH				Kim, Ha-Na; Han, Kyungdo; Song, Sang-Wook; Lee, Ji Hyun			Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; ANGIOTENSIN-II; VASCULAR DYSFUNCTION; EPIDEMIOLOGY; PREVALENCE; DISEASE; ASSOCIATION; MECHANISMS; SEVERITY; GENES	Psoriasis is a chronic inflammatory skin disease that is characterized by T-cell mediated immune response, and has been known to increase the risk of developing hypertension. However, the risk of psoriasis in patients with hypertension is not clear. Therefore, we investigated the risk of psoriasis in patients with hypertension. A total of 256,356 adults (42,726 in the hypertension group and 213,630 in the control group) were followed from 2003 to 2013 in a nationwide population-based cohort study. During the follow-up, 9,254 participants (3.6%) were found to have psoriasis (2,152 [5.0%] in the hypertension group and 7,102 [3.3%] in the control group). The hypertension group had a higher risk of psoriasis incidence (hazard ratio [HR] 1.54, 95% confidence interval [CI] 1.47-1.61, P < 0.001), and the association remained significant after adjusting for comorbidities of diabetes and dyslipidemia, antihypertensive medication and nonsteroidal anti-inflammatory drug use, and sociodemo-graphic factors (HR 1.18, 95% CI 1.08-1.28, P < 0.001). In conclusion, hypertension was significantly associated with an increased risk of psoriasis incidence. Further studies are needed to confirm whether hypertension is associated with the incidence of psoriasis.	[Kim, Ha-Na; Song, Sang-Wook] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Family Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Ji Hyun] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Lee, JH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea.	ejee@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2015R1C1A2A01054767]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1C1A2A01054767) to JHL, http://www.nrf.re.kr/index.	Armesto S, 2012, J EUR ACAD DERMATOL, V26, P785, DOI 10.1111/j.1468-3083.2011.04108.x; Armstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1; Armstrong AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018227; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Chang YT, 2009, ACTA DERM-VENEREOL, V89, P262, DOI 10.2340/00015555-0642; Cheng H, 2014, J INVEST DERMATOL, V134, P359, DOI 10.1038/jid.2013.317; Cohen AD, 2005, ACTA DERM-VENEREOL, V85, P299, DOI 10.1080/00015550510032823; Cohen AD, 2001, ACTA DERM-VENEREOL, V81, P347; Cohen AD, 2010, ACTA DERM-VENEREOL, V90, P23, DOI 10.2340/00015555-0741; De Venecia T, 2016, POSTGRAD MED, V128, P201, DOI 10.1080/00325481.2016.1147927; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Elder JT, 2009, GENES IMMUN, V10, P201, DOI 10.1038/gene.2009.11; ENA P, 1985, ACTA CARDIOL, V40, P199; Esteban V, 2005, CIRC RES, V96, P965, DOI 10.1161/01.RES.0000166326.91395.74; Franklin SS, 2012, J CLIN HYPERTENS, V14, P779, DOI 10.1111/j.1751-7176.2012.00703.x; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Han JH, 2018, ACTA DERM-VENEREOL, V98, P396, DOI 10.2340/00015555-2877; Karbach S, 2014, ARTERIOSCL THROM VAS, V34, P2658, DOI 10.1161/ATVBAHA.114.304108; Kitamura A, 2017, CIRC J, V81, P1022, DOI 10.1253/circj.CJ-16-1129; Kubota K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006450; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Michalek IM, 2017, J EUR ACAD DERMATOL, V31, P205, DOI 10.1111/jdv.13854; Morris BJ, 2015, HYPERTENSION, V65, P956, DOI 10.1161/HYPERTENSIONAHA.114.04366; Nakada TA, 2011, CHEST, V139, P1042, DOI 10.1378/chest.10-2517; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Phan C, 2016, ANN DERMATOL VENER, V143, P264, DOI 10.1016/j.annder.2015.06.024; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Takeshita J, 2017, J AM ACAD DERMATOL, V76, P377, DOI 10.1016/j.jaad.2016.07.064; Takeshita J, 2015, JAMA DERMATOL, V151, P161, DOI 10.1001/jamadermatol.2014.2094; Wu SW, 2014, JAMA DERMATOL, V150, P957, DOI 10.1001/jamadermatol.2013.9957; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015	35	25	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202854	10.1371/journal.pone.0202854	http://dx.doi.org/10.1371/journal.pone.0202854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142208	Green Submitted, Green Published, gold			2022-12-26	WOS:000442722500040
J	Enko, D; Meinitzer, A; Brandmayr, W; Halwachs-Baumann, G; Schnedl, WJ; Kriegshauser, G				Enko, Dietmar; Meinitzer, Andreas; Brandmayr, Wolfgang; Halwachs-Baumann, Gabriele; Schnedl, Wolfgang J.; Kriegshaeuser, Gernot			Association between increased plasma levels of homocysteine and depression observed in individuals with primary lactose malabsorption	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; FOLIC-ACID; SERUM HOMOCYSTEINE; FOLATE; VITAMIN-B-12; POPULATION; METABOLISM; SYMPTOMS; DISORDER; OUTPATIENTS	Background Current literature proposes associations between homocysteine (HCY), folic acid (FA), vitamin B12 metabolism and depression. However, the exact underlying biological mechanisms remain unclear. This study aimed at evaluating a possible link between primary adult-type lactose malabsorption (PALM), HCY, FA and vitamin B12 metabolism and depressive disorder. Methods Plasma levels of HCY, FA and vitamin B12 were determined in 78 patients with PALM and 160 individuals with lactase persistence sub-grouped by the presence or absence of major depression. Results In 78 patients with PALM, the subgroup of 22 individuals with major depression showed significantly higher median (interquartile range) HCY (10.10 [8.46-12.03] vs. 8.9 [7.54-9.86] mu mol/L, p = 0.029) and lower plasma FA levels (5.7 [4.68-9.14] vs. 6.95 [5.24-10.56] mu mol/L, p = 0.272) compared to the subgroup of 56 individuals without depression, respectively. No such associations could be observed for those 160 individuals without PALM (i.e., lactase persistence) Plasma HCY levels were positively correlated with depressive symptoms (p = 0.052), and showed negative correlations with FA (p = < 0.001) and vitamin B12 (p = 0.029), respectively. Conclusion Depressed individuals with PALM were found with significantly higher HCY and lower FA levels compared to non-depressed individuals with PALM, however, this association was absent in the subgroup of lactase persistent individuals. These findings suggest an association between increased HCY levels, lactose malabsorption and depression.	[Enko, Dietmar; Halwachs-Baumann, Gabriele; Kriegshaeuser, Gernot] Gen Hosp Steyr, Inst Clin Chem & Lab Med, Steyr, Austria; [Enko, Dietmar; Meinitzer, Andreas; Kriegshaeuser, Gernot] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Brandmayr, Wolfgang] Gen Hosp Steyr, Dept Psychiat & Psychotherapeut Med, Steyr, Austria; [Schnedl, Wolfgang J.] Practice Gen Internal Med, Bruck Mur, Austria	Medical University of Graz	Enko, D (corresponding author), Gen Hosp Steyr, Inst Clin Chem & Lab Med, Steyr, Austria.; Enko, D (corresponding author), Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria.	dietmar.enko@gespag.at		Schnedl, Wolfgang/0000-0002-5212-5230				Bender A, 2017, J PSYCHIATR RES, V95, P9, DOI 10.1016/j.jpsychires.2017.07.019; Bhatia P, 2015, FUND CLIN PHARMACOL, V29, P522, DOI 10.1111/fcp.12145; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Bottiglieri T, 2005, PROG NEURO-PSYCHOPH, V29, P1103, DOI 10.1016/j.pnpbp.2005.06.021; Bottiglieri T, 2000, J NEUROL NEUROSUR PS, V69, P228, DOI 10.1136/jnnp.69.2.228; Camilo E, 1996, GASTROENTEROLOGY, V110, P991, DOI 10.1053/gast.1996.v110.pm8613033; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Enko D, 2016, EUR J CLIN NUTR, V70, P1000, DOI 10.1038/ejcn.2016.66; Enko D, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/464382; Farrell CJL, 2013, CLIN CHEM LAB MED, V51, P555, DOI 10.1515/cclm-2012-0639; Fava M, 1997, AM J PSYCHIAT, V154, P426; Frieling H, 2008, J PSYCHIATR RES, V42, P83, DOI 10.1016/j.jpsychires.2006.10.007; Gu P, 2012, J CLIN PSYCHIAT, V73, P691, DOI 10.4088/JCP.11m07223; Herran A, 1999, PSYCHIAT CLIN NEUROS, V53, P531, DOI 10.1046/j.1440-1819.1999.00572.x; Kim JM, 2008, BRIT J PSYCHIAT, V192, P268, DOI 10.1192/bjp.bp.107.039511; Ledochowski M, 1999, CLIN CHEM, V45, P2013; Ledochowski M, DIG DIS SCI, V43, P2513; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2017, NEUROL SCI, V38, P811, DOI 10.1007/s10072-017-2848-2; Morris DW, 2008, J ALTERN COMPLEM MED, V14, P277, DOI 10.1089/acm.2007.0663; Morris MS, 2003, PSYCHOTHER PSYCHOSOM, V72, P80, DOI 10.1159/000068692; Nabi H, 2013, PSYCHONEUROENDOCRINO, V38, P2309, DOI 10.1016/j.psyneuen.2013.04.018; Ng TP, 2009, J AM GERIATR SOC, V57, P871, DOI 10.1111/j.1532-5415.2009.02229.x; Obeid R, 2007, CLIN CHEM LAB MED, V45, P1590, DOI 10.1515/CCLM.2007.356; Papakostas GI, 2005, INT J NEUROPSYCHOPH, V8, P523, DOI 10.1017/S1461145705005195; Paul RTP, 2004, HUM PSYCHOPHARM CLIN, V19, P477, DOI 10.1002/hup.614; Payne Martha E., 2009, Journal of Nutrition for the Elderly, V28, P348, DOI 10.1080/01639360903417181; Reynolds EH, 2002, BMJ-BRIT MED J, V324, P1512, DOI 10.1136/bmj.324.7352.1512; Seppala J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-145; Shane B, 2008, FOOD NUTR BULL, V29, pS5, DOI 10.1177/15648265080292S103; Shen CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106625; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; Tolmunen T, 2004, AM J CLIN NUTR, V80, P1574, DOI 10.1093/ajcn/80.6.1574; Usai-Satta Paolo, 2012, World J Gastrointest Pharmacol Ther, V3, P29, DOI 10.4292/wjgpt.v3.i3.29	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202567	10.1371/journal.pone.0202567	http://dx.doi.org/10.1371/journal.pone.0202567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6TZ	30138390	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100085
J	Oh, T; el Kouni, MH				Oh, Taesung; el Kouni, Mahmoud H.			Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase	PLOS ONE			English	Article							CELL GROWTH-FACTOR; PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES; ANGIOGENIC ACTIVITY; BLOOD-PLATELETS; TUMOR-GROWTH; EXPRESSION; PROTEINS; LIVER; 5-FLUORO-2'-DEOXYURIDINE; KERATINOCYTES	Thymidine phosphorylase (TP; EC 2.4.2.4) is involved regulation of intra- or extracellular thymidine concentration, angiogenesis, cancer chemotherapy, radiotherapy, as well as tumor imaging. Although the liver is main site of pyrimidine metabolism and contains high levels of TP, nonetheless, purification and characterization of human hepatic TP has not been accomplished. We here report the purification and characterization of native human hepatic TP. The enzyme was purified to apparent homogeneity by a procedure shorter and more efficient than previously reported methods. Human hepatic TP has an apparent K-thymidine of 285 +/- 55 mu M. Like the enzyme from other tissues, it is highly specific to 2'-deoxyribo-sides. However, in contrast to TP from other normal tissues, the hepatic enzyme is active in the phosphorolysis of 5'-deoxy-5-fluorouridine, and the riboside 5-fluorouridine. Furthermore, native hepatic TP exists in different aggregates of 50 kDa subunits, with unknown aggregation factor(s) while TP from extra tissues exists as a homodimer. Isoelectric point was determined as 4.3. A total of 65 residues in the N-terminal were sequenced. The sequence of these 65 amino acids in hepatic TP has 100% sequence and location homology to the deduced amino acid sequence of the platelet derived-endothelial cell growth factor (PD-ECGF) cDNA. However, and contrary to PD-ECGF, the N-terminal of hepatic TP is blocked. The block was neither N-formyl nor pyrrolidone carboxylic acid moieties. The differences in substrate specificities, existence in multimers, and weak interaction with hydroxy-apatite resin strongly suggest that hepatic TP is distinct from the enzyme in normal extrahepatic tissues. These results may have important clinical implications when TP is involved in activation or deactivation of chemotherapeutic agents in different tissues.	[Oh, Taesung; el Kouni, Mahmoud H.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Comprehens Canc Ctr, Ctr AIDS Res,Gen Clin Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	el Kouni, MH (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Comprehens Canc Ctr, Ctr AIDS Res,Gen Clin Res Ctr, Birmingham, AL 35294 USA.	melkouni@uab.edu						Boschetti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110583; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown NS, 1998, BIOCHEM J, V334, P1; Desgranges C, 1981, BIOCHIM BIOPHYS ACTA, V654, P211; Deves C, 2014, MOL BIOSYST, V10, P592, DOI 10.1039/c3mb70453j; ELKOUNI MH, 1993, CANCER RES, V53, P3687; ENSMINGER WD, 1978, CANCER RES, V38, P3784; FAN TPD, 1992, NATO ADV SCI I A-LIF, V227, P317; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FURUKAWA T, 1992, NATURE, V356, P668, DOI 10.1038/356668a0; GALLO RC, 1967, J BIOL CHEM, V242, P5059; GOTTLIEB M, 1987, ANAL BIOCHEM, V165, P33, DOI 10.1016/0003-2697(87)90197-7; HAMMERBERG C, 1991, J INVEST DERMATOL, V97, P286, DOI 10.1111/1523-1747.ep12480547; HARAGUCHI M, 1994, NATURE, V368, P198, DOI 10.1038/368198a0; ILTZSCH MH, 1985, BIOCHEMISTRY-US, V24, P6799, DOI 10.1021/bi00345a011; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; JANION C, 1961, ACTA BIOCHIM POL, V8, P337; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KONO A, 1984, CHEM PHARM BULL, V32, P1919; KUBILUS J, 1978, BIOCHIM BIOPHYS ACTA, V527, P221, DOI 10.1016/0005-2744(78)90271-1; LACRETA FP, 1989, CANCER RES, V49, P2567; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBOWITZ J, 1994, PROTEIN SCI, V3, P1374, DOI 10.1002/pro.5560030903; LEES VC, 1994, BRIT J PLAST SURG, V47, P349, DOI 10.1016/0007-1226(94)90095-7; Li W, 2014, CIRC RES, V115, P997, DOI 10.1161/CIRCRESAHA.115.304591; McRorie D. K., 1993, SELF ASSOCIATING SYS; MIYADERA K, 1995, BIOCHEM BIOPH RES CO, V212, P1040, DOI 10.1006/bbrc.1995.2074; MIYADERA K, 1995, CANCER RES, V55, P1687; MIYATAKE N, 1993, EUR J BIOCHEM, V212, P785, DOI 10.1111/j.1432-1033.1993.tb17719.x; MOGHADDAM A, 1995, P NATL ACAD SCI USA, V92, P998, DOI 10.1073/pnas.92.4.998; Nishino I, 2000, ANN NEUROL, V47, P792; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PATTERSON AV, 1995, BRIT J CANCER, V72, P669, DOI 10.1038/bjc.1995.392; PISZKIEW.D, 1970, BIOCHEM BIOPH RES CO, V40, P1173, DOI 10.1016/0006-291X(70)90918-6; REYNOLDS K, 1994, J NATL CANCER I, V86, P1234, DOI 10.1093/jnci/86.16.1234; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuller J, 2000, CANCER CHEMOTH PHARM, V45, P291, DOI 10.1007/s002800050043; SCHWARTZ PM, 1988, ANN NY ACAD SCI, V548, P115, DOI 10.1111/j.1749-6632.1988.tb18798.x; SCHWARTZ PM, 1988, BIOCHEM PHARMACOL, V37, P353, DOI 10.1016/0006-2952(88)90740-X; SCHWARTZ PM, 1988, J INVEST DERMATOL, V90, P8, DOI 10.1111/1523-1747.ep12462412; SHAW T, 1988, MUTAT RES, V200, P99, DOI 10.1016/0027-5107(88)90074-7; SHAW T, 1988, MUTAT RES, V200, P67, DOI 10.1016/0027-5107(88)90073-5; Tsukamoto Y, 2001, PHARM RES-DORDR, V18, P1190, DOI 10.1023/A:1010939329562; Uchimiya H, 2002, CANCER RES, V62, P2834; USUKI K, 1994, BBA-MOL CELL RES, V1222, P411, DOI 10.1016/0167-4889(94)90049-3; Walker JM, 1994, ELECTROPHORESIS PEPT, V32, P49; WOODMAN PW, 1980, CANCER RES, V40, P507; YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202826	10.1371/journal.pone.0202826	http://dx.doi.org/10.1371/journal.pone.0202826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138393	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100133
J	Pelizzo, G; Guazzotti, M; Klersy, C; Nakib, G; Costanzo, F; Andreatta, E; Bassotti, G; Calcaterra, V				Pelizzo, Gloria; Guazzotti, Marinella; Klersy, Catherine; Nakib, Ghassan; Costanzo, Federico; Andreatta, Erika; Bassotti, Gabrio; Calcaterra, Valeria			Spleen size evaluation in children: Time to define splenomegaly for pediatric surgeons and pediatricians	PLOS ONE			English	Article							CONVENTIONAL LAPAROSCOPIC SPLENECTOMY; SCHOOL-AGE-CHILDREN; SOUTH-EAST NIGERIA; NORMAL VALUES; SONOGRAPHIC ASSESSMENT; COMPUTED-TOMOGRAPHY; KIDNEY DIMENSIONS; NORMAL LIMITS; INFANTS; LIVER	Background We determined the range of normal spleen dimensions evaluated by ultrasonography (US) in children according to sex and age and the relationship between splenic measurements, auxological data and body proportions, in order to define splenomegaly parameters in support of the surgical mini-invasive approaches in pediatrics. Methods We prospectively examined 317 caucasian children of both sexes. The patients were divided into three groups: 0-3 years; 4-10 years; 11-18 years. Sex, weight, height/length, body mass index (BMI), waist circumference and xipho-pubic distance were determined for each child. US spleen evaluation included longitudinal/antero-posterior/transverse diameters, transverse area and volume. Spleen volume/abdominal volume, longitudinal spleen diameter/longitudinal left kidney diameter and longitudinal spleen diameter/xipho-pubic distance ratios were also calculated. Results For caucasian subjects, in different age groups spleen volume, transverse area and diameter increased while the spleen/abdominal volume ratio decreased significantly (p<0.001). A significant (p<0.001) decrease in longitudinal spleen diameter/xipho-pubic distance ratio was noted between the 0-3 years group and both 4-10 and 11-18 years group. Age and auxological data, except BMI, showed a high correlation with spleen dimension (r >= 0.8). Conclusions The current concept of splenomegaly is not applicable in pediatric surgery. A dedicated classification of splenomegaly is needed for children and would improve the safety and feasibility of treatment.	[Pelizzo, Gloria] Childrens Hosp, Pediat Surg Unit, Ist Mediterraneo Eccellenza Pediat, Palermo, Italy; [Guazzotti, Marinella; Costanzo, Federico; Andreatta, Erika] Fdn IRCCS Policlin San Matteo, Pediat Surg Unit, Dept Mother & Child Hlth, Pavia, Italy; [Klersy, Catherine] Fdn IRCCS Policlin San Matteo, Sci Direct, Biometry & Clin Epidemiol, Pavia, Italy; [Nakib, Ghassan] Mediclin City Hosp, Dept Paediat Surg, Medclin Middle East, Dubai, U Arab Emirates; [Bassotti, Gabrio] Univ Perugia, Med Sch, Dept Med, Gastroenterol Sect, Perugia, Italy; [Calcaterra, Valeria] Univ Pavia, Pediat Unit, Dept Mother & Child Hlth, Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Calcaterra, Valeria] Univ Pavia, Dept Internal Med, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Perugia; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia	Pelizzo, G (corresponding author), Childrens Hosp, Pediat Surg Unit, Ist Mediterraneo Eccellenza Pediat, Palermo, Italy.	gloria.pelizzo@gmail.com	klersy, catherine/AAA-3003-2019; Calcaterra, Valeria/AAB-7563-2022	klersy, catherine/0000-0003-0314-8548; Calcaterra, Valeria/0000-0002-2137-5974; Pelizzo, Gloria/0000-0002-5253-8828	Association "4CHILDREN CC Onlus"	Association "4CHILDREN CC Onlus"	The authors would thank Dr. Elisa Zambaiti for support in the acquisition of data; Dr. L. Kelly for English revision of the manuscript; Prof. L. Cavallo for your expertise; the Association "4CHILDREN C&C Onlus" for supporting research in our Pediatric Surgery Unit.	al-Imam O, 2000, East Mediterr Health J, V6, P514; Al-Salem AH, 2016, J PEDIAT HEMATOL ONC, V38, P1, DOI 10.1097/MPH.0000000000000121; Benter T, 2011, J ULTRAS MED, V30, P1281; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BURDI AR, 1969, AM J ANAT, V125, P113, DOI 10.1002/aja.1001250106; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Chiorean L, 2014, MED ULTRASON, V16, P48, DOI 10.11152/mu.2014.2066.161.lc1mz2; Chow KU, 2016, RADIOLOGY, V279, P306, DOI 10.1148/radiol.2015150887; Coquet B, 2010, SURG RADIOL ANAT, V32, P25, DOI 10.1007/s00276-009-0535-6; Corcione F, 2012, SURG ENDOSC, V26, P2870, DOI 10.1007/s00464-012-2272-x; Deng XG, 2012, PEDIATR SURG INT, V28, P1201, DOI 10.1007/s00383-012-3215-2; Dhingra B, 2010, INDIAN PEDIATR, V47, P487, DOI 10.1007/s13312-010-0090-6; DITTRICH M, 1983, PEDIATR RADIOL, V13, P206, DOI 10.1007/BF00973157; Esposito C, 2001, J PEDIATR SURG, V36, P309, DOI 10.1053/jpsu.2001.20703; Eze CU, 2014, AFR HEALTH SCI, V14, P246, DOI 10.4314/ahs.v14i1.38; Eze CU, 2013, AFR HEALTH SCI, V13, P384, DOI 10.4314/ahs.v13i2.27; Ezeofor SN, 2014, NIGER J CLIN PRACT, V17, P484, DOI 10.4103/1119-3077.134046; French J, 1996, NELSON TXB PEDIAT, P1439; GAIRDNER D, 1971, ARCH DIS CHILD, V46, P783, DOI 10.1136/adc.46.250.783; GOERG C, 1990, J CLIN ULTRASOUND, V18, P569, DOI 10.1002/jcu.1870180708; Habermalz B, 2008, SURG ENDOSC, V22, P821, DOI 10.1007/s00464-007-9735-5; Hassan ME, 2014, JSLS, V18; Kebede Tesfaye, 2009, Ethiop Med J, V47, P49; Kim DJ, 2014, ANN SURG TREAT RES, V86, P314, DOI 10.4174/astr.2014.86.6.314; Konus OL, 1998, AM J ROENTGENOL, V171, P1693, DOI 10.2214/ajr.171.6.9843315; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Monclova JL, 2013, SURG ENDOSC, V27, P895, DOI 10.1007/s00464-012-2530-y; Mahon D, 2003, ANN ROY COLL SURG, V85, P248, DOI 10.1308/003588403766274953; Megremis SD, 2004, RADIOLOGY, V231, P129, DOI 10.1148/radiol.2311020963; Megremis S, 2007, J ULTRAS MED, V26, P329, DOI 10.7863/jum.2007.26.3.329; MIMOUNI F, 1985, CLIN PEDIATR, V24, P197, DOI 10.1177/000992288502400403; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Park A, 2000, SURG ENDOSC-ULTRAS, V14, P527, DOI 10.1007/s004640000152; Qian DH, 2014, ANZ J SURG, V84, P915, DOI 10.1111/ans.12597; Robertson F, 2001, EUR RADIOL, V11, P80, DOI 10.1007/s003300000528; ROCHE AF, 1986, HUM BIOL, V58, P893; Safak AA, 2005, J ULTRAS MED, V24, P1359, DOI 10.7863/jum.2005.24.10.1359; Sauerbrei EE, 1987, PRACTICAL GUIDE ULTR, P15; Skeete D, 2008, SAGES MANUAL STRATEG, P387; Tan M, 2003, WORLD J GASTROENTERO, V9, P1086; Van Der Veken E, 2016, SURG ENDOSC, V30, P4962, DOI 10.1007/s00464-016-4838-5; Vecchio R, 2013, UPDATES SURG-ITALY, V65, P337, DOI 10.1007/s13304-012-0186-8; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P118, DOI 10.1597/1545-1569(1992)029<0118:CSMBOC>2.3.CO;2; Walsh RM, 2004, SURG ENDOSC, V18, P272, DOI 10.1007/s00464-003-8916-0; Wright E, 1996, STATA TECH B, V34, P24; Wright EM, 1999, STAT METHODS MED RES, V8, P93, DOI 10.1191/096228099672225506; ZHANG B, 1989, CLIN LAB HAEMATOL, V11, P7, DOI 10.1111/j.1365-2257.1989.tb00168.x	48	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202741	10.1371/journal.pone.0202741	http://dx.doi.org/10.1371/journal.pone.0202741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138410	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100114
J	Lait, LA; Hebert, PDN				Lait, Linda A.; Hebert, Paul D. N.			A survey of molecular diversity and population genetic structure in North American clearwing moths (Lepidoptera: Sesiidae) using cytochrome c oxidase I	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIFFERENTIATION; FRESH-WATER; PHYLOGEOGRAPHY; REFUGIA; ICE; MICROSATELLITE; FRAGMENTATION; CONSEQUENCES; SWALLOWTAIL; BUTTERFLIES	The phylogeographic structure of insect species in North America is poorly understood. The moth family Sesiidae (Lepidoptera) contains many economically important pests of agriculture and forestry, as well as beneficial species used in biological control. Despite their significance, this study constitutes the first broad-ranging population genetic study on North American sesiids. It probes the population structure of eight species of sesiid moths based on sequence variation in cytochrome c oxidase I (N = 191). Haplotype diversity levels were high in seven of the eight species, while nucleotide diversity varied considerably. Patterns ranged from limited structure and a starburst pattern in the raspberry crown borer Pennisetia marginata to highly geographically structured populations in the peachtree borer Synanthedon exitiosa and the maple callus borer Synanthedon acerni. These varied patterns suggest differing evolutionary histories and dispersal abilities. By elucidating population genetic structure and barriers to dispersal we can begin to devise conservation and management plans.	[Lait, Linda A.; Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada	University of Guelph	Lait, LA (corresponding author), Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada.	llait@uoguelph.ca			Natural Sciences and Engineering Research Council (NSERC) Discovery Grant; Canada First Research Excellence Fund	Natural Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada First Research Excellence Fund	This work was supported by a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to PDNH and is a contribution to the "Food From Thought" research program funded by the Canada First Research Excellence Fund.	Aurelian VM, 2015, CAN ENTOMOL, V147, P227, DOI 10.4039/tce.2014.47; Austin JD, 2004, MOL PHYLOGENET EVOL, V32, P799, DOI 10.1016/j.ympev.2004.03.006; AVISE JC, 1986, P NATL ACAD SCI USA, V83, P4350, DOI 10.1073/pnas.83.12.4350; Avise John C., 2004, P1; BALL RM, 1988, P NATL ACAD SCI USA, V85, P1558, DOI 10.1073/pnas.85.5.1558; BALL RM, 1992, AUK, V109, P626; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergh JC, 2003, CAN ENTOMOL, V135, P615; BERMINGHAM E, 1986, GENETICS, V113, P939; Brant SV, 2003, MOL ECOL, V12, P1435, DOI 10.1046/j.1365-294X.2003.01789.x; Brower AVZ, 2004, ANN ENTOMOL SOC AM, V97, P519, DOI 10.1603/0013-8746(2004)097[0519:GPASON]2.0.CO;2; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; CARR SM, 1995, MOL ECOL, V4, P79, DOI 10.1111/j.1365-294X.1995.tb00194.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cronin MA, 2006, CAN J ZOOL, V84, P655, DOI 10.1139/Z06-039; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Eichlin T.D., 1988, P1; Eichlin Thomas D., 1992, Tropical Lepidoptera, V3, P135; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Fordyce JA, 2003, EVOLUTION, V57, P1089, DOI 10.1111/j.0014-3820.2003.tb00318.x; Foster F. R., 1947, SCIENCE, V106, P399; Franklin MT, 2011, EVOL APPL, V4, P89, DOI 10.1111/j.1752-4571.2010.00135.x; FU YX, 1993, GENETICS, V133, P693; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Godbout J, 2010, AM J BOT, V97, P1903, DOI 10.3732/ajb.1000148; Graham BA, 2012, J AVIAN BIOL, V43, P198, DOI 10.1111/j.1600-048X.2012.05604.x; Hansen JA, 2012, ANN ENTOMOL SOC AM, V105, P520, DOI 10.1603/AN11028; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holland WJ, 1968, MOTH BOOK POPULAR GU; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Knaus Brian J., 2011, BMC Ecology, V11, P10, DOI 10.1186/1472-6785-11-10; Lait LA, 2013, HEREDITY, V111, P321, DOI 10.1038/hdy.2013.54; LEHMAN N, 1991, GENETICS, V128, P405; Lesieur V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168370; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Manthey JD, 2011, MOL PHYLOGENET EVOL, V58, P502, DOI 10.1016/j.ympev.2010.12.003; McKern JA, 2008, J AGR URBAN ENTOMOL, V25, P165, DOI 10.3954/1523-5475-25.3.165; McKern JA, 2008, J AGR URBAN ENTOMOL, V25, P25, DOI 10.3954/1523-5475-25.1.25; McKnight M. E., 1973, North Dakota Farm Research, V30, P8; Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304; Mila B, 2007, MOL ECOL, V16, P159, DOI 10.1111/j.1365-294X.2006.03119.x; Nilsson T., 1983, PLEISTOCENE GEOLOGY; PIELOU EC, 1991, ICE AGE RETURN LIFE; Pohl GR, 2016, WORKING PAPER; Puehringer Franz, 2004, Mitteilungen der Entomologischen Arbeitsgemeinschaft Salzkammergut, V4, P1; Pulgarin-R PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040412; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rugman-Jones PF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118264; RUSSELL W G, 1969, Journal of the Tennessee Academy of Science, V44, P85; Solomon, 1995, GUIDE INSECT BORERS; SOLOMON JD, 1975, ANN ENTOMOL SOC AM, V68, P325, DOI 10.1093/aesa/68.2.325; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stump AD, 2003, GREAT LAKES ENTOMOL, V36, P41; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Szalanski AL, 2000, ANN ENTOMOL SOC AM, V93, P589, DOI 10.1603/0013-8746(2000)093[0589:PGAPOT]2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; USDA NRCS, 2017, PLANTS DAT; van Els P, 2012, MOL PHYLOGENET EVOL, V63, P456, DOI 10.1016/j.ympev.2012.01.019; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Wooding S, 1997, MOL BIOL EVOL, V14, P1096, DOI 10.1093/oxfordjournals.molbev.a025719; Zhang ZQ, 2013, ZOOTAXA, V3703, P17; Zhang ZQ, 2013, ZOOTAXA, V3703, P5; ZINK RM, 1993, WILSON BULL, V105, P399; Zink RM, 2008, CONDOR, V110, P482, DOI 10.1525/cond.2008.8496	78	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202281	10.1371/journal.pone.0202281	http://dx.doi.org/10.1371/journal.pone.0202281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133486	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400063
J	Ferrelli, ML; Pidre, ML; Ghiringhelli, PD; Torres, S; Fabre, ML; Masson, T; Cedola, MT; Sciocco-Cap, A; Romanowski, V				Leticia Ferrelli, Maria; Luis Pidre, Matias; Daniel Ghiringhelli, Pablo; Torres, Sofia; Laura Fabre, Maria; Masson, Tomas; Tatiana Cedola, Maia; Sciocco-Cap, Alicia; Romanowski, Victor			Genomic analysis of an Argentinean isolate of Spodoptera frugiperda granulovirus reveals that various baculoviruses code for Lef-7 proteins with three F-box domains	PLOS ONE			English	Article							COMPLETE SEQUENCE; DNA; LEPIDOPTERA; MECHANISMS	A new isolate of the Spodoptera frugiperda granulovirus, SfGV ARG, was completely sequenced and analyzed. The SfGV ARG genome is 139,812 bp long and encodes 151 putative open reading frames. Of these ORFs, 56 were found in betabaculoviruses, 19 of which are present only in GVs closely related to SfGV. Seven ORFs found homologs in this small GV group and also in noctuid NPVs. ORF066 codes a 74 amino acid protein, overlapped with nudix gene, with several homologs in baculovirus, found by tblastn search. Comparison with the genome of the Colombian isolate SfGV VG008 resulted in SfGV being 1101 bp smaller and lacking a homologue of VG008 ORF084, which codes for Lef-7. However, we found that ORF051 shows remote homology to Lef-7 proteins. Moreover, analysis of ORF051 along with Lef-7 proteins coded by a group of noctuid specific GVs and NPVs indicated that Lef-7 proteins coded by these viruses include three F-box domains in contrast to the single one reported for AcMNPV Lef-7. SfGV ARG genome also contains a split photolyase as a distinct feature not found in VG008. BlastX analysis revealed that a complete photolyase is coded considering a putative frameshift in a poly-A tract, which resembles known slippery sequences involved in programmed ribosome frameshifting.	[Leticia Ferrelli, Maria; Luis Pidre, Matias; Torres, Sofia; Laura Fabre, Maria; Masson, Tomas; Tatiana Cedola, Maia; Romanowski, Victor] Univ Nacl La Plata, IBBM, UNLP, Fac Ciencias Exactas,CONICET, La Plata, Buenos Aires, Argentina; [Daniel Ghiringhelli, Pablo] Univ Nacl Quilmes, LIGBCM, AVI, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Sciocco-Cap, Alicia] INTA, IMYZA CICVyA, CC 25 B1712WAA, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Ferrelli, ML (corresponding author), Univ Nacl La Plata, IBBM, UNLP, Fac Ciencias Exactas,CONICET, La Plata, Buenos Aires, Argentina.	lferrelli@biol.unip.edu.ar	Ghiringhelli, Pablo D/N-8073-2017	Ghiringhelli, Pablo D/0000-0002-2003-0106; Ferrelli, Maria Leticia/0000-0001-9086-4563; Romanowski, Victor/0000-0001-6378-7929; Pidre, Matias/0000-0002-8606-021X; Masson, Tomas/0000-0002-2634-6283; Fabre, Maria Laura/0000-0003-1875-4196	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2013-0762]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by a grant from the Agencia Nacional de Promocion Cientifica y Tecnologica (www.agencia.mincyt.gob.ar) to MLF (PICT 2013-0762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardisson-Araujo D, 2014, VIRUS GENES, P1; Braunagel SC, 1996, VIROLOGY, V222, P100, DOI 10.1006/viro.1996.0401; Chateigner A, 2015, VIRUSES-BASEL, V7, P3625, DOI 10.3390/v7072788; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; Costa Navarro GS, 2017, THESIS; Cuartas PE, 2015, VIRUSES-BASEL, V7, P394, DOI 10.3390/v7010394; de Brito AF, 2016, GENOME BIOL EVOL, V8, P94, DOI 10.1093/gbe/evv231; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Garavaglia MJ, 2012, J VIROLOGY; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Haase S, 2015, VIRUSES-BASEL, V7, P2230, DOI 10.3390/v7052230; Harrison RL, 2017, VIRUS GENES; Harrison RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170510; Herniou EA., 2011, VIRUS TAXONOMY, P163; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Javed MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02115-16; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mitchell JK, 2013, J VIROL, V87, P12592, DOI 10.1128/JVI.02501-13; MORIKAWA S, 1991, VIROLOGY, V183, P288, DOI 10.1016/0042-6822(91)90141-W; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parola AD, 2002, VIRUS GENES, V25, P329, DOI 10.1023/A:1020992412175; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Shapiro M, 2000, J ECON ENTOMOL, V93, P1633, DOI 10.1603/0022-0493-93.6.1633; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Stokstad E, 2017, SCIENCE, V356, P473, DOI 10.1126/science.356.6337.473; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Q, 2017, J INVERTEBR PATHOL, V149, P82, DOI 10.1016/j.jip.2017.08.004; Theze J, 2015, VIRUSES-BASEL, V7, P1960, DOI 10.3390/v7041960; van Oers MM, 2008, DNA REPAIR, V7, P1309, DOI 10.1016/j.dnarep.2008.04.013; Wei YL, 2014, J INVERTEBR PATHOL, V122, P40, DOI 10.1016/j.jip.2014.08.003; Xu Y-P, 2013, GENOMICS; Zhu SY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-91	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0202598	10.1371/journal.pone.0202598	http://dx.doi.org/10.1371/journal.pone.0202598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133523	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400086
J	Korovina, I; Neuwirth, A; Sprott, D; Weber, S; Pasha, SPBS; Gercken, B; Breier, G; El-Armouche, A; Deussen, A; Karl, MO; Wielockx, B; Chavakis, T; Klotzsche-von Ameln, A				Korovina, Irina; Neuwirth, Ales; Sprott, David; Weber, Silvio; Pasha, Sheik Pran Babu Sardar; Gercken, Bettina; Breier, Georg; El-Armouche, Ali; Deussen, Andreas; Karl, Mike O.; Wielockx, Ben; Chavakis, Triantafyllos; Klotzsche-von Ameln, Anne			Hematopoietic hypoxia-inducible factor 2 deficiency ameliorates pathological retinal neovascularization via modulation of endothelial cell apoptosis	FASEB JOURNAL			English	Article						microglia; retinopathy; angiogenesis; FasL; Adam17	OXYGEN-INDUCED RETINOPATHY; FAS LIGAND; INFLAMMATION; MICROGLIA; ANGIOGENESIS; PATHOGENESIS; ACTIVATION; INHIBITION; CLEAVAGE; ADAM17	A hallmark of proliferative retinopathies, such as retinopathy of prematurity (ROP), is a pathological neovascularization orchestrated by hypoxia and the resulting hypoxia-inducible factor (HIF)-dependent response. We studied the role of Hif2 in hematopoietic cells for pathological retina neovascularization in the murine model of ROP, the oxygen-induced retinopathy (OIR) model. Hematopoietic-specific deficiency of Hif2 ameliorated pathological neovascularization in the OIR model, which was accompanied by enhanced endothelial cell apoptosis. That latter finding was associated with up-regulation of the apoptosis-inducer FasL in Hif2-deficient microglia. Consistently, pharmacological inhibition of the FasL reversed the reduced pathological neovascularization from hematopoietic-specific Hif2 deficiency. Our study found that the hematopoietic cell Hif2 contributes to pathological retina angiogenesis. Our findings not only provide novel insights regarding the complex interplay between immune cells and endothelial cells in hypoxia-driven retina neovascularization but also may have therapeutic implications for proliferative retinopathies.Korovina, I., Neuwirth, A., Sprott, D., Weber, S., Sardar Pasha, S. P. B., Gercken, B., Breier, G., El-Armouche, A., Deussen, A., Karl, M. O., Wielockx, B., Chavakis, T., Klotzsche-von Ameln, A. Hematopoietic hypoxia-inducible factor 2 deficiency ameliorates pathological retinal neovascularization via modulation of endothelial cell apoptosis.	[Korovina, Irina; Neuwirth, Ales; Sprott, David; Gercken, Bettina; Wielockx, Ben; Chavakis, Triantafyllos; Klotzsche-von Ameln, Anne] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany; [Weber, Silvio; El-Armouche, Ali] Tech Univ Dresden, Inst Pharmacol & Toxicol, Fac Med, Dresden, Germany; [Pasha, Sheik Pran Babu Sardar; Karl, Mike O.; Wielockx, Ben] Tech Univ Dresden, DFG, Ctr Regenerat Therapies, CMCB, Dresden, Germany; [Breier, Georg] Tech Univ Dresden, Med Biol, Dept Psychiat, Fac Med, Dresden, Germany; [Deussen, Andreas; Klotzsche-von Ameln, Anne] Tech Univ Dresden, Inst Physiol, Fac Med, Dresden, Germany; [Karl, Mike O.] German Ctr Neurodegenerat Dis DZNE Dresden, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; German Research Foundation (DFG); Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Klotzsche-von Ameln, A (corresponding author), Tech Univ Dresden, Inst Physiol, Fetscherstr 74, D-01307 Dresden, Germany.	anne.klotzsche-von_ameln@tu-dresden.de	Pasha, Pran Babu Sardar/AAH-8388-2019; Chavakis, Triantafyllos/ABE-8845-2020; Wielockx, Ben/AAC-6854-2020; PASHA, PRAN BABU SARDAR/AAS-7266-2020; Karl, Mike O./E-7246-2010	Wielockx, Ben/0000-0002-4923-2596; PASHA, PRAN BABU SARDAR/0000-0001-8974-7562; Karl, Mike O./0000-0002-0926-6556	Medical Theoretical Center (MTZ) Imaging Facility of the Technische Universitat Dresden; European Research Council (ENDHOMRET) Grant [281296]; Excellence Initiative from the German Federal and State Governments of Technische Universitat Dresden	Medical Theoretical Center (MTZ) Imaging Facility of the Technische Universitat Dresden; European Research Council (ENDHOMRET) Grant; Excellence Initiative from the German Federal and State Governments of Technische Universitat Dresden	The authors thank Sylvia Grossklaus, Janine Gebler, Christine Mund, Bianca Muller, and Carmen Friebel (Technische Universitat Dresden) for technical assistance and the Medical Theoretical Center (MTZ) Imaging Facility of the Technische Universitat Dresden for their support. The authors thank Dr. Matina Economopoulou (Technische Universitat Dresden) for helpful discussions. This work was supported by the European Research Council (ENDHOMRET) Grant 281296, and by "Support-the Best" funding from the Excellence Initiative from the German Federal and State Governments of Technische Universitat Dresden. The authors declare no conflicts of interest.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Alexaki VI, 2018, MOL PSYCHIATR, V23, P1410, DOI 10.1038/mp.2017.167; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Barreiro R, 2003, INVEST OPHTH VIS SCI, V44, P1282, DOI 10.1167/iovs.02-0478; Barsoum IB, 2011, CANCER RES, V71, P7433, DOI 10.1158/0008-5472.CAN-11-2104; Caprara C, 2012, PROG RETIN EYE RES, V31, P89, DOI 10.1016/j.preteyeres.2011.11.003; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Davies MH, 2003, INVEST OPHTH VIS SCI, V44, P3202, DOI 10.1167/iovs.03-0050; Davies M, 2006, MOL VIS, V12, P467; Dejda A, 2014, J CLIN INVEST, V124, P4807, DOI 10.1172/JCI76492; Ebsen H, 2015, MOL IMMUNOL, V65, P416, DOI 10.1016/j.molimm.2015.02.008; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Economopoulou M, 2015, THROMB HAEMOSTASIS, V114, P1241, DOI 10.1160/TH15-01-0051; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fischer F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-120; Fleck D, 2013, J NEUROSCI, V33, P7856, DOI 10.1523/JNEUROSCI.3372-12.2013; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hewing NJ, 2013, INVEST OPHTH VIS SCI, V54, P864, DOI 10.1167/iovs.12-10954; Horton SM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00365; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kaplan HJ, 1999, NAT MED, V5, P292, DOI 10.1038/6509; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Klotzsche-von Ameln A, 2017, THROMB HAEMOSTASIS, V117, P1150, DOI 10.1160/TH16-05-0354; Klotzsche-von Ameln A, 2013, MOL CANCER RES, V11, P1337, DOI 10.1158/1541-7786.MCR-13-0201; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Linkermann A, 2005, EXPERT OPIN THER TAR, V9, P119, DOI 10.1517/14728222.9.1.119; Liyanage SE, 2016, ARTERIOSCL THROM VAS, V36, P19, DOI 10.1161/ATVBAHA.115.306681; Matsuno H, 2001, J RHEUMATOL, V28, P22; Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571; Mitsiades N, 2001, CANCER RES, V61, P577; Mogi M, 2001, LAB INVEST, V81, P177, DOI 10.1038/labinvest.3780225; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017; Nagamine Y, 2016, AM J RESP CELL MOL, V55, P878, DOI 10.1165/rcmb.2015-0266OC; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Roychoudhury J, 2010, INVEST OPHTH VIS SCI, V51, P3560, DOI 10.1167/iovs.09-3890; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Semkova I, 2006, FASEB J, V20, P1689, DOI 10.1096/fj.05-5653fje; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Voss Matthias, 2008, Cell Commun Signal, V6, P11, DOI 10.1186/1478-811X-6-11; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Wigginton JM, 2001, J CLIN INVEST, V108, P51; Wong K, 2017, NAT IMMUNOL, V18, P633, DOI 10.1038/ni.3743; Zhao H, 2013, INVEST OPHTH VIS SCI, V54, P5321, DOI 10.1167/iovs.13-12122; Zheng XG, 2007, CANCER SCI, V98, P674, DOI 10.1111/j.1349-7006.2007.00440.x	68	11	10	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1758	1770		10.1096/fj.201800430R	http://dx.doi.org/10.1096/fj.201800430R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30156910				2022-12-26	WOS:000457296600020
J	Zdralevic, M; Brand, A; Di Ianni, L; Dettmer, K; Reinders, J; Singer, K; Peter, K; Schnell, A; Bruss, C; Decking, SM; Koehl, G; Felipe-Abrio, B; Durivault, J; Bayer, P; Evangelista, M; O'Brien, T; Oefner, PJ; Renner, K; Pouyssegur, J; Kreutz, M				Zdralevic, Masa; Brand, Almut; Di Ianni, Lorenza; Dettmer, Katja; Reinders, Joerg; Singer, Katrin; Peter, Katrin; Schnell, Annette; Bruss, Christina; Decking, Sonja-Maria; Koehl, Gudrun; Felipe-Abrio, Blanca; Durivault, Jerome; Bayer, Pascale; Evangelista, Marie; O'Brien, Thomas; Oefner, Peter J.; Renner, Kathrin; Pouyssegur, Jacques; Kreutz, Marina			Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Warburg effect; glycolysis; glucose metabolism; pentose phosphate pathway (PPP); lactic acid; cancer biology; tumor metabolism; CRISPR; Cas; genetic disruption; lactate dehydrogenase; LDHA; LDHB; metabolic plasticity; OXPHOS; tumor growth	HYPOXIA-INDUCIBLE FACTORS; LACTIC-ACID; CELL-PROLIFERATION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; CANCER-THERAPY; BREAST-CANCER; INHIBITION; EXPRESSION; SPECIFICITY	Increased glucose consumption distinguishes cancer cells from normal cells and is known as the Warburg effect because of increased glycolysis. Lactate dehydrogenase A (LDHA) is a key glycolytic enzyme, a hallmark of aggressive cancers, and believed to be the major enzyme responsible for pyruvate-to-lactate conversion. To elucidate its role in tumor growth, we disrupted both the LDHA and LDHB genes in two cancer cell lines (human colon adenocarcinoma and murine melanoma cells). Surprisingly, neither LDHA nor LDHB knockout strongly reduced lactate secretion. In contrast, double knockout (LDHA/B-DKO) fully suppressed LDH activity and lactate secretion. Furthermore, under normoxia, LDHA/B-DKO cells survived the genetic block by shifting their metabolism to oxidative phosphorylation (OXPHOS), entailing a 2-fold reduction in proliferation rates in vitro and in vivo compared with their WT counterparts. Under hypoxia (1% oxygen), however, LDHA/B suppression completely abolished in vitro growth, consistent with the reliance on OXPHOS. Interestingly, activation of the respiratory capacity operated by the LDHA/B-DKO genetic block as well as the resilient growth were not consequences of long-term adaptation. They could be reproduced pharmacologically by treating WT cells with an LDHA/B-specific inhibitor (GNE-140). These findings demonstrate that the Warburg effect is not only based on high LDHA expression, as both LDHA and LDHB need to be deleted to suppress fermentative glycolysis. Finally, we demonstrate that the Warburg effect is dispensable even in aggressive tumors and that the metabolic shift to OXPHOS caused by LDHA/B genetic disruptions is responsible for the tumors' escape and growth.	[Zdralevic, Masa; Brand, Almut; Di Ianni, Lorenza; Felipe-Abrio, Blanca; Pouyssegur, Jacques] Univ Cote Azur, IRCAN, Ctr A Lacassagne, CNRS,INSERM, F-06189 Nice, France; [Brand, Almut; Singer, Katrin; Peter, Katrin; Schnell, Annette; Bruss, Christina; Decking, Sonja-Maria; Bayer, Pascale; Renner, Kathrin; Kreutz, Marina] Univ Hosp Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany; [Koehl, Gudrun] Univ Hosp Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Dettmer, Katja; Reinders, Joerg; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Peter, Katrin; Renner, Kathrin; Kreutz, Marina] Univ Regensburg, Ctr Intervent Immunol, D-93053 Regensburg, Germany; [Bayer, Pascale] Univ Cote Azur, Univ Hosp Pasteur, Clin Chem Lab, F-06001 Nice, France; [Evangelista, Marie; O'Brien, Thomas] Genentech Inc, Discovery & Translat Oncol, San Francisco, CA 94080 USA; [Durivault, Jerome; Pouyssegur, Jacques] Ctr Sci Monaco, Dept Med Biol, MC-98000 Monaco, Monaco	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Roche Holding; Genentech	Pouyssegur, J (corresponding author), Univ Cote Azur, IRCAN, Ctr A Lacassagne, CNRS,INSERM, F-06189 Nice, France.; Kreutz, M (corresponding author), Univ Hosp Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany.; Kreutz, M (corresponding author), Univ Regensburg, Ctr Intervent Immunol, D-93053 Regensburg, Germany.; Pouyssegur, J (corresponding author), Ctr Sci Monaco, Dept Med Biol, MC-98000 Monaco, Monaco.	pouysseg@unice.fr; Marina.Kreutz@klinik.uni-regensburg.de	Ždralević, Maša/P-2823-2019; Renner, Kathrin/H-3211-2013; Zdralevic, Masa/H-7200-2014; Dettmer, Katja/D-6218-2018	Zdralevic, Masa/0000-0003-2236-7957; Dettmer, Katja/0000-0001-7337-2380; Felipe-Abrio, Blanca/0000-0001-7025-3247; Renner, Kathrin/0000-0002-7116-1368; Reinders, Joerg/0000-0003-1025-7849	Conseil General 06; Fonds europeen de developpement regional (FEDER); Ministe re de l'Enseignement Superieur; Region Provence Alpes-Cote d'Azur; INSERM	Conseil General 06(Region Provence-Alpes-Cote d'Azur); Fonds europeen de developpement regional (FEDER)(European Commission); Ministe re de l'Enseignement Superieur; Region Provence Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank Ludovic Cervera for cell sorting assistance on the CytoMed platform at the flow cytometry facility at the Institute for Research on Cancer and Aging, Nice (IRCAN). The materials of CytoMed were supported by Conseil General 06, Fonds europeen de developpement regional (FEDER), the Ministe re de l'Enseignement Superieur, the Region Provence Alpes-Cote d'Azur, and INSERM. We also thank Claude Fabre and Claire Tworek, technicians in the clinical chemistry laboratory at the University Hospital of Nice. We thank Milica Vucetic and Valerie Vial for help with mouse experiments at Centre Scientifique de Monaco (CSM), Monaco.	Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Costa ASH, 2017, INT REV CEL MOL BIO, V332, P213, DOI 10.1016/bs.ircmb.2017.01.001; Damgaci S., 2018, IMMUNOLOGY; de Padua MC, 2017, ONCOTARGET, V8, P87623, DOI 10.18632/oncotarget.21007; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feist M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03803-x; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gillies R J, 2001, Novartis Found Symp, V240, P1; GOLDBERG E, 1971, P NATL ACAD SCI USA, V68, P349, DOI 10.1073/pnas.68.2.349; Granchi C, 2013, FUTURE MED CHEM, V5, P1967, DOI [10.4155/FMC.13.151, 10.4155/fmc.13.151]; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubbi ME, 2015, AM J PHYSIOL-CELL PH, V309, pC775, DOI 10.1152/ajpcell.00279.2015; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOEN AL, 1969, BIOCHEM GENET, V3, P457, DOI 10.1007/BF00485606; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Marchiq I, 2016, J MOL MED, V94, P155, DOI 10.1007/s00109-015-1307-x; Marchiq I, 2015, CANCER RES, V75, P171, DOI 10.1158/0008-5472.CAN-14-2260; MARKERT CL, 1959, P NATL ACAD SCI USA, V45, P753, DOI 10.1073/pnas.45.5.753; McCleland ML, 2013, CLIN CANCER RES, V19, P773, DOI 10.1158/1078-0432.CCR-12-2638; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Parks S. K., 2017, J PHYSL; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Parks SK, 2013, J CELL PHYSIOL, V228, P1854, DOI 10.1002/jcp.24346; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; POUYSSEGUR J, 1982, P NATL ACAD SCI-BIOL, V79, P3935, DOI 10.1073/pnas.79.13.3935; POUYSSEGUR J, 1980, NATURE, V287, P445, DOI 10.1038/287445a0; POUYSSEGUR J, 1980, P NATL ACAD SCI-BIOL, V77, P2698, DOI 10.1073/pnas.77.5.2698; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Sun WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125976; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; VANDERLINDE RE, 1985, ANN CLIN LAB SCI, V15, P13; VESELL ES, 1965, SCIENCE, V150, P1590, DOI 10.1126/science.150.3703.1590; Vucetic M., 2018, FRONT ONCOL; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Zhang Y, 2015, J PROTEOME RES, V14, P4359, DOI 10.1021/acs.jproteome.5b00543	56	110	115	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15947	15961		10.1074/jbc.RA118.004180	http://dx.doi.org/10.1074/jbc.RA118.004180			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30158244	Green Published, hybrid			2022-12-26	WOS:000447256000017
J	Singh, R; Stoneham, C; Lim, C; Jia, XF; Guenaga, J; Wyatt, R; Wertheim, JO; Xiong, Y; Guatelli, J				Singh, Rajendra; Stoneham, Charlotte; Lim, Christopher; Jia, Xiaofei; Guenaga, Javier; Wyatt, Richard; Wertheim, Joel O.; Xiong, Yong; Guatelli, John			Phosphoserine acidic cluster motifs bind distinct basic regions on the mu subunits of clathrin adaptor protein complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host-pathogen interaction; human immunodeficiency virus (HIV); kinetics; membrane trafficking; phosphorylation; protein complex; protein chemistry; clathrin; adaptor protein; medium subunit; acidic cluster; phosphoserine; HIV-1 Vpu; furin; Serinc3	TRANS-GOLGI NETWORK; CYTOPLASMIC DOMAIN; VPU PROTEIN; HIV-1 NEF; STRUCTURAL EXPLANATION; MEDIATED ENDOCYTOSIS; ESCHERICHIA-COLI; DOWN-MODULATION; CELL-SURFACE; VIRUS	Protein trafficking in the endosomal system involves the recognition of specific signals within the cytoplasmic domains (CDs) of transmembrane proteins by clathrin adaptors. One such signal is the phosphoserine acidic cluster (PSAC), the prototype of which is in the endoprotease furin. How PSACs are recognized by clathrin adaptors has been controversial. We reported previously that HIV-1 Vpu, which modulates cellular immunoreceptors, contains a PSAC that binds to the subunits of clathrin adaptor protein (AP) complexes. Here, we show that the CD of furin binds the subunits of AP-1 and AP-2 in a phosphorylation-dependent manner. Moreover, we identify a potential PSAC in a cytoplasmic loop of the cellular transmembrane Serinc3, an inhibitor of the infectivity of retroviruses. The two serines within the PSAC of Serinc3 are phosphorylated by casein kinase II and mediate interaction with the subunits in vitro. The sites of these serines vary among mammals in a manner suggesting host-pathogen conflict, yet the Serinc3 PSAC seems dispensable for anti-HIV activity and for counteraction by HIV-1 Nef. The CDs of Vpu and furin and the PSAC-containing loop of Serinc3 each bind the subunit of AP-2 (2) with similar affinities, but they appear to utilize different basic regions on 2. The Serinc3 loop requires a region previously reported to bind the acidic plasma membrane lipid phosphatidylinositol 4,5-bisphosphate. These data suggest that the PSACs within different proteins recognize different basic regions on the surface, providing the potential to inhibit the activity of viral proteins without necessarily affecting cellular protein trafficking.	[Singh, Rajendra; Stoneham, Charlotte; Wertheim, Joel O.; Guatelli, John] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lim, Christopher; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Jia, Xiaofei] Univ Massachusetts, Dept Chem & Biochem, Dartmouth, MA 02747 USA; [Guenaga, Javier; Wyatt, Richard] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Guatelli, John] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; Yale University; University of Massachusetts System; University Massachusetts Dartmouth; Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Singh, R; Guatelli, J (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Guatelli, J (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	rks003@ucsd.edu; jguatelli@ucsd.edu		Stoneham, Charlotte/0000-0003-3729-6936	National Institutes of Health [P30 AI036214, R37 AI081668, R01 AI129706, R01 AI102778, P01 AI104722, K01 AI110181, R21 AI115701]; International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI110181, R01AI129706, R21AI115701, P30AI036214, R37AI081668, R01AI102778, P01AI104722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants P30 AI036214 (CFAR supplement) (to R. S.), R37 AI081668 and R01 AI129706 (to J. G.), R01 AI102778 (to Y. X.), P01 AI104722 (to R. W.), and K01 AI110181 and R21 AI115701 (to J. O. W.). This work was also supported by the International AIDS Vaccine Initiative (IAVI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chande A, 2016, P NATL ACAD SCI USA, V113, P13197, DOI 10.1073/pnas.1612044113; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Dai WW, 2018, CELL REP, V22, P869, DOI 10.1016/j.celrep.2017.12.082; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Davies A. K. I., 2017, AP 4 VESICLES UNMASK, DOI [10.1101/235226, DOI 10.1101/235226]; Day JR, 2006, J VIROL METHODS, V137, P125, DOI 10.1016/j.jviromet.2006.06.019; Ghosh P, 2004, ARCH BIOCHEM BIOPHYS, V426, P225, DOI 10.1016/j.abb.2004.02.011; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kueck T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005141; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Murrell B, 2016, J VIROL, V90, P8085, DOI 10.1128/JVI.00972-16; Negredo PN, 2017, J CELL BIOL, V216, P2927, DOI 10.1083/jcb.201602058; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Ramirez PW, 2014, CELL REP, V7, P2019, DOI 10.1016/j.celrep.2014.05.015; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Singh RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008364; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Stoneham CA, 2017, TRAFFIC, V18, P545, DOI 10.1111/tra.12495; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2014, J VIROL, V88, P3443, DOI 10.1128/JVI.01933-13; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073	49	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15678	15690		10.1074/jbc.RA118.003080	http://dx.doi.org/10.1074/jbc.RA118.003080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135209	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000446549200030
J	Maduranga, K; Attanayake, RN; Santhirasegaram, S; Weerakoon, G; Paranagama, PA				Maduranga, Kasun; Attanayake, Renuka Nilmini; Santhirasegaram, Sinthujah; Weerakoon, Gothamie; Paranagama, Priyani Ashoka			Molecular phylogeny and bioprospecting of Endolichenic Fungi (ELF) inhabiting in the lichens collected from a mangrove ecosystem in Sri Lanka	PLOS ONE			English	Article							NATURAL-PRODUCTS; ERYSIPHE-TRIFOLII; POWDERY MILDEW; REGION; DIVERSITY; DNA	Endolichenic fungi (ELF) are unexplored group of organisms as a source for the production of bioactive secondary metabolites with radical scavenging activity, antilipase and amylase inhibitory activities. Endolichenic fungi in lichens collected from mangrove or mangrove associated plants are least known for their fungal diversity and potential to produce bioactive compounds. A total of 171 ELF strains were isolated from the lichens collected from mangrove and mangrove associated plants in Puttalam lagoon. Out of this collection, 70 isolates were identified using rDNA-ITS region sequence homology to the GenBank accessions and a phylogenetic analysis was performed. Commonly isolated genera of ELF from lichens were Aspergillus, Byssochlamys, Talaromyces, Diaporthe, Phomopsis, Endomelanconiopsis, Schizophyllum, Cerrena, Trichoderma, Xylaria, Hypoxylon, Daldinia, Preussia, Sordaria, Neurospora, and Lasiodiplodia. In the present study, the effectiveness of ethyl acetate extracts of the ELF isolates were investigated against antioxidant activity, antilipase activity and a-amylase inhibition activity in in-vitro conditions. The results revealed that the extracts of Daldinia eschscholtzii, Diaporthe musigena and Sordaria sp. had the highest radical scavenging activity with smaller IC50 values (25 mu g/mL to 31 mu g/mL) compared to the IC50 values of BHT (76.50 +/- 1.47 mu g/mL). Antilipase assay revealed that 13 extracts from ELF showed promising antiobesity activity ranged between 25% to 40%. Amylase inhibitory assay indicated that the test extracts do not contain antidiabetic secondary metabolites.	[Maduranga, Kasun; Santhirasegaram, Sinthujah; Paranagama, Priyani Ashoka] Univ Kelaniya, Dept Chem, Kelaniya, Sri Lanka; [Attanayake, Renuka Nilmini] Univ Kelaniya, Dept Bot, Kelaniya, Sri Lanka; [Weerakoon, Gothamie] Field Museum Nat Hist, Dept Sci & Educ, Integrat Res Ctr, Chicago, IL 60605 USA; [Weerakoon, Gothamie] Nat Hist Museum, Dept Life Sci, Algae Fungi & Plants Div, London, England	University Kelaniya; University Kelaniya; Field Museum of Natural History (Chicago); Natural History Museum London	Paranagama, PA (corresponding author), Univ Kelaniya, Dept Chem, Kelaniya, Sri Lanka.	priyani@kln.ac.lk	Weerakoon, Gothamie/AAJ-3035-2021	Paranagama, Priyani/0000-0001-5489-081X	National Research Council, Sri Lanka [NRC/15-08]	National Research Council, Sri Lanka	This research project was funded by National Research Council, Sri Lanka under the grant number NRC/15-08 to PAP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Attanayake RN, 2010, PLANT PATHOL, V59, P712, DOI 10.1111/j.1365-3059.2010.02306.x; Attanayake RN, 2009, PLANT DIS, V93, P797, DOI 10.1094/PDIS-93-8-0797; Bhutkar M. A., 2012, International Journal of Chemical Sciences, V10, P457; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chatatikun M., 2013, Journal of Chemical and Pharmaceutical Research, V5, P97; Chowdhary K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141444; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P1305, DOI 10.1007/s11274-009-0013-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003; Gupta M, 2015, J ENZYM INHIB MED CH, V30, P15, DOI 10.3109/14756366.2013.871007; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jayakumar K, 2016, RES J PHARM BIOL CHE, V7, P1412; Khan AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158207; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Manthrirathna MATP, 2018, J NATN SCI FDN SRI L; Muggia L, 2016, FUNGAL DIVERS, V76, P119, DOI 10.1007/s13225-015-0343-8; Nielsen JC, 2017, SYN SYST BIOTECHNO, V2, P5, DOI 10.1016/j.synbio.2017.02.002; Orange A., 2001, MICROCHEMICAL METHOD; Paranagama PA, 2007, J NAT PROD, V70, P1700, DOI 10.1021/np070466w; Pinto L., 1986, PUBLICATION NATL RES; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Raja HA, 2017, J NAT PROD, V80, P756, DOI 10.1021/acs.jnatprod.6b01085; Reynolds CL, 2017, PLOS ONE, V12, P180; Samanthi KAU, 2015, J NATL SCI FOUND SRI, V43, P217, DOI 10.4038/jnsfsr.v43i3.7950; Samanthi KAU, 2015, J NATL SCI FOUND SRI, V43, P119, DOI 10.4038/jnsfsr.v43i2.7939; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Upreti D. K., 1999, Tropical Ecology, V40, P41; Weerakoon G, 2016, PHYTOTAXA, V280, P152, DOI 10.11646/phytotaxa.280.2.5; Zhang T, 2016, EXTREMOPHILES, V20, P461, DOI 10.1007/s00792-016-0836-8; Zhao Q, 2015, J NAT PROD, V78, P1221, DOI 10.1021/np500912t	38	16	20	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0200711	10.1371/journal.pone.0200711	http://dx.doi.org/10.1371/journal.pone.0200711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157176	Green Submitted, Green Published, gold			2022-12-26	WOS:000443071400005
J	Shumilov, K; Real, MA; Valderrama-Carvajal, A; Rivera, A				Shumilov, Kirill; Angeles Real, M.; Valderrama-Carvajal, Alejandra; Rivera, Alicia			Selective ablation of striatal striosomes produces the deregulation of dopamine nigrostriatal pathway	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; IN-SITU HYBRIDIZATION; CHOLINERGIC INTERNEURONS; PATCH COMPARTMENT; DORSAL STRIATUM; SUBSTANCE-P; RAT-BRAIN; NEURONS; EXPRESSION; PROJECTIONS	The striatum is a complex structure in which the organization in two compartments (striosomes and matrix) have been defined by their neurochemical profile and their input-output connections. The striosomes receive afferences from the limbic brain areas and send projections to the dopamine neurons of the substantia nigra pars compacta. Thereby, it has been suggested that the striosomes exert a limbic control over the motor function mediated by the surrounding matrix. However, the functionality of the striosomes are not completely understood. To elucidate the role of the striosomes on the regulation of the nigral dopamine neurons, we have induced specific ablation of this compartment by striatal injections of the neurotoxin dermorphin-saporin (DS) and dopamine neurotransmission markers have been analyzed by immunohistochemistry. The degeneration of the striosomes resulted in a nigrostriatal projections imbalance between the two striatal compartments, with an increase of the dopamine neurotransmission in the striosomes and a decrease in the matrix. The present results highlight the key function of the striosomes for the maintenance of the striatal dopamine tone and would contribute to the understanding of their involvement in some neurological disorders such as Huntington's disease.	[Shumilov, Kirill; Angeles Real, M.; Valderrama-Carvajal, Alejandra; Rivera, Alicia] Univ Malaga, Dept Cell Biol, Inst Invest Biomed, Malaga, Spain	Universidad de Malaga	Rivera, A (corresponding author), Univ Malaga, Dept Cell Biol, Inst Invest Biomed, Malaga, Spain.	arivera@uma.es	Rivera, Alicia/L-2098-2014; Valderrama-Carvajal, Alejandra/F-3852-2016; Valderrama-Carvajal, Alejandra/AAB-4325-2020; Real/L-2950-2014; Shumilov, Kirill/J-2190-2018	Rivera, Alicia/0000-0002-7282-0441; Valderrama-Carvajal, Alejandra/0000-0002-9412-1713; Valderrama-Carvajal, Alejandra/0000-0002-9412-1713; Real/0000-0001-8823-9419; Shumilov, Kirill/0000-0001-8961-1702	Junta de Andalucia [CTS-0161, BIO121]; Universidad de Malaga	Junta de Andalucia(Junta de Andalucia); Universidad de Malaga	This work was supported by Junta de Andalucia (grant numbers CTS-0161 to A.R. and BIO121 to M.A.R) and Universidad de Malaga.	ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Austin S, 2014, STRIATAL CHOLINERGIC; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Beste C, 2017, MOVEMENT DISORD, V32, P576, DOI 10.1002/mds.26895; Brimblecombe KR, 2017, ACS CHEM NEUROSCI, V8, P235, DOI 10.1021/acschemneuro.6b00333; Brown LL, DIFFERENTIAL METABOL; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Crittenden JR, 2016, P NATL ACAD SCI USA; Cui YJ, 2014, NAT NEUROSCI, V17, P254, DOI 10.1038/nn.3622; DELFS JM, 1994, J COMP NEUROL, V345, P46, DOI 10.1002/cne.903450104; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Gago B, 2007, J COMP NEUROL, V502, P358, DOI 10.1002/cne.21327; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GIAGNONI G, 1984, NEUROPEPTIDES, V5, P157, DOI 10.1016/0143-4179(84)90051-9; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Graybiel AM, 2015, COLD SPRING HARB PER, V7; Guttenberg ND, 1996, NEUROREPORT, V7, P2119, DOI 10.1097/00001756-199609020-00011; HERKENHAM M, 1981, NATURE, V291, P415, DOI 10.1038/291415a0; HERSCH SM, 1994, J NEUROSCI, V14, P3351; Hontanilla B, 1998, BRAIN RES BULL, V47, P107, DOI 10.1016/S0361-9230(98)00035-5; Jabourian M, 2005, EUR J NEUROSCI, V21, P3301, DOI 10.1111/j.1460-9568.2005.04154.x; Jabourian M, 2007, EUR J NEUROSCI, V25, P1546, DOI 10.1111/j.1460-9568.2007.05375.x; JIMENEZCASTELLANOS J, 1989, NEUROSCIENCE, V32, P297, DOI 10.1016/0306-4522(89)90080-8; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Lanciego JL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009621; Lawhorn C, 2009, NEUROSCIENCE, V163, P109, DOI 10.1016/j.neuroscience.2009.05.021; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McMahon A, 1998, MOL BRAIN RES, V54, P56, DOI 10.1016/S0169-328X(97)00305-7; Murray RC, 2015, BRAIN RES, V1618, P286, DOI 10.1016/j.brainres.2015.06.012; Murray RC, 2014, BRAIN STRUCT FUNCT, V219, P1213, DOI 10.1007/s00429-013-0559-x; OLSON L, 1972, BRAIN RES, V44, P283, DOI 10.1016/0006-8993(72)90385-X; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ponterio G, 2013, NEUROPHARMACOLOGY, V75, P78, DOI 10.1016/j.neuropharm.2013.07.006; Porreca F, 2001, J NEUROSCI, V21, P5281, DOI 10.1523/JNEUROSCI.21-14-05281.2001; Rivera A, 2002, J NEUROCHEM, V80, P219, DOI 10.1046/j.0022-3042.2001.00702.x; Rivera A, 2017, ADDICT BIOL, V22, P1232, DOI 10.1111/adb.12407; Smith JB, 2016, NEURON, V91, P1069, DOI 10.1016/j.neuron.2016.07.046; Tajima K, 2013, NEUROSCIENCE, V241, P215, DOI 10.1016/j.neuroscience.2013.03.012; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; Tokuno H, 2002, NEUROSCI LETT, V332, P5, DOI 10.1016/S0304-3940(02)00837-6; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wang H, 1999, J COMP NEUROL, V412, P132, DOI 10.1002/(SICI)1096-9861(19990913)412:1<132::AID-CNE10>3.0.CO;2-B; Wang HB, 2007, NEUROSCI LETT, V425, P195, DOI 10.1016/j.neulet.2007.08.033; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wiley RG, 2000, J NEUROSCI METH, V103, P73, DOI 10.1016/S0165-0270(00)00297-1; Winzer-Serhan UH, 2003, J CHEM NEUROANAT, V26, P17, DOI 10.1016/S0891-0618(03)00031-0; Wirtshafter D, 2004, J CHEM NEUROANAT, V28, P107, DOI 10.1016/j.jchemneu.2004.05.007; Xu MY, 2015, P NATL ACAD SCI USA, V112, P893, DOI 10.1073/pnas.1419533112; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203135	10.1371/journal.pone.0203135	http://dx.doi.org/10.1371/journal.pone.0203135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157254	Green Published, Green Submitted, gold			2022-12-26	WOS:000443071400094
J	Hsi, RS; Schlunk, SG; Tierney, JE; Dei, K; Jones, R; George, M; Karve, P; Duddu, R; Byram, BC				Hsi, Ryan S.; Schlunk, Siegfried G.; Tierney, Jaime E.; Dei, Kazuyuki; Jones, Rebecca; George, Mark; Karve, Pranav; Duddu, Ravindra; Byram, Brett C.			Feasibility of non-linear beamforming ultrasound methods to characterize and size kidney stones	PLOS ONE			English	Article							SONOGRAPHIC TWINKLING ARTIFACT; LAG SPATIAL COHERENCE; PULSE ARRIVAL-TIME; COMPUTED-TOMOGRAPHY; MEDICAL ULTRASOUND; CLINICAL EFFECTIVENESS; CLUTTER REDUCTION; RENAL-CALCULUS; ABDOMINAL-WALL; ULTRASONOGRAPHY	Purpose Ultrasound methods for kidney stone imaging suffer from poor sensitivity and size overestimation. The study objective was to demonstrate feasibility of non-linear ultrasound beamforming methods for stone imaging, including plane wave synthetic focusing (PWSF), short-lag spatial coherence (SLSC) imaging, mid-lag spatial coherence (MLSC) imaging with incoherent compounding, and aperture domain model image reconstruction (ADMIRE). Materials and methods The ultrasound techniques were evaluated in an in vitro kidney stone model and in a pilot study of 5 human stone formers (n = 6 stones). Stone contrast, contrast-to-noise ratio (CNR), sizing, posterior shadow contrast, and shadow width sizing were compared among the different techniques and to B-mode. CT imaging within 60 days was considered the gold standard stone size. Paired t-tests using Bonferroni correction were performed to evaluate comparing each technique with B-mode. Results Mean CT measured stone size was 6.0mm (range 2.9-12.2mm) with mean skin-to-stone distance 10.2cm (range 5.4-16.3cm). Compared to B-mode, stone contrast was best with ADMIRE (mean +12.2dB), while SLSC and MLSC showed statistically improved CNR. Sizing was best with ADMIRE (mean +1.3mm error), however this was not significantly improved over B-mode (+2.4mm). PWSF performed similarly to B-mode for stone contrast, CNR, SNR, and stone sizing. In the in vitro model, the shadow contrast was highest with ADMIRE (mean 10.5 dB vs 3.1 dB with B-mode). Shadow sizing was best with SLSC (mean error +0.9mm +/- 2.9), however the difference compared to B-mode was not significant. Conclusions The detection and sizing of stones are feasible with advanced beamforming methods with ultrasound. ADMIRE, SLSC, and MLSC hold promise for improving stone detection, shadow contrast, and sizing.	[Hsi, Ryan S.] Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN 37232 USA; [Schlunk, Siegfried G.; Tierney, Jaime E.; Dei, Kazuyuki; Jones, Rebecca; George, Mark; Byram, Brett C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Karve, Pranav; Duddu, Ravindra] Vanderbilt Univ, Dept Civil & Environm Engn, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Hsi, RS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN 37232 USA.	ryan.hsi@vanderbilt.edu	Karve, Pranav/AAN-2258-2021; Byram, Brett/B-3559-2016; Duddu, Ravindra/A-6854-2015	Byram, Brett/0000-0003-3693-1459; Hsi, Ryan/0000-0003-1652-694X; Duddu, Ravindra/0000-0002-4205-0247	Vanderbilt Institute of Surgery and Engineering (VISE); VISE Surgeon in Residence Award [R01EB020040]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020040] Funding Source: NIH RePORTER	Vanderbilt Institute of Surgery and Engineering (VISE); VISE Surgeon in Residence Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was received from Vanderbilt Institute of Surgery and Engineering (VISE) Pilot and Feasibility Award, VISE Surgeon in Residence Award, R01EB020040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja-Fernandez S, 2015, KNOWL-BASED SYST, V83, P1, DOI 10.1016/j.knosys.2015.02.029; Anderson ME, 1998, J ACOUST SOC AM, V104, P3099, DOI 10.1121/1.423889; Anderson ME, 2000, J ACOUST SOC AM, V107, P3540, DOI 10.1121/1.429422; BLY SHP, 1985, ULTRASOUND MED BIOL, V11, P99, DOI 10.1016/0301-5629(85)90012-2; Bottenus N, 2013, IEEE T ULTRASON FERR, V60, P1816, DOI 10.1109/TUFFC.2013.2768; Brisbane W, 2016, NAT REV UROL, V13, P654, DOI 10.1038/nrurol.2016.154; Byram B., 2015, P INT ULTR S IUS OCT, P1; Byram B, 2016, ULTR S IUS 2016 IEEE; Byram B, 2015, IEEE T ULTRASON FERR, V62, P1913, DOI 10.1109/TUFFC.2015.007004; Byram B, 2014, IEEE T ULTRASON FERR, V61, P428, DOI 10.1109/TUFFC.2014.2928; CARSON PL, 1977, RADIOLOGY, V122, P765, DOI 10.1148/122.3.765; Dai JC, 2018, WORLD J UROL, V36, P727, DOI 10.1007/s00345-017-2156-8; Dei K, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.2.027001; Dei K, 2018, ULTRASONICS, V89, P34, DOI 10.1016/j.ultras.2018.04.011; Dillman JR, 2011, RADIOLOGY, V259, P911, DOI 10.1148/radiol.11102128; Dunmire B, 2016, J UROLOGY, V195, P171, DOI 10.1016/j.juro.2015.05.111; Dunmire B, 2015, J ENDOUROL, V29, P147, DOI 10.1089/end.2014.0332; FLAX SW, 1988, IEEE T ULTRASON FERR, V35, P758, DOI 10.1109/58.9333; Fowler KAB, 2002, RADIOLOGY, V222, P109, DOI 10.1148/radiol.2221010453; Fulgham PF, 2013, J UROLOGY, V189, P1203, DOI 10.1016/j.juro.2012.10.031; Ganesan V, 2017, BJU INT, V119, P464, DOI 10.1111/bju.13605; HINKELMAN LM, 1994, J ACOUST SOC AM, V95, P530, DOI 10.1121/1.408347; Hyun D, 2017, IEEE T ULTRASON FERR, V64, P500, DOI 10.1109/TUFFC.2016.2634004; Kruizinga P, 2012, IEEE T ULTRASON FERR, V59, P2684, DOI 10.1109/TUFFC.2012.2509; Lediju MA, 2011, IEEE T ULTRASON FERR, V58, P1377, DOI 10.1109/TUFFC.2011.1957; Lediju MA, 2008, ULTRASONIC IMAGING, V30, P151, DOI 10.1177/016173460803000302; LO T, 1991, ELECTRON LETT, V27, P350, DOI 10.1049/el:19910222; Masch WR, 2016, AM J ROENTGENOL, V206, P326, DOI 10.2214/AJR.15.14998; Mitterberger M, 2009, INT BRAZ J UROL, V35, P532, DOI 10.1590/S1677-55382009000500004; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Nicolau C, 2015, INSIGHTS IMAGING, V6, P441, DOI 10.1007/s13244-015-0396-y; Omar M, 2015, J ENDOUROL, V29, P1122, DOI 10.1089/end.2015.0088; Pinton GF, 2011, IEEE T ULTRASON FERR, V58, P1272, DOI 10.1109/TUFFC.2011.1938; Ray AA, 2010, UROLOGY, V76, P295, DOI 10.1016/j.urology.2009.12.015; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Semins MJ, 2014, NAT REV UROL, V11, P163, DOI 10.1038/nrurol.2014.17; SMITH SW, 1986, ULTRASOUND MED BIOL, V12, P229, DOI 10.1016/0301-5629(86)90314-5; SMITH SW, 1983, IEEE T SON ULTRASON, V30, P164, DOI 10.1109/T-SU.1983.31405; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446; Sternberg KM, 2016, UROLOGY, V95, P67, DOI 10.1016/j.urology.2016.06.002; SUMINO Y, 1991, J ACOUST SOC AM, V90, P2924, DOI 10.1121/1.401766; Tabei M, 2003, J ACOUST SOC AM, V113, P1166, DOI 10.1121/1.1531986; Tierney JE, 2019, UROLITHIASIS, V47, P181, DOI 10.1007/s00240-018-1036-z; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; Ulusan S, 2007, J CLIN ULTRASOUND, V35, P256, DOI 10.1002/jcu.20347; Unal D, 2003, UROL INT, V70, P31, DOI 10.1159/000067702; Vouras P, 2016, CONF REC ASILOMAR C, P669, DOI 10.1109/ACSSC.2016.7869128; Waag RC, 1986, SONICS ULTRASONICS I, V32, P36; Wang LT, 2012, SENSORS-BASEL, V12, P12424, DOI 10.3390/s120912424; Winkel RR, 2012, ULTRASOUND MED BIOL, DOI [10.1016/j.ultrasmedbio.2012.03, DOI 10.1016/J.ULTRASMEDBIO.2012.03]; ZHU Q, 1992, ULTRASONIC IMAGING, V14, P276, DOI 10.1016/0161-7346(92)90067-6	51	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203138	10.1371/journal.pone.0203138	http://dx.doi.org/10.1371/journal.pone.0203138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153279	Green Published, gold			2022-12-26	WOS:000443001700047
J	Milner, GR; Boldsen, JL; Ousley, SD; Getz, SM; Weise, S; Tarp, P; Steadman, DW				Milner, George R.; Boldsen, Jesper L.; Ousley, Stephen D.; Getz, Sara M.; Weise, Svenja; Tarp, Peter; Steadman, Dawnie W.			Selective mortality in middle-aged American women with Diffuse Idiopathic Skeletal Hyperostosis (DISH)	PLOS ONE			English	Article							HYPER-OSTOSIS DISH; ANKYLOSING SPINAL-DISORDERS; OF-THE-LITERATURE; RISK-FACTORS; EXTRASPINAL MANIFESTATIONS; CLASSIFICATION CRITERIA; CARDIOVASCULAR-DISEASES; SPONDYLOSIS DEFORMANS; METABOLIC SYNDROME; PREVALENCE	Objective A mortality sample of white American male and female skeletons was examined to illustrate a simple means of identifying skeletal conditions associated with an increased risk of dying relatively early in adulthood and to determine if males and females with Diffuse Idiopathic Skeletal Hyperostosis (DISH) displayed the same general age-specific pattern of mortality. Methods Age-specific probability distributions for DISH were generated from 416 white Americans who died from the 1980s to the present, and whose remains were donated to the University of Tennessee Forensic Anthropology Center. The age-specific frequency of DISH is analyzed using an empirical smoothing algorithm. Doing so allows for the identification of deviations (i.e., local maxima) from monotonically increasing age-specific probabilities. Results In females (N = 199), there is a peak in the frequency of individuals with DISH around 60 years of age where 37.0% of the individuals have DISH. It is matched only by the frequency (38.7%) in the oldest females, those over 85 years old. In contrast, DISH frequencies for males (N = 217) increase monotonically with advancing age, reaching 62.5% in the >86 years age group. There was an association between DISH and high body weight in women, particularly those who died before they reached the age of 75. Conclusions Early-onset DISH in white American women is associated with an increased risk of dying indicated by a local maximum in the probability curve. Should this finding be replicated in additional mortality samples and the reason DISH is associated with early death is established, beyond being heavy, this radiologically visible ossification of the spine could be a potential component of health-monitoring programs for middle-aged women.	[Milner, George R.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Boldsen, Jesper L.; Weise, Svenja; Tarp, Peter] Univ Southern Denmark, Dept Forens Med, Unit Anthropol, ADBOU, Odense, Denmark; [Ousley, Stephen D.] Mercyhurst Univ, Dept Math & Informat Sci, Erie, PA USA; [Getz, Sara M.] Idaho State Univ, Dept Anthropol, Pocatello, ID 83209 USA; [Steadman, Dawnie W.] Univ Tennessee, Dept Anthropol, Forens Anthropol Ctr, Knoxville, TN 37996 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Southern Denmark; Idaho; Idaho State University; University of Tennessee System; University of Tennessee Knoxville	Milner, GR (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	ost@psu.edu	Steadman, Dawnie/AAG-4216-2020	Steadman, Dawnie/0000-0003-0812-0739	National Institute of Justice (NIJ) [2014-DN-BX-K007]	National Institute of Justice (NIJ)	This work was funded by a National Institute of Justice (NIJ) grant, 2014-DN-BX-K007, awarded to GRM, JLB, and SDO. The NIJ had no role in data collection, analysis, or manuscript preparation.	Aceves-Avila FJ, 1998, J RHEUMATOL, V25, P776; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ARRIAZA BT, 1993, AM J PHYS ANTHROPOL, V92, P243, DOI 10.1002/ajpa.1330920302; ARRIAZA BT, 1993, AM J PHYS ANTHROPOL, V91, P263, DOI 10.1002/ajpa.1330910302; Bazzocchi A, 2017, RADIOL CLIN N AM, V55, P943, DOI 10.1016/j.rcl.2017.04.003; BLOOM RA, 1984, SCAND J RHEUMATOL, V13, P181, DOI 10.3109/03009748409100384; Caron T, 2010, SPINE, V35, pE458, DOI 10.1097/BRS.0b013e3181cc764f; CASSIM B, 1990, BRIT J RHEUMATOL, V29, P131; Connell B., 2012, MOLA MONOGRAPH, V60; Crawley M.J., 2007, R BOOK; Crubezy E, 1993, REV RHUM, V60, P489; Denko CW, 2006, RHEUMATOL INT, V26, P292, DOI 10.1007/s00296-005-0588-8; Diederichs G, 2011, OSTEOPOROSIS INT, V22, P1789, DOI 10.1007/s00198-010-1409-9; Faccia K, 2016, QUATERN INT, V405, P66, DOI 10.1016/j.quaint.2015.10.011; FORESTIER J, 1950, ANN RHEUM DIS, V9, P321, DOI 10.1136/ard.9.4.321; FORESTIER J, 1971, CLIN ORTHOP RELAT R, P65; Foster A, 2018, J ARCHAEOL SCI-REP, V18, P408, DOI 10.1016/j.jasrep.2018.01.002; Giuffra V, 2010, EUR SPINE J, V19, pS103, DOI 10.1007/s00586-009-1125-3; GRAN JT, 1993, SEMIN ARTHRITIS RHEU, V22, P319, DOI 10.1016/S0049-0172(05)80011-3; Hartmann S, 2017, GLOB SPINE J, V7, P469, DOI 10.1177/2192568217700108; HENDRIX RW, 1994, AM J ROENTGENOL, V162, P899, DOI 10.2214/ajr.162.4.8141015; Hirasawa A, 2016, J ORTHOP SCI, V21, P287, DOI 10.1016/j.jos.2016.02.001; Hlavenkova L, 2013, ANTHROPOL ANZ, V70, P261, DOI 10.1127/0003-5548/2013/0309; Holgate RLV, 2016, CLIN ANAT, V29, P870, DOI 10.1002/ca.22716; Jankauskas R, 2003, INT J OSTEOARCHAEOL, V13, P289, DOI 10.1002/oa.697; JULKUNEN H, 1981, SCAND J RHEUMATOL, V10, P193, DOI 10.3109/03009748109095298; JULKUNEN H, 1975, SCAND J RHEUMATOL, V4, P23; JULKUNEN H, 1981, SCAND J RHEUMATOL, V10, P241, DOI 10.3109/03009748109095306; JULKUNEN H, 1971, ANN RHEUM DIS, V30, P605, DOI 10.1136/ard.30.6.605; Kagotani R, 2015, J BONE MINER METAB, V33, P221, DOI 10.1007/s00774-014-0583-9; Katzman WB, 2017, J AM GERIATR SOC, V65, P1476, DOI 10.1111/jgs.14810; Kim MJ, 2012, INT J OSTEOARCHAEOL, V22, P235, DOI 10.1002/oa.1203; Kim SK, 2004, J RHEUMATOL, V31, P2032; Kiss C, 2002, RHEUMATOLOGY, V41, P27, DOI 10.1093/rheumatology/41.1.27; Kiss C, 2002, SCAND J RHEUMATOL, V31, P226, DOI 10.1080/030097402320318422; KRAMAR C, 1990, SCAND J RHEUMATOL, V19, P163, DOI 10.3109/03009749009102121; Kuperus JS, 2017, RHEUMATOLOGY, V56, P1123, DOI 10.1093/rheumatology/kex056; LITTLEJOHN GO, 1985, CLIN RHEUMATOL, V4, P294, DOI 10.1007/BF02031611; MAAT GJR, 1995, INT J OSTEOARCHAEOL, V5, P289, DOI 10.1002/oa.1390050308; Mader R, 2009, OSTEOARTHR CARTILAGE, V17, P825, DOI 10.1016/j.joca.2008.12.004; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; Mader R, 2013, RHEUMATOLOGY, V52, P326, DOI 10.1093/rheumatology/kes257; Mader R, 2012, NAT REV RHEUMATOL, V8, P10, DOI 10.1038/nrrheum.2011.189; Mader R, 2010, J RHEUMATOL, V37, P1911, DOI 10.3899/jrheum.091008; Mader R, 2009, RHEUMATOLOGY, V48, P1478, DOI 10.1093/rheumatology/kep308; Mader R, 2009, SEMIN ARTHRITIS RHEU, V38, P361, DOI 10.1016/j.semarthrit.2008.01.010; MAERTENS M, 1992, CLIN RHEUMATOL, V11, P551, DOI 10.1007/BF02283118; Mata S, 1998, SEMIN ARTHRITIS RHEU, V28, P88, DOI 10.1016/S0049-0172(98)80041-3; Mays S., 2000, J PATHOL, V12, P25; Mays S, 2016, AM J PHYS ANTHROPOL, V159, P577, DOI 10.1002/ajpa.22912; Milner GR, 2017, INT J PALEOPATHOL, V17, P26, DOI 10.1016/j.ijpp.2017.03.007; Miyazawa N, 2006, SPINE, V31, pE225, DOI 10.1097/01.brs.0000214949.75361.f4; Mori K, 2017, J ORTHOP SCI, V22, P38, DOI 10.1016/j.jos.2016.09.003; Okada E, 2017, J ORTHOP SCI, V22, P3, DOI 10.1016/j.jos.2016.09.011; Olivieri I, 2013, J RHEUMATOL, V40, P1251, DOI 10.3899/jrheum.130647; Olivieri Ignazio, 2009, Curr Rheumatol Rep, V11, P321; Osz Brigitta, 2009, Acta Biologica Szegediensis, V53, P125; Oudkerk SF, 2017, EUR RADIOL, V27, P188, DOI 10.1007/s00330-016-4355-x; Oxenham MF, 2006, INT J OSTEOARCHAEOL, V16, P34, DOI 10.1002/oa.803; Paja Laszio, 2010, Acta Biologica Szegediensis, V54, P75; PALEY D, 1991, CLIN ORTHOP RELAT R, P22; Pillai Sruti, 2014, Open Rheumatol J, V8, P116, DOI 10.2174/1874312901408010116; Quintelier K, 2014, AM J PHYS ANTHROPOL, V153, P203, DOI 10.1002/ajpa.22420; Reale B, 1999, INT J OSTEOARCHAEOL, V9, P369; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; RESNICK D, 1975, RADIOLOGY, V115, P513, DOI 10.1148/15.3.513; RESNICK D, 1978, SEMIN ARTHRITIS RHEU, V7, P153, DOI 10.1016/0049-0172(78)90036-7; ROGERS J, 1990, BRIT MED J, V300, P367, DOI 10.1136/bmj.300.6721.367; ROGERS J, 1985, ANN RHEUM DIS, V44, P113, DOI 10.1136/ard.44.2.113; Rogers J, 2001, INT J OSTEOARCHAEOL, V11, P357, DOI 10.1002/oa.574; Rustagi T, 2017, J ORTHOP TRAUMA, V31, pS57, DOI 10.1097/BOT.0000000000000953; Smith MO, 2013, INT J PALEOPATHOL, V3, P11, DOI 10.1016/j.ijpp.2013.03.001; Stroud G, 1993, CEMETERIES ST ANDREW; SUZUKI T, 1993, ANTHROPOL SCI, V101, P273, DOI 10.1537/ase.101.273; Toyoda H, 2017, ASIAN SPINE J, V11, P63, DOI 10.4184/asj.2017.11.1.63; UTSINGER PD, 1985, CLIN RHEUM DIS, V11, P325; van der Merwe AE, 2012, HOMO, V63, P202, DOI 10.1016/j.jchb.2012.03.005; Venables WN., 2002, MODERN APPL STAT S 4; Verlaan JJ, 2007, EUR SPINE J, V16, P1129, DOI 10.1007/s00586-007-0342-x; Verlaan JJ, 2011, EUR SPINE J, V20, P1474, DOI 10.1007/s00586-011-1719-4; Vezyroglou G, 1996, J RHEUMATOL, V23, P672; Vidal P, 2000, JOINT BONE SPINE, V67, P210; WALDRON T, 1985, BRIT MED J, V291, P1762, DOI 10.1136/bmj.291.6511.1762; Waldron T., 1991, INT J OSTEOARCHAEOL, V1, P103, DOI DOI 10.1002/0A.1390010206; Waldron T, 2007, ST PETERS BARTON UPO, V2; Weinfeld RM, 1997, SKELETAL RADIOL, V26, P222, DOI 10.1007/s002560050225; Weisz GM, 2011, RHEUMATOL INT, V31, P1649, DOI 10.1007/s00296-010-1563-6; Westerveld LA, 2014, SPINE J, V14, P729, DOI 10.1016/j.spinee.2013.06.038; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Westerveld LA, 2008, J RHEUMATOL, V35, P1635; William M., BASS DONATED SKELETA; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Zincarelli C, 2012, ARTHRIT CARE RES, V64, P1765, DOI 10.1002/acr.21742	94	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202283	10.1371/journal.pone.0202283	http://dx.doi.org/10.1371/journal.pone.0202283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153267	Green Submitted, Green Published, gold			2022-12-26	WOS:000443001700012
J	Pandey, K; Lahiani, MH; Hicks, VK; Hudson, MK; Green, MJ; Khodakovskaya, M				Pandey, Kamal; Lahiani, Mohamed H.; Hicks, Victoria K.; Hudson, M. Keith; Green, Micah J.; Khodakovskaya, Mariya			Effects of carbon-based nanomaterials on seed germination, biomass accumulation and salt stress response of bioenergy crops	PLOS ONE			English	Article							AQUAPORIN GENE; GROWTH; WATER; SALINITY; NANOTUBES; PLANTS; DESALINATION; IRRIGATION; POTENTIALS; TOLERANCE	Bioenergy crops are an attractive option for use in energy production. A good plant candidate for bioenergy applications should produce a high amount of biomass and resist harsh environmental conditions. Carbon-based nanomaterials (CBNs) have been described as promising seed germination and plant growth regulators. In this paper, we tested the impact of two CBNs: graphene and multi-walled carbon nanotubes (CNTs) on germination and biomass production of two major bioenergy crops (sorghum and switchgrass). The application of graphene and CNTs increased the germination rate of switchgrass seeds and led to an early germination of sorghum seeds. The exposure of switchgrass to graphene (200 mg/l) resulted in a 28% increase of total biomass produced compared to untreated plants. We tested the impact of CBNs on bioenergy crops under salt stress conditions and discovered that CBNs can significantly reduce symptoms of salt stress imposed by the addition of NaCl into the growth medium. Using an ion selective electrode, we demonstrated that the concentration of Na+ ions in NaCl solution can be significantly decreased by the addition of CNTs to the salt solution. Our data confirmed the potential of CBNs as plant growth regulators for non-food crops and demonstrated the role of CBNs in the protection of plants against salt stress by desalination of saline growth medium.	[Pandey, Kamal; Lahiani, Mohamed H.; Khodakovskaya, Mariya] Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA; [Hicks, Victoria K.; Green, Micah J.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA; [Hudson, M. Keith] Univ Arkansas, Dept Chem, Little Rock, AR 72204 USA; [Khodakovskaya, Mariya] Russian Acad Sci, Far Eastern Branch, Fed Sci Ctr East Asia Terr Biodivers, Vladivostok, Russia	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences	Khodakovskaya, M (corresponding author), Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA.; Khodakovskaya, M (corresponding author), Russian Acad Sci, Far Eastern Branch, Fed Sci Ctr East Asia Terr Biodivers, Vladivostok, Russia.	mvkhodakovsk@ualr.edu	; Green, Micah/C-7647-2011	Lahiani, Mohamed H./0000-0003-0551-2606; Green, Micah/0000-0001-5691-0861	Arkansas Science and Technology Authority [15-B-24]	Arkansas Science and Technology Authority	This study was supported by the Arkansas Science and Technology Authority (Award 15-B-24 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohammadi M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295101; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; Das R, 2014, DESALINATION, V336, P97, DOI 10.1016/j.desal.2013.12.026; Demirbas AH, 2007, ENERG CONVERS MANAGE, V48, P2386, DOI 10.1016/j.enconman.2007.03.005; Dipti P, 2013, INT J ENV ENG MANAG, V4, P265; Erb KH, 2012, ENERG POLICY, V47, P260, DOI 10.1016/j.enpol.2012.04.066; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Irin F, 2012, CARBON, V50, P4441, DOI 10.1016/j.carbon.2012.05.022; Johnson J.M.F., 2007, AM J PLANT SCI BIOTE, V1, P1; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Khodakovskaya M, 2009, ACS NANO, V3, P3221, DOI 10.1021/nn900887m; Khodakovskaya MV, 2013, SMALL, V9, P115, DOI 10.1002/smll.201201225; Khodakovskaya MV, 2012, ACS NANO, V6, P2128, DOI 10.1021/nn204643g; Khodakovskaya MV, 2011, P NATL ACAD SCI USA, V108, P1028, DOI 10.1073/pnas.1008856108; Lahiani MH, 2017, J APPL TOXICOL, V37, P1305, DOI 10.1002/jat.3477; Lahiani MH, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/26/265102; Lahiani MH, 2015, CARBON, V81, P607, DOI 10.1016/j.carbon.2014.09.095; Lahiani MH, 2013, ACS APPL MATER INTER, V5, P7965, DOI 10.1021/am402052x; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Martinez-Alvarez V, 2016, DESALINATION, V381, P58, DOI 10.1016/j.desal.2015.11.032; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P47, DOI 10.1016/S0960-8524(01)00119-5; Moser LE, 1995, FORAGES INTRO GRASSL, V1, P409; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Netondo GW, 2004, CROP SCI, V44, P797, DOI 10.2135/cropsci2004.0797; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; Silber A, 2015, WATER RESOUR RES, V51, P450, DOI 10.1002/2014WR016398; Skoog MA, 1971, PRINCIPLES INSTRUMEN, P473; Smeets EMW, 2007, PROG ENERG COMBUST, V33, P56, DOI 10.1016/j.pecs.2006.08.001; Stavridou E, 2017, GCB BIOENERGY, V9, P92, DOI 10.1111/gcbb.12351; Tofighy MA, 2010, DESALINATION, V258, P182, DOI 10.1016/j.desal.2010.03.017; Torney F, 2007, CURR OPIN BIOTECH, V18, P193, DOI 10.1016/j.copbio.2007.03.006; Vadez V., 2015, PLANT GENE, V1, P18, DOI DOI 10.1016/J.PLGENE.2014.12.002; Villagarcia H, 2012, SMALL, V8, P2328, DOI 10.1002/smll.201102661; Volkmar KM, 1998, CAN J PLANT SCI, V78, P19, DOI 10.4141/P97-020; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Yang Hui Ying, 2013, Nat Commun, V4, P2220, DOI 10.1038/ncomms3220; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001	43	55	56	10	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202274	10.1371/journal.pone.0202274	http://dx.doi.org/10.1371/journal.pone.0202274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153261	gold, Green Published, Green Submitted			2022-12-26	WOS:000443001700011
J	Liu, AR; Hildebrand, AM; Dixon, S; Sontrop, JM; Clark, WF; Lazo-Langner, A; Nash, D; Garg, AX				Liu, Aiden R.; Hildebrand, Ainslie M.; Dixon, Stephanie; Sontrop, Jessica M.; Clark, William F.; Lazo-Langner, Alejandro; Nash, Danielle; Garg, Amit X.			A matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy	PLOS ONE			English	Article							THROMBOCYTOPENIC PURPURA; VALIDATION; DIAGNOSIS	Several case reports suggest that non-steroidal anti-inflammatory drug (NSAID) use is associated with development of thrombotic microangiopathy (TMA). We conducted a matched population-based case-control study using linked administrative healthcare data in Ontario, Canada to assess the relationship between TMA hospitalization and recent exposure to prescription NSAIDs versus acetaminophen (acetaminophen was chosen as the referent drug because it has no known association with TMA). Cases and controls were drawn from a source population of adults who filled a prescription for either NSAIDs or acetaminophen between 1991 and 2015 (restricted to adults with prescription drug benefits [n = 3.6 million]). We identified 44 eligible cases with a hospital admission for incident TMA and a recent prescription for NSAIDs or acetaminophen. We successfully matched 38 cases (1: 4) to 152 controls without TMA on demographics, risk factors for TMA, and indications for NSAID use. Cases and controls were similar with respect to age (71 years) and sex (63% women); however, on average, cases had more comorbidities than controls (12 vs. 14; p<0.05) and more primary care visits in the year before the index date (19 vs. 12; p<0.05). Cases were significantly less likely than controls to have received a recent prescription for NSAIDs (19/38 [50%] vs. 115/152 [76%], respectively; adjusted odds ratio 0.37, 95% confidence interval: 0.16 to 0.84). Results were similar in several sensitivity analyses. Overall, the results of this study do not support a harmful association between NSAID use and the development of TMA.	[Liu, Aiden R.; Dixon, Stephanie; Sontrop, Jessica M.; Garg, Amit X.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Liu, Aiden R.; Dixon, Stephanie; Sontrop, Jessica M.; Nash, Danielle; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hildebrand, Ainslie M.] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada; [Clark, William F.; Garg, Amit X.] Western Univ, Dept Med, Div Nephrol, London, ON, Canada; [Lazo-Langner, Alejandro] Western Univ, Dept Med, Div Hematol, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; University of Alberta; Western University (University of Western Ontario); Western University (University of Western Ontario)	Liu, AR (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.; Liu, AR (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	aidenxliu@gmail.com	Lazo-Langner, Alejandro/G-3318-2011; Lazo-Langner, Alejandro/E-6993-2011; Garg, Amit X/G-3295-2011; Clark, Bill/G-3287-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Lazo-Langner, Alejandro/0000-0001-6869-8431; Sontrop, Jessica M./0000-0001-7784-2028	Canadian Institute of Health Research; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry at Western University; Lawson Health Research Institute; Lilibeth Caberto Kidney Clinical Research Unit; Ontario Drug Policy Research Network; Canadian Institute for Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program; Dr. Adam Linton Chair in Kidney Health Analytics; Opportunities Fund of the Academic Health Sciences Centre Alternative Funding Plan of AMOSO; Academic Medical Organization of South Western Ontario (AMOSO) Opportunities fund; Institute for Clinical Evaluative Sciences Western Faculty Scholars program	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry at Western University; Lawson Health Research Institute; Lilibeth Caberto Kidney Clinical Research Unit; Ontario Drug Policy Research Network; Canadian Institute for Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program; Dr. Adam Linton Chair in Kidney Health Analytics; Opportunities Fund of the Academic Health Sciences Centre Alternative Funding Plan of AMOSO; Academic Medical Organization of South Western Ontario (AMOSO) Opportunities fund; Institute for Clinical Evaluative Sciences Western Faculty Scholars program	This study was funded by the Canadian Institute of Health Research and supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The study was conducted by the Kidney, Dialysis and Transplantation program at the ICES Western facility, which received financial support from Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry at Western University and the Lawson Health Research Institute. The Thrombotic Microangiopathy Database created under the efforts of Ainslie Hildebrand provided the laboratory values for this study. Aiden Liu was a trainee on this project, and was supported by the Lilibeth Caberto Kidney Clinical Research Unit, the Ontario Drug Policy Research Network, and the Canadian Institute for Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program. Amit Garg was supported by the Dr. Adam Linton Chair in Kidney Health Analytics, and the Opportunities Fund of the Academic Health Sciences Centre Alternative Funding Plan of AMOSO. The opinions, results and conclusions are those of the authors and are independent from the funding sources. Dr. Lazo-Langner was supported in part by a grant from the Academic Medical Organization of South Western Ontario (AMOSO) Opportunities fund and by the Institute for Clinical Evaluative Sciences Western Faculty Scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nouri ZL, 2015, BLOOD, V125, P616, DOI 10.1182/blood-2014-11-611335; Benmoussa J, 2016, AM J EMERG MED, V34, DOI 10.1016/j.ajem.2015.10.044; Catizone L, 1974, Minerva Nefrol, V21, P439; Conaghan PG, 2012, RHEUMATOL INT, V32, P1491, DOI 10.1007/s00296-011-2263-6; Goel V, 1996, PATTERNS HLTH CARE O; GONZALEZ IC, 1989, MED CLIN-BARCELONA, V92, P396; Hazra A, 2016, INDIAN J DERMATOL, V61, P137, DOI 10.4103/0019-5154.177775; Hussain MA, 2016, CLIN INVEST MED, V39, pE73; Nissen Trygve, 2014, BMC Res Notes, V7, P264, DOI 10.1186/1756-0500-7-264; Odueyungbo A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-28; Okura H, 1999, Rinsho Ketsueki, V40, P663; Oregel KZ, 2013, CLIN MED INSIGHTS-BL, V6, P19, DOI 10.4137/CMBD.S12843; Radhi M, 2012, INT SCH RES NOT INT, V2012, DOI [10.5402/2012/310596, DOI 10.5402/2012/310596]; RANDI ML, 1993, BRIT MED J, V306, P186, DOI 10.1136/bmj.306.6871.186-b; Schoenmaker NJ, 2007, CLIN NEPHROL, V68, P177; Schwartz KL, 2015, HUM VACC IMMUNOTHER, V11, P1840, DOI 10.1080/21645515.2015.1043499; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Shenkman B, 2014, AUTOIMMUN REV, V13, P584, DOI 10.1016/j.autrev.2014.01.004; Singh G, 2000, Am J Ther, V7, P115, DOI 10.1097/00045391-200007020-00008; TRICE JM, 1983, ARCH INTERN MED, V143, P1487, DOI 10.1001/archinte.143.7.1487; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311	21	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202801	10.1371/journal.pone.0202801	http://dx.doi.org/10.1371/journal.pone.0202801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142223	Green Published, Green Submitted, gold			2022-12-26	WOS:000442722500035
J	Power, J; Westle, A; Dowsett, GW; Lucke, J; Tucker, JD; Sugarman, J; Lewin, SR; Hill, S; Brown, G; Wallace, J; Richmond, J				Power, Jennifer; Westle, Andrew; Dowsett, Gary W.; Lucke, Jayne; Tucker, Joseph D.; Sugarman, Jeremy; Lewin, Sharon R.; Hill, Sophie; Brown, Graham; Wallace, Jack; Richmond, Jacqui			Perceptions of HIV cure research among people living with HIV in Australia	PLOS ONE			English	Article							CONTEXT	Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interruption may pose substantial individual risks for people living with HIV (PLHIV) without any therapeutic benefit. As such, it is important that the views of PLHIV are considered in the design of HIV cure research trials. Examining the lived experience of PLHIV provides unique and valuable perspectives on the risks and benefits of HIV cure research. In this study, we interviewed 20 PLHIV in Australia about their knowledge and attitudes toward clinical HIV cure research and explored their views regarding participation in HIV cure clinical trials, including those that involve ART interruption. Data were analysed thematically, using both inductive and deductive coding techniques, to identity themes related to perceptions of HIV cure research and PLHIV's assessment of the possible risks and benefits of trial participation. Study findings revealed interviewees were willing to consider participation in HIV cure research for social reasons, most notably the opportunity to help others. Concerns raised about ART interruption related to the social and emotional impact of viral rebound, including fear of onward HIV transmission and anxiety about losing control. These findings reveal the ways in which PLHIV perspectives deepen our understanding of HIV cure research, moving beyond a purely clinical assessment of risks and benefits in order to consider the social context.	[Power, Jennifer; Westle, Andrew; Dowsett, Gary W.; Lucke, Jayne; Brown, Graham; Wallace, Jack; Richmond, Jacqui] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Dowsett, Gary W.; Brown, Graham] Univ NSW, Ctr Social Res Hlth, Sydney, NSW, Australia; [Lucke, Jayne] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Tucker, Joseph D.] Univ N Carolina, UNC Project China, Guangzhou, Guangdong, Peoples R China; [Tucker, Joseph D.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Tucker, Joseph D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia; [Hill, Sophie] La Trobe Univ, Ctr Hlth Commun & Participat, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Richmond, Jacqui] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia	La Trobe University; University of New South Wales Sydney; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins University; University of Melbourne; Royal Melbourne Hospital; Monash University; La Trobe University; University of Melbourne	Power, J (corresponding author), La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia.	jennifer.power@latrobe.edu.au	Wallace, Jack/ABE-3351-2021; Lucke, Jayne C/A-5538-2008; Lewin, Sharon/Z-3297-2019	Wallace, Jack/0000-0002-4738-7316; Lucke, Jayne C/0000-0002-2885-5292; Dowsett, Gary W./0000-0002-0841-3964; Brown, Graham/0000-0003-4901-0974; Power, Jennifer/0000-0002-6566-3214; Sugarman, Jeremy/0000-0001-7022-8332; Lewin, Sharon Ruth/0000-0002-0330-8241	La Trobe University Building Healthy Communities Research Focus Area (GWD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R01AI108366, U19AI096113] Funding Source: NIH RePORTER	La Trobe University Building Healthy Communities Research Focus Area (GWD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a seeding grant from the La Trobe University Building Healthy Communities Research Focus Area (GWD).	Anderson JL, 2015, AIDS RES HUM RETROV, V31, P36, DOI [10.1089/aid.2014.0236, 10.1089/AID.2014.0236]; Arnold MP, 2015, J VIRUS ERAD, V1, P43; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burt RS, 2005, BROKERAGE CLOSURE IN; Charmaz, 2007, SAGE HDB GROUNDED TH, P97; Clarridge KE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006792; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Dube K, 2018, AIDS RES HUM RETROV, V34, P67, DOI [10.1089/aid.2017.0067, 10.1089/AID.2017.0067]; Dube K, 2018, J EMPIR RES HUM RES, V13, P3, DOI 10.1177/1556264617734061; Dube K, 2017, J VIRUS ERAD, V3, P40; Dube K, 2015, J VIRUS ERAD, V1, P250; Dube K, 2014, TRENDS MICROBIOL, V22, P547, DOI 10.1016/j.tim.2014.08.003; Epstein Steven., 1996, IMPURE SCI; Eshleman SH, 2017, JAIDS-J ACQ IMM DEF, V74, P112, DOI 10.1097/QAI.0000000000001158; Evans D, 2017, J MED ETHICS, V43, P100, DOI 10.1136/medethics-2015-103120; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Garner SA, 2017, J VIRUS ERAD, V3, P82; Grace D, 2015, AIDS EDUC PREV, V27, P333, DOI 10.1521/aeap.2015.27.4.333; Grossman CI, 2016, TRENDS MICROBIOL, V24, P5, DOI 10.1016/j.tim.2015.10.011; Henderson GE, 2017, J MED ETHICS; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hyde K.F., 2000, QUAL MARK RES, V3, P82, DOI [10.1108/13522750010322089, DOI 10.1108/13522750010322089]; Jenkins N, 2010, QUAL RES, V10, P175, DOI 10.1177/1468794109356737; Kippax S, 2011, AIDS EDUC PREV, V23, P393, DOI 10.1521/aeap.2011.23.5.393; Kirby Institute, 2017, VIR HEP MAPP PROJ NA; Lo B, 2013, CURR OPIN AIDS, V8; Lo YR, 2015, AIDS PATIENT CARE ST, V29, P389, DOI 10.1089/apc.2014.0348; McIntosh MJ, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615597674; McMahon JH, 2015, AIDS, V29, P248, DOI 10.1097/QAD.0000000000000534; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Persson A, 2003, HEALTH, V7, P397, DOI 10.1177/13634593030074002; Power J, 2011, MOVEMENT KNOWLEDGE E; Power J., 2014, COLLABORATIVE PROJEC; Power J, 2017, J VIRUS ERAD, V3, P229; Power J, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00050; Rendina HJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25055; Sendziuk P., 2003, LEARNING TRUST AUSTR; Simmons R, 2017, HIV MED, V18, P73, DOI 10.1111/hiv.12391; Stecher M, 2016, OPEN FORUM INFECT DI; Sylla L, 2018, AIDS RES HUM RETROV, V34, P56, DOI [10.1089/aid.2017.0178, 10.1089/AID.2017.0178]; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Treatment Action Group, 2018, RES CUR TRIALS TREAT; UNAIDS, 2007, POL BRIEF GREAT INV, P4; Volberding Paul A, 2017, Top Antivir Med, V25, P17	47	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202647	10.1371/journal.pone.0202647	http://dx.doi.org/10.1371/journal.pone.0202647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142171	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000442722500022
J	Garczyk, S; Schneider, U; Lurje, I; Becker, K; Vogeli, TA; Gaisa, NT; Knuchel, R				Garczyk, Stefan; Schneider, Ursula; Lurje, Isabella; Becker, Katharina; Voegeli, Thomas A.; Gaisa, Nadine T.; Knuechel, Ruth			ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?	PLOS ONE			English	Article							SWI/SNF COMPLEXES; TUMOR-SUPPRESSOR; EAU GUIDELINES; CARCINOMA; ARID1A; POLYCOMB; EXPRESSION; MUTATIONS; GENOME; INACTIVATION	Bladder cancer therapy relies on aggressive treatments highlighting the need for new, targeted therapies with reduced side effects. SWI/SNF complexes are mutated in similar to 20% across human cancers and dependency of SWI/SNF-deficient tumors on EZH2 has been uncovered recently. To systematically dissect the frequency of genetic alterations in SWI/SNF complexes potentially contributing to their inactivation, mutations and copy number variations in 25 SWI/SNF subunit genes were analyzed making use of publicly available sequencing data for 408 muscle-invasive bladder carcinoma samples. ARID1A truncating mutations were identified as the by far most common alterations of SWI/SNF complexes in urothelial bladder cancer. As current ARID1A protein expression data in bladder cancer are inconsistent and incomplete we examined if the frequency of truncating ARID1A mutations translates into a similar frequency of cases showing ARID1A protein loss. We applied a validated ARID1A antibody conducting a comprehensive immunohistochemistry-based expression analysis in urothelial bladder cancer (n = 362) including carcinoma in situ (CIS) cases. While observing increased median ARID1A protein levels in all carcinoma subgroups compared to normal urothelial controls (n = 21), the percentage of cases showing ARID1A protein loss was positively correlated with increasing stage and grade culminating in a rate of 14.1% in muscle-invasive disease. ARID1A-depletion did neither increase EZH2 protein or trimethylated H3K27 levels in vitro nor did ARID1A expression correlate with EZH2 or H3K27me3 amounts in human bladder carcinomas. Importantly, ARID1A-deficiency was neither associated with enhanced sensitivity towards inhibition of EZH2 enzymatic activity nor depletion of EZH2 protein. In summary, ARID1A truncating mutations, potentially translating into ARID1A protein loss in a subset of high-grade bladder cancers, are the most common SWI/SNF genetic alterations in bladder cancer. Our data do not support ARID1A-deficiency as predictive biomarker for EZH2-inhibitor treatment response in bladder cancer underlining the need for future bladder cancer-specific, drug screens for successfull discovery of ARID1A-deficiency-based targeted drugs.	[Garczyk, Stefan; Schneider, Ursula; Lurje, Isabella; Becker, Katharina; Gaisa, Nadine T.; Knuechel, Ruth] Univ Hosp RWTH Aachen, Inst Pathol, Uropathol Grp, Aachen, Germany; [Voegeli, Thomas A.] Univ Hosp RWTH Aachen, Dept Urol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Garczyk, S (corresponding author), Univ Hosp RWTH Aachen, Inst Pathol, Uropathol Grp, Aachen, Germany.	sgarczyk@ukaachen.de	Garczyk, Stefan/AAD-3755-2019	Lurje, Isabella/0000-0002-4006-7707	START-Program of the Faculty of Medicine, RWTH Aachen [06/17]	START-Program of the Faculty of Medicine, RWTH Aachen(Austrian Science Fund (FWF))	This research project is supported by the START-Program of the Faculty of Medicine, RWTH Aachen. Grant Number: 06/17 (SG). http://www.medizin.rwth-aachen.de/cms/Medizin/Forschung/Foerderung/Interne-Programme/similar to tfy/START/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaimy A, 2016, VIRCHOWS ARCH, V469, P321, DOI 10.1007/s00428-016-1977-y; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Balbas-Martinez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062483; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Faraj SF, 2014, HUM PATHOL, V45, P2233, DOI 10.1016/j.humpath.2014.07.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Garczyk S, 2017, ONCOTARGET, V8, P36246, DOI 10.18632/oncotarget.16121; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guidi CJ, 2006, CANCER RES, V66, P8076, DOI 10.1158/0008-5472.CAN-06-1451; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kim PH, 2015, EUR UROL, V67, P198, DOI 10.1016/j.eururo.2014.06.050; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JH, 2016, HUM PATHOL, V55, P17, DOI 10.1016/j.humpath.2016.04.006; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; Pietzak EJ, 2017, EUR UROL, V72, P952, DOI 10.1016/j.eururo.2017.05.032; REMMELE W, 1987, PATHOLOGE, V8, P138; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Scott SN, 2017, CANCER CYTOPATHOL, V125, P416, DOI 10.1002/cncy.21847; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Vandekerkhove G, 2017, CLIN CANCER RES, V23, P6487, DOI 10.1158/1078-0432.CCR-17-1140; Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Witjes JA, 2017, EUR UROL, V71, P462, DOI 10.1016/j.eururo.2016.06.020; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]	53	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202965	10.1371/journal.pone.0202965	http://dx.doi.org/10.1371/journal.pone.0202965			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138427	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100146
J	Manin, BO; Drakeley, CJ; Chua, TH				Manin, Benny Obrain; Drakeley, Chris J.; Chua, Tock H.			Mitochondrial variation in subpopulations of Anopheles balabacensis Baisas in Sabah, Malaysia (Diptera: Culicidae)	PLOS ONE			English	Article							PLASMODIUM-KNOWLESI MALARIA; POPULATION-STRUCTURE; DNA; GENE; EVOLUTION; TRANSMISSION; HYPOTHESIS; DIVERSITY; SEQUENCES; PATTERNS	Anopheles balabacensis, the primary vector of Plasmodium knowlesi in Sabah, Malaysia, is both zoophilic and anthropophilic, feeding on macaques as well as humans. It is the dominant Anopheles species found in Kudat Division where it is responsible for all the cases of P. knowlesi. However there is a paucity of basic biological and ecological information on this vector. We investigated the genetic variation of this species using the sequences of cox1 (1,383 bp) and cox2 (685 bp) to gain an insight into the population genetics and inter-population gene flow in Sabah. A total of 71 An. balabacensis were collected from seven districts constituting 14 subpopulations. A total of 17, 10 and 25 haplotypes were detected in the sub-populations respectively using the cox1, cox2 and the combined sequence. Some of the haplotypes were common among the subpopulations due to gene flow occurring between them. AMOVA showed that the genetic variation was high within subpopulations as compared to between subpopulations. Mantel test results showed that the variation between subpopulations was not due to the geographical distance between them. Furthermore, Tajima's D and Fu's Fs tests showed that An. balabacensis in Sabah is experiencing population expansion and growth. High gene flow between the subpopulations was indicated by the low genetic distance and high gene diversity in the cox1, cox2 and the combined sequence. However the population at Lipasu Lama appeared to be isolated possibly due to its higher altitude at 873 m above sea level.	[Manin, Benny Obrain; Chua, Tock H.] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Pathobiol & Med Diagnost, Kota Kinabalu, Sabah, Malaysia; [Drakeley, Chris J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England	Universiti Malaysia Sabah; University of London; London School of Hygiene & Tropical Medicine	Chua, TH (corresponding author), Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Pathobiol & Med Diagnost, Kota Kinabalu, Sabah, Malaysia.	thchua@ums.edu.my	Chua, Tock H./E-4157-2012	Chua, Tock H./0000-0002-8984-8723; Drakeley, Chris/0000-0003-4863-075X	Medical Research Council, Natural Environment Research Council; Economic and Social Research Council; Biotechnology and Biosciences Research Council through the Environmental & Social Ecology of Human Infectious Diseases Initiative (ESEI), MRC Grant [G1100796]; Malaysian Ministry of Higher Education; MRC [G1100796] Funding Source: UKRI	Medical Research Council, Natural Environment Research Council; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biosciences Research Council through the Environmental & Social Ecology of Human Infectious Diseases Initiative (ESEI), MRC Grant; Malaysian Ministry of Higher Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by: Medical Research Council, Natural Environment Research Council, Economic and Social Research Council, and Biotechnology and Biosciences Research Council for the funding received for this project through the Environmental & Social Ecology of Human Infectious Diseases Initiative (ESEI), MRC Grant Number: G1100796. BOM would also like to thank the Malaysian Ministry of Higher Education or providing a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brant HL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1416-1; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Cagampang-Ramos A, 1970, TECHNICAL REPORT, V70, P1; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feng XY, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2013-z; Fornace KM, 2016, J INFECT DIS, V213, P784, DOI 10.1093/infdis/jiv475; Fu YX, 1997, GENETICS, V147, P915; Hao YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07977-0; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; HII JLK, 1988, ANN TROP MED PARASIT, V82, P91, DOI 10.1080/00034983.1988.11812214; Liao PC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-124; Logue K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-64; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Luo AR, 2015, ECOL EVOL, V5, pS869, DOI 10.1002/ece3.1846; Makhawi AM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-290; Manin BO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005064; MANTEL N, 1967, CANCER RES, V27, P209; Mohanty A, 2009, INFECT GENET EVOL, V9, P1204, DOI 10.1016/j.meegid.2009.06.021; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Nakazawa S, 2009, INT J PARASITOL, V39, P1533, DOI 10.1016/j.ijpara.2009.08.005; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Norris DE, 2002, INT J PARASITOL, V32, P1607, DOI 10.1016/S0020-7519(02)00189-3; PHILLIPS AJ, 1995, ANN ENTOMOL SOC AM, V88, P281, DOI 10.1093/aesa/88.3.281; Rajahram GS, 2016, EMERG INFECT DIS, V22, P41, DOI 10.3201/eid2201.151305; Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sallum MAM, 2005, REV BRAS ENTOMOL, V49, P1, DOI 10.1590/S0085-56262005000500001; Sarma DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-76; Scarpassa VM, 2006, GENET MOL RES, V5, P493; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; SLATKIN M, 1995, GENETICS, V139, P457; Spencer PS, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204006; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2018, PARASITOLOGY, V145, P32, DOI 10.1017/S0031182016000901; Vythilingam I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-436; Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377; Wang G, 2017, MITOCHONDRIAL DNA A, V28, P769, DOI 10.1080/24701394.2016.1186665; William T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-390; Wong ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004135; Yang MN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-216	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202905	10.1371/journal.pone.0202905	http://dx.doi.org/10.1371/journal.pone.0202905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138386	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000442800100139
J	Shrotriya, S; Walsh, D; Nowacki, AS; Lorton, C; Aktas, A; Hullihen, B; Benanni-Baiti, N; Hauser, K; Ayvaz, S; Estfan, B				Shrotriya, Shiva; Walsh, Declan; Nowacki, Amy S.; Lorton, Cliona; Aktas, Aynur; Hullihen, Barbara; Benanni-Baiti, Nabila; Hauser, Katherine; Ayvaz, Serkan; Estfan, Bassam			Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; NUTRITIONAL-STATUS; CANCER-PATIENTS; RESECTION; SURVIVAL; MARKERS; EXPRESSION; MORTALITY; CARCINOMA; OUTCOMES	Introduction Prognostication in cancer is challenging and inaccurate. C-Reactive Protein (CRP), a cheap and sensitive marker of inflammation may help. This study investigated the relationship between CRP and prognosis in a large cohort of solid tumors with mixed cancer diagnoses and stages. Methods Electronic medical records of 4931 adults with solid tumors who attended the Taussig Cancer Institute from 2006-2012 were reviewed. Demographic and clinical characteristics were recorded. Maximum CRP (mCRP) was identified for each individual. CRP was analysed as a time-dependent, continuous and categorical variable for association with survival. Results Two thirds of patients had a high mCRP. This was consistently associated with shorter survival, even after correction for time from diagnosis, and when analysed as a continuous or a categorical variable. When mCRP values above 10 mg/L were subcategorized, a higher mCRP was always worse. Even among those with normal values, statistically and clinically significant shorter survival was noted at mCRP levels >5 mg/L. Conclusions In a large representative cohort of consecutive solid tumor patients the risk of death was clinically and statistically significantly greater with a high mCRP. This was independent of other variables and regardless of statistical method from both dates of diagnosis and test. CRP appeared to be underutilized. Our results support the routine use of CRP as a universal cost-effective independent prognostic indicator in most solid tumors.	[Shrotriya, Shiva; Walsh, Declan; Aktas, Aynur; Hullihen, Barbara; Benanni-Baiti, Nabila; Hauser, Katherine; Estfan, Bassam] Cleveland Clin, Taussig Canc Inst, Dept Solid Tumor Oncol, Sect Palliat Med & Support Oncol, Cleveland, OH 44106 USA; [Shrotriya, Shiva; Walsh, Declan; Aktas, Aynur; Hullihen, Barbara; Benanni-Baiti, Nabila; Hauser, Katherine; Estfan, Bassam] Cleveland Clin, Taussig Canc Inst, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44106 USA; [Shrotriya, Shiva] Michigan State Univ, Dept Internal Med, E Lansing, MI 48824 USA; [Walsh, Declan; Lorton, Cliona] Trinity Coll Dublin, Fac Hlth Sci, Dublin, Ireland; [Walsh, Declan] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Nowacki, Amy S.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Ayvaz, Serkan] Cleveland Clin, ITD Analyt eRes Dept, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Michigan State University; Trinity College Dublin; University College Dublin; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Walsh, D (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Solid Tumor Oncol, Sect Palliat Med & Support Oncol, Cleveland, OH 44106 USA.; Walsh, D (corresponding author), Cleveland Clin, Taussig Canc Inst, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44106 USA.; Walsh, D (corresponding author), Trinity Coll Dublin, Fac Hlth Sci, Dublin, Ireland.; Walsh, D (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland.	declan.walsh@atriumhealth.org	Ayvaz, Serkan/AAY-5208-2021; Aktas, Aynur/P-9055-2014; Ayvaz, Serkan/ABI-3938-2020	Ayvaz, Serkan/0000-0003-2016-4443; Aktas, Aynur/0000-0003-3631-7563; Ayvaz, Serkan/0000-0003-2016-4443; Walsh, (Thomas) Declan/0000-0002-9310-1729; Nowacki, Amy/0000-0002-1216-1448				Amano K, 2016, J PAIN SYMPTOM MANAG, V51, P860, DOI 10.1016/j.jpainsymman.2015.11.025; [Anonymous], 2000, WHO TECHN REP SER; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Dolan RD, 2017, CRIT REV ONCOL HEMAT, V116, P134, DOI 10.1016/j.critrevonc.2017.06.002; Emery P, 2007, RHEUMATOL INT, V27, P793, DOI 10.1007/s00296-007-0357-y; Glare Paul, 2005, J Support Oncol, V3, P331; Harris RE, 2003, CANCER RES, V63, P6096; He X, 2018, J CANCER, V9, P1877, DOI 10.7150/jca.23320; Iwasa S, 2011, INT J CLIN ONCOL, V16, P57, DOI 10.1007/s10147-010-0135-9; Jaye DL, 1997, PEDIATR INFECT DIS J, V16, P735, DOI 10.1097/00006454-199708000-00003; Jaye DL, 1997, PEDIATR INFECT DIS J, V16, P46; Ko YJ, 2012, CANCER EPIDEM BIOMAR, V21, P2076, DOI 10.1158/1055-9965.EPI-12-0611; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; Moschos SJ, 2006, J CLIN ONCOL, V24, P3164, DOI 10.1200/JCO.2005.05.2498; Nakatsu T, 2012, SURG TODAY, V42, P652, DOI 10.1007/s00595-012-0147-3; Pastorino U, 2017, EUR J CANCER, V79, P90, DOI 10.1016/j.ejca.2017.03.020; Ramsey S, 2008, BJU INT, V101, P959, DOI 10.1111/j.1464-410X.2007.07363.x; Saito K, 2009, EUR UROL, V55, P1145, DOI 10.1016/j.eururo.2008.10.012; Sarhill N, 2003, SUPPORT CARE CANCER, V11, P652, DOI 10.1007/s00520-003-0486-0; Schilsky RL, 2002, SEMIN ONCOL, V29, P211, DOI 10.1053/sonc.2002.32890; Shinohara S, 2018, ANTICANCER RES, V38, P3193, DOI 10.21873/anticanres.12584; Shrotriya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143080; Slattery ML, 2011, INT J CANCER, V128, P2726, DOI 10.1002/ijc.25721; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Walsh D, 2003, SUPPORT CARE CANCER, V11, P60, DOI [10.1007/s00520-002-0390-z, 10.1007/s00520-003-0530-0]; Yang SH, 2011, ANN SURG ONCOL, V18, P1907, DOI 10.1245/s10434-011-1575-9	28	42	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202555	10.1371/journal.pone.0202555	http://dx.doi.org/10.1371/journal.pone.0202555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138391	Green Published, Green Submitted, gold			2022-12-26	WOS:000442800100082
J	Wald, DS; Tsolaki, E; Bestwick, JP; Bertazzo, S				Wald, David S.; Tsolaki, Elena; Bestwick, Jonathan P.; Bertazzo, Sergio			Scanning electron microscopy for blood micro-crystals in aortic stenosis patients	PLOS ONE			English	Article							CALCIFICATION; CALCIUM	Background Micro-crystals of calcium phosphate have been detected on the aortic valve of patients with aortic stenosis using scanning electron microscopy. It is not known whether crystalisation is specific to heart valve tissue or a general blood-derived process. Methods To this end we modified the method to determine whether calcium phosphate micro-crystals were present in the blood of patients with aortic stenosis. The method was first validated by adding synthetic calcium phosphate hydroxyapatite micro-crystals to healthy volunteer blood samples and determining the lower limit of detection. Then the method was used to examine the blood of 63 patients with echocardiographically confirmed aortic stenosis and 69 unaffected controls undergoing echocardiography for other reasons. Serum calcium and phosphate were measured and the calcium phosphate product compared in cases and controls. Results In the validation study, synthetic hydroxyapatite micro-crystals were identified down to a lower concentration limit of 0.008mg/mL. In the experimental study no particles were identified in any patient, with or without aortic stenosis, even though serum calcium phosphate was higher in cases compared with controls 2.6mmol/L (2.58-2.77) versus 2.47mmol/L (2.36-2.57), p = 0.005 for the difference. Conclusion The results of our study confirm a positive association between serum calcium phosphate and aortic stenosis, but indicate that the calcium phosphate particles found in valve tissue do not precipitate freely in the blood.	[Wald, David S.; Bestwick, Jonathan P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [Tsolaki, Elena; Bertazzo, Sergio] UCL, Dept Med Phys & Biomed Engn, London, England	University of London; Queen Mary University London; University of London; University College London	Wald, DS (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	d.s.wald@qmul.ac.uk		Tsolaki, Elena/0000-0003-1436-7834				Akat K, 2010, AM J CARDIOL, V105, P862, DOI 10.1016/j.amjcard.2009.10.065; AMADOR E, 1972, CLIN CHEM, V18, P601; [Anonymous], GROW BLUE COPPER SUL; Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Ghadially FN, 2001, ULTRASTRUCT PATHOL, V25, P243; Henry T.J., 1974, CLIN CHEM, V2nd; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Kahnooj Masoumeh, 2010, J Tehran Heart Cent, V5, P78; Koos R, 2009, EUR HEART J, V30, P2054, DOI 10.1093/eurheartj/ehp158; Kuro-o M, 2014, NEFROLOGIA, V34, P1, DOI 10.3265/Nefrologia.pre2013.Dec.12385; Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029; Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Rosenhek R, 2004, EUR HEART J, V25, P199, DOI 10.1016/j.ehj.2003.12.002; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Tsang HG, 2018, MOL MED REP, V17, P2100, DOI 10.3892/mmr.2017.8163; Wald DS, 2017, J INTERN MED, V281, P407, DOI 10.1111/joim.12593; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Yang ZK, 2015, J ZHEJIANG UNIV-SC B, V16, P362, DOI 10.1631/jzus.B1400292	21	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202282	10.1371/journal.pone.0202282	http://dx.doi.org/10.1371/journal.pone.0202282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138333	gold, Green Published, Green Submitted			2022-12-26	WOS:000442800100049
J	Watanabe, S; Murakami, Y; Hasegawa, E				Watanabe, Saori; Murakami, Yuuka; Hasegawa, Eisuke			Effects of aphid parasitism on host plant fitness in an aphid-host relationship	PLOS ONE			English	Article							CUCULUS-CANORUS; KIN SELECTION; DISCRIMINATION; COEVOLUTION; EVOLUTION; CUCKOO	Aphids are serious agricultural insect pests which exploit the phloem sap of host plants and thus transmit pathogens to their hosts. However, the degree to which aphid parsitism affects the fitness of the host plants is not well understood. The aphid, Macrosiphoniella yomogicola, parasitizes the mugwort Artemisia montana in Japan. During summer most mugworts carry aphids, but most aphid colonies die out after the budding of A. montana inflorescences in late summer. A few aphid colonies survive to late autumn, at which point sexuparae appear to later lay overwintering eggs after copulation. The death of the aphid colonies seems to be caused by biochemical changes in the phloem sap in the host plant coincident with the budding of inflorescences. The surviving aphid colonies may suppress the budding of inflorescences to allow persistence of their genetic line into the following year. Our investigations demonstrate that aphid parasitism did not affect host plant growth, but that it did significantly decrease the number of inflorescences and the average weight of floral buds. Our results indicate that aphid parasitism has a strong negative effect on the fitness of host plants. The manner in which the aphids suppress floral budding in their hosts is worth examining from the perspective of the evolution of aphid-plant interactions.	[Watanabe, Saori; Murakami, Yuuka; Hasegawa, Eisuke] Hokkaido Univ, Grad Sch Agr, Dept Ecol & Systemat, Lab Anim Ecol, Sapporo, Hokkaido, Japan; [Murakami, Yuuka] Hokkaido Univ, Dept Neuropharmacol, Grad Sch Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Hasegawa, E (corresponding author), Hokkaido Univ, Grad Sch Agr, Dept Ecol & Systemat, Lab Anim Ecol, Sapporo, Hokkaido, Japan.	ehase@res.agr.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26440228, 18H02502]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Nos. 26440228 and 18H02502 to EH, https://www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAWA H, 1995, ECOL RES, V10, P301, DOI 10.1007/BF02347856; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2021, LANG ENV STAT COMP; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hasegawa E, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170816; Ishizaki S, 2011, J PLANT INTERACT, V6, P193, DOI 10.1080/17429145.2010.544770; Kelly JK, 1996, AM NAT, V147, P899, DOI 10.1086/285885; Krebs JR, 1993, INTRO BEHAV ECOLOGY; LARSON KC, 1991, OECOLOGIA, V88, P15, DOI 10.1007/BF00328398; Luijten SH, 2000, CONSERV BIOL, V14, P1776, DOI 10.1111/j.1523-1739.2000.99345.x; MartinTanguy J, 1997, PHYSIOL PLANTARUM, V100, P675, DOI 10.1034/j.1399-3054.1997.1000331.x; NAKAMURA R R, 1980, Evolutionary Theory, V5, P113; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; QUELLER DC, 1983, J THEOR BIOL, V100, P153, DOI 10.1016/0022-5193(83)90099-1; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Shimid-Hempel P, 2011, EVOLUTIONARY PARASIT; Temmerman W, 2000, J BACTERIOL, V182, P5832, DOI 10.1128/JB.182.20.5832-5840.2000; van Emden H.F., 2017, APHIDS CROP PESTS; Watanabe S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20159-w; Watanabe S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600606	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2018	13	8							e0202411	10.1371/journal.pone.0202411	http://dx.doi.org/10.1371/journal.pone.0202411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6TZ	30138411	Green Published, gold, Green Submitted			2022-12-26	WOS:000442800100064
J	Abdollah, D; Lopez, Y; Lal, SP; Taherzadeh, G; Sattar, A; Tsunoda, T; Sharma, A				Dehzangi, Abdollah; Lopez, Yosvany; Lal, Sunil Pranit; Taherzadeh, Ghazaleh; Sattar, Abdul; Tsunoda, Tatsuhiko; Sharma, Alok			Improving succinylation prediction accuracy by incorporating the secondary structure via helix, strand and coil, and evolutionary information from profile bigrams	PLOS ONE			English	Article							ACCESSIBLE SURFACE-AREA; AMINO-ACID-COMPOSITION; LYSINE SUCCINYLATION; SUBCELLULAR-LOCALIZATION; SCORING MATRIX; POSTTRANSLATIONAL MODIFICATION; PSEUDO COMPONENTS; WEB SERVER; K-TUPLE; SITES	Post-translational modification refers to the biological mechanism involved in the enzymatic modification of proteins after being translated in the ribosome. This mechanism comprises a wide range of structural modifications, which bring dramatic variations to the biological function of proteins. One of the recently discovered modifications is succinylation. Although succinylation can be detected through mass spectrometry, its current experimental detection turns out to be a timely process unable to meet the exponential growth of sequenced proteins. Therefore, the implementation of fast and accurate computational methods has emerged as a feasible solution. This paper proposes a novel classification approach, which effectively incorporates the secondary structure and evolutionary information of proteins through profile bigrams for succinylation prediction. The proposed predictor, abbreviated as SSEvol-Suc, made use of the above features for training an AdaBoost classifier and consequently predicting succinylated lysine residues. When SSEvol-Suc was compared with four benchmark predictors, it outperformed them in metrics such as sensitivity (0.909), accuracy (0.875) and Matthews correlation coefficient (0.75).	[Dehzangi, Abdollah] Morgan State Univ, Dept Comp Sci, Baltimore, MD 21239 USA; [Lopez, Yosvany; Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan; [Lopez, Yosvany; Tsunoda, Tatsuhiko; Sharma, Alok] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Lal, Sunil Pranit] Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand; [Taherzadeh, Ghazaleh; Sattar, Abdul] Griffith Univ, Sch Informat & Commun Technol, Nathan, Qld, Australia; [Sattar, Abdul; Sharma, Alok] Griffith Univ, Inst Integrated & Intelligent Syst, Nathan, Qld, Australia; [Tsunoda, Tatsuhiko] JST, CREST, Tokyo, Japan; [Sharma, Alok] Univ South Pacific, Sch Phys & Engn, Suva, Fiji	Morgan State University; Tokyo Medical & Dental University (TMDU); RIKEN; Massey University; Griffith University; Griffith University; Japan Science & Technology Agency (JST); University of the South Pacific	Lopez, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan.; Lopez, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan.	yosvany.lopez.alvarez@gmail.com	Sousa, Caio Victor/D-7060-2016; Knechtle, Beat/ABC-5529-2020; Sharma, Alok/AAE-4725-2022; Nikolaidis, Pantelis Theodoros/K-8664-2017; Tsunoda, Tatsuhiko/K-2061-2014	Sousa, Caio Victor/0000-0002-0499-2372; Knechtle, Beat/0000-0002-2412-9103; Sharma, Alok/0000-0002-7668-3501; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sattar, Abdul/0000-0002-2567-2052; Di Gangi, Stefania/0000-0002-2847-6399	Grants-in-Aid for Scientific Research [15F15385] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2017, NAT SCI, DOI DOI 10.4236/NS.2017.99032; Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen W, 2017, ONCOTARGET, V8, P4208, DOI 10.18632/oncotarget.13758; Chen W, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.37; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Cheng X, 2018, GENOMICS, V110, P231, DOI 10.1016/j.ygeno.2017.10.002; Cheng X, 2018, GENOMICS, V110, P50, DOI 10.1016/j.ygeno.2017.08.005; Chou K.-C., 2009, NAT SCI, V1, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2017, CURR TOP MED CHEM, V17, P2337, DOI 10.2174/1568026617666170414145508; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COMB DG, 1966, J BIOL CHEM, V241, P1857; Dehzangi Abdollah, 2013, Pattern Recognition in Bioinformatics. 8th IAPR International Conference, PRIB 2013. Proceedings: LNCS 7986, P208, DOI 10.1007/978-3-642-39159-0_19; Dehzangi Abdollah, 2013, Pattern Recognition in Bioinformatics. 8th IAPR International Conference, PRIB 2013. Proceedings: LNCS 7986, P196, DOI 10.1007/978-3-642-39159-0_18; Dehzangi A, 2010, AUSTR J INTELLIGENT, V10, P32; Dehzangi A, 2017, J THEOR BIOL, V425, P97, DOI 10.1016/j.jtbi.2017.05.005; Dehzangi A, 2015, INT J DATA MIN BIOIN, V11, P115, DOI 10.1504/IJDMB.2015.066359; Dehzangi A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S4-S1; Dehzangi A, 2015, J THEOR BIOL, V364, P284, DOI 10.1016/j.jtbi.2014.09.029; Dehzangi A, 2014, IEEE ACM T COMPUT BI, V11, P510, DOI 10.1109/TCBB.2013.2296317; Dehzangi A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S2; Dehzangi A, 2013, IEEE ACM T COMPUT BI, V10, P564, DOI 10.1109/TCBB.2013.65; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Feng PM, 2017, MOL THER-NUCL ACIDS, V7, P155, DOI 10.1016/j.omtn.2017.03.006; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hasan MM, 2016, MOL BIOSYST, V12, P786, DOI 10.1039/c5mb00853k; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Jia JH, 2016, BIOINFORMATICS, V32, P3133, DOI 10.1093/bioinformatics/btw387; Jia JH, 2016, ONCOTARGET, V7, P34558, DOI 10.18632/oncotarget.9148; Jia JH, 2016, J THEOR BIOL, V394, P223, DOI 10.1016/j.jtbi.2016.01.020; Jia JH, 2016, ANAL BIOCHEM, V497, P48, DOI 10.1016/j.ab.2015.12.009; Knorre DG, 2009, ACTA NATURAE, V1, P29, DOI 10.32607/20758251-2009-1-3-29-51; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Liu B., 2017, NAT SCI, V09, P67, DOI [10.4236/ns.2017.94007, DOI 10.4236/NS.2017.94007]; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, J THEOR BIOL, V385, P153, DOI 10.1016/j.jtbi.2015.08.025; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu LM, 2017, MED CHEM, V13, P552, DOI 10.2174/1573406413666170515120507; Liu ZX, 2014, NUCLEIC ACIDS RES, V42, pD531, DOI 10.1093/nar/gkt1093; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Liu Z, 2015, ANAL BIOCHEM, V474, P69, DOI 10.1016/j.ab.2014.12.009; Lopez Y, 2017, ANAL BIOCHEM, V527, P24, DOI 10.1016/j.ab.2017.03.021; Lyons J, 2014, J COMPUT CHEM, V35, P2040, DOI 10.1002/jcc.23718; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Niu B, 2017, ONCOTARGET, V8, P57149, DOI 10.18632/oncotarget.19169; Paliwal KK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S12; Paliwal KK, 2014, IEEE T NANOBIOSCI, V13, P44, DOI 10.1109/TNB.2013.2296050; Qiu WR, 2017, MED CHEM, V13, P734, DOI 10.2174/1573406413666170623082245; Qiu WR, 2017, MOL INFORM, V36, DOI 10.1002/minf.201600010; Qiu WR, 2017, ONCOTARGET, V8, P41178, DOI 10.18632/oncotarget.17104; Qiu WR, 2016, ONCOTARGET, V7, P51270, DOI 10.18632/oncotarget.9987; Qiu WR, 2016, ONCOTARGET, V7, P44310, DOI 10.18632/oncotarget.10027; Qiu WR, 2016, BIOINFORMATICS, V32, P3116, DOI 10.1093/bioinformatics/btw380; Qiu WR, 2015, J BIOMOL STRUCT DYN, V33, P1731, DOI 10.1080/07391102.2014.968875; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Saini H, 2015, J THEOR BIOL, V380, P291, DOI 10.1016/j.jtbi.2015.05.030; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089890; Sharma A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-233; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Sharma R, 2015, IEEE T NANOBIOSCI, V14, P915, DOI 10.1109/TNB.2015.2500186; Su Q, 2017, ONCOTARGET, V8, P49359, DOI 10.18632/oncotarget.17210; Xiao X, 2015, J BIOMOL STRUCT DYN, V33, P2221, DOI 10.1080/07391102.2014.998710; Xu HD, 2015, BIOINFORMATICS, V31, P3748, DOI 10.1093/bioinformatics/btv439; Xu MF, 2016, MOLECULES, V21, DOI 10.3390/molecules21010086; Xu Y, 2017, MED CHEM, V13, P544, DOI 10.2174/1573406413666170419150052; Xu Y, 2016, CURR TOP MED CHEM, V16, P591, DOI 10.2174/1568026615666150819110421; Xu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10184; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105018; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao XW, 2015, J THEOR BIOL, V374, P60, DOI 10.1016/j.jtbi.2015.03.029	87	55	56	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191900	10.1371/journal.pone.0191900	http://dx.doi.org/10.1371/journal.pone.0191900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432431	Green Published, gold, Green Submitted			2022-12-26	WOS:000424814300013
J	Nikolaidis, PT; Di Gangi, S; de Sousa, CV; Valeri, F; Rosemann, T; Knechtle, B				Nikolaidis, Pantelis Theodoros; Di Gangi, Stefania; de Sousa, Caio Victor; Valeri, Fabio; Rosemann, Thomas; Knechtle, Beat			Sex difference in open-water swimming-The Triple Crown of Open Water Swimming 1875-2017	PLOS ONE			English	Article							PERFORMANCE; MEN; SWIMMERS	The aim of the present study was to compare swimming performances of successful finishers of the ' Triple Crown of Open Water Swimming' from 1875 to 2017, assessing the effects of sex, the place of event and the nationality of swimmers. Data from 535 finishers in ` Catalina Channel Swim', 1,606 finishers in ` English Channel Swim' and 774 finishers in ` Manhattan Island Marathon Swim' were analysed. We performed different analyses and regression model fittings for all swimmers and annual top-5 finishers. Effects (sex, event, time, nationality) and interaction terms (event D time) were examined through a multi-variable spline mixed regression model. Considering all swimmers, we found that (i) women were approximately 0.06 km/h faster than men (p = 0.011) and (ii) Australians were 0.13 km/h faster than Americans (p = 0.004) and Americans were 0.19 km/h faster than British (p< 0.001) and 0.21 km/h faster than Canadians (p = 0.015). When considering annual top-5 finishers, we found that (i) women were 0.07 km/h slower than men (p = 0.042) and (ii) Australians were not faster than Americans (p = 0.149) but Americans were 0.21 km/h faster than British (p< 0.001). Our findings improved the knowledge about swim performances over time, in the three events, considering the effects of sex and the nationality of swimmers.	[Nikolaidis, Pantelis Theodoros] Exercise Physiol Lab, Nikaia, Greece; [Di Gangi, Stefania; Valeri, Fabio; Rosemann, Thomas; Knechtle, Beat] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [de Sousa, Caio Victor] Univ Catolica Brasilia, Grad Program Phys Educ, Brasilia, DF, Brazil; [Knechtle, Beat] Medbase St Gallen Vadianpl, St Gallen, Switzerland	University of Zurich; Universidade Catolica de Brasilia	Knechtle, B (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.; Knechtle, B (corresponding author), Medbase St Gallen Vadianpl, St Gallen, Switzerland.	beat.knechtle@hispeed.ch	Sousa, Caio Victor/D-7060-2016; Knechtle, Beat/ABC-5529-2020; Sharma, Alok/AAE-4725-2022; Nikolaidis, Pantelis Theodoros/K-8664-2017; Tsunoda, Tatsuhiko/K-2061-2014	Sousa, Caio Victor/0000-0002-0499-2372; Knechtle, Beat/0000-0002-2412-9103; Sharma, Alok/0000-0002-7668-3501; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sattar, Abdul/0000-0002-2567-2052; Di Gangi, Stefania/0000-0002-2847-6399	Grants-in-Aid for Scientific Research [15F15385] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bam J, 1997, MED SCI SPORT EXER, V29, P244, DOI 10.1097/00005768-199702000-00013; Beneke R, 2005, BRIT J SPORT MED, V39, P410, DOI 10.1136/bjsm.2004.017574; Coast JR, 2004, CAN J APPL PHYSIOL, V29, P139, DOI 10.1139/h04-010; Dahler P, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-16; Eichenberger E, 2013, J STRENGTH COND RES, V27, P1362, DOI 10.1519/JSC.0b013e318265a3e9; Eichenberger E, 2012, J SPORT SCI, V30, P1295, DOI 10.1080/02640414.2012.709264; Fischer G, 2013, SCAND J MED SCI SPOR, V23, pe48, DOI 10.1111/sms.12008; Gerrard DF, 1999, CLIN SPORT MED, V18, P337, DOI 10.1016/S0278-5919(05)70149-6; Knechtle B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1086-4; Knechtle B, 2014, INT J SPORT PHYSIOL, V9, P913, DOI 10.1123/ijspp.2013-0375; Knechtle B, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-34; Nikolaidis PT, 2018, RES SPORTS MED, V26, P332, DOI 10.1080/15438627.2018.1447471; Pyne DB, 2004, J SPORT SCI, V22, P613, DOI 10.1080/02640410310001655822; Rust CA, 2014, APPL PHYSIOL NUTR ME, V39, P270, DOI 10.1139/apnm-2013-0222; Rust CA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-86; Trewin CB, 2004, J SPORT SCI, V22, P339, DOI 10.1080/02640410310001641610; Vogt P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-603; Zingg MA, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-7; Zingg MA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-2	19	55	56	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202003	10.1371/journal.pone.0202003	http://dx.doi.org/10.1371/journal.pone.0202003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	29432431	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000443071400024
